data_2ks9_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ks9 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.457 0 N-CA-C 108.377 -0.971 . . . . 97.08 108.377 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.427 ' HB3' ' OD1' ' A' ' 276' ' ' ASP . 46.6 t30 -110.61 155.42 22.39 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-O 122.103 0.954 . . . . 123.41 110.737 -172.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.927 HG11 HD13 ' A' ' 15' ' ' ILE . 28.7 m -134.58 -162.38 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.487 1 N-CA-C 100.093 -4.04 . . . . 151.3 100.093 173.732 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.974 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.63 -38.61 58.55 Favored Pre-proline 0 N--CA 1.439 -0.981 0 C-N-CA 115.961 -2.295 . . . . 169.25 106.123 178.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.974 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 58.0 Cg_exo -81.28 168.53 16.65 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 122.255 0.608 . . . . 185.76 110.536 171.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.854 HG12 ' CE2' ' A' ' 282' ' ' PHE . 92.0 t -64.47 -25.93 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 C-N-CA 127.022 2.129 . . . . 145.47 110.343 -177.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.713 ' O ' HG21 ' A' ' 4' ' ' VAL . 39.2 t0 -84.33 157.41 21.5 Favored 'General case' 0 CA--C 1.499 -0.988 0 O-C-N 121.073 -1.017 . . . . 102.76 109.459 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.5 p -82.59 154.17 25.1 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 107.988 -1.115 . . . . 106.25 107.988 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.92 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 46.7 p-10 -105.89 51.89 0.74 Allowed 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 117.772 -1.571 . . . . 157.81 107.628 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.16 -45.9 91.51 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 103.586 -2.746 . . . . 150.2 103.586 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.458 ' C ' ' H ' ' A' ' 14' ' ' ASN . 70.8 m -87.05 164.68 35.29 Favored Pre-proline 0 N--CA 1.422 -1.872 0 N-CA-C 103.672 -2.714 . . . . 183.52 103.672 172.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -76.77 6.87 3.84 Favored 'Trans proline' 0 C--N 1.281 -2.998 0 N-CA-C 109.988 -0.812 . . . . 235.61 109.988 176.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.458 ' H ' ' C ' ' A' ' 12' ' ' SER . 34.6 t-20 -57.93 -41.25 82.33 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 124.809 1.244 . . . . 113.77 113.379 -170.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.927 HD13 HG11 ' A' ' 4' ' ' VAL . 33.4 pt -52.16 136.22 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-N 119.558 1.072 . . . . 150.85 110.984 -176.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.49 156.26 46.39 Favored 'General case' 0 C--N 1.36 1.064 0 N-CA-C 107.625 -1.25 . . . . 100.42 107.625 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 1.025 HG23 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.05 142.61 58.35 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 121.953 0.882 . . . . 129.36 110.444 -174.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.764 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.06 -25.5 68.4 Favored 'General case' 0 CA--C 1.494 -1.208 0 C-N-CA 126.303 1.841 . . . . 112.34 106.689 -177.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 1.012 HG21 ' HA2' ' A' ' 101' ' ' GLY . 85.8 m -74.14 -40.14 62.81 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.542 -0.754 . . . . 131.73 111.744 177.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 1.025 ' H ' HG23 ' A' ' 17' ' ' THR . 71.2 m -84.45 -42.86 15.18 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 116.994 2.22 . . . . 80.49 116.994 -174.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.529 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.4 mt-10 -145.99 174.54 3.34 Favored Pre-proline 0 N--CA 1.443 -0.817 0 C-N-CA 118.152 -1.419 . . . . 98.98 111.198 -169.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.881 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.333 85.7 Cg_exo -61.79 -10.73 18.04 Favored 'Trans proline' 0 C--N 1.321 -0.887 1 N-CA-C 128.934 6.475 . . . . 246.95 128.934 -170.085 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.675 HD22 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.61 17.55 8.7 Favored 'General case' 0 C--N 1.324 -0.515 1 CA-C-N 126.15 4.068 . . . . 269.62 114.216 175.655 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.581 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.6 mt-30 -67.14 -27.26 67.16 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 107.802 -1.184 . . . . 86.8 107.802 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.502 ' CE1' ' CG2' ' A' ' 26' ' ' VAL . 50.3 p90 -66.81 -29.34 69.25 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 121.115 -0.991 . . . . 85.91 110.501 -178.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.888 HG11 ' OE1' ' A' ' 284' ' ' GLN . 40.4 t -68.54 -40.21 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 C-N-CA 123.695 0.798 . . . . 82.0 111.346 -177.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.931 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.4 167.73 12.48 Favored Pre-proline 0 CA--C 1.489 -1.4 0 N-CA-C 108.552 -0.907 . . . . 120.73 108.552 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.842 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -64.0 149.76 89.82 Favored 'Trans proline' 0 N--CA 1.432 -2.123 0 C-N-CA 120.616 0.877 . . . . 87.86 109.91 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.82 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.03 -37.96 89.28 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 108.846 -0.798 . . . . 36.46 108.846 -176.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.841 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.8 p-90 -63.8 -33.86 76.61 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 107.807 -1.183 . . . . 150.6 107.807 -176.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.931 ' OE1' ' HB2' ' A' ' 27' ' ' GLN . 80.5 mt-30 -62.21 -32.71 73.41 Favored 'General case' 0 CA--C 1.49 -1.334 0 O-C-N 121.291 -0.88 . . . . 123.26 108.666 -178.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.855 HG23 ' O ' ' A' ' 93' ' ' ALA . 1.7 mp -61.47 -47.17 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.57 0 N-CA-C 109.157 -0.682 . . . . 120.14 109.157 176.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 30' ' ' TRP . 20.2 m -67.41 -31.03 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 107.873 -1.158 . . . . 112.19 107.873 -178.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.841 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.5 tp -62.98 -47.12 84.51 Favored 'General case' 0 N--CA 1.432 -1.337 0 C-N-CA 119.921 -0.712 . . . . 60.87 109.601 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.691 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.03 -35.67 81.18 Favored 'General case' 0 CA--C 1.489 -1.382 0 C-N-CA 119.965 -0.694 . . . . 157.57 110.364 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.785 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.61 -40.89 98.39 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 108.629 -0.878 . . . . 47.06 108.629 178.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.841 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.77 -41.28 98.01 Favored 'General case' 0 CA--C 1.496 -1.121 0 O-C-N 121.756 -0.59 . . . . 43.94 109.557 -177.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.766 ' O ' HG21 ' A' ' 41' ' ' VAL . . . -61.81 -43.3 99.12 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.726 -0.842 . . . . 42.61 108.726 -176.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.96 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.38 -41.26 93.94 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 116.623 -0.262 . . . . 140.66 111.029 -178.364 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.841 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.78 -43.96 97.81 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 118.58 -1.248 . . . . 116.04 110.234 -175.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.766 HG21 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.44 -38.75 83.24 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.292 0 N-CA-C 108.731 -0.84 . . . . 97.16 108.731 -177.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.915 HD11 ' HD1' ' A' ' 39' ' ' TYR . 93.2 mt -61.28 -40.0 84.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 N-CA-C 108.975 -0.75 . . . . 54.85 108.975 -176.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.974 HG23 HG22 ' A' ' 86' ' ' THR . 92.9 t -57.71 -42.34 81.48 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.301 0 N-CA-C 108.873 -0.788 . . . . 45.39 108.873 -175.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.403 ' O ' HG22 ' A' ' 48' ' ' VAL . 97.2 t -63.52 -50.97 76.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 C-N-CA 118.848 -1.141 . . . . 48.64 110.171 -177.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.794 ' HG1' ' CE ' ' A' ' 299' ' ' MET . 10.6 t -65.27 -47.04 78.08 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 120.163 -0.615 . . . . 116.65 111.711 -174.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.641 ' N ' HG23 ' A' ' 45' ' ' THR . 50.8 m -61.96 -43.94 97.79 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 109.715 -0.476 . . . . 51.16 109.715 -174.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 43' ' ' VAL . 97.4 t -65.54 -48.93 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 C-N-CA 119.852 -0.739 . . . . 44.3 110.85 -176.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.875 ' O ' HG22 ' A' ' 52' ' ' VAL . 93.8 t -64.75 -46.94 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 C-N-CA 120.299 -0.56 . . . . 48.82 111.032 -174.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.77 -44.15 95.21 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 120.513 -0.851 . . . . 58.7 112.006 -174.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -72.63 -34.21 67.17 Favored 'General case' 0 CA--C 1.488 -1.432 0 O-C-N 122.086 -0.655 . . . . 101.4 111.027 -175.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.814 HG11 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.9 -38.73 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 107.745 -1.206 . . . . 103.57 107.745 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.875 HG22 ' O ' ' A' ' 48' ' ' VAL . 72.0 t -61.43 -43.05 96.06 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.225 0 N-CA-C 108.975 -0.75 . . . . 61.89 108.975 -178.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.639 ' O ' HG21 ' A' ' 56' ' ' ILE . 81.8 t -63.44 -50.96 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 N-CA-C 109.47 -0.567 . . . . 70.01 109.47 -178.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.717 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.94 -43.39 98.92 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 109.13 -0.693 . . . . 132.1 109.13 -176.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.674 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.23 -46.62 83.02 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 116.677 -0.238 . . . . 104.5 110.441 -176.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.896 HD11 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.67 -49.88 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 C-N-CA 120.212 -0.595 . . . . 142.96 111.271 -173.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 1.039 HD12 HG13 ' A' ' 72' ' ' VAL 0.279 24.8 pt -64.79 -41.68 92.87 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.661 0 C-N-CA 116.947 -1.901 . . . . 158.32 110.877 -175.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.717 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.72 -41.39 98.09 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 117.725 -1.59 . . . . 137.11 109.48 178.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.36 -44.54 91.11 Favored 'General case' 0 N--CA 1.436 -1.165 0 O-C-N 122.164 -0.335 . . . . 54.66 111.019 -176.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.951 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.41 117.12 29.4 Favored 'General case' 0 CA--C 1.491 -1.322 0 CA-C-O 121.623 0.725 . . . . 127.18 109.586 -174.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 1.102 ' HB3' ' HG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.83 -36.84 80.12 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 124.099 0.96 . . . . 87.93 110.832 -176.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 1.064 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.38 -34.67 78.7 Favored 'General case' 0 CA--C 1.49 -1.33 0 O-C-N 121.657 -0.652 . . . . 131.12 111.509 -175.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 1.008 ' HG3' ' CE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.61 69.43 7.12 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 115.313 -2.555 . . . . 246.56 109.606 -175.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 61' ' ' LYS . 9.6 mmp_? -123.21 91.45 3.48 Favored 'General case' 0 CA--C 1.474 -1.966 0 N-CA-C 105.484 -2.043 . . . . 339.35 105.484 177.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.856 ' HG1' ' H ' ' A' ' 68' ' ' ASN . 82.5 p -124.15 165.27 17.85 Favored 'General case' 0 N--CA 1.414 -2.248 0 N-CA-C 102.992 -2.966 . . . . 114.66 102.992 176.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.954 HG22 ' HG1' ' A' ' 147' ' ' THR . 7.7 p -63.15 -39.44 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 N-CA-C 106.78 -1.563 . . . . 143.28 106.78 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.993 HG21 HD13 ' A' ' 71' ' ' LEU . 95.4 m -59.69 -38.05 80.5 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 108.687 -0.856 . . . . 160.22 108.687 -176.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.856 ' H ' ' HG1' ' A' ' 65' ' ' THR . 86.3 m-20 -62.34 -31.78 72.46 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 108.872 -0.788 . . . . 120.54 108.872 -177.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.939 ' O ' HG21 ' A' ' 72' ' ' VAL . 89.8 m-85 -63.59 -43.81 95.86 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 109.481 -0.563 . . . . 67.22 109.481 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.936 ' CE2' HG23 ' A' ' 66' ' ' VAL . 82.5 m-85 -66.53 -39.76 88.78 Favored 'General case' 0 CA--C 1.498 -1.055 0 O-C-N 121.488 -0.758 . . . . 138.6 109.668 -177.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.993 HD13 HG21 ' A' ' 67' ' ' THR . 10.1 mp -63.58 -35.91 82.05 Favored 'General case' 0 CA--C 1.493 -1.237 0 C-N-CA 122.479 0.312 . . . . 151.46 110.641 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 1.039 HG13 HD12 ' A' ' 57' ' ' ILE . 24.2 m -62.56 -37.95 80.2 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.227 0 C-N-CA 117.39 -1.724 . . . . 117.93 106.715 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.529 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.1 t30 -60.07 -46.03 90.92 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 107.859 -1.163 . . . . 56.82 107.859 -177.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.911 HD21 ' CE ' ' A' ' 123' ' ' MET . 8.7 mp -61.36 -43.91 98.07 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 108.931 -0.766 . . . . 145.3 108.931 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.05 -40.35 95.47 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 108.521 -0.918 . . . . 45.71 108.521 -175.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -62.4 -42.02 99.11 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.377 -0.601 . . . . 105.61 109.377 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.12 -39.45 92.59 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 108.646 -0.872 . . . . 47.89 108.646 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.705 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.56 -37.37 84.83 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 109.966 -0.383 . . . . 124.53 109.966 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.86 -41.22 99.28 Favored 'General case' 0 CA--C 1.496 -1.099 0 O-C-N 121.952 -0.467 . . . . 35.89 109.843 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.8 t -62.23 -37.3 84.86 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 107.025 -1.472 . . . . 88.97 107.025 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.84 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.17 -49.17 76.88 Favored 'General case' 0 N--CA 1.428 -1.55 0 C-N-CA 119.831 -0.748 . . . . 239.91 109.047 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.599 ' O ' HG21 ' A' ' 86' ' ' THR . . . -65.38 -43.4 90.81 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 121.536 -0.728 . . . . 146.1 110.596 -177.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.16 -58.23 3.4 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 117.397 -1.721 . . . . 91.74 113.852 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -76.55 -61.38 1.98 Allowed 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 115.748 1.759 . . . . 197.45 115.748 -173.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.99 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.25 -42.26 55.52 Favored 'General case' 0 CA--C 1.49 -1.365 0 C-N-CA 117.897 -1.521 . . . . 242.6 114.046 -170.036 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.974 HG22 HG23 ' A' ' 43' ' ' VAL . 4.6 t -65.4 -36.55 84.3 Favored 'General case' 0 N--CA 1.434 -1.254 0 C-N-CA 118.912 -1.115 . . . . 215.61 109.838 -172.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.458 ' N ' HG23 ' A' ' 86' ' ' THR . 72.3 t -60.3 -46.94 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 O-C-N 121.828 -0.545 . . . . 87.19 110.459 -175.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.896 HG21 ' NE2' ' A' ' 108' ' ' HIS . 63.6 t -65.93 -41.86 90.75 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.112 0 N-CA-C 109.731 -0.47 . . . . 231.82 109.731 -178.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.96 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 11.0 m120 -62.32 -34.14 76.06 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 108.317 -0.994 . . . . 364.98 108.317 -177.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.657 ' CE1' ' HB3' ' A' ' 36' ' ' ALA . 85.3 t80 -68.19 -44.72 75.25 Favored 'General case' 0 N--CA 1.438 -1.054 0 O-C-N 121.543 -0.723 . . . . 181.63 111.275 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.899 HG21 ' HD2' ' A' ' 95' ' ' HIS . 57.7 m -60.87 -45.78 93.19 Favored 'General case' 0 CA--C 1.478 -1.809 0 N-CA-C 107.432 -1.321 . . . . 269.02 107.432 -175.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 1.072 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.72 -45.03 93.4 Favored 'General case' 0 N--CA 1.416 -2.149 0 C-N-CA 118.657 -1.217 . . . . 562.66 110.023 -179.058 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.855 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.11 -45.24 95.51 Favored 'General case' 0 CA--C 1.479 -1.787 0 C-N-CA 118.696 -1.202 . . . . 446.75 108.097 -167.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.785 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.388 6.1 m -70.51 -26.31 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 C-N-CA 115.837 -2.345 . . . . 370.05 112.216 -178.755 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.899 ' HD2' HG21 ' A' ' 91' ' ' THR . 90.0 m-70 -74.48 -26.5 60.06 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 121.593 -0.692 . . . . 354.91 112.513 175.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.881 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.4 m-20 82.8 4.53 0.99 Allowed 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 125.067 1.347 . . . . 462.44 111.905 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.764 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.266 11.9 mm-40 -172.35 178.06 2.91 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-O 122.015 0.912 . . . . 652.37 111.122 171.786 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.832 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.73 86.3 2.17 Favored 'General case' 0 N--CA 1.428 -1.565 0 C-N-CA 128.489 2.715 . . . . 905.99 107.929 -174.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -67.87 -36.4 80.21 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 108.244 -1.021 . . . . 570.43 108.244 -176.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.844 ' HB3' ' CG ' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.57 -36.35 82.4 Favored 'General case' 0 N--CA 1.428 -1.54 0 C-N-CA 125.318 1.447 . . . . 453.22 111.157 -174.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 1.012 ' HA2' HG21 ' A' ' 19' ' ' THR . . . 97.55 178.66 33.9 Favored Glycine 0 C--N 1.349 1.292 0 C-N-CA 118.768 -1.682 . . . . 445.63 109.891 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.0 mt -56.41 -41.23 75.99 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 125.275 1.43 . . . . 457.72 112.357 -170.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -58.63 -46.93 86.03 Favored 'General case' 0 CA--C 1.484 -1.56 0 C-N-CA 118.662 -1.215 . . . . 340.58 109.296 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.844 ' CG ' ' HB3' ' A' ' 100' ' ' TYR . 88.1 m-85 -68.71 -32.14 71.72 Favored 'General case' 0 N--CA 1.423 -1.775 0 C-N-CA 118.774 -1.171 . . . . 453.6 111.577 -176.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.729 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.05 -40.35 73.37 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 105.976 -1.861 . . . . 541.48 105.976 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.452 ' HD2' ' HA2' ' A' ' 166' ' ' GLY . 27.0 ttpt -65.83 -47.14 75.99 Favored 'General case' 0 CA--C 1.486 -1.514 0 O-C-N 123.991 0.807 . . . . 466.68 110.866 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -61.74 -47.08 86.86 Favored 'General case' 0 N--CA 1.427 -1.607 0 C-N-CA 117.48 -1.688 . . . . 427.34 107.315 -178.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.896 ' NE2' HG21 ' A' ' 88' ' ' VAL . 47.6 m80 -67.1 -36.79 82.72 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 112.415 0.524 . . . . 537.87 112.415 -174.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.582 ' HB2' ' HB3' ' A' ' 180' ' ' CYS . 2.9 t-20 -69.4 -42.69 74.77 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 116.847 -1.941 . . . . 422.12 111.593 175.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.913 ' O ' HG21 ' A' ' 113' ' ' ILE . 75.9 t80 -59.05 -50.1 75.37 Favored 'General case' 0 CA--C 1.502 -0.883 0 O-C-N 121.324 -0.86 . . . . 340.17 111.834 -173.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.486 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 61.6 m-85 -65.29 -46.54 71.37 Favored Pre-proline 0 N--CA 1.443 -0.811 0 C-N-CA 119.082 -1.047 . . . . 258.06 111.723 -176.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.99 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.0 Cg_exo -61.52 -31.54 87.64 Favored 'Trans proline' 0 N--CA 1.435 -1.943 0 N-CA-C 115.368 1.257 . . . . 305.71 115.368 176.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.943 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.91 -40.41 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 N-CA-C 108.687 -0.857 . . . . 252.7 108.687 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.423 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.92 -40.6 93.8 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 107.801 -1.185 . . . . 149.27 107.801 -179.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.0 -44.81 95.93 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 120.625 -0.43 . . . . 138.08 111.506 -176.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.751 HG23 ' CZ2' ' A' ' 261' ' ' TRP . 65.1 t -66.94 -42.39 88.77 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 O-C-N 121.575 -0.703 . . . . 132.89 110.96 -177.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.946 ' CE1' HG22 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.76 -44.67 92.79 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 108.884 -0.784 . . . . 193.61 108.884 -177.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.605 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.48 -37.66 84.46 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 122.804 0.442 . . . . 63.83 110.085 -175.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.9 m -64.02 -52.39 59.69 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 120.747 -0.381 . . . . 76.4 111.228 -177.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.805 HD11 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.99 -41.63 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 108.185 -1.042 . . . . 171.13 108.185 -174.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 1.069 ' HB2' HD12 ' A' ' 154' ' ' ILE . 29.3 m-85 -63.8 -38.56 91.56 Favored 'General case' 0 N--CA 1.433 -1.311 0 O-C-N 121.834 -0.541 . . . . 78.3 110.635 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.554 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.6 t -67.11 -35.74 80.42 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 118.901 -1.12 . . . . 92.36 109.216 -178.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' MET . . . . . 1.087 ' HA ' ' HE1' ' A' ' 123' ' ' MET . 5.9 mmt -62.5 -34.28 76.55 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 108.173 -1.047 . . . . 93.73 108.173 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.978 HG22 HG13 ' A' ' 212' ' ' ILE . 33.2 p -67.42 -41.65 84.49 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 119.215 -0.994 . . . . 132.74 109.33 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.28 -42.08 94.68 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.18 -1.415 . . . . 43.39 107.18 -177.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.866 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.0 t -58.46 -41.99 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 N-CA-C 108.607 -0.886 . . . . 59.34 108.607 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.401 ' HB3' ' HB1' ' A' ' 215' ' ' ALA . . . -63.48 -44.07 95.45 Favored 'General case' 0 CA--C 1.497 -1.064 0 O-C-N 121.804 -0.56 . . . . 69.68 110.519 -177.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.469 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.3 t80 -65.47 -42.77 91.9 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.326 -0.99 . . . . 106.98 108.326 -177.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.866 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.35 -35.61 81.42 Favored 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 119.662 -0.815 . . . . 147.63 108.951 -177.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.764 ' NH1' ' HE2' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.16 -41.54 99.27 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 108.541 -0.911 . . . . 190.06 108.541 178.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.963 ' HD2' ' HE3' ' A' ' 132' ' ' MET . 66.5 t80 -61.34 -44.06 97.82 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.31 -0.996 . . . . 118.85 108.31 -177.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 1.12 ' HA ' ' HE1' ' A' ' 132' ' ' MET . 4.5 mmt -63.36 -42.66 98.89 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 109.986 -0.375 . . . . 102.5 109.986 -177.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.99 -41.62 95.25 Favored 'General case' 0 CA--C 1.489 -1.39 0 O-C-N 121.82 -0.55 . . . . 89.98 109.841 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.889 ' CD1' HG12 ' A' ' 219' ' ' VAL . 95.3 mt -66.52 -50.72 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 C-N-CA 118.13 -1.428 . . . . 106.09 110.991 -177.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.798 HD12 ' HE1' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.07 -48.32 38.42 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.099 0 C-N-CA 117.098 -1.841 . . . . 227.74 111.815 -174.792 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.79 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.85 100.08 50.98 Favored Pre-proline 0 CA--C 1.486 -1.505 0 C-N-CA 116.242 -2.183 . . . . 262.55 110.059 -175.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.471 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.2 Cg_endo -69.6 -10.39 28.56 Favored 'Trans proline' 0 C--N 1.29 -2.544 0 C-N-CA 121.618 1.545 . . . . 210.25 111.358 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.81 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.28 112.02 1.0 Allowed 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 106.523 -1.658 . . . . 270.58 106.523 -178.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.888 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.82 -39.5 23.87 Favored Pre-proline 0 N--CA 1.43 -1.451 0 CA-C-N 115.358 -0.837 . . . . 129.84 112.347 -175.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.853 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 82.1 Cg_exo -61.36 -26.6 81.77 Favored 'Trans proline' 0 N--CA 1.431 -2.163 0 N-CA-C 116.297 1.614 . . . . 330.71 116.297 -174.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.79 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.03 77.2 7.95 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 114.479 -2.888 . . . . 204.51 107.277 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.878 HD12 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.72 147.43 0.09 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 107.435 -1.32 . . . . 387.41 107.435 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.878 ' N ' HD12 ' A' ' 142' ' ' LEU . 47.4 t -143.71 147.02 33.63 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 118.794 -1.162 . . . . 166.22 109.475 178.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.84 -40.76 88.03 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 107.847 -1.168 . . . . 44.23 107.847 176.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.474 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.6 m -60.3 -39.14 85.89 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 108.176 -1.046 . . . . 28.8 108.176 -175.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.643 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.81 -38.79 92.1 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 109.101 -0.703 . . . . 30.29 109.101 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.954 ' HG1' HG22 ' A' ' 66' ' ' VAL . 89.9 m -59.61 -43.03 93.88 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 108.982 -0.748 . . . . 46.11 108.982 -176.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.459 ' HD3' ' HA ' ' A' ' 145' ' ' THR . 0.2 OUTLIER -62.46 -42.14 99.26 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 107.693 -1.225 . . . . 87.33 107.693 -179.632 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.789 ' O ' HG22 ' A' ' 153' ' ' VAL . 96.6 t -61.67 -42.08 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 107.93 -1.137 . . . . 23.69 107.93 -178.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.8 t -63.19 -44.29 99.25 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 109.704 -0.48 . . . . 43.86 109.704 -178.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.935 ' O ' HG23 ' A' ' 154' ' ' ILE . 46.0 mm -61.28 -42.54 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 108.326 -0.991 . . . . 91.13 108.326 -176.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . 0.505 ' O ' HG22 ' A' ' 156' ' ' VAL . 52.2 t -62.6 -37.96 88.29 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.754 -0.832 . . . . 65.88 108.754 -178.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.789 HG22 ' O ' ' A' ' 149' ' ' VAL . 95.4 t -62.11 -41.85 92.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.225 0 N-CA-C 109.551 -0.537 . . . . 33.86 109.551 -177.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 1.069 HD12 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.4 -40.33 85.87 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.183 0 N-CA-C 107.585 -1.265 . . . . 146.52 107.585 -176.799 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . 0.775 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.1 m95 -62.86 -38.36 90.51 Favored 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 119.497 -0.881 . . . . 75.44 108.896 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 152' ' ' CYS . 98.7 t -60.54 -48.4 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 O-C-N 121.028 -1.045 . . . . 43.64 109.71 -177.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.811 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.7 -38.0 89.47 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 109.029 -0.73 . . . . 102.57 109.029 -178.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.0 -41.09 86.83 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.417 -1.327 . . . . 58.16 107.417 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.82 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.07 -32.48 73.87 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.032 -0.729 . . . . 121.11 109.032 178.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.811 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.02 -42.34 85.09 Favored 'General case' 0 CA--C 1.489 -1.395 0 C-N-CA 118.576 -1.249 . . . . 153.15 109.923 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.998 HD12 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.05 -43.75 19.07 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 113.106 -3.437 . . . . 133.67 113.527 173.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.535 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -62.97 -39.9 96.08 Favored 'General case' 0 CA--C 1.489 -1.371 0 O-C-N 120.916 -1.115 . . . . 157.42 112.192 -171.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.518 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.3 t80 -74.45 -36.11 2.45 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 115.012 1.486 . . . . 250.91 115.012 -173.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.518 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.292 52.9 Cg_exo -59.5 -25.48 78.84 Favored 'Trans proline' 0 CA--C 1.488 -1.791 0 N-CA-C 118.007 2.272 . . . . 207.34 118.007 -174.351 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 1.026 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 87.6 mt-30 -61.17 -34.19 74.65 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 106.951 -1.5 . . . . 192.46 106.951 178.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.452 ' HA2' ' HD2' ' A' ' 106' ' ' LYS . . . -64.52 -41.03 98.09 Favored Glycine 0 C--N 1.353 1.501 0 N-CA-C 107.969 -2.053 . . . . 261.0 107.969 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.79 159.11 25.96 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 101.513 -3.514 . . . . 491.4 101.513 172.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -59.96 106.82 0.54 Allowed 'General case' 0 CA--C 1.488 -1.434 0 C-N-CA 116.247 -2.181 . . . . 386.1 109.83 -176.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 1.026 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 73.9 m -154.03 -166.61 2.42 Favored 'General case' 0 N--CA 1.415 -2.224 0 N-CA-C 103.541 -2.763 . . . . 289.8 103.541 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 1.11 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.92 175.4 0.86 Allowed 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 117.736 -1.126 . . . . 402.06 109.565 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.782 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 73.0 p -165.27 177.5 7.56 Favored 'General case' 0 CA--C 1.586 2.353 0 C-N-CA 127.343 2.257 . . . . 690.53 114.94 177.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.572 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.9 mm-40 132.34 160.56 0.0 OUTLIER 'General case' 1 C--N 1.429 4.057 1 N-CA-C 123.19 4.515 . . . . 633.62 123.19 162.704 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.827 HG21 ' SG ' ' A' ' 180' ' ' CYS . 69.2 p -85.63 153.83 22.1 Favored 'General case' 0 C--N 1.389 2.3 0 C-N-CA 127.376 2.27 . . . . 617.99 110.903 178.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' MET . . . . . 1.119 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.69 174.4 6.0 Favored Pre-proline 0 C--N 1.364 1.206 0 C-N-CA 130.271 3.428 . . . . 434.98 113.405 -175.417 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 1.119 ' HD2' ' HB3' ' A' ' 174' ' ' MET . 51.8 Cg_endo -44.24 -65.65 0.19 Allowed 'Trans proline' 0 N--CA 1.441 -1.56 0 N-CA-C 122.418 3.969 . . . . 365.88 122.418 -168.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' SER . . . . . 0.788 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.306 70.5 m -84.89 20.95 1.69 Allowed 'General case' 0 CA--C 1.467 -2.239 0 N-CA-C 104.797 -2.298 . . . . 635.81 104.797 178.144 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.777 ' HB3' ' H ' ' A' ' 179' ' ' VAL 0.456 5.0 mmp_? -94.39 152.24 18.78 Favored 'General case' 1 CA--C 1.419 -4.064 3 N-CA-C 131.98 7.771 . . . . 999.99 131.98 -135.76 . . . . . . . . 5 3 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 1.072 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.911 37.1 t -131.84 73.18 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.772 1 CA-C-N 103.3 -6.318 . . . . 594.32 113.599 149.217 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.821 HG12 ' HB2' ' A' ' 174' ' ' MET . 7.3 p -144.2 144.1 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.639 1 N-CA-C 98.291 -4.707 . . . . 811.91 98.291 162.374 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . 0.827 ' SG ' HG21 ' A' ' 173' ' ' THR . 3.8 m -118.46 144.53 45.92 Favored 'General case' 0 CA--C 1.489 -1.401 0 C-N-CA 117.058 -1.857 . . . . 999.99 109.427 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.821 ' HE1' ' CE2' ' A' ' 264' ' ' PHE . 70.8 mmm -147.19 -175.61 4.9 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-O 122.004 0.907 . . . . 431.86 110.054 -177.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 1.061 HD12 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.13 148.67 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 C-N-CA 124.351 1.06 . . . . 457.18 108.801 -177.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . 0.826 ' HB3' ' HB ' ' A' ' 170' ' ' THR . 3.6 tp10 -77.32 85.47 3.75 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 124.14 0.976 . . . . 458.77 113.503 -174.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 1.015 ' CZ3' HG23 ' A' ' 182' ' ' ILE . 1.9 p90 -76.37 -31.57 0.98 Allowed Pre-proline 0 N--CA 1.438 -1.048 0 C-N-CA 124.961 1.304 . . . . 999.99 112.426 168.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.946 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -65.95 -45.77 5.65 Favored 'Trans proline' 0 N--CA 1.438 -1.789 0 N-CA-C 120.875 3.375 . . . . 999.99 120.875 -174.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.557 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.56 171.74 8.15 Favored 'General case' 0 CA--C 1.472 -2.047 0 C-N-CA 117.166 -1.814 . . . . 81.18 107.26 -172.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.843 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.8 p-80 -109.14 45.14 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.848 0 C-N-CA 115.503 -2.479 . . . . 999.99 108.754 177.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 1.055 ' HB2' HD11 ' A' ' 191' ' ' ILE . 87.5 Cg_endo -41.57 101.81 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.14 1 C-N-CA 126.042 4.494 . . . . 999.99 105.683 -170.737 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -62.27 -44.02 97.48 Favored 'General case' 0 CA--C 1.483 -1.599 0 C-N-CA 126.747 2.019 . . . . 967.72 112.048 -165.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -60.26 -36.55 78.05 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.748 -1.575 . . . . 934.3 106.748 -175.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 1.055 HD11 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.56 -30.25 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 C-N-CA 129.2 3.0 . . . . 565.15 113.923 -178.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 61.53 55.4 2.81 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 118.444 0.565 . . . . 755.61 109.869 -175.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 1.11 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.5 -49.28 67.1 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.551 1.141 . . . . 325.89 113.242 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.897 ' HG3' ' HH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.82 -44.95 78.4 Favored 'General case' 0 CA--C 1.495 -1.16 0 C-N-CA 123.56 0.744 . . . . 250.21 111.627 -169.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.3 t -64.72 -43.35 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 CA-C-O 121.585 0.707 . . . . 142.46 110.382 -175.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . 1.061 ' CD2' HD12 ' A' ' 182' ' ' ILE . 34.8 t80 -61.12 -41.52 96.85 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 123.981 0.912 . . . . 247.69 108.815 -173.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' HIS . . . . . 0.891 ' HE2' ' HA ' ' A' ' 269' ' ' LEU . 23.0 t60 -60.53 -51.31 69.97 Favored 'General case' 0 CA--C 1.491 -1.289 0 C-N-CA 125.424 1.49 . . . . 199.61 113.107 -175.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.2 mt -65.35 -44.48 94.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 107.715 -1.217 . . . . 106.73 107.715 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . 0.785 ' O ' HD12 ' A' ' 203' ' ' LEU . 41.6 t -59.15 -48.53 81.27 Favored 'General case' 0 CA--C 1.487 -1.479 0 CA-C-N 115.867 -0.606 . . . . 115.01 110.231 -173.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.998 HG13 HD12 ' A' ' 161' ' ' LEU . 86.1 t -65.24 -49.15 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.657 0 C-N-CA 119.418 -0.913 . . . . 129.42 111.854 -174.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.815 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.2 m -61.88 -53.15 59.72 Favored 'General case' 0 CA--C 1.483 -1.63 0 C-N-CA 118.224 -1.39 . . . . 172.48 109.952 -172.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.676 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.1 t -63.85 -54.26 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 C-N-CA 120.512 -0.475 . . . . 55.86 110.972 -174.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.785 HD12 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.54 -51.56 58.95 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 118.542 -1.263 . . . . 184.68 111.513 -174.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . 0.981 ' HB ' HD13 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.61 -52.4 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 C-N-CA 116.643 -2.023 . . . . 291.81 114.743 -174.699 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.432 ' HB2' ' CE1' ' A' ' 265' ' ' HIS . 87.8 t80 -82.05 -55.01 4.83 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 115.148 1.536 . . . . 130.66 115.148 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . 0.815 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.8 m-85 -66.88 -48.5 68.56 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 114.488 1.292 . . . . 80.16 114.488 -170.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.929 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.55 -45.47 83.16 Favored Pre-proline 0 N--CA 1.435 -1.195 0 C-N-CA 119.965 -0.694 . . . . 136.02 109.506 -174.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.929 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.8 Cg_exo -64.81 -27.12 59.62 Favored 'Trans proline' 0 N--CA 1.433 -2.08 0 N-CA-C 110.621 -0.569 . . . . 92.17 110.621 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.774 HD22 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.34 -41.37 76.72 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 107.494 -1.298 . . . . 135.6 107.494 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.16 -44.69 91.33 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 109.591 -0.522 . . . . 52.1 109.591 -176.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . 0.7 HG13 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.71 -43.49 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 109.09 -0.707 . . . . 95.89 109.09 -176.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.978 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.27 -42.34 93.16 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 N-CA-C 106.695 -1.595 . . . . 43.41 106.695 -178.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.44 -42.28 99.08 Favored Glycine 0 N--CA 1.432 -1.624 0 N-CA-C 109.367 -1.493 . . . . 27.69 109.367 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . 0.904 ' O ' HG21 ' A' ' 217' ' ' THR . 77.9 t80 -65.68 -47.38 75.65 Favored 'General case' 0 CA--C 1.497 -1.086 0 O-C-N 122.195 -0.591 . . . . 54.41 110.456 -177.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . 0.895 ' O ' HG13 ' A' ' 218' ' ' VAL . . . -61.43 -34.1 74.83 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 106.96 -1.496 . . . . 53.88 106.96 -177.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -60.76 -40.83 93.97 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 108.48 -0.933 . . . . 68.29 108.48 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' THR . . . . . 0.904 HG21 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.78 -39.04 92.95 Favored 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 119.701 -0.799 . . . . 107.59 110.615 -175.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.895 HG13 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.02 -38.36 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 C-N-CA 119.606 -0.838 . . . . 111.61 109.509 -177.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.889 HG12 ' CD1' ' A' ' 134' ' ' ILE . 79.8 t -63.28 -22.51 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 N-CA-C 108.401 -0.963 . . . . 85.26 108.401 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.85 -41.94 99.39 Favored Glycine 0 C--N 1.349 1.283 0 N-CA-C 111.062 -0.815 . . . . 40.71 111.062 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.72 -44.06 96.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 108.412 -0.959 . . . . 95.86 108.412 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.846 ' CB ' HG22 ' A' ' 134' ' ' ILE . 67.3 p -76.93 -137.52 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 108.441 -0.948 . . . . 144.37 108.441 -176.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.928 HD21 ' NE ' ' A' ' 244' ' ' ARG . 87.6 mt -55.36 132.12 47.35 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 107.599 -1.26 . . . . 326.72 107.599 -177.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' TRP . . . . . 0.444 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.33 -168.04 1.51 Allowed 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 106.033 -1.84 . . . . 158.38 106.033 -176.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . 0.444 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.32 -41.94 98.95 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 109.661 -0.496 . . . . 36.78 109.661 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.6 m -61.13 125.85 25.22 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 119.151 -1.019 . . . . 85.46 109.82 -174.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.774 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.87 126.53 8.84 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 105.542 -2.021 . . . . 127.78 105.542 176.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.982 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.03 139.9 34.82 Favored Pre-proline 0 CA--C 1.493 -1.239 0 N-CA-C 105.952 -1.87 . . . . 164.84 105.952 -179.592 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.982 ' N ' HD13 ' A' ' 228' ' ' ILE . 82.0 Cg_exo -56.8 -39.92 87.93 Favored 'Trans proline' 0 N--CA 1.431 -2.17 0 N-CA-C 113.937 0.707 . . . . 222.35 113.937 -176.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . 0.805 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -83.13 166.99 44.94 Favored Glycine 0 N--CA 1.428 -1.894 0 N-CA-C 106.424 -2.67 . . . . 45.22 106.424 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.924 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.94 -45.79 93.29 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 106.029 -1.841 . . . . 107.57 106.029 177.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' SER . . . . . 0.734 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.6 m -65.76 141.81 58.2 Favored 'General case' 0 N--CA 1.429 -1.517 0 C-N-CA 118.906 -1.118 . . . . 167.96 109.153 -175.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.872 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.2 m 99.51 106.7 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 126.706 2.002 . . . . 280.68 109.734 176.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.779 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.7 m-20 56.01 11.27 0.71 Allowed 'General case' 0 N--CA 1.434 -1.274 0 C-N-CA 124.459 1.103 . . . . 218.25 110.701 174.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.933 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.38 137.62 54.78 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 105.236 -2.135 . . . . 343.57 105.236 177.395 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.581 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.6 t80 -111.97 81.9 1.54 Allowed 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 106.867 -1.531 . . . . 263.29 106.867 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' HIS . . . . . 0.66 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.4 m-70 104.29 147.05 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.283 0 C-N-CA 126.563 1.945 . . . . 261.92 108.497 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.21 -38.1 89.85 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 107.879 -1.156 . . . . 106.81 107.879 -177.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.758 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.43 -39.94 94.97 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 118.371 -1.331 . . . . 112.2 107.552 -178.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.749 HG13 ' NH1' ' A' ' 244' ' ' ARG . 75.5 t -64.26 -39.82 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.275 0 N-CA-C 109.263 -0.643 . . . . 45.41 109.263 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.866 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.1 p -70.92 -32.07 68.87 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 110.264 -0.273 . . . . 97.62 110.264 -178.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.39 -39.61 81.66 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 123.696 0.799 . . . . 59.29 110.978 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.758 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.24 -36.54 83.99 Favored 'General case' 0 CA--C 1.492 -1.275 0 C-N-CA 124.658 1.183 . . . . 106.49 110.666 -174.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.933 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.96 -30.65 69.23 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 108.299 -1.0 . . . . 106.62 108.299 -176.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.571 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -66.02 -41.02 91.49 Favored 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 121.832 -0.542 . . . . 75.97 110.045 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.879 ' CG1' ' HE3' ' A' ' 250' ' ' MET . 76.6 t -65.54 -40.86 89.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 C-N-CA 122.917 0.487 . . . . 65.27 109.774 -178.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.836 HG11 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -64.0 -41.58 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 C-N-CA 120.401 -0.519 . . . . 107.94 110.162 -177.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . 0.571 ' HE2' ' HA ' ' A' ' 245' ' ' LYS . 59.1 pttt -63.54 -40.81 97.98 Favored 'General case' 0 N--CA 1.434 -1.247 0 O-C-N 121.687 -0.633 . . . . 87.98 110.284 -176.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' MET . . . . . 1.06 ' HE2' ' CD1' ' A' ' 305' ' ' TYR . 21.3 ttt -63.65 -40.4 96.78 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 118.832 -1.147 . . . . 65.5 108.363 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' MET . . . . . 0.879 ' HE3' ' CG1' ' A' ' 246' ' ' VAL . 68.5 mtt -61.7 -36.37 80.71 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 108.146 -1.057 . . . . 85.05 108.146 -177.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . 0.518 HD11 ' HA ' ' A' ' 248' ' ' LYS . 86.9 mt -63.49 -45.74 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 N-CA-C 109.07 -0.715 . . . . 42.25 109.07 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . 0.875 HG13 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.34 -38.26 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 C-N-CA 119.548 -0.861 . . . . 91.01 109.402 -176.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 1.03 HG21 HD11 ' A' ' 304' ' ' ILE . 65.9 t -58.86 -41.54 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 N-CA-C 107.988 -1.116 . . . . 66.09 107.988 -178.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 250' ' ' MET . 94.8 t -66.09 -43.18 92.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 C-N-CA 120.754 -0.379 . . . . 52.39 110.31 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.1 m -61.74 -46.78 88.15 Favored 'General case' 0 CA--C 1.489 -1.391 0 O-C-N 121.889 -0.507 . . . . 46.42 109.866 -174.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' THR . . . . . 0.819 ' O ' HG23 ' A' ' 259' ' ' ILE . 9.5 t -62.33 -38.13 88.26 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 108.324 -0.991 . . . . 116.51 108.324 -177.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' PHE . . . . . 0.54 ' N ' HG23 ' A' ' 256' ' ' THR . 86.1 t80 -60.26 -48.23 82.64 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.394 -0.595 . . . . 65.18 109.394 -178.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.96 -42.68 97.2 Favored 'General case' 0 CA--C 1.49 -1.365 0 O-C-N 122.133 -0.354 . . . . 51.33 110.443 -175.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . 0.819 HG23 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.62 -43.37 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 C-N-CA 118.919 -1.112 . . . . 126.3 109.0 -176.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' CYS . . . . . 0.566 ' N ' HG22 ' A' ' 259' ' ' ILE . 69.7 m -65.58 -49.33 69.22 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 119.529 -0.868 . . . . 133.94 112.485 -176.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.868 ' CH2' ' HB2' ' A' ' 294' ' ' ALA . 97.0 m95 -80.68 -33.38 35.52 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 116.856 2.169 . . . . 134.84 116.856 -176.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.799 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.9 tp -58.43 -41.62 90.27 Favored Pre-proline 0 CA--C 1.493 -1.235 0 O-C-N 121.659 -0.65 . . . . 72.23 111.643 -167.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' PRO . . . . . 0.818 ' O ' HG21 ' A' ' 266' ' ' ILE . 80.7 Cg_exo -60.66 -35.98 87.1 Favored 'Trans proline' 0 C--N 1.295 -2.278 0 CA-C-N 119.848 0.981 . . . . 106.13 111.349 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' PHE . . . . . 0.846 ' CA ' HG21 ' A' ' 290' ' ' ILE . 71.7 t80 -66.41 -44.68 82.32 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 119.749 -0.78 . . . . 128.35 110.03 -178.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' HIS . . . . . 0.696 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.42 -37.88 89.06 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 110.202 -0.296 . . . . 100.73 110.202 -177.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.818 HG21 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.25 -44.56 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 C-N-CA 119.31 -0.956 . . . . 172.72 109.142 -179.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . 0.751 ' HD1' ' O ' ' A' ' 263' ' ' PRO . 61.6 m-85 -66.6 -28.07 68.21 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 108.206 -1.035 . . . . 249.23 108.206 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' PHE . . . . . 0.898 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.56 -55.1 35.85 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 106.679 -1.6 . . . . 259.78 106.679 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' LEU . . . . . 0.891 ' HA ' ' HE2' ' A' ' 197' ' ' HIS . 89.3 mt -69.17 -44.18 72.72 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 113.588 0.959 . . . . 233.11 113.588 -176.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . 0.851 HD12 HD21 ' A' ' 279' ' ' LEU . 88.8 mt -61.37 -48.3 91.47 Favored Pre-proline 0 N--CA 1.44 -0.968 0 C-N-CA 119.183 -1.007 . . . . 169.54 110.596 -171.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . 0.682 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.6 Cg_exo -61.13 -24.56 79.49 Favored 'Trans proline' 0 N--CA 1.43 -2.259 0 C-N-CA 116.729 -1.714 . . . . 255.47 114.66 174.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' TYR . . . . . 0.897 ' HH ' ' HG3' ' A' ' 194' ' ' LYS . 19.5 t80 -63.56 -44.22 94.75 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 119.225 0.921 . . . . 279.03 108.904 177.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . 0.835 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.33 -44.79 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 110.081 -0.34 . . . . 162.21 110.081 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' ASN . . . . . 0.775 ' N ' HD11 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.41 84.87 59.33 Favored Pre-proline 0 N--CA 1.431 -1.406 0 C-N-CA 118.747 -1.181 . . . . 128.13 108.069 -178.081 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.25 164.04 11.26 Favored 'Trans proline' 0 C--N 1.295 -2.281 0 N-CA-C 107.46 -1.785 . . . . 278.35 107.46 177.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . 0.85 ' O ' HD22 ' A' ' 277' ' ' LEU . 39.3 t0 66.11 15.04 9.93 Favored 'General case' 0 N--CA 1.428 -1.533 0 O-C-N 123.8 0.687 . . . . 312.91 109.334 175.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.85 HD22 ' O ' ' A' ' 276' ' ' ASP . 28.3 mt -132.71 -170.68 2.49 Favored 'General case' 0 CA--C 1.481 -1.679 0 N-CA-C 106.537 -1.653 . . . . 353.54 106.537 177.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 1.023 ' HA ' ' CB ' ' A' ' 282' ' ' PHE . 42.8 p90 -115.66 142.25 46.99 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 107.427 -1.323 . . . . 251.26 107.427 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.851 HD21 HD12 ' A' ' 270' ' ' LEU . 1.7 tm? -76.96 -118.74 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 102.081 -3.303 . . . . 175.26 102.081 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . 0.777 ' HB3' ' HE3' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.5 -44.97 96.12 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 100.878 -3.749 . . . . 99.07 100.878 172.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . 0.777 ' HE3' ' HB3' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.42 124.18 9.19 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 103.494 -2.78 . . . . 243.21 103.494 171.161 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 1.023 ' CB ' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.98 112.96 25.1 Favored 'General case' 0 CA--C 1.474 -1.979 0 C-N-CA 116.049 -2.261 . . . . 201.04 105.278 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' ILE . . . . . 0.74 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.93 173.72 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.09 0 C-N-CA 116.0 -2.28 . . . . 201.36 108.787 -175.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' GLN . . . . . 1.061 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.282 0.6 OUTLIER -59.5 -41.44 89.89 Favored 'General case' 0 N--CA 1.415 -2.179 0 CA-C-N 113.247 -1.797 . . . . 203.82 107.864 174.463 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . 0.917 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.31 -45.71 86.76 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 118.22 -1.392 . . . . 215.06 112.543 -171.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.636 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.3 t -65.68 -46.42 89.3 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.466 0 C-N-CA 118.578 -1.249 . . . . 125.28 112.912 -171.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' TYR . . . . . 0.853 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.79 -37.0 86.14 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 107.193 -1.41 . . . . 268.9 107.193 -171.883 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . 0.872 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.22 -45.01 74.47 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 125.65 1.58 . . . . 280.88 108.795 -172.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.64 -47.48 86.05 Favored 'General case' 0 N--CA 1.428 -1.547 0 C-N-CA 118.97 -1.092 . . . . 184.47 109.002 -172.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . 0.846 HG21 ' CA ' ' A' ' 264' ' ' PHE . 1.8 mp -67.94 -42.11 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 C-N-CA 119.279 -0.968 . . . . 167.92 112.73 -175.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' MET . . . . . 0.662 ' HE2' ' HG2' ' A' ' 181' ' ' MET . 21.8 ttt -65.75 -38.8 90.11 Favored 'General case' 0 CA--C 1.495 -1.144 0 C-N-CA 117.758 -1.577 . . . . 367.18 110.771 -175.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' TRP . . . . . 0.572 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.4 m95 -67.16 -32.71 73.99 Favored 'General case' 0 N--CA 1.435 -1.215 0 O-C-N 121.851 -0.531 . . . . 173.97 110.449 177.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.2 tp -64.46 -36.76 85.23 Favored 'General case' 0 CA--C 1.499 -1.011 0 C-N-CA 123.542 0.737 . . . . 119.66 109.806 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . 0.868 ' HB2' ' CH2' ' A' ' 261' ' ' TRP . . . -61.25 -33.98 74.39 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.697 -1.224 . . . . 112.3 107.697 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' MET . . . . . 0.712 ' O ' HG21 ' A' ' 298' ' ' THR . 21.9 mmt -63.09 -32.05 73.33 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 116.235 -0.439 . . . . 174.17 110.237 -177.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.7 m -64.73 -22.78 67.06 Favored 'General case' 0 CA--C 1.485 -1.525 0 C-N-CA 124.676 1.191 . . . . 145.27 110.608 -175.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' SER . . . . . 0.83 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.5 m -57.61 -35.38 70.37 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 108.078 -1.082 . . . . 170.15 108.078 -175.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.84 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.7 t -55.3 -34.15 63.89 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 116.315 -0.402 . . . . 214.57 110.632 -171.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' MET . . . . . 0.794 ' CE ' ' HG1' ' A' ' 45' ' ' THR . 28.1 ttt -77.2 -33.19 56.33 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 126.072 1.749 . . . . 168.29 115.544 177.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' TYR . . . . . 0.83 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.42 -34.87 79.2 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 114.056 1.132 . . . . 167.15 114.056 -168.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . 0.747 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.282 18.8 p-10 -64.21 -38.29 33.22 Favored Pre-proline 0 N--CA 1.434 -1.264 0 C-N-CA 115.515 -2.474 . . . . 165.13 113.93 -171.599 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' PRO . . . . . 0.747 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.1 Cg_exo -62.54 -31.83 80.02 Favored 'Trans proline' 0 N--CA 1.433 -2.042 0 CA-C-N 122.791 2.033 . . . . 123.92 111.251 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' ILE . . . . . 0.786 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.78 -42.53 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 C-N-CA 118.875 -1.13 . . . . 110.55 109.779 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' ILE . . . . . 1.03 HD11 HG21 ' A' ' 253' ' ' VAL . 31.1 pt -61.16 -40.02 84.43 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.158 0 N-CA-C 108.828 -0.804 . . . . 145.31 108.828 -177.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . 1.06 ' CD1' ' HE2' ' A' ' 249' ' ' MET 0.253 63.2 m-85 -58.11 -48.84 78.97 Favored 'General case' 0 CA--C 1.494 -1.182 0 C-N-CA 119.413 -0.915 . . . . 246.68 109.823 -177.477 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.6 m -62.19 -47.51 84.16 Favored 'General case' 0 CA--C 1.485 -1.538 0 C-N-CA 119.55 -0.86 . . . . 64.43 109.571 -173.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.8 t -66.78 -45.07 79.61 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 118.989 -1.084 . . . . 80.72 110.244 -177.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.757 HD22 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.49 -35.69 75.81 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 115.998 1.851 . . . . 140.44 115.998 -173.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . 0.62 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.83 132.23 34.34 Favored 'General case' 0 N--CA 1.434 -1.26 0 C-N-CA 112.711 -3.596 . . . . 178.87 113.056 -177.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . 0.703 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.03 -37.07 86.41 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 114.405 -1.271 . . . . 110.22 110.111 -177.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . 0.852 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.74 -50.59 72.7 Favored 'General case' 0 CA--C 1.492 -1.256 0 O-C-N 121.752 -0.592 . . . . 174.78 109.739 -174.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.979 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.2 m-85 -64.89 -41.69 95.41 Favored 'General case' 0 CA--C 1.484 -1.579 0 N-CA-C 108.245 -1.02 . . . . 161.84 108.245 178.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . 0.479 ' HE ' HD21 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.33 -50.22 73.64 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 109.198 -0.667 . . . . 117.2 109.198 -173.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.839 ' HB3' HD12 ' A' ' 326' ' ' ILE . 3.0 mm? -68.51 -44.1 75.37 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 120.373 -0.531 . . . . 112.6 111.061 -177.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . 1.122 ' HA2' ' HD1' ' A' ' 318' ' ' HIS . . . -64.04 -37.43 94.59 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 110.646 -0.982 . . . . 101.46 110.646 -177.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' PHE . . . . . 0.979 ' CE2' ' HB3' ' A' ' 312' ' ' PHE . 36.7 m-85 -62.16 -45.99 90.94 Favored 'General case' 0 CA--C 1.491 -1.296 0 CA-C-N 118.492 1.146 . . . . 151.49 109.522 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . 0.467 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.1 -36.3 77.13 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 106.949 -1.501 . . . . 142.32 106.949 -175.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' HIS . . . . . 1.122 ' HD1' ' HA2' ' A' ' 315' ' ' GLY . 50.0 m80 -59.79 -41.82 92.01 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 106.891 -1.522 . . . . 109.09 106.891 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.85 -42.43 85.72 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.336 -0.228 . . . . 76.11 111.03 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -61.43 -55.48 30.84 Favored 'General case' 0 CA--C 1.49 -1.361 0 C-N-CA 119.87 -0.732 . . . . 120.24 109.32 -174.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . 0.752 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.4 mtt180 -74.33 131.54 41.24 Favored 'General case' 0 CA--C 1.482 -1.657 0 N-CA-C 102.935 -2.987 . . . . 192.73 102.935 177.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.16 -44.22 92.1 Favored 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 119.021 -1.072 . . . . 176.29 109.194 -172.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' CYS . . . . . 0.814 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.2 m -79.38 -177.11 0.81 Allowed Pre-proline 0 CA--C 1.487 -1.443 0 N-CA-C 106.294 -1.743 . . . . 69.68 106.294 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.569 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.6 Cg_exo -58.99 -75.58 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.389 0 C-N-CA 118.347 -0.635 . . . . 191.05 112.591 176.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' PHE . . . . . 0.814 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.5 m-85 47.49 43.88 16.25 Favored 'General case' 0 CA--C 1.493 -1.228 0 O-C-N 123.574 0.546 . . . . 287.03 109.764 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . 0.847 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.51 78.57 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.933 0 C-N-CA 112.956 -3.497 . . . . 292.29 109.839 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' SER . . . . . 0.507 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.3 t -77.47 -152.84 0.05 Allowed 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 104.208 -2.515 . . . . 184.57 104.208 178.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.7 8.68 4.95 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 113.063 0.764 . . . . 274.56 113.063 176.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.97 0.91 57.27 Favored Glycine 0 C--N 1.348 1.228 0 C-N-CA 117.729 -2.177 . . . . 268.24 113.457 172.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' ASP . . . . . 0.724 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.7 m-20 51.6 -172.04 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.071 0 CA-C-N 118.667 1.233 . . . . 200.06 110.747 177.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.852 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.89 -33.0 74.73 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 107.879 -1.156 . . . . 114.44 107.879 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' GLU . . . . . 0.599 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.26 46.06 21.92 Favored 'General case' 0 CA--C 1.484 -1.592 0 N-CA-C 107.625 -1.25 . . . . 263.81 107.625 -177.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' GLY . . . . . 0.651 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.32 -137.35 3.6 Favored Glycine 0 CA--C 1.479 -2.217 1 N-CA-C 102.531 -4.228 . . . . 103.79 102.531 -179.846 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . 0.987 HD21 ' HA ' ' A' ' 337' ' ' LYS . 61.2 mt -88.28 95.62 10.25 Favored 'General case' 0 N--CA 1.419 -2.007 0 C-N-CA 114.937 -2.705 . . . . 117.3 106.016 176.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . 1.058 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.96 -39.79 90.72 Favored 'General case' 0 CA--C 1.468 -2.188 1 N-CA-C 98.004 -4.813 . . . . 231.58 98.004 167.23 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' MET . . . . . 1.064 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.95 163.48 29.08 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 102.072 -3.307 . . . . 303.24 102.072 168.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' LYS . . . . . 0.987 ' HA ' HD21 ' A' ' 334' ' ' LEU . 84.3 tttt -62.63 -48.61 78.61 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 116.051 -2.259 . . . . 112.72 108.409 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' SER . . . . . 0.412 ' HB3' ' SD ' ' A' ' 336' ' ' MET . 47.9 t -61.02 -63.66 1.22 Allowed 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 109.103 -0.703 . . . . 83.22 109.103 -176.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' THR . . . . . 0.911 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.1 m -156.28 -126.2 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 103.831 -2.655 . . . . 174.36 103.831 -178.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . 1.058 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.87 160.96 8.78 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 105.763 -1.94 . . . . 202.73 105.763 177.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . 1.028 ' HH ' ' HA3' ' A' ' 315' ' ' GLY . 0.2 OUTLIER -131.95 149.04 52.55 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 107.064 -1.458 . . . . 180.62 107.064 176.392 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . 0.944 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.5 tp -178.51 -171.86 0.27 Allowed 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 105.394 -2.076 . . . . 145.25 105.394 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' GLN . . . . . 0.944 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.09 -43.14 88.13 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 106.127 -1.805 . . . . 66.05 106.127 174.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' THR . . . . . 0.761 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.7 -152.14 0.48 Allowed 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 103.505 -2.776 . . . . 266.49 103.505 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' GLN . . . . . 0.609 ' CD ' HD23 ' A' ' 342' ' ' LEU . 79.4 mt-30 66.31 -124.93 0.28 Allowed 'General case' 0 N--CA 1.428 -1.574 0 C-N-CA 117.033 -1.867 . . . . 219.2 107.772 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 346' ' ' GLY . . . . . 0.998 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.07 -37.4 94.13 Favored Glycine 0 N--CA 1.426 -2.032 0 CA-C-N 114.544 -1.207 . . . . 94.78 112.855 -176.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 347' ' ' SER . . . . . 1.102 ' HG ' ' HB3' ' A' ' 61' ' ' LYS . 48.3 t -81.17 100.41 9.07 Favored 'General case' 0 CA--C 1.484 -1.589 0 C-N-CA 112.327 -3.749 . . . . 121.41 109.479 -171.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 348' ' ' VAL . . . . . 0.672 ' O ' ' HE2' ' A' ' 336' ' ' MET . 94.5 t -73.06 145.5 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 108.953 -0.758 . . . . 85.34 108.953 -176.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 349' ' ' TYR . . . . . 0.505 ' N ' HG13 ' A' ' 348' ' ' VAL . 48.5 p90 -57.73 143.43 41.89 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.842 -1.17 . . . . 267.57 107.842 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 350' ' ' LYS . . . . . 0.508 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.03 69.59 0.59 Allowed 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 109.539 -0.541 . . . . 226.1 109.539 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 351' ' ' VAL . . . . . 1.046 ' HB ' ' HE1' ' A' ' 336' ' ' MET . 7.5 p -51.0 156.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 N-CA-C 106.993 -1.484 . . . . 154.84 106.993 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 352' ' ' SER . . . . . 0.506 ' N ' HG23 ' A' ' 351' ' ' VAL . 71.5 m -61.35 161.96 8.47 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.603 0.716 . . . . 180.01 110.711 -173.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 353' ' ' ARG . . . . . 0.877 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.46 156.92 23.66 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 106.946 -1.501 . . . . 333.78 106.946 -178.616 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 354' ' ' LEU . . . . . 0.991 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.04 142.52 48.76 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.356 -1.35 . . . . 335.2 107.356 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.991 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.5 mm-40 82.82 158.9 0.13 Allowed 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 108.74 -0.837 . . . . 266.47 108.74 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.5 m -60.61 -46.88 88.6 Favored 'General case' 0 CA--C 1.487 -1.462 0 N-CA-C 105.677 -1.972 . . . . 59.34 105.677 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.58 173.86 11.97 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 104.431 -2.433 . . . . 201.26 104.431 176.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.783 HG21 ' O ' ' A' ' 360' ' ' THR . 69.1 mt -95.91 106.71 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.555 0 C-N-CA 116.34 -2.144 . . . . 56.23 105.524 -179.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 359' ' ' SER . . . . . 0.521 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.7 m -61.19 -59.47 5.28 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 109.287 -0.634 . . . . 87.58 109.287 -175.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 360' ' ' THR . . . . . 0.888 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.2 t -85.5 153.76 22.24 Favored 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 107.835 -1.172 . . . . 219.95 107.835 -177.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 361' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 361' ' ' VAL . 16.0 m -82.02 83.81 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 C-N-CA 116.339 -2.144 . . . . 121.79 105.452 177.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.619 HG13 ' N ' ' A' ' 363' ' ' GLY . 64.6 t -154.11 159.74 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 N-CA-C 105.826 -1.916 . . . . 53.85 105.826 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . 0.619 ' N ' HG13 ' A' ' 362' ' ' VAL . . . 72.22 16.61 77.06 Favored Glycine 0 N--CA 1.428 -1.88 0 N-CA-C 106.044 -2.822 . . . . 196.55 106.044 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.674 0 N-CA-C 107.87 -1.159 . . . . 35.88 107.87 -178.914 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 365' ' ' ARG . . . . . 0.418 ' N ' ' CD ' ' B' ' 366' ' ' PRO . 4.5 ttp180 . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 108.895 -0.78 . . . . 1.0 108.895 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 366' ' ' PRO . . . . . 0.418 ' CD ' ' N ' ' B' ' 365' ' ' ARG . 52.4 Cg_endo -66.94 141.99 60.58 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.086 1.857 . . . . 1.0 110.172 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 367' ' ' LYS . . . . . 0.763 ' HE2' ' HA ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -64.38 143.26 98.47 Favored Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 119.85 -0.74 . . . . 1.0 109.603 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 368' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -68.25 150.42 76.57 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.31 2.007 . . . . 1.0 111.759 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 369' ' ' GLN . . . . . 0.513 ' O ' ' HG3' ' B' ' 369' ' ' GLN . 0.0 OUTLIER -70.72 131.72 44.3 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.739 -0.384 . . . . 1.0 110.265 179.42 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -101.97 115.85 31.42 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.696 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 371' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -63.65 -42.39 98.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.365 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 372' ' ' PHE . . . . . 0.451 ' HD1' ' HA ' ' B' ' 372' ' ' PHE . 0.1 OUTLIER -65.01 -36.25 83.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.945 -0.57 . . . . 1.0 110.663 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -59.72 -32.98 75.69 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.869 -0.892 . . . . 1.0 110.869 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 374' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.267 0 CA-C-O 120.834 0.349 . . . . 1.0 110.154 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.429 -1.478 0 N-CA-C 108.388 -0.967 . . . . 97.08 108.388 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.689 ' ND2' ' HG3' ' B' ' 366' ' ' PRO . 46.6 t30 -110.62 155.44 22.37 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 122.07 0.938 . . . . 123.41 110.724 -172.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.842 HG12 HD13 ' A' ' 15' ' ' ILE . 28.8 m -134.6 -162.38 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.498 1 N-CA-C 100.117 -4.031 . . . . 151.3 100.117 173.741 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.975 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.1 mp -60.68 -38.58 57.96 Favored Pre-proline 0 N--CA 1.439 -0.995 0 C-N-CA 115.953 -2.299 . . . . 169.25 106.13 178.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.975 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 57.6 Cg_exo -81.26 168.49 16.73 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 122.267 0.614 . . . . 185.76 110.53 171.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.853 HG12 ' CE2' ' A' ' 282' ' ' PHE . 92.3 t -64.44 -25.87 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 C-N-CA 127.037 2.135 . . . . 145.47 110.381 -177.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.832 ' O ' HG23 ' A' ' 4' ' ' VAL . 39.2 t0 -84.34 157.39 21.5 Favored 'General case' 0 CA--C 1.499 -1.014 0 O-C-N 121.043 -1.036 . . . . 102.76 109.473 -178.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.6 p -82.64 154.21 25.02 Favored 'General case' 0 CA--C 1.492 -1.269 0 N-CA-C 107.973 -1.121 . . . . 106.25 107.973 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.923 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 46.8 p-10 -105.89 51.88 0.74 Allowed 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 117.778 -1.569 . . . . 157.81 107.656 178.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.15 -45.86 91.64 Favored 'General case' 0 CA--C 1.481 -1.681 0 N-CA-C 103.593 -2.743 . . . . 150.2 103.593 178.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.458 ' C ' ' H ' ' A' ' 14' ' ' ASN . 70.4 m -87.1 164.73 34.96 Favored Pre-proline 0 N--CA 1.421 -1.899 0 N-CA-C 103.663 -2.717 . . . . 183.52 103.663 172.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -76.82 6.91 3.83 Favored 'Trans proline' 0 C--N 1.281 -2.977 0 N-CA-C 109.992 -0.811 . . . . 235.61 109.992 176.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.458 ' H ' ' C ' ' A' ' 12' ' ' SER . 34.6 t-20 -57.9 -41.29 82.31 Favored 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 124.813 1.245 . . . . 113.77 113.401 -170.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.923 ' CD1' ' HB3' ' A' ' 10' ' ' ASP . 33.3 pt -52.13 136.19 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 CA-C-N 119.517 1.053 . . . . 150.85 110.986 -176.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.46 156.28 46.41 Favored 'General case' 0 C--N 1.36 1.065 0 N-CA-C 107.631 -1.248 . . . . 100.42 107.631 178.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 1.026 HG23 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.09 142.64 58.32 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 122.009 0.909 . . . . 129.36 110.412 -174.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.764 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.06 -25.51 68.4 Favored 'General case' 0 CA--C 1.494 -1.189 0 C-N-CA 126.285 1.834 . . . . 112.34 106.677 -177.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 1.006 HG21 ' HA2' ' A' ' 101' ' ' GLY . 86.1 m -74.17 -40.15 62.74 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 115.567 -0.742 . . . . 131.73 111.705 177.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 1.026 ' H ' HG23 ' A' ' 17' ' ' THR . 71.3 m -84.35 -42.93 15.24 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 117.034 2.235 . . . . 80.49 117.034 -174.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.529 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.5 mt-10 -145.98 174.54 3.34 Favored Pre-proline 0 N--CA 1.443 -0.798 0 C-N-CA 118.127 -1.429 . . . . 98.98 111.191 -169.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.88 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.334 85.7 Cg_exo -61.74 -10.81 18.16 Favored 'Trans proline' 0 C--N 1.322 -0.853 1 N-CA-C 128.939 6.476 . . . . 246.95 128.939 -170.069 . . . . . . . . 4 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.674 HD22 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.68 17.5 8.74 Favored 'General case' 0 C--N 1.325 -0.494 1 CA-C-N 126.153 4.07 . . . . 269.62 114.231 175.677 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.58 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.5 mt-30 -67.1 -27.31 67.24 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 107.838 -1.171 . . . . 86.8 107.838 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.66 ' CE1' HG21 ' A' ' 26' ' ' VAL . 50.3 p90 -66.76 -29.42 69.37 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 121.09 -1.006 . . . . 85.91 110.508 -178.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.86 HG13 ' OE1' ' A' ' 284' ' ' GLN . 40.3 t -68.48 -40.23 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 C-N-CA 123.717 0.807 . . . . 82.0 111.362 -177.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.932 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.39 167.79 12.37 Favored Pre-proline 0 CA--C 1.489 -1.398 0 N-CA-C 108.558 -0.905 . . . . 120.73 108.558 -178.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.842 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -64.04 149.76 89.79 Favored 'Trans proline' 0 N--CA 1.432 -2.116 0 C-N-CA 120.599 0.866 . . . . 87.86 109.9 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.821 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -62.99 -37.96 89.23 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 108.864 -0.791 . . . . 36.46 108.864 -176.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.841 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.9 p-90 -63.81 -33.9 76.7 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 107.797 -1.186 . . . . 150.6 107.797 -176.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.932 ' OE1' ' HB2' ' A' ' 27' ' ' GLN . 80.5 mt-30 -62.22 -32.67 73.37 Favored 'General case' 0 CA--C 1.491 -1.312 0 O-C-N 121.311 -0.868 . . . . 123.26 108.666 -178.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.821 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.46 -47.18 94.58 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.582 0 N-CA-C 109.166 -0.679 . . . . 120.14 109.166 176.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 30' ' ' TRP . 20.3 m -67.42 -31.05 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 N-CA-C 107.855 -1.165 . . . . 112.19 107.855 -178.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.841 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.5 tp -62.96 -47.14 84.49 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 119.917 -0.713 . . . . 60.87 109.648 -178.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.69 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.0 -35.67 81.21 Favored 'General case' 0 CA--C 1.489 -1.391 0 C-N-CA 119.974 -0.69 . . . . 157.57 110.375 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.785 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.65 -40.88 98.42 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 108.591 -0.892 . . . . 47.06 108.591 178.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.841 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.79 -41.23 97.97 Favored 'General case' 0 CA--C 1.496 -1.114 0 O-C-N 121.714 -0.616 . . . . 43.94 109.558 -177.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.766 ' O ' HG21 ' A' ' 41' ' ' VAL . . . -61.89 -43.26 99.2 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 108.697 -0.853 . . . . 42.61 108.697 -176.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.961 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.41 -41.23 93.85 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 116.66 -0.246 . . . . 140.66 111.029 -178.333 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.841 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.82 -43.92 97.88 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 118.579 -1.248 . . . . 116.04 110.215 -175.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.766 HG21 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.47 -38.7 83.1 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.325 0 N-CA-C 108.761 -0.829 . . . . 97.16 108.761 -177.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.917 HD11 ' HD1' ' A' ' 39' ' ' TYR . 93.1 mt -61.32 -39.97 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 N-CA-C 108.969 -0.752 . . . . 54.85 108.969 -176.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.971 HG23 HG22 ' A' ' 86' ' ' THR . 92.9 t -57.76 -42.28 81.49 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.314 0 N-CA-C 108.888 -0.782 . . . . 45.39 108.888 -175.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.403 ' O ' HG22 ' A' ' 48' ' ' VAL . 97.0 t -63.52 -51.01 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 C-N-CA 118.876 -1.13 . . . . 48.64 110.179 -177.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.796 ' HG1' ' CE ' ' A' ' 299' ' ' MET . 10.6 t -65.27 -47.04 78.09 Favored 'General case' 0 N--CA 1.436 -1.175 0 C-N-CA 120.181 -0.608 . . . . 116.65 111.701 -174.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.641 ' N ' HG23 ' A' ' 45' ' ' THR . 50.7 m -62.01 -43.89 97.89 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.706 -0.479 . . . . 51.16 109.706 -174.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 43' ' ' VAL . 97.3 t -65.55 -48.97 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 C-N-CA 119.88 -0.728 . . . . 44.3 110.803 -176.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.875 ' O ' HG22 ' A' ' 52' ' ' VAL . 93.9 t -64.75 -46.94 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 C-N-CA 120.266 -0.574 . . . . 48.82 111.052 -174.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.71 -44.15 95.29 Favored Glycine 0 N--CA 1.437 -1.272 0 C-N-CA 120.479 -0.867 . . . . 58.7 112.064 -174.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -72.62 -34.23 67.19 Favored 'General case' 0 CA--C 1.488 -1.439 0 O-C-N 122.071 -0.664 . . . . 101.4 110.999 -175.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.814 HG11 ' O ' ' A' ' 48' ' ' VAL . 8.4 p -66.91 -38.71 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 107.71 -1.218 . . . . 103.57 107.71 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.875 HG22 ' O ' ' A' ' 48' ' ' VAL . 71.3 t -61.46 -43.03 96.08 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 108.948 -0.76 . . . . 61.89 108.948 -178.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.64 ' O ' HG21 ' A' ' 56' ' ' ILE . 82.1 t -63.47 -50.96 76.31 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 C-N-CA 120.277 -0.569 . . . . 70.01 109.47 -178.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.718 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.9 -43.38 98.96 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 109.184 -0.672 . . . . 132.1 109.184 -176.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.674 ' N ' ' HG3' ' A' ' 54' ' ' MET . 61.9 t-105 -64.21 -46.67 82.88 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 116.685 -0.234 . . . . 104.5 110.458 -176.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.896 HD11 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.69 -49.83 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 C-N-CA 120.192 -0.603 . . . . 142.96 111.306 -173.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 1.045 HD12 HG13 ' A' ' 72' ' ' VAL 0.279 24.9 pt -64.76 -41.71 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 C-N-CA 116.968 -1.893 . . . . 158.32 110.879 -176.035 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.718 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.7 -41.43 98.11 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 117.755 -1.578 . . . . 137.11 109.46 178.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.36 -44.53 91.13 Favored 'General case' 0 N--CA 1.435 -1.216 0 O-C-N 122.189 -0.319 . . . . 54.66 111.012 -176.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.949 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.44 117.13 29.42 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-O 121.633 0.73 . . . . 127.18 109.568 -174.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 1.1 ' HB3' ' HG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.83 -36.89 80.25 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 124.122 0.969 . . . . 87.93 110.78 -175.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 1.064 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.32 -34.69 78.73 Favored 'General case' 0 CA--C 1.49 -1.334 0 O-C-N 121.649 -0.657 . . . . 131.12 111.506 -175.592 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 1.009 ' HG3' ' CE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.63 69.45 7.14 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 115.337 -2.545 . . . . 246.56 109.612 -175.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 61' ' ' LYS . 9.6 mmp_? -123.27 91.45 3.48 Favored 'General case' 0 CA--C 1.474 -1.958 0 N-CA-C 105.488 -2.041 . . . . 339.35 105.488 177.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.858 ' HG1' ' H ' ' A' ' 68' ' ' ASN . 82.5 p -124.13 165.24 17.88 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 103.025 -2.954 . . . . 114.66 103.025 176.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.958 HG22 ' HG1' ' A' ' 147' ' ' THR . 7.7 p -63.08 -39.47 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.624 0 N-CA-C 106.825 -1.546 . . . . 143.28 106.825 178.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.993 HG21 HD13 ' A' ' 71' ' ' LEU . 95.6 m -59.67 -38.03 80.36 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 108.731 -0.84 . . . . 160.22 108.731 -176.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.858 ' H ' ' HG1' ' A' ' 65' ' ' THR . 86.3 m-20 -62.36 -31.81 72.51 Favored 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 108.866 -0.791 . . . . 120.54 108.866 -177.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.939 ' O ' HG21 ' A' ' 72' ' ' VAL . 89.8 m-85 -63.5 -43.87 95.98 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 109.484 -0.562 . . . . 67.22 109.484 178.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.935 ' CE2' HG23 ' A' ' 66' ' ' VAL . 82.5 m-85 -66.49 -39.81 88.94 Favored 'General case' 0 CA--C 1.498 -1.051 0 O-C-N 121.533 -0.729 . . . . 138.6 109.662 -177.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.993 HD13 HG21 ' A' ' 67' ' ' THR . 10.1 mp -63.54 -35.93 82.1 Favored 'General case' 0 CA--C 1.492 -1.253 0 C-N-CA 122.509 0.323 . . . . 151.46 110.648 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 1.045 HG13 HD12 ' A' ' 57' ' ' ILE . 24.0 m -62.54 -37.94 80.16 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.237 0 C-N-CA 117.383 -1.727 . . . . 117.93 106.739 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.528 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.1 t30 -60.11 -46.04 90.94 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.824 -1.176 . . . . 56.82 107.824 -177.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.912 HD21 ' CE ' ' A' ' 123' ' ' MET . 8.7 mp -61.3 -43.94 98.04 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 108.93 -0.767 . . . . 145.3 108.93 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.04 -40.38 95.52 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 108.527 -0.916 . . . . 45.71 108.527 -175.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -62.42 -41.99 99.11 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 109.34 -0.615 . . . . 105.61 109.34 -178.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.12 -39.48 92.69 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 108.652 -0.87 . . . . 47.89 108.652 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.707 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.57 -37.39 84.85 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 109.922 -0.399 . . . . 124.53 109.922 179.706 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.86 -41.18 99.28 Favored 'General case' 0 CA--C 1.496 -1.101 0 O-C-N 121.931 -0.481 . . . . 35.89 109.85 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.9 t -62.28 -37.28 84.92 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 107.01 -1.478 . . . . 88.97 107.01 -178.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.84 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.2 -49.19 76.77 Favored 'General case' 0 N--CA 1.428 -1.531 0 C-N-CA 119.847 -0.741 . . . . 239.91 109.026 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.599 ' O ' HG21 ' A' ' 86' ' ' THR . . . -65.35 -43.42 90.94 Favored 'General case' 0 N--CA 1.431 -1.396 0 O-C-N 121.503 -0.748 . . . . 146.1 110.593 -177.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.15 -58.24 3.4 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 117.417 -1.713 . . . . 91.74 113.877 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -76.51 -61.39 1.97 Allowed 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 115.761 1.763 . . . . 197.45 115.761 -173.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.984 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.25 -42.29 55.53 Favored 'General case' 0 CA--C 1.49 -1.348 0 C-N-CA 117.902 -1.519 . . . . 242.6 114.014 -170.009 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.971 HG22 HG23 ' A' ' 43' ' ' VAL . 4.6 t -65.35 -36.57 84.41 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 118.949 -1.1 . . . . 215.61 109.859 -172.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.459 ' N ' HG23 ' A' ' 86' ' ' THR . 72.3 t -60.33 -46.93 94.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 O-C-N 121.818 -0.551 . . . . 87.19 110.442 -175.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.895 HG22 ' CD2' ' A' ' 108' ' ' HIS . 63.3 t -65.91 -41.94 90.95 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.132 0 N-CA-C 109.716 -0.476 . . . . 231.82 109.716 -178.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.961 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 11.0 m120 -62.28 -34.15 76.01 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 108.296 -1.002 . . . . 364.98 108.296 -177.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.659 ' CE1' ' HB3' ' A' ' 36' ' ' ALA . 85.2 t80 -68.24 -44.67 75.17 Favored 'General case' 0 N--CA 1.438 -1.043 0 O-C-N 121.563 -0.71 . . . . 181.63 111.299 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.897 HG21 ' HD2' ' A' ' 95' ' ' HIS . 58.2 m -60.92 -45.75 93.42 Favored 'General case' 0 CA--C 1.478 -1.797 0 N-CA-C 107.405 -1.331 . . . . 269.02 107.405 -175.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 1.071 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.71 -45.06 93.29 Favored 'General case' 0 CA--C 1.469 -2.143 0 C-N-CA 118.694 -1.202 . . . . 562.66 109.994 -179.081 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.695 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -61.1 -45.25 95.46 Favored 'General case' 0 CA--C 1.479 -1.761 0 C-N-CA 118.719 -1.193 . . . . 446.75 108.098 -167.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.785 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.389 6.1 m -70.47 -26.37 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 C-N-CA 115.816 -2.354 . . . . 370.05 112.196 -178.769 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.897 ' HD2' HG21 ' A' ' 91' ' ' THR . 90.0 m-70 -74.51 -26.45 60.0 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 121.597 -0.689 . . . . 354.91 112.501 175.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.88 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.6 m-20 82.81 4.53 0.99 Allowed 'General case' 0 CA--C 1.499 -0.984 0 C-N-CA 125.075 1.35 . . . . 462.44 111.902 -178.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.764 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.267 11.9 mm-40 -172.32 178.06 2.92 Favored 'General case' 0 CA--C 1.488 -1.436 0 CA-C-O 122.02 0.914 . . . . 652.37 111.092 171.808 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.831 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.72 86.29 2.17 Favored 'General case' 0 N--CA 1.427 -1.576 0 C-N-CA 128.493 2.717 . . . . 905.99 107.931 -174.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -67.84 -36.47 80.41 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 108.254 -1.017 . . . . 570.43 108.254 -176.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.843 ' HB3' ' CG ' ' A' ' 104' ' ' TYR . 94.0 m-85 -62.46 -36.36 82.22 Favored 'General case' 0 N--CA 1.428 -1.531 0 C-N-CA 125.324 1.449 . . . . 453.22 111.203 -174.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 1.006 ' HA2' HG21 ' A' ' 19' ' ' THR . . . 97.52 178.61 33.93 Favored Glycine 0 C--N 1.35 1.32 0 C-N-CA 118.744 -1.693 . . . . 445.63 109.892 177.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.782 HD12 HD13 ' B' ' 374' ' ' LEU . 89.1 mt -56.41 -41.19 75.93 Favored 'General case' 0 CA--C 1.498 -1.041 0 C-N-CA 125.243 1.417 . . . . 457.72 112.396 -170.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -58.62 -46.9 86.05 Favored 'General case' 0 CA--C 1.485 -1.546 0 C-N-CA 118.671 -1.212 . . . . 340.58 109.291 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.843 ' CG ' ' HB3' ' A' ' 100' ' ' TYR . 88.3 m-85 -68.73 -32.16 71.74 Favored 'General case' 0 N--CA 1.424 -1.751 0 C-N-CA 118.799 -1.16 . . . . 453.6 111.552 -176.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.728 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.2 t -56.08 -40.35 73.47 Favored 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 105.964 -1.865 . . . . 541.48 105.964 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.452 ' HD2' ' HA2' ' A' ' 166' ' ' GLY . 27.0 ttpt -65.82 -47.18 75.92 Favored 'General case' 0 CA--C 1.486 -1.504 0 O-C-N 124.02 0.825 . . . . 466.68 110.826 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -61.73 -47.08 86.84 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 117.487 -1.685 . . . . 427.34 107.277 -178.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.895 ' CD2' HG22 ' A' ' 88' ' ' VAL . 47.5 m80 -67.09 -36.76 82.66 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 112.405 0.521 . . . . 537.87 112.405 -174.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.583 ' HB2' ' HB3' ' A' ' 180' ' ' CYS . 2.9 t-20 -69.46 -42.67 74.59 Favored 'General case' 0 N--CA 1.433 -1.325 0 C-N-CA 116.869 -1.932 . . . . 422.12 111.543 175.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.914 ' O ' HG21 ' A' ' 113' ' ' ILE . 76.0 t80 -59.06 -50.14 75.2 Favored 'General case' 0 CA--C 1.502 -0.894 0 O-C-N 121.324 -0.86 . . . . 340.17 111.813 -173.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.486 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 61.4 m-85 -65.25 -46.56 71.84 Favored Pre-proline 0 N--CA 1.443 -0.808 0 C-N-CA 119.109 -1.036 . . . . 258.06 111.713 -176.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.984 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.2 Cg_exo -61.47 -31.59 87.98 Favored 'Trans proline' 0 N--CA 1.434 -1.993 0 N-CA-C 115.391 1.266 . . . . 305.71 115.391 176.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.942 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.89 -40.43 76.49 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 108.701 -0.851 . . . . 252.7 108.701 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.422 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.92 -40.61 93.84 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 107.821 -1.178 . . . . 149.27 107.821 -179.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.93 -44.87 95.87 Favored 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 120.668 -0.413 . . . . 138.08 111.502 -176.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.752 HG23 ' CZ2' ' A' ' 261' ' ' TRP . 65.0 t -66.92 -42.36 88.79 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 O-C-N 121.6 -0.688 . . . . 132.89 110.98 -177.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.946 ' CE1' HG22 ' A' ' 204' ' ' ILE . 26.6 m-85 -63.75 -44.67 92.78 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 119.752 -0.779 . . . . 193.61 108.904 -177.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.605 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.45 -37.73 84.63 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 122.85 0.46 . . . . 63.83 110.055 -175.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.7 m -64.03 -52.38 59.71 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 120.701 -0.4 . . . . 76.4 111.237 -177.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.805 HD11 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.94 -41.67 93.64 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 N-CA-C 108.175 -1.046 . . . . 171.13 108.175 -175.01 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 1.074 ' HB2' HD12 ' A' ' 154' ' ' ILE . 29.5 m-85 -63.75 -38.59 91.66 Favored 'General case' 0 N--CA 1.433 -1.315 0 O-C-N 121.814 -0.554 . . . . 78.3 110.686 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.554 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.6 t -67.09 -35.75 80.48 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 118.926 -1.11 . . . . 92.36 109.197 -178.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' MET . . . . . 1.089 ' HA ' ' HE1' ' A' ' 123' ' ' MET . 5.9 mmt -62.55 -34.2 76.46 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 108.176 -1.046 . . . . 93.73 108.176 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.976 HG22 HG13 ' A' ' 212' ' ' ILE . 33.4 p -67.52 -41.56 84.21 Favored 'General case' 0 CA--C 1.494 -1.202 0 C-N-CA 119.171 -1.012 . . . . 132.74 109.332 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.28 -42.14 94.8 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 107.158 -1.423 . . . . 43.39 107.158 -177.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.865 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 94.8 t -58.45 -41.97 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 N-CA-C 108.633 -0.877 . . . . 59.34 108.633 -178.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.401 ' HB3' ' HB1' ' A' ' 215' ' ' ALA . . . -63.47 -44.09 95.44 Favored 'General case' 0 CA--C 1.498 -1.043 0 O-C-N 121.815 -0.553 . . . . 69.68 110.556 -177.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.468 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.2 t80 -65.44 -42.72 92.09 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.375 -0.972 . . . . 106.98 108.375 -177.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.865 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.38 -35.58 81.35 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 119.663 -0.815 . . . . 147.63 108.981 -177.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.764 ' NH1' ' HE2' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.21 -41.51 99.16 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 108.503 -0.925 . . . . 190.06 108.503 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.963 ' HD2' ' HE3' ' A' ' 132' ' ' MET . 66.6 t80 -61.34 -44.05 97.84 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 108.328 -0.99 . . . . 118.85 108.328 -177.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 1.12 ' HA ' ' HE1' ' A' ' 132' ' ' MET . 4.5 mmt -63.42 -42.63 98.73 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 110.009 -0.367 . . . . 102.5 110.009 -177.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.99 -41.63 95.23 Favored 'General case' 0 CA--C 1.488 -1.405 0 O-C-N 121.837 -0.539 . . . . 89.98 109.828 -176.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.889 ' CD1' HG12 ' A' ' 219' ' ' VAL . 95.4 mt -66.51 -50.72 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 C-N-CA 118.113 -1.435 . . . . 106.09 110.999 -177.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.8 HD12 ' HE1' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.05 -48.3 38.62 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.109 0 C-N-CA 117.133 -1.827 . . . . 227.74 111.86 -174.831 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.789 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 23.8 p80 -118.88 100.06 50.96 Favored Pre-proline 0 CA--C 1.486 -1.498 0 C-N-CA 116.27 -2.172 . . . . 262.55 110.032 -175.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.469 ' HD2' ' O ' ' A' ' 135' ' ' ILE . 9.2 Cg_endo -69.61 -10.37 28.5 Favored 'Trans proline' 0 C--N 1.29 -2.534 0 C-N-CA 121.58 1.52 . . . . 210.25 111.335 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.809 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.26 112.03 1.0 Allowed 'General case' 0 CA--C 1.491 -1.313 0 N-CA-C 106.547 -1.649 . . . . 270.58 106.547 -178.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.89 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.76 -39.55 24.66 Favored Pre-proline 0 N--CA 1.43 -1.46 0 CA-C-N 115.361 -0.836 . . . . 129.84 112.377 -176.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.854 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 82.3 Cg_exo -61.35 -26.58 81.76 Favored 'Trans proline' 0 N--CA 1.432 -2.133 0 N-CA-C 116.291 1.612 . . . . 330.71 116.291 -174.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.789 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.03 77.19 7.95 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 114.497 -2.881 . . . . 204.51 107.263 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.878 HD12 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.73 147.4 0.09 Allowed 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 107.497 -1.297 . . . . 387.41 107.497 178.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.878 ' N ' HD12 ' A' ' 142' ' ' LEU . 47.4 t -143.66 146.99 33.66 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 118.807 -1.157 . . . . 166.22 109.496 178.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.81 -40.8 88.19 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.873 -1.158 . . . . 44.23 107.873 176.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.475 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.5 m -60.27 -39.15 85.82 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 108.184 -1.043 . . . . 28.8 108.184 -175.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.643 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.84 -38.74 92.01 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 109.08 -0.711 . . . . 30.29 109.08 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.958 ' HG1' HG22 ' A' ' 66' ' ' VAL . 90.1 m -59.59 -43.06 93.8 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 108.975 -0.75 . . . . 46.11 108.975 -176.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.459 ' HD3' ' HA ' ' A' ' 145' ' ' THR . 0.2 OUTLIER -62.49 -42.09 99.26 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 107.656 -1.238 . . . . 87.33 107.656 -179.598 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.789 ' O ' HG22 ' A' ' 153' ' ' VAL . 96.4 t -61.71 -42.1 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 N-CA-C 107.894 -1.15 . . . . 23.69 107.894 -178.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.7 t -63.18 -44.31 99.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 109.686 -0.487 . . . . 43.86 109.686 -178.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.934 ' O ' HG23 ' A' ' 154' ' ' ILE . 46.0 mm -61.28 -42.47 93.66 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 108.321 -0.992 . . . . 91.13 108.321 -176.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . 0.504 ' O ' HG22 ' A' ' 156' ' ' VAL . 52.2 t -62.69 -37.94 88.43 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 108.715 -0.846 . . . . 65.88 108.715 -178.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.789 HG22 ' O ' ' A' ' 149' ' ' VAL . 95.3 t -62.12 -41.84 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 N-CA-C 109.523 -0.547 . . . . 33.86 109.523 -177.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 1.074 HD12 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.42 -40.33 85.93 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.147 0 N-CA-C 107.527 -1.286 . . . . 146.52 107.527 -176.749 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . 0.773 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.1 m95 -62.85 -38.34 90.43 Favored 'General case' 0 N--CA 1.428 -1.529 0 C-N-CA 119.501 -0.88 . . . . 75.44 108.934 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.504 HG22 ' O ' ' A' ' 152' ' ' CYS . 98.8 t -60.53 -48.42 88.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 O-C-N 121.023 -1.048 . . . . 43.64 109.711 -177.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.813 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.71 -38.01 89.5 Favored 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 109.013 -0.736 . . . . 102.57 109.013 -178.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.97 -41.05 86.62 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.437 -1.32 . . . . 58.16 107.437 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.819 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.08 -32.54 73.94 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.995 -0.743 . . . . 121.11 108.995 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.813 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.0 -42.3 84.88 Favored 'General case' 0 CA--C 1.489 -1.383 0 C-N-CA 118.594 -1.242 . . . . 153.15 109.916 -178.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.997 HD12 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.13 -43.68 19.04 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 113.107 -3.437 . . . . 133.67 113.515 173.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.537 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -63.01 -39.87 96.07 Favored 'General case' 0 CA--C 1.489 -1.401 0 O-C-N 120.941 -1.1 . . . . 157.42 112.242 -171.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.518 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.2 t80 -74.44 -36.1 2.44 Favored Pre-proline 0 N--CA 1.437 -1.106 0 N-CA-C 115.06 1.504 . . . . 250.91 115.06 -173.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.518 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.293 53.5 Cg_exo -59.47 -25.49 78.83 Favored 'Trans proline' 0 CA--C 1.488 -1.809 0 N-CA-C 118.015 2.275 . . . . 207.34 118.015 -174.385 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 1.024 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 87.6 mt-30 -61.16 -34.24 74.71 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.951 -1.5 . . . . 192.46 106.951 178.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.452 ' HA2' ' HD2' ' A' ' 106' ' ' LYS . . . -64.48 -41.02 98.14 Favored Glycine 0 C--N 1.353 1.499 0 N-CA-C 107.991 -2.044 . . . . 261.0 107.991 177.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.8 159.1 26.04 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 101.519 -3.511 . . . . 491.4 101.519 172.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -59.93 106.79 0.54 Allowed 'General case' 0 CA--C 1.487 -1.443 0 C-N-CA 116.281 -2.168 . . . . 386.1 109.836 -176.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 1.024 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 73.8 m -154.06 -166.6 2.41 Favored 'General case' 0 N--CA 1.414 -2.249 0 N-CA-C 103.531 -2.766 . . . . 289.8 103.531 -178.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 1.11 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.94 175.37 0.87 Allowed 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 117.767 -1.111 . . . . 402.06 109.566 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.782 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 73.4 p -165.22 177.5 7.59 Favored 'General case' 0 CA--C 1.586 2.361 0 C-N-CA 127.329 2.252 . . . . 690.53 114.909 177.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.572 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.8 mm-40 132.38 160.58 0.0 OUTLIER 'General case' 1 C--N 1.429 4.057 1 N-CA-C 123.149 4.5 . . . . 633.62 123.149 162.669 . . . . . . . . 4 3 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.791 HG22 ' SG ' ' A' ' 180' ' ' CYS . 68.9 p -85.61 153.78 22.15 Favored 'General case' 0 C--N 1.389 2.29 0 C-N-CA 127.424 2.289 . . . . 617.99 110.892 178.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' MET . . . . . 1.122 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.65 174.35 6.08 Favored Pre-proline 0 C--N 1.363 1.182 0 C-N-CA 130.268 3.427 . . . . 434.98 113.429 -175.499 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 1.122 ' HD2' ' HB3' ' A' ' 174' ' ' MET . 52.7 Cg_endo -44.23 -65.67 0.18 Allowed 'Trans proline' 0 N--CA 1.442 -1.557 0 N-CA-C 122.357 3.945 . . . . 365.88 122.357 -168.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' SER . . . . . 0.787 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.305 70.4 m -84.91 20.93 1.7 Allowed 'General case' 0 CA--C 1.467 -2.228 0 N-CA-C 104.772 -2.307 . . . . 635.81 104.772 178.197 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.775 ' HB3' ' H ' ' A' ' 179' ' ' VAL 0.456 5.0 mmp_? -94.35 152.28 18.76 Favored 'General case' 1 CA--C 1.419 -4.092 3 N-CA-C 131.969 7.766 . . . . 999.99 131.969 -135.771 . . . . . . . . 5 3 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 1.071 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.911 37.1 t -131.86 73.18 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.383 -3.797 1 CA-C-N 103.288 -6.323 . . . . 594.32 113.628 149.186 . . . . . . . . 4 3 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.775 ' H ' ' HB3' ' A' ' 177' ' ' ARG . 7.3 p -144.21 144.11 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.642 1 N-CA-C 98.296 -4.705 . . . . 811.91 98.296 162.403 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . 0.791 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.9 m -118.46 144.54 45.92 Favored 'General case' 0 CA--C 1.488 -1.413 0 C-N-CA 117.081 -1.848 . . . . 999.99 109.408 -178.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.821 ' HE1' ' CE2' ' A' ' 264' ' ' PHE . 70.8 mmm -147.21 -175.59 4.89 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-O 121.988 0.899 . . . . 431.86 110.058 -177.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 1.061 HD12 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.19 148.66 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 C-N-CA 124.345 1.058 . . . . 457.18 108.811 -177.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . 0.828 ' HB3' ' HB ' ' A' ' 170' ' ' THR . 3.6 tp10 -77.32 85.46 3.74 Favored 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 124.132 0.973 . . . . 458.77 113.495 -174.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 1.015 ' CZ3' HG23 ' A' ' 182' ' ' ILE . 1.9 p90 -76.37 -31.56 0.98 Allowed Pre-proline 0 N--CA 1.438 -1.055 0 C-N-CA 124.98 1.312 . . . . 999.99 112.425 168.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.945 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -65.94 -45.81 5.62 Favored 'Trans proline' 0 N--CA 1.437 -1.817 0 N-CA-C 120.847 3.364 . . . . 999.99 120.847 -174.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.558 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.59 171.75 8.14 Favored 'General case' 0 CA--C 1.472 -2.033 0 C-N-CA 117.156 -1.817 . . . . 81.18 107.213 -172.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.843 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.7 p-80 -109.15 45.16 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.84 0 C-N-CA 115.498 -2.481 . . . . 999.99 108.72 177.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 1.06 ' HB2' HD11 ' A' ' 191' ' ' ILE . 87.2 Cg_endo -41.58 101.8 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.146 1 C-N-CA 126.021 4.481 . . . . 999.99 105.696 -170.75 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -62.21 -44.07 97.41 Favored 'General case' 0 CA--C 1.484 -1.586 0 C-N-CA 126.755 2.022 . . . . 967.72 112.062 -165.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -60.24 -36.57 78.03 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 106.732 -1.581 . . . . 934.3 106.732 -175.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 1.06 HD11 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.57 -30.29 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 C-N-CA 129.2 3.0 . . . . 565.15 113.888 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 61.54 55.42 2.8 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-N 118.464 0.575 . . . . 755.61 109.855 -175.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 1.11 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.49 -49.27 67.16 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 124.532 1.133 . . . . 325.89 113.278 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.897 ' HG3' ' HH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.8 -44.96 78.29 Favored 'General case' 0 CA--C 1.495 -1.163 0 C-N-CA 123.537 0.735 . . . . 250.21 111.679 -169.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.5 t -64.72 -43.35 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-O 121.589 0.709 . . . . 142.46 110.389 -175.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . 1.061 ' CD2' HD12 ' A' ' 182' ' ' ILE . 34.7 t80 -61.07 -41.54 96.83 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 123.986 0.914 . . . . 247.69 108.836 -173.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' HIS . . . . . 0.891 ' HE2' ' HA ' ' A' ' 269' ' ' LEU . 23.1 t60 -60.49 -51.37 69.75 Favored 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 125.45 1.5 . . . . 199.61 113.059 -175.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.1 mt -65.37 -44.42 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 107.732 -1.21 . . . . 106.73 107.732 -177.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . 0.784 ' O ' HD12 ' A' ' 203' ' ' LEU . 41.6 t -59.21 -48.49 81.42 Favored 'General case' 0 CA--C 1.486 -1.495 0 CA-C-N 115.881 -0.599 . . . . 115.01 110.245 -173.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.997 HG13 HD12 ' A' ' 161' ' ' LEU . 86.2 t -65.21 -49.21 80.24 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.671 0 C-N-CA 119.428 -0.909 . . . . 129.42 111.846 -174.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.814 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.9 m -61.84 -53.13 60.02 Favored 'General case' 0 CA--C 1.482 -1.651 0 C-N-CA 118.213 -1.395 . . . . 172.48 109.971 -172.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.677 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.5 t -63.9 -54.26 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 C-N-CA 120.519 -0.472 . . . . 55.86 110.946 -174.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.784 HD12 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.53 -51.54 59.13 Favored 'General case' 0 N--CA 1.432 -1.362 0 C-N-CA 118.533 -1.267 . . . . 184.68 111.541 -174.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . 0.984 ' HB ' HD13 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.6 -52.45 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 C-N-CA 116.663 -2.015 . . . . 291.81 114.704 -174.713 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.432 ' HB2' ' CE1' ' A' ' 265' ' ' HIS . 87.8 t80 -82.1 -54.97 4.86 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 115.136 1.532 . . . . 130.66 115.136 -178.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . 0.814 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.7 m-85 -66.84 -48.57 68.47 Favored 'General case' 0 CA--C 1.496 -1.096 0 N-CA-C 114.473 1.286 . . . . 80.16 114.473 -170.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.928 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.48 -45.5 83.63 Favored Pre-proline 0 N--CA 1.435 -1.201 0 C-N-CA 119.97 -0.692 . . . . 136.02 109.504 -174.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.928 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.3 Cg_exo -64.82 -27.13 59.55 Favored 'Trans proline' 0 N--CA 1.433 -2.065 0 N-CA-C 110.595 -0.579 . . . . 92.17 110.595 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.775 HD22 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.29 -41.48 76.76 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 107.456 -1.312 . . . . 135.6 107.456 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.17 -44.68 91.3 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 109.555 -0.535 . . . . 52.1 109.555 -176.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . 0.7 HG13 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.72 -43.5 97.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 109.055 -0.72 . . . . 95.89 109.055 -176.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.976 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.25 -42.39 93.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 106.699 -1.593 . . . . 43.41 106.699 -178.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.39 -42.32 99.14 Favored Glycine 0 N--CA 1.432 -1.626 0 N-CA-C 109.384 -1.487 . . . . 27.69 109.384 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . 0.903 ' O ' HG21 ' A' ' 217' ' ' THR . 78.0 t80 -65.63 -47.41 75.71 Favored 'General case' 0 CA--C 1.497 -1.086 0 O-C-N 122.209 -0.583 . . . . 54.41 110.466 -177.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . 0.896 ' O ' HG13 ' A' ' 218' ' ' VAL . . . -61.43 -34.07 74.78 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 106.989 -1.485 . . . . 53.88 106.989 -177.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -60.82 -40.76 93.97 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 108.447 -0.946 . . . . 68.29 108.447 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' THR . . . . . 0.903 HG21 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.85 -38.99 92.83 Favored 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 119.677 -0.809 . . . . 107.59 110.618 -175.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.896 HG13 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.06 -38.35 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 C-N-CA 119.615 -0.834 . . . . 111.61 109.488 -177.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.889 HG12 ' CD1' ' A' ' 134' ' ' ILE . 79.8 t -63.27 -22.51 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.392 -0.966 . . . . 85.26 108.392 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.85 -41.95 99.4 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.07 -0.812 . . . . 40.71 111.07 -176.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.5 mm -64.72 -44.0 96.53 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 N-CA-C 108.414 -0.958 . . . . 95.86 108.414 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.845 ' CB ' HG22 ' A' ' 134' ' ' ILE . 67.9 p -76.99 -137.5 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.408 -0.96 . . . . 144.37 108.408 -176.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.928 HD21 ' NE ' ' A' ' 244' ' ' ARG . 87.6 mt -55.36 132.14 47.4 Favored 'General case' 0 CA--C 1.487 -1.452 0 N-CA-C 107.63 -1.248 . . . . 326.72 107.63 -177.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' TRP . . . . . 0.462 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 9.0 t90 -119.32 -168.07 1.51 Allowed 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 106.011 -1.848 . . . . 158.38 106.011 -176.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . 0.462 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.37 -41.93 98.85 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 109.627 -0.509 . . . . 36.78 109.627 -178.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 73.0 m -61.19 125.88 25.35 Favored 'General case' 0 N--CA 1.434 -1.274 0 C-N-CA 119.115 -1.034 . . . . 85.46 109.802 -174.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.775 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.86 126.54 8.85 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 105.538 -2.023 . . . . 127.78 105.538 176.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.983 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -85.99 139.89 34.89 Favored Pre-proline 0 CA--C 1.492 -1.253 0 N-CA-C 105.964 -1.865 . . . . 164.84 105.964 -179.624 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.983 ' N ' HD13 ' A' ' 228' ' ' ILE . 81.3 Cg_exo -56.8 -39.89 88.15 Favored 'Trans proline' 0 N--CA 1.431 -2.185 0 N-CA-C 113.977 0.722 . . . . 222.35 113.977 -176.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . 0.807 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -83.12 166.96 44.93 Favored Glycine 0 N--CA 1.427 -1.912 0 N-CA-C 106.432 -2.667 . . . . 45.22 106.432 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.925 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.8 t0 -60.93 -45.77 93.37 Favored 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 106.045 -1.835 . . . . 107.57 106.045 177.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' SER . . . . . 0.734 ' O ' HG21 ' A' ' 228' ' ' ILE . 68.0 m -65.82 141.82 58.16 Favored 'General case' 0 N--CA 1.428 -1.539 0 C-N-CA 118.907 -1.117 . . . . 167.96 109.128 -175.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.873 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.1 m 99.53 106.73 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 126.729 2.012 . . . . 280.68 109.754 176.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.778 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.6 m-20 56.06 11.18 0.7 Allowed 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 124.417 1.087 . . . . 218.25 110.679 174.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.933 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.32 137.61 54.8 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 105.222 -2.14 . . . . 343.57 105.222 177.448 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.583 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.5 t80 -111.98 81.94 1.54 Allowed 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 106.852 -1.536 . . . . 263.29 106.852 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' HIS . . . . . 0.661 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.4 m-70 104.27 147.08 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.283 0 C-N-CA 126.602 1.961 . . . . 261.92 108.497 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.23 -38.08 89.75 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 107.882 -1.155 . . . . 106.81 107.882 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.759 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.49 -39.87 94.86 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 118.325 -1.35 . . . . 112.2 107.549 -178.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.75 HG13 ' NH1' ' A' ' 244' ' ' ARG . 75.7 t -64.32 -39.8 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 N-CA-C 109.254 -0.647 . . . . 45.41 109.254 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.864 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.4 p -70.93 -32.02 68.8 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 110.296 -0.261 . . . . 97.62 110.296 -178.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.42 -39.62 81.51 Favored 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 123.713 0.805 . . . . 59.29 110.959 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.759 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.23 -36.58 84.11 Favored 'General case' 0 CA--C 1.492 -1.265 0 C-N-CA 124.722 1.209 . . . . 106.49 110.682 -174.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.933 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.95 -30.64 69.22 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 108.313 -0.995 . . . . 106.62 108.313 -176.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.571 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -66.03 -40.99 91.48 Favored 'General case' 0 N--CA 1.435 -1.175 0 O-C-N 121.821 -0.55 . . . . 75.97 110.065 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.879 ' CG1' ' HE3' ' A' ' 250' ' ' MET . 76.8 t -65.55 -40.82 89.26 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 C-N-CA 122.926 0.49 . . . . 65.27 109.815 -178.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.836 HG11 ' O ' ' A' ' 244' ' ' ARG . 7.9 p -63.99 -41.65 93.16 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 C-N-CA 120.42 -0.512 . . . . 107.94 110.125 -177.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . 0.571 ' HE2' ' HA ' ' A' ' 245' ' ' LYS . 59.1 pttt -63.55 -40.77 97.86 Favored 'General case' 0 N--CA 1.434 -1.239 0 O-C-N 121.71 -0.619 . . . . 87.98 110.286 -176.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' MET . . . . . 1.061 ' HE2' ' CD1' ' A' ' 305' ' ' TYR . 21.3 ttt -63.65 -40.4 96.76 Favored 'General case' 0 CA--C 1.492 -1.268 0 C-N-CA 118.849 -1.141 . . . . 65.5 108.355 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' MET . . . . . 0.879 ' HE3' ' CG1' ' A' ' 246' ' ' VAL . 68.5 mtt -61.75 -36.36 80.8 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 108.095 -1.076 . . . . 85.05 108.095 -177.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . 0.518 HD11 ' HA ' ' A' ' 248' ' ' LYS . 86.8 mt -63.5 -45.76 96.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 N-CA-C 109.032 -0.729 . . . . 42.25 109.032 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . 0.877 HG13 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.3 -38.27 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 C-N-CA 119.594 -0.842 . . . . 91.01 109.443 -176.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 1.03 HG21 HD11 ' A' ' 304' ' ' ILE . 65.9 t -58.9 -41.55 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 N-CA-C 107.965 -1.124 . . . . 66.09 107.965 -178.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 250' ' ' MET . 94.7 t -66.08 -43.18 92.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 C-N-CA 120.719 -0.393 . . . . 52.39 110.323 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.1 m -61.7 -46.79 88.18 Favored 'General case' 0 CA--C 1.489 -1.4 0 O-C-N 121.847 -0.533 . . . . 46.42 109.877 -174.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' THR . . . . . 0.821 ' O ' HG23 ' A' ' 259' ' ' ILE . 9.5 t -62.31 -38.12 88.19 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 108.322 -0.992 . . . . 116.51 108.322 -177.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' PHE . . . . . 0.54 ' N ' HG23 ' A' ' 256' ' ' THR . 86.1 t80 -60.28 -48.25 82.53 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 109.358 -0.608 . . . . 65.18 109.358 -178.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.91 -42.72 97.33 Favored 'General case' 0 CA--C 1.49 -1.358 0 CA-C-O 120.869 0.366 . . . . 51.33 110.458 -175.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . 0.821 HG23 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.57 -43.38 98.22 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.573 0 C-N-CA 118.89 -1.124 . . . . 126.3 109.038 -176.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' CYS . . . . . 0.567 ' N ' HG22 ' A' ' 259' ' ' ILE . 69.5 m -65.6 -49.32 69.23 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 119.521 -0.872 . . . . 133.94 112.462 -176.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.868 ' CH2' ' HB2' ' A' ' 294' ' ' ALA . 97.0 m95 -80.68 -33.29 35.57 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 116.888 2.181 . . . . 134.84 116.888 -176.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.8 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.9 tp -58.48 -41.6 90.06 Favored Pre-proline 0 CA--C 1.493 -1.219 0 O-C-N 121.689 -0.632 . . . . 72.23 111.658 -167.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' PRO . . . . . 0.818 ' O ' HG21 ' A' ' 266' ' ' ILE . 79.8 Cg_exo -60.7 -35.94 87.09 Favored 'Trans proline' 0 C--N 1.295 -2.281 0 CA-C-N 119.813 0.969 . . . . 106.13 111.368 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' PHE . . . . . 0.847 ' CA ' HG21 ' A' ' 290' ' ' ILE . 71.6 t80 -66.42 -44.69 82.27 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 119.775 -0.77 . . . . 128.35 110.045 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' HIS . . . . . 0.696 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.43 -37.83 88.9 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 110.249 -0.278 . . . . 100.73 110.249 -177.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.818 HG21 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.22 -44.6 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 C-N-CA 119.346 -0.942 . . . . 172.72 109.149 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . 0.749 ' HD1' ' O ' ' A' ' 263' ' ' PRO . 61.7 m-85 -66.59 -28.03 68.19 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 108.264 -1.013 . . . . 249.23 108.264 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' PHE . . . . . 0.902 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.57 -55.14 35.4 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.687 -1.597 . . . . 259.78 106.687 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' LEU . . . . . 0.891 ' HA ' ' HE2' ' A' ' 197' ' ' HIS . 89.2 mt -69.17 -44.12 72.88 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 113.612 0.967 . . . . 233.11 113.612 -176.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . 0.849 HD12 HD21 ' A' ' 279' ' ' LEU . 89.1 mt -61.37 -48.31 91.41 Favored Pre-proline 0 N--CA 1.439 -0.976 0 C-N-CA 119.155 -1.018 . . . . 169.54 110.642 -171.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . 0.681 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.9 Cg_exo -61.13 -24.49 79.34 Favored 'Trans proline' 0 N--CA 1.429 -2.276 0 C-N-CA 116.715 -1.723 . . . . 255.47 114.698 174.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' TYR . . . . . 0.897 ' HH ' ' HG3' ' A' ' 194' ' ' LYS . 19.6 t80 -63.58 -44.26 94.6 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 119.228 0.922 . . . . 279.03 108.854 177.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . 0.835 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.36 -44.77 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 N-CA-C 110.056 -0.35 . . . . 162.21 110.056 -178.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' ASN . . . . . 0.774 ' N ' HD11 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.38 84.87 59.27 Favored Pre-proline 0 N--CA 1.43 -1.428 0 C-N-CA 118.775 -1.17 . . . . 128.13 108.12 -178.119 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.5 Cg_endo -85.22 164.01 11.3 Favored 'Trans proline' 0 C--N 1.294 -2.304 0 N-CA-C 107.455 -1.787 . . . . 278.35 107.455 177.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . 0.851 ' O ' HD22 ' A' ' 277' ' ' LEU . 39.4 t0 66.12 15.01 9.92 Favored 'General case' 0 N--CA 1.428 -1.569 0 O-C-N 123.777 0.673 . . . . 312.91 109.326 175.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.851 HD22 ' O ' ' A' ' 276' ' ' ASP . 28.3 mt -132.71 -170.67 2.49 Favored 'General case' 0 CA--C 1.481 -1.679 0 N-CA-C 106.556 -1.646 . . . . 353.54 106.556 177.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 1.023 ' HA ' ' CB ' ' A' ' 282' ' ' PHE . 42.8 p90 -115.67 142.25 46.99 Favored 'General case' 0 N--CA 1.427 -1.619 0 N-CA-C 107.439 -1.319 . . . . 251.26 107.439 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.849 HD21 HD12 ' A' ' 270' ' ' LEU . 1.7 tm? -76.97 -118.71 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 102.103 -3.295 . . . . 175.26 102.103 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . 0.778 ' HB3' ' HE3' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.5 -44.96 96.14 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 100.884 -3.747 . . . . 99.07 100.884 172.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . 0.778 ' HE3' ' HB3' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.45 124.18 9.17 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 103.45 -2.796 . . . . 243.21 103.45 171.186 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 1.023 ' CB ' ' HA ' ' A' ' 278' ' ' TYR . 77.1 t80 -93.0 112.98 25.13 Favored 'General case' 0 CA--C 1.473 -2.003 0 C-N-CA 116.065 -2.254 . . . . 201.04 105.286 178.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' ILE . . . . . 0.766 HG23 ' N ' ' A' ' 285' ' ' GLN . 10.7 tp -147.96 173.71 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.085 0 C-N-CA 116.004 -2.278 . . . . 201.36 108.802 -175.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' GLN . . . . . 1.066 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.283 0.6 OUTLIER -59.48 -41.44 89.8 Favored 'General case' 0 N--CA 1.415 -2.176 0 CA-C-N 113.233 -1.803 . . . . 203.82 107.896 174.462 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . 0.915 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.29 -45.72 86.77 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 118.215 -1.394 . . . . 215.06 112.553 -171.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.636 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.2 t -65.63 -46.45 89.36 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.476 0 C-N-CA 118.565 -1.254 . . . . 125.28 112.951 -171.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' TYR . . . . . 0.852 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.73 -37.04 86.23 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 107.205 -1.405 . . . . 268.9 107.205 -171.896 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . 0.871 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.26 -44.97 74.41 Favored 'General case' 0 N--CA 1.427 -1.583 0 C-N-CA 125.657 1.583 . . . . 280.88 108.762 -172.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.67 -47.47 86.11 Favored 'General case' 0 N--CA 1.428 -1.564 0 C-N-CA 118.987 -1.085 . . . . 184.47 108.979 -172.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . 0.847 HG21 ' CA ' ' A' ' 264' ' ' PHE . 1.8 mp -67.94 -42.1 85.28 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 C-N-CA 119.247 -0.981 . . . . 167.92 112.739 -175.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' MET . . . . . 0.661 ' HE2' ' HG2' ' A' ' 181' ' ' MET . 21.8 ttt -65.72 -38.83 90.26 Favored 'General case' 0 CA--C 1.495 -1.136 0 C-N-CA 117.751 -1.58 . . . . 367.18 110.802 -175.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' TRP . . . . . 0.572 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.5 m95 -67.14 -32.7 74.0 Favored 'General case' 0 N--CA 1.435 -1.208 0 O-C-N 121.856 -0.527 . . . . 173.97 110.466 177.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.1 tp -64.44 -36.85 85.51 Favored 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 123.6 0.76 . . . . 119.66 109.777 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . 0.868 ' HB2' ' CH2' ' A' ' 261' ' ' TRP . . . -61.16 -33.99 74.3 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 107.734 -1.21 . . . . 112.3 107.734 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' MET . . . . . 0.713 ' O ' HG21 ' A' ' 298' ' ' THR . 21.9 mmt -63.13 -32.04 73.33 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 116.202 -0.454 . . . . 174.17 110.237 -177.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.7 m -64.69 -22.76 67.06 Favored 'General case' 0 CA--C 1.485 -1.536 0 C-N-CA 124.629 1.171 . . . . 145.27 110.645 -175.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' SER . . . . . 0.829 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.6 m -57.65 -35.35 70.41 Favored 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 108.084 -1.08 . . . . 170.15 108.084 -175.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.84 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.7 t -55.28 -34.21 63.9 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 116.282 -0.417 . . . . 214.57 110.64 -171.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' MET . . . . . 0.796 ' CE ' ' HG1' ' A' ' 45' ' ' THR . 28.1 ttt -77.17 -33.22 56.52 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 126.065 1.746 . . . . 168.29 115.534 177.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' TYR . . . . . 0.829 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.4 p90 -64.38 -34.86 79.13 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 114.066 1.135 . . . . 167.15 114.066 -168.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . 0.747 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.282 18.8 p-10 -64.23 -38.32 33.25 Favored Pre-proline 0 N--CA 1.434 -1.266 0 C-N-CA 115.52 -2.472 . . . . 165.13 113.921 -171.59 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' PRO . . . . . 0.747 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.2 Cg_exo -62.52 -31.84 80.17 Favored 'Trans proline' 0 N--CA 1.433 -2.035 0 CA-C-N 122.755 2.019 . . . . 123.92 111.271 -178.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' ILE . . . . . 0.786 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.0 pt -68.75 -42.55 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 C-N-CA 118.869 -1.132 . . . . 110.55 109.755 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' ILE . . . . . 1.03 HD11 HG21 ' A' ' 253' ' ' VAL . 31.1 pt -61.2 -39.99 84.37 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.168 0 N-CA-C 108.806 -0.813 . . . . 145.31 108.806 -177.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . 1.061 ' CD1' ' HE2' ' A' ' 249' ' ' MET 0.253 63.2 m-85 -58.13 -48.78 79.17 Favored 'General case' 0 CA--C 1.493 -1.212 0 C-N-CA 119.375 -0.93 . . . . 246.68 109.837 -177.499 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 87.3 m -62.23 -47.52 84.03 Favored 'General case' 0 CA--C 1.485 -1.532 0 C-N-CA 119.549 -0.86 . . . . 64.43 109.52 -173.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.7 t -66.83 -45.01 79.61 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 118.993 -1.083 . . . . 80.72 110.226 -177.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.757 HD22 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.53 -35.69 75.7 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 115.972 1.841 . . . . 140.44 115.972 -173.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . 0.619 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.85 132.23 34.3 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 112.685 -3.606 . . . . 178.87 113.064 -177.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . 0.702 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.6 p-10 -65.03 -37.03 86.29 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 114.382 -1.281 . . . . 110.22 110.113 -177.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . 0.853 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.75 -50.59 72.72 Favored 'General case' 0 CA--C 1.492 -1.263 0 O-C-N 121.697 -0.627 . . . . 174.78 109.765 -174.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.978 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.1 m-85 -64.87 -41.7 95.44 Favored 'General case' 0 CA--C 1.485 -1.536 0 N-CA-C 108.228 -1.027 . . . . 161.84 108.228 178.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . 0.479 ' HE ' HD21 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.31 -50.22 73.62 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.196 -0.668 . . . . 117.2 109.196 -173.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.839 ' HB3' HD12 ' A' ' 326' ' ' ILE . 3.0 mm? -68.54 -44.06 75.36 Favored 'General case' 0 N--CA 1.433 -1.275 0 C-N-CA 120.352 -0.539 . . . . 112.6 111.092 -177.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . 1.124 ' HA2' ' HD1' ' A' ' 318' ' ' HIS . . . -64.08 -37.43 94.57 Favored Glycine 0 N--CA 1.431 -1.678 0 N-CA-C 110.59 -1.004 . . . . 101.46 110.59 -177.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' PHE . . . . . 0.978 ' CE2' ' HB3' ' A' ' 312' ' ' PHE . 36.6 m-85 -62.17 -46.01 90.86 Favored 'General case' 0 CA--C 1.491 -1.307 0 CA-C-N 118.521 1.16 . . . . 151.49 109.523 -178.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . 0.427 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.07 -36.3 77.06 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 106.957 -1.498 . . . . 142.32 106.957 -175.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' HIS . . . . . 1.124 ' HD1' ' HA2' ' A' ' 315' ' ' GLY . 49.9 m80 -59.79 -41.82 92.01 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 106.903 -1.517 . . . . 109.09 106.903 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.86 -42.41 85.71 Favored 'General case' 0 N--CA 1.435 -1.177 0 O-C-N 122.334 -0.228 . . . . 76.11 111.037 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -61.46 -55.43 31.37 Favored 'General case' 0 CA--C 1.49 -1.36 0 C-N-CA 119.849 -0.74 . . . . 120.24 109.331 -174.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . 0.752 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.5 mtt180 -74.34 131.52 41.21 Favored 'General case' 0 CA--C 1.482 -1.66 0 N-CA-C 102.957 -2.979 . . . . 192.73 102.957 177.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.14 -44.24 92.05 Favored 'General case' 0 CA--C 1.492 -1.266 0 C-N-CA 119.042 -1.063 . . . . 176.29 109.153 -172.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' CYS . . . . . 0.813 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.6 m -79.37 -177.07 0.8 Allowed Pre-proline 0 CA--C 1.487 -1.453 0 N-CA-C 106.241 -1.762 . . . . 69.68 106.241 178.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.5 Cg_exo -59.08 -75.51 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.403 0 C-N-CA 118.31 -0.66 . . . . 191.05 112.614 176.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' PHE . . . . . 0.813 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.5 m-85 47.48 43.92 16.24 Favored 'General case' 0 CA--C 1.493 -1.229 0 O-C-N 123.575 0.547 . . . . 287.03 109.737 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . 0.847 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.51 78.59 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.474 -1.946 0 C-N-CA 112.992 -3.483 . . . . 292.29 109.8 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' SER . . . . . 0.507 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.3 t -77.53 -152.81 0.05 Allowed 'General case' 0 N--CA 1.424 -1.775 0 N-CA-C 104.209 -2.515 . . . . 184.57 104.209 178.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.74 8.6 4.92 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 113.045 0.757 . . . . 274.56 113.045 176.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.97 0.91 57.26 Favored Glycine 0 C--N 1.348 1.198 0 C-N-CA 117.746 -2.168 . . . . 268.24 113.465 172.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' ASP . . . . . 0.724 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.5 m-20 51.59 -172.04 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.063 0 CA-C-N 118.677 1.239 . . . . 200.06 110.734 177.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.853 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.88 -32.98 74.68 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 107.878 -1.156 . . . . 114.44 107.878 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' GLU . . . . . 0.601 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.28 46.04 21.92 Favored 'General case' 0 CA--C 1.484 -1.591 0 N-CA-C 107.638 -1.245 . . . . 263.81 107.638 -177.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' GLY . . . . . 0.652 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.3 -137.36 3.61 Favored Glycine 0 CA--C 1.479 -2.204 1 N-CA-C 102.556 -4.218 . . . . 103.79 102.556 -179.815 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . 0.992 HD21 ' HA ' ' A' ' 337' ' ' LYS . 61.2 mt -88.26 95.54 10.22 Favored 'General case' 0 N--CA 1.419 -1.996 0 C-N-CA 114.936 -2.706 . . . . 117.3 106.018 177.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . 1.064 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.91 -39.83 90.91 Favored 'General case' 0 CA--C 1.469 -2.16 1 N-CA-C 97.994 -4.817 . . . . 231.58 97.994 167.264 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' MET . . . . . 1.064 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.92 163.49 29.05 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 102.11 -3.293 . . . . 303.24 102.11 168.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' LYS . . . . . 0.992 ' HA ' HD21 ' A' ' 334' ' ' LEU . 84.3 tttt -62.62 -48.6 78.68 Favored 'General case' 0 N--CA 1.432 -1.365 0 C-N-CA 116.038 -2.265 . . . . 112.72 108.411 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' SER . . . . . 0.411 ' HB3' ' SD ' ' A' ' 336' ' ' MET . 47.9 t -61.04 -63.63 1.23 Allowed 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 109.117 -0.697 . . . . 83.22 109.117 -176.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' THR . . . . . 0.91 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.1 m -156.28 -126.21 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 103.833 -2.654 . . . . 174.36 103.833 -178.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . 1.064 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.86 160.95 8.77 Favored 'General case' 0 CA--C 1.486 -1.504 0 N-CA-C 105.761 -1.94 . . . . 202.73 105.761 177.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . 1.029 ' HH ' ' HA3' ' A' ' 315' ' ' GLY . 0.2 OUTLIER -131.98 149.08 52.53 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 107.046 -1.465 . . . . 180.62 107.046 176.358 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . 0.945 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.4 tp -178.52 -171.86 0.27 Allowed 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 105.409 -2.071 . . . . 145.25 105.409 178.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' GLN . . . . . 0.945 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.08 -43.17 88.11 Favored 'General case' 0 CA--C 1.487 -1.477 0 N-CA-C 106.129 -1.804 . . . . 66.05 106.129 174.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' THR . . . . . 0.758 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.1 t -132.68 -152.12 0.48 Allowed 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 103.505 -2.776 . . . . 266.49 103.505 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' GLN . . . . . 0.609 ' CD ' HD23 ' A' ' 342' ' ' LEU . 79.4 mt-30 66.27 -124.96 0.28 Allowed 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 117.043 -1.863 . . . . 219.2 107.801 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 346' ' ' GLY . . . . . 1.001 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.02 -37.43 94.23 Favored Glycine 0 N--CA 1.425 -2.044 0 CA-C-N 114.558 -1.201 . . . . 94.78 112.852 -176.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 347' ' ' SER . . . . . 1.1 ' HG ' ' HB3' ' A' ' 61' ' ' LYS . 48.4 t -81.11 100.38 9.01 Favored 'General case' 0 CA--C 1.484 -1.575 0 C-N-CA 112.316 -3.753 . . . . 121.41 109.468 -171.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 348' ' ' VAL . . . . . 0.672 ' O ' ' HE2' ' A' ' 336' ' ' MET . 94.8 t -72.99 145.47 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 108.997 -0.742 . . . . 85.34 108.997 -176.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 349' ' ' TYR . . . . . 0.505 ' N ' HG13 ' A' ' 348' ' ' VAL . 48.5 p90 -57.76 143.47 41.86 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 107.839 -1.171 . . . . 267.57 107.839 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 350' ' ' LYS . . . . . 0.509 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.01 69.58 0.6 Allowed 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 109.553 -0.536 . . . . 226.1 109.553 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 351' ' ' VAL . . . . . 1.047 ' HB ' ' HE1' ' A' ' 336' ' ' MET . 7.5 p -50.94 156.94 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.315 0 N-CA-C 106.994 -1.484 . . . . 154.84 106.994 177.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 352' ' ' SER . . . . . 0.506 ' N ' HG23 ' A' ' 351' ' ' VAL . 71.4 m -61.35 161.87 8.59 Favored 'General case' 0 CA--C 1.494 -1.21 0 CA-C-O 121.588 0.709 . . . . 180.01 110.722 -173.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 353' ' ' ARG . . . . . 0.88 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.41 156.92 23.6 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 106.976 -1.49 . . . . 333.78 106.976 -178.653 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 354' ' ' LEU . . . . . 0.99 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.06 142.51 48.79 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 107.364 -1.347 . . . . 335.2 107.364 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.99 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.6 mm-40 82.88 158.91 0.13 Allowed 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 108.703 -0.851 . . . . 266.47 108.703 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.8 m -60.66 -46.92 88.5 Favored 'General case' 0 CA--C 1.487 -1.465 0 N-CA-C 105.632 -1.988 . . . . 59.34 105.632 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.53 173.87 11.97 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 104.462 -2.421 . . . . 201.26 104.462 176.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.782 HG21 ' O ' ' A' ' 360' ' ' THR . 69.3 mt -95.94 106.78 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 C-N-CA 116.29 -2.164 . . . . 56.23 105.503 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 359' ' ' SER . . . . . 0.52 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.9 m -61.19 -59.45 5.29 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 109.319 -0.623 . . . . 87.58 109.319 -175.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 360' ' ' THR . . . . . 0.89 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.2 t -85.55 153.74 22.22 Favored 'General case' 0 CA--C 1.485 -1.535 0 N-CA-C 107.821 -1.178 . . . . 219.95 107.821 -177.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 361' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 361' ' ' VAL . 16.0 m -81.98 83.85 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 C-N-CA 116.35 -2.14 . . . . 121.79 105.432 177.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.621 HG13 ' N ' ' A' ' 363' ' ' GLY . 64.3 t -154.14 159.72 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.559 0 N-CA-C 105.78 -1.933 . . . . 53.85 105.78 -179.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . 0.621 ' N ' HG13 ' A' ' 362' ' ' VAL . . . 72.2 16.62 77.02 Favored Glycine 0 N--CA 1.428 -1.889 0 N-CA-C 106.029 -2.828 . . . . 196.55 106.029 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.653 0 N-CA-C 107.883 -1.154 . . . . 35.88 107.883 -178.971 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 365' ' ' ARG . . . . . 0.555 ' HE ' ' HB3' ' B' ' 365' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 108.867 -0.79 . . . . 1.0 108.867 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 366' ' ' PRO . . . . . 0.689 ' HG3' ' ND2' ' A' ' 3' ' ' ASN . 52.3 Cg_endo -66.89 142.0 60.98 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.059 1.839 . . . . 1.0 110.195 179.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 367' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -64.46 143.29 98.53 Favored Pre-proline 0 C--N 1.324 -0.503 0 C-N-CA 119.854 -0.738 . . . . 1.0 109.545 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 368' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.25 150.39 76.56 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.312 2.008 . . . . 1.0 111.738 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 369' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.71 131.71 44.29 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.709 -0.396 . . . . 1.0 110.248 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -101.95 115.9 31.54 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.372 -0.377 . . . . 1.0 110.727 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 371' ' ' PHE . . . . . 0.445 ' HA ' HD11 ' B' ' 374' ' ' LEU . 86.1 m-85 -63.6 -42.51 98.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.318 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 372' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -65.07 -36.14 83.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.839 -0.619 . . . . 1.0 110.672 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -59.73 -33.08 76.12 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.776 -0.93 . . . . 1.0 110.776 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 374' ' ' LEU . . . . . 0.782 HD13 HD12 ' A' ' 102' ' ' LEU . 3.2 mt . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 120.929 0.395 . . . . 1.0 110.16 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.471 0 N-CA-C 108.398 -0.964 . . . . 97.08 108.398 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.654 ' ND2' ' HG3' ' B' ' 366' ' ' PRO . 46.5 t30 -110.62 155.43 22.38 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-O 122.172 0.987 . . . . 123.41 110.671 -172.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.841 HG12 HD13 ' A' ' 15' ' ' ILE . 28.8 m -134.56 -162.33 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.477 1 N-CA-C 100.121 -4.029 . . . . 151.3 100.121 173.72 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.976 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.69 -38.6 58.17 Favored Pre-proline 0 N--CA 1.439 -0.985 0 C-N-CA 115.961 -2.296 . . . . 169.25 106.104 178.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.976 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 57.6 Cg_exo -81.28 168.53 16.66 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 122.283 0.623 . . . . 185.76 110.568 171.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.851 HG12 ' CE2' ' A' ' 282' ' ' PHE . 91.7 t -64.5 -25.92 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 C-N-CA 127.041 2.137 . . . . 145.47 110.332 -177.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.832 ' O ' HG23 ' A' ' 4' ' ' VAL . 39.2 t0 -84.32 157.44 21.5 Favored 'General case' 0 CA--C 1.499 -0.993 0 O-C-N 121.087 -1.008 . . . . 102.76 109.45 -178.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.6 p -82.6 154.23 25.06 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 107.943 -1.132 . . . . 106.25 107.943 178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.924 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 46.7 p-10 -105.97 51.93 0.74 Allowed 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 117.763 -1.575 . . . . 157.81 107.597 178.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.22 -45.87 91.71 Favored 'General case' 0 CA--C 1.481 -1.698 0 N-CA-C 103.58 -2.748 . . . . 150.2 103.58 178.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.457 ' C ' ' H ' ' A' ' 14' ' ' ASN . 71.0 m -87.01 164.69 35.36 Favored Pre-proline 0 N--CA 1.421 -1.9 0 N-CA-C 103.689 -2.708 . . . . 183.52 103.689 172.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -76.75 6.86 3.84 Favored 'Trans proline' 0 C--N 1.281 -2.987 0 N-CA-C 110.011 -0.803 . . . . 235.61 110.011 176.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.457 ' H ' ' C ' ' A' ' 12' ' ' SER . 34.5 t-20 -57.92 -41.24 82.26 Favored 'General case' 0 N--CA 1.435 -1.198 0 C-N-CA 124.82 1.248 . . . . 113.77 113.386 -170.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.924 ' CD1' ' HB3' ' A' ' 10' ' ' ASP . 33.3 pt -52.22 136.26 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.912 0 CA-C-N 119.553 1.069 . . . . 150.85 110.942 -176.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.51 156.24 46.39 Favored 'General case' 0 C--N 1.36 1.06 0 N-CA-C 107.61 -1.256 . . . . 100.42 107.61 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 1.037 HG21 ' H ' ' A' ' 20' ' ' SER . 14.2 t -64.99 142.6 58.38 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 121.971 0.891 . . . . 129.36 110.449 -174.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.765 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.1 -25.5 68.39 Favored 'General case' 0 CA--C 1.494 -1.174 0 C-N-CA 126.28 1.832 . . . . 112.34 106.645 -177.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 1.003 HG21 ' HA2' ' A' ' 101' ' ' GLY . 85.3 m -74.11 -40.13 62.88 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 115.562 -0.744 . . . . 131.73 111.769 177.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 1.037 ' H ' HG21 ' A' ' 17' ' ' THR . 70.8 m -84.47 -42.84 15.18 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 117.006 2.225 . . . . 80.49 117.006 -174.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.529 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.4 mt-10 -145.99 174.52 3.36 Favored Pre-proline 0 N--CA 1.442 -0.827 0 C-N-CA 118.124 -1.43 . . . . 98.98 111.172 -169.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.881 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.332 85.6 Cg_exo -61.84 -10.67 18.0 Favored 'Trans proline' 0 C--N 1.321 -0.87 1 N-CA-C 128.882 6.455 . . . . 246.95 128.882 -170.053 . . . . . . . . 4 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.675 HD22 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.58 17.52 8.65 Favored 'General case' 0 C--N 1.324 -0.519 1 CA-C-N 126.181 4.082 . . . . 269.62 114.237 175.65 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.58 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.5 mt-30 -67.1 -27.24 67.17 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 107.806 -1.183 . . . . 86.8 107.806 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.661 ' CE1' HG21 ' A' ' 26' ' ' VAL . 50.4 p90 -66.85 -29.29 69.16 Favored 'General case' 0 N--CA 1.431 -1.391 0 O-C-N 121.166 -0.959 . . . . 85.91 110.514 -178.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.859 HG13 ' OE1' ' A' ' 284' ' ' GLN . 40.4 t -68.59 -40.2 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 C-N-CA 123.734 0.814 . . . . 82.0 111.312 -177.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.933 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.41 167.73 12.48 Favored Pre-proline 0 CA--C 1.489 -1.401 0 N-CA-C 108.551 -0.907 . . . . 120.73 108.551 -178.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.842 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -64.0 149.76 89.82 Favored 'Trans proline' 0 N--CA 1.432 -2.136 0 C-N-CA 120.645 0.896 . . . . 87.86 109.912 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.822 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.03 -37.94 89.2 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.829 -0.804 . . . . 36.46 108.829 -176.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.841 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 28.0 p-90 -63.83 -33.84 76.58 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 107.837 -1.171 . . . . 150.6 107.837 -176.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.933 ' OE1' ' HB2' ' A' ' 27' ' ' GLN . 80.4 mt-30 -62.22 -32.66 73.35 Favored 'General case' 0 CA--C 1.49 -1.328 0 O-C-N 121.303 -0.873 . . . . 123.26 108.705 -178.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.855 HG23 ' O ' ' A' ' 93' ' ' ALA . 1.7 mp -61.5 -47.19 94.54 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.59 0 N-CA-C 109.162 -0.681 . . . . 120.14 109.162 176.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 30' ' ' TRP . 20.3 m -67.38 -31.04 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 N-CA-C 107.865 -1.161 . . . . 112.19 107.865 -178.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.841 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.6 tp -62.99 -47.1 84.58 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 119.887 -0.725 . . . . 60.87 109.588 -178.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.69 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.04 -35.67 81.16 Favored 'General case' 0 CA--C 1.489 -1.389 0 C-N-CA 119.999 -0.681 . . . . 157.57 110.309 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.813 ' CB ' HG12 ' A' ' 94' ' ' VAL . . . -62.68 -40.83 98.33 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 108.617 -0.883 . . . . 47.06 108.617 178.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.841 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.8 -41.27 97.95 Favored 'General case' 0 CA--C 1.496 -1.112 0 O-C-N 121.728 -0.607 . . . . 43.94 109.535 -177.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.766 ' O ' HG21 ' A' ' 41' ' ' VAL . . . -61.84 -43.31 99.1 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 108.714 -0.847 . . . . 42.61 108.714 -176.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.961 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.33 -41.29 94.11 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 116.615 -0.266 . . . . 140.66 111.018 -178.351 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.841 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.82 -43.91 97.91 Favored 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 118.547 -1.261 . . . . 116.04 110.252 -175.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.766 HG21 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.5 -38.71 83.1 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.29 0 N-CA-C 108.71 -0.848 . . . . 97.16 108.71 -177.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.915 HD11 ' HD1' ' A' ' 39' ' ' TYR . 93.2 mt -61.27 -39.99 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 108.995 -0.743 . . . . 54.85 108.995 -176.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 1.004 HG23 HG23 ' A' ' 86' ' ' THR . 92.6 t -57.73 -42.33 81.52 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.312 0 N-CA-C 108.864 -0.791 . . . . 45.39 108.864 -175.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.402 ' O ' HG22 ' A' ' 48' ' ' VAL . 97.2 t -63.56 -50.95 76.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 C-N-CA 118.875 -1.13 . . . . 48.64 110.163 -177.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.796 ' HG1' ' CE ' ' A' ' 299' ' ' MET . 10.5 t -65.29 -46.99 78.21 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 120.119 -0.633 . . . . 116.65 111.731 -174.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.641 ' N ' HG23 ' A' ' 45' ' ' THR . 50.7 m -61.98 -43.96 97.74 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 109.729 -0.471 . . . . 51.16 109.729 -174.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 43' ' ' VAL . 97.9 t -65.48 -48.95 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 C-N-CA 119.872 -0.731 . . . . 44.3 110.88 -177.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.874 ' O ' HG22 ' A' ' 52' ' ' VAL . 93.8 t -64.75 -46.94 90.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 C-N-CA 120.296 -0.561 . . . . 48.82 111.043 -174.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.79 -44.11 95.24 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 120.479 -0.867 . . . . 58.7 112.015 -174.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -72.67 -34.21 67.07 Favored 'General case' 0 CA--C 1.488 -1.418 0 O-C-N 122.102 -0.646 . . . . 101.4 111.014 -175.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.814 HG11 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.85 -38.77 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 107.755 -1.202 . . . . 103.57 107.755 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.874 HG22 ' O ' ' A' ' 48' ' ' VAL . 72.1 t -61.4 -43.04 96.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 N-CA-C 109.016 -0.735 . . . . 61.89 109.016 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.64 ' O ' HG21 ' A' ' 56' ' ' ILE . 82.1 t -63.43 -50.95 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 C-N-CA 120.284 -0.566 . . . . 70.01 109.506 -178.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.718 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.9 -43.45 98.77 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 109.142 -0.688 . . . . 132.1 109.142 -176.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.673 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.1 t-105 -64.18 -46.65 83.03 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 116.671 -0.24 . . . . 104.5 110.442 -176.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.896 HD11 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.68 -49.87 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 C-N-CA 120.216 -0.594 . . . . 142.96 111.244 -173.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 1.046 HD12 HG13 ' A' ' 72' ' ' VAL 0.278 24.8 pt -64.78 -41.67 92.82 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 C-N-CA 116.933 -1.907 . . . . 158.32 110.878 -175.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.718 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.76 -41.34 98.0 Favored 'General case' 0 N--CA 1.434 -1.273 0 C-N-CA 117.713 -1.595 . . . . 137.11 109.451 178.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.35 -44.6 90.94 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 122.128 -0.358 . . . . 54.66 110.994 -176.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.949 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.38 117.15 29.43 Favored 'General case' 0 CA--C 1.491 -1.323 0 CA-C-O 121.63 0.728 . . . . 127.18 109.572 -174.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 1.097 ' HB3' ' HG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.87 -36.79 80.09 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 124.022 0.929 . . . . 87.93 110.857 -176.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 1.065 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.38 -34.7 78.77 Favored 'General case' 0 CA--C 1.49 -1.356 0 O-C-N 121.623 -0.673 . . . . 131.12 111.467 -175.622 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 1.009 ' HG3' ' CE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.62 69.44 7.13 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 115.34 -2.544 . . . . 246.56 109.583 -175.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 61' ' ' LYS . 9.6 mmp_? -123.2 91.42 3.48 Favored 'General case' 0 CA--C 1.474 -1.974 0 N-CA-C 105.514 -2.032 . . . . 339.35 105.514 177.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.858 ' HG1' ' H ' ' A' ' 68' ' ' ASN . 82.5 p -124.15 165.2 17.96 Favored 'General case' 0 N--CA 1.413 -2.275 0 N-CA-C 102.987 -2.968 . . . . 114.66 102.987 176.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.96 HG22 ' HG1' ' A' ' 147' ' ' THR . 7.7 p -63.07 -39.51 85.51 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.604 0 N-CA-C 106.798 -1.556 . . . . 143.28 106.798 178.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.994 HG21 HD13 ' A' ' 71' ' ' LEU . 95.1 m -59.63 -38.08 80.4 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 108.704 -0.851 . . . . 160.22 108.704 -176.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.858 ' H ' ' HG1' ' A' ' 65' ' ' THR . 86.3 m-20 -62.3 -31.79 72.44 Favored 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 108.918 -0.771 . . . . 120.54 108.918 -177.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.938 ' O ' HG21 ' A' ' 72' ' ' VAL . 89.8 m-85 -63.61 -43.74 96.01 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 109.511 -0.552 . . . . 67.22 109.511 178.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.934 ' CE2' HG23 ' A' ' 66' ' ' VAL . 82.4 m-85 -66.56 -39.77 88.67 Favored 'General case' 0 CA--C 1.498 -1.033 0 O-C-N 121.455 -0.778 . . . . 138.6 109.659 -177.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.994 HD13 HG21 ' A' ' 67' ' ' THR . 10.1 mp -63.52 -35.95 82.17 Favored 'General case' 0 CA--C 1.492 -1.26 0 C-N-CA 122.5 0.32 . . . . 151.46 110.638 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 1.046 HG13 HD12 ' A' ' 57' ' ' ILE . 24.2 m -62.56 -37.98 80.29 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.225 0 C-N-CA 117.445 -1.702 . . . . 117.93 106.69 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.528 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.1 t30 -60.06 -46.01 90.97 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.833 -1.173 . . . . 56.82 107.833 -177.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.911 HD21 ' CE ' ' A' ' 123' ' ' MET . 8.7 mp -61.43 -43.83 98.18 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 108.93 -0.767 . . . . 145.3 108.93 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.13 -40.29 95.42 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 108.493 -0.929 . . . . 45.71 108.493 -175.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -62.48 -41.98 99.16 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 109.356 -0.609 . . . . 105.61 109.356 -178.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.14 -39.46 92.67 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 108.655 -0.869 . . . . 47.89 108.655 -178.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.707 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.55 -37.36 84.83 Favored 'General case' 0 N--CA 1.438 -1.042 0 O-C-N 122.08 -0.388 . . . . 124.53 109.967 179.677 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.9 -41.16 99.33 Favored 'General case' 0 N--CA 1.436 -1.14 0 O-C-N 121.912 -0.492 . . . . 35.89 109.873 -178.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.9 t -62.24 -37.37 85.14 Favored 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 106.988 -1.486 . . . . 88.97 106.988 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.841 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.13 -49.2 76.84 Favored 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 119.813 -0.755 . . . . 239.91 109.041 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.6 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.37 -43.35 91.06 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 121.487 -0.758 . . . . 146.1 110.636 -177.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.2 -58.24 3.4 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 117.374 -1.73 . . . . 91.74 113.843 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -76.49 -61.46 1.95 Allowed 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 115.739 1.755 . . . . 197.45 115.739 -173.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.984 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.23 -42.28 55.67 Favored 'General case' 0 CA--C 1.489 -1.388 0 C-N-CA 117.928 -1.509 . . . . 242.6 114.028 -170.012 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 1.004 HG23 HG23 ' A' ' 43' ' ' VAL . 4.6 t -65.39 -36.51 84.2 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 118.938 -1.105 . . . . 215.61 109.902 -172.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.423 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.8 t -60.39 -46.91 94.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 C-N-CA 120.31 -0.556 . . . . 87.19 110.445 -175.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.895 HG22 ' CD2' ' A' ' 108' ' ' HIS . 63.3 t -65.9 -41.83 90.76 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.124 0 N-CA-C 109.765 -0.457 . . . . 231.82 109.765 -178.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.961 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 11.0 m120 -62.34 -34.16 76.11 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.329 -0.989 . . . . 364.98 108.329 -177.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.658 ' CE1' ' HB3' ' A' ' 36' ' ' ALA . 85.2 t80 -68.12 -44.75 75.42 Favored 'General case' 0 N--CA 1.438 -1.074 0 O-C-N 121.496 -0.752 . . . . 181.63 111.298 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.896 HG21 ' HD2' ' A' ' 95' ' ' HIS . 58.0 m -60.83 -45.83 92.92 Favored 'General case' 0 CA--C 1.478 -1.82 0 N-CA-C 107.424 -1.324 . . . . 269.02 107.424 -175.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 1.07 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.68 -45.04 93.26 Favored 'General case' 0 CA--C 1.468 -2.178 0 C-N-CA 118.626 -1.23 . . . . 562.66 110.054 -179.061 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.855 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.12 -45.21 95.62 Favored 'General case' 0 CA--C 1.478 -1.791 0 C-N-CA 118.712 -1.195 . . . . 446.75 108.107 -167.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.813 HG12 ' CB ' ' A' ' 36' ' ' ALA 0.386 6.0 m -70.55 -26.27 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.768 0 C-N-CA 115.824 -2.35 . . . . 370.05 112.206 -178.75 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.896 ' HD2' HG21 ' A' ' 91' ' ' THR . 89.9 m-70 -74.51 -26.44 60.0 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 121.556 -0.715 . . . . 354.91 112.518 175.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.881 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.4 m-20 82.8 4.47 0.99 Allowed 'General case' 0 CA--C 1.499 -0.988 0 C-N-CA 125.07 1.348 . . . . 462.44 111.93 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.765 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.266 11.9 mm-40 -172.34 178.05 2.92 Favored 'General case' 0 CA--C 1.488 -1.426 0 CA-C-O 122.005 0.907 . . . . 652.37 111.131 171.809 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.83 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.75 86.31 2.18 Favored 'General case' 0 N--CA 1.428 -1.564 0 C-N-CA 128.472 2.709 . . . . 905.99 107.909 -174.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -67.82 -36.43 80.37 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 108.241 -1.022 . . . . 570.43 108.241 -176.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.843 ' HB3' ' CG ' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.59 -36.35 82.45 Favored 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 125.299 1.44 . . . . 453.22 111.147 -174.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 1.003 ' HA2' HG21 ' A' ' 19' ' ' THR . . . 97.55 178.64 33.9 Favored Glycine 0 C--N 1.35 1.324 0 C-N-CA 118.751 -1.69 . . . . 445.63 109.906 177.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.821 ' CD1' ' HG ' ' B' ' 374' ' ' LEU . 89.0 mt -56.37 -41.21 75.84 Favored 'General case' 0 CA--C 1.499 -1.005 0 C-N-CA 125.25 1.42 . . . . 457.72 112.403 -170.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -58.67 -46.92 86.16 Favored 'General case' 0 CA--C 1.485 -1.525 0 C-N-CA 118.64 -1.224 . . . . 340.58 109.3 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.843 ' CG ' ' HB3' ' A' ' 100' ' ' TYR . 88.2 m-85 -68.67 -32.2 71.86 Favored 'General case' 0 N--CA 1.424 -1.774 0 C-N-CA 118.765 -1.174 . . . . 453.6 111.544 -176.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.73 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.04 -40.33 73.33 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 105.972 -1.862 . . . . 541.48 105.972 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.453 ' HD2' ' HA2' ' A' ' 166' ' ' GLY . 27.0 ttpt -65.82 -47.15 76.01 Favored 'General case' 0 CA--C 1.486 -1.484 0 O-C-N 123.945 0.778 . . . . 466.68 110.879 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -61.72 -47.12 86.7 Favored 'General case' 0 N--CA 1.427 -1.605 0 C-N-CA 117.429 -1.709 . . . . 427.34 107.334 -178.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.895 ' CD2' HG22 ' A' ' 88' ' ' VAL . 47.5 m80 -67.07 -36.74 82.69 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 112.441 0.534 . . . . 537.87 112.441 -174.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.584 ' HB2' ' HB3' ' A' ' 180' ' ' CYS . 2.9 t-20 -69.48 -42.6 74.59 Favored 'General case' 0 N--CA 1.433 -1.323 0 C-N-CA 116.821 -1.952 . . . . 422.12 111.611 175.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.914 ' O ' HG21 ' A' ' 113' ' ' ILE . 75.9 t80 -59.1 -50.05 75.55 Favored 'General case' 0 N--CA 1.441 -0.879 0 O-C-N 121.323 -0.861 . . . . 340.17 111.846 -173.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.484 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 61.7 m-85 -65.34 -46.49 70.84 Favored Pre-proline 0 N--CA 1.442 -0.848 0 C-N-CA 119.078 -1.049 . . . . 258.06 111.728 -176.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.984 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.2 Cg_exo -61.54 -31.56 87.44 Favored 'Trans proline' 0 N--CA 1.435 -1.958 0 N-CA-C 115.353 1.251 . . . . 305.71 115.353 176.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.942 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.89 -40.36 76.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 108.739 -0.838 . . . . 252.7 108.739 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.422 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.94 -40.63 94.01 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 107.806 -1.183 . . . . 149.27 107.806 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.95 -44.84 95.92 Favored 'General case' 0 N--CA 1.436 -1.155 0 C-N-CA 120.608 -0.437 . . . . 138.08 111.519 -176.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.752 HG23 ' CZ2' ' A' ' 261' ' ' TRP . 64.9 t -66.91 -42.4 88.88 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.94 0 O-C-N 121.565 -0.71 . . . . 132.89 110.942 -177.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.946 ' CE1' HG22 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.74 -44.65 92.89 Favored 'General case' 0 N--CA 1.433 -1.287 0 C-N-CA 119.748 -0.781 . . . . 193.61 108.923 -177.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.606 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.51 -37.63 84.43 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 122.81 0.444 . . . . 63.83 110.121 -175.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.8 m -64.0 -52.37 59.86 Favored 'General case' 0 N--CA 1.435 -1.221 0 C-N-CA 120.712 -0.395 . . . . 76.4 111.276 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.805 HD11 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -63.01 -41.65 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 N-CA-C 108.157 -1.053 . . . . 171.13 108.157 -174.991 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 1.077 ' HB2' HD12 ' A' ' 154' ' ' ILE . 29.3 m-85 -63.77 -38.57 91.6 Favored 'General case' 0 N--CA 1.433 -1.294 0 O-C-N 121.846 -0.534 . . . . 78.3 110.631 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.554 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.2 t -67.04 -35.79 80.65 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 118.939 -1.104 . . . . 92.36 109.238 -178.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' MET . . . . . 1.088 ' HA ' ' HE1' ' A' ' 123' ' ' MET . 5.9 mmt -62.51 -34.27 76.55 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 108.151 -1.055 . . . . 93.73 108.151 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.976 HG22 HG13 ' A' ' 212' ' ' ILE . 33.2 p -67.45 -41.63 84.39 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.204 -0.998 . . . . 132.74 109.324 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.26 -42.12 94.68 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 107.203 -1.406 . . . . 43.39 107.203 -177.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.865 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 94.4 t -58.41 -42.02 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 N-CA-C 108.582 -0.895 . . . . 59.34 108.582 -178.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.402 ' HB3' ' HB1' ' A' ' 215' ' ' ALA . . . -63.48 -44.07 95.45 Favored 'General case' 0 CA--C 1.497 -1.081 0 O-C-N 121.75 -0.594 . . . . 69.68 110.525 -177.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.468 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.4 t80 -65.5 -42.73 91.81 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.36 -0.978 . . . . 106.98 108.36 -177.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.865 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.39 -35.59 81.39 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 119.622 -0.831 . . . . 147.63 108.937 -177.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.762 ' NH1' ' HE2' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.09 -41.58 99.43 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.533 -0.914 . . . . 190.06 108.533 178.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.963 ' HD2' ' HE3' ' A' ' 132' ' ' MET . 66.3 t80 -61.37 -44.06 97.81 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 108.256 -1.016 . . . . 118.85 108.256 -177.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 1.122 ' HA ' ' HE1' ' A' ' 132' ' ' MET . 4.4 mmt -63.37 -42.65 98.88 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 109.981 -0.377 . . . . 102.5 109.981 -177.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.95 -41.64 95.3 Favored 'General case' 0 CA--C 1.489 -1.383 0 O-C-N 121.813 -0.554 . . . . 89.98 109.839 -176.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.888 ' CD1' HG12 ' A' ' 219' ' ' VAL . 95.3 mt -66.55 -50.7 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.666 0 C-N-CA 118.106 -1.438 . . . . 106.09 110.975 -177.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.801 HD12 ' HE1' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.09 -48.34 38.25 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.091 0 C-N-CA 117.114 -1.834 . . . . 227.74 111.797 -174.787 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.788 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.1 p80 -118.79 100.07 51.06 Favored Pre-proline 0 CA--C 1.486 -1.51 0 C-N-CA 116.249 -2.18 . . . . 262.55 110.07 -175.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.468 ' HD2' ' O ' ' A' ' 135' ' ' ILE . 9.2 Cg_endo -69.63 -10.33 28.39 Favored 'Trans proline' 0 C--N 1.29 -2.548 0 C-N-CA 121.622 1.548 . . . . 210.25 111.366 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.81 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.32 112.07 1.01 Allowed 'General case' 0 CA--C 1.49 -1.34 0 N-CA-C 106.505 -1.665 . . . . 270.58 106.505 -178.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.891 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.87 -39.5 23.44 Favored Pre-proline 0 N--CA 1.431 -1.418 0 CA-C-N 115.355 -0.839 . . . . 129.84 112.295 -175.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.855 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 82.1 Cg_exo -61.43 -26.56 81.39 Favored 'Trans proline' 0 N--CA 1.431 -2.185 0 N-CA-C 116.287 1.611 . . . . 330.71 116.287 -174.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.788 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.02 77.23 7.94 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 114.513 -2.875 . . . . 204.51 107.29 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.879 HD12 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.7 147.41 0.09 Allowed 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.485 -1.302 . . . . 387.41 107.485 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.879 ' N ' HD12 ' A' ' 142' ' ' LEU . 47.5 t -143.71 147.07 33.7 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 118.763 -1.175 . . . . 166.22 109.431 178.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.9 -40.76 87.81 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 107.806 -1.183 . . . . 44.23 107.806 176.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.477 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.3 m -60.25 -39.18 85.87 Favored 'General case' 0 CA--C 1.492 -1.285 0 N-CA-C 108.157 -1.053 . . . . 28.8 108.157 -175.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.642 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.81 -38.76 91.98 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 109.084 -0.71 . . . . 30.29 109.084 -179.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.96 ' HG1' HG22 ' A' ' 66' ' ' VAL . 89.9 m -59.66 -43.01 94.12 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 108.964 -0.754 . . . . 46.11 108.964 -176.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.459 ' HD3' ' HA ' ' A' ' 145' ' ' THR . 0.2 OUTLIER -62.4 -42.18 99.23 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 107.713 -1.217 . . . . 87.33 107.713 -179.682 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.789 ' O ' HG22 ' A' ' 153' ' ' VAL . 96.5 t -61.69 -42.05 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 N-CA-C 107.952 -1.129 . . . . 23.69 107.952 -178.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.8 t -63.18 -44.32 99.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 N-CA-C 109.672 -0.492 . . . . 43.86 109.672 -178.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.933 ' O ' HG23 ' A' ' 154' ' ' ILE . 46.1 mm -61.23 -42.57 93.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 N-CA-C 108.334 -0.987 . . . . 91.13 108.334 -176.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . 0.505 ' O ' HG22 ' A' ' 156' ' ' VAL . 52.1 t -62.56 -37.99 88.3 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 108.712 -0.848 . . . . 65.88 108.712 -178.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.789 HG22 ' O ' ' A' ' 149' ' ' VAL . 95.1 t -62.09 -41.87 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 N-CA-C 109.529 -0.545 . . . . 33.86 109.529 -177.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 1.077 HD12 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.35 -40.32 85.79 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.171 0 N-CA-C 107.576 -1.268 . . . . 146.52 107.576 -176.786 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . 0.773 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.1 m95 -62.9 -38.35 90.57 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 119.483 -0.887 . . . . 75.44 108.849 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 152' ' ' CYS . 98.9 t -60.54 -48.47 88.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 O-C-N 121.073 -1.017 . . . . 43.64 109.699 -177.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.814 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.64 -37.99 89.41 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 109.068 -0.716 . . . . 102.57 109.068 -178.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.01 -41.05 86.79 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.433 -1.321 . . . . 58.16 107.433 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.817 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.12 -32.44 73.83 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 109.045 -0.724 . . . . 121.11 109.045 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.814 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.04 -42.33 85.16 Favored 'General case' 0 CA--C 1.489 -1.404 0 C-N-CA 118.567 -1.253 . . . . 153.15 109.938 -178.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.994 HD12 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.05 -43.72 19.11 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 113.154 -3.419 . . . . 133.67 113.545 173.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.537 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -63.01 -39.88 96.09 Favored 'General case' 0 CA--C 1.49 -1.352 0 O-C-N 120.951 -1.093 . . . . 157.42 112.189 -171.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.519 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.3 t80 -74.45 -36.07 2.43 Favored Pre-proline 0 N--CA 1.436 -1.129 0 N-CA-C 115.056 1.502 . . . . 250.91 115.056 -173.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.519 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.291 52.1 Cg_exo -59.59 -25.43 78.82 Favored 'Trans proline' 0 CA--C 1.489 -1.736 0 N-CA-C 117.968 2.257 . . . . 207.34 117.968 -174.331 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 1.024 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 87.6 mt-30 -61.2 -34.16 74.63 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 106.967 -1.494 . . . . 192.46 106.967 178.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.453 ' HA2' ' HD2' ' A' ' 106' ' ' LYS . . . -64.5 -41.07 98.11 Favored Glycine 0 C--N 1.353 1.513 0 N-CA-C 107.949 -2.06 . . . . 261.0 107.949 177.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.8 159.1 26.03 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 101.466 -3.531 . . . . 491.4 101.466 172.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -59.89 106.76 0.53 Allowed 'General case' 0 CA--C 1.488 -1.422 0 C-N-CA 116.239 -2.184 . . . . 386.1 109.849 -176.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 1.024 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 74.0 m -153.99 -166.6 2.42 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 103.583 -2.747 . . . . 289.8 103.583 -178.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 1.111 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.97 175.47 0.86 Allowed 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 117.748 -1.12 . . . . 402.06 109.555 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.782 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 73.6 p -165.27 177.53 7.54 Favored 'General case' 0 CA--C 1.586 2.363 0 C-N-CA 127.308 2.243 . . . . 690.53 114.912 177.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.572 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 40.0 mm-40 132.33 160.53 0.0 OUTLIER 'General case' 1 C--N 1.43 4.066 1 N-CA-C 123.195 4.517 . . . . 633.62 123.195 162.673 . . . . . . . . 4 3 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.791 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.1 p -85.59 153.85 22.12 Favored 'General case' 0 C--N 1.389 2.283 0 C-N-CA 127.413 2.285 . . . . 617.99 110.886 178.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' MET . . . . . 1.123 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.7 174.37 6.04 Favored Pre-proline 0 C--N 1.363 1.18 0 C-N-CA 130.304 3.442 . . . . 434.98 113.433 -175.433 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 1.123 ' HD2' ' HB3' ' A' ' 174' ' ' MET . 51.8 Cg_endo -44.26 -65.63 0.19 Allowed 'Trans proline' 0 N--CA 1.441 -1.569 0 N-CA-C 122.414 3.967 . . . . 365.88 122.414 -168.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' SER . . . . . 0.787 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.304 70.8 m -84.87 20.92 1.69 Allowed 'General case' 0 CA--C 1.467 -2.249 0 N-CA-C 104.812 -2.292 . . . . 635.81 104.812 178.102 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.774 ' HB3' ' H ' ' A' ' 179' ' ' VAL 0.458 5.0 mmp_? -94.35 152.16 18.85 Favored 'General case' 1 CA--C 1.419 -4.066 3 N-CA-C 131.952 7.76 . . . . 999.99 131.952 -135.714 . . . . . . . . 5 3 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 1.07 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.91 37.0 t -131.84 73.2 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.763 1 CA-C-N 103.288 -6.324 . . . . 594.32 113.611 149.169 . . . . . . . . 4 3 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.774 ' H ' ' HB3' ' A' ' 177' ' ' ARG . 7.4 p -144.2 144.1 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.599 1 N-CA-C 98.285 -4.709 . . . . 811.91 98.285 162.382 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . 0.791 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.8 m -118.49 144.52 45.96 Favored 'General case' 0 CA--C 1.488 -1.409 0 C-N-CA 117.014 -1.874 . . . . 999.99 109.42 -178.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.822 ' HE1' ' CE2' ' A' ' 264' ' ' PHE . 70.7 mmm -147.19 -175.6 4.89 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-O 122.0 0.905 . . . . 431.86 110.055 -177.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 1.061 HD12 ' CD2' ' A' ' 196' ' ' TYR . 11.3 tt -69.15 148.73 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 C-N-CA 124.31 1.044 . . . . 457.18 108.782 -177.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . 0.829 ' HB3' ' HB ' ' A' ' 170' ' ' THR . 3.6 tp10 -77.32 85.44 3.74 Favored 'General case' 0 CA--C 1.5 -0.955 0 C-N-CA 124.155 0.982 . . . . 458.77 113.527 -174.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 1.016 ' CZ3' HG23 ' A' ' 182' ' ' ILE . 1.9 p90 -76.4 -31.57 0.97 Allowed Pre-proline 0 N--CA 1.438 -1.058 0 C-N-CA 124.992 1.317 . . . . 999.99 112.384 168.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.945 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.2 Cg_exo -65.96 -45.77 5.64 Favored 'Trans proline' 0 N--CA 1.438 -1.79 0 N-CA-C 120.883 3.378 . . . . 999.99 120.883 -174.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.557 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 54.9 mt-10 -119.56 171.78 8.12 Favored 'General case' 0 CA--C 1.471 -2.066 0 C-N-CA 117.129 -1.829 . . . . 81.18 107.239 -172.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.841 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.7 p-80 -109.16 45.16 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.865 0 CA-C-O 114.875 -2.488 . . . . 999.99 108.703 177.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 1.061 ' HB2' HD11 ' A' ' 191' ' ' ILE . 88.3 Cg_endo -41.57 101.86 0.04 OUTLIER 'Trans proline' 0 CA--C 1.502 -1.121 1 C-N-CA 126.071 4.514 . . . . 999.99 105.634 -170.745 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -62.28 -44.01 97.5 Favored 'General case' 0 CA--C 1.483 -1.597 0 C-N-CA 126.726 2.01 . . . . 967.72 112.059 -165.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -60.28 -36.55 78.08 Favored 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 106.724 -1.584 . . . . 934.3 106.724 -175.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 1.061 HD11 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.65 -30.16 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 C-N-CA 129.167 2.987 . . . . 565.15 113.925 -178.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 61.54 55.31 2.82 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-N 118.425 0.557 . . . . 755.61 109.903 -175.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 1.111 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.44 -49.29 67.19 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 124.57 1.148 . . . . 325.89 113.26 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.896 ' HG3' ' HH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.8 -44.97 78.31 Favored 'General case' 0 CA--C 1.495 -1.17 0 C-N-CA 123.558 0.743 . . . . 250.21 111.631 -169.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 98.0 t -64.75 -43.28 96.52 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 CA-C-O 121.595 0.712 . . . . 142.46 110.383 -175.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . 1.061 ' CD2' HD12 ' A' ' 182' ' ' ILE . 34.8 t80 -61.19 -41.46 96.85 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 123.985 0.914 . . . . 247.69 108.821 -173.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' HIS . . . . . 0.891 ' HE2' ' HA ' ' A' ' 269' ' ' LEU . 23.1 t60 -60.55 -51.33 69.89 Favored 'General case' 0 CA--C 1.491 -1.292 0 C-N-CA 125.411 1.484 . . . . 199.61 113.081 -175.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 82.7 mt -65.34 -44.46 94.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 N-CA-C 107.759 -1.201 . . . . 106.73 107.759 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . 0.785 ' O ' HD12 ' A' ' 203' ' ' LEU . 41.7 t -59.17 -48.53 81.27 Favored 'General case' 0 CA--C 1.487 -1.473 0 CA-C-N 115.801 -0.636 . . . . 115.01 110.214 -173.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.994 HG13 HD12 ' A' ' 161' ' ' LEU . 85.6 t -65.25 -49.18 80.31 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.655 0 C-N-CA 119.418 -0.913 . . . . 129.42 111.818 -174.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.814 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.4 m -61.85 -53.12 60.16 Favored 'General case' 0 CA--C 1.483 -1.612 0 C-N-CA 118.228 -1.389 . . . . 172.48 109.968 -172.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.677 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.5 t -63.89 -54.29 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 C-N-CA 120.539 -0.465 . . . . 55.86 110.933 -174.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.785 HD12 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.57 -51.53 59.07 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.56 -1.256 . . . . 184.68 111.489 -174.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . 0.984 ' HB ' HD13 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.62 -52.37 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 C-N-CA 116.637 -2.025 . . . . 291.81 114.757 -174.706 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.432 ' N ' ' CG2' ' A' ' 204' ' ' ILE . 87.8 t80 -82.05 -55.0 4.84 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 115.16 1.541 . . . . 130.66 115.16 -178.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . 0.814 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.8 m-85 -66.88 -48.49 68.61 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 114.515 1.302 . . . . 80.16 114.515 -170.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.928 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.54 -45.5 83.29 Favored Pre-proline 0 N--CA 1.435 -1.196 0 C-N-CA 119.981 -0.688 . . . . 136.02 109.494 -174.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.928 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.8 Cg_exo -64.8 -27.16 59.72 Favored 'Trans proline' 0 N--CA 1.432 -2.105 0 CA-C-N 118.703 0.572 . . . . 92.17 110.622 -179.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.775 HD22 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.3 -41.39 76.82 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 107.501 -1.296 . . . . 135.6 107.501 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.17 -44.7 91.26 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 109.563 -0.532 . . . . 52.1 109.563 -176.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . 0.701 HG13 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.67 -43.54 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 N-CA-C 109.063 -0.718 . . . . 95.89 109.063 -176.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.976 HG13 HG22 ' A' ' 124' ' ' THR . 94.5 mt -61.28 -42.36 93.23 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.398 0 N-CA-C 106.684 -1.599 . . . . 43.41 106.684 -178.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.44 -42.25 99.09 Favored Glycine 0 N--CA 1.432 -1.606 0 N-CA-C 109.376 -1.49 . . . . 27.69 109.376 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . 0.902 ' O ' HG21 ' A' ' 217' ' ' THR . 77.9 t80 -65.66 -47.42 75.59 Favored 'General case' 0 CA--C 1.497 -1.094 0 O-C-N 122.213 -0.581 . . . . 54.41 110.483 -177.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . 0.894 ' O ' HG13 ' A' ' 218' ' ' VAL . . . -61.42 -34.11 74.83 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 106.955 -1.498 . . . . 53.88 106.955 -177.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -60.74 -40.89 94.06 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 108.49 -0.929 . . . . 68.29 108.49 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' THR . . . . . 0.902 HG21 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.67 -39.12 93.12 Favored 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 119.721 -0.792 . . . . 107.59 110.631 -175.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.894 HG13 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.02 -38.39 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 C-N-CA 119.605 -0.838 . . . . 111.61 109.481 -177.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.888 HG12 ' CD1' ' A' ' 134' ' ' ILE . 79.3 t -63.28 -22.48 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.372 -0.973 . . . . 85.26 108.372 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.87 -41.94 99.43 Favored Glycine 0 C--N 1.349 1.265 0 N-CA-C 111.07 -0.812 . . . . 40.71 111.07 -176.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.5 mm -64.76 -44.05 96.47 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 N-CA-C 108.378 -0.971 . . . . 95.86 108.378 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.845 ' CB ' HG22 ' A' ' 134' ' ' ILE . 67.6 p -76.93 -137.52 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 108.434 -0.95 . . . . 144.37 108.434 -176.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.928 HD21 ' NE ' ' A' ' 244' ' ' ARG . 87.6 mt -55.38 132.11 47.38 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 107.573 -1.269 . . . . 326.72 107.573 -177.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' TRP . . . . . 0.461 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.35 -168.05 1.51 Allowed 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 106.013 -1.847 . . . . 158.38 106.013 -176.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . 0.461 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.27 -42.01 99.09 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 109.649 -0.5 . . . . 36.78 109.649 -178.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.6 m -61.06 125.82 25.12 Favored 'General case' 0 N--CA 1.434 -1.271 0 C-N-CA 119.198 -1.001 . . . . 85.46 109.793 -174.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.775 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.89 126.55 8.83 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 105.58 -2.008 . . . . 127.78 105.58 176.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.983 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.04 139.9 34.78 Favored Pre-proline 0 CA--C 1.493 -1.236 0 N-CA-C 105.982 -1.859 . . . . 164.84 105.982 -179.576 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.983 ' N ' HD13 ' A' ' 228' ' ' ILE . 83.4 Cg_exo -56.8 -39.93 87.87 Favored 'Trans proline' 0 N--CA 1.431 -2.16 0 N-CA-C 113.914 0.698 . . . . 222.35 113.914 -175.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . 0.808 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -83.11 167.02 45.01 Favored Glycine 0 N--CA 1.428 -1.899 0 N-CA-C 106.446 -2.662 . . . . 45.22 106.446 178.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.924 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.99 -45.71 93.7 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 106.065 -1.828 . . . . 107.57 106.065 177.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' SER . . . . . 0.736 ' O ' HG21 ' A' ' 228' ' ' ILE . 68.1 m -65.82 141.83 58.15 Favored 'General case' 0 N--CA 1.429 -1.525 0 C-N-CA 118.89 -1.124 . . . . 167.96 109.155 -175.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.873 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.6 m 99.52 106.64 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.219 0 C-N-CA 126.695 1.998 . . . . 280.68 109.761 176.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.779 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.7 m-20 56.05 11.28 0.71 Allowed 'General case' 0 N--CA 1.433 -1.279 0 C-N-CA 124.492 1.117 . . . . 218.25 110.702 174.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.933 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.38 137.64 54.78 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 105.243 -2.132 . . . . 343.57 105.243 177.412 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.584 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.6 t80 -111.99 81.84 1.53 Allowed 'General case' 0 CA--C 1.491 -1.323 0 N-CA-C 106.871 -1.529 . . . . 263.29 106.871 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' HIS . . . . . 0.662 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.4 m-70 104.31 147.09 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 126.607 1.963 . . . . 261.92 108.511 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.25 -38.13 89.94 Favored 'General case' 0 CA--C 1.488 -1.415 0 N-CA-C 107.822 -1.177 . . . . 106.81 107.822 -177.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.758 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.42 -39.92 94.87 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 118.348 -1.341 . . . . 112.2 107.58 -178.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.75 HG13 ' NH1' ' A' ' 244' ' ' ARG . 75.2 t -64.26 -39.81 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 109.285 -0.635 . . . . 45.41 109.285 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.863 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.2 p -70.95 -32.04 68.8 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 110.269 -0.271 . . . . 97.62 110.269 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.43 -39.56 81.5 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 123.65 0.78 . . . . 59.29 110.981 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.758 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.31 -36.47 83.81 Favored 'General case' 0 CA--C 1.491 -1.292 0 C-N-CA 124.655 1.182 . . . . 106.49 110.647 -174.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.933 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -60.0 -30.58 69.23 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 108.331 -0.988 . . . . 106.62 108.331 -176.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.569 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -66.09 -41.0 91.25 Favored 'General case' 0 N--CA 1.436 -1.175 0 O-C-N 121.84 -0.537 . . . . 75.97 110.052 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.879 ' CG1' ' HE3' ' A' ' 250' ' ' MET . 77.0 t -65.55 -40.84 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 C-N-CA 122.957 0.503 . . . . 65.27 109.804 -178.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.837 HG11 ' O ' ' A' ' 244' ' ' ARG . 7.7 p -63.99 -41.58 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 C-N-CA 120.385 -0.526 . . . . 107.94 110.186 -177.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . 0.569 ' HE2' ' HA ' ' A' ' 245' ' ' LYS . 59.2 pttt -63.55 -40.78 97.9 Favored 'General case' 0 N--CA 1.434 -1.259 0 O-C-N 121.679 -0.638 . . . . 87.98 110.31 -176.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' MET . . . . . 1.062 ' HE2' ' CD1' ' A' ' 305' ' ' TYR . 21.3 ttt -63.64 -40.42 96.81 Favored 'General case' 0 N--CA 1.434 -1.247 0 C-N-CA 118.875 -1.13 . . . . 65.5 108.329 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' MET . . . . . 0.879 ' HE3' ' CG1' ' A' ' 246' ' ' VAL . 68.5 mtt -61.73 -36.33 80.66 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 108.169 -1.049 . . . . 85.05 108.169 -177.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . 0.518 HD11 ' HA ' ' A' ' 248' ' ' LYS . 86.7 mt -63.48 -45.76 96.97 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 N-CA-C 109.082 -0.711 . . . . 42.25 109.082 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . 0.877 HG13 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.26 -38.31 82.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 C-N-CA 119.556 -0.858 . . . . 91.01 109.43 -176.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 1.03 HG21 HD11 ' A' ' 304' ' ' ILE . 65.8 t -58.88 -41.48 83.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 N-CA-C 107.998 -1.112 . . . . 66.09 107.998 -178.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 250' ' ' MET . 94.7 t -66.17 -43.12 92.17 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.363 0 O-C-N 122.089 -0.382 . . . . 52.39 110.287 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.4 m -61.73 -46.83 87.96 Favored 'General case' 0 CA--C 1.489 -1.393 0 O-C-N 121.851 -0.531 . . . . 46.42 109.858 -174.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' THR . . . . . 0.822 ' O ' HG23 ' A' ' 259' ' ' ILE . 9.5 t -62.3 -38.1 88.09 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 108.335 -0.987 . . . . 116.51 108.335 -177.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' PHE . . . . . 0.539 ' N ' HG23 ' A' ' 256' ' ' THR . 86.0 t80 -60.32 -48.2 82.78 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.365 -0.606 . . . . 65.18 109.365 -178.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.99 -42.68 97.12 Favored 'General case' 0 CA--C 1.489 -1.385 0 O-C-N 122.107 -0.371 . . . . 51.33 110.429 -175.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . 0.822 HG23 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.6 -43.45 98.21 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 C-N-CA 118.968 -1.093 . . . . 126.3 108.938 -176.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' CYS . . . . . 0.568 ' N ' HG22 ' A' ' 259' ' ' ILE . 69.8 m -65.51 -49.35 69.31 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.524 -0.87 . . . . 133.94 112.513 -176.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.869 ' CH2' ' HB2' ' A' ' 294' ' ' ALA . 97.0 m95 -80.72 -33.34 35.34 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 116.819 2.155 . . . . 134.84 116.819 -176.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.801 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.6 tp -58.43 -41.61 90.17 Favored Pre-proline 0 CA--C 1.493 -1.222 0 CA-C-N 118.641 0.655 . . . . 72.23 111.671 -167.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' PRO . . . . . 0.819 ' O ' HG21 ' A' ' 266' ' ' ILE . 81.3 Cg_exo -60.67 -36.02 86.89 Favored 'Trans proline' 0 C--N 1.294 -2.309 0 CA-C-N 119.822 0.972 . . . . 106.13 111.357 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' PHE . . . . . 0.847 ' CA ' HG21 ' A' ' 290' ' ' ILE . 71.6 t80 -66.32 -44.71 82.61 Favored 'General case' 0 N--CA 1.433 -1.3 0 C-N-CA 119.769 -0.772 . . . . 128.35 110.056 -178.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' HIS . . . . . 0.694 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.4 m-70 -64.41 -37.86 88.99 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 110.244 -0.28 . . . . 100.73 110.244 -177.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.819 HG21 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.29 -44.51 94.92 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 C-N-CA 119.257 -0.977 . . . . 172.72 109.126 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . 0.75 ' HD1' ' O ' ' A' ' 263' ' ' PRO . 61.5 m-85 -66.62 -28.12 68.24 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 108.17 -1.048 . . . . 249.23 108.17 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' PHE . . . . . 0.901 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.52 -55.14 35.37 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 106.698 -1.593 . . . . 259.78 106.698 178.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' LEU . . . . . 0.891 ' HA ' ' HE2' ' A' ' 197' ' ' HIS . 89.5 mt -69.13 -44.17 72.88 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 113.611 0.967 . . . . 233.11 113.611 -176.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . 0.849 HD12 HD21 ' A' ' 279' ' ' LEU . 88.6 mt -61.4 -48.31 91.28 Favored Pre-proline 0 N--CA 1.44 -0.947 0 C-N-CA 119.13 -1.028 . . . . 169.54 110.567 -171.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . 0.682 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 12.0 Cg_exo -61.05 -24.59 79.8 Favored 'Trans proline' 0 N--CA 1.429 -2.302 0 C-N-CA 116.756 -1.696 . . . . 255.47 114.7 174.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' TYR . . . . . 0.896 ' HH ' ' HG3' ' A' ' 194' ' ' LYS . 19.6 t80 -63.58 -44.22 94.69 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 119.232 0.924 . . . . 279.03 108.874 177.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . 0.835 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.33 -44.76 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 N-CA-C 110.104 -0.332 . . . . 162.21 110.104 -178.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' ASN . . . . . 0.773 ' N ' HD11 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.45 84.88 59.4 Favored Pre-proline 0 N--CA 1.43 -1.432 0 C-N-CA 118.73 -1.188 . . . . 128.13 108.064 -178.078 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.3 Cg_endo -85.3 164.08 11.19 Favored 'Trans proline' 0 C--N 1.295 -2.268 0 N-CA-C 107.44 -1.792 . . . . 278.35 107.44 177.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . 0.85 ' O ' HD22 ' A' ' 277' ' ' LEU . 39.2 t0 66.06 15.06 9.93 Favored 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 123.83 0.706 . . . . 312.91 109.335 175.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.85 HD22 ' O ' ' A' ' 276' ' ' ASP . 28.3 mt -132.69 -170.66 2.48 Favored 'General case' 0 CA--C 1.481 -1.675 0 N-CA-C 106.531 -1.655 . . . . 353.54 106.531 177.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 1.022 ' HA ' ' HB2' ' A' ' 282' ' ' PHE . 42.8 p90 -115.68 142.23 47.03 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 107.398 -1.334 . . . . 251.26 107.398 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.849 HD21 HD12 ' A' ' 270' ' ' LEU . 1.7 tm? -76.98 -118.81 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 102.024 -3.324 . . . . 175.26 102.024 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . 0.776 ' HB3' ' HE3' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.46 -44.97 96.17 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 100.883 -3.747 . . . . 99.07 100.883 172.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . 0.776 ' HE3' ' HB3' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.43 124.18 9.18 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 103.46 -2.793 . . . . 243.21 103.46 171.173 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 1.022 ' HB2' ' HA ' ' A' ' 278' ' ' TYR . 77.3 t80 -92.97 112.99 25.14 Favored 'General case' 0 CA--C 1.473 -1.982 0 C-N-CA 116.007 -2.277 . . . . 201.04 105.265 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' ILE . . . . . 0.767 HG23 ' N ' ' A' ' 285' ' ' GLN . 10.7 tp -147.94 173.72 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.071 0 C-N-CA 116.001 -2.279 . . . . 201.36 108.768 -175.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' GLN . . . . . 1.067 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.284 0.6 OUTLIER -59.54 -41.42 90.03 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-N 113.243 -1.799 . . . . 203.82 107.864 174.447 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . 0.914 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.26 -45.71 86.89 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 118.226 -1.389 . . . . 215.06 112.576 -171.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.636 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.0 t -65.69 -46.42 89.26 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.473 0 C-N-CA 118.587 -1.245 . . . . 125.28 112.903 -171.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' TYR . . . . . 0.853 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.78 -37.05 86.29 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 107.155 -1.424 . . . . 268.9 107.155 -171.861 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . 0.87 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.16 -45.05 74.56 Favored 'General case' 0 CA--C 1.483 -1.607 0 C-N-CA 125.63 1.572 . . . . 280.88 108.821 -172.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.6 -47.43 86.24 Favored 'General case' 0 CA--C 1.484 -1.564 0 C-N-CA 118.947 -1.101 . . . . 184.47 109.087 -172.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . 0.847 HG21 ' CA ' ' A' ' 264' ' ' PHE . 1.8 mp -67.98 -42.11 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 C-N-CA 119.263 -0.975 . . . . 167.92 112.732 -175.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' MET . . . . . 0.66 ' HE2' ' HG2' ' A' ' 181' ' ' MET . 21.7 ttt -65.72 -38.76 90.07 Favored 'General case' 0 CA--C 1.495 -1.136 0 C-N-CA 117.784 -1.566 . . . . 367.18 110.822 -175.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' TRP . . . . . 0.571 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.4 m95 -67.22 -32.67 73.87 Favored 'General case' 0 N--CA 1.435 -1.197 0 O-C-N 121.872 -0.517 . . . . 173.97 110.448 177.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.4 tp -64.49 -36.71 85.09 Favored 'General case' 0 CA--C 1.499 -0.986 0 C-N-CA 123.509 0.724 . . . . 119.66 109.797 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . 0.869 ' HB2' ' CH2' ' A' ' 261' ' ' TRP . . . -61.23 -34.03 74.46 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 107.711 -1.218 . . . . 112.3 107.711 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' MET . . . . . 0.713 ' O ' HG21 ' A' ' 298' ' ' THR . 21.9 mmt -63.03 -32.11 73.4 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 116.211 -0.45 . . . . 174.17 110.222 -177.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.9 m -64.67 -22.8 67.07 Favored 'General case' 0 CA--C 1.486 -1.507 0 C-N-CA 124.648 1.179 . . . . 145.27 110.606 -175.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' SER . . . . . 0.83 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.7 m -57.67 -35.33 70.41 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 108.043 -1.095 . . . . 170.15 108.043 -175.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.841 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.8 t -55.33 -34.16 63.97 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 116.324 -0.398 . . . . 214.57 110.61 -171.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' MET . . . . . 0.796 ' CE ' ' HG1' ' A' ' 45' ' ' THR . 28.1 ttt -77.16 -33.19 56.58 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 126.108 1.763 . . . . 168.29 115.539 177.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' TYR . . . . . 0.83 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.44 -34.84 79.14 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 114.072 1.138 . . . . 167.15 114.072 -168.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . 0.747 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.283 18.8 p-10 -64.2 -38.31 33.47 Favored Pre-proline 0 N--CA 1.434 -1.253 0 C-N-CA 115.532 -2.467 . . . . 165.13 113.935 -171.619 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' PRO . . . . . 0.747 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 83.9 Cg_exo -62.54 -31.87 79.97 Favored 'Trans proline' 0 N--CA 1.433 -2.048 0 CA-C-N 122.769 2.025 . . . . 123.92 111.28 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' ILE . . . . . 0.787 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.1 pt -68.72 -42.57 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 C-N-CA 118.857 -1.137 . . . . 110.55 109.796 -179.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' ILE . . . . . 1.03 HD11 HG21 ' A' ' 253' ' ' VAL . 31.1 pt -61.09 -40.08 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 108.852 -0.796 . . . . 145.31 108.852 -177.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . 1.062 ' CD1' ' HE2' ' A' ' 249' ' ' MET 0.253 63.1 m-85 -58.1 -48.83 78.97 Favored 'General case' 0 CA--C 1.494 -1.191 0 C-N-CA 119.409 -0.916 . . . . 246.68 109.796 -177.473 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.6 m -62.24 -47.46 84.3 Favored 'General case' 0 CA--C 1.485 -1.539 0 C-N-CA 119.565 -0.854 . . . . 64.43 109.6 -173.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.8 t -66.8 -45.08 79.48 Favored 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 118.973 -1.091 . . . . 80.72 110.227 -177.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.757 HD22 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.41 -35.71 76.0 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 116.034 1.864 . . . . 140.44 116.034 -173.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . 0.62 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.85 132.23 34.32 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 112.692 -3.603 . . . . 178.87 113.048 -177.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . 0.702 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.04 -37.09 86.45 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 114.392 -1.277 . . . . 110.22 110.075 -177.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . 0.852 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 38.9 ttm180 -57.7 -50.62 72.59 Favored 'General case' 0 CA--C 1.492 -1.251 0 O-C-N 121.802 -0.561 . . . . 174.78 109.708 -174.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.978 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.3 m-85 -64.87 -41.67 95.46 Favored 'General case' 0 CA--C 1.484 -1.571 0 N-CA-C 108.262 -1.014 . . . . 161.84 108.262 178.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . 0.478 ' HE ' HD21 ' A' ' 314' ' ' LEU . 57.7 ttp180 -57.38 -50.2 73.72 Favored 'General case' 0 CA--C 1.49 -1.353 0 N-CA-C 109.183 -0.673 . . . . 117.2 109.183 -173.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.841 ' HB3' HD12 ' A' ' 326' ' ' ILE . 3.0 mm? -68.55 -44.1 75.22 Favored 'General case' 0 N--CA 1.434 -1.235 0 C-N-CA 120.355 -0.538 . . . . 112.6 111.03 -177.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . 1.125 ' HA2' ' HD1' ' A' ' 318' ' ' HIS . . . -63.95 -37.52 94.74 Favored Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 110.675 -0.97 . . . . 101.46 110.675 -177.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' PHE . . . . . 0.978 ' CE2' ' HB3' ' A' ' 312' ' ' PHE . 36.7 m-85 -62.16 -45.92 91.29 Favored 'General case' 0 CA--C 1.491 -1.31 0 CA-C-N 118.452 1.126 . . . . 151.49 109.55 -178.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . 0.429 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.19 -36.24 77.17 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 106.922 -1.51 . . . . 142.32 106.922 -175.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' HIS . . . . . 1.125 ' HD1' ' HA2' ' A' ' 315' ' ' GLY . 49.9 m80 -59.85 -41.84 92.33 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 106.846 -1.539 . . . . 109.09 106.846 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.84 -42.42 85.81 Favored 'General case' 0 N--CA 1.435 -1.208 0 O-C-N 122.312 -0.242 . . . . 76.11 111.062 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -61.38 -55.51 30.67 Favored 'General case' 0 CA--C 1.489 -1.374 0 C-N-CA 119.861 -0.736 . . . . 120.24 109.339 -174.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . 0.752 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.4 mtt180 -74.26 131.53 41.28 Favored 'General case' 0 CA--C 1.482 -1.66 0 N-CA-C 102.946 -2.983 . . . . 192.73 102.946 177.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.4 p -59.14 -44.25 92.05 Favored 'General case' 0 CA--C 1.491 -1.296 0 C-N-CA 119.006 -1.078 . . . . 176.29 109.204 -172.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' CYS . . . . . 0.813 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.5 m -79.35 -177.11 0.81 Allowed Pre-proline 0 CA--C 1.488 -1.436 0 N-CA-C 106.239 -1.763 . . . . 69.68 106.239 178.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.8 Cg_exo -59.0 -75.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.382 0 CA-C-O 118.662 -0.641 . . . . 191.05 112.566 176.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' PHE . . . . . 0.813 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.3 m-85 47.49 43.89 16.24 Favored 'General case' 0 CA--C 1.493 -1.245 0 O-C-N 123.612 0.57 . . . . 287.03 109.763 178.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . 0.847 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.1 tt -104.55 78.58 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.474 -1.951 0 C-N-CA 112.988 -3.485 . . . . 292.29 109.854 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' SER . . . . . 0.507 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.1 t -77.43 -152.89 0.05 OUTLIER 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 104.198 -2.519 . . . . 184.57 104.198 178.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.76 8.65 4.91 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 113.064 0.764 . . . . 274.56 113.064 176.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.96 0.89 57.28 Favored Glycine 0 C--N 1.348 1.233 0 C-N-CA 117.792 -2.147 . . . . 268.24 113.496 172.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' ASP . . . . . 0.724 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.8 m-20 51.65 -172.07 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.092 0 CA-C-N 118.673 1.236 . . . . 200.06 110.75 177.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.852 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.91 -33.02 74.76 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 107.854 -1.165 . . . . 114.44 107.854 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' GLU . . . . . 0.601 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.36 46.03 21.72 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 107.589 -1.263 . . . . 263.81 107.589 -177.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' GLY . . . . . 0.651 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.3 -137.36 3.61 Favored Glycine 0 CA--C 1.478 -2.231 1 N-CA-C 102.471 -4.251 . . . . 103.79 102.471 -179.837 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . 0.993 HD21 ' HA ' ' A' ' 337' ' ' LYS . 61.2 mt -88.33 95.68 10.29 Favored 'General case' 0 N--CA 1.419 -1.993 0 C-N-CA 114.892 -2.723 . . . . 117.3 105.995 177.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . 1.067 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.97 -39.76 90.65 Favored 'General case' 0 CA--C 1.468 -2.202 1 N-CA-C 98.023 -4.806 . . . . 231.58 98.023 167.206 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' MET . . . . . 1.065 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.96 163.48 29.08 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 102.115 -3.291 . . . . 303.24 102.115 168.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' LYS . . . . . 0.993 ' HA ' HD21 ' A' ' 334' ' ' LEU . 84.3 tttt -62.64 -48.6 78.66 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 116.03 -2.268 . . . . 112.72 108.423 179.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' SER . . . . . 0.411 ' HB3' ' SD ' ' A' ' 336' ' ' MET . 47.9 t -61.05 -63.64 1.23 Allowed 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 109.083 -0.71 . . . . 83.22 109.083 -176.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' THR . . . . . 0.91 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 35.9 m -156.27 -126.16 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 103.87 -2.641 . . . . 174.36 103.87 -178.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . 1.067 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.93 160.96 8.89 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 105.771 -1.937 . . . . 202.73 105.771 177.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . 1.029 ' HH ' ' HA3' ' A' ' 315' ' ' GLY . 0.2 OUTLIER -131.97 149.01 52.55 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 107.061 -1.459 . . . . 180.62 107.061 176.422 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . 0.946 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.5 tp -178.45 -171.82 0.27 Allowed 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 105.376 -2.083 . . . . 145.25 105.376 178.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' GLN . . . . . 0.946 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.1 tt0 -66.14 -43.14 87.94 Favored 'General case' 0 CA--C 1.487 -1.446 0 N-CA-C 106.078 -1.823 . . . . 66.05 106.078 174.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' THR . . . . . 0.758 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.71 -152.18 0.48 Allowed 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 103.486 -2.783 . . . . 266.49 103.486 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 345' ' ' GLN . . . . . 0.609 ' CD ' HD23 ' A' ' 342' ' ' LEU . 79.3 mt-30 66.37 -124.88 0.28 Allowed 'General case' 0 CA--C 1.485 -1.545 0 C-N-CA 117.038 -1.865 . . . . 219.2 107.742 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 346' ' ' GLY . . . . . 1.002 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.16 -37.38 94.01 Favored Glycine 0 N--CA 1.425 -2.063 0 CA-C-N 114.555 -1.202 . . . . 94.78 112.84 -175.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 347' ' ' SER . . . . . 1.097 ' HG ' ' HB3' ' A' ' 61' ' ' LYS . 48.3 t -81.12 100.38 9.02 Favored 'General case' 0 CA--C 1.483 -1.598 0 C-N-CA 112.346 -3.742 . . . . 121.41 109.477 -171.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 348' ' ' VAL . . . . . 0.671 ' O ' ' HE2' ' A' ' 336' ' ' MET . 94.5 t -73.05 145.47 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 N-CA-C 108.951 -0.759 . . . . 85.34 108.951 -176.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 349' ' ' TYR . . . . . 0.506 ' N ' HG13 ' A' ' 348' ' ' VAL . 48.5 p90 -57.74 143.44 41.88 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 107.826 -1.176 . . . . 267.57 107.826 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 350' ' ' LYS . . . . . 0.509 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.03 69.61 0.59 Allowed 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 109.514 -0.55 . . . . 226.1 109.514 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 351' ' ' VAL . . . . . 1.045 ' HB ' ' HE1' ' A' ' 336' ' ' MET . 7.5 p -51.0 156.92 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 N-CA-C 106.986 -1.487 . . . . 154.84 106.986 177.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 352' ' ' SER . . . . . 0.504 ' N ' HG23 ' A' ' 351' ' ' VAL . 71.8 m -61.36 161.92 8.54 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.566 0.698 . . . . 180.01 110.732 -173.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 353' ' ' ARG . . . . . 0.882 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.42 156.86 23.73 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 106.971 -1.492 . . . . 333.78 106.971 -178.595 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 354' ' ' LEU . . . . . 0.989 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.01 142.55 48.71 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 107.371 -1.344 . . . . 335.2 107.371 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.989 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.5 mm-40 82.77 158.9 0.13 Allowed 'General case' 0 CA--C 1.492 -1.281 0 N-CA-C 108.735 -0.839 . . . . 266.47 108.735 179.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.5 m -60.62 -46.85 88.73 Favored 'General case' 0 CA--C 1.488 -1.441 0 N-CA-C 105.653 -1.98 . . . . 59.34 105.653 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.4 t -81.64 173.9 11.91 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 104.376 -2.453 . . . . 201.26 104.376 176.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.782 HG21 ' O ' ' A' ' 360' ' ' THR . 68.9 mt -95.91 106.73 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 C-N-CA 116.308 -2.157 . . . . 56.23 105.548 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 359' ' ' SER . . . . . 0.52 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.9 m -61.23 -59.43 5.33 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 109.326 -0.62 . . . . 87.58 109.326 -175.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 360' ' ' THR . . . . . 0.891 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.1 t -85.47 153.72 22.28 Favored 'General case' 0 CA--C 1.485 -1.533 0 N-CA-C 107.855 -1.165 . . . . 219.95 107.855 -177.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 361' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 361' ' ' VAL . 16.0 m -82.01 83.82 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.641 0 C-N-CA 116.324 -2.15 . . . . 121.79 105.448 177.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.623 HG13 ' N ' ' A' ' 363' ' ' GLY . 64.6 t -154.12 159.72 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.575 0 N-CA-C 105.851 -1.907 . . . . 53.85 105.851 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . 0.623 ' N ' HG13 ' A' ' 362' ' ' VAL . . . 72.27 16.57 77.13 Favored Glycine 0 N--CA 1.428 -1.87 0 N-CA-C 106.023 -2.831 . . . . 196.55 106.023 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.674 0 N-CA-C 107.909 -1.145 . . . . 35.88 107.909 -178.949 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 365' ' ' ARG . . . . . 0.516 ' HA ' ' HD3' ' B' ' 365' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 108.884 -0.784 . . . . 1.0 108.884 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 366' ' ' PRO . . . . . 0.779 ' HB3' ' C ' ' A' ' 4' ' ' VAL . 52.8 Cg_endo -66.85 142.01 61.24 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.056 1.837 . . . . 1.0 110.223 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 367' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -64.42 143.24 98.5 Favored Pre-proline 0 C--N 1.325 -0.496 0 C-N-CA 119.841 -0.744 . . . . 1.0 109.595 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 368' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.27 150.38 76.43 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.331 2.021 . . . . 1.0 111.746 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 369' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -70.71 131.8 44.42 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.688 -0.405 . . . . 1.0 110.181 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -102.05 115.88 31.49 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.716 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 371' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -63.69 -42.38 98.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.365 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 372' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -64.96 -36.26 83.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.86 -0.609 . . . . 1.0 110.728 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -59.7 -33.08 76.03 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.819 -0.912 . . . . 1.0 110.819 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 374' ' ' LEU . . . . . 0.821 ' HG ' ' CD1' ' A' ' 102' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 120.93 0.395 . . . . 1.0 110.213 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.466 0 N-CA-C 108.386 -0.968 . . . . 97.08 108.386 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.429 ' HB3' ' OD1' ' A' ' 276' ' ' ASP . 46.5 t30 -110.61 155.44 22.37 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-O 122.147 0.975 . . . . 123.41 110.711 -172.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.923 HG11 HD13 ' A' ' 15' ' ' ILE . 28.6 m -134.59 -162.41 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.476 1 N-CA-C 100.12 -4.029 . . . . 151.3 100.12 173.697 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.968 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.6 -38.65 59.16 Favored Pre-proline 0 N--CA 1.439 -0.984 0 C-N-CA 115.948 -2.301 . . . . 169.25 106.102 178.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.968 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 59.2 Cg_exo -81.29 168.54 16.63 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 N-CA-C 110.513 -0.61 . . . . 185.76 110.513 171.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.855 HG12 ' CE2' ' A' ' 282' ' ' PHE . 92.2 t -64.45 -25.95 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 C-N-CA 127.012 2.125 . . . . 145.47 110.369 -177.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.713 ' O ' HG21 ' A' ' 4' ' ' VAL . 39.1 t0 -84.26 157.38 21.59 Favored 'General case' 0 N--CA 1.439 -1.005 0 O-C-N 121.08 -1.013 . . . . 102.76 109.53 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.3 p -82.57 154.14 25.15 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 107.985 -1.117 . . . . 106.25 107.985 178.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.923 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 46.7 p-10 -105.88 51.88 0.74 Allowed 'General case' 0 N--CA 1.428 -1.547 0 C-N-CA 117.766 -1.574 . . . . 157.81 107.623 178.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.11 -45.91 91.39 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 103.617 -2.734 . . . . 150.2 103.617 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.458 ' C ' ' H ' ' A' ' 14' ' ' ASN . 70.8 m -87.09 164.69 35.16 Favored Pre-proline 0 N--CA 1.422 -1.84 0 N-CA-C 103.624 -2.732 . . . . 183.52 103.624 172.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -76.76 6.89 3.83 Favored 'Trans proline' 0 C--N 1.282 -2.97 0 N-CA-C 109.957 -0.824 . . . . 235.61 109.957 176.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.458 ' H ' ' C ' ' A' ' 12' ' ' SER . 34.5 t-20 -57.92 -41.27 82.35 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 124.813 1.245 . . . . 113.77 113.395 -170.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.923 HD13 HG11 ' A' ' 4' ' ' VAL . 33.4 pt -52.14 136.21 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-N 119.522 1.055 . . . . 150.85 110.954 -176.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.49 156.26 46.4 Favored 'General case' 0 C--N 1.36 1.061 0 N-CA-C 107.622 -1.251 . . . . 100.42 107.622 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 1.031 HG21 ' H ' ' A' ' 20' ' ' SER . 14.2 t -64.96 142.62 58.37 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 121.99 0.9 . . . . 129.36 110.43 -174.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.765 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.13 -25.51 68.39 Favored 'General case' 0 CA--C 1.493 -1.221 0 C-N-CA 126.328 1.851 . . . . 112.34 106.63 -177.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 1.008 HG21 ' HA2' ' A' ' 101' ' ' GLY . 85.9 m -74.18 -40.08 62.76 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 115.575 -0.739 . . . . 131.73 111.724 177.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 1.031 ' H ' HG21 ' A' ' 17' ' ' THR . 70.9 m -84.52 -42.79 15.17 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 116.985 2.217 . . . . 80.49 116.985 -174.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.526 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.5 mt-10 -145.99 174.56 3.33 Favored Pre-proline 0 N--CA 1.442 -0.848 0 C-N-CA 118.176 -1.409 . . . . 98.98 111.216 -169.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.88 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.332 85.4 Cg_exo -61.84 -10.74 18.23 Favored 'Trans proline' 0 C--N 1.322 -0.868 1 N-CA-C 128.922 6.47 . . . . 246.95 128.922 -170.091 . . . . . . . . 4 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.676 HD22 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.7 17.46 8.72 Favored 'General case' 0 C--N 1.324 -0.512 1 CA-C-N 126.175 4.079 . . . . 269.62 114.213 175.628 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.582 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.6 mt-30 -67.09 -27.34 67.27 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 107.782 -1.192 . . . . 86.8 107.782 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.501 ' CE1' ' CG2' ' A' ' 26' ' ' VAL . 50.4 p90 -66.76 -29.33 69.27 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 121.153 -0.967 . . . . 85.91 110.549 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.889 HG11 ' OE1' ' A' ' 284' ' ' GLN . 40.3 t -68.51 -40.25 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 C-N-CA 123.706 0.803 . . . . 82.0 111.333 -177.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.929 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.4 167.71 12.52 Favored Pre-proline 0 CA--C 1.488 -1.407 0 N-CA-C 108.55 -0.907 . . . . 120.73 108.55 -178.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.844 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.6 Cg_endo -64.04 149.77 89.77 Favored 'Trans proline' 0 N--CA 1.432 -2.106 0 C-N-CA 120.638 0.892 . . . . 87.86 109.89 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.819 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.07 -37.94 89.2 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 108.808 -0.812 . . . . 36.46 108.808 -176.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.841 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 28.0 p-90 -63.84 -33.86 76.62 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 107.757 -1.201 . . . . 150.6 107.757 -176.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.929 ' OE1' ' HB2' ' A' ' 27' ' ' GLN . 80.5 mt-30 -62.23 -32.66 73.37 Favored 'General case' 0 CA--C 1.49 -1.351 0 O-C-N 121.272 -0.893 . . . . 123.26 108.686 -178.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.856 HG23 ' O ' ' A' ' 93' ' ' ALA . 1.7 mp -61.49 -47.13 94.84 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 N-CA-C 109.188 -0.671 . . . . 120.14 109.188 176.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 30' ' ' TRP . 20.3 m -67.47 -30.96 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 N-CA-C 107.868 -1.16 . . . . 112.19 107.868 -178.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.841 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.5 tp -63.02 -47.11 84.5 Favored 'General case' 0 N--CA 1.433 -1.323 0 C-N-CA 119.895 -0.722 . . . . 60.87 109.623 -178.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.688 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.01 -35.68 81.2 Favored 'General case' 0 CA--C 1.489 -1.402 0 C-N-CA 119.952 -0.699 . . . . 157.57 110.349 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.816 ' CB ' HG12 ' A' ' 94' ' ' VAL . . . -62.63 -40.86 98.34 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 108.638 -0.875 . . . . 47.06 108.638 178.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.842 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.81 -41.28 97.92 Favored 'General case' 0 CA--C 1.496 -1.115 0 O-C-N 121.724 -0.61 . . . . 43.94 109.522 -177.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.768 ' O ' HG21 ' A' ' 41' ' ' VAL . . . -61.84 -43.25 99.22 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 108.752 -0.833 . . . . 42.61 108.752 -176.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.962 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.4 -41.22 93.9 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 116.649 -0.25 . . . . 140.66 111.059 -178.42 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.842 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.86 -43.93 97.86 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 118.588 -1.245 . . . . 116.04 110.214 -175.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.768 HG21 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.45 -38.72 83.16 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.28 0 N-CA-C 108.73 -0.841 . . . . 97.16 108.73 -177.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.918 HD11 ' HD1' ' A' ' 39' ' ' TYR . 93.3 mt -61.31 -40.03 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 N-CA-C 108.956 -0.757 . . . . 54.85 108.956 -176.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 1.009 HG23 HG23 ' A' ' 86' ' ' THR . 92.7 t -57.72 -42.31 81.42 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.302 0 N-CA-C 108.848 -0.797 . . . . 45.39 108.848 -175.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.401 ' O ' HG22 ' A' ' 48' ' ' VAL . 97.2 t -63.55 -50.98 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 C-N-CA 118.839 -1.144 . . . . 48.64 110.162 -177.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.799 ' HG1' ' CE ' ' A' ' 299' ' ' MET . 10.6 t -65.23 -47.08 78.06 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 120.197 -0.601 . . . . 116.65 111.694 -174.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.642 ' N ' HG23 ' A' ' 45' ' ' THR . 50.8 m -61.98 -43.88 97.9 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 109.73 -0.471 . . . . 51.16 109.73 -174.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 43' ' ' VAL . 97.1 t -65.63 -48.86 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 C-N-CA 119.846 -0.741 . . . . 44.3 110.818 -176.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.875 ' O ' HG22 ' A' ' 52' ' ' VAL . 94.0 t -64.75 -46.97 90.54 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 C-N-CA 120.291 -0.564 . . . . 48.82 111.068 -174.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.73 -44.2 95.2 Favored Glycine 0 N--CA 1.437 -1.299 0 C-N-CA 120.515 -0.85 . . . . 58.7 112.021 -174.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -72.55 -34.28 67.41 Favored 'General case' 0 CA--C 1.488 -1.436 0 O-C-N 122.061 -0.67 . . . . 101.4 111.072 -175.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.813 HG11 ' O ' ' A' ' 48' ' ' VAL . 8.4 p -66.83 -38.77 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 107.73 -1.211 . . . . 103.57 107.73 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.875 HG22 ' O ' ' A' ' 48' ' ' VAL . 72.0 t -61.44 -43.01 96.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 N-CA-C 108.974 -0.75 . . . . 61.89 108.974 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.637 ' O ' HG21 ' A' ' 56' ' ' ILE . 81.6 t -63.5 -50.93 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 109.437 -0.579 . . . . 70.01 109.437 -178.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.718 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.98 -43.35 99.02 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 109.122 -0.696 . . . . 132.1 109.122 -176.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.675 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.1 t-105 -64.23 -46.63 82.96 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 116.666 -0.243 . . . . 104.5 110.434 -176.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.901 HD11 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.69 -49.88 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 C-N-CA 120.194 -0.602 . . . . 142.96 111.235 -173.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 1.045 HD12 HG13 ' A' ' 72' ' ' VAL 0.278 24.8 pt -64.78 -41.68 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.707 0 C-N-CA 116.904 -1.919 . . . . 158.32 110.905 -175.973 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.718 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.69 -41.32 98.16 Favored 'General case' 0 N--CA 1.433 -1.308 0 C-N-CA 117.701 -1.599 . . . . 137.11 109.527 178.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.39 -44.53 91.03 Favored 'General case' 0 N--CA 1.436 -1.141 0 O-C-N 122.147 -0.346 . . . . 54.66 111.024 -176.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.949 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.42 117.1 29.39 Favored 'General case' 0 CA--C 1.491 -1.294 0 CA-C-O 121.576 0.703 . . . . 127.18 109.586 -174.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 1.106 ' HB3' ' HG ' ' A' ' 347' ' ' SER . 84.3 tttt -60.81 -36.87 80.13 Favored 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 124.072 0.949 . . . . 87.93 110.819 -176.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 1.06 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.34 -34.66 78.66 Favored 'General case' 0 CA--C 1.49 -1.355 0 O-C-N 121.636 -0.665 . . . . 131.12 111.541 -175.63 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 1.013 ' HG3' ' CE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.67 69.49 7.2 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 115.311 -2.556 . . . . 246.56 109.555 -175.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 61' ' ' LYS . 9.6 mmp_? -123.27 91.44 3.48 Favored 'General case' 0 CA--C 1.473 -1.987 0 N-CA-C 105.495 -2.039 . . . . 339.35 105.495 177.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.86 ' HG1' ' H ' ' A' ' 68' ' ' ASN . 82.6 p -124.18 165.29 17.84 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 102.986 -2.968 . . . . 114.66 102.986 176.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.956 HG22 ' HG1' ' A' ' 147' ' ' THR . 7.7 p -63.14 -39.44 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 N-CA-C 106.773 -1.566 . . . . 143.28 106.773 178.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.986 HG21 HD13 ' A' ' 71' ' ' LEU . 95.4 m -59.75 -37.99 80.52 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 108.652 -0.87 . . . . 160.22 108.652 -176.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.86 ' H ' ' HG1' ' A' ' 65' ' ' THR . 86.3 m-20 -62.36 -31.77 72.47 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 108.86 -0.793 . . . . 120.54 108.86 -177.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.938 ' O ' HG21 ' A' ' 72' ' ' VAL . 89.9 m-85 -63.6 -43.77 95.96 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.523 -0.547 . . . . 67.22 109.523 178.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.934 ' CE2' HG23 ' A' ' 66' ' ' VAL . 82.4 m-85 -66.6 -39.72 88.52 Favored 'General case' 0 CA--C 1.498 -1.041 0 O-C-N 121.487 -0.758 . . . . 138.6 109.639 -177.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.986 HD13 HG21 ' A' ' 67' ' ' THR . 10.1 mp -63.62 -35.87 81.96 Favored 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 122.435 0.294 . . . . 151.46 110.639 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 1.045 HG13 HD12 ' A' ' 57' ' ' ILE . 24.0 m -62.54 -37.96 80.2 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.228 0 C-N-CA 117.41 -1.716 . . . . 117.93 106.732 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.528 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.0 t30 -60.11 -46.04 90.96 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 107.839 -1.171 . . . . 56.82 107.839 -177.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.912 HD21 ' CE ' ' A' ' 123' ' ' MET . 8.6 mp -61.33 -43.87 98.14 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 109.005 -0.739 . . . . 145.3 109.005 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.09 -40.33 95.49 Favored 'General case' 0 CA--C 1.492 -1.256 0 N-CA-C 108.5 -0.926 . . . . 45.71 108.5 -175.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -62.43 -42.01 99.13 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 109.346 -0.613 . . . . 105.61 109.346 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.14 -39.44 92.62 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 108.667 -0.864 . . . . 47.89 108.667 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.706 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.56 -37.38 84.84 Favored 'General case' 0 N--CA 1.439 -1.014 0 O-C-N 122.059 -0.401 . . . . 124.53 109.969 179.662 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.81 -41.29 99.24 Favored 'General case' 0 CA--C 1.496 -1.116 0 O-C-N 121.991 -0.443 . . . . 35.89 109.858 -178.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.7 t -62.14 -37.34 84.79 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 107.052 -1.462 . . . . 88.97 107.052 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.841 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.7 ttm -62.2 -49.19 76.76 Favored 'General case' 0 N--CA 1.428 -1.571 0 C-N-CA 119.816 -0.754 . . . . 239.91 109.03 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.599 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.37 -43.43 90.8 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 121.532 -0.73 . . . . 146.1 110.56 -177.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.13 -58.22 3.41 Favored 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 117.416 -1.714 . . . . 91.74 113.888 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -76.54 -61.41 1.97 Allowed 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 115.75 1.759 . . . . 197.45 115.75 -173.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.981 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.24 -42.23 55.72 Favored 'General case' 0 CA--C 1.49 -1.357 0 C-N-CA 117.876 -1.53 . . . . 242.6 114.061 -170.02 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 1.009 HG23 HG23 ' A' ' 43' ' ' VAL . 4.6 t -65.39 -36.59 84.42 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 118.941 -1.103 . . . . 215.61 109.812 -172.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.421 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.4 t -60.31 -46.95 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 O-C-N 121.824 -0.548 . . . . 87.19 110.426 -175.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.892 HG22 ' CD2' ' A' ' 108' ' ' HIS . 63.7 t -65.94 -41.84 90.67 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.098 0 N-CA-C 109.727 -0.471 . . . . 231.82 109.727 -178.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.962 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 11.0 m120 -62.33 -34.11 76.0 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 108.365 -0.976 . . . . 364.98 108.365 -177.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.658 ' CE1' ' HB3' ' A' ' 36' ' ' ALA . 85.0 t80 -68.16 -44.76 75.27 Favored 'General case' 0 N--CA 1.438 -1.07 0 O-C-N 121.56 -0.713 . . . . 181.63 111.271 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.899 HG21 ' HD2' ' A' ' 95' ' ' HIS . 57.6 m -60.85 -45.8 93.1 Favored 'General case' 0 CA--C 1.477 -1.831 0 N-CA-C 107.438 -1.319 . . . . 269.02 107.438 -175.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 1.073 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.74 -45.01 93.53 Favored 'General case' 0 N--CA 1.416 -2.165 0 C-N-CA 118.683 -1.207 . . . . 562.66 110.037 -179.056 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.856 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.08 -45.31 95.24 Favored 'General case' 0 CA--C 1.479 -1.768 0 C-N-CA 118.697 -1.201 . . . . 446.75 108.042 -167.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.816 HG12 ' CB ' ' A' ' 36' ' ' ALA 0.387 6.1 m -70.5 -26.28 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.752 0 C-N-CA 115.819 -2.352 . . . . 370.05 112.244 -178.72 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.899 ' HD2' HG21 ' A' ' 91' ' ' THR . 90.0 m-70 -74.46 -26.54 60.1 Favored 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 121.592 -0.692 . . . . 354.91 112.469 175.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.88 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.4 m-20 82.85 4.51 0.98 Allowed 'General case' 0 CA--C 1.5 -0.951 0 C-N-CA 125.044 1.338 . . . . 462.44 111.881 -178.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.765 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.267 11.9 mm-40 -172.36 178.06 2.91 Favored 'General case' 0 CA--C 1.488 -1.409 0 CA-C-O 122.025 0.916 . . . . 652.37 111.122 171.813 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.831 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.72 86.31 2.17 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 128.516 2.726 . . . . 905.99 107.924 -174.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -67.9 -36.43 80.19 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 108.217 -1.031 . . . . 570.43 108.217 -176.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.845 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.58 -36.34 82.38 Favored 'General case' 0 N--CA 1.427 -1.586 0 C-N-CA 125.361 1.464 . . . . 453.22 111.152 -174.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 1.008 ' HA2' HG21 ' A' ' 19' ' ' THR . . . 97.55 178.69 33.89 Favored Glycine 0 C--N 1.349 1.266 0 C-N-CA 118.777 -1.678 . . . . 445.63 109.854 177.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.1 mt -56.38 -41.23 75.89 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 125.257 1.423 . . . . 457.72 112.377 -170.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -58.71 -46.86 86.39 Favored 'General case' 0 CA--C 1.484 -1.56 0 C-N-CA 118.622 -1.231 . . . . 340.58 109.281 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.845 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.2 m-85 -68.72 -32.14 71.72 Favored 'General case' 0 N--CA 1.423 -1.778 0 C-N-CA 118.784 -1.166 . . . . 453.6 111.576 -176.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.728 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.2 t -56.08 -40.32 73.44 Favored 'General case' 0 CA--C 1.488 -1.441 0 N-CA-C 105.948 -1.871 . . . . 541.48 105.948 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.452 ' HD2' ' HA2' ' A' ' 166' ' ' GLY . 27.0 ttpt -65.87 -47.17 75.79 Favored 'General case' 0 CA--C 1.485 -1.532 0 O-C-N 123.959 0.787 . . . . 466.68 110.869 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -61.63 -47.14 86.74 Favored 'General case' 0 N--CA 1.427 -1.621 0 C-N-CA 117.501 -1.68 . . . . 427.34 107.361 -178.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.892 ' CD2' HG22 ' A' ' 88' ' ' VAL . 47.5 m80 -67.05 -36.77 82.78 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 112.456 0.539 . . . . 537.87 112.456 -174.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.583 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.38 -42.68 74.83 Favored 'General case' 0 N--CA 1.432 -1.344 0 C-N-CA 116.884 -1.926 . . . . 422.12 111.608 175.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.913 ' O ' HG21 ' A' ' 113' ' ' ILE . 75.9 t80 -59.1 -50.08 75.41 Favored 'General case' 0 CA--C 1.501 -0.909 0 O-C-N 121.342 -0.849 . . . . 340.17 111.815 -173.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.484 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 61.6 m-85 -65.32 -46.48 71.03 Favored Pre-proline 0 N--CA 1.443 -0.816 0 C-N-CA 119.1 -1.04 . . . . 258.06 111.696 -176.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.981 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.1 Cg_exo -61.57 -31.54 87.24 Favored 'Trans proline' 0 N--CA 1.435 -1.925 0 N-CA-C 115.341 1.246 . . . . 305.71 115.341 176.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.944 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.87 -40.45 76.54 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.363 0 N-CA-C 108.686 -0.857 . . . . 252.7 108.686 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.422 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.93 -40.57 93.76 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 107.825 -1.176 . . . . 149.27 107.825 -179.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.99 -44.84 95.88 Favored 'General case' 0 N--CA 1.436 -1.165 0 C-N-CA 120.614 -0.434 . . . . 138.08 111.497 -176.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.753 HG23 ' CZ2' ' A' ' 261' ' ' TRP . 65.2 t -66.94 -42.34 88.7 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.944 0 O-C-N 121.604 -0.685 . . . . 132.89 110.969 -177.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.944 ' CE2' HG13 ' A' ' 113' ' ' ILE . 26.6 m-85 -63.76 -44.7 92.69 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 108.871 -0.788 . . . . 193.61 108.871 -177.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.605 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.43 -37.71 84.5 Favored 'General case' 0 N--CA 1.435 -1.177 0 C-N-CA 122.811 0.445 . . . . 63.83 110.094 -175.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 72.0 m -63.95 -52.46 59.64 Favored 'General case' 0 N--CA 1.435 -1.194 0 O-C-N 122.031 -0.418 . . . . 76.4 111.221 -177.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.809 HD11 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.96 -41.7 93.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 108.179 -1.045 . . . . 171.13 108.179 -174.963 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 1.069 ' HB2' HD12 ' A' ' 154' ' ' ILE . 29.2 m-85 -63.79 -38.53 91.46 Favored 'General case' 0 N--CA 1.433 -1.3 0 O-C-N 121.839 -0.538 . . . . 78.3 110.631 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.553 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.5 t -67.11 -35.73 80.4 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 118.854 -1.138 . . . . 92.36 109.229 -178.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' MET . . . . . 1.093 ' HA ' ' HE1' ' A' ' 123' ' ' MET . 5.9 mmt -62.47 -34.27 76.49 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 108.218 -1.03 . . . . 93.73 108.218 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.974 HG22 HG13 ' A' ' 212' ' ' ILE . 32.9 p -67.38 -41.72 84.58 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.209 -0.996 . . . . 132.74 109.302 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.28 -42.04 94.59 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 107.2 -1.408 . . . . 43.39 107.2 -177.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.866 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.0 t -58.48 -41.95 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 N-CA-C 108.606 -0.887 . . . . 59.34 108.606 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.404 ' HB3' ' HB1' ' A' ' 215' ' ' ALA . . . -63.55 -44.07 95.23 Favored 'General case' 0 CA--C 1.498 -1.039 0 O-C-N 121.844 -0.535 . . . . 69.68 110.474 -177.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.468 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.3 t80 -65.44 -42.8 92.01 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 108.313 -0.995 . . . . 106.98 108.313 -177.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.866 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.34 -35.58 81.35 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 119.632 -0.827 . . . . 147.63 108.982 -177.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.766 ' NH1' ' HE2' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.16 -41.52 99.26 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 108.562 -0.903 . . . . 190.06 108.562 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.964 ' HD2' ' HE3' ' A' ' 132' ' ' MET . 66.4 t80 -61.34 -44.12 97.72 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.253 -1.017 . . . . 118.85 108.253 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 1.114 ' HA ' ' HE1' ' A' ' 132' ' ' MET . 4.4 mmt -63.36 -42.66 98.9 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 109.979 -0.378 . . . . 102.5 109.979 -177.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.91 -41.7 95.35 Favored 'General case' 0 CA--C 1.489 -1.399 0 O-C-N 121.817 -0.552 . . . . 89.98 109.836 -176.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.888 ' CD1' HG12 ' A' ' 219' ' ' VAL . 95.4 mt -66.52 -50.7 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.719 0 C-N-CA 118.103 -1.439 . . . . 106.09 110.997 -177.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.798 HD12 ' HE1' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.03 -48.37 38.49 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.13 0 C-N-CA 117.092 -1.843 . . . . 227.74 111.824 -174.824 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.791 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 23.9 p80 -118.85 100.11 50.98 Favored Pre-proline 0 CA--C 1.486 -1.503 0 C-N-CA 116.26 -2.176 . . . . 262.55 110.061 -175.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.469 ' HD2' ' O ' ' A' ' 135' ' ' ILE . 9.2 Cg_endo -69.63 -10.35 28.45 Favored 'Trans proline' 0 C--N 1.289 -2.574 0 C-N-CA 121.607 1.538 . . . . 210.25 111.327 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.806 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.35 112.04 1.01 Allowed 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 106.483 -1.673 . . . . 270.58 106.483 -178.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.886 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.2 tt0 -66.77 -39.53 24.48 Favored Pre-proline 0 N--CA 1.431 -1.425 0 CA-C-N 115.329 -0.851 . . . . 129.84 112.362 -176.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.85 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 82.3 Cg_exo -61.36 -26.57 81.72 Favored 'Trans proline' 0 N--CA 1.431 -2.176 0 N-CA-C 116.322 1.624 . . . . 330.71 116.322 -174.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.791 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.07 77.24 7.99 Favored 'General case' 0 N--CA 1.429 -1.514 0 C-N-CA 114.47 -2.892 . . . . 204.51 107.3 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.875 HD12 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.68 147.38 0.09 Allowed 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.482 -1.303 . . . . 387.41 107.482 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.875 ' N ' HD12 ' A' ' 142' ' ' LEU . 47.3 t -143.68 147.0 33.64 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 118.824 -1.151 . . . . 166.22 109.515 178.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.8 -40.77 88.21 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 107.869 -1.159 . . . . 44.23 107.869 176.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.475 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.7 m -60.33 -39.08 85.8 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 108.181 -1.044 . . . . 28.8 108.181 -175.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.642 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.86 -38.75 92.06 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 109.087 -0.708 . . . . 30.29 109.087 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.956 ' HG1' HG22 ' A' ' 66' ' ' VAL . 90.3 m -59.62 -43.03 93.94 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 109.011 -0.737 . . . . 46.11 109.011 -176.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.459 ' HD3' ' HA ' ' A' ' 145' ' ' THR . 0.2 OUTLIER -62.46 -42.12 99.25 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 107.7 -1.222 . . . . 87.33 107.7 -179.654 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.791 ' O ' HG22 ' A' ' 153' ' ' VAL . 96.4 t -61.71 -42.06 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.359 0 N-CA-C 107.874 -1.158 . . . . 23.69 107.874 -178.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.8 t -63.2 -44.26 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 N-CA-C 109.73 -0.47 . . . . 43.86 109.73 -178.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.933 ' O ' HG23 ' A' ' 154' ' ' ILE . 46.1 mm -61.24 -42.54 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 108.359 -0.978 . . . . 91.13 108.359 -176.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . 0.506 ' O ' HG22 ' A' ' 156' ' ' VAL . 52.3 t -62.62 -37.95 88.31 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 108.735 -0.839 . . . . 65.88 108.735 -178.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.791 HG22 ' O ' ' A' ' 149' ' ' VAL . 95.5 t -62.1 -41.88 92.89 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 109.552 -0.536 . . . . 33.86 109.552 -177.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 1.069 HD12 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.37 -40.37 85.97 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.159 0 N-CA-C 107.583 -1.266 . . . . 146.52 107.583 -176.791 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . 0.773 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.1 m95 -62.84 -38.35 90.43 Favored 'General case' 0 N--CA 1.428 -1.538 0 C-N-CA 119.502 -0.879 . . . . 75.44 108.942 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 152' ' ' CYS . 98.9 t -60.5 -48.42 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 O-C-N 121.058 -1.026 . . . . 43.64 109.749 -177.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.814 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.65 -38.05 89.67 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 109.041 -0.726 . . . . 102.57 109.041 -178.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.99 -41.06 86.7 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.433 -1.321 . . . . 58.16 107.433 -178.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.822 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.08 -32.55 73.95 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.014 -0.736 . . . . 121.11 109.014 178.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.814 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.0 -42.3 84.92 Favored 'General case' 0 CA--C 1.489 -1.381 0 C-N-CA 118.554 -1.258 . . . . 153.15 109.966 -178.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 1.0 HD12 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.09 -43.71 19.07 Favored 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 113.06 -3.456 . . . . 133.67 113.532 173.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.536 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -63.0 -39.83 95.96 Favored 'General case' 0 CA--C 1.49 -1.344 0 O-C-N 120.888 -1.132 . . . . 157.42 112.196 -171.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.519 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.3 t80 -74.51 -36.08 2.4 Favored Pre-proline 0 N--CA 1.437 -1.112 0 N-CA-C 114.974 1.472 . . . . 250.91 114.974 -173.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.519 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.293 53.0 Cg_exo -59.53 -25.46 78.83 Favored 'Trans proline' 0 CA--C 1.488 -1.817 0 N-CA-C 118.043 2.286 . . . . 207.34 118.043 -174.37 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 1.022 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 87.7 mt-30 -61.18 -34.23 74.71 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 106.953 -1.499 . . . . 192.46 106.953 178.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.452 ' HA2' ' HD2' ' A' ' 106' ' ' LYS . . . -64.46 -41.07 98.16 Favored Glycine 0 C--N 1.353 1.513 0 N-CA-C 107.974 -2.05 . . . . 261.0 107.974 177.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.78 159.07 26.02 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 101.548 -3.501 . . . . 491.4 101.548 172.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -59.92 106.79 0.53 Allowed 'General case' 0 CA--C 1.488 -1.42 0 C-N-CA 116.282 -2.167 . . . . 386.1 109.831 -176.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 1.022 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 74.0 m -154.05 -166.61 2.42 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 103.553 -2.758 . . . . 289.8 103.553 -178.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 1.103 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.1 p -62.91 175.44 0.86 Allowed 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 117.723 -1.132 . . . . 402.06 109.554 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.783 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 72.5 p -165.3 177.5 7.54 Favored 'General case' 0 CA--C 1.587 2.383 0 C-N-CA 127.309 2.243 . . . . 690.53 114.927 177.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.57 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.8 mm-40 132.32 160.57 0.0 OUTLIER 'General case' 1 C--N 1.428 4.007 1 N-CA-C 123.183 4.512 . . . . 633.62 123.183 162.691 . . . . . . . . 4 3 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.79 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.4 p -85.68 153.82 22.08 Favored 'General case' 0 C--N 1.389 2.313 0 C-N-CA 127.373 2.269 . . . . 617.99 110.874 178.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' MET . . . . . 1.118 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.66 174.45 5.93 Favored Pre-proline 0 C--N 1.364 1.233 0 C-N-CA 130.284 3.433 . . . . 434.98 113.387 -175.365 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 1.118 ' HD2' ' HB3' ' A' ' 174' ' ' MET . 52.9 Cg_endo -44.31 -65.63 0.19 Allowed 'Trans proline' 0 N--CA 1.441 -1.576 0 N-CA-C 122.386 3.956 . . . . 365.88 122.386 -168.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' SER . . . . . 0.787 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.306 70.4 m -84.91 20.94 1.7 Allowed 'General case' 0 CA--C 1.466 -2.257 0 N-CA-C 104.807 -2.294 . . . . 635.81 104.807 178.147 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.775 ' HB3' ' H ' ' A' ' 179' ' ' VAL 0.457 5.0 mmp_? -94.33 152.24 18.8 Favored 'General case' 1 CA--C 1.419 -4.081 3 N-CA-C 132.031 7.789 . . . . 999.99 132.031 -135.787 . . . . . . . . 5 3 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 1.073 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.912 37.3 t -131.83 73.12 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.383 -3.8 1 CA-C-N 103.343 -6.299 . . . . 594.32 113.606 149.235 . . . . . . . . 4 3 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.775 ' H ' ' HB3' ' A' ' 177' ' ' ARG . 7.3 p -144.16 144.14 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.603 1 N-CA-C 98.244 -4.724 . . . . 811.91 98.244 162.404 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . 0.79 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.9 m -118.48 144.49 45.97 Favored 'General case' 0 CA--C 1.489 -1.391 0 C-N-CA 117.099 -1.84 . . . . 999.99 109.429 -178.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.822 ' HE1' ' CE2' ' A' ' 264' ' ' PHE . 70.9 mmm -147.17 -175.6 4.89 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 122.019 0.914 . . . . 431.86 110.069 -177.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 1.061 HD12 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.11 148.65 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 C-N-CA 124.397 1.079 . . . . 457.18 108.796 -177.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . 0.827 ' HB3' ' HB ' ' A' ' 170' ' ' THR . 3.6 tp10 -77.31 85.41 3.74 Favored 'General case' 0 CA--C 1.5 -0.944 0 C-N-CA 124.147 0.979 . . . . 458.77 113.515 -174.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 1.015 ' CZ3' HG23 ' A' ' 182' ' ' ILE . 1.9 p90 -76.35 -31.55 0.98 Allowed Pre-proline 0 N--CA 1.438 -1.065 0 C-N-CA 124.941 1.296 . . . . 999.99 112.452 168.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.947 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 50.9 Cg_exo -66.0 -45.71 5.64 Favored 'Trans proline' 0 N--CA 1.438 -1.766 0 N-CA-C 120.895 3.383 . . . . 999.99 120.895 -174.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.557 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 54.9 mt-10 -119.54 171.73 8.15 Favored 'General case' 0 CA--C 1.472 -2.054 0 C-N-CA 117.204 -1.798 . . . . 81.18 107.285 -172.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.844 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.9 p-80 -109.13 45.14 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.828 0 C-N-CA 115.466 -2.493 . . . . 999.99 108.777 177.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 1.062 ' HB2' HD11 ' A' ' 191' ' ' ILE . 87.3 Cg_endo -41.56 101.84 0.04 OUTLIER 'Trans proline' 0 CA--C 1.5 -1.184 1 C-N-CA 126.039 4.492 . . . . 999.99 105.683 -170.749 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -62.34 -44.01 97.49 Favored 'General case' 0 CA--C 1.484 -1.586 0 C-N-CA 126.777 2.031 . . . . 967.72 112.024 -165.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -60.31 -36.49 78.01 Favored 'General case' 0 CA--C 1.487 -1.475 0 N-CA-C 106.741 -1.578 . . . . 934.3 106.741 -175.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 1.062 HD11 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.62 -30.22 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 C-N-CA 129.185 2.994 . . . . 565.15 113.918 -178.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 61.56 55.38 2.79 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-N 118.469 0.577 . . . . 755.61 109.853 -175.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 1.103 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.5 -49.33 66.94 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 124.563 1.145 . . . . 325.89 113.265 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.897 ' HG3' ' HH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.76 -45.0 78.18 Favored 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 123.573 0.749 . . . . 250.21 111.637 -169.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 96.8 t -64.73 -43.29 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 C-N-CA 119.959 -0.696 . . . . 142.46 110.389 -175.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . 1.061 ' CD2' HD12 ' A' ' 182' ' ' ILE . 34.9 t80 -61.15 -41.5 96.86 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 123.982 0.913 . . . . 247.69 108.814 -173.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' HIS . . . . . 0.889 ' HE2' ' HA ' ' A' ' 269' ' ' LEU . 23.0 t60 -60.52 -51.36 69.75 Favored 'General case' 0 CA--C 1.492 -1.279 0 C-N-CA 125.454 1.502 . . . . 199.61 113.049 -175.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 82.8 mt -65.31 -44.52 94.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 107.727 -1.212 . . . . 106.73 107.727 -177.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . 0.787 ' O ' HD12 ' A' ' 203' ' ' LEU . 41.5 t -59.11 -48.55 81.21 Favored 'General case' 0 CA--C 1.486 -1.519 0 CA-C-N 115.858 -0.61 . . . . 115.01 110.245 -173.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 1.0 HG13 HD12 ' A' ' 161' ' ' LEU . 86.1 t -65.27 -49.15 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.647 0 C-N-CA 119.458 -0.897 . . . . 129.42 111.823 -174.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.813 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.1 m -61.89 -53.14 59.82 Favored 'General case' 0 CA--C 1.483 -1.614 0 C-N-CA 118.245 -1.382 . . . . 172.48 109.953 -172.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.677 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 85.6 t -63.83 -54.24 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 C-N-CA 120.523 -0.471 . . . . 55.86 110.989 -174.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.787 HD12 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.58 -51.54 58.96 Favored 'General case' 0 N--CA 1.432 -1.355 0 C-N-CA 118.526 -1.27 . . . . 184.68 111.496 -174.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . 0.99 ' HB ' HD13 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.6 -52.44 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 C-N-CA 116.696 -2.002 . . . . 291.81 114.737 -174.683 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.433 ' HB2' ' CE1' ' A' ' 265' ' ' HIS . 87.8 t80 -82.04 -55.0 4.84 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 115.142 1.534 . . . . 130.66 115.142 -178.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . 0.813 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.9 m-85 -66.87 -48.49 68.62 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 114.532 1.308 . . . . 80.16 114.532 -170.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.925 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.57 -45.48 83.07 Favored Pre-proline 0 N--CA 1.436 -1.165 0 C-N-CA 119.91 -0.716 . . . . 136.02 109.495 -174.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.925 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.7 Cg_exo -64.76 -27.16 60.0 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 110.629 -0.566 . . . . 92.17 110.629 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.774 HD22 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.29 -41.41 76.83 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 107.495 -1.298 . . . . 135.6 107.495 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.8 mt -64.17 -44.73 91.17 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 109.57 -0.529 . . . . 52.1 109.57 -176.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . 0.699 HG13 ' O ' ' A' ' 208' ' ' PRO . 13.7 p -61.61 -43.53 97.18 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 109.12 -0.696 . . . . 95.89 109.12 -176.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.974 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.23 -42.35 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 106.728 -1.582 . . . . 43.41 106.728 -178.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.47 -42.26 99.04 Favored Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 109.361 -1.496 . . . . 27.69 109.361 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . 0.9 ' O ' HG21 ' A' ' 217' ' ' THR . 77.9 t80 -65.65 -47.4 75.69 Favored 'General case' 0 CA--C 1.496 -1.113 0 CA-C-N 117.38 0.59 . . . . 54.41 110.497 -177.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . 0.898 ' O ' HG13 ' A' ' 218' ' ' VAL . . . -61.41 -34.13 74.85 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 106.968 -1.493 . . . . 53.88 106.968 -177.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -60.74 -40.86 93.98 Favored 'General case' 0 N--CA 1.426 -1.628 0 N-CA-C 108.492 -0.929 . . . . 68.29 108.492 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' THR . . . . . 0.9 HG21 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.74 -39.06 92.99 Favored 'General case' 0 CA--C 1.497 -1.088 0 C-N-CA 119.69 -0.804 . . . . 107.59 110.619 -175.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.898 HG13 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.03 -38.36 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 C-N-CA 119.607 -0.837 . . . . 111.61 109.488 -177.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.888 HG12 ' CD1' ' A' ' 134' ' ' ILE . 79.6 t -63.29 -22.52 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 N-CA-C 108.389 -0.967 . . . . 85.26 108.389 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.84 -41.95 99.39 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 111.051 -0.82 . . . . 40.71 111.051 -176.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.7 mm -64.66 -44.09 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 108.42 -0.955 . . . . 95.86 108.42 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.845 ' CB ' HG22 ' A' ' 134' ' ' ILE . 67.1 p -76.94 -137.57 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.417 -0.956 . . . . 144.37 108.417 -176.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.929 HD21 ' NE ' ' A' ' 244' ' ' ARG . 87.7 mt -55.31 132.1 47.16 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 107.633 -1.247 . . . . 326.72 107.633 -177.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' TRP . . . . . 0.463 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.31 -168.02 1.5 Allowed 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 106.059 -1.83 . . . . 158.38 106.059 -176.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . 0.463 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.39 -41.93 98.79 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 109.619 -0.512 . . . . 36.78 109.619 -178.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.8 m -61.13 125.81 25.07 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 119.144 -1.022 . . . . 85.46 109.813 -174.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.776 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.82 126.56 8.89 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 105.547 -2.02 . . . . 127.78 105.547 176.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.982 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.04 139.92 34.8 Favored Pre-proline 0 CA--C 1.493 -1.214 0 N-CA-C 105.946 -1.872 . . . . 164.84 105.946 -179.548 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.982 ' N ' HD13 ' A' ' 228' ' ' ILE . 82.3 Cg_exo -56.87 -39.85 88.44 Favored 'Trans proline' 0 N--CA 1.431 -2.184 0 N-CA-C 113.945 0.71 . . . . 222.35 113.945 -175.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . 0.806 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -83.18 167.0 44.85 Favored Glycine 0 N--CA 1.428 -1.838 0 N-CA-C 106.39 -2.684 . . . . 45.22 106.39 178.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.924 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.6 t0 -60.97 -45.79 93.34 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 105.997 -1.853 . . . . 107.57 105.997 177.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' SER . . . . . 0.733 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.5 m -65.72 141.78 58.23 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 118.899 -1.12 . . . . 167.96 109.192 -175.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.874 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.3 m 99.5 106.7 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.248 0 C-N-CA 126.73 2.012 . . . . 280.68 109.768 176.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.777 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.5 m-20 55.99 11.31 0.71 Allowed 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 124.42 1.088 . . . . 218.25 110.717 174.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.932 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.41 137.68 54.76 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 105.217 -2.142 . . . . 343.57 105.217 177.368 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.585 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.6 t80 -112.0 81.92 1.54 Allowed 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 106.826 -1.546 . . . . 263.29 106.826 179.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' HIS . . . . . 0.662 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.3 m-70 104.29 147.03 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.285 0 C-N-CA 126.576 1.951 . . . . 261.92 108.486 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.21 -38.07 89.73 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 107.911 -1.144 . . . . 106.81 107.911 -177.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.759 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.42 -39.95 94.96 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 118.362 -1.335 . . . . 112.2 107.552 -178.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.749 HG13 ' NH1' ' A' ' 244' ' ' ARG . 75.5 t -64.25 -39.85 86.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 N-CA-C 109.254 -0.647 . . . . 45.41 109.254 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.863 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.0 p -70.94 -32.01 68.78 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 110.278 -0.267 . . . . 97.62 110.278 -178.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.38 -39.61 81.7 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 123.698 0.799 . . . . 59.29 111.012 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.759 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.25 -36.55 84.03 Favored 'General case' 0 CA--C 1.491 -1.3 0 C-N-CA 124.664 1.186 . . . . 106.49 110.683 -174.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.932 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.95 -30.67 69.24 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 108.293 -1.002 . . . . 106.62 108.293 -176.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.571 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -65.97 -41.06 91.68 Favored 'General case' 0 N--CA 1.436 -1.141 0 O-C-N 121.841 -0.537 . . . . 75.97 110.062 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.877 ' CG1' ' HE3' ' A' ' 250' ' ' MET . 76.8 t -65.53 -40.84 89.36 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 C-N-CA 122.92 0.488 . . . . 65.27 109.779 -178.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.835 HG11 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -64.03 -41.62 93.07 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.317 0 C-N-CA 120.398 -0.521 . . . . 107.94 110.12 -177.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . 0.571 ' HE2' ' HA ' ' A' ' 245' ' ' LYS . 59.2 pttt -63.47 -40.81 98.11 Favored 'General case' 0 N--CA 1.434 -1.239 0 O-C-N 121.663 -0.648 . . . . 87.98 110.328 -176.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' MET . . . . . 1.061 ' HE2' ' CD1' ' A' ' 305' ' ' TYR . 21.3 ttt -63.68 -40.41 96.76 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 118.824 -1.15 . . . . 65.5 108.35 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' MET . . . . . 0.877 ' HE3' ' CG1' ' A' ' 246' ' ' VAL . 68.5 mtt -61.64 -36.41 80.71 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.141 -1.059 . . . . 85.05 108.141 -177.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . 0.517 HD11 ' HA ' ' A' ' 248' ' ' LYS . 86.9 mt -63.48 -45.71 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 N-CA-C 109.061 -0.718 . . . . 42.25 109.061 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . 0.874 HG13 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.4 -38.19 81.93 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.13 0 C-N-CA 119.551 -0.86 . . . . 91.01 109.376 -176.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 1.03 HG21 HD11 ' A' ' 304' ' ' ILE . 66.5 t -58.93 -41.53 83.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 N-CA-C 107.931 -1.137 . . . . 66.09 107.931 -178.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 250' ' ' MET . 94.3 t -66.14 -43.15 92.24 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 C-N-CA 120.729 -0.388 . . . . 52.39 110.282 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.5 m -61.73 -46.75 88.3 Favored 'General case' 0 CA--C 1.489 -1.384 0 O-C-N 121.913 -0.492 . . . . 46.42 109.903 -174.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' THR . . . . . 0.821 ' O ' HG23 ' A' ' 259' ' ' ILE . 9.5 t -62.33 -38.18 88.45 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 108.333 -0.988 . . . . 116.51 108.333 -177.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' PHE . . . . . 0.541 ' N ' HG23 ' A' ' 256' ' ' THR . 86.1 t80 -60.23 -48.23 82.6 Favored 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 109.405 -0.591 . . . . 65.18 109.405 -178.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.94 -42.65 97.26 Favored 'General case' 0 CA--C 1.49 -1.364 0 CA-C-O 120.872 0.368 . . . . 51.33 110.468 -175.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . 0.821 HG23 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.62 -43.41 98.16 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 C-N-CA 118.941 -1.103 . . . . 126.3 108.974 -176.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' CYS . . . . . 0.568 ' N ' HG22 ' A' ' 259' ' ' ILE . 69.7 m -65.58 -49.3 69.31 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 119.518 -0.873 . . . . 133.94 112.495 -176.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.867 ' CH2' ' HB2' ' A' ' 294' ' ' ALA . 97.0 m95 -80.69 -33.4 35.47 Favored 'General case' 0 CA--C 1.497 -1.071 0 N-CA-C 116.823 2.157 . . . . 134.84 116.823 -176.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.796 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.9 tp -58.47 -41.56 89.88 Favored Pre-proline 0 CA--C 1.493 -1.225 0 O-C-N 121.628 -0.67 . . . . 72.23 111.648 -167.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' PRO . . . . . 0.817 ' O ' HG21 ' A' ' 266' ' ' ILE . 81.9 Cg_exo -60.75 -35.94 86.76 Favored 'Trans proline' 0 C--N 1.294 -2.298 0 CA-C-N 119.837 0.978 . . . . 106.13 111.302 -178.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' PHE . . . . . 0.844 ' CA ' HG21 ' A' ' 290' ' ' ILE . 71.5 t80 -66.4 -44.67 82.37 Favored 'General case' 0 N--CA 1.433 -1.321 0 C-N-CA 119.793 -0.763 . . . . 128.35 110.061 -178.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' HIS . . . . . 0.697 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.47 -37.84 88.95 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 110.236 -0.283 . . . . 100.73 110.236 -177.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.817 HG21 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.28 -44.52 94.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 C-N-CA 119.329 -0.949 . . . . 172.72 109.139 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . 0.75 ' HD1' ' O ' ' A' ' 263' ' ' PRO . 61.6 m-85 -66.61 -28.06 68.2 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 108.235 -1.024 . . . . 249.23 108.235 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' PHE . . . . . 0.903 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.3 t80 -55.56 -55.13 35.52 Favored 'General case' 0 N--CA 1.433 -1.325 0 N-CA-C 106.653 -1.61 . . . . 259.78 106.653 178.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' LEU . . . . . 0.889 ' HA ' ' HE2' ' A' ' 197' ' ' HIS . 89.5 mt -69.14 -44.2 72.82 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 113.606 0.965 . . . . 233.11 113.606 -176.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . 0.847 HD12 HD21 ' A' ' 279' ' ' LEU . 88.7 mt -61.4 -48.34 91.21 Favored Pre-proline 0 CA--C 1.5 -0.946 0 C-N-CA 119.199 -1.0 . . . . 169.54 110.553 -171.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . 0.682 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.8 Cg_exo -61.05 -24.64 79.89 Favored 'Trans proline' 0 N--CA 1.429 -2.287 0 C-N-CA 116.797 -1.668 . . . . 255.47 114.64 174.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' TYR . . . . . 0.897 ' HH ' ' HG3' ' A' ' 194' ' ' LYS . 19.6 t80 -63.57 -44.17 94.88 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 119.233 0.924 . . . . 279.03 108.91 177.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . 0.831 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.34 -44.82 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 N-CA-C 110.076 -0.342 . . . . 162.21 110.076 -178.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' ASN . . . . . 0.774 ' N ' HD11 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.38 84.89 59.25 Favored Pre-proline 0 N--CA 1.431 -1.423 0 C-N-CA 118.761 -1.176 . . . . 128.13 108.067 -178.078 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.26 164.06 11.25 Favored 'Trans proline' 0 C--N 1.295 -2.281 0 N-CA-C 107.487 -1.774 . . . . 278.35 107.487 177.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . 0.863 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.09 15.07 9.94 Favored 'General case' 0 N--CA 1.429 -1.518 0 O-C-N 123.752 0.658 . . . . 312.91 109.319 175.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.863 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.2 mt -132.72 -170.69 2.49 Favored 'General case' 0 CA--C 1.481 -1.686 0 N-CA-C 106.533 -1.654 . . . . 353.54 106.533 177.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 1.022 ' HA ' ' CB ' ' A' ' 282' ' ' PHE . 42.8 p90 -115.63 142.26 46.98 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 107.419 -1.326 . . . . 251.26 107.419 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.847 HD21 HD12 ' A' ' 270' ' ' LEU . 1.7 tm? -76.92 -118.74 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 102.1 -3.296 . . . . 175.26 102.1 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . 0.779 ' HB3' ' HE3' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.51 -44.96 96.13 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 100.892 -3.744 . . . . 99.07 100.892 172.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . 0.779 ' HE3' ' HB3' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.42 124.15 9.18 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 103.508 -2.775 . . . . 243.21 103.508 171.157 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 1.022 ' CB ' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.97 113.01 25.16 Favored 'General case' 0 CA--C 1.474 -1.967 0 C-N-CA 116.004 -2.278 . . . . 201.04 105.287 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' ILE . . . . . 0.768 HG23 ' N ' ' A' ' 285' ' ' GLN . 10.7 tp -147.95 173.71 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.098 0 C-N-CA 116.006 -2.277 . . . . 201.36 108.789 -175.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' GLN . . . . . 1.065 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.283 0.6 OUTLIER -59.48 -41.46 89.84 Favored 'General case' 0 N--CA 1.415 -2.189 0 CA-C-N 113.28 -1.782 . . . . 203.82 107.881 174.44 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . 0.918 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.29 -45.75 86.62 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 118.221 -1.392 . . . . 215.06 112.532 -171.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.638 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.2 t -65.64 -46.41 89.46 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.461 0 C-N-CA 118.562 -1.255 . . . . 125.28 112.948 -171.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' TYR . . . . . 0.855 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.76 -37.01 86.17 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 107.211 -1.404 . . . . 268.9 107.211 -171.929 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . 0.869 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.26 -44.98 74.4 Favored 'General case' 0 CA--C 1.483 -1.603 0 C-N-CA 125.614 1.566 . . . . 280.88 108.769 -172.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.66 -47.53 85.85 Favored 'General case' 0 CA--C 1.485 -1.534 0 C-N-CA 118.985 -1.086 . . . . 184.47 108.959 -172.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . 0.844 HG21 ' CA ' ' A' ' 264' ' ' PHE . 1.8 mp -67.93 -42.09 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 C-N-CA 119.273 -0.971 . . . . 167.92 112.724 -175.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' MET . . . . . 0.661 ' HE2' ' HG2' ' A' ' 181' ' ' MET . 21.7 ttt -65.7 -38.88 90.45 Favored 'General case' 0 CA--C 1.495 -1.139 0 C-N-CA 117.764 -1.574 . . . . 367.18 110.767 -175.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' TRP . . . . . 0.571 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.5 m95 -67.12 -32.69 73.99 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 121.804 -0.56 . . . . 173.97 110.477 177.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.4 tp -64.48 -36.73 85.13 Favored 'General case' 0 CA--C 1.499 -1.0 0 C-N-CA 123.517 0.727 . . . . 119.66 109.824 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . 0.867 ' HB2' ' CH2' ' A' ' 261' ' ' TRP . . . -61.26 -33.99 74.44 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 107.659 -1.237 . . . . 112.3 107.659 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' MET . . . . . 0.714 ' O ' HG21 ' A' ' 298' ' ' THR . 21.9 mmt -63.12 -31.99 73.26 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 116.252 -0.431 . . . . 174.17 110.246 -177.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.7 m -64.75 -22.77 67.06 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 124.661 1.184 . . . . 145.27 110.6 -175.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' SER . . . . . 0.827 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.5 m -57.61 -35.39 70.39 Favored 'General case' 0 N--CA 1.426 -1.675 0 N-CA-C 108.055 -1.091 . . . . 170.15 108.055 -175.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.841 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.8 t -55.33 -34.08 63.9 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 116.285 -0.416 . . . . 214.57 110.653 -171.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' MET . . . . . 0.799 ' CE ' ' HG1' ' A' ' 45' ' ' THR . 28.1 ttt -77.25 -33.24 56.02 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 126.093 1.757 . . . . 168.29 115.499 177.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' TYR . . . . . 0.827 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.41 -34.83 79.08 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 114.098 1.148 . . . . 167.15 114.098 -168.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . 0.749 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.282 18.8 p-10 -64.2 -38.36 33.84 Favored Pre-proline 0 N--CA 1.434 -1.274 0 C-N-CA 115.536 -2.465 . . . . 165.13 113.89 -171.625 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' PRO . . . . . 0.749 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.4 Cg_exo -62.51 -31.81 80.22 Favored 'Trans proline' 0 N--CA 1.434 -2.004 0 CA-C-N 122.762 2.022 . . . . 123.92 111.272 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' ILE . . . . . 0.785 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.81 -42.57 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 C-N-CA 118.878 -1.129 . . . . 110.55 109.743 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' ILE . . . . . 1.03 HD11 HG21 ' A' ' 253' ' ' VAL . 31.0 pt -61.17 -39.97 84.29 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.146 0 N-CA-C 108.843 -0.799 . . . . 145.31 108.843 -177.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . 1.061 ' CD1' ' HE2' ' A' ' 249' ' ' MET 0.254 63.4 m-85 -58.17 -48.75 79.3 Favored 'General case' 0 CA--C 1.494 -1.174 0 C-N-CA 119.373 -0.931 . . . . 246.68 109.846 -177.509 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.5 m -62.25 -47.47 84.25 Favored 'General case' 0 CA--C 1.485 -1.536 0 C-N-CA 119.536 -0.866 . . . . 64.43 109.559 -173.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.8 t -66.85 -45.03 79.48 Favored 'General case' 0 N--CA 1.428 -1.532 0 C-N-CA 118.963 -1.095 . . . . 80.72 110.259 -177.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.757 HD22 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.46 -35.71 75.88 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 116.007 1.855 . . . . 140.44 116.007 -173.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . 0.617 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.82 132.22 34.36 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 112.704 -3.598 . . . . 178.87 113.08 -177.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . 0.704 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.02 -37.09 86.47 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 114.406 -1.27 . . . . 110.22 110.093 -177.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . 0.857 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.73 -50.61 72.63 Favored 'General case' 0 CA--C 1.492 -1.258 0 O-C-N 121.714 -0.617 . . . . 174.78 109.737 -174.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.979 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.1 m-85 -64.87 -41.74 95.41 Favored 'General case' 0 CA--C 1.484 -1.573 0 N-CA-C 108.212 -1.033 . . . . 161.84 108.212 178.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . 0.479 ' HE ' HD21 ' A' ' 314' ' ' LEU . 57.7 ttp180 -57.24 -50.3 73.3 Favored 'General case' 0 CA--C 1.49 -1.327 0 N-CA-C 109.206 -0.664 . . . . 117.2 109.206 -173.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.841 ' HB3' HD12 ' A' ' 326' ' ' ILE . 3.0 mm? -68.52 -44.06 75.42 Favored 'General case' 0 N--CA 1.433 -1.277 0 C-N-CA 120.385 -0.526 . . . . 112.6 111.038 -177.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . 1.129 ' HA2' ' HD1' ' A' ' 318' ' ' HIS . . . -64.09 -37.42 94.55 Favored Glycine 0 N--CA 1.43 -1.759 0 N-CA-C 110.644 -0.982 . . . . 101.46 110.644 -177.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' PHE . . . . . 0.979 ' CE2' ' HB3' ' A' ' 312' ' ' PHE . 36.6 m-85 -62.15 -45.99 90.96 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-N 118.491 1.145 . . . . 151.49 109.519 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . 0.466 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.6 ttmt -60.1 -36.33 77.18 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 106.942 -1.503 . . . . 142.32 106.942 -175.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' HIS . . . . . 1.129 ' HD1' ' HA2' ' A' ' 315' ' ' GLY . 49.9 m80 -59.75 -41.84 91.9 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.883 -1.525 . . . . 109.09 106.883 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.84 -42.45 85.76 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.353 -0.217 . . . . 76.11 110.999 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -61.41 -55.55 30.2 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 119.914 -0.714 . . . . 120.24 109.299 -174.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . 0.753 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.4 mtt180 -74.3 131.52 41.25 Favored 'General case' 0 CA--C 1.482 -1.651 0 N-CA-C 102.973 -2.973 . . . . 192.73 102.973 177.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.16 -44.17 92.11 Favored 'General case' 0 CA--C 1.491 -1.312 0 C-N-CA 119.0 -1.08 . . . . 176.29 109.238 -172.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' CYS . . . . . 0.812 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.2 m -79.34 -177.06 0.8 Allowed Pre-proline 0 N--CA 1.43 -1.47 0 N-CA-C 106.35 -1.722 . . . . 69.68 106.35 178.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.568 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.7 Cg_exo -59.04 -75.58 0.02 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.373 0 C-N-CA 118.337 -0.642 . . . . 191.05 112.589 176.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' PHE . . . . . 0.812 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.4 m-85 47.5 43.9 16.28 Favored 'General case' 0 CA--C 1.493 -1.212 0 O-C-N 123.613 0.571 . . . . 287.03 109.73 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . 0.846 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.53 78.62 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.474 -1.955 0 C-N-CA 112.918 -3.513 . . . . 292.29 109.844 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' SER . . . . . 0.507 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.2 t -77.5 -152.87 0.05 Allowed 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 104.237 -2.505 . . . . 184.57 104.237 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.69 8.75 4.95 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 113.039 0.755 . . . . 274.56 113.039 176.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.96 0.84 57.3 Favored Glycine 0 C--N 1.349 1.26 0 C-N-CA 117.717 -2.182 . . . . 268.24 113.48 172.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' ASP . . . . . 0.724 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.8 m-20 51.62 -172.07 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.085 0 CA-C-N 118.694 1.247 . . . . 200.06 110.737 177.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.857 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.3 t80 -63.84 -33.04 74.78 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 107.915 -1.143 . . . . 114.44 107.915 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' GLU . . . . . 0.597 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.27 46.09 21.83 Favored 'General case' 0 CA--C 1.484 -1.571 0 N-CA-C 107.59 -1.263 . . . . 263.81 107.59 -177.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' GLY . . . . . 0.65 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.3 -137.35 3.6 Favored Glycine 0 CA--C 1.479 -2.204 1 N-CA-C 102.529 -4.228 . . . . 103.79 102.529 -179.871 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . 0.991 HD21 ' HA ' ' A' ' 337' ' ' LYS . 61.5 mt -88.25 95.67 10.26 Favored 'General case' 0 N--CA 1.419 -2.017 0 C-N-CA 114.91 -2.716 . . . . 117.3 105.997 177.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . 1.061 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -66.0 -39.8 90.59 Favored 'General case' 0 CA--C 1.469 -2.173 1 N-CA-C 97.961 -4.829 . . . . 231.58 97.961 167.235 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' MET . . . . . 1.06 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.93 163.5 29.03 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 102.112 -3.292 . . . . 303.24 102.112 169.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' LYS . . . . . 0.991 ' HA ' HD21 ' A' ' 334' ' ' LEU . 84.3 tttt -62.69 -48.56 78.72 Favored 'General case' 0 N--CA 1.432 -1.365 0 C-N-CA 115.997 -2.281 . . . . 112.72 108.381 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' SER . . . . . 0.411 ' HB3' ' SD ' ' A' ' 336' ' ' MET . 47.9 t -61.02 -63.67 1.22 Allowed 'General case' 0 CA--C 1.49 -1.334 0 N-CA-C 109.121 -0.696 . . . . 83.22 109.121 -176.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' THR . . . . . 0.912 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.0 m -156.25 -126.25 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 103.806 -2.664 . . . . 174.36 103.806 -178.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . 1.061 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.84 160.93 8.77 Favored 'General case' 0 CA--C 1.485 -1.552 0 N-CA-C 105.796 -1.927 . . . . 202.73 105.796 177.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . 1.031 ' HH ' ' HA3' ' A' ' 315' ' ' GLY . 0.2 OUTLIER -131.94 149.01 52.56 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 107.071 -1.455 . . . . 180.62 107.071 176.413 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . 0.945 ' H ' ' HB2' ' A' ' 347' ' ' SER . 53.5 tp -178.48 -171.88 0.27 Allowed 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 105.393 -2.077 . . . . 145.25 105.393 178.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' GLN . . . . . 0.943 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.06 -43.15 88.27 Favored 'General case' 0 CA--C 1.487 -1.455 0 N-CA-C 106.165 -1.791 . . . . 66.05 106.165 174.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' THR . . . . . 0.758 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.67 -152.2 0.49 Allowed 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 103.498 -2.778 . . . . 266.49 103.498 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 345' ' ' GLN . . . . . 0.609 ' CD ' HD23 ' A' ' 342' ' ' LEU . 79.3 mt-30 66.35 -124.96 0.28 Allowed 'General case' 0 CA--C 1.485 -1.549 0 C-N-CA 116.99 -1.884 . . . . 219.2 107.742 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 346' ' ' GLY . . . . . 0.995 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.07 -37.38 94.11 Favored Glycine 0 N--CA 1.425 -2.067 0 CA-C-N 114.572 -1.195 . . . . 94.78 112.865 -175.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 347' ' ' SER . . . . . 1.106 ' HG ' ' HB3' ' A' ' 61' ' ' LYS . 48.4 t -81.23 100.41 9.11 Favored 'General case' 0 CA--C 1.484 -1.566 0 C-N-CA 112.359 -3.736 . . . . 121.41 109.467 -171.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 348' ' ' VAL . . . . . 0.671 ' O ' ' HE2' ' A' ' 336' ' ' MET . 94.6 t -73.03 145.49 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 N-CA-C 108.974 -0.75 . . . . 85.34 108.974 -176.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 349' ' ' TYR . . . . . 0.506 ' N ' HG13 ' A' ' 348' ' ' VAL . 48.6 p90 -57.73 143.37 42.12 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 107.825 -1.176 . . . . 267.57 107.825 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 350' ' ' LYS . . . . . 0.508 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.07 69.61 0.59 Allowed 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 109.529 -0.545 . . . . 226.1 109.529 -179.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 351' ' ' VAL . . . . . 1.047 ' HB ' ' HE1' ' A' ' 336' ' ' MET . 7.5 p -51.08 156.95 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 N-CA-C 106.928 -1.508 . . . . 154.84 106.928 177.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 352' ' ' SER . . . . . 0.505 ' N ' HG23 ' A' ' 351' ' ' VAL . 71.5 m -61.31 161.91 8.46 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-O 121.595 0.712 . . . . 180.01 110.728 -173.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 353' ' ' ARG . . . . . 0.88 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.43 156.94 23.59 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 106.923 -1.51 . . . . 333.78 106.923 -178.597 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 354' ' ' LEU . . . . . 0.995 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.04 142.51 48.77 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 107.37 -1.345 . . . . 335.2 107.37 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.995 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.6 mm-40 82.84 158.91 0.13 Allowed 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 108.729 -0.841 . . . . 266.47 108.729 179.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.9 m -60.66 -46.83 88.84 Favored 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 105.678 -1.971 . . . . 59.34 105.678 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.58 173.85 11.97 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 104.408 -2.441 . . . . 201.26 104.408 176.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.783 HG21 ' O ' ' A' ' 360' ' ' THR . 69.1 mt -95.88 106.77 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.529 0 C-N-CA 116.343 -2.143 . . . . 56.23 105.521 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 359' ' ' SER . . . . . 0.523 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.5 m -61.24 -59.43 5.32 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 109.272 -0.64 . . . . 87.58 109.272 -175.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 360' ' ' THR . . . . . 0.886 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.2 t -85.59 153.74 22.19 Favored 'General case' 0 CA--C 1.486 -1.496 0 N-CA-C 107.811 -1.181 . . . . 219.95 107.811 -177.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 361' ' ' VAL . . . . . 0.562 HG22 ' O ' ' A' ' 361' ' ' VAL . 15.9 m -82.04 83.86 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 C-N-CA 116.29 -2.164 . . . . 121.79 105.436 177.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.621 HG13 ' N ' ' A' ' 363' ' ' GLY . 64.7 t -154.09 159.72 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.548 0 N-CA-C 105.843 -1.91 . . . . 53.85 105.843 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . 0.621 ' N ' HG13 ' A' ' 362' ' ' VAL . . . 72.22 16.64 77.07 Favored Glycine 0 N--CA 1.428 -1.87 0 N-CA-C 106.057 -2.817 . . . . 196.55 106.057 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.662 0 N-CA-C 107.911 -1.144 . . . . 35.88 107.911 -178.942 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 365' ' ' ARG . . . . . 0.603 HH21 ' CG ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 108.865 -0.791 . . . . 1.0 108.865 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 366' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' B' ' 365' ' ' ARG . 52.6 Cg_endo -66.89 142.02 61.05 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.08 1.854 . . . . 1.0 110.245 178.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 367' ' ' LYS . . . . . 0.859 ' HB3' HD11 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -64.43 143.3 98.51 Favored Pre-proline 0 C--N 1.325 -0.498 0 C-N-CA 119.825 -0.75 . . . . 1.0 109.587 -179.894 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 368' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.29 150.44 76.38 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.349 2.033 . . . . 1.0 111.712 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 369' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.74 131.78 44.37 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.749 -0.38 . . . . 1.0 110.243 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.01 115.82 31.36 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.646 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 371' ' ' PHE . . . . . 0.57 ' HD1' ' HA ' ' B' ' 371' ' ' PHE . 0.0 OUTLIER -63.69 -42.3 98.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.481 . . . . 1.0 110.422 179.566 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 372' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.03 -36.26 83.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.678 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -59.68 -33.09 75.92 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.811 -0.916 . . . . 1.0 110.811 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 374' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 120.873 0.368 . . . . 1.0 110.192 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.442 0 N-CA-C 108.377 -0.971 . . . . 97.08 108.377 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.43 ' HB3' ' OD1' ' A' ' 276' ' ' ASP . 46.6 t30 -110.62 155.44 22.37 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-O 122.123 0.963 . . . . 123.41 110.711 -172.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.844 HG12 HD13 ' A' ' 15' ' ' ILE . 28.7 m -134.6 -162.38 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.479 1 N-CA-C 100.081 -4.044 . . . . 151.3 100.081 173.754 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.965 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.67 -38.57 57.91 Favored Pre-proline 0 N--CA 1.439 -0.996 0 C-N-CA 115.968 -2.293 . . . . 169.25 106.115 178.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.965 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 58.3 Cg_exo -81.32 168.51 16.61 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 122.281 0.621 . . . . 185.76 110.505 171.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.855 HG12 ' CE2' ' A' ' 282' ' ' PHE . 91.7 t -64.47 -25.92 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 C-N-CA 127.028 2.131 . . . . 145.47 110.347 -177.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.837 ' O ' HG23 ' A' ' 4' ' ' VAL . 39.1 t0 -84.3 157.42 21.53 Favored 'General case' 0 N--CA 1.439 -0.981 0 O-C-N 121.078 -1.014 . . . . 102.76 109.464 -178.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.6 p -82.58 154.19 25.11 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 107.976 -1.12 . . . . 106.25 107.976 178.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.925 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 46.7 p-10 -105.89 51.85 0.74 Allowed 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 117.769 -1.573 . . . . 157.81 107.599 178.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.1 tp -60.1 -45.94 91.29 Favored 'General case' 0 CA--C 1.481 -1.696 0 N-CA-C 103.607 -2.738 . . . . 150.2 103.607 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.457 ' C ' ' H ' ' A' ' 14' ' ' ASN . 70.9 m -87.07 164.69 35.22 Favored Pre-proline 0 N--CA 1.422 -1.867 0 N-CA-C 103.653 -2.721 . . . . 183.52 103.653 172.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -76.78 6.86 3.85 Favored 'Trans proline' 0 C--N 1.281 -2.988 0 N-CA-C 109.986 -0.813 . . . . 235.61 109.986 176.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.457 ' H ' ' C ' ' A' ' 12' ' ' SER . 34.5 t-20 -57.88 -41.27 82.15 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 124.813 1.245 . . . . 113.77 113.398 -170.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.925 ' CD1' ' HB3' ' A' ' 10' ' ' ASP . 33.4 pt -52.19 136.24 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-N 119.541 1.064 . . . . 150.85 110.963 -176.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.8 t -140.49 156.24 46.4 Favored 'General case' 0 C--N 1.36 1.036 0 N-CA-C 107.634 -1.247 . . . . 100.42 107.634 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 1.026 HG23 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.0 142.64 58.36 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 121.895 0.855 . . . . 129.36 110.455 -174.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.764 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.12 -25.5 68.39 Favored 'General case' 0 CA--C 1.493 -1.213 0 C-N-CA 126.309 1.843 . . . . 112.34 106.668 -177.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 1.005 HG21 ' HA2' ' A' ' 101' ' ' GLY . 85.8 m -74.11 -40.2 62.84 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 115.538 -0.756 . . . . 131.73 111.741 177.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 1.026 ' H ' HG23 ' A' ' 17' ' ' THR . 71.4 m -84.42 -42.89 15.19 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 116.989 2.218 . . . . 80.49 116.989 -174.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.525 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.5 mt-10 -145.96 174.54 3.35 Favored Pre-proline 0 N--CA 1.442 -0.847 0 C-N-CA 118.179 -1.408 . . . . 98.98 111.234 -169.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.879 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.334 85.7 Cg_exo -61.72 -10.86 18.23 Favored 'Trans proline' 0 C--N 1.321 -0.907 1 N-CA-C 128.931 6.473 . . . . 246.95 128.931 -170.104 . . . . . . . . 4 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.676 HD22 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.68 17.54 8.76 Favored 'General case' 0 C--N 1.324 -0.518 1 CA-C-N 126.154 4.07 . . . . 269.62 114.22 175.68 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.583 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.5 mt-30 -67.14 -27.26 67.17 Favored 'General case' 0 CA--C 1.495 -1.154 0 N-CA-C 107.814 -1.18 . . . . 86.8 107.814 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.5 ' CE1' ' CG2' ' A' ' 26' ' ' VAL . 50.3 p90 -66.87 -29.3 69.17 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 121.116 -0.99 . . . . 85.91 110.467 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.89 HG11 ' OE1' ' A' ' 284' ' ' GLN . 40.4 t -68.59 -40.18 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 C-N-CA 123.734 0.814 . . . . 82.0 111.346 -177.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.927 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.39 167.74 12.47 Favored Pre-proline 0 CA--C 1.489 -1.391 0 N-CA-C 108.559 -0.904 . . . . 120.73 108.559 -178.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.847 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -63.99 149.75 89.86 Favored 'Trans proline' 0 N--CA 1.433 -2.07 0 C-N-CA 120.644 0.896 . . . . 87.86 109.847 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.82 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.0 -37.98 89.37 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 108.87 -0.789 . . . . 36.46 108.87 -176.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.84 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.9 p-90 -63.82 -33.83 76.56 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 107.81 -1.181 . . . . 150.6 107.81 -176.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.927 ' OE1' ' HB2' ' A' ' 27' ' ' GLN . 80.5 mt-30 -62.24 -32.72 73.44 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 108.624 -0.88 . . . . 123.26 108.624 -178.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.856 HG23 ' O ' ' A' ' 93' ' ' ALA . 1.7 mp -61.43 -47.27 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 N-CA-C 109.125 -0.694 . . . . 120.14 109.125 176.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 30' ' ' TRP . 20.3 m -67.4 -31.03 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 N-CA-C 107.866 -1.161 . . . . 112.19 107.866 -178.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.84 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.5 tp -62.96 -47.13 84.53 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 119.973 -0.691 . . . . 60.87 109.61 -178.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.687 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.08 -35.66 81.11 Favored 'General case' 0 CA--C 1.489 -1.386 0 C-N-CA 119.974 -0.69 . . . . 157.57 110.325 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.819 ' CB ' HG12 ' A' ' 94' ' ' VAL . . . -62.6 -40.87 98.29 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 108.65 -0.871 . . . . 47.06 108.65 178.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.843 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.76 -41.29 98.01 Favored 'General case' 0 CA--C 1.496 -1.111 0 O-C-N 121.76 -0.587 . . . . 43.94 109.546 -177.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.767 ' O ' HG21 ' A' ' 41' ' ' VAL . . . -61.83 -43.38 98.96 Favored 'General case' 0 CA--C 1.49 -1.364 0 N-CA-C 108.657 -0.868 . . . . 42.61 108.657 -176.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.964 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.29 -41.25 94.3 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 116.631 -0.259 . . . . 140.66 111.079 -178.367 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.843 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.77 -43.98 97.79 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 118.576 -1.249 . . . . 116.04 110.239 -175.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.767 HG21 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.47 -38.69 83.06 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.302 0 N-CA-C 108.726 -0.842 . . . . 97.16 108.726 -177.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.919 HD11 ' HD1' ' A' ' 39' ' ' TYR . 93.2 mt -61.29 -40.05 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 N-CA-C 108.944 -0.761 . . . . 54.85 108.944 -176.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.981 HG23 HG22 ' A' ' 86' ' ' THR . 93.0 t -57.69 -42.35 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.32 0 N-CA-C 108.878 -0.786 . . . . 45.39 108.878 -175.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.401 ' O ' HG22 ' A' ' 48' ' ' VAL . 97.5 t -63.5 -50.98 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 C-N-CA 118.844 -1.142 . . . . 48.64 110.218 -177.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.803 ' HG1' ' CE ' ' A' ' 299' ' ' MET . 10.6 t -65.3 -46.95 78.35 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 120.117 -0.633 . . . . 116.65 111.744 -174.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.642 ' N ' HG23 ' A' ' 45' ' ' THR . 50.7 m -62.0 -43.94 97.79 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 109.718 -0.475 . . . . 51.16 109.718 -174.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 43' ' ' VAL . 97.4 t -65.56 -48.93 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 C-N-CA 119.885 -0.726 . . . . 44.3 110.818 -176.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.876 ' O ' HG22 ' A' ' 52' ' ' VAL . 93.7 t -64.78 -46.93 90.59 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.048 0 C-N-CA 120.34 -0.544 . . . . 48.82 111.005 -174.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.78 -44.14 95.21 Favored Glycine 0 N--CA 1.438 -1.213 0 C-N-CA 120.529 -0.843 . . . . 58.7 112.02 -174.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -72.67 -34.19 67.06 Favored 'General case' 0 CA--C 1.488 -1.433 0 O-C-N 122.107 -0.643 . . . . 101.4 110.993 -175.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.812 HG11 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.94 -38.69 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 107.761 -1.199 . . . . 103.57 107.761 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.876 HG22 ' O ' ' A' ' 48' ' ' VAL . 71.8 t -61.43 -43.05 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 108.989 -0.745 . . . . 61.89 108.989 -178.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.634 ' O ' HG21 ' A' ' 56' ' ' ILE . 81.8 t -63.42 -50.99 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 109.458 -0.571 . . . . 70.01 109.458 -178.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.873 ' O ' HD12 ' A' ' 58' ' ' LEU . 26.0 ptm -62.95 -43.41 98.85 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.13 -0.693 . . . . 132.1 109.13 -176.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.677 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.12 -46.69 83.02 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 116.705 -0.225 . . . . 104.5 110.469 -176.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.904 HD11 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.63 -49.93 80.24 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 C-N-CA 120.254 -0.578 . . . . 142.96 111.253 -173.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 1.035 HD12 HG11 ' A' ' 72' ' ' VAL 0.277 24.7 pt -64.79 -41.66 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.639 0 C-N-CA 116.956 -1.898 . . . . 158.32 110.868 -175.965 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.873 HD12 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.76 -41.3 98.02 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 117.699 -1.6 . . . . 137.11 109.514 178.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.46 -44.49 90.94 Favored 'General case' 0 N--CA 1.436 -1.156 0 O-C-N 122.117 -0.364 . . . . 54.66 110.972 -176.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.954 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.9 m-70 -91.42 117.13 29.41 Favored 'General case' 0 CA--C 1.49 -1.348 0 CA-C-O 121.662 0.744 . . . . 127.18 109.555 -174.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 1.107 ' HB3' ' HG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.83 -36.81 80.06 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 124.089 0.956 . . . . 87.93 110.877 -176.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 1.06 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.37 -34.7 78.77 Favored 'General case' 0 CA--C 1.49 -1.341 0 O-C-N 121.622 -0.674 . . . . 131.12 111.512 -175.669 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 1.004 ' HG3' ' CE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.61 69.46 7.12 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 115.307 -2.557 . . . . 246.56 109.647 -175.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 61' ' ' LYS . 9.6 mmp_? -123.23 91.44 3.48 Favored 'General case' 0 CA--C 1.474 -1.946 0 N-CA-C 105.465 -2.05 . . . . 339.35 105.465 177.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.861 ' HG1' ' H ' ' A' ' 68' ' ' ASN . 82.5 p -124.15 165.27 17.85 Favored 'General case' 0 N--CA 1.414 -2.251 0 N-CA-C 103.01 -2.959 . . . . 114.66 103.01 176.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.958 HG22 ' HG1' ' A' ' 147' ' ' THR . 7.7 p -63.14 -39.49 85.44 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.615 0 N-CA-C 106.748 -1.575 . . . . 143.28 106.748 178.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.984 HG21 HD13 ' A' ' 71' ' ' LEU . 95.8 m -59.66 -38.05 80.4 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 108.676 -0.861 . . . . 160.22 108.676 -176.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.861 ' H ' ' HG1' ' A' ' 65' ' ' THR . 86.3 m-20 -62.39 -31.73 72.44 Favored 'General case' 0 CA--C 1.489 -1.37 0 N-CA-C 108.858 -0.793 . . . . 120.54 108.858 -177.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.885 ' O ' HG23 ' A' ' 72' ' ' VAL . 89.7 m-85 -63.64 -43.76 95.85 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.465 -0.569 . . . . 67.22 109.465 178.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.932 ' CE2' HG23 ' A' ' 66' ' ' VAL . 82.6 m-85 -66.53 -39.8 88.78 Favored 'General case' 0 CA--C 1.498 -1.057 0 O-C-N 121.533 -0.729 . . . . 138.6 109.675 -177.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.984 HD13 HG21 ' A' ' 67' ' ' THR . 10.1 mp -63.56 -35.9 82.02 Favored 'General case' 0 CA--C 1.492 -1.26 0 C-N-CA 122.487 0.315 . . . . 151.46 110.663 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 1.035 HG11 HD12 ' A' ' 57' ' ' ILE . 23.9 m -62.55 -37.92 80.13 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 C-N-CA 117.406 -1.717 . . . . 117.93 106.753 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.489 ' N ' HG22 ' A' ' 72' ' ' VAL . 66.0 t30 -60.17 -45.95 91.34 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 107.837 -1.171 . . . . 56.82 107.837 -177.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.911 HD21 ' CE ' ' A' ' 123' ' ' MET . 8.7 mp -61.38 -43.89 98.09 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 108.941 -0.763 . . . . 145.3 108.941 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.07 -40.36 95.53 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 108.535 -0.913 . . . . 45.71 108.535 -175.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -62.44 -41.95 99.11 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 109.399 -0.593 . . . . 105.61 109.399 -178.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.16 -39.48 92.79 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 108.605 -0.887 . . . . 47.89 108.605 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.707 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.56 -37.31 84.69 Favored 'General case' 0 N--CA 1.438 -1.062 0 O-C-N 122.084 -0.385 . . . . 124.53 109.988 179.692 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.88 -41.25 99.33 Favored 'General case' 0 N--CA 1.437 -1.089 0 O-C-N 121.942 -0.474 . . . . 35.89 109.819 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.7 t -62.16 -37.35 84.9 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 107.048 -1.464 . . . . 88.97 107.048 -178.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.84 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.7 ttm -62.16 -49.18 76.88 Favored 'General case' 0 N--CA 1.427 -1.579 0 C-N-CA 119.792 -0.763 . . . . 239.91 109.055 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.599 ' O ' HG21 ' A' ' 86' ' ' THR . . . -65.36 -43.37 91.02 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 121.579 -0.7 . . . . 146.1 110.62 -177.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.18 -58.22 3.41 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 117.403 -1.719 . . . . 91.74 113.826 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -76.57 -61.37 1.98 Allowed 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 115.746 1.758 . . . . 197.45 115.746 -173.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.981 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.25 -42.26 55.6 Favored 'General case' 0 CA--C 1.49 -1.36 0 C-N-CA 117.884 -1.527 . . . . 242.6 114.056 -170.045 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.981 HG22 HG23 ' A' ' 43' ' ' VAL . 4.7 t -65.45 -36.55 84.23 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 118.926 -1.109 . . . . 215.61 109.821 -172.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.461 ' N ' HG23 ' A' ' 86' ' ' THR . 71.9 t -60.25 -46.96 94.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 O-C-N 121.811 -0.556 . . . . 87.19 110.505 -175.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.89 HG22 ' CD2' ' A' ' 108' ' ' HIS . 63.7 t -65.94 -41.88 90.74 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.122 0 N-CA-C 109.704 -0.48 . . . . 231.82 109.704 -178.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.964 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 11.0 m120 -62.33 -34.1 75.98 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 108.335 -0.987 . . . . 364.98 108.335 -177.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.66 ' CE1' ' HB3' ' A' ' 36' ' ' ALA . 85.4 t80 -68.24 -44.66 75.2 Favored 'General case' 0 N--CA 1.438 -1.064 0 O-C-N 121.507 -0.746 . . . . 181.63 111.257 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.897 HG21 ' HD2' ' A' ' 95' ' ' HIS . 57.4 m -60.89 -45.81 93.14 Favored 'General case' 0 CA--C 1.477 -1.829 0 N-CA-C 107.422 -1.325 . . . . 269.02 107.422 -175.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 1.074 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.66 -45.07 93.16 Favored 'General case' 0 CA--C 1.469 -2.164 0 C-N-CA 118.684 -1.206 . . . . 562.66 110.052 -179.063 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.856 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.09 -45.3 95.26 Favored 'General case' 0 CA--C 1.479 -1.788 0 C-N-CA 118.744 -1.183 . . . . 446.75 108.067 -167.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.819 HG12 ' CB ' ' A' ' 36' ' ' ALA 0.388 6.1 m -70.48 -26.23 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 C-N-CA 115.791 -2.364 . . . . 370.05 112.283 -178.746 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.897 ' HD2' HG21 ' A' ' 91' ' ' THR . 89.8 m-70 -74.58 -26.42 59.92 Favored 'General case' 0 CA--C 1.506 -0.747 0 O-C-N 121.626 -0.672 . . . . 354.91 112.483 175.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.879 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.4 m-20 82.75 4.53 1.01 Allowed 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 125.078 1.351 . . . . 462.44 111.926 -178.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.764 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.267 11.9 mm-40 -172.37 178.03 2.91 Favored 'General case' 0 CA--C 1.488 -1.429 0 CA-C-O 122.044 0.926 . . . . 652.37 111.087 171.797 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.83 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.68 86.27 2.15 Favored 'General case' 0 N--CA 1.428 -1.558 0 C-N-CA 128.494 2.718 . . . . 905.99 107.95 -174.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -67.85 -36.42 80.28 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 108.266 -1.013 . . . . 570.43 108.266 -176.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.845 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.56 -36.35 82.36 Favored 'General case' 0 N--CA 1.428 -1.569 0 C-N-CA 125.343 1.457 . . . . 453.22 111.166 -174.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 1.005 ' HA2' HG21 ' A' ' 19' ' ' THR . . . 97.56 178.66 33.88 Favored Glycine 0 C--N 1.349 1.288 0 C-N-CA 118.753 -1.689 . . . . 445.63 109.882 177.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.0 mt -56.41 -41.25 76.04 Favored 'General case' 0 CA--C 1.498 -1.022 0 C-N-CA 125.276 1.43 . . . . 457.72 112.351 -170.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -58.64 -46.87 86.2 Favored 'General case' 0 CA--C 1.484 -1.562 0 C-N-CA 118.63 -1.228 . . . . 340.58 109.326 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.845 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.0 m-85 -68.76 -32.16 71.71 Favored 'General case' 0 N--CA 1.423 -1.786 0 C-N-CA 118.741 -1.184 . . . . 453.6 111.559 -176.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.727 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.02 -40.29 73.19 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 105.971 -1.863 . . . . 541.48 105.971 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.451 ' HD2' ' HA2' ' A' ' 166' ' ' GLY . 27.0 ttpt -65.89 -47.1 75.95 Favored 'General case' 0 CA--C 1.485 -1.536 0 O-C-N 124.017 0.823 . . . . 466.68 110.852 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -61.78 -47.11 86.63 Favored 'General case' 0 N--CA 1.427 -1.6 0 C-N-CA 117.506 -1.678 . . . . 427.34 107.256 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.89 ' CD2' HG22 ' A' ' 88' ' ' VAL . 47.6 m80 -67.08 -36.78 82.75 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 112.425 0.528 . . . . 537.87 112.425 -174.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.583 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.4 -42.67 74.8 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 116.861 -1.936 . . . . 422.12 111.607 175.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.913 ' O ' HG21 ' A' ' 113' ' ' ILE . 75.9 t80 -59.12 -50.05 75.54 Favored 'General case' 0 CA--C 1.502 -0.882 0 O-C-N 121.335 -0.853 . . . . 340.17 111.827 -173.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.481 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 61.6 m-85 -65.26 -46.57 71.71 Favored Pre-proline 0 N--CA 1.443 -0.801 0 C-N-CA 119.095 -1.042 . . . . 258.06 111.715 -176.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.981 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.2 Cg_exo -61.49 -31.58 87.84 Favored 'Trans proline' 0 N--CA 1.435 -1.927 0 N-CA-C 115.363 1.255 . . . . 305.71 115.363 176.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.944 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.84 -40.46 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 108.689 -0.856 . . . . 252.7 108.689 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.421 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.9 -40.6 93.7 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 107.807 -1.183 . . . . 149.27 107.807 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.0 -44.83 95.89 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 120.639 -0.424 . . . . 138.08 111.468 -176.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.755 HG23 ' CZ2' ' A' ' 261' ' ' TRP . 65.1 t -66.98 -42.33 88.57 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.937 0 O-C-N 121.581 -0.699 . . . . 132.89 110.96 -177.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.944 ' CE2' HG13 ' A' ' 113' ' ' ILE . 26.5 m-85 -63.77 -44.64 92.81 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 108.898 -0.779 . . . . 193.61 108.898 -177.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.604 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.5 -37.68 84.57 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 122.811 0.444 . . . . 63.83 110.069 -175.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 72.0 m -64.03 -52.37 59.79 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 120.721 -0.392 . . . . 76.4 111.242 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.812 HD11 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.96 -41.65 93.59 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 N-CA-C 108.17 -1.048 . . . . 171.13 108.17 -175.005 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 1.068 ' HB2' HD12 ' A' ' 154' ' ' ILE . 29.1 m-85 -63.84 -38.57 91.58 Favored 'General case' 0 N--CA 1.432 -1.331 0 O-C-N 121.838 -0.539 . . . . 78.3 110.614 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.552 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.5 t -67.1 -35.69 80.32 Favored 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 118.893 -1.123 . . . . 92.36 109.247 -178.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' MET . . . . . 1.099 ' HA ' ' HE1' ' A' ' 123' ' ' MET . 5.9 mmt -62.55 -34.24 76.54 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 108.154 -1.054 . . . . 93.73 108.154 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.97 HG22 HG13 ' A' ' 212' ' ' ILE . 33.3 p -67.44 -41.65 84.4 Favored 'General case' 0 CA--C 1.495 -1.159 0 C-N-CA 119.224 -0.99 . . . . 132.74 109.318 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.28 -42.09 94.7 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 107.158 -1.423 . . . . 43.39 107.158 -177.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.864 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.4 t -58.47 -41.98 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.369 0 N-CA-C 108.568 -0.901 . . . . 59.34 108.568 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.406 ' HB3' ' HB1' ' A' ' 215' ' ' ALA . . . -63.53 -44.02 95.42 Favored 'General case' 0 CA--C 1.497 -1.067 0 O-C-N 121.808 -0.558 . . . . 69.68 110.529 -177.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.468 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.3 t80 -65.41 -42.82 92.13 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.348 -0.982 . . . . 106.98 108.348 -177.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.864 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.37 -35.51 81.14 Favored 'General case' 0 N--CA 1.433 -1.306 0 C-N-CA 119.598 -0.841 . . . . 147.63 108.972 -177.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.767 ' NH1' ' HE2' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.19 -41.54 99.19 Favored 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 108.524 -0.917 . . . . 190.06 108.524 178.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.964 ' HD2' ' HE3' ' A' ' 132' ' ' MET . 66.4 t80 -61.35 -44.08 97.78 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 108.29 -1.004 . . . . 118.85 108.29 -177.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 1.112 ' HA ' ' HE1' ' A' ' 132' ' ' MET . 4.5 mmt -63.34 -42.64 98.96 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 109.994 -0.373 . . . . 102.5 109.994 -177.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.98 -41.69 95.21 Favored 'General case' 0 CA--C 1.488 -1.418 0 O-C-N 121.799 -0.563 . . . . 89.98 109.82 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.989 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.2 mt -66.54 -50.66 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.711 0 C-N-CA 118.119 -1.432 . . . . 106.09 111.024 -177.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.798 HD12 ' HE1' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.1 -48.29 38.41 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.09 0 C-N-CA 117.078 -1.849 . . . . 227.74 111.832 -174.84 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.792 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.84 100.07 50.99 Favored Pre-proline 0 CA--C 1.486 -1.496 0 C-N-CA 116.268 -2.173 . . . . 262.55 110.069 -175.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.468 ' HD2' ' O ' ' A' ' 135' ' ' ILE . 9.3 Cg_endo -69.61 -10.36 28.49 Favored 'Trans proline' 0 C--N 1.289 -2.558 0 C-N-CA 121.564 1.509 . . . . 210.25 111.386 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.691 HD12 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.3 111.99 1.0 Allowed 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 106.54 -1.652 . . . . 270.58 106.54 -178.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.884 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.77 -39.51 24.23 Favored Pre-proline 0 N--CA 1.43 -1.453 0 CA-C-N 115.358 -0.837 . . . . 129.84 112.325 -175.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.849 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 81.5 Cg_exo -61.44 -26.51 81.28 Favored 'Trans proline' 0 N--CA 1.431 -2.166 0 N-CA-C 116.311 1.62 . . . . 330.71 116.311 -174.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.792 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.09 77.28 8.0 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 114.445 -2.902 . . . . 204.51 107.257 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.873 HD12 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.7 147.38 0.09 Allowed 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 107.488 -1.301 . . . . 387.41 107.488 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.873 ' N ' HD12 ' A' ' 142' ' ' LEU . 47.3 t -143.68 147.0 33.64 Favored 'General case' 0 CA--C 1.496 -1.116 0 C-N-CA 118.841 -1.144 . . . . 166.22 109.484 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.4 ' O ' ' HD2' ' A' ' 148' ' ' LYS . . . -66.85 -40.72 88.0 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 107.872 -1.159 . . . . 44.23 107.872 176.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.482 ' O ' HG22 ' A' ' 149' ' ' VAL . 88.0 m -60.32 -39.12 85.88 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 108.15 -1.055 . . . . 28.8 108.15 -175.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.642 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.88 -38.78 92.21 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 109.055 -0.721 . . . . 30.29 109.055 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.958 ' HG1' HG22 ' A' ' 66' ' ' VAL . 90.1 m -59.59 -43.01 93.83 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 109.035 -0.728 . . . . 46.11 109.035 -176.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.458 ' HD3' ' HA ' ' A' ' 145' ' ' THR . 0.2 OUTLIER -62.46 -42.2 99.3 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 107.665 -1.235 . . . . 87.33 107.665 -179.651 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.789 ' O ' HG22 ' A' ' 153' ' ' VAL . 96.7 t -61.58 -42.13 92.89 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.366 0 N-CA-C 107.973 -1.121 . . . . 23.69 107.973 -178.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.6 t -63.2 -44.28 99.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 N-CA-C 109.678 -0.489 . . . . 43.86 109.678 -178.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.933 ' O ' HG23 ' A' ' 154' ' ' ILE . 46.0 mm -61.29 -42.49 93.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 N-CA-C 108.327 -0.99 . . . . 91.13 108.327 -176.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . 0.505 ' O ' HG22 ' A' ' 156' ' ' VAL . 52.2 t -62.57 -38.0 88.4 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 108.786 -0.82 . . . . 65.88 108.786 -178.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.789 HG22 ' O ' ' A' ' 149' ' ' VAL . 95.7 t -62.08 -41.86 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 N-CA-C 109.559 -0.534 . . . . 33.86 109.559 -177.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 1.068 HD12 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.35 -40.32 85.76 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.217 0 N-CA-C 107.642 -1.244 . . . . 146.52 107.642 -176.815 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . 0.778 ' O ' HD22 ' A' ' 159' ' ' LEU . 88.3 m95 -62.86 -38.36 90.54 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 119.477 -0.889 . . . . 75.44 108.942 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 152' ' ' CYS . 98.8 t -60.53 -48.44 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 O-C-N 120.976 -1.078 . . . . 43.64 109.71 -177.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.818 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.7 -37.98 89.39 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 109.034 -0.728 . . . . 102.57 109.034 -178.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.93 -41.13 86.6 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 107.437 -1.32 . . . . 58.16 107.437 -178.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.872 HD13 ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.06 -32.51 73.9 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 109.015 -0.735 . . . . 121.11 109.015 178.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.818 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.01 -42.34 85.02 Favored 'General case' 0 CA--C 1.488 -1.416 0 C-N-CA 118.586 -1.246 . . . . 153.15 109.951 -178.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 1.043 HD13 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.05 -43.75 19.05 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 113.079 -3.448 . . . . 133.67 113.522 173.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.536 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -62.95 -39.92 96.1 Favored 'General case' 0 CA--C 1.49 -1.335 0 O-C-N 120.938 -1.101 . . . . 157.42 112.184 -171.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.519 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.2 t80 -74.4 -36.1 2.47 Favored Pre-proline 0 N--CA 1.437 -1.105 0 N-CA-C 115.058 1.503 . . . . 250.91 115.058 -173.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.519 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.291 52.6 Cg_exo -59.58 -25.4 78.75 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 N-CA-C 117.976 2.26 . . . . 207.34 117.976 -174.309 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 1.019 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 87.6 mt-30 -61.22 -34.18 74.69 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 106.954 -1.498 . . . . 192.46 106.954 178.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.451 ' HA2' ' HD2' ' A' ' 106' ' ' LYS . . . -64.52 -41.09 98.07 Favored Glycine 0 C--N 1.353 1.523 0 N-CA-C 107.963 -2.055 . . . . 261.0 107.963 177.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -65.71 159.13 25.71 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 101.537 -3.505 . . . . 491.4 101.537 172.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -59.98 106.82 0.54 Allowed 'General case' 0 CA--C 1.489 -1.403 0 C-N-CA 116.256 -2.178 . . . . 386.1 109.809 -176.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 1.019 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 73.8 m -154.07 -166.62 2.42 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 103.533 -2.765 . . . . 289.8 103.533 -178.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 1.096 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.3 p -62.93 175.42 0.86 Allowed 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 117.766 -1.112 . . . . 402.06 109.538 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.783 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 72.9 p -165.24 177.5 7.58 Favored 'General case' 0 CA--C 1.586 2.355 0 C-N-CA 127.336 2.254 . . . . 690.53 114.935 177.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.57 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.9 mm-40 132.33 160.53 0.0 OUTLIER 'General case' 1 C--N 1.429 4.048 1 N-CA-C 123.195 4.517 . . . . 633.62 123.195 162.689 . . . . . . . . 4 3 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.828 HG21 ' SG ' ' A' ' 180' ' ' CYS . 69.3 p -85.62 153.81 22.13 Favored 'General case' 0 C--N 1.389 2.284 0 C-N-CA 127.414 2.286 . . . . 617.99 110.887 177.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' MET . . . . . 1.116 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.7 174.44 5.94 Favored Pre-proline 0 C--N 1.364 1.213 0 C-N-CA 130.213 3.405 . . . . 434.98 113.382 -175.385 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 1.116 ' HD2' ' HB3' ' A' ' 174' ' ' MET . 51.5 Cg_endo -44.25 -65.59 0.19 Allowed 'Trans proline' 0 N--CA 1.442 -1.503 0 N-CA-C 122.42 3.969 . . . . 365.88 122.42 -168.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' SER . . . . . 0.788 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.305 70.8 m -84.93 20.91 1.72 Allowed 'General case' 0 CA--C 1.467 -2.224 0 N-CA-C 104.79 -2.3 . . . . 635.81 104.79 178.148 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.773 ' HB3' ' H ' ' A' ' 179' ' ' VAL 0.458 5.0 mmp_? -94.28 152.22 18.84 Favored 'General case' 1 CA--C 1.419 -4.059 3 N-CA-C 131.984 7.772 . . . . 999.99 131.984 -135.756 . . . . . . . . 5 3 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 1.074 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.911 37.2 t -131.88 73.16 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.765 1 CA-C-N 103.298 -6.319 . . . . 594.32 113.603 149.185 . . . . . . . . 4 3 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.773 ' H ' ' HB3' ' A' ' 177' ' ' ARG . 7.3 p -144.17 144.12 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.653 1 N-CA-C 98.31 -4.7 . . . . 811.91 98.31 162.331 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . 0.828 ' SG ' HG21 ' A' ' 173' ' ' THR . 3.8 m -118.44 144.53 45.9 Favored 'General case' 0 CA--C 1.488 -1.41 0 C-N-CA 117.056 -1.858 . . . . 999.99 109.414 -178.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.823 ' HE1' ' CE2' ' A' ' 264' ' ' PHE . 70.7 mmm -147.18 -175.6 4.89 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-O 121.979 0.895 . . . . 431.86 110.09 -177.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 1.06 HD12 ' CD2' ' A' ' 196' ' ' TYR . 11.3 tt -69.2 148.68 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 C-N-CA 124.357 1.063 . . . . 457.18 108.796 -177.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . 0.827 ' HB3' ' HB ' ' A' ' 170' ' ' THR . 3.6 tp10 -77.34 85.5 3.76 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 124.164 0.985 . . . . 458.77 113.472 -174.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.993 ' CZ3' HG21 ' A' ' 182' ' ' ILE . 1.9 p90 -76.42 -31.46 0.96 Allowed Pre-proline 0 N--CA 1.438 -1.062 0 C-N-CA 124.937 1.295 . . . . 999.99 112.447 168.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.948 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 50.9 Cg_exo -66.03 -45.79 5.48 Favored 'Trans proline' 0 N--CA 1.438 -1.772 0 N-CA-C 120.812 3.351 . . . . 999.99 120.812 -174.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.558 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 54.9 mt-10 -119.58 171.75 8.14 Favored 'General case' 0 CA--C 1.472 -2.051 0 C-N-CA 117.174 -1.81 . . . . 81.18 107.273 -172.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.843 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.9 p-80 -109.11 45.1 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.857 0 C-N-CA 115.505 -2.478 . . . . 999.99 108.759 177.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 1.068 ' HB2' HD11 ' A' ' 191' ' ' ILE . 86.4 Cg_endo -41.51 101.81 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.164 1 C-N-CA 126.037 4.491 . . . . 999.99 105.709 -170.75 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -62.32 -44.0 97.51 Favored 'General case' 0 CA--C 1.482 -1.642 0 C-N-CA 126.775 2.03 . . . . 967.72 112.043 -165.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -60.29 -36.55 78.1 Favored 'General case' 0 CA--C 1.487 -1.48 0 N-CA-C 106.745 -1.576 . . . . 934.3 106.745 -175.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 1.068 HD11 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.54 -30.25 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 C-N-CA 129.154 2.981 . . . . 565.15 113.954 -178.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 61.58 55.4 2.78 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-N 118.403 0.547 . . . . 755.61 109.828 -175.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 1.096 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.49 -49.26 67.18 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 124.551 1.14 . . . . 325.89 113.286 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.896 ' HG3' ' HH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.82 -44.98 78.42 Favored 'General case' 0 CA--C 1.495 -1.157 0 C-N-CA 123.576 0.75 . . . . 250.21 111.629 -169.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.4 t -64.7 -43.36 96.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 CA-C-O 121.581 0.705 . . . . 142.46 110.374 -175.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . 1.06 ' CD2' HD12 ' A' ' 182' ' ' ILE . 34.7 t80 -61.15 -41.48 96.82 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 123.935 0.894 . . . . 247.69 108.813 -173.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' HIS . . . . . 0.887 ' HE2' ' HA ' ' A' ' 269' ' ' LEU . 23.1 t60 -60.53 -51.4 69.6 Favored 'General case' 0 CA--C 1.492 -1.28 0 C-N-CA 125.465 1.506 . . . . 199.61 113.058 -175.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 82.8 mt -65.29 -44.47 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 107.748 -1.205 . . . . 106.73 107.748 -177.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . 0.591 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.8 t -59.2 -48.51 81.34 Favored 'General case' 0 CA--C 1.487 -1.459 0 CA-C-N 115.867 -0.606 . . . . 115.01 110.201 -173.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 1.043 HG13 HD13 ' A' ' 161' ' ' LEU . 86.2 t -65.24 -49.17 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.626 0 C-N-CA 119.398 -0.921 . . . . 129.42 111.847 -174.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.811 HG22 ' CD1' ' A' ' 206' ' ' PHE . 69.1 m -61.85 -53.13 60.07 Favored 'General case' 0 CA--C 1.482 -1.639 0 C-N-CA 118.186 -1.406 . . . . 172.48 109.977 -172.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.678 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 85.6 t -63.85 -54.25 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 C-N-CA 120.546 -0.462 . . . . 55.86 110.979 -174.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.591 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.58 -51.54 59.01 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 118.57 -1.252 . . . . 184.68 111.502 -174.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . 1.001 ' HB ' HD11 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.65 -52.38 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 C-N-CA 116.607 -2.037 . . . . 291.81 114.731 -174.696 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.434 ' HB2' ' CE1' ' A' ' 265' ' ' HIS . 87.8 t80 -82.04 -55.03 4.83 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 115.143 1.534 . . . . 130.66 115.143 -178.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . 0.811 ' CD1' HG22 ' A' ' 201' ' ' THR . 40.0 m-85 -66.86 -48.51 68.58 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 114.492 1.293 . . . . 80.16 114.492 -170.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.92 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.52 -45.52 83.37 Favored Pre-proline 0 N--CA 1.435 -1.185 0 C-N-CA 119.989 -0.685 . . . . 136.02 109.504 -174.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.92 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 88.2 Cg_exo -64.76 -27.16 60.01 Favored 'Trans proline' 0 N--CA 1.433 -2.063 0 N-CA-C 110.616 -0.571 . . . . 92.17 110.616 -179.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.773 HD22 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.39 -41.33 76.62 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 107.492 -1.299 . . . . 135.6 107.492 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.2 -44.66 91.28 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 109.577 -0.527 . . . . 52.1 109.577 -176.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . 0.678 HG11 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.71 -43.46 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 N-CA-C 109.088 -0.708 . . . . 95.89 109.088 -176.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.97 HG13 HG22 ' A' ' 124' ' ' THR . 94.7 mt -61.33 -42.31 93.15 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.386 0 N-CA-C 106.663 -1.606 . . . . 43.41 106.663 -178.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.46 -42.3 99.05 Favored Glycine 0 N--CA 1.432 -1.63 0 N-CA-C 109.343 -1.503 . . . . 27.69 109.343 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . 0.904 ' O ' HG22 ' A' ' 217' ' ' THR . 77.8 t80 -65.72 -47.29 75.83 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 117.409 0.604 . . . . 54.41 110.467 -177.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . 0.898 ' O ' HG13 ' A' ' 218' ' ' VAL . . . -61.47 -34.11 74.89 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 106.916 -1.513 . . . . 53.88 106.916 -177.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -60.78 -40.81 93.96 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 108.492 -0.929 . . . . 68.29 108.492 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' THR . . . . . 0.904 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.81 -38.98 92.79 Favored 'General case' 0 CA--C 1.497 -1.086 0 C-N-CA 119.704 -0.799 . . . . 107.59 110.619 -175.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.898 HG13 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.06 -38.37 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 119.584 -0.846 . . . . 111.61 109.49 -177.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.989 HG13 ' CD1' ' A' ' 134' ' ' ILE . 79.5 t -63.3 -22.45 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 N-CA-C 108.428 -0.952 . . . . 85.26 108.428 -178.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.89 -41.95 99.45 Favored Glycine 0 C--N 1.35 1.324 0 N-CA-C 111.014 -0.834 . . . . 40.71 111.014 -176.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.73 -43.99 96.52 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 N-CA-C 108.414 -0.958 . . . . 95.86 108.414 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.844 ' CB ' HG22 ' A' ' 134' ' ' ILE . 67.4 p -76.98 -137.47 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.452 -0.944 . . . . 144.37 108.452 -176.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.929 HD21 ' NE ' ' A' ' 244' ' ' ARG . 87.6 mt -55.39 132.16 47.51 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 107.574 -1.269 . . . . 326.72 107.574 -177.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' TRP . . . . . 0.466 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 9.0 t90 -119.37 -168.05 1.51 Allowed 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 106.006 -1.85 . . . . 158.38 106.006 -176.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . 0.466 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.34 -41.96 98.9 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 109.632 -0.507 . . . . 36.78 109.632 -178.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.8 m -61.09 125.86 25.25 Favored 'General case' 0 N--CA 1.433 -1.32 0 C-N-CA 119.167 -1.013 . . . . 85.46 109.81 -174.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.777 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.88 126.52 8.82 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 105.54 -2.022 . . . . 127.78 105.54 176.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.981 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.01 139.93 34.85 Favored Pre-proline 0 CA--C 1.493 -1.241 0 N-CA-C 105.977 -1.86 . . . . 164.84 105.977 -179.614 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.981 ' N ' HD13 ' A' ' 228' ' ' ILE . 83.1 Cg_exo -56.86 -39.9 88.08 Favored 'Trans proline' 0 N--CA 1.431 -2.183 0 N-CA-C 113.916 0.698 . . . . 222.35 113.916 -175.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . 0.763 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.16 167.02 44.92 Favored Glycine 0 N--CA 1.427 -1.915 0 N-CA-C 106.423 -2.671 . . . . 45.22 106.423 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.925 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.9 t0 -60.93 -45.76 93.4 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 106.045 -1.835 . . . . 107.57 106.045 177.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' SER . . . . . 0.761 ' O ' HG22 ' A' ' 228' ' ' ILE . 67.9 m -65.77 141.83 58.18 Favored 'General case' 0 N--CA 1.429 -1.509 0 C-N-CA 118.894 -1.122 . . . . 167.96 109.145 -175.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.827 ' O ' ' HD2' ' A' ' 235' ' ' ARG . 68.3 m 99.52 106.74 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 126.746 2.019 . . . . 280.68 109.707 176.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.777 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.7 m-20 56.03 11.21 0.7 Allowed 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 124.452 1.101 . . . . 218.25 110.675 174.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.931 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.35 137.62 54.79 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 105.213 -2.143 . . . . 343.57 105.213 177.407 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.586 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.5 t80 -111.93 81.87 1.53 Allowed 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 106.873 -1.529 . . . . 263.29 106.873 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' HIS . . . . . 0.663 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.4 m-70 104.27 147.07 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.268 0 C-N-CA 126.58 1.952 . . . . 261.92 108.522 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.18 -38.13 89.96 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 107.853 -1.166 . . . . 106.81 107.853 -177.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.758 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.48 -39.9 94.93 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 118.366 -1.334 . . . . 112.2 107.536 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.748 HG13 ' NH1' ' A' ' 244' ' ' ARG . 75.8 t -64.27 -39.78 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 N-CA-C 109.263 -0.643 . . . . 45.41 109.263 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.86 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.2 p -70.93 -32.13 68.95 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 110.233 -0.284 . . . . 97.62 110.233 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.34 -39.66 81.83 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 123.73 0.812 . . . . 59.29 110.972 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.758 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.2 -36.56 84.04 Favored 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 124.601 1.16 . . . . 106.49 110.67 -174.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.931 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.97 -30.63 69.23 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 108.294 -1.002 . . . . 106.62 108.294 -176.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.573 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.5 mttm -65.97 -41.04 91.69 Favored 'General case' 0 N--CA 1.435 -1.201 0 O-C-N 121.771 -0.581 . . . . 75.97 110.094 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.877 ' CG1' ' HE3' ' A' ' 250' ' ' MET . 76.0 t -65.6 -40.81 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 C-N-CA 122.908 0.483 . . . . 65.27 109.763 -178.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.835 HG11 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -64.01 -41.55 92.84 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.343 0 C-N-CA 120.39 -0.524 . . . . 107.94 110.185 -177.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . 0.573 ' HE2' ' HA ' ' A' ' 245' ' ' LYS . 59.2 pttt -63.54 -40.85 98.07 Favored 'General case' 0 N--CA 1.433 -1.279 0 O-C-N 121.68 -0.638 . . . . 87.98 110.281 -176.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' MET . . . . . 1.063 ' HE2' ' CD1' ' A' ' 305' ' ' TYR . 21.3 ttt -63.58 -40.44 96.98 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 118.863 -1.135 . . . . 65.5 108.405 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' MET . . . . . 0.877 ' HE3' ' CG1' ' A' ' 246' ' ' VAL . 68.5 mtt -61.7 -36.38 80.74 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 108.141 -1.059 . . . . 85.05 108.141 -177.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . 0.516 HD11 ' HA ' ' A' ' 248' ' ' LYS . 86.9 mt -63.47 -45.76 97.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 109.061 -0.718 . . . . 42.25 109.061 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . 0.874 HG13 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.32 -38.24 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 C-N-CA 119.568 -0.853 . . . . 91.01 109.396 -176.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 1.031 HG21 HD11 ' A' ' 304' ' ' ILE . 65.9 t -58.89 -41.53 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 N-CA-C 108.009 -1.108 . . . . 66.09 108.009 -178.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 250' ' ' MET . 94.8 t -66.07 -43.22 92.45 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.298 0 O-C-N 122.093 -0.379 . . . . 52.39 110.285 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 83.9 m -61.76 -46.71 88.44 Favored 'General case' 0 CA--C 1.489 -1.389 0 O-C-N 121.892 -0.505 . . . . 46.42 109.873 -174.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' THR . . . . . 0.821 ' O ' HG23 ' A' ' 259' ' ' ILE . 9.5 t -62.34 -38.2 88.6 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 108.314 -0.995 . . . . 116.51 108.314 -177.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' PHE . . . . . 0.543 ' N ' HG23 ' A' ' 256' ' ' THR . 86.0 t80 -60.21 -48.24 82.59 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 109.38 -0.6 . . . . 65.18 109.38 -178.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.99 -42.63 97.13 Favored 'General case' 0 CA--C 1.489 -1.373 0 O-C-N 122.093 -0.379 . . . . 51.33 110.448 -175.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . 0.821 HG23 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.65 -43.37 98.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 C-N-CA 118.883 -1.127 . . . . 126.3 109.015 -176.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' CYS . . . . . 0.571 ' N ' HG22 ' A' ' 259' ' ' ILE . 69.7 m -65.54 -49.34 69.28 Favored 'General case' 0 N--CA 1.432 -1.325 0 C-N-CA 119.512 -0.875 . . . . 133.94 112.508 -176.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.866 ' CH2' ' HB2' ' A' ' 294' ' ' ALA . 97.1 m95 -80.63 -33.38 35.79 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 116.869 2.174 . . . . 134.84 116.869 -176.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.796 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.9 tp -58.49 -41.58 89.94 Favored Pre-proline 0 CA--C 1.493 -1.242 0 O-C-N 121.663 -0.648 . . . . 72.23 111.643 -167.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' PRO . . . . . 0.816 ' O ' HG21 ' A' ' 266' ' ' ILE . 80.9 Cg_exo -60.63 -36.02 87.14 Favored 'Trans proline' 0 N--CA 1.429 -2.287 0 CA-C-N 119.884 0.994 . . . . 106.13 111.349 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' PHE . . . . . 0.902 ' N ' HG22 ' A' ' 290' ' ' ILE . 71.8 t80 -66.45 -44.6 82.36 Favored 'General case' 0 N--CA 1.434 -1.273 0 C-N-CA 119.7 -0.8 . . . . 128.35 110.019 -178.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' HIS . . . . . 0.697 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.48 -37.87 89.05 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 110.195 -0.298 . . . . 100.73 110.195 -177.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.816 HG21 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.23 -44.52 95.14 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 C-N-CA 119.294 -0.962 . . . . 172.72 109.191 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . 0.75 ' HD1' ' O ' ' A' ' 263' ' ' PRO . 61.5 m-85 -66.63 -28.07 68.19 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 108.199 -1.037 . . . . 249.23 108.199 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' PHE . . . . . 0.921 ' CZ ' HG22 ' A' ' 182' ' ' ILE . 20.4 t80 -55.58 -55.1 35.99 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 106.673 -1.603 . . . . 259.78 106.673 178.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' LEU . . . . . 0.887 ' HA ' ' HE2' ' A' ' 197' ' ' HIS . 89.4 mt -69.16 -44.22 72.7 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 113.58 0.955 . . . . 233.11 113.58 -176.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . 0.834 HD12 HD22 ' A' ' 279' ' ' LEU . 88.6 mt -61.36 -48.27 91.57 Favored Pre-proline 0 N--CA 1.44 -0.967 0 C-N-CA 119.193 -1.003 . . . . 169.54 110.615 -171.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . 0.682 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.6 Cg_exo -61.21 -24.5 79.13 Favored 'Trans proline' 0 N--CA 1.43 -2.25 0 C-N-CA 116.689 -1.741 . . . . 255.47 114.639 174.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' TYR . . . . . 0.896 ' HH ' ' HG3' ' A' ' 194' ' ' LYS . 19.6 t80 -63.61 -44.2 94.66 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 119.271 0.941 . . . . 279.03 108.905 177.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . 0.829 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.27 -44.8 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 N-CA-C 110.102 -0.333 . . . . 162.21 110.102 -178.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' ASN . . . . . 0.771 ' N ' HD11 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.45 84.86 59.42 Favored Pre-proline 0 N--CA 1.431 -1.387 0 C-N-CA 118.76 -1.176 . . . . 128.13 108.029 -178.039 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.5 Cg_endo -85.22 163.99 11.3 Favored 'Trans proline' 0 C--N 1.295 -2.284 0 N-CA-C 107.482 -1.776 . . . . 278.35 107.482 177.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . 0.852 ' O ' HD22 ' A' ' 277' ' ' LEU . 39.3 t0 66.14 15.02 9.93 Favored 'General case' 0 N--CA 1.429 -1.524 0 O-C-N 123.794 0.684 . . . . 312.91 109.328 175.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.852 HD22 ' O ' ' A' ' 276' ' ' ASP . 28.5 mt -132.73 -170.72 2.5 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 106.557 -1.646 . . . . 353.54 106.557 177.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 1.027 ' HA ' ' HB2' ' A' ' 282' ' ' PHE . 42.7 p90 -115.61 142.22 47.03 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 107.441 -1.318 . . . . 251.26 107.441 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.834 HD22 HD12 ' A' ' 270' ' ' LEU . 1.7 tm? -76.94 -118.76 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 102.097 -3.297 . . . . 175.26 102.097 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . 0.779 ' HB3' ' HE3' ' A' ' 281' ' ' LYS . 34.1 ttmt -61.45 -45.02 96.01 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 100.889 -3.745 . . . . 99.07 100.889 172.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . 0.779 ' HE3' ' HB3' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.36 124.15 9.21 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 103.488 -2.782 . . . . 243.21 103.488 171.171 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 1.027 ' HB2' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.95 112.98 25.13 Favored 'General case' 0 CA--C 1.474 -1.979 0 C-N-CA 116.037 -2.265 . . . . 201.04 105.294 178.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' ILE . . . . . 0.771 HG23 ' N ' ' A' ' 285' ' ' GLN . 10.7 tp -147.93 173.69 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.064 0 C-N-CA 116.036 -2.266 . . . . 201.36 108.754 -175.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' GLN . . . . . 1.069 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.282 0.6 OUTLIER -59.5 -41.43 89.87 Favored 'General case' 0 N--CA 1.416 -2.164 0 CA-C-N 113.184 -1.825 . . . . 203.82 107.829 174.47 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . 0.92 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.31 -45.75 86.59 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 118.249 -1.38 . . . . 215.06 112.55 -171.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.64 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.7 t -65.66 -46.44 89.31 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.467 0 C-N-CA 118.606 -1.237 . . . . 125.28 112.886 -171.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' TYR . . . . . 0.857 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.83 -36.95 86.0 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 107.169 -1.419 . . . . 268.9 107.169 -171.836 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . 0.867 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.24 -45.02 74.36 Favored 'General case' 0 N--CA 1.427 -1.602 0 C-N-CA 125.644 1.577 . . . . 280.88 108.808 -172.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.61 -47.53 85.8 Favored 'General case' 0 N--CA 1.428 -1.567 0 C-N-CA 119.01 -1.076 . . . . 184.47 108.988 -172.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . 0.902 HG22 ' N ' ' A' ' 264' ' ' PHE . 1.8 mp -67.91 -42.1 85.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 C-N-CA 119.298 -0.961 . . . . 167.92 112.732 -175.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' MET . . . . . 0.664 ' HE2' ' HG2' ' A' ' 181' ' ' MET . 21.8 ttt -65.79 -38.75 89.84 Favored 'General case' 0 CA--C 1.495 -1.146 0 C-N-CA 117.779 -1.569 . . . . 367.18 110.785 -175.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' TRP . . . . . 0.571 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.4 m95 -67.19 -32.71 73.97 Favored 'General case' 0 N--CA 1.435 -1.205 0 O-C-N 121.892 -0.505 . . . . 173.97 110.46 177.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.3 tp -64.48 -36.69 85.01 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 123.523 0.729 . . . . 119.66 109.815 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . 0.866 ' HB2' ' CH2' ' A' ' 261' ' ' TRP . . . -61.29 -33.91 74.34 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.752 -1.203 . . . . 112.3 107.752 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' MET . . . . . 0.714 ' O ' HG21 ' A' ' 298' ' ' THR . 21.9 mmt -63.11 -32.09 73.39 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 116.193 -0.458 . . . . 174.17 110.185 -177.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.5 m -64.74 -22.7 67.04 Favored 'General case' 0 CA--C 1.485 -1.525 0 C-N-CA 124.669 1.188 . . . . 145.27 110.638 -175.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' SER . . . . . 0.826 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.6 m -57.66 -35.36 70.45 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 108.056 -1.091 . . . . 170.15 108.056 -175.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.84 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.7 t -55.34 -34.14 63.96 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 116.32 -0.4 . . . . 214.57 110.654 -171.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' MET . . . . . 0.803 ' CE ' ' HG1' ' A' ' 45' ' ' THR . 28.1 ttt -77.18 -33.2 56.45 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 126.065 1.746 . . . . 168.29 115.545 177.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' TYR . . . . . 0.826 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.4 p90 -64.45 -34.86 79.19 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 114.02 1.119 . . . . 167.15 114.02 -168.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . 0.75 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.281 18.8 p-10 -64.22 -38.25 32.78 Favored Pre-proline 0 N--CA 1.433 -1.295 0 C-N-CA 115.536 -2.466 . . . . 165.13 113.961 -171.595 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' PRO . . . . . 0.75 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 83.8 Cg_exo -62.56 -31.8 79.83 Favored 'Trans proline' 0 N--CA 1.433 -2.061 0 CA-C-N 122.791 2.033 . . . . 123.92 111.254 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' ILE . . . . . 0.784 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.76 -42.58 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 C-N-CA 118.859 -1.136 . . . . 110.55 109.739 -179.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' ILE . . . . . 1.031 HD11 HG21 ' A' ' 253' ' ' VAL . 31.1 pt -61.16 -40.02 84.43 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.179 0 N-CA-C 108.825 -0.806 . . . . 145.31 108.825 -177.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . 1.063 ' CD1' ' HE2' ' A' ' 249' ' ' MET 0.253 63.1 m-85 -58.12 -48.84 78.98 Favored 'General case' 0 CA--C 1.495 -1.171 0 C-N-CA 119.416 -0.914 . . . . 246.68 109.824 -177.48 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.7 m -62.14 -47.53 84.17 Favored 'General case' 0 CA--C 1.484 -1.564 0 C-N-CA 119.526 -0.87 . . . . 64.43 109.587 -173.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.6 t -66.83 -45.01 79.62 Favored 'General case' 0 N--CA 1.428 -1.553 0 C-N-CA 118.992 -1.083 . . . . 80.72 110.226 -177.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.759 HD22 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.56 -35.66 75.61 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 115.937 1.828 . . . . 140.44 115.937 -173.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . 0.617 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.8 p30 -136.83 132.2 34.3 Favored 'General case' 0 N--CA 1.434 -1.245 0 C-N-CA 112.723 -3.591 . . . . 178.87 113.039 -177.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . 0.705 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.06 -37.0 86.13 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 114.409 -1.269 . . . . 110.22 110.151 -177.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . 0.86 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.77 -50.58 72.77 Favored 'General case' 0 CA--C 1.492 -1.27 0 O-C-N 121.753 -0.592 . . . . 174.78 109.737 -174.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.978 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.1 m-85 -64.92 -41.65 95.38 Favored 'General case' 0 CA--C 1.484 -1.575 0 N-CA-C 108.24 -1.022 . . . . 161.84 108.24 178.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . 0.479 ' HE ' HD21 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.32 -50.24 73.58 Favored 'General case' 0 CA--C 1.49 -1.331 0 N-CA-C 109.182 -0.673 . . . . 117.2 109.182 -173.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.84 ' HB3' HD12 ' A' ' 326' ' ' ILE . 3.0 mm? -68.48 -44.16 75.37 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 120.364 -0.534 . . . . 112.6 111.037 -177.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . 1.136 ' HA2' ' HD1' ' A' ' 318' ' ' HIS . . . -63.99 -37.48 94.68 Favored Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 110.648 -0.981 . . . . 101.46 110.648 -177.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' PHE . . . . . 0.978 ' CE2' ' HB3' ' A' ' 312' ' ' PHE . 36.6 m-85 -62.15 -46.01 90.9 Favored 'General case' 0 CA--C 1.492 -1.265 0 CA-C-N 118.493 1.147 . . . . 151.49 109.5 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . 0.465 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.06 -36.34 77.12 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 106.959 -1.497 . . . . 142.32 106.959 -175.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' HIS . . . . . 1.136 ' HD1' ' HA2' ' A' ' 315' ' ' GLY . 50.0 m80 -59.82 -41.76 92.02 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 106.892 -1.521 . . . . 109.09 106.892 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.9 -42.46 85.45 Favored 'General case' 0 N--CA 1.435 -1.183 0 O-C-N 122.368 -0.208 . . . . 76.11 110.979 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -61.37 -55.49 30.98 Favored 'General case' 0 CA--C 1.49 -1.36 0 C-N-CA 119.866 -0.734 . . . . 120.24 109.361 -174.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . 0.755 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.4 mtt180 -74.36 131.54 41.22 Favored 'General case' 0 CA--C 1.482 -1.649 0 N-CA-C 102.943 -2.984 . . . . 192.73 102.943 177.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.11 -44.27 91.96 Favored 'General case' 0 CA--C 1.492 -1.27 0 C-N-CA 119.008 -1.077 . . . . 176.29 109.212 -172.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' CYS . . . . . 0.811 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 77.9 m -79.34 -177.14 0.82 Allowed Pre-proline 0 N--CA 1.43 -1.439 0 N-CA-C 106.364 -1.717 . . . . 69.68 106.364 178.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.568 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 84.2 Cg_exo -58.93 -75.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.389 0 C-N-CA 118.343 -0.638 . . . . 191.05 112.637 176.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' PHE . . . . . 0.811 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.6 m-85 47.45 43.88 16.09 Favored 'General case' 0 CA--C 1.493 -1.234 0 O-C-N 123.571 0.544 . . . . 287.03 109.803 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . 0.844 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.52 78.65 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.474 -1.944 0 C-N-CA 112.885 -3.526 . . . . 292.29 109.847 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' SER . . . . . 0.507 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.4 t -77.48 -152.84 0.05 Allowed 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 104.199 -2.519 . . . . 184.57 104.199 178.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.65 8.67 4.99 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 113.091 0.775 . . . . 274.56 113.091 176.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 99.0 0.89 57.23 Favored Glycine 0 C--N 1.348 1.248 0 C-N-CA 117.725 -2.178 . . . . 268.24 113.473 172.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' ASP . . . . . 0.724 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.9 m-20 51.6 -172.05 0.03 OUTLIER 'General case' 0 CA--C 1.496 -1.099 0 CA-C-N 118.676 1.238 . . . . 200.06 110.782 177.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.86 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.3 t80 -63.86 -33.02 74.75 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 107.892 -1.151 . . . . 114.44 107.892 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' GLU . . . . . 0.597 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.27 46.05 21.91 Favored 'General case' 0 CA--C 1.484 -1.581 0 N-CA-C 107.627 -1.249 . . . . 263.81 107.627 -177.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' GLY . . . . . 0.65 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.31 -137.37 3.61 Favored Glycine 0 CA--C 1.478 -2.229 1 N-CA-C 102.548 -4.221 . . . . 103.79 102.548 -179.804 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . 0.994 HD21 ' HA ' ' A' ' 337' ' ' LYS . 61.4 mt -88.27 95.61 10.25 Favored 'General case' 0 N--CA 1.419 -1.983 0 C-N-CA 114.95 -2.7 . . . . 117.3 106.013 176.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . 1.065 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.97 -39.8 90.68 Favored 'General case' 0 CA--C 1.468 -2.177 1 N-CA-C 97.977 -4.823 . . . . 231.58 97.977 167.232 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' MET . . . . . 1.06 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.91 163.53 28.95 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 102.092 -3.299 . . . . 303.24 102.092 168.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' LYS . . . . . 0.994 ' HA ' HD21 ' A' ' 334' ' ' LEU . 84.4 tttt -62.6 -48.64 78.54 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 116.066 -2.253 . . . . 112.72 108.442 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' SER . . . . . 0.411 ' HB3' ' SD ' ' A' ' 336' ' ' MET . 47.9 t -61.03 -63.68 1.22 Allowed 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 109.091 -0.707 . . . . 83.22 109.091 -176.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 339' ' ' THR . . . . . 0.911 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.4 m -156.28 -126.18 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 103.858 -2.645 . . . . 174.36 103.858 -178.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . 1.065 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.88 160.94 8.81 Favored 'General case' 0 CA--C 1.486 -1.515 0 N-CA-C 105.789 -1.93 . . . . 202.73 105.789 177.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . 1.033 ' HH ' ' HA3' ' A' ' 315' ' ' GLY . 0.2 OUTLIER -131.94 149.0 52.56 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 107.065 -1.457 . . . . 180.62 107.065 176.432 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . 0.946 ' H ' ' HB2' ' A' ' 347' ' ' SER . 53.6 tp -178.49 -171.85 0.27 Allowed 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 105.407 -2.072 . . . . 145.25 105.407 178.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' GLN . . . . . 0.944 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.06 -43.2 88.13 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 106.113 -1.81 . . . . 66.05 106.113 174.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' THR . . . . . 0.757 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.66 -152.14 0.48 Allowed 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 103.521 -2.77 . . . . 266.49 103.521 179.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 345' ' ' GLN . . . . . 0.61 ' CD ' HD23 ' A' ' 342' ' ' LEU . 79.5 mt-30 66.28 -124.97 0.28 Allowed 'General case' 0 N--CA 1.428 -1.572 0 C-N-CA 117.076 -1.85 . . . . 219.2 107.739 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 346' ' ' GLY . . . . . 0.991 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -64.96 -37.43 94.26 Favored Glycine 0 N--CA 1.426 -2.013 0 CA-C-N 114.536 -1.211 . . . . 94.78 112.895 -176.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 347' ' ' SER . . . . . 1.107 ' HG ' ' HB3' ' A' ' 61' ' ' LYS . 48.4 t -81.21 100.45 9.12 Favored 'General case' 0 CA--C 1.483 -1.599 0 C-N-CA 112.327 -3.749 . . . . 121.41 109.441 -171.047 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 348' ' ' VAL . . . . . 0.671 ' O ' ' HE2' ' A' ' 336' ' ' MET . 94.2 t -73.09 145.55 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 108.961 -0.755 . . . . 85.34 108.961 -176.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 349' ' ' TYR . . . . . 0.434 ' N ' HG11 ' A' ' 348' ' ' VAL . 48.5 p90 -57.78 143.44 42.09 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.848 -1.167 . . . . 267.57 107.848 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 350' ' ' LYS . . . . . 0.508 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.08 69.53 0.6 Allowed 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 109.532 -0.544 . . . . 226.1 109.532 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 351' ' ' VAL . . . . . 1.05 ' HB ' ' HE1' ' A' ' 336' ' ' MET . 7.5 p -50.96 156.97 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.315 0 N-CA-C 107.017 -1.475 . . . . 154.84 107.017 177.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 352' ' ' SER . . . . . 0.608 ' N ' HG21 ' A' ' 351' ' ' VAL . 71.5 m -61.4 161.92 8.64 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-O 121.602 0.715 . . . . 180.01 110.721 -173.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 353' ' ' ARG . . . . . 0.879 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.45 156.91 23.66 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 106.913 -1.514 . . . . 333.78 106.913 -178.615 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 354' ' ' LEU . . . . . 0.997 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.03 142.54 48.73 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 107.325 -1.361 . . . . 335.2 107.325 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.997 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.5 mm-40 82.79 158.88 0.13 Allowed 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 108.753 -0.832 . . . . 266.47 108.753 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.5 m -60.6 -46.84 88.74 Favored 'General case' 0 CA--C 1.487 -1.467 0 N-CA-C 105.708 -1.96 . . . . 59.34 105.708 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.6 173.83 11.98 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 104.444 -2.428 . . . . 201.26 104.444 176.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.78 HG21 ' O ' ' A' ' 360' ' ' THR . 69.2 mt -95.92 106.7 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 C-N-CA 116.323 -2.151 . . . . 56.23 105.53 -179.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 359' ' ' SER . . . . . 0.523 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.7 m -61.15 -59.48 5.26 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 109.308 -0.627 . . . . 87.58 109.308 -175.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 360' ' ' THR . . . . . 0.884 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.1 t -85.49 153.71 22.27 Favored 'General case' 0 CA--C 1.486 -1.513 0 N-CA-C 107.871 -1.159 . . . . 219.95 107.871 -177.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 361' ' ' VAL . . . . . 0.563 HG22 ' O ' ' A' ' 361' ' ' VAL . 16.0 m -81.98 83.86 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.656 0 C-N-CA 116.326 -2.15 . . . . 121.79 105.434 177.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.567 HG11 ' N ' ' A' ' 363' ' ' GLY . 64.5 t -154.16 159.68 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 N-CA-C 105.824 -1.917 . . . . 53.85 105.824 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . 0.567 ' N ' HG11 ' A' ' 362' ' ' VAL . . . 72.28 16.59 77.15 Favored Glycine 0 N--CA 1.428 -1.875 0 N-CA-C 106.046 -2.822 . . . . 196.55 106.046 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.681 0 N-CA-C 107.849 -1.167 . . . . 35.88 107.849 -178.9 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 365' ' ' ARG . . . . . 0.477 HH11 ' HD2' ' B' ' 365' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 108.808 -0.812 . . . . 1.0 108.808 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 366' ' ' PRO . . . . . 0.416 ' CD ' ' N ' ' B' ' 365' ' ' ARG . 52.8 Cg_endo -66.91 141.99 60.78 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.086 1.858 . . . . 1.0 110.228 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 367' ' ' LYS . . . . . 0.905 ' HG3' HD12 ' A' ' 5' ' ' LEU . 0.8 OUTLIER -64.35 143.26 98.45 Favored Pre-proline 0 C--N 1.326 -0.445 0 C-N-CA 119.888 -0.725 . . . . 1.0 109.576 -179.875 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 368' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.31 150.44 76.26 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.272 1.981 . . . . 1.0 111.728 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 369' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.77 131.75 44.3 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.724 -0.39 . . . . 1.0 110.165 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 370' ' ' GLN . . . . . 0.711 ' NE2' ' HA ' ' B' ' 370' ' ' GLN . 0.0 OUTLIER -102.01 115.93 31.61 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.672 -179.831 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 371' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -63.71 -42.36 97.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.347 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 372' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -65.03 -36.21 83.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.871 -0.604 . . . . 1.0 110.652 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -59.78 -33.0 76.05 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.839 -0.905 . . . . 1.0 110.839 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 374' ' ' LEU . . . . . 0.996 HD12 ' HA ' ' A' ' 20' ' ' SER . 10.0 tp . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 120.885 0.374 . . . . 1.0 110.173 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.457 0 N-CA-C 108.377 -0.971 . . . . 97.08 108.377 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.427 ' HB3' ' OD1' ' A' ' 276' ' ' ASP . 46.6 t30 -110.61 155.42 22.39 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-O 122.103 0.954 . . . . 123.41 110.737 -172.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.927 HG11 HD13 ' A' ' 15' ' ' ILE . 28.7 m -134.58 -162.38 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.487 1 N-CA-C 100.093 -4.04 . . . . 151.3 100.093 173.732 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.974 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.63 -38.61 58.55 Favored Pre-proline 0 N--CA 1.439 -0.981 0 C-N-CA 115.961 -2.295 . . . . 169.25 106.123 178.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.974 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 58.0 Cg_exo -81.28 168.53 16.65 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 122.255 0.608 . . . . 185.76 110.536 171.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.854 HG12 ' CE2' ' A' ' 282' ' ' PHE . 92.0 t -64.47 -25.93 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 C-N-CA 127.022 2.129 . . . . 145.47 110.343 -177.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.713 ' O ' HG21 ' A' ' 4' ' ' VAL . 39.2 t0 -84.33 157.41 21.5 Favored 'General case' 0 CA--C 1.499 -0.988 0 O-C-N 121.073 -1.017 . . . . 102.76 109.459 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.5 p -82.59 154.17 25.1 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 107.988 -1.115 . . . . 106.25 107.988 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.92 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 46.7 p-10 -105.89 51.89 0.74 Allowed 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 117.772 -1.571 . . . . 157.81 107.628 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.16 -45.9 91.51 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 103.586 -2.746 . . . . 150.2 103.586 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.458 ' C ' ' H ' ' A' ' 14' ' ' ASN . 70.8 m -87.05 164.68 35.29 Favored Pre-proline 0 N--CA 1.422 -1.872 0 N-CA-C 103.672 -2.714 . . . . 183.52 103.672 172.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -76.77 6.87 3.84 Favored 'Trans proline' 0 C--N 1.281 -2.998 0 N-CA-C 109.988 -0.812 . . . . 235.61 109.988 176.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.458 ' H ' ' C ' ' A' ' 12' ' ' SER . 34.6 t-20 -57.93 -41.25 82.33 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 124.809 1.244 . . . . 113.77 113.379 -170.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.927 HD13 HG11 ' A' ' 4' ' ' VAL . 33.4 pt -52.16 136.22 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-N 119.558 1.072 . . . . 150.85 110.984 -176.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.49 156.26 46.39 Favored 'General case' 0 C--N 1.36 1.064 0 N-CA-C 107.625 -1.25 . . . . 100.42 107.625 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 1.025 HG23 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.05 142.61 58.35 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 121.953 0.882 . . . . 129.36 110.444 -174.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.764 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.06 -25.5 68.4 Favored 'General case' 0 CA--C 1.494 -1.208 0 C-N-CA 126.303 1.841 . . . . 112.34 106.689 -177.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 1.012 HG21 ' HA2' ' A' ' 101' ' ' GLY . 85.8 m -74.14 -40.14 62.81 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.542 -0.754 . . . . 131.73 111.744 177.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 1.025 ' H ' HG23 ' A' ' 17' ' ' THR . 71.2 m -84.45 -42.86 15.18 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 116.994 2.22 . . . . 80.49 116.994 -174.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.529 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.4 mt-10 -145.99 174.54 3.34 Favored Pre-proline 0 N--CA 1.443 -0.817 0 C-N-CA 118.152 -1.419 . . . . 98.98 111.198 -169.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.881 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.333 85.7 Cg_exo -61.79 -10.73 18.04 Favored 'Trans proline' 0 C--N 1.321 -0.887 1 N-CA-C 128.934 6.475 . . . . 246.95 128.934 -170.085 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.675 HD22 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.61 17.55 8.7 Favored 'General case' 0 C--N 1.324 -0.515 1 CA-C-N 126.15 4.068 . . . . 269.62 114.216 175.655 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.581 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.6 mt-30 -67.14 -27.26 67.16 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 107.802 -1.184 . . . . 86.8 107.802 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.502 ' CE1' ' CG2' ' A' ' 26' ' ' VAL . 50.3 p90 -66.81 -29.34 69.25 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 121.115 -0.991 . . . . 85.91 110.501 -178.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.888 HG11 ' OE1' ' A' ' 284' ' ' GLN . 40.4 t -68.54 -40.21 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 C-N-CA 123.695 0.798 . . . . 82.0 111.346 -177.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.931 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.4 167.73 12.48 Favored Pre-proline 0 CA--C 1.489 -1.4 0 N-CA-C 108.552 -0.907 . . . . 120.73 108.552 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.842 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -64.0 149.76 89.82 Favored 'Trans proline' 0 N--CA 1.432 -2.123 0 C-N-CA 120.616 0.877 . . . . 87.86 109.91 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.82 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.03 -37.96 89.28 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 108.846 -0.798 . . . . 36.46 108.846 -176.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.841 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.8 p-90 -63.8 -33.86 76.61 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 107.807 -1.183 . . . . 150.6 107.807 -176.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.931 ' OE1' ' HB2' ' A' ' 27' ' ' GLN . 80.5 mt-30 -62.21 -32.71 73.41 Favored 'General case' 0 CA--C 1.49 -1.334 0 O-C-N 121.291 -0.88 . . . . 123.26 108.666 -178.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.855 HG23 ' O ' ' A' ' 93' ' ' ALA . 1.7 mp -61.47 -47.17 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.57 0 N-CA-C 109.157 -0.682 . . . . 120.14 109.157 176.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 30' ' ' TRP . 20.2 m -67.41 -31.03 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 107.873 -1.158 . . . . 112.19 107.873 -178.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.841 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.5 tp -62.98 -47.12 84.51 Favored 'General case' 0 N--CA 1.432 -1.337 0 C-N-CA 119.921 -0.712 . . . . 60.87 109.601 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.691 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.03 -35.67 81.18 Favored 'General case' 0 CA--C 1.489 -1.382 0 C-N-CA 119.965 -0.694 . . . . 157.57 110.364 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.785 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.61 -40.89 98.39 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 108.629 -0.878 . . . . 47.06 108.629 178.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.841 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.77 -41.28 98.01 Favored 'General case' 0 CA--C 1.496 -1.121 0 O-C-N 121.756 -0.59 . . . . 43.94 109.557 -177.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.766 ' O ' HG21 ' A' ' 41' ' ' VAL . . . -61.81 -43.3 99.12 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.726 -0.842 . . . . 42.61 108.726 -176.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.96 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.38 -41.26 93.94 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 116.623 -0.262 . . . . 140.66 111.029 -178.364 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.841 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.78 -43.96 97.81 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 118.58 -1.248 . . . . 116.04 110.234 -175.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.766 HG21 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.44 -38.75 83.24 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.292 0 N-CA-C 108.731 -0.84 . . . . 97.16 108.731 -177.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.915 HD11 ' HD1' ' A' ' 39' ' ' TYR . 93.2 mt -61.28 -40.0 84.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 N-CA-C 108.975 -0.75 . . . . 54.85 108.975 -176.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.974 HG23 HG22 ' A' ' 86' ' ' THR . 92.9 t -57.71 -42.34 81.48 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.301 0 N-CA-C 108.873 -0.788 . . . . 45.39 108.873 -175.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.403 ' O ' HG22 ' A' ' 48' ' ' VAL . 97.2 t -63.52 -50.97 76.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 C-N-CA 118.848 -1.141 . . . . 48.64 110.171 -177.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.794 ' HG1' ' CE ' ' A' ' 299' ' ' MET . 10.6 t -65.27 -47.04 78.08 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 120.163 -0.615 . . . . 116.65 111.711 -174.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.641 ' N ' HG23 ' A' ' 45' ' ' THR . 50.8 m -61.96 -43.94 97.79 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 109.715 -0.476 . . . . 51.16 109.715 -174.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 43' ' ' VAL . 97.4 t -65.54 -48.93 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 C-N-CA 119.852 -0.739 . . . . 44.3 110.85 -176.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.875 ' O ' HG22 ' A' ' 52' ' ' VAL . 93.8 t -64.75 -46.94 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 C-N-CA 120.299 -0.56 . . . . 48.82 111.032 -174.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.77 -44.15 95.21 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 120.513 -0.851 . . . . 58.7 112.006 -174.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -72.63 -34.21 67.17 Favored 'General case' 0 CA--C 1.488 -1.432 0 O-C-N 122.086 -0.655 . . . . 101.4 111.027 -175.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.814 HG11 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.9 -38.73 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 107.745 -1.206 . . . . 103.57 107.745 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.875 HG22 ' O ' ' A' ' 48' ' ' VAL . 72.0 t -61.43 -43.05 96.06 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.225 0 N-CA-C 108.975 -0.75 . . . . 61.89 108.975 -178.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.639 ' O ' HG21 ' A' ' 56' ' ' ILE . 81.8 t -63.44 -50.96 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 N-CA-C 109.47 -0.567 . . . . 70.01 109.47 -178.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.717 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.94 -43.39 98.92 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 109.13 -0.693 . . . . 132.1 109.13 -176.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.674 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.23 -46.62 83.02 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 116.677 -0.238 . . . . 104.5 110.441 -176.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.896 HD11 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.67 -49.88 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 C-N-CA 120.212 -0.595 . . . . 142.96 111.271 -173.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 1.039 HD12 HG13 ' A' ' 72' ' ' VAL 0.279 24.8 pt -64.79 -41.68 92.87 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.661 0 C-N-CA 116.947 -1.901 . . . . 158.32 110.877 -175.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.717 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.72 -41.39 98.09 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 117.725 -1.59 . . . . 137.11 109.48 178.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.36 -44.54 91.11 Favored 'General case' 0 N--CA 1.436 -1.165 0 O-C-N 122.164 -0.335 . . . . 54.66 111.019 -176.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.951 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.41 117.12 29.4 Favored 'General case' 0 CA--C 1.491 -1.322 0 CA-C-O 121.623 0.725 . . . . 127.18 109.586 -174.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 1.102 ' HB3' ' HG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.83 -36.84 80.12 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 124.099 0.96 . . . . 87.93 110.832 -176.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 1.064 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.38 -34.67 78.7 Favored 'General case' 0 CA--C 1.49 -1.33 0 O-C-N 121.657 -0.652 . . . . 131.12 111.509 -175.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 1.008 ' HG3' ' CE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.61 69.43 7.12 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 115.313 -2.555 . . . . 246.56 109.606 -175.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 61' ' ' LYS . 9.6 mmp_? -123.21 91.45 3.48 Favored 'General case' 0 CA--C 1.474 -1.966 0 N-CA-C 105.484 -2.043 . . . . 339.35 105.484 177.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.856 ' HG1' ' H ' ' A' ' 68' ' ' ASN . 82.5 p -124.15 165.27 17.85 Favored 'General case' 0 N--CA 1.414 -2.248 0 N-CA-C 102.992 -2.966 . . . . 114.66 102.992 176.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.954 HG22 ' HG1' ' A' ' 147' ' ' THR . 7.7 p -63.15 -39.44 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 N-CA-C 106.78 -1.563 . . . . 143.28 106.78 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.993 HG21 HD13 ' A' ' 71' ' ' LEU . 95.4 m -59.69 -38.05 80.5 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 108.687 -0.856 . . . . 160.22 108.687 -176.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.856 ' H ' ' HG1' ' A' ' 65' ' ' THR . 86.3 m-20 -62.34 -31.78 72.46 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 108.872 -0.788 . . . . 120.54 108.872 -177.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.939 ' O ' HG21 ' A' ' 72' ' ' VAL . 89.8 m-85 -63.59 -43.81 95.86 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 109.481 -0.563 . . . . 67.22 109.481 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.936 ' CE2' HG23 ' A' ' 66' ' ' VAL . 82.5 m-85 -66.53 -39.76 88.78 Favored 'General case' 0 CA--C 1.498 -1.055 0 O-C-N 121.488 -0.758 . . . . 138.6 109.668 -177.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.993 HD13 HG21 ' A' ' 67' ' ' THR . 10.1 mp -63.58 -35.91 82.05 Favored 'General case' 0 CA--C 1.493 -1.237 0 C-N-CA 122.479 0.312 . . . . 151.46 110.641 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 1.039 HG13 HD12 ' A' ' 57' ' ' ILE . 24.2 m -62.56 -37.95 80.2 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.227 0 C-N-CA 117.39 -1.724 . . . . 117.93 106.715 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.529 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.1 t30 -60.07 -46.03 90.92 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 107.859 -1.163 . . . . 56.82 107.859 -177.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.911 HD21 ' CE ' ' A' ' 123' ' ' MET . 8.7 mp -61.36 -43.91 98.07 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 108.931 -0.766 . . . . 145.3 108.931 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.05 -40.35 95.47 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 108.521 -0.918 . . . . 45.71 108.521 -175.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -62.4 -42.02 99.11 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.377 -0.601 . . . . 105.61 109.377 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.12 -39.45 92.59 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 108.646 -0.872 . . . . 47.89 108.646 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.705 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.56 -37.37 84.83 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 109.966 -0.383 . . . . 124.53 109.966 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.86 -41.22 99.28 Favored 'General case' 0 CA--C 1.496 -1.099 0 O-C-N 121.952 -0.467 . . . . 35.89 109.843 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.8 t -62.23 -37.3 84.86 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 107.025 -1.472 . . . . 88.97 107.025 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.84 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.17 -49.17 76.88 Favored 'General case' 0 N--CA 1.428 -1.55 0 C-N-CA 119.831 -0.748 . . . . 239.91 109.047 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.599 ' O ' HG21 ' A' ' 86' ' ' THR . . . -65.38 -43.4 90.81 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 121.536 -0.728 . . . . 146.1 110.596 -177.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.16 -58.23 3.4 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 117.397 -1.721 . . . . 91.74 113.852 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -76.55 -61.38 1.98 Allowed 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 115.748 1.759 . . . . 197.45 115.748 -173.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.99 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.25 -42.26 55.52 Favored 'General case' 0 CA--C 1.49 -1.365 0 C-N-CA 117.897 -1.521 . . . . 242.6 114.046 -170.036 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.974 HG22 HG23 ' A' ' 43' ' ' VAL . 4.6 t -65.4 -36.55 84.3 Favored 'General case' 0 N--CA 1.434 -1.254 0 C-N-CA 118.912 -1.115 . . . . 215.61 109.838 -172.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.458 ' N ' HG23 ' A' ' 86' ' ' THR . 72.3 t -60.3 -46.94 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 O-C-N 121.828 -0.545 . . . . 87.19 110.459 -175.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.896 HG21 ' NE2' ' A' ' 108' ' ' HIS . 63.6 t -65.93 -41.86 90.75 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.112 0 N-CA-C 109.731 -0.47 . . . . 231.82 109.731 -178.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.96 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 11.0 m120 -62.32 -34.14 76.06 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 108.317 -0.994 . . . . 364.98 108.317 -177.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.657 ' CE1' ' HB3' ' A' ' 36' ' ' ALA . 85.3 t80 -68.19 -44.72 75.25 Favored 'General case' 0 N--CA 1.438 -1.054 0 O-C-N 121.543 -0.723 . . . . 181.63 111.275 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.899 HG21 ' HD2' ' A' ' 95' ' ' HIS . 57.7 m -60.87 -45.78 93.19 Favored 'General case' 0 CA--C 1.478 -1.809 0 N-CA-C 107.432 -1.321 . . . . 269.02 107.432 -175.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 1.072 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.72 -45.03 93.4 Favored 'General case' 0 N--CA 1.416 -2.149 0 C-N-CA 118.657 -1.217 . . . . 562.66 110.023 -179.058 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.855 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.11 -45.24 95.51 Favored 'General case' 0 CA--C 1.479 -1.787 0 C-N-CA 118.696 -1.202 . . . . 446.75 108.097 -167.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.785 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.388 6.1 m -70.51 -26.31 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 C-N-CA 115.837 -2.345 . . . . 370.05 112.216 -178.755 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.899 ' HD2' HG21 ' A' ' 91' ' ' THR . 90.0 m-70 -74.48 -26.5 60.06 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 121.593 -0.692 . . . . 354.91 112.513 175.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.881 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.4 m-20 82.8 4.53 0.99 Allowed 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 125.067 1.347 . . . . 462.44 111.905 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.764 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.266 11.9 mm-40 -172.35 178.06 2.91 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-O 122.015 0.912 . . . . 652.37 111.122 171.786 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.832 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.73 86.3 2.17 Favored 'General case' 0 N--CA 1.428 -1.565 0 C-N-CA 128.489 2.715 . . . . 905.99 107.929 -174.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -67.87 -36.4 80.21 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 108.244 -1.021 . . . . 570.43 108.244 -176.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.844 ' HB3' ' CG ' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.57 -36.35 82.4 Favored 'General case' 0 N--CA 1.428 -1.54 0 C-N-CA 125.318 1.447 . . . . 453.22 111.157 -174.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 1.012 ' HA2' HG21 ' A' ' 19' ' ' THR . . . 97.55 178.66 33.9 Favored Glycine 0 C--N 1.349 1.292 0 C-N-CA 118.768 -1.682 . . . . 445.63 109.891 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.0 mt -56.41 -41.23 75.99 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 125.275 1.43 . . . . 457.72 112.357 -170.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -58.63 -46.93 86.03 Favored 'General case' 0 CA--C 1.484 -1.56 0 C-N-CA 118.662 -1.215 . . . . 340.58 109.296 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.844 ' CG ' ' HB3' ' A' ' 100' ' ' TYR . 88.1 m-85 -68.71 -32.14 71.72 Favored 'General case' 0 N--CA 1.423 -1.775 0 C-N-CA 118.774 -1.171 . . . . 453.6 111.577 -176.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.729 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.05 -40.35 73.37 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 105.976 -1.861 . . . . 541.48 105.976 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.452 ' HD2' ' HA2' ' A' ' 166' ' ' GLY . 27.0 ttpt -65.83 -47.14 75.99 Favored 'General case' 0 CA--C 1.486 -1.514 0 O-C-N 123.991 0.807 . . . . 466.68 110.866 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -61.74 -47.08 86.86 Favored 'General case' 0 N--CA 1.427 -1.607 0 C-N-CA 117.48 -1.688 . . . . 427.34 107.315 -178.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.896 ' NE2' HG21 ' A' ' 88' ' ' VAL . 47.6 m80 -67.1 -36.79 82.72 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 112.415 0.524 . . . . 537.87 112.415 -174.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.582 ' HB2' ' HB3' ' A' ' 180' ' ' CYS . 2.9 t-20 -69.4 -42.69 74.77 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 116.847 -1.941 . . . . 422.12 111.593 175.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.913 ' O ' HG21 ' A' ' 113' ' ' ILE . 75.9 t80 -59.05 -50.1 75.37 Favored 'General case' 0 CA--C 1.502 -0.883 0 O-C-N 121.324 -0.86 . . . . 340.17 111.834 -173.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.486 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 61.6 m-85 -65.29 -46.54 71.37 Favored Pre-proline 0 N--CA 1.443 -0.811 0 C-N-CA 119.082 -1.047 . . . . 258.06 111.723 -176.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.99 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.0 Cg_exo -61.52 -31.54 87.64 Favored 'Trans proline' 0 N--CA 1.435 -1.943 0 N-CA-C 115.368 1.257 . . . . 305.71 115.368 176.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.943 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.91 -40.41 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 N-CA-C 108.687 -0.857 . . . . 252.7 108.687 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.423 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.92 -40.6 93.8 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 107.801 -1.185 . . . . 149.27 107.801 -179.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.0 -44.81 95.93 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 120.625 -0.43 . . . . 138.08 111.506 -176.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.751 HG23 ' CZ2' ' A' ' 261' ' ' TRP . 65.1 t -66.94 -42.39 88.77 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 O-C-N 121.575 -0.703 . . . . 132.89 110.96 -177.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.946 ' CE1' HG22 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.76 -44.67 92.79 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 108.884 -0.784 . . . . 193.61 108.884 -177.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.605 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.48 -37.66 84.46 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 122.804 0.442 . . . . 63.83 110.085 -175.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.9 m -64.02 -52.39 59.69 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 120.747 -0.381 . . . . 76.4 111.228 -177.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.805 HD11 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.99 -41.63 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 108.185 -1.042 . . . . 171.13 108.185 -174.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 1.069 ' HB2' HD12 ' A' ' 154' ' ' ILE . 29.3 m-85 -63.8 -38.56 91.56 Favored 'General case' 0 N--CA 1.433 -1.311 0 O-C-N 121.834 -0.541 . . . . 78.3 110.635 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.554 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.6 t -67.11 -35.74 80.42 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 118.901 -1.12 . . . . 92.36 109.216 -178.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' MET . . . . . 1.087 ' HA ' ' HE1' ' A' ' 123' ' ' MET . 5.9 mmt -62.5 -34.28 76.55 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 108.173 -1.047 . . . . 93.73 108.173 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.978 HG22 HG13 ' A' ' 212' ' ' ILE . 33.2 p -67.42 -41.65 84.49 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 119.215 -0.994 . . . . 132.74 109.33 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.28 -42.08 94.68 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.18 -1.415 . . . . 43.39 107.18 -177.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.866 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.0 t -58.46 -41.99 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 N-CA-C 108.607 -0.886 . . . . 59.34 108.607 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.401 ' HB3' ' HB1' ' A' ' 215' ' ' ALA . . . -63.48 -44.07 95.45 Favored 'General case' 0 CA--C 1.497 -1.064 0 O-C-N 121.804 -0.56 . . . . 69.68 110.519 -177.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.469 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.3 t80 -65.47 -42.77 91.9 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.326 -0.99 . . . . 106.98 108.326 -177.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.866 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.35 -35.61 81.42 Favored 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 119.662 -0.815 . . . . 147.63 108.951 -177.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.764 ' NH1' ' HE2' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.16 -41.54 99.27 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 108.541 -0.911 . . . . 190.06 108.541 178.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.963 ' HD2' ' HE3' ' A' ' 132' ' ' MET . 66.5 t80 -61.34 -44.06 97.82 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.31 -0.996 . . . . 118.85 108.31 -177.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 1.12 ' HA ' ' HE1' ' A' ' 132' ' ' MET . 4.5 mmt -63.36 -42.66 98.89 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 109.986 -0.375 . . . . 102.5 109.986 -177.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.99 -41.62 95.25 Favored 'General case' 0 CA--C 1.489 -1.39 0 O-C-N 121.82 -0.55 . . . . 89.98 109.841 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.889 ' CD1' HG12 ' A' ' 219' ' ' VAL . 95.3 mt -66.52 -50.72 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 C-N-CA 118.13 -1.428 . . . . 106.09 110.991 -177.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.798 HD12 ' HE1' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.07 -48.32 38.42 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.099 0 C-N-CA 117.098 -1.841 . . . . 227.74 111.815 -174.792 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.79 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.85 100.08 50.98 Favored Pre-proline 0 CA--C 1.486 -1.505 0 C-N-CA 116.242 -2.183 . . . . 262.55 110.059 -175.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.471 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.2 Cg_endo -69.6 -10.39 28.56 Favored 'Trans proline' 0 C--N 1.29 -2.544 0 C-N-CA 121.618 1.545 . . . . 210.25 111.358 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.81 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.28 112.02 1.0 Allowed 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 106.523 -1.658 . . . . 270.58 106.523 -178.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.888 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.82 -39.5 23.87 Favored Pre-proline 0 N--CA 1.43 -1.451 0 CA-C-N 115.358 -0.837 . . . . 129.84 112.347 -175.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.853 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 82.1 Cg_exo -61.36 -26.6 81.77 Favored 'Trans proline' 0 N--CA 1.431 -2.163 0 N-CA-C 116.297 1.614 . . . . 330.71 116.297 -174.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.79 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.03 77.2 7.95 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 114.479 -2.888 . . . . 204.51 107.277 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.878 HD12 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.72 147.43 0.09 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 107.435 -1.32 . . . . 387.41 107.435 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.878 ' N ' HD12 ' A' ' 142' ' ' LEU . 47.4 t -143.71 147.02 33.63 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 118.794 -1.162 . . . . 166.22 109.475 178.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.84 -40.76 88.03 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 107.847 -1.168 . . . . 44.23 107.847 176.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.474 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.6 m -60.3 -39.14 85.89 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 108.176 -1.046 . . . . 28.8 108.176 -175.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.643 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.81 -38.79 92.1 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 109.101 -0.703 . . . . 30.29 109.101 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.954 ' HG1' HG22 ' A' ' 66' ' ' VAL . 89.9 m -59.61 -43.03 93.88 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 108.982 -0.748 . . . . 46.11 108.982 -176.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.459 ' HD3' ' HA ' ' A' ' 145' ' ' THR . 0.2 OUTLIER -62.46 -42.14 99.26 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 107.693 -1.225 . . . . 87.33 107.693 -179.632 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.789 ' O ' HG22 ' A' ' 153' ' ' VAL . 96.6 t -61.67 -42.08 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 107.93 -1.137 . . . . 23.69 107.93 -178.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.8 t -63.19 -44.29 99.25 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 109.704 -0.48 . . . . 43.86 109.704 -178.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.935 ' O ' HG23 ' A' ' 154' ' ' ILE . 46.0 mm -61.28 -42.54 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 108.326 -0.991 . . . . 91.13 108.326 -176.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . 0.505 ' O ' HG22 ' A' ' 156' ' ' VAL . 52.2 t -62.6 -37.96 88.29 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.754 -0.832 . . . . 65.88 108.754 -178.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.789 HG22 ' O ' ' A' ' 149' ' ' VAL . 95.4 t -62.11 -41.85 92.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.225 0 N-CA-C 109.551 -0.537 . . . . 33.86 109.551 -177.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 1.069 HD12 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.4 -40.33 85.87 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.183 0 N-CA-C 107.585 -1.265 . . . . 146.52 107.585 -176.799 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . 0.775 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.1 m95 -62.86 -38.36 90.51 Favored 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 119.497 -0.881 . . . . 75.44 108.896 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 152' ' ' CYS . 98.7 t -60.54 -48.4 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 O-C-N 121.028 -1.045 . . . . 43.64 109.71 -177.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.811 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.7 -38.0 89.47 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 109.029 -0.73 . . . . 102.57 109.029 -178.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.0 -41.09 86.83 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.417 -1.327 . . . . 58.16 107.417 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.82 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.07 -32.48 73.87 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.032 -0.729 . . . . 121.11 109.032 178.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.811 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.02 -42.34 85.09 Favored 'General case' 0 CA--C 1.489 -1.395 0 C-N-CA 118.576 -1.249 . . . . 153.15 109.923 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.998 HD12 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.05 -43.75 19.07 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 113.106 -3.437 . . . . 133.67 113.527 173.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.535 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -62.97 -39.9 96.08 Favored 'General case' 0 CA--C 1.489 -1.371 0 O-C-N 120.916 -1.115 . . . . 157.42 112.192 -171.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.518 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.3 t80 -74.45 -36.11 2.45 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 115.012 1.486 . . . . 250.91 115.012 -173.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.518 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.292 52.9 Cg_exo -59.5 -25.48 78.84 Favored 'Trans proline' 0 CA--C 1.488 -1.791 0 N-CA-C 118.007 2.272 . . . . 207.34 118.007 -174.351 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 1.026 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 87.6 mt-30 -61.17 -34.19 74.65 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 106.951 -1.5 . . . . 192.46 106.951 178.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.452 ' HA2' ' HD2' ' A' ' 106' ' ' LYS . . . -64.52 -41.03 98.09 Favored Glycine 0 C--N 1.353 1.501 0 N-CA-C 107.969 -2.053 . . . . 261.0 107.969 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.79 159.11 25.96 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 101.513 -3.514 . . . . 491.4 101.513 172.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -59.96 106.82 0.54 Allowed 'General case' 0 CA--C 1.488 -1.434 0 C-N-CA 116.247 -2.181 . . . . 386.1 109.83 -176.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 1.026 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 73.9 m -154.03 -166.61 2.42 Favored 'General case' 0 N--CA 1.415 -2.224 0 N-CA-C 103.541 -2.763 . . . . 289.8 103.541 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 1.11 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.92 175.4 0.86 Allowed 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 117.736 -1.126 . . . . 402.06 109.565 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.782 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 73.0 p -165.27 177.5 7.56 Favored 'General case' 0 CA--C 1.586 2.353 0 C-N-CA 127.343 2.257 . . . . 690.53 114.94 177.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.572 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.9 mm-40 132.34 160.56 0.0 OUTLIER 'General case' 1 C--N 1.429 4.057 1 N-CA-C 123.19 4.515 . . . . 633.62 123.19 162.704 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.827 HG21 ' SG ' ' A' ' 180' ' ' CYS . 69.2 p -85.63 153.83 22.1 Favored 'General case' 0 C--N 1.389 2.3 0 C-N-CA 127.376 2.27 . . . . 617.99 110.903 178.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' MET . . . . . 1.119 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.69 174.4 6.0 Favored Pre-proline 0 C--N 1.364 1.206 0 C-N-CA 130.271 3.428 . . . . 434.98 113.405 -175.417 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 1.119 ' HD2' ' HB3' ' A' ' 174' ' ' MET . 51.8 Cg_endo -44.24 -65.65 0.19 Allowed 'Trans proline' 0 N--CA 1.441 -1.56 0 N-CA-C 122.418 3.969 . . . . 365.88 122.418 -168.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' SER . . . . . 0.788 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.306 70.5 m -84.89 20.95 1.69 Allowed 'General case' 0 CA--C 1.467 -2.239 0 N-CA-C 104.797 -2.298 . . . . 635.81 104.797 178.144 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.777 ' HB3' ' H ' ' A' ' 179' ' ' VAL 0.456 5.0 mmp_? -94.39 152.24 18.78 Favored 'General case' 1 CA--C 1.419 -4.064 3 N-CA-C 131.98 7.771 . . . . 999.99 131.98 -135.76 . . . . . . . . 5 3 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 1.072 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.911 37.1 t -131.84 73.18 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.772 1 CA-C-N 103.3 -6.318 . . . . 594.32 113.599 149.217 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.821 HG12 ' HB2' ' A' ' 174' ' ' MET . 7.3 p -144.2 144.1 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.639 1 N-CA-C 98.291 -4.707 . . . . 811.91 98.291 162.374 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.827 ' SG ' HG21 ' A' ' 173' ' ' THR . 3.8 m -118.46 144.53 45.92 Favored 'General case' 0 CA--C 1.489 -1.401 0 C-N-CA 117.058 -1.857 . . . . 999.99 109.427 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.821 ' HE1' ' CE2' ' A' ' 264' ' ' PHE . 70.8 mmm -147.19 -175.61 4.9 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-O 122.004 0.907 . . . . 431.86 110.054 -177.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 1.061 HD12 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.13 148.67 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 C-N-CA 124.351 1.06 . . . . 457.18 108.801 -177.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . 0.826 ' HB3' ' HB ' ' A' ' 170' ' ' THR . 3.6 tp10 -77.32 85.47 3.75 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 124.14 0.976 . . . . 458.77 113.503 -174.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 1.015 ' CZ3' HG23 ' A' ' 182' ' ' ILE . 1.9 p90 -76.37 -31.57 0.98 Allowed Pre-proline 0 N--CA 1.438 -1.048 0 C-N-CA 124.961 1.304 . . . . 999.99 112.426 168.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.946 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -65.95 -45.77 5.65 Favored 'Trans proline' 0 N--CA 1.438 -1.789 0 N-CA-C 120.875 3.375 . . . . 999.99 120.875 -174.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.557 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.56 171.74 8.15 Favored 'General case' 0 CA--C 1.472 -2.047 0 C-N-CA 117.166 -1.814 . . . . 81.18 107.26 -172.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.843 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.8 p-80 -109.14 45.14 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.848 0 C-N-CA 115.503 -2.479 . . . . 999.99 108.754 177.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 1.055 ' HB2' HD11 ' A' ' 191' ' ' ILE . 87.5 Cg_endo -41.57 101.81 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.14 1 C-N-CA 126.042 4.494 . . . . 999.99 105.683 -170.737 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -62.27 -44.02 97.48 Favored 'General case' 0 CA--C 1.483 -1.599 0 C-N-CA 126.747 2.019 . . . . 967.72 112.048 -165.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -60.26 -36.55 78.05 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.748 -1.575 . . . . 934.3 106.748 -175.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 1.055 HD11 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.56 -30.25 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 C-N-CA 129.2 3.0 . . . . 565.15 113.923 -178.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 61.53 55.4 2.81 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 118.444 0.565 . . . . 755.61 109.869 -175.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 1.11 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.5 -49.28 67.1 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.551 1.141 . . . . 325.89 113.242 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.897 ' HG3' ' HH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.82 -44.95 78.4 Favored 'General case' 0 CA--C 1.495 -1.16 0 C-N-CA 123.56 0.744 . . . . 250.21 111.627 -169.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.3 t -64.72 -43.35 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 CA-C-O 121.585 0.707 . . . . 142.46 110.382 -175.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . 1.061 ' CD2' HD12 ' A' ' 182' ' ' ILE . 34.8 t80 -61.12 -41.52 96.85 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 123.981 0.912 . . . . 247.69 108.815 -173.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.891 ' HE2' ' HA ' ' A' ' 269' ' ' LEU . 23.0 t60 -60.53 -51.31 69.97 Favored 'General case' 0 CA--C 1.491 -1.289 0 C-N-CA 125.424 1.49 . . . . 199.61 113.107 -175.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.2 mt -65.35 -44.48 94.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 107.715 -1.217 . . . . 106.73 107.715 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . 0.785 ' O ' HD12 ' A' ' 203' ' ' LEU . 41.6 t -59.15 -48.53 81.27 Favored 'General case' 0 CA--C 1.487 -1.479 0 CA-C-N 115.867 -0.606 . . . . 115.01 110.231 -173.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.998 HG13 HD12 ' A' ' 161' ' ' LEU . 86.1 t -65.24 -49.15 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.657 0 C-N-CA 119.418 -0.913 . . . . 129.42 111.854 -174.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.815 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.2 m -61.88 -53.15 59.72 Favored 'General case' 0 CA--C 1.483 -1.63 0 C-N-CA 118.224 -1.39 . . . . 172.48 109.952 -172.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.676 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.1 t -63.85 -54.26 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 C-N-CA 120.512 -0.475 . . . . 55.86 110.972 -174.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.785 HD12 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.54 -51.56 58.95 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 118.542 -1.263 . . . . 184.68 111.513 -174.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . 0.981 ' HB ' HD13 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.61 -52.4 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 C-N-CA 116.643 -2.023 . . . . 291.81 114.743 -174.699 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.432 ' HB2' ' CE1' ' A' ' 265' ' ' HIS . 87.8 t80 -82.05 -55.01 4.83 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 115.148 1.536 . . . . 130.66 115.148 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . 0.815 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.8 m-85 -66.88 -48.5 68.56 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 114.488 1.292 . . . . 80.16 114.488 -170.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.929 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.55 -45.47 83.16 Favored Pre-proline 0 N--CA 1.435 -1.195 0 C-N-CA 119.965 -0.694 . . . . 136.02 109.506 -174.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.929 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.8 Cg_exo -64.81 -27.12 59.62 Favored 'Trans proline' 0 N--CA 1.433 -2.08 0 N-CA-C 110.621 -0.569 . . . . 92.17 110.621 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.774 HD22 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.34 -41.37 76.72 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 107.494 -1.298 . . . . 135.6 107.494 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.16 -44.69 91.33 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 109.591 -0.522 . . . . 52.1 109.591 -176.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . 0.7 HG13 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.71 -43.49 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 109.09 -0.707 . . . . 95.89 109.09 -176.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.978 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.27 -42.34 93.16 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 N-CA-C 106.695 -1.595 . . . . 43.41 106.695 -178.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.44 -42.28 99.08 Favored Glycine 0 N--CA 1.432 -1.624 0 N-CA-C 109.367 -1.493 . . . . 27.69 109.367 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . 0.904 ' O ' HG21 ' A' ' 217' ' ' THR . 77.9 t80 -65.68 -47.38 75.65 Favored 'General case' 0 CA--C 1.497 -1.086 0 O-C-N 122.195 -0.591 . . . . 54.41 110.456 -177.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . 0.895 ' O ' HG13 ' A' ' 218' ' ' VAL . . . -61.43 -34.1 74.83 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 106.96 -1.496 . . . . 53.88 106.96 -177.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -60.76 -40.83 93.97 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 108.48 -0.933 . . . . 68.29 108.48 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' THR . . . . . 0.904 HG21 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.78 -39.04 92.95 Favored 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 119.701 -0.799 . . . . 107.59 110.615 -175.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.895 HG13 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.02 -38.36 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 C-N-CA 119.606 -0.838 . . . . 111.61 109.509 -177.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.889 HG12 ' CD1' ' A' ' 134' ' ' ILE . 79.8 t -63.28 -22.51 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 N-CA-C 108.401 -0.963 . . . . 85.26 108.401 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.85 -41.94 99.39 Favored Glycine 0 C--N 1.349 1.283 0 N-CA-C 111.062 -0.815 . . . . 40.71 111.062 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.72 -44.06 96.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 108.412 -0.959 . . . . 95.86 108.412 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.846 ' CB ' HG22 ' A' ' 134' ' ' ILE . 67.3 p -76.93 -137.52 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 108.441 -0.948 . . . . 144.37 108.441 -176.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.928 HD21 ' NE ' ' A' ' 244' ' ' ARG . 87.6 mt -55.36 132.12 47.35 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 107.599 -1.26 . . . . 326.72 107.599 -177.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' TRP . . . . . 0.444 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.33 -168.04 1.51 Allowed 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 106.033 -1.84 . . . . 158.38 106.033 -176.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . 0.444 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.32 -41.94 98.95 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 109.661 -0.496 . . . . 36.78 109.661 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.6 m -61.13 125.85 25.22 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 119.151 -1.019 . . . . 85.46 109.82 -174.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.774 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.87 126.53 8.84 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 105.542 -2.021 . . . . 127.78 105.542 176.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.982 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.03 139.9 34.82 Favored Pre-proline 0 CA--C 1.493 -1.239 0 N-CA-C 105.952 -1.87 . . . . 164.84 105.952 -179.592 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.982 ' N ' HD13 ' A' ' 228' ' ' ILE . 82.0 Cg_exo -56.8 -39.92 87.93 Favored 'Trans proline' 0 N--CA 1.431 -2.17 0 N-CA-C 113.937 0.707 . . . . 222.35 113.937 -176.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . 0.805 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -83.13 166.99 44.94 Favored Glycine 0 N--CA 1.428 -1.894 0 N-CA-C 106.424 -2.67 . . . . 45.22 106.424 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.924 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.94 -45.79 93.29 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 106.029 -1.841 . . . . 107.57 106.029 177.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' SER . . . . . 0.734 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.6 m -65.76 141.81 58.2 Favored 'General case' 0 N--CA 1.429 -1.517 0 C-N-CA 118.906 -1.118 . . . . 167.96 109.153 -175.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.872 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.2 m 99.51 106.7 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 126.706 2.002 . . . . 280.68 109.734 176.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.779 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.7 m-20 56.01 11.27 0.71 Allowed 'General case' 0 N--CA 1.434 -1.274 0 C-N-CA 124.459 1.103 . . . . 218.25 110.701 174.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.933 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.38 137.62 54.78 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 105.236 -2.135 . . . . 343.57 105.236 177.395 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.581 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.6 t80 -111.97 81.9 1.54 Allowed 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 106.867 -1.531 . . . . 263.29 106.867 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' HIS . . . . . 0.66 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.4 m-70 104.29 147.05 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.283 0 C-N-CA 126.563 1.945 . . . . 261.92 108.497 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.21 -38.1 89.85 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 107.879 -1.156 . . . . 106.81 107.879 -177.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.758 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.43 -39.94 94.97 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 118.371 -1.331 . . . . 112.2 107.552 -178.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.749 HG13 ' NH1' ' A' ' 244' ' ' ARG . 75.5 t -64.26 -39.82 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.275 0 N-CA-C 109.263 -0.643 . . . . 45.41 109.263 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.866 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.1 p -70.92 -32.07 68.87 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 110.264 -0.273 . . . . 97.62 110.264 -178.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.39 -39.61 81.66 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 123.696 0.799 . . . . 59.29 110.978 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.758 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.24 -36.54 83.99 Favored 'General case' 0 CA--C 1.492 -1.275 0 C-N-CA 124.658 1.183 . . . . 106.49 110.666 -174.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.933 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.96 -30.65 69.23 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 108.299 -1.0 . . . . 106.62 108.299 -176.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.571 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -66.02 -41.02 91.49 Favored 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 121.832 -0.542 . . . . 75.97 110.045 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.879 ' CG1' ' HE3' ' A' ' 250' ' ' MET . 76.6 t -65.54 -40.86 89.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 C-N-CA 122.917 0.487 . . . . 65.27 109.774 -178.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.836 HG11 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -64.0 -41.58 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 C-N-CA 120.401 -0.519 . . . . 107.94 110.162 -177.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.571 ' HE2' ' HA ' ' A' ' 245' ' ' LYS . 59.1 pttt -63.54 -40.81 97.98 Favored 'General case' 0 N--CA 1.434 -1.247 0 O-C-N 121.687 -0.633 . . . . 87.98 110.284 -176.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' MET . . . . . 1.06 ' HE2' ' CD1' ' A' ' 305' ' ' TYR . 21.3 ttt -63.65 -40.4 96.78 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 118.832 -1.147 . . . . 65.5 108.363 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' MET . . . . . 0.879 ' HE3' ' CG1' ' A' ' 246' ' ' VAL . 68.5 mtt -61.7 -36.37 80.71 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 108.146 -1.057 . . . . 85.05 108.146 -177.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.518 HD11 ' HA ' ' A' ' 248' ' ' LYS . 86.9 mt -63.49 -45.74 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 N-CA-C 109.07 -0.715 . . . . 42.25 109.07 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . 0.875 HG13 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.34 -38.26 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 C-N-CA 119.548 -0.861 . . . . 91.01 109.402 -176.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 1.03 HG21 HD11 ' A' ' 304' ' ' ILE . 65.9 t -58.86 -41.54 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 N-CA-C 107.988 -1.116 . . . . 66.09 107.988 -178.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 250' ' ' MET . 94.8 t -66.09 -43.18 92.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 C-N-CA 120.754 -0.379 . . . . 52.39 110.31 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.1 m -61.74 -46.78 88.15 Favored 'General case' 0 CA--C 1.489 -1.391 0 O-C-N 121.889 -0.507 . . . . 46.42 109.866 -174.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' THR . . . . . 0.819 ' O ' HG23 ' A' ' 259' ' ' ILE . 9.5 t -62.33 -38.13 88.26 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 108.324 -0.991 . . . . 116.51 108.324 -177.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' PHE . . . . . 0.54 ' N ' HG23 ' A' ' 256' ' ' THR . 86.1 t80 -60.26 -48.23 82.64 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.394 -0.595 . . . . 65.18 109.394 -178.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.96 -42.68 97.2 Favored 'General case' 0 CA--C 1.49 -1.365 0 O-C-N 122.133 -0.354 . . . . 51.33 110.443 -175.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . 0.819 HG23 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.62 -43.37 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 C-N-CA 118.919 -1.112 . . . . 126.3 109.0 -176.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' CYS . . . . . 0.566 ' N ' HG22 ' A' ' 259' ' ' ILE . 69.7 m -65.58 -49.33 69.22 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 119.529 -0.868 . . . . 133.94 112.485 -176.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.868 ' CH2' ' HB2' ' A' ' 294' ' ' ALA . 97.0 m95 -80.68 -33.38 35.52 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 116.856 2.169 . . . . 134.84 116.856 -176.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.799 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.9 tp -58.43 -41.62 90.27 Favored Pre-proline 0 CA--C 1.493 -1.235 0 O-C-N 121.659 -0.65 . . . . 72.23 111.643 -167.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' PRO . . . . . 0.818 ' O ' HG21 ' A' ' 266' ' ' ILE . 80.7 Cg_exo -60.66 -35.98 87.1 Favored 'Trans proline' 0 C--N 1.295 -2.278 0 CA-C-N 119.848 0.981 . . . . 106.13 111.349 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' PHE . . . . . 0.846 ' CA ' HG21 ' A' ' 290' ' ' ILE . 71.7 t80 -66.41 -44.68 82.32 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 119.749 -0.78 . . . . 128.35 110.03 -178.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' HIS . . . . . 0.696 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.42 -37.88 89.06 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 110.202 -0.296 . . . . 100.73 110.202 -177.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.818 HG21 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.25 -44.56 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 C-N-CA 119.31 -0.956 . . . . 172.72 109.142 -179.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . 0.751 ' HD1' ' O ' ' A' ' 263' ' ' PRO . 61.6 m-85 -66.6 -28.07 68.21 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 108.206 -1.035 . . . . 249.23 108.206 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' PHE . . . . . 0.898 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.56 -55.1 35.85 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 106.679 -1.6 . . . . 259.78 106.679 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . 0.891 ' HA ' ' HE2' ' A' ' 197' ' ' HIS . 89.3 mt -69.17 -44.18 72.72 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 113.588 0.959 . . . . 233.11 113.588 -176.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.851 HD12 HD21 ' A' ' 279' ' ' LEU . 88.8 mt -61.37 -48.3 91.47 Favored Pre-proline 0 N--CA 1.44 -0.968 0 C-N-CA 119.183 -1.007 . . . . 169.54 110.596 -171.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . 0.682 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.6 Cg_exo -61.13 -24.56 79.49 Favored 'Trans proline' 0 N--CA 1.43 -2.259 0 C-N-CA 116.729 -1.714 . . . . 255.47 114.66 174.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' TYR . . . . . 0.897 ' HH ' ' HG3' ' A' ' 194' ' ' LYS . 19.5 t80 -63.56 -44.22 94.75 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 119.225 0.921 . . . . 279.03 108.904 177.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . 0.835 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.33 -44.79 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 110.081 -0.34 . . . . 162.21 110.081 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' ASN . . . . . 0.775 ' N ' HD11 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.41 84.87 59.33 Favored Pre-proline 0 N--CA 1.431 -1.406 0 C-N-CA 118.747 -1.181 . . . . 128.13 108.069 -178.081 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.25 164.04 11.26 Favored 'Trans proline' 0 C--N 1.295 -2.281 0 N-CA-C 107.46 -1.785 . . . . 278.35 107.46 177.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . 0.85 ' O ' HD22 ' A' ' 277' ' ' LEU . 39.3 t0 66.11 15.04 9.93 Favored 'General case' 0 N--CA 1.428 -1.533 0 O-C-N 123.8 0.687 . . . . 312.91 109.334 175.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.85 HD22 ' O ' ' A' ' 276' ' ' ASP . 28.3 mt -132.71 -170.68 2.49 Favored 'General case' 0 CA--C 1.481 -1.679 0 N-CA-C 106.537 -1.653 . . . . 353.54 106.537 177.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 1.023 ' HA ' ' CB ' ' A' ' 282' ' ' PHE . 42.8 p90 -115.66 142.25 46.99 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 107.427 -1.323 . . . . 251.26 107.427 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.851 HD21 HD12 ' A' ' 270' ' ' LEU . 1.7 tm? -76.96 -118.74 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 102.081 -3.303 . . . . 175.26 102.081 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . 0.777 ' HB3' ' HE3' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.5 -44.97 96.12 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 100.878 -3.749 . . . . 99.07 100.878 172.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . 0.777 ' HE3' ' HB3' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.42 124.18 9.19 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 103.494 -2.78 . . . . 243.21 103.494 171.161 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 1.023 ' CB ' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.98 112.96 25.1 Favored 'General case' 0 CA--C 1.474 -1.979 0 C-N-CA 116.049 -2.261 . . . . 201.04 105.278 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' ILE . . . . . 0.74 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.93 173.72 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.09 0 C-N-CA 116.0 -2.28 . . . . 201.36 108.787 -175.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . 1.061 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.282 0.6 OUTLIER -59.5 -41.44 89.89 Favored 'General case' 0 N--CA 1.415 -2.179 0 CA-C-N 113.247 -1.797 . . . . 203.82 107.864 174.463 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . 0.917 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.31 -45.71 86.76 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 118.22 -1.392 . . . . 215.06 112.543 -171.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.636 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.3 t -65.68 -46.42 89.3 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.466 0 C-N-CA 118.578 -1.249 . . . . 125.28 112.912 -171.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' TYR . . . . . 0.853 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.79 -37.0 86.14 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 107.193 -1.41 . . . . 268.9 107.193 -171.883 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . 0.872 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.22 -45.01 74.47 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 125.65 1.58 . . . . 280.88 108.795 -172.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.64 -47.48 86.05 Favored 'General case' 0 N--CA 1.428 -1.547 0 C-N-CA 118.97 -1.092 . . . . 184.47 109.002 -172.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . 0.846 HG21 ' CA ' ' A' ' 264' ' ' PHE . 1.8 mp -67.94 -42.11 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 C-N-CA 119.279 -0.968 . . . . 167.92 112.73 -175.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' MET . . . . . 0.662 ' HE2' ' HG2' ' A' ' 181' ' ' MET . 21.8 ttt -65.75 -38.8 90.11 Favored 'General case' 0 CA--C 1.495 -1.144 0 C-N-CA 117.758 -1.577 . . . . 367.18 110.771 -175.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' TRP . . . . . 0.572 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.4 m95 -67.16 -32.71 73.99 Favored 'General case' 0 N--CA 1.435 -1.215 0 O-C-N 121.851 -0.531 . . . . 173.97 110.449 177.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.2 tp -64.46 -36.76 85.23 Favored 'General case' 0 CA--C 1.499 -1.011 0 C-N-CA 123.542 0.737 . . . . 119.66 109.806 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . 0.868 ' HB2' ' CH2' ' A' ' 261' ' ' TRP . . . -61.25 -33.98 74.39 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.697 -1.224 . . . . 112.3 107.697 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' MET . . . . . 0.712 ' O ' HG21 ' A' ' 298' ' ' THR . 21.9 mmt -63.09 -32.05 73.33 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 116.235 -0.439 . . . . 174.17 110.237 -177.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.7 m -64.73 -22.78 67.06 Favored 'General case' 0 CA--C 1.485 -1.525 0 C-N-CA 124.676 1.191 . . . . 145.27 110.608 -175.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' SER . . . . . 0.83 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.5 m -57.61 -35.38 70.37 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 108.078 -1.082 . . . . 170.15 108.078 -175.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.84 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.7 t -55.3 -34.15 63.89 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 116.315 -0.402 . . . . 214.57 110.632 -171.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' MET . . . . . 0.794 ' CE ' ' HG1' ' A' ' 45' ' ' THR . 28.1 ttt -77.2 -33.19 56.33 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 126.072 1.749 . . . . 168.29 115.544 177.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' TYR . . . . . 0.83 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.42 -34.87 79.2 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 114.056 1.132 . . . . 167.15 114.056 -168.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . 0.747 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.282 18.8 p-10 -64.21 -38.29 33.22 Favored Pre-proline 0 N--CA 1.434 -1.264 0 C-N-CA 115.515 -2.474 . . . . 165.13 113.93 -171.599 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' PRO . . . . . 0.747 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.1 Cg_exo -62.54 -31.83 80.02 Favored 'Trans proline' 0 N--CA 1.433 -2.042 0 CA-C-N 122.791 2.033 . . . . 123.92 111.251 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' ILE . . . . . 0.786 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.78 -42.53 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 C-N-CA 118.875 -1.13 . . . . 110.55 109.779 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' ILE . . . . . 1.03 HD11 HG21 ' A' ' 253' ' ' VAL . 31.1 pt -61.16 -40.02 84.43 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.158 0 N-CA-C 108.828 -0.804 . . . . 145.31 108.828 -177.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . 1.06 ' CD1' ' HE2' ' A' ' 249' ' ' MET 0.253 63.2 m-85 -58.11 -48.84 78.97 Favored 'General case' 0 CA--C 1.494 -1.182 0 C-N-CA 119.413 -0.915 . . . . 246.68 109.823 -177.477 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.6 m -62.19 -47.51 84.16 Favored 'General case' 0 CA--C 1.485 -1.538 0 C-N-CA 119.55 -0.86 . . . . 64.43 109.571 -173.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.8 t -66.78 -45.07 79.61 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 118.989 -1.084 . . . . 80.72 110.244 -177.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.757 HD22 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.49 -35.69 75.81 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 115.998 1.851 . . . . 140.44 115.998 -173.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . 0.62 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.83 132.23 34.34 Favored 'General case' 0 N--CA 1.434 -1.26 0 C-N-CA 112.711 -3.596 . . . . 178.87 113.056 -177.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . 0.703 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.03 -37.07 86.41 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 114.405 -1.271 . . . . 110.22 110.111 -177.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . 0.852 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.74 -50.59 72.7 Favored 'General case' 0 CA--C 1.492 -1.256 0 O-C-N 121.752 -0.592 . . . . 174.78 109.739 -174.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.979 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.2 m-85 -64.89 -41.69 95.41 Favored 'General case' 0 CA--C 1.484 -1.579 0 N-CA-C 108.245 -1.02 . . . . 161.84 108.245 178.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . 0.479 ' HE ' HD21 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.33 -50.22 73.64 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 109.198 -0.667 . . . . 117.2 109.198 -173.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.839 ' HB3' HD12 ' A' ' 326' ' ' ILE . 3.0 mm? -68.51 -44.1 75.37 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 120.373 -0.531 . . . . 112.6 111.061 -177.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . 1.122 ' HA2' ' HD1' ' A' ' 318' ' ' HIS . . . -64.04 -37.43 94.59 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 110.646 -0.982 . . . . 101.46 110.646 -177.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' PHE . . . . . 0.979 ' CE2' ' HB3' ' A' ' 312' ' ' PHE . 36.7 m-85 -62.16 -45.99 90.94 Favored 'General case' 0 CA--C 1.491 -1.296 0 CA-C-N 118.492 1.146 . . . . 151.49 109.522 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . 0.467 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.1 -36.3 77.13 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 106.949 -1.501 . . . . 142.32 106.949 -175.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' HIS . . . . . 1.122 ' HD1' ' HA2' ' A' ' 315' ' ' GLY . 50.0 m80 -59.79 -41.82 92.01 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 106.891 -1.522 . . . . 109.09 106.891 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.85 -42.43 85.72 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.336 -0.228 . . . . 76.11 111.03 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -61.43 -55.48 30.84 Favored 'General case' 0 CA--C 1.49 -1.361 0 C-N-CA 119.87 -0.732 . . . . 120.24 109.32 -174.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . 0.752 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.4 mtt180 -74.33 131.54 41.24 Favored 'General case' 0 CA--C 1.482 -1.657 0 N-CA-C 102.935 -2.987 . . . . 192.73 102.935 177.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.16 -44.22 92.1 Favored 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 119.021 -1.072 . . . . 176.29 109.194 -172.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' CYS . . . . . 0.814 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.2 m -79.38 -177.11 0.81 Allowed Pre-proline 0 CA--C 1.487 -1.443 0 N-CA-C 106.294 -1.743 . . . . 69.68 106.294 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.569 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.6 Cg_exo -58.99 -75.58 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.389 0 C-N-CA 118.347 -0.635 . . . . 191.05 112.591 176.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' PHE . . . . . 0.814 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.5 m-85 47.49 43.88 16.25 Favored 'General case' 0 CA--C 1.493 -1.228 0 O-C-N 123.574 0.546 . . . . 287.03 109.764 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . 0.847 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.51 78.57 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.933 0 C-N-CA 112.956 -3.497 . . . . 292.29 109.839 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' SER . . . . . 0.507 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.3 t -77.47 -152.84 0.05 Allowed 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 104.208 -2.515 . . . . 184.57 104.208 178.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.7 8.68 4.95 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 113.063 0.764 . . . . 274.56 113.063 176.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.97 0.91 57.27 Favored Glycine 0 C--N 1.348 1.228 0 C-N-CA 117.729 -2.177 . . . . 268.24 113.457 172.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' ASP . . . . . 0.724 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.7 m-20 51.6 -172.04 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.071 0 CA-C-N 118.667 1.233 . . . . 200.06 110.747 177.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.852 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.89 -33.0 74.73 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 107.879 -1.156 . . . . 114.44 107.879 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' GLU . . . . . 0.599 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.26 46.06 21.92 Favored 'General case' 0 CA--C 1.484 -1.592 0 N-CA-C 107.625 -1.25 . . . . 263.81 107.625 -177.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' GLY . . . . . 0.651 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.32 -137.35 3.6 Favored Glycine 0 CA--C 1.479 -2.217 1 N-CA-C 102.531 -4.228 . . . . 103.79 102.531 -179.846 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . 0.987 HD21 ' HA ' ' A' ' 337' ' ' LYS . 61.2 mt -88.28 95.62 10.25 Favored 'General case' 0 N--CA 1.419 -2.007 0 C-N-CA 114.937 -2.705 . . . . 117.3 106.016 176.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . 1.058 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.96 -39.79 90.72 Favored 'General case' 0 CA--C 1.468 -2.188 1 N-CA-C 98.004 -4.813 . . . . 231.58 98.004 167.23 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 1.064 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.95 163.48 29.08 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 102.072 -3.307 . . . . 303.24 102.072 168.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' LYS . . . . . 0.987 ' HA ' HD21 ' A' ' 334' ' ' LEU . 84.3 tttt -62.63 -48.61 78.61 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 116.051 -2.259 . . . . 112.72 108.409 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' SER . . . . . 0.412 ' HB3' ' SD ' ' A' ' 336' ' ' MET . 47.9 t -61.02 -63.66 1.22 Allowed 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 109.103 -0.703 . . . . 83.22 109.103 -176.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' THR . . . . . 0.911 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.1 m -156.28 -126.2 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 103.831 -2.655 . . . . 174.36 103.831 -178.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . 1.058 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.87 160.96 8.78 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 105.763 -1.94 . . . . 202.73 105.763 177.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . 1.028 ' HH ' ' HA3' ' A' ' 315' ' ' GLY . 0.2 OUTLIER -131.95 149.04 52.55 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 107.064 -1.458 . . . . 180.62 107.064 176.392 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . 0.944 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.5 tp -178.51 -171.86 0.27 Allowed 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 105.394 -2.076 . . . . 145.25 105.394 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' GLN . . . . . 0.944 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.09 -43.14 88.13 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 106.127 -1.805 . . . . 66.05 106.127 174.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' THR . . . . . 0.761 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.7 -152.14 0.48 Allowed 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 103.505 -2.776 . . . . 266.49 103.505 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' GLN . . . . . 0.609 ' CD ' HD23 ' A' ' 342' ' ' LEU . 79.4 mt-30 66.31 -124.93 0.28 Allowed 'General case' 0 N--CA 1.428 -1.574 0 C-N-CA 117.033 -1.867 . . . . 219.2 107.772 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . 0.998 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.07 -37.4 94.13 Favored Glycine 0 N--CA 1.426 -2.032 0 CA-C-N 114.544 -1.207 . . . . 94.78 112.855 -176.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' SER . . . . . 1.102 ' HG ' ' HB3' ' A' ' 61' ' ' LYS . 48.3 t -81.17 100.41 9.07 Favored 'General case' 0 CA--C 1.484 -1.589 0 C-N-CA 112.327 -3.749 . . . . 121.41 109.479 -171.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . 0.672 ' O ' ' HE2' ' A' ' 336' ' ' MET . 94.5 t -73.06 145.5 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 108.953 -0.758 . . . . 85.34 108.953 -176.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' TYR . . . . . 0.505 ' N ' HG13 ' A' ' 348' ' ' VAL . 48.5 p90 -57.73 143.43 41.89 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.842 -1.17 . . . . 267.57 107.842 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . 0.508 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.03 69.59 0.59 Allowed 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 109.539 -0.541 . . . . 226.1 109.539 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' VAL . . . . . 1.046 ' HB ' ' HE1' ' A' ' 336' ' ' MET . 7.5 p -51.0 156.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 N-CA-C 106.993 -1.484 . . . . 154.84 106.993 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' SER . . . . . 0.506 ' N ' HG23 ' A' ' 351' ' ' VAL . 71.5 m -61.35 161.96 8.47 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.603 0.716 . . . . 180.01 110.711 -173.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' ARG . . . . . 0.877 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.46 156.92 23.66 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 106.946 -1.501 . . . . 333.78 106.946 -178.616 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . 0.991 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.04 142.52 48.76 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.356 -1.35 . . . . 335.2 107.356 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.991 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.5 mm-40 82.82 158.9 0.13 Allowed 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 108.74 -0.837 . . . . 266.47 108.74 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.5 m -60.61 -46.88 88.6 Favored 'General case' 0 CA--C 1.487 -1.462 0 N-CA-C 105.677 -1.972 . . . . 59.34 105.677 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.58 173.86 11.97 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 104.431 -2.433 . . . . 201.26 104.431 176.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.783 HG21 ' O ' ' A' ' 360' ' ' THR . 69.1 mt -95.91 106.71 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.555 0 C-N-CA 116.34 -2.144 . . . . 56.23 105.524 -179.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' SER . . . . . 0.521 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.7 m -61.19 -59.47 5.28 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 109.287 -0.634 . . . . 87.58 109.287 -175.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' THR . . . . . 0.888 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.2 t -85.5 153.76 22.24 Favored 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 107.835 -1.172 . . . . 219.95 107.835 -177.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 361' ' ' VAL . 16.0 m -82.02 83.81 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 C-N-CA 116.339 -2.144 . . . . 121.79 105.452 177.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.619 HG13 ' N ' ' A' ' 363' ' ' GLY . 64.6 t -154.11 159.74 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 N-CA-C 105.826 -1.916 . . . . 53.85 105.826 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . 0.619 ' N ' HG13 ' A' ' 362' ' ' VAL . . . 72.22 16.61 77.06 Favored Glycine 0 N--CA 1.428 -1.88 0 N-CA-C 106.044 -2.822 . . . . 196.55 106.044 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.674 0 N-CA-C 107.87 -1.159 . . . . 35.88 107.87 -178.914 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 365' ' ' ARG . . . . . 0.418 ' N ' ' CD ' ' B' ' 366' ' ' PRO . 4.5 ttp180 . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 108.895 -0.78 . . . . 1.0 108.895 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 366' ' ' PRO . . . . . 0.418 ' CD ' ' N ' ' B' ' 365' ' ' ARG . 52.4 Cg_endo -66.94 141.99 60.58 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.086 1.857 . . . . 1.0 110.172 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 367' ' ' LYS . . . . . 0.763 ' HE2' ' HA ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -64.38 143.26 98.47 Favored Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 119.85 -0.74 . . . . 1.0 109.603 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 368' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -68.25 150.42 76.57 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.31 2.007 . . . . 1.0 111.759 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 369' ' ' GLN . . . . . 0.513 ' O ' ' HG3' ' B' ' 369' ' ' GLN . 0.0 OUTLIER -70.72 131.72 44.3 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.739 -0.384 . . . . 1.0 110.265 179.42 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -101.97 115.85 31.42 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.696 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 371' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -63.65 -42.39 98.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.365 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 372' ' ' PHE . . . . . 0.451 ' HD1' ' HA ' ' B' ' 372' ' ' PHE . 0.1 OUTLIER -65.01 -36.25 83.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.945 -0.57 . . . . 1.0 110.663 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -59.72 -32.98 75.69 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.869 -0.892 . . . . 1.0 110.869 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 374' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.83 131.35 45.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.834 0.349 . . . . 1.0 110.154 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 375' ' ' MET . . . . . 0.72 ' HB2' ' HG ' ' A' ' 20' ' ' SER . 0.7 OUTLIER . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 117.946 -1.026 . . . . 1.0 110.558 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.429 -1.478 0 N-CA-C 108.388 -0.967 . . . . 97.08 108.388 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.689 ' ND2' ' HG3' ' B' ' 366' ' ' PRO . 46.6 t30 -110.62 155.44 22.37 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 122.07 0.938 . . . . 123.41 110.724 -172.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.842 HG12 HD13 ' A' ' 15' ' ' ILE . 28.8 m -134.6 -162.38 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.498 1 N-CA-C 100.117 -4.031 . . . . 151.3 100.117 173.741 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.975 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.1 mp -60.68 -38.58 57.96 Favored Pre-proline 0 N--CA 1.439 -0.995 0 C-N-CA 115.953 -2.299 . . . . 169.25 106.13 178.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.975 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 57.6 Cg_exo -81.26 168.49 16.73 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 122.267 0.614 . . . . 185.76 110.53 171.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.853 HG12 ' CE2' ' A' ' 282' ' ' PHE . 92.3 t -64.44 -25.87 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 C-N-CA 127.037 2.135 . . . . 145.47 110.381 -177.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.832 ' O ' HG23 ' A' ' 4' ' ' VAL . 39.2 t0 -84.34 157.39 21.5 Favored 'General case' 0 CA--C 1.499 -1.014 0 O-C-N 121.043 -1.036 . . . . 102.76 109.473 -178.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.6 p -82.64 154.21 25.02 Favored 'General case' 0 CA--C 1.492 -1.269 0 N-CA-C 107.973 -1.121 . . . . 106.25 107.973 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.923 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 46.8 p-10 -105.89 51.88 0.74 Allowed 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 117.778 -1.569 . . . . 157.81 107.656 178.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.15 -45.86 91.64 Favored 'General case' 0 CA--C 1.481 -1.681 0 N-CA-C 103.593 -2.743 . . . . 150.2 103.593 178.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.458 ' C ' ' H ' ' A' ' 14' ' ' ASN . 70.4 m -87.1 164.73 34.96 Favored Pre-proline 0 N--CA 1.421 -1.899 0 N-CA-C 103.663 -2.717 . . . . 183.52 103.663 172.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -76.82 6.91 3.83 Favored 'Trans proline' 0 C--N 1.281 -2.977 0 N-CA-C 109.992 -0.811 . . . . 235.61 109.992 176.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.458 ' H ' ' C ' ' A' ' 12' ' ' SER . 34.6 t-20 -57.9 -41.29 82.31 Favored 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 124.813 1.245 . . . . 113.77 113.401 -170.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.923 ' CD1' ' HB3' ' A' ' 10' ' ' ASP . 33.3 pt -52.13 136.19 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 CA-C-N 119.517 1.053 . . . . 150.85 110.986 -176.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.46 156.28 46.41 Favored 'General case' 0 C--N 1.36 1.065 0 N-CA-C 107.631 -1.248 . . . . 100.42 107.631 178.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 1.026 HG23 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.09 142.64 58.32 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 122.009 0.909 . . . . 129.36 110.412 -174.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.764 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.06 -25.51 68.4 Favored 'General case' 0 CA--C 1.494 -1.189 0 C-N-CA 126.285 1.834 . . . . 112.34 106.677 -177.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 1.006 HG21 ' HA2' ' A' ' 101' ' ' GLY . 86.1 m -74.17 -40.15 62.74 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 115.567 -0.742 . . . . 131.73 111.705 177.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 1.026 ' H ' HG23 ' A' ' 17' ' ' THR . 71.3 m -84.35 -42.93 15.24 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 117.034 2.235 . . . . 80.49 117.034 -174.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.529 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.5 mt-10 -145.98 174.54 3.34 Favored Pre-proline 0 N--CA 1.443 -0.798 0 C-N-CA 118.127 -1.429 . . . . 98.98 111.191 -169.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.88 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.334 85.7 Cg_exo -61.74 -10.81 18.16 Favored 'Trans proline' 0 C--N 1.322 -0.853 1 N-CA-C 128.939 6.476 . . . . 246.95 128.939 -170.069 . . . . . . . . 4 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.674 HD22 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.68 17.5 8.74 Favored 'General case' 0 C--N 1.325 -0.494 1 CA-C-N 126.153 4.07 . . . . 269.62 114.231 175.677 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.58 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.5 mt-30 -67.1 -27.31 67.24 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 107.838 -1.171 . . . . 86.8 107.838 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.66 ' CE1' HG21 ' A' ' 26' ' ' VAL . 50.3 p90 -66.76 -29.42 69.37 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 121.09 -1.006 . . . . 85.91 110.508 -178.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.86 HG13 ' OE1' ' A' ' 284' ' ' GLN . 40.3 t -68.48 -40.23 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 C-N-CA 123.717 0.807 . . . . 82.0 111.362 -177.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.932 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.39 167.79 12.37 Favored Pre-proline 0 CA--C 1.489 -1.398 0 N-CA-C 108.558 -0.905 . . . . 120.73 108.558 -178.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.842 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -64.04 149.76 89.79 Favored 'Trans proline' 0 N--CA 1.432 -2.116 0 C-N-CA 120.599 0.866 . . . . 87.86 109.9 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.821 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -62.99 -37.96 89.23 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 108.864 -0.791 . . . . 36.46 108.864 -176.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.841 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.9 p-90 -63.81 -33.9 76.7 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 107.797 -1.186 . . . . 150.6 107.797 -176.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.932 ' OE1' ' HB2' ' A' ' 27' ' ' GLN . 80.5 mt-30 -62.22 -32.67 73.37 Favored 'General case' 0 CA--C 1.491 -1.312 0 O-C-N 121.311 -0.868 . . . . 123.26 108.666 -178.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.821 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.46 -47.18 94.58 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.582 0 N-CA-C 109.166 -0.679 . . . . 120.14 109.166 176.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 30' ' ' TRP . 20.3 m -67.42 -31.05 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 N-CA-C 107.855 -1.165 . . . . 112.19 107.855 -178.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.841 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.5 tp -62.96 -47.14 84.49 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 119.917 -0.713 . . . . 60.87 109.648 -178.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.69 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.0 -35.67 81.21 Favored 'General case' 0 CA--C 1.489 -1.391 0 C-N-CA 119.974 -0.69 . . . . 157.57 110.375 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.785 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.65 -40.88 98.42 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 108.591 -0.892 . . . . 47.06 108.591 178.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.841 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.79 -41.23 97.97 Favored 'General case' 0 CA--C 1.496 -1.114 0 O-C-N 121.714 -0.616 . . . . 43.94 109.558 -177.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.766 ' O ' HG21 ' A' ' 41' ' ' VAL . . . -61.89 -43.26 99.2 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 108.697 -0.853 . . . . 42.61 108.697 -176.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.961 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.41 -41.23 93.85 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 116.66 -0.246 . . . . 140.66 111.029 -178.333 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.841 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.82 -43.92 97.88 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 118.579 -1.248 . . . . 116.04 110.215 -175.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.766 HG21 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.47 -38.7 83.1 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.325 0 N-CA-C 108.761 -0.829 . . . . 97.16 108.761 -177.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.917 HD11 ' HD1' ' A' ' 39' ' ' TYR . 93.1 mt -61.32 -39.97 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 N-CA-C 108.969 -0.752 . . . . 54.85 108.969 -176.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.971 HG23 HG22 ' A' ' 86' ' ' THR . 92.9 t -57.76 -42.28 81.49 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.314 0 N-CA-C 108.888 -0.782 . . . . 45.39 108.888 -175.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.403 ' O ' HG22 ' A' ' 48' ' ' VAL . 97.0 t -63.52 -51.01 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 C-N-CA 118.876 -1.13 . . . . 48.64 110.179 -177.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.796 ' HG1' ' CE ' ' A' ' 299' ' ' MET . 10.6 t -65.27 -47.04 78.09 Favored 'General case' 0 N--CA 1.436 -1.175 0 C-N-CA 120.181 -0.608 . . . . 116.65 111.701 -174.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.641 ' N ' HG23 ' A' ' 45' ' ' THR . 50.7 m -62.01 -43.89 97.89 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.706 -0.479 . . . . 51.16 109.706 -174.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 43' ' ' VAL . 97.3 t -65.55 -48.97 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 C-N-CA 119.88 -0.728 . . . . 44.3 110.803 -176.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.875 ' O ' HG22 ' A' ' 52' ' ' VAL . 93.9 t -64.75 -46.94 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 C-N-CA 120.266 -0.574 . . . . 48.82 111.052 -174.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.71 -44.15 95.29 Favored Glycine 0 N--CA 1.437 -1.272 0 C-N-CA 120.479 -0.867 . . . . 58.7 112.064 -174.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -72.62 -34.23 67.19 Favored 'General case' 0 CA--C 1.488 -1.439 0 O-C-N 122.071 -0.664 . . . . 101.4 110.999 -175.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.814 HG11 ' O ' ' A' ' 48' ' ' VAL . 8.4 p -66.91 -38.71 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 107.71 -1.218 . . . . 103.57 107.71 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.875 HG22 ' O ' ' A' ' 48' ' ' VAL . 71.3 t -61.46 -43.03 96.08 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 108.948 -0.76 . . . . 61.89 108.948 -178.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.64 ' O ' HG21 ' A' ' 56' ' ' ILE . 82.1 t -63.47 -50.96 76.31 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 C-N-CA 120.277 -0.569 . . . . 70.01 109.47 -178.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.718 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.9 -43.38 98.96 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 109.184 -0.672 . . . . 132.1 109.184 -176.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.674 ' N ' ' HG3' ' A' ' 54' ' ' MET . 61.9 t-105 -64.21 -46.67 82.88 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 116.685 -0.234 . . . . 104.5 110.458 -176.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.896 HD11 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.69 -49.83 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 C-N-CA 120.192 -0.603 . . . . 142.96 111.306 -173.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 1.045 HD12 HG13 ' A' ' 72' ' ' VAL 0.279 24.9 pt -64.76 -41.71 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 C-N-CA 116.968 -1.893 . . . . 158.32 110.879 -176.035 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.718 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.7 -41.43 98.11 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 117.755 -1.578 . . . . 137.11 109.46 178.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.36 -44.53 91.13 Favored 'General case' 0 N--CA 1.435 -1.216 0 O-C-N 122.189 -0.319 . . . . 54.66 111.012 -176.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.949 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.44 117.13 29.42 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-O 121.633 0.73 . . . . 127.18 109.568 -174.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 1.1 ' HB3' ' HG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.83 -36.89 80.25 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 124.122 0.969 . . . . 87.93 110.78 -175.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 1.064 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.32 -34.69 78.73 Favored 'General case' 0 CA--C 1.49 -1.334 0 O-C-N 121.649 -0.657 . . . . 131.12 111.506 -175.592 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 1.009 ' HG3' ' CE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.63 69.45 7.14 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 115.337 -2.545 . . . . 246.56 109.612 -175.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 61' ' ' LYS . 9.6 mmp_? -123.27 91.45 3.48 Favored 'General case' 0 CA--C 1.474 -1.958 0 N-CA-C 105.488 -2.041 . . . . 339.35 105.488 177.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.858 ' HG1' ' H ' ' A' ' 68' ' ' ASN . 82.5 p -124.13 165.24 17.88 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 103.025 -2.954 . . . . 114.66 103.025 176.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.958 HG22 ' HG1' ' A' ' 147' ' ' THR . 7.7 p -63.08 -39.47 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.624 0 N-CA-C 106.825 -1.546 . . . . 143.28 106.825 178.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.993 HG21 HD13 ' A' ' 71' ' ' LEU . 95.6 m -59.67 -38.03 80.36 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 108.731 -0.84 . . . . 160.22 108.731 -176.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.858 ' H ' ' HG1' ' A' ' 65' ' ' THR . 86.3 m-20 -62.36 -31.81 72.51 Favored 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 108.866 -0.791 . . . . 120.54 108.866 -177.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.939 ' O ' HG21 ' A' ' 72' ' ' VAL . 89.8 m-85 -63.5 -43.87 95.98 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 109.484 -0.562 . . . . 67.22 109.484 178.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.935 ' CE2' HG23 ' A' ' 66' ' ' VAL . 82.5 m-85 -66.49 -39.81 88.94 Favored 'General case' 0 CA--C 1.498 -1.051 0 O-C-N 121.533 -0.729 . . . . 138.6 109.662 -177.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.993 HD13 HG21 ' A' ' 67' ' ' THR . 10.1 mp -63.54 -35.93 82.1 Favored 'General case' 0 CA--C 1.492 -1.253 0 C-N-CA 122.509 0.323 . . . . 151.46 110.648 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 1.045 HG13 HD12 ' A' ' 57' ' ' ILE . 24.0 m -62.54 -37.94 80.16 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.237 0 C-N-CA 117.383 -1.727 . . . . 117.93 106.739 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.528 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.1 t30 -60.11 -46.04 90.94 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.824 -1.176 . . . . 56.82 107.824 -177.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.912 HD21 ' CE ' ' A' ' 123' ' ' MET . 8.7 mp -61.3 -43.94 98.04 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 108.93 -0.767 . . . . 145.3 108.93 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.04 -40.38 95.52 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 108.527 -0.916 . . . . 45.71 108.527 -175.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -62.42 -41.99 99.11 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 109.34 -0.615 . . . . 105.61 109.34 -178.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.12 -39.48 92.69 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 108.652 -0.87 . . . . 47.89 108.652 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.707 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.57 -37.39 84.85 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 109.922 -0.399 . . . . 124.53 109.922 179.706 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.86 -41.18 99.28 Favored 'General case' 0 CA--C 1.496 -1.101 0 O-C-N 121.931 -0.481 . . . . 35.89 109.85 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.9 t -62.28 -37.28 84.92 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 107.01 -1.478 . . . . 88.97 107.01 -178.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.84 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.2 -49.19 76.77 Favored 'General case' 0 N--CA 1.428 -1.531 0 C-N-CA 119.847 -0.741 . . . . 239.91 109.026 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.599 ' O ' HG21 ' A' ' 86' ' ' THR . . . -65.35 -43.42 90.94 Favored 'General case' 0 N--CA 1.431 -1.396 0 O-C-N 121.503 -0.748 . . . . 146.1 110.593 -177.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.15 -58.24 3.4 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 117.417 -1.713 . . . . 91.74 113.877 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -76.51 -61.39 1.97 Allowed 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 115.761 1.763 . . . . 197.45 115.761 -173.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.984 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.25 -42.29 55.53 Favored 'General case' 0 CA--C 1.49 -1.348 0 C-N-CA 117.902 -1.519 . . . . 242.6 114.014 -170.009 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.971 HG22 HG23 ' A' ' 43' ' ' VAL . 4.6 t -65.35 -36.57 84.41 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 118.949 -1.1 . . . . 215.61 109.859 -172.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.459 ' N ' HG23 ' A' ' 86' ' ' THR . 72.3 t -60.33 -46.93 94.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 O-C-N 121.818 -0.551 . . . . 87.19 110.442 -175.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.895 HG22 ' CD2' ' A' ' 108' ' ' HIS . 63.3 t -65.91 -41.94 90.95 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.132 0 N-CA-C 109.716 -0.476 . . . . 231.82 109.716 -178.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.961 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 11.0 m120 -62.28 -34.15 76.01 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 108.296 -1.002 . . . . 364.98 108.296 -177.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.659 ' CE1' ' HB3' ' A' ' 36' ' ' ALA . 85.2 t80 -68.24 -44.67 75.17 Favored 'General case' 0 N--CA 1.438 -1.043 0 O-C-N 121.563 -0.71 . . . . 181.63 111.299 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.897 HG21 ' HD2' ' A' ' 95' ' ' HIS . 58.2 m -60.92 -45.75 93.42 Favored 'General case' 0 CA--C 1.478 -1.797 0 N-CA-C 107.405 -1.331 . . . . 269.02 107.405 -175.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 1.071 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.71 -45.06 93.29 Favored 'General case' 0 CA--C 1.469 -2.143 0 C-N-CA 118.694 -1.202 . . . . 562.66 109.994 -179.081 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.695 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -61.1 -45.25 95.46 Favored 'General case' 0 CA--C 1.479 -1.761 0 C-N-CA 118.719 -1.193 . . . . 446.75 108.098 -167.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.785 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.389 6.1 m -70.47 -26.37 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 C-N-CA 115.816 -2.354 . . . . 370.05 112.196 -178.769 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.897 ' HD2' HG21 ' A' ' 91' ' ' THR . 90.0 m-70 -74.51 -26.45 60.0 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 121.597 -0.689 . . . . 354.91 112.501 175.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.88 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.6 m-20 82.81 4.53 0.99 Allowed 'General case' 0 CA--C 1.499 -0.984 0 C-N-CA 125.075 1.35 . . . . 462.44 111.902 -178.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.764 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.267 11.9 mm-40 -172.32 178.06 2.92 Favored 'General case' 0 CA--C 1.488 -1.436 0 CA-C-O 122.02 0.914 . . . . 652.37 111.092 171.808 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.831 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.72 86.29 2.17 Favored 'General case' 0 N--CA 1.427 -1.576 0 C-N-CA 128.493 2.717 . . . . 905.99 107.931 -174.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -67.84 -36.47 80.41 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 108.254 -1.017 . . . . 570.43 108.254 -176.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.843 ' HB3' ' CG ' ' A' ' 104' ' ' TYR . 94.0 m-85 -62.46 -36.36 82.22 Favored 'General case' 0 N--CA 1.428 -1.531 0 C-N-CA 125.324 1.449 . . . . 453.22 111.203 -174.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 1.006 ' HA2' HG21 ' A' ' 19' ' ' THR . . . 97.52 178.61 33.93 Favored Glycine 0 C--N 1.35 1.32 0 C-N-CA 118.744 -1.693 . . . . 445.63 109.892 177.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.782 HD12 HD13 ' B' ' 374' ' ' LEU . 89.1 mt -56.41 -41.19 75.93 Favored 'General case' 0 CA--C 1.498 -1.041 0 C-N-CA 125.243 1.417 . . . . 457.72 112.396 -170.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -58.62 -46.9 86.05 Favored 'General case' 0 CA--C 1.485 -1.546 0 C-N-CA 118.671 -1.212 . . . . 340.58 109.291 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.843 ' CG ' ' HB3' ' A' ' 100' ' ' TYR . 88.3 m-85 -68.73 -32.16 71.74 Favored 'General case' 0 N--CA 1.424 -1.751 0 C-N-CA 118.799 -1.16 . . . . 453.6 111.552 -176.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.728 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.2 t -56.08 -40.35 73.47 Favored 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 105.964 -1.865 . . . . 541.48 105.964 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.452 ' HD2' ' HA2' ' A' ' 166' ' ' GLY . 27.0 ttpt -65.82 -47.18 75.92 Favored 'General case' 0 CA--C 1.486 -1.504 0 O-C-N 124.02 0.825 . . . . 466.68 110.826 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -61.73 -47.08 86.84 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 117.487 -1.685 . . . . 427.34 107.277 -178.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.895 ' CD2' HG22 ' A' ' 88' ' ' VAL . 47.5 m80 -67.09 -36.76 82.66 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 112.405 0.521 . . . . 537.87 112.405 -174.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.583 ' HB2' ' HB3' ' A' ' 180' ' ' CYS . 2.9 t-20 -69.46 -42.67 74.59 Favored 'General case' 0 N--CA 1.433 -1.325 0 C-N-CA 116.869 -1.932 . . . . 422.12 111.543 175.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.914 ' O ' HG21 ' A' ' 113' ' ' ILE . 76.0 t80 -59.06 -50.14 75.2 Favored 'General case' 0 CA--C 1.502 -0.894 0 O-C-N 121.324 -0.86 . . . . 340.17 111.813 -173.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.486 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 61.4 m-85 -65.25 -46.56 71.84 Favored Pre-proline 0 N--CA 1.443 -0.808 0 C-N-CA 119.109 -1.036 . . . . 258.06 111.713 -176.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.984 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.2 Cg_exo -61.47 -31.59 87.98 Favored 'Trans proline' 0 N--CA 1.434 -1.993 0 N-CA-C 115.391 1.266 . . . . 305.71 115.391 176.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.942 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.89 -40.43 76.49 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 108.701 -0.851 . . . . 252.7 108.701 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.422 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.92 -40.61 93.84 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 107.821 -1.178 . . . . 149.27 107.821 -179.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.93 -44.87 95.87 Favored 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 120.668 -0.413 . . . . 138.08 111.502 -176.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.752 HG23 ' CZ2' ' A' ' 261' ' ' TRP . 65.0 t -66.92 -42.36 88.79 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 O-C-N 121.6 -0.688 . . . . 132.89 110.98 -177.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.946 ' CE1' HG22 ' A' ' 204' ' ' ILE . 26.6 m-85 -63.75 -44.67 92.78 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 119.752 -0.779 . . . . 193.61 108.904 -177.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.605 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.45 -37.73 84.63 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 122.85 0.46 . . . . 63.83 110.055 -175.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.7 m -64.03 -52.38 59.71 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 120.701 -0.4 . . . . 76.4 111.237 -177.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.805 HD11 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.94 -41.67 93.64 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 N-CA-C 108.175 -1.046 . . . . 171.13 108.175 -175.01 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 1.074 ' HB2' HD12 ' A' ' 154' ' ' ILE . 29.5 m-85 -63.75 -38.59 91.66 Favored 'General case' 0 N--CA 1.433 -1.315 0 O-C-N 121.814 -0.554 . . . . 78.3 110.686 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.554 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.6 t -67.09 -35.75 80.48 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 118.926 -1.11 . . . . 92.36 109.197 -178.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' MET . . . . . 1.089 ' HA ' ' HE1' ' A' ' 123' ' ' MET . 5.9 mmt -62.55 -34.2 76.46 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 108.176 -1.046 . . . . 93.73 108.176 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.976 HG22 HG13 ' A' ' 212' ' ' ILE . 33.4 p -67.52 -41.56 84.21 Favored 'General case' 0 CA--C 1.494 -1.202 0 C-N-CA 119.171 -1.012 . . . . 132.74 109.332 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.28 -42.14 94.8 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 107.158 -1.423 . . . . 43.39 107.158 -177.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.865 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 94.8 t -58.45 -41.97 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 N-CA-C 108.633 -0.877 . . . . 59.34 108.633 -178.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.401 ' HB3' ' HB1' ' A' ' 215' ' ' ALA . . . -63.47 -44.09 95.44 Favored 'General case' 0 CA--C 1.498 -1.043 0 O-C-N 121.815 -0.553 . . . . 69.68 110.556 -177.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.468 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.2 t80 -65.44 -42.72 92.09 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.375 -0.972 . . . . 106.98 108.375 -177.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.865 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.38 -35.58 81.35 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 119.663 -0.815 . . . . 147.63 108.981 -177.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.764 ' NH1' ' HE2' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.21 -41.51 99.16 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 108.503 -0.925 . . . . 190.06 108.503 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.963 ' HD2' ' HE3' ' A' ' 132' ' ' MET . 66.6 t80 -61.34 -44.05 97.84 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 108.328 -0.99 . . . . 118.85 108.328 -177.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 1.12 ' HA ' ' HE1' ' A' ' 132' ' ' MET . 4.5 mmt -63.42 -42.63 98.73 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 110.009 -0.367 . . . . 102.5 110.009 -177.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.99 -41.63 95.23 Favored 'General case' 0 CA--C 1.488 -1.405 0 O-C-N 121.837 -0.539 . . . . 89.98 109.828 -176.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.889 ' CD1' HG12 ' A' ' 219' ' ' VAL . 95.4 mt -66.51 -50.72 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 C-N-CA 118.113 -1.435 . . . . 106.09 110.999 -177.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.8 HD12 ' HE1' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.05 -48.3 38.62 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.109 0 C-N-CA 117.133 -1.827 . . . . 227.74 111.86 -174.831 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.789 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 23.8 p80 -118.88 100.06 50.96 Favored Pre-proline 0 CA--C 1.486 -1.498 0 C-N-CA 116.27 -2.172 . . . . 262.55 110.032 -175.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.469 ' HD2' ' O ' ' A' ' 135' ' ' ILE . 9.2 Cg_endo -69.61 -10.37 28.5 Favored 'Trans proline' 0 C--N 1.29 -2.534 0 C-N-CA 121.58 1.52 . . . . 210.25 111.335 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.809 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.26 112.03 1.0 Allowed 'General case' 0 CA--C 1.491 -1.313 0 N-CA-C 106.547 -1.649 . . . . 270.58 106.547 -178.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.89 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.76 -39.55 24.66 Favored Pre-proline 0 N--CA 1.43 -1.46 0 CA-C-N 115.361 -0.836 . . . . 129.84 112.377 -176.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.854 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 82.3 Cg_exo -61.35 -26.58 81.76 Favored 'Trans proline' 0 N--CA 1.432 -2.133 0 N-CA-C 116.291 1.612 . . . . 330.71 116.291 -174.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.789 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.03 77.19 7.95 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 114.497 -2.881 . . . . 204.51 107.263 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.878 HD12 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.73 147.4 0.09 Allowed 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 107.497 -1.297 . . . . 387.41 107.497 178.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.878 ' N ' HD12 ' A' ' 142' ' ' LEU . 47.4 t -143.66 146.99 33.66 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 118.807 -1.157 . . . . 166.22 109.496 178.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.81 -40.8 88.19 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.873 -1.158 . . . . 44.23 107.873 176.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.475 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.5 m -60.27 -39.15 85.82 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 108.184 -1.043 . . . . 28.8 108.184 -175.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.643 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.84 -38.74 92.01 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 109.08 -0.711 . . . . 30.29 109.08 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.958 ' HG1' HG22 ' A' ' 66' ' ' VAL . 90.1 m -59.59 -43.06 93.8 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 108.975 -0.75 . . . . 46.11 108.975 -176.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.459 ' HD3' ' HA ' ' A' ' 145' ' ' THR . 0.2 OUTLIER -62.49 -42.09 99.26 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 107.656 -1.238 . . . . 87.33 107.656 -179.598 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.789 ' O ' HG22 ' A' ' 153' ' ' VAL . 96.4 t -61.71 -42.1 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 N-CA-C 107.894 -1.15 . . . . 23.69 107.894 -178.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.7 t -63.18 -44.31 99.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 109.686 -0.487 . . . . 43.86 109.686 -178.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.934 ' O ' HG23 ' A' ' 154' ' ' ILE . 46.0 mm -61.28 -42.47 93.66 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 108.321 -0.992 . . . . 91.13 108.321 -176.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . 0.504 ' O ' HG22 ' A' ' 156' ' ' VAL . 52.2 t -62.69 -37.94 88.43 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 108.715 -0.846 . . . . 65.88 108.715 -178.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.789 HG22 ' O ' ' A' ' 149' ' ' VAL . 95.3 t -62.12 -41.84 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 N-CA-C 109.523 -0.547 . . . . 33.86 109.523 -177.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 1.074 HD12 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.42 -40.33 85.93 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.147 0 N-CA-C 107.527 -1.286 . . . . 146.52 107.527 -176.749 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . 0.773 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.1 m95 -62.85 -38.34 90.43 Favored 'General case' 0 N--CA 1.428 -1.529 0 C-N-CA 119.501 -0.88 . . . . 75.44 108.934 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.504 HG22 ' O ' ' A' ' 152' ' ' CYS . 98.8 t -60.53 -48.42 88.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 O-C-N 121.023 -1.048 . . . . 43.64 109.711 -177.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.813 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.71 -38.01 89.5 Favored 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 109.013 -0.736 . . . . 102.57 109.013 -178.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.97 -41.05 86.62 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.437 -1.32 . . . . 58.16 107.437 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.819 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.08 -32.54 73.94 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.995 -0.743 . . . . 121.11 108.995 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.813 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.0 -42.3 84.88 Favored 'General case' 0 CA--C 1.489 -1.383 0 C-N-CA 118.594 -1.242 . . . . 153.15 109.916 -178.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.997 HD12 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.13 -43.68 19.04 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 113.107 -3.437 . . . . 133.67 113.515 173.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.537 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -63.01 -39.87 96.07 Favored 'General case' 0 CA--C 1.489 -1.401 0 O-C-N 120.941 -1.1 . . . . 157.42 112.242 -171.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.518 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.2 t80 -74.44 -36.1 2.44 Favored Pre-proline 0 N--CA 1.437 -1.106 0 N-CA-C 115.06 1.504 . . . . 250.91 115.06 -173.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.518 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.293 53.5 Cg_exo -59.47 -25.49 78.83 Favored 'Trans proline' 0 CA--C 1.488 -1.809 0 N-CA-C 118.015 2.275 . . . . 207.34 118.015 -174.385 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 1.024 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 87.6 mt-30 -61.16 -34.24 74.71 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.951 -1.5 . . . . 192.46 106.951 178.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.452 ' HA2' ' HD2' ' A' ' 106' ' ' LYS . . . -64.48 -41.02 98.14 Favored Glycine 0 C--N 1.353 1.499 0 N-CA-C 107.991 -2.044 . . . . 261.0 107.991 177.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.8 159.1 26.04 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 101.519 -3.511 . . . . 491.4 101.519 172.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -59.93 106.79 0.54 Allowed 'General case' 0 CA--C 1.487 -1.443 0 C-N-CA 116.281 -2.168 . . . . 386.1 109.836 -176.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 1.024 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 73.8 m -154.06 -166.6 2.41 Favored 'General case' 0 N--CA 1.414 -2.249 0 N-CA-C 103.531 -2.766 . . . . 289.8 103.531 -178.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 1.11 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.94 175.37 0.87 Allowed 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 117.767 -1.111 . . . . 402.06 109.566 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.782 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 73.4 p -165.22 177.5 7.59 Favored 'General case' 0 CA--C 1.586 2.361 0 C-N-CA 127.329 2.252 . . . . 690.53 114.909 177.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.572 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.8 mm-40 132.38 160.58 0.0 OUTLIER 'General case' 1 C--N 1.429 4.057 1 N-CA-C 123.149 4.5 . . . . 633.62 123.149 162.669 . . . . . . . . 4 3 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.791 HG22 ' SG ' ' A' ' 180' ' ' CYS . 68.9 p -85.61 153.78 22.15 Favored 'General case' 0 C--N 1.389 2.29 0 C-N-CA 127.424 2.289 . . . . 617.99 110.892 178.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' MET . . . . . 1.122 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.65 174.35 6.08 Favored Pre-proline 0 C--N 1.363 1.182 0 C-N-CA 130.268 3.427 . . . . 434.98 113.429 -175.499 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 1.122 ' HD2' ' HB3' ' A' ' 174' ' ' MET . 52.7 Cg_endo -44.23 -65.67 0.18 Allowed 'Trans proline' 0 N--CA 1.442 -1.557 0 N-CA-C 122.357 3.945 . . . . 365.88 122.357 -168.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' SER . . . . . 0.787 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.305 70.4 m -84.91 20.93 1.7 Allowed 'General case' 0 CA--C 1.467 -2.228 0 N-CA-C 104.772 -2.307 . . . . 635.81 104.772 178.197 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.775 ' HB3' ' H ' ' A' ' 179' ' ' VAL 0.456 5.0 mmp_? -94.35 152.28 18.76 Favored 'General case' 1 CA--C 1.419 -4.092 3 N-CA-C 131.969 7.766 . . . . 999.99 131.969 -135.771 . . . . . . . . 5 3 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 1.071 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.911 37.1 t -131.86 73.18 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.383 -3.797 1 CA-C-N 103.288 -6.323 . . . . 594.32 113.628 149.186 . . . . . . . . 4 3 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.775 ' H ' ' HB3' ' A' ' 177' ' ' ARG . 7.3 p -144.21 144.11 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.642 1 N-CA-C 98.296 -4.705 . . . . 811.91 98.296 162.403 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.791 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.9 m -118.46 144.54 45.92 Favored 'General case' 0 CA--C 1.488 -1.413 0 C-N-CA 117.081 -1.848 . . . . 999.99 109.408 -178.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.821 ' HE1' ' CE2' ' A' ' 264' ' ' PHE . 70.8 mmm -147.21 -175.59 4.89 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-O 121.988 0.899 . . . . 431.86 110.058 -177.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 1.061 HD12 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.19 148.66 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 C-N-CA 124.345 1.058 . . . . 457.18 108.811 -177.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . 0.828 ' HB3' ' HB ' ' A' ' 170' ' ' THR . 3.6 tp10 -77.32 85.46 3.74 Favored 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 124.132 0.973 . . . . 458.77 113.495 -174.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 1.015 ' CZ3' HG23 ' A' ' 182' ' ' ILE . 1.9 p90 -76.37 -31.56 0.98 Allowed Pre-proline 0 N--CA 1.438 -1.055 0 C-N-CA 124.98 1.312 . . . . 999.99 112.425 168.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.945 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -65.94 -45.81 5.62 Favored 'Trans proline' 0 N--CA 1.437 -1.817 0 N-CA-C 120.847 3.364 . . . . 999.99 120.847 -174.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.558 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.59 171.75 8.14 Favored 'General case' 0 CA--C 1.472 -2.033 0 C-N-CA 117.156 -1.817 . . . . 81.18 107.213 -172.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.843 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.7 p-80 -109.15 45.16 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.84 0 C-N-CA 115.498 -2.481 . . . . 999.99 108.72 177.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 1.06 ' HB2' HD11 ' A' ' 191' ' ' ILE . 87.2 Cg_endo -41.58 101.8 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.146 1 C-N-CA 126.021 4.481 . . . . 999.99 105.696 -170.75 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -62.21 -44.07 97.41 Favored 'General case' 0 CA--C 1.484 -1.586 0 C-N-CA 126.755 2.022 . . . . 967.72 112.062 -165.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -60.24 -36.57 78.03 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 106.732 -1.581 . . . . 934.3 106.732 -175.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 1.06 HD11 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.57 -30.29 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 C-N-CA 129.2 3.0 . . . . 565.15 113.888 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 61.54 55.42 2.8 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-N 118.464 0.575 . . . . 755.61 109.855 -175.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 1.11 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.49 -49.27 67.16 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 124.532 1.133 . . . . 325.89 113.278 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.897 ' HG3' ' HH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.8 -44.96 78.29 Favored 'General case' 0 CA--C 1.495 -1.163 0 C-N-CA 123.537 0.735 . . . . 250.21 111.679 -169.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.5 t -64.72 -43.35 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-O 121.589 0.709 . . . . 142.46 110.389 -175.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . 1.061 ' CD2' HD12 ' A' ' 182' ' ' ILE . 34.7 t80 -61.07 -41.54 96.83 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 123.986 0.914 . . . . 247.69 108.836 -173.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.891 ' HE2' ' HA ' ' A' ' 269' ' ' LEU . 23.1 t60 -60.49 -51.37 69.75 Favored 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 125.45 1.5 . . . . 199.61 113.059 -175.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.1 mt -65.37 -44.42 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 107.732 -1.21 . . . . 106.73 107.732 -177.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . 0.784 ' O ' HD12 ' A' ' 203' ' ' LEU . 41.6 t -59.21 -48.49 81.42 Favored 'General case' 0 CA--C 1.486 -1.495 0 CA-C-N 115.881 -0.599 . . . . 115.01 110.245 -173.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.997 HG13 HD12 ' A' ' 161' ' ' LEU . 86.2 t -65.21 -49.21 80.24 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.671 0 C-N-CA 119.428 -0.909 . . . . 129.42 111.846 -174.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.814 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.9 m -61.84 -53.13 60.02 Favored 'General case' 0 CA--C 1.482 -1.651 0 C-N-CA 118.213 -1.395 . . . . 172.48 109.971 -172.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.677 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.5 t -63.9 -54.26 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 C-N-CA 120.519 -0.472 . . . . 55.86 110.946 -174.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.784 HD12 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.53 -51.54 59.13 Favored 'General case' 0 N--CA 1.432 -1.362 0 C-N-CA 118.533 -1.267 . . . . 184.68 111.541 -174.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . 0.984 ' HB ' HD13 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.6 -52.45 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 C-N-CA 116.663 -2.015 . . . . 291.81 114.704 -174.713 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.432 ' HB2' ' CE1' ' A' ' 265' ' ' HIS . 87.8 t80 -82.1 -54.97 4.86 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 115.136 1.532 . . . . 130.66 115.136 -178.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . 0.814 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.7 m-85 -66.84 -48.57 68.47 Favored 'General case' 0 CA--C 1.496 -1.096 0 N-CA-C 114.473 1.286 . . . . 80.16 114.473 -170.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.928 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.48 -45.5 83.63 Favored Pre-proline 0 N--CA 1.435 -1.201 0 C-N-CA 119.97 -0.692 . . . . 136.02 109.504 -174.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.928 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.3 Cg_exo -64.82 -27.13 59.55 Favored 'Trans proline' 0 N--CA 1.433 -2.065 0 N-CA-C 110.595 -0.579 . . . . 92.17 110.595 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.775 HD22 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.29 -41.48 76.76 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 107.456 -1.312 . . . . 135.6 107.456 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.17 -44.68 91.3 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 109.555 -0.535 . . . . 52.1 109.555 -176.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . 0.7 HG13 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.72 -43.5 97.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 109.055 -0.72 . . . . 95.89 109.055 -176.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.976 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.25 -42.39 93.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 106.699 -1.593 . . . . 43.41 106.699 -178.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.39 -42.32 99.14 Favored Glycine 0 N--CA 1.432 -1.626 0 N-CA-C 109.384 -1.487 . . . . 27.69 109.384 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . 0.903 ' O ' HG21 ' A' ' 217' ' ' THR . 78.0 t80 -65.63 -47.41 75.71 Favored 'General case' 0 CA--C 1.497 -1.086 0 O-C-N 122.209 -0.583 . . . . 54.41 110.466 -177.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . 0.896 ' O ' HG13 ' A' ' 218' ' ' VAL . . . -61.43 -34.07 74.78 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 106.989 -1.485 . . . . 53.88 106.989 -177.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -60.82 -40.76 93.97 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 108.447 -0.946 . . . . 68.29 108.447 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' THR . . . . . 0.903 HG21 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.85 -38.99 92.83 Favored 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 119.677 -0.809 . . . . 107.59 110.618 -175.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.896 HG13 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.06 -38.35 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 C-N-CA 119.615 -0.834 . . . . 111.61 109.488 -177.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.889 HG12 ' CD1' ' A' ' 134' ' ' ILE . 79.8 t -63.27 -22.51 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.392 -0.966 . . . . 85.26 108.392 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.85 -41.95 99.4 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.07 -0.812 . . . . 40.71 111.07 -176.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.5 mm -64.72 -44.0 96.53 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 N-CA-C 108.414 -0.958 . . . . 95.86 108.414 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.845 ' CB ' HG22 ' A' ' 134' ' ' ILE . 67.9 p -76.99 -137.5 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.408 -0.96 . . . . 144.37 108.408 -176.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.928 HD21 ' NE ' ' A' ' 244' ' ' ARG . 87.6 mt -55.36 132.14 47.4 Favored 'General case' 0 CA--C 1.487 -1.452 0 N-CA-C 107.63 -1.248 . . . . 326.72 107.63 -177.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' TRP . . . . . 0.462 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 9.0 t90 -119.32 -168.07 1.51 Allowed 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 106.011 -1.848 . . . . 158.38 106.011 -176.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . 0.462 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.37 -41.93 98.85 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 109.627 -0.509 . . . . 36.78 109.627 -178.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 73.0 m -61.19 125.88 25.35 Favored 'General case' 0 N--CA 1.434 -1.274 0 C-N-CA 119.115 -1.034 . . . . 85.46 109.802 -174.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.775 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.86 126.54 8.85 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 105.538 -2.023 . . . . 127.78 105.538 176.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.983 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -85.99 139.89 34.89 Favored Pre-proline 0 CA--C 1.492 -1.253 0 N-CA-C 105.964 -1.865 . . . . 164.84 105.964 -179.624 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.983 ' N ' HD13 ' A' ' 228' ' ' ILE . 81.3 Cg_exo -56.8 -39.89 88.15 Favored 'Trans proline' 0 N--CA 1.431 -2.185 0 N-CA-C 113.977 0.722 . . . . 222.35 113.977 -176.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . 0.807 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -83.12 166.96 44.93 Favored Glycine 0 N--CA 1.427 -1.912 0 N-CA-C 106.432 -2.667 . . . . 45.22 106.432 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.925 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.8 t0 -60.93 -45.77 93.37 Favored 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 106.045 -1.835 . . . . 107.57 106.045 177.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' SER . . . . . 0.734 ' O ' HG21 ' A' ' 228' ' ' ILE . 68.0 m -65.82 141.82 58.16 Favored 'General case' 0 N--CA 1.428 -1.539 0 C-N-CA 118.907 -1.117 . . . . 167.96 109.128 -175.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.873 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.1 m 99.53 106.73 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 126.729 2.012 . . . . 280.68 109.754 176.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.778 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.6 m-20 56.06 11.18 0.7 Allowed 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 124.417 1.087 . . . . 218.25 110.679 174.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.933 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.32 137.61 54.8 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 105.222 -2.14 . . . . 343.57 105.222 177.448 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.583 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.5 t80 -111.98 81.94 1.54 Allowed 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 106.852 -1.536 . . . . 263.29 106.852 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' HIS . . . . . 0.661 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.4 m-70 104.27 147.08 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.283 0 C-N-CA 126.602 1.961 . . . . 261.92 108.497 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.23 -38.08 89.75 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 107.882 -1.155 . . . . 106.81 107.882 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.759 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.49 -39.87 94.86 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 118.325 -1.35 . . . . 112.2 107.549 -178.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.75 HG13 ' NH1' ' A' ' 244' ' ' ARG . 75.7 t -64.32 -39.8 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 N-CA-C 109.254 -0.647 . . . . 45.41 109.254 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.864 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.4 p -70.93 -32.02 68.8 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 110.296 -0.261 . . . . 97.62 110.296 -178.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.42 -39.62 81.51 Favored 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 123.713 0.805 . . . . 59.29 110.959 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.759 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.23 -36.58 84.11 Favored 'General case' 0 CA--C 1.492 -1.265 0 C-N-CA 124.722 1.209 . . . . 106.49 110.682 -174.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.933 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.95 -30.64 69.22 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 108.313 -0.995 . . . . 106.62 108.313 -176.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.571 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -66.03 -40.99 91.48 Favored 'General case' 0 N--CA 1.435 -1.175 0 O-C-N 121.821 -0.55 . . . . 75.97 110.065 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.879 ' CG1' ' HE3' ' A' ' 250' ' ' MET . 76.8 t -65.55 -40.82 89.26 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 C-N-CA 122.926 0.49 . . . . 65.27 109.815 -178.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.836 HG11 ' O ' ' A' ' 244' ' ' ARG . 7.9 p -63.99 -41.65 93.16 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 C-N-CA 120.42 -0.512 . . . . 107.94 110.125 -177.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.571 ' HE2' ' HA ' ' A' ' 245' ' ' LYS . 59.1 pttt -63.55 -40.77 97.86 Favored 'General case' 0 N--CA 1.434 -1.239 0 O-C-N 121.71 -0.619 . . . . 87.98 110.286 -176.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' MET . . . . . 1.061 ' HE2' ' CD1' ' A' ' 305' ' ' TYR . 21.3 ttt -63.65 -40.4 96.76 Favored 'General case' 0 CA--C 1.492 -1.268 0 C-N-CA 118.849 -1.141 . . . . 65.5 108.355 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' MET . . . . . 0.879 ' HE3' ' CG1' ' A' ' 246' ' ' VAL . 68.5 mtt -61.75 -36.36 80.8 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 108.095 -1.076 . . . . 85.05 108.095 -177.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.518 HD11 ' HA ' ' A' ' 248' ' ' LYS . 86.8 mt -63.5 -45.76 96.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 N-CA-C 109.032 -0.729 . . . . 42.25 109.032 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . 0.877 HG13 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.3 -38.27 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 C-N-CA 119.594 -0.842 . . . . 91.01 109.443 -176.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 1.03 HG21 HD11 ' A' ' 304' ' ' ILE . 65.9 t -58.9 -41.55 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 N-CA-C 107.965 -1.124 . . . . 66.09 107.965 -178.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 250' ' ' MET . 94.7 t -66.08 -43.18 92.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 C-N-CA 120.719 -0.393 . . . . 52.39 110.323 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.1 m -61.7 -46.79 88.18 Favored 'General case' 0 CA--C 1.489 -1.4 0 O-C-N 121.847 -0.533 . . . . 46.42 109.877 -174.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' THR . . . . . 0.821 ' O ' HG23 ' A' ' 259' ' ' ILE . 9.5 t -62.31 -38.12 88.19 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 108.322 -0.992 . . . . 116.51 108.322 -177.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' PHE . . . . . 0.54 ' N ' HG23 ' A' ' 256' ' ' THR . 86.1 t80 -60.28 -48.25 82.53 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 109.358 -0.608 . . . . 65.18 109.358 -178.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.91 -42.72 97.33 Favored 'General case' 0 CA--C 1.49 -1.358 0 CA-C-O 120.869 0.366 . . . . 51.33 110.458 -175.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . 0.821 HG23 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.57 -43.38 98.22 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.573 0 C-N-CA 118.89 -1.124 . . . . 126.3 109.038 -176.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' CYS . . . . . 0.567 ' N ' HG22 ' A' ' 259' ' ' ILE . 69.5 m -65.6 -49.32 69.23 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 119.521 -0.872 . . . . 133.94 112.462 -176.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.868 ' CH2' ' HB2' ' A' ' 294' ' ' ALA . 97.0 m95 -80.68 -33.29 35.57 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 116.888 2.181 . . . . 134.84 116.888 -176.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.8 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.9 tp -58.48 -41.6 90.06 Favored Pre-proline 0 CA--C 1.493 -1.219 0 O-C-N 121.689 -0.632 . . . . 72.23 111.658 -167.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' PRO . . . . . 0.818 ' O ' HG21 ' A' ' 266' ' ' ILE . 79.8 Cg_exo -60.7 -35.94 87.09 Favored 'Trans proline' 0 C--N 1.295 -2.281 0 CA-C-N 119.813 0.969 . . . . 106.13 111.368 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' PHE . . . . . 0.847 ' CA ' HG21 ' A' ' 290' ' ' ILE . 71.6 t80 -66.42 -44.69 82.27 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 119.775 -0.77 . . . . 128.35 110.045 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' HIS . . . . . 0.696 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.43 -37.83 88.9 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 110.249 -0.278 . . . . 100.73 110.249 -177.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.818 HG21 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.22 -44.6 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 C-N-CA 119.346 -0.942 . . . . 172.72 109.149 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . 0.749 ' HD1' ' O ' ' A' ' 263' ' ' PRO . 61.7 m-85 -66.59 -28.03 68.19 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 108.264 -1.013 . . . . 249.23 108.264 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' PHE . . . . . 0.902 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.57 -55.14 35.4 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.687 -1.597 . . . . 259.78 106.687 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . 0.891 ' HA ' ' HE2' ' A' ' 197' ' ' HIS . 89.2 mt -69.17 -44.12 72.88 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 113.612 0.967 . . . . 233.11 113.612 -176.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.849 HD12 HD21 ' A' ' 279' ' ' LEU . 89.1 mt -61.37 -48.31 91.41 Favored Pre-proline 0 N--CA 1.439 -0.976 0 C-N-CA 119.155 -1.018 . . . . 169.54 110.642 -171.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . 0.681 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.9 Cg_exo -61.13 -24.49 79.34 Favored 'Trans proline' 0 N--CA 1.429 -2.276 0 C-N-CA 116.715 -1.723 . . . . 255.47 114.698 174.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' TYR . . . . . 0.897 ' HH ' ' HG3' ' A' ' 194' ' ' LYS . 19.6 t80 -63.58 -44.26 94.6 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 119.228 0.922 . . . . 279.03 108.854 177.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . 0.835 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.36 -44.77 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 N-CA-C 110.056 -0.35 . . . . 162.21 110.056 -178.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' ASN . . . . . 0.774 ' N ' HD11 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.38 84.87 59.27 Favored Pre-proline 0 N--CA 1.43 -1.428 0 C-N-CA 118.775 -1.17 . . . . 128.13 108.12 -178.119 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.5 Cg_endo -85.22 164.01 11.3 Favored 'Trans proline' 0 C--N 1.294 -2.304 0 N-CA-C 107.455 -1.787 . . . . 278.35 107.455 177.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . 0.851 ' O ' HD22 ' A' ' 277' ' ' LEU . 39.4 t0 66.12 15.01 9.92 Favored 'General case' 0 N--CA 1.428 -1.569 0 O-C-N 123.777 0.673 . . . . 312.91 109.326 175.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.851 HD22 ' O ' ' A' ' 276' ' ' ASP . 28.3 mt -132.71 -170.67 2.49 Favored 'General case' 0 CA--C 1.481 -1.679 0 N-CA-C 106.556 -1.646 . . . . 353.54 106.556 177.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 1.023 ' HA ' ' CB ' ' A' ' 282' ' ' PHE . 42.8 p90 -115.67 142.25 46.99 Favored 'General case' 0 N--CA 1.427 -1.619 0 N-CA-C 107.439 -1.319 . . . . 251.26 107.439 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.849 HD21 HD12 ' A' ' 270' ' ' LEU . 1.7 tm? -76.97 -118.71 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 102.103 -3.295 . . . . 175.26 102.103 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . 0.778 ' HB3' ' HE3' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.5 -44.96 96.14 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 100.884 -3.747 . . . . 99.07 100.884 172.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . 0.778 ' HE3' ' HB3' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.45 124.18 9.17 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 103.45 -2.796 . . . . 243.21 103.45 171.186 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 1.023 ' CB ' ' HA ' ' A' ' 278' ' ' TYR . 77.1 t80 -93.0 112.98 25.13 Favored 'General case' 0 CA--C 1.473 -2.003 0 C-N-CA 116.065 -2.254 . . . . 201.04 105.286 178.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' ILE . . . . . 0.766 HG23 ' N ' ' A' ' 285' ' ' GLN . 10.7 tp -147.96 173.71 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.085 0 C-N-CA 116.004 -2.278 . . . . 201.36 108.802 -175.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . 1.066 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.283 0.6 OUTLIER -59.48 -41.44 89.8 Favored 'General case' 0 N--CA 1.415 -2.176 0 CA-C-N 113.233 -1.803 . . . . 203.82 107.896 174.462 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . 0.915 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.29 -45.72 86.77 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 118.215 -1.394 . . . . 215.06 112.553 -171.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.636 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.2 t -65.63 -46.45 89.36 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.476 0 C-N-CA 118.565 -1.254 . . . . 125.28 112.951 -171.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' TYR . . . . . 0.852 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.73 -37.04 86.23 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 107.205 -1.405 . . . . 268.9 107.205 -171.896 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . 0.871 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.26 -44.97 74.41 Favored 'General case' 0 N--CA 1.427 -1.583 0 C-N-CA 125.657 1.583 . . . . 280.88 108.762 -172.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.67 -47.47 86.11 Favored 'General case' 0 N--CA 1.428 -1.564 0 C-N-CA 118.987 -1.085 . . . . 184.47 108.979 -172.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . 0.847 HG21 ' CA ' ' A' ' 264' ' ' PHE . 1.8 mp -67.94 -42.1 85.28 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 C-N-CA 119.247 -0.981 . . . . 167.92 112.739 -175.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' MET . . . . . 0.661 ' HE2' ' HG2' ' A' ' 181' ' ' MET . 21.8 ttt -65.72 -38.83 90.26 Favored 'General case' 0 CA--C 1.495 -1.136 0 C-N-CA 117.751 -1.58 . . . . 367.18 110.802 -175.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' TRP . . . . . 0.572 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.5 m95 -67.14 -32.7 74.0 Favored 'General case' 0 N--CA 1.435 -1.208 0 O-C-N 121.856 -0.527 . . . . 173.97 110.466 177.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.1 tp -64.44 -36.85 85.51 Favored 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 123.6 0.76 . . . . 119.66 109.777 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . 0.868 ' HB2' ' CH2' ' A' ' 261' ' ' TRP . . . -61.16 -33.99 74.3 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 107.734 -1.21 . . . . 112.3 107.734 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' MET . . . . . 0.713 ' O ' HG21 ' A' ' 298' ' ' THR . 21.9 mmt -63.13 -32.04 73.33 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 116.202 -0.454 . . . . 174.17 110.237 -177.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.7 m -64.69 -22.76 67.06 Favored 'General case' 0 CA--C 1.485 -1.536 0 C-N-CA 124.629 1.171 . . . . 145.27 110.645 -175.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' SER . . . . . 0.829 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.6 m -57.65 -35.35 70.41 Favored 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 108.084 -1.08 . . . . 170.15 108.084 -175.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.84 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.7 t -55.28 -34.21 63.9 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 116.282 -0.417 . . . . 214.57 110.64 -171.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' MET . . . . . 0.796 ' CE ' ' HG1' ' A' ' 45' ' ' THR . 28.1 ttt -77.17 -33.22 56.52 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 126.065 1.746 . . . . 168.29 115.534 177.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' TYR . . . . . 0.829 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.4 p90 -64.38 -34.86 79.13 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 114.066 1.135 . . . . 167.15 114.066 -168.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . 0.747 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.282 18.8 p-10 -64.23 -38.32 33.25 Favored Pre-proline 0 N--CA 1.434 -1.266 0 C-N-CA 115.52 -2.472 . . . . 165.13 113.921 -171.59 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' PRO . . . . . 0.747 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.2 Cg_exo -62.52 -31.84 80.17 Favored 'Trans proline' 0 N--CA 1.433 -2.035 0 CA-C-N 122.755 2.019 . . . . 123.92 111.271 -178.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' ILE . . . . . 0.786 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.0 pt -68.75 -42.55 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 C-N-CA 118.869 -1.132 . . . . 110.55 109.755 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' ILE . . . . . 1.03 HD11 HG21 ' A' ' 253' ' ' VAL . 31.1 pt -61.2 -39.99 84.37 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.168 0 N-CA-C 108.806 -0.813 . . . . 145.31 108.806 -177.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . 1.061 ' CD1' ' HE2' ' A' ' 249' ' ' MET 0.253 63.2 m-85 -58.13 -48.78 79.17 Favored 'General case' 0 CA--C 1.493 -1.212 0 C-N-CA 119.375 -0.93 . . . . 246.68 109.837 -177.499 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 87.3 m -62.23 -47.52 84.03 Favored 'General case' 0 CA--C 1.485 -1.532 0 C-N-CA 119.549 -0.86 . . . . 64.43 109.52 -173.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.7 t -66.83 -45.01 79.61 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 118.993 -1.083 . . . . 80.72 110.226 -177.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.757 HD22 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.53 -35.69 75.7 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 115.972 1.841 . . . . 140.44 115.972 -173.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . 0.619 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.85 132.23 34.3 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 112.685 -3.606 . . . . 178.87 113.064 -177.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . 0.702 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.6 p-10 -65.03 -37.03 86.29 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 114.382 -1.281 . . . . 110.22 110.113 -177.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . 0.853 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.75 -50.59 72.72 Favored 'General case' 0 CA--C 1.492 -1.263 0 O-C-N 121.697 -0.627 . . . . 174.78 109.765 -174.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.978 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.1 m-85 -64.87 -41.7 95.44 Favored 'General case' 0 CA--C 1.485 -1.536 0 N-CA-C 108.228 -1.027 . . . . 161.84 108.228 178.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . 0.479 ' HE ' HD21 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.31 -50.22 73.62 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.196 -0.668 . . . . 117.2 109.196 -173.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.839 ' HB3' HD12 ' A' ' 326' ' ' ILE . 3.0 mm? -68.54 -44.06 75.36 Favored 'General case' 0 N--CA 1.433 -1.275 0 C-N-CA 120.352 -0.539 . . . . 112.6 111.092 -177.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . 1.124 ' HA2' ' HD1' ' A' ' 318' ' ' HIS . . . -64.08 -37.43 94.57 Favored Glycine 0 N--CA 1.431 -1.678 0 N-CA-C 110.59 -1.004 . . . . 101.46 110.59 -177.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' PHE . . . . . 0.978 ' CE2' ' HB3' ' A' ' 312' ' ' PHE . 36.6 m-85 -62.17 -46.01 90.86 Favored 'General case' 0 CA--C 1.491 -1.307 0 CA-C-N 118.521 1.16 . . . . 151.49 109.523 -178.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . 0.427 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.07 -36.3 77.06 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 106.957 -1.498 . . . . 142.32 106.957 -175.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' HIS . . . . . 1.124 ' HD1' ' HA2' ' A' ' 315' ' ' GLY . 49.9 m80 -59.79 -41.82 92.01 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 106.903 -1.517 . . . . 109.09 106.903 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.86 -42.41 85.71 Favored 'General case' 0 N--CA 1.435 -1.177 0 O-C-N 122.334 -0.228 . . . . 76.11 111.037 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -61.46 -55.43 31.37 Favored 'General case' 0 CA--C 1.49 -1.36 0 C-N-CA 119.849 -0.74 . . . . 120.24 109.331 -174.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . 0.752 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.5 mtt180 -74.34 131.52 41.21 Favored 'General case' 0 CA--C 1.482 -1.66 0 N-CA-C 102.957 -2.979 . . . . 192.73 102.957 177.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.14 -44.24 92.05 Favored 'General case' 0 CA--C 1.492 -1.266 0 C-N-CA 119.042 -1.063 . . . . 176.29 109.153 -172.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' CYS . . . . . 0.813 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.6 m -79.37 -177.07 0.8 Allowed Pre-proline 0 CA--C 1.487 -1.453 0 N-CA-C 106.241 -1.762 . . . . 69.68 106.241 178.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.5 Cg_exo -59.08 -75.51 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.403 0 C-N-CA 118.31 -0.66 . . . . 191.05 112.614 176.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' PHE . . . . . 0.813 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.5 m-85 47.48 43.92 16.24 Favored 'General case' 0 CA--C 1.493 -1.229 0 O-C-N 123.575 0.547 . . . . 287.03 109.737 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . 0.847 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.51 78.59 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.474 -1.946 0 C-N-CA 112.992 -3.483 . . . . 292.29 109.8 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' SER . . . . . 0.507 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.3 t -77.53 -152.81 0.05 Allowed 'General case' 0 N--CA 1.424 -1.775 0 N-CA-C 104.209 -2.515 . . . . 184.57 104.209 178.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.74 8.6 4.92 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 113.045 0.757 . . . . 274.56 113.045 176.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.97 0.91 57.26 Favored Glycine 0 C--N 1.348 1.198 0 C-N-CA 117.746 -2.168 . . . . 268.24 113.465 172.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' ASP . . . . . 0.724 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.5 m-20 51.59 -172.04 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.063 0 CA-C-N 118.677 1.239 . . . . 200.06 110.734 177.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.853 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.88 -32.98 74.68 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 107.878 -1.156 . . . . 114.44 107.878 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' GLU . . . . . 0.601 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.28 46.04 21.92 Favored 'General case' 0 CA--C 1.484 -1.591 0 N-CA-C 107.638 -1.245 . . . . 263.81 107.638 -177.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' GLY . . . . . 0.652 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.3 -137.36 3.61 Favored Glycine 0 CA--C 1.479 -2.204 1 N-CA-C 102.556 -4.218 . . . . 103.79 102.556 -179.815 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . 0.992 HD21 ' HA ' ' A' ' 337' ' ' LYS . 61.2 mt -88.26 95.54 10.22 Favored 'General case' 0 N--CA 1.419 -1.996 0 C-N-CA 114.936 -2.706 . . . . 117.3 106.018 177.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . 1.064 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.91 -39.83 90.91 Favored 'General case' 0 CA--C 1.469 -2.16 1 N-CA-C 97.994 -4.817 . . . . 231.58 97.994 167.264 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 1.064 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.92 163.49 29.05 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 102.11 -3.293 . . . . 303.24 102.11 168.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' LYS . . . . . 0.992 ' HA ' HD21 ' A' ' 334' ' ' LEU . 84.3 tttt -62.62 -48.6 78.68 Favored 'General case' 0 N--CA 1.432 -1.365 0 C-N-CA 116.038 -2.265 . . . . 112.72 108.411 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' SER . . . . . 0.411 ' HB3' ' SD ' ' A' ' 336' ' ' MET . 47.9 t -61.04 -63.63 1.23 Allowed 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 109.117 -0.697 . . . . 83.22 109.117 -176.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' THR . . . . . 0.91 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.1 m -156.28 -126.21 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 103.833 -2.654 . . . . 174.36 103.833 -178.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . 1.064 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.86 160.95 8.77 Favored 'General case' 0 CA--C 1.486 -1.504 0 N-CA-C 105.761 -1.94 . . . . 202.73 105.761 177.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . 1.029 ' HH ' ' HA3' ' A' ' 315' ' ' GLY . 0.2 OUTLIER -131.98 149.08 52.53 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 107.046 -1.465 . . . . 180.62 107.046 176.358 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . 0.945 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.4 tp -178.52 -171.86 0.27 Allowed 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 105.409 -2.071 . . . . 145.25 105.409 178.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' GLN . . . . . 0.945 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.08 -43.17 88.11 Favored 'General case' 0 CA--C 1.487 -1.477 0 N-CA-C 106.129 -1.804 . . . . 66.05 106.129 174.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' THR . . . . . 0.758 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.1 t -132.68 -152.12 0.48 Allowed 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 103.505 -2.776 . . . . 266.49 103.505 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' GLN . . . . . 0.609 ' CD ' HD23 ' A' ' 342' ' ' LEU . 79.4 mt-30 66.27 -124.96 0.28 Allowed 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 117.043 -1.863 . . . . 219.2 107.801 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . 1.001 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.02 -37.43 94.23 Favored Glycine 0 N--CA 1.425 -2.044 0 CA-C-N 114.558 -1.201 . . . . 94.78 112.852 -176.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' SER . . . . . 1.1 ' HG ' ' HB3' ' A' ' 61' ' ' LYS . 48.4 t -81.11 100.38 9.01 Favored 'General case' 0 CA--C 1.484 -1.575 0 C-N-CA 112.316 -3.753 . . . . 121.41 109.468 -171.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . 0.672 ' O ' ' HE2' ' A' ' 336' ' ' MET . 94.8 t -72.99 145.47 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 108.997 -0.742 . . . . 85.34 108.997 -176.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' TYR . . . . . 0.505 ' N ' HG13 ' A' ' 348' ' ' VAL . 48.5 p90 -57.76 143.47 41.86 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 107.839 -1.171 . . . . 267.57 107.839 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . 0.509 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.01 69.58 0.6 Allowed 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 109.553 -0.536 . . . . 226.1 109.553 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' VAL . . . . . 1.047 ' HB ' ' HE1' ' A' ' 336' ' ' MET . 7.5 p -50.94 156.94 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.315 0 N-CA-C 106.994 -1.484 . . . . 154.84 106.994 177.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' SER . . . . . 0.506 ' N ' HG23 ' A' ' 351' ' ' VAL . 71.4 m -61.35 161.87 8.59 Favored 'General case' 0 CA--C 1.494 -1.21 0 CA-C-O 121.588 0.709 . . . . 180.01 110.722 -173.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' ARG . . . . . 0.88 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.41 156.92 23.6 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 106.976 -1.49 . . . . 333.78 106.976 -178.653 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . 0.99 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.06 142.51 48.79 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 107.364 -1.347 . . . . 335.2 107.364 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.99 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.6 mm-40 82.88 158.91 0.13 Allowed 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 108.703 -0.851 . . . . 266.47 108.703 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.8 m -60.66 -46.92 88.5 Favored 'General case' 0 CA--C 1.487 -1.465 0 N-CA-C 105.632 -1.988 . . . . 59.34 105.632 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.53 173.87 11.97 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 104.462 -2.421 . . . . 201.26 104.462 176.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.782 HG21 ' O ' ' A' ' 360' ' ' THR . 69.3 mt -95.94 106.78 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 C-N-CA 116.29 -2.164 . . . . 56.23 105.503 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' SER . . . . . 0.52 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.9 m -61.19 -59.45 5.29 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 109.319 -0.623 . . . . 87.58 109.319 -175.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' THR . . . . . 0.89 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.2 t -85.55 153.74 22.22 Favored 'General case' 0 CA--C 1.485 -1.535 0 N-CA-C 107.821 -1.178 . . . . 219.95 107.821 -177.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 361' ' ' VAL . 16.0 m -81.98 83.85 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 C-N-CA 116.35 -2.14 . . . . 121.79 105.432 177.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.621 HG13 ' N ' ' A' ' 363' ' ' GLY . 64.3 t -154.14 159.72 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.559 0 N-CA-C 105.78 -1.933 . . . . 53.85 105.78 -179.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . 0.621 ' N ' HG13 ' A' ' 362' ' ' VAL . . . 72.2 16.62 77.02 Favored Glycine 0 N--CA 1.428 -1.889 0 N-CA-C 106.029 -2.828 . . . . 196.55 106.029 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.653 0 N-CA-C 107.883 -1.154 . . . . 35.88 107.883 -178.971 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 365' ' ' ARG . . . . . 0.555 ' HE ' ' HB3' ' B' ' 365' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 108.867 -0.79 . . . . 1.0 108.867 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 366' ' ' PRO . . . . . 0.689 ' HG3' ' ND2' ' A' ' 3' ' ' ASN . 52.3 Cg_endo -66.89 142.0 60.98 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.059 1.839 . . . . 1.0 110.195 179.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 367' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -64.46 143.29 98.53 Favored Pre-proline 0 C--N 1.324 -0.503 0 C-N-CA 119.854 -0.738 . . . . 1.0 109.545 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 368' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.25 150.39 76.56 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.312 2.008 . . . . 1.0 111.738 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 369' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.71 131.71 44.29 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.709 -0.396 . . . . 1.0 110.248 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -101.95 115.9 31.54 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.372 -0.377 . . . . 1.0 110.727 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 371' ' ' PHE . . . . . 0.445 ' HA ' HD11 ' B' ' 374' ' ' LEU . 86.1 m-85 -63.6 -42.51 98.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.318 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 372' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -65.07 -36.14 83.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.839 -0.619 . . . . 1.0 110.672 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -59.73 -33.08 76.12 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.776 -0.93 . . . . 1.0 110.776 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 374' ' ' LEU . . . . . 0.782 HD13 HD12 ' A' ' 102' ' ' LEU . 3.2 mt -67.85 131.38 45.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.929 0.395 . . . . 1.0 110.16 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 375' ' ' MET . . . . . 0.499 ' HE1' ' HB2' ' B' ' 375' ' ' MET . 0.4 OUTLIER . . . . . 0 C--O 1.221 -0.424 0 CA-C-O 118.014 -0.993 . . . . 1.0 110.534 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.471 0 N-CA-C 108.398 -0.964 . . . . 97.08 108.398 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.654 ' ND2' ' HG3' ' B' ' 366' ' ' PRO . 46.5 t30 -110.62 155.43 22.38 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-O 122.172 0.987 . . . . 123.41 110.671 -172.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.841 HG12 HD13 ' A' ' 15' ' ' ILE . 28.8 m -134.56 -162.33 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.477 1 N-CA-C 100.121 -4.029 . . . . 151.3 100.121 173.72 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.976 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.69 -38.6 58.17 Favored Pre-proline 0 N--CA 1.439 -0.985 0 C-N-CA 115.961 -2.296 . . . . 169.25 106.104 178.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.976 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 57.6 Cg_exo -81.28 168.53 16.66 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 122.283 0.623 . . . . 185.76 110.568 171.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.851 HG12 ' CE2' ' A' ' 282' ' ' PHE . 91.7 t -64.5 -25.92 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 C-N-CA 127.041 2.137 . . . . 145.47 110.332 -177.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.832 ' O ' HG23 ' A' ' 4' ' ' VAL . 39.2 t0 -84.32 157.44 21.5 Favored 'General case' 0 CA--C 1.499 -0.993 0 O-C-N 121.087 -1.008 . . . . 102.76 109.45 -178.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.6 p -82.6 154.23 25.06 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 107.943 -1.132 . . . . 106.25 107.943 178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.924 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 46.7 p-10 -105.97 51.93 0.74 Allowed 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 117.763 -1.575 . . . . 157.81 107.597 178.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.22 -45.87 91.71 Favored 'General case' 0 CA--C 1.481 -1.698 0 N-CA-C 103.58 -2.748 . . . . 150.2 103.58 178.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.457 ' C ' ' H ' ' A' ' 14' ' ' ASN . 71.0 m -87.01 164.69 35.36 Favored Pre-proline 0 N--CA 1.421 -1.9 0 N-CA-C 103.689 -2.708 . . . . 183.52 103.689 172.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -76.75 6.86 3.84 Favored 'Trans proline' 0 C--N 1.281 -2.987 0 N-CA-C 110.011 -0.803 . . . . 235.61 110.011 176.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.457 ' H ' ' C ' ' A' ' 12' ' ' SER . 34.5 t-20 -57.92 -41.24 82.26 Favored 'General case' 0 N--CA 1.435 -1.198 0 C-N-CA 124.82 1.248 . . . . 113.77 113.386 -170.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.924 ' CD1' ' HB3' ' A' ' 10' ' ' ASP . 33.3 pt -52.22 136.26 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.912 0 CA-C-N 119.553 1.069 . . . . 150.85 110.942 -176.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.51 156.24 46.39 Favored 'General case' 0 C--N 1.36 1.06 0 N-CA-C 107.61 -1.256 . . . . 100.42 107.61 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 1.037 HG21 ' H ' ' A' ' 20' ' ' SER . 14.2 t -64.99 142.6 58.38 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 121.971 0.891 . . . . 129.36 110.449 -174.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.765 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.1 -25.5 68.39 Favored 'General case' 0 CA--C 1.494 -1.174 0 C-N-CA 126.28 1.832 . . . . 112.34 106.645 -177.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 1.003 HG21 ' HA2' ' A' ' 101' ' ' GLY . 85.3 m -74.11 -40.13 62.88 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 115.562 -0.744 . . . . 131.73 111.769 177.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 1.037 ' H ' HG21 ' A' ' 17' ' ' THR . 70.8 m -84.47 -42.84 15.18 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 117.006 2.225 . . . . 80.49 117.006 -174.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.529 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.4 mt-10 -145.99 174.52 3.36 Favored Pre-proline 0 N--CA 1.442 -0.827 0 C-N-CA 118.124 -1.43 . . . . 98.98 111.172 -169.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.881 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.332 85.6 Cg_exo -61.84 -10.67 18.0 Favored 'Trans proline' 0 C--N 1.321 -0.87 1 N-CA-C 128.882 6.455 . . . . 246.95 128.882 -170.053 . . . . . . . . 4 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.675 HD22 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.58 17.52 8.65 Favored 'General case' 0 C--N 1.324 -0.519 1 CA-C-N 126.181 4.082 . . . . 269.62 114.237 175.65 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.58 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.5 mt-30 -67.1 -27.24 67.17 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 107.806 -1.183 . . . . 86.8 107.806 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.661 ' CE1' HG21 ' A' ' 26' ' ' VAL . 50.4 p90 -66.85 -29.29 69.16 Favored 'General case' 0 N--CA 1.431 -1.391 0 O-C-N 121.166 -0.959 . . . . 85.91 110.514 -178.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.859 HG13 ' OE1' ' A' ' 284' ' ' GLN . 40.4 t -68.59 -40.2 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 C-N-CA 123.734 0.814 . . . . 82.0 111.312 -177.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.933 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.41 167.73 12.48 Favored Pre-proline 0 CA--C 1.489 -1.401 0 N-CA-C 108.551 -0.907 . . . . 120.73 108.551 -178.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.842 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -64.0 149.76 89.82 Favored 'Trans proline' 0 N--CA 1.432 -2.136 0 C-N-CA 120.645 0.896 . . . . 87.86 109.912 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.822 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.03 -37.94 89.2 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.829 -0.804 . . . . 36.46 108.829 -176.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.841 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 28.0 p-90 -63.83 -33.84 76.58 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 107.837 -1.171 . . . . 150.6 107.837 -176.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.933 ' OE1' ' HB2' ' A' ' 27' ' ' GLN . 80.4 mt-30 -62.22 -32.66 73.35 Favored 'General case' 0 CA--C 1.49 -1.328 0 O-C-N 121.303 -0.873 . . . . 123.26 108.705 -178.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.855 HG23 ' O ' ' A' ' 93' ' ' ALA . 1.7 mp -61.5 -47.19 94.54 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.59 0 N-CA-C 109.162 -0.681 . . . . 120.14 109.162 176.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 30' ' ' TRP . 20.3 m -67.38 -31.04 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 N-CA-C 107.865 -1.161 . . . . 112.19 107.865 -178.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.841 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.6 tp -62.99 -47.1 84.58 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 119.887 -0.725 . . . . 60.87 109.588 -178.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.69 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.04 -35.67 81.16 Favored 'General case' 0 CA--C 1.489 -1.389 0 C-N-CA 119.999 -0.681 . . . . 157.57 110.309 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.813 ' CB ' HG12 ' A' ' 94' ' ' VAL . . . -62.68 -40.83 98.33 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 108.617 -0.883 . . . . 47.06 108.617 178.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.841 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.8 -41.27 97.95 Favored 'General case' 0 CA--C 1.496 -1.112 0 O-C-N 121.728 -0.607 . . . . 43.94 109.535 -177.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.766 ' O ' HG21 ' A' ' 41' ' ' VAL . . . -61.84 -43.31 99.1 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 108.714 -0.847 . . . . 42.61 108.714 -176.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.961 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.33 -41.29 94.11 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 116.615 -0.266 . . . . 140.66 111.018 -178.351 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.841 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.82 -43.91 97.91 Favored 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 118.547 -1.261 . . . . 116.04 110.252 -175.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.766 HG21 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.5 -38.71 83.1 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.29 0 N-CA-C 108.71 -0.848 . . . . 97.16 108.71 -177.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.915 HD11 ' HD1' ' A' ' 39' ' ' TYR . 93.2 mt -61.27 -39.99 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 108.995 -0.743 . . . . 54.85 108.995 -176.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 1.004 HG23 HG23 ' A' ' 86' ' ' THR . 92.6 t -57.73 -42.33 81.52 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.312 0 N-CA-C 108.864 -0.791 . . . . 45.39 108.864 -175.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.402 ' O ' HG22 ' A' ' 48' ' ' VAL . 97.2 t -63.56 -50.95 76.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 C-N-CA 118.875 -1.13 . . . . 48.64 110.163 -177.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.796 ' HG1' ' CE ' ' A' ' 299' ' ' MET . 10.5 t -65.29 -46.99 78.21 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 120.119 -0.633 . . . . 116.65 111.731 -174.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.641 ' N ' HG23 ' A' ' 45' ' ' THR . 50.7 m -61.98 -43.96 97.74 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 109.729 -0.471 . . . . 51.16 109.729 -174.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 43' ' ' VAL . 97.9 t -65.48 -48.95 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 C-N-CA 119.872 -0.731 . . . . 44.3 110.88 -177.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.874 ' O ' HG22 ' A' ' 52' ' ' VAL . 93.8 t -64.75 -46.94 90.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 C-N-CA 120.296 -0.561 . . . . 48.82 111.043 -174.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.79 -44.11 95.24 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 120.479 -0.867 . . . . 58.7 112.015 -174.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -72.67 -34.21 67.07 Favored 'General case' 0 CA--C 1.488 -1.418 0 O-C-N 122.102 -0.646 . . . . 101.4 111.014 -175.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.814 HG11 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.85 -38.77 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 107.755 -1.202 . . . . 103.57 107.755 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.874 HG22 ' O ' ' A' ' 48' ' ' VAL . 72.1 t -61.4 -43.04 96.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 N-CA-C 109.016 -0.735 . . . . 61.89 109.016 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.64 ' O ' HG21 ' A' ' 56' ' ' ILE . 82.1 t -63.43 -50.95 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 C-N-CA 120.284 -0.566 . . . . 70.01 109.506 -178.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.718 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.9 -43.45 98.77 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 109.142 -0.688 . . . . 132.1 109.142 -176.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.673 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.1 t-105 -64.18 -46.65 83.03 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 116.671 -0.24 . . . . 104.5 110.442 -176.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.896 HD11 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.68 -49.87 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 C-N-CA 120.216 -0.594 . . . . 142.96 111.244 -173.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 1.046 HD12 HG13 ' A' ' 72' ' ' VAL 0.278 24.8 pt -64.78 -41.67 92.82 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 C-N-CA 116.933 -1.907 . . . . 158.32 110.878 -175.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.718 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.76 -41.34 98.0 Favored 'General case' 0 N--CA 1.434 -1.273 0 C-N-CA 117.713 -1.595 . . . . 137.11 109.451 178.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.35 -44.6 90.94 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 122.128 -0.358 . . . . 54.66 110.994 -176.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.949 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.38 117.15 29.43 Favored 'General case' 0 CA--C 1.491 -1.323 0 CA-C-O 121.63 0.728 . . . . 127.18 109.572 -174.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 1.097 ' HB3' ' HG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.87 -36.79 80.09 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 124.022 0.929 . . . . 87.93 110.857 -176.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 1.065 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.38 -34.7 78.77 Favored 'General case' 0 CA--C 1.49 -1.356 0 O-C-N 121.623 -0.673 . . . . 131.12 111.467 -175.622 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 1.009 ' HG3' ' CE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.62 69.44 7.13 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 115.34 -2.544 . . . . 246.56 109.583 -175.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 61' ' ' LYS . 9.6 mmp_? -123.2 91.42 3.48 Favored 'General case' 0 CA--C 1.474 -1.974 0 N-CA-C 105.514 -2.032 . . . . 339.35 105.514 177.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.858 ' HG1' ' H ' ' A' ' 68' ' ' ASN . 82.5 p -124.15 165.2 17.96 Favored 'General case' 0 N--CA 1.413 -2.275 0 N-CA-C 102.987 -2.968 . . . . 114.66 102.987 176.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.96 HG22 ' HG1' ' A' ' 147' ' ' THR . 7.7 p -63.07 -39.51 85.51 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.604 0 N-CA-C 106.798 -1.556 . . . . 143.28 106.798 178.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.994 HG21 HD13 ' A' ' 71' ' ' LEU . 95.1 m -59.63 -38.08 80.4 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 108.704 -0.851 . . . . 160.22 108.704 -176.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.858 ' H ' ' HG1' ' A' ' 65' ' ' THR . 86.3 m-20 -62.3 -31.79 72.44 Favored 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 108.918 -0.771 . . . . 120.54 108.918 -177.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.938 ' O ' HG21 ' A' ' 72' ' ' VAL . 89.8 m-85 -63.61 -43.74 96.01 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 109.511 -0.552 . . . . 67.22 109.511 178.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.934 ' CE2' HG23 ' A' ' 66' ' ' VAL . 82.4 m-85 -66.56 -39.77 88.67 Favored 'General case' 0 CA--C 1.498 -1.033 0 O-C-N 121.455 -0.778 . . . . 138.6 109.659 -177.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.994 HD13 HG21 ' A' ' 67' ' ' THR . 10.1 mp -63.52 -35.95 82.17 Favored 'General case' 0 CA--C 1.492 -1.26 0 C-N-CA 122.5 0.32 . . . . 151.46 110.638 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 1.046 HG13 HD12 ' A' ' 57' ' ' ILE . 24.2 m -62.56 -37.98 80.29 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.225 0 C-N-CA 117.445 -1.702 . . . . 117.93 106.69 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.528 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.1 t30 -60.06 -46.01 90.97 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.833 -1.173 . . . . 56.82 107.833 -177.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.911 HD21 ' CE ' ' A' ' 123' ' ' MET . 8.7 mp -61.43 -43.83 98.18 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 108.93 -0.767 . . . . 145.3 108.93 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.13 -40.29 95.42 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 108.493 -0.929 . . . . 45.71 108.493 -175.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -62.48 -41.98 99.16 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 109.356 -0.609 . . . . 105.61 109.356 -178.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.14 -39.46 92.67 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 108.655 -0.869 . . . . 47.89 108.655 -178.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.707 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.55 -37.36 84.83 Favored 'General case' 0 N--CA 1.438 -1.042 0 O-C-N 122.08 -0.388 . . . . 124.53 109.967 179.677 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.9 -41.16 99.33 Favored 'General case' 0 N--CA 1.436 -1.14 0 O-C-N 121.912 -0.492 . . . . 35.89 109.873 -178.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.9 t -62.24 -37.37 85.14 Favored 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 106.988 -1.486 . . . . 88.97 106.988 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.841 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.13 -49.2 76.84 Favored 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 119.813 -0.755 . . . . 239.91 109.041 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.6 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.37 -43.35 91.06 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 121.487 -0.758 . . . . 146.1 110.636 -177.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.2 -58.24 3.4 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 117.374 -1.73 . . . . 91.74 113.843 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -76.49 -61.46 1.95 Allowed 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 115.739 1.755 . . . . 197.45 115.739 -173.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.984 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.23 -42.28 55.67 Favored 'General case' 0 CA--C 1.489 -1.388 0 C-N-CA 117.928 -1.509 . . . . 242.6 114.028 -170.012 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 1.004 HG23 HG23 ' A' ' 43' ' ' VAL . 4.6 t -65.39 -36.51 84.2 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 118.938 -1.105 . . . . 215.61 109.902 -172.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.423 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.8 t -60.39 -46.91 94.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 C-N-CA 120.31 -0.556 . . . . 87.19 110.445 -175.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.895 HG22 ' CD2' ' A' ' 108' ' ' HIS . 63.3 t -65.9 -41.83 90.76 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.124 0 N-CA-C 109.765 -0.457 . . . . 231.82 109.765 -178.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.961 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 11.0 m120 -62.34 -34.16 76.11 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.329 -0.989 . . . . 364.98 108.329 -177.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.658 ' CE1' ' HB3' ' A' ' 36' ' ' ALA . 85.2 t80 -68.12 -44.75 75.42 Favored 'General case' 0 N--CA 1.438 -1.074 0 O-C-N 121.496 -0.752 . . . . 181.63 111.298 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.896 HG21 ' HD2' ' A' ' 95' ' ' HIS . 58.0 m -60.83 -45.83 92.92 Favored 'General case' 0 CA--C 1.478 -1.82 0 N-CA-C 107.424 -1.324 . . . . 269.02 107.424 -175.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 1.07 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.68 -45.04 93.26 Favored 'General case' 0 CA--C 1.468 -2.178 0 C-N-CA 118.626 -1.23 . . . . 562.66 110.054 -179.061 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.855 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.12 -45.21 95.62 Favored 'General case' 0 CA--C 1.478 -1.791 0 C-N-CA 118.712 -1.195 . . . . 446.75 108.107 -167.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.813 HG12 ' CB ' ' A' ' 36' ' ' ALA 0.386 6.0 m -70.55 -26.27 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.768 0 C-N-CA 115.824 -2.35 . . . . 370.05 112.206 -178.75 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.896 ' HD2' HG21 ' A' ' 91' ' ' THR . 89.9 m-70 -74.51 -26.44 60.0 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 121.556 -0.715 . . . . 354.91 112.518 175.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.881 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.4 m-20 82.8 4.47 0.99 Allowed 'General case' 0 CA--C 1.499 -0.988 0 C-N-CA 125.07 1.348 . . . . 462.44 111.93 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.765 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.266 11.9 mm-40 -172.34 178.05 2.92 Favored 'General case' 0 CA--C 1.488 -1.426 0 CA-C-O 122.005 0.907 . . . . 652.37 111.131 171.809 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.83 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.75 86.31 2.18 Favored 'General case' 0 N--CA 1.428 -1.564 0 C-N-CA 128.472 2.709 . . . . 905.99 107.909 -174.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -67.82 -36.43 80.37 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 108.241 -1.022 . . . . 570.43 108.241 -176.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.843 ' HB3' ' CG ' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.59 -36.35 82.45 Favored 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 125.299 1.44 . . . . 453.22 111.147 -174.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 1.003 ' HA2' HG21 ' A' ' 19' ' ' THR . . . 97.55 178.64 33.9 Favored Glycine 0 C--N 1.35 1.324 0 C-N-CA 118.751 -1.69 . . . . 445.63 109.906 177.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.821 ' CD1' ' HG ' ' B' ' 374' ' ' LEU . 89.0 mt -56.37 -41.21 75.84 Favored 'General case' 0 CA--C 1.499 -1.005 0 C-N-CA 125.25 1.42 . . . . 457.72 112.403 -170.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -58.67 -46.92 86.16 Favored 'General case' 0 CA--C 1.485 -1.525 0 C-N-CA 118.64 -1.224 . . . . 340.58 109.3 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.843 ' CG ' ' HB3' ' A' ' 100' ' ' TYR . 88.2 m-85 -68.67 -32.2 71.86 Favored 'General case' 0 N--CA 1.424 -1.774 0 C-N-CA 118.765 -1.174 . . . . 453.6 111.544 -176.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.73 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.04 -40.33 73.33 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 105.972 -1.862 . . . . 541.48 105.972 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.453 ' HD2' ' HA2' ' A' ' 166' ' ' GLY . 27.0 ttpt -65.82 -47.15 76.01 Favored 'General case' 0 CA--C 1.486 -1.484 0 O-C-N 123.945 0.778 . . . . 466.68 110.879 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -61.72 -47.12 86.7 Favored 'General case' 0 N--CA 1.427 -1.605 0 C-N-CA 117.429 -1.709 . . . . 427.34 107.334 -178.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.895 ' CD2' HG22 ' A' ' 88' ' ' VAL . 47.5 m80 -67.07 -36.74 82.69 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 112.441 0.534 . . . . 537.87 112.441 -174.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.584 ' HB2' ' HB3' ' A' ' 180' ' ' CYS . 2.9 t-20 -69.48 -42.6 74.59 Favored 'General case' 0 N--CA 1.433 -1.323 0 C-N-CA 116.821 -1.952 . . . . 422.12 111.611 175.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.914 ' O ' HG21 ' A' ' 113' ' ' ILE . 75.9 t80 -59.1 -50.05 75.55 Favored 'General case' 0 N--CA 1.441 -0.879 0 O-C-N 121.323 -0.861 . . . . 340.17 111.846 -173.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.484 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 61.7 m-85 -65.34 -46.49 70.84 Favored Pre-proline 0 N--CA 1.442 -0.848 0 C-N-CA 119.078 -1.049 . . . . 258.06 111.728 -176.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.984 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.2 Cg_exo -61.54 -31.56 87.44 Favored 'Trans proline' 0 N--CA 1.435 -1.958 0 N-CA-C 115.353 1.251 . . . . 305.71 115.353 176.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.942 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.89 -40.36 76.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 108.739 -0.838 . . . . 252.7 108.739 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.422 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.94 -40.63 94.01 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 107.806 -1.183 . . . . 149.27 107.806 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.95 -44.84 95.92 Favored 'General case' 0 N--CA 1.436 -1.155 0 C-N-CA 120.608 -0.437 . . . . 138.08 111.519 -176.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.752 HG23 ' CZ2' ' A' ' 261' ' ' TRP . 64.9 t -66.91 -42.4 88.88 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.94 0 O-C-N 121.565 -0.71 . . . . 132.89 110.942 -177.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.946 ' CE1' HG22 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.74 -44.65 92.89 Favored 'General case' 0 N--CA 1.433 -1.287 0 C-N-CA 119.748 -0.781 . . . . 193.61 108.923 -177.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.606 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.51 -37.63 84.43 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 122.81 0.444 . . . . 63.83 110.121 -175.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.8 m -64.0 -52.37 59.86 Favored 'General case' 0 N--CA 1.435 -1.221 0 C-N-CA 120.712 -0.395 . . . . 76.4 111.276 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.805 HD11 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -63.01 -41.65 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 N-CA-C 108.157 -1.053 . . . . 171.13 108.157 -174.991 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 1.077 ' HB2' HD12 ' A' ' 154' ' ' ILE . 29.3 m-85 -63.77 -38.57 91.6 Favored 'General case' 0 N--CA 1.433 -1.294 0 O-C-N 121.846 -0.534 . . . . 78.3 110.631 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.554 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.2 t -67.04 -35.79 80.65 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 118.939 -1.104 . . . . 92.36 109.238 -178.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' MET . . . . . 1.088 ' HA ' ' HE1' ' A' ' 123' ' ' MET . 5.9 mmt -62.51 -34.27 76.55 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 108.151 -1.055 . . . . 93.73 108.151 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.976 HG22 HG13 ' A' ' 212' ' ' ILE . 33.2 p -67.45 -41.63 84.39 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.204 -0.998 . . . . 132.74 109.324 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.26 -42.12 94.68 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 107.203 -1.406 . . . . 43.39 107.203 -177.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.865 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 94.4 t -58.41 -42.02 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 N-CA-C 108.582 -0.895 . . . . 59.34 108.582 -178.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.402 ' HB3' ' HB1' ' A' ' 215' ' ' ALA . . . -63.48 -44.07 95.45 Favored 'General case' 0 CA--C 1.497 -1.081 0 O-C-N 121.75 -0.594 . . . . 69.68 110.525 -177.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.468 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.4 t80 -65.5 -42.73 91.81 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.36 -0.978 . . . . 106.98 108.36 -177.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.865 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.39 -35.59 81.39 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 119.622 -0.831 . . . . 147.63 108.937 -177.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.762 ' NH1' ' HE2' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.09 -41.58 99.43 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.533 -0.914 . . . . 190.06 108.533 178.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.963 ' HD2' ' HE3' ' A' ' 132' ' ' MET . 66.3 t80 -61.37 -44.06 97.81 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 108.256 -1.016 . . . . 118.85 108.256 -177.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 1.122 ' HA ' ' HE1' ' A' ' 132' ' ' MET . 4.4 mmt -63.37 -42.65 98.88 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 109.981 -0.377 . . . . 102.5 109.981 -177.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.95 -41.64 95.3 Favored 'General case' 0 CA--C 1.489 -1.383 0 O-C-N 121.813 -0.554 . . . . 89.98 109.839 -176.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.888 ' CD1' HG12 ' A' ' 219' ' ' VAL . 95.3 mt -66.55 -50.7 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.666 0 C-N-CA 118.106 -1.438 . . . . 106.09 110.975 -177.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.801 HD12 ' HE1' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.09 -48.34 38.25 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.091 0 C-N-CA 117.114 -1.834 . . . . 227.74 111.797 -174.787 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.788 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.1 p80 -118.79 100.07 51.06 Favored Pre-proline 0 CA--C 1.486 -1.51 0 C-N-CA 116.249 -2.18 . . . . 262.55 110.07 -175.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.468 ' HD2' ' O ' ' A' ' 135' ' ' ILE . 9.2 Cg_endo -69.63 -10.33 28.39 Favored 'Trans proline' 0 C--N 1.29 -2.548 0 C-N-CA 121.622 1.548 . . . . 210.25 111.366 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.81 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.32 112.07 1.01 Allowed 'General case' 0 CA--C 1.49 -1.34 0 N-CA-C 106.505 -1.665 . . . . 270.58 106.505 -178.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.891 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.87 -39.5 23.44 Favored Pre-proline 0 N--CA 1.431 -1.418 0 CA-C-N 115.355 -0.839 . . . . 129.84 112.295 -175.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.855 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 82.1 Cg_exo -61.43 -26.56 81.39 Favored 'Trans proline' 0 N--CA 1.431 -2.185 0 N-CA-C 116.287 1.611 . . . . 330.71 116.287 -174.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.788 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.02 77.23 7.94 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 114.513 -2.875 . . . . 204.51 107.29 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.879 HD12 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.7 147.41 0.09 Allowed 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.485 -1.302 . . . . 387.41 107.485 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.879 ' N ' HD12 ' A' ' 142' ' ' LEU . 47.5 t -143.71 147.07 33.7 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 118.763 -1.175 . . . . 166.22 109.431 178.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.9 -40.76 87.81 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 107.806 -1.183 . . . . 44.23 107.806 176.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.477 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.3 m -60.25 -39.18 85.87 Favored 'General case' 0 CA--C 1.492 -1.285 0 N-CA-C 108.157 -1.053 . . . . 28.8 108.157 -175.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.642 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.81 -38.76 91.98 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 109.084 -0.71 . . . . 30.29 109.084 -179.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.96 ' HG1' HG22 ' A' ' 66' ' ' VAL . 89.9 m -59.66 -43.01 94.12 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 108.964 -0.754 . . . . 46.11 108.964 -176.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.459 ' HD3' ' HA ' ' A' ' 145' ' ' THR . 0.2 OUTLIER -62.4 -42.18 99.23 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 107.713 -1.217 . . . . 87.33 107.713 -179.682 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.789 ' O ' HG22 ' A' ' 153' ' ' VAL . 96.5 t -61.69 -42.05 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 N-CA-C 107.952 -1.129 . . . . 23.69 107.952 -178.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.8 t -63.18 -44.32 99.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 N-CA-C 109.672 -0.492 . . . . 43.86 109.672 -178.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.933 ' O ' HG23 ' A' ' 154' ' ' ILE . 46.1 mm -61.23 -42.57 93.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 N-CA-C 108.334 -0.987 . . . . 91.13 108.334 -176.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . 0.505 ' O ' HG22 ' A' ' 156' ' ' VAL . 52.1 t -62.56 -37.99 88.3 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 108.712 -0.848 . . . . 65.88 108.712 -178.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.789 HG22 ' O ' ' A' ' 149' ' ' VAL . 95.1 t -62.09 -41.87 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 N-CA-C 109.529 -0.545 . . . . 33.86 109.529 -177.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 1.077 HD12 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.35 -40.32 85.79 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.171 0 N-CA-C 107.576 -1.268 . . . . 146.52 107.576 -176.786 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . 0.773 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.1 m95 -62.9 -38.35 90.57 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 119.483 -0.887 . . . . 75.44 108.849 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 152' ' ' CYS . 98.9 t -60.54 -48.47 88.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 O-C-N 121.073 -1.017 . . . . 43.64 109.699 -177.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.814 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.64 -37.99 89.41 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 109.068 -0.716 . . . . 102.57 109.068 -178.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.01 -41.05 86.79 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.433 -1.321 . . . . 58.16 107.433 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.817 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.12 -32.44 73.83 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 109.045 -0.724 . . . . 121.11 109.045 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.814 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.04 -42.33 85.16 Favored 'General case' 0 CA--C 1.489 -1.404 0 C-N-CA 118.567 -1.253 . . . . 153.15 109.938 -178.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.994 HD12 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.05 -43.72 19.11 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 113.154 -3.419 . . . . 133.67 113.545 173.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.537 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -63.01 -39.88 96.09 Favored 'General case' 0 CA--C 1.49 -1.352 0 O-C-N 120.951 -1.093 . . . . 157.42 112.189 -171.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.519 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.3 t80 -74.45 -36.07 2.43 Favored Pre-proline 0 N--CA 1.436 -1.129 0 N-CA-C 115.056 1.502 . . . . 250.91 115.056 -173.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.519 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.291 52.1 Cg_exo -59.59 -25.43 78.82 Favored 'Trans proline' 0 CA--C 1.489 -1.736 0 N-CA-C 117.968 2.257 . . . . 207.34 117.968 -174.331 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 1.024 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 87.6 mt-30 -61.2 -34.16 74.63 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 106.967 -1.494 . . . . 192.46 106.967 178.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.453 ' HA2' ' HD2' ' A' ' 106' ' ' LYS . . . -64.5 -41.07 98.11 Favored Glycine 0 C--N 1.353 1.513 0 N-CA-C 107.949 -2.06 . . . . 261.0 107.949 177.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.8 159.1 26.03 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 101.466 -3.531 . . . . 491.4 101.466 172.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -59.89 106.76 0.53 Allowed 'General case' 0 CA--C 1.488 -1.422 0 C-N-CA 116.239 -2.184 . . . . 386.1 109.849 -176.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 1.024 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 74.0 m -153.99 -166.6 2.42 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 103.583 -2.747 . . . . 289.8 103.583 -178.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 1.111 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.97 175.47 0.86 Allowed 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 117.748 -1.12 . . . . 402.06 109.555 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.782 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 73.6 p -165.27 177.53 7.54 Favored 'General case' 0 CA--C 1.586 2.363 0 C-N-CA 127.308 2.243 . . . . 690.53 114.912 177.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.572 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 40.0 mm-40 132.33 160.53 0.0 OUTLIER 'General case' 1 C--N 1.43 4.066 1 N-CA-C 123.195 4.517 . . . . 633.62 123.195 162.673 . . . . . . . . 4 3 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.791 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.1 p -85.59 153.85 22.12 Favored 'General case' 0 C--N 1.389 2.283 0 C-N-CA 127.413 2.285 . . . . 617.99 110.886 178.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' MET . . . . . 1.123 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.7 174.37 6.04 Favored Pre-proline 0 C--N 1.363 1.18 0 C-N-CA 130.304 3.442 . . . . 434.98 113.433 -175.433 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 1.123 ' HD2' ' HB3' ' A' ' 174' ' ' MET . 51.8 Cg_endo -44.26 -65.63 0.19 Allowed 'Trans proline' 0 N--CA 1.441 -1.569 0 N-CA-C 122.414 3.967 . . . . 365.88 122.414 -168.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' SER . . . . . 0.787 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.304 70.8 m -84.87 20.92 1.69 Allowed 'General case' 0 CA--C 1.467 -2.249 0 N-CA-C 104.812 -2.292 . . . . 635.81 104.812 178.102 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.774 ' HB3' ' H ' ' A' ' 179' ' ' VAL 0.458 5.0 mmp_? -94.35 152.16 18.85 Favored 'General case' 1 CA--C 1.419 -4.066 3 N-CA-C 131.952 7.76 . . . . 999.99 131.952 -135.714 . . . . . . . . 5 3 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 1.07 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.91 37.0 t -131.84 73.2 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.763 1 CA-C-N 103.288 -6.324 . . . . 594.32 113.611 149.169 . . . . . . . . 4 3 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.774 ' H ' ' HB3' ' A' ' 177' ' ' ARG . 7.4 p -144.2 144.1 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.599 1 N-CA-C 98.285 -4.709 . . . . 811.91 98.285 162.382 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.791 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.8 m -118.49 144.52 45.96 Favored 'General case' 0 CA--C 1.488 -1.409 0 C-N-CA 117.014 -1.874 . . . . 999.99 109.42 -178.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.822 ' HE1' ' CE2' ' A' ' 264' ' ' PHE . 70.7 mmm -147.19 -175.6 4.89 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-O 122.0 0.905 . . . . 431.86 110.055 -177.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 1.061 HD12 ' CD2' ' A' ' 196' ' ' TYR . 11.3 tt -69.15 148.73 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 C-N-CA 124.31 1.044 . . . . 457.18 108.782 -177.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . 0.829 ' HB3' ' HB ' ' A' ' 170' ' ' THR . 3.6 tp10 -77.32 85.44 3.74 Favored 'General case' 0 CA--C 1.5 -0.955 0 C-N-CA 124.155 0.982 . . . . 458.77 113.527 -174.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 1.016 ' CZ3' HG23 ' A' ' 182' ' ' ILE . 1.9 p90 -76.4 -31.57 0.97 Allowed Pre-proline 0 N--CA 1.438 -1.058 0 C-N-CA 124.992 1.317 . . . . 999.99 112.384 168.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.945 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.2 Cg_exo -65.96 -45.77 5.64 Favored 'Trans proline' 0 N--CA 1.438 -1.79 0 N-CA-C 120.883 3.378 . . . . 999.99 120.883 -174.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.557 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 54.9 mt-10 -119.56 171.78 8.12 Favored 'General case' 0 CA--C 1.471 -2.066 0 C-N-CA 117.129 -1.829 . . . . 81.18 107.239 -172.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.841 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.7 p-80 -109.16 45.16 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.865 0 CA-C-O 114.875 -2.488 . . . . 999.99 108.703 177.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 1.061 ' HB2' HD11 ' A' ' 191' ' ' ILE . 88.3 Cg_endo -41.57 101.86 0.04 OUTLIER 'Trans proline' 0 CA--C 1.502 -1.121 1 C-N-CA 126.071 4.514 . . . . 999.99 105.634 -170.745 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -62.28 -44.01 97.5 Favored 'General case' 0 CA--C 1.483 -1.597 0 C-N-CA 126.726 2.01 . . . . 967.72 112.059 -165.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -60.28 -36.55 78.08 Favored 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 106.724 -1.584 . . . . 934.3 106.724 -175.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 1.061 HD11 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.65 -30.16 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 C-N-CA 129.167 2.987 . . . . 565.15 113.925 -178.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 61.54 55.31 2.82 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-N 118.425 0.557 . . . . 755.61 109.903 -175.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 1.111 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.44 -49.29 67.19 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 124.57 1.148 . . . . 325.89 113.26 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.896 ' HG3' ' HH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.8 -44.97 78.31 Favored 'General case' 0 CA--C 1.495 -1.17 0 C-N-CA 123.558 0.743 . . . . 250.21 111.631 -169.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 98.0 t -64.75 -43.28 96.52 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 CA-C-O 121.595 0.712 . . . . 142.46 110.383 -175.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . 1.061 ' CD2' HD12 ' A' ' 182' ' ' ILE . 34.8 t80 -61.19 -41.46 96.85 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 123.985 0.914 . . . . 247.69 108.821 -173.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.891 ' HE2' ' HA ' ' A' ' 269' ' ' LEU . 23.1 t60 -60.55 -51.33 69.89 Favored 'General case' 0 CA--C 1.491 -1.292 0 C-N-CA 125.411 1.484 . . . . 199.61 113.081 -175.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 82.7 mt -65.34 -44.46 94.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 N-CA-C 107.759 -1.201 . . . . 106.73 107.759 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . 0.785 ' O ' HD12 ' A' ' 203' ' ' LEU . 41.7 t -59.17 -48.53 81.27 Favored 'General case' 0 CA--C 1.487 -1.473 0 CA-C-N 115.801 -0.636 . . . . 115.01 110.214 -173.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.994 HG13 HD12 ' A' ' 161' ' ' LEU . 85.6 t -65.25 -49.18 80.31 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.655 0 C-N-CA 119.418 -0.913 . . . . 129.42 111.818 -174.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.814 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.4 m -61.85 -53.12 60.16 Favored 'General case' 0 CA--C 1.483 -1.612 0 C-N-CA 118.228 -1.389 . . . . 172.48 109.968 -172.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.677 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.5 t -63.89 -54.29 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 C-N-CA 120.539 -0.465 . . . . 55.86 110.933 -174.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.785 HD12 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.57 -51.53 59.07 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.56 -1.256 . . . . 184.68 111.489 -174.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . 0.984 ' HB ' HD13 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.62 -52.37 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 C-N-CA 116.637 -2.025 . . . . 291.81 114.757 -174.706 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.432 ' N ' ' CG2' ' A' ' 204' ' ' ILE . 87.8 t80 -82.05 -55.0 4.84 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 115.16 1.541 . . . . 130.66 115.16 -178.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . 0.814 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.8 m-85 -66.88 -48.49 68.61 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 114.515 1.302 . . . . 80.16 114.515 -170.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.928 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.54 -45.5 83.29 Favored Pre-proline 0 N--CA 1.435 -1.196 0 C-N-CA 119.981 -0.688 . . . . 136.02 109.494 -174.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.928 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.8 Cg_exo -64.8 -27.16 59.72 Favored 'Trans proline' 0 N--CA 1.432 -2.105 0 CA-C-N 118.703 0.572 . . . . 92.17 110.622 -179.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.775 HD22 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.3 -41.39 76.82 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 107.501 -1.296 . . . . 135.6 107.501 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.17 -44.7 91.26 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 109.563 -0.532 . . . . 52.1 109.563 -176.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . 0.701 HG13 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.67 -43.54 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 N-CA-C 109.063 -0.718 . . . . 95.89 109.063 -176.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.976 HG13 HG22 ' A' ' 124' ' ' THR . 94.5 mt -61.28 -42.36 93.23 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.398 0 N-CA-C 106.684 -1.599 . . . . 43.41 106.684 -178.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.44 -42.25 99.09 Favored Glycine 0 N--CA 1.432 -1.606 0 N-CA-C 109.376 -1.49 . . . . 27.69 109.376 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . 0.902 ' O ' HG21 ' A' ' 217' ' ' THR . 77.9 t80 -65.66 -47.42 75.59 Favored 'General case' 0 CA--C 1.497 -1.094 0 O-C-N 122.213 -0.581 . . . . 54.41 110.483 -177.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . 0.894 ' O ' HG13 ' A' ' 218' ' ' VAL . . . -61.42 -34.11 74.83 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 106.955 -1.498 . . . . 53.88 106.955 -177.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -60.74 -40.89 94.06 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 108.49 -0.929 . . . . 68.29 108.49 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' THR . . . . . 0.902 HG21 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.67 -39.12 93.12 Favored 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 119.721 -0.792 . . . . 107.59 110.631 -175.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.894 HG13 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.02 -38.39 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 C-N-CA 119.605 -0.838 . . . . 111.61 109.481 -177.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.888 HG12 ' CD1' ' A' ' 134' ' ' ILE . 79.3 t -63.28 -22.48 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.372 -0.973 . . . . 85.26 108.372 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.87 -41.94 99.43 Favored Glycine 0 C--N 1.349 1.265 0 N-CA-C 111.07 -0.812 . . . . 40.71 111.07 -176.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.5 mm -64.76 -44.05 96.47 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 N-CA-C 108.378 -0.971 . . . . 95.86 108.378 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.845 ' CB ' HG22 ' A' ' 134' ' ' ILE . 67.6 p -76.93 -137.52 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 108.434 -0.95 . . . . 144.37 108.434 -176.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.928 HD21 ' NE ' ' A' ' 244' ' ' ARG . 87.6 mt -55.38 132.11 47.38 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 107.573 -1.269 . . . . 326.72 107.573 -177.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' TRP . . . . . 0.461 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.35 -168.05 1.51 Allowed 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 106.013 -1.847 . . . . 158.38 106.013 -176.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . 0.461 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.27 -42.01 99.09 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 109.649 -0.5 . . . . 36.78 109.649 -178.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.6 m -61.06 125.82 25.12 Favored 'General case' 0 N--CA 1.434 -1.271 0 C-N-CA 119.198 -1.001 . . . . 85.46 109.793 -174.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.775 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.89 126.55 8.83 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 105.58 -2.008 . . . . 127.78 105.58 176.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.983 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.04 139.9 34.78 Favored Pre-proline 0 CA--C 1.493 -1.236 0 N-CA-C 105.982 -1.859 . . . . 164.84 105.982 -179.576 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.983 ' N ' HD13 ' A' ' 228' ' ' ILE . 83.4 Cg_exo -56.8 -39.93 87.87 Favored 'Trans proline' 0 N--CA 1.431 -2.16 0 N-CA-C 113.914 0.698 . . . . 222.35 113.914 -175.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . 0.808 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -83.11 167.02 45.01 Favored Glycine 0 N--CA 1.428 -1.899 0 N-CA-C 106.446 -2.662 . . . . 45.22 106.446 178.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.924 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.99 -45.71 93.7 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 106.065 -1.828 . . . . 107.57 106.065 177.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' SER . . . . . 0.736 ' O ' HG21 ' A' ' 228' ' ' ILE . 68.1 m -65.82 141.83 58.15 Favored 'General case' 0 N--CA 1.429 -1.525 0 C-N-CA 118.89 -1.124 . . . . 167.96 109.155 -175.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.873 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.6 m 99.52 106.64 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.219 0 C-N-CA 126.695 1.998 . . . . 280.68 109.761 176.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.779 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.7 m-20 56.05 11.28 0.71 Allowed 'General case' 0 N--CA 1.433 -1.279 0 C-N-CA 124.492 1.117 . . . . 218.25 110.702 174.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.933 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.38 137.64 54.78 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 105.243 -2.132 . . . . 343.57 105.243 177.412 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.584 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.6 t80 -111.99 81.84 1.53 Allowed 'General case' 0 CA--C 1.491 -1.323 0 N-CA-C 106.871 -1.529 . . . . 263.29 106.871 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' HIS . . . . . 0.662 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.4 m-70 104.31 147.09 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 126.607 1.963 . . . . 261.92 108.511 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.25 -38.13 89.94 Favored 'General case' 0 CA--C 1.488 -1.415 0 N-CA-C 107.822 -1.177 . . . . 106.81 107.822 -177.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.758 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.42 -39.92 94.87 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 118.348 -1.341 . . . . 112.2 107.58 -178.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.75 HG13 ' NH1' ' A' ' 244' ' ' ARG . 75.2 t -64.26 -39.81 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 109.285 -0.635 . . . . 45.41 109.285 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.863 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.2 p -70.95 -32.04 68.8 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 110.269 -0.271 . . . . 97.62 110.269 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.43 -39.56 81.5 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 123.65 0.78 . . . . 59.29 110.981 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.758 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.31 -36.47 83.81 Favored 'General case' 0 CA--C 1.491 -1.292 0 C-N-CA 124.655 1.182 . . . . 106.49 110.647 -174.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.933 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -60.0 -30.58 69.23 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 108.331 -0.988 . . . . 106.62 108.331 -176.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.569 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -66.09 -41.0 91.25 Favored 'General case' 0 N--CA 1.436 -1.175 0 O-C-N 121.84 -0.537 . . . . 75.97 110.052 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.879 ' CG1' ' HE3' ' A' ' 250' ' ' MET . 77.0 t -65.55 -40.84 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 C-N-CA 122.957 0.503 . . . . 65.27 109.804 -178.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.837 HG11 ' O ' ' A' ' 244' ' ' ARG . 7.7 p -63.99 -41.58 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 C-N-CA 120.385 -0.526 . . . . 107.94 110.186 -177.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.569 ' HE2' ' HA ' ' A' ' 245' ' ' LYS . 59.2 pttt -63.55 -40.78 97.9 Favored 'General case' 0 N--CA 1.434 -1.259 0 O-C-N 121.679 -0.638 . . . . 87.98 110.31 -176.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' MET . . . . . 1.062 ' HE2' ' CD1' ' A' ' 305' ' ' TYR . 21.3 ttt -63.64 -40.42 96.81 Favored 'General case' 0 N--CA 1.434 -1.247 0 C-N-CA 118.875 -1.13 . . . . 65.5 108.329 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' MET . . . . . 0.879 ' HE3' ' CG1' ' A' ' 246' ' ' VAL . 68.5 mtt -61.73 -36.33 80.66 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 108.169 -1.049 . . . . 85.05 108.169 -177.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.518 HD11 ' HA ' ' A' ' 248' ' ' LYS . 86.7 mt -63.48 -45.76 96.97 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 N-CA-C 109.082 -0.711 . . . . 42.25 109.082 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . 0.877 HG13 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.26 -38.31 82.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 C-N-CA 119.556 -0.858 . . . . 91.01 109.43 -176.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 1.03 HG21 HD11 ' A' ' 304' ' ' ILE . 65.8 t -58.88 -41.48 83.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 N-CA-C 107.998 -1.112 . . . . 66.09 107.998 -178.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 250' ' ' MET . 94.7 t -66.17 -43.12 92.17 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.363 0 O-C-N 122.089 -0.382 . . . . 52.39 110.287 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.4 m -61.73 -46.83 87.96 Favored 'General case' 0 CA--C 1.489 -1.393 0 O-C-N 121.851 -0.531 . . . . 46.42 109.858 -174.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' THR . . . . . 0.822 ' O ' HG23 ' A' ' 259' ' ' ILE . 9.5 t -62.3 -38.1 88.09 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 108.335 -0.987 . . . . 116.51 108.335 -177.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' PHE . . . . . 0.539 ' N ' HG23 ' A' ' 256' ' ' THR . 86.0 t80 -60.32 -48.2 82.78 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.365 -0.606 . . . . 65.18 109.365 -178.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.99 -42.68 97.12 Favored 'General case' 0 CA--C 1.489 -1.385 0 O-C-N 122.107 -0.371 . . . . 51.33 110.429 -175.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . 0.822 HG23 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.6 -43.45 98.21 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 C-N-CA 118.968 -1.093 . . . . 126.3 108.938 -176.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' CYS . . . . . 0.568 ' N ' HG22 ' A' ' 259' ' ' ILE . 69.8 m -65.51 -49.35 69.31 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.524 -0.87 . . . . 133.94 112.513 -176.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.869 ' CH2' ' HB2' ' A' ' 294' ' ' ALA . 97.0 m95 -80.72 -33.34 35.34 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 116.819 2.155 . . . . 134.84 116.819 -176.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.801 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.6 tp -58.43 -41.61 90.17 Favored Pre-proline 0 CA--C 1.493 -1.222 0 CA-C-N 118.641 0.655 . . . . 72.23 111.671 -167.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' PRO . . . . . 0.819 ' O ' HG21 ' A' ' 266' ' ' ILE . 81.3 Cg_exo -60.67 -36.02 86.89 Favored 'Trans proline' 0 C--N 1.294 -2.309 0 CA-C-N 119.822 0.972 . . . . 106.13 111.357 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' PHE . . . . . 0.847 ' CA ' HG21 ' A' ' 290' ' ' ILE . 71.6 t80 -66.32 -44.71 82.61 Favored 'General case' 0 N--CA 1.433 -1.3 0 C-N-CA 119.769 -0.772 . . . . 128.35 110.056 -178.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' HIS . . . . . 0.694 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.4 m-70 -64.41 -37.86 88.99 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 110.244 -0.28 . . . . 100.73 110.244 -177.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.819 HG21 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.29 -44.51 94.92 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 C-N-CA 119.257 -0.977 . . . . 172.72 109.126 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . 0.75 ' HD1' ' O ' ' A' ' 263' ' ' PRO . 61.5 m-85 -66.62 -28.12 68.24 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 108.17 -1.048 . . . . 249.23 108.17 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' PHE . . . . . 0.901 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.52 -55.14 35.37 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 106.698 -1.593 . . . . 259.78 106.698 178.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . 0.891 ' HA ' ' HE2' ' A' ' 197' ' ' HIS . 89.5 mt -69.13 -44.17 72.88 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 113.611 0.967 . . . . 233.11 113.611 -176.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.849 HD12 HD21 ' A' ' 279' ' ' LEU . 88.6 mt -61.4 -48.31 91.28 Favored Pre-proline 0 N--CA 1.44 -0.947 0 C-N-CA 119.13 -1.028 . . . . 169.54 110.567 -171.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . 0.682 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 12.0 Cg_exo -61.05 -24.59 79.8 Favored 'Trans proline' 0 N--CA 1.429 -2.302 0 C-N-CA 116.756 -1.696 . . . . 255.47 114.7 174.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' TYR . . . . . 0.896 ' HH ' ' HG3' ' A' ' 194' ' ' LYS . 19.6 t80 -63.58 -44.22 94.69 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 119.232 0.924 . . . . 279.03 108.874 177.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . 0.835 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.33 -44.76 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 N-CA-C 110.104 -0.332 . . . . 162.21 110.104 -178.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' ASN . . . . . 0.773 ' N ' HD11 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.45 84.88 59.4 Favored Pre-proline 0 N--CA 1.43 -1.432 0 C-N-CA 118.73 -1.188 . . . . 128.13 108.064 -178.078 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.3 Cg_endo -85.3 164.08 11.19 Favored 'Trans proline' 0 C--N 1.295 -2.268 0 N-CA-C 107.44 -1.792 . . . . 278.35 107.44 177.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . 0.85 ' O ' HD22 ' A' ' 277' ' ' LEU . 39.2 t0 66.06 15.06 9.93 Favored 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 123.83 0.706 . . . . 312.91 109.335 175.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.85 HD22 ' O ' ' A' ' 276' ' ' ASP . 28.3 mt -132.69 -170.66 2.48 Favored 'General case' 0 CA--C 1.481 -1.675 0 N-CA-C 106.531 -1.655 . . . . 353.54 106.531 177.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 1.022 ' HA ' ' HB2' ' A' ' 282' ' ' PHE . 42.8 p90 -115.68 142.23 47.03 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 107.398 -1.334 . . . . 251.26 107.398 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.849 HD21 HD12 ' A' ' 270' ' ' LEU . 1.7 tm? -76.98 -118.81 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 102.024 -3.324 . . . . 175.26 102.024 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . 0.776 ' HB3' ' HE3' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.46 -44.97 96.17 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 100.883 -3.747 . . . . 99.07 100.883 172.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . 0.776 ' HE3' ' HB3' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.43 124.18 9.18 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 103.46 -2.793 . . . . 243.21 103.46 171.173 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 1.022 ' HB2' ' HA ' ' A' ' 278' ' ' TYR . 77.3 t80 -92.97 112.99 25.14 Favored 'General case' 0 CA--C 1.473 -1.982 0 C-N-CA 116.007 -2.277 . . . . 201.04 105.265 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' ILE . . . . . 0.767 HG23 ' N ' ' A' ' 285' ' ' GLN . 10.7 tp -147.94 173.72 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.071 0 C-N-CA 116.001 -2.279 . . . . 201.36 108.768 -175.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . 1.067 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.284 0.6 OUTLIER -59.54 -41.42 90.03 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-N 113.243 -1.799 . . . . 203.82 107.864 174.447 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . 0.914 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.26 -45.71 86.89 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 118.226 -1.389 . . . . 215.06 112.576 -171.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.636 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.0 t -65.69 -46.42 89.26 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.473 0 C-N-CA 118.587 -1.245 . . . . 125.28 112.903 -171.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' TYR . . . . . 0.853 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.78 -37.05 86.29 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 107.155 -1.424 . . . . 268.9 107.155 -171.861 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . 0.87 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.16 -45.05 74.56 Favored 'General case' 0 CA--C 1.483 -1.607 0 C-N-CA 125.63 1.572 . . . . 280.88 108.821 -172.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.6 -47.43 86.24 Favored 'General case' 0 CA--C 1.484 -1.564 0 C-N-CA 118.947 -1.101 . . . . 184.47 109.087 -172.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . 0.847 HG21 ' CA ' ' A' ' 264' ' ' PHE . 1.8 mp -67.98 -42.11 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 C-N-CA 119.263 -0.975 . . . . 167.92 112.732 -175.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' MET . . . . . 0.66 ' HE2' ' HG2' ' A' ' 181' ' ' MET . 21.7 ttt -65.72 -38.76 90.07 Favored 'General case' 0 CA--C 1.495 -1.136 0 C-N-CA 117.784 -1.566 . . . . 367.18 110.822 -175.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' TRP . . . . . 0.571 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.4 m95 -67.22 -32.67 73.87 Favored 'General case' 0 N--CA 1.435 -1.197 0 O-C-N 121.872 -0.517 . . . . 173.97 110.448 177.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.4 tp -64.49 -36.71 85.09 Favored 'General case' 0 CA--C 1.499 -0.986 0 C-N-CA 123.509 0.724 . . . . 119.66 109.797 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . 0.869 ' HB2' ' CH2' ' A' ' 261' ' ' TRP . . . -61.23 -34.03 74.46 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 107.711 -1.218 . . . . 112.3 107.711 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' MET . . . . . 0.713 ' O ' HG21 ' A' ' 298' ' ' THR . 21.9 mmt -63.03 -32.11 73.4 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 116.211 -0.45 . . . . 174.17 110.222 -177.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.9 m -64.67 -22.8 67.07 Favored 'General case' 0 CA--C 1.486 -1.507 0 C-N-CA 124.648 1.179 . . . . 145.27 110.606 -175.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' SER . . . . . 0.83 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.7 m -57.67 -35.33 70.41 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 108.043 -1.095 . . . . 170.15 108.043 -175.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.841 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.8 t -55.33 -34.16 63.97 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 116.324 -0.398 . . . . 214.57 110.61 -171.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' MET . . . . . 0.796 ' CE ' ' HG1' ' A' ' 45' ' ' THR . 28.1 ttt -77.16 -33.19 56.58 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 126.108 1.763 . . . . 168.29 115.539 177.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' TYR . . . . . 0.83 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.44 -34.84 79.14 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 114.072 1.138 . . . . 167.15 114.072 -168.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . 0.747 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.283 18.8 p-10 -64.2 -38.31 33.47 Favored Pre-proline 0 N--CA 1.434 -1.253 0 C-N-CA 115.532 -2.467 . . . . 165.13 113.935 -171.619 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' PRO . . . . . 0.747 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 83.9 Cg_exo -62.54 -31.87 79.97 Favored 'Trans proline' 0 N--CA 1.433 -2.048 0 CA-C-N 122.769 2.025 . . . . 123.92 111.28 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' ILE . . . . . 0.787 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.1 pt -68.72 -42.57 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 C-N-CA 118.857 -1.137 . . . . 110.55 109.796 -179.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' ILE . . . . . 1.03 HD11 HG21 ' A' ' 253' ' ' VAL . 31.1 pt -61.09 -40.08 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 108.852 -0.796 . . . . 145.31 108.852 -177.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . 1.062 ' CD1' ' HE2' ' A' ' 249' ' ' MET 0.253 63.1 m-85 -58.1 -48.83 78.97 Favored 'General case' 0 CA--C 1.494 -1.191 0 C-N-CA 119.409 -0.916 . . . . 246.68 109.796 -177.473 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.6 m -62.24 -47.46 84.3 Favored 'General case' 0 CA--C 1.485 -1.539 0 C-N-CA 119.565 -0.854 . . . . 64.43 109.6 -173.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.8 t -66.8 -45.08 79.48 Favored 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 118.973 -1.091 . . . . 80.72 110.227 -177.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.757 HD22 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.41 -35.71 76.0 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 116.034 1.864 . . . . 140.44 116.034 -173.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . 0.62 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.85 132.23 34.32 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 112.692 -3.603 . . . . 178.87 113.048 -177.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . 0.702 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.04 -37.09 86.45 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 114.392 -1.277 . . . . 110.22 110.075 -177.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . 0.852 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 38.9 ttm180 -57.7 -50.62 72.59 Favored 'General case' 0 CA--C 1.492 -1.251 0 O-C-N 121.802 -0.561 . . . . 174.78 109.708 -174.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.978 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.3 m-85 -64.87 -41.67 95.46 Favored 'General case' 0 CA--C 1.484 -1.571 0 N-CA-C 108.262 -1.014 . . . . 161.84 108.262 178.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . 0.478 ' HE ' HD21 ' A' ' 314' ' ' LEU . 57.7 ttp180 -57.38 -50.2 73.72 Favored 'General case' 0 CA--C 1.49 -1.353 0 N-CA-C 109.183 -0.673 . . . . 117.2 109.183 -173.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.841 ' HB3' HD12 ' A' ' 326' ' ' ILE . 3.0 mm? -68.55 -44.1 75.22 Favored 'General case' 0 N--CA 1.434 -1.235 0 C-N-CA 120.355 -0.538 . . . . 112.6 111.03 -177.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . 1.125 ' HA2' ' HD1' ' A' ' 318' ' ' HIS . . . -63.95 -37.52 94.74 Favored Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 110.675 -0.97 . . . . 101.46 110.675 -177.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' PHE . . . . . 0.978 ' CE2' ' HB3' ' A' ' 312' ' ' PHE . 36.7 m-85 -62.16 -45.92 91.29 Favored 'General case' 0 CA--C 1.491 -1.31 0 CA-C-N 118.452 1.126 . . . . 151.49 109.55 -178.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . 0.429 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.19 -36.24 77.17 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 106.922 -1.51 . . . . 142.32 106.922 -175.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' HIS . . . . . 1.125 ' HD1' ' HA2' ' A' ' 315' ' ' GLY . 49.9 m80 -59.85 -41.84 92.33 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 106.846 -1.539 . . . . 109.09 106.846 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.84 -42.42 85.81 Favored 'General case' 0 N--CA 1.435 -1.208 0 O-C-N 122.312 -0.242 . . . . 76.11 111.062 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -61.38 -55.51 30.67 Favored 'General case' 0 CA--C 1.489 -1.374 0 C-N-CA 119.861 -0.736 . . . . 120.24 109.339 -174.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . 0.752 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.4 mtt180 -74.26 131.53 41.28 Favored 'General case' 0 CA--C 1.482 -1.66 0 N-CA-C 102.946 -2.983 . . . . 192.73 102.946 177.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.4 p -59.14 -44.25 92.05 Favored 'General case' 0 CA--C 1.491 -1.296 0 C-N-CA 119.006 -1.078 . . . . 176.29 109.204 -172.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' CYS . . . . . 0.813 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.5 m -79.35 -177.11 0.81 Allowed Pre-proline 0 CA--C 1.488 -1.436 0 N-CA-C 106.239 -1.763 . . . . 69.68 106.239 178.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.8 Cg_exo -59.0 -75.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.382 0 CA-C-O 118.662 -0.641 . . . . 191.05 112.566 176.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' PHE . . . . . 0.813 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.3 m-85 47.49 43.89 16.24 Favored 'General case' 0 CA--C 1.493 -1.245 0 O-C-N 123.612 0.57 . . . . 287.03 109.763 178.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . 0.847 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.1 tt -104.55 78.58 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.474 -1.951 0 C-N-CA 112.988 -3.485 . . . . 292.29 109.854 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' SER . . . . . 0.507 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.1 t -77.43 -152.89 0.05 OUTLIER 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 104.198 -2.519 . . . . 184.57 104.198 178.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.76 8.65 4.91 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 113.064 0.764 . . . . 274.56 113.064 176.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.96 0.89 57.28 Favored Glycine 0 C--N 1.348 1.233 0 C-N-CA 117.792 -2.147 . . . . 268.24 113.496 172.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' ASP . . . . . 0.724 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.8 m-20 51.65 -172.07 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.092 0 CA-C-N 118.673 1.236 . . . . 200.06 110.75 177.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.852 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.91 -33.02 74.76 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 107.854 -1.165 . . . . 114.44 107.854 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' GLU . . . . . 0.601 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.36 46.03 21.72 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 107.589 -1.263 . . . . 263.81 107.589 -177.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' GLY . . . . . 0.651 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.3 -137.36 3.61 Favored Glycine 0 CA--C 1.478 -2.231 1 N-CA-C 102.471 -4.251 . . . . 103.79 102.471 -179.837 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . 0.993 HD21 ' HA ' ' A' ' 337' ' ' LYS . 61.2 mt -88.33 95.68 10.29 Favored 'General case' 0 N--CA 1.419 -1.993 0 C-N-CA 114.892 -2.723 . . . . 117.3 105.995 177.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . 1.067 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.97 -39.76 90.65 Favored 'General case' 0 CA--C 1.468 -2.202 1 N-CA-C 98.023 -4.806 . . . . 231.58 98.023 167.206 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 1.065 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.96 163.48 29.08 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 102.115 -3.291 . . . . 303.24 102.115 168.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' LYS . . . . . 0.993 ' HA ' HD21 ' A' ' 334' ' ' LEU . 84.3 tttt -62.64 -48.6 78.66 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 116.03 -2.268 . . . . 112.72 108.423 179.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' SER . . . . . 0.411 ' HB3' ' SD ' ' A' ' 336' ' ' MET . 47.9 t -61.05 -63.64 1.23 Allowed 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 109.083 -0.71 . . . . 83.22 109.083 -176.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' THR . . . . . 0.91 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 35.9 m -156.27 -126.16 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 103.87 -2.641 . . . . 174.36 103.87 -178.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . 1.067 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.93 160.96 8.89 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 105.771 -1.937 . . . . 202.73 105.771 177.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . 1.029 ' HH ' ' HA3' ' A' ' 315' ' ' GLY . 0.2 OUTLIER -131.97 149.01 52.55 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 107.061 -1.459 . . . . 180.62 107.061 176.422 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . 0.946 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.5 tp -178.45 -171.82 0.27 Allowed 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 105.376 -2.083 . . . . 145.25 105.376 178.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' GLN . . . . . 0.946 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.1 tt0 -66.14 -43.14 87.94 Favored 'General case' 0 CA--C 1.487 -1.446 0 N-CA-C 106.078 -1.823 . . . . 66.05 106.078 174.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' THR . . . . . 0.758 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.71 -152.18 0.48 Allowed 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 103.486 -2.783 . . . . 266.49 103.486 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' GLN . . . . . 0.609 ' CD ' HD23 ' A' ' 342' ' ' LEU . 79.3 mt-30 66.37 -124.88 0.28 Allowed 'General case' 0 CA--C 1.485 -1.545 0 C-N-CA 117.038 -1.865 . . . . 219.2 107.742 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . 1.002 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.16 -37.38 94.01 Favored Glycine 0 N--CA 1.425 -2.063 0 CA-C-N 114.555 -1.202 . . . . 94.78 112.84 -175.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' SER . . . . . 1.097 ' HG ' ' HB3' ' A' ' 61' ' ' LYS . 48.3 t -81.12 100.38 9.02 Favored 'General case' 0 CA--C 1.483 -1.598 0 C-N-CA 112.346 -3.742 . . . . 121.41 109.477 -171.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . 0.671 ' O ' ' HE2' ' A' ' 336' ' ' MET . 94.5 t -73.05 145.47 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 N-CA-C 108.951 -0.759 . . . . 85.34 108.951 -176.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' TYR . . . . . 0.506 ' N ' HG13 ' A' ' 348' ' ' VAL . 48.5 p90 -57.74 143.44 41.88 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 107.826 -1.176 . . . . 267.57 107.826 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . 0.509 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.03 69.61 0.59 Allowed 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 109.514 -0.55 . . . . 226.1 109.514 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' VAL . . . . . 1.045 ' HB ' ' HE1' ' A' ' 336' ' ' MET . 7.5 p -51.0 156.92 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 N-CA-C 106.986 -1.487 . . . . 154.84 106.986 177.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' SER . . . . . 0.504 ' N ' HG23 ' A' ' 351' ' ' VAL . 71.8 m -61.36 161.92 8.54 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.566 0.698 . . . . 180.01 110.732 -173.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' ARG . . . . . 0.882 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.42 156.86 23.73 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 106.971 -1.492 . . . . 333.78 106.971 -178.595 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . 0.989 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.01 142.55 48.71 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 107.371 -1.344 . . . . 335.2 107.371 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.989 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.5 mm-40 82.77 158.9 0.13 Allowed 'General case' 0 CA--C 1.492 -1.281 0 N-CA-C 108.735 -0.839 . . . . 266.47 108.735 179.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.5 m -60.62 -46.85 88.73 Favored 'General case' 0 CA--C 1.488 -1.441 0 N-CA-C 105.653 -1.98 . . . . 59.34 105.653 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.4 t -81.64 173.9 11.91 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 104.376 -2.453 . . . . 201.26 104.376 176.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.782 HG21 ' O ' ' A' ' 360' ' ' THR . 68.9 mt -95.91 106.73 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 C-N-CA 116.308 -2.157 . . . . 56.23 105.548 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' SER . . . . . 0.52 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.9 m -61.23 -59.43 5.33 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 109.326 -0.62 . . . . 87.58 109.326 -175.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' THR . . . . . 0.891 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.1 t -85.47 153.72 22.28 Favored 'General case' 0 CA--C 1.485 -1.533 0 N-CA-C 107.855 -1.165 . . . . 219.95 107.855 -177.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 361' ' ' VAL . 16.0 m -82.01 83.82 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.641 0 C-N-CA 116.324 -2.15 . . . . 121.79 105.448 177.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.623 HG13 ' N ' ' A' ' 363' ' ' GLY . 64.6 t -154.12 159.72 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.575 0 N-CA-C 105.851 -1.907 . . . . 53.85 105.851 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . 0.623 ' N ' HG13 ' A' ' 362' ' ' VAL . . . 72.27 16.57 77.13 Favored Glycine 0 N--CA 1.428 -1.87 0 N-CA-C 106.023 -2.831 . . . . 196.55 106.023 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.674 0 N-CA-C 107.909 -1.145 . . . . 35.88 107.909 -178.949 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 365' ' ' ARG . . . . . 0.516 ' HA ' ' HD3' ' B' ' 365' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 108.884 -0.784 . . . . 1.0 108.884 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 366' ' ' PRO . . . . . 0.779 ' HB3' ' C ' ' A' ' 4' ' ' VAL . 52.8 Cg_endo -66.85 142.01 61.24 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.056 1.837 . . . . 1.0 110.223 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 367' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -64.42 143.24 98.5 Favored Pre-proline 0 C--N 1.325 -0.496 0 C-N-CA 119.841 -0.744 . . . . 1.0 109.595 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 368' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.27 150.38 76.43 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.331 2.021 . . . . 1.0 111.746 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 369' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -70.71 131.8 44.42 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.688 -0.405 . . . . 1.0 110.181 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -102.05 115.88 31.49 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.716 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 371' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -63.69 -42.38 98.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.365 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 372' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -64.96 -36.26 83.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.86 -0.609 . . . . 1.0 110.728 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -59.7 -33.08 76.03 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.819 -0.912 . . . . 1.0 110.819 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 374' ' ' LEU . . . . . 0.821 ' HG ' ' CD1' ' A' ' 102' ' ' LEU . 0.5 OUTLIER -67.82 131.31 45.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.93 0.395 . . . . 1.0 110.213 179.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 375' ' ' MET . . . . . . . . . . . . . 36.8 mmm . . . . . 0 C--O 1.219 -0.534 0 CA-C-O 117.993 -1.003 . . . . 1.0 110.545 -179.778 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.466 0 N-CA-C 108.386 -0.968 . . . . 97.08 108.386 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.429 ' HB3' ' OD1' ' A' ' 276' ' ' ASP . 46.5 t30 -110.61 155.44 22.37 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-O 122.147 0.975 . . . . 123.41 110.711 -172.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.923 HG11 HD13 ' A' ' 15' ' ' ILE . 28.6 m -134.59 -162.41 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.476 1 N-CA-C 100.12 -4.029 . . . . 151.3 100.12 173.697 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.968 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.6 -38.65 59.16 Favored Pre-proline 0 N--CA 1.439 -0.984 0 C-N-CA 115.948 -2.301 . . . . 169.25 106.102 178.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.968 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 59.2 Cg_exo -81.29 168.54 16.63 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 N-CA-C 110.513 -0.61 . . . . 185.76 110.513 171.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.855 HG12 ' CE2' ' A' ' 282' ' ' PHE . 92.2 t -64.45 -25.95 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 C-N-CA 127.012 2.125 . . . . 145.47 110.369 -177.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.713 ' O ' HG21 ' A' ' 4' ' ' VAL . 39.1 t0 -84.26 157.38 21.59 Favored 'General case' 0 N--CA 1.439 -1.005 0 O-C-N 121.08 -1.013 . . . . 102.76 109.53 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.3 p -82.57 154.14 25.15 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 107.985 -1.117 . . . . 106.25 107.985 178.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.923 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 46.7 p-10 -105.88 51.88 0.74 Allowed 'General case' 0 N--CA 1.428 -1.547 0 C-N-CA 117.766 -1.574 . . . . 157.81 107.623 178.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.11 -45.91 91.39 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 103.617 -2.734 . . . . 150.2 103.617 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.458 ' C ' ' H ' ' A' ' 14' ' ' ASN . 70.8 m -87.09 164.69 35.16 Favored Pre-proline 0 N--CA 1.422 -1.84 0 N-CA-C 103.624 -2.732 . . . . 183.52 103.624 172.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -76.76 6.89 3.83 Favored 'Trans proline' 0 C--N 1.282 -2.97 0 N-CA-C 109.957 -0.824 . . . . 235.61 109.957 176.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.458 ' H ' ' C ' ' A' ' 12' ' ' SER . 34.5 t-20 -57.92 -41.27 82.35 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 124.813 1.245 . . . . 113.77 113.395 -170.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.923 HD13 HG11 ' A' ' 4' ' ' VAL . 33.4 pt -52.14 136.21 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-N 119.522 1.055 . . . . 150.85 110.954 -176.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.49 156.26 46.4 Favored 'General case' 0 C--N 1.36 1.061 0 N-CA-C 107.622 -1.251 . . . . 100.42 107.622 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 1.031 HG21 ' H ' ' A' ' 20' ' ' SER . 14.2 t -64.96 142.62 58.37 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 121.99 0.9 . . . . 129.36 110.43 -174.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.765 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.13 -25.51 68.39 Favored 'General case' 0 CA--C 1.493 -1.221 0 C-N-CA 126.328 1.851 . . . . 112.34 106.63 -177.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 1.008 HG21 ' HA2' ' A' ' 101' ' ' GLY . 85.9 m -74.18 -40.08 62.76 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 115.575 -0.739 . . . . 131.73 111.724 177.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 1.031 ' H ' HG21 ' A' ' 17' ' ' THR . 70.9 m -84.52 -42.79 15.17 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 116.985 2.217 . . . . 80.49 116.985 -174.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.526 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.5 mt-10 -145.99 174.56 3.33 Favored Pre-proline 0 N--CA 1.442 -0.848 0 C-N-CA 118.176 -1.409 . . . . 98.98 111.216 -169.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.88 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.332 85.4 Cg_exo -61.84 -10.74 18.23 Favored 'Trans proline' 0 C--N 1.322 -0.868 1 N-CA-C 128.922 6.47 . . . . 246.95 128.922 -170.091 . . . . . . . . 4 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.676 HD22 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.7 17.46 8.72 Favored 'General case' 0 C--N 1.324 -0.512 1 CA-C-N 126.175 4.079 . . . . 269.62 114.213 175.628 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.582 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.6 mt-30 -67.09 -27.34 67.27 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 107.782 -1.192 . . . . 86.8 107.782 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.501 ' CE1' ' CG2' ' A' ' 26' ' ' VAL . 50.4 p90 -66.76 -29.33 69.27 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 121.153 -0.967 . . . . 85.91 110.549 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.889 HG11 ' OE1' ' A' ' 284' ' ' GLN . 40.3 t -68.51 -40.25 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 C-N-CA 123.706 0.803 . . . . 82.0 111.333 -177.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.929 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.4 167.71 12.52 Favored Pre-proline 0 CA--C 1.488 -1.407 0 N-CA-C 108.55 -0.907 . . . . 120.73 108.55 -178.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.844 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.6 Cg_endo -64.04 149.77 89.77 Favored 'Trans proline' 0 N--CA 1.432 -2.106 0 C-N-CA 120.638 0.892 . . . . 87.86 109.89 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.819 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.07 -37.94 89.2 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 108.808 -0.812 . . . . 36.46 108.808 -176.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.841 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 28.0 p-90 -63.84 -33.86 76.62 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 107.757 -1.201 . . . . 150.6 107.757 -176.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.929 ' OE1' ' HB2' ' A' ' 27' ' ' GLN . 80.5 mt-30 -62.23 -32.66 73.37 Favored 'General case' 0 CA--C 1.49 -1.351 0 O-C-N 121.272 -0.893 . . . . 123.26 108.686 -178.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.856 HG23 ' O ' ' A' ' 93' ' ' ALA . 1.7 mp -61.49 -47.13 94.84 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 N-CA-C 109.188 -0.671 . . . . 120.14 109.188 176.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 30' ' ' TRP . 20.3 m -67.47 -30.96 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 N-CA-C 107.868 -1.16 . . . . 112.19 107.868 -178.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.841 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.5 tp -63.02 -47.11 84.5 Favored 'General case' 0 N--CA 1.433 -1.323 0 C-N-CA 119.895 -0.722 . . . . 60.87 109.623 -178.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.688 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.01 -35.68 81.2 Favored 'General case' 0 CA--C 1.489 -1.402 0 C-N-CA 119.952 -0.699 . . . . 157.57 110.349 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.816 ' CB ' HG12 ' A' ' 94' ' ' VAL . . . -62.63 -40.86 98.34 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 108.638 -0.875 . . . . 47.06 108.638 178.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.842 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.81 -41.28 97.92 Favored 'General case' 0 CA--C 1.496 -1.115 0 O-C-N 121.724 -0.61 . . . . 43.94 109.522 -177.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.768 ' O ' HG21 ' A' ' 41' ' ' VAL . . . -61.84 -43.25 99.22 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 108.752 -0.833 . . . . 42.61 108.752 -176.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.962 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.4 -41.22 93.9 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 116.649 -0.25 . . . . 140.66 111.059 -178.42 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.842 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.86 -43.93 97.86 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 118.588 -1.245 . . . . 116.04 110.214 -175.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.768 HG21 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.45 -38.72 83.16 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.28 0 N-CA-C 108.73 -0.841 . . . . 97.16 108.73 -177.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.918 HD11 ' HD1' ' A' ' 39' ' ' TYR . 93.3 mt -61.31 -40.03 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 N-CA-C 108.956 -0.757 . . . . 54.85 108.956 -176.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 1.009 HG23 HG23 ' A' ' 86' ' ' THR . 92.7 t -57.72 -42.31 81.42 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.302 0 N-CA-C 108.848 -0.797 . . . . 45.39 108.848 -175.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.401 ' O ' HG22 ' A' ' 48' ' ' VAL . 97.2 t -63.55 -50.98 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 C-N-CA 118.839 -1.144 . . . . 48.64 110.162 -177.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.799 ' HG1' ' CE ' ' A' ' 299' ' ' MET . 10.6 t -65.23 -47.08 78.06 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 120.197 -0.601 . . . . 116.65 111.694 -174.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.642 ' N ' HG23 ' A' ' 45' ' ' THR . 50.8 m -61.98 -43.88 97.9 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 109.73 -0.471 . . . . 51.16 109.73 -174.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 43' ' ' VAL . 97.1 t -65.63 -48.86 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 C-N-CA 119.846 -0.741 . . . . 44.3 110.818 -176.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.875 ' O ' HG22 ' A' ' 52' ' ' VAL . 94.0 t -64.75 -46.97 90.54 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 C-N-CA 120.291 -0.564 . . . . 48.82 111.068 -174.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.73 -44.2 95.2 Favored Glycine 0 N--CA 1.437 -1.299 0 C-N-CA 120.515 -0.85 . . . . 58.7 112.021 -174.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -72.55 -34.28 67.41 Favored 'General case' 0 CA--C 1.488 -1.436 0 O-C-N 122.061 -0.67 . . . . 101.4 111.072 -175.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.813 HG11 ' O ' ' A' ' 48' ' ' VAL . 8.4 p -66.83 -38.77 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 107.73 -1.211 . . . . 103.57 107.73 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.875 HG22 ' O ' ' A' ' 48' ' ' VAL . 72.0 t -61.44 -43.01 96.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 N-CA-C 108.974 -0.75 . . . . 61.89 108.974 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.637 ' O ' HG21 ' A' ' 56' ' ' ILE . 81.6 t -63.5 -50.93 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 109.437 -0.579 . . . . 70.01 109.437 -178.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.718 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.98 -43.35 99.02 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 109.122 -0.696 . . . . 132.1 109.122 -176.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.675 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.1 t-105 -64.23 -46.63 82.96 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 116.666 -0.243 . . . . 104.5 110.434 -176.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.901 HD11 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.69 -49.88 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 C-N-CA 120.194 -0.602 . . . . 142.96 111.235 -173.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 1.045 HD12 HG13 ' A' ' 72' ' ' VAL 0.278 24.8 pt -64.78 -41.68 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.707 0 C-N-CA 116.904 -1.919 . . . . 158.32 110.905 -175.973 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.718 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.69 -41.32 98.16 Favored 'General case' 0 N--CA 1.433 -1.308 0 C-N-CA 117.701 -1.599 . . . . 137.11 109.527 178.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.39 -44.53 91.03 Favored 'General case' 0 N--CA 1.436 -1.141 0 O-C-N 122.147 -0.346 . . . . 54.66 111.024 -176.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.949 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.42 117.1 29.39 Favored 'General case' 0 CA--C 1.491 -1.294 0 CA-C-O 121.576 0.703 . . . . 127.18 109.586 -174.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 1.106 ' HB3' ' HG ' ' A' ' 347' ' ' SER . 84.3 tttt -60.81 -36.87 80.13 Favored 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 124.072 0.949 . . . . 87.93 110.819 -176.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 1.06 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.34 -34.66 78.66 Favored 'General case' 0 CA--C 1.49 -1.355 0 O-C-N 121.636 -0.665 . . . . 131.12 111.541 -175.63 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 1.013 ' HG3' ' CE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.67 69.49 7.2 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 115.311 -2.556 . . . . 246.56 109.555 -175.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 61' ' ' LYS . 9.6 mmp_? -123.27 91.44 3.48 Favored 'General case' 0 CA--C 1.473 -1.987 0 N-CA-C 105.495 -2.039 . . . . 339.35 105.495 177.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.86 ' HG1' ' H ' ' A' ' 68' ' ' ASN . 82.6 p -124.18 165.29 17.84 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 102.986 -2.968 . . . . 114.66 102.986 176.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.956 HG22 ' HG1' ' A' ' 147' ' ' THR . 7.7 p -63.14 -39.44 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 N-CA-C 106.773 -1.566 . . . . 143.28 106.773 178.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.986 HG21 HD13 ' A' ' 71' ' ' LEU . 95.4 m -59.75 -37.99 80.52 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 108.652 -0.87 . . . . 160.22 108.652 -176.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.86 ' H ' ' HG1' ' A' ' 65' ' ' THR . 86.3 m-20 -62.36 -31.77 72.47 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 108.86 -0.793 . . . . 120.54 108.86 -177.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.938 ' O ' HG21 ' A' ' 72' ' ' VAL . 89.9 m-85 -63.6 -43.77 95.96 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.523 -0.547 . . . . 67.22 109.523 178.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.934 ' CE2' HG23 ' A' ' 66' ' ' VAL . 82.4 m-85 -66.6 -39.72 88.52 Favored 'General case' 0 CA--C 1.498 -1.041 0 O-C-N 121.487 -0.758 . . . . 138.6 109.639 -177.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.986 HD13 HG21 ' A' ' 67' ' ' THR . 10.1 mp -63.62 -35.87 81.96 Favored 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 122.435 0.294 . . . . 151.46 110.639 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 1.045 HG13 HD12 ' A' ' 57' ' ' ILE . 24.0 m -62.54 -37.96 80.2 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.228 0 C-N-CA 117.41 -1.716 . . . . 117.93 106.732 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.528 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.0 t30 -60.11 -46.04 90.96 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 107.839 -1.171 . . . . 56.82 107.839 -177.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.912 HD21 ' CE ' ' A' ' 123' ' ' MET . 8.6 mp -61.33 -43.87 98.14 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 109.005 -0.739 . . . . 145.3 109.005 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.09 -40.33 95.49 Favored 'General case' 0 CA--C 1.492 -1.256 0 N-CA-C 108.5 -0.926 . . . . 45.71 108.5 -175.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -62.43 -42.01 99.13 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 109.346 -0.613 . . . . 105.61 109.346 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.14 -39.44 92.62 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 108.667 -0.864 . . . . 47.89 108.667 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.706 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.56 -37.38 84.84 Favored 'General case' 0 N--CA 1.439 -1.014 0 O-C-N 122.059 -0.401 . . . . 124.53 109.969 179.662 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.81 -41.29 99.24 Favored 'General case' 0 CA--C 1.496 -1.116 0 O-C-N 121.991 -0.443 . . . . 35.89 109.858 -178.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.7 t -62.14 -37.34 84.79 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 107.052 -1.462 . . . . 88.97 107.052 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.841 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.7 ttm -62.2 -49.19 76.76 Favored 'General case' 0 N--CA 1.428 -1.571 0 C-N-CA 119.816 -0.754 . . . . 239.91 109.03 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.599 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.37 -43.43 90.8 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 121.532 -0.73 . . . . 146.1 110.56 -177.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.13 -58.22 3.41 Favored 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 117.416 -1.714 . . . . 91.74 113.888 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -76.54 -61.41 1.97 Allowed 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 115.75 1.759 . . . . 197.45 115.75 -173.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.981 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.24 -42.23 55.72 Favored 'General case' 0 CA--C 1.49 -1.357 0 C-N-CA 117.876 -1.53 . . . . 242.6 114.061 -170.02 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 1.009 HG23 HG23 ' A' ' 43' ' ' VAL . 4.6 t -65.39 -36.59 84.42 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 118.941 -1.103 . . . . 215.61 109.812 -172.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.421 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.4 t -60.31 -46.95 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 O-C-N 121.824 -0.548 . . . . 87.19 110.426 -175.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.892 HG22 ' CD2' ' A' ' 108' ' ' HIS . 63.7 t -65.94 -41.84 90.67 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.098 0 N-CA-C 109.727 -0.471 . . . . 231.82 109.727 -178.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.962 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 11.0 m120 -62.33 -34.11 76.0 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 108.365 -0.976 . . . . 364.98 108.365 -177.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.658 ' CE1' ' HB3' ' A' ' 36' ' ' ALA . 85.0 t80 -68.16 -44.76 75.27 Favored 'General case' 0 N--CA 1.438 -1.07 0 O-C-N 121.56 -0.713 . . . . 181.63 111.271 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.899 HG21 ' HD2' ' A' ' 95' ' ' HIS . 57.6 m -60.85 -45.8 93.1 Favored 'General case' 0 CA--C 1.477 -1.831 0 N-CA-C 107.438 -1.319 . . . . 269.02 107.438 -175.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 1.073 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.74 -45.01 93.53 Favored 'General case' 0 N--CA 1.416 -2.165 0 C-N-CA 118.683 -1.207 . . . . 562.66 110.037 -179.056 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.856 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.08 -45.31 95.24 Favored 'General case' 0 CA--C 1.479 -1.768 0 C-N-CA 118.697 -1.201 . . . . 446.75 108.042 -167.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.816 HG12 ' CB ' ' A' ' 36' ' ' ALA 0.387 6.1 m -70.5 -26.28 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.752 0 C-N-CA 115.819 -2.352 . . . . 370.05 112.244 -178.72 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.899 ' HD2' HG21 ' A' ' 91' ' ' THR . 90.0 m-70 -74.46 -26.54 60.1 Favored 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 121.592 -0.692 . . . . 354.91 112.469 175.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.88 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.4 m-20 82.85 4.51 0.98 Allowed 'General case' 0 CA--C 1.5 -0.951 0 C-N-CA 125.044 1.338 . . . . 462.44 111.881 -178.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.765 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.267 11.9 mm-40 -172.36 178.06 2.91 Favored 'General case' 0 CA--C 1.488 -1.409 0 CA-C-O 122.025 0.916 . . . . 652.37 111.122 171.813 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.831 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.72 86.31 2.17 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 128.516 2.726 . . . . 905.99 107.924 -174.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -67.9 -36.43 80.19 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 108.217 -1.031 . . . . 570.43 108.217 -176.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.845 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.58 -36.34 82.38 Favored 'General case' 0 N--CA 1.427 -1.586 0 C-N-CA 125.361 1.464 . . . . 453.22 111.152 -174.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 1.008 ' HA2' HG21 ' A' ' 19' ' ' THR . . . 97.55 178.69 33.89 Favored Glycine 0 C--N 1.349 1.266 0 C-N-CA 118.777 -1.678 . . . . 445.63 109.854 177.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.1 mt -56.38 -41.23 75.89 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 125.257 1.423 . . . . 457.72 112.377 -170.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -58.71 -46.86 86.39 Favored 'General case' 0 CA--C 1.484 -1.56 0 C-N-CA 118.622 -1.231 . . . . 340.58 109.281 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.845 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.2 m-85 -68.72 -32.14 71.72 Favored 'General case' 0 N--CA 1.423 -1.778 0 C-N-CA 118.784 -1.166 . . . . 453.6 111.576 -176.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.728 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.2 t -56.08 -40.32 73.44 Favored 'General case' 0 CA--C 1.488 -1.441 0 N-CA-C 105.948 -1.871 . . . . 541.48 105.948 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.452 ' HD2' ' HA2' ' A' ' 166' ' ' GLY . 27.0 ttpt -65.87 -47.17 75.79 Favored 'General case' 0 CA--C 1.485 -1.532 0 O-C-N 123.959 0.787 . . . . 466.68 110.869 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -61.63 -47.14 86.74 Favored 'General case' 0 N--CA 1.427 -1.621 0 C-N-CA 117.501 -1.68 . . . . 427.34 107.361 -178.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.892 ' CD2' HG22 ' A' ' 88' ' ' VAL . 47.5 m80 -67.05 -36.77 82.78 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 112.456 0.539 . . . . 537.87 112.456 -174.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.583 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.38 -42.68 74.83 Favored 'General case' 0 N--CA 1.432 -1.344 0 C-N-CA 116.884 -1.926 . . . . 422.12 111.608 175.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.913 ' O ' HG21 ' A' ' 113' ' ' ILE . 75.9 t80 -59.1 -50.08 75.41 Favored 'General case' 0 CA--C 1.501 -0.909 0 O-C-N 121.342 -0.849 . . . . 340.17 111.815 -173.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.484 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 61.6 m-85 -65.32 -46.48 71.03 Favored Pre-proline 0 N--CA 1.443 -0.816 0 C-N-CA 119.1 -1.04 . . . . 258.06 111.696 -176.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.981 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.1 Cg_exo -61.57 -31.54 87.24 Favored 'Trans proline' 0 N--CA 1.435 -1.925 0 N-CA-C 115.341 1.246 . . . . 305.71 115.341 176.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.944 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.87 -40.45 76.54 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.363 0 N-CA-C 108.686 -0.857 . . . . 252.7 108.686 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.422 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.93 -40.57 93.76 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 107.825 -1.176 . . . . 149.27 107.825 -179.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.99 -44.84 95.88 Favored 'General case' 0 N--CA 1.436 -1.165 0 C-N-CA 120.614 -0.434 . . . . 138.08 111.497 -176.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.753 HG23 ' CZ2' ' A' ' 261' ' ' TRP . 65.2 t -66.94 -42.34 88.7 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.944 0 O-C-N 121.604 -0.685 . . . . 132.89 110.969 -177.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.944 ' CE2' HG13 ' A' ' 113' ' ' ILE . 26.6 m-85 -63.76 -44.7 92.69 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 108.871 -0.788 . . . . 193.61 108.871 -177.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.605 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.43 -37.71 84.5 Favored 'General case' 0 N--CA 1.435 -1.177 0 C-N-CA 122.811 0.445 . . . . 63.83 110.094 -175.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 72.0 m -63.95 -52.46 59.64 Favored 'General case' 0 N--CA 1.435 -1.194 0 O-C-N 122.031 -0.418 . . . . 76.4 111.221 -177.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.809 HD11 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.96 -41.7 93.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 108.179 -1.045 . . . . 171.13 108.179 -174.963 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 1.069 ' HB2' HD12 ' A' ' 154' ' ' ILE . 29.2 m-85 -63.79 -38.53 91.46 Favored 'General case' 0 N--CA 1.433 -1.3 0 O-C-N 121.839 -0.538 . . . . 78.3 110.631 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.553 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.5 t -67.11 -35.73 80.4 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 118.854 -1.138 . . . . 92.36 109.229 -178.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' MET . . . . . 1.093 ' HA ' ' HE1' ' A' ' 123' ' ' MET . 5.9 mmt -62.47 -34.27 76.49 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 108.218 -1.03 . . . . 93.73 108.218 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.974 HG22 HG13 ' A' ' 212' ' ' ILE . 32.9 p -67.38 -41.72 84.58 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.209 -0.996 . . . . 132.74 109.302 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.28 -42.04 94.59 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 107.2 -1.408 . . . . 43.39 107.2 -177.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.866 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.0 t -58.48 -41.95 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 N-CA-C 108.606 -0.887 . . . . 59.34 108.606 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.404 ' HB3' ' HB1' ' A' ' 215' ' ' ALA . . . -63.55 -44.07 95.23 Favored 'General case' 0 CA--C 1.498 -1.039 0 O-C-N 121.844 -0.535 . . . . 69.68 110.474 -177.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.468 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.3 t80 -65.44 -42.8 92.01 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 108.313 -0.995 . . . . 106.98 108.313 -177.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.866 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.34 -35.58 81.35 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 119.632 -0.827 . . . . 147.63 108.982 -177.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.766 ' NH1' ' HE2' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.16 -41.52 99.26 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 108.562 -0.903 . . . . 190.06 108.562 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.964 ' HD2' ' HE3' ' A' ' 132' ' ' MET . 66.4 t80 -61.34 -44.12 97.72 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.253 -1.017 . . . . 118.85 108.253 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 1.114 ' HA ' ' HE1' ' A' ' 132' ' ' MET . 4.4 mmt -63.36 -42.66 98.9 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 109.979 -0.378 . . . . 102.5 109.979 -177.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.91 -41.7 95.35 Favored 'General case' 0 CA--C 1.489 -1.399 0 O-C-N 121.817 -0.552 . . . . 89.98 109.836 -176.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.888 ' CD1' HG12 ' A' ' 219' ' ' VAL . 95.4 mt -66.52 -50.7 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.719 0 C-N-CA 118.103 -1.439 . . . . 106.09 110.997 -177.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.798 HD12 ' HE1' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.03 -48.37 38.49 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.13 0 C-N-CA 117.092 -1.843 . . . . 227.74 111.824 -174.824 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.791 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 23.9 p80 -118.85 100.11 50.98 Favored Pre-proline 0 CA--C 1.486 -1.503 0 C-N-CA 116.26 -2.176 . . . . 262.55 110.061 -175.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.469 ' HD2' ' O ' ' A' ' 135' ' ' ILE . 9.2 Cg_endo -69.63 -10.35 28.45 Favored 'Trans proline' 0 C--N 1.289 -2.574 0 C-N-CA 121.607 1.538 . . . . 210.25 111.327 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.806 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.35 112.04 1.01 Allowed 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 106.483 -1.673 . . . . 270.58 106.483 -178.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.886 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.2 tt0 -66.77 -39.53 24.48 Favored Pre-proline 0 N--CA 1.431 -1.425 0 CA-C-N 115.329 -0.851 . . . . 129.84 112.362 -176.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.85 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 82.3 Cg_exo -61.36 -26.57 81.72 Favored 'Trans proline' 0 N--CA 1.431 -2.176 0 N-CA-C 116.322 1.624 . . . . 330.71 116.322 -174.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.791 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.07 77.24 7.99 Favored 'General case' 0 N--CA 1.429 -1.514 0 C-N-CA 114.47 -2.892 . . . . 204.51 107.3 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.875 HD12 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.68 147.38 0.09 Allowed 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.482 -1.303 . . . . 387.41 107.482 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.875 ' N ' HD12 ' A' ' 142' ' ' LEU . 47.3 t -143.68 147.0 33.64 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 118.824 -1.151 . . . . 166.22 109.515 178.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.8 -40.77 88.21 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 107.869 -1.159 . . . . 44.23 107.869 176.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.475 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.7 m -60.33 -39.08 85.8 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 108.181 -1.044 . . . . 28.8 108.181 -175.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.642 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.86 -38.75 92.06 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 109.087 -0.708 . . . . 30.29 109.087 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.956 ' HG1' HG22 ' A' ' 66' ' ' VAL . 90.3 m -59.62 -43.03 93.94 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 109.011 -0.737 . . . . 46.11 109.011 -176.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.459 ' HD3' ' HA ' ' A' ' 145' ' ' THR . 0.2 OUTLIER -62.46 -42.12 99.25 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 107.7 -1.222 . . . . 87.33 107.7 -179.654 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.791 ' O ' HG22 ' A' ' 153' ' ' VAL . 96.4 t -61.71 -42.06 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.359 0 N-CA-C 107.874 -1.158 . . . . 23.69 107.874 -178.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.8 t -63.2 -44.26 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 N-CA-C 109.73 -0.47 . . . . 43.86 109.73 -178.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.933 ' O ' HG23 ' A' ' 154' ' ' ILE . 46.1 mm -61.24 -42.54 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 108.359 -0.978 . . . . 91.13 108.359 -176.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . 0.506 ' O ' HG22 ' A' ' 156' ' ' VAL . 52.3 t -62.62 -37.95 88.31 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 108.735 -0.839 . . . . 65.88 108.735 -178.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.791 HG22 ' O ' ' A' ' 149' ' ' VAL . 95.5 t -62.1 -41.88 92.89 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 109.552 -0.536 . . . . 33.86 109.552 -177.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 1.069 HD12 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.37 -40.37 85.97 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.159 0 N-CA-C 107.583 -1.266 . . . . 146.52 107.583 -176.791 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . 0.773 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.1 m95 -62.84 -38.35 90.43 Favored 'General case' 0 N--CA 1.428 -1.538 0 C-N-CA 119.502 -0.879 . . . . 75.44 108.942 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 152' ' ' CYS . 98.9 t -60.5 -48.42 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 O-C-N 121.058 -1.026 . . . . 43.64 109.749 -177.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.814 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.65 -38.05 89.67 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 109.041 -0.726 . . . . 102.57 109.041 -178.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.99 -41.06 86.7 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.433 -1.321 . . . . 58.16 107.433 -178.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.822 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.08 -32.55 73.95 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.014 -0.736 . . . . 121.11 109.014 178.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.814 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.0 -42.3 84.92 Favored 'General case' 0 CA--C 1.489 -1.381 0 C-N-CA 118.554 -1.258 . . . . 153.15 109.966 -178.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 1.0 HD12 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.09 -43.71 19.07 Favored 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 113.06 -3.456 . . . . 133.67 113.532 173.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.536 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -63.0 -39.83 95.96 Favored 'General case' 0 CA--C 1.49 -1.344 0 O-C-N 120.888 -1.132 . . . . 157.42 112.196 -171.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.519 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.3 t80 -74.51 -36.08 2.4 Favored Pre-proline 0 N--CA 1.437 -1.112 0 N-CA-C 114.974 1.472 . . . . 250.91 114.974 -173.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.519 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.293 53.0 Cg_exo -59.53 -25.46 78.83 Favored 'Trans proline' 0 CA--C 1.488 -1.817 0 N-CA-C 118.043 2.286 . . . . 207.34 118.043 -174.37 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 1.022 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 87.7 mt-30 -61.18 -34.23 74.71 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 106.953 -1.499 . . . . 192.46 106.953 178.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.452 ' HA2' ' HD2' ' A' ' 106' ' ' LYS . . . -64.46 -41.07 98.16 Favored Glycine 0 C--N 1.353 1.513 0 N-CA-C 107.974 -2.05 . . . . 261.0 107.974 177.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.78 159.07 26.02 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 101.548 -3.501 . . . . 491.4 101.548 172.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -59.92 106.79 0.53 Allowed 'General case' 0 CA--C 1.488 -1.42 0 C-N-CA 116.282 -2.167 . . . . 386.1 109.831 -176.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 1.022 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 74.0 m -154.05 -166.61 2.42 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 103.553 -2.758 . . . . 289.8 103.553 -178.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 1.103 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.1 p -62.91 175.44 0.86 Allowed 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 117.723 -1.132 . . . . 402.06 109.554 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.783 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 72.5 p -165.3 177.5 7.54 Favored 'General case' 0 CA--C 1.587 2.383 0 C-N-CA 127.309 2.243 . . . . 690.53 114.927 177.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.57 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.8 mm-40 132.32 160.57 0.0 OUTLIER 'General case' 1 C--N 1.428 4.007 1 N-CA-C 123.183 4.512 . . . . 633.62 123.183 162.691 . . . . . . . . 4 3 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.79 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.4 p -85.68 153.82 22.08 Favored 'General case' 0 C--N 1.389 2.313 0 C-N-CA 127.373 2.269 . . . . 617.99 110.874 178.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' MET . . . . . 1.118 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.66 174.45 5.93 Favored Pre-proline 0 C--N 1.364 1.233 0 C-N-CA 130.284 3.433 . . . . 434.98 113.387 -175.365 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 1.118 ' HD2' ' HB3' ' A' ' 174' ' ' MET . 52.9 Cg_endo -44.31 -65.63 0.19 Allowed 'Trans proline' 0 N--CA 1.441 -1.576 0 N-CA-C 122.386 3.956 . . . . 365.88 122.386 -168.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' SER . . . . . 0.787 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.306 70.4 m -84.91 20.94 1.7 Allowed 'General case' 0 CA--C 1.466 -2.257 0 N-CA-C 104.807 -2.294 . . . . 635.81 104.807 178.147 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.775 ' HB3' ' H ' ' A' ' 179' ' ' VAL 0.457 5.0 mmp_? -94.33 152.24 18.8 Favored 'General case' 1 CA--C 1.419 -4.081 3 N-CA-C 132.031 7.789 . . . . 999.99 132.031 -135.787 . . . . . . . . 5 3 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 1.073 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.912 37.3 t -131.83 73.12 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.383 -3.8 1 CA-C-N 103.343 -6.299 . . . . 594.32 113.606 149.235 . . . . . . . . 4 3 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.775 ' H ' ' HB3' ' A' ' 177' ' ' ARG . 7.3 p -144.16 144.14 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.603 1 N-CA-C 98.244 -4.724 . . . . 811.91 98.244 162.404 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.79 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.9 m -118.48 144.49 45.97 Favored 'General case' 0 CA--C 1.489 -1.391 0 C-N-CA 117.099 -1.84 . . . . 999.99 109.429 -178.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.822 ' HE1' ' CE2' ' A' ' 264' ' ' PHE . 70.9 mmm -147.17 -175.6 4.89 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 122.019 0.914 . . . . 431.86 110.069 -177.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 1.061 HD12 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.11 148.65 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 C-N-CA 124.397 1.079 . . . . 457.18 108.796 -177.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . 0.827 ' HB3' ' HB ' ' A' ' 170' ' ' THR . 3.6 tp10 -77.31 85.41 3.74 Favored 'General case' 0 CA--C 1.5 -0.944 0 C-N-CA 124.147 0.979 . . . . 458.77 113.515 -174.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 1.015 ' CZ3' HG23 ' A' ' 182' ' ' ILE . 1.9 p90 -76.35 -31.55 0.98 Allowed Pre-proline 0 N--CA 1.438 -1.065 0 C-N-CA 124.941 1.296 . . . . 999.99 112.452 168.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.947 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 50.9 Cg_exo -66.0 -45.71 5.64 Favored 'Trans proline' 0 N--CA 1.438 -1.766 0 N-CA-C 120.895 3.383 . . . . 999.99 120.895 -174.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.557 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 54.9 mt-10 -119.54 171.73 8.15 Favored 'General case' 0 CA--C 1.472 -2.054 0 C-N-CA 117.204 -1.798 . . . . 81.18 107.285 -172.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.844 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.9 p-80 -109.13 45.14 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.828 0 C-N-CA 115.466 -2.493 . . . . 999.99 108.777 177.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 1.062 ' HB2' HD11 ' A' ' 191' ' ' ILE . 87.3 Cg_endo -41.56 101.84 0.04 OUTLIER 'Trans proline' 0 CA--C 1.5 -1.184 1 C-N-CA 126.039 4.492 . . . . 999.99 105.683 -170.749 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -62.34 -44.01 97.49 Favored 'General case' 0 CA--C 1.484 -1.586 0 C-N-CA 126.777 2.031 . . . . 967.72 112.024 -165.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -60.31 -36.49 78.01 Favored 'General case' 0 CA--C 1.487 -1.475 0 N-CA-C 106.741 -1.578 . . . . 934.3 106.741 -175.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 1.062 HD11 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.62 -30.22 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 C-N-CA 129.185 2.994 . . . . 565.15 113.918 -178.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 61.56 55.38 2.79 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-N 118.469 0.577 . . . . 755.61 109.853 -175.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 1.103 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.5 -49.33 66.94 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 124.563 1.145 . . . . 325.89 113.265 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.897 ' HG3' ' HH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.76 -45.0 78.18 Favored 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 123.573 0.749 . . . . 250.21 111.637 -169.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 96.8 t -64.73 -43.29 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 C-N-CA 119.959 -0.696 . . . . 142.46 110.389 -175.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . 1.061 ' CD2' HD12 ' A' ' 182' ' ' ILE . 34.9 t80 -61.15 -41.5 96.86 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 123.982 0.913 . . . . 247.69 108.814 -173.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.889 ' HE2' ' HA ' ' A' ' 269' ' ' LEU . 23.0 t60 -60.52 -51.36 69.75 Favored 'General case' 0 CA--C 1.492 -1.279 0 C-N-CA 125.454 1.502 . . . . 199.61 113.049 -175.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 82.8 mt -65.31 -44.52 94.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 107.727 -1.212 . . . . 106.73 107.727 -177.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . 0.787 ' O ' HD12 ' A' ' 203' ' ' LEU . 41.5 t -59.11 -48.55 81.21 Favored 'General case' 0 CA--C 1.486 -1.519 0 CA-C-N 115.858 -0.61 . . . . 115.01 110.245 -173.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 1.0 HG13 HD12 ' A' ' 161' ' ' LEU . 86.1 t -65.27 -49.15 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.647 0 C-N-CA 119.458 -0.897 . . . . 129.42 111.823 -174.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.813 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.1 m -61.89 -53.14 59.82 Favored 'General case' 0 CA--C 1.483 -1.614 0 C-N-CA 118.245 -1.382 . . . . 172.48 109.953 -172.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.677 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 85.6 t -63.83 -54.24 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 C-N-CA 120.523 -0.471 . . . . 55.86 110.989 -174.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.787 HD12 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.58 -51.54 58.96 Favored 'General case' 0 N--CA 1.432 -1.355 0 C-N-CA 118.526 -1.27 . . . . 184.68 111.496 -174.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . 0.99 ' HB ' HD13 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.6 -52.44 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 C-N-CA 116.696 -2.002 . . . . 291.81 114.737 -174.683 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.433 ' HB2' ' CE1' ' A' ' 265' ' ' HIS . 87.8 t80 -82.04 -55.0 4.84 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 115.142 1.534 . . . . 130.66 115.142 -178.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . 0.813 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.9 m-85 -66.87 -48.49 68.62 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 114.532 1.308 . . . . 80.16 114.532 -170.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.925 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.57 -45.48 83.07 Favored Pre-proline 0 N--CA 1.436 -1.165 0 C-N-CA 119.91 -0.716 . . . . 136.02 109.495 -174.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.925 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.7 Cg_exo -64.76 -27.16 60.0 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 110.629 -0.566 . . . . 92.17 110.629 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.774 HD22 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.29 -41.41 76.83 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 107.495 -1.298 . . . . 135.6 107.495 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.8 mt -64.17 -44.73 91.17 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 109.57 -0.529 . . . . 52.1 109.57 -176.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . 0.699 HG13 ' O ' ' A' ' 208' ' ' PRO . 13.7 p -61.61 -43.53 97.18 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 109.12 -0.696 . . . . 95.89 109.12 -176.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.974 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.23 -42.35 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 106.728 -1.582 . . . . 43.41 106.728 -178.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.47 -42.26 99.04 Favored Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 109.361 -1.496 . . . . 27.69 109.361 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . 0.9 ' O ' HG21 ' A' ' 217' ' ' THR . 77.9 t80 -65.65 -47.4 75.69 Favored 'General case' 0 CA--C 1.496 -1.113 0 CA-C-N 117.38 0.59 . . . . 54.41 110.497 -177.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . 0.898 ' O ' HG13 ' A' ' 218' ' ' VAL . . . -61.41 -34.13 74.85 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 106.968 -1.493 . . . . 53.88 106.968 -177.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -60.74 -40.86 93.98 Favored 'General case' 0 N--CA 1.426 -1.628 0 N-CA-C 108.492 -0.929 . . . . 68.29 108.492 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' THR . . . . . 0.9 HG21 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.74 -39.06 92.99 Favored 'General case' 0 CA--C 1.497 -1.088 0 C-N-CA 119.69 -0.804 . . . . 107.59 110.619 -175.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.898 HG13 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.03 -38.36 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 C-N-CA 119.607 -0.837 . . . . 111.61 109.488 -177.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.888 HG12 ' CD1' ' A' ' 134' ' ' ILE . 79.6 t -63.29 -22.52 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 N-CA-C 108.389 -0.967 . . . . 85.26 108.389 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.84 -41.95 99.39 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 111.051 -0.82 . . . . 40.71 111.051 -176.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.7 mm -64.66 -44.09 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 108.42 -0.955 . . . . 95.86 108.42 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.845 ' CB ' HG22 ' A' ' 134' ' ' ILE . 67.1 p -76.94 -137.57 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.417 -0.956 . . . . 144.37 108.417 -176.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.929 HD21 ' NE ' ' A' ' 244' ' ' ARG . 87.7 mt -55.31 132.1 47.16 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 107.633 -1.247 . . . . 326.72 107.633 -177.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' TRP . . . . . 0.463 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.31 -168.02 1.5 Allowed 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 106.059 -1.83 . . . . 158.38 106.059 -176.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . 0.463 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.39 -41.93 98.79 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 109.619 -0.512 . . . . 36.78 109.619 -178.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.8 m -61.13 125.81 25.07 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 119.144 -1.022 . . . . 85.46 109.813 -174.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.776 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.82 126.56 8.89 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 105.547 -2.02 . . . . 127.78 105.547 176.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.982 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.04 139.92 34.8 Favored Pre-proline 0 CA--C 1.493 -1.214 0 N-CA-C 105.946 -1.872 . . . . 164.84 105.946 -179.548 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.982 ' N ' HD13 ' A' ' 228' ' ' ILE . 82.3 Cg_exo -56.87 -39.85 88.44 Favored 'Trans proline' 0 N--CA 1.431 -2.184 0 N-CA-C 113.945 0.71 . . . . 222.35 113.945 -175.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . 0.806 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -83.18 167.0 44.85 Favored Glycine 0 N--CA 1.428 -1.838 0 N-CA-C 106.39 -2.684 . . . . 45.22 106.39 178.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.924 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.6 t0 -60.97 -45.79 93.34 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 105.997 -1.853 . . . . 107.57 105.997 177.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' SER . . . . . 0.733 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.5 m -65.72 141.78 58.23 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 118.899 -1.12 . . . . 167.96 109.192 -175.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.874 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.3 m 99.5 106.7 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.248 0 C-N-CA 126.73 2.012 . . . . 280.68 109.768 176.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.777 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.5 m-20 55.99 11.31 0.71 Allowed 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 124.42 1.088 . . . . 218.25 110.717 174.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.932 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.41 137.68 54.76 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 105.217 -2.142 . . . . 343.57 105.217 177.368 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.585 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.6 t80 -112.0 81.92 1.54 Allowed 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 106.826 -1.546 . . . . 263.29 106.826 179.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' HIS . . . . . 0.662 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.3 m-70 104.29 147.03 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.285 0 C-N-CA 126.576 1.951 . . . . 261.92 108.486 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.21 -38.07 89.73 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 107.911 -1.144 . . . . 106.81 107.911 -177.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.759 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.42 -39.95 94.96 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 118.362 -1.335 . . . . 112.2 107.552 -178.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.749 HG13 ' NH1' ' A' ' 244' ' ' ARG . 75.5 t -64.25 -39.85 86.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 N-CA-C 109.254 -0.647 . . . . 45.41 109.254 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.863 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.0 p -70.94 -32.01 68.78 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 110.278 -0.267 . . . . 97.62 110.278 -178.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.38 -39.61 81.7 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 123.698 0.799 . . . . 59.29 111.012 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.759 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.25 -36.55 84.03 Favored 'General case' 0 CA--C 1.491 -1.3 0 C-N-CA 124.664 1.186 . . . . 106.49 110.683 -174.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.932 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.95 -30.67 69.24 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 108.293 -1.002 . . . . 106.62 108.293 -176.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.571 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -65.97 -41.06 91.68 Favored 'General case' 0 N--CA 1.436 -1.141 0 O-C-N 121.841 -0.537 . . . . 75.97 110.062 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.877 ' CG1' ' HE3' ' A' ' 250' ' ' MET . 76.8 t -65.53 -40.84 89.36 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 C-N-CA 122.92 0.488 . . . . 65.27 109.779 -178.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.835 HG11 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -64.03 -41.62 93.07 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.317 0 C-N-CA 120.398 -0.521 . . . . 107.94 110.12 -177.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.571 ' HE2' ' HA ' ' A' ' 245' ' ' LYS . 59.2 pttt -63.47 -40.81 98.11 Favored 'General case' 0 N--CA 1.434 -1.239 0 O-C-N 121.663 -0.648 . . . . 87.98 110.328 -176.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' MET . . . . . 1.061 ' HE2' ' CD1' ' A' ' 305' ' ' TYR . 21.3 ttt -63.68 -40.41 96.76 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 118.824 -1.15 . . . . 65.5 108.35 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' MET . . . . . 0.877 ' HE3' ' CG1' ' A' ' 246' ' ' VAL . 68.5 mtt -61.64 -36.41 80.71 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.141 -1.059 . . . . 85.05 108.141 -177.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.517 HD11 ' HA ' ' A' ' 248' ' ' LYS . 86.9 mt -63.48 -45.71 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 N-CA-C 109.061 -0.718 . . . . 42.25 109.061 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . 0.874 HG13 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.4 -38.19 81.93 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.13 0 C-N-CA 119.551 -0.86 . . . . 91.01 109.376 -176.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 1.03 HG21 HD11 ' A' ' 304' ' ' ILE . 66.5 t -58.93 -41.53 83.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 N-CA-C 107.931 -1.137 . . . . 66.09 107.931 -178.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 250' ' ' MET . 94.3 t -66.14 -43.15 92.24 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 C-N-CA 120.729 -0.388 . . . . 52.39 110.282 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.5 m -61.73 -46.75 88.3 Favored 'General case' 0 CA--C 1.489 -1.384 0 O-C-N 121.913 -0.492 . . . . 46.42 109.903 -174.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' THR . . . . . 0.821 ' O ' HG23 ' A' ' 259' ' ' ILE . 9.5 t -62.33 -38.18 88.45 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 108.333 -0.988 . . . . 116.51 108.333 -177.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' PHE . . . . . 0.541 ' N ' HG23 ' A' ' 256' ' ' THR . 86.1 t80 -60.23 -48.23 82.6 Favored 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 109.405 -0.591 . . . . 65.18 109.405 -178.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.94 -42.65 97.26 Favored 'General case' 0 CA--C 1.49 -1.364 0 CA-C-O 120.872 0.368 . . . . 51.33 110.468 -175.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . 0.821 HG23 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.62 -43.41 98.16 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 C-N-CA 118.941 -1.103 . . . . 126.3 108.974 -176.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' CYS . . . . . 0.568 ' N ' HG22 ' A' ' 259' ' ' ILE . 69.7 m -65.58 -49.3 69.31 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 119.518 -0.873 . . . . 133.94 112.495 -176.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.867 ' CH2' ' HB2' ' A' ' 294' ' ' ALA . 97.0 m95 -80.69 -33.4 35.47 Favored 'General case' 0 CA--C 1.497 -1.071 0 N-CA-C 116.823 2.157 . . . . 134.84 116.823 -176.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.796 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.9 tp -58.47 -41.56 89.88 Favored Pre-proline 0 CA--C 1.493 -1.225 0 O-C-N 121.628 -0.67 . . . . 72.23 111.648 -167.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' PRO . . . . . 0.817 ' O ' HG21 ' A' ' 266' ' ' ILE . 81.9 Cg_exo -60.75 -35.94 86.76 Favored 'Trans proline' 0 C--N 1.294 -2.298 0 CA-C-N 119.837 0.978 . . . . 106.13 111.302 -178.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' PHE . . . . . 0.844 ' CA ' HG21 ' A' ' 290' ' ' ILE . 71.5 t80 -66.4 -44.67 82.37 Favored 'General case' 0 N--CA 1.433 -1.321 0 C-N-CA 119.793 -0.763 . . . . 128.35 110.061 -178.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' HIS . . . . . 0.697 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.47 -37.84 88.95 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 110.236 -0.283 . . . . 100.73 110.236 -177.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.817 HG21 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.28 -44.52 94.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 C-N-CA 119.329 -0.949 . . . . 172.72 109.139 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . 0.75 ' HD1' ' O ' ' A' ' 263' ' ' PRO . 61.6 m-85 -66.61 -28.06 68.2 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 108.235 -1.024 . . . . 249.23 108.235 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' PHE . . . . . 0.903 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.3 t80 -55.56 -55.13 35.52 Favored 'General case' 0 N--CA 1.433 -1.325 0 N-CA-C 106.653 -1.61 . . . . 259.78 106.653 178.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . 0.889 ' HA ' ' HE2' ' A' ' 197' ' ' HIS . 89.5 mt -69.14 -44.2 72.82 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 113.606 0.965 . . . . 233.11 113.606 -176.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.847 HD12 HD21 ' A' ' 279' ' ' LEU . 88.7 mt -61.4 -48.34 91.21 Favored Pre-proline 0 CA--C 1.5 -0.946 0 C-N-CA 119.199 -1.0 . . . . 169.54 110.553 -171.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . 0.682 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.8 Cg_exo -61.05 -24.64 79.89 Favored 'Trans proline' 0 N--CA 1.429 -2.287 0 C-N-CA 116.797 -1.668 . . . . 255.47 114.64 174.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' TYR . . . . . 0.897 ' HH ' ' HG3' ' A' ' 194' ' ' LYS . 19.6 t80 -63.57 -44.17 94.88 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 119.233 0.924 . . . . 279.03 108.91 177.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . 0.831 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.34 -44.82 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 N-CA-C 110.076 -0.342 . . . . 162.21 110.076 -178.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' ASN . . . . . 0.774 ' N ' HD11 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.38 84.89 59.25 Favored Pre-proline 0 N--CA 1.431 -1.423 0 C-N-CA 118.761 -1.176 . . . . 128.13 108.067 -178.078 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.26 164.06 11.25 Favored 'Trans proline' 0 C--N 1.295 -2.281 0 N-CA-C 107.487 -1.774 . . . . 278.35 107.487 177.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . 0.863 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.09 15.07 9.94 Favored 'General case' 0 N--CA 1.429 -1.518 0 O-C-N 123.752 0.658 . . . . 312.91 109.319 175.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.863 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.2 mt -132.72 -170.69 2.49 Favored 'General case' 0 CA--C 1.481 -1.686 0 N-CA-C 106.533 -1.654 . . . . 353.54 106.533 177.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 1.022 ' HA ' ' CB ' ' A' ' 282' ' ' PHE . 42.8 p90 -115.63 142.26 46.98 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 107.419 -1.326 . . . . 251.26 107.419 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.847 HD21 HD12 ' A' ' 270' ' ' LEU . 1.7 tm? -76.92 -118.74 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 102.1 -3.296 . . . . 175.26 102.1 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . 0.779 ' HB3' ' HE3' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.51 -44.96 96.13 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 100.892 -3.744 . . . . 99.07 100.892 172.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . 0.779 ' HE3' ' HB3' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.42 124.15 9.18 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 103.508 -2.775 . . . . 243.21 103.508 171.157 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 1.022 ' CB ' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.97 113.01 25.16 Favored 'General case' 0 CA--C 1.474 -1.967 0 C-N-CA 116.004 -2.278 . . . . 201.04 105.287 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' ILE . . . . . 0.768 HG23 ' N ' ' A' ' 285' ' ' GLN . 10.7 tp -147.95 173.71 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.098 0 C-N-CA 116.006 -2.277 . . . . 201.36 108.789 -175.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . 1.065 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.283 0.6 OUTLIER -59.48 -41.46 89.84 Favored 'General case' 0 N--CA 1.415 -2.189 0 CA-C-N 113.28 -1.782 . . . . 203.82 107.881 174.44 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . 0.918 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.29 -45.75 86.62 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 118.221 -1.392 . . . . 215.06 112.532 -171.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.638 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.2 t -65.64 -46.41 89.46 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.461 0 C-N-CA 118.562 -1.255 . . . . 125.28 112.948 -171.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' TYR . . . . . 0.855 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.76 -37.01 86.17 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 107.211 -1.404 . . . . 268.9 107.211 -171.929 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . 0.869 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.26 -44.98 74.4 Favored 'General case' 0 CA--C 1.483 -1.603 0 C-N-CA 125.614 1.566 . . . . 280.88 108.769 -172.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.66 -47.53 85.85 Favored 'General case' 0 CA--C 1.485 -1.534 0 C-N-CA 118.985 -1.086 . . . . 184.47 108.959 -172.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . 0.844 HG21 ' CA ' ' A' ' 264' ' ' PHE . 1.8 mp -67.93 -42.09 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 C-N-CA 119.273 -0.971 . . . . 167.92 112.724 -175.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' MET . . . . . 0.661 ' HE2' ' HG2' ' A' ' 181' ' ' MET . 21.7 ttt -65.7 -38.88 90.45 Favored 'General case' 0 CA--C 1.495 -1.139 0 C-N-CA 117.764 -1.574 . . . . 367.18 110.767 -175.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' TRP . . . . . 0.571 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.5 m95 -67.12 -32.69 73.99 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 121.804 -0.56 . . . . 173.97 110.477 177.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.4 tp -64.48 -36.73 85.13 Favored 'General case' 0 CA--C 1.499 -1.0 0 C-N-CA 123.517 0.727 . . . . 119.66 109.824 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . 0.867 ' HB2' ' CH2' ' A' ' 261' ' ' TRP . . . -61.26 -33.99 74.44 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 107.659 -1.237 . . . . 112.3 107.659 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' MET . . . . . 0.714 ' O ' HG21 ' A' ' 298' ' ' THR . 21.9 mmt -63.12 -31.99 73.26 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 116.252 -0.431 . . . . 174.17 110.246 -177.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.7 m -64.75 -22.77 67.06 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 124.661 1.184 . . . . 145.27 110.6 -175.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' SER . . . . . 0.827 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.5 m -57.61 -35.39 70.39 Favored 'General case' 0 N--CA 1.426 -1.675 0 N-CA-C 108.055 -1.091 . . . . 170.15 108.055 -175.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.841 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.8 t -55.33 -34.08 63.9 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 116.285 -0.416 . . . . 214.57 110.653 -171.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' MET . . . . . 0.799 ' CE ' ' HG1' ' A' ' 45' ' ' THR . 28.1 ttt -77.25 -33.24 56.02 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 126.093 1.757 . . . . 168.29 115.499 177.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' TYR . . . . . 0.827 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.41 -34.83 79.08 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 114.098 1.148 . . . . 167.15 114.098 -168.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . 0.749 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.282 18.8 p-10 -64.2 -38.36 33.84 Favored Pre-proline 0 N--CA 1.434 -1.274 0 C-N-CA 115.536 -2.465 . . . . 165.13 113.89 -171.625 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' PRO . . . . . 0.749 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.4 Cg_exo -62.51 -31.81 80.22 Favored 'Trans proline' 0 N--CA 1.434 -2.004 0 CA-C-N 122.762 2.022 . . . . 123.92 111.272 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' ILE . . . . . 0.785 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.81 -42.57 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 C-N-CA 118.878 -1.129 . . . . 110.55 109.743 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' ILE . . . . . 1.03 HD11 HG21 ' A' ' 253' ' ' VAL . 31.0 pt -61.17 -39.97 84.29 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.146 0 N-CA-C 108.843 -0.799 . . . . 145.31 108.843 -177.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . 1.061 ' CD1' ' HE2' ' A' ' 249' ' ' MET 0.254 63.4 m-85 -58.17 -48.75 79.3 Favored 'General case' 0 CA--C 1.494 -1.174 0 C-N-CA 119.373 -0.931 . . . . 246.68 109.846 -177.509 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.5 m -62.25 -47.47 84.25 Favored 'General case' 0 CA--C 1.485 -1.536 0 C-N-CA 119.536 -0.866 . . . . 64.43 109.559 -173.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.8 t -66.85 -45.03 79.48 Favored 'General case' 0 N--CA 1.428 -1.532 0 C-N-CA 118.963 -1.095 . . . . 80.72 110.259 -177.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.757 HD22 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.46 -35.71 75.88 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 116.007 1.855 . . . . 140.44 116.007 -173.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . 0.617 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.82 132.22 34.36 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 112.704 -3.598 . . . . 178.87 113.08 -177.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . 0.704 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.02 -37.09 86.47 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 114.406 -1.27 . . . . 110.22 110.093 -177.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . 0.857 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.73 -50.61 72.63 Favored 'General case' 0 CA--C 1.492 -1.258 0 O-C-N 121.714 -0.617 . . . . 174.78 109.737 -174.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.979 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.1 m-85 -64.87 -41.74 95.41 Favored 'General case' 0 CA--C 1.484 -1.573 0 N-CA-C 108.212 -1.033 . . . . 161.84 108.212 178.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . 0.479 ' HE ' HD21 ' A' ' 314' ' ' LEU . 57.7 ttp180 -57.24 -50.3 73.3 Favored 'General case' 0 CA--C 1.49 -1.327 0 N-CA-C 109.206 -0.664 . . . . 117.2 109.206 -173.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.841 ' HB3' HD12 ' A' ' 326' ' ' ILE . 3.0 mm? -68.52 -44.06 75.42 Favored 'General case' 0 N--CA 1.433 -1.277 0 C-N-CA 120.385 -0.526 . . . . 112.6 111.038 -177.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . 1.129 ' HA2' ' HD1' ' A' ' 318' ' ' HIS . . . -64.09 -37.42 94.55 Favored Glycine 0 N--CA 1.43 -1.759 0 N-CA-C 110.644 -0.982 . . . . 101.46 110.644 -177.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' PHE . . . . . 0.979 ' CE2' ' HB3' ' A' ' 312' ' ' PHE . 36.6 m-85 -62.15 -45.99 90.96 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-N 118.491 1.145 . . . . 151.49 109.519 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . 0.466 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.6 ttmt -60.1 -36.33 77.18 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 106.942 -1.503 . . . . 142.32 106.942 -175.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' HIS . . . . . 1.129 ' HD1' ' HA2' ' A' ' 315' ' ' GLY . 49.9 m80 -59.75 -41.84 91.9 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.883 -1.525 . . . . 109.09 106.883 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.84 -42.45 85.76 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.353 -0.217 . . . . 76.11 110.999 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -61.41 -55.55 30.2 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 119.914 -0.714 . . . . 120.24 109.299 -174.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . 0.753 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.4 mtt180 -74.3 131.52 41.25 Favored 'General case' 0 CA--C 1.482 -1.651 0 N-CA-C 102.973 -2.973 . . . . 192.73 102.973 177.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.16 -44.17 92.11 Favored 'General case' 0 CA--C 1.491 -1.312 0 C-N-CA 119.0 -1.08 . . . . 176.29 109.238 -172.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' CYS . . . . . 0.812 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.2 m -79.34 -177.06 0.8 Allowed Pre-proline 0 N--CA 1.43 -1.47 0 N-CA-C 106.35 -1.722 . . . . 69.68 106.35 178.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.568 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.7 Cg_exo -59.04 -75.58 0.02 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.373 0 C-N-CA 118.337 -0.642 . . . . 191.05 112.589 176.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' PHE . . . . . 0.812 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.4 m-85 47.5 43.9 16.28 Favored 'General case' 0 CA--C 1.493 -1.212 0 O-C-N 123.613 0.571 . . . . 287.03 109.73 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . 0.846 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.53 78.62 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.474 -1.955 0 C-N-CA 112.918 -3.513 . . . . 292.29 109.844 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' SER . . . . . 0.507 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.2 t -77.5 -152.87 0.05 Allowed 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 104.237 -2.505 . . . . 184.57 104.237 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.69 8.75 4.95 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 113.039 0.755 . . . . 274.56 113.039 176.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.96 0.84 57.3 Favored Glycine 0 C--N 1.349 1.26 0 C-N-CA 117.717 -2.182 . . . . 268.24 113.48 172.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' ASP . . . . . 0.724 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.8 m-20 51.62 -172.07 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.085 0 CA-C-N 118.694 1.247 . . . . 200.06 110.737 177.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.857 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.3 t80 -63.84 -33.04 74.78 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 107.915 -1.143 . . . . 114.44 107.915 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' GLU . . . . . 0.597 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.27 46.09 21.83 Favored 'General case' 0 CA--C 1.484 -1.571 0 N-CA-C 107.59 -1.263 . . . . 263.81 107.59 -177.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' GLY . . . . . 0.65 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.3 -137.35 3.6 Favored Glycine 0 CA--C 1.479 -2.204 1 N-CA-C 102.529 -4.228 . . . . 103.79 102.529 -179.871 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . 0.991 HD21 ' HA ' ' A' ' 337' ' ' LYS . 61.5 mt -88.25 95.67 10.26 Favored 'General case' 0 N--CA 1.419 -2.017 0 C-N-CA 114.91 -2.716 . . . . 117.3 105.997 177.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . 1.061 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -66.0 -39.8 90.59 Favored 'General case' 0 CA--C 1.469 -2.173 1 N-CA-C 97.961 -4.829 . . . . 231.58 97.961 167.235 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 1.06 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.93 163.5 29.03 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 102.112 -3.292 . . . . 303.24 102.112 169.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' LYS . . . . . 0.991 ' HA ' HD21 ' A' ' 334' ' ' LEU . 84.3 tttt -62.69 -48.56 78.72 Favored 'General case' 0 N--CA 1.432 -1.365 0 C-N-CA 115.997 -2.281 . . . . 112.72 108.381 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' SER . . . . . 0.411 ' HB3' ' SD ' ' A' ' 336' ' ' MET . 47.9 t -61.02 -63.67 1.22 Allowed 'General case' 0 CA--C 1.49 -1.334 0 N-CA-C 109.121 -0.696 . . . . 83.22 109.121 -176.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' THR . . . . . 0.912 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.0 m -156.25 -126.25 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 103.806 -2.664 . . . . 174.36 103.806 -178.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . 1.061 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.84 160.93 8.77 Favored 'General case' 0 CA--C 1.485 -1.552 0 N-CA-C 105.796 -1.927 . . . . 202.73 105.796 177.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . 1.031 ' HH ' ' HA3' ' A' ' 315' ' ' GLY . 0.2 OUTLIER -131.94 149.01 52.56 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 107.071 -1.455 . . . . 180.62 107.071 176.413 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . 0.945 ' H ' ' HB2' ' A' ' 347' ' ' SER . 53.5 tp -178.48 -171.88 0.27 Allowed 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 105.393 -2.077 . . . . 145.25 105.393 178.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' GLN . . . . . 0.943 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.06 -43.15 88.27 Favored 'General case' 0 CA--C 1.487 -1.455 0 N-CA-C 106.165 -1.791 . . . . 66.05 106.165 174.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' THR . . . . . 0.758 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.67 -152.2 0.49 Allowed 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 103.498 -2.778 . . . . 266.49 103.498 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' GLN . . . . . 0.609 ' CD ' HD23 ' A' ' 342' ' ' LEU . 79.3 mt-30 66.35 -124.96 0.28 Allowed 'General case' 0 CA--C 1.485 -1.549 0 C-N-CA 116.99 -1.884 . . . . 219.2 107.742 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . 0.995 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.07 -37.38 94.11 Favored Glycine 0 N--CA 1.425 -2.067 0 CA-C-N 114.572 -1.195 . . . . 94.78 112.865 -175.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' SER . . . . . 1.106 ' HG ' ' HB3' ' A' ' 61' ' ' LYS . 48.4 t -81.23 100.41 9.11 Favored 'General case' 0 CA--C 1.484 -1.566 0 C-N-CA 112.359 -3.736 . . . . 121.41 109.467 -171.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . 0.671 ' O ' ' HE2' ' A' ' 336' ' ' MET . 94.6 t -73.03 145.49 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 N-CA-C 108.974 -0.75 . . . . 85.34 108.974 -176.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' TYR . . . . . 0.506 ' N ' HG13 ' A' ' 348' ' ' VAL . 48.6 p90 -57.73 143.37 42.12 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 107.825 -1.176 . . . . 267.57 107.825 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . 0.508 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.07 69.61 0.59 Allowed 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 109.529 -0.545 . . . . 226.1 109.529 -179.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' VAL . . . . . 1.047 ' HB ' ' HE1' ' A' ' 336' ' ' MET . 7.5 p -51.08 156.95 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 N-CA-C 106.928 -1.508 . . . . 154.84 106.928 177.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' SER . . . . . 0.505 ' N ' HG23 ' A' ' 351' ' ' VAL . 71.5 m -61.31 161.91 8.46 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-O 121.595 0.712 . . . . 180.01 110.728 -173.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' ARG . . . . . 0.88 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.43 156.94 23.59 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 106.923 -1.51 . . . . 333.78 106.923 -178.597 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . 0.995 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.04 142.51 48.77 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 107.37 -1.345 . . . . 335.2 107.37 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.995 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.6 mm-40 82.84 158.91 0.13 Allowed 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 108.729 -0.841 . . . . 266.47 108.729 179.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.9 m -60.66 -46.83 88.84 Favored 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 105.678 -1.971 . . . . 59.34 105.678 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.58 173.85 11.97 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 104.408 -2.441 . . . . 201.26 104.408 176.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.783 HG21 ' O ' ' A' ' 360' ' ' THR . 69.1 mt -95.88 106.77 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.529 0 C-N-CA 116.343 -2.143 . . . . 56.23 105.521 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' SER . . . . . 0.523 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.5 m -61.24 -59.43 5.32 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 109.272 -0.64 . . . . 87.58 109.272 -175.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' THR . . . . . 0.886 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.2 t -85.59 153.74 22.19 Favored 'General case' 0 CA--C 1.486 -1.496 0 N-CA-C 107.811 -1.181 . . . . 219.95 107.811 -177.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' VAL . . . . . 0.562 HG22 ' O ' ' A' ' 361' ' ' VAL . 15.9 m -82.04 83.86 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 C-N-CA 116.29 -2.164 . . . . 121.79 105.436 177.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.621 HG13 ' N ' ' A' ' 363' ' ' GLY . 64.7 t -154.09 159.72 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.548 0 N-CA-C 105.843 -1.91 . . . . 53.85 105.843 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . 0.621 ' N ' HG13 ' A' ' 362' ' ' VAL . . . 72.22 16.64 77.07 Favored Glycine 0 N--CA 1.428 -1.87 0 N-CA-C 106.057 -2.817 . . . . 196.55 106.057 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.662 0 N-CA-C 107.911 -1.144 . . . . 35.88 107.911 -178.942 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 365' ' ' ARG . . . . . 0.603 HH21 ' CG ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 108.865 -0.791 . . . . 1.0 108.865 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 366' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' B' ' 365' ' ' ARG . 52.6 Cg_endo -66.89 142.02 61.05 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.08 1.854 . . . . 1.0 110.245 178.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 367' ' ' LYS . . . . . 0.859 ' HB3' HD11 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -64.43 143.3 98.51 Favored Pre-proline 0 C--N 1.325 -0.498 0 C-N-CA 119.825 -0.75 . . . . 1.0 109.587 -179.894 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 368' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.29 150.44 76.38 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.349 2.033 . . . . 1.0 111.712 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 369' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.74 131.78 44.37 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.749 -0.38 . . . . 1.0 110.243 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.01 115.82 31.36 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.646 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 371' ' ' PHE . . . . . 0.57 ' HD1' ' HA ' ' B' ' 371' ' ' PHE . 0.0 OUTLIER -63.69 -42.3 98.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.481 . . . . 1.0 110.422 179.566 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 372' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.03 -36.26 83.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.678 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -59.68 -33.09 75.92 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.811 -0.916 . . . . 1.0 110.811 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 374' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.79 131.3 45.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.873 0.368 . . . . 1.0 110.192 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 375' ' ' MET . . . . . . . . . . . . . 2.5 mtt . . . . . 0 C--O 1.221 -0.434 0 CA-C-O 118.026 -0.988 . . . . 1.0 110.495 -179.802 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.442 0 N-CA-C 108.377 -0.971 . . . . 97.08 108.377 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.43 ' HB3' ' OD1' ' A' ' 276' ' ' ASP . 46.6 t30 -110.62 155.44 22.37 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-O 122.123 0.963 . . . . 123.41 110.711 -172.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.844 HG12 HD13 ' A' ' 15' ' ' ILE . 28.7 m -134.6 -162.38 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.479 1 N-CA-C 100.081 -4.044 . . . . 151.3 100.081 173.754 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.965 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.67 -38.57 57.91 Favored Pre-proline 0 N--CA 1.439 -0.996 0 C-N-CA 115.968 -2.293 . . . . 169.25 106.115 178.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.965 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 58.3 Cg_exo -81.32 168.51 16.61 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 122.281 0.621 . . . . 185.76 110.505 171.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.855 HG12 ' CE2' ' A' ' 282' ' ' PHE . 91.7 t -64.47 -25.92 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 C-N-CA 127.028 2.131 . . . . 145.47 110.347 -177.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.837 ' O ' HG23 ' A' ' 4' ' ' VAL . 39.1 t0 -84.3 157.42 21.53 Favored 'General case' 0 N--CA 1.439 -0.981 0 O-C-N 121.078 -1.014 . . . . 102.76 109.464 -178.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.6 p -82.58 154.19 25.11 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 107.976 -1.12 . . . . 106.25 107.976 178.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.925 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 46.7 p-10 -105.89 51.85 0.74 Allowed 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 117.769 -1.573 . . . . 157.81 107.599 178.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.1 tp -60.1 -45.94 91.29 Favored 'General case' 0 CA--C 1.481 -1.696 0 N-CA-C 103.607 -2.738 . . . . 150.2 103.607 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.457 ' C ' ' H ' ' A' ' 14' ' ' ASN . 70.9 m -87.07 164.69 35.22 Favored Pre-proline 0 N--CA 1.422 -1.867 0 N-CA-C 103.653 -2.721 . . . . 183.52 103.653 172.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -76.78 6.86 3.85 Favored 'Trans proline' 0 C--N 1.281 -2.988 0 N-CA-C 109.986 -0.813 . . . . 235.61 109.986 176.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.457 ' H ' ' C ' ' A' ' 12' ' ' SER . 34.5 t-20 -57.88 -41.27 82.15 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 124.813 1.245 . . . . 113.77 113.398 -170.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.925 ' CD1' ' HB3' ' A' ' 10' ' ' ASP . 33.4 pt -52.19 136.24 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-N 119.541 1.064 . . . . 150.85 110.963 -176.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.8 t -140.49 156.24 46.4 Favored 'General case' 0 C--N 1.36 1.036 0 N-CA-C 107.634 -1.247 . . . . 100.42 107.634 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 1.026 HG23 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.0 142.64 58.36 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 121.895 0.855 . . . . 129.36 110.455 -174.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.764 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.12 -25.5 68.39 Favored 'General case' 0 CA--C 1.493 -1.213 0 C-N-CA 126.309 1.843 . . . . 112.34 106.668 -177.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 1.005 HG21 ' HA2' ' A' ' 101' ' ' GLY . 85.8 m -74.11 -40.2 62.84 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 115.538 -0.756 . . . . 131.73 111.741 177.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 1.026 ' H ' HG23 ' A' ' 17' ' ' THR . 71.4 m -84.42 -42.89 15.19 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 116.989 2.218 . . . . 80.49 116.989 -174.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.525 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.5 mt-10 -145.96 174.54 3.35 Favored Pre-proline 0 N--CA 1.442 -0.847 0 C-N-CA 118.179 -1.408 . . . . 98.98 111.234 -169.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.879 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.334 85.7 Cg_exo -61.72 -10.86 18.23 Favored 'Trans proline' 0 C--N 1.321 -0.907 1 N-CA-C 128.931 6.473 . . . . 246.95 128.931 -170.104 . . . . . . . . 4 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.676 HD22 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.68 17.54 8.76 Favored 'General case' 0 C--N 1.324 -0.518 1 CA-C-N 126.154 4.07 . . . . 269.62 114.22 175.68 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.583 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.5 mt-30 -67.14 -27.26 67.17 Favored 'General case' 0 CA--C 1.495 -1.154 0 N-CA-C 107.814 -1.18 . . . . 86.8 107.814 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.5 ' CE1' ' CG2' ' A' ' 26' ' ' VAL . 50.3 p90 -66.87 -29.3 69.17 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 121.116 -0.99 . . . . 85.91 110.467 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.89 HG11 ' OE1' ' A' ' 284' ' ' GLN . 40.4 t -68.59 -40.18 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 C-N-CA 123.734 0.814 . . . . 82.0 111.346 -177.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.927 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.39 167.74 12.47 Favored Pre-proline 0 CA--C 1.489 -1.391 0 N-CA-C 108.559 -0.904 . . . . 120.73 108.559 -178.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.847 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -63.99 149.75 89.86 Favored 'Trans proline' 0 N--CA 1.433 -2.07 0 C-N-CA 120.644 0.896 . . . . 87.86 109.847 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.82 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.0 -37.98 89.37 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 108.87 -0.789 . . . . 36.46 108.87 -176.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.84 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.9 p-90 -63.82 -33.83 76.56 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 107.81 -1.181 . . . . 150.6 107.81 -176.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.927 ' OE1' ' HB2' ' A' ' 27' ' ' GLN . 80.5 mt-30 -62.24 -32.72 73.44 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 108.624 -0.88 . . . . 123.26 108.624 -178.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.856 HG23 ' O ' ' A' ' 93' ' ' ALA . 1.7 mp -61.43 -47.27 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 N-CA-C 109.125 -0.694 . . . . 120.14 109.125 176.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 30' ' ' TRP . 20.3 m -67.4 -31.03 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 N-CA-C 107.866 -1.161 . . . . 112.19 107.866 -178.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.84 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.5 tp -62.96 -47.13 84.53 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 119.973 -0.691 . . . . 60.87 109.61 -178.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.687 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.08 -35.66 81.11 Favored 'General case' 0 CA--C 1.489 -1.386 0 C-N-CA 119.974 -0.69 . . . . 157.57 110.325 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.819 ' CB ' HG12 ' A' ' 94' ' ' VAL . . . -62.6 -40.87 98.29 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 108.65 -0.871 . . . . 47.06 108.65 178.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.843 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.76 -41.29 98.01 Favored 'General case' 0 CA--C 1.496 -1.111 0 O-C-N 121.76 -0.587 . . . . 43.94 109.546 -177.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.767 ' O ' HG21 ' A' ' 41' ' ' VAL . . . -61.83 -43.38 98.96 Favored 'General case' 0 CA--C 1.49 -1.364 0 N-CA-C 108.657 -0.868 . . . . 42.61 108.657 -176.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.964 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.29 -41.25 94.3 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 116.631 -0.259 . . . . 140.66 111.079 -178.367 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.843 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.77 -43.98 97.79 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 118.576 -1.249 . . . . 116.04 110.239 -175.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.767 HG21 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.47 -38.69 83.06 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.302 0 N-CA-C 108.726 -0.842 . . . . 97.16 108.726 -177.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.919 HD11 ' HD1' ' A' ' 39' ' ' TYR . 93.2 mt -61.29 -40.05 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 N-CA-C 108.944 -0.761 . . . . 54.85 108.944 -176.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.981 HG23 HG22 ' A' ' 86' ' ' THR . 93.0 t -57.69 -42.35 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.32 0 N-CA-C 108.878 -0.786 . . . . 45.39 108.878 -175.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.401 ' O ' HG22 ' A' ' 48' ' ' VAL . 97.5 t -63.5 -50.98 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 C-N-CA 118.844 -1.142 . . . . 48.64 110.218 -177.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.803 ' HG1' ' CE ' ' A' ' 299' ' ' MET . 10.6 t -65.3 -46.95 78.35 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 120.117 -0.633 . . . . 116.65 111.744 -174.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.642 ' N ' HG23 ' A' ' 45' ' ' THR . 50.7 m -62.0 -43.94 97.79 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 109.718 -0.475 . . . . 51.16 109.718 -174.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 43' ' ' VAL . 97.4 t -65.56 -48.93 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 C-N-CA 119.885 -0.726 . . . . 44.3 110.818 -176.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.876 ' O ' HG22 ' A' ' 52' ' ' VAL . 93.7 t -64.78 -46.93 90.59 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.048 0 C-N-CA 120.34 -0.544 . . . . 48.82 111.005 -174.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.78 -44.14 95.21 Favored Glycine 0 N--CA 1.438 -1.213 0 C-N-CA 120.529 -0.843 . . . . 58.7 112.02 -174.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -72.67 -34.19 67.06 Favored 'General case' 0 CA--C 1.488 -1.433 0 O-C-N 122.107 -0.643 . . . . 101.4 110.993 -175.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.812 HG11 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.94 -38.69 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 107.761 -1.199 . . . . 103.57 107.761 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.876 HG22 ' O ' ' A' ' 48' ' ' VAL . 71.8 t -61.43 -43.05 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 108.989 -0.745 . . . . 61.89 108.989 -178.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.634 ' O ' HG21 ' A' ' 56' ' ' ILE . 81.8 t -63.42 -50.99 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 109.458 -0.571 . . . . 70.01 109.458 -178.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.873 ' O ' HD12 ' A' ' 58' ' ' LEU . 26.0 ptm -62.95 -43.41 98.85 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.13 -0.693 . . . . 132.1 109.13 -176.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.677 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.12 -46.69 83.02 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 116.705 -0.225 . . . . 104.5 110.469 -176.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.904 HD11 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.63 -49.93 80.24 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 C-N-CA 120.254 -0.578 . . . . 142.96 111.253 -173.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 1.035 HD12 HG11 ' A' ' 72' ' ' VAL 0.277 24.7 pt -64.79 -41.66 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.639 0 C-N-CA 116.956 -1.898 . . . . 158.32 110.868 -175.965 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.873 HD12 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.76 -41.3 98.02 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 117.699 -1.6 . . . . 137.11 109.514 178.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.46 -44.49 90.94 Favored 'General case' 0 N--CA 1.436 -1.156 0 O-C-N 122.117 -0.364 . . . . 54.66 110.972 -176.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.954 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.9 m-70 -91.42 117.13 29.41 Favored 'General case' 0 CA--C 1.49 -1.348 0 CA-C-O 121.662 0.744 . . . . 127.18 109.555 -174.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 1.107 ' HB3' ' HG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.83 -36.81 80.06 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 124.089 0.956 . . . . 87.93 110.877 -176.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 1.06 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.37 -34.7 78.77 Favored 'General case' 0 CA--C 1.49 -1.341 0 O-C-N 121.622 -0.674 . . . . 131.12 111.512 -175.669 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 1.004 ' HG3' ' CE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.61 69.46 7.12 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 115.307 -2.557 . . . . 246.56 109.647 -175.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 61' ' ' LYS . 9.6 mmp_? -123.23 91.44 3.48 Favored 'General case' 0 CA--C 1.474 -1.946 0 N-CA-C 105.465 -2.05 . . . . 339.35 105.465 177.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.861 ' HG1' ' H ' ' A' ' 68' ' ' ASN . 82.5 p -124.15 165.27 17.85 Favored 'General case' 0 N--CA 1.414 -2.251 0 N-CA-C 103.01 -2.959 . . . . 114.66 103.01 176.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.958 HG22 ' HG1' ' A' ' 147' ' ' THR . 7.7 p -63.14 -39.49 85.44 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.615 0 N-CA-C 106.748 -1.575 . . . . 143.28 106.748 178.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.984 HG21 HD13 ' A' ' 71' ' ' LEU . 95.8 m -59.66 -38.05 80.4 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 108.676 -0.861 . . . . 160.22 108.676 -176.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.861 ' H ' ' HG1' ' A' ' 65' ' ' THR . 86.3 m-20 -62.39 -31.73 72.44 Favored 'General case' 0 CA--C 1.489 -1.37 0 N-CA-C 108.858 -0.793 . . . . 120.54 108.858 -177.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.885 ' O ' HG23 ' A' ' 72' ' ' VAL . 89.7 m-85 -63.64 -43.76 95.85 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.465 -0.569 . . . . 67.22 109.465 178.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.932 ' CE2' HG23 ' A' ' 66' ' ' VAL . 82.6 m-85 -66.53 -39.8 88.78 Favored 'General case' 0 CA--C 1.498 -1.057 0 O-C-N 121.533 -0.729 . . . . 138.6 109.675 -177.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.984 HD13 HG21 ' A' ' 67' ' ' THR . 10.1 mp -63.56 -35.9 82.02 Favored 'General case' 0 CA--C 1.492 -1.26 0 C-N-CA 122.487 0.315 . . . . 151.46 110.663 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 1.035 HG11 HD12 ' A' ' 57' ' ' ILE . 23.9 m -62.55 -37.92 80.13 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 C-N-CA 117.406 -1.717 . . . . 117.93 106.753 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.489 ' N ' HG22 ' A' ' 72' ' ' VAL . 66.0 t30 -60.17 -45.95 91.34 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 107.837 -1.171 . . . . 56.82 107.837 -177.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.911 HD21 ' CE ' ' A' ' 123' ' ' MET . 8.7 mp -61.38 -43.89 98.09 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 108.941 -0.763 . . . . 145.3 108.941 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.07 -40.36 95.53 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 108.535 -0.913 . . . . 45.71 108.535 -175.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -62.44 -41.95 99.11 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 109.399 -0.593 . . . . 105.61 109.399 -178.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.16 -39.48 92.79 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 108.605 -0.887 . . . . 47.89 108.605 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.707 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.56 -37.31 84.69 Favored 'General case' 0 N--CA 1.438 -1.062 0 O-C-N 122.084 -0.385 . . . . 124.53 109.988 179.692 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.88 -41.25 99.33 Favored 'General case' 0 N--CA 1.437 -1.089 0 O-C-N 121.942 -0.474 . . . . 35.89 109.819 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.7 t -62.16 -37.35 84.9 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 107.048 -1.464 . . . . 88.97 107.048 -178.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.84 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.7 ttm -62.16 -49.18 76.88 Favored 'General case' 0 N--CA 1.427 -1.579 0 C-N-CA 119.792 -0.763 . . . . 239.91 109.055 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.599 ' O ' HG21 ' A' ' 86' ' ' THR . . . -65.36 -43.37 91.02 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 121.579 -0.7 . . . . 146.1 110.62 -177.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.18 -58.22 3.41 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 117.403 -1.719 . . . . 91.74 113.826 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -76.57 -61.37 1.98 Allowed 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 115.746 1.758 . . . . 197.45 115.746 -173.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.981 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.25 -42.26 55.6 Favored 'General case' 0 CA--C 1.49 -1.36 0 C-N-CA 117.884 -1.527 . . . . 242.6 114.056 -170.045 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.981 HG22 HG23 ' A' ' 43' ' ' VAL . 4.7 t -65.45 -36.55 84.23 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 118.926 -1.109 . . . . 215.61 109.821 -172.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.461 ' N ' HG23 ' A' ' 86' ' ' THR . 71.9 t -60.25 -46.96 94.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 O-C-N 121.811 -0.556 . . . . 87.19 110.505 -175.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.89 HG22 ' CD2' ' A' ' 108' ' ' HIS . 63.7 t -65.94 -41.88 90.74 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.122 0 N-CA-C 109.704 -0.48 . . . . 231.82 109.704 -178.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.964 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 11.0 m120 -62.33 -34.1 75.98 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 108.335 -0.987 . . . . 364.98 108.335 -177.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.66 ' CE1' ' HB3' ' A' ' 36' ' ' ALA . 85.4 t80 -68.24 -44.66 75.2 Favored 'General case' 0 N--CA 1.438 -1.064 0 O-C-N 121.507 -0.746 . . . . 181.63 111.257 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.897 HG21 ' HD2' ' A' ' 95' ' ' HIS . 57.4 m -60.89 -45.81 93.14 Favored 'General case' 0 CA--C 1.477 -1.829 0 N-CA-C 107.422 -1.325 . . . . 269.02 107.422 -175.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 1.074 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.66 -45.07 93.16 Favored 'General case' 0 CA--C 1.469 -2.164 0 C-N-CA 118.684 -1.206 . . . . 562.66 110.052 -179.063 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.856 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.09 -45.3 95.26 Favored 'General case' 0 CA--C 1.479 -1.788 0 C-N-CA 118.744 -1.183 . . . . 446.75 108.067 -167.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.819 HG12 ' CB ' ' A' ' 36' ' ' ALA 0.388 6.1 m -70.48 -26.23 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 C-N-CA 115.791 -2.364 . . . . 370.05 112.283 -178.746 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.897 ' HD2' HG21 ' A' ' 91' ' ' THR . 89.8 m-70 -74.58 -26.42 59.92 Favored 'General case' 0 CA--C 1.506 -0.747 0 O-C-N 121.626 -0.672 . . . . 354.91 112.483 175.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.879 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.4 m-20 82.75 4.53 1.01 Allowed 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 125.078 1.351 . . . . 462.44 111.926 -178.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.764 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.267 11.9 mm-40 -172.37 178.03 2.91 Favored 'General case' 0 CA--C 1.488 -1.429 0 CA-C-O 122.044 0.926 . . . . 652.37 111.087 171.797 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.83 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.68 86.27 2.15 Favored 'General case' 0 N--CA 1.428 -1.558 0 C-N-CA 128.494 2.718 . . . . 905.99 107.95 -174.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -67.85 -36.42 80.28 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 108.266 -1.013 . . . . 570.43 108.266 -176.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.845 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.56 -36.35 82.36 Favored 'General case' 0 N--CA 1.428 -1.569 0 C-N-CA 125.343 1.457 . . . . 453.22 111.166 -174.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 1.005 ' HA2' HG21 ' A' ' 19' ' ' THR . . . 97.56 178.66 33.88 Favored Glycine 0 C--N 1.349 1.288 0 C-N-CA 118.753 -1.689 . . . . 445.63 109.882 177.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.0 mt -56.41 -41.25 76.04 Favored 'General case' 0 CA--C 1.498 -1.022 0 C-N-CA 125.276 1.43 . . . . 457.72 112.351 -170.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -58.64 -46.87 86.2 Favored 'General case' 0 CA--C 1.484 -1.562 0 C-N-CA 118.63 -1.228 . . . . 340.58 109.326 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.845 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.0 m-85 -68.76 -32.16 71.71 Favored 'General case' 0 N--CA 1.423 -1.786 0 C-N-CA 118.741 -1.184 . . . . 453.6 111.559 -176.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.727 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.02 -40.29 73.19 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 105.971 -1.863 . . . . 541.48 105.971 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.451 ' HD2' ' HA2' ' A' ' 166' ' ' GLY . 27.0 ttpt -65.89 -47.1 75.95 Favored 'General case' 0 CA--C 1.485 -1.536 0 O-C-N 124.017 0.823 . . . . 466.68 110.852 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -61.78 -47.11 86.63 Favored 'General case' 0 N--CA 1.427 -1.6 0 C-N-CA 117.506 -1.678 . . . . 427.34 107.256 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.89 ' CD2' HG22 ' A' ' 88' ' ' VAL . 47.6 m80 -67.08 -36.78 82.75 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 112.425 0.528 . . . . 537.87 112.425 -174.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.583 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.4 -42.67 74.8 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 116.861 -1.936 . . . . 422.12 111.607 175.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.913 ' O ' HG21 ' A' ' 113' ' ' ILE . 75.9 t80 -59.12 -50.05 75.54 Favored 'General case' 0 CA--C 1.502 -0.882 0 O-C-N 121.335 -0.853 . . . . 340.17 111.827 -173.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.481 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 61.6 m-85 -65.26 -46.57 71.71 Favored Pre-proline 0 N--CA 1.443 -0.801 0 C-N-CA 119.095 -1.042 . . . . 258.06 111.715 -176.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.981 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.2 Cg_exo -61.49 -31.58 87.84 Favored 'Trans proline' 0 N--CA 1.435 -1.927 0 N-CA-C 115.363 1.255 . . . . 305.71 115.363 176.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.944 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.84 -40.46 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 108.689 -0.856 . . . . 252.7 108.689 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.421 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.9 -40.6 93.7 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 107.807 -1.183 . . . . 149.27 107.807 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.0 -44.83 95.89 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 120.639 -0.424 . . . . 138.08 111.468 -176.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.755 HG23 ' CZ2' ' A' ' 261' ' ' TRP . 65.1 t -66.98 -42.33 88.57 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.937 0 O-C-N 121.581 -0.699 . . . . 132.89 110.96 -177.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.944 ' CE2' HG13 ' A' ' 113' ' ' ILE . 26.5 m-85 -63.77 -44.64 92.81 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 108.898 -0.779 . . . . 193.61 108.898 -177.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.604 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.5 -37.68 84.57 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 122.811 0.444 . . . . 63.83 110.069 -175.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 72.0 m -64.03 -52.37 59.79 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 120.721 -0.392 . . . . 76.4 111.242 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.812 HD11 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.96 -41.65 93.59 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 N-CA-C 108.17 -1.048 . . . . 171.13 108.17 -175.005 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 1.068 ' HB2' HD12 ' A' ' 154' ' ' ILE . 29.1 m-85 -63.84 -38.57 91.58 Favored 'General case' 0 N--CA 1.432 -1.331 0 O-C-N 121.838 -0.539 . . . . 78.3 110.614 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.552 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.5 t -67.1 -35.69 80.32 Favored 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 118.893 -1.123 . . . . 92.36 109.247 -178.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' MET . . . . . 1.099 ' HA ' ' HE1' ' A' ' 123' ' ' MET . 5.9 mmt -62.55 -34.24 76.54 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 108.154 -1.054 . . . . 93.73 108.154 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.97 HG22 HG13 ' A' ' 212' ' ' ILE . 33.3 p -67.44 -41.65 84.4 Favored 'General case' 0 CA--C 1.495 -1.159 0 C-N-CA 119.224 -0.99 . . . . 132.74 109.318 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.28 -42.09 94.7 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 107.158 -1.423 . . . . 43.39 107.158 -177.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.864 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.4 t -58.47 -41.98 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.369 0 N-CA-C 108.568 -0.901 . . . . 59.34 108.568 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.406 ' HB3' ' HB1' ' A' ' 215' ' ' ALA . . . -63.53 -44.02 95.42 Favored 'General case' 0 CA--C 1.497 -1.067 0 O-C-N 121.808 -0.558 . . . . 69.68 110.529 -177.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.468 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.3 t80 -65.41 -42.82 92.13 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.348 -0.982 . . . . 106.98 108.348 -177.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.864 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.37 -35.51 81.14 Favored 'General case' 0 N--CA 1.433 -1.306 0 C-N-CA 119.598 -0.841 . . . . 147.63 108.972 -177.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.767 ' NH1' ' HE2' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.19 -41.54 99.19 Favored 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 108.524 -0.917 . . . . 190.06 108.524 178.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.964 ' HD2' ' HE3' ' A' ' 132' ' ' MET . 66.4 t80 -61.35 -44.08 97.78 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 108.29 -1.004 . . . . 118.85 108.29 -177.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 1.112 ' HA ' ' HE1' ' A' ' 132' ' ' MET . 4.5 mmt -63.34 -42.64 98.96 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 109.994 -0.373 . . . . 102.5 109.994 -177.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.98 -41.69 95.21 Favored 'General case' 0 CA--C 1.488 -1.418 0 O-C-N 121.799 -0.563 . . . . 89.98 109.82 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.989 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.2 mt -66.54 -50.66 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.711 0 C-N-CA 118.119 -1.432 . . . . 106.09 111.024 -177.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.798 HD12 ' HE1' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.1 -48.29 38.41 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.09 0 C-N-CA 117.078 -1.849 . . . . 227.74 111.832 -174.84 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.792 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.84 100.07 50.99 Favored Pre-proline 0 CA--C 1.486 -1.496 0 C-N-CA 116.268 -2.173 . . . . 262.55 110.069 -175.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.468 ' HD2' ' O ' ' A' ' 135' ' ' ILE . 9.3 Cg_endo -69.61 -10.36 28.49 Favored 'Trans proline' 0 C--N 1.289 -2.558 0 C-N-CA 121.564 1.509 . . . . 210.25 111.386 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.691 HD12 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.3 111.99 1.0 Allowed 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 106.54 -1.652 . . . . 270.58 106.54 -178.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.884 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.77 -39.51 24.23 Favored Pre-proline 0 N--CA 1.43 -1.453 0 CA-C-N 115.358 -0.837 . . . . 129.84 112.325 -175.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.849 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 81.5 Cg_exo -61.44 -26.51 81.28 Favored 'Trans proline' 0 N--CA 1.431 -2.166 0 N-CA-C 116.311 1.62 . . . . 330.71 116.311 -174.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.792 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.09 77.28 8.0 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 114.445 -2.902 . . . . 204.51 107.257 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.873 HD12 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.7 147.38 0.09 Allowed 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 107.488 -1.301 . . . . 387.41 107.488 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.873 ' N ' HD12 ' A' ' 142' ' ' LEU . 47.3 t -143.68 147.0 33.64 Favored 'General case' 0 CA--C 1.496 -1.116 0 C-N-CA 118.841 -1.144 . . . . 166.22 109.484 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.4 ' O ' ' HD2' ' A' ' 148' ' ' LYS . . . -66.85 -40.72 88.0 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 107.872 -1.159 . . . . 44.23 107.872 176.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.482 ' O ' HG22 ' A' ' 149' ' ' VAL . 88.0 m -60.32 -39.12 85.88 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 108.15 -1.055 . . . . 28.8 108.15 -175.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.642 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.88 -38.78 92.21 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 109.055 -0.721 . . . . 30.29 109.055 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.958 ' HG1' HG22 ' A' ' 66' ' ' VAL . 90.1 m -59.59 -43.01 93.83 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 109.035 -0.728 . . . . 46.11 109.035 -176.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.458 ' HD3' ' HA ' ' A' ' 145' ' ' THR . 0.2 OUTLIER -62.46 -42.2 99.3 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 107.665 -1.235 . . . . 87.33 107.665 -179.651 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.789 ' O ' HG22 ' A' ' 153' ' ' VAL . 96.7 t -61.58 -42.13 92.89 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.366 0 N-CA-C 107.973 -1.121 . . . . 23.69 107.973 -178.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.6 t -63.2 -44.28 99.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 N-CA-C 109.678 -0.489 . . . . 43.86 109.678 -178.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.933 ' O ' HG23 ' A' ' 154' ' ' ILE . 46.0 mm -61.29 -42.49 93.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 N-CA-C 108.327 -0.99 . . . . 91.13 108.327 -176.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . 0.505 ' O ' HG22 ' A' ' 156' ' ' VAL . 52.2 t -62.57 -38.0 88.4 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 108.786 -0.82 . . . . 65.88 108.786 -178.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.789 HG22 ' O ' ' A' ' 149' ' ' VAL . 95.7 t -62.08 -41.86 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 N-CA-C 109.559 -0.534 . . . . 33.86 109.559 -177.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 1.068 HD12 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.35 -40.32 85.76 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.217 0 N-CA-C 107.642 -1.244 . . . . 146.52 107.642 -176.815 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . 0.778 ' O ' HD22 ' A' ' 159' ' ' LEU . 88.3 m95 -62.86 -38.36 90.54 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 119.477 -0.889 . . . . 75.44 108.942 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 152' ' ' CYS . 98.8 t -60.53 -48.44 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 O-C-N 120.976 -1.078 . . . . 43.64 109.71 -177.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.818 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.7 -37.98 89.39 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 109.034 -0.728 . . . . 102.57 109.034 -178.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.93 -41.13 86.6 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 107.437 -1.32 . . . . 58.16 107.437 -178.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.872 HD13 ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.06 -32.51 73.9 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 109.015 -0.735 . . . . 121.11 109.015 178.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.818 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.01 -42.34 85.02 Favored 'General case' 0 CA--C 1.488 -1.416 0 C-N-CA 118.586 -1.246 . . . . 153.15 109.951 -178.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 1.043 HD13 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.05 -43.75 19.05 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 113.079 -3.448 . . . . 133.67 113.522 173.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.536 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -62.95 -39.92 96.1 Favored 'General case' 0 CA--C 1.49 -1.335 0 O-C-N 120.938 -1.101 . . . . 157.42 112.184 -171.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.519 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.2 t80 -74.4 -36.1 2.47 Favored Pre-proline 0 N--CA 1.437 -1.105 0 N-CA-C 115.058 1.503 . . . . 250.91 115.058 -173.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.519 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.291 52.6 Cg_exo -59.58 -25.4 78.75 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 N-CA-C 117.976 2.26 . . . . 207.34 117.976 -174.309 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 1.019 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 87.6 mt-30 -61.22 -34.18 74.69 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 106.954 -1.498 . . . . 192.46 106.954 178.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.451 ' HA2' ' HD2' ' A' ' 106' ' ' LYS . . . -64.52 -41.09 98.07 Favored Glycine 0 C--N 1.353 1.523 0 N-CA-C 107.963 -2.055 . . . . 261.0 107.963 177.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -65.71 159.13 25.71 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 101.537 -3.505 . . . . 491.4 101.537 172.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -59.98 106.82 0.54 Allowed 'General case' 0 CA--C 1.489 -1.403 0 C-N-CA 116.256 -2.178 . . . . 386.1 109.809 -176.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 1.019 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 73.8 m -154.07 -166.62 2.42 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 103.533 -2.765 . . . . 289.8 103.533 -178.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 1.096 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.3 p -62.93 175.42 0.86 Allowed 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 117.766 -1.112 . . . . 402.06 109.538 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.783 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 72.9 p -165.24 177.5 7.58 Favored 'General case' 0 CA--C 1.586 2.355 0 C-N-CA 127.336 2.254 . . . . 690.53 114.935 177.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.57 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.9 mm-40 132.33 160.53 0.0 OUTLIER 'General case' 1 C--N 1.429 4.048 1 N-CA-C 123.195 4.517 . . . . 633.62 123.195 162.689 . . . . . . . . 4 3 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.828 HG21 ' SG ' ' A' ' 180' ' ' CYS . 69.3 p -85.62 153.81 22.13 Favored 'General case' 0 C--N 1.389 2.284 0 C-N-CA 127.414 2.286 . . . . 617.99 110.887 177.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' MET . . . . . 1.116 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.7 174.44 5.94 Favored Pre-proline 0 C--N 1.364 1.213 0 C-N-CA 130.213 3.405 . . . . 434.98 113.382 -175.385 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 1.116 ' HD2' ' HB3' ' A' ' 174' ' ' MET . 51.5 Cg_endo -44.25 -65.59 0.19 Allowed 'Trans proline' 0 N--CA 1.442 -1.503 0 N-CA-C 122.42 3.969 . . . . 365.88 122.42 -168.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' SER . . . . . 0.788 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.305 70.8 m -84.93 20.91 1.72 Allowed 'General case' 0 CA--C 1.467 -2.224 0 N-CA-C 104.79 -2.3 . . . . 635.81 104.79 178.148 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.773 ' HB3' ' H ' ' A' ' 179' ' ' VAL 0.458 5.0 mmp_? -94.28 152.22 18.84 Favored 'General case' 1 CA--C 1.419 -4.059 3 N-CA-C 131.984 7.772 . . . . 999.99 131.984 -135.756 . . . . . . . . 5 3 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 1.074 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.911 37.2 t -131.88 73.16 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.765 1 CA-C-N 103.298 -6.319 . . . . 594.32 113.603 149.185 . . . . . . . . 4 3 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.773 ' H ' ' HB3' ' A' ' 177' ' ' ARG . 7.3 p -144.17 144.12 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.653 1 N-CA-C 98.31 -4.7 . . . . 811.91 98.31 162.331 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . 0.828 ' SG ' HG21 ' A' ' 173' ' ' THR . 3.8 m -118.44 144.53 45.9 Favored 'General case' 0 CA--C 1.488 -1.41 0 C-N-CA 117.056 -1.858 . . . . 999.99 109.414 -178.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.823 ' HE1' ' CE2' ' A' ' 264' ' ' PHE . 70.7 mmm -147.18 -175.6 4.89 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-O 121.979 0.895 . . . . 431.86 110.09 -177.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 1.06 HD12 ' CD2' ' A' ' 196' ' ' TYR . 11.3 tt -69.2 148.68 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 C-N-CA 124.357 1.063 . . . . 457.18 108.796 -177.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . 0.827 ' HB3' ' HB ' ' A' ' 170' ' ' THR . 3.6 tp10 -77.34 85.5 3.76 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 124.164 0.985 . . . . 458.77 113.472 -174.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.993 ' CZ3' HG21 ' A' ' 182' ' ' ILE . 1.9 p90 -76.42 -31.46 0.96 Allowed Pre-proline 0 N--CA 1.438 -1.062 0 C-N-CA 124.937 1.295 . . . . 999.99 112.447 168.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.948 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 50.9 Cg_exo -66.03 -45.79 5.48 Favored 'Trans proline' 0 N--CA 1.438 -1.772 0 N-CA-C 120.812 3.351 . . . . 999.99 120.812 -174.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.558 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 54.9 mt-10 -119.58 171.75 8.14 Favored 'General case' 0 CA--C 1.472 -2.051 0 C-N-CA 117.174 -1.81 . . . . 81.18 107.273 -172.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.843 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.9 p-80 -109.11 45.1 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.857 0 C-N-CA 115.505 -2.478 . . . . 999.99 108.759 177.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 1.068 ' HB2' HD11 ' A' ' 191' ' ' ILE . 86.4 Cg_endo -41.51 101.81 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.164 1 C-N-CA 126.037 4.491 . . . . 999.99 105.709 -170.75 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -62.32 -44.0 97.51 Favored 'General case' 0 CA--C 1.482 -1.642 0 C-N-CA 126.775 2.03 . . . . 967.72 112.043 -165.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -60.29 -36.55 78.1 Favored 'General case' 0 CA--C 1.487 -1.48 0 N-CA-C 106.745 -1.576 . . . . 934.3 106.745 -175.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 1.068 HD11 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.54 -30.25 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 C-N-CA 129.154 2.981 . . . . 565.15 113.954 -178.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 61.58 55.4 2.78 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-N 118.403 0.547 . . . . 755.61 109.828 -175.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 1.096 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.49 -49.26 67.18 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 124.551 1.14 . . . . 325.89 113.286 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.896 ' HG3' ' HH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.82 -44.98 78.42 Favored 'General case' 0 CA--C 1.495 -1.157 0 C-N-CA 123.576 0.75 . . . . 250.21 111.629 -169.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.4 t -64.7 -43.36 96.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 CA-C-O 121.581 0.705 . . . . 142.46 110.374 -175.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . 1.06 ' CD2' HD12 ' A' ' 182' ' ' ILE . 34.7 t80 -61.15 -41.48 96.82 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 123.935 0.894 . . . . 247.69 108.813 -173.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . 0.887 ' HE2' ' HA ' ' A' ' 269' ' ' LEU . 23.1 t60 -60.53 -51.4 69.6 Favored 'General case' 0 CA--C 1.492 -1.28 0 C-N-CA 125.465 1.506 . . . . 199.61 113.058 -175.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 82.8 mt -65.29 -44.47 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 107.748 -1.205 . . . . 106.73 107.748 -177.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . 0.591 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.8 t -59.2 -48.51 81.34 Favored 'General case' 0 CA--C 1.487 -1.459 0 CA-C-N 115.867 -0.606 . . . . 115.01 110.201 -173.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 1.043 HG13 HD13 ' A' ' 161' ' ' LEU . 86.2 t -65.24 -49.17 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.626 0 C-N-CA 119.398 -0.921 . . . . 129.42 111.847 -174.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.811 HG22 ' CD1' ' A' ' 206' ' ' PHE . 69.1 m -61.85 -53.13 60.07 Favored 'General case' 0 CA--C 1.482 -1.639 0 C-N-CA 118.186 -1.406 . . . . 172.48 109.977 -172.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.678 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 85.6 t -63.85 -54.25 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 C-N-CA 120.546 -0.462 . . . . 55.86 110.979 -174.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.591 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.58 -51.54 59.01 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 118.57 -1.252 . . . . 184.68 111.502 -174.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . 1.001 ' HB ' HD11 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.65 -52.38 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 C-N-CA 116.607 -2.037 . . . . 291.81 114.731 -174.696 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.434 ' HB2' ' CE1' ' A' ' 265' ' ' HIS . 87.8 t80 -82.04 -55.03 4.83 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 115.143 1.534 . . . . 130.66 115.143 -178.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . 0.811 ' CD1' HG22 ' A' ' 201' ' ' THR . 40.0 m-85 -66.86 -48.51 68.58 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 114.492 1.293 . . . . 80.16 114.492 -170.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.92 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.52 -45.52 83.37 Favored Pre-proline 0 N--CA 1.435 -1.185 0 C-N-CA 119.989 -0.685 . . . . 136.02 109.504 -174.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.92 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 88.2 Cg_exo -64.76 -27.16 60.01 Favored 'Trans proline' 0 N--CA 1.433 -2.063 0 N-CA-C 110.616 -0.571 . . . . 92.17 110.616 -179.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.773 HD22 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.39 -41.33 76.62 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 107.492 -1.299 . . . . 135.6 107.492 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.2 -44.66 91.28 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 109.577 -0.527 . . . . 52.1 109.577 -176.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . 0.678 HG11 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.71 -43.46 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 N-CA-C 109.088 -0.708 . . . . 95.89 109.088 -176.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.97 HG13 HG22 ' A' ' 124' ' ' THR . 94.7 mt -61.33 -42.31 93.15 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.386 0 N-CA-C 106.663 -1.606 . . . . 43.41 106.663 -178.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.46 -42.3 99.05 Favored Glycine 0 N--CA 1.432 -1.63 0 N-CA-C 109.343 -1.503 . . . . 27.69 109.343 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . 0.904 ' O ' HG22 ' A' ' 217' ' ' THR . 77.8 t80 -65.72 -47.29 75.83 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 117.409 0.604 . . . . 54.41 110.467 -177.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . 0.898 ' O ' HG13 ' A' ' 218' ' ' VAL . . . -61.47 -34.11 74.89 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 106.916 -1.513 . . . . 53.88 106.916 -177.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -60.78 -40.81 93.96 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 108.492 -0.929 . . . . 68.29 108.492 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' THR . . . . . 0.904 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.81 -38.98 92.79 Favored 'General case' 0 CA--C 1.497 -1.086 0 C-N-CA 119.704 -0.799 . . . . 107.59 110.619 -175.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.898 HG13 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.06 -38.37 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 119.584 -0.846 . . . . 111.61 109.49 -177.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.989 HG13 ' CD1' ' A' ' 134' ' ' ILE . 79.5 t -63.3 -22.45 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 N-CA-C 108.428 -0.952 . . . . 85.26 108.428 -178.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.89 -41.95 99.45 Favored Glycine 0 C--N 1.35 1.324 0 N-CA-C 111.014 -0.834 . . . . 40.71 111.014 -176.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.73 -43.99 96.52 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 N-CA-C 108.414 -0.958 . . . . 95.86 108.414 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.844 ' CB ' HG22 ' A' ' 134' ' ' ILE . 67.4 p -76.98 -137.47 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.452 -0.944 . . . . 144.37 108.452 -176.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.929 HD21 ' NE ' ' A' ' 244' ' ' ARG . 87.6 mt -55.39 132.16 47.51 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 107.574 -1.269 . . . . 326.72 107.574 -177.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' TRP . . . . . 0.466 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 9.0 t90 -119.37 -168.05 1.51 Allowed 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 106.006 -1.85 . . . . 158.38 106.006 -176.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . 0.466 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.34 -41.96 98.9 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 109.632 -0.507 . . . . 36.78 109.632 -178.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.8 m -61.09 125.86 25.25 Favored 'General case' 0 N--CA 1.433 -1.32 0 C-N-CA 119.167 -1.013 . . . . 85.46 109.81 -174.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.777 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.88 126.52 8.82 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 105.54 -2.022 . . . . 127.78 105.54 176.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.981 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.01 139.93 34.85 Favored Pre-proline 0 CA--C 1.493 -1.241 0 N-CA-C 105.977 -1.86 . . . . 164.84 105.977 -179.614 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.981 ' N ' HD13 ' A' ' 228' ' ' ILE . 83.1 Cg_exo -56.86 -39.9 88.08 Favored 'Trans proline' 0 N--CA 1.431 -2.183 0 N-CA-C 113.916 0.698 . . . . 222.35 113.916 -175.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . 0.763 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.16 167.02 44.92 Favored Glycine 0 N--CA 1.427 -1.915 0 N-CA-C 106.423 -2.671 . . . . 45.22 106.423 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.925 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.9 t0 -60.93 -45.76 93.4 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 106.045 -1.835 . . . . 107.57 106.045 177.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' SER . . . . . 0.761 ' O ' HG22 ' A' ' 228' ' ' ILE . 67.9 m -65.77 141.83 58.18 Favored 'General case' 0 N--CA 1.429 -1.509 0 C-N-CA 118.894 -1.122 . . . . 167.96 109.145 -175.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.827 ' O ' ' HD2' ' A' ' 235' ' ' ARG . 68.3 m 99.52 106.74 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 126.746 2.019 . . . . 280.68 109.707 176.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.777 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.7 m-20 56.03 11.21 0.7 Allowed 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 124.452 1.101 . . . . 218.25 110.675 174.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.931 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.35 137.62 54.79 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 105.213 -2.143 . . . . 343.57 105.213 177.407 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.586 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.5 t80 -111.93 81.87 1.53 Allowed 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 106.873 -1.529 . . . . 263.29 106.873 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' HIS . . . . . 0.663 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.4 m-70 104.27 147.07 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.268 0 C-N-CA 126.58 1.952 . . . . 261.92 108.522 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.18 -38.13 89.96 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 107.853 -1.166 . . . . 106.81 107.853 -177.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.758 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.48 -39.9 94.93 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 118.366 -1.334 . . . . 112.2 107.536 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.748 HG13 ' NH1' ' A' ' 244' ' ' ARG . 75.8 t -64.27 -39.78 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 N-CA-C 109.263 -0.643 . . . . 45.41 109.263 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.86 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.2 p -70.93 -32.13 68.95 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 110.233 -0.284 . . . . 97.62 110.233 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.34 -39.66 81.83 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 123.73 0.812 . . . . 59.29 110.972 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.758 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.2 -36.56 84.04 Favored 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 124.601 1.16 . . . . 106.49 110.67 -174.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.931 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.97 -30.63 69.23 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 108.294 -1.002 . . . . 106.62 108.294 -176.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.573 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.5 mttm -65.97 -41.04 91.69 Favored 'General case' 0 N--CA 1.435 -1.201 0 O-C-N 121.771 -0.581 . . . . 75.97 110.094 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.877 ' CG1' ' HE3' ' A' ' 250' ' ' MET . 76.0 t -65.6 -40.81 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 C-N-CA 122.908 0.483 . . . . 65.27 109.763 -178.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.835 HG11 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -64.01 -41.55 92.84 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.343 0 C-N-CA 120.39 -0.524 . . . . 107.94 110.185 -177.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.573 ' HE2' ' HA ' ' A' ' 245' ' ' LYS . 59.2 pttt -63.54 -40.85 98.07 Favored 'General case' 0 N--CA 1.433 -1.279 0 O-C-N 121.68 -0.638 . . . . 87.98 110.281 -176.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' MET . . . . . 1.063 ' HE2' ' CD1' ' A' ' 305' ' ' TYR . 21.3 ttt -63.58 -40.44 96.98 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 118.863 -1.135 . . . . 65.5 108.405 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' MET . . . . . 0.877 ' HE3' ' CG1' ' A' ' 246' ' ' VAL . 68.5 mtt -61.7 -36.38 80.74 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 108.141 -1.059 . . . . 85.05 108.141 -177.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.516 HD11 ' HA ' ' A' ' 248' ' ' LYS . 86.9 mt -63.47 -45.76 97.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 109.061 -0.718 . . . . 42.25 109.061 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . 0.874 HG13 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.32 -38.24 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 C-N-CA 119.568 -0.853 . . . . 91.01 109.396 -176.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 1.031 HG21 HD11 ' A' ' 304' ' ' ILE . 65.9 t -58.89 -41.53 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 N-CA-C 108.009 -1.108 . . . . 66.09 108.009 -178.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 250' ' ' MET . 94.8 t -66.07 -43.22 92.45 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.298 0 O-C-N 122.093 -0.379 . . . . 52.39 110.285 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 83.9 m -61.76 -46.71 88.44 Favored 'General case' 0 CA--C 1.489 -1.389 0 O-C-N 121.892 -0.505 . . . . 46.42 109.873 -174.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' THR . . . . . 0.821 ' O ' HG23 ' A' ' 259' ' ' ILE . 9.5 t -62.34 -38.2 88.6 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 108.314 -0.995 . . . . 116.51 108.314 -177.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' PHE . . . . . 0.543 ' N ' HG23 ' A' ' 256' ' ' THR . 86.0 t80 -60.21 -48.24 82.59 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 109.38 -0.6 . . . . 65.18 109.38 -178.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.99 -42.63 97.13 Favored 'General case' 0 CA--C 1.489 -1.373 0 O-C-N 122.093 -0.379 . . . . 51.33 110.448 -175.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . 0.821 HG23 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.65 -43.37 98.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 C-N-CA 118.883 -1.127 . . . . 126.3 109.015 -176.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' CYS . . . . . 0.571 ' N ' HG22 ' A' ' 259' ' ' ILE . 69.7 m -65.54 -49.34 69.28 Favored 'General case' 0 N--CA 1.432 -1.325 0 C-N-CA 119.512 -0.875 . . . . 133.94 112.508 -176.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.866 ' CH2' ' HB2' ' A' ' 294' ' ' ALA . 97.1 m95 -80.63 -33.38 35.79 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 116.869 2.174 . . . . 134.84 116.869 -176.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.796 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.9 tp -58.49 -41.58 89.94 Favored Pre-proline 0 CA--C 1.493 -1.242 0 O-C-N 121.663 -0.648 . . . . 72.23 111.643 -167.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' PRO . . . . . 0.816 ' O ' HG21 ' A' ' 266' ' ' ILE . 80.9 Cg_exo -60.63 -36.02 87.14 Favored 'Trans proline' 0 N--CA 1.429 -2.287 0 CA-C-N 119.884 0.994 . . . . 106.13 111.349 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' PHE . . . . . 0.902 ' N ' HG22 ' A' ' 290' ' ' ILE . 71.8 t80 -66.45 -44.6 82.36 Favored 'General case' 0 N--CA 1.434 -1.273 0 C-N-CA 119.7 -0.8 . . . . 128.35 110.019 -178.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' HIS . . . . . 0.697 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.48 -37.87 89.05 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 110.195 -0.298 . . . . 100.73 110.195 -177.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.816 HG21 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.23 -44.52 95.14 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 C-N-CA 119.294 -0.962 . . . . 172.72 109.191 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . 0.75 ' HD1' ' O ' ' A' ' 263' ' ' PRO . 61.5 m-85 -66.63 -28.07 68.19 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 108.199 -1.037 . . . . 249.23 108.199 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' PHE . . . . . 0.921 ' CZ ' HG22 ' A' ' 182' ' ' ILE . 20.4 t80 -55.58 -55.1 35.99 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 106.673 -1.603 . . . . 259.78 106.673 178.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . 0.887 ' HA ' ' HE2' ' A' ' 197' ' ' HIS . 89.4 mt -69.16 -44.22 72.7 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 113.58 0.955 . . . . 233.11 113.58 -176.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.834 HD12 HD22 ' A' ' 279' ' ' LEU . 88.6 mt -61.36 -48.27 91.57 Favored Pre-proline 0 N--CA 1.44 -0.967 0 C-N-CA 119.193 -1.003 . . . . 169.54 110.615 -171.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . 0.682 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.6 Cg_exo -61.21 -24.5 79.13 Favored 'Trans proline' 0 N--CA 1.43 -2.25 0 C-N-CA 116.689 -1.741 . . . . 255.47 114.639 174.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' TYR . . . . . 0.896 ' HH ' ' HG3' ' A' ' 194' ' ' LYS . 19.6 t80 -63.61 -44.2 94.66 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 119.271 0.941 . . . . 279.03 108.905 177.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . 0.829 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.27 -44.8 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 N-CA-C 110.102 -0.333 . . . . 162.21 110.102 -178.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' ASN . . . . . 0.771 ' N ' HD11 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.45 84.86 59.42 Favored Pre-proline 0 N--CA 1.431 -1.387 0 C-N-CA 118.76 -1.176 . . . . 128.13 108.029 -178.039 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.5 Cg_endo -85.22 163.99 11.3 Favored 'Trans proline' 0 C--N 1.295 -2.284 0 N-CA-C 107.482 -1.776 . . . . 278.35 107.482 177.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . 0.852 ' O ' HD22 ' A' ' 277' ' ' LEU . 39.3 t0 66.14 15.02 9.93 Favored 'General case' 0 N--CA 1.429 -1.524 0 O-C-N 123.794 0.684 . . . . 312.91 109.328 175.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.852 HD22 ' O ' ' A' ' 276' ' ' ASP . 28.5 mt -132.73 -170.72 2.5 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 106.557 -1.646 . . . . 353.54 106.557 177.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 1.027 ' HA ' ' HB2' ' A' ' 282' ' ' PHE . 42.7 p90 -115.61 142.22 47.03 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 107.441 -1.318 . . . . 251.26 107.441 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.834 HD22 HD12 ' A' ' 270' ' ' LEU . 1.7 tm? -76.94 -118.76 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 102.097 -3.297 . . . . 175.26 102.097 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . 0.779 ' HB3' ' HE3' ' A' ' 281' ' ' LYS . 34.1 ttmt -61.45 -45.02 96.01 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 100.889 -3.745 . . . . 99.07 100.889 172.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . 0.779 ' HE3' ' HB3' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.36 124.15 9.21 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 103.488 -2.782 . . . . 243.21 103.488 171.171 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 1.027 ' HB2' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.95 112.98 25.13 Favored 'General case' 0 CA--C 1.474 -1.979 0 C-N-CA 116.037 -2.265 . . . . 201.04 105.294 178.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' ILE . . . . . 0.771 HG23 ' N ' ' A' ' 285' ' ' GLN . 10.7 tp -147.93 173.69 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.064 0 C-N-CA 116.036 -2.266 . . . . 201.36 108.754 -175.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . 1.069 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.282 0.6 OUTLIER -59.5 -41.43 89.87 Favored 'General case' 0 N--CA 1.416 -2.164 0 CA-C-N 113.184 -1.825 . . . . 203.82 107.829 174.47 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . 0.92 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.31 -45.75 86.59 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 118.249 -1.38 . . . . 215.06 112.55 -171.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.64 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.7 t -65.66 -46.44 89.31 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.467 0 C-N-CA 118.606 -1.237 . . . . 125.28 112.886 -171.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' TYR . . . . . 0.857 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.83 -36.95 86.0 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 107.169 -1.419 . . . . 268.9 107.169 -171.836 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . 0.867 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.24 -45.02 74.36 Favored 'General case' 0 N--CA 1.427 -1.602 0 C-N-CA 125.644 1.577 . . . . 280.88 108.808 -172.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.61 -47.53 85.8 Favored 'General case' 0 N--CA 1.428 -1.567 0 C-N-CA 119.01 -1.076 . . . . 184.47 108.988 -172.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . 0.902 HG22 ' N ' ' A' ' 264' ' ' PHE . 1.8 mp -67.91 -42.1 85.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 C-N-CA 119.298 -0.961 . . . . 167.92 112.732 -175.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' MET . . . . . 0.664 ' HE2' ' HG2' ' A' ' 181' ' ' MET . 21.8 ttt -65.79 -38.75 89.84 Favored 'General case' 0 CA--C 1.495 -1.146 0 C-N-CA 117.779 -1.569 . . . . 367.18 110.785 -175.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' TRP . . . . . 0.571 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.4 m95 -67.19 -32.71 73.97 Favored 'General case' 0 N--CA 1.435 -1.205 0 O-C-N 121.892 -0.505 . . . . 173.97 110.46 177.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.3 tp -64.48 -36.69 85.01 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 123.523 0.729 . . . . 119.66 109.815 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . 0.866 ' HB2' ' CH2' ' A' ' 261' ' ' TRP . . . -61.29 -33.91 74.34 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.752 -1.203 . . . . 112.3 107.752 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' MET . . . . . 0.714 ' O ' HG21 ' A' ' 298' ' ' THR . 21.9 mmt -63.11 -32.09 73.39 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 116.193 -0.458 . . . . 174.17 110.185 -177.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.5 m -64.74 -22.7 67.04 Favored 'General case' 0 CA--C 1.485 -1.525 0 C-N-CA 124.669 1.188 . . . . 145.27 110.638 -175.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' SER . . . . . 0.826 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.6 m -57.66 -35.36 70.45 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 108.056 -1.091 . . . . 170.15 108.056 -175.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.84 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.7 t -55.34 -34.14 63.96 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 116.32 -0.4 . . . . 214.57 110.654 -171.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' MET . . . . . 0.803 ' CE ' ' HG1' ' A' ' 45' ' ' THR . 28.1 ttt -77.18 -33.2 56.45 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 126.065 1.746 . . . . 168.29 115.545 177.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' TYR . . . . . 0.826 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.4 p90 -64.45 -34.86 79.19 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 114.02 1.119 . . . . 167.15 114.02 -168.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . 0.75 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.281 18.8 p-10 -64.22 -38.25 32.78 Favored Pre-proline 0 N--CA 1.433 -1.295 0 C-N-CA 115.536 -2.466 . . . . 165.13 113.961 -171.595 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' PRO . . . . . 0.75 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 83.8 Cg_exo -62.56 -31.8 79.83 Favored 'Trans proline' 0 N--CA 1.433 -2.061 0 CA-C-N 122.791 2.033 . . . . 123.92 111.254 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' ILE . . . . . 0.784 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.76 -42.58 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 C-N-CA 118.859 -1.136 . . . . 110.55 109.739 -179.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' ILE . . . . . 1.031 HD11 HG21 ' A' ' 253' ' ' VAL . 31.1 pt -61.16 -40.02 84.43 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.179 0 N-CA-C 108.825 -0.806 . . . . 145.31 108.825 -177.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . 1.063 ' CD1' ' HE2' ' A' ' 249' ' ' MET 0.253 63.1 m-85 -58.12 -48.84 78.98 Favored 'General case' 0 CA--C 1.495 -1.171 0 C-N-CA 119.416 -0.914 . . . . 246.68 109.824 -177.48 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.7 m -62.14 -47.53 84.17 Favored 'General case' 0 CA--C 1.484 -1.564 0 C-N-CA 119.526 -0.87 . . . . 64.43 109.587 -173.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.6 t -66.83 -45.01 79.62 Favored 'General case' 0 N--CA 1.428 -1.553 0 C-N-CA 118.992 -1.083 . . . . 80.72 110.226 -177.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.759 HD22 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.56 -35.66 75.61 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 115.937 1.828 . . . . 140.44 115.937 -173.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . 0.617 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.8 p30 -136.83 132.2 34.3 Favored 'General case' 0 N--CA 1.434 -1.245 0 C-N-CA 112.723 -3.591 . . . . 178.87 113.039 -177.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . 0.705 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.06 -37.0 86.13 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 114.409 -1.269 . . . . 110.22 110.151 -177.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . 0.86 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.77 -50.58 72.77 Favored 'General case' 0 CA--C 1.492 -1.27 0 O-C-N 121.753 -0.592 . . . . 174.78 109.737 -174.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.978 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.1 m-85 -64.92 -41.65 95.38 Favored 'General case' 0 CA--C 1.484 -1.575 0 N-CA-C 108.24 -1.022 . . . . 161.84 108.24 178.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . 0.479 ' HE ' HD21 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.32 -50.24 73.58 Favored 'General case' 0 CA--C 1.49 -1.331 0 N-CA-C 109.182 -0.673 . . . . 117.2 109.182 -173.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.84 ' HB3' HD12 ' A' ' 326' ' ' ILE . 3.0 mm? -68.48 -44.16 75.37 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 120.364 -0.534 . . . . 112.6 111.037 -177.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . 1.136 ' HA2' ' HD1' ' A' ' 318' ' ' HIS . . . -63.99 -37.48 94.68 Favored Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 110.648 -0.981 . . . . 101.46 110.648 -177.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' PHE . . . . . 0.978 ' CE2' ' HB3' ' A' ' 312' ' ' PHE . 36.6 m-85 -62.15 -46.01 90.9 Favored 'General case' 0 CA--C 1.492 -1.265 0 CA-C-N 118.493 1.147 . . . . 151.49 109.5 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . 0.465 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.06 -36.34 77.12 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 106.959 -1.497 . . . . 142.32 106.959 -175.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' HIS . . . . . 1.136 ' HD1' ' HA2' ' A' ' 315' ' ' GLY . 50.0 m80 -59.82 -41.76 92.02 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 106.892 -1.521 . . . . 109.09 106.892 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.9 -42.46 85.45 Favored 'General case' 0 N--CA 1.435 -1.183 0 O-C-N 122.368 -0.208 . . . . 76.11 110.979 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -61.37 -55.49 30.98 Favored 'General case' 0 CA--C 1.49 -1.36 0 C-N-CA 119.866 -0.734 . . . . 120.24 109.361 -174.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . 0.755 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.4 mtt180 -74.36 131.54 41.22 Favored 'General case' 0 CA--C 1.482 -1.649 0 N-CA-C 102.943 -2.984 . . . . 192.73 102.943 177.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.11 -44.27 91.96 Favored 'General case' 0 CA--C 1.492 -1.27 0 C-N-CA 119.008 -1.077 . . . . 176.29 109.212 -172.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' CYS . . . . . 0.811 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 77.9 m -79.34 -177.14 0.82 Allowed Pre-proline 0 N--CA 1.43 -1.439 0 N-CA-C 106.364 -1.717 . . . . 69.68 106.364 178.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.568 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 84.2 Cg_exo -58.93 -75.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.389 0 C-N-CA 118.343 -0.638 . . . . 191.05 112.637 176.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' PHE . . . . . 0.811 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.6 m-85 47.45 43.88 16.09 Favored 'General case' 0 CA--C 1.493 -1.234 0 O-C-N 123.571 0.544 . . . . 287.03 109.803 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . 0.844 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.52 78.65 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.474 -1.944 0 C-N-CA 112.885 -3.526 . . . . 292.29 109.847 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' SER . . . . . 0.507 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.4 t -77.48 -152.84 0.05 Allowed 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 104.199 -2.519 . . . . 184.57 104.199 178.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.65 8.67 4.99 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 113.091 0.775 . . . . 274.56 113.091 176.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 99.0 0.89 57.23 Favored Glycine 0 C--N 1.348 1.248 0 C-N-CA 117.725 -2.178 . . . . 268.24 113.473 172.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' ASP . . . . . 0.724 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.9 m-20 51.6 -172.05 0.03 OUTLIER 'General case' 0 CA--C 1.496 -1.099 0 CA-C-N 118.676 1.238 . . . . 200.06 110.782 177.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.86 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.3 t80 -63.86 -33.02 74.75 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 107.892 -1.151 . . . . 114.44 107.892 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' GLU . . . . . 0.597 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.27 46.05 21.91 Favored 'General case' 0 CA--C 1.484 -1.581 0 N-CA-C 107.627 -1.249 . . . . 263.81 107.627 -177.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' GLY . . . . . 0.65 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.31 -137.37 3.61 Favored Glycine 0 CA--C 1.478 -2.229 1 N-CA-C 102.548 -4.221 . . . . 103.79 102.548 -179.804 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . 0.994 HD21 ' HA ' ' A' ' 337' ' ' LYS . 61.4 mt -88.27 95.61 10.25 Favored 'General case' 0 N--CA 1.419 -1.983 0 C-N-CA 114.95 -2.7 . . . . 117.3 106.013 176.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . 1.065 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.97 -39.8 90.68 Favored 'General case' 0 CA--C 1.468 -2.177 1 N-CA-C 97.977 -4.823 . . . . 231.58 97.977 167.232 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 1.06 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.91 163.53 28.95 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 102.092 -3.299 . . . . 303.24 102.092 168.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' LYS . . . . . 0.994 ' HA ' HD21 ' A' ' 334' ' ' LEU . 84.4 tttt -62.6 -48.64 78.54 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 116.066 -2.253 . . . . 112.72 108.442 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' SER . . . . . 0.411 ' HB3' ' SD ' ' A' ' 336' ' ' MET . 47.9 t -61.03 -63.68 1.22 Allowed 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 109.091 -0.707 . . . . 83.22 109.091 -176.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' THR . . . . . 0.911 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.4 m -156.28 -126.18 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 103.858 -2.645 . . . . 174.36 103.858 -178.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . 1.065 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.88 160.94 8.81 Favored 'General case' 0 CA--C 1.486 -1.515 0 N-CA-C 105.789 -1.93 . . . . 202.73 105.789 177.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . 1.033 ' HH ' ' HA3' ' A' ' 315' ' ' GLY . 0.2 OUTLIER -131.94 149.0 52.56 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 107.065 -1.457 . . . . 180.62 107.065 176.432 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . 0.946 ' H ' ' HB2' ' A' ' 347' ' ' SER . 53.6 tp -178.49 -171.85 0.27 Allowed 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 105.407 -2.072 . . . . 145.25 105.407 178.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' GLN . . . . . 0.944 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.06 -43.2 88.13 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 106.113 -1.81 . . . . 66.05 106.113 174.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' THR . . . . . 0.757 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.66 -152.14 0.48 Allowed 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 103.521 -2.77 . . . . 266.49 103.521 179.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' GLN . . . . . 0.61 ' CD ' HD23 ' A' ' 342' ' ' LEU . 79.5 mt-30 66.28 -124.97 0.28 Allowed 'General case' 0 N--CA 1.428 -1.572 0 C-N-CA 117.076 -1.85 . . . . 219.2 107.739 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . 0.991 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -64.96 -37.43 94.26 Favored Glycine 0 N--CA 1.426 -2.013 0 CA-C-N 114.536 -1.211 . . . . 94.78 112.895 -176.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' SER . . . . . 1.107 ' HG ' ' HB3' ' A' ' 61' ' ' LYS . 48.4 t -81.21 100.45 9.12 Favored 'General case' 0 CA--C 1.483 -1.599 0 C-N-CA 112.327 -3.749 . . . . 121.41 109.441 -171.047 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . 0.671 ' O ' ' HE2' ' A' ' 336' ' ' MET . 94.2 t -73.09 145.55 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 108.961 -0.755 . . . . 85.34 108.961 -176.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' TYR . . . . . 0.434 ' N ' HG11 ' A' ' 348' ' ' VAL . 48.5 p90 -57.78 143.44 42.09 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.848 -1.167 . . . . 267.57 107.848 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . 0.508 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.08 69.53 0.6 Allowed 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 109.532 -0.544 . . . . 226.1 109.532 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' VAL . . . . . 1.05 ' HB ' ' HE1' ' A' ' 336' ' ' MET . 7.5 p -50.96 156.97 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.315 0 N-CA-C 107.017 -1.475 . . . . 154.84 107.017 177.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' SER . . . . . 0.608 ' N ' HG21 ' A' ' 351' ' ' VAL . 71.5 m -61.4 161.92 8.64 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-O 121.602 0.715 . . . . 180.01 110.721 -173.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' ARG . . . . . 0.879 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.45 156.91 23.66 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 106.913 -1.514 . . . . 333.78 106.913 -178.615 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . 0.997 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.03 142.54 48.73 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 107.325 -1.361 . . . . 335.2 107.325 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.997 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.5 mm-40 82.79 158.88 0.13 Allowed 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 108.753 -0.832 . . . . 266.47 108.753 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.5 m -60.6 -46.84 88.74 Favored 'General case' 0 CA--C 1.487 -1.467 0 N-CA-C 105.708 -1.96 . . . . 59.34 105.708 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.6 173.83 11.98 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 104.444 -2.428 . . . . 201.26 104.444 176.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.78 HG21 ' O ' ' A' ' 360' ' ' THR . 69.2 mt -95.92 106.7 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 C-N-CA 116.323 -2.151 . . . . 56.23 105.53 -179.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' SER . . . . . 0.523 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.7 m -61.15 -59.48 5.26 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 109.308 -0.627 . . . . 87.58 109.308 -175.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' THR . . . . . 0.884 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.1 t -85.49 153.71 22.27 Favored 'General case' 0 CA--C 1.486 -1.513 0 N-CA-C 107.871 -1.159 . . . . 219.95 107.871 -177.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' VAL . . . . . 0.563 HG22 ' O ' ' A' ' 361' ' ' VAL . 16.0 m -81.98 83.86 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.656 0 C-N-CA 116.326 -2.15 . . . . 121.79 105.434 177.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.567 HG11 ' N ' ' A' ' 363' ' ' GLY . 64.5 t -154.16 159.68 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 N-CA-C 105.824 -1.917 . . . . 53.85 105.824 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . 0.567 ' N ' HG11 ' A' ' 362' ' ' VAL . . . 72.28 16.59 77.15 Favored Glycine 0 N--CA 1.428 -1.875 0 N-CA-C 106.046 -2.822 . . . . 196.55 106.046 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.681 0 N-CA-C 107.849 -1.167 . . . . 35.88 107.849 -178.9 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 365' ' ' ARG . . . . . 0.477 HH11 ' HD2' ' B' ' 365' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 108.808 -0.812 . . . . 1.0 108.808 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 366' ' ' PRO . . . . . 0.416 ' CD ' ' N ' ' B' ' 365' ' ' ARG . 52.8 Cg_endo -66.91 141.99 60.78 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.086 1.858 . . . . 1.0 110.228 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 367' ' ' LYS . . . . . 0.905 ' HG3' HD12 ' A' ' 5' ' ' LEU . 0.8 OUTLIER -64.35 143.26 98.45 Favored Pre-proline 0 C--N 1.326 -0.445 0 C-N-CA 119.888 -0.725 . . . . 1.0 109.576 -179.875 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 368' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.31 150.44 76.26 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.272 1.981 . . . . 1.0 111.728 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 369' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.77 131.75 44.3 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.724 -0.39 . . . . 1.0 110.165 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 370' ' ' GLN . . . . . 0.711 ' NE2' ' HA ' ' B' ' 370' ' ' GLN . 0.0 OUTLIER -102.01 115.93 31.61 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.672 -179.831 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 371' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -63.71 -42.36 97.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.347 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 372' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -65.03 -36.21 83.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.871 -0.604 . . . . 1.0 110.652 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -59.78 -33.0 76.05 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.839 -0.905 . . . . 1.0 110.839 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 374' ' ' LEU . . . . . 0.996 HD12 ' HA ' ' A' ' 20' ' ' SER . 10.0 tp -67.83 131.36 45.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.885 0.374 . . . . 1.0 110.173 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 375' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 117.947 -1.025 . . . . 1.0 110.588 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.457 0 N-CA-C 108.377 -0.971 . . . . 97.079999999999998 108.377 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -110.61 155.42 22.39 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-O 122.103 0.954 . . . . 123.41 110.737 -172.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.877 HG11 HD13 ' A' ' 15' ' ' ILE . 28.7 m -134.58 -162.38 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.487 1 N-CA-C 100.093 -4.04 . . . . 151.30000000000001 100.093 173.732 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.908 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.63 -38.61 58.55 Favored Pre-proline 0 N--CA 1.439 -0.981 0 C-N-CA 115.961 -2.295 . . . . 169.25 106.123 178.106 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.908 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 58.0 Cg_exo -81.28 168.53 16.65 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 122.255 0.608 . . . . 185.75999999999999 110.536 171.273 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.906 HG13 ' CE2' ' A' ' 282' ' ' PHE . 92.0 t -64.47 -25.93 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 C-N-CA 127.022 2.129 . . . . 145.47 110.343 -177.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.774 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.2 t0 -84.33 157.41 21.5 Favored 'General case' 0 CA--C 1.499 -0.988 0 O-C-N 121.073 -1.017 . . . . 102.76000000000001 109.459 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.5 p -82.59 154.17 25.1 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 107.988 -1.115 . . . . 106.25 107.988 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.918 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.7 p-10 -105.89 51.89 0.74 Allowed 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 117.772 -1.571 . . . . 157.81 107.628 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.16 -45.9 91.51 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 103.586 -2.746 . . . . 150.19999999999999 103.586 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.8 m -87.05 164.68 35.29 Favored Pre-proline 0 N--CA 1.422 -1.872 0 N-CA-C 103.672 -2.714 . . . . 183.52000000000001 103.672 172.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -76.77 6.87 3.84 Favored 'Trans proline' 0 C--N 1.281 -2.998 0 N-CA-C 109.988 -0.812 . . . . 235.61000000000001 109.988 176.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.422 ' C ' HD21 ' A' ' 14' ' ' ASN . 0.4 OUTLIER -57.93 -41.25 82.33 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 124.809 1.244 . . . . 113.77 113.379 -170.108 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.918 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.4 pt -52.16 136.22 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-N 119.558 1.072 . . . . 150.84999999999999 110.984 -176.167 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.49 156.26 46.39 Favored 'General case' 0 C--N 1.36 1.064 0 N-CA-C 107.625 -1.25 . . . . 100.42 107.625 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . 1.08 HG23 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.05 142.61 58.35 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 121.953 0.882 . . . . 129.36000000000001 110.444 -174.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.775 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 74.5 m-20 -63.06 -25.5 68.4 Favored 'General case' 0 CA--C 1.494 -1.208 0 C-N-CA 126.303 1.841 . . . . 112.34 106.689 -177.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.941 HG23 ' HA2' ' A' ' 101' ' ' GLY . 85.8 m -74.14 -40.14 62.81 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.542 -0.754 . . . . 131.72999999999999 111.744 177.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . 1.08 ' H ' HG23 ' A' ' 17' ' ' THR . 71.2 m -84.45 -42.86 15.18 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 116.994 2.22 . . . . 80.489999999999995 116.994 -174.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.549 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.4 mt-10 -145.99 174.54 3.34 Favored Pre-proline 0 N--CA 1.443 -0.817 0 C-N-CA 118.152 -1.419 . . . . 98.980000000000004 111.198 -169.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.823 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.333 85.7 Cg_exo -61.79 -10.73 18.04 Favored 'Trans proline' 0 C--N 1.321 -0.887 1 N-CA-C 128.934 6.475 . . . . 246.94999999999999 128.934 -170.085 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.0 m120 61.61 17.55 8.7 Favored 'General case' 0 C--N 1.324 -0.515 1 CA-C-N 126.15 4.068 . . . . 269.62 114.216 175.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.495 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 80.8 mt-30 -67.14 -27.26 67.16 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 107.802 -1.184 . . . . 86.799999999999997 107.802 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.551 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.3 p90 -66.81 -29.34 69.25 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 121.115 -0.991 . . . . 85.909999999999997 110.501 -178.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.873 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.4 t -68.54 -40.21 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 C-N-CA 123.695 0.798 . . . . 82.0 111.346 -177.027 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.896 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 27.6 pt20 -151.4 167.73 12.48 Favored Pre-proline 0 CA--C 1.489 -1.4 0 N-CA-C 108.552 -0.907 . . . . 120.73 108.552 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.902 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -64.0 149.76 89.82 Favored 'Trans proline' 0 N--CA 1.432 -2.123 0 C-N-CA 120.616 0.877 . . . . 87.859999999999999 109.91 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.744 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.03 -37.96 89.28 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 108.846 -0.798 . . . . 36.460000000000001 108.846 -176.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.814 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.8 p-90 -63.8 -33.86 76.61 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 107.807 -1.183 . . . . 150.59999999999999 107.807 -176.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.902 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.5 mt-30 -62.21 -32.71 73.41 Favored 'General case' 0 CA--C 1.49 -1.334 0 O-C-N 121.291 -0.88 . . . . 123.26000000000001 108.666 -178.321 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.744 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.47 -47.17 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.57 0 N-CA-C 109.157 -0.682 . . . . 120.14 109.157 176.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.785 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.2 m -67.41 -31.03 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 107.873 -1.158 . . . . 112.19 107.873 -178.169 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.814 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.5 tp -62.98 -47.12 84.51 Favored 'General case' 0 N--CA 1.432 -1.337 0 C-N-CA 119.921 -0.712 . . . . 60.869999999999997 109.601 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.672 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.03 -35.67 81.18 Favored 'General case' 0 CA--C 1.489 -1.382 0 C-N-CA 119.965 -0.694 . . . . 157.56999999999999 110.364 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.747 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.61 -40.89 98.39 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 108.629 -0.878 . . . . 47.060000000000002 108.629 178.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.805 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.77 -41.28 98.01 Favored 'General case' 0 CA--C 1.496 -1.121 0 O-C-N 121.756 -0.59 . . . . 43.939999999999998 109.557 -177.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.731 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.81 -43.3 99.12 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.726 -0.842 . . . . 42.609999999999999 108.726 -176.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.902 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.38 -41.26 93.94 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 116.623 -0.262 . . . . 140.66 111.029 -178.364 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.805 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.78 -43.96 97.81 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 118.58 -1.248 . . . . 116.04000000000001 110.234 -175.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.673 HG22 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.44 -38.75 83.24 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.292 0 N-CA-C 108.731 -0.84 . . . . 97.159999999999997 108.731 -177.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.852 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.2 mt -61.28 -40.0 84.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 N-CA-C 108.975 -0.75 . . . . 54.850000000000001 108.975 -176.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.956 HG22 HG21 ' A' ' 86' ' ' THR . 92.9 t -57.71 -42.34 81.48 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.301 0 N-CA-C 108.873 -0.788 . . . . 45.390000000000001 108.873 -175.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 48' ' ' VAL . 97.2 t -63.52 -50.97 76.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 C-N-CA 118.848 -1.141 . . . . 48.640000000000001 110.171 -177.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.751 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.6 t -65.27 -47.04 78.08 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 120.163 -0.615 . . . . 116.65000000000001 111.711 -174.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.59 ' N ' HG23 ' A' ' 45' ' ' THR . 50.8 m -61.96 -43.94 97.79 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 109.715 -0.476 . . . . 51.159999999999997 109.715 -174.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.4 t -65.54 -48.93 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 C-N-CA 119.852 -0.739 . . . . 44.299999999999997 110.85 -176.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.866 ' O ' HG23 ' A' ' 52' ' ' VAL . 93.8 t -64.75 -46.94 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 C-N-CA 120.299 -0.56 . . . . 48.82 111.032 -174.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.77 -44.15 95.21 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 120.513 -0.851 . . . . 58.700000000000003 112.006 -174.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -72.63 -34.21 67.17 Favored 'General case' 0 CA--C 1.488 -1.432 0 O-C-N 122.086 -0.655 . . . . 101.40000000000001 111.027 -175.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.742 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.9 -38.73 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 107.745 -1.206 . . . . 103.56999999999999 107.745 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 48' ' ' VAL . 72.0 t -61.43 -43.05 96.06 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.225 0 N-CA-C 108.975 -0.75 . . . . 61.890000000000001 108.975 -178.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.535 ' O ' HG22 ' A' ' 56' ' ' ILE . 81.8 t -63.44 -50.96 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 N-CA-C 109.47 -0.567 . . . . 70.010000000000005 109.47 -178.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.803 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.94 -43.39 98.92 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 109.13 -0.693 . . . . 132.09999999999999 109.13 -176.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.643 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.23 -46.62 83.02 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 116.677 -0.238 . . . . 104.5 110.441 -176.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 1.018 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.67 -49.88 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 C-N-CA 120.212 -0.595 . . . . 142.96000000000001 111.271 -173.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.949 HD11 HG12 ' A' ' 72' ' ' VAL 0.279 24.8 pt -64.79 -41.68 92.87 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.661 0 C-N-CA 116.947 -1.901 . . . . 158.31999999999999 110.877 -175.971 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.803 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.72 -41.39 98.09 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 117.725 -1.59 . . . . 137.11000000000001 109.48 178.181 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.36 -44.54 91.11 Favored 'General case' 0 N--CA 1.436 -1.165 0 O-C-N 122.164 -0.335 . . . . 54.659999999999997 111.019 -176.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.925 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.41 117.12 29.4 Favored 'General case' 0 CA--C 1.491 -1.322 0 CA-C-O 121.623 0.725 . . . . 127.18000000000001 109.586 -174.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.62 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.83 -36.84 80.12 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 124.099 0.96 . . . . 87.930000000000007 110.832 -176.034 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 1.036 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.38 -34.67 78.7 Favored 'General case' 0 CA--C 1.49 -1.33 0 O-C-N 121.657 -0.652 . . . . 131.12 111.509 -175.625 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' MET . . . . . 1.019 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.61 69.43 7.12 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 115.313 -2.555 . . . . 246.56 109.606 -175.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.412 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.21 91.45 3.48 Favored 'General case' 0 CA--C 1.474 -1.966 0 N-CA-C 105.484 -2.043 . . . . 339.35000000000002 105.484 177.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.444 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.5 p -124.15 165.27 17.85 Favored 'General case' 0 N--CA 1.414 -2.248 0 N-CA-C 102.992 -2.966 . . . . 114.66 102.992 176.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.88 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.15 -39.44 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 N-CA-C 106.78 -1.563 . . . . 143.28 106.78 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.836 HG22 HD13 ' A' ' 71' ' ' LEU . 95.4 m -59.69 -38.05 80.5 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 108.687 -0.856 . . . . 160.22 108.687 -176.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.523 ' O ' HG13 ' A' ' 72' ' ' VAL . 5.3 m120 -62.34 -31.78 72.46 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 108.872 -0.788 . . . . 120.54000000000001 108.872 -177.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.901 ' O ' HG22 ' A' ' 72' ' ' VAL . 89.8 m-85 -63.59 -43.81 95.86 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 109.481 -0.563 . . . . 67.219999999999999 109.481 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.88 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.5 m-85 -66.53 -39.76 88.78 Favored 'General case' 0 CA--C 1.498 -1.055 0 O-C-N 121.488 -0.758 . . . . 138.59999999999999 109.668 -177.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.925 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.58 -35.91 82.05 Favored 'General case' 0 CA--C 1.493 -1.237 0 C-N-CA 122.479 0.312 . . . . 151.46000000000001 110.641 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.949 HG12 HD11 ' A' ' 57' ' ' ILE . 24.2 m -62.56 -37.95 80.2 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.227 0 C-N-CA 117.39 -1.724 . . . . 117.93000000000001 106.715 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.45 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.1 t30 -60.07 -46.03 90.92 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 107.859 -1.163 . . . . 56.82 107.859 -177.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.999 HD21 ' HE1' ' A' ' 123' ' ' MET . 8.7 mp -61.36 -43.91 98.07 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 108.931 -0.766 . . . . 145.30000000000001 108.931 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.05 -40.35 95.47 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 108.521 -0.918 . . . . 45.710000000000001 108.521 -175.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -62.4 -42.02 99.11 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.377 -0.601 . . . . 105.61 109.377 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.12 -39.45 92.59 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 108.646 -0.872 . . . . 47.890000000000001 108.646 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.588 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.56 -37.37 84.83 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 109.966 -0.383 . . . . 124.53 109.966 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.86 -41.22 99.28 Favored 'General case' 0 CA--C 1.496 -1.099 0 O-C-N 121.952 -0.467 . . . . 35.890000000000001 109.843 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.8 t -62.23 -37.3 84.86 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 107.025 -1.472 . . . . 88.969999999999999 107.025 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.82 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.17 -49.17 76.88 Favored 'General case' 0 N--CA 1.428 -1.55 0 C-N-CA 119.831 -0.748 . . . . 239.91 109.047 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.62 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.38 -43.4 90.81 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 121.536 -0.728 . . . . 146.09999999999999 110.596 -177.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.418 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.16 -58.23 3.4 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 117.397 -1.721 . . . . 91.739999999999995 113.852 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -76.55 -61.38 1.98 Allowed 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 115.748 1.759 . . . . 197.44999999999999 115.748 -173.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.933 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.25 -42.26 55.52 Favored 'General case' 0 CA--C 1.49 -1.365 0 C-N-CA 117.897 -1.521 . . . . 242.59999999999999 114.046 -170.036 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.956 HG21 HG22 ' A' ' 43' ' ' VAL . 4.6 t -65.4 -36.55 84.3 Favored 'General case' 0 N--CA 1.434 -1.254 0 C-N-CA 118.912 -1.115 . . . . 215.61000000000001 109.838 -172.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.423 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.3 t -60.3 -46.94 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 O-C-N 121.828 -0.545 . . . . 87.189999999999998 110.459 -175.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.842 HG21 ' CD2' ' A' ' 108' ' ' HIS . 63.6 t -65.93 -41.86 90.75 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.112 0 N-CA-C 109.731 -0.47 . . . . 231.81999999999999 109.731 -178.04 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.902 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 87.8 m-20 -62.32 -34.14 76.06 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 108.317 -0.994 . . . . 364.98000000000002 108.317 -177.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.667 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.3 t80 -68.19 -44.72 75.25 Favored 'General case' 0 N--CA 1.438 -1.054 0 O-C-N 121.543 -0.723 . . . . 181.63 111.275 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.475 HG22 ' ND1' ' A' ' 95' ' ' HIS . 57.7 m -60.87 -45.78 93.19 Favored 'General case' 0 CA--C 1.478 -1.809 0 N-CA-C 107.432 -1.321 . . . . 269.01999999999998 107.432 -175.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 1.055 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.72 -45.03 93.4 Favored 'General case' 0 N--CA 1.416 -2.149 0 C-N-CA 118.657 -1.217 . . . . 562.65999999999997 110.023 -179.058 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.707 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.11 -45.24 95.51 Favored 'General case' 0 CA--C 1.479 -1.787 0 C-N-CA 118.696 -1.202 . . . . 446.75 108.097 -167.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.747 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.388 6.1 m -70.51 -26.31 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 C-N-CA 115.837 -2.345 . . . . 370.05000000000001 112.216 -178.755 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.496 ' O ' ' HB2' ' A' ' 96' ' ' ASN . 40.8 m80 -74.48 -26.5 60.06 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 121.593 -0.692 . . . . 354.91000000000003 112.513 175.09 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.823 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.4 m-20 82.8 4.53 0.99 Allowed 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 125.067 1.347 . . . . 462.44 111.905 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.775 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.266 11.9 mm-40 -172.35 178.06 2.91 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-O 122.015 0.912 . . . . 652.37 111.122 171.786 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.791 ' HE3' ' HA ' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.73 86.3 2.17 Favored 'General case' 0 N--CA 1.428 -1.565 0 C-N-CA 128.489 2.715 . . . . 905.99000000000001 107.929 -174.24 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -67.87 -36.4 80.21 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 108.244 -1.021 . . . . 570.42999999999995 108.244 -176.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.848 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.57 -36.35 82.4 Favored 'General case' 0 N--CA 1.428 -1.54 0 C-N-CA 125.318 1.447 . . . . 453.22000000000003 111.157 -174.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.941 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.55 178.66 33.9 Favored Glycine 0 C--N 1.349 1.292 0 C-N-CA 118.768 -1.682 . . . . 445.63 109.891 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.0 mt -56.41 -41.23 75.99 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 125.275 1.43 . . . . 457.72000000000003 112.357 -170.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -58.63 -46.93 86.03 Favored 'General case' 0 CA--C 1.484 -1.56 0 C-N-CA 118.662 -1.215 . . . . 340.57999999999998 109.296 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.848 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.1 m-85 -68.71 -32.14 71.72 Favored 'General case' 0 N--CA 1.423 -1.775 0 C-N-CA 118.774 -1.171 . . . . 453.60000000000002 111.577 -176.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.764 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.05 -40.35 73.37 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 105.976 -1.861 . . . . 541.48000000000002 105.976 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.83 -47.14 75.99 Favored 'General case' 0 CA--C 1.486 -1.514 0 O-C-N 123.991 0.807 . . . . 466.68000000000001 110.866 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -61.74 -47.08 86.86 Favored 'General case' 0 N--CA 1.427 -1.607 0 C-N-CA 117.48 -1.688 . . . . 427.33999999999997 107.315 -178.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.842 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.6 m80 -67.1 -36.79 82.72 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 112.415 0.524 . . . . 537.87 112.415 -174.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.574 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.4 -42.69 74.77 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 116.847 -1.941 . . . . 422.12 111.593 175.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.858 ' O ' HG22 ' A' ' 113' ' ' ILE . 75.9 t80 -59.05 -50.1 75.37 Favored 'General case' 0 CA--C 1.502 -0.883 0 O-C-N 121.324 -0.86 . . . . 340.17000000000002 111.834 -173.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -65.29 -46.54 71.37 Favored Pre-proline 0 N--CA 1.443 -0.811 0 C-N-CA 119.082 -1.047 . . . . 258.06 111.723 -176.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.933 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.0 Cg_exo -61.52 -31.54 87.64 Favored 'Trans proline' 0 N--CA 1.435 -1.943 0 N-CA-C 115.368 1.257 . . . . 305.70999999999998 115.368 176.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.876 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.91 -40.41 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 N-CA-C 108.687 -0.857 . . . . 252.69999999999999 108.687 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.423 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.92 -40.6 93.8 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 107.801 -1.185 . . . . 149.27000000000001 107.801 -179.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.0 -44.81 95.93 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 120.625 -0.43 . . . . 138.08000000000001 111.506 -176.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.653 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 65.1 t -66.94 -42.39 88.77 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 O-C-N 121.575 -0.703 . . . . 132.88999999999999 110.96 -177.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.923 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.76 -44.67 92.79 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 108.884 -0.784 . . . . 193.61000000000001 108.884 -177.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.555 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.48 -37.66 84.46 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 122.804 0.442 . . . . 63.829999999999998 110.085 -175.297 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.9 m -64.02 -52.39 59.69 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 120.747 -0.381 . . . . 76.400000000000006 111.228 -177.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.749 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.99 -41.63 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 108.185 -1.042 . . . . 171.13 108.185 -174.992 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 1.098 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.3 m-85 -63.8 -38.56 91.56 Favored 'General case' 0 N--CA 1.433 -1.311 0 O-C-N 121.834 -0.541 . . . . 78.299999999999997 110.635 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.557 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.6 t -67.11 -35.74 80.42 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 118.901 -1.12 . . . . 92.359999999999999 109.216 -178.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.999 ' HE1' HD21 ' A' ' 74' ' ' LEU . 5.9 mmt -62.5 -34.28 76.55 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 108.173 -1.047 . . . . 93.730000000000004 108.173 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.902 HG22 HG13 ' A' ' 212' ' ' ILE . 33.2 p -67.42 -41.65 84.49 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 119.215 -0.994 . . . . 132.74000000000001 109.33 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.28 -42.08 94.68 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.18 -1.415 . . . . 43.390000000000001 107.18 -177.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.827 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.0 t -58.46 -41.99 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 N-CA-C 108.607 -0.886 . . . . 59.340000000000003 108.607 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.48 -44.07 95.45 Favored 'General case' 0 CA--C 1.497 -1.064 0 O-C-N 121.804 -0.56 . . . . 69.680000000000007 110.519 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.469 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.3 t80 -65.47 -42.77 91.9 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.326 -0.99 . . . . 106.98 108.326 -177.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.827 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.35 -35.61 81.42 Favored 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 119.662 -0.815 . . . . 147.63 108.951 -177.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.705 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.16 -41.54 99.27 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 108.541 -0.911 . . . . 190.06 108.541 178.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.6 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.5 t80 -61.34 -44.06 97.82 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.31 -0.996 . . . . 118.84999999999999 108.31 -177.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.805 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.5 mmt -63.36 -42.66 98.89 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 109.986 -0.375 . . . . 102.5 109.986 -177.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.99 -41.62 95.25 Favored 'General case' 0 CA--C 1.489 -1.39 0 O-C-N 121.82 -0.55 . . . . 89.980000000000004 109.841 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.92 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.3 mt -66.52 -50.72 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 C-N-CA 118.13 -1.428 . . . . 106.09 110.991 -177.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.749 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.07 -48.32 38.42 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.099 0 C-N-CA 117.098 -1.841 . . . . 227.74000000000001 111.815 -174.792 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.756 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.85 100.08 50.98 Favored Pre-proline 0 CA--C 1.486 -1.505 0 C-N-CA 116.242 -2.183 . . . . 262.55000000000001 110.059 -175.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.2 Cg_endo -69.6 -10.39 28.56 Favored 'Trans proline' 0 C--N 1.29 -2.544 0 C-N-CA 121.618 1.545 . . . . 210.25 111.358 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.705 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.28 112.02 1.0 Allowed 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 106.523 -1.658 . . . . 270.57999999999998 106.523 -178.086 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.886 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.82 -39.5 23.87 Favored Pre-proline 0 N--CA 1.43 -1.451 0 CA-C-N 115.358 -0.837 . . . . 129.84 112.347 -175.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.859 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 82.1 Cg_exo -61.36 -26.6 81.77 Favored 'Trans proline' 0 N--CA 1.431 -2.163 0 N-CA-C 116.297 1.614 . . . . 330.70999999999998 116.297 -174.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.756 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.03 77.2 7.95 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 114.479 -2.888 . . . . 204.50999999999999 107.277 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.877 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.72 147.43 0.09 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 107.435 -1.32 . . . . 387.41000000000003 107.435 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.877 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.4 t -143.71 147.02 33.63 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 118.794 -1.162 . . . . 166.22 109.475 178.044 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.84 -40.76 88.03 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 107.847 -1.168 . . . . 44.229999999999997 107.847 176.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.483 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.6 m -60.3 -39.14 85.89 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 108.176 -1.046 . . . . 28.800000000000001 108.176 -175.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.668 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.81 -38.79 92.1 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 109.101 -0.703 . . . . 30.289999999999999 109.101 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.847 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 89.9 m -59.61 -43.03 93.88 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 108.982 -0.748 . . . . 46.109999999999999 108.982 -176.193 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.46 -42.14 99.26 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 107.693 -1.225 . . . . 87.329999999999998 107.693 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.77 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.6 t -61.67 -42.08 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 107.93 -1.137 . . . . 23.690000000000001 107.93 -178.081 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.8 t -63.19 -44.29 99.25 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 109.704 -0.48 . . . . 43.859999999999999 109.704 -178.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.918 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.0 mm -61.28 -42.54 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 108.326 -0.991 . . . . 91.129999999999995 108.326 -176.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' CYS . . . . . 0.483 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.2 t -62.6 -37.96 88.29 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.754 -0.832 . . . . 65.879999999999995 108.754 -178.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.4 t -62.11 -41.85 92.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.225 0 N-CA-C 109.551 -0.537 . . . . 33.859999999999999 109.551 -177.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 1.098 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.4 -40.33 85.87 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.183 0 N-CA-C 107.585 -1.265 . . . . 146.52000000000001 107.585 -176.799 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 155' ' ' TRP . . . . . 0.7 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.1 m95 -62.86 -38.36 90.51 Favored 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 119.497 -0.881 . . . . 75.439999999999998 108.896 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.7 t -60.54 -48.4 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 O-C-N 121.028 -1.045 . . . . 43.640000000000001 109.71 -177.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.791 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.7 -38.0 89.47 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 109.029 -0.73 . . . . 102.56999999999999 109.029 -178.089 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.0 -41.09 86.83 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.417 -1.327 . . . . 58.159999999999997 107.417 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.801 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.07 -32.48 73.87 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.032 -0.729 . . . . 121.11 109.032 178.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.791 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.02 -42.34 85.09 Favored 'General case' 0 CA--C 1.489 -1.395 0 C-N-CA 118.576 -1.249 . . . . 153.15000000000001 109.923 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 1.057 HD13 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.05 -43.75 19.07 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 113.106 -3.437 . . . . 133.66999999999999 113.527 173.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.478 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -62.97 -39.9 96.08 Favored 'General case' 0 CA--C 1.489 -1.371 0 O-C-N 120.916 -1.115 . . . . 157.41999999999999 112.192 -171.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.522 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.3 t80 -74.45 -36.11 2.45 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 115.012 1.486 . . . . 250.91 115.012 -173.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.292 52.9 Cg_exo -59.5 -25.48 78.84 Favored 'Trans proline' 0 CA--C 1.488 -1.791 0 N-CA-C 118.007 2.272 . . . . 207.34 118.007 -174.351 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.915 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 32.4 mt-30 -61.17 -34.19 74.65 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 106.951 -1.5 . . . . 192.46000000000001 106.951 178.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.52 -41.03 98.09 Favored Glycine 0 C--N 1.353 1.501 0 N-CA-C 107.969 -2.053 . . . . 261.0 107.969 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.79 159.11 25.96 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 101.513 -3.514 . . . . 491.39999999999998 101.513 172.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -59.96 106.82 0.54 Allowed 'General case' 0 CA--C 1.488 -1.434 0 C-N-CA 116.247 -2.181 . . . . 386.10000000000002 109.83 -176.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.915 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 73.9 m -154.03 -166.61 2.42 Favored 'General case' 0 N--CA 1.415 -2.224 0 N-CA-C 103.541 -2.763 . . . . 289.80000000000001 103.541 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' THR . . . . . 1.14 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.92 175.4 0.86 Allowed 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 117.736 -1.126 . . . . 402.06 109.565 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.788 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 73.0 p -165.27 177.5 7.56 Favored 'General case' 0 CA--C 1.586 2.353 0 C-N-CA 127.343 2.257 . . . . 690.52999999999997 114.94 177.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.487 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.9 mm-40 132.34 160.56 0.0 OUTLIER 'General case' 1 C--N 1.429 4.057 1 N-CA-C 123.19 4.515 . . . . 633.62 123.19 162.704 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.762 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.2 p -85.63 153.83 22.1 Favored 'General case' 0 C--N 1.389 2.3 0 C-N-CA 127.376 2.27 . . . . 617.99000000000001 110.903 178.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' MET . . . . . 1.047 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.69 174.4 6.0 Favored Pre-proline 0 C--N 1.364 1.206 0 C-N-CA 130.271 3.428 . . . . 434.98000000000002 113.405 -175.417 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 1.092 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 51.8 Cg_endo -44.24 -65.65 0.19 Allowed 'Trans proline' 0 N--CA 1.441 -1.56 0 N-CA-C 122.418 3.969 . . . . 365.88 122.418 -168.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' SER . . . . . 0.778 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.306 70.5 m -84.89 20.95 1.69 Allowed 'General case' 0 CA--C 1.467 -2.239 0 N-CA-C 104.797 -2.298 . . . . 635.80999999999995 104.797 178.144 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.75 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.456 5.0 mmp_? -94.39 152.24 18.78 Favored 'General case' 1 CA--C 1.419 -4.064 3 N-CA-C 131.98 7.771 . . . . 999.99000000000001 131.98 -135.76 . . . . . . . . 5 3 . 1 . 001 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 1.055 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.911 37.1 t -131.84 73.18 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.772 1 CA-C-N 103.3 -6.318 . . . . 594.32000000000005 113.599 149.217 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.726 HG13 ' HB2' ' A' ' 174' ' ' MET . 7.3 p -144.2 144.1 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.639 1 N-CA-C 98.291 -4.707 . . . . 811.90999999999997 98.291 162.374 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.762 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.8 m -118.46 144.53 45.92 Favored 'General case' 0 CA--C 1.489 -1.401 0 C-N-CA 117.058 -1.857 . . . . 999.99000000000001 109.427 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.97 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.8 mmm -147.19 -175.61 4.9 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-O 122.004 0.907 . . . . 431.86000000000001 110.054 -177.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 1.038 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.13 148.67 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 C-N-CA 124.351 1.06 . . . . 457.18000000000001 108.801 -177.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' GLU . . . . . 0.788 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.32 85.47 3.75 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 124.14 0.976 . . . . 458.76999999999998 113.503 -174.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.958 ' CZ3' HG22 ' A' ' 182' ' ' ILE . 1.9 p90 -76.37 -31.57 0.98 Allowed Pre-proline 0 N--CA 1.438 -1.048 0 C-N-CA 124.961 1.304 . . . . 999.99000000000001 112.426 168.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.956 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -65.95 -45.77 5.65 Favored 'Trans proline' 0 N--CA 1.438 -1.789 0 N-CA-C 120.875 3.375 . . . . 999.99000000000001 120.875 -174.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.508 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.56 171.74 8.15 Favored 'General case' 0 CA--C 1.472 -2.047 0 C-N-CA 117.166 -1.814 . . . . 81.180000000000007 107.26 -172.098 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.834 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 6.4 p80 -109.14 45.14 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.848 0 C-N-CA 115.503 -2.479 . . . . 999.99000000000001 108.754 177.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 1.072 ' HB2' HD12 ' A' ' 191' ' ' ILE . 87.5 Cg_endo -41.57 101.81 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.14 1 C-N-CA 126.042 4.494 . . . . 999.99000000000001 105.683 -170.737 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -62.27 -44.02 97.48 Favored 'General case' 0 CA--C 1.483 -1.599 0 C-N-CA 126.747 2.019 . . . . 967.72000000000003 112.048 -165.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 190' ' ' LYS . 30.3 mmtp -60.26 -36.55 78.05 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.748 -1.575 . . . . 934.29999999999995 106.748 -175.223 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 1.072 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.56 -30.25 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 C-N-CA 129.2 3.0 . . . . 565.14999999999998 113.923 -178.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 61.53 55.4 2.81 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 118.444 0.565 . . . . 755.61000000000001 109.869 -175.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 1.14 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.5 -49.28 67.1 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.551 1.141 . . . . 325.88999999999999 113.242 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.633 ' HE3' ' OH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.82 -44.95 78.4 Favored 'General case' 0 CA--C 1.495 -1.16 0 C-N-CA 123.56 0.744 . . . . 250.21000000000001 111.627 -169.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.3 t -64.72 -43.35 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 CA-C-O 121.585 0.707 . . . . 142.46000000000001 110.382 -175.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 1.038 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.8 t80 -61.12 -41.52 96.85 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 123.981 0.912 . . . . 247.69 108.815 -173.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' HIS . . . . . 0.825 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 23.0 t60 -60.53 -51.31 69.97 Favored 'General case' 0 CA--C 1.491 -1.289 0 C-N-CA 125.424 1.49 . . . . 199.61000000000001 113.107 -175.111 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.2 mt -65.35 -44.48 94.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 107.715 -1.217 . . . . 106.73 107.715 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' CYS . . . . . 0.722 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.6 t -59.15 -48.53 81.27 Favored 'General case' 0 CA--C 1.487 -1.479 0 CA-C-N 115.867 -0.606 . . . . 115.01000000000001 110.231 -173.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 1.057 HG13 HD13 ' A' ' 161' ' ' LEU . 86.1 t -65.24 -49.15 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.657 0 C-N-CA 119.418 -0.913 . . . . 129.41999999999999 111.854 -174.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' THR . . . . . 0.794 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.2 m -61.88 -53.15 59.72 Favored 'General case' 0 CA--C 1.483 -1.63 0 C-N-CA 118.224 -1.39 . . . . 172.47999999999999 109.952 -172.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.632 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.1 t -63.85 -54.26 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 C-N-CA 120.512 -0.475 . . . . 55.859999999999999 110.972 -174.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.722 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.54 -51.56 58.95 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 118.542 -1.263 . . . . 184.68000000000001 111.513 -174.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 1.044 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.61 -52.4 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 C-N-CA 116.643 -2.023 . . . . 291.81 114.743 -174.699 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.549 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.8 t80 -82.05 -55.01 4.83 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 115.148 1.536 . . . . 130.66 115.148 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' PHE . . . . . 0.794 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.8 m-85 -66.88 -48.5 68.56 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 114.488 1.292 . . . . 80.159999999999997 114.488 -170.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.894 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.55 -45.47 83.16 Favored Pre-proline 0 N--CA 1.435 -1.195 0 C-N-CA 119.965 -0.694 . . . . 136.02000000000001 109.506 -174.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.894 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.8 Cg_exo -64.81 -27.12 59.62 Favored 'Trans proline' 0 N--CA 1.433 -2.08 0 N-CA-C 110.621 -0.569 . . . . 92.170000000000002 110.621 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.686 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.34 -41.37 76.72 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 107.494 -1.298 . . . . 135.59999999999999 107.494 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.16 -44.69 91.33 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 109.591 -0.522 . . . . 52.100000000000001 109.591 -176.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.618 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.71 -43.49 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 109.09 -0.707 . . . . 95.890000000000001 109.09 -176.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.902 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.27 -42.34 93.16 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 N-CA-C 106.695 -1.595 . . . . 43.409999999999997 106.695 -178.24 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.44 -42.28 99.08 Favored Glycine 0 N--CA 1.432 -1.624 0 N-CA-C 109.367 -1.493 . . . . 27.690000000000001 109.367 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' TYR . . . . . 0.884 ' O ' HG22 ' A' ' 217' ' ' THR . 77.9 t80 -65.68 -47.38 75.65 Favored 'General case' 0 CA--C 1.497 -1.086 0 O-C-N 122.195 -0.591 . . . . 54.409999999999997 110.456 -177.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ALA . . . . . 0.827 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.43 -34.1 74.83 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 106.96 -1.496 . . . . 53.880000000000003 106.96 -177.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -60.76 -40.83 93.97 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 108.48 -0.933 . . . . 68.290000000000006 108.48 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' THR . . . . . 0.884 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.78 -39.04 92.95 Favored 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 119.701 -0.799 . . . . 107.59 110.615 -175.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.827 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.02 -38.36 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 C-N-CA 119.606 -0.838 . . . . 111.61 109.509 -177.089 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.92 HG13 ' CD1' ' A' ' 134' ' ' ILE . 79.8 t -63.28 -22.51 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 N-CA-C 108.401 -0.963 . . . . 85.260000000000005 108.401 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.85 -41.94 99.39 Favored Glycine 0 C--N 1.349 1.283 0 N-CA-C 111.062 -0.815 . . . . 40.710000000000001 111.062 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.72 -44.06 96.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 108.412 -0.959 . . . . 95.859999999999999 108.412 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.824 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.3 p -76.93 -137.52 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 108.441 -0.948 . . . . 144.37 108.441 -176.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.904 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.6 mt -55.36 132.12 47.35 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 107.599 -1.26 . . . . 326.72000000000003 107.599 -177.246 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 224' ' ' TRP . . . . . 0.461 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.33 -168.04 1.51 Allowed 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 106.033 -1.84 . . . . 158.38 106.033 -176.169 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' ALA . . . . . 0.461 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.32 -41.94 98.95 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 109.661 -0.496 . . . . 36.780000000000001 109.661 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.6 m -61.13 125.85 25.22 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 119.151 -1.019 . . . . 85.459999999999994 109.82 -174.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' GLU . . . . . 0.692 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.87 126.53 8.84 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 105.542 -2.021 . . . . 127.78 105.542 176.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.927 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.03 139.9 34.82 Favored Pre-proline 0 CA--C 1.493 -1.239 0 N-CA-C 105.952 -1.87 . . . . 164.84 105.952 -179.592 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.927 ' N ' HD13 ' A' ' 228' ' ' ILE . 82.0 Cg_exo -56.8 -39.92 87.93 Favored 'Trans proline' 0 N--CA 1.431 -2.17 0 N-CA-C 113.937 0.707 . . . . 222.34999999999999 113.937 -176.001 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 230' ' ' GLY . . . . . 0.744 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.13 166.99 44.94 Favored Glycine 0 N--CA 1.428 -1.894 0 N-CA-C 106.424 -2.67 . . . . 45.219999999999999 106.424 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.882 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.94 -45.79 93.29 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 106.029 -1.841 . . . . 107.56999999999999 106.029 177.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' SER . . . . . 0.73 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.6 m -65.76 141.81 58.2 Favored 'General case' 0 N--CA 1.429 -1.517 0 C-N-CA 118.906 -1.118 . . . . 167.96000000000001 109.153 -175.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.83 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.2 m 99.51 106.7 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 126.706 2.002 . . . . 280.68000000000001 109.734 176.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.71 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.7 m-20 56.01 11.27 0.71 Allowed 'General case' 0 N--CA 1.434 -1.274 0 C-N-CA 124.459 1.103 . . . . 218.25 110.701 174.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.921 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.38 137.62 54.78 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 105.236 -2.135 . . . . 343.56999999999999 105.236 177.395 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.478 ' O ' HG21 ' A' ' 240' ' ' VAL . 85.6 t80 -111.97 81.9 1.54 Allowed 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 106.867 -1.531 . . . . 263.29000000000002 106.867 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 237' ' ' HIS . . . . . 0.626 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 64.5 m80 104.29 147.05 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.283 0 C-N-CA 126.563 1.945 . . . . 261.92000000000002 108.497 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.21 -38.1 89.85 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 107.879 -1.156 . . . . 106.81 107.879 -177.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.737 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.43 -39.94 94.97 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 118.371 -1.331 . . . . 112.2 107.552 -178.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.738 HG12 ' NH1' ' A' ' 244' ' ' ARG . 75.5 t -64.26 -39.82 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.275 0 N-CA-C 109.263 -0.643 . . . . 45.409999999999997 109.263 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' SER . . . . . 0.807 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.1 p -70.92 -32.07 68.87 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 110.264 -0.273 . . . . 97.620000000000005 110.264 -178.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.39 -39.61 81.66 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 123.696 0.799 . . . . 59.289999999999999 110.978 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.737 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.24 -36.54 83.99 Favored 'General case' 0 CA--C 1.492 -1.275 0 C-N-CA 124.658 1.183 . . . . 106.48999999999999 110.666 -174.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.921 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.96 -30.65 69.23 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 108.299 -1.0 . . . . 106.62 108.299 -176.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.533 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -66.02 -41.02 91.49 Favored 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 121.832 -0.542 . . . . 75.969999999999999 110.045 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.441 ' CG1' ' CE ' ' A' ' 250' ' ' MET . 76.6 t -65.54 -40.86 89.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 C-N-CA 122.917 0.487 . . . . 65.269999999999996 109.774 -178.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.775 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -64.0 -41.58 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 C-N-CA 120.401 -0.519 . . . . 107.94 110.162 -177.448 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.537 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.1 pttt -63.54 -40.81 97.98 Favored 'General case' 0 N--CA 1.434 -1.247 0 O-C-N 121.687 -0.633 . . . . 87.980000000000004 110.284 -176.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 249' ' ' MET . . . . . 0.822 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.65 -40.4 96.78 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 118.832 -1.147 . . . . 65.5 108.363 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 250' ' ' MET . . . . . 0.761 ' CE ' HG21 ' A' ' 67' ' ' THR . 68.5 mtt -61.7 -36.37 80.71 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 108.146 -1.057 . . . . 85.049999999999997 108.146 -177.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.537 HD12 ' HA ' ' A' ' 248' ' ' LYS . 86.9 mt -63.49 -45.74 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 N-CA-C 109.07 -0.715 . . . . 42.25 109.07 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 252' ' ' VAL . . . . . 0.822 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.34 -38.26 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 C-N-CA 119.548 -0.861 . . . . 91.010000000000005 109.402 -176.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 1.001 HG22 ' CD1' ' A' ' 304' ' ' ILE . 65.9 t -58.86 -41.54 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 N-CA-C 107.988 -1.116 . . . . 66.090000000000003 107.988 -178.141 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 250' ' ' MET . 94.8 t -66.09 -43.18 92.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 C-N-CA 120.754 -0.379 . . . . 52.390000000000001 110.31 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.1 m -61.74 -46.78 88.15 Favored 'General case' 0 CA--C 1.489 -1.391 0 O-C-N 121.889 -0.507 . . . . 46.420000000000002 109.866 -174.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 256' ' ' THR . . . . . 0.743 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.5 t -62.33 -38.13 88.26 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 108.324 -0.991 . . . . 116.51000000000001 108.324 -177.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 257' ' ' PHE . . . . . 0.487 ' N ' HG23 ' A' ' 256' ' ' THR . 86.1 t80 -60.26 -48.23 82.64 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.394 -0.595 . . . . 65.180000000000007 109.394 -178.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.96 -42.68 97.2 Favored 'General case' 0 CA--C 1.49 -1.365 0 O-C-N 122.133 -0.354 . . . . 51.329999999999998 110.443 -175.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 259' ' ' ILE . . . . . 0.743 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.62 -43.37 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 C-N-CA 118.919 -1.112 . . . . 126.3 109.0 -176.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 260' ' ' CYS . . . . . 0.51 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.7 m -65.58 -49.33 69.22 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 119.529 -0.868 . . . . 133.94 112.485 -176.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.82 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.0 m95 -80.68 -33.38 35.52 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 116.856 2.169 . . . . 134.84 116.856 -176.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.784 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.9 tp -58.43 -41.62 90.27 Favored Pre-proline 0 CA--C 1.493 -1.235 0 O-C-N 121.659 -0.65 . . . . 72.230000000000004 111.643 -167.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 263' ' ' PRO . . . . . 0.784 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 80.7 Cg_exo -60.66 -35.98 87.1 Favored 'Trans proline' 0 C--N 1.295 -2.278 0 CA-C-N 119.848 0.981 . . . . 106.13 111.349 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 264' ' ' PHE . . . . . 0.851 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.7 t80 -66.41 -44.68 82.32 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 119.749 -0.78 . . . . 128.34999999999999 110.03 -178.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 265' ' ' HIS . . . . . 0.643 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.42 -37.88 89.06 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 110.202 -0.296 . . . . 100.73 110.202 -177.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.745 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.25 -44.56 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 C-N-CA 119.31 -0.956 . . . . 172.72 109.142 -179.122 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 267' ' ' PHE . . . . . 0.736 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.6 m-85 -66.6 -28.07 68.21 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 108.206 -1.035 . . . . 249.22999999999999 108.206 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 268' ' ' PHE . . . . . 0.898 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.56 -55.1 35.85 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 106.679 -1.6 . . . . 259.77999999999997 106.679 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 269' ' ' LEU . . . . . 0.491 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.3 mt -69.17 -44.18 72.72 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 113.588 0.959 . . . . 233.11000000000001 113.588 -176.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 270' ' ' LEU . . . . . 0.837 ' O ' HG13 ' A' ' 273' ' ' ILE . 88.8 mt -61.37 -48.3 91.47 Favored Pre-proline 0 N--CA 1.44 -0.968 0 C-N-CA 119.183 -1.007 . . . . 169.53999999999999 110.596 -171.026 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 271' ' ' PRO . . . . . 0.736 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.6 Cg_exo -61.13 -24.56 79.49 Favored 'Trans proline' 0 N--CA 1.43 -2.259 0 C-N-CA 116.729 -1.714 . . . . 255.47 114.66 174.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 272' ' ' TYR . . . . . 0.825 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.5 t80 -63.56 -44.22 94.75 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 119.225 0.921 . . . . 279.02999999999997 108.904 177.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.837 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.33 -44.79 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 110.081 -0.34 . . . . 162.21000000000001 110.081 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 274' ' ' ASN . . . . . 0.868 HD22 HD12 ' A' ' 277' ' ' LEU . 49.1 t30 -125.41 84.87 59.33 Favored Pre-proline 0 N--CA 1.431 -1.406 0 C-N-CA 118.747 -1.181 . . . . 128.13 108.069 -178.081 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 275' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.25 164.04 11.26 Favored 'Trans proline' 0 C--N 1.295 -2.281 0 N-CA-C 107.46 -1.785 . . . . 278.35000000000002 107.46 177.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 276' ' ' ASP . . . . . 0.87 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.11 15.04 9.93 Favored 'General case' 0 N--CA 1.428 -1.533 0 O-C-N 123.8 0.687 . . . . 312.91000000000003 109.334 175.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.87 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.3 mt -132.71 -170.68 2.49 Favored 'General case' 0 CA--C 1.481 -1.679 0 N-CA-C 106.537 -1.653 . . . . 353.54000000000002 106.537 177.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 1.011 ' HA ' ' HB2' ' A' ' 282' ' ' PHE . 42.8 p90 -115.66 142.25 46.99 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 107.427 -1.323 . . . . 251.25999999999999 107.427 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.764 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -76.96 -118.74 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 102.081 -3.303 . . . . 175.25999999999999 102.081 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 280' ' ' LYS . . . . . 0.794 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.5 -44.97 96.12 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 100.878 -3.749 . . . . 99.069999999999993 100.878 172.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 281' ' ' LYS . . . . . 0.794 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.42 124.18 9.19 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 103.494 -2.78 . . . . 243.21000000000001 103.494 171.161 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 1.011 ' HB2' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.98 112.96 25.1 Favored 'General case' 0 CA--C 1.474 -1.979 0 C-N-CA 116.049 -2.261 . . . . 201.03999999999999 105.278 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 283' ' ' ILE . . . . . 0.776 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.93 173.72 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.09 0 C-N-CA 116.0 -2.28 . . . . 201.36000000000001 108.787 -175.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 284' ' ' GLN . . . . . 1.092 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.282 0.6 OUTLIER -59.5 -41.44 89.89 Favored 'General case' 0 N--CA 1.415 -2.179 0 CA-C-N 113.247 -1.797 . . . . 203.81999999999999 107.864 174.463 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 285' ' ' GLN . . . . . 0.925 ' HG2' HE21 ' A' ' 284' ' ' GLN . 1.2 mm100 -64.31 -45.71 86.76 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 118.22 -1.392 . . . . 215.06 112.543 -171.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.551 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.3 t -65.68 -46.42 89.3 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.466 0 C-N-CA 118.578 -1.249 . . . . 125.28 112.912 -171.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 287' ' ' TYR . . . . . 0.952 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.79 -37.0 86.14 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 107.193 -1.41 . . . . 268.89999999999998 107.193 -171.883 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.798 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.22 -45.01 74.47 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 125.65 1.58 . . . . 280.88 108.795 -172.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.64 -47.48 86.05 Favored 'General case' 0 N--CA 1.428 -1.547 0 C-N-CA 118.97 -1.092 . . . . 184.47 109.002 -172.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 290' ' ' ILE . . . . . 0.851 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.8 mp -67.94 -42.11 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 C-N-CA 119.279 -0.968 . . . . 167.91999999999999 112.73 -175.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 291' ' ' MET . . . . . 0.5 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.8 ttt -65.75 -38.8 90.11 Favored 'General case' 0 CA--C 1.495 -1.144 0 C-N-CA 117.758 -1.577 . . . . 367.18000000000001 110.771 -175.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 292' ' ' TRP . . . . . 0.548 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.4 m95 -67.16 -32.71 73.99 Favored 'General case' 0 N--CA 1.435 -1.215 0 O-C-N 121.851 -0.531 . . . . 173.97 110.449 177.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.2 tp -64.46 -36.76 85.23 Favored 'General case' 0 CA--C 1.499 -1.011 0 C-N-CA 123.542 0.737 . . . . 119.66 109.806 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 294' ' ' ALA . . . . . 0.82 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.25 -33.98 74.39 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.697 -1.224 . . . . 112.3 107.697 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 295' ' ' MET . . . . . 0.772 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.09 -32.05 73.33 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 116.235 -0.439 . . . . 174.16999999999999 110.237 -177.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.7 m -64.73 -22.78 67.06 Favored 'General case' 0 CA--C 1.485 -1.525 0 C-N-CA 124.676 1.191 . . . . 145.27000000000001 110.608 -175.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 297' ' ' SER . . . . . 0.76 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.5 m -57.61 -35.38 70.37 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 108.078 -1.082 . . . . 170.15000000000001 108.078 -175.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.82 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.7 t -55.3 -34.15 63.89 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 116.315 -0.402 . . . . 214.56999999999999 110.632 -171.106 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 299' ' ' MET . . . . . 0.751 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.1 ttt -77.2 -33.19 56.33 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 126.072 1.749 . . . . 168.28999999999999 115.544 177.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 300' ' ' TYR . . . . . 0.76 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.42 -34.87 79.2 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 114.056 1.132 . . . . 167.15000000000001 114.056 -168.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 301' ' ' ASN . . . . . 0.722 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.282 18.8 p-10 -64.21 -38.29 33.22 Favored Pre-proline 0 N--CA 1.434 -1.264 0 C-N-CA 115.515 -2.474 . . . . 165.13 113.93 -171.599 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 302' ' ' PRO . . . . . 0.722 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.1 Cg_exo -62.54 -31.83 80.02 Favored 'Trans proline' 0 N--CA 1.433 -2.042 0 CA-C-N 122.791 2.033 . . . . 123.92 111.251 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 303' ' ' ILE . . . . . 0.715 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.78 -42.53 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 C-N-CA 118.875 -1.13 . . . . 110.55 109.779 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 304' ' ' ILE . . . . . 1.001 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.1 pt -61.16 -40.02 84.43 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.158 0 N-CA-C 108.828 -0.804 . . . . 145.31 108.828 -177.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 305' ' ' TYR . . . . . 0.925 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.253 63.2 m-85 -58.11 -48.84 78.97 Favored 'General case' 0 CA--C 1.494 -1.182 0 C-N-CA 119.413 -0.915 . . . . 246.68000000000001 109.823 -177.477 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.6 m -62.19 -47.51 84.16 Favored 'General case' 0 CA--C 1.485 -1.538 0 C-N-CA 119.55 -0.86 . . . . 64.430000000000007 109.571 -173.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.8 t -66.78 -45.07 79.61 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 118.989 -1.084 . . . . 80.719999999999999 110.244 -177.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.708 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.49 -35.69 75.81 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 115.998 1.851 . . . . 140.44 115.998 -173.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 309' ' ' ASN . . . . . 0.658 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.83 132.23 34.34 Favored 'General case' 0 N--CA 1.434 -1.26 0 C-N-CA 112.711 -3.596 . . . . 178.87 113.056 -177.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 310' ' ' ASP . . . . . 0.612 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.03 -37.07 86.41 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 114.405 -1.271 . . . . 110.22 110.111 -177.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 311' ' ' ARG . . . . . 0.855 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.74 -50.59 72.7 Favored 'General case' 0 CA--C 1.492 -1.256 0 O-C-N 121.752 -0.592 . . . . 174.78 109.739 -174.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.96 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.2 m-85 -64.89 -41.69 95.41 Favored 'General case' 0 CA--C 1.484 -1.579 0 N-CA-C 108.245 -1.02 . . . . 161.84 108.245 178.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 313' ' ' ARG . . . . . 0.518 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.33 -50.22 73.64 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 109.198 -0.667 . . . . 117.2 109.198 -173.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.799 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.51 -44.1 75.37 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 120.373 -0.531 . . . . 112.59999999999999 111.061 -177.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 315' ' ' GLY . . . . . 0.871 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -64.04 -37.43 94.59 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 110.646 -0.982 . . . . 101.45999999999999 110.646 -177.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 316' ' ' PHE . . . . . 1.018 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.7 m-85 -62.16 -45.99 90.94 Favored 'General case' 0 CA--C 1.491 -1.296 0 CA-C-N 118.492 1.146 . . . . 151.49000000000001 109.522 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 317' ' ' LYS . . . . . 0.422 ' HE3' ' HB2' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.1 -36.3 77.13 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 106.949 -1.501 . . . . 142.31999999999999 106.949 -175.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 318' ' ' HIS . . . . . 0.827 ' NE2' HG21 ' A' ' 326' ' ' ILE . 50.0 m80 -59.79 -41.82 92.01 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 106.891 -1.522 . . . . 109.09 106.891 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.85 -42.43 85.72 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.336 -0.228 . . . . 76.109999999999999 111.03 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -61.43 -55.48 30.84 Favored 'General case' 0 CA--C 1.49 -1.361 0 C-N-CA 119.87 -0.732 . . . . 120.23999999999999 109.32 -174.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 321' ' ' ARG . . . . . 0.578 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.4 mtt180 -74.33 131.54 41.24 Favored 'General case' 0 CA--C 1.482 -1.657 0 N-CA-C 102.935 -2.987 . . . . 192.72999999999999 102.935 177.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.16 -44.22 92.1 Favored 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 119.021 -1.072 . . . . 176.28999999999999 109.194 -172.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 323' ' ' CYS . . . . . 0.754 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.2 m -79.38 -177.11 0.81 Allowed Pre-proline 0 CA--C 1.487 -1.443 0 N-CA-C 106.294 -1.743 . . . . 69.680000000000007 106.294 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.569 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.6 Cg_exo -58.99 -75.58 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.389 0 C-N-CA 118.347 -0.635 . . . . 191.05000000000001 112.591 176.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 325' ' ' PHE . . . . . 0.754 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.5 m-85 47.49 43.88 16.25 Favored 'General case' 0 CA--C 1.493 -1.228 0 O-C-N 123.574 0.546 . . . . 287.02999999999997 109.764 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 326' ' ' ILE . . . . . 0.827 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.51 78.57 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.933 0 C-N-CA 112.956 -3.497 . . . . 292.29000000000002 109.839 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 327' ' ' SER . . . . . 0.481 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.3 t -77.47 -152.84 0.05 Allowed 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 104.208 -2.515 . . . . 184.56999999999999 104.208 178.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 328' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.7 8.68 4.95 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 113.063 0.764 . . . . 274.56 113.063 176.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.97 0.91 57.27 Favored Glycine 0 C--N 1.348 1.228 0 C-N-CA 117.729 -2.177 . . . . 268.24000000000001 113.457 172.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 330' ' ' ASP . . . . . 0.699 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.7 m-20 51.6 -172.04 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.071 0 CA-C-N 118.667 1.233 . . . . 200.06 110.747 177.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.855 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.89 -33.0 74.73 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 107.879 -1.156 . . . . 114.44 107.879 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 332' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.26 46.06 21.92 Favored 'General case' 0 CA--C 1.484 -1.592 0 N-CA-C 107.625 -1.25 . . . . 263.81 107.625 -177.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 333' ' ' GLY . . . . . 0.634 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.32 -137.35 3.6 Favored Glycine 0 CA--C 1.479 -2.217 1 N-CA-C 102.531 -4.228 . . . . 103.79000000000001 102.531 -179.846 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 1.049 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.2 mt -88.28 95.62 10.25 Favored 'General case' 0 N--CA 1.419 -2.007 0 C-N-CA 114.937 -2.705 . . . . 117.3 106.016 176.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 335' ' ' GLU . . . . . 1.027 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.96 -39.79 90.72 Favored 'General case' 0 CA--C 1.468 -2.188 1 N-CA-C 98.004 -4.813 . . . . 231.58000000000001 98.004 167.23 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 336' ' ' MET . . . . . 1.036 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.95 163.48 29.08 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 102.072 -3.307 . . . . 303.24000000000001 102.072 168.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 337' ' ' LYS . . . . . 1.049 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.3 tttt -62.63 -48.61 78.61 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 116.051 -2.259 . . . . 112.72 108.409 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.9 t -61.02 -63.66 1.22 Allowed 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 109.103 -0.703 . . . . 83.219999999999999 109.103 -176.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 339' ' ' THR . . . . . 0.883 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.1 m -156.28 -126.2 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 103.831 -2.655 . . . . 174.36000000000001 103.831 -178.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 340' ' ' ARG . . . . . 1.027 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.87 160.96 8.78 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 105.763 -1.94 . . . . 202.72999999999999 105.763 177.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 341' ' ' TYR . . . . . 1.019 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.95 149.04 52.55 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 107.064 -1.458 . . . . 180.62 107.064 176.392 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 342' ' ' LEU . . . . . 0.933 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.5 tp -178.51 -171.86 0.27 Allowed 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 105.394 -2.076 . . . . 145.25 105.394 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 343' ' ' GLN . . . . . 0.933 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.09 -43.14 88.13 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 106.127 -1.805 . . . . 66.049999999999997 106.127 174.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 344' ' ' THR . . . . . 0.767 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.7 -152.14 0.48 Allowed 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 103.505 -2.776 . . . . 266.49000000000001 103.505 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 345' ' ' GLN . . . . . 0.7 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.4 mt-30 66.31 -124.93 0.28 Allowed 'General case' 0 N--CA 1.428 -1.574 0 C-N-CA 117.033 -1.867 . . . . 219.19999999999999 107.772 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 346' ' ' GLY . . . . . 0.902 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.07 -37.4 94.13 Favored Glycine 0 N--CA 1.426 -2.032 0 CA-C-N 114.544 -1.207 . . . . 94.780000000000001 112.855 -176.006 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 347' ' ' SER . . . . . 0.825 ' HB2' ' H ' ' A' ' 342' ' ' LEU . 48.3 t -81.17 100.41 9.07 Favored 'General case' 0 CA--C 1.484 -1.589 0 C-N-CA 112.327 -3.749 . . . . 121.41 109.479 -171.085 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 348' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.5 t -73.06 145.5 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 108.953 -0.758 . . . . 85.340000000000003 108.953 -176.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 349' ' ' TYR . . . . . 0.442 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.5 p90 -57.73 143.43 41.89 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.842 -1.17 . . . . 267.56999999999999 107.842 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 350' ' ' LYS . . . . . 0.523 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.03 69.59 0.59 Allowed 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 109.539 -0.541 . . . . 226.09999999999999 109.539 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 351' ' ' VAL . . . . . 0.826 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.5 p -51.0 156.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 N-CA-C 106.993 -1.484 . . . . 154.84 106.993 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 352' ' ' SER . . . . . 0.582 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.5 m -61.35 161.96 8.47 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.603 0.716 . . . . 180.00999999999999 110.711 -173.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 353' ' ' ARG . . . . . 0.893 ' H ' ' HD3' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.46 156.92 23.66 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 106.946 -1.501 . . . . 333.77999999999997 106.946 -178.616 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 354' ' ' LEU . . . . . 0.975 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.04 142.52 48.76 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.356 -1.35 . . . . 335.19999999999999 107.356 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.975 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.5 mm-40 82.82 158.9 0.13 Allowed 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 108.74 -0.837 . . . . 266.47000000000003 108.74 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.5 m -60.61 -46.88 88.6 Favored 'General case' 0 CA--C 1.487 -1.462 0 N-CA-C 105.677 -1.972 . . . . 59.340000000000003 105.677 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.58 173.86 11.97 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 104.431 -2.433 . . . . 201.25999999999999 104.431 176.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.75 HG22 ' O ' ' A' ' 360' ' ' THR . 69.1 mt -95.91 106.71 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.555 0 C-N-CA 116.34 -2.144 . . . . 56.229999999999997 105.524 -179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 359' ' ' SER . . . . . 0.466 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.7 m -61.19 -59.47 5.28 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 109.287 -0.634 . . . . 87.579999999999998 109.287 -175.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 360' ' ' THR . . . . . 0.886 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.2 t -85.5 153.76 22.24 Favored 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 107.835 -1.172 . . . . 219.94999999999999 107.835 -177.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 361' ' ' VAL . . . . . 0.587 ' O ' HG23 ' A' ' 361' ' ' VAL . 16.0 m -82.02 83.81 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 C-N-CA 116.339 -2.144 . . . . 121.79000000000001 105.452 177.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.598 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.6 t -154.11 159.74 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 N-CA-C 105.826 -1.916 . . . . 53.850000000000001 105.826 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 363' ' ' GLY . . . . . 0.598 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.22 16.61 77.06 Favored Glycine 0 N--CA 1.428 -1.88 0 N-CA-C 106.044 -2.822 . . . . 196.55000000000001 106.044 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.674 0 N-CA-C 107.87 -1.159 . . . . 35.880000000000003 107.87 -178.914 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 365' ' ' ARG . . . . . 0.418 ' N ' ' CD ' ' B' ' 366' ' ' PRO . 4.5 ttp180 . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 108.895 -0.78 . . . . 1.0 108.895 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 366' ' ' PRO . . . . . 0.418 ' CD ' ' N ' ' B' ' 365' ' ' ARG . 52.4 Cg_endo -66.94 141.99 60.58 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.086 1.857 . . . . 1.0 110.172 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 367' ' ' LYS . . . . . 0.738 ' HE2' ' HA ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -64.38 143.26 98.47 Favored Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 119.85 -0.74 . . . . 1.0 109.603 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 368' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -68.25 150.42 76.57 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.31 2.007 . . . . 1.0 111.759 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 369' ' ' GLN . . . . . 0.476 ' O ' ' HG3' ' B' ' 369' ' ' GLN . 0.0 OUTLIER -70.72 131.72 44.3 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.739 -0.384 . . . . 1.0 110.265 179.42 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -101.97 115.85 31.42 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.696 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 371' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -63.65 -42.39 98.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.365 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 372' ' ' PHE . . . . . 0.424 ' HD1' ' HA ' ' B' ' 372' ' ' PHE . 0.1 OUTLIER -65.01 -36.25 83.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.945 -0.57 . . . . 1.0 110.663 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -59.72 -32.98 75.69 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.869 -0.892 . . . . 1.0 110.869 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 374' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.267 0 CA-C-O 120.834 0.349 . . . . 1.0 110.154 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.429 -1.478 0 N-CA-C 108.388 -0.967 . . . . 97.079999999999998 108.388 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.581 ' OD1' ' HG3' ' B' ' 366' ' ' PRO . 14.2 t-20 -110.62 155.44 22.37 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 122.07 0.938 . . . . 123.41 110.724 -172.085 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.881 HG11 HD13 ' A' ' 15' ' ' ILE . 28.8 m -134.6 -162.38 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.498 1 N-CA-C 100.117 -4.031 . . . . 151.30000000000001 100.117 173.741 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.909 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.1 mp -60.68 -38.58 57.96 Favored Pre-proline 0 N--CA 1.439 -0.995 0 C-N-CA 115.953 -2.299 . . . . 169.25 106.13 178.093 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.909 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 57.6 Cg_exo -81.26 168.49 16.73 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 122.267 0.614 . . . . 185.75999999999999 110.53 171.248 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.904 HG13 ' CE2' ' A' ' 282' ' ' PHE . 92.3 t -64.44 -25.87 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 C-N-CA 127.037 2.135 . . . . 145.47 110.381 -177.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.774 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.2 t0 -84.34 157.39 21.5 Favored 'General case' 0 CA--C 1.499 -1.014 0 O-C-N 121.043 -1.036 . . . . 102.76000000000001 109.473 -178.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.6 p -82.64 154.21 25.02 Favored 'General case' 0 CA--C 1.492 -1.269 0 N-CA-C 107.973 -1.121 . . . . 106.25 107.973 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.921 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.8 p-10 -105.89 51.88 0.74 Allowed 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 117.778 -1.569 . . . . 157.81 107.656 178.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.15 -45.86 91.64 Favored 'General case' 0 CA--C 1.481 -1.681 0 N-CA-C 103.593 -2.743 . . . . 150.19999999999999 103.593 178.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.4 m -87.1 164.73 34.96 Favored Pre-proline 0 N--CA 1.421 -1.899 0 N-CA-C 103.663 -2.717 . . . . 183.52000000000001 103.663 172.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -76.82 6.91 3.83 Favored 'Trans proline' 0 C--N 1.281 -2.977 0 N-CA-C 109.992 -0.811 . . . . 235.61000000000001 109.992 176.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.422 ' C ' HD21 ' A' ' 14' ' ' ASN . 0.4 OUTLIER -57.9 -41.29 82.31 Favored 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 124.813 1.245 . . . . 113.77 113.401 -170.118 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.921 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.3 pt -52.13 136.19 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 CA-C-N 119.517 1.053 . . . . 150.84999999999999 110.986 -176.18 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.46 156.28 46.41 Favored 'General case' 0 C--N 1.36 1.065 0 N-CA-C 107.631 -1.248 . . . . 100.42 107.631 178.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . 1.081 HG23 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.09 142.64 58.32 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 122.009 0.909 . . . . 129.36000000000001 110.412 -174.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.774 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 74.6 m-20 -63.06 -25.51 68.4 Favored 'General case' 0 CA--C 1.494 -1.189 0 C-N-CA 126.285 1.834 . . . . 112.34 106.677 -177.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.936 HG23 ' HA2' ' A' ' 101' ' ' GLY . 86.1 m -74.17 -40.15 62.74 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 115.567 -0.742 . . . . 131.72999999999999 111.705 177.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . 1.081 ' H ' HG23 ' A' ' 17' ' ' THR . 71.3 m -84.35 -42.93 15.24 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 117.034 2.235 . . . . 80.489999999999995 117.034 -174.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.55 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.5 mt-10 -145.98 174.54 3.34 Favored Pre-proline 0 N--CA 1.443 -0.798 0 C-N-CA 118.127 -1.429 . . . . 98.980000000000004 111.191 -169.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.823 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.334 85.7 Cg_exo -61.74 -10.81 18.16 Favored 'Trans proline' 0 C--N 1.322 -0.853 1 N-CA-C 128.939 6.476 . . . . 246.94999999999999 128.939 -170.069 . . . . . . . . 4 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.0 m120 61.68 17.5 8.74 Favored 'General case' 0 C--N 1.325 -0.494 1 CA-C-N 126.153 4.07 . . . . 269.62 114.231 175.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.495 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 80.8 mt-30 -67.1 -27.31 67.24 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 107.838 -1.171 . . . . 86.799999999999997 107.838 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.551 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.3 p90 -66.76 -29.42 69.37 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 121.09 -1.006 . . . . 85.909999999999997 110.508 -178.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.874 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.3 t -68.48 -40.23 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 C-N-CA 123.717 0.807 . . . . 82.0 111.362 -177.028 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.896 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 27.6 pt20 -151.39 167.79 12.37 Favored Pre-proline 0 CA--C 1.489 -1.398 0 N-CA-C 108.558 -0.905 . . . . 120.73 108.558 -178.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.902 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -64.04 149.76 89.79 Favored 'Trans proline' 0 N--CA 1.432 -2.116 0 C-N-CA 120.599 0.866 . . . . 87.859999999999999 109.9 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.744 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -62.99 -37.96 89.23 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 108.864 -0.791 . . . . 36.460000000000001 108.864 -176.18 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.813 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.9 p-90 -63.81 -33.9 76.7 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 107.797 -1.186 . . . . 150.59999999999999 107.797 -176.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.902 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.5 mt-30 -62.22 -32.67 73.37 Favored 'General case' 0 CA--C 1.491 -1.312 0 O-C-N 121.311 -0.868 . . . . 123.26000000000001 108.666 -178.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.744 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.46 -47.18 94.58 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.582 0 N-CA-C 109.166 -0.679 . . . . 120.14 109.166 176.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.786 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.3 m -67.42 -31.05 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 N-CA-C 107.855 -1.165 . . . . 112.19 107.855 -178.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.813 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.5 tp -62.96 -47.14 84.49 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 119.917 -0.713 . . . . 60.869999999999997 109.648 -178.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.672 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.0 -35.67 81.21 Favored 'General case' 0 CA--C 1.489 -1.391 0 C-N-CA 119.974 -0.69 . . . . 157.56999999999999 110.375 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.747 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.65 -40.88 98.42 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 108.591 -0.892 . . . . 47.060000000000002 108.591 178.062 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.806 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.79 -41.23 97.97 Favored 'General case' 0 CA--C 1.496 -1.114 0 O-C-N 121.714 -0.616 . . . . 43.939999999999998 109.558 -177.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.731 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.89 -43.26 99.2 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 108.697 -0.853 . . . . 42.609999999999999 108.697 -176.475 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.904 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.41 -41.23 93.85 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 116.66 -0.246 . . . . 140.66 111.029 -178.333 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.806 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.82 -43.92 97.88 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 118.579 -1.248 . . . . 116.04000000000001 110.215 -175.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.47 -38.7 83.1 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.325 0 N-CA-C 108.761 -0.829 . . . . 97.159999999999997 108.761 -177.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.854 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.1 mt -61.32 -39.97 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 N-CA-C 108.969 -0.752 . . . . 54.850000000000001 108.969 -176.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.958 HG22 HG21 ' A' ' 86' ' ' THR . 92.9 t -57.76 -42.28 81.49 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.314 0 N-CA-C 108.888 -0.782 . . . . 45.390000000000001 108.888 -175.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.431 ' O ' HG23 ' A' ' 48' ' ' VAL . 97.0 t -63.52 -51.01 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 C-N-CA 118.876 -1.13 . . . . 48.640000000000001 110.179 -177.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.751 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.6 t -65.27 -47.04 78.09 Favored 'General case' 0 N--CA 1.436 -1.175 0 C-N-CA 120.181 -0.608 . . . . 116.65000000000001 111.701 -174.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.589 ' N ' HG23 ' A' ' 45' ' ' THR . 50.7 m -62.01 -43.89 97.89 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.706 -0.479 . . . . 51.159999999999997 109.706 -174.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.3 t -65.55 -48.97 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 C-N-CA 119.88 -0.728 . . . . 44.299999999999997 110.803 -176.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.866 ' O ' HG23 ' A' ' 52' ' ' VAL . 93.9 t -64.75 -46.94 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 C-N-CA 120.266 -0.574 . . . . 48.82 111.052 -174.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.71 -44.15 95.29 Favored Glycine 0 N--CA 1.437 -1.272 0 C-N-CA 120.479 -0.867 . . . . 58.700000000000003 112.064 -174.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -72.62 -34.23 67.19 Favored 'General case' 0 CA--C 1.488 -1.439 0 O-C-N 122.071 -0.664 . . . . 101.40000000000001 110.999 -175.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.741 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.4 p -66.91 -38.71 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 107.71 -1.218 . . . . 103.56999999999999 107.71 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 48' ' ' VAL . 71.3 t -61.46 -43.03 96.08 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 108.948 -0.76 . . . . 61.890000000000001 108.948 -178.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.537 ' O ' HG22 ' A' ' 56' ' ' ILE . 82.1 t -63.47 -50.96 76.31 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 C-N-CA 120.277 -0.569 . . . . 70.010000000000005 109.47 -178.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.805 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.9 -43.38 98.96 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 109.184 -0.672 . . . . 132.09999999999999 109.184 -176.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.643 ' N ' ' HG3' ' A' ' 54' ' ' MET . 61.9 t-105 -64.21 -46.67 82.88 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 116.685 -0.234 . . . . 104.5 110.458 -176.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 1.017 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.69 -49.83 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 C-N-CA 120.192 -0.603 . . . . 142.96000000000001 111.306 -173.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.953 HD11 HG12 ' A' ' 72' ' ' VAL 0.279 24.9 pt -64.76 -41.71 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 C-N-CA 116.968 -1.893 . . . . 158.31999999999999 110.879 -176.035 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.805 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.7 -41.43 98.11 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 117.755 -1.578 . . . . 137.11000000000001 109.46 178.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.36 -44.53 91.13 Favored 'General case' 0 N--CA 1.435 -1.216 0 O-C-N 122.189 -0.319 . . . . 54.659999999999997 111.012 -176.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.922 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.44 117.13 29.42 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-O 121.633 0.73 . . . . 127.18000000000001 109.568 -174.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.619 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.83 -36.89 80.25 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 124.122 0.969 . . . . 87.930000000000007 110.78 -175.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 1.036 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.32 -34.69 78.73 Favored 'General case' 0 CA--C 1.49 -1.334 0 O-C-N 121.649 -0.657 . . . . 131.12 111.506 -175.592 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' MET . . . . . 1.018 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.63 69.45 7.14 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 115.337 -2.545 . . . . 246.56 109.612 -175.21 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.413 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.27 91.45 3.48 Favored 'General case' 0 CA--C 1.474 -1.958 0 N-CA-C 105.488 -2.041 . . . . 339.35000000000002 105.488 177.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.443 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.5 p -124.13 165.24 17.88 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 103.025 -2.954 . . . . 114.66 103.025 176.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.88 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.08 -39.47 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.624 0 N-CA-C 106.825 -1.546 . . . . 143.28 106.825 178.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.835 HG22 HD13 ' A' ' 71' ' ' LEU . 95.6 m -59.67 -38.03 80.36 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 108.731 -0.84 . . . . 160.22 108.731 -176.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.524 ' ND2' ' HB3' ' A' ' 63' ' ' MET . 86.3 m-20 -62.36 -31.81 72.51 Favored 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 108.866 -0.791 . . . . 120.54000000000001 108.866 -177.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.901 ' O ' HG22 ' A' ' 72' ' ' VAL . 89.8 m-85 -63.5 -43.87 95.98 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 109.484 -0.562 . . . . 67.219999999999999 109.484 178.118 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.88 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.5 m-85 -66.49 -39.81 88.94 Favored 'General case' 0 CA--C 1.498 -1.051 0 O-C-N 121.533 -0.729 . . . . 138.59999999999999 109.662 -177.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.923 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.54 -35.93 82.1 Favored 'General case' 0 CA--C 1.492 -1.253 0 C-N-CA 122.509 0.323 . . . . 151.46000000000001 110.648 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.953 HG12 HD11 ' A' ' 57' ' ' ILE . 24.0 m -62.54 -37.94 80.16 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.237 0 C-N-CA 117.383 -1.727 . . . . 117.93000000000001 106.739 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.449 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.1 t30 -60.11 -46.04 90.94 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.824 -1.176 . . . . 56.82 107.824 -177.078 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.991 HD21 ' HE1' ' A' ' 123' ' ' MET . 8.7 mp -61.3 -43.94 98.04 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 108.93 -0.767 . . . . 145.30000000000001 108.93 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.04 -40.38 95.52 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 108.527 -0.916 . . . . 45.710000000000001 108.527 -175.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -62.42 -41.99 99.11 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 109.34 -0.615 . . . . 105.61 109.34 -178.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.12 -39.48 92.69 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 108.652 -0.87 . . . . 47.890000000000001 108.652 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.588 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.57 -37.39 84.85 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 109.922 -0.399 . . . . 124.53 109.922 179.706 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.86 -41.18 99.28 Favored 'General case' 0 CA--C 1.496 -1.101 0 O-C-N 121.931 -0.481 . . . . 35.890000000000001 109.85 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.9 t -62.28 -37.28 84.92 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 107.01 -1.478 . . . . 88.969999999999999 107.01 -178.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.82 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.2 -49.19 76.77 Favored 'General case' 0 N--CA 1.428 -1.531 0 C-N-CA 119.847 -0.741 . . . . 239.91 109.026 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.62 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.35 -43.42 90.94 Favored 'General case' 0 N--CA 1.431 -1.396 0 O-C-N 121.503 -0.748 . . . . 146.09999999999999 110.593 -177.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.417 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.15 -58.24 3.4 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 117.417 -1.713 . . . . 91.739999999999995 113.877 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -76.51 -61.39 1.97 Allowed 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 115.761 1.763 . . . . 197.44999999999999 115.761 -173.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.935 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.25 -42.29 55.53 Favored 'General case' 0 CA--C 1.49 -1.348 0 C-N-CA 117.902 -1.519 . . . . 242.59999999999999 114.014 -170.009 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.958 HG21 HG22 ' A' ' 43' ' ' VAL . 4.6 t -65.35 -36.57 84.41 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 118.949 -1.1 . . . . 215.61000000000001 109.859 -172.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.423 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.3 t -60.33 -46.93 94.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 O-C-N 121.818 -0.551 . . . . 87.189999999999998 110.442 -175.323 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.841 HG21 ' CD2' ' A' ' 108' ' ' HIS . 63.3 t -65.91 -41.94 90.95 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.132 0 N-CA-C 109.716 -0.476 . . . . 231.81999999999999 109.716 -178.032 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.904 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 87.7 m-20 -62.28 -34.15 76.01 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 108.296 -1.002 . . . . 364.98000000000002 108.296 -177.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.668 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.2 t80 -68.24 -44.67 75.17 Favored 'General case' 0 N--CA 1.438 -1.043 0 O-C-N 121.563 -0.71 . . . . 181.63 111.299 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.476 HG22 ' ND1' ' A' ' 95' ' ' HIS . 58.2 m -60.92 -45.75 93.42 Favored 'General case' 0 CA--C 1.478 -1.797 0 N-CA-C 107.405 -1.331 . . . . 269.01999999999998 107.405 -175.208 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 1.057 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.71 -45.06 93.29 Favored 'General case' 0 CA--C 1.469 -2.143 0 C-N-CA 118.694 -1.202 . . . . 562.65999999999997 109.994 -179.081 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.705 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.1 -45.25 95.46 Favored 'General case' 0 CA--C 1.479 -1.761 0 C-N-CA 118.719 -1.193 . . . . 446.75 108.098 -167.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.747 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.389 6.1 m -70.47 -26.37 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 C-N-CA 115.816 -2.354 . . . . 370.05000000000001 112.196 -178.769 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.497 ' O ' ' HB2' ' A' ' 96' ' ' ASN . 40.7 m80 -74.51 -26.45 60.0 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 121.597 -0.689 . . . . 354.91000000000003 112.501 175.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.823 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.6 m-20 82.81 4.53 0.99 Allowed 'General case' 0 CA--C 1.499 -0.984 0 C-N-CA 125.075 1.35 . . . . 462.44 111.902 -178.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.774 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.267 11.9 mm-40 -172.32 178.06 2.92 Favored 'General case' 0 CA--C 1.488 -1.436 0 CA-C-O 122.02 0.914 . . . . 652.37 111.092 171.808 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.791 ' HE3' ' HA ' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.72 86.29 2.17 Favored 'General case' 0 N--CA 1.427 -1.576 0 C-N-CA 128.493 2.717 . . . . 905.99000000000001 107.931 -174.273 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -67.84 -36.47 80.41 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 108.254 -1.017 . . . . 570.42999999999995 108.254 -176.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.846 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.0 m-85 -62.46 -36.36 82.22 Favored 'General case' 0 N--CA 1.428 -1.531 0 C-N-CA 125.324 1.449 . . . . 453.22000000000003 111.203 -174.19 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.936 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.52 178.61 33.93 Favored Glycine 0 C--N 1.35 1.32 0 C-N-CA 118.744 -1.693 . . . . 445.63 109.892 177.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.656 HD11 ' CD1' ' B' ' 374' ' ' LEU . 89.1 mt -56.41 -41.19 75.93 Favored 'General case' 0 CA--C 1.498 -1.041 0 C-N-CA 125.243 1.417 . . . . 457.72000000000003 112.396 -170.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -58.62 -46.9 86.05 Favored 'General case' 0 CA--C 1.485 -1.546 0 C-N-CA 118.671 -1.212 . . . . 340.57999999999998 109.291 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.846 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.3 m-85 -68.73 -32.16 71.74 Favored 'General case' 0 N--CA 1.424 -1.751 0 C-N-CA 118.799 -1.16 . . . . 453.60000000000002 111.552 -176.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.764 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.2 t -56.08 -40.35 73.47 Favored 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 105.964 -1.865 . . . . 541.48000000000002 105.964 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.82 -47.18 75.92 Favored 'General case' 0 CA--C 1.486 -1.504 0 O-C-N 124.02 0.825 . . . . 466.68000000000001 110.826 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -61.73 -47.08 86.84 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 117.487 -1.685 . . . . 427.33999999999997 107.277 -178.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.841 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.5 m80 -67.09 -36.76 82.66 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 112.405 0.521 . . . . 537.87 112.405 -174.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.574 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.46 -42.67 74.59 Favored 'General case' 0 N--CA 1.433 -1.325 0 C-N-CA 116.869 -1.932 . . . . 422.12 111.543 175.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.856 ' O ' HG22 ' A' ' 113' ' ' ILE . 76.0 t80 -59.06 -50.14 75.2 Favored 'General case' 0 CA--C 1.502 -0.894 0 O-C-N 121.324 -0.86 . . . . 340.17000000000002 111.813 -173.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -65.25 -46.56 71.84 Favored Pre-proline 0 N--CA 1.443 -0.808 0 C-N-CA 119.109 -1.036 . . . . 258.06 111.713 -176.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.935 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.2 Cg_exo -61.47 -31.59 87.98 Favored 'Trans proline' 0 N--CA 1.434 -1.993 0 N-CA-C 115.391 1.266 . . . . 305.70999999999998 115.391 176.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.875 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.89 -40.43 76.49 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 108.701 -0.851 . . . . 252.69999999999999 108.701 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.422 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.92 -40.61 93.84 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 107.821 -1.178 . . . . 149.27000000000001 107.821 -179.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.93 -44.87 95.87 Favored 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 120.668 -0.413 . . . . 138.08000000000001 111.502 -176.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.652 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 65.0 t -66.92 -42.36 88.79 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 O-C-N 121.6 -0.688 . . . . 132.88999999999999 110.98 -177.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.924 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.6 m-85 -63.75 -44.67 92.78 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 119.752 -0.779 . . . . 193.61000000000001 108.904 -177.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.555 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.45 -37.73 84.63 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 122.85 0.46 . . . . 63.829999999999998 110.055 -175.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.7 m -64.03 -52.38 59.71 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 120.701 -0.4 . . . . 76.400000000000006 111.237 -177.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.749 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.94 -41.67 93.64 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 N-CA-C 108.175 -1.046 . . . . 171.13 108.175 -175.01 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 1.098 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.5 m-85 -63.75 -38.59 91.66 Favored 'General case' 0 N--CA 1.433 -1.315 0 O-C-N 121.814 -0.554 . . . . 78.299999999999997 110.686 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.556 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.6 t -67.09 -35.75 80.48 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 118.926 -1.11 . . . . 92.359999999999999 109.197 -178.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.991 ' HE1' HD21 ' A' ' 74' ' ' LEU . 5.9 mmt -62.55 -34.2 76.46 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 108.176 -1.046 . . . . 93.730000000000004 108.176 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.904 HG22 HG13 ' A' ' 212' ' ' ILE . 33.4 p -67.52 -41.56 84.21 Favored 'General case' 0 CA--C 1.494 -1.202 0 C-N-CA 119.171 -1.012 . . . . 132.74000000000001 109.332 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.28 -42.14 94.8 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 107.158 -1.423 . . . . 43.390000000000001 107.158 -177.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.827 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 94.8 t -58.45 -41.97 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 N-CA-C 108.633 -0.877 . . . . 59.340000000000003 108.633 -178.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.47 -44.09 95.44 Favored 'General case' 0 CA--C 1.498 -1.043 0 O-C-N 121.815 -0.553 . . . . 69.680000000000007 110.556 -177.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.468 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.2 t80 -65.44 -42.72 92.09 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.375 -0.972 . . . . 106.98 108.375 -177.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.827 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.38 -35.58 81.35 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 119.663 -0.815 . . . . 147.63 108.981 -177.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.704 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.21 -41.51 99.16 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 108.503 -0.925 . . . . 190.06 108.503 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.598 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.6 t80 -61.34 -44.05 97.84 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 108.328 -0.99 . . . . 118.84999999999999 108.328 -177.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.804 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.5 mmt -63.42 -42.63 98.73 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 110.009 -0.367 . . . . 102.5 110.009 -177.141 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.99 -41.63 95.23 Favored 'General case' 0 CA--C 1.488 -1.405 0 O-C-N 121.837 -0.539 . . . . 89.980000000000004 109.828 -176.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.92 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.4 mt -66.51 -50.72 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 C-N-CA 118.113 -1.435 . . . . 106.09 110.999 -177.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.75 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.05 -48.3 38.62 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.109 0 C-N-CA 117.133 -1.827 . . . . 227.74000000000001 111.86 -174.831 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.754 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 23.8 p80 -118.88 100.06 50.96 Favored Pre-proline 0 CA--C 1.486 -1.498 0 C-N-CA 116.27 -2.172 . . . . 262.55000000000001 110.032 -175.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.2 Cg_endo -69.61 -10.37 28.5 Favored 'Trans proline' 0 C--N 1.29 -2.534 0 C-N-CA 121.58 1.52 . . . . 210.25 111.335 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.706 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.26 112.03 1.0 Allowed 'General case' 0 CA--C 1.491 -1.313 0 N-CA-C 106.547 -1.649 . . . . 270.57999999999998 106.547 -178.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.891 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.76 -39.55 24.66 Favored Pre-proline 0 N--CA 1.43 -1.46 0 CA-C-N 115.361 -0.836 . . . . 129.84 112.377 -176.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.86 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 82.3 Cg_exo -61.35 -26.58 81.76 Favored 'Trans proline' 0 N--CA 1.432 -2.133 0 N-CA-C 116.291 1.612 . . . . 330.70999999999998 116.291 -174.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.754 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.03 77.19 7.95 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 114.497 -2.881 . . . . 204.50999999999999 107.263 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.876 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.73 147.4 0.09 Allowed 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 107.497 -1.297 . . . . 387.41000000000003 107.497 178.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.876 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.4 t -143.66 146.99 33.66 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 118.807 -1.157 . . . . 166.22 109.496 178.08 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.81 -40.8 88.19 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.873 -1.158 . . . . 44.229999999999997 107.873 176.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.484 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.5 m -60.27 -39.15 85.82 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 108.184 -1.043 . . . . 28.800000000000001 108.184 -175.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.668 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.84 -38.74 92.01 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 109.08 -0.711 . . . . 30.289999999999999 109.08 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.847 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 90.1 m -59.59 -43.06 93.8 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 108.975 -0.75 . . . . 46.109999999999999 108.975 -176.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.49 -42.09 99.26 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 107.656 -1.238 . . . . 87.329999999999998 107.656 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.77 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.4 t -61.71 -42.1 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 N-CA-C 107.894 -1.15 . . . . 23.690000000000001 107.894 -178.06 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.7 t -63.18 -44.31 99.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 109.686 -0.487 . . . . 43.859999999999999 109.686 -178.039 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.919 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.0 mm -61.28 -42.47 93.66 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 108.321 -0.992 . . . . 91.129999999999995 108.321 -176.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' CYS . . . . . 0.482 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.2 t -62.69 -37.94 88.43 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 108.715 -0.846 . . . . 65.879999999999995 108.715 -178.213 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.3 t -62.12 -41.84 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 N-CA-C 109.523 -0.547 . . . . 33.859999999999999 109.523 -177.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 1.098 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.42 -40.33 85.93 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.147 0 N-CA-C 107.527 -1.286 . . . . 146.52000000000001 107.527 -176.749 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 155' ' ' TRP . . . . . 0.699 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.1 m95 -62.85 -38.34 90.43 Favored 'General case' 0 N--CA 1.428 -1.529 0 C-N-CA 119.501 -0.88 . . . . 75.439999999999998 108.934 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.8 t -60.53 -48.42 88.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 O-C-N 121.023 -1.048 . . . . 43.640000000000001 109.711 -177.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.792 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.71 -38.01 89.5 Favored 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 109.013 -0.736 . . . . 102.56999999999999 109.013 -178.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.97 -41.05 86.62 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.437 -1.32 . . . . 58.159999999999997 107.437 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.799 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.08 -32.54 73.94 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.995 -0.743 . . . . 121.11 108.995 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.792 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.0 -42.3 84.88 Favored 'General case' 0 CA--C 1.489 -1.383 0 C-N-CA 118.594 -1.242 . . . . 153.15000000000001 109.916 -178.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 1.057 HD13 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.13 -43.68 19.04 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 113.107 -3.437 . . . . 133.66999999999999 113.515 173.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.478 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -63.01 -39.87 96.07 Favored 'General case' 0 CA--C 1.489 -1.401 0 O-C-N 120.941 -1.1 . . . . 157.41999999999999 112.242 -171.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.522 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.2 t80 -74.44 -36.1 2.44 Favored Pre-proline 0 N--CA 1.437 -1.106 0 N-CA-C 115.06 1.504 . . . . 250.91 115.06 -173.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.293 53.5 Cg_exo -59.47 -25.49 78.83 Favored 'Trans proline' 0 CA--C 1.488 -1.809 0 N-CA-C 118.015 2.275 . . . . 207.34 118.015 -174.385 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.916 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 32.4 mt-30 -61.16 -34.24 74.71 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.951 -1.5 . . . . 192.46000000000001 106.951 178.05 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.48 -41.02 98.14 Favored Glycine 0 C--N 1.353 1.499 0 N-CA-C 107.991 -2.044 . . . . 261.0 107.991 177.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.8 159.1 26.04 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 101.519 -3.511 . . . . 491.39999999999998 101.519 172.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -59.93 106.79 0.54 Allowed 'General case' 0 CA--C 1.487 -1.443 0 C-N-CA 116.281 -2.168 . . . . 386.10000000000002 109.836 -176.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.916 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 73.8 m -154.06 -166.6 2.41 Favored 'General case' 0 N--CA 1.414 -2.249 0 N-CA-C 103.531 -2.766 . . . . 289.80000000000001 103.531 -178.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' THR . . . . . 1.139 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.94 175.37 0.87 Allowed 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 117.767 -1.111 . . . . 402.06 109.566 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.788 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 73.4 p -165.22 177.5 7.59 Favored 'General case' 0 CA--C 1.586 2.361 0 C-N-CA 127.329 2.252 . . . . 690.52999999999997 114.909 177.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.488 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.8 mm-40 132.38 160.58 0.0 OUTLIER 'General case' 1 C--N 1.429 4.057 1 N-CA-C 123.149 4.5 . . . . 633.62 123.149 162.669 . . . . . . . . 4 3 . 1 . 002 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.761 HG22 ' SG ' ' A' ' 180' ' ' CYS . 68.9 p -85.61 153.78 22.15 Favored 'General case' 0 C--N 1.389 2.29 0 C-N-CA 127.424 2.289 . . . . 617.99000000000001 110.892 178.008 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' MET . . . . . 1.043 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.65 174.35 6.08 Favored Pre-proline 0 C--N 1.363 1.182 0 C-N-CA 130.268 3.427 . . . . 434.98000000000002 113.429 -175.499 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 1.091 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 52.7 Cg_endo -44.23 -65.67 0.18 Allowed 'Trans proline' 0 N--CA 1.442 -1.557 0 N-CA-C 122.357 3.945 . . . . 365.88 122.357 -168.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' SER . . . . . 0.778 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.305 70.4 m -84.91 20.93 1.7 Allowed 'General case' 0 CA--C 1.467 -2.228 0 N-CA-C 104.772 -2.307 . . . . 635.80999999999995 104.772 178.197 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.75 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.456 5.0 mmp_? -94.35 152.28 18.76 Favored 'General case' 1 CA--C 1.419 -4.092 3 N-CA-C 131.969 7.766 . . . . 999.99000000000001 131.969 -135.771 . . . . . . . . 5 3 . 1 . 002 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 1.057 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.911 37.1 t -131.86 73.18 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.383 -3.797 1 CA-C-N 103.288 -6.323 . . . . 594.32000000000005 113.628 149.186 . . . . . . . . 4 3 . 1 . 002 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.729 HG13 ' HB2' ' A' ' 174' ' ' MET . 7.3 p -144.21 144.11 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.642 1 N-CA-C 98.296 -4.705 . . . . 811.90999999999997 98.296 162.403 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.761 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.9 m -118.46 144.54 45.92 Favored 'General case' 0 CA--C 1.488 -1.413 0 C-N-CA 117.081 -1.848 . . . . 999.99000000000001 109.408 -178.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.971 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.8 mmm -147.21 -175.59 4.89 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-O 121.988 0.899 . . . . 431.86000000000001 110.058 -177.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 1.037 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.19 148.66 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 C-N-CA 124.345 1.058 . . . . 457.18000000000001 108.811 -177.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' GLU . . . . . 0.788 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.32 85.46 3.74 Favored 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 124.132 0.973 . . . . 458.76999999999998 113.495 -174.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.957 ' CZ3' HG22 ' A' ' 182' ' ' ILE . 1.9 p90 -76.37 -31.56 0.98 Allowed Pre-proline 0 N--CA 1.438 -1.055 0 C-N-CA 124.98 1.312 . . . . 999.99000000000001 112.425 168.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.956 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -65.94 -45.81 5.62 Favored 'Trans proline' 0 N--CA 1.437 -1.817 0 N-CA-C 120.847 3.364 . . . . 999.99000000000001 120.847 -174.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.507 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.59 171.75 8.14 Favored 'General case' 0 CA--C 1.472 -2.033 0 C-N-CA 117.156 -1.817 . . . . 81.180000000000007 107.213 -172.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.834 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 6.4 p80 -109.15 45.16 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.84 0 C-N-CA 115.498 -2.481 . . . . 999.99000000000001 108.72 177.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 1.074 ' HB2' HD12 ' A' ' 191' ' ' ILE . 87.2 Cg_endo -41.58 101.8 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.146 1 C-N-CA 126.021 4.481 . . . . 999.99000000000001 105.696 -170.75 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -62.21 -44.07 97.41 Favored 'General case' 0 CA--C 1.484 -1.586 0 C-N-CA 126.755 2.022 . . . . 967.72000000000003 112.062 -165.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 190' ' ' LYS . 30.3 mmtp -60.24 -36.57 78.03 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 106.732 -1.581 . . . . 934.29999999999995 106.732 -175.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 1.074 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.57 -30.29 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 C-N-CA 129.2 3.0 . . . . 565.14999999999998 113.888 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 61.54 55.42 2.8 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-N 118.464 0.575 . . . . 755.61000000000001 109.855 -175.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 1.139 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.49 -49.27 67.16 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 124.532 1.133 . . . . 325.88999999999999 113.278 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.632 ' HE3' ' OH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.8 -44.96 78.29 Favored 'General case' 0 CA--C 1.495 -1.163 0 C-N-CA 123.537 0.735 . . . . 250.21000000000001 111.679 -169.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.5 t -64.72 -43.35 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-O 121.589 0.709 . . . . 142.46000000000001 110.389 -175.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 1.037 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.7 t80 -61.07 -41.54 96.83 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 123.986 0.914 . . . . 247.69 108.836 -173.19 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' HIS . . . . . 0.824 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 23.1 t60 -60.49 -51.37 69.75 Favored 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 125.45 1.5 . . . . 199.61000000000001 113.059 -175.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.1 mt -65.37 -44.42 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 107.732 -1.21 . . . . 106.73 107.732 -177.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' CYS . . . . . 0.722 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.6 t -59.21 -48.49 81.42 Favored 'General case' 0 CA--C 1.486 -1.495 0 CA-C-N 115.881 -0.599 . . . . 115.01000000000001 110.245 -173.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 1.057 HG13 HD13 ' A' ' 161' ' ' LEU . 86.2 t -65.21 -49.21 80.24 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.671 0 C-N-CA 119.428 -0.909 . . . . 129.41999999999999 111.846 -174.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' THR . . . . . 0.793 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.9 m -61.84 -53.13 60.02 Favored 'General case' 0 CA--C 1.482 -1.651 0 C-N-CA 118.213 -1.395 . . . . 172.47999999999999 109.971 -172.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.632 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.5 t -63.9 -54.26 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 C-N-CA 120.519 -0.472 . . . . 55.859999999999999 110.946 -174.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.722 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.53 -51.54 59.13 Favored 'General case' 0 N--CA 1.432 -1.362 0 C-N-CA 118.533 -1.267 . . . . 184.68000000000001 111.541 -174.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 1.05 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.6 -52.45 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 C-N-CA 116.663 -2.015 . . . . 291.81 114.704 -174.713 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.549 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.8 t80 -82.1 -54.97 4.86 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 115.136 1.532 . . . . 130.66 115.136 -178.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' PHE . . . . . 0.793 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.7 m-85 -66.84 -48.57 68.47 Favored 'General case' 0 CA--C 1.496 -1.096 0 N-CA-C 114.473 1.286 . . . . 80.159999999999997 114.473 -170.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.894 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.48 -45.5 83.63 Favored Pre-proline 0 N--CA 1.435 -1.201 0 C-N-CA 119.97 -0.692 . . . . 136.02000000000001 109.504 -174.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.894 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.3 Cg_exo -64.82 -27.13 59.55 Favored 'Trans proline' 0 N--CA 1.433 -2.065 0 N-CA-C 110.595 -0.579 . . . . 92.170000000000002 110.595 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.686 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.29 -41.48 76.76 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 107.456 -1.312 . . . . 135.59999999999999 107.456 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.17 -44.68 91.3 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 109.555 -0.535 . . . . 52.100000000000001 109.555 -176.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.616 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.72 -43.5 97.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 109.055 -0.72 . . . . 95.890000000000001 109.055 -176.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.904 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.25 -42.39 93.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 106.699 -1.593 . . . . 43.409999999999997 106.699 -178.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.39 -42.32 99.14 Favored Glycine 0 N--CA 1.432 -1.626 0 N-CA-C 109.384 -1.487 . . . . 27.690000000000001 109.384 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' TYR . . . . . 0.887 ' O ' HG22 ' A' ' 217' ' ' THR . 78.0 t80 -65.63 -47.41 75.71 Favored 'General case' 0 CA--C 1.497 -1.086 0 O-C-N 122.209 -0.583 . . . . 54.409999999999997 110.466 -177.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ALA . . . . . 0.827 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.43 -34.07 74.78 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 106.989 -1.485 . . . . 53.880000000000003 106.989 -177.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -60.82 -40.76 93.97 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 108.447 -0.946 . . . . 68.290000000000006 108.447 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' THR . . . . . 0.887 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.85 -38.99 92.83 Favored 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 119.677 -0.809 . . . . 107.59 110.618 -175.266 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.827 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.06 -38.35 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 C-N-CA 119.615 -0.834 . . . . 111.61 109.488 -177.095 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.92 HG13 ' CD1' ' A' ' 134' ' ' ILE . 79.8 t -63.27 -22.51 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.392 -0.966 . . . . 85.260000000000005 108.392 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.85 -41.95 99.4 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.07 -0.812 . . . . 40.710000000000001 111.07 -176.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.5 mm -64.72 -44.0 96.53 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 N-CA-C 108.414 -0.958 . . . . 95.859999999999999 108.414 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.822 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.9 p -76.99 -137.5 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.408 -0.96 . . . . 144.37 108.408 -176.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.902 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.6 mt -55.36 132.14 47.4 Favored 'General case' 0 CA--C 1.487 -1.452 0 N-CA-C 107.63 -1.248 . . . . 326.72000000000003 107.63 -177.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 224' ' ' TRP . . . . . 0.462 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 9.0 t90 -119.32 -168.07 1.51 Allowed 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 106.011 -1.848 . . . . 158.38 106.011 -176.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' ALA . . . . . 0.462 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.37 -41.93 98.85 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 109.627 -0.509 . . . . 36.780000000000001 109.627 -178.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 73.0 m -61.19 125.88 25.35 Favored 'General case' 0 N--CA 1.434 -1.274 0 C-N-CA 119.115 -1.034 . . . . 85.459999999999994 109.802 -174.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' GLU . . . . . 0.693 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.86 126.54 8.85 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 105.538 -2.023 . . . . 127.78 105.538 176.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.927 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -85.99 139.89 34.89 Favored Pre-proline 0 CA--C 1.492 -1.253 0 N-CA-C 105.964 -1.865 . . . . 164.84 105.964 -179.624 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.927 ' N ' HD13 ' A' ' 228' ' ' ILE . 81.3 Cg_exo -56.8 -39.89 88.15 Favored 'Trans proline' 0 N--CA 1.431 -2.185 0 N-CA-C 113.977 0.722 . . . . 222.34999999999999 113.977 -176.04 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' GLY . . . . . 0.744 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.12 166.96 44.93 Favored Glycine 0 N--CA 1.427 -1.912 0 N-CA-C 106.432 -2.667 . . . . 45.219999999999999 106.432 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.882 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.8 t0 -60.93 -45.77 93.37 Favored 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 106.045 -1.835 . . . . 107.56999999999999 106.045 177.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' SER . . . . . 0.73 ' O ' HG21 ' A' ' 228' ' ' ILE . 68.0 m -65.82 141.82 58.16 Favored 'General case' 0 N--CA 1.428 -1.539 0 C-N-CA 118.907 -1.117 . . . . 167.96000000000001 109.128 -175.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.828 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.1 m 99.53 106.73 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 126.729 2.012 . . . . 280.68000000000001 109.754 176.147 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.711 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.6 m-20 56.06 11.18 0.7 Allowed 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 124.417 1.087 . . . . 218.25 110.679 174.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.921 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.32 137.61 54.8 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 105.222 -2.14 . . . . 343.56999999999999 105.222 177.448 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.48 ' O ' HG21 ' A' ' 240' ' ' VAL . 85.5 t80 -111.98 81.94 1.54 Allowed 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 106.852 -1.536 . . . . 263.29000000000002 106.852 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 237' ' ' HIS . . . . . 0.625 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 64.6 m80 104.27 147.08 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.283 0 C-N-CA 126.602 1.961 . . . . 261.92000000000002 108.497 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.23 -38.08 89.75 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 107.882 -1.155 . . . . 106.81 107.882 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.738 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.49 -39.87 94.86 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 118.325 -1.35 . . . . 112.2 107.549 -178.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.736 HG12 ' NH1' ' A' ' 244' ' ' ARG . 75.7 t -64.32 -39.8 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 N-CA-C 109.254 -0.647 . . . . 45.409999999999997 109.254 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' SER . . . . . 0.805 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.4 p -70.93 -32.02 68.8 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 110.296 -0.261 . . . . 97.620000000000005 110.296 -178.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.42 -39.62 81.51 Favored 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 123.713 0.805 . . . . 59.289999999999999 110.959 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.738 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.23 -36.58 84.11 Favored 'General case' 0 CA--C 1.492 -1.265 0 C-N-CA 124.722 1.209 . . . . 106.48999999999999 110.682 -174.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.921 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.95 -30.64 69.22 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 108.313 -0.995 . . . . 106.62 108.313 -176.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.531 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -66.03 -40.99 91.48 Favored 'General case' 0 N--CA 1.435 -1.175 0 O-C-N 121.821 -0.55 . . . . 75.969999999999999 110.065 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.444 ' CG1' ' HE1' ' A' ' 250' ' ' MET . 76.8 t -65.55 -40.82 89.26 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 C-N-CA 122.926 0.49 . . . . 65.269999999999996 109.815 -178.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.775 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.9 p -63.99 -41.65 93.16 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 C-N-CA 120.42 -0.512 . . . . 107.94 110.125 -177.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.536 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.1 pttt -63.55 -40.77 97.86 Favored 'General case' 0 N--CA 1.434 -1.239 0 O-C-N 121.71 -0.619 . . . . 87.980000000000004 110.286 -176.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 249' ' ' MET . . . . . 0.823 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.65 -40.4 96.76 Favored 'General case' 0 CA--C 1.492 -1.268 0 C-N-CA 118.849 -1.141 . . . . 65.5 108.355 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 250' ' ' MET . . . . . 0.772 ' HE2' ' CG2' ' A' ' 67' ' ' THR . 68.5 mtt -61.75 -36.36 80.8 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 108.095 -1.076 . . . . 85.049999999999997 108.095 -177.062 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.536 HD12 ' HA ' ' A' ' 248' ' ' LYS . 86.8 mt -63.5 -45.76 96.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 N-CA-C 109.032 -0.729 . . . . 42.25 109.032 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 252' ' ' VAL . . . . . 0.823 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.3 -38.27 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 C-N-CA 119.594 -0.842 . . . . 91.010000000000005 109.443 -176.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 1.002 HG22 ' CD1' ' A' ' 304' ' ' ILE . 65.9 t -58.9 -41.55 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 N-CA-C 107.965 -1.124 . . . . 66.090000000000003 107.965 -178.122 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 250' ' ' MET . 94.7 t -66.08 -43.18 92.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 C-N-CA 120.719 -0.393 . . . . 52.390000000000001 110.323 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.1 m -61.7 -46.79 88.18 Favored 'General case' 0 CA--C 1.489 -1.4 0 O-C-N 121.847 -0.533 . . . . 46.420000000000002 109.877 -174.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 256' ' ' THR . . . . . 0.744 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.5 t -62.31 -38.12 88.19 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 108.322 -0.992 . . . . 116.51000000000001 108.322 -177.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 257' ' ' PHE . . . . . 0.488 ' N ' HG23 ' A' ' 256' ' ' THR . 86.1 t80 -60.28 -48.25 82.53 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 109.358 -0.608 . . . . 65.180000000000007 109.358 -178.118 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.91 -42.72 97.33 Favored 'General case' 0 CA--C 1.49 -1.358 0 CA-C-O 120.869 0.366 . . . . 51.329999999999998 110.458 -175.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' ILE . . . . . 0.744 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.57 -43.38 98.22 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.573 0 C-N-CA 118.89 -1.124 . . . . 126.3 109.038 -176.236 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 260' ' ' CYS . . . . . 0.509 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.5 m -65.6 -49.32 69.23 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 119.521 -0.872 . . . . 133.94 112.462 -176.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.82 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.0 m95 -80.68 -33.29 35.57 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 116.888 2.181 . . . . 134.84 116.888 -176.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.785 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.9 tp -58.48 -41.6 90.06 Favored Pre-proline 0 CA--C 1.493 -1.219 0 O-C-N 121.689 -0.632 . . . . 72.230000000000004 111.658 -167.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 263' ' ' PRO . . . . . 0.785 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 79.8 Cg_exo -60.7 -35.94 87.09 Favored 'Trans proline' 0 C--N 1.295 -2.281 0 CA-C-N 119.813 0.969 . . . . 106.13 111.368 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 264' ' ' PHE . . . . . 0.851 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.6 t80 -66.42 -44.69 82.27 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 119.775 -0.77 . . . . 128.34999999999999 110.045 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 265' ' ' HIS . . . . . 0.643 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.43 -37.83 88.9 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 110.249 -0.278 . . . . 100.73 110.249 -177.268 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.745 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.22 -44.6 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 C-N-CA 119.346 -0.942 . . . . 172.72 109.149 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 267' ' ' PHE . . . . . 0.734 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.7 m-85 -66.59 -28.03 68.19 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 108.264 -1.013 . . . . 249.22999999999999 108.264 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 268' ' ' PHE . . . . . 0.9 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.57 -55.14 35.4 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.687 -1.597 . . . . 259.77999999999997 106.687 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 269' ' ' LEU . . . . . 0.492 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.2 mt -69.17 -44.12 72.88 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 113.612 0.967 . . . . 233.11000000000001 113.612 -176.093 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 270' ' ' LEU . . . . . 0.838 ' O ' HG13 ' A' ' 273' ' ' ILE . 89.1 mt -61.37 -48.31 91.41 Favored Pre-proline 0 N--CA 1.439 -0.976 0 C-N-CA 119.155 -1.018 . . . . 169.53999999999999 110.642 -171.07 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 271' ' ' PRO . . . . . 0.734 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.9 Cg_exo -61.13 -24.49 79.34 Favored 'Trans proline' 0 N--CA 1.429 -2.276 0 C-N-CA 116.715 -1.723 . . . . 255.47 114.698 174.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 272' ' ' TYR . . . . . 0.824 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.6 t80 -63.58 -44.26 94.6 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 119.228 0.922 . . . . 279.02999999999997 108.854 177.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.838 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.36 -44.77 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 N-CA-C 110.056 -0.35 . . . . 162.21000000000001 110.056 -178.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 274' ' ' ASN . . . . . 0.867 HD22 HD12 ' A' ' 277' ' ' LEU . 49.0 t30 -125.38 84.87 59.27 Favored Pre-proline 0 N--CA 1.43 -1.428 0 C-N-CA 118.775 -1.17 . . . . 128.13 108.12 -178.119 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 275' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.5 Cg_endo -85.22 164.01 11.3 Favored 'Trans proline' 0 C--N 1.294 -2.304 0 N-CA-C 107.455 -1.787 . . . . 278.35000000000002 107.455 177.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 276' ' ' ASP . . . . . 0.869 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.4 t0 66.12 15.01 9.92 Favored 'General case' 0 N--CA 1.428 -1.569 0 O-C-N 123.777 0.673 . . . . 312.91000000000003 109.326 175.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.869 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.3 mt -132.71 -170.67 2.49 Favored 'General case' 0 CA--C 1.481 -1.679 0 N-CA-C 106.556 -1.646 . . . . 353.54000000000002 106.556 177.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 1.009 ' HA ' ' CB ' ' A' ' 282' ' ' PHE . 42.8 p90 -115.67 142.25 46.99 Favored 'General case' 0 N--CA 1.427 -1.619 0 N-CA-C 107.439 -1.319 . . . . 251.25999999999999 107.439 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.762 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -76.97 -118.71 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 102.103 -3.295 . . . . 175.25999999999999 102.103 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 280' ' ' LYS . . . . . 0.796 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.5 -44.96 96.14 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 100.884 -3.747 . . . . 99.069999999999993 100.884 172.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 281' ' ' LYS . . . . . 0.796 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.45 124.18 9.17 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 103.45 -2.796 . . . . 243.21000000000001 103.45 171.186 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 1.009 ' CB ' ' HA ' ' A' ' 278' ' ' TYR . 77.1 t80 -93.0 112.98 25.13 Favored 'General case' 0 CA--C 1.473 -2.003 0 C-N-CA 116.065 -2.254 . . . . 201.03999999999999 105.286 178.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 283' ' ' ILE . . . . . 0.776 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.96 173.71 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.085 0 C-N-CA 116.004 -2.278 . . . . 201.36000000000001 108.802 -175.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 284' ' ' GLN . . . . . 1.091 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.283 0.6 OUTLIER -59.48 -41.44 89.8 Favored 'General case' 0 N--CA 1.415 -2.176 0 CA-C-N 113.233 -1.803 . . . . 203.81999999999999 107.896 174.462 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 285' ' ' GLN . . . . . 0.923 ' HG2' HE21 ' A' ' 284' ' ' GLN . 1.2 mm100 -64.29 -45.72 86.77 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 118.215 -1.394 . . . . 215.06 112.553 -171.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.552 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.2 t -65.63 -46.45 89.36 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.476 0 C-N-CA 118.565 -1.254 . . . . 125.28 112.951 -171.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 287' ' ' TYR . . . . . 0.952 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.73 -37.04 86.23 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 107.205 -1.405 . . . . 268.89999999999998 107.205 -171.896 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.796 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.26 -44.97 74.41 Favored 'General case' 0 N--CA 1.427 -1.583 0 C-N-CA 125.657 1.583 . . . . 280.88 108.762 -172.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.67 -47.47 86.11 Favored 'General case' 0 N--CA 1.428 -1.564 0 C-N-CA 118.987 -1.085 . . . . 184.47 108.979 -172.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 290' ' ' ILE . . . . . 0.851 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.8 mp -67.94 -42.1 85.28 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 C-N-CA 119.247 -0.981 . . . . 167.91999999999999 112.739 -175.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 291' ' ' MET . . . . . 0.501 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.8 ttt -65.72 -38.83 90.26 Favored 'General case' 0 CA--C 1.495 -1.136 0 C-N-CA 117.751 -1.58 . . . . 367.18000000000001 110.802 -175.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 292' ' ' TRP . . . . . 0.548 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.5 m95 -67.14 -32.7 74.0 Favored 'General case' 0 N--CA 1.435 -1.208 0 O-C-N 121.856 -0.527 . . . . 173.97 110.466 177.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.1 tp -64.44 -36.85 85.51 Favored 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 123.6 0.76 . . . . 119.66 109.777 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 294' ' ' ALA . . . . . 0.82 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.16 -33.99 74.3 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 107.734 -1.21 . . . . 112.3 107.734 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 295' ' ' MET . . . . . 0.773 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.13 -32.04 73.33 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 116.202 -0.454 . . . . 174.16999999999999 110.237 -177.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.7 m -64.69 -22.76 67.06 Favored 'General case' 0 CA--C 1.485 -1.536 0 C-N-CA 124.629 1.171 . . . . 145.27000000000001 110.645 -175.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 297' ' ' SER . . . . . 0.758 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.6 m -57.65 -35.35 70.41 Favored 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 108.084 -1.08 . . . . 170.15000000000001 108.084 -175.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.82 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.7 t -55.28 -34.21 63.9 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 116.282 -0.417 . . . . 214.56999999999999 110.64 -171.124 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 299' ' ' MET . . . . . 0.751 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.1 ttt -77.17 -33.22 56.52 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 126.065 1.746 . . . . 168.28999999999999 115.534 177.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 300' ' ' TYR . . . . . 0.758 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.4 p90 -64.38 -34.86 79.13 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 114.066 1.135 . . . . 167.15000000000001 114.066 -168.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 301' ' ' ASN . . . . . 0.723 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.282 18.8 p-10 -64.23 -38.32 33.25 Favored Pre-proline 0 N--CA 1.434 -1.266 0 C-N-CA 115.52 -2.472 . . . . 165.13 113.921 -171.59 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 302' ' ' PRO . . . . . 0.723 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.2 Cg_exo -62.52 -31.84 80.17 Favored 'Trans proline' 0 N--CA 1.433 -2.035 0 CA-C-N 122.755 2.019 . . . . 123.92 111.271 -178.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 303' ' ' ILE . . . . . 0.717 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.0 pt -68.75 -42.55 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 C-N-CA 118.869 -1.132 . . . . 110.55 109.755 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 304' ' ' ILE . . . . . 1.002 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.1 pt -61.2 -39.99 84.37 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.168 0 N-CA-C 108.806 -0.813 . . . . 145.31 108.806 -177.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 305' ' ' TYR . . . . . 0.923 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.253 63.2 m-85 -58.13 -48.78 79.17 Favored 'General case' 0 CA--C 1.493 -1.212 0 C-N-CA 119.375 -0.93 . . . . 246.68000000000001 109.837 -177.499 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 87.3 m -62.23 -47.52 84.03 Favored 'General case' 0 CA--C 1.485 -1.532 0 C-N-CA 119.549 -0.86 . . . . 64.430000000000007 109.52 -173.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.7 t -66.83 -45.01 79.61 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 118.993 -1.083 . . . . 80.719999999999999 110.226 -177.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.709 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.53 -35.69 75.7 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 115.972 1.841 . . . . 140.44 115.972 -173.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 309' ' ' ASN . . . . . 0.657 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.85 132.23 34.3 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 112.685 -3.606 . . . . 178.87 113.064 -177.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 310' ' ' ASP . . . . . 0.614 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.6 p-10 -65.03 -37.03 86.29 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 114.382 -1.281 . . . . 110.22 110.113 -177.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 311' ' ' ARG . . . . . 0.856 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.75 -50.59 72.72 Favored 'General case' 0 CA--C 1.492 -1.263 0 O-C-N 121.697 -0.627 . . . . 174.78 109.765 -174.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.958 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.1 m-85 -64.87 -41.7 95.44 Favored 'General case' 0 CA--C 1.485 -1.536 0 N-CA-C 108.228 -1.027 . . . . 161.84 108.228 178.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 313' ' ' ARG . . . . . 0.517 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.31 -50.22 73.62 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.196 -0.668 . . . . 117.2 109.196 -173.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.797 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.54 -44.06 75.36 Favored 'General case' 0 N--CA 1.433 -1.275 0 C-N-CA 120.352 -0.539 . . . . 112.59999999999999 111.092 -177.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 315' ' ' GLY . . . . . 0.872 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -64.08 -37.43 94.57 Favored Glycine 0 N--CA 1.431 -1.678 0 N-CA-C 110.59 -1.004 . . . . 101.45999999999999 110.59 -177.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 316' ' ' PHE . . . . . 1.017 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.6 m-85 -62.17 -46.01 90.86 Favored 'General case' 0 CA--C 1.491 -1.307 0 CA-C-N 118.521 1.16 . . . . 151.49000000000001 109.523 -178.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 317' ' ' LYS . . . . . 0.422 ' HE3' ' HB2' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.07 -36.3 77.06 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 106.957 -1.498 . . . . 142.31999999999999 106.957 -175.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 318' ' ' HIS . . . . . 0.826 ' NE2' HG21 ' A' ' 326' ' ' ILE . 49.9 m80 -59.79 -41.82 92.01 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 106.903 -1.517 . . . . 109.09 106.903 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.86 -42.41 85.71 Favored 'General case' 0 N--CA 1.435 -1.177 0 O-C-N 122.334 -0.228 . . . . 76.109999999999999 111.037 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -61.46 -55.43 31.37 Favored 'General case' 0 CA--C 1.49 -1.36 0 C-N-CA 119.849 -0.74 . . . . 120.23999999999999 109.331 -174.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 321' ' ' ARG . . . . . 0.578 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.5 mtt180 -74.34 131.52 41.21 Favored 'General case' 0 CA--C 1.482 -1.66 0 N-CA-C 102.957 -2.979 . . . . 192.72999999999999 102.957 177.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.14 -44.24 92.05 Favored 'General case' 0 CA--C 1.492 -1.266 0 C-N-CA 119.042 -1.063 . . . . 176.28999999999999 109.153 -172.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 323' ' ' CYS . . . . . 0.753 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.6 m -79.37 -177.07 0.8 Allowed Pre-proline 0 CA--C 1.487 -1.453 0 N-CA-C 106.241 -1.762 . . . . 69.680000000000007 106.241 178.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.567 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.5 Cg_exo -59.08 -75.51 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.403 0 C-N-CA 118.31 -0.66 . . . . 191.05000000000001 112.614 176.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 325' ' ' PHE . . . . . 0.753 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.5 m-85 47.48 43.92 16.24 Favored 'General case' 0 CA--C 1.493 -1.229 0 O-C-N 123.575 0.547 . . . . 287.02999999999997 109.737 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 326' ' ' ILE . . . . . 0.826 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.51 78.59 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.474 -1.946 0 C-N-CA 112.992 -3.483 . . . . 292.29000000000002 109.8 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 327' ' ' SER . . . . . 0.48 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.3 t -77.53 -152.81 0.05 Allowed 'General case' 0 N--CA 1.424 -1.775 0 N-CA-C 104.209 -2.515 . . . . 184.56999999999999 104.209 178.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 328' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.74 8.6 4.92 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 113.045 0.757 . . . . 274.56 113.045 176.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.97 0.91 57.26 Favored Glycine 0 C--N 1.348 1.198 0 C-N-CA 117.746 -2.168 . . . . 268.24000000000001 113.465 172.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 330' ' ' ASP . . . . . 0.698 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.5 m-20 51.59 -172.04 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.063 0 CA-C-N 118.677 1.239 . . . . 200.06 110.734 177.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.856 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.88 -32.98 74.68 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 107.878 -1.156 . . . . 114.44 107.878 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 332' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.28 46.04 21.92 Favored 'General case' 0 CA--C 1.484 -1.591 0 N-CA-C 107.638 -1.245 . . . . 263.81 107.638 -177.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 333' ' ' GLY . . . . . 0.634 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.3 -137.36 3.61 Favored Glycine 0 CA--C 1.479 -2.204 1 N-CA-C 102.556 -4.218 . . . . 103.79000000000001 102.556 -179.815 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 1.048 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.2 mt -88.26 95.54 10.22 Favored 'General case' 0 N--CA 1.419 -1.996 0 C-N-CA 114.936 -2.706 . . . . 117.3 106.018 177.028 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 335' ' ' GLU . . . . . 1.028 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.91 -39.83 90.91 Favored 'General case' 0 CA--C 1.469 -2.16 1 N-CA-C 97.994 -4.817 . . . . 231.58000000000001 97.994 167.264 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 336' ' ' MET . . . . . 1.036 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.92 163.49 29.05 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 102.11 -3.293 . . . . 303.24000000000001 102.11 168.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 337' ' ' LYS . . . . . 1.048 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.3 tttt -62.62 -48.6 78.68 Favored 'General case' 0 N--CA 1.432 -1.365 0 C-N-CA 116.038 -2.265 . . . . 112.72 108.411 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.9 t -61.04 -63.63 1.23 Allowed 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 109.117 -0.697 . . . . 83.219999999999999 109.117 -176.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 339' ' ' THR . . . . . 0.884 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.1 m -156.28 -126.21 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 103.833 -2.654 . . . . 174.36000000000001 103.833 -178.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 340' ' ' ARG . . . . . 1.028 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.86 160.95 8.77 Favored 'General case' 0 CA--C 1.486 -1.504 0 N-CA-C 105.761 -1.94 . . . . 202.72999999999999 105.761 177.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 341' ' ' TYR . . . . . 1.018 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.98 149.08 52.53 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 107.046 -1.465 . . . . 180.62 107.046 176.358 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 342' ' ' LEU . . . . . 0.931 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.4 tp -178.52 -171.86 0.27 Allowed 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 105.409 -2.071 . . . . 145.25 105.409 178.098 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 343' ' ' GLN . . . . . 0.931 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.08 -43.17 88.11 Favored 'General case' 0 CA--C 1.487 -1.477 0 N-CA-C 106.129 -1.804 . . . . 66.049999999999997 106.129 174.236 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 344' ' ' THR . . . . . 0.766 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.1 t -132.68 -152.12 0.48 Allowed 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 103.505 -2.776 . . . . 266.49000000000001 103.505 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 345' ' ' GLN . . . . . 0.699 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.4 mt-30 66.27 -124.96 0.28 Allowed 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 117.043 -1.863 . . . . 219.19999999999999 107.801 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 346' ' ' GLY . . . . . 0.902 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.02 -37.43 94.23 Favored Glycine 0 N--CA 1.425 -2.044 0 CA-C-N 114.558 -1.201 . . . . 94.780000000000001 112.852 -176.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 347' ' ' SER . . . . . 0.826 ' HB2' ' H ' ' A' ' 342' ' ' LEU . 48.4 t -81.11 100.38 9.01 Favored 'General case' 0 CA--C 1.484 -1.575 0 C-N-CA 112.316 -3.753 . . . . 121.41 109.468 -171.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 348' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.8 t -72.99 145.47 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 108.997 -0.742 . . . . 85.340000000000003 108.997 -176.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 349' ' ' TYR . . . . . 0.441 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.5 p90 -57.76 143.47 41.86 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 107.839 -1.171 . . . . 267.56999999999999 107.839 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 350' ' ' LYS . . . . . 0.525 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.01 69.58 0.6 Allowed 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 109.553 -0.536 . . . . 226.09999999999999 109.553 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 351' ' ' VAL . . . . . 0.825 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.5 p -50.94 156.94 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.315 0 N-CA-C 106.994 -1.484 . . . . 154.84 106.994 177.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 352' ' ' SER . . . . . 0.582 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.4 m -61.35 161.87 8.59 Favored 'General case' 0 CA--C 1.494 -1.21 0 CA-C-O 121.588 0.709 . . . . 180.00999999999999 110.722 -173.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 353' ' ' ARG . . . . . 0.895 ' H ' ' HD3' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.41 156.92 23.6 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 106.976 -1.49 . . . . 333.77999999999997 106.976 -178.653 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 354' ' ' LEU . . . . . 0.974 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.06 142.51 48.79 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 107.364 -1.347 . . . . 335.19999999999999 107.364 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.974 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.6 mm-40 82.88 158.91 0.13 Allowed 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 108.703 -0.851 . . . . 266.47000000000003 108.703 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.8 m -60.66 -46.92 88.5 Favored 'General case' 0 CA--C 1.487 -1.465 0 N-CA-C 105.632 -1.988 . . . . 59.340000000000003 105.632 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.53 173.87 11.97 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 104.462 -2.421 . . . . 201.25999999999999 104.462 176.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.748 HG22 ' O ' ' A' ' 360' ' ' THR . 69.3 mt -95.94 106.78 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 C-N-CA 116.29 -2.164 . . . . 56.229999999999997 105.503 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 359' ' ' SER . . . . . 0.464 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.9 m -61.19 -59.45 5.29 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 109.319 -0.623 . . . . 87.579999999999998 109.319 -175.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 360' ' ' THR . . . . . 0.891 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.2 t -85.55 153.74 22.22 Favored 'General case' 0 CA--C 1.485 -1.535 0 N-CA-C 107.821 -1.178 . . . . 219.94999999999999 107.821 -177.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 361' ' ' VAL . . . . . 0.588 ' O ' HG23 ' A' ' 361' ' ' VAL . 16.0 m -81.98 83.85 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 C-N-CA 116.35 -2.14 . . . . 121.79000000000001 105.432 177.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.597 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.3 t -154.14 159.72 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.559 0 N-CA-C 105.78 -1.933 . . . . 53.850000000000001 105.78 -179.177 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 363' ' ' GLY . . . . . 0.597 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.2 16.62 77.02 Favored Glycine 0 N--CA 1.428 -1.889 0 N-CA-C 106.029 -2.828 . . . . 196.55000000000001 106.029 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.653 0 N-CA-C 107.883 -1.154 . . . . 35.880000000000003 107.883 -178.971 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 365' ' ' ARG . . . . . 0.512 ' HE ' ' HB3' ' B' ' 365' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 108.867 -0.79 . . . . 1.0 108.867 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 366' ' ' PRO . . . . . 0.581 ' HG3' ' OD1' ' A' ' 3' ' ' ASN . 52.3 Cg_endo -66.89 142.0 60.98 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.059 1.839 . . . . 1.0 110.195 179.004 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 367' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -64.46 143.29 98.53 Favored Pre-proline 0 C--N 1.324 -0.503 0 C-N-CA 119.854 -0.738 . . . . 1.0 109.545 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 368' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.25 150.39 76.56 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.312 2.008 . . . . 1.0 111.738 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 369' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.71 131.71 44.29 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.709 -0.396 . . . . 1.0 110.248 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -101.95 115.9 31.54 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.372 -0.377 . . . . 1.0 110.727 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 371' ' ' PHE . . . . . 0.405 ' HA ' HD12 ' B' ' 374' ' ' LEU . 86.1 m-85 -63.6 -42.51 98.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.318 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 372' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -65.07 -36.14 83.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.839 -0.619 . . . . 1.0 110.672 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -59.73 -33.08 76.12 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.776 -0.93 . . . . 1.0 110.776 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 374' ' ' LEU . . . . . 0.656 ' CD1' HD11 ' A' ' 102' ' ' LEU . 3.2 mt . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 120.929 0.395 . . . . 1.0 110.16 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.471 0 N-CA-C 108.398 -0.964 . . . . 97.079999999999998 108.398 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.682 ' ND2' ' HG3' ' B' ' 366' ' ' PRO . 46.5 t30 -110.62 155.43 22.38 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-O 122.172 0.987 . . . . 123.41 110.671 -172.077 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.881 HG11 HD13 ' A' ' 15' ' ' ILE . 28.8 m -134.56 -162.33 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.477 1 N-CA-C 100.121 -4.029 . . . . 151.30000000000001 100.121 173.72 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.908 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.69 -38.6 58.17 Favored Pre-proline 0 N--CA 1.439 -0.985 0 C-N-CA 115.961 -2.296 . . . . 169.25 106.104 178.086 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.908 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 57.6 Cg_exo -81.28 168.53 16.66 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 122.283 0.623 . . . . 185.75999999999999 110.568 171.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.904 HG13 ' CE2' ' A' ' 282' ' ' PHE . 91.7 t -64.5 -25.92 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 C-N-CA 127.041 2.137 . . . . 145.47 110.332 -177.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.774 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.2 t0 -84.32 157.44 21.5 Favored 'General case' 0 CA--C 1.499 -0.993 0 O-C-N 121.087 -1.008 . . . . 102.76000000000001 109.45 -178.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.6 p -82.6 154.23 25.06 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 107.943 -1.132 . . . . 106.25 107.943 178.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.921 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.7 p-10 -105.97 51.93 0.74 Allowed 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 117.763 -1.575 . . . . 157.81 107.597 178.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.22 -45.87 91.71 Favored 'General case' 0 CA--C 1.481 -1.698 0 N-CA-C 103.58 -2.748 . . . . 150.19999999999999 103.58 178.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 71.0 m -87.01 164.69 35.36 Favored Pre-proline 0 N--CA 1.421 -1.9 0 N-CA-C 103.689 -2.708 . . . . 183.52000000000001 103.689 172.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -76.75 6.86 3.84 Favored 'Trans proline' 0 C--N 1.281 -2.987 0 N-CA-C 110.011 -0.803 . . . . 235.61000000000001 110.011 176.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.423 ' C ' HD21 ' A' ' 14' ' ' ASN . 0.4 OUTLIER -57.92 -41.24 82.26 Favored 'General case' 0 N--CA 1.435 -1.198 0 C-N-CA 124.82 1.248 . . . . 113.77 113.386 -170.105 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.921 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.3 pt -52.22 136.26 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.912 0 CA-C-N 119.553 1.069 . . . . 150.84999999999999 110.942 -176.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.51 156.24 46.39 Favored 'General case' 0 C--N 1.36 1.06 0 N-CA-C 107.61 -1.256 . . . . 100.42 107.61 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . 1.081 HG23 ' H ' ' A' ' 20' ' ' SER . 14.2 t -64.99 142.6 58.38 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 121.971 0.891 . . . . 129.36000000000001 110.449 -174.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.775 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 74.7 m-20 -63.1 -25.5 68.39 Favored 'General case' 0 CA--C 1.494 -1.174 0 C-N-CA 126.28 1.832 . . . . 112.34 106.645 -177.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.935 HG23 ' HA2' ' A' ' 101' ' ' GLY . 85.3 m -74.11 -40.13 62.88 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 115.562 -0.744 . . . . 131.72999999999999 111.769 177.418 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . 1.081 ' H ' HG23 ' A' ' 17' ' ' THR . 70.8 m -84.47 -42.84 15.18 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 117.006 2.225 . . . . 80.489999999999995 117.006 -174.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.549 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.4 mt-10 -145.99 174.52 3.36 Favored Pre-proline 0 N--CA 1.442 -0.827 0 C-N-CA 118.124 -1.43 . . . . 98.980000000000004 111.172 -169.213 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.822 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.332 85.6 Cg_exo -61.84 -10.67 18.0 Favored 'Trans proline' 0 C--N 1.321 -0.87 1 N-CA-C 128.882 6.455 . . . . 246.94999999999999 128.882 -170.053 . . . . . . . . 4 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.0 m120 61.58 17.52 8.65 Favored 'General case' 0 C--N 1.324 -0.519 1 CA-C-N 126.181 4.082 . . . . 269.62 114.237 175.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.495 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 80.8 mt-30 -67.1 -27.24 67.17 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 107.806 -1.183 . . . . 86.799999999999997 107.806 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.552 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.4 p90 -66.85 -29.29 69.16 Favored 'General case' 0 N--CA 1.431 -1.391 0 O-C-N 121.166 -0.959 . . . . 85.909999999999997 110.514 -178.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.872 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.4 t -68.59 -40.2 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 C-N-CA 123.734 0.814 . . . . 82.0 111.312 -177.015 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.897 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 27.6 pt20 -151.41 167.73 12.48 Favored Pre-proline 0 CA--C 1.489 -1.401 0 N-CA-C 108.551 -0.907 . . . . 120.73 108.551 -178.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.904 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -64.0 149.76 89.82 Favored 'Trans proline' 0 N--CA 1.432 -2.136 0 C-N-CA 120.645 0.896 . . . . 87.859999999999999 109.912 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.743 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.03 -37.94 89.2 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.829 -0.804 . . . . 36.460000000000001 108.829 -176.157 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.813 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 28.0 p-90 -63.83 -33.84 76.58 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 107.837 -1.171 . . . . 150.59999999999999 107.837 -176.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.904 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.4 mt-30 -62.22 -32.66 73.35 Favored 'General case' 0 CA--C 1.49 -1.328 0 O-C-N 121.303 -0.873 . . . . 123.26000000000001 108.705 -178.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.743 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.5 -47.19 94.54 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.59 0 N-CA-C 109.162 -0.681 . . . . 120.14 109.162 176.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.785 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.3 m -67.38 -31.04 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 N-CA-C 107.865 -1.161 . . . . 112.19 107.865 -178.167 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.813 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.6 tp -62.99 -47.1 84.58 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 119.887 -0.725 . . . . 60.869999999999997 109.588 -178.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.672 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.04 -35.67 81.16 Favored 'General case' 0 CA--C 1.489 -1.389 0 C-N-CA 119.999 -0.681 . . . . 157.56999999999999 110.309 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.747 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.68 -40.83 98.33 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 108.617 -0.883 . . . . 47.060000000000002 108.617 178.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.805 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.8 -41.27 97.95 Favored 'General case' 0 CA--C 1.496 -1.112 0 O-C-N 121.728 -0.607 . . . . 43.939999999999998 109.535 -177.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.728 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.84 -43.31 99.1 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 108.714 -0.847 . . . . 42.609999999999999 108.714 -176.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.904 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.33 -41.29 94.11 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 116.615 -0.266 . . . . 140.66 111.018 -178.351 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.805 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.82 -43.91 97.91 Favored 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 118.547 -1.261 . . . . 116.04000000000001 110.252 -175.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.5 -38.71 83.1 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.29 0 N-CA-C 108.71 -0.848 . . . . 97.159999999999997 108.71 -177.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.855 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.2 mt -61.27 -39.99 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 108.995 -0.743 . . . . 54.850000000000001 108.995 -176.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.961 HG22 HG21 ' A' ' 86' ' ' THR . 92.6 t -57.73 -42.33 81.52 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.312 0 N-CA-C 108.864 -0.791 . . . . 45.390000000000001 108.864 -175.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 48' ' ' VAL . 97.2 t -63.56 -50.95 76.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 C-N-CA 118.875 -1.13 . . . . 48.640000000000001 110.163 -177.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.75 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.5 t -65.29 -46.99 78.21 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 120.119 -0.633 . . . . 116.65000000000001 111.731 -174.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.587 ' N ' HG23 ' A' ' 45' ' ' THR . 50.7 m -61.98 -43.96 97.74 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 109.729 -0.471 . . . . 51.159999999999997 109.729 -174.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.9 t -65.48 -48.95 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 C-N-CA 119.872 -0.731 . . . . 44.299999999999997 110.88 -177.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.866 ' O ' HG23 ' A' ' 52' ' ' VAL . 93.8 t -64.75 -46.94 90.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 C-N-CA 120.296 -0.561 . . . . 48.82 111.043 -174.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.79 -44.11 95.24 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 120.479 -0.867 . . . . 58.700000000000003 112.015 -174.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -72.67 -34.21 67.07 Favored 'General case' 0 CA--C 1.488 -1.418 0 O-C-N 122.102 -0.646 . . . . 101.40000000000001 111.014 -175.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.742 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.85 -38.77 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 107.755 -1.202 . . . . 103.56999999999999 107.755 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 48' ' ' VAL . 72.1 t -61.4 -43.04 96.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 N-CA-C 109.016 -0.735 . . . . 61.890000000000001 109.016 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.536 ' O ' HG22 ' A' ' 56' ' ' ILE . 82.1 t -63.43 -50.95 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 C-N-CA 120.284 -0.566 . . . . 70.010000000000005 109.506 -178.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.806 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.9 -43.45 98.77 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 109.142 -0.688 . . . . 132.09999999999999 109.142 -176.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.644 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.1 t-105 -64.18 -46.65 83.03 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 116.671 -0.24 . . . . 104.5 110.442 -176.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 1.015 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.68 -49.87 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 C-N-CA 120.216 -0.594 . . . . 142.96000000000001 111.244 -173.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.953 HD11 HG12 ' A' ' 72' ' ' VAL 0.278 24.8 pt -64.78 -41.67 92.82 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 C-N-CA 116.933 -1.907 . . . . 158.31999999999999 110.878 -175.98 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.806 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.76 -41.34 98.0 Favored 'General case' 0 N--CA 1.434 -1.273 0 C-N-CA 117.713 -1.595 . . . . 137.11000000000001 109.451 178.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.35 -44.6 90.94 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 122.128 -0.358 . . . . 54.659999999999997 110.994 -176.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.923 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.38 117.15 29.43 Favored 'General case' 0 CA--C 1.491 -1.323 0 CA-C-O 121.63 0.728 . . . . 127.18000000000001 109.572 -174.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.619 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.87 -36.79 80.09 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 124.022 0.929 . . . . 87.930000000000007 110.857 -176.069 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 1.036 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.38 -34.7 78.77 Favored 'General case' 0 CA--C 1.49 -1.356 0 O-C-N 121.623 -0.673 . . . . 131.12 111.467 -175.622 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' MET . . . . . 1.02 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.62 69.44 7.13 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 115.34 -2.544 . . . . 246.56 109.583 -175.179 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.411 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.2 91.42 3.48 Favored 'General case' 0 CA--C 1.474 -1.974 0 N-CA-C 105.514 -2.032 . . . . 339.35000000000002 105.514 177.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.445 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.5 p -124.15 165.2 17.96 Favored 'General case' 0 N--CA 1.413 -2.275 0 N-CA-C 102.987 -2.968 . . . . 114.66 102.987 176.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.879 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.07 -39.51 85.51 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.604 0 N-CA-C 106.798 -1.556 . . . . 143.28 106.798 178.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.835 HG22 HD13 ' A' ' 71' ' ' LEU . 95.1 m -59.63 -38.08 80.4 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 108.704 -0.851 . . . . 160.22 108.704 -176.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.524 ' ND2' ' HB3' ' A' ' 63' ' ' MET . 86.3 m-20 -62.3 -31.79 72.44 Favored 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 108.918 -0.771 . . . . 120.54000000000001 108.918 -177.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.9 ' O ' HG22 ' A' ' 72' ' ' VAL . 89.8 m-85 -63.61 -43.74 96.01 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 109.511 -0.552 . . . . 67.219999999999999 109.511 178.123 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.879 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.4 m-85 -66.56 -39.77 88.67 Favored 'General case' 0 CA--C 1.498 -1.033 0 O-C-N 121.455 -0.778 . . . . 138.59999999999999 109.659 -177.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.921 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.52 -35.95 82.17 Favored 'General case' 0 CA--C 1.492 -1.26 0 C-N-CA 122.5 0.32 . . . . 151.46000000000001 110.638 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.953 HG12 HD11 ' A' ' 57' ' ' ILE . 24.2 m -62.56 -37.98 80.29 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.225 0 C-N-CA 117.445 -1.702 . . . . 117.93000000000001 106.69 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.449 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.1 t30 -60.06 -46.01 90.97 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.833 -1.173 . . . . 56.82 107.833 -177.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.889 HD21 ' CE ' ' A' ' 123' ' ' MET . 8.7 mp -61.43 -43.83 98.18 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 108.93 -0.767 . . . . 145.30000000000001 108.93 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.13 -40.29 95.42 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 108.493 -0.929 . . . . 45.710000000000001 108.493 -175.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -62.48 -41.98 99.16 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 109.356 -0.609 . . . . 105.61 109.356 -178.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.14 -39.46 92.67 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 108.655 -0.869 . . . . 47.890000000000001 108.655 -178.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.59 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.55 -37.36 84.83 Favored 'General case' 0 N--CA 1.438 -1.042 0 O-C-N 122.08 -0.388 . . . . 124.53 109.967 179.677 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.9 -41.16 99.33 Favored 'General case' 0 N--CA 1.436 -1.14 0 O-C-N 121.912 -0.492 . . . . 35.890000000000001 109.873 -178.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.9 t -62.24 -37.37 85.14 Favored 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 106.988 -1.486 . . . . 88.969999999999999 106.988 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.82 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.13 -49.2 76.84 Favored 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 119.813 -0.755 . . . . 239.91 109.041 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.62 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.37 -43.35 91.06 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 121.487 -0.758 . . . . 146.09999999999999 110.636 -177.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.417 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.2 -58.24 3.4 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 117.374 -1.73 . . . . 91.739999999999995 113.843 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -76.49 -61.46 1.95 Allowed 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 115.739 1.755 . . . . 197.44999999999999 115.739 -173.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.936 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.23 -42.28 55.67 Favored 'General case' 0 CA--C 1.489 -1.388 0 C-N-CA 117.928 -1.509 . . . . 242.59999999999999 114.028 -170.012 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.961 HG21 HG22 ' A' ' 43' ' ' VAL . 4.6 t -65.39 -36.51 84.2 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 118.938 -1.105 . . . . 215.61000000000001 109.902 -172.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.423 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.8 t -60.39 -46.91 94.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 C-N-CA 120.31 -0.556 . . . . 87.189999999999998 110.445 -175.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.842 HG21 ' CD2' ' A' ' 108' ' ' HIS . 63.3 t -65.9 -41.83 90.76 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.124 0 N-CA-C 109.765 -0.457 . . . . 231.81999999999999 109.765 -178.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.904 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 87.6 m-20 -62.34 -34.16 76.11 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.329 -0.989 . . . . 364.98000000000002 108.329 -177.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.668 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.2 t80 -68.12 -44.75 75.42 Favored 'General case' 0 N--CA 1.438 -1.074 0 O-C-N 121.496 -0.752 . . . . 181.63 111.298 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.477 HG22 ' ND1' ' A' ' 95' ' ' HIS . 58.0 m -60.83 -45.83 92.92 Favored 'General case' 0 CA--C 1.478 -1.82 0 N-CA-C 107.424 -1.324 . . . . 269.01999999999998 107.424 -175.198 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 1.058 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.68 -45.04 93.26 Favored 'General case' 0 CA--C 1.468 -2.178 0 C-N-CA 118.626 -1.23 . . . . 562.65999999999997 110.054 -179.061 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.704 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.12 -45.21 95.62 Favored 'General case' 0 CA--C 1.478 -1.791 0 C-N-CA 118.712 -1.195 . . . . 446.75 108.107 -167.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.747 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.386 6.0 m -70.55 -26.27 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.768 0 C-N-CA 115.824 -2.35 . . . . 370.05000000000001 112.206 -178.75 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.496 ' O ' ' HB2' ' A' ' 96' ' ' ASN . 40.7 m80 -74.51 -26.44 60.0 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 121.556 -0.715 . . . . 354.91000000000003 112.518 175.109 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.822 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.4 m-20 82.8 4.47 0.99 Allowed 'General case' 0 CA--C 1.499 -0.988 0 C-N-CA 125.07 1.348 . . . . 462.44 111.93 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.775 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.266 11.9 mm-40 -172.34 178.05 2.92 Favored 'General case' 0 CA--C 1.488 -1.426 0 CA-C-O 122.005 0.907 . . . . 652.37 111.131 171.809 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.791 ' HE3' ' HA ' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.75 86.31 2.18 Favored 'General case' 0 N--CA 1.428 -1.564 0 C-N-CA 128.472 2.709 . . . . 905.99000000000001 107.909 -174.213 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -67.82 -36.43 80.37 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 108.241 -1.022 . . . . 570.42999999999995 108.241 -176.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.845 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.59 -36.35 82.45 Favored 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 125.299 1.44 . . . . 453.22000000000003 111.147 -174.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.935 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.55 178.64 33.9 Favored Glycine 0 C--N 1.35 1.324 0 C-N-CA 118.751 -1.69 . . . . 445.63 109.906 177.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.805 ' CD1' ' HG ' ' B' ' 374' ' ' LEU . 89.0 mt -56.37 -41.21 75.84 Favored 'General case' 0 CA--C 1.499 -1.005 0 C-N-CA 125.25 1.42 . . . . 457.72000000000003 112.403 -170.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -58.67 -46.92 86.16 Favored 'General case' 0 CA--C 1.485 -1.525 0 C-N-CA 118.64 -1.224 . . . . 340.57999999999998 109.3 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.845 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.2 m-85 -68.67 -32.2 71.86 Favored 'General case' 0 N--CA 1.424 -1.774 0 C-N-CA 118.765 -1.174 . . . . 453.60000000000002 111.544 -176.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.764 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.04 -40.33 73.33 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 105.972 -1.862 . . . . 541.48000000000002 105.972 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.82 -47.15 76.01 Favored 'General case' 0 CA--C 1.486 -1.484 0 O-C-N 123.945 0.778 . . . . 466.68000000000001 110.879 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -61.72 -47.12 86.7 Favored 'General case' 0 N--CA 1.427 -1.605 0 C-N-CA 117.429 -1.709 . . . . 427.33999999999997 107.334 -178.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.842 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.5 m80 -67.07 -36.74 82.69 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 112.441 0.534 . . . . 537.87 112.441 -174.196 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.575 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.48 -42.6 74.59 Favored 'General case' 0 N--CA 1.433 -1.323 0 C-N-CA 116.821 -1.952 . . . . 422.12 111.611 175.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.856 ' O ' HG22 ' A' ' 113' ' ' ILE . 75.9 t80 -59.1 -50.05 75.55 Favored 'General case' 0 N--CA 1.441 -0.879 0 O-C-N 121.323 -0.861 . . . . 340.17000000000002 111.846 -173.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -65.34 -46.49 70.84 Favored Pre-proline 0 N--CA 1.442 -0.848 0 C-N-CA 119.078 -1.049 . . . . 258.06 111.728 -176.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.936 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.2 Cg_exo -61.54 -31.56 87.44 Favored 'Trans proline' 0 N--CA 1.435 -1.958 0 N-CA-C 115.353 1.251 . . . . 305.70999999999998 115.353 176.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.875 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.89 -40.36 76.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 108.739 -0.838 . . . . 252.69999999999999 108.739 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.422 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.94 -40.63 94.01 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 107.806 -1.183 . . . . 149.27000000000001 107.806 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.95 -44.84 95.92 Favored 'General case' 0 N--CA 1.436 -1.155 0 C-N-CA 120.608 -0.437 . . . . 138.08000000000001 111.519 -176.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.651 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 64.9 t -66.91 -42.4 88.88 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.94 0 O-C-N 121.565 -0.71 . . . . 132.88999999999999 110.942 -177.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.924 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.74 -44.65 92.89 Favored 'General case' 0 N--CA 1.433 -1.287 0 C-N-CA 119.748 -0.781 . . . . 193.61000000000001 108.923 -177.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.556 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.51 -37.63 84.43 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 122.81 0.444 . . . . 63.829999999999998 110.121 -175.295 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.8 m -64.0 -52.37 59.86 Favored 'General case' 0 N--CA 1.435 -1.221 0 C-N-CA 120.712 -0.395 . . . . 76.400000000000006 111.276 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.748 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -63.01 -41.65 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 N-CA-C 108.157 -1.053 . . . . 171.13 108.157 -174.991 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 1.095 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.3 m-85 -63.77 -38.57 91.6 Favored 'General case' 0 N--CA 1.433 -1.294 0 O-C-N 121.846 -0.534 . . . . 78.299999999999997 110.631 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.555 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.2 t -67.04 -35.79 80.65 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 118.939 -1.104 . . . . 92.359999999999999 109.238 -178.435 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.976 ' HA ' ' HE2' ' A' ' 123' ' ' MET . 5.9 mmt -62.51 -34.27 76.55 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 108.151 -1.055 . . . . 93.730000000000004 108.151 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.903 HG22 HG13 ' A' ' 212' ' ' ILE . 33.2 p -67.45 -41.63 84.39 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.204 -0.998 . . . . 132.74000000000001 109.324 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.26 -42.12 94.68 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 107.203 -1.406 . . . . 43.390000000000001 107.203 -177.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.827 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 94.4 t -58.41 -42.02 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 N-CA-C 108.582 -0.895 . . . . 59.340000000000003 108.582 -178.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.48 -44.07 95.45 Favored 'General case' 0 CA--C 1.497 -1.081 0 O-C-N 121.75 -0.594 . . . . 69.680000000000007 110.525 -177.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.468 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.4 t80 -65.5 -42.73 91.81 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.36 -0.978 . . . . 106.98 108.36 -177.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.827 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.39 -35.59 81.39 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 119.622 -0.831 . . . . 147.63 108.937 -177.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.704 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.09 -41.58 99.43 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.533 -0.914 . . . . 190.06 108.533 178.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.6 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.3 t80 -61.37 -44.06 97.81 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 108.256 -1.016 . . . . 118.84999999999999 108.256 -177.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.806 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.4 mmt -63.37 -42.65 98.88 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 109.981 -0.377 . . . . 102.5 109.981 -177.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.95 -41.64 95.3 Favored 'General case' 0 CA--C 1.489 -1.383 0 O-C-N 121.813 -0.554 . . . . 89.980000000000004 109.839 -176.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.92 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.3 mt -66.55 -50.7 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.666 0 C-N-CA 118.106 -1.438 . . . . 106.09 110.975 -177.205 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.748 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.09 -48.34 38.25 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.091 0 C-N-CA 117.114 -1.834 . . . . 227.74000000000001 111.797 -174.787 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.754 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.1 p80 -118.79 100.07 51.06 Favored Pre-proline 0 CA--C 1.486 -1.51 0 C-N-CA 116.249 -2.18 . . . . 262.55000000000001 110.07 -175.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.2 Cg_endo -69.63 -10.33 28.39 Favored 'Trans proline' 0 C--N 1.29 -2.548 0 C-N-CA 121.622 1.548 . . . . 210.25 111.366 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.705 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.32 112.07 1.01 Allowed 'General case' 0 CA--C 1.49 -1.34 0 N-CA-C 106.505 -1.665 . . . . 270.57999999999998 106.505 -178.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.891 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.87 -39.5 23.44 Favored Pre-proline 0 N--CA 1.431 -1.418 0 CA-C-N 115.355 -0.839 . . . . 129.84 112.295 -175.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.86 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 82.1 Cg_exo -61.43 -26.56 81.39 Favored 'Trans proline' 0 N--CA 1.431 -2.185 0 N-CA-C 116.287 1.611 . . . . 330.70999999999998 116.287 -174.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.754 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.02 77.23 7.94 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 114.513 -2.875 . . . . 204.50999999999999 107.29 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.876 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.7 147.41 0.09 Allowed 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.485 -1.302 . . . . 387.41000000000003 107.485 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.876 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.5 t -143.71 147.07 33.7 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 118.763 -1.175 . . . . 166.22 109.431 178.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.9 -40.76 87.81 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 107.806 -1.183 . . . . 44.229999999999997 107.806 176.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.485 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.3 m -60.25 -39.18 85.87 Favored 'General case' 0 CA--C 1.492 -1.285 0 N-CA-C 108.157 -1.053 . . . . 28.800000000000001 108.157 -175.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.667 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.81 -38.76 91.98 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 109.084 -0.71 . . . . 30.289999999999999 109.084 -179.141 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.847 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 89.9 m -59.66 -43.01 94.12 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 108.964 -0.754 . . . . 46.109999999999999 108.964 -176.172 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.4 -42.18 99.23 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 107.713 -1.217 . . . . 87.329999999999998 107.713 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.77 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.5 t -61.69 -42.05 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 N-CA-C 107.952 -1.129 . . . . 23.690000000000001 107.952 -178.06 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.8 t -63.18 -44.32 99.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 N-CA-C 109.672 -0.492 . . . . 43.859999999999999 109.672 -178.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.919 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.1 mm -61.23 -42.57 93.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 N-CA-C 108.334 -0.987 . . . . 91.129999999999995 108.334 -176.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' CYS . . . . . 0.482 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.1 t -62.56 -37.99 88.3 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 108.712 -0.848 . . . . 65.879999999999995 108.712 -178.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.1 t -62.09 -41.87 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 N-CA-C 109.529 -0.545 . . . . 33.859999999999999 109.529 -177.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 1.095 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.35 -40.32 85.79 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.171 0 N-CA-C 107.576 -1.268 . . . . 146.52000000000001 107.576 -176.786 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 155' ' ' TRP . . . . . 0.699 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.1 m95 -62.9 -38.35 90.57 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 119.483 -0.887 . . . . 75.439999999999998 108.849 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.9 t -60.54 -48.47 88.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 O-C-N 121.073 -1.017 . . . . 43.640000000000001 109.699 -177.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.793 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.64 -37.99 89.41 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 109.068 -0.716 . . . . 102.56999999999999 109.068 -178.09 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.01 -41.05 86.79 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.433 -1.321 . . . . 58.159999999999997 107.433 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.798 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.12 -32.44 73.83 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 109.045 -0.724 . . . . 121.11 109.045 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.793 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.04 -42.33 85.16 Favored 'General case' 0 CA--C 1.489 -1.404 0 C-N-CA 118.567 -1.253 . . . . 153.15000000000001 109.938 -178.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 1.056 HD13 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.05 -43.72 19.11 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 113.154 -3.419 . . . . 133.66999999999999 113.545 173.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.479 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -63.01 -39.88 96.09 Favored 'General case' 0 CA--C 1.49 -1.352 0 O-C-N 120.951 -1.093 . . . . 157.41999999999999 112.189 -171.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.523 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.3 t80 -74.45 -36.07 2.43 Favored Pre-proline 0 N--CA 1.436 -1.129 0 N-CA-C 115.056 1.502 . . . . 250.91 115.056 -173.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.523 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.291 52.1 Cg_exo -59.59 -25.43 78.82 Favored 'Trans proline' 0 CA--C 1.489 -1.736 0 N-CA-C 117.968 2.257 . . . . 207.34 117.968 -174.331 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.917 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 32.4 mt-30 -61.2 -34.16 74.63 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 106.967 -1.494 . . . . 192.46000000000001 106.967 178.057 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.5 -41.07 98.11 Favored Glycine 0 C--N 1.353 1.513 0 N-CA-C 107.949 -2.06 . . . . 261.0 107.949 177.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.8 159.1 26.03 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 101.466 -3.531 . . . . 491.39999999999998 101.466 172.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -59.89 106.76 0.53 Allowed 'General case' 0 CA--C 1.488 -1.422 0 C-N-CA 116.239 -2.184 . . . . 386.10000000000002 109.849 -176.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.917 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 74.0 m -153.99 -166.6 2.42 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 103.583 -2.747 . . . . 289.80000000000001 103.583 -178.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' THR . . . . . 1.14 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.97 175.47 0.86 Allowed 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 117.748 -1.12 . . . . 402.06 109.555 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.789 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 73.6 p -165.27 177.53 7.54 Favored 'General case' 0 CA--C 1.586 2.363 0 C-N-CA 127.308 2.243 . . . . 690.52999999999997 114.912 177.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.488 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 40.0 mm-40 132.33 160.53 0.0 OUTLIER 'General case' 1 C--N 1.43 4.066 1 N-CA-C 123.195 4.517 . . . . 633.62 123.195 162.673 . . . . . . . . 4 3 . 1 . 003 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.761 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.1 p -85.59 153.85 22.12 Favored 'General case' 0 C--N 1.389 2.283 0 C-N-CA 127.413 2.285 . . . . 617.99000000000001 110.886 178.002 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' MET . . . . . 1.04 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.7 174.37 6.04 Favored Pre-proline 0 C--N 1.363 1.18 0 C-N-CA 130.304 3.442 . . . . 434.98000000000002 113.433 -175.433 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 1.092 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 51.8 Cg_endo -44.26 -65.63 0.19 Allowed 'Trans proline' 0 N--CA 1.441 -1.569 0 N-CA-C 122.414 3.967 . . . . 365.88 122.414 -168.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' SER . . . . . 0.778 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.304 70.8 m -84.87 20.92 1.69 Allowed 'General case' 0 CA--C 1.467 -2.249 0 N-CA-C 104.812 -2.292 . . . . 635.80999999999995 104.812 178.102 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.749 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.458 5.0 mmp_? -94.35 152.16 18.85 Favored 'General case' 1 CA--C 1.419 -4.066 3 N-CA-C 131.952 7.76 . . . . 999.99000000000001 131.952 -135.714 . . . . . . . . 5 3 . 1 . 003 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 1.058 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.91 37.0 t -131.84 73.2 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.763 1 CA-C-N 103.288 -6.324 . . . . 594.32000000000005 113.611 149.169 . . . . . . . . 4 3 . 1 . 003 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.729 HG13 ' HB2' ' A' ' 174' ' ' MET . 7.4 p -144.2 144.1 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.599 1 N-CA-C 98.285 -4.709 . . . . 811.90999999999997 98.285 162.382 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.761 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.8 m -118.49 144.52 45.96 Favored 'General case' 0 CA--C 1.488 -1.409 0 C-N-CA 117.014 -1.874 . . . . 999.99000000000001 109.42 -178.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.973 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.7 mmm -147.19 -175.6 4.89 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-O 122.0 0.905 . . . . 431.86000000000001 110.055 -177.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 1.037 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.3 tt -69.15 148.73 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 C-N-CA 124.31 1.044 . . . . 457.18000000000001 108.782 -177.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' GLU . . . . . 0.789 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.32 85.44 3.74 Favored 'General case' 0 CA--C 1.5 -0.955 0 C-N-CA 124.155 0.982 . . . . 458.76999999999998 113.527 -174.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.956 ' CZ3' HG22 ' A' ' 182' ' ' ILE . 1.9 p90 -76.4 -31.57 0.97 Allowed Pre-proline 0 N--CA 1.438 -1.058 0 C-N-CA 124.992 1.317 . . . . 999.99000000000001 112.384 168.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.955 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.2 Cg_exo -65.96 -45.77 5.64 Favored 'Trans proline' 0 N--CA 1.438 -1.79 0 N-CA-C 120.883 3.378 . . . . 999.99000000000001 120.883 -174.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.508 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 54.9 mt-10 -119.56 171.78 8.12 Favored 'General case' 0 CA--C 1.471 -2.066 0 C-N-CA 117.129 -1.829 . . . . 81.180000000000007 107.239 -172.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.834 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 6.3 p80 -109.16 45.16 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.865 0 CA-C-O 114.875 -2.488 . . . . 999.99000000000001 108.703 177.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 1.076 ' HB2' HD12 ' A' ' 191' ' ' ILE . 88.3 Cg_endo -41.57 101.86 0.04 OUTLIER 'Trans proline' 0 CA--C 1.502 -1.121 1 C-N-CA 126.071 4.514 . . . . 999.99000000000001 105.634 -170.745 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -62.28 -44.01 97.5 Favored 'General case' 0 CA--C 1.483 -1.597 0 C-N-CA 126.726 2.01 . . . . 967.72000000000003 112.059 -165.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' LYS . . . . . 0.402 ' HD3' ' HA ' ' A' ' 190' ' ' LYS . 30.3 mmtp -60.28 -36.55 78.08 Favored 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 106.724 -1.584 . . . . 934.29999999999995 106.724 -175.197 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 1.076 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.65 -30.16 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 C-N-CA 129.167 2.987 . . . . 565.14999999999998 113.925 -178.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 61.54 55.31 2.82 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-N 118.425 0.557 . . . . 755.61000000000001 109.903 -175.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 1.14 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.44 -49.29 67.19 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 124.57 1.148 . . . . 325.88999999999999 113.26 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.633 ' HE3' ' OH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.8 -44.97 78.31 Favored 'General case' 0 CA--C 1.495 -1.17 0 C-N-CA 123.558 0.743 . . . . 250.21000000000001 111.631 -169.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 98.0 t -64.75 -43.28 96.52 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 CA-C-O 121.595 0.712 . . . . 142.46000000000001 110.383 -175.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 1.037 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.8 t80 -61.19 -41.46 96.85 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 123.985 0.914 . . . . 247.69 108.821 -173.151 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' HIS . . . . . 0.824 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 23.1 t60 -60.55 -51.33 69.89 Favored 'General case' 0 CA--C 1.491 -1.292 0 C-N-CA 125.411 1.484 . . . . 199.61000000000001 113.081 -175.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 82.7 mt -65.34 -44.46 94.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 N-CA-C 107.759 -1.201 . . . . 106.73 107.759 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' CYS . . . . . 0.722 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.7 t -59.17 -48.53 81.27 Favored 'General case' 0 CA--C 1.487 -1.473 0 CA-C-N 115.801 -0.636 . . . . 115.01000000000001 110.214 -173.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 1.056 HG13 HD13 ' A' ' 161' ' ' LEU . 85.6 t -65.25 -49.18 80.31 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.655 0 C-N-CA 119.418 -0.913 . . . . 129.41999999999999 111.818 -174.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' THR . . . . . 0.793 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.4 m -61.85 -53.12 60.16 Favored 'General case' 0 CA--C 1.483 -1.612 0 C-N-CA 118.228 -1.389 . . . . 172.47999999999999 109.968 -172.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.631 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.5 t -63.89 -54.29 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 C-N-CA 120.539 -0.465 . . . . 55.859999999999999 110.933 -174.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.722 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.57 -51.53 59.07 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.56 -1.256 . . . . 184.68000000000001 111.489 -174.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 1.05 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.62 -52.37 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 C-N-CA 116.637 -2.025 . . . . 291.81 114.757 -174.706 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.548 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.8 t80 -82.05 -55.0 4.84 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 115.16 1.541 . . . . 130.66 115.16 -178.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' PHE . . . . . 0.793 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.8 m-85 -66.88 -48.49 68.61 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 114.515 1.302 . . . . 80.159999999999997 114.515 -170.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.894 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.54 -45.5 83.29 Favored Pre-proline 0 N--CA 1.435 -1.196 0 C-N-CA 119.981 -0.688 . . . . 136.02000000000001 109.494 -174.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.894 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.8 Cg_exo -64.8 -27.16 59.72 Favored 'Trans proline' 0 N--CA 1.432 -2.105 0 CA-C-N 118.703 0.572 . . . . 92.170000000000002 110.622 -179.035 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.688 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.3 -41.39 76.82 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 107.501 -1.296 . . . . 135.59999999999999 107.501 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.17 -44.7 91.26 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 109.563 -0.532 . . . . 52.100000000000001 109.563 -176.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.618 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.67 -43.54 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 N-CA-C 109.063 -0.718 . . . . 95.890000000000001 109.063 -176.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.903 HG13 HG22 ' A' ' 124' ' ' THR . 94.5 mt -61.28 -42.36 93.23 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.398 0 N-CA-C 106.684 -1.599 . . . . 43.409999999999997 106.684 -178.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.44 -42.25 99.09 Favored Glycine 0 N--CA 1.432 -1.606 0 N-CA-C 109.376 -1.49 . . . . 27.690000000000001 109.376 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' TYR . . . . . 0.886 ' O ' HG22 ' A' ' 217' ' ' THR . 77.9 t80 -65.66 -47.42 75.59 Favored 'General case' 0 CA--C 1.497 -1.094 0 O-C-N 122.213 -0.581 . . . . 54.409999999999997 110.483 -177.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ALA . . . . . 0.828 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.42 -34.11 74.83 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 106.955 -1.498 . . . . 53.880000000000003 106.955 -177.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -60.74 -40.89 94.06 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 108.49 -0.929 . . . . 68.290000000000006 108.49 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' THR . . . . . 0.886 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.67 -39.12 93.12 Favored 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 119.721 -0.792 . . . . 107.59 110.631 -175.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.828 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.02 -38.39 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 C-N-CA 119.605 -0.838 . . . . 111.61 109.481 -177.019 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.92 HG13 ' CD1' ' A' ' 134' ' ' ILE . 79.3 t -63.28 -22.48 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.372 -0.973 . . . . 85.260000000000005 108.372 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.87 -41.94 99.43 Favored Glycine 0 C--N 1.349 1.265 0 N-CA-C 111.07 -0.812 . . . . 40.710000000000001 111.07 -176.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.5 mm -64.76 -44.05 96.47 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 N-CA-C 108.378 -0.971 . . . . 95.859999999999999 108.378 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.823 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.6 p -76.93 -137.52 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 108.434 -0.95 . . . . 144.37 108.434 -176.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.902 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.6 mt -55.38 132.11 47.38 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 107.573 -1.269 . . . . 326.72000000000003 107.573 -177.2 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 224' ' ' TRP . . . . . 0.461 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.35 -168.05 1.51 Allowed 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 106.013 -1.847 . . . . 158.38 106.013 -176.184 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' ALA . . . . . 0.461 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.27 -42.01 99.09 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 109.649 -0.5 . . . . 36.780000000000001 109.649 -178.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.6 m -61.06 125.82 25.12 Favored 'General case' 0 N--CA 1.434 -1.271 0 C-N-CA 119.198 -1.001 . . . . 85.459999999999994 109.793 -174.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' GLU . . . . . 0.693 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.89 126.55 8.83 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 105.58 -2.008 . . . . 127.78 105.58 176.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.927 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.04 139.9 34.78 Favored Pre-proline 0 CA--C 1.493 -1.236 0 N-CA-C 105.982 -1.859 . . . . 164.84 105.982 -179.576 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.927 ' N ' HD13 ' A' ' 228' ' ' ILE . 83.4 Cg_exo -56.8 -39.93 87.87 Favored 'Trans proline' 0 N--CA 1.431 -2.16 0 N-CA-C 113.914 0.698 . . . . 222.34999999999999 113.914 -175.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' GLY . . . . . 0.745 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.11 167.02 45.01 Favored Glycine 0 N--CA 1.428 -1.899 0 N-CA-C 106.446 -2.662 . . . . 45.219999999999999 106.446 178.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.882 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.99 -45.71 93.7 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 106.065 -1.828 . . . . 107.56999999999999 106.065 177.483 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 232' ' ' SER . . . . . 0.732 ' O ' HG21 ' A' ' 228' ' ' ILE . 68.1 m -65.82 141.83 58.15 Favored 'General case' 0 N--CA 1.429 -1.525 0 C-N-CA 118.89 -1.124 . . . . 167.96000000000001 109.155 -175.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.828 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.6 m 99.52 106.64 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.219 0 C-N-CA 126.695 1.998 . . . . 280.68000000000001 109.761 176.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.712 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.7 m-20 56.05 11.28 0.71 Allowed 'General case' 0 N--CA 1.433 -1.279 0 C-N-CA 124.492 1.117 . . . . 218.25 110.702 174.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.922 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.38 137.64 54.78 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 105.243 -2.132 . . . . 343.56999999999999 105.243 177.412 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.479 ' O ' HG21 ' A' ' 240' ' ' VAL . 85.6 t80 -111.99 81.84 1.53 Allowed 'General case' 0 CA--C 1.491 -1.323 0 N-CA-C 106.871 -1.529 . . . . 263.29000000000002 106.871 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 237' ' ' HIS . . . . . 0.626 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 64.5 m80 104.31 147.09 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 126.607 1.963 . . . . 261.92000000000002 108.511 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.25 -38.13 89.94 Favored 'General case' 0 CA--C 1.488 -1.415 0 N-CA-C 107.822 -1.177 . . . . 106.81 107.822 -177.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.737 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.42 -39.92 94.87 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 118.348 -1.341 . . . . 112.2 107.58 -178.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.736 HG12 ' NH1' ' A' ' 244' ' ' ARG . 75.2 t -64.26 -39.81 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 109.285 -0.635 . . . . 45.409999999999997 109.285 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 241' ' ' SER . . . . . 0.806 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.2 p -70.95 -32.04 68.8 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 110.269 -0.271 . . . . 97.620000000000005 110.269 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.43 -39.56 81.5 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 123.65 0.78 . . . . 59.289999999999999 110.981 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.737 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.31 -36.47 83.81 Favored 'General case' 0 CA--C 1.491 -1.292 0 C-N-CA 124.655 1.182 . . . . 106.48999999999999 110.647 -174.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.922 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -60.0 -30.58 69.23 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 108.331 -0.988 . . . . 106.62 108.331 -176.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.531 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -66.09 -41.0 91.25 Favored 'General case' 0 N--CA 1.436 -1.175 0 O-C-N 121.84 -0.537 . . . . 75.969999999999999 110.052 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.444 ' CG1' ' HE1' ' A' ' 250' ' ' MET . 77.0 t -65.55 -40.84 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 C-N-CA 122.957 0.503 . . . . 65.269999999999996 109.804 -178.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.775 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.7 p -63.99 -41.58 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 C-N-CA 120.385 -0.526 . . . . 107.94 110.186 -177.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.536 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.2 pttt -63.55 -40.78 97.9 Favored 'General case' 0 N--CA 1.434 -1.259 0 O-C-N 121.679 -0.638 . . . . 87.980000000000004 110.31 -176.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 249' ' ' MET . . . . . 0.823 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.64 -40.42 96.81 Favored 'General case' 0 N--CA 1.434 -1.247 0 C-N-CA 118.875 -1.13 . . . . 65.5 108.329 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' MET . . . . . 0.773 ' HE2' ' CG2' ' A' ' 67' ' ' THR . 68.5 mtt -61.73 -36.33 80.66 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 108.169 -1.049 . . . . 85.049999999999997 108.169 -177.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.536 HD12 ' HA ' ' A' ' 248' ' ' LYS . 86.7 mt -63.48 -45.76 96.97 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 N-CA-C 109.082 -0.711 . . . . 42.25 109.082 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 252' ' ' VAL . . . . . 0.823 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.26 -38.31 82.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 C-N-CA 119.556 -0.858 . . . . 91.010000000000005 109.43 -176.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 1.001 HG22 ' CD1' ' A' ' 304' ' ' ILE . 65.8 t -58.88 -41.48 83.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 N-CA-C 107.998 -1.112 . . . . 66.090000000000003 107.998 -178.124 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 250' ' ' MET . 94.7 t -66.17 -43.12 92.17 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.363 0 O-C-N 122.089 -0.382 . . . . 52.390000000000001 110.287 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.4 m -61.73 -46.83 87.96 Favored 'General case' 0 CA--C 1.489 -1.393 0 O-C-N 121.851 -0.531 . . . . 46.420000000000002 109.858 -174.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 256' ' ' THR . . . . . 0.745 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.5 t -62.3 -38.1 88.09 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 108.335 -0.987 . . . . 116.51000000000001 108.335 -177.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 257' ' ' PHE . . . . . 0.488 ' N ' HG23 ' A' ' 256' ' ' THR . 86.0 t80 -60.32 -48.2 82.78 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.365 -0.606 . . . . 65.180000000000007 109.365 -178.121 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.99 -42.68 97.12 Favored 'General case' 0 CA--C 1.489 -1.385 0 O-C-N 122.107 -0.371 . . . . 51.329999999999998 110.429 -175.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 259' ' ' ILE . . . . . 0.745 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.6 -43.45 98.21 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 C-N-CA 118.968 -1.093 . . . . 126.3 108.938 -176.191 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 260' ' ' CYS . . . . . 0.509 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.8 m -65.51 -49.35 69.31 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.524 -0.87 . . . . 133.94 112.513 -176.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.82 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.0 m95 -80.72 -33.34 35.34 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 116.819 2.155 . . . . 134.84 116.819 -176.192 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.786 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.6 tp -58.43 -41.61 90.17 Favored Pre-proline 0 CA--C 1.493 -1.222 0 CA-C-N 118.641 0.655 . . . . 72.230000000000004 111.671 -167.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 263' ' ' PRO . . . . . 0.786 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 81.3 Cg_exo -60.67 -36.02 86.89 Favored 'Trans proline' 0 C--N 1.294 -2.309 0 CA-C-N 119.822 0.972 . . . . 106.13 111.357 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 264' ' ' PHE . . . . . 0.852 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.6 t80 -66.32 -44.71 82.61 Favored 'General case' 0 N--CA 1.433 -1.3 0 C-N-CA 119.769 -0.772 . . . . 128.34999999999999 110.056 -178.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 265' ' ' HIS . . . . . 0.64 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.4 m-70 -64.41 -37.86 88.99 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 110.244 -0.28 . . . . 100.73 110.244 -177.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.746 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.29 -44.51 94.92 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 C-N-CA 119.257 -0.977 . . . . 172.72 109.126 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 267' ' ' PHE . . . . . 0.734 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.5 m-85 -66.62 -28.12 68.24 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 108.17 -1.048 . . . . 249.22999999999999 108.17 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 268' ' ' PHE . . . . . 0.899 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.52 -55.14 35.37 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 106.698 -1.593 . . . . 259.77999999999997 106.698 178.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 269' ' ' LEU . . . . . 0.492 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.5 mt -69.13 -44.17 72.88 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 113.611 0.967 . . . . 233.11000000000001 113.611 -176.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 270' ' ' LEU . . . . . 0.837 ' O ' HG13 ' A' ' 273' ' ' ILE . 88.6 mt -61.4 -48.31 91.28 Favored Pre-proline 0 N--CA 1.44 -0.947 0 C-N-CA 119.13 -1.028 . . . . 169.53999999999999 110.567 -171.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 271' ' ' PRO . . . . . 0.734 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 12.0 Cg_exo -61.05 -24.59 79.8 Favored 'Trans proline' 0 N--CA 1.429 -2.302 0 C-N-CA 116.756 -1.696 . . . . 255.47 114.7 174.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 272' ' ' TYR . . . . . 0.824 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.6 t80 -63.58 -44.22 94.69 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 119.232 0.924 . . . . 279.02999999999997 108.874 177.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.837 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.33 -44.76 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 N-CA-C 110.104 -0.332 . . . . 162.21000000000001 110.104 -178.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 274' ' ' ASN . . . . . 0.867 HD22 HD12 ' A' ' 277' ' ' LEU . 49.1 t30 -125.45 84.88 59.4 Favored Pre-proline 0 N--CA 1.43 -1.432 0 C-N-CA 118.73 -1.188 . . . . 128.13 108.064 -178.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 275' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.3 Cg_endo -85.3 164.08 11.19 Favored 'Trans proline' 0 C--N 1.295 -2.268 0 N-CA-C 107.44 -1.792 . . . . 278.35000000000002 107.44 177.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 276' ' ' ASP . . . . . 0.868 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.2 t0 66.06 15.06 9.93 Favored 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 123.83 0.706 . . . . 312.91000000000003 109.335 175.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.868 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.3 mt -132.69 -170.66 2.48 Favored 'General case' 0 CA--C 1.481 -1.675 0 N-CA-C 106.531 -1.655 . . . . 353.54000000000002 106.531 177.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 1.007 ' HA ' ' CB ' ' A' ' 282' ' ' PHE . 42.8 p90 -115.68 142.23 47.03 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 107.398 -1.334 . . . . 251.25999999999999 107.398 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.761 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -76.98 -118.81 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 102.024 -3.324 . . . . 175.25999999999999 102.024 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 280' ' ' LYS . . . . . 0.794 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.46 -44.97 96.17 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 100.883 -3.747 . . . . 99.069999999999993 100.883 172.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 281' ' ' LYS . . . . . 0.794 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.43 124.18 9.18 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 103.46 -2.793 . . . . 243.21000000000001 103.46 171.173 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 1.007 ' CB ' ' HA ' ' A' ' 278' ' ' TYR . 77.3 t80 -92.97 112.99 25.14 Favored 'General case' 0 CA--C 1.473 -1.982 0 C-N-CA 116.007 -2.277 . . . . 201.03999999999999 105.265 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 283' ' ' ILE . . . . . 0.777 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.94 173.72 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.071 0 C-N-CA 116.001 -2.279 . . . . 201.36000000000001 108.768 -175.176 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 284' ' ' GLN . . . . . 1.092 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.284 0.6 OUTLIER -59.54 -41.42 90.03 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-N 113.243 -1.799 . . . . 203.81999999999999 107.864 174.447 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 285' ' ' GLN . . . . . 0.921 ' HG2' HE21 ' A' ' 284' ' ' GLN . 1.2 mm100 -64.26 -45.71 86.89 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 118.226 -1.389 . . . . 215.06 112.576 -171.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.552 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.0 t -65.69 -46.42 89.26 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.473 0 C-N-CA 118.587 -1.245 . . . . 125.28 112.903 -171.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 287' ' ' TYR . . . . . 0.952 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.78 -37.05 86.29 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 107.155 -1.424 . . . . 268.89999999999998 107.155 -171.861 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.798 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.16 -45.05 74.56 Favored 'General case' 0 CA--C 1.483 -1.607 0 C-N-CA 125.63 1.572 . . . . 280.88 108.821 -172.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.6 -47.43 86.24 Favored 'General case' 0 CA--C 1.484 -1.564 0 C-N-CA 118.947 -1.101 . . . . 184.47 109.087 -172.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 290' ' ' ILE . . . . . 0.852 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.8 mp -67.98 -42.11 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 C-N-CA 119.263 -0.975 . . . . 167.91999999999999 112.732 -175.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 291' ' ' MET . . . . . 0.5 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.7 ttt -65.72 -38.76 90.07 Favored 'General case' 0 CA--C 1.495 -1.136 0 C-N-CA 117.784 -1.566 . . . . 367.18000000000001 110.822 -175.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 292' ' ' TRP . . . . . 0.548 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.4 m95 -67.22 -32.67 73.87 Favored 'General case' 0 N--CA 1.435 -1.197 0 O-C-N 121.872 -0.517 . . . . 173.97 110.448 177.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.4 tp -64.49 -36.71 85.09 Favored 'General case' 0 CA--C 1.499 -0.986 0 C-N-CA 123.509 0.724 . . . . 119.66 109.797 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 294' ' ' ALA . . . . . 0.82 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.23 -34.03 74.46 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 107.711 -1.218 . . . . 112.3 107.711 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 295' ' ' MET . . . . . 0.772 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.03 -32.11 73.4 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 116.211 -0.45 . . . . 174.16999999999999 110.222 -177.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.9 m -64.67 -22.8 67.07 Favored 'General case' 0 CA--C 1.486 -1.507 0 C-N-CA 124.648 1.179 . . . . 145.27000000000001 110.606 -175.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 297' ' ' SER . . . . . 0.758 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.7 m -57.67 -35.33 70.41 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 108.043 -1.095 . . . . 170.15000000000001 108.043 -175.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.82 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.8 t -55.33 -34.16 63.97 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 116.324 -0.398 . . . . 214.56999999999999 110.61 -171.111 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 299' ' ' MET . . . . . 0.75 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.1 ttt -77.16 -33.19 56.58 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 126.108 1.763 . . . . 168.28999999999999 115.539 177.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 300' ' ' TYR . . . . . 0.758 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.44 -34.84 79.14 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 114.072 1.138 . . . . 167.15000000000001 114.072 -168.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 301' ' ' ASN . . . . . 0.723 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.283 18.8 p-10 -64.2 -38.31 33.47 Favored Pre-proline 0 N--CA 1.434 -1.253 0 C-N-CA 115.532 -2.467 . . . . 165.13 113.935 -171.619 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 302' ' ' PRO . . . . . 0.723 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 83.9 Cg_exo -62.54 -31.87 79.97 Favored 'Trans proline' 0 N--CA 1.433 -2.048 0 CA-C-N 122.769 2.025 . . . . 123.92 111.28 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 303' ' ' ILE . . . . . 0.716 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.1 pt -68.72 -42.57 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 C-N-CA 118.857 -1.137 . . . . 110.55 109.796 -179.09 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 304' ' ' ILE . . . . . 1.001 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.1 pt -61.09 -40.08 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 108.852 -0.796 . . . . 145.31 108.852 -177.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 305' ' ' TYR . . . . . 0.921 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.253 63.1 m-85 -58.1 -48.83 78.97 Favored 'General case' 0 CA--C 1.494 -1.191 0 C-N-CA 119.409 -0.916 . . . . 246.68000000000001 109.796 -177.473 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.6 m -62.24 -47.46 84.3 Favored 'General case' 0 CA--C 1.485 -1.539 0 C-N-CA 119.565 -0.854 . . . . 64.430000000000007 109.6 -173.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.8 t -66.8 -45.08 79.48 Favored 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 118.973 -1.091 . . . . 80.719999999999999 110.227 -177.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.708 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.41 -35.71 76.0 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 116.034 1.864 . . . . 140.44 116.034 -173.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 309' ' ' ASN . . . . . 0.655 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.85 132.23 34.32 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 112.692 -3.603 . . . . 178.87 113.048 -177.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 310' ' ' ASP . . . . . 0.613 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.04 -37.09 86.45 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 114.392 -1.277 . . . . 110.22 110.075 -177.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 311' ' ' ARG . . . . . 0.855 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 38.9 ttm180 -57.7 -50.62 72.59 Favored 'General case' 0 CA--C 1.492 -1.251 0 O-C-N 121.802 -0.561 . . . . 174.78 109.708 -174.176 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.96 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.3 m-85 -64.87 -41.67 95.46 Favored 'General case' 0 CA--C 1.484 -1.571 0 N-CA-C 108.262 -1.014 . . . . 161.84 108.262 178.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 313' ' ' ARG . . . . . 0.516 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.7 ttp180 -57.38 -50.2 73.72 Favored 'General case' 0 CA--C 1.49 -1.353 0 N-CA-C 109.183 -0.673 . . . . 117.2 109.183 -173.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.797 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.55 -44.1 75.22 Favored 'General case' 0 N--CA 1.434 -1.235 0 C-N-CA 120.355 -0.538 . . . . 112.59999999999999 111.03 -177.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 315' ' ' GLY . . . . . 0.872 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -63.95 -37.52 94.74 Favored Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 110.675 -0.97 . . . . 101.45999999999999 110.675 -177.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 316' ' ' PHE . . . . . 1.015 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.7 m-85 -62.16 -45.92 91.29 Favored 'General case' 0 CA--C 1.491 -1.31 0 CA-C-N 118.452 1.126 . . . . 151.49000000000001 109.55 -178.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 317' ' ' LYS . . . . . 0.423 ' HE3' ' HB2' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.19 -36.24 77.17 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 106.922 -1.51 . . . . 142.31999999999999 106.922 -175.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 318' ' ' HIS . . . . . 0.826 ' NE2' HG21 ' A' ' 326' ' ' ILE . 49.9 m80 -59.85 -41.84 92.33 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 106.846 -1.539 . . . . 109.09 106.846 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.84 -42.42 85.81 Favored 'General case' 0 N--CA 1.435 -1.208 0 O-C-N 122.312 -0.242 . . . . 76.109999999999999 111.062 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -61.38 -55.51 30.67 Favored 'General case' 0 CA--C 1.489 -1.374 0 C-N-CA 119.861 -0.736 . . . . 120.23999999999999 109.339 -174.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 321' ' ' ARG . . . . . 0.579 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.4 mtt180 -74.26 131.53 41.28 Favored 'General case' 0 CA--C 1.482 -1.66 0 N-CA-C 102.946 -2.983 . . . . 192.72999999999999 102.946 177.038 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.4 p -59.14 -44.25 92.05 Favored 'General case' 0 CA--C 1.491 -1.296 0 C-N-CA 119.006 -1.078 . . . . 176.28999999999999 109.204 -172.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 323' ' ' CYS . . . . . 0.752 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.5 m -79.35 -177.11 0.81 Allowed Pre-proline 0 CA--C 1.488 -1.436 0 N-CA-C 106.239 -1.763 . . . . 69.680000000000007 106.239 178.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.567 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.8 Cg_exo -59.0 -75.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.382 0 CA-C-O 118.662 -0.641 . . . . 191.05000000000001 112.566 176.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 325' ' ' PHE . . . . . 0.752 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.3 m-85 47.49 43.89 16.24 Favored 'General case' 0 CA--C 1.493 -1.245 0 O-C-N 123.612 0.57 . . . . 287.02999999999997 109.763 178.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 326' ' ' ILE . . . . . 0.826 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.1 tt -104.55 78.58 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.474 -1.951 0 C-N-CA 112.988 -3.485 . . . . 292.29000000000002 109.854 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 327' ' ' SER . . . . . 0.479 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.1 t -77.43 -152.89 0.05 OUTLIER 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 104.198 -2.519 . . . . 184.56999999999999 104.198 178.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 328' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.76 8.65 4.91 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 113.064 0.764 . . . . 274.56 113.064 176.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.96 0.89 57.28 Favored Glycine 0 C--N 1.348 1.233 0 C-N-CA 117.792 -2.147 . . . . 268.24000000000001 113.496 172.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 330' ' ' ASP . . . . . 0.7 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.8 m-20 51.65 -172.07 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.092 0 CA-C-N 118.673 1.236 . . . . 200.06 110.75 177.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.855 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.91 -33.02 74.76 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 107.854 -1.165 . . . . 114.44 107.854 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 332' ' ' GLU . . . . . 0.543 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.36 46.03 21.72 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 107.589 -1.263 . . . . 263.81 107.589 -177.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 333' ' ' GLY . . . . . 0.634 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.3 -137.36 3.61 Favored Glycine 0 CA--C 1.478 -2.231 1 N-CA-C 102.471 -4.251 . . . . 103.79000000000001 102.471 -179.837 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 1.05 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.2 mt -88.33 95.68 10.29 Favored 'General case' 0 N--CA 1.419 -1.993 0 C-N-CA 114.892 -2.723 . . . . 117.3 105.995 177.038 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 335' ' ' GLU . . . . . 1.025 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.97 -39.76 90.65 Favored 'General case' 0 CA--C 1.468 -2.202 1 N-CA-C 98.023 -4.806 . . . . 231.58000000000001 98.023 167.206 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 336' ' ' MET . . . . . 1.036 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.96 163.48 29.08 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 102.115 -3.291 . . . . 303.24000000000001 102.115 168.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 337' ' ' LYS . . . . . 1.05 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.3 tttt -62.64 -48.6 78.66 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 116.03 -2.268 . . . . 112.72 108.423 179.197 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.9 t -61.05 -63.64 1.23 Allowed 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 109.083 -0.71 . . . . 83.219999999999999 109.083 -176.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 339' ' ' THR . . . . . 0.884 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 35.9 m -156.27 -126.16 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 103.87 -2.641 . . . . 174.36000000000001 103.87 -178.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 340' ' ' ARG . . . . . 1.025 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.93 160.96 8.89 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 105.771 -1.937 . . . . 202.72999999999999 105.771 177.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 341' ' ' TYR . . . . . 1.02 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.97 149.01 52.55 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 107.061 -1.459 . . . . 180.62 107.061 176.422 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 342' ' ' LEU . . . . . 0.932 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.5 tp -178.45 -171.82 0.27 Allowed 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 105.376 -2.083 . . . . 145.25 105.376 178.075 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 343' ' ' GLN . . . . . 0.932 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.1 tt0 -66.14 -43.14 87.94 Favored 'General case' 0 CA--C 1.487 -1.446 0 N-CA-C 106.078 -1.823 . . . . 66.049999999999997 106.078 174.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 344' ' ' THR . . . . . 0.765 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.71 -152.18 0.48 Allowed 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 103.486 -2.783 . . . . 266.49000000000001 103.486 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 345' ' ' GLN . . . . . 0.699 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.3 mt-30 66.37 -124.88 0.28 Allowed 'General case' 0 CA--C 1.485 -1.545 0 C-N-CA 117.038 -1.865 . . . . 219.19999999999999 107.742 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 346' ' ' GLY . . . . . 0.902 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.16 -37.38 94.01 Favored Glycine 0 N--CA 1.425 -2.063 0 CA-C-N 114.555 -1.202 . . . . 94.780000000000001 112.84 -175.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 347' ' ' SER . . . . . 0.826 ' HB2' ' H ' ' A' ' 342' ' ' LEU . 48.3 t -81.12 100.38 9.02 Favored 'General case' 0 CA--C 1.483 -1.598 0 C-N-CA 112.346 -3.742 . . . . 121.41 109.477 -171.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 348' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.5 t -73.05 145.47 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 N-CA-C 108.951 -0.759 . . . . 85.340000000000003 108.951 -176.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 349' ' ' TYR . . . . . 0.441 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.5 p90 -57.74 143.44 41.88 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 107.826 -1.176 . . . . 267.56999999999999 107.826 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 350' ' ' LYS . . . . . 0.525 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.03 69.61 0.59 Allowed 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 109.514 -0.55 . . . . 226.09999999999999 109.514 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 351' ' ' VAL . . . . . 0.824 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.5 p -51.0 156.92 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 N-CA-C 106.986 -1.487 . . . . 154.84 106.986 177.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 352' ' ' SER . . . . . 0.581 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.8 m -61.36 161.92 8.54 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.566 0.698 . . . . 180.00999999999999 110.732 -173.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 353' ' ' ARG . . . . . 0.896 ' H ' ' HD3' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.42 156.86 23.73 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 106.971 -1.492 . . . . 333.77999999999997 106.971 -178.595 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 354' ' ' LEU . . . . . 0.974 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.01 142.55 48.71 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 107.371 -1.344 . . . . 335.19999999999999 107.371 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.974 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.5 mm-40 82.77 158.9 0.13 Allowed 'General case' 0 CA--C 1.492 -1.281 0 N-CA-C 108.735 -0.839 . . . . 266.47000000000003 108.735 179.189 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.5 m -60.62 -46.85 88.73 Favored 'General case' 0 CA--C 1.488 -1.441 0 N-CA-C 105.653 -1.98 . . . . 59.340000000000003 105.653 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.4 t -81.64 173.9 11.91 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 104.376 -2.453 . . . . 201.25999999999999 104.376 176.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.747 HG22 ' O ' ' A' ' 360' ' ' THR . 68.9 mt -95.91 106.73 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 C-N-CA 116.308 -2.157 . . . . 56.229999999999997 105.548 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 359' ' ' SER . . . . . 0.465 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.9 m -61.23 -59.43 5.33 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 109.326 -0.62 . . . . 87.579999999999998 109.326 -175.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 360' ' ' THR . . . . . 0.891 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.1 t -85.47 153.72 22.28 Favored 'General case' 0 CA--C 1.485 -1.533 0 N-CA-C 107.855 -1.165 . . . . 219.94999999999999 107.855 -177.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 361' ' ' VAL . . . . . 0.588 ' O ' HG23 ' A' ' 361' ' ' VAL . 16.0 m -82.01 83.82 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.641 0 C-N-CA 116.324 -2.15 . . . . 121.79000000000001 105.448 177.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.599 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.6 t -154.12 159.72 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.575 0 N-CA-C 105.851 -1.907 . . . . 53.850000000000001 105.851 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 363' ' ' GLY . . . . . 0.599 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.27 16.57 77.13 Favored Glycine 0 N--CA 1.428 -1.87 0 N-CA-C 106.023 -2.831 . . . . 196.55000000000001 106.023 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.674 0 N-CA-C 107.909 -1.145 . . . . 35.880000000000003 107.909 -178.949 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 365' ' ' ARG . . . . . 0.494 ' HD3' ' HA ' ' B' ' 365' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 108.884 -0.784 . . . . 1.0 108.884 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 366' ' ' PRO . . . . . 0.698 ' HB3' ' C ' ' A' ' 4' ' ' VAL . 52.8 Cg_endo -66.85 142.01 61.24 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.056 1.837 . . . . 1.0 110.223 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 367' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -64.42 143.24 98.5 Favored Pre-proline 0 C--N 1.325 -0.496 0 C-N-CA 119.841 -0.744 . . . . 1.0 109.595 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 368' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.27 150.38 76.43 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.331 2.021 . . . . 1.0 111.746 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 369' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.71 131.8 44.42 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.688 -0.405 . . . . 1.0 110.181 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -102.05 115.88 31.49 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.716 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 371' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -63.69 -42.38 98.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.365 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 372' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -64.96 -36.26 83.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.86 -0.609 . . . . 1.0 110.728 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -59.7 -33.08 76.03 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.819 -0.912 . . . . 1.0 110.819 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 374' ' ' LEU . . . . . 0.805 ' HG ' ' CD1' ' A' ' 102' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 120.93 0.395 . . . . 1.0 110.213 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.466 0 N-CA-C 108.386 -0.968 . . . . 97.079999999999998 108.386 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -110.61 155.44 22.37 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-O 122.147 0.975 . . . . 123.41 110.711 -172.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.883 HG11 HD13 ' A' ' 15' ' ' ILE . 28.6 m -134.59 -162.41 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.476 1 N-CA-C 100.12 -4.029 . . . . 151.30000000000001 100.12 173.697 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.912 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.6 -38.65 59.16 Favored Pre-proline 0 N--CA 1.439 -0.984 0 C-N-CA 115.948 -2.301 . . . . 169.25 106.102 178.12 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.912 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 59.2 Cg_exo -81.29 168.54 16.63 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 N-CA-C 110.513 -0.61 . . . . 185.75999999999999 110.513 171.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.909 HG13 ' CE2' ' A' ' 282' ' ' PHE . 92.2 t -64.45 -25.95 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 C-N-CA 127.012 2.125 . . . . 145.47 110.369 -177.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.776 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.1 t0 -84.26 157.38 21.59 Favored 'General case' 0 N--CA 1.439 -1.005 0 O-C-N 121.08 -1.013 . . . . 102.76000000000001 109.53 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.3 p -82.57 154.14 25.15 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 107.985 -1.117 . . . . 106.25 107.985 178.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.919 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.7 p-10 -105.88 51.88 0.74 Allowed 'General case' 0 N--CA 1.428 -1.547 0 C-N-CA 117.766 -1.574 . . . . 157.81 107.623 178.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.11 -45.91 91.39 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 103.617 -2.734 . . . . 150.19999999999999 103.617 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.8 m -87.09 164.69 35.16 Favored Pre-proline 0 N--CA 1.422 -1.84 0 N-CA-C 103.624 -2.732 . . . . 183.52000000000001 103.624 172.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -76.76 6.89 3.83 Favored 'Trans proline' 0 C--N 1.282 -2.97 0 N-CA-C 109.957 -0.824 . . . . 235.61000000000001 109.957 176.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.424 ' C ' HD21 ' A' ' 14' ' ' ASN . 0.4 OUTLIER -57.92 -41.27 82.35 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 124.813 1.245 . . . . 113.77 113.395 -170.104 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.919 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.4 pt -52.14 136.21 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-N 119.522 1.055 . . . . 150.84999999999999 110.954 -176.148 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.49 156.26 46.4 Favored 'General case' 0 C--N 1.36 1.061 0 N-CA-C 107.622 -1.251 . . . . 100.42 107.622 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . 1.081 HG23 ' H ' ' A' ' 20' ' ' SER . 14.2 t -64.96 142.62 58.37 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 121.99 0.9 . . . . 129.36000000000001 110.43 -174.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.773 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 74.7 m-20 -63.13 -25.51 68.39 Favored 'General case' 0 CA--C 1.493 -1.221 0 C-N-CA 126.328 1.851 . . . . 112.34 106.63 -177.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.941 HG23 ' HA2' ' A' ' 101' ' ' GLY . 85.9 m -74.18 -40.08 62.76 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 115.575 -0.739 . . . . 131.72999999999999 111.724 177.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . 1.081 ' H ' HG23 ' A' ' 17' ' ' THR . 70.9 m -84.52 -42.79 15.17 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 116.985 2.217 . . . . 80.489999999999995 116.985 -174.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.549 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.5 mt-10 -145.99 174.56 3.33 Favored Pre-proline 0 N--CA 1.442 -0.848 0 C-N-CA 118.176 -1.409 . . . . 98.980000000000004 111.216 -169.231 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.822 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.332 85.4 Cg_exo -61.84 -10.74 18.23 Favored 'Trans proline' 0 C--N 1.322 -0.868 1 N-CA-C 128.922 6.47 . . . . 246.94999999999999 128.922 -170.091 . . . . . . . . 4 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.0 m120 61.7 17.46 8.72 Favored 'General case' 0 C--N 1.324 -0.512 1 CA-C-N 126.175 4.079 . . . . 269.62 114.213 175.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.495 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 80.8 mt-30 -67.09 -27.34 67.27 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 107.782 -1.192 . . . . 86.799999999999997 107.782 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.551 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.4 p90 -66.76 -29.33 69.27 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 121.153 -0.967 . . . . 85.909999999999997 110.549 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.877 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.3 t -68.51 -40.25 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 C-N-CA 123.706 0.803 . . . . 82.0 111.333 -177.061 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.897 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 27.6 pt20 -151.4 167.71 12.52 Favored Pre-proline 0 CA--C 1.488 -1.407 0 N-CA-C 108.55 -0.907 . . . . 120.73 108.55 -178.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.903 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.6 Cg_endo -64.04 149.77 89.77 Favored 'Trans proline' 0 N--CA 1.432 -2.106 0 C-N-CA 120.638 0.892 . . . . 87.859999999999999 109.89 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.744 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.07 -37.94 89.2 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 108.808 -0.812 . . . . 36.460000000000001 108.808 -176.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.814 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 28.0 p-90 -63.84 -33.86 76.62 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 107.757 -1.201 . . . . 150.59999999999999 107.757 -176.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.903 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.5 mt-30 -62.23 -32.66 73.37 Favored 'General case' 0 CA--C 1.49 -1.351 0 O-C-N 121.272 -0.893 . . . . 123.26000000000001 108.686 -178.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.744 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.49 -47.13 94.84 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 N-CA-C 109.188 -0.671 . . . . 120.14 109.188 176.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.786 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.3 m -67.47 -30.96 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 N-CA-C 107.868 -1.16 . . . . 112.19 107.868 -178.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.814 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.5 tp -63.02 -47.11 84.5 Favored 'General case' 0 N--CA 1.433 -1.323 0 C-N-CA 119.895 -0.722 . . . . 60.869999999999997 109.623 -178.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.67 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.01 -35.68 81.2 Favored 'General case' 0 CA--C 1.489 -1.402 0 C-N-CA 119.952 -0.699 . . . . 157.56999999999999 110.349 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.745 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.63 -40.86 98.34 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 108.638 -0.875 . . . . 47.060000000000002 108.638 178.087 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.806 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.81 -41.28 97.92 Favored 'General case' 0 CA--C 1.496 -1.115 0 O-C-N 121.724 -0.61 . . . . 43.939999999999998 109.522 -177.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.728 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.84 -43.25 99.22 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 108.752 -0.833 . . . . 42.609999999999999 108.752 -176.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.905 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.4 -41.22 93.9 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 116.649 -0.25 . . . . 140.66 111.059 -178.42 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.806 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.86 -43.93 97.86 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 118.588 -1.245 . . . . 116.04000000000001 110.214 -175.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.675 HG22 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.45 -38.72 83.16 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.28 0 N-CA-C 108.73 -0.841 . . . . 97.159999999999997 108.73 -177.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.854 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.3 mt -61.31 -40.03 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 N-CA-C 108.956 -0.757 . . . . 54.850000000000001 108.956 -176.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.951 HG22 HG21 ' A' ' 86' ' ' THR . 92.7 t -57.72 -42.31 81.42 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.302 0 N-CA-C 108.848 -0.797 . . . . 45.390000000000001 108.848 -175.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.431 ' O ' HG23 ' A' ' 48' ' ' VAL . 97.2 t -63.55 -50.98 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 C-N-CA 118.839 -1.144 . . . . 48.640000000000001 110.162 -177.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.752 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.6 t -65.23 -47.08 78.06 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 120.197 -0.601 . . . . 116.65000000000001 111.694 -174.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.589 ' N ' HG23 ' A' ' 45' ' ' THR . 50.8 m -61.98 -43.88 97.9 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 109.73 -0.471 . . . . 51.159999999999997 109.73 -174.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.1 t -65.63 -48.86 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 C-N-CA 119.846 -0.741 . . . . 44.299999999999997 110.818 -176.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.868 ' O ' HG23 ' A' ' 52' ' ' VAL . 94.0 t -64.75 -46.97 90.54 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 C-N-CA 120.291 -0.564 . . . . 48.82 111.068 -174.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.73 -44.2 95.2 Favored Glycine 0 N--CA 1.437 -1.299 0 C-N-CA 120.515 -0.85 . . . . 58.700000000000003 112.021 -174.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -72.55 -34.28 67.41 Favored 'General case' 0 CA--C 1.488 -1.436 0 O-C-N 122.061 -0.67 . . . . 101.40000000000001 111.072 -175.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.739 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.4 p -66.83 -38.77 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 107.73 -1.211 . . . . 103.56999999999999 107.73 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 48' ' ' VAL . 72.0 t -61.44 -43.01 96.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 N-CA-C 108.974 -0.75 . . . . 61.890000000000001 108.974 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.537 ' O ' HG22 ' A' ' 56' ' ' ILE . 81.6 t -63.5 -50.93 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 109.437 -0.579 . . . . 70.010000000000005 109.437 -178.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.8 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.98 -43.35 99.02 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 109.122 -0.696 . . . . 132.09999999999999 109.122 -176.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.644 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.1 t-105 -64.23 -46.63 82.96 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 116.666 -0.243 . . . . 104.5 110.434 -176.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 1.011 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.69 -49.88 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 C-N-CA 120.194 -0.602 . . . . 142.96000000000001 111.235 -173.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.954 HD11 HG12 ' A' ' 72' ' ' VAL 0.278 24.8 pt -64.78 -41.68 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.707 0 C-N-CA 116.904 -1.919 . . . . 158.31999999999999 110.905 -175.973 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.8 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.69 -41.32 98.16 Favored 'General case' 0 N--CA 1.433 -1.308 0 C-N-CA 117.701 -1.599 . . . . 137.11000000000001 109.527 178.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.39 -44.53 91.03 Favored 'General case' 0 N--CA 1.436 -1.141 0 O-C-N 122.147 -0.346 . . . . 54.659999999999997 111.024 -176.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.923 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.42 117.1 29.39 Favored 'General case' 0 CA--C 1.491 -1.294 0 CA-C-O 121.576 0.703 . . . . 127.18000000000001 109.586 -174.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.621 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.3 tttt -60.81 -36.87 80.13 Favored 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 124.072 0.949 . . . . 87.930000000000007 110.819 -176.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 1.031 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.34 -34.66 78.66 Favored 'General case' 0 CA--C 1.49 -1.355 0 O-C-N 121.636 -0.665 . . . . 131.12 111.541 -175.63 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' MET . . . . . 1.012 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.67 69.49 7.2 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 115.311 -2.556 . . . . 246.56 109.555 -175.164 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.411 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.27 91.44 3.48 Favored 'General case' 0 CA--C 1.473 -1.987 0 N-CA-C 105.495 -2.039 . . . . 339.35000000000002 105.495 177.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.444 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.6 p -124.18 165.29 17.84 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 102.986 -2.968 . . . . 114.66 102.986 176.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.881 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.14 -39.44 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 N-CA-C 106.773 -1.566 . . . . 143.28 106.773 178.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.833 HG22 HD13 ' A' ' 71' ' ' LEU . 95.4 m -59.75 -37.99 80.52 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 108.652 -0.87 . . . . 160.22 108.652 -176.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.527 ' ND2' ' HB3' ' A' ' 63' ' ' MET . 86.3 m-20 -62.36 -31.77 72.47 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 108.86 -0.793 . . . . 120.54000000000001 108.86 -177.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.903 ' O ' HG22 ' A' ' 72' ' ' VAL . 89.9 m-85 -63.6 -43.77 95.96 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.523 -0.547 . . . . 67.219999999999999 109.523 178.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.881 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.4 m-85 -66.6 -39.72 88.52 Favored 'General case' 0 CA--C 1.498 -1.041 0 O-C-N 121.487 -0.758 . . . . 138.59999999999999 109.639 -177.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.927 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.62 -35.87 81.96 Favored 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 122.435 0.294 . . . . 151.46000000000001 110.639 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.954 HG12 HD11 ' A' ' 57' ' ' ILE . 24.0 m -62.54 -37.96 80.2 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.228 0 C-N-CA 117.41 -1.716 . . . . 117.93000000000001 106.732 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.45 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.0 t30 -60.11 -46.04 90.96 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 107.839 -1.171 . . . . 56.82 107.839 -177.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.999 HD21 ' HE1' ' A' ' 123' ' ' MET . 8.6 mp -61.33 -43.87 98.14 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 109.005 -0.739 . . . . 145.30000000000001 109.005 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.09 -40.33 95.49 Favored 'General case' 0 CA--C 1.492 -1.256 0 N-CA-C 108.5 -0.926 . . . . 45.710000000000001 108.5 -175.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -62.43 -42.01 99.13 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 109.346 -0.613 . . . . 105.61 109.346 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.14 -39.44 92.62 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 108.667 -0.864 . . . . 47.890000000000001 108.667 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.587 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.56 -37.38 84.84 Favored 'General case' 0 N--CA 1.439 -1.014 0 O-C-N 122.059 -0.401 . . . . 124.53 109.969 179.662 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.81 -41.29 99.24 Favored 'General case' 0 CA--C 1.496 -1.116 0 O-C-N 121.991 -0.443 . . . . 35.890000000000001 109.858 -178.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.7 t -62.14 -37.34 84.79 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 107.052 -1.462 . . . . 88.969999999999999 107.052 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.82 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.7 ttm -62.2 -49.19 76.76 Favored 'General case' 0 N--CA 1.428 -1.571 0 C-N-CA 119.816 -0.754 . . . . 239.91 109.03 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.619 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.37 -43.43 90.8 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 121.532 -0.73 . . . . 146.09999999999999 110.56 -177.123 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.418 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.13 -58.22 3.41 Favored 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 117.416 -1.714 . . . . 91.739999999999995 113.888 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -76.54 -61.41 1.97 Allowed 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 115.75 1.759 . . . . 197.44999999999999 115.75 -173.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.939 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.24 -42.23 55.72 Favored 'General case' 0 CA--C 1.49 -1.357 0 C-N-CA 117.876 -1.53 . . . . 242.59999999999999 114.061 -170.02 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.951 HG21 HG22 ' A' ' 43' ' ' VAL . 4.6 t -65.39 -36.59 84.42 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 118.941 -1.103 . . . . 215.61000000000001 109.812 -172.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.421 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.4 t -60.31 -46.95 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 O-C-N 121.824 -0.548 . . . . 87.189999999999998 110.426 -175.306 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.839 HG21 ' CD2' ' A' ' 108' ' ' HIS . 63.7 t -65.94 -41.84 90.67 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.098 0 N-CA-C 109.727 -0.471 . . . . 231.81999999999999 109.727 -178.016 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.905 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 87.7 m-20 -62.33 -34.11 76.0 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 108.365 -0.976 . . . . 364.98000000000002 108.365 -177.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.669 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.0 t80 -68.16 -44.76 75.27 Favored 'General case' 0 N--CA 1.438 -1.07 0 O-C-N 121.56 -0.713 . . . . 181.63 111.271 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.476 HG22 ' ND1' ' A' ' 95' ' ' HIS . 57.6 m -60.85 -45.8 93.1 Favored 'General case' 0 CA--C 1.477 -1.831 0 N-CA-C 107.438 -1.319 . . . . 269.01999999999998 107.438 -175.212 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 1.05 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.74 -45.01 93.53 Favored 'General case' 0 N--CA 1.416 -2.165 0 C-N-CA 118.683 -1.207 . . . . 562.65999999999997 110.037 -179.056 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.706 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.08 -45.31 95.24 Favored 'General case' 0 CA--C 1.479 -1.768 0 C-N-CA 118.697 -1.201 . . . . 446.75 108.042 -167.136 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.745 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.387 6.1 m -70.5 -26.28 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.752 0 C-N-CA 115.819 -2.352 . . . . 370.05000000000001 112.244 -178.72 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.496 ' O ' ' HB2' ' A' ' 96' ' ' ASN . 40.7 m80 -74.46 -26.54 60.1 Favored 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 121.592 -0.692 . . . . 354.91000000000003 112.469 175.082 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.822 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.4 m-20 82.85 4.51 0.98 Allowed 'General case' 0 CA--C 1.5 -0.951 0 C-N-CA 125.044 1.338 . . . . 462.44 111.881 -178.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.773 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.267 11.9 mm-40 -172.36 178.06 2.91 Favored 'General case' 0 CA--C 1.488 -1.409 0 CA-C-O 122.025 0.916 . . . . 652.37 111.122 171.813 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.791 ' HE3' ' HA ' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.72 86.31 2.17 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 128.516 2.726 . . . . 905.99000000000001 107.924 -174.245 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -67.9 -36.43 80.19 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 108.217 -1.031 . . . . 570.42999999999995 108.217 -176.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.849 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.58 -36.34 82.38 Favored 'General case' 0 N--CA 1.427 -1.586 0 C-N-CA 125.361 1.464 . . . . 453.22000000000003 111.152 -174.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.941 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.55 178.69 33.89 Favored Glycine 0 C--N 1.349 1.266 0 C-N-CA 118.777 -1.678 . . . . 445.63 109.854 177.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.1 mt -56.38 -41.23 75.89 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 125.257 1.423 . . . . 457.72000000000003 112.377 -170.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -58.71 -46.86 86.39 Favored 'General case' 0 CA--C 1.484 -1.56 0 C-N-CA 118.622 -1.231 . . . . 340.57999999999998 109.281 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.849 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.2 m-85 -68.72 -32.14 71.72 Favored 'General case' 0 N--CA 1.423 -1.778 0 C-N-CA 118.784 -1.166 . . . . 453.60000000000002 111.576 -176.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.764 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.2 t -56.08 -40.32 73.44 Favored 'General case' 0 CA--C 1.488 -1.441 0 N-CA-C 105.948 -1.871 . . . . 541.48000000000002 105.948 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.87 -47.17 75.79 Favored 'General case' 0 CA--C 1.485 -1.532 0 O-C-N 123.959 0.787 . . . . 466.68000000000001 110.869 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -61.63 -47.14 86.74 Favored 'General case' 0 N--CA 1.427 -1.621 0 C-N-CA 117.501 -1.68 . . . . 427.33999999999997 107.361 -178.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.839 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.5 m80 -67.05 -36.77 82.78 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 112.456 0.539 . . . . 537.87 112.456 -174.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.574 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.38 -42.68 74.83 Favored 'General case' 0 N--CA 1.432 -1.344 0 C-N-CA 116.884 -1.926 . . . . 422.12 111.608 175.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.856 ' O ' HG22 ' A' ' 113' ' ' ILE . 75.9 t80 -59.1 -50.08 75.41 Favored 'General case' 0 CA--C 1.501 -0.909 0 O-C-N 121.342 -0.849 . . . . 340.17000000000002 111.815 -173.323 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -65.32 -46.48 71.03 Favored Pre-proline 0 N--CA 1.443 -0.816 0 C-N-CA 119.1 -1.04 . . . . 258.06 111.696 -176.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.939 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.1 Cg_exo -61.57 -31.54 87.24 Favored 'Trans proline' 0 N--CA 1.435 -1.925 0 N-CA-C 115.341 1.246 . . . . 305.70999999999998 115.341 176.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.878 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.87 -40.45 76.54 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.363 0 N-CA-C 108.686 -0.857 . . . . 252.69999999999999 108.686 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.422 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.93 -40.57 93.76 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 107.825 -1.176 . . . . 149.27000000000001 107.825 -179.098 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.99 -44.84 95.88 Favored 'General case' 0 N--CA 1.436 -1.165 0 C-N-CA 120.614 -0.434 . . . . 138.08000000000001 111.497 -176.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.651 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 65.2 t -66.94 -42.34 88.7 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.944 0 O-C-N 121.604 -0.685 . . . . 132.88999999999999 110.969 -177.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.922 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.6 m-85 -63.76 -44.7 92.69 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 108.871 -0.788 . . . . 193.61000000000001 108.871 -177.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.555 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.43 -37.71 84.5 Favored 'General case' 0 N--CA 1.435 -1.177 0 C-N-CA 122.811 0.445 . . . . 63.829999999999998 110.094 -175.284 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 72.0 m -63.95 -52.46 59.64 Favored 'General case' 0 N--CA 1.435 -1.194 0 O-C-N 122.031 -0.418 . . . . 76.400000000000006 111.221 -177.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.752 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.96 -41.7 93.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 108.179 -1.045 . . . . 171.13 108.179 -174.963 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 1.103 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.2 m-85 -63.79 -38.53 91.46 Favored 'General case' 0 N--CA 1.433 -1.3 0 O-C-N 121.839 -0.538 . . . . 78.299999999999997 110.631 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.556 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.5 t -67.11 -35.73 80.4 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 118.854 -1.138 . . . . 92.359999999999999 109.229 -178.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.999 ' HE1' HD21 ' A' ' 74' ' ' LEU . 5.9 mmt -62.47 -34.27 76.49 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 108.218 -1.03 . . . . 93.730000000000004 108.218 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.9 HG22 HG13 ' A' ' 212' ' ' ILE . 32.9 p -67.38 -41.72 84.58 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.209 -0.996 . . . . 132.74000000000001 109.302 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.28 -42.04 94.59 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 107.2 -1.408 . . . . 43.390000000000001 107.2 -177.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.827 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.0 t -58.48 -41.95 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 N-CA-C 108.606 -0.887 . . . . 59.340000000000003 108.606 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.55 -44.07 95.23 Favored 'General case' 0 CA--C 1.498 -1.039 0 O-C-N 121.844 -0.535 . . . . 69.680000000000007 110.474 -177.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.468 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.3 t80 -65.44 -42.8 92.01 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 108.313 -0.995 . . . . 106.98 108.313 -177.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.827 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.34 -35.58 81.35 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 119.632 -0.827 . . . . 147.63 108.982 -177.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.703 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.16 -41.52 99.26 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 108.562 -0.903 . . . . 190.06 108.562 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.599 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.4 t80 -61.34 -44.12 97.72 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.253 -1.017 . . . . 118.84999999999999 108.253 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.803 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.4 mmt -63.36 -42.66 98.9 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 109.979 -0.378 . . . . 102.5 109.979 -177.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.91 -41.7 95.35 Favored 'General case' 0 CA--C 1.489 -1.399 0 O-C-N 121.817 -0.552 . . . . 89.980000000000004 109.836 -176.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.92 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.4 mt -66.52 -50.7 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.719 0 C-N-CA 118.103 -1.439 . . . . 106.09 110.997 -177.198 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.75 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.03 -48.37 38.49 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.13 0 C-N-CA 117.092 -1.843 . . . . 227.74000000000001 111.824 -174.824 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.756 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 23.9 p80 -118.85 100.11 50.98 Favored Pre-proline 0 CA--C 1.486 -1.503 0 C-N-CA 116.26 -2.176 . . . . 262.55000000000001 110.061 -175.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.2 Cg_endo -69.63 -10.35 28.45 Favored 'Trans proline' 0 C--N 1.289 -2.574 0 C-N-CA 121.607 1.538 . . . . 210.25 111.327 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.706 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.35 112.04 1.01 Allowed 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 106.483 -1.673 . . . . 270.57999999999998 106.483 -178.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.887 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.2 tt0 -66.77 -39.53 24.48 Favored Pre-proline 0 N--CA 1.431 -1.425 0 CA-C-N 115.329 -0.851 . . . . 129.84 112.362 -176.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.857 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 82.3 Cg_exo -61.36 -26.57 81.72 Favored 'Trans proline' 0 N--CA 1.431 -2.176 0 N-CA-C 116.322 1.624 . . . . 330.70999999999998 116.322 -174.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.756 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.07 77.24 7.99 Favored 'General case' 0 N--CA 1.429 -1.514 0 C-N-CA 114.47 -2.892 . . . . 204.50999999999999 107.3 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.877 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.68 147.38 0.09 Allowed 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.482 -1.303 . . . . 387.41000000000003 107.482 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.877 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.3 t -143.68 147.0 33.64 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 118.824 -1.151 . . . . 166.22 109.515 178.054 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.8 -40.77 88.21 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 107.869 -1.159 . . . . 44.229999999999997 107.869 176.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.481 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.7 m -60.33 -39.08 85.8 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 108.181 -1.044 . . . . 28.800000000000001 108.181 -175.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.668 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.86 -38.75 92.06 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 109.087 -0.708 . . . . 30.289999999999999 109.087 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.847 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 90.3 m -59.62 -43.03 93.94 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 109.011 -0.737 . . . . 46.109999999999999 109.011 -176.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.46 -42.12 99.25 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 107.7 -1.222 . . . . 87.329999999999998 107.7 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.766 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.4 t -61.71 -42.06 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.359 0 N-CA-C 107.874 -1.158 . . . . 23.690000000000001 107.874 -178.043 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.8 t -63.2 -44.26 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 N-CA-C 109.73 -0.47 . . . . 43.859999999999999 109.73 -178.036 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.92 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.1 mm -61.24 -42.54 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 108.359 -0.978 . . . . 91.129999999999995 108.359 -176.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' CYS . . . . . 0.484 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.3 t -62.62 -37.95 88.31 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 108.735 -0.839 . . . . 65.879999999999995 108.735 -178.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.766 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.5 t -62.1 -41.88 92.89 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 109.552 -0.536 . . . . 33.859999999999999 109.552 -177.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 1.103 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.37 -40.37 85.97 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.159 0 N-CA-C 107.583 -1.266 . . . . 146.52000000000001 107.583 -176.791 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 155' ' ' TRP . . . . . 0.699 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.1 m95 -62.84 -38.35 90.43 Favored 'General case' 0 N--CA 1.428 -1.538 0 C-N-CA 119.502 -0.879 . . . . 75.439999999999998 108.942 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.9 t -60.5 -48.42 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 O-C-N 121.058 -1.026 . . . . 43.640000000000001 109.749 -177.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.791 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.65 -38.05 89.67 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 109.041 -0.726 . . . . 102.56999999999999 109.041 -178.09 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.99 -41.06 86.7 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.433 -1.321 . . . . 58.159999999999997 107.433 -178.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.802 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.08 -32.55 73.95 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.014 -0.736 . . . . 121.11 109.014 178.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.791 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.0 -42.3 84.92 Favored 'General case' 0 CA--C 1.489 -1.381 0 C-N-CA 118.554 -1.258 . . . . 153.15000000000001 109.966 -178.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 1.059 HD13 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.09 -43.71 19.07 Favored 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 113.06 -3.456 . . . . 133.66999999999999 113.532 173.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.479 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -63.0 -39.83 95.96 Favored 'General case' 0 CA--C 1.49 -1.344 0 O-C-N 120.888 -1.132 . . . . 157.41999999999999 112.196 -171.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.524 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.3 t80 -74.51 -36.08 2.4 Favored Pre-proline 0 N--CA 1.437 -1.112 0 N-CA-C 114.974 1.472 . . . . 250.91 114.974 -173.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.293 53.0 Cg_exo -59.53 -25.46 78.83 Favored 'Trans proline' 0 CA--C 1.488 -1.817 0 N-CA-C 118.043 2.286 . . . . 207.34 118.043 -174.37 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.916 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 32.4 mt-30 -61.18 -34.23 74.71 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 106.953 -1.499 . . . . 192.46000000000001 106.953 178.07 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.46 -41.07 98.16 Favored Glycine 0 C--N 1.353 1.513 0 N-CA-C 107.974 -2.05 . . . . 261.0 107.974 177.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.78 159.07 26.02 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 101.548 -3.501 . . . . 491.39999999999998 101.548 172.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -59.92 106.79 0.53 Allowed 'General case' 0 CA--C 1.488 -1.42 0 C-N-CA 116.282 -2.167 . . . . 386.10000000000002 109.831 -176.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.916 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 74.0 m -154.05 -166.61 2.42 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 103.553 -2.758 . . . . 289.80000000000001 103.553 -178.345 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' THR . . . . . 1.142 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.1 p -62.91 175.44 0.86 Allowed 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 117.723 -1.132 . . . . 402.06 109.554 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.788 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 72.5 p -165.3 177.5 7.54 Favored 'General case' 0 CA--C 1.587 2.383 0 C-N-CA 127.309 2.243 . . . . 690.52999999999997 114.927 177.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.486 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.8 mm-40 132.32 160.57 0.0 OUTLIER 'General case' 1 C--N 1.428 4.007 1 N-CA-C 123.183 4.512 . . . . 633.62 123.183 162.691 . . . . . . . . 4 3 . 1 . 004 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.76 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.4 p -85.68 153.82 22.08 Favored 'General case' 0 C--N 1.389 2.313 0 C-N-CA 127.373 2.269 . . . . 617.99000000000001 110.874 178.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' MET . . . . . 1.047 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.66 174.45 5.93 Favored Pre-proline 0 C--N 1.364 1.233 0 C-N-CA 130.284 3.433 . . . . 434.98000000000002 113.387 -175.365 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 1.091 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 52.9 Cg_endo -44.31 -65.63 0.19 Allowed 'Trans proline' 0 N--CA 1.441 -1.576 0 N-CA-C 122.386 3.956 . . . . 365.88 122.386 -168.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' SER . . . . . 0.777 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.306 70.4 m -84.91 20.94 1.7 Allowed 'General case' 0 CA--C 1.466 -2.257 0 N-CA-C 104.807 -2.294 . . . . 635.80999999999995 104.807 178.147 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.75 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.457 5.0 mmp_? -94.33 152.24 18.8 Favored 'General case' 1 CA--C 1.419 -4.081 3 N-CA-C 132.031 7.789 . . . . 999.99000000000001 132.031 -135.787 . . . . . . . . 5 3 . 1 . 004 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 1.05 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.912 37.3 t -131.83 73.12 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.383 -3.8 1 CA-C-N 103.343 -6.299 . . . . 594.32000000000005 113.606 149.235 . . . . . . . . 4 3 . 1 . 004 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.729 HG13 ' HB2' ' A' ' 174' ' ' MET . 7.3 p -144.16 144.14 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.603 1 N-CA-C 98.244 -4.724 . . . . 811.90999999999997 98.244 162.404 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.76 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.9 m -118.48 144.49 45.97 Favored 'General case' 0 CA--C 1.489 -1.391 0 C-N-CA 117.099 -1.84 . . . . 999.99000000000001 109.429 -178.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.971 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.9 mmm -147.17 -175.6 4.89 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 122.019 0.914 . . . . 431.86000000000001 110.069 -177.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 1.037 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.11 148.65 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 C-N-CA 124.397 1.079 . . . . 457.18000000000001 108.796 -177.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' GLU . . . . . 0.788 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.31 85.41 3.74 Favored 'General case' 0 CA--C 1.5 -0.944 0 C-N-CA 124.147 0.979 . . . . 458.76999999999998 113.515 -174.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.96 ' CZ3' HG22 ' A' ' 182' ' ' ILE . 1.9 p90 -76.35 -31.55 0.98 Allowed Pre-proline 0 N--CA 1.438 -1.065 0 C-N-CA 124.941 1.296 . . . . 999.99000000000001 112.452 168.298 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.957 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 50.9 Cg_exo -66.0 -45.71 5.64 Favored 'Trans proline' 0 N--CA 1.438 -1.766 0 N-CA-C 120.895 3.383 . . . . 999.99000000000001 120.895 -174.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.507 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 54.9 mt-10 -119.54 171.73 8.15 Favored 'General case' 0 CA--C 1.472 -2.054 0 C-N-CA 117.204 -1.798 . . . . 81.180000000000007 107.285 -172.149 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.834 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 6.4 p80 -109.13 45.14 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.828 0 C-N-CA 115.466 -2.493 . . . . 999.99000000000001 108.777 177.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 1.076 ' HB2' HD12 ' A' ' 191' ' ' ILE . 87.3 Cg_endo -41.56 101.84 0.04 OUTLIER 'Trans proline' 0 CA--C 1.5 -1.184 1 C-N-CA 126.039 4.492 . . . . 999.99000000000001 105.683 -170.749 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -62.34 -44.01 97.49 Favored 'General case' 0 CA--C 1.484 -1.586 0 C-N-CA 126.777 2.031 . . . . 967.72000000000003 112.024 -165.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -60.31 -36.49 78.01 Favored 'General case' 0 CA--C 1.487 -1.475 0 N-CA-C 106.741 -1.578 . . . . 934.29999999999995 106.741 -175.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 1.076 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.62 -30.22 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 C-N-CA 129.185 2.994 . . . . 565.14999999999998 113.918 -178.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 61.56 55.38 2.79 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-N 118.469 0.577 . . . . 755.61000000000001 109.853 -175.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 1.142 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.5 -49.33 66.94 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 124.563 1.145 . . . . 325.88999999999999 113.265 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.632 ' HE3' ' OH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.76 -45.0 78.18 Favored 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 123.573 0.749 . . . . 250.21000000000001 111.637 -169.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 96.8 t -64.73 -43.29 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 C-N-CA 119.959 -0.696 . . . . 142.46000000000001 110.389 -175.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 1.037 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.9 t80 -61.15 -41.5 96.86 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 123.982 0.913 . . . . 247.69 108.814 -173.162 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' HIS . . . . . 0.824 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 23.0 t60 -60.52 -51.36 69.75 Favored 'General case' 0 CA--C 1.492 -1.279 0 C-N-CA 125.454 1.502 . . . . 199.61000000000001 113.049 -175.091 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 82.8 mt -65.31 -44.52 94.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 107.727 -1.212 . . . . 106.73 107.727 -177.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' CYS . . . . . 0.72 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.5 t -59.11 -48.55 81.21 Favored 'General case' 0 CA--C 1.486 -1.519 0 CA-C-N 115.858 -0.61 . . . . 115.01000000000001 110.245 -173.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 1.059 HG13 HD13 ' A' ' 161' ' ' LEU . 86.1 t -65.27 -49.15 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.647 0 C-N-CA 119.458 -0.897 . . . . 129.41999999999999 111.823 -174.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' THR . . . . . 0.791 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.1 m -61.89 -53.14 59.82 Favored 'General case' 0 CA--C 1.483 -1.614 0 C-N-CA 118.245 -1.382 . . . . 172.47999999999999 109.953 -172.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.631 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 85.6 t -63.83 -54.24 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 C-N-CA 120.523 -0.471 . . . . 55.859999999999999 110.989 -174.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.72 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.58 -51.54 58.96 Favored 'General case' 0 N--CA 1.432 -1.355 0 C-N-CA 118.526 -1.27 . . . . 184.68000000000001 111.496 -174.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 1.051 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.6 -52.44 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 C-N-CA 116.696 -2.002 . . . . 291.81 114.737 -174.683 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.55 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.8 t80 -82.04 -55.0 4.84 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 115.142 1.534 . . . . 130.66 115.142 -178.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' PHE . . . . . 0.791 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.9 m-85 -66.87 -48.49 68.62 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 114.532 1.308 . . . . 80.159999999999997 114.532 -170.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.898 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.57 -45.48 83.07 Favored Pre-proline 0 N--CA 1.436 -1.165 0 C-N-CA 119.91 -0.716 . . . . 136.02000000000001 109.495 -174.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.898 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.7 Cg_exo -64.76 -27.16 60.0 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 110.629 -0.566 . . . . 92.170000000000002 110.629 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.686 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.29 -41.41 76.83 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 107.495 -1.298 . . . . 135.59999999999999 107.495 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.8 mt -64.17 -44.73 91.17 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 109.57 -0.529 . . . . 52.100000000000001 109.57 -176.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.617 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.7 p -61.61 -43.53 97.18 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 109.12 -0.696 . . . . 95.890000000000001 109.12 -176.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.9 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.23 -42.35 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 106.728 -1.582 . . . . 43.409999999999997 106.728 -178.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.47 -42.26 99.04 Favored Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 109.361 -1.496 . . . . 27.690000000000001 109.361 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' TYR . . . . . 0.883 ' O ' HG22 ' A' ' 217' ' ' THR . 77.9 t80 -65.65 -47.4 75.69 Favored 'General case' 0 CA--C 1.496 -1.113 0 CA-C-N 117.38 0.59 . . . . 54.409999999999997 110.497 -177.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ALA . . . . . 0.826 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.41 -34.13 74.85 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 106.968 -1.493 . . . . 53.880000000000003 106.968 -177.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -60.74 -40.86 93.98 Favored 'General case' 0 N--CA 1.426 -1.628 0 N-CA-C 108.492 -0.929 . . . . 68.290000000000006 108.492 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' THR . . . . . 0.883 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.74 -39.06 92.99 Favored 'General case' 0 CA--C 1.497 -1.088 0 C-N-CA 119.69 -0.804 . . . . 107.59 110.619 -175.305 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.826 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.03 -38.36 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 C-N-CA 119.607 -0.837 . . . . 111.61 109.488 -177.064 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.92 HG13 ' CD1' ' A' ' 134' ' ' ILE . 79.6 t -63.29 -22.52 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 N-CA-C 108.389 -0.967 . . . . 85.260000000000005 108.389 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.84 -41.95 99.39 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 111.051 -0.82 . . . . 40.710000000000001 111.051 -176.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.7 mm -64.66 -44.09 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 108.42 -0.955 . . . . 95.859999999999999 108.42 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.822 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.1 p -76.94 -137.57 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.417 -0.956 . . . . 144.37 108.417 -176.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.901 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.7 mt -55.31 132.1 47.16 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 107.633 -1.247 . . . . 326.72000000000003 107.633 -177.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 224' ' ' TRP . . . . . 0.463 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.31 -168.02 1.5 Allowed 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 106.059 -1.83 . . . . 158.38 106.059 -176.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' ALA . . . . . 0.463 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.39 -41.93 98.79 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 109.619 -0.512 . . . . 36.780000000000001 109.619 -178.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.8 m -61.13 125.81 25.07 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 119.144 -1.022 . . . . 85.459999999999994 109.813 -174.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' GLU . . . . . 0.692 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.82 126.56 8.89 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 105.547 -2.02 . . . . 127.78 105.547 176.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.928 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.04 139.92 34.8 Favored Pre-proline 0 CA--C 1.493 -1.214 0 N-CA-C 105.946 -1.872 . . . . 164.84 105.946 -179.548 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.928 ' N ' HD13 ' A' ' 228' ' ' ILE . 82.3 Cg_exo -56.87 -39.85 88.44 Favored 'Trans proline' 0 N--CA 1.431 -2.184 0 N-CA-C 113.945 0.71 . . . . 222.34999999999999 113.945 -175.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 230' ' ' GLY . . . . . 0.745 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.18 167.0 44.85 Favored Glycine 0 N--CA 1.428 -1.838 0 N-CA-C 106.39 -2.684 . . . . 45.219999999999999 106.39 178.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.883 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.6 t0 -60.97 -45.79 93.34 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 105.997 -1.853 . . . . 107.56999999999999 105.997 177.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' SER . . . . . 0.73 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.5 m -65.72 141.78 58.23 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 118.899 -1.12 . . . . 167.96000000000001 109.192 -175.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.829 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.3 m 99.5 106.7 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.248 0 C-N-CA 126.73 2.012 . . . . 280.68000000000001 109.768 176.135 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.709 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.5 m-20 55.99 11.31 0.71 Allowed 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 124.42 1.088 . . . . 218.25 110.717 174.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.921 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.41 137.68 54.76 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 105.217 -2.142 . . . . 343.56999999999999 105.217 177.368 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.48 ' O ' HG21 ' A' ' 240' ' ' VAL . 85.6 t80 -112.0 81.92 1.54 Allowed 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 106.826 -1.546 . . . . 263.29000000000002 106.826 179.117 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 237' ' ' HIS . . . . . 0.627 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 64.5 m80 104.29 147.03 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.285 0 C-N-CA 126.576 1.951 . . . . 261.92000000000002 108.486 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.21 -38.07 89.73 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 107.911 -1.144 . . . . 106.81 107.911 -177.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.739 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.42 -39.95 94.96 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 118.362 -1.335 . . . . 112.2 107.552 -178.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.738 HG12 ' NH1' ' A' ' 244' ' ' ARG . 75.5 t -64.25 -39.85 86.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 N-CA-C 109.254 -0.647 . . . . 45.409999999999997 109.254 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 241' ' ' SER . . . . . 0.803 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.0 p -70.94 -32.01 68.78 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 110.278 -0.267 . . . . 97.620000000000005 110.278 -178.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.38 -39.61 81.7 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 123.698 0.799 . . . . 59.289999999999999 111.012 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.739 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.25 -36.55 84.03 Favored 'General case' 0 CA--C 1.491 -1.3 0 C-N-CA 124.664 1.186 . . . . 106.48999999999999 110.683 -174.127 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.921 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.95 -30.67 69.24 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 108.293 -1.002 . . . . 106.62 108.293 -176.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.534 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -65.97 -41.06 91.68 Favored 'General case' 0 N--CA 1.436 -1.141 0 O-C-N 121.841 -0.537 . . . . 75.969999999999999 110.062 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.44 ' CG1' ' CE ' ' A' ' 250' ' ' MET . 76.8 t -65.53 -40.84 89.36 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 C-N-CA 122.92 0.488 . . . . 65.269999999999996 109.779 -178.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.775 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -64.03 -41.62 93.07 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.317 0 C-N-CA 120.398 -0.521 . . . . 107.94 110.12 -177.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.536 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.2 pttt -63.47 -40.81 98.11 Favored 'General case' 0 N--CA 1.434 -1.239 0 O-C-N 121.663 -0.648 . . . . 87.980000000000004 110.328 -176.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 249' ' ' MET . . . . . 0.821 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.68 -40.41 96.76 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 118.824 -1.15 . . . . 65.5 108.35 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 250' ' ' MET . . . . . 0.76 ' CE ' HG21 ' A' ' 67' ' ' THR . 68.5 mtt -61.64 -36.41 80.71 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.141 -1.059 . . . . 85.049999999999997 108.141 -177.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.536 HD12 ' HA ' ' A' ' 248' ' ' LYS . 86.9 mt -63.48 -45.71 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 N-CA-C 109.061 -0.718 . . . . 42.25 109.061 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 252' ' ' VAL . . . . . 0.821 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.4 -38.19 81.93 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.13 0 C-N-CA 119.551 -0.86 . . . . 91.010000000000005 109.376 -176.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 1.0 HG22 ' CD1' ' A' ' 304' ' ' ILE . 66.5 t -58.93 -41.53 83.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 N-CA-C 107.931 -1.137 . . . . 66.090000000000003 107.931 -178.114 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 250' ' ' MET . 94.3 t -66.14 -43.15 92.24 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 C-N-CA 120.729 -0.388 . . . . 52.390000000000001 110.282 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.5 m -61.73 -46.75 88.3 Favored 'General case' 0 CA--C 1.489 -1.384 0 O-C-N 121.913 -0.492 . . . . 46.420000000000002 109.903 -174.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 256' ' ' THR . . . . . 0.744 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.5 t -62.33 -38.18 88.45 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 108.333 -0.988 . . . . 116.51000000000001 108.333 -177.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 257' ' ' PHE . . . . . 0.489 ' N ' HG23 ' A' ' 256' ' ' THR . 86.1 t80 -60.23 -48.23 82.6 Favored 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 109.405 -0.591 . . . . 65.180000000000007 109.405 -178.136 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.94 -42.65 97.26 Favored 'General case' 0 CA--C 1.49 -1.364 0 CA-C-O 120.872 0.368 . . . . 51.329999999999998 110.468 -175.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' ILE . . . . . 0.744 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.62 -43.41 98.16 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 C-N-CA 118.941 -1.103 . . . . 126.3 108.974 -176.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 260' ' ' CYS . . . . . 0.508 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.7 m -65.58 -49.3 69.31 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 119.518 -0.873 . . . . 133.94 112.495 -176.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.817 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.0 m95 -80.69 -33.4 35.47 Favored 'General case' 0 CA--C 1.497 -1.071 0 N-CA-C 116.823 2.157 . . . . 134.84 116.823 -176.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.781 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.9 tp -58.47 -41.56 89.88 Favored Pre-proline 0 CA--C 1.493 -1.225 0 O-C-N 121.628 -0.67 . . . . 72.230000000000004 111.648 -167.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 263' ' ' PRO . . . . . 0.781 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 81.9 Cg_exo -60.75 -35.94 86.76 Favored 'Trans proline' 0 C--N 1.294 -2.298 0 CA-C-N 119.837 0.978 . . . . 106.13 111.302 -178.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 264' ' ' PHE . . . . . 0.849 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.5 t80 -66.4 -44.67 82.37 Favored 'General case' 0 N--CA 1.433 -1.321 0 C-N-CA 119.793 -0.763 . . . . 128.34999999999999 110.061 -178.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 265' ' ' HIS . . . . . 0.643 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.47 -37.84 88.95 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 110.236 -0.283 . . . . 100.73 110.236 -177.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.743 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.28 -44.52 94.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 C-N-CA 119.329 -0.949 . . . . 172.72 109.139 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 267' ' ' PHE . . . . . 0.735 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.6 m-85 -66.61 -28.06 68.2 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 108.235 -1.024 . . . . 249.22999999999999 108.235 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 268' ' ' PHE . . . . . 0.902 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.3 t80 -55.56 -55.13 35.52 Favored 'General case' 0 N--CA 1.433 -1.325 0 N-CA-C 106.653 -1.61 . . . . 259.77999999999997 106.653 178.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 269' ' ' LEU . . . . . 0.492 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.5 mt -69.14 -44.2 72.82 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 113.606 0.965 . . . . 233.11000000000001 113.606 -176.083 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 270' ' ' LEU . . . . . 0.836 ' O ' HG13 ' A' ' 273' ' ' ILE . 88.7 mt -61.4 -48.34 91.21 Favored Pre-proline 0 CA--C 1.5 -0.946 0 C-N-CA 119.199 -1.0 . . . . 169.53999999999999 110.553 -171.026 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 271' ' ' PRO . . . . . 0.735 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.8 Cg_exo -61.05 -24.64 79.89 Favored 'Trans proline' 0 N--CA 1.429 -2.287 0 C-N-CA 116.797 -1.668 . . . . 255.47 114.64 174.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 272' ' ' TYR . . . . . 0.824 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.6 t80 -63.57 -44.17 94.88 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 119.233 0.924 . . . . 279.02999999999997 108.91 177.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.836 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.34 -44.82 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 N-CA-C 110.076 -0.342 . . . . 162.21000000000001 110.076 -178.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 274' ' ' ASN . . . . . 0.867 HD22 HD12 ' A' ' 277' ' ' LEU . 49.1 t30 -125.38 84.89 59.25 Favored Pre-proline 0 N--CA 1.431 -1.423 0 C-N-CA 118.761 -1.176 . . . . 128.13 108.067 -178.078 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 275' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.26 164.06 11.25 Favored 'Trans proline' 0 C--N 1.295 -2.281 0 N-CA-C 107.487 -1.774 . . . . 278.35000000000002 107.487 177.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 276' ' ' ASP . . . . . 0.866 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.09 15.07 9.94 Favored 'General case' 0 N--CA 1.429 -1.518 0 O-C-N 123.752 0.658 . . . . 312.91000000000003 109.319 175.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.867 HD12 HD22 ' A' ' 274' ' ' ASN . 28.2 mt -132.72 -170.69 2.49 Favored 'General case' 0 CA--C 1.481 -1.686 0 N-CA-C 106.533 -1.654 . . . . 353.54000000000002 106.533 177.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 1.008 ' HA ' ' CB ' ' A' ' 282' ' ' PHE . 42.8 p90 -115.63 142.26 46.98 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 107.419 -1.326 . . . . 251.25999999999999 107.419 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.764 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -76.92 -118.74 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 102.1 -3.296 . . . . 175.25999999999999 102.1 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 280' ' ' LYS . . . . . 0.793 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.51 -44.96 96.13 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 100.892 -3.744 . . . . 99.069999999999993 100.892 172.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 281' ' ' LYS . . . . . 0.793 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.42 124.15 9.18 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 103.508 -2.775 . . . . 243.21000000000001 103.508 171.157 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 1.008 ' CB ' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.97 113.01 25.16 Favored 'General case' 0 CA--C 1.474 -1.967 0 C-N-CA 116.004 -2.278 . . . . 201.03999999999999 105.287 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 283' ' ' ILE . . . . . 0.777 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.95 173.71 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.098 0 C-N-CA 116.006 -2.277 . . . . 201.36000000000001 108.789 -175.167 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 284' ' ' GLN . . . . . 1.091 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.283 0.6 OUTLIER -59.48 -41.46 89.84 Favored 'General case' 0 N--CA 1.415 -2.189 0 CA-C-N 113.28 -1.782 . . . . 203.81999999999999 107.881 174.44 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 285' ' ' GLN . . . . . 0.925 ' HG2' HE21 ' A' ' 284' ' ' GLN . 1.2 mm100 -64.29 -45.75 86.62 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 118.221 -1.392 . . . . 215.06 112.532 -171.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.553 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.2 t -65.64 -46.41 89.46 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.461 0 C-N-CA 118.562 -1.255 . . . . 125.28 112.948 -171.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 287' ' ' TYR . . . . . 0.951 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.76 -37.01 86.17 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 107.211 -1.404 . . . . 268.89999999999998 107.211 -171.929 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.794 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.26 -44.98 74.4 Favored 'General case' 0 CA--C 1.483 -1.603 0 C-N-CA 125.614 1.566 . . . . 280.88 108.769 -172.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.66 -47.53 85.85 Favored 'General case' 0 CA--C 1.485 -1.534 0 C-N-CA 118.985 -1.086 . . . . 184.47 108.959 -172.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 290' ' ' ILE . . . . . 0.849 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.8 mp -67.93 -42.09 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 C-N-CA 119.273 -0.971 . . . . 167.91999999999999 112.724 -175.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 291' ' ' MET . . . . . 0.502 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.7 ttt -65.7 -38.88 90.45 Favored 'General case' 0 CA--C 1.495 -1.139 0 C-N-CA 117.764 -1.574 . . . . 367.18000000000001 110.767 -175.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 292' ' ' TRP . . . . . 0.548 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.5 m95 -67.12 -32.69 73.99 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 121.804 -0.56 . . . . 173.97 110.477 177.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.4 tp -64.48 -36.73 85.13 Favored 'General case' 0 CA--C 1.499 -1.0 0 C-N-CA 123.517 0.727 . . . . 119.66 109.824 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 294' ' ' ALA . . . . . 0.817 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.26 -33.99 74.44 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 107.659 -1.237 . . . . 112.3 107.659 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 295' ' ' MET . . . . . 0.773 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.12 -31.99 73.26 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 116.252 -0.431 . . . . 174.16999999999999 110.246 -177.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.7 m -64.75 -22.77 67.06 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 124.661 1.184 . . . . 145.27000000000001 110.6 -175.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 297' ' ' SER . . . . . 0.757 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.5 m -57.61 -35.39 70.39 Favored 'General case' 0 N--CA 1.426 -1.675 0 N-CA-C 108.055 -1.091 . . . . 170.15000000000001 108.055 -175.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.82 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.8 t -55.33 -34.08 63.9 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 116.285 -0.416 . . . . 214.56999999999999 110.653 -171.083 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 299' ' ' MET . . . . . 0.752 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.1 ttt -77.25 -33.24 56.02 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 126.093 1.757 . . . . 168.28999999999999 115.499 177.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 300' ' ' TYR . . . . . 0.757 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.41 -34.83 79.08 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 114.098 1.148 . . . . 167.15000000000001 114.098 -168.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 301' ' ' ASN . . . . . 0.725 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.282 18.8 p-10 -64.2 -38.36 33.84 Favored Pre-proline 0 N--CA 1.434 -1.274 0 C-N-CA 115.536 -2.465 . . . . 165.13 113.89 -171.625 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 302' ' ' PRO . . . . . 0.725 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.4 Cg_exo -62.51 -31.81 80.22 Favored 'Trans proline' 0 N--CA 1.434 -2.004 0 CA-C-N 122.762 2.022 . . . . 123.92 111.272 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 303' ' ' ILE . . . . . 0.714 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.81 -42.57 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 C-N-CA 118.878 -1.129 . . . . 110.55 109.743 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 304' ' ' ILE . . . . . 1.0 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.0 pt -61.17 -39.97 84.29 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.146 0 N-CA-C 108.843 -0.799 . . . . 145.31 108.843 -177.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 305' ' ' TYR . . . . . 0.927 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.254 63.4 m-85 -58.17 -48.75 79.3 Favored 'General case' 0 CA--C 1.494 -1.174 0 C-N-CA 119.373 -0.931 . . . . 246.68000000000001 109.846 -177.509 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.5 m -62.25 -47.47 84.25 Favored 'General case' 0 CA--C 1.485 -1.536 0 C-N-CA 119.536 -0.866 . . . . 64.430000000000007 109.559 -173.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.8 t -66.85 -45.03 79.48 Favored 'General case' 0 N--CA 1.428 -1.532 0 C-N-CA 118.963 -1.095 . . . . 80.719999999999999 110.259 -177.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.708 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.46 -35.71 75.88 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 116.007 1.855 . . . . 140.44 116.007 -173.372 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 309' ' ' ASN . . . . . 0.658 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.82 132.22 34.36 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 112.704 -3.598 . . . . 178.87 113.08 -177.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 310' ' ' ASP . . . . . 0.609 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.02 -37.09 86.47 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 114.406 -1.27 . . . . 110.22 110.093 -177.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 311' ' ' ARG . . . . . 0.859 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.73 -50.61 72.63 Favored 'General case' 0 CA--C 1.492 -1.258 0 O-C-N 121.714 -0.617 . . . . 174.78 109.737 -174.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.96 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.1 m-85 -64.87 -41.74 95.41 Favored 'General case' 0 CA--C 1.484 -1.573 0 N-CA-C 108.212 -1.033 . . . . 161.84 108.212 178.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 313' ' ' ARG . . . . . 0.518 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.7 ttp180 -57.24 -50.3 73.3 Favored 'General case' 0 CA--C 1.49 -1.327 0 N-CA-C 109.206 -0.664 . . . . 117.2 109.206 -173.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.798 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.52 -44.06 75.42 Favored 'General case' 0 N--CA 1.433 -1.277 0 C-N-CA 120.385 -0.526 . . . . 112.59999999999999 111.038 -177.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 315' ' ' GLY . . . . . 0.87 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -64.09 -37.42 94.55 Favored Glycine 0 N--CA 1.43 -1.759 0 N-CA-C 110.644 -0.982 . . . . 101.45999999999999 110.644 -177.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 316' ' ' PHE . . . . . 1.011 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.6 m-85 -62.15 -45.99 90.96 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-N 118.491 1.145 . . . . 151.49000000000001 109.519 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 317' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 317' ' ' LYS . 25.6 ttmt -60.1 -36.33 77.18 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 106.942 -1.503 . . . . 142.31999999999999 106.942 -175.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 318' ' ' HIS . . . . . 0.825 ' NE2' HG21 ' A' ' 326' ' ' ILE . 49.9 m80 -59.75 -41.84 91.9 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.883 -1.525 . . . . 109.09 106.883 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.84 -42.45 85.76 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.353 -0.217 . . . . 76.109999999999999 110.999 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -61.41 -55.55 30.2 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 119.914 -0.714 . . . . 120.23999999999999 109.299 -174.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 321' ' ' ARG . . . . . 0.58 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.4 mtt180 -74.3 131.52 41.25 Favored 'General case' 0 CA--C 1.482 -1.651 0 N-CA-C 102.973 -2.973 . . . . 192.72999999999999 102.973 177.092 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.16 -44.17 92.11 Favored 'General case' 0 CA--C 1.491 -1.312 0 C-N-CA 119.0 -1.08 . . . . 176.28999999999999 109.238 -172.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 323' ' ' CYS . . . . . 0.752 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.2 m -79.34 -177.06 0.8 Allowed Pre-proline 0 N--CA 1.43 -1.47 0 N-CA-C 106.35 -1.722 . . . . 69.680000000000007 106.35 178.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.7 Cg_exo -59.04 -75.58 0.02 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.373 0 C-N-CA 118.337 -0.642 . . . . 191.05000000000001 112.589 176.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 325' ' ' PHE . . . . . 0.752 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.4 m-85 47.5 43.9 16.28 Favored 'General case' 0 CA--C 1.493 -1.212 0 O-C-N 123.613 0.571 . . . . 287.02999999999997 109.73 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 326' ' ' ILE . . . . . 0.825 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.53 78.62 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.474 -1.955 0 C-N-CA 112.918 -3.513 . . . . 292.29000000000002 109.844 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 327' ' ' SER . . . . . 0.48 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.2 t -77.5 -152.87 0.05 Allowed 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 104.237 -2.505 . . . . 184.56999999999999 104.237 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 328' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.69 8.75 4.95 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 113.039 0.755 . . . . 274.56 113.039 176.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.96 0.84 57.3 Favored Glycine 0 C--N 1.349 1.26 0 C-N-CA 117.717 -2.182 . . . . 268.24000000000001 113.48 172.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 330' ' ' ASP . . . . . 0.699 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.8 m-20 51.62 -172.07 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.085 0 CA-C-N 118.694 1.247 . . . . 200.06 110.737 177.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.859 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.3 t80 -63.84 -33.04 74.78 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 107.915 -1.143 . . . . 114.44 107.915 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 332' ' ' GLU . . . . . 0.547 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.27 46.09 21.83 Favored 'General case' 0 CA--C 1.484 -1.571 0 N-CA-C 107.59 -1.263 . . . . 263.81 107.59 -177.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 333' ' ' GLY . . . . . 0.633 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.3 -137.35 3.6 Favored Glycine 0 CA--C 1.479 -2.204 1 N-CA-C 102.529 -4.228 . . . . 103.79000000000001 102.529 -179.871 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 1.04 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.5 mt -88.25 95.67 10.26 Favored 'General case' 0 N--CA 1.419 -2.017 0 C-N-CA 114.91 -2.716 . . . . 117.3 105.997 177.011 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 335' ' ' GLU . . . . . 1.021 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -66.0 -39.8 90.59 Favored 'General case' 0 CA--C 1.469 -2.173 1 N-CA-C 97.961 -4.829 . . . . 231.58000000000001 97.961 167.235 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 336' ' ' MET . . . . . 1.031 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.93 163.5 29.03 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 102.112 -3.292 . . . . 303.24000000000001 102.112 169.008 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 337' ' ' LYS . . . . . 1.04 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.3 tttt -62.69 -48.56 78.72 Favored 'General case' 0 N--CA 1.432 -1.365 0 C-N-CA 115.997 -2.281 . . . . 112.72 108.381 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.9 t -61.02 -63.67 1.22 Allowed 'General case' 0 CA--C 1.49 -1.334 0 N-CA-C 109.121 -0.696 . . . . 83.219999999999999 109.121 -176.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 339' ' ' THR . . . . . 0.883 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.0 m -156.25 -126.25 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 103.806 -2.664 . . . . 174.36000000000001 103.806 -178.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 340' ' ' ARG . . . . . 1.021 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.84 160.93 8.77 Favored 'General case' 0 CA--C 1.485 -1.552 0 N-CA-C 105.796 -1.927 . . . . 202.72999999999999 105.796 177.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 341' ' ' TYR . . . . . 1.012 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.94 149.01 52.56 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 107.071 -1.455 . . . . 180.62 107.071 176.413 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 342' ' ' LEU . . . . . 0.929 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.5 tp -178.48 -171.88 0.27 Allowed 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 105.393 -2.077 . . . . 145.25 105.393 178.07 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 343' ' ' GLN . . . . . 0.929 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.06 -43.15 88.27 Favored 'General case' 0 CA--C 1.487 -1.455 0 N-CA-C 106.165 -1.791 . . . . 66.049999999999997 106.165 174.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 344' ' ' THR . . . . . 0.764 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.67 -152.2 0.49 Allowed 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 103.498 -2.778 . . . . 266.49000000000001 103.498 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 345' ' ' GLN . . . . . 0.701 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.3 mt-30 66.35 -124.96 0.28 Allowed 'General case' 0 CA--C 1.485 -1.549 0 C-N-CA 116.99 -1.884 . . . . 219.19999999999999 107.742 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 346' ' ' GLY . . . . . 0.9 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.07 -37.38 94.11 Favored Glycine 0 N--CA 1.425 -2.067 0 CA-C-N 114.572 -1.195 . . . . 94.780000000000001 112.865 -175.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 347' ' ' SER . . . . . 0.825 ' HA ' ' SD ' ' A' ' 336' ' ' MET . 48.4 t -81.23 100.41 9.11 Favored 'General case' 0 CA--C 1.484 -1.566 0 C-N-CA 112.359 -3.736 . . . . 121.41 109.467 -171.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 348' ' ' VAL . . . . . 0.439 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.6 t -73.03 145.49 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 N-CA-C 108.974 -0.75 . . . . 85.340000000000003 108.974 -176.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 349' ' ' TYR . . . . . 0.439 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.6 p90 -57.73 143.37 42.12 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 107.825 -1.176 . . . . 267.56999999999999 107.825 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 350' ' ' LYS . . . . . 0.525 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.07 69.61 0.59 Allowed 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 109.529 -0.545 . . . . 226.09999999999999 109.529 -179.087 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 351' ' ' VAL . . . . . 0.825 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.5 p -51.08 156.95 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 N-CA-C 106.928 -1.508 . . . . 154.84 106.928 177.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 352' ' ' SER . . . . . 0.582 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.5 m -61.31 161.91 8.46 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-O 121.595 0.712 . . . . 180.00999999999999 110.728 -173.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 353' ' ' ARG . . . . . 0.895 ' H ' ' HD3' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.43 156.94 23.59 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 106.923 -1.51 . . . . 333.77999999999997 106.923 -178.597 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 354' ' ' LEU . . . . . 0.976 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.04 142.51 48.77 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 107.37 -1.345 . . . . 335.19999999999999 107.37 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.976 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.6 mm-40 82.84 158.91 0.13 Allowed 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 108.729 -0.841 . . . . 266.47000000000003 108.729 179.164 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.9 m -60.66 -46.83 88.84 Favored 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 105.678 -1.971 . . . . 59.340000000000003 105.678 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.58 173.85 11.97 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 104.408 -2.441 . . . . 201.25999999999999 104.408 176.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.75 HG22 ' O ' ' A' ' 360' ' ' THR . 69.1 mt -95.88 106.77 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.529 0 C-N-CA 116.343 -2.143 . . . . 56.229999999999997 105.521 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 359' ' ' SER . . . . . 0.468 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.5 m -61.24 -59.43 5.32 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 109.272 -0.64 . . . . 87.579999999999998 109.272 -175.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 360' ' ' THR . . . . . 0.887 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.2 t -85.59 153.74 22.19 Favored 'General case' 0 CA--C 1.486 -1.496 0 N-CA-C 107.811 -1.181 . . . . 219.94999999999999 107.811 -177.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 361' ' ' VAL . . . . . 0.589 ' O ' HG23 ' A' ' 361' ' ' VAL . 15.9 m -82.04 83.86 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 C-N-CA 116.29 -2.164 . . . . 121.79000000000001 105.436 177.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.596 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.7 t -154.09 159.72 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.548 0 N-CA-C 105.843 -1.91 . . . . 53.850000000000001 105.843 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 363' ' ' GLY . . . . . 0.596 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.22 16.64 77.07 Favored Glycine 0 N--CA 1.428 -1.87 0 N-CA-C 106.057 -2.817 . . . . 196.55000000000001 106.057 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.662 0 N-CA-C 107.911 -1.144 . . . . 35.880000000000003 107.911 -178.942 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 365' ' ' ARG . . . . . 0.62 HH21 ' CG ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 108.865 -0.791 . . . . 1.0 108.865 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 366' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' B' ' 365' ' ' ARG . 52.6 Cg_endo -66.89 142.02 61.05 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.08 1.854 . . . . 1.0 110.245 178.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 367' ' ' LYS . . . . . 0.767 ' HB3' HD11 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -64.43 143.3 98.51 Favored Pre-proline 0 C--N 1.325 -0.498 0 C-N-CA 119.825 -0.75 . . . . 1.0 109.587 -179.894 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 368' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.29 150.44 76.38 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.349 2.033 . . . . 1.0 111.712 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 369' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.74 131.78 44.37 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.749 -0.38 . . . . 1.0 110.243 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.01 115.82 31.36 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.646 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 371' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -63.69 -42.3 98.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.481 . . . . 1.0 110.422 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 372' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.03 -36.26 83.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.678 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -59.68 -33.09 75.92 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.811 -0.916 . . . . 1.0 110.811 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 374' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 120.873 0.368 . . . . 1.0 110.192 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.442 0 N-CA-C 108.377 -0.971 . . . . 97.079999999999998 108.377 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -110.62 155.44 22.37 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-O 122.123 0.963 . . . . 123.41 110.711 -172.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.885 HG11 HD13 ' A' ' 15' ' ' ILE . 28.7 m -134.6 -162.38 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.479 1 N-CA-C 100.081 -4.044 . . . . 151.30000000000001 100.081 173.754 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.915 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.67 -38.57 57.91 Favored Pre-proline 0 N--CA 1.439 -0.996 0 C-N-CA 115.968 -2.293 . . . . 169.25 106.115 178.088 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.915 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 58.3 Cg_exo -81.32 168.51 16.61 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 122.281 0.621 . . . . 185.75999999999999 110.505 171.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.908 HG13 ' CE2' ' A' ' 282' ' ' PHE . 91.7 t -64.47 -25.92 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 C-N-CA 127.028 2.131 . . . . 145.47 110.347 -177.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.778 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.1 t0 -84.3 157.42 21.53 Favored 'General case' 0 N--CA 1.439 -0.981 0 O-C-N 121.078 -1.014 . . . . 102.76000000000001 109.464 -178.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.6 p -82.58 154.19 25.11 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 107.976 -1.12 . . . . 106.25 107.976 178.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.919 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.7 p-10 -105.89 51.85 0.74 Allowed 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 117.769 -1.573 . . . . 157.81 107.599 178.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.1 tp -60.1 -45.94 91.29 Favored 'General case' 0 CA--C 1.481 -1.696 0 N-CA-C 103.607 -2.738 . . . . 150.19999999999999 103.607 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.9 m -87.07 164.69 35.22 Favored Pre-proline 0 N--CA 1.422 -1.867 0 N-CA-C 103.653 -2.721 . . . . 183.52000000000001 103.653 172.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -76.78 6.86 3.85 Favored 'Trans proline' 0 C--N 1.281 -2.988 0 N-CA-C 109.986 -0.813 . . . . 235.61000000000001 109.986 176.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.421 ' C ' HD21 ' A' ' 14' ' ' ASN . 0.4 OUTLIER -57.88 -41.27 82.15 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 124.813 1.245 . . . . 113.77 113.398 -170.125 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.919 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.4 pt -52.19 136.24 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-N 119.541 1.064 . . . . 150.84999999999999 110.963 -176.137 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.8 t -140.49 156.24 46.4 Favored 'General case' 0 C--N 1.36 1.036 0 N-CA-C 107.634 -1.247 . . . . 100.42 107.634 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . 1.083 HG23 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.0 142.64 58.36 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 121.895 0.855 . . . . 129.36000000000001 110.455 -174.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.772 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 74.5 m-20 -63.12 -25.5 68.39 Favored 'General case' 0 CA--C 1.493 -1.213 0 C-N-CA 126.309 1.843 . . . . 112.34 106.668 -177.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.938 HG23 ' HA2' ' A' ' 101' ' ' GLY . 85.8 m -74.11 -40.2 62.84 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 115.538 -0.756 . . . . 131.72999999999999 111.741 177.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . 1.083 ' H ' HG23 ' A' ' 17' ' ' THR . 71.4 m -84.42 -42.89 15.19 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 116.989 2.218 . . . . 80.489999999999995 116.989 -174.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.551 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.5 mt-10 -145.96 174.54 3.35 Favored Pre-proline 0 N--CA 1.442 -0.847 0 C-N-CA 118.179 -1.408 . . . . 98.980000000000004 111.234 -169.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.822 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.334 85.7 Cg_exo -61.72 -10.86 18.23 Favored 'Trans proline' 0 C--N 1.321 -0.907 1 N-CA-C 128.931 6.473 . . . . 246.94999999999999 128.931 -170.104 . . . . . . . . 4 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.0 m120 61.68 17.54 8.76 Favored 'General case' 0 C--N 1.324 -0.518 1 CA-C-N 126.154 4.07 . . . . 269.62 114.22 175.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.496 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 80.8 mt-30 -67.14 -27.26 67.17 Favored 'General case' 0 CA--C 1.495 -1.154 0 N-CA-C 107.814 -1.18 . . . . 86.799999999999997 107.814 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.551 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.3 p90 -66.87 -29.3 69.17 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 121.116 -0.99 . . . . 85.909999999999997 110.467 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.877 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.4 t -68.59 -40.18 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 C-N-CA 123.734 0.814 . . . . 82.0 111.346 -177.006 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.898 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 27.6 pt20 -151.39 167.74 12.47 Favored Pre-proline 0 CA--C 1.489 -1.391 0 N-CA-C 108.559 -0.904 . . . . 120.73 108.559 -178.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.903 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -63.99 149.75 89.86 Favored 'Trans proline' 0 N--CA 1.433 -2.07 0 C-N-CA 120.644 0.896 . . . . 87.859999999999999 109.847 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.743 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.0 -37.98 89.37 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 108.87 -0.789 . . . . 36.460000000000001 108.87 -176.227 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.814 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.9 p-90 -63.82 -33.83 76.56 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 107.81 -1.181 . . . . 150.59999999999999 107.81 -176.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.903 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.5 mt-30 -62.24 -32.72 73.44 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 108.624 -0.88 . . . . 123.26000000000001 108.624 -178.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.743 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.43 -47.27 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 N-CA-C 109.125 -0.694 . . . . 120.14 109.125 176.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.786 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.3 m -67.4 -31.03 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 N-CA-C 107.866 -1.161 . . . . 112.19 107.866 -178.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.814 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.5 tp -62.96 -47.13 84.53 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 119.973 -0.691 . . . . 60.869999999999997 109.61 -178.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.669 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.08 -35.66 81.11 Favored 'General case' 0 CA--C 1.489 -1.386 0 C-N-CA 119.974 -0.69 . . . . 157.56999999999999 110.325 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.744 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.6 -40.87 98.29 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 108.65 -0.871 . . . . 47.060000000000002 108.65 178.023 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.807 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.76 -41.29 98.01 Favored 'General case' 0 CA--C 1.496 -1.111 0 O-C-N 121.76 -0.587 . . . . 43.939999999999998 109.546 -177.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.727 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.83 -43.38 98.96 Favored 'General case' 0 CA--C 1.49 -1.364 0 N-CA-C 108.657 -0.868 . . . . 42.609999999999999 108.657 -176.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.906 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.29 -41.25 94.3 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 116.631 -0.259 . . . . 140.66 111.079 -178.367 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.807 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.77 -43.98 97.79 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 118.576 -1.249 . . . . 116.04000000000001 110.239 -175.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.673 HG22 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.47 -38.69 83.06 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.302 0 N-CA-C 108.726 -0.842 . . . . 97.159999999999997 108.726 -177.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.854 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.2 mt -61.29 -40.05 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 N-CA-C 108.944 -0.761 . . . . 54.850000000000001 108.944 -176.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.949 HG22 HG21 ' A' ' 86' ' ' THR . 93.0 t -57.69 -42.35 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.32 0 N-CA-C 108.878 -0.786 . . . . 45.390000000000001 108.878 -175.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 48' ' ' VAL . 97.5 t -63.5 -50.98 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 C-N-CA 118.844 -1.142 . . . . 48.640000000000001 110.218 -177.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.75 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.6 t -65.3 -46.95 78.35 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 120.117 -0.633 . . . . 116.65000000000001 111.744 -174.5 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.588 ' N ' HG23 ' A' ' 45' ' ' THR . 50.7 m -62.0 -43.94 97.79 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 109.718 -0.475 . . . . 51.159999999999997 109.718 -174.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.4 t -65.56 -48.93 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 C-N-CA 119.885 -0.726 . . . . 44.299999999999997 110.818 -176.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.868 ' O ' HG23 ' A' ' 52' ' ' VAL . 93.7 t -64.78 -46.93 90.59 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.048 0 C-N-CA 120.34 -0.544 . . . . 48.82 111.005 -174.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.78 -44.14 95.21 Favored Glycine 0 N--CA 1.438 -1.213 0 C-N-CA 120.529 -0.843 . . . . 58.700000000000003 112.02 -174.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -72.67 -34.19 67.06 Favored 'General case' 0 CA--C 1.488 -1.433 0 O-C-N 122.107 -0.643 . . . . 101.40000000000001 110.993 -175.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.74 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.94 -38.69 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 107.761 -1.199 . . . . 103.56999999999999 107.761 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 48' ' ' VAL . 71.8 t -61.43 -43.05 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 108.989 -0.745 . . . . 61.890000000000001 108.989 -178.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.54 ' O ' HG22 ' A' ' 56' ' ' ILE . 81.8 t -63.42 -50.99 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 109.458 -0.571 . . . . 70.010000000000005 109.458 -178.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.8 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.95 -43.41 98.85 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.13 -0.693 . . . . 132.09999999999999 109.13 -176.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.645 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.12 -46.69 83.02 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 116.705 -0.225 . . . . 104.5 110.469 -176.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 1.006 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.63 -49.93 80.24 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 C-N-CA 120.254 -0.578 . . . . 142.96000000000001 111.253 -173.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.957 HD11 HG12 ' A' ' 72' ' ' VAL 0.277 24.7 pt -64.79 -41.66 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.639 0 C-N-CA 116.956 -1.898 . . . . 158.31999999999999 110.868 -175.965 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.8 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.76 -41.3 98.02 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 117.699 -1.6 . . . . 137.11000000000001 109.514 178.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.46 -44.49 90.94 Favored 'General case' 0 N--CA 1.436 -1.156 0 O-C-N 122.117 -0.364 . . . . 54.659999999999997 110.972 -176.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.921 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.9 m-70 -91.42 117.13 29.41 Favored 'General case' 0 CA--C 1.49 -1.348 0 CA-C-O 121.662 0.744 . . . . 127.18000000000001 109.555 -174.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.621 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.83 -36.81 80.06 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 124.089 0.956 . . . . 87.930000000000007 110.877 -176.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 1.028 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.37 -34.7 78.77 Favored 'General case' 0 CA--C 1.49 -1.341 0 O-C-N 121.622 -0.674 . . . . 131.12 111.512 -175.669 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' MET . . . . . 1.01 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.61 69.46 7.12 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 115.307 -2.557 . . . . 246.56 109.647 -175.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.413 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.23 91.44 3.48 Favored 'General case' 0 CA--C 1.474 -1.946 0 N-CA-C 105.465 -2.05 . . . . 339.35000000000002 105.465 177.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.444 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.5 p -124.15 165.27 17.85 Favored 'General case' 0 N--CA 1.414 -2.251 0 N-CA-C 103.01 -2.959 . . . . 114.66 103.01 176.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.881 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.14 -39.49 85.44 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.615 0 N-CA-C 106.748 -1.575 . . . . 143.28 106.748 178.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.833 HG22 HD13 ' A' ' 71' ' ' LEU . 95.8 m -59.66 -38.05 80.4 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 108.676 -0.861 . . . . 160.22 108.676 -176.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.528 ' ND2' ' HB3' ' A' ' 63' ' ' MET . 86.3 m-20 -62.39 -31.73 72.44 Favored 'General case' 0 CA--C 1.489 -1.37 0 N-CA-C 108.858 -0.793 . . . . 120.54000000000001 108.858 -177.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.903 ' O ' HG22 ' A' ' 72' ' ' VAL . 89.7 m-85 -63.64 -43.76 95.85 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.465 -0.569 . . . . 67.219999999999999 109.465 178.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.881 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.6 m-85 -66.53 -39.8 88.78 Favored 'General case' 0 CA--C 1.498 -1.057 0 O-C-N 121.533 -0.729 . . . . 138.59999999999999 109.675 -177.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.925 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.56 -35.9 82.02 Favored 'General case' 0 CA--C 1.492 -1.26 0 C-N-CA 122.487 0.315 . . . . 151.46000000000001 110.663 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.957 HG12 HD11 ' A' ' 57' ' ' ILE . 23.9 m -62.55 -37.92 80.13 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 C-N-CA 117.406 -1.717 . . . . 117.93000000000001 106.753 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.449 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.0 t30 -60.17 -45.95 91.34 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 107.837 -1.171 . . . . 56.82 107.837 -177.068 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.987 HD21 ' HE1' ' A' ' 123' ' ' MET . 8.7 mp -61.38 -43.89 98.09 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 108.941 -0.763 . . . . 145.30000000000001 108.941 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.07 -40.36 95.53 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 108.535 -0.913 . . . . 45.710000000000001 108.535 -175.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -62.44 -41.95 99.11 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 109.399 -0.593 . . . . 105.61 109.399 -178.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.16 -39.48 92.79 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 108.605 -0.887 . . . . 47.890000000000001 108.605 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.588 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.56 -37.31 84.69 Favored 'General case' 0 N--CA 1.438 -1.062 0 O-C-N 122.084 -0.385 . . . . 124.53 109.988 179.692 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.88 -41.25 99.33 Favored 'General case' 0 N--CA 1.437 -1.089 0 O-C-N 121.942 -0.474 . . . . 35.890000000000001 109.819 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.7 t -62.16 -37.35 84.9 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 107.048 -1.464 . . . . 88.969999999999999 107.048 -178.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.82 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.7 ttm -62.16 -49.18 76.88 Favored 'General case' 0 N--CA 1.427 -1.579 0 C-N-CA 119.792 -0.763 . . . . 239.91 109.055 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.618 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.36 -43.37 91.02 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 121.579 -0.7 . . . . 146.09999999999999 110.62 -177.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.418 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.18 -58.22 3.41 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 117.403 -1.719 . . . . 91.739999999999995 113.826 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -76.57 -61.37 1.98 Allowed 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 115.746 1.758 . . . . 197.44999999999999 115.746 -173.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.945 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.25 -42.26 55.6 Favored 'General case' 0 CA--C 1.49 -1.36 0 C-N-CA 117.884 -1.527 . . . . 242.59999999999999 114.056 -170.045 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.949 HG21 HG22 ' A' ' 43' ' ' VAL . 4.7 t -65.45 -36.55 84.23 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 118.926 -1.109 . . . . 215.61000000000001 109.821 -172.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.422 ' N ' ' CG2' ' A' ' 86' ' ' THR . 71.9 t -60.25 -46.96 94.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 O-C-N 121.811 -0.556 . . . . 87.189999999999998 110.505 -175.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.836 HG21 ' CD2' ' A' ' 108' ' ' HIS . 63.7 t -65.94 -41.88 90.74 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.122 0 N-CA-C 109.704 -0.48 . . . . 231.81999999999999 109.704 -178.029 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.906 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 87.8 m-20 -62.33 -34.1 75.98 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 108.335 -0.987 . . . . 364.98000000000002 108.335 -177.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.67 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.4 t80 -68.24 -44.66 75.2 Favored 'General case' 0 N--CA 1.438 -1.064 0 O-C-N 121.507 -0.746 . . . . 181.63 111.257 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.474 HG22 ' ND1' ' A' ' 95' ' ' HIS . 57.4 m -60.89 -45.81 93.14 Favored 'General case' 0 CA--C 1.477 -1.829 0 N-CA-C 107.422 -1.325 . . . . 269.01999999999998 107.422 -175.248 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 1.048 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.66 -45.07 93.16 Favored 'General case' 0 CA--C 1.469 -2.164 0 C-N-CA 118.684 -1.206 . . . . 562.65999999999997 110.052 -179.063 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.705 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.09 -45.3 95.26 Favored 'General case' 0 CA--C 1.479 -1.788 0 C-N-CA 118.744 -1.183 . . . . 446.75 108.067 -167.133 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.744 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.388 6.1 m -70.48 -26.23 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 C-N-CA 115.791 -2.364 . . . . 370.05000000000001 112.283 -178.746 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.497 ' O ' ' HB2' ' A' ' 96' ' ' ASN . 40.6 m80 -74.58 -26.42 59.92 Favored 'General case' 0 CA--C 1.506 -0.747 0 O-C-N 121.626 -0.672 . . . . 354.91000000000003 112.483 175.085 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.822 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.4 m-20 82.75 4.53 1.01 Allowed 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 125.078 1.351 . . . . 462.44 111.926 -178.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.772 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.267 11.9 mm-40 -172.37 178.03 2.91 Favored 'General case' 0 CA--C 1.488 -1.429 0 CA-C-O 122.044 0.926 . . . . 652.37 111.087 171.797 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.789 ' HE3' ' HA ' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.68 86.27 2.15 Favored 'General case' 0 N--CA 1.428 -1.558 0 C-N-CA 128.494 2.718 . . . . 905.99000000000001 107.95 -174.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -67.85 -36.42 80.28 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 108.266 -1.013 . . . . 570.42999999999995 108.266 -176.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.847 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.56 -36.35 82.36 Favored 'General case' 0 N--CA 1.428 -1.569 0 C-N-CA 125.343 1.457 . . . . 453.22000000000003 111.166 -174.176 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.938 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.56 178.66 33.88 Favored Glycine 0 C--N 1.349 1.288 0 C-N-CA 118.753 -1.689 . . . . 445.63 109.882 177.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.0 mt -56.41 -41.25 76.04 Favored 'General case' 0 CA--C 1.498 -1.022 0 C-N-CA 125.276 1.43 . . . . 457.72000000000003 112.351 -170.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -58.64 -46.87 86.2 Favored 'General case' 0 CA--C 1.484 -1.562 0 C-N-CA 118.63 -1.228 . . . . 340.57999999999998 109.326 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.847 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.0 m-85 -68.76 -32.16 71.71 Favored 'General case' 0 N--CA 1.423 -1.786 0 C-N-CA 118.741 -1.184 . . . . 453.60000000000002 111.559 -176.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.762 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.02 -40.29 73.19 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 105.971 -1.863 . . . . 541.48000000000002 105.971 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.89 -47.1 75.95 Favored 'General case' 0 CA--C 1.485 -1.536 0 O-C-N 124.017 0.823 . . . . 466.68000000000001 110.852 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -61.78 -47.11 86.63 Favored 'General case' 0 N--CA 1.427 -1.6 0 C-N-CA 117.506 -1.678 . . . . 427.33999999999997 107.256 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.836 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.6 m80 -67.08 -36.78 82.75 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 112.425 0.528 . . . . 537.87 112.425 -174.182 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.574 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.4 -42.67 74.8 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 116.861 -1.936 . . . . 422.12 111.607 175.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.855 ' O ' HG22 ' A' ' 113' ' ' ILE . 75.9 t80 -59.12 -50.05 75.54 Favored 'General case' 0 CA--C 1.502 -0.882 0 O-C-N 121.335 -0.853 . . . . 340.17000000000002 111.827 -173.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -65.26 -46.57 71.71 Favored Pre-proline 0 N--CA 1.443 -0.801 0 C-N-CA 119.095 -1.042 . . . . 258.06 111.715 -176.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.945 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.2 Cg_exo -61.49 -31.58 87.84 Favored 'Trans proline' 0 N--CA 1.435 -1.927 0 N-CA-C 115.363 1.255 . . . . 305.70999999999998 115.363 176.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.877 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.84 -40.46 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 108.689 -0.856 . . . . 252.69999999999999 108.689 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.421 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.9 -40.6 93.7 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 107.807 -1.183 . . . . 149.27000000000001 107.807 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.0 -44.83 95.89 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 120.639 -0.424 . . . . 138.08000000000001 111.468 -176.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.651 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 65.1 t -66.98 -42.33 88.57 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.937 0 O-C-N 121.581 -0.699 . . . . 132.88999999999999 110.96 -177.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.92 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.77 -44.64 92.81 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 108.898 -0.779 . . . . 193.61000000000001 108.898 -177.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.554 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.5 -37.68 84.57 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 122.811 0.444 . . . . 63.829999999999998 110.069 -175.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 72.0 m -64.03 -52.37 59.79 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 120.721 -0.392 . . . . 76.400000000000006 111.242 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.757 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.96 -41.65 93.59 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 N-CA-C 108.17 -1.048 . . . . 171.13 108.17 -175.005 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 1.105 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.1 m-85 -63.84 -38.57 91.58 Favored 'General case' 0 N--CA 1.432 -1.331 0 O-C-N 121.838 -0.539 . . . . 78.299999999999997 110.614 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.554 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.5 t -67.1 -35.69 80.32 Favored 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 118.893 -1.123 . . . . 92.359999999999999 109.247 -178.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.987 ' HE1' HD21 ' A' ' 74' ' ' LEU . 5.9 mmt -62.55 -34.24 76.54 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 108.154 -1.054 . . . . 93.730000000000004 108.154 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.896 HG22 HG13 ' A' ' 212' ' ' ILE . 33.3 p -67.44 -41.65 84.4 Favored 'General case' 0 CA--C 1.495 -1.159 0 C-N-CA 119.224 -0.99 . . . . 132.74000000000001 109.318 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.28 -42.09 94.7 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 107.158 -1.423 . . . . 43.390000000000001 107.158 -177.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.827 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.4 t -58.47 -41.98 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.369 0 N-CA-C 108.568 -0.901 . . . . 59.340000000000003 108.568 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.53 -44.02 95.42 Favored 'General case' 0 CA--C 1.497 -1.067 0 O-C-N 121.808 -0.558 . . . . 69.680000000000007 110.529 -177.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.468 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.3 t80 -65.41 -42.82 92.13 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.348 -0.982 . . . . 106.98 108.348 -177.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.827 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.37 -35.51 81.14 Favored 'General case' 0 N--CA 1.433 -1.306 0 C-N-CA 119.598 -0.841 . . . . 147.63 108.972 -177.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.702 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.19 -41.54 99.19 Favored 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 108.524 -0.917 . . . . 190.06 108.524 178.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.6 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.4 t80 -61.35 -44.08 97.78 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 108.29 -1.004 . . . . 118.84999999999999 108.29 -177.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.803 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.5 mmt -63.34 -42.64 98.96 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 109.994 -0.373 . . . . 102.5 109.994 -177.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.98 -41.69 95.21 Favored 'General case' 0 CA--C 1.488 -1.418 0 O-C-N 121.799 -0.563 . . . . 89.980000000000004 109.82 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.92 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.2 mt -66.54 -50.66 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.711 0 C-N-CA 118.119 -1.432 . . . . 106.09 111.024 -177.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.75 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.1 -48.29 38.41 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.09 0 C-N-CA 117.078 -1.849 . . . . 227.74000000000001 111.832 -174.84 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.756 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.84 100.07 50.99 Favored Pre-proline 0 CA--C 1.486 -1.496 0 C-N-CA 116.268 -2.173 . . . . 262.55000000000001 110.069 -175.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.3 Cg_endo -69.61 -10.36 28.49 Favored 'Trans proline' 0 C--N 1.289 -2.558 0 C-N-CA 121.564 1.509 . . . . 210.25 111.386 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.707 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.3 111.99 1.0 Allowed 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 106.54 -1.652 . . . . 270.57999999999998 106.54 -178.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.885 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.77 -39.51 24.23 Favored Pre-proline 0 N--CA 1.43 -1.453 0 CA-C-N 115.358 -0.837 . . . . 129.84 112.325 -175.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.857 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 81.5 Cg_exo -61.44 -26.51 81.28 Favored 'Trans proline' 0 N--CA 1.431 -2.166 0 N-CA-C 116.311 1.62 . . . . 330.70999999999998 116.311 -174.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.756 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.09 77.28 8.0 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 114.445 -2.902 . . . . 204.50999999999999 107.257 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.878 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.7 147.38 0.09 Allowed 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 107.488 -1.301 . . . . 387.41000000000003 107.488 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.878 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.3 t -143.68 147.0 33.64 Favored 'General case' 0 CA--C 1.496 -1.116 0 C-N-CA 118.841 -1.144 . . . . 166.22 109.484 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.85 -40.72 88.0 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 107.872 -1.159 . . . . 44.229999999999997 107.872 176.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.48 ' O ' HG23 ' A' ' 149' ' ' VAL . 88.0 m -60.32 -39.12 85.88 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 108.15 -1.055 . . . . 28.800000000000001 108.15 -175.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.667 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.88 -38.78 92.21 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 109.055 -0.721 . . . . 30.289999999999999 109.055 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.847 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 90.1 m -59.59 -43.01 93.83 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 109.035 -0.728 . . . . 46.109999999999999 109.035 -176.214 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.46 -42.2 99.3 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 107.665 -1.235 . . . . 87.329999999999998 107.665 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.765 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.7 t -61.58 -42.13 92.89 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.366 0 N-CA-C 107.973 -1.121 . . . . 23.690000000000001 107.973 -178.072 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.6 t -63.2 -44.28 99.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 N-CA-C 109.678 -0.489 . . . . 43.859999999999999 109.678 -178.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.919 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.0 mm -61.29 -42.49 93.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 N-CA-C 108.327 -0.99 . . . . 91.129999999999995 108.327 -176.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' CYS . . . . . 0.482 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.2 t -62.57 -38.0 88.4 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 108.786 -0.82 . . . . 65.879999999999995 108.786 -178.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.765 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.7 t -62.08 -41.86 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 N-CA-C 109.559 -0.534 . . . . 33.859999999999999 109.559 -177.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 1.105 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.35 -40.32 85.76 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.217 0 N-CA-C 107.642 -1.244 . . . . 146.52000000000001 107.642 -176.815 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 155' ' ' TRP . . . . . 0.696 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.3 m95 -62.86 -38.36 90.54 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 119.477 -0.889 . . . . 75.439999999999998 108.942 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.8 t -60.53 -48.44 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 O-C-N 120.976 -1.078 . . . . 43.640000000000001 109.71 -177.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.792 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.7 -37.98 89.39 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 109.034 -0.728 . . . . 102.56999999999999 109.034 -178.073 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.93 -41.13 86.6 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 107.437 -1.32 . . . . 58.159999999999997 107.437 -178.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.801 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.06 -32.51 73.9 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 109.015 -0.735 . . . . 121.11 109.015 178.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.792 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.01 -42.34 85.02 Favored 'General case' 0 CA--C 1.488 -1.416 0 C-N-CA 118.586 -1.246 . . . . 153.15000000000001 109.951 -178.421 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 1.061 HD13 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.05 -43.75 19.05 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 113.079 -3.448 . . . . 133.66999999999999 113.522 173.345 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.478 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -62.95 -39.92 96.1 Favored 'General case' 0 CA--C 1.49 -1.335 0 O-C-N 120.938 -1.101 . . . . 157.41999999999999 112.184 -171.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.524 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.2 t80 -74.4 -36.1 2.47 Favored Pre-proline 0 N--CA 1.437 -1.105 0 N-CA-C 115.058 1.503 . . . . 250.91 115.058 -173.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.291 52.6 Cg_exo -59.58 -25.4 78.75 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 N-CA-C 117.976 2.26 . . . . 207.34 117.976 -174.309 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.919 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 32.4 mt-30 -61.22 -34.18 74.69 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 106.954 -1.498 . . . . 192.46000000000001 106.954 178.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.52 -41.09 98.07 Favored Glycine 0 C--N 1.353 1.523 0 N-CA-C 107.963 -2.055 . . . . 261.0 107.963 177.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -65.71 159.13 25.71 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 101.537 -3.505 . . . . 491.39999999999998 101.537 172.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -59.98 106.82 0.54 Allowed 'General case' 0 CA--C 1.489 -1.403 0 C-N-CA 116.256 -2.178 . . . . 386.10000000000002 109.809 -176.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.919 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 73.8 m -154.07 -166.62 2.42 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 103.533 -2.765 . . . . 289.80000000000001 103.533 -178.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' THR . . . . . 1.144 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.3 p -62.93 175.42 0.86 Allowed 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 117.766 -1.112 . . . . 402.06 109.538 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.789 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 72.9 p -165.24 177.5 7.58 Favored 'General case' 0 CA--C 1.586 2.355 0 C-N-CA 127.336 2.254 . . . . 690.52999999999997 114.935 177.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.485 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.9 mm-40 132.33 160.53 0.0 OUTLIER 'General case' 1 C--N 1.429 4.048 1 N-CA-C 123.195 4.517 . . . . 633.62 123.195 162.689 . . . . . . . . 4 3 . 1 . 005 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.76 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.3 p -85.62 153.81 22.13 Favored 'General case' 0 C--N 1.389 2.284 0 C-N-CA 127.414 2.286 . . . . 617.99000000000001 110.887 177.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' MET . . . . . 1.049 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.7 174.44 5.94 Favored Pre-proline 0 C--N 1.364 1.213 0 C-N-CA 130.213 3.405 . . . . 434.98000000000002 113.382 -175.385 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 1.092 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 51.5 Cg_endo -44.25 -65.59 0.19 Allowed 'Trans proline' 0 N--CA 1.442 -1.503 0 N-CA-C 122.42 3.969 . . . . 365.88 122.42 -168.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' SER . . . . . 0.777 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.305 70.8 m -84.93 20.91 1.72 Allowed 'General case' 0 CA--C 1.467 -2.224 0 N-CA-C 104.79 -2.3 . . . . 635.80999999999995 104.79 178.148 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.747 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.458 5.0 mmp_? -94.28 152.22 18.84 Favored 'General case' 1 CA--C 1.419 -4.059 3 N-CA-C 131.984 7.772 . . . . 999.99000000000001 131.984 -135.756 . . . . . . . . 5 3 . 1 . 005 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 1.048 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.911 37.2 t -131.88 73.16 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.765 1 CA-C-N 103.298 -6.319 . . . . 594.32000000000005 113.603 149.185 . . . . . . . . 4 3 . 1 . 005 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.731 HG13 ' HB2' ' A' ' 174' ' ' MET . 7.3 p -144.17 144.12 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.653 1 N-CA-C 98.31 -4.7 . . . . 811.90999999999997 98.31 162.331 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 180' ' ' CYS . . . . . 0.76 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.8 m -118.44 144.53 45.9 Favored 'General case' 0 CA--C 1.488 -1.41 0 C-N-CA 117.056 -1.858 . . . . 999.99000000000001 109.414 -178.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.945 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.7 mmm -147.18 -175.6 4.89 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-O 121.979 0.895 . . . . 431.86000000000001 110.09 -177.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 1.037 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.3 tt -69.2 148.68 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 C-N-CA 124.357 1.063 . . . . 457.18000000000001 108.796 -177.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' GLU . . . . . 0.789 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.34 85.5 3.76 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 124.164 0.985 . . . . 458.76999999999998 113.472 -174.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.962 ' CZ3' HG22 ' A' ' 182' ' ' ILE . 1.9 p90 -76.42 -31.46 0.96 Allowed Pre-proline 0 N--CA 1.438 -1.062 0 C-N-CA 124.937 1.295 . . . . 999.99000000000001 112.447 168.24 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.957 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 50.9 Cg_exo -66.03 -45.79 5.48 Favored 'Trans proline' 0 N--CA 1.438 -1.772 0 N-CA-C 120.812 3.351 . . . . 999.99000000000001 120.812 -174.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.506 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 54.9 mt-10 -119.58 171.75 8.14 Favored 'General case' 0 CA--C 1.472 -2.051 0 C-N-CA 117.174 -1.81 . . . . 81.180000000000007 107.273 -172.12 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.834 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 6.4 p80 -109.11 45.1 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.857 0 C-N-CA 115.505 -2.478 . . . . 999.99000000000001 108.759 177.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 1.076 ' HB2' HD12 ' A' ' 191' ' ' ILE . 86.4 Cg_endo -41.51 101.81 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.164 1 C-N-CA 126.037 4.491 . . . . 999.99000000000001 105.709 -170.75 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -62.32 -44.0 97.51 Favored 'General case' 0 CA--C 1.482 -1.642 0 C-N-CA 126.775 2.03 . . . . 967.72000000000003 112.043 -165.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -60.29 -36.55 78.1 Favored 'General case' 0 CA--C 1.487 -1.48 0 N-CA-C 106.745 -1.576 . . . . 934.29999999999995 106.745 -175.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 1.076 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.54 -30.25 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 C-N-CA 129.154 2.981 . . . . 565.14999999999998 113.954 -178.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 61.58 55.4 2.78 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-N 118.403 0.547 . . . . 755.61000000000001 109.828 -175.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 1.144 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.49 -49.26 67.18 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 124.551 1.14 . . . . 325.88999999999999 113.286 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.632 ' HE3' ' OH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.82 -44.98 78.42 Favored 'General case' 0 CA--C 1.495 -1.157 0 C-N-CA 123.576 0.75 . . . . 250.21000000000001 111.629 -169.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.4 t -64.7 -43.36 96.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 CA-C-O 121.581 0.705 . . . . 142.46000000000001 110.374 -175.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 1.037 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.7 t80 -61.15 -41.48 96.82 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 123.935 0.894 . . . . 247.69 108.813 -173.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' HIS . . . . . 0.822 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 23.1 t60 -60.53 -51.4 69.6 Favored 'General case' 0 CA--C 1.492 -1.28 0 C-N-CA 125.465 1.506 . . . . 199.61000000000001 113.058 -175.116 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 82.8 mt -65.29 -44.47 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 107.748 -1.205 . . . . 106.73 107.748 -177.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' CYS . . . . . 0.719 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.8 t -59.2 -48.51 81.34 Favored 'General case' 0 CA--C 1.487 -1.459 0 CA-C-N 115.867 -0.606 . . . . 115.01000000000001 110.201 -173.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 1.061 HG13 HD13 ' A' ' 161' ' ' LEU . 86.2 t -65.24 -49.17 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.626 0 C-N-CA 119.398 -0.921 . . . . 129.41999999999999 111.847 -174.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' THR . . . . . 0.79 HG22 ' CD1' ' A' ' 206' ' ' PHE . 69.1 m -61.85 -53.13 60.07 Favored 'General case' 0 CA--C 1.482 -1.639 0 C-N-CA 118.186 -1.406 . . . . 172.47999999999999 109.977 -172.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.631 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 85.6 t -63.85 -54.25 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 C-N-CA 120.546 -0.462 . . . . 55.859999999999999 110.979 -174.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.719 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.58 -51.54 59.01 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 118.57 -1.252 . . . . 184.68000000000001 111.502 -174.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 1.056 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.65 -52.38 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 C-N-CA 116.607 -2.037 . . . . 291.81 114.731 -174.696 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.552 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.8 t80 -82.04 -55.03 4.83 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 115.143 1.534 . . . . 130.66 115.143 -178.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' PHE . . . . . 0.79 ' CD1' HG22 ' A' ' 201' ' ' THR . 40.0 m-85 -66.86 -48.51 68.58 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 114.492 1.293 . . . . 80.159999999999997 114.492 -170.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.905 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.52 -45.52 83.37 Favored Pre-proline 0 N--CA 1.435 -1.185 0 C-N-CA 119.989 -0.685 . . . . 136.02000000000001 109.504 -174.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.905 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 88.2 Cg_exo -64.76 -27.16 60.01 Favored 'Trans proline' 0 N--CA 1.433 -2.063 0 N-CA-C 110.616 -0.571 . . . . 92.170000000000002 110.616 -179.045 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.685 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.39 -41.33 76.62 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 107.492 -1.299 . . . . 135.59999999999999 107.492 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.2 -44.66 91.28 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 109.577 -0.527 . . . . 52.100000000000001 109.577 -176.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.617 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.71 -43.46 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 N-CA-C 109.088 -0.708 . . . . 95.890000000000001 109.088 -176.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.896 HG13 HG22 ' A' ' 124' ' ' THR . 94.7 mt -61.33 -42.31 93.15 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.386 0 N-CA-C 106.663 -1.606 . . . . 43.409999999999997 106.663 -178.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.46 -42.3 99.05 Favored Glycine 0 N--CA 1.432 -1.63 0 N-CA-C 109.343 -1.503 . . . . 27.690000000000001 109.343 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' TYR . . . . . 0.882 ' O ' HG22 ' A' ' 217' ' ' THR . 77.8 t80 -65.72 -47.29 75.83 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 117.409 0.604 . . . . 54.409999999999997 110.467 -177.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ALA . . . . . 0.825 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.47 -34.11 74.89 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 106.916 -1.513 . . . . 53.880000000000003 106.916 -177.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -60.78 -40.81 93.96 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 108.492 -0.929 . . . . 68.290000000000006 108.492 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' THR . . . . . 0.882 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.81 -38.98 92.79 Favored 'General case' 0 CA--C 1.497 -1.086 0 C-N-CA 119.704 -0.799 . . . . 107.59 110.619 -175.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.825 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.06 -38.37 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 119.584 -0.846 . . . . 111.61 109.49 -177.105 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.92 HG13 ' CD1' ' A' ' 134' ' ' ILE . 79.5 t -63.3 -22.45 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 N-CA-C 108.428 -0.952 . . . . 85.260000000000005 108.428 -178.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.89 -41.95 99.45 Favored Glycine 0 C--N 1.35 1.324 0 N-CA-C 111.014 -0.834 . . . . 40.710000000000001 111.014 -176.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.73 -43.99 96.52 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 N-CA-C 108.414 -0.958 . . . . 95.859999999999999 108.414 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.819 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.4 p -76.98 -137.47 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.452 -0.944 . . . . 144.37 108.452 -176.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.898 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.6 mt -55.39 132.16 47.51 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 107.574 -1.269 . . . . 326.72000000000003 107.574 -177.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' TRP . . . . . 0.466 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 9.0 t90 -119.37 -168.05 1.51 Allowed 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 106.006 -1.85 . . . . 158.38 106.006 -176.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' ALA . . . . . 0.466 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.34 -41.96 98.9 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 109.632 -0.507 . . . . 36.780000000000001 109.632 -178.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.8 m -61.09 125.86 25.25 Favored 'General case' 0 N--CA 1.433 -1.32 0 C-N-CA 119.167 -1.013 . . . . 85.459999999999994 109.81 -174.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' GLU . . . . . 0.693 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.88 126.52 8.82 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 105.54 -2.022 . . . . 127.78 105.54 176.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.928 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.01 139.93 34.85 Favored Pre-proline 0 CA--C 1.493 -1.241 0 N-CA-C 105.977 -1.86 . . . . 164.84 105.977 -179.614 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.928 ' N ' HD13 ' A' ' 228' ' ' ILE . 83.1 Cg_exo -56.86 -39.9 88.08 Favored 'Trans proline' 0 N--CA 1.431 -2.183 0 N-CA-C 113.916 0.698 . . . . 222.34999999999999 113.916 -175.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 230' ' ' GLY . . . . . 0.747 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.16 167.02 44.92 Favored Glycine 0 N--CA 1.427 -1.915 0 N-CA-C 106.423 -2.671 . . . . 45.219999999999999 106.423 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.882 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.9 t0 -60.93 -45.76 93.4 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 106.045 -1.835 . . . . 107.56999999999999 106.045 177.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 232' ' ' SER . . . . . 0.731 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.9 m -65.77 141.83 58.18 Favored 'General case' 0 N--CA 1.429 -1.509 0 C-N-CA 118.894 -1.122 . . . . 167.96000000000001 109.145 -175.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.83 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.3 m 99.52 106.74 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 126.746 2.019 . . . . 280.68000000000001 109.707 176.087 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.709 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.7 m-20 56.03 11.21 0.7 Allowed 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 124.452 1.101 . . . . 218.25 110.675 174.04 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.922 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.35 137.62 54.79 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 105.213 -2.143 . . . . 343.56999999999999 105.213 177.407 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.481 ' O ' HG21 ' A' ' 240' ' ' VAL . 85.5 t80 -111.93 81.87 1.53 Allowed 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 106.873 -1.529 . . . . 263.29000000000002 106.873 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 237' ' ' HIS . . . . . 0.627 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 64.6 m80 104.27 147.07 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.268 0 C-N-CA 126.58 1.952 . . . . 261.92000000000002 108.522 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.18 -38.13 89.96 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 107.853 -1.166 . . . . 106.81 107.853 -177.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.738 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.48 -39.9 94.93 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 118.366 -1.334 . . . . 112.2 107.536 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.738 HG12 ' NH1' ' A' ' 244' ' ' ARG . 75.8 t -64.27 -39.78 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 N-CA-C 109.263 -0.643 . . . . 45.409999999999997 109.263 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 241' ' ' SER . . . . . 0.802 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.2 p -70.93 -32.13 68.95 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 110.233 -0.284 . . . . 97.620000000000005 110.233 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.34 -39.66 81.83 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 123.73 0.812 . . . . 59.289999999999999 110.972 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.738 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.2 -36.56 84.04 Favored 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 124.601 1.16 . . . . 106.48999999999999 110.67 -174.15 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.922 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.97 -30.63 69.23 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 108.294 -1.002 . . . . 106.62 108.294 -176.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.533 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.5 mttm -65.97 -41.04 91.69 Favored 'General case' 0 N--CA 1.435 -1.201 0 O-C-N 121.771 -0.581 . . . . 75.969999999999999 110.094 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.438 ' CG1' ' CE ' ' A' ' 250' ' ' MET . 76.0 t -65.6 -40.81 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 C-N-CA 122.908 0.483 . . . . 65.269999999999996 109.763 -178.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.775 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -64.01 -41.55 92.84 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.343 0 C-N-CA 120.39 -0.524 . . . . 107.94 110.185 -177.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.536 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.2 pttt -63.54 -40.85 98.07 Favored 'General case' 0 N--CA 1.433 -1.279 0 O-C-N 121.68 -0.638 . . . . 87.980000000000004 110.281 -176.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 249' ' ' MET . . . . . 0.822 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.58 -40.44 96.98 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 118.863 -1.135 . . . . 65.5 108.405 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 250' ' ' MET . . . . . 0.758 ' CE ' HG21 ' A' ' 67' ' ' THR . 68.5 mtt -61.7 -36.38 80.74 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 108.141 -1.059 . . . . 85.049999999999997 108.141 -177.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.536 HD12 ' HA ' ' A' ' 248' ' ' LYS . 86.9 mt -63.47 -45.76 97.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 109.061 -0.718 . . . . 42.25 109.061 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 252' ' ' VAL . . . . . 0.822 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.32 -38.24 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 C-N-CA 119.568 -0.853 . . . . 91.010000000000005 109.396 -176.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 1.0 HG22 ' CD1' ' A' ' 304' ' ' ILE . 65.9 t -58.89 -41.53 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 N-CA-C 108.009 -1.108 . . . . 66.090000000000003 108.009 -178.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 250' ' ' MET . 94.8 t -66.07 -43.22 92.45 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.298 0 O-C-N 122.093 -0.379 . . . . 52.390000000000001 110.285 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 83.9 m -61.76 -46.71 88.44 Favored 'General case' 0 CA--C 1.489 -1.389 0 O-C-N 121.892 -0.505 . . . . 46.420000000000002 109.873 -174.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 256' ' ' THR . . . . . 0.744 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.5 t -62.34 -38.2 88.6 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 108.314 -0.995 . . . . 116.51000000000001 108.314 -177.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 257' ' ' PHE . . . . . 0.491 ' N ' HG23 ' A' ' 256' ' ' THR . 86.0 t80 -60.21 -48.24 82.59 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 109.38 -0.6 . . . . 65.180000000000007 109.38 -178.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.99 -42.63 97.13 Favored 'General case' 0 CA--C 1.489 -1.373 0 O-C-N 122.093 -0.379 . . . . 51.329999999999998 110.448 -175.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 259' ' ' ILE . . . . . 0.744 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.65 -43.37 98.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 C-N-CA 118.883 -1.127 . . . . 126.3 109.015 -176.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 260' ' ' CYS . . . . . 0.506 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.7 m -65.54 -49.34 69.28 Favored 'General case' 0 N--CA 1.432 -1.325 0 C-N-CA 119.512 -0.875 . . . . 133.94 112.508 -176.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.817 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.1 m95 -80.63 -33.38 35.79 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 116.869 2.174 . . . . 134.84 116.869 -176.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.782 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.9 tp -58.49 -41.58 89.94 Favored Pre-proline 0 CA--C 1.493 -1.242 0 O-C-N 121.663 -0.648 . . . . 72.230000000000004 111.643 -167.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 263' ' ' PRO . . . . . 0.782 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 80.9 Cg_exo -60.63 -36.02 87.14 Favored 'Trans proline' 0 N--CA 1.429 -2.287 0 CA-C-N 119.884 0.994 . . . . 106.13 111.349 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 264' ' ' PHE . . . . . 0.847 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.8 t80 -66.45 -44.6 82.36 Favored 'General case' 0 N--CA 1.434 -1.273 0 C-N-CA 119.7 -0.8 . . . . 128.34999999999999 110.019 -178.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 265' ' ' HIS . . . . . 0.643 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.48 -37.87 89.05 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 110.195 -0.298 . . . . 100.73 110.195 -177.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.743 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.23 -44.52 95.14 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 C-N-CA 119.294 -0.962 . . . . 172.72 109.191 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 267' ' ' PHE . . . . . 0.732 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.5 m-85 -66.63 -28.07 68.19 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 108.199 -1.037 . . . . 249.22999999999999 108.199 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 268' ' ' PHE . . . . . 0.904 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.58 -55.1 35.99 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 106.673 -1.603 . . . . 259.77999999999997 106.673 178.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 269' ' ' LEU . . . . . 0.492 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.4 mt -69.16 -44.22 72.7 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 113.58 0.955 . . . . 233.11000000000001 113.58 -176.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 270' ' ' LEU . . . . . 0.835 ' O ' HG13 ' A' ' 273' ' ' ILE . 88.6 mt -61.36 -48.27 91.57 Favored Pre-proline 0 N--CA 1.44 -0.967 0 C-N-CA 119.193 -1.003 . . . . 169.53999999999999 110.615 -171.061 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 271' ' ' PRO . . . . . 0.732 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.6 Cg_exo -61.21 -24.5 79.13 Favored 'Trans proline' 0 N--CA 1.43 -2.25 0 C-N-CA 116.689 -1.741 . . . . 255.47 114.639 174.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 272' ' ' TYR . . . . . 0.822 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.6 t80 -63.61 -44.2 94.66 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 119.271 0.941 . . . . 279.02999999999997 108.905 177.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.835 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.27 -44.8 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 N-CA-C 110.102 -0.333 . . . . 162.21000000000001 110.102 -178.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 274' ' ' ASN . . . . . 0.865 HD22 HD12 ' A' ' 277' ' ' LEU . 49.0 t30 -125.45 84.86 59.42 Favored Pre-proline 0 N--CA 1.431 -1.387 0 C-N-CA 118.76 -1.176 . . . . 128.13 108.029 -178.039 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 275' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.5 Cg_endo -85.22 163.99 11.3 Favored 'Trans proline' 0 C--N 1.295 -2.284 0 N-CA-C 107.482 -1.776 . . . . 278.35000000000002 107.482 177.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 276' ' ' ASP . . . . . 0.864 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.14 15.02 9.93 Favored 'General case' 0 N--CA 1.429 -1.524 0 O-C-N 123.794 0.684 . . . . 312.91000000000003 109.328 175.213 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.865 HD12 HD22 ' A' ' 274' ' ' ASN . 28.5 mt -132.73 -170.72 2.5 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 106.557 -1.646 . . . . 353.54000000000002 106.557 177.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 1.006 ' HA ' ' CB ' ' A' ' 282' ' ' PHE . 42.7 p90 -115.61 142.22 47.03 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 107.441 -1.318 . . . . 251.25999999999999 107.441 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.762 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -76.94 -118.76 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 102.097 -3.297 . . . . 175.25999999999999 102.097 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 280' ' ' LYS . . . . . 0.792 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.1 ttmt -61.45 -45.02 96.01 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 100.889 -3.745 . . . . 99.069999999999993 100.889 172.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 281' ' ' LYS . . . . . 0.792 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.36 124.15 9.21 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 103.488 -2.782 . . . . 243.21000000000001 103.488 171.171 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 1.006 ' CB ' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.95 112.98 25.13 Favored 'General case' 0 CA--C 1.474 -1.979 0 C-N-CA 116.037 -2.265 . . . . 201.03999999999999 105.294 178.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 283' ' ' ILE . . . . . 0.778 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.93 173.69 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.064 0 C-N-CA 116.036 -2.266 . . . . 201.36000000000001 108.754 -175.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 284' ' ' GLN . . . . . 1.092 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.282 0.6 OUTLIER -59.5 -41.43 89.87 Favored 'General case' 0 N--CA 1.416 -2.164 0 CA-C-N 113.184 -1.825 . . . . 203.81999999999999 107.829 174.47 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 285' ' ' GLN . . . . . 0.924 ' HG2' HE21 ' A' ' 284' ' ' GLN . 1.2 mm100 -64.31 -45.75 86.59 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 118.249 -1.38 . . . . 215.06 112.55 -171.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.556 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.7 t -65.66 -46.44 89.31 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.467 0 C-N-CA 118.606 -1.237 . . . . 125.28 112.886 -171.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 287' ' ' TYR . . . . . 0.949 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.83 -36.95 86.0 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 107.169 -1.419 . . . . 268.89999999999998 107.169 -171.836 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.795 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.24 -45.02 74.36 Favored 'General case' 0 N--CA 1.427 -1.602 0 C-N-CA 125.644 1.577 . . . . 280.88 108.808 -172.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.61 -47.53 85.8 Favored 'General case' 0 N--CA 1.428 -1.567 0 C-N-CA 119.01 -1.076 . . . . 184.47 108.988 -172.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 290' ' ' ILE . . . . . 0.847 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.8 mp -67.91 -42.1 85.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 C-N-CA 119.298 -0.961 . . . . 167.91999999999999 112.732 -175.384 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 291' ' ' MET . . . . . 0.502 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.8 ttt -65.79 -38.75 89.84 Favored 'General case' 0 CA--C 1.495 -1.146 0 C-N-CA 117.779 -1.569 . . . . 367.18000000000001 110.785 -175.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 292' ' ' TRP . . . . . 0.55 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.4 m95 -67.19 -32.71 73.97 Favored 'General case' 0 N--CA 1.435 -1.205 0 O-C-N 121.892 -0.505 . . . . 173.97 110.46 177.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.3 tp -64.48 -36.69 85.01 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 123.523 0.729 . . . . 119.66 109.815 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 294' ' ' ALA . . . . . 0.817 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.29 -33.91 74.34 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.752 -1.203 . . . . 112.3 107.752 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 295' ' ' MET . . . . . 0.773 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.11 -32.09 73.39 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 116.193 -0.458 . . . . 174.16999999999999 110.185 -177.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.5 m -64.74 -22.7 67.04 Favored 'General case' 0 CA--C 1.485 -1.525 0 C-N-CA 124.669 1.188 . . . . 145.27000000000001 110.638 -175.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 297' ' ' SER . . . . . 0.756 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.6 m -57.66 -35.36 70.45 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 108.056 -1.091 . . . . 170.15000000000001 108.056 -175.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.82 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.7 t -55.34 -34.14 63.96 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 116.32 -0.4 . . . . 214.56999999999999 110.654 -171.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 299' ' ' MET . . . . . 0.75 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.1 ttt -77.18 -33.2 56.45 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 126.065 1.746 . . . . 168.28999999999999 115.545 177.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 300' ' ' TYR . . . . . 0.756 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.4 p90 -64.45 -34.86 79.19 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 114.02 1.119 . . . . 167.15000000000001 114.02 -168.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 301' ' ' ASN . . . . . 0.726 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.281 18.8 p-10 -64.22 -38.25 32.78 Favored Pre-proline 0 N--CA 1.433 -1.295 0 C-N-CA 115.536 -2.466 . . . . 165.13 113.961 -171.595 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 302' ' ' PRO . . . . . 0.726 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 83.8 Cg_exo -62.56 -31.8 79.83 Favored 'Trans proline' 0 N--CA 1.433 -2.061 0 CA-C-N 122.791 2.033 . . . . 123.92 111.254 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 303' ' ' ILE . . . . . 0.712 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.76 -42.58 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 C-N-CA 118.859 -1.136 . . . . 110.55 109.739 -179.045 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 304' ' ' ILE . . . . . 1.0 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.1 pt -61.16 -40.02 84.43 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.179 0 N-CA-C 108.825 -0.806 . . . . 145.31 108.825 -177.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 305' ' ' TYR . . . . . 0.925 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.253 63.1 m-85 -58.12 -48.84 78.98 Favored 'General case' 0 CA--C 1.495 -1.171 0 C-N-CA 119.416 -0.914 . . . . 246.68000000000001 109.824 -177.48 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.7 m -62.14 -47.53 84.17 Favored 'General case' 0 CA--C 1.484 -1.564 0 C-N-CA 119.526 -0.87 . . . . 64.430000000000007 109.587 -173.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.6 t -66.83 -45.01 79.62 Favored 'General case' 0 N--CA 1.428 -1.553 0 C-N-CA 118.992 -1.083 . . . . 80.719999999999999 110.226 -177.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.707 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.56 -35.66 75.61 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 115.937 1.828 . . . . 140.44 115.937 -173.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 309' ' ' ASN . . . . . 0.659 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.8 p30 -136.83 132.2 34.3 Favored 'General case' 0 N--CA 1.434 -1.245 0 C-N-CA 112.723 -3.591 . . . . 178.87 113.039 -177.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 310' ' ' ASP . . . . . 0.609 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.06 -37.0 86.13 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 114.409 -1.269 . . . . 110.22 110.151 -177.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 311' ' ' ARG . . . . . 0.86 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.77 -50.58 72.77 Favored 'General case' 0 CA--C 1.492 -1.27 0 O-C-N 121.753 -0.592 . . . . 174.78 109.737 -174.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.958 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.1 m-85 -64.92 -41.65 95.38 Favored 'General case' 0 CA--C 1.484 -1.575 0 N-CA-C 108.24 -1.022 . . . . 161.84 108.24 178.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 313' ' ' ARG . . . . . 0.518 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.32 -50.24 73.58 Favored 'General case' 0 CA--C 1.49 -1.331 0 N-CA-C 109.182 -0.673 . . . . 117.2 109.182 -173.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.802 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.48 -44.16 75.37 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 120.364 -0.534 . . . . 112.59999999999999 111.037 -177.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 315' ' ' GLY . . . . . 0.869 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -63.99 -37.48 94.68 Favored Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 110.648 -0.981 . . . . 101.45999999999999 110.648 -177.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 316' ' ' PHE . . . . . 1.006 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.6 m-85 -62.15 -46.01 90.9 Favored 'General case' 0 CA--C 1.492 -1.265 0 CA-C-N 118.493 1.147 . . . . 151.49000000000001 109.5 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 317' ' ' LYS . . . . . 0.417 ' HE3' ' HB2' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.06 -36.34 77.12 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 106.959 -1.497 . . . . 142.31999999999999 106.959 -175.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 318' ' ' HIS . . . . . 0.824 ' NE2' HG21 ' A' ' 326' ' ' ILE . 50.0 m80 -59.82 -41.76 92.02 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 106.892 -1.521 . . . . 109.09 106.892 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.9 -42.46 85.45 Favored 'General case' 0 N--CA 1.435 -1.183 0 O-C-N 122.368 -0.208 . . . . 76.109999999999999 110.979 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -61.37 -55.49 30.98 Favored 'General case' 0 CA--C 1.49 -1.36 0 C-N-CA 119.866 -0.734 . . . . 120.23999999999999 109.361 -174.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 321' ' ' ARG . . . . . 0.578 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.4 mtt180 -74.36 131.54 41.22 Favored 'General case' 0 CA--C 1.482 -1.649 0 N-CA-C 102.943 -2.984 . . . . 192.72999999999999 102.943 177.05 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.11 -44.27 91.96 Favored 'General case' 0 CA--C 1.492 -1.27 0 C-N-CA 119.008 -1.077 . . . . 176.28999999999999 109.212 -172.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 323' ' ' CYS . . . . . 0.754 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 77.9 m -79.34 -177.14 0.82 Allowed Pre-proline 0 N--CA 1.43 -1.439 0 N-CA-C 106.364 -1.717 . . . . 69.680000000000007 106.364 178.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.571 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 84.2 Cg_exo -58.93 -75.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.389 0 C-N-CA 118.343 -0.638 . . . . 191.05000000000001 112.637 176.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 325' ' ' PHE . . . . . 0.754 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.6 m-85 47.45 43.88 16.09 Favored 'General case' 0 CA--C 1.493 -1.234 0 O-C-N 123.571 0.544 . . . . 287.02999999999997 109.803 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 326' ' ' ILE . . . . . 0.824 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.52 78.65 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.474 -1.944 0 C-N-CA 112.885 -3.526 . . . . 292.29000000000002 109.847 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 327' ' ' SER . . . . . 0.48 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.4 t -77.48 -152.84 0.05 Allowed 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 104.199 -2.519 . . . . 184.56999999999999 104.199 178.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 328' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.65 8.67 4.99 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 113.091 0.775 . . . . 274.56 113.091 176.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 99.0 0.89 57.23 Favored Glycine 0 C--N 1.348 1.248 0 C-N-CA 117.725 -2.178 . . . . 268.24000000000001 113.473 172.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 330' ' ' ASP . . . . . 0.699 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.9 m-20 51.6 -172.05 0.03 OUTLIER 'General case' 0 CA--C 1.496 -1.099 0 CA-C-N 118.676 1.238 . . . . 200.06 110.782 177.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.86 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.3 t80 -63.86 -33.02 74.75 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 107.892 -1.151 . . . . 114.44 107.892 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 332' ' ' GLU . . . . . 0.549 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.27 46.05 21.91 Favored 'General case' 0 CA--C 1.484 -1.581 0 N-CA-C 107.627 -1.249 . . . . 263.81 107.627 -177.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 333' ' ' GLY . . . . . 0.633 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.31 -137.37 3.61 Favored Glycine 0 CA--C 1.478 -2.229 1 N-CA-C 102.548 -4.221 . . . . 103.79000000000001 102.548 -179.804 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 1.035 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.4 mt -88.27 95.61 10.25 Favored 'General case' 0 N--CA 1.419 -1.983 0 C-N-CA 114.95 -2.7 . . . . 117.3 106.013 176.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 335' ' ' GLU . . . . . 1.014 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.97 -39.8 90.68 Favored 'General case' 0 CA--C 1.468 -2.177 1 N-CA-C 97.977 -4.823 . . . . 231.58000000000001 97.977 167.232 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 336' ' ' MET . . . . . 1.028 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.91 163.53 28.95 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 102.092 -3.299 . . . . 303.24000000000001 102.092 168.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 337' ' ' LYS . . . . . 1.035 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.4 tttt -62.6 -48.64 78.54 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 116.066 -2.253 . . . . 112.72 108.442 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.9 t -61.03 -63.68 1.22 Allowed 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 109.091 -0.707 . . . . 83.219999999999999 109.091 -176.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 339' ' ' THR . . . . . 0.883 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.4 m -156.28 -126.18 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 103.858 -2.645 . . . . 174.36000000000001 103.858 -178.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 340' ' ' ARG . . . . . 1.014 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.88 160.94 8.81 Favored 'General case' 0 CA--C 1.486 -1.515 0 N-CA-C 105.789 -1.93 . . . . 202.72999999999999 105.789 177.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 341' ' ' TYR . . . . . 1.01 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.94 149.0 52.56 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 107.065 -1.457 . . . . 180.62 107.065 176.432 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 342' ' ' LEU . . . . . 0.927 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.6 tp -178.49 -171.85 0.27 Allowed 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 105.407 -2.072 . . . . 145.25 105.407 178.05 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 343' ' ' GLN . . . . . 0.927 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.06 -43.2 88.13 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 106.113 -1.81 . . . . 66.049999999999997 106.113 174.24 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 344' ' ' THR . . . . . 0.765 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.66 -152.14 0.48 Allowed 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 103.521 -2.77 . . . . 266.49000000000001 103.521 179.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 345' ' ' GLN . . . . . 0.702 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.5 mt-30 66.28 -124.97 0.28 Allowed 'General case' 0 N--CA 1.428 -1.572 0 C-N-CA 117.076 -1.85 . . . . 219.19999999999999 107.739 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 346' ' ' GLY . . . . . 0.897 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -64.96 -37.43 94.26 Favored Glycine 0 N--CA 1.426 -2.013 0 CA-C-N 114.536 -1.211 . . . . 94.780000000000001 112.895 -176.034 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 347' ' ' SER . . . . . 0.825 ' HB2' ' H ' ' A' ' 342' ' ' LEU . 48.4 t -81.21 100.45 9.12 Favored 'General case' 0 CA--C 1.483 -1.599 0 C-N-CA 112.327 -3.749 . . . . 121.41 109.441 -171.047 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 348' ' ' VAL . . . . . 0.439 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.2 t -73.09 145.55 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 108.961 -0.755 . . . . 85.340000000000003 108.961 -176.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 349' ' ' TYR . . . . . 0.439 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.5 p90 -57.78 143.44 42.09 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.848 -1.167 . . . . 267.56999999999999 107.848 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 350' ' ' LYS . . . . . 0.526 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.08 69.53 0.6 Allowed 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 109.532 -0.544 . . . . 226.09999999999999 109.532 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 351' ' ' VAL . . . . . 0.827 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.5 p -50.96 156.97 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.315 0 N-CA-C 107.017 -1.475 . . . . 154.84 107.017 177.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 352' ' ' SER . . . . . 0.581 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.5 m -61.4 161.92 8.64 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-O 121.602 0.715 . . . . 180.00999999999999 110.721 -173.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 353' ' ' ARG . . . . . 0.897 ' H ' ' HD3' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.45 156.91 23.66 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 106.913 -1.514 . . . . 333.77999999999997 106.913 -178.615 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 354' ' ' LEU . . . . . 0.978 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.03 142.54 48.73 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 107.325 -1.361 . . . . 335.19999999999999 107.325 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.978 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.5 mm-40 82.79 158.88 0.13 Allowed 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 108.753 -0.832 . . . . 266.47000000000003 108.753 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.5 m -60.6 -46.84 88.74 Favored 'General case' 0 CA--C 1.487 -1.467 0 N-CA-C 105.708 -1.96 . . . . 59.340000000000003 105.708 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.6 173.83 11.98 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 104.444 -2.428 . . . . 201.25999999999999 104.444 176.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.747 HG22 ' O ' ' A' ' 360' ' ' THR . 69.2 mt -95.92 106.7 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 C-N-CA 116.323 -2.151 . . . . 56.229999999999997 105.53 -179.287 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 359' ' ' SER . . . . . 0.468 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.7 m -61.15 -59.48 5.26 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 109.308 -0.627 . . . . 87.579999999999998 109.308 -175.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 360' ' ' THR . . . . . 0.885 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.1 t -85.49 153.71 22.27 Favored 'General case' 0 CA--C 1.486 -1.513 0 N-CA-C 107.871 -1.159 . . . . 219.94999999999999 107.871 -177.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 361' ' ' VAL . . . . . 0.59 ' O ' HG23 ' A' ' 361' ' ' VAL . 16.0 m -81.98 83.86 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.656 0 C-N-CA 116.326 -2.15 . . . . 121.79000000000001 105.434 177.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.597 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.5 t -154.16 159.68 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 N-CA-C 105.824 -1.917 . . . . 53.850000000000001 105.824 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 363' ' ' GLY . . . . . 0.597 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.28 16.59 77.15 Favored Glycine 0 N--CA 1.428 -1.875 0 N-CA-C 106.046 -2.822 . . . . 196.55000000000001 106.046 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.681 0 N-CA-C 107.849 -1.167 . . . . 35.880000000000003 107.849 -178.9 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 365' ' ' ARG . . . . . 0.46 HH11 ' HD2' ' B' ' 365' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 108.808 -0.812 . . . . 1.0 108.808 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 366' ' ' PRO . . . . . 0.416 ' CD ' ' N ' ' B' ' 365' ' ' ARG . 52.8 Cg_endo -66.91 141.99 60.78 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.086 1.858 . . . . 1.0 110.228 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 367' ' ' LYS . . . . . 0.888 ' HG3' HD11 ' A' ' 5' ' ' LEU . 0.8 OUTLIER -64.35 143.26 98.45 Favored Pre-proline 0 C--N 1.326 -0.445 0 C-N-CA 119.888 -0.725 . . . . 1.0 109.576 -179.875 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 368' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.31 150.44 76.26 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.272 1.981 . . . . 1.0 111.728 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 369' ' ' GLN . . . . . 0.401 ' OE1' HG21 ' A' ' 19' ' ' THR . 0.0 OUTLIER -70.77 131.75 44.3 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.724 -0.39 . . . . 1.0 110.165 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 370' ' ' GLN . . . . . 0.455 ' OE1' ' HA ' ' B' ' 370' ' ' GLN . 0.0 OUTLIER -102.01 115.93 31.61 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.672 -179.831 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 371' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -63.71 -42.36 97.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.347 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 372' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -65.03 -36.21 83.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.871 -0.604 . . . . 1.0 110.652 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -59.78 -33.0 76.05 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.839 -0.905 . . . . 1.0 110.839 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 374' ' ' LEU . . . . . 0.918 HD13 ' HA ' ' A' ' 20' ' ' SER . 10.0 tp . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 120.885 0.374 . . . . 1.0 110.173 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.457 0 N-CA-C 108.377 -0.971 . . . . 97.079999999999998 108.377 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -110.61 155.42 22.39 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-O 122.103 0.954 . . . . 123.41 110.737 -172.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.877 HG11 HD13 ' A' ' 15' ' ' ILE . 28.7 m -134.58 -162.38 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.487 1 N-CA-C 100.093 -4.04 . . . . 151.30000000000001 100.093 173.732 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.908 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.63 -38.61 58.55 Favored Pre-proline 0 N--CA 1.439 -0.981 0 C-N-CA 115.961 -2.295 . . . . 169.25 106.123 178.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.908 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 58.0 Cg_exo -81.28 168.53 16.65 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 122.255 0.608 . . . . 185.75999999999999 110.536 171.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.906 HG13 ' CE2' ' A' ' 282' ' ' PHE . 92.0 t -64.47 -25.93 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 C-N-CA 127.022 2.129 . . . . 145.47 110.343 -177.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.774 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.2 t0 -84.33 157.41 21.5 Favored 'General case' 0 CA--C 1.499 -0.988 0 O-C-N 121.073 -1.017 . . . . 102.76000000000001 109.459 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.5 p -82.59 154.17 25.1 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 107.988 -1.115 . . . . 106.25 107.988 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.918 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.7 p-10 -105.89 51.89 0.74 Allowed 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 117.772 -1.571 . . . . 157.81 107.628 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.16 -45.9 91.51 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 103.586 -2.746 . . . . 150.19999999999999 103.586 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.8 m -87.05 164.68 35.29 Favored Pre-proline 0 N--CA 1.422 -1.872 0 N-CA-C 103.672 -2.714 . . . . 183.52000000000001 103.672 172.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -76.77 6.87 3.84 Favored 'Trans proline' 0 C--N 1.281 -2.998 0 N-CA-C 109.988 -0.812 . . . . 235.61000000000001 109.988 176.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.422 ' C ' HD21 ' A' ' 14' ' ' ASN . 0.4 OUTLIER -57.93 -41.25 82.33 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 124.809 1.244 . . . . 113.77 113.379 -170.108 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.918 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.4 pt -52.16 136.22 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-N 119.558 1.072 . . . . 150.84999999999999 110.984 -176.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.49 156.26 46.39 Favored 'General case' 0 C--N 1.36 1.064 0 N-CA-C 107.625 -1.25 . . . . 100.42 107.625 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . 1.08 HG23 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.05 142.61 58.35 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 121.953 0.882 . . . . 129.36000000000001 110.444 -174.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.775 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 74.5 m-20 -63.06 -25.5 68.4 Favored 'General case' 0 CA--C 1.494 -1.208 0 C-N-CA 126.303 1.841 . . . . 112.34 106.689 -177.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.941 HG23 ' HA2' ' A' ' 101' ' ' GLY . 85.8 m -74.14 -40.14 62.81 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.542 -0.754 . . . . 131.72999999999999 111.744 177.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . 1.08 ' H ' HG23 ' A' ' 17' ' ' THR . 71.2 m -84.45 -42.86 15.18 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 116.994 2.22 . . . . 80.489999999999995 116.994 -174.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.549 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.4 mt-10 -145.99 174.54 3.34 Favored Pre-proline 0 N--CA 1.443 -0.817 0 C-N-CA 118.152 -1.419 . . . . 98.980000000000004 111.198 -169.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.823 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.333 85.7 Cg_exo -61.79 -10.73 18.04 Favored 'Trans proline' 0 C--N 1.321 -0.887 1 N-CA-C 128.934 6.475 . . . . 246.94999999999999 128.934 -170.085 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.0 m120 61.61 17.55 8.7 Favored 'General case' 0 C--N 1.324 -0.515 1 CA-C-N 126.15 4.068 . . . . 269.62 114.216 175.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.495 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 80.8 mt-30 -67.14 -27.26 67.16 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 107.802 -1.184 . . . . 86.799999999999997 107.802 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.551 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.3 p90 -66.81 -29.34 69.25 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 121.115 -0.991 . . . . 85.909999999999997 110.501 -178.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.873 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.4 t -68.54 -40.21 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 C-N-CA 123.695 0.798 . . . . 82.0 111.346 -177.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.896 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 27.6 pt20 -151.4 167.73 12.48 Favored Pre-proline 0 CA--C 1.489 -1.4 0 N-CA-C 108.552 -0.907 . . . . 120.73 108.552 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.902 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -64.0 149.76 89.82 Favored 'Trans proline' 0 N--CA 1.432 -2.123 0 C-N-CA 120.616 0.877 . . . . 87.859999999999999 109.91 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.744 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.03 -37.96 89.28 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 108.846 -0.798 . . . . 36.460000000000001 108.846 -176.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.814 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.8 p-90 -63.8 -33.86 76.61 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 107.807 -1.183 . . . . 150.59999999999999 107.807 -176.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.902 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.5 mt-30 -62.21 -32.71 73.41 Favored 'General case' 0 CA--C 1.49 -1.334 0 O-C-N 121.291 -0.88 . . . . 123.26000000000001 108.666 -178.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.744 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.47 -47.17 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.57 0 N-CA-C 109.157 -0.682 . . . . 120.14 109.157 176.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.785 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.2 m -67.41 -31.03 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 107.873 -1.158 . . . . 112.19 107.873 -178.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.814 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.5 tp -62.98 -47.12 84.51 Favored 'General case' 0 N--CA 1.432 -1.337 0 C-N-CA 119.921 -0.712 . . . . 60.869999999999997 109.601 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.672 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.03 -35.67 81.18 Favored 'General case' 0 CA--C 1.489 -1.382 0 C-N-CA 119.965 -0.694 . . . . 157.56999999999999 110.364 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.747 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.61 -40.89 98.39 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 108.629 -0.878 . . . . 47.060000000000002 108.629 178.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.805 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.77 -41.28 98.01 Favored 'General case' 0 CA--C 1.496 -1.121 0 O-C-N 121.756 -0.59 . . . . 43.939999999999998 109.557 -177.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.731 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.81 -43.3 99.12 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.726 -0.842 . . . . 42.609999999999999 108.726 -176.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.902 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.38 -41.26 93.94 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 116.623 -0.262 . . . . 140.66 111.029 -178.364 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.805 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.78 -43.96 97.81 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 118.58 -1.248 . . . . 116.04000000000001 110.234 -175.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.673 HG22 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.44 -38.75 83.24 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.292 0 N-CA-C 108.731 -0.84 . . . . 97.159999999999997 108.731 -177.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.852 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.2 mt -61.28 -40.0 84.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 N-CA-C 108.975 -0.75 . . . . 54.850000000000001 108.975 -176.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.956 HG22 HG21 ' A' ' 86' ' ' THR . 92.9 t -57.71 -42.34 81.48 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.301 0 N-CA-C 108.873 -0.788 . . . . 45.390000000000001 108.873 -175.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 48' ' ' VAL . 97.2 t -63.52 -50.97 76.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 C-N-CA 118.848 -1.141 . . . . 48.640000000000001 110.171 -177.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.751 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.6 t -65.27 -47.04 78.08 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 120.163 -0.615 . . . . 116.65000000000001 111.711 -174.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.59 ' N ' HG23 ' A' ' 45' ' ' THR . 50.8 m -61.96 -43.94 97.79 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 109.715 -0.476 . . . . 51.159999999999997 109.715 -174.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.4 t -65.54 -48.93 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 C-N-CA 119.852 -0.739 . . . . 44.299999999999997 110.85 -176.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.866 ' O ' HG23 ' A' ' 52' ' ' VAL . 93.8 t -64.75 -46.94 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 C-N-CA 120.299 -0.56 . . . . 48.82 111.032 -174.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.77 -44.15 95.21 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 120.513 -0.851 . . . . 58.700000000000003 112.006 -174.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -72.63 -34.21 67.17 Favored 'General case' 0 CA--C 1.488 -1.432 0 O-C-N 122.086 -0.655 . . . . 101.40000000000001 111.027 -175.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.742 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.9 -38.73 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 107.745 -1.206 . . . . 103.56999999999999 107.745 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 48' ' ' VAL . 72.0 t -61.43 -43.05 96.06 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.225 0 N-CA-C 108.975 -0.75 . . . . 61.890000000000001 108.975 -178.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.535 ' O ' HG22 ' A' ' 56' ' ' ILE . 81.8 t -63.44 -50.96 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 N-CA-C 109.47 -0.567 . . . . 70.010000000000005 109.47 -178.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.803 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.94 -43.39 98.92 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 109.13 -0.693 . . . . 132.09999999999999 109.13 -176.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.643 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.23 -46.62 83.02 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 116.677 -0.238 . . . . 104.5 110.441 -176.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 1.018 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.67 -49.88 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 C-N-CA 120.212 -0.595 . . . . 142.96000000000001 111.271 -173.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.949 HD11 HG12 ' A' ' 72' ' ' VAL 0.279 24.8 pt -64.79 -41.68 92.87 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.661 0 C-N-CA 116.947 -1.901 . . . . 158.31999999999999 110.877 -175.971 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.803 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.72 -41.39 98.09 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 117.725 -1.59 . . . . 137.11000000000001 109.48 178.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.36 -44.54 91.11 Favored 'General case' 0 N--CA 1.436 -1.165 0 O-C-N 122.164 -0.335 . . . . 54.659999999999997 111.019 -176.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.925 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.41 117.12 29.4 Favored 'General case' 0 CA--C 1.491 -1.322 0 CA-C-O 121.623 0.725 . . . . 127.18000000000001 109.586 -174.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.62 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.83 -36.84 80.12 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 124.099 0.96 . . . . 87.930000000000007 110.832 -176.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 1.036 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.38 -34.67 78.7 Favored 'General case' 0 CA--C 1.49 -1.33 0 O-C-N 121.657 -0.652 . . . . 131.12 111.509 -175.625 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' MET . . . . . 1.019 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.61 69.43 7.12 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 115.313 -2.555 . . . . 246.56 109.606 -175.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.412 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.21 91.45 3.48 Favored 'General case' 0 CA--C 1.474 -1.966 0 N-CA-C 105.484 -2.043 . . . . 339.35000000000002 105.484 177.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.444 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.5 p -124.15 165.27 17.85 Favored 'General case' 0 N--CA 1.414 -2.248 0 N-CA-C 102.992 -2.966 . . . . 114.66 102.992 176.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.88 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.15 -39.44 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 N-CA-C 106.78 -1.563 . . . . 143.28 106.78 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.836 HG22 HD13 ' A' ' 71' ' ' LEU . 95.4 m -59.69 -38.05 80.5 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 108.687 -0.856 . . . . 160.22 108.687 -176.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.523 ' O ' HG13 ' A' ' 72' ' ' VAL . 5.3 m120 -62.34 -31.78 72.46 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 108.872 -0.788 . . . . 120.54000000000001 108.872 -177.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.901 ' O ' HG22 ' A' ' 72' ' ' VAL . 89.8 m-85 -63.59 -43.81 95.86 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 109.481 -0.563 . . . . 67.219999999999999 109.481 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.88 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.5 m-85 -66.53 -39.76 88.78 Favored 'General case' 0 CA--C 1.498 -1.055 0 O-C-N 121.488 -0.758 . . . . 138.59999999999999 109.668 -177.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.925 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.58 -35.91 82.05 Favored 'General case' 0 CA--C 1.493 -1.237 0 C-N-CA 122.479 0.312 . . . . 151.46000000000001 110.641 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.949 HG12 HD11 ' A' ' 57' ' ' ILE . 24.2 m -62.56 -37.95 80.2 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.227 0 C-N-CA 117.39 -1.724 . . . . 117.93000000000001 106.715 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.45 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.1 t30 -60.07 -46.03 90.92 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 107.859 -1.163 . . . . 56.82 107.859 -177.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.999 HD21 ' HE1' ' A' ' 123' ' ' MET . 8.7 mp -61.36 -43.91 98.07 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 108.931 -0.766 . . . . 145.30000000000001 108.931 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.05 -40.35 95.47 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 108.521 -0.918 . . . . 45.710000000000001 108.521 -175.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -62.4 -42.02 99.11 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.377 -0.601 . . . . 105.61 109.377 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.12 -39.45 92.59 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 108.646 -0.872 . . . . 47.890000000000001 108.646 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.588 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.56 -37.37 84.83 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 109.966 -0.383 . . . . 124.53 109.966 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.86 -41.22 99.28 Favored 'General case' 0 CA--C 1.496 -1.099 0 O-C-N 121.952 -0.467 . . . . 35.890000000000001 109.843 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.8 t -62.23 -37.3 84.86 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 107.025 -1.472 . . . . 88.969999999999999 107.025 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.82 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.17 -49.17 76.88 Favored 'General case' 0 N--CA 1.428 -1.55 0 C-N-CA 119.831 -0.748 . . . . 239.91 109.047 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.62 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.38 -43.4 90.81 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 121.536 -0.728 . . . . 146.09999999999999 110.596 -177.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.418 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.16 -58.23 3.4 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 117.397 -1.721 . . . . 91.739999999999995 113.852 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -76.55 -61.38 1.98 Allowed 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 115.748 1.759 . . . . 197.44999999999999 115.748 -173.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.933 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.25 -42.26 55.52 Favored 'General case' 0 CA--C 1.49 -1.365 0 C-N-CA 117.897 -1.521 . . . . 242.59999999999999 114.046 -170.036 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.956 HG21 HG22 ' A' ' 43' ' ' VAL . 4.6 t -65.4 -36.55 84.3 Favored 'General case' 0 N--CA 1.434 -1.254 0 C-N-CA 118.912 -1.115 . . . . 215.61000000000001 109.838 -172.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.423 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.3 t -60.3 -46.94 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 O-C-N 121.828 -0.545 . . . . 87.189999999999998 110.459 -175.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.842 HG21 ' CD2' ' A' ' 108' ' ' HIS . 63.6 t -65.93 -41.86 90.75 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.112 0 N-CA-C 109.731 -0.47 . . . . 231.81999999999999 109.731 -178.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.902 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 87.8 m-20 -62.32 -34.14 76.06 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 108.317 -0.994 . . . . 364.98000000000002 108.317 -177.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.667 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.3 t80 -68.19 -44.72 75.25 Favored 'General case' 0 N--CA 1.438 -1.054 0 O-C-N 121.543 -0.723 . . . . 181.63 111.275 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.475 HG22 ' ND1' ' A' ' 95' ' ' HIS . 57.7 m -60.87 -45.78 93.19 Favored 'General case' 0 CA--C 1.478 -1.809 0 N-CA-C 107.432 -1.321 . . . . 269.01999999999998 107.432 -175.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 1.055 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.72 -45.03 93.4 Favored 'General case' 0 N--CA 1.416 -2.149 0 C-N-CA 118.657 -1.217 . . . . 562.65999999999997 110.023 -179.058 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.707 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.11 -45.24 95.51 Favored 'General case' 0 CA--C 1.479 -1.787 0 C-N-CA 118.696 -1.202 . . . . 446.75 108.097 -167.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.747 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.388 6.1 m -70.51 -26.31 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 C-N-CA 115.837 -2.345 . . . . 370.05000000000001 112.216 -178.755 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.496 ' O ' ' HB2' ' A' ' 96' ' ' ASN . 40.8 m80 -74.48 -26.5 60.06 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 121.593 -0.692 . . . . 354.91000000000003 112.513 175.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.823 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.4 m-20 82.8 4.53 0.99 Allowed 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 125.067 1.347 . . . . 462.44 111.905 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.775 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.266 11.9 mm-40 -172.35 178.06 2.91 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-O 122.015 0.912 . . . . 652.37 111.122 171.786 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.791 ' HE3' ' HA ' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.73 86.3 2.17 Favored 'General case' 0 N--CA 1.428 -1.565 0 C-N-CA 128.489 2.715 . . . . 905.99000000000001 107.929 -174.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -67.87 -36.4 80.21 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 108.244 -1.021 . . . . 570.42999999999995 108.244 -176.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.848 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.57 -36.35 82.4 Favored 'General case' 0 N--CA 1.428 -1.54 0 C-N-CA 125.318 1.447 . . . . 453.22000000000003 111.157 -174.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.941 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.55 178.66 33.9 Favored Glycine 0 C--N 1.349 1.292 0 C-N-CA 118.768 -1.682 . . . . 445.63 109.891 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.0 mt -56.41 -41.23 75.99 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 125.275 1.43 . . . . 457.72000000000003 112.357 -170.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -58.63 -46.93 86.03 Favored 'General case' 0 CA--C 1.484 -1.56 0 C-N-CA 118.662 -1.215 . . . . 340.57999999999998 109.296 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.848 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.1 m-85 -68.71 -32.14 71.72 Favored 'General case' 0 N--CA 1.423 -1.775 0 C-N-CA 118.774 -1.171 . . . . 453.60000000000002 111.577 -176.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.764 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.05 -40.35 73.37 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 105.976 -1.861 . . . . 541.48000000000002 105.976 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.83 -47.14 75.99 Favored 'General case' 0 CA--C 1.486 -1.514 0 O-C-N 123.991 0.807 . . . . 466.68000000000001 110.866 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -61.74 -47.08 86.86 Favored 'General case' 0 N--CA 1.427 -1.607 0 C-N-CA 117.48 -1.688 . . . . 427.33999999999997 107.315 -178.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.842 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.6 m80 -67.1 -36.79 82.72 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 112.415 0.524 . . . . 537.87 112.415 -174.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.574 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.4 -42.69 74.77 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 116.847 -1.941 . . . . 422.12 111.593 175.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.858 ' O ' HG22 ' A' ' 113' ' ' ILE . 75.9 t80 -59.05 -50.1 75.37 Favored 'General case' 0 CA--C 1.502 -0.883 0 O-C-N 121.324 -0.86 . . . . 340.17000000000002 111.834 -173.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -65.29 -46.54 71.37 Favored Pre-proline 0 N--CA 1.443 -0.811 0 C-N-CA 119.082 -1.047 . . . . 258.06 111.723 -176.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.933 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.0 Cg_exo -61.52 -31.54 87.64 Favored 'Trans proline' 0 N--CA 1.435 -1.943 0 N-CA-C 115.368 1.257 . . . . 305.70999999999998 115.368 176.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.876 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.91 -40.41 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 N-CA-C 108.687 -0.857 . . . . 252.69999999999999 108.687 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.423 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.92 -40.6 93.8 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 107.801 -1.185 . . . . 149.27000000000001 107.801 -179.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.0 -44.81 95.93 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 120.625 -0.43 . . . . 138.08000000000001 111.506 -176.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.653 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 65.1 t -66.94 -42.39 88.77 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 O-C-N 121.575 -0.703 . . . . 132.88999999999999 110.96 -177.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.923 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.76 -44.67 92.79 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 108.884 -0.784 . . . . 193.61000000000001 108.884 -177.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.555 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.48 -37.66 84.46 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 122.804 0.442 . . . . 63.829999999999998 110.085 -175.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.9 m -64.02 -52.39 59.69 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 120.747 -0.381 . . . . 76.400000000000006 111.228 -177.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.749 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.99 -41.63 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 108.185 -1.042 . . . . 171.13 108.185 -174.992 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 1.098 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.3 m-85 -63.8 -38.56 91.56 Favored 'General case' 0 N--CA 1.433 -1.311 0 O-C-N 121.834 -0.541 . . . . 78.299999999999997 110.635 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.557 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.6 t -67.11 -35.74 80.42 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 118.901 -1.12 . . . . 92.359999999999999 109.216 -178.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.999 ' HE1' HD21 ' A' ' 74' ' ' LEU . 5.9 mmt -62.5 -34.28 76.55 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 108.173 -1.047 . . . . 93.730000000000004 108.173 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.902 HG22 HG13 ' A' ' 212' ' ' ILE . 33.2 p -67.42 -41.65 84.49 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 119.215 -0.994 . . . . 132.74000000000001 109.33 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.28 -42.08 94.68 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.18 -1.415 . . . . 43.390000000000001 107.18 -177.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.827 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.0 t -58.46 -41.99 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 N-CA-C 108.607 -0.886 . . . . 59.340000000000003 108.607 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.48 -44.07 95.45 Favored 'General case' 0 CA--C 1.497 -1.064 0 O-C-N 121.804 -0.56 . . . . 69.680000000000007 110.519 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.469 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.3 t80 -65.47 -42.77 91.9 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.326 -0.99 . . . . 106.98 108.326 -177.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.827 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.35 -35.61 81.42 Favored 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 119.662 -0.815 . . . . 147.63 108.951 -177.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.705 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.16 -41.54 99.27 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 108.541 -0.911 . . . . 190.06 108.541 178.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.6 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.5 t80 -61.34 -44.06 97.82 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.31 -0.996 . . . . 118.84999999999999 108.31 -177.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.805 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.5 mmt -63.36 -42.66 98.89 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 109.986 -0.375 . . . . 102.5 109.986 -177.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.99 -41.62 95.25 Favored 'General case' 0 CA--C 1.489 -1.39 0 O-C-N 121.82 -0.55 . . . . 89.980000000000004 109.841 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.92 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.3 mt -66.52 -50.72 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 C-N-CA 118.13 -1.428 . . . . 106.09 110.991 -177.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.749 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.07 -48.32 38.42 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.099 0 C-N-CA 117.098 -1.841 . . . . 227.74000000000001 111.815 -174.792 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.756 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.85 100.08 50.98 Favored Pre-proline 0 CA--C 1.486 -1.505 0 C-N-CA 116.242 -2.183 . . . . 262.55000000000001 110.059 -175.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.2 Cg_endo -69.6 -10.39 28.56 Favored 'Trans proline' 0 C--N 1.29 -2.544 0 C-N-CA 121.618 1.545 . . . . 210.25 111.358 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.705 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.28 112.02 1.0 Allowed 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 106.523 -1.658 . . . . 270.57999999999998 106.523 -178.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.886 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.82 -39.5 23.87 Favored Pre-proline 0 N--CA 1.43 -1.451 0 CA-C-N 115.358 -0.837 . . . . 129.84 112.347 -175.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.859 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 82.1 Cg_exo -61.36 -26.6 81.77 Favored 'Trans proline' 0 N--CA 1.431 -2.163 0 N-CA-C 116.297 1.614 . . . . 330.70999999999998 116.297 -174.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.756 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.03 77.2 7.95 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 114.479 -2.888 . . . . 204.50999999999999 107.277 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.877 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.72 147.43 0.09 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 107.435 -1.32 . . . . 387.41000000000003 107.435 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.877 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.4 t -143.71 147.02 33.63 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 118.794 -1.162 . . . . 166.22 109.475 178.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.84 -40.76 88.03 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 107.847 -1.168 . . . . 44.229999999999997 107.847 176.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.483 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.6 m -60.3 -39.14 85.89 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 108.176 -1.046 . . . . 28.800000000000001 108.176 -175.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.668 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.81 -38.79 92.1 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 109.101 -0.703 . . . . 30.289999999999999 109.101 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.847 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 89.9 m -59.61 -43.03 93.88 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 108.982 -0.748 . . . . 46.109999999999999 108.982 -176.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.46 -42.14 99.26 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 107.693 -1.225 . . . . 87.329999999999998 107.693 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.77 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.6 t -61.67 -42.08 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 107.93 -1.137 . . . . 23.690000000000001 107.93 -178.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.8 t -63.19 -44.29 99.25 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 109.704 -0.48 . . . . 43.859999999999999 109.704 -178.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.918 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.0 mm -61.28 -42.54 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 108.326 -0.991 . . . . 91.129999999999995 108.326 -176.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' CYS . . . . . 0.483 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.2 t -62.6 -37.96 88.29 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.754 -0.832 . . . . 65.879999999999995 108.754 -178.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.4 t -62.11 -41.85 92.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.225 0 N-CA-C 109.551 -0.537 . . . . 33.859999999999999 109.551 -177.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 1.098 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.4 -40.33 85.87 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.183 0 N-CA-C 107.585 -1.265 . . . . 146.52000000000001 107.585 -176.799 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 155' ' ' TRP . . . . . 0.7 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.1 m95 -62.86 -38.36 90.51 Favored 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 119.497 -0.881 . . . . 75.439999999999998 108.896 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.7 t -60.54 -48.4 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 O-C-N 121.028 -1.045 . . . . 43.640000000000001 109.71 -177.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.791 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.7 -38.0 89.47 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 109.029 -0.73 . . . . 102.56999999999999 109.029 -178.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.0 -41.09 86.83 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.417 -1.327 . . . . 58.159999999999997 107.417 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.801 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.07 -32.48 73.87 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.032 -0.729 . . . . 121.11 109.032 178.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.791 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.02 -42.34 85.09 Favored 'General case' 0 CA--C 1.489 -1.395 0 C-N-CA 118.576 -1.249 . . . . 153.15000000000001 109.923 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 1.057 HD13 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.05 -43.75 19.07 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 113.106 -3.437 . . . . 133.66999999999999 113.527 173.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.478 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -62.97 -39.9 96.08 Favored 'General case' 0 CA--C 1.489 -1.371 0 O-C-N 120.916 -1.115 . . . . 157.41999999999999 112.192 -171.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.522 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.3 t80 -74.45 -36.11 2.45 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 115.012 1.486 . . . . 250.91 115.012 -173.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.292 52.9 Cg_exo -59.5 -25.48 78.84 Favored 'Trans proline' 0 CA--C 1.488 -1.791 0 N-CA-C 118.007 2.272 . . . . 207.34 118.007 -174.351 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.915 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 32.4 mt-30 -61.17 -34.19 74.65 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 106.951 -1.5 . . . . 192.46000000000001 106.951 178.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.52 -41.03 98.09 Favored Glycine 0 C--N 1.353 1.501 0 N-CA-C 107.969 -2.053 . . . . 261.0 107.969 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.79 159.11 25.96 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 101.513 -3.514 . . . . 491.39999999999998 101.513 172.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -59.96 106.82 0.54 Allowed 'General case' 0 CA--C 1.488 -1.434 0 C-N-CA 116.247 -2.181 . . . . 386.10000000000002 109.83 -176.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.915 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 73.9 m -154.03 -166.61 2.42 Favored 'General case' 0 N--CA 1.415 -2.224 0 N-CA-C 103.541 -2.763 . . . . 289.80000000000001 103.541 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' THR . . . . . 1.14 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.92 175.4 0.86 Allowed 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 117.736 -1.126 . . . . 402.06 109.565 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.788 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 73.0 p -165.27 177.5 7.56 Favored 'General case' 0 CA--C 1.586 2.353 0 C-N-CA 127.343 2.257 . . . . 690.52999999999997 114.94 177.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.487 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.9 mm-40 132.34 160.56 0.0 OUTLIER 'General case' 1 C--N 1.429 4.057 1 N-CA-C 123.19 4.515 . . . . 633.62 123.19 162.704 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.762 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.2 p -85.63 153.83 22.1 Favored 'General case' 0 C--N 1.389 2.3 0 C-N-CA 127.376 2.27 . . . . 617.99000000000001 110.903 178.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' MET . . . . . 1.047 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.69 174.4 6.0 Favored Pre-proline 0 C--N 1.364 1.206 0 C-N-CA 130.271 3.428 . . . . 434.98000000000002 113.405 -175.417 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 1.092 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 51.8 Cg_endo -44.24 -65.65 0.19 Allowed 'Trans proline' 0 N--CA 1.441 -1.56 0 N-CA-C 122.418 3.969 . . . . 365.88 122.418 -168.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' SER . . . . . 0.778 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.306 70.5 m -84.89 20.95 1.69 Allowed 'General case' 0 CA--C 1.467 -2.239 0 N-CA-C 104.797 -2.298 . . . . 635.80999999999995 104.797 178.144 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.75 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.456 5.0 mmp_? -94.39 152.24 18.78 Favored 'General case' 1 CA--C 1.419 -4.064 3 N-CA-C 131.98 7.771 . . . . 999.99000000000001 131.98 -135.76 . . . . . . . . 5 3 . 1 . 001 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 1.055 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.911 37.1 t -131.84 73.18 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.772 1 CA-C-N 103.3 -6.318 . . . . 594.32000000000005 113.599 149.217 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.726 HG13 ' HB2' ' A' ' 174' ' ' MET . 7.3 p -144.2 144.1 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.639 1 N-CA-C 98.291 -4.707 . . . . 811.90999999999997 98.291 162.374 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.762 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.8 m -118.46 144.53 45.92 Favored 'General case' 0 CA--C 1.489 -1.401 0 C-N-CA 117.058 -1.857 . . . . 999.99000000000001 109.427 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.97 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.8 mmm -147.19 -175.61 4.9 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-O 122.004 0.907 . . . . 431.86000000000001 110.054 -177.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 1.038 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.13 148.67 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 C-N-CA 124.351 1.06 . . . . 457.18000000000001 108.801 -177.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' GLU . . . . . 0.788 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.32 85.47 3.75 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 124.14 0.976 . . . . 458.76999999999998 113.503 -174.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.958 ' CZ3' HG22 ' A' ' 182' ' ' ILE . 1.9 p90 -76.37 -31.57 0.98 Allowed Pre-proline 0 N--CA 1.438 -1.048 0 C-N-CA 124.961 1.304 . . . . 999.99000000000001 112.426 168.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.956 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -65.95 -45.77 5.65 Favored 'Trans proline' 0 N--CA 1.438 -1.789 0 N-CA-C 120.875 3.375 . . . . 999.99000000000001 120.875 -174.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.508 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.56 171.74 8.15 Favored 'General case' 0 CA--C 1.472 -2.047 0 C-N-CA 117.166 -1.814 . . . . 81.180000000000007 107.26 -172.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.834 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 6.4 p80 -109.14 45.14 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.848 0 C-N-CA 115.503 -2.479 . . . . 999.99000000000001 108.754 177.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 1.072 ' HB2' HD12 ' A' ' 191' ' ' ILE . 87.5 Cg_endo -41.57 101.81 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.14 1 C-N-CA 126.042 4.494 . . . . 999.99000000000001 105.683 -170.737 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -62.27 -44.02 97.48 Favored 'General case' 0 CA--C 1.483 -1.599 0 C-N-CA 126.747 2.019 . . . . 967.72000000000003 112.048 -165.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 190' ' ' LYS . 30.3 mmtp -60.26 -36.55 78.05 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.748 -1.575 . . . . 934.29999999999995 106.748 -175.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 1.072 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.56 -30.25 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 C-N-CA 129.2 3.0 . . . . 565.14999999999998 113.923 -178.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 61.53 55.4 2.81 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 118.444 0.565 . . . . 755.61000000000001 109.869 -175.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 1.14 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.5 -49.28 67.1 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.551 1.141 . . . . 325.88999999999999 113.242 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.633 ' HE3' ' OH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.82 -44.95 78.4 Favored 'General case' 0 CA--C 1.495 -1.16 0 C-N-CA 123.56 0.744 . . . . 250.21000000000001 111.627 -169.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.3 t -64.72 -43.35 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 CA-C-O 121.585 0.707 . . . . 142.46000000000001 110.382 -175.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 1.038 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.8 t80 -61.12 -41.52 96.85 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 123.981 0.912 . . . . 247.69 108.815 -173.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.825 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 23.0 t60 -60.53 -51.31 69.97 Favored 'General case' 0 CA--C 1.491 -1.289 0 C-N-CA 125.424 1.49 . . . . 199.61000000000001 113.107 -175.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.2 mt -65.35 -44.48 94.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 107.715 -1.217 . . . . 106.73 107.715 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' CYS . . . . . 0.722 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.6 t -59.15 -48.53 81.27 Favored 'General case' 0 CA--C 1.487 -1.479 0 CA-C-N 115.867 -0.606 . . . . 115.01000000000001 110.231 -173.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 1.057 HG13 HD13 ' A' ' 161' ' ' LEU . 86.1 t -65.24 -49.15 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.657 0 C-N-CA 119.418 -0.913 . . . . 129.41999999999999 111.854 -174.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.794 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.2 m -61.88 -53.15 59.72 Favored 'General case' 0 CA--C 1.483 -1.63 0 C-N-CA 118.224 -1.39 . . . . 172.47999999999999 109.952 -172.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.632 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.1 t -63.85 -54.26 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 C-N-CA 120.512 -0.475 . . . . 55.859999999999999 110.972 -174.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.722 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.54 -51.56 58.95 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 118.542 -1.263 . . . . 184.68000000000001 111.513 -174.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 1.044 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.61 -52.4 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 C-N-CA 116.643 -2.023 . . . . 291.81 114.743 -174.699 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.549 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.8 t80 -82.05 -55.01 4.83 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 115.148 1.536 . . . . 130.66 115.148 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' PHE . . . . . 0.794 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.8 m-85 -66.88 -48.5 68.56 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 114.488 1.292 . . . . 80.159999999999997 114.488 -170.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.894 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.55 -45.47 83.16 Favored Pre-proline 0 N--CA 1.435 -1.195 0 C-N-CA 119.965 -0.694 . . . . 136.02000000000001 109.506 -174.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.894 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.8 Cg_exo -64.81 -27.12 59.62 Favored 'Trans proline' 0 N--CA 1.433 -2.08 0 N-CA-C 110.621 -0.569 . . . . 92.170000000000002 110.621 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.686 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.34 -41.37 76.72 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 107.494 -1.298 . . . . 135.59999999999999 107.494 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.16 -44.69 91.33 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 109.591 -0.522 . . . . 52.100000000000001 109.591 -176.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.618 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.71 -43.49 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 109.09 -0.707 . . . . 95.890000000000001 109.09 -176.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.902 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.27 -42.34 93.16 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 N-CA-C 106.695 -1.595 . . . . 43.409999999999997 106.695 -178.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.44 -42.28 99.08 Favored Glycine 0 N--CA 1.432 -1.624 0 N-CA-C 109.367 -1.493 . . . . 27.690000000000001 109.367 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' TYR . . . . . 0.884 ' O ' HG22 ' A' ' 217' ' ' THR . 77.9 t80 -65.68 -47.38 75.65 Favored 'General case' 0 CA--C 1.497 -1.086 0 O-C-N 122.195 -0.591 . . . . 54.409999999999997 110.456 -177.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ALA . . . . . 0.827 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.43 -34.1 74.83 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 106.96 -1.496 . . . . 53.880000000000003 106.96 -177.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -60.76 -40.83 93.97 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 108.48 -0.933 . . . . 68.290000000000006 108.48 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' THR . . . . . 0.884 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.78 -39.04 92.95 Favored 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 119.701 -0.799 . . . . 107.59 110.615 -175.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.827 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.02 -38.36 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 C-N-CA 119.606 -0.838 . . . . 111.61 109.509 -177.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.92 HG13 ' CD1' ' A' ' 134' ' ' ILE . 79.8 t -63.28 -22.51 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 N-CA-C 108.401 -0.963 . . . . 85.260000000000005 108.401 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.85 -41.94 99.39 Favored Glycine 0 C--N 1.349 1.283 0 N-CA-C 111.062 -0.815 . . . . 40.710000000000001 111.062 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.72 -44.06 96.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 108.412 -0.959 . . . . 95.859999999999999 108.412 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.824 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.3 p -76.93 -137.52 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 108.441 -0.948 . . . . 144.37 108.441 -176.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.904 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.6 mt -55.36 132.12 47.35 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 107.599 -1.26 . . . . 326.72000000000003 107.599 -177.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' TRP . . . . . 0.461 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.33 -168.04 1.51 Allowed 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 106.033 -1.84 . . . . 158.38 106.033 -176.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.461 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.32 -41.94 98.95 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 109.661 -0.496 . . . . 36.780000000000001 109.661 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.6 m -61.13 125.85 25.22 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 119.151 -1.019 . . . . 85.459999999999994 109.82 -174.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' GLU . . . . . 0.692 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.87 126.53 8.84 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 105.542 -2.021 . . . . 127.78 105.542 176.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.927 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.03 139.9 34.82 Favored Pre-proline 0 CA--C 1.493 -1.239 0 N-CA-C 105.952 -1.87 . . . . 164.84 105.952 -179.592 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.927 ' N ' HD13 ' A' ' 228' ' ' ILE . 82.0 Cg_exo -56.8 -39.92 87.93 Favored 'Trans proline' 0 N--CA 1.431 -2.17 0 N-CA-C 113.937 0.707 . . . . 222.34999999999999 113.937 -176.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' GLY . . . . . 0.744 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.13 166.99 44.94 Favored Glycine 0 N--CA 1.428 -1.894 0 N-CA-C 106.424 -2.67 . . . . 45.219999999999999 106.424 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.882 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.94 -45.79 93.29 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 106.029 -1.841 . . . . 107.56999999999999 106.029 177.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' SER . . . . . 0.73 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.6 m -65.76 141.81 58.2 Favored 'General case' 0 N--CA 1.429 -1.517 0 C-N-CA 118.906 -1.118 . . . . 167.96000000000001 109.153 -175.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.83 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.2 m 99.51 106.7 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 126.706 2.002 . . . . 280.68000000000001 109.734 176.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.71 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.7 m-20 56.01 11.27 0.71 Allowed 'General case' 0 N--CA 1.434 -1.274 0 C-N-CA 124.459 1.103 . . . . 218.25 110.701 174.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.921 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.38 137.62 54.78 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 105.236 -2.135 . . . . 343.56999999999999 105.236 177.395 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.478 ' O ' HG21 ' A' ' 240' ' ' VAL . 85.6 t80 -111.97 81.9 1.54 Allowed 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 106.867 -1.531 . . . . 263.29000000000002 106.867 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' HIS . . . . . 0.626 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 64.5 m80 104.29 147.05 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.283 0 C-N-CA 126.563 1.945 . . . . 261.92000000000002 108.497 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.21 -38.1 89.85 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 107.879 -1.156 . . . . 106.81 107.879 -177.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.737 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.43 -39.94 94.97 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 118.371 -1.331 . . . . 112.2 107.552 -178.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.738 HG12 ' NH1' ' A' ' 244' ' ' ARG . 75.5 t -64.26 -39.82 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.275 0 N-CA-C 109.263 -0.643 . . . . 45.409999999999997 109.263 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' SER . . . . . 0.807 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.1 p -70.92 -32.07 68.87 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 110.264 -0.273 . . . . 97.620000000000005 110.264 -178.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.39 -39.61 81.66 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 123.696 0.799 . . . . 59.289999999999999 110.978 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.737 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.24 -36.54 83.99 Favored 'General case' 0 CA--C 1.492 -1.275 0 C-N-CA 124.658 1.183 . . . . 106.48999999999999 110.666 -174.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.921 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.96 -30.65 69.23 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 108.299 -1.0 . . . . 106.62 108.299 -176.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.533 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -66.02 -41.02 91.49 Favored 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 121.832 -0.542 . . . . 75.969999999999999 110.045 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.441 ' CG1' ' CE ' ' A' ' 250' ' ' MET . 76.6 t -65.54 -40.86 89.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 C-N-CA 122.917 0.487 . . . . 65.269999999999996 109.774 -178.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.775 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -64.0 -41.58 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 C-N-CA 120.401 -0.519 . . . . 107.94 110.162 -177.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.537 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.1 pttt -63.54 -40.81 97.98 Favored 'General case' 0 N--CA 1.434 -1.247 0 O-C-N 121.687 -0.633 . . . . 87.980000000000004 110.284 -176.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' MET . . . . . 0.822 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.65 -40.4 96.78 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 118.832 -1.147 . . . . 65.5 108.363 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' MET . . . . . 0.761 ' CE ' HG21 ' A' ' 67' ' ' THR . 68.5 mtt -61.7 -36.37 80.71 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 108.146 -1.057 . . . . 85.049999999999997 108.146 -177.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.537 HD12 ' HA ' ' A' ' 248' ' ' LYS . 86.9 mt -63.49 -45.74 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 N-CA-C 109.07 -0.715 . . . . 42.25 109.07 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.822 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.34 -38.26 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 C-N-CA 119.548 -0.861 . . . . 91.010000000000005 109.402 -176.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 1.001 HG22 ' CD1' ' A' ' 304' ' ' ILE . 65.9 t -58.86 -41.54 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 N-CA-C 107.988 -1.116 . . . . 66.090000000000003 107.988 -178.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 250' ' ' MET . 94.8 t -66.09 -43.18 92.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 C-N-CA 120.754 -0.379 . . . . 52.390000000000001 110.31 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.1 m -61.74 -46.78 88.15 Favored 'General case' 0 CA--C 1.489 -1.391 0 O-C-N 121.889 -0.507 . . . . 46.420000000000002 109.866 -174.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' THR . . . . . 0.743 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.5 t -62.33 -38.13 88.26 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 108.324 -0.991 . . . . 116.51000000000001 108.324 -177.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' PHE . . . . . 0.487 ' N ' HG23 ' A' ' 256' ' ' THR . 86.1 t80 -60.26 -48.23 82.64 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.394 -0.595 . . . . 65.180000000000007 109.394 -178.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.96 -42.68 97.2 Favored 'General case' 0 CA--C 1.49 -1.365 0 O-C-N 122.133 -0.354 . . . . 51.329999999999998 110.443 -175.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' ILE . . . . . 0.743 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.62 -43.37 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 C-N-CA 118.919 -1.112 . . . . 126.3 109.0 -176.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' CYS . . . . . 0.51 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.7 m -65.58 -49.33 69.22 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 119.529 -0.868 . . . . 133.94 112.485 -176.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.82 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.0 m95 -80.68 -33.38 35.52 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 116.856 2.169 . . . . 134.84 116.856 -176.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.784 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.9 tp -58.43 -41.62 90.27 Favored Pre-proline 0 CA--C 1.493 -1.235 0 O-C-N 121.659 -0.65 . . . . 72.230000000000004 111.643 -167.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' PRO . . . . . 0.784 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 80.7 Cg_exo -60.66 -35.98 87.1 Favored 'Trans proline' 0 C--N 1.295 -2.278 0 CA-C-N 119.848 0.981 . . . . 106.13 111.349 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 264' ' ' PHE . . . . . 0.851 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.7 t80 -66.41 -44.68 82.32 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 119.749 -0.78 . . . . 128.34999999999999 110.03 -178.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' HIS . . . . . 0.643 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.42 -37.88 89.06 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 110.202 -0.296 . . . . 100.73 110.202 -177.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.745 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.25 -44.56 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 C-N-CA 119.31 -0.956 . . . . 172.72 109.142 -179.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' PHE . . . . . 0.736 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.6 m-85 -66.6 -28.07 68.21 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 108.206 -1.035 . . . . 249.22999999999999 108.206 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' PHE . . . . . 0.898 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.56 -55.1 35.85 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 106.679 -1.6 . . . . 259.77999999999997 106.679 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 269' ' ' LEU . . . . . 0.491 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.3 mt -69.17 -44.18 72.72 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 113.588 0.959 . . . . 233.11000000000001 113.588 -176.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.837 ' O ' HG13 ' A' ' 273' ' ' ILE . 88.8 mt -61.37 -48.3 91.47 Favored Pre-proline 0 N--CA 1.44 -0.968 0 C-N-CA 119.183 -1.007 . . . . 169.53999999999999 110.596 -171.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 271' ' ' PRO . . . . . 0.736 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.6 Cg_exo -61.13 -24.56 79.49 Favored 'Trans proline' 0 N--CA 1.43 -2.259 0 C-N-CA 116.729 -1.714 . . . . 255.47 114.66 174.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 272' ' ' TYR . . . . . 0.825 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.5 t80 -63.56 -44.22 94.75 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 119.225 0.921 . . . . 279.02999999999997 108.904 177.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.837 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.33 -44.79 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 110.081 -0.34 . . . . 162.21000000000001 110.081 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 274' ' ' ASN . . . . . 0.868 HD22 HD12 ' A' ' 277' ' ' LEU . 49.1 t30 -125.41 84.87 59.33 Favored Pre-proline 0 N--CA 1.431 -1.406 0 C-N-CA 118.747 -1.181 . . . . 128.13 108.069 -178.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 275' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.25 164.04 11.26 Favored 'Trans proline' 0 C--N 1.295 -2.281 0 N-CA-C 107.46 -1.785 . . . . 278.35000000000002 107.46 177.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 276' ' ' ASP . . . . . 0.87 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.11 15.04 9.93 Favored 'General case' 0 N--CA 1.428 -1.533 0 O-C-N 123.8 0.687 . . . . 312.91000000000003 109.334 175.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.87 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.3 mt -132.71 -170.68 2.49 Favored 'General case' 0 CA--C 1.481 -1.679 0 N-CA-C 106.537 -1.653 . . . . 353.54000000000002 106.537 177.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 1.011 ' HA ' ' HB2' ' A' ' 282' ' ' PHE . 42.8 p90 -115.66 142.25 46.99 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 107.427 -1.323 . . . . 251.25999999999999 107.427 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.764 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -76.96 -118.74 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 102.081 -3.303 . . . . 175.25999999999999 102.081 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' LYS . . . . . 0.794 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.5 -44.97 96.12 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 100.878 -3.749 . . . . 99.069999999999993 100.878 172.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 281' ' ' LYS . . . . . 0.794 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.42 124.18 9.19 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 103.494 -2.78 . . . . 243.21000000000001 103.494 171.161 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 1.011 ' HB2' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.98 112.96 25.1 Favored 'General case' 0 CA--C 1.474 -1.979 0 C-N-CA 116.049 -2.261 . . . . 201.03999999999999 105.278 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 283' ' ' ILE . . . . . 0.776 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.93 173.72 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.09 0 C-N-CA 116.0 -2.28 . . . . 201.36000000000001 108.787 -175.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 284' ' ' GLN . . . . . 1.092 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.282 0.6 OUTLIER -59.5 -41.44 89.89 Favored 'General case' 0 N--CA 1.415 -2.179 0 CA-C-N 113.247 -1.797 . . . . 203.81999999999999 107.864 174.463 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 285' ' ' GLN . . . . . 0.925 ' HG2' HE21 ' A' ' 284' ' ' GLN . 1.2 mm100 -64.31 -45.71 86.76 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 118.22 -1.392 . . . . 215.06 112.543 -171.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.551 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.3 t -65.68 -46.42 89.3 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.466 0 C-N-CA 118.578 -1.249 . . . . 125.28 112.912 -171.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 287' ' ' TYR . . . . . 0.952 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.79 -37.0 86.14 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 107.193 -1.41 . . . . 268.89999999999998 107.193 -171.883 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.798 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.22 -45.01 74.47 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 125.65 1.58 . . . . 280.88 108.795 -172.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.64 -47.48 86.05 Favored 'General case' 0 N--CA 1.428 -1.547 0 C-N-CA 118.97 -1.092 . . . . 184.47 109.002 -172.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' ILE . . . . . 0.851 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.8 mp -67.94 -42.11 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 C-N-CA 119.279 -0.968 . . . . 167.91999999999999 112.73 -175.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 291' ' ' MET . . . . . 0.5 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.8 ttt -65.75 -38.8 90.11 Favored 'General case' 0 CA--C 1.495 -1.144 0 C-N-CA 117.758 -1.577 . . . . 367.18000000000001 110.771 -175.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 292' ' ' TRP . . . . . 0.548 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.4 m95 -67.16 -32.71 73.99 Favored 'General case' 0 N--CA 1.435 -1.215 0 O-C-N 121.851 -0.531 . . . . 173.97 110.449 177.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.2 tp -64.46 -36.76 85.23 Favored 'General case' 0 CA--C 1.499 -1.011 0 C-N-CA 123.542 0.737 . . . . 119.66 109.806 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' ALA . . . . . 0.82 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.25 -33.98 74.39 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.697 -1.224 . . . . 112.3 107.697 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 295' ' ' MET . . . . . 0.772 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.09 -32.05 73.33 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 116.235 -0.439 . . . . 174.16999999999999 110.237 -177.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.7 m -64.73 -22.78 67.06 Favored 'General case' 0 CA--C 1.485 -1.525 0 C-N-CA 124.676 1.191 . . . . 145.27000000000001 110.608 -175.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' SER . . . . . 0.76 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.5 m -57.61 -35.38 70.37 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 108.078 -1.082 . . . . 170.15000000000001 108.078 -175.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.82 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.7 t -55.3 -34.15 63.89 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 116.315 -0.402 . . . . 214.56999999999999 110.632 -171.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 299' ' ' MET . . . . . 0.751 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.1 ttt -77.2 -33.19 56.33 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 126.072 1.749 . . . . 168.28999999999999 115.544 177.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 300' ' ' TYR . . . . . 0.76 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.42 -34.87 79.2 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 114.056 1.132 . . . . 167.15000000000001 114.056 -168.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 301' ' ' ASN . . . . . 0.722 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.282 18.8 p-10 -64.21 -38.29 33.22 Favored Pre-proline 0 N--CA 1.434 -1.264 0 C-N-CA 115.515 -2.474 . . . . 165.13 113.93 -171.599 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 302' ' ' PRO . . . . . 0.722 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.1 Cg_exo -62.54 -31.83 80.02 Favored 'Trans proline' 0 N--CA 1.433 -2.042 0 CA-C-N 122.791 2.033 . . . . 123.92 111.251 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 303' ' ' ILE . . . . . 0.715 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.78 -42.53 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 C-N-CA 118.875 -1.13 . . . . 110.55 109.779 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 304' ' ' ILE . . . . . 1.001 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.1 pt -61.16 -40.02 84.43 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.158 0 N-CA-C 108.828 -0.804 . . . . 145.31 108.828 -177.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 305' ' ' TYR . . . . . 0.925 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.253 63.2 m-85 -58.11 -48.84 78.97 Favored 'General case' 0 CA--C 1.494 -1.182 0 C-N-CA 119.413 -0.915 . . . . 246.68000000000001 109.823 -177.477 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.6 m -62.19 -47.51 84.16 Favored 'General case' 0 CA--C 1.485 -1.538 0 C-N-CA 119.55 -0.86 . . . . 64.430000000000007 109.571 -173.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.8 t -66.78 -45.07 79.61 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 118.989 -1.084 . . . . 80.719999999999999 110.244 -177.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.708 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.49 -35.69 75.81 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 115.998 1.851 . . . . 140.44 115.998 -173.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 309' ' ' ASN . . . . . 0.658 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.83 132.23 34.34 Favored 'General case' 0 N--CA 1.434 -1.26 0 C-N-CA 112.711 -3.596 . . . . 178.87 113.056 -177.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 310' ' ' ASP . . . . . 0.612 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.03 -37.07 86.41 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 114.405 -1.271 . . . . 110.22 110.111 -177.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.855 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.74 -50.59 72.7 Favored 'General case' 0 CA--C 1.492 -1.256 0 O-C-N 121.752 -0.592 . . . . 174.78 109.739 -174.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.96 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.2 m-85 -64.89 -41.69 95.41 Favored 'General case' 0 CA--C 1.484 -1.579 0 N-CA-C 108.245 -1.02 . . . . 161.84 108.245 178.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 313' ' ' ARG . . . . . 0.518 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.33 -50.22 73.64 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 109.198 -0.667 . . . . 117.2 109.198 -173.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.799 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.51 -44.1 75.37 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 120.373 -0.531 . . . . 112.59999999999999 111.061 -177.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 315' ' ' GLY . . . . . 0.871 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -64.04 -37.43 94.59 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 110.646 -0.982 . . . . 101.45999999999999 110.646 -177.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 316' ' ' PHE . . . . . 1.018 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.7 m-85 -62.16 -45.99 90.94 Favored 'General case' 0 CA--C 1.491 -1.296 0 CA-C-N 118.492 1.146 . . . . 151.49000000000001 109.522 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 317' ' ' LYS . . . . . 0.422 ' HE3' ' HB2' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.1 -36.3 77.13 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 106.949 -1.501 . . . . 142.31999999999999 106.949 -175.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 318' ' ' HIS . . . . . 0.827 ' NE2' HG21 ' A' ' 326' ' ' ILE . 50.0 m80 -59.79 -41.82 92.01 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 106.891 -1.522 . . . . 109.09 106.891 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.85 -42.43 85.72 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.336 -0.228 . . . . 76.109999999999999 111.03 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -61.43 -55.48 30.84 Favored 'General case' 0 CA--C 1.49 -1.361 0 C-N-CA 119.87 -0.732 . . . . 120.23999999999999 109.32 -174.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.578 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.4 mtt180 -74.33 131.54 41.24 Favored 'General case' 0 CA--C 1.482 -1.657 0 N-CA-C 102.935 -2.987 . . . . 192.72999999999999 102.935 177.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.16 -44.22 92.1 Favored 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 119.021 -1.072 . . . . 176.28999999999999 109.194 -172.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' CYS . . . . . 0.754 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.2 m -79.38 -177.11 0.81 Allowed Pre-proline 0 CA--C 1.487 -1.443 0 N-CA-C 106.294 -1.743 . . . . 69.680000000000007 106.294 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.569 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.6 Cg_exo -58.99 -75.58 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.389 0 C-N-CA 118.347 -0.635 . . . . 191.05000000000001 112.591 176.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 325' ' ' PHE . . . . . 0.754 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.5 m-85 47.49 43.88 16.25 Favored 'General case' 0 CA--C 1.493 -1.228 0 O-C-N 123.574 0.546 . . . . 287.02999999999997 109.764 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 326' ' ' ILE . . . . . 0.827 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.51 78.57 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.933 0 C-N-CA 112.956 -3.497 . . . . 292.29000000000002 109.839 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 327' ' ' SER . . . . . 0.481 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.3 t -77.47 -152.84 0.05 Allowed 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 104.208 -2.515 . . . . 184.56999999999999 104.208 178.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 328' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.7 8.68 4.95 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 113.063 0.764 . . . . 274.56 113.063 176.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.97 0.91 57.27 Favored Glycine 0 C--N 1.348 1.228 0 C-N-CA 117.729 -2.177 . . . . 268.24000000000001 113.457 172.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 330' ' ' ASP . . . . . 0.699 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.7 m-20 51.6 -172.04 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.071 0 CA-C-N 118.667 1.233 . . . . 200.06 110.747 177.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.855 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.89 -33.0 74.73 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 107.879 -1.156 . . . . 114.44 107.879 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 332' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.26 46.06 21.92 Favored 'General case' 0 CA--C 1.484 -1.592 0 N-CA-C 107.625 -1.25 . . . . 263.81 107.625 -177.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 333' ' ' GLY . . . . . 0.634 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.32 -137.35 3.6 Favored Glycine 0 CA--C 1.479 -2.217 1 N-CA-C 102.531 -4.228 . . . . 103.79000000000001 102.531 -179.846 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 1.049 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.2 mt -88.28 95.62 10.25 Favored 'General case' 0 N--CA 1.419 -2.007 0 C-N-CA 114.937 -2.705 . . . . 117.3 106.016 176.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 335' ' ' GLU . . . . . 1.027 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.96 -39.79 90.72 Favored 'General case' 0 CA--C 1.468 -2.188 1 N-CA-C 98.004 -4.813 . . . . 231.58000000000001 98.004 167.23 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 336' ' ' MET . . . . . 1.036 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.95 163.48 29.08 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 102.072 -3.307 . . . . 303.24000000000001 102.072 168.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 337' ' ' LYS . . . . . 1.049 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.3 tttt -62.63 -48.61 78.61 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 116.051 -2.259 . . . . 112.72 108.409 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.9 t -61.02 -63.66 1.22 Allowed 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 109.103 -0.703 . . . . 83.219999999999999 109.103 -176.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 339' ' ' THR . . . . . 0.883 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.1 m -156.28 -126.2 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 103.831 -2.655 . . . . 174.36000000000001 103.831 -178.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 340' ' ' ARG . . . . . 1.027 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.87 160.96 8.78 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 105.763 -1.94 . . . . 202.72999999999999 105.763 177.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 341' ' ' TYR . . . . . 1.019 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.95 149.04 52.55 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 107.064 -1.458 . . . . 180.62 107.064 176.392 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.933 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.5 tp -178.51 -171.86 0.27 Allowed 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 105.394 -2.076 . . . . 145.25 105.394 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 343' ' ' GLN . . . . . 0.933 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.09 -43.14 88.13 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 106.127 -1.805 . . . . 66.049999999999997 106.127 174.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 344' ' ' THR . . . . . 0.767 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.7 -152.14 0.48 Allowed 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 103.505 -2.776 . . . . 266.49000000000001 103.505 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 345' ' ' GLN . . . . . 0.7 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.4 mt-30 66.31 -124.93 0.28 Allowed 'General case' 0 N--CA 1.428 -1.574 0 C-N-CA 117.033 -1.867 . . . . 219.19999999999999 107.772 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 346' ' ' GLY . . . . . 0.902 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.07 -37.4 94.13 Favored Glycine 0 N--CA 1.426 -2.032 0 CA-C-N 114.544 -1.207 . . . . 94.780000000000001 112.855 -176.006 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 347' ' ' SER . . . . . 0.825 ' HB2' ' H ' ' A' ' 342' ' ' LEU . 48.3 t -81.17 100.41 9.07 Favored 'General case' 0 CA--C 1.484 -1.589 0 C-N-CA 112.327 -3.749 . . . . 121.41 109.479 -171.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 348' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.5 t -73.06 145.5 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 108.953 -0.758 . . . . 85.340000000000003 108.953 -176.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 349' ' ' TYR . . . . . 0.442 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.5 p90 -57.73 143.43 41.89 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.842 -1.17 . . . . 267.56999999999999 107.842 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 350' ' ' LYS . . . . . 0.523 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.03 69.59 0.59 Allowed 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 109.539 -0.541 . . . . 226.09999999999999 109.539 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 351' ' ' VAL . . . . . 0.826 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.5 p -51.0 156.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 N-CA-C 106.993 -1.484 . . . . 154.84 106.993 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 352' ' ' SER . . . . . 0.582 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.5 m -61.35 161.96 8.47 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.603 0.716 . . . . 180.00999999999999 110.711 -173.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 353' ' ' ARG . . . . . 0.893 ' H ' ' HD3' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.46 156.92 23.66 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 106.946 -1.501 . . . . 333.77999999999997 106.946 -178.616 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 354' ' ' LEU . . . . . 0.975 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.04 142.52 48.76 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.356 -1.35 . . . . 335.19999999999999 107.356 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.975 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.5 mm-40 82.82 158.9 0.13 Allowed 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 108.74 -0.837 . . . . 266.47000000000003 108.74 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.5 m -60.61 -46.88 88.6 Favored 'General case' 0 CA--C 1.487 -1.462 0 N-CA-C 105.677 -1.972 . . . . 59.340000000000003 105.677 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.58 173.86 11.97 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 104.431 -2.433 . . . . 201.25999999999999 104.431 176.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.75 HG22 ' O ' ' A' ' 360' ' ' THR . 69.1 mt -95.91 106.71 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.555 0 C-N-CA 116.34 -2.144 . . . . 56.229999999999997 105.524 -179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 359' ' ' SER . . . . . 0.466 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.7 m -61.19 -59.47 5.28 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 109.287 -0.634 . . . . 87.579999999999998 109.287 -175.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 360' ' ' THR . . . . . 0.886 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.2 t -85.5 153.76 22.24 Favored 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 107.835 -1.172 . . . . 219.94999999999999 107.835 -177.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 361' ' ' VAL . . . . . 0.587 ' O ' HG23 ' A' ' 361' ' ' VAL . 16.0 m -82.02 83.81 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 C-N-CA 116.339 -2.144 . . . . 121.79000000000001 105.452 177.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.598 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.6 t -154.11 159.74 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 N-CA-C 105.826 -1.916 . . . . 53.850000000000001 105.826 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 363' ' ' GLY . . . . . 0.598 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.22 16.61 77.06 Favored Glycine 0 N--CA 1.428 -1.88 0 N-CA-C 106.044 -2.822 . . . . 196.55000000000001 106.044 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.674 0 N-CA-C 107.87 -1.159 . . . . 35.880000000000003 107.87 -178.914 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 365' ' ' ARG . . . . . 0.418 ' N ' ' CD ' ' B' ' 366' ' ' PRO . 4.5 ttp180 . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 108.895 -0.78 . . . . 1.0 108.895 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 366' ' ' PRO . . . . . 0.418 ' CD ' ' N ' ' B' ' 365' ' ' ARG . 52.4 Cg_endo -66.94 141.99 60.58 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.086 1.857 . . . . 1.0 110.172 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 367' ' ' LYS . . . . . 0.738 ' HE2' ' HA ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -64.38 143.26 98.47 Favored Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 119.85 -0.74 . . . . 1.0 109.603 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 368' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -68.25 150.42 76.57 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.31 2.007 . . . . 1.0 111.759 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 369' ' ' GLN . . . . . 0.476 ' O ' ' HG3' ' B' ' 369' ' ' GLN . 0.0 OUTLIER -70.72 131.72 44.3 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.739 -0.384 . . . . 1.0 110.265 179.42 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -101.97 115.85 31.42 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.696 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 371' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -63.65 -42.39 98.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.365 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 372' ' ' PHE . . . . . 0.424 ' HD1' ' HA ' ' B' ' 372' ' ' PHE . 0.1 OUTLIER -65.01 -36.25 83.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.945 -0.57 . . . . 1.0 110.663 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -59.72 -32.98 75.69 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.869 -0.892 . . . . 1.0 110.869 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 374' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.83 131.35 45.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.834 0.349 . . . . 1.0 110.154 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 375' ' ' MET . . . . . 0.439 ' HB2' ' OG ' ' A' ' 20' ' ' SER . 0.7 OUTLIER . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 117.946 -1.026 . . . . 1.0 110.558 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.429 -1.478 0 N-CA-C 108.388 -0.967 . . . . 97.079999999999998 108.388 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.581 ' OD1' ' HG3' ' B' ' 366' ' ' PRO . 14.2 t-20 -110.62 155.44 22.37 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 122.07 0.938 . . . . 123.41 110.724 -172.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.881 HG11 HD13 ' A' ' 15' ' ' ILE . 28.8 m -134.6 -162.38 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.498 1 N-CA-C 100.117 -4.031 . . . . 151.30000000000001 100.117 173.741 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.909 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.1 mp -60.68 -38.58 57.96 Favored Pre-proline 0 N--CA 1.439 -0.995 0 C-N-CA 115.953 -2.299 . . . . 169.25 106.13 178.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.909 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 57.6 Cg_exo -81.26 168.49 16.73 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 122.267 0.614 . . . . 185.75999999999999 110.53 171.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.904 HG13 ' CE2' ' A' ' 282' ' ' PHE . 92.3 t -64.44 -25.87 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 C-N-CA 127.037 2.135 . . . . 145.47 110.381 -177.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.774 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.2 t0 -84.34 157.39 21.5 Favored 'General case' 0 CA--C 1.499 -1.014 0 O-C-N 121.043 -1.036 . . . . 102.76000000000001 109.473 -178.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.6 p -82.64 154.21 25.02 Favored 'General case' 0 CA--C 1.492 -1.269 0 N-CA-C 107.973 -1.121 . . . . 106.25 107.973 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.921 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.8 p-10 -105.89 51.88 0.74 Allowed 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 117.778 -1.569 . . . . 157.81 107.656 178.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.15 -45.86 91.64 Favored 'General case' 0 CA--C 1.481 -1.681 0 N-CA-C 103.593 -2.743 . . . . 150.19999999999999 103.593 178.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.4 m -87.1 164.73 34.96 Favored Pre-proline 0 N--CA 1.421 -1.899 0 N-CA-C 103.663 -2.717 . . . . 183.52000000000001 103.663 172.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -76.82 6.91 3.83 Favored 'Trans proline' 0 C--N 1.281 -2.977 0 N-CA-C 109.992 -0.811 . . . . 235.61000000000001 109.992 176.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.422 ' C ' HD21 ' A' ' 14' ' ' ASN . 0.4 OUTLIER -57.9 -41.29 82.31 Favored 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 124.813 1.245 . . . . 113.77 113.401 -170.118 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.921 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.3 pt -52.13 136.19 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 CA-C-N 119.517 1.053 . . . . 150.84999999999999 110.986 -176.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.46 156.28 46.41 Favored 'General case' 0 C--N 1.36 1.065 0 N-CA-C 107.631 -1.248 . . . . 100.42 107.631 178.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . 1.081 HG23 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.09 142.64 58.32 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 122.009 0.909 . . . . 129.36000000000001 110.412 -174.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.774 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 74.6 m-20 -63.06 -25.51 68.4 Favored 'General case' 0 CA--C 1.494 -1.189 0 C-N-CA 126.285 1.834 . . . . 112.34 106.677 -177.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.936 HG23 ' HA2' ' A' ' 101' ' ' GLY . 86.1 m -74.17 -40.15 62.74 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 115.567 -0.742 . . . . 131.72999999999999 111.705 177.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . 1.081 ' H ' HG23 ' A' ' 17' ' ' THR . 71.3 m -84.35 -42.93 15.24 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 117.034 2.235 . . . . 80.489999999999995 117.034 -174.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.55 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.5 mt-10 -145.98 174.54 3.34 Favored Pre-proline 0 N--CA 1.443 -0.798 0 C-N-CA 118.127 -1.429 . . . . 98.980000000000004 111.191 -169.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.823 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.334 85.7 Cg_exo -61.74 -10.81 18.16 Favored 'Trans proline' 0 C--N 1.322 -0.853 1 N-CA-C 128.939 6.476 . . . . 246.94999999999999 128.939 -170.069 . . . . . . . . 4 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.0 m120 61.68 17.5 8.74 Favored 'General case' 0 C--N 1.325 -0.494 1 CA-C-N 126.153 4.07 . . . . 269.62 114.231 175.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.495 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 80.8 mt-30 -67.1 -27.31 67.24 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 107.838 -1.171 . . . . 86.799999999999997 107.838 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.551 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.3 p90 -66.76 -29.42 69.37 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 121.09 -1.006 . . . . 85.909999999999997 110.508 -178.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.874 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.3 t -68.48 -40.23 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 C-N-CA 123.717 0.807 . . . . 82.0 111.362 -177.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.896 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 27.6 pt20 -151.39 167.79 12.37 Favored Pre-proline 0 CA--C 1.489 -1.398 0 N-CA-C 108.558 -0.905 . . . . 120.73 108.558 -178.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.902 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -64.04 149.76 89.79 Favored 'Trans proline' 0 N--CA 1.432 -2.116 0 C-N-CA 120.599 0.866 . . . . 87.859999999999999 109.9 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.744 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -62.99 -37.96 89.23 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 108.864 -0.791 . . . . 36.460000000000001 108.864 -176.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.813 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.9 p-90 -63.81 -33.9 76.7 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 107.797 -1.186 . . . . 150.59999999999999 107.797 -176.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.902 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.5 mt-30 -62.22 -32.67 73.37 Favored 'General case' 0 CA--C 1.491 -1.312 0 O-C-N 121.311 -0.868 . . . . 123.26000000000001 108.666 -178.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.744 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.46 -47.18 94.58 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.582 0 N-CA-C 109.166 -0.679 . . . . 120.14 109.166 176.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.786 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.3 m -67.42 -31.05 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 N-CA-C 107.855 -1.165 . . . . 112.19 107.855 -178.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.813 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.5 tp -62.96 -47.14 84.49 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 119.917 -0.713 . . . . 60.869999999999997 109.648 -178.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.672 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.0 -35.67 81.21 Favored 'General case' 0 CA--C 1.489 -1.391 0 C-N-CA 119.974 -0.69 . . . . 157.56999999999999 110.375 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.747 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.65 -40.88 98.42 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 108.591 -0.892 . . . . 47.060000000000002 108.591 178.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.806 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.79 -41.23 97.97 Favored 'General case' 0 CA--C 1.496 -1.114 0 O-C-N 121.714 -0.616 . . . . 43.939999999999998 109.558 -177.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.731 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.89 -43.26 99.2 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 108.697 -0.853 . . . . 42.609999999999999 108.697 -176.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.904 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.41 -41.23 93.85 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 116.66 -0.246 . . . . 140.66 111.029 -178.333 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.806 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.82 -43.92 97.88 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 118.579 -1.248 . . . . 116.04000000000001 110.215 -175.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.47 -38.7 83.1 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.325 0 N-CA-C 108.761 -0.829 . . . . 97.159999999999997 108.761 -177.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.854 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.1 mt -61.32 -39.97 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 N-CA-C 108.969 -0.752 . . . . 54.850000000000001 108.969 -176.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.958 HG22 HG21 ' A' ' 86' ' ' THR . 92.9 t -57.76 -42.28 81.49 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.314 0 N-CA-C 108.888 -0.782 . . . . 45.390000000000001 108.888 -175.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.431 ' O ' HG23 ' A' ' 48' ' ' VAL . 97.0 t -63.52 -51.01 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 C-N-CA 118.876 -1.13 . . . . 48.640000000000001 110.179 -177.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.751 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.6 t -65.27 -47.04 78.09 Favored 'General case' 0 N--CA 1.436 -1.175 0 C-N-CA 120.181 -0.608 . . . . 116.65000000000001 111.701 -174.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.589 ' N ' HG23 ' A' ' 45' ' ' THR . 50.7 m -62.01 -43.89 97.89 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.706 -0.479 . . . . 51.159999999999997 109.706 -174.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.3 t -65.55 -48.97 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 C-N-CA 119.88 -0.728 . . . . 44.299999999999997 110.803 -176.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.866 ' O ' HG23 ' A' ' 52' ' ' VAL . 93.9 t -64.75 -46.94 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 C-N-CA 120.266 -0.574 . . . . 48.82 111.052 -174.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.71 -44.15 95.29 Favored Glycine 0 N--CA 1.437 -1.272 0 C-N-CA 120.479 -0.867 . . . . 58.700000000000003 112.064 -174.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -72.62 -34.23 67.19 Favored 'General case' 0 CA--C 1.488 -1.439 0 O-C-N 122.071 -0.664 . . . . 101.40000000000001 110.999 -175.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.741 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.4 p -66.91 -38.71 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 107.71 -1.218 . . . . 103.56999999999999 107.71 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 48' ' ' VAL . 71.3 t -61.46 -43.03 96.08 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 108.948 -0.76 . . . . 61.890000000000001 108.948 -178.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.537 ' O ' HG22 ' A' ' 56' ' ' ILE . 82.1 t -63.47 -50.96 76.31 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 C-N-CA 120.277 -0.569 . . . . 70.010000000000005 109.47 -178.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.805 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.9 -43.38 98.96 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 109.184 -0.672 . . . . 132.09999999999999 109.184 -176.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.643 ' N ' ' HG3' ' A' ' 54' ' ' MET . 61.9 t-105 -64.21 -46.67 82.88 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 116.685 -0.234 . . . . 104.5 110.458 -176.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 1.017 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.69 -49.83 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 C-N-CA 120.192 -0.603 . . . . 142.96000000000001 111.306 -173.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.953 HD11 HG12 ' A' ' 72' ' ' VAL 0.279 24.9 pt -64.76 -41.71 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 C-N-CA 116.968 -1.893 . . . . 158.31999999999999 110.879 -176.035 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.805 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.7 -41.43 98.11 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 117.755 -1.578 . . . . 137.11000000000001 109.46 178.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.36 -44.53 91.13 Favored 'General case' 0 N--CA 1.435 -1.216 0 O-C-N 122.189 -0.319 . . . . 54.659999999999997 111.012 -176.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.922 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.44 117.13 29.42 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-O 121.633 0.73 . . . . 127.18000000000001 109.568 -174.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.619 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.83 -36.89 80.25 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 124.122 0.969 . . . . 87.930000000000007 110.78 -175.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 1.036 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.32 -34.69 78.73 Favored 'General case' 0 CA--C 1.49 -1.334 0 O-C-N 121.649 -0.657 . . . . 131.12 111.506 -175.592 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' MET . . . . . 1.018 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.63 69.45 7.14 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 115.337 -2.545 . . . . 246.56 109.612 -175.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.413 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.27 91.45 3.48 Favored 'General case' 0 CA--C 1.474 -1.958 0 N-CA-C 105.488 -2.041 . . . . 339.35000000000002 105.488 177.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.443 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.5 p -124.13 165.24 17.88 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 103.025 -2.954 . . . . 114.66 103.025 176.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.88 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.08 -39.47 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.624 0 N-CA-C 106.825 -1.546 . . . . 143.28 106.825 178.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.835 HG22 HD13 ' A' ' 71' ' ' LEU . 95.6 m -59.67 -38.03 80.36 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 108.731 -0.84 . . . . 160.22 108.731 -176.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.524 ' ND2' ' HB3' ' A' ' 63' ' ' MET . 86.3 m-20 -62.36 -31.81 72.51 Favored 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 108.866 -0.791 . . . . 120.54000000000001 108.866 -177.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.901 ' O ' HG22 ' A' ' 72' ' ' VAL . 89.8 m-85 -63.5 -43.87 95.98 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 109.484 -0.562 . . . . 67.219999999999999 109.484 178.118 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.88 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.5 m-85 -66.49 -39.81 88.94 Favored 'General case' 0 CA--C 1.498 -1.051 0 O-C-N 121.533 -0.729 . . . . 138.59999999999999 109.662 -177.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.923 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.54 -35.93 82.1 Favored 'General case' 0 CA--C 1.492 -1.253 0 C-N-CA 122.509 0.323 . . . . 151.46000000000001 110.648 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.953 HG12 HD11 ' A' ' 57' ' ' ILE . 24.0 m -62.54 -37.94 80.16 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.237 0 C-N-CA 117.383 -1.727 . . . . 117.93000000000001 106.739 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.449 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.1 t30 -60.11 -46.04 90.94 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.824 -1.176 . . . . 56.82 107.824 -177.078 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.991 HD21 ' HE1' ' A' ' 123' ' ' MET . 8.7 mp -61.3 -43.94 98.04 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 108.93 -0.767 . . . . 145.30000000000001 108.93 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.04 -40.38 95.52 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 108.527 -0.916 . . . . 45.710000000000001 108.527 -175.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -62.42 -41.99 99.11 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 109.34 -0.615 . . . . 105.61 109.34 -178.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.12 -39.48 92.69 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 108.652 -0.87 . . . . 47.890000000000001 108.652 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.588 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.57 -37.39 84.85 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 109.922 -0.399 . . . . 124.53 109.922 179.706 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.86 -41.18 99.28 Favored 'General case' 0 CA--C 1.496 -1.101 0 O-C-N 121.931 -0.481 . . . . 35.890000000000001 109.85 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.9 t -62.28 -37.28 84.92 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 107.01 -1.478 . . . . 88.969999999999999 107.01 -178.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.82 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.2 -49.19 76.77 Favored 'General case' 0 N--CA 1.428 -1.531 0 C-N-CA 119.847 -0.741 . . . . 239.91 109.026 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.62 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.35 -43.42 90.94 Favored 'General case' 0 N--CA 1.431 -1.396 0 O-C-N 121.503 -0.748 . . . . 146.09999999999999 110.593 -177.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.417 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.15 -58.24 3.4 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 117.417 -1.713 . . . . 91.739999999999995 113.877 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -76.51 -61.39 1.97 Allowed 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 115.761 1.763 . . . . 197.44999999999999 115.761 -173.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.935 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.25 -42.29 55.53 Favored 'General case' 0 CA--C 1.49 -1.348 0 C-N-CA 117.902 -1.519 . . . . 242.59999999999999 114.014 -170.009 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.958 HG21 HG22 ' A' ' 43' ' ' VAL . 4.6 t -65.35 -36.57 84.41 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 118.949 -1.1 . . . . 215.61000000000001 109.859 -172.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.423 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.3 t -60.33 -46.93 94.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 O-C-N 121.818 -0.551 . . . . 87.189999999999998 110.442 -175.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.841 HG21 ' CD2' ' A' ' 108' ' ' HIS . 63.3 t -65.91 -41.94 90.95 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.132 0 N-CA-C 109.716 -0.476 . . . . 231.81999999999999 109.716 -178.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.904 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 87.7 m-20 -62.28 -34.15 76.01 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 108.296 -1.002 . . . . 364.98000000000002 108.296 -177.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.668 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.2 t80 -68.24 -44.67 75.17 Favored 'General case' 0 N--CA 1.438 -1.043 0 O-C-N 121.563 -0.71 . . . . 181.63 111.299 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.476 HG22 ' ND1' ' A' ' 95' ' ' HIS . 58.2 m -60.92 -45.75 93.42 Favored 'General case' 0 CA--C 1.478 -1.797 0 N-CA-C 107.405 -1.331 . . . . 269.01999999999998 107.405 -175.208 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 1.057 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.71 -45.06 93.29 Favored 'General case' 0 CA--C 1.469 -2.143 0 C-N-CA 118.694 -1.202 . . . . 562.65999999999997 109.994 -179.081 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.705 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.1 -45.25 95.46 Favored 'General case' 0 CA--C 1.479 -1.761 0 C-N-CA 118.719 -1.193 . . . . 446.75 108.098 -167.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.747 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.389 6.1 m -70.47 -26.37 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 C-N-CA 115.816 -2.354 . . . . 370.05000000000001 112.196 -178.769 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.497 ' O ' ' HB2' ' A' ' 96' ' ' ASN . 40.7 m80 -74.51 -26.45 60.0 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 121.597 -0.689 . . . . 354.91000000000003 112.501 175.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.823 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.6 m-20 82.81 4.53 0.99 Allowed 'General case' 0 CA--C 1.499 -0.984 0 C-N-CA 125.075 1.35 . . . . 462.44 111.902 -178.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.774 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.267 11.9 mm-40 -172.32 178.06 2.92 Favored 'General case' 0 CA--C 1.488 -1.436 0 CA-C-O 122.02 0.914 . . . . 652.37 111.092 171.808 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.791 ' HE3' ' HA ' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.72 86.29 2.17 Favored 'General case' 0 N--CA 1.427 -1.576 0 C-N-CA 128.493 2.717 . . . . 905.99000000000001 107.931 -174.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -67.84 -36.47 80.41 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 108.254 -1.017 . . . . 570.42999999999995 108.254 -176.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.846 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.0 m-85 -62.46 -36.36 82.22 Favored 'General case' 0 N--CA 1.428 -1.531 0 C-N-CA 125.324 1.449 . . . . 453.22000000000003 111.203 -174.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.936 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.52 178.61 33.93 Favored Glycine 0 C--N 1.35 1.32 0 C-N-CA 118.744 -1.693 . . . . 445.63 109.892 177.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.656 HD11 ' CD1' ' B' ' 374' ' ' LEU . 89.1 mt -56.41 -41.19 75.93 Favored 'General case' 0 CA--C 1.498 -1.041 0 C-N-CA 125.243 1.417 . . . . 457.72000000000003 112.396 -170.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -58.62 -46.9 86.05 Favored 'General case' 0 CA--C 1.485 -1.546 0 C-N-CA 118.671 -1.212 . . . . 340.57999999999998 109.291 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.846 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.3 m-85 -68.73 -32.16 71.74 Favored 'General case' 0 N--CA 1.424 -1.751 0 C-N-CA 118.799 -1.16 . . . . 453.60000000000002 111.552 -176.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.764 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.2 t -56.08 -40.35 73.47 Favored 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 105.964 -1.865 . . . . 541.48000000000002 105.964 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.82 -47.18 75.92 Favored 'General case' 0 CA--C 1.486 -1.504 0 O-C-N 124.02 0.825 . . . . 466.68000000000001 110.826 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -61.73 -47.08 86.84 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 117.487 -1.685 . . . . 427.33999999999997 107.277 -178.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.841 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.5 m80 -67.09 -36.76 82.66 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 112.405 0.521 . . . . 537.87 112.405 -174.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.574 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.46 -42.67 74.59 Favored 'General case' 0 N--CA 1.433 -1.325 0 C-N-CA 116.869 -1.932 . . . . 422.12 111.543 175.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.856 ' O ' HG22 ' A' ' 113' ' ' ILE . 76.0 t80 -59.06 -50.14 75.2 Favored 'General case' 0 CA--C 1.502 -0.894 0 O-C-N 121.324 -0.86 . . . . 340.17000000000002 111.813 -173.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -65.25 -46.56 71.84 Favored Pre-proline 0 N--CA 1.443 -0.808 0 C-N-CA 119.109 -1.036 . . . . 258.06 111.713 -176.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.935 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.2 Cg_exo -61.47 -31.59 87.98 Favored 'Trans proline' 0 N--CA 1.434 -1.993 0 N-CA-C 115.391 1.266 . . . . 305.70999999999998 115.391 176.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.875 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.89 -40.43 76.49 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 108.701 -0.851 . . . . 252.69999999999999 108.701 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.422 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.92 -40.61 93.84 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 107.821 -1.178 . . . . 149.27000000000001 107.821 -179.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.93 -44.87 95.87 Favored 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 120.668 -0.413 . . . . 138.08000000000001 111.502 -176.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.652 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 65.0 t -66.92 -42.36 88.79 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 O-C-N 121.6 -0.688 . . . . 132.88999999999999 110.98 -177.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.924 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.6 m-85 -63.75 -44.67 92.78 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 119.752 -0.779 . . . . 193.61000000000001 108.904 -177.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.555 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.45 -37.73 84.63 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 122.85 0.46 . . . . 63.829999999999998 110.055 -175.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.7 m -64.03 -52.38 59.71 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 120.701 -0.4 . . . . 76.400000000000006 111.237 -177.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.749 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.94 -41.67 93.64 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 N-CA-C 108.175 -1.046 . . . . 171.13 108.175 -175.01 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 1.098 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.5 m-85 -63.75 -38.59 91.66 Favored 'General case' 0 N--CA 1.433 -1.315 0 O-C-N 121.814 -0.554 . . . . 78.299999999999997 110.686 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.556 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.6 t -67.09 -35.75 80.48 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 118.926 -1.11 . . . . 92.359999999999999 109.197 -178.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.991 ' HE1' HD21 ' A' ' 74' ' ' LEU . 5.9 mmt -62.55 -34.2 76.46 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 108.176 -1.046 . . . . 93.730000000000004 108.176 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.904 HG22 HG13 ' A' ' 212' ' ' ILE . 33.4 p -67.52 -41.56 84.21 Favored 'General case' 0 CA--C 1.494 -1.202 0 C-N-CA 119.171 -1.012 . . . . 132.74000000000001 109.332 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.28 -42.14 94.8 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 107.158 -1.423 . . . . 43.390000000000001 107.158 -177.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.827 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 94.8 t -58.45 -41.97 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 N-CA-C 108.633 -0.877 . . . . 59.340000000000003 108.633 -178.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.47 -44.09 95.44 Favored 'General case' 0 CA--C 1.498 -1.043 0 O-C-N 121.815 -0.553 . . . . 69.680000000000007 110.556 -177.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.468 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.2 t80 -65.44 -42.72 92.09 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.375 -0.972 . . . . 106.98 108.375 -177.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.827 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.38 -35.58 81.35 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 119.663 -0.815 . . . . 147.63 108.981 -177.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.704 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.21 -41.51 99.16 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 108.503 -0.925 . . . . 190.06 108.503 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.598 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.6 t80 -61.34 -44.05 97.84 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 108.328 -0.99 . . . . 118.84999999999999 108.328 -177.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.804 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.5 mmt -63.42 -42.63 98.73 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 110.009 -0.367 . . . . 102.5 110.009 -177.141 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.99 -41.63 95.23 Favored 'General case' 0 CA--C 1.488 -1.405 0 O-C-N 121.837 -0.539 . . . . 89.980000000000004 109.828 -176.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.92 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.4 mt -66.51 -50.72 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 C-N-CA 118.113 -1.435 . . . . 106.09 110.999 -177.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.75 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.05 -48.3 38.62 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.109 0 C-N-CA 117.133 -1.827 . . . . 227.74000000000001 111.86 -174.831 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.754 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 23.8 p80 -118.88 100.06 50.96 Favored Pre-proline 0 CA--C 1.486 -1.498 0 C-N-CA 116.27 -2.172 . . . . 262.55000000000001 110.032 -175.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.2 Cg_endo -69.61 -10.37 28.5 Favored 'Trans proline' 0 C--N 1.29 -2.534 0 C-N-CA 121.58 1.52 . . . . 210.25 111.335 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.706 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.26 112.03 1.0 Allowed 'General case' 0 CA--C 1.491 -1.313 0 N-CA-C 106.547 -1.649 . . . . 270.57999999999998 106.547 -178.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.891 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.76 -39.55 24.66 Favored Pre-proline 0 N--CA 1.43 -1.46 0 CA-C-N 115.361 -0.836 . . . . 129.84 112.377 -176.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.86 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 82.3 Cg_exo -61.35 -26.58 81.76 Favored 'Trans proline' 0 N--CA 1.432 -2.133 0 N-CA-C 116.291 1.612 . . . . 330.70999999999998 116.291 -174.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.754 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.03 77.19 7.95 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 114.497 -2.881 . . . . 204.50999999999999 107.263 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.876 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.73 147.4 0.09 Allowed 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 107.497 -1.297 . . . . 387.41000000000003 107.497 178.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.876 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.4 t -143.66 146.99 33.66 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 118.807 -1.157 . . . . 166.22 109.496 178.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.81 -40.8 88.19 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.873 -1.158 . . . . 44.229999999999997 107.873 176.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.484 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.5 m -60.27 -39.15 85.82 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 108.184 -1.043 . . . . 28.800000000000001 108.184 -175.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.668 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.84 -38.74 92.01 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 109.08 -0.711 . . . . 30.289999999999999 109.08 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.847 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 90.1 m -59.59 -43.06 93.8 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 108.975 -0.75 . . . . 46.109999999999999 108.975 -176.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.49 -42.09 99.26 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 107.656 -1.238 . . . . 87.329999999999998 107.656 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.77 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.4 t -61.71 -42.1 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 N-CA-C 107.894 -1.15 . . . . 23.690000000000001 107.894 -178.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.7 t -63.18 -44.31 99.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 109.686 -0.487 . . . . 43.859999999999999 109.686 -178.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.919 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.0 mm -61.28 -42.47 93.66 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 108.321 -0.992 . . . . 91.129999999999995 108.321 -176.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' CYS . . . . . 0.482 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.2 t -62.69 -37.94 88.43 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 108.715 -0.846 . . . . 65.879999999999995 108.715 -178.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.3 t -62.12 -41.84 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 N-CA-C 109.523 -0.547 . . . . 33.859999999999999 109.523 -177.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 1.098 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.42 -40.33 85.93 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.147 0 N-CA-C 107.527 -1.286 . . . . 146.52000000000001 107.527 -176.749 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 155' ' ' TRP . . . . . 0.699 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.1 m95 -62.85 -38.34 90.43 Favored 'General case' 0 N--CA 1.428 -1.529 0 C-N-CA 119.501 -0.88 . . . . 75.439999999999998 108.934 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.8 t -60.53 -48.42 88.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 O-C-N 121.023 -1.048 . . . . 43.640000000000001 109.711 -177.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.792 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.71 -38.01 89.5 Favored 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 109.013 -0.736 . . . . 102.56999999999999 109.013 -178.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.97 -41.05 86.62 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.437 -1.32 . . . . 58.159999999999997 107.437 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.799 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.08 -32.54 73.94 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.995 -0.743 . . . . 121.11 108.995 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.792 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.0 -42.3 84.88 Favored 'General case' 0 CA--C 1.489 -1.383 0 C-N-CA 118.594 -1.242 . . . . 153.15000000000001 109.916 -178.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 1.057 HD13 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.13 -43.68 19.04 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 113.107 -3.437 . . . . 133.66999999999999 113.515 173.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.478 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -63.01 -39.87 96.07 Favored 'General case' 0 CA--C 1.489 -1.401 0 O-C-N 120.941 -1.1 . . . . 157.41999999999999 112.242 -171.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.522 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.2 t80 -74.44 -36.1 2.44 Favored Pre-proline 0 N--CA 1.437 -1.106 0 N-CA-C 115.06 1.504 . . . . 250.91 115.06 -173.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.293 53.5 Cg_exo -59.47 -25.49 78.83 Favored 'Trans proline' 0 CA--C 1.488 -1.809 0 N-CA-C 118.015 2.275 . . . . 207.34 118.015 -174.385 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.916 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 32.4 mt-30 -61.16 -34.24 74.71 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.951 -1.5 . . . . 192.46000000000001 106.951 178.05 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.48 -41.02 98.14 Favored Glycine 0 C--N 1.353 1.499 0 N-CA-C 107.991 -2.044 . . . . 261.0 107.991 177.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.8 159.1 26.04 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 101.519 -3.511 . . . . 491.39999999999998 101.519 172.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -59.93 106.79 0.54 Allowed 'General case' 0 CA--C 1.487 -1.443 0 C-N-CA 116.281 -2.168 . . . . 386.10000000000002 109.836 -176.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.916 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 73.8 m -154.06 -166.6 2.41 Favored 'General case' 0 N--CA 1.414 -2.249 0 N-CA-C 103.531 -2.766 . . . . 289.80000000000001 103.531 -178.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' THR . . . . . 1.139 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.94 175.37 0.87 Allowed 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 117.767 -1.111 . . . . 402.06 109.566 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.788 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 73.4 p -165.22 177.5 7.59 Favored 'General case' 0 CA--C 1.586 2.361 0 C-N-CA 127.329 2.252 . . . . 690.52999999999997 114.909 177.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.488 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.8 mm-40 132.38 160.58 0.0 OUTLIER 'General case' 1 C--N 1.429 4.057 1 N-CA-C 123.149 4.5 . . . . 633.62 123.149 162.669 . . . . . . . . 4 3 . 1 . 002 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.761 HG22 ' SG ' ' A' ' 180' ' ' CYS . 68.9 p -85.61 153.78 22.15 Favored 'General case' 0 C--N 1.389 2.29 0 C-N-CA 127.424 2.289 . . . . 617.99000000000001 110.892 178.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' MET . . . . . 1.043 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.65 174.35 6.08 Favored Pre-proline 0 C--N 1.363 1.182 0 C-N-CA 130.268 3.427 . . . . 434.98000000000002 113.429 -175.499 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 1.091 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 52.7 Cg_endo -44.23 -65.67 0.18 Allowed 'Trans proline' 0 N--CA 1.442 -1.557 0 N-CA-C 122.357 3.945 . . . . 365.88 122.357 -168.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' SER . . . . . 0.778 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.305 70.4 m -84.91 20.93 1.7 Allowed 'General case' 0 CA--C 1.467 -2.228 0 N-CA-C 104.772 -2.307 . . . . 635.80999999999995 104.772 178.197 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.75 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.456 5.0 mmp_? -94.35 152.28 18.76 Favored 'General case' 1 CA--C 1.419 -4.092 3 N-CA-C 131.969 7.766 . . . . 999.99000000000001 131.969 -135.771 . . . . . . . . 5 3 . 1 . 002 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 1.057 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.911 37.1 t -131.86 73.18 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.383 -3.797 1 CA-C-N 103.288 -6.323 . . . . 594.32000000000005 113.628 149.186 . . . . . . . . 4 3 . 1 . 002 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.729 HG13 ' HB2' ' A' ' 174' ' ' MET . 7.3 p -144.21 144.11 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.642 1 N-CA-C 98.296 -4.705 . . . . 811.90999999999997 98.296 162.403 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.761 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.9 m -118.46 144.54 45.92 Favored 'General case' 0 CA--C 1.488 -1.413 0 C-N-CA 117.081 -1.848 . . . . 999.99000000000001 109.408 -178.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.971 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.8 mmm -147.21 -175.59 4.89 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-O 121.988 0.899 . . . . 431.86000000000001 110.058 -177.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 1.037 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.19 148.66 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 C-N-CA 124.345 1.058 . . . . 457.18000000000001 108.811 -177.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' GLU . . . . . 0.788 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.32 85.46 3.74 Favored 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 124.132 0.973 . . . . 458.76999999999998 113.495 -174.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.957 ' CZ3' HG22 ' A' ' 182' ' ' ILE . 1.9 p90 -76.37 -31.56 0.98 Allowed Pre-proline 0 N--CA 1.438 -1.055 0 C-N-CA 124.98 1.312 . . . . 999.99000000000001 112.425 168.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.956 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -65.94 -45.81 5.62 Favored 'Trans proline' 0 N--CA 1.437 -1.817 0 N-CA-C 120.847 3.364 . . . . 999.99000000000001 120.847 -174.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.507 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.59 171.75 8.14 Favored 'General case' 0 CA--C 1.472 -2.033 0 C-N-CA 117.156 -1.817 . . . . 81.180000000000007 107.213 -172.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.834 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 6.4 p80 -109.15 45.16 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.84 0 C-N-CA 115.498 -2.481 . . . . 999.99000000000001 108.72 177.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 1.074 ' HB2' HD12 ' A' ' 191' ' ' ILE . 87.2 Cg_endo -41.58 101.8 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.146 1 C-N-CA 126.021 4.481 . . . . 999.99000000000001 105.696 -170.75 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -62.21 -44.07 97.41 Favored 'General case' 0 CA--C 1.484 -1.586 0 C-N-CA 126.755 2.022 . . . . 967.72000000000003 112.062 -165.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 190' ' ' LYS . 30.3 mmtp -60.24 -36.57 78.03 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 106.732 -1.581 . . . . 934.29999999999995 106.732 -175.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 1.074 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.57 -30.29 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 C-N-CA 129.2 3.0 . . . . 565.14999999999998 113.888 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 61.54 55.42 2.8 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-N 118.464 0.575 . . . . 755.61000000000001 109.855 -175.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 1.139 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.49 -49.27 67.16 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 124.532 1.133 . . . . 325.88999999999999 113.278 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.632 ' HE3' ' OH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.8 -44.96 78.29 Favored 'General case' 0 CA--C 1.495 -1.163 0 C-N-CA 123.537 0.735 . . . . 250.21000000000001 111.679 -169.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.5 t -64.72 -43.35 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-O 121.589 0.709 . . . . 142.46000000000001 110.389 -175.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 1.037 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.7 t80 -61.07 -41.54 96.83 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 123.986 0.914 . . . . 247.69 108.836 -173.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.824 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 23.1 t60 -60.49 -51.37 69.75 Favored 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 125.45 1.5 . . . . 199.61000000000001 113.059 -175.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.1 mt -65.37 -44.42 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 107.732 -1.21 . . . . 106.73 107.732 -177.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' CYS . . . . . 0.722 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.6 t -59.21 -48.49 81.42 Favored 'General case' 0 CA--C 1.486 -1.495 0 CA-C-N 115.881 -0.599 . . . . 115.01000000000001 110.245 -173.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 1.057 HG13 HD13 ' A' ' 161' ' ' LEU . 86.2 t -65.21 -49.21 80.24 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.671 0 C-N-CA 119.428 -0.909 . . . . 129.41999999999999 111.846 -174.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.793 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.9 m -61.84 -53.13 60.02 Favored 'General case' 0 CA--C 1.482 -1.651 0 C-N-CA 118.213 -1.395 . . . . 172.47999999999999 109.971 -172.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.632 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.5 t -63.9 -54.26 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 C-N-CA 120.519 -0.472 . . . . 55.859999999999999 110.946 -174.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.722 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.53 -51.54 59.13 Favored 'General case' 0 N--CA 1.432 -1.362 0 C-N-CA 118.533 -1.267 . . . . 184.68000000000001 111.541 -174.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 1.05 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.6 -52.45 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 C-N-CA 116.663 -2.015 . . . . 291.81 114.704 -174.713 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.549 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.8 t80 -82.1 -54.97 4.86 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 115.136 1.532 . . . . 130.66 115.136 -178.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' PHE . . . . . 0.793 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.7 m-85 -66.84 -48.57 68.47 Favored 'General case' 0 CA--C 1.496 -1.096 0 N-CA-C 114.473 1.286 . . . . 80.159999999999997 114.473 -170.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.894 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.48 -45.5 83.63 Favored Pre-proline 0 N--CA 1.435 -1.201 0 C-N-CA 119.97 -0.692 . . . . 136.02000000000001 109.504 -174.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.894 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.3 Cg_exo -64.82 -27.13 59.55 Favored 'Trans proline' 0 N--CA 1.433 -2.065 0 N-CA-C 110.595 -0.579 . . . . 92.170000000000002 110.595 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.686 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.29 -41.48 76.76 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 107.456 -1.312 . . . . 135.59999999999999 107.456 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.17 -44.68 91.3 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 109.555 -0.535 . . . . 52.100000000000001 109.555 -176.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.616 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.72 -43.5 97.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 109.055 -0.72 . . . . 95.890000000000001 109.055 -176.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.904 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.25 -42.39 93.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 106.699 -1.593 . . . . 43.409999999999997 106.699 -178.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.39 -42.32 99.14 Favored Glycine 0 N--CA 1.432 -1.626 0 N-CA-C 109.384 -1.487 . . . . 27.690000000000001 109.384 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' TYR . . . . . 0.887 ' O ' HG22 ' A' ' 217' ' ' THR . 78.0 t80 -65.63 -47.41 75.71 Favored 'General case' 0 CA--C 1.497 -1.086 0 O-C-N 122.209 -0.583 . . . . 54.409999999999997 110.466 -177.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ALA . . . . . 0.827 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.43 -34.07 74.78 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 106.989 -1.485 . . . . 53.880000000000003 106.989 -177.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -60.82 -40.76 93.97 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 108.447 -0.946 . . . . 68.290000000000006 108.447 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' THR . . . . . 0.887 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.85 -38.99 92.83 Favored 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 119.677 -0.809 . . . . 107.59 110.618 -175.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.827 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.06 -38.35 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 C-N-CA 119.615 -0.834 . . . . 111.61 109.488 -177.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.92 HG13 ' CD1' ' A' ' 134' ' ' ILE . 79.8 t -63.27 -22.51 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.392 -0.966 . . . . 85.260000000000005 108.392 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.85 -41.95 99.4 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.07 -0.812 . . . . 40.710000000000001 111.07 -176.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.5 mm -64.72 -44.0 96.53 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 N-CA-C 108.414 -0.958 . . . . 95.859999999999999 108.414 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.822 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.9 p -76.99 -137.5 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.408 -0.96 . . . . 144.37 108.408 -176.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.902 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.6 mt -55.36 132.14 47.4 Favored 'General case' 0 CA--C 1.487 -1.452 0 N-CA-C 107.63 -1.248 . . . . 326.72000000000003 107.63 -177.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' TRP . . . . . 0.462 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 9.0 t90 -119.32 -168.07 1.51 Allowed 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 106.011 -1.848 . . . . 158.38 106.011 -176.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.462 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.37 -41.93 98.85 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 109.627 -0.509 . . . . 36.780000000000001 109.627 -178.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 73.0 m -61.19 125.88 25.35 Favored 'General case' 0 N--CA 1.434 -1.274 0 C-N-CA 119.115 -1.034 . . . . 85.459999999999994 109.802 -174.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' GLU . . . . . 0.693 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.86 126.54 8.85 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 105.538 -2.023 . . . . 127.78 105.538 176.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.927 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -85.99 139.89 34.89 Favored Pre-proline 0 CA--C 1.492 -1.253 0 N-CA-C 105.964 -1.865 . . . . 164.84 105.964 -179.624 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.927 ' N ' HD13 ' A' ' 228' ' ' ILE . 81.3 Cg_exo -56.8 -39.89 88.15 Favored 'Trans proline' 0 N--CA 1.431 -2.185 0 N-CA-C 113.977 0.722 . . . . 222.34999999999999 113.977 -176.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' GLY . . . . . 0.744 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.12 166.96 44.93 Favored Glycine 0 N--CA 1.427 -1.912 0 N-CA-C 106.432 -2.667 . . . . 45.219999999999999 106.432 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.882 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.8 t0 -60.93 -45.77 93.37 Favored 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 106.045 -1.835 . . . . 107.56999999999999 106.045 177.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' SER . . . . . 0.73 ' O ' HG21 ' A' ' 228' ' ' ILE . 68.0 m -65.82 141.82 58.16 Favored 'General case' 0 N--CA 1.428 -1.539 0 C-N-CA 118.907 -1.117 . . . . 167.96000000000001 109.128 -175.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.828 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.1 m 99.53 106.73 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 126.729 2.012 . . . . 280.68000000000001 109.754 176.147 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.711 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.6 m-20 56.06 11.18 0.7 Allowed 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 124.417 1.087 . . . . 218.25 110.679 174.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.921 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.32 137.61 54.8 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 105.222 -2.14 . . . . 343.56999999999999 105.222 177.448 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.48 ' O ' HG21 ' A' ' 240' ' ' VAL . 85.5 t80 -111.98 81.94 1.54 Allowed 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 106.852 -1.536 . . . . 263.29000000000002 106.852 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' HIS . . . . . 0.625 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 64.6 m80 104.27 147.08 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.283 0 C-N-CA 126.602 1.961 . . . . 261.92000000000002 108.497 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.23 -38.08 89.75 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 107.882 -1.155 . . . . 106.81 107.882 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.738 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.49 -39.87 94.86 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 118.325 -1.35 . . . . 112.2 107.549 -178.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.736 HG12 ' NH1' ' A' ' 244' ' ' ARG . 75.7 t -64.32 -39.8 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 N-CA-C 109.254 -0.647 . . . . 45.409999999999997 109.254 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' SER . . . . . 0.805 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.4 p -70.93 -32.02 68.8 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 110.296 -0.261 . . . . 97.620000000000005 110.296 -178.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.42 -39.62 81.51 Favored 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 123.713 0.805 . . . . 59.289999999999999 110.959 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.738 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.23 -36.58 84.11 Favored 'General case' 0 CA--C 1.492 -1.265 0 C-N-CA 124.722 1.209 . . . . 106.48999999999999 110.682 -174.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.921 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.95 -30.64 69.22 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 108.313 -0.995 . . . . 106.62 108.313 -176.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.531 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -66.03 -40.99 91.48 Favored 'General case' 0 N--CA 1.435 -1.175 0 O-C-N 121.821 -0.55 . . . . 75.969999999999999 110.065 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.444 ' CG1' ' HE1' ' A' ' 250' ' ' MET . 76.8 t -65.55 -40.82 89.26 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 C-N-CA 122.926 0.49 . . . . 65.269999999999996 109.815 -178.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.775 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.9 p -63.99 -41.65 93.16 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 C-N-CA 120.42 -0.512 . . . . 107.94 110.125 -177.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.536 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.1 pttt -63.55 -40.77 97.86 Favored 'General case' 0 N--CA 1.434 -1.239 0 O-C-N 121.71 -0.619 . . . . 87.980000000000004 110.286 -176.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 249' ' ' MET . . . . . 0.823 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.65 -40.4 96.76 Favored 'General case' 0 CA--C 1.492 -1.268 0 C-N-CA 118.849 -1.141 . . . . 65.5 108.355 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' MET . . . . . 0.772 ' HE2' ' CG2' ' A' ' 67' ' ' THR . 68.5 mtt -61.75 -36.36 80.8 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 108.095 -1.076 . . . . 85.049999999999997 108.095 -177.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.536 HD12 ' HA ' ' A' ' 248' ' ' LYS . 86.8 mt -63.5 -45.76 96.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 N-CA-C 109.032 -0.729 . . . . 42.25 109.032 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.823 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.3 -38.27 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 C-N-CA 119.594 -0.842 . . . . 91.010000000000005 109.443 -176.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 1.002 HG22 ' CD1' ' A' ' 304' ' ' ILE . 65.9 t -58.9 -41.55 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 N-CA-C 107.965 -1.124 . . . . 66.090000000000003 107.965 -178.122 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 250' ' ' MET . 94.7 t -66.08 -43.18 92.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 C-N-CA 120.719 -0.393 . . . . 52.390000000000001 110.323 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.1 m -61.7 -46.79 88.18 Favored 'General case' 0 CA--C 1.489 -1.4 0 O-C-N 121.847 -0.533 . . . . 46.420000000000002 109.877 -174.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' THR . . . . . 0.744 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.5 t -62.31 -38.12 88.19 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 108.322 -0.992 . . . . 116.51000000000001 108.322 -177.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 257' ' ' PHE . . . . . 0.488 ' N ' HG23 ' A' ' 256' ' ' THR . 86.1 t80 -60.28 -48.25 82.53 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 109.358 -0.608 . . . . 65.180000000000007 109.358 -178.118 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.91 -42.72 97.33 Favored 'General case' 0 CA--C 1.49 -1.358 0 CA-C-O 120.869 0.366 . . . . 51.329999999999998 110.458 -175.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' ILE . . . . . 0.744 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.57 -43.38 98.22 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.573 0 C-N-CA 118.89 -1.124 . . . . 126.3 109.038 -176.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 260' ' ' CYS . . . . . 0.509 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.5 m -65.6 -49.32 69.23 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 119.521 -0.872 . . . . 133.94 112.462 -176.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.82 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.0 m95 -80.68 -33.29 35.57 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 116.888 2.181 . . . . 134.84 116.888 -176.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.785 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.9 tp -58.48 -41.6 90.06 Favored Pre-proline 0 CA--C 1.493 -1.219 0 O-C-N 121.689 -0.632 . . . . 72.230000000000004 111.658 -167.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 263' ' ' PRO . . . . . 0.785 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 79.8 Cg_exo -60.7 -35.94 87.09 Favored 'Trans proline' 0 C--N 1.295 -2.281 0 CA-C-N 119.813 0.969 . . . . 106.13 111.368 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 264' ' ' PHE . . . . . 0.851 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.6 t80 -66.42 -44.69 82.27 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 119.775 -0.77 . . . . 128.34999999999999 110.045 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 265' ' ' HIS . . . . . 0.643 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.43 -37.83 88.9 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 110.249 -0.278 . . . . 100.73 110.249 -177.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.745 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.22 -44.6 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 C-N-CA 119.346 -0.942 . . . . 172.72 109.149 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 267' ' ' PHE . . . . . 0.734 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.7 m-85 -66.59 -28.03 68.19 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 108.264 -1.013 . . . . 249.22999999999999 108.264 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 268' ' ' PHE . . . . . 0.9 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.57 -55.14 35.4 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.687 -1.597 . . . . 259.77999999999997 106.687 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 269' ' ' LEU . . . . . 0.492 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.2 mt -69.17 -44.12 72.88 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 113.612 0.967 . . . . 233.11000000000001 113.612 -176.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.838 ' O ' HG13 ' A' ' 273' ' ' ILE . 89.1 mt -61.37 -48.31 91.41 Favored Pre-proline 0 N--CA 1.439 -0.976 0 C-N-CA 119.155 -1.018 . . . . 169.53999999999999 110.642 -171.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 271' ' ' PRO . . . . . 0.734 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.9 Cg_exo -61.13 -24.49 79.34 Favored 'Trans proline' 0 N--CA 1.429 -2.276 0 C-N-CA 116.715 -1.723 . . . . 255.47 114.698 174.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 272' ' ' TYR . . . . . 0.824 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.6 t80 -63.58 -44.26 94.6 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 119.228 0.922 . . . . 279.02999999999997 108.854 177.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.838 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.36 -44.77 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 N-CA-C 110.056 -0.35 . . . . 162.21000000000001 110.056 -178.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 274' ' ' ASN . . . . . 0.867 HD22 HD12 ' A' ' 277' ' ' LEU . 49.0 t30 -125.38 84.87 59.27 Favored Pre-proline 0 N--CA 1.43 -1.428 0 C-N-CA 118.775 -1.17 . . . . 128.13 108.12 -178.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 275' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.5 Cg_endo -85.22 164.01 11.3 Favored 'Trans proline' 0 C--N 1.294 -2.304 0 N-CA-C 107.455 -1.787 . . . . 278.35000000000002 107.455 177.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 276' ' ' ASP . . . . . 0.869 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.4 t0 66.12 15.01 9.92 Favored 'General case' 0 N--CA 1.428 -1.569 0 O-C-N 123.777 0.673 . . . . 312.91000000000003 109.326 175.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.869 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.3 mt -132.71 -170.67 2.49 Favored 'General case' 0 CA--C 1.481 -1.679 0 N-CA-C 106.556 -1.646 . . . . 353.54000000000002 106.556 177.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 1.009 ' HA ' ' CB ' ' A' ' 282' ' ' PHE . 42.8 p90 -115.67 142.25 46.99 Favored 'General case' 0 N--CA 1.427 -1.619 0 N-CA-C 107.439 -1.319 . . . . 251.25999999999999 107.439 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.762 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -76.97 -118.71 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 102.103 -3.295 . . . . 175.25999999999999 102.103 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 280' ' ' LYS . . . . . 0.796 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.5 -44.96 96.14 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 100.884 -3.747 . . . . 99.069999999999993 100.884 172.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 281' ' ' LYS . . . . . 0.796 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.45 124.18 9.17 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 103.45 -2.796 . . . . 243.21000000000001 103.45 171.186 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 1.009 ' CB ' ' HA ' ' A' ' 278' ' ' TYR . 77.1 t80 -93.0 112.98 25.13 Favored 'General case' 0 CA--C 1.473 -2.003 0 C-N-CA 116.065 -2.254 . . . . 201.03999999999999 105.286 178.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 283' ' ' ILE . . . . . 0.776 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.96 173.71 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.085 0 C-N-CA 116.004 -2.278 . . . . 201.36000000000001 108.802 -175.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 284' ' ' GLN . . . . . 1.091 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.283 0.6 OUTLIER -59.48 -41.44 89.8 Favored 'General case' 0 N--CA 1.415 -2.176 0 CA-C-N 113.233 -1.803 . . . . 203.81999999999999 107.896 174.462 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 285' ' ' GLN . . . . . 0.923 ' HG2' HE21 ' A' ' 284' ' ' GLN . 1.2 mm100 -64.29 -45.72 86.77 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 118.215 -1.394 . . . . 215.06 112.553 -171.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.552 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.2 t -65.63 -46.45 89.36 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.476 0 C-N-CA 118.565 -1.254 . . . . 125.28 112.951 -171.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 287' ' ' TYR . . . . . 0.952 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.73 -37.04 86.23 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 107.205 -1.405 . . . . 268.89999999999998 107.205 -171.896 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.796 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.26 -44.97 74.41 Favored 'General case' 0 N--CA 1.427 -1.583 0 C-N-CA 125.657 1.583 . . . . 280.88 108.762 -172.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.67 -47.47 86.11 Favored 'General case' 0 N--CA 1.428 -1.564 0 C-N-CA 118.987 -1.085 . . . . 184.47 108.979 -172.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' ILE . . . . . 0.851 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.8 mp -67.94 -42.1 85.28 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 C-N-CA 119.247 -0.981 . . . . 167.91999999999999 112.739 -175.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 291' ' ' MET . . . . . 0.501 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.8 ttt -65.72 -38.83 90.26 Favored 'General case' 0 CA--C 1.495 -1.136 0 C-N-CA 117.751 -1.58 . . . . 367.18000000000001 110.802 -175.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 292' ' ' TRP . . . . . 0.548 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.5 m95 -67.14 -32.7 74.0 Favored 'General case' 0 N--CA 1.435 -1.208 0 O-C-N 121.856 -0.527 . . . . 173.97 110.466 177.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.1 tp -64.44 -36.85 85.51 Favored 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 123.6 0.76 . . . . 119.66 109.777 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 294' ' ' ALA . . . . . 0.82 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.16 -33.99 74.3 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 107.734 -1.21 . . . . 112.3 107.734 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 295' ' ' MET . . . . . 0.773 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.13 -32.04 73.33 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 116.202 -0.454 . . . . 174.16999999999999 110.237 -177.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.7 m -64.69 -22.76 67.06 Favored 'General case' 0 CA--C 1.485 -1.536 0 C-N-CA 124.629 1.171 . . . . 145.27000000000001 110.645 -175.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 297' ' ' SER . . . . . 0.758 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.6 m -57.65 -35.35 70.41 Favored 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 108.084 -1.08 . . . . 170.15000000000001 108.084 -175.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.82 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.7 t -55.28 -34.21 63.9 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 116.282 -0.417 . . . . 214.56999999999999 110.64 -171.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 299' ' ' MET . . . . . 0.751 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.1 ttt -77.17 -33.22 56.52 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 126.065 1.746 . . . . 168.28999999999999 115.534 177.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 300' ' ' TYR . . . . . 0.758 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.4 p90 -64.38 -34.86 79.13 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 114.066 1.135 . . . . 167.15000000000001 114.066 -168.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 301' ' ' ASN . . . . . 0.723 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.282 18.8 p-10 -64.23 -38.32 33.25 Favored Pre-proline 0 N--CA 1.434 -1.266 0 C-N-CA 115.52 -2.472 . . . . 165.13 113.921 -171.59 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 302' ' ' PRO . . . . . 0.723 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.2 Cg_exo -62.52 -31.84 80.17 Favored 'Trans proline' 0 N--CA 1.433 -2.035 0 CA-C-N 122.755 2.019 . . . . 123.92 111.271 -178.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 303' ' ' ILE . . . . . 0.717 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.0 pt -68.75 -42.55 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 C-N-CA 118.869 -1.132 . . . . 110.55 109.755 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 304' ' ' ILE . . . . . 1.002 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.1 pt -61.2 -39.99 84.37 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.168 0 N-CA-C 108.806 -0.813 . . . . 145.31 108.806 -177.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 305' ' ' TYR . . . . . 0.923 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.253 63.2 m-85 -58.13 -48.78 79.17 Favored 'General case' 0 CA--C 1.493 -1.212 0 C-N-CA 119.375 -0.93 . . . . 246.68000000000001 109.837 -177.499 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 87.3 m -62.23 -47.52 84.03 Favored 'General case' 0 CA--C 1.485 -1.532 0 C-N-CA 119.549 -0.86 . . . . 64.430000000000007 109.52 -173.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.7 t -66.83 -45.01 79.61 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 118.993 -1.083 . . . . 80.719999999999999 110.226 -177.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.709 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.53 -35.69 75.7 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 115.972 1.841 . . . . 140.44 115.972 -173.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 309' ' ' ASN . . . . . 0.657 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.85 132.23 34.3 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 112.685 -3.606 . . . . 178.87 113.064 -177.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 310' ' ' ASP . . . . . 0.614 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.6 p-10 -65.03 -37.03 86.29 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 114.382 -1.281 . . . . 110.22 110.113 -177.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.856 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.75 -50.59 72.72 Favored 'General case' 0 CA--C 1.492 -1.263 0 O-C-N 121.697 -0.627 . . . . 174.78 109.765 -174.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.958 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.1 m-85 -64.87 -41.7 95.44 Favored 'General case' 0 CA--C 1.485 -1.536 0 N-CA-C 108.228 -1.027 . . . . 161.84 108.228 178.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 313' ' ' ARG . . . . . 0.517 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.31 -50.22 73.62 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.196 -0.668 . . . . 117.2 109.196 -173.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.797 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.54 -44.06 75.36 Favored 'General case' 0 N--CA 1.433 -1.275 0 C-N-CA 120.352 -0.539 . . . . 112.59999999999999 111.092 -177.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 315' ' ' GLY . . . . . 0.872 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -64.08 -37.43 94.57 Favored Glycine 0 N--CA 1.431 -1.678 0 N-CA-C 110.59 -1.004 . . . . 101.45999999999999 110.59 -177.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 316' ' ' PHE . . . . . 1.017 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.6 m-85 -62.17 -46.01 90.86 Favored 'General case' 0 CA--C 1.491 -1.307 0 CA-C-N 118.521 1.16 . . . . 151.49000000000001 109.523 -178.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 317' ' ' LYS . . . . . 0.422 ' HE3' ' HB2' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.07 -36.3 77.06 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 106.957 -1.498 . . . . 142.31999999999999 106.957 -175.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 318' ' ' HIS . . . . . 0.826 ' NE2' HG21 ' A' ' 326' ' ' ILE . 49.9 m80 -59.79 -41.82 92.01 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 106.903 -1.517 . . . . 109.09 106.903 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.86 -42.41 85.71 Favored 'General case' 0 N--CA 1.435 -1.177 0 O-C-N 122.334 -0.228 . . . . 76.109999999999999 111.037 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -61.46 -55.43 31.37 Favored 'General case' 0 CA--C 1.49 -1.36 0 C-N-CA 119.849 -0.74 . . . . 120.23999999999999 109.331 -174.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.578 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.5 mtt180 -74.34 131.52 41.21 Favored 'General case' 0 CA--C 1.482 -1.66 0 N-CA-C 102.957 -2.979 . . . . 192.72999999999999 102.957 177.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.14 -44.24 92.05 Favored 'General case' 0 CA--C 1.492 -1.266 0 C-N-CA 119.042 -1.063 . . . . 176.28999999999999 109.153 -172.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 323' ' ' CYS . . . . . 0.753 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.6 m -79.37 -177.07 0.8 Allowed Pre-proline 0 CA--C 1.487 -1.453 0 N-CA-C 106.241 -1.762 . . . . 69.680000000000007 106.241 178.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.567 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.5 Cg_exo -59.08 -75.51 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.403 0 C-N-CA 118.31 -0.66 . . . . 191.05000000000001 112.614 176.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 325' ' ' PHE . . . . . 0.753 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.5 m-85 47.48 43.92 16.24 Favored 'General case' 0 CA--C 1.493 -1.229 0 O-C-N 123.575 0.547 . . . . 287.02999999999997 109.737 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 326' ' ' ILE . . . . . 0.826 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.51 78.59 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.474 -1.946 0 C-N-CA 112.992 -3.483 . . . . 292.29000000000002 109.8 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 327' ' ' SER . . . . . 0.48 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.3 t -77.53 -152.81 0.05 Allowed 'General case' 0 N--CA 1.424 -1.775 0 N-CA-C 104.209 -2.515 . . . . 184.56999999999999 104.209 178.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 328' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.74 8.6 4.92 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 113.045 0.757 . . . . 274.56 113.045 176.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.97 0.91 57.26 Favored Glycine 0 C--N 1.348 1.198 0 C-N-CA 117.746 -2.168 . . . . 268.24000000000001 113.465 172.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 330' ' ' ASP . . . . . 0.698 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.5 m-20 51.59 -172.04 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.063 0 CA-C-N 118.677 1.239 . . . . 200.06 110.734 177.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.856 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.88 -32.98 74.68 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 107.878 -1.156 . . . . 114.44 107.878 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 332' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.28 46.04 21.92 Favored 'General case' 0 CA--C 1.484 -1.591 0 N-CA-C 107.638 -1.245 . . . . 263.81 107.638 -177.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 333' ' ' GLY . . . . . 0.634 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.3 -137.36 3.61 Favored Glycine 0 CA--C 1.479 -2.204 1 N-CA-C 102.556 -4.218 . . . . 103.79000000000001 102.556 -179.815 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 1.048 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.2 mt -88.26 95.54 10.22 Favored 'General case' 0 N--CA 1.419 -1.996 0 C-N-CA 114.936 -2.706 . . . . 117.3 106.018 177.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 335' ' ' GLU . . . . . 1.028 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.91 -39.83 90.91 Favored 'General case' 0 CA--C 1.469 -2.16 1 N-CA-C 97.994 -4.817 . . . . 231.58000000000001 97.994 167.264 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 336' ' ' MET . . . . . 1.036 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.92 163.49 29.05 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 102.11 -3.293 . . . . 303.24000000000001 102.11 168.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 337' ' ' LYS . . . . . 1.048 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.3 tttt -62.62 -48.6 78.68 Favored 'General case' 0 N--CA 1.432 -1.365 0 C-N-CA 116.038 -2.265 . . . . 112.72 108.411 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.9 t -61.04 -63.63 1.23 Allowed 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 109.117 -0.697 . . . . 83.219999999999999 109.117 -176.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 339' ' ' THR . . . . . 0.884 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.1 m -156.28 -126.21 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 103.833 -2.654 . . . . 174.36000000000001 103.833 -178.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 340' ' ' ARG . . . . . 1.028 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.86 160.95 8.77 Favored 'General case' 0 CA--C 1.486 -1.504 0 N-CA-C 105.761 -1.94 . . . . 202.72999999999999 105.761 177.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 341' ' ' TYR . . . . . 1.018 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.98 149.08 52.53 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 107.046 -1.465 . . . . 180.62 107.046 176.358 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.931 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.4 tp -178.52 -171.86 0.27 Allowed 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 105.409 -2.071 . . . . 145.25 105.409 178.098 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 343' ' ' GLN . . . . . 0.931 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.08 -43.17 88.11 Favored 'General case' 0 CA--C 1.487 -1.477 0 N-CA-C 106.129 -1.804 . . . . 66.049999999999997 106.129 174.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 344' ' ' THR . . . . . 0.766 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.1 t -132.68 -152.12 0.48 Allowed 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 103.505 -2.776 . . . . 266.49000000000001 103.505 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 345' ' ' GLN . . . . . 0.699 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.4 mt-30 66.27 -124.96 0.28 Allowed 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 117.043 -1.863 . . . . 219.19999999999999 107.801 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 346' ' ' GLY . . . . . 0.902 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.02 -37.43 94.23 Favored Glycine 0 N--CA 1.425 -2.044 0 CA-C-N 114.558 -1.201 . . . . 94.780000000000001 112.852 -176.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 347' ' ' SER . . . . . 0.826 ' HB2' ' H ' ' A' ' 342' ' ' LEU . 48.4 t -81.11 100.38 9.01 Favored 'General case' 0 CA--C 1.484 -1.575 0 C-N-CA 112.316 -3.753 . . . . 121.41 109.468 -171.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 348' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.8 t -72.99 145.47 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 108.997 -0.742 . . . . 85.340000000000003 108.997 -176.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 349' ' ' TYR . . . . . 0.441 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.5 p90 -57.76 143.47 41.86 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 107.839 -1.171 . . . . 267.56999999999999 107.839 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 350' ' ' LYS . . . . . 0.525 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.01 69.58 0.6 Allowed 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 109.553 -0.536 . . . . 226.09999999999999 109.553 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 351' ' ' VAL . . . . . 0.825 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.5 p -50.94 156.94 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.315 0 N-CA-C 106.994 -1.484 . . . . 154.84 106.994 177.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 352' ' ' SER . . . . . 0.582 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.4 m -61.35 161.87 8.59 Favored 'General case' 0 CA--C 1.494 -1.21 0 CA-C-O 121.588 0.709 . . . . 180.00999999999999 110.722 -173.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 353' ' ' ARG . . . . . 0.895 ' H ' ' HD3' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.41 156.92 23.6 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 106.976 -1.49 . . . . 333.77999999999997 106.976 -178.653 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 354' ' ' LEU . . . . . 0.974 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.06 142.51 48.79 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 107.364 -1.347 . . . . 335.19999999999999 107.364 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.974 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.6 mm-40 82.88 158.91 0.13 Allowed 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 108.703 -0.851 . . . . 266.47000000000003 108.703 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.8 m -60.66 -46.92 88.5 Favored 'General case' 0 CA--C 1.487 -1.465 0 N-CA-C 105.632 -1.988 . . . . 59.340000000000003 105.632 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.53 173.87 11.97 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 104.462 -2.421 . . . . 201.25999999999999 104.462 176.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.748 HG22 ' O ' ' A' ' 360' ' ' THR . 69.3 mt -95.94 106.78 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 C-N-CA 116.29 -2.164 . . . . 56.229999999999997 105.503 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 359' ' ' SER . . . . . 0.464 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.9 m -61.19 -59.45 5.29 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 109.319 -0.623 . . . . 87.579999999999998 109.319 -175.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 360' ' ' THR . . . . . 0.891 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.2 t -85.55 153.74 22.22 Favored 'General case' 0 CA--C 1.485 -1.535 0 N-CA-C 107.821 -1.178 . . . . 219.94999999999999 107.821 -177.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 361' ' ' VAL . . . . . 0.588 ' O ' HG23 ' A' ' 361' ' ' VAL . 16.0 m -81.98 83.85 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 C-N-CA 116.35 -2.14 . . . . 121.79000000000001 105.432 177.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.597 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.3 t -154.14 159.72 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.559 0 N-CA-C 105.78 -1.933 . . . . 53.850000000000001 105.78 -179.177 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 363' ' ' GLY . . . . . 0.597 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.2 16.62 77.02 Favored Glycine 0 N--CA 1.428 -1.889 0 N-CA-C 106.029 -2.828 . . . . 196.55000000000001 106.029 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.653 0 N-CA-C 107.883 -1.154 . . . . 35.880000000000003 107.883 -178.971 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 365' ' ' ARG . . . . . 0.512 ' HE ' ' HB3' ' B' ' 365' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 108.867 -0.79 . . . . 1.0 108.867 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 366' ' ' PRO . . . . . 0.581 ' HG3' ' OD1' ' A' ' 3' ' ' ASN . 52.3 Cg_endo -66.89 142.0 60.98 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.059 1.839 . . . . 1.0 110.195 179.004 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 367' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -64.46 143.29 98.53 Favored Pre-proline 0 C--N 1.324 -0.503 0 C-N-CA 119.854 -0.738 . . . . 1.0 109.545 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 368' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.25 150.39 76.56 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.312 2.008 . . . . 1.0 111.738 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 369' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.71 131.71 44.29 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.709 -0.396 . . . . 1.0 110.248 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -101.95 115.9 31.54 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.372 -0.377 . . . . 1.0 110.727 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 371' ' ' PHE . . . . . 0.405 ' HA ' HD12 ' B' ' 374' ' ' LEU . 86.1 m-85 -63.6 -42.51 98.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.318 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 372' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -65.07 -36.14 83.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.839 -0.619 . . . . 1.0 110.672 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -59.73 -33.08 76.12 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.776 -0.93 . . . . 1.0 110.776 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 374' ' ' LEU . . . . . 0.656 ' CD1' HD11 ' A' ' 102' ' ' LEU . 3.2 mt -67.85 131.38 45.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.929 0.395 . . . . 1.0 110.16 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 375' ' ' MET . . . . . 0.416 ' HE2' ' HB2' ' B' ' 375' ' ' MET . 0.4 OUTLIER . . . . . 0 C--O 1.221 -0.424 0 CA-C-O 118.014 -0.993 . . . . 1.0 110.534 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.471 0 N-CA-C 108.398 -0.964 . . . . 97.079999999999998 108.398 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.682 ' ND2' ' HG3' ' B' ' 366' ' ' PRO . 46.5 t30 -110.62 155.43 22.38 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-O 122.172 0.987 . . . . 123.41 110.671 -172.077 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.881 HG11 HD13 ' A' ' 15' ' ' ILE . 28.8 m -134.56 -162.33 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.477 1 N-CA-C 100.121 -4.029 . . . . 151.30000000000001 100.121 173.72 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.908 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.69 -38.6 58.17 Favored Pre-proline 0 N--CA 1.439 -0.985 0 C-N-CA 115.961 -2.296 . . . . 169.25 106.104 178.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.908 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 57.6 Cg_exo -81.28 168.53 16.66 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 122.283 0.623 . . . . 185.75999999999999 110.568 171.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.904 HG13 ' CE2' ' A' ' 282' ' ' PHE . 91.7 t -64.5 -25.92 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 C-N-CA 127.041 2.137 . . . . 145.47 110.332 -177.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.774 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.2 t0 -84.32 157.44 21.5 Favored 'General case' 0 CA--C 1.499 -0.993 0 O-C-N 121.087 -1.008 . . . . 102.76000000000001 109.45 -178.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.6 p -82.6 154.23 25.06 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 107.943 -1.132 . . . . 106.25 107.943 178.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.921 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.7 p-10 -105.97 51.93 0.74 Allowed 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 117.763 -1.575 . . . . 157.81 107.597 178.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.22 -45.87 91.71 Favored 'General case' 0 CA--C 1.481 -1.698 0 N-CA-C 103.58 -2.748 . . . . 150.19999999999999 103.58 178.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 71.0 m -87.01 164.69 35.36 Favored Pre-proline 0 N--CA 1.421 -1.9 0 N-CA-C 103.689 -2.708 . . . . 183.52000000000001 103.689 172.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -76.75 6.86 3.84 Favored 'Trans proline' 0 C--N 1.281 -2.987 0 N-CA-C 110.011 -0.803 . . . . 235.61000000000001 110.011 176.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.423 ' C ' HD21 ' A' ' 14' ' ' ASN . 0.4 OUTLIER -57.92 -41.24 82.26 Favored 'General case' 0 N--CA 1.435 -1.198 0 C-N-CA 124.82 1.248 . . . . 113.77 113.386 -170.105 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.921 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.3 pt -52.22 136.26 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.912 0 CA-C-N 119.553 1.069 . . . . 150.84999999999999 110.942 -176.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.51 156.24 46.39 Favored 'General case' 0 C--N 1.36 1.06 0 N-CA-C 107.61 -1.256 . . . . 100.42 107.61 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . 1.081 HG23 ' H ' ' A' ' 20' ' ' SER . 14.2 t -64.99 142.6 58.38 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 121.971 0.891 . . . . 129.36000000000001 110.449 -174.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.775 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 74.7 m-20 -63.1 -25.5 68.39 Favored 'General case' 0 CA--C 1.494 -1.174 0 C-N-CA 126.28 1.832 . . . . 112.34 106.645 -177.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.935 HG23 ' HA2' ' A' ' 101' ' ' GLY . 85.3 m -74.11 -40.13 62.88 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 115.562 -0.744 . . . . 131.72999999999999 111.769 177.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . 1.081 ' H ' HG23 ' A' ' 17' ' ' THR . 70.8 m -84.47 -42.84 15.18 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 117.006 2.225 . . . . 80.489999999999995 117.006 -174.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.549 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.4 mt-10 -145.99 174.52 3.36 Favored Pre-proline 0 N--CA 1.442 -0.827 0 C-N-CA 118.124 -1.43 . . . . 98.980000000000004 111.172 -169.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.822 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.332 85.6 Cg_exo -61.84 -10.67 18.0 Favored 'Trans proline' 0 C--N 1.321 -0.87 1 N-CA-C 128.882 6.455 . . . . 246.94999999999999 128.882 -170.053 . . . . . . . . 4 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.0 m120 61.58 17.52 8.65 Favored 'General case' 0 C--N 1.324 -0.519 1 CA-C-N 126.181 4.082 . . . . 269.62 114.237 175.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.495 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 80.8 mt-30 -67.1 -27.24 67.17 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 107.806 -1.183 . . . . 86.799999999999997 107.806 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.552 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.4 p90 -66.85 -29.29 69.16 Favored 'General case' 0 N--CA 1.431 -1.391 0 O-C-N 121.166 -0.959 . . . . 85.909999999999997 110.514 -178.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.872 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.4 t -68.59 -40.2 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 C-N-CA 123.734 0.814 . . . . 82.0 111.312 -177.015 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.897 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 27.6 pt20 -151.41 167.73 12.48 Favored Pre-proline 0 CA--C 1.489 -1.401 0 N-CA-C 108.551 -0.907 . . . . 120.73 108.551 -178.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.904 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -64.0 149.76 89.82 Favored 'Trans proline' 0 N--CA 1.432 -2.136 0 C-N-CA 120.645 0.896 . . . . 87.859999999999999 109.912 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.743 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.03 -37.94 89.2 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.829 -0.804 . . . . 36.460000000000001 108.829 -176.157 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.813 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 28.0 p-90 -63.83 -33.84 76.58 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 107.837 -1.171 . . . . 150.59999999999999 107.837 -176.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.904 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.4 mt-30 -62.22 -32.66 73.35 Favored 'General case' 0 CA--C 1.49 -1.328 0 O-C-N 121.303 -0.873 . . . . 123.26000000000001 108.705 -178.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.743 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.5 -47.19 94.54 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.59 0 N-CA-C 109.162 -0.681 . . . . 120.14 109.162 176.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.785 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.3 m -67.38 -31.04 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 N-CA-C 107.865 -1.161 . . . . 112.19 107.865 -178.167 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.813 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.6 tp -62.99 -47.1 84.58 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 119.887 -0.725 . . . . 60.869999999999997 109.588 -178.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.672 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.04 -35.67 81.16 Favored 'General case' 0 CA--C 1.489 -1.389 0 C-N-CA 119.999 -0.681 . . . . 157.56999999999999 110.309 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.747 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.68 -40.83 98.33 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 108.617 -0.883 . . . . 47.060000000000002 108.617 178.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.805 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.8 -41.27 97.95 Favored 'General case' 0 CA--C 1.496 -1.112 0 O-C-N 121.728 -0.607 . . . . 43.939999999999998 109.535 -177.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.728 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.84 -43.31 99.1 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 108.714 -0.847 . . . . 42.609999999999999 108.714 -176.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.904 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.33 -41.29 94.11 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 116.615 -0.266 . . . . 140.66 111.018 -178.351 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.805 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.82 -43.91 97.91 Favored 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 118.547 -1.261 . . . . 116.04000000000001 110.252 -175.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.5 -38.71 83.1 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.29 0 N-CA-C 108.71 -0.848 . . . . 97.159999999999997 108.71 -177.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.855 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.2 mt -61.27 -39.99 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 108.995 -0.743 . . . . 54.850000000000001 108.995 -176.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.961 HG22 HG21 ' A' ' 86' ' ' THR . 92.6 t -57.73 -42.33 81.52 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.312 0 N-CA-C 108.864 -0.791 . . . . 45.390000000000001 108.864 -175.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 48' ' ' VAL . 97.2 t -63.56 -50.95 76.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 C-N-CA 118.875 -1.13 . . . . 48.640000000000001 110.163 -177.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.75 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.5 t -65.29 -46.99 78.21 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 120.119 -0.633 . . . . 116.65000000000001 111.731 -174.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.587 ' N ' HG23 ' A' ' 45' ' ' THR . 50.7 m -61.98 -43.96 97.74 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 109.729 -0.471 . . . . 51.159999999999997 109.729 -174.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.9 t -65.48 -48.95 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 C-N-CA 119.872 -0.731 . . . . 44.299999999999997 110.88 -177.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.866 ' O ' HG23 ' A' ' 52' ' ' VAL . 93.8 t -64.75 -46.94 90.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 C-N-CA 120.296 -0.561 . . . . 48.82 111.043 -174.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.79 -44.11 95.24 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 120.479 -0.867 . . . . 58.700000000000003 112.015 -174.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -72.67 -34.21 67.07 Favored 'General case' 0 CA--C 1.488 -1.418 0 O-C-N 122.102 -0.646 . . . . 101.40000000000001 111.014 -175.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.742 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.85 -38.77 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 107.755 -1.202 . . . . 103.56999999999999 107.755 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 48' ' ' VAL . 72.1 t -61.4 -43.04 96.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 N-CA-C 109.016 -0.735 . . . . 61.890000000000001 109.016 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.536 ' O ' HG22 ' A' ' 56' ' ' ILE . 82.1 t -63.43 -50.95 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 C-N-CA 120.284 -0.566 . . . . 70.010000000000005 109.506 -178.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.806 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.9 -43.45 98.77 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 109.142 -0.688 . . . . 132.09999999999999 109.142 -176.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.644 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.1 t-105 -64.18 -46.65 83.03 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 116.671 -0.24 . . . . 104.5 110.442 -176.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 1.015 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.68 -49.87 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 C-N-CA 120.216 -0.594 . . . . 142.96000000000001 111.244 -173.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.953 HD11 HG12 ' A' ' 72' ' ' VAL 0.278 24.8 pt -64.78 -41.67 92.82 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 C-N-CA 116.933 -1.907 . . . . 158.31999999999999 110.878 -175.98 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.806 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.76 -41.34 98.0 Favored 'General case' 0 N--CA 1.434 -1.273 0 C-N-CA 117.713 -1.595 . . . . 137.11000000000001 109.451 178.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.35 -44.6 90.94 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 122.128 -0.358 . . . . 54.659999999999997 110.994 -176.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.923 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.38 117.15 29.43 Favored 'General case' 0 CA--C 1.491 -1.323 0 CA-C-O 121.63 0.728 . . . . 127.18000000000001 109.572 -174.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.619 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.87 -36.79 80.09 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 124.022 0.929 . . . . 87.930000000000007 110.857 -176.069 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 1.036 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.38 -34.7 78.77 Favored 'General case' 0 CA--C 1.49 -1.356 0 O-C-N 121.623 -0.673 . . . . 131.12 111.467 -175.622 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' MET . . . . . 1.02 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.62 69.44 7.13 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 115.34 -2.544 . . . . 246.56 109.583 -175.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.411 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.2 91.42 3.48 Favored 'General case' 0 CA--C 1.474 -1.974 0 N-CA-C 105.514 -2.032 . . . . 339.35000000000002 105.514 177.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.445 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.5 p -124.15 165.2 17.96 Favored 'General case' 0 N--CA 1.413 -2.275 0 N-CA-C 102.987 -2.968 . . . . 114.66 102.987 176.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.879 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.07 -39.51 85.51 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.604 0 N-CA-C 106.798 -1.556 . . . . 143.28 106.798 178.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.835 HG22 HD13 ' A' ' 71' ' ' LEU . 95.1 m -59.63 -38.08 80.4 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 108.704 -0.851 . . . . 160.22 108.704 -176.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.524 ' ND2' ' HB3' ' A' ' 63' ' ' MET . 86.3 m-20 -62.3 -31.79 72.44 Favored 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 108.918 -0.771 . . . . 120.54000000000001 108.918 -177.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.9 ' O ' HG22 ' A' ' 72' ' ' VAL . 89.8 m-85 -63.61 -43.74 96.01 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 109.511 -0.552 . . . . 67.219999999999999 109.511 178.123 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.879 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.4 m-85 -66.56 -39.77 88.67 Favored 'General case' 0 CA--C 1.498 -1.033 0 O-C-N 121.455 -0.778 . . . . 138.59999999999999 109.659 -177.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.921 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.52 -35.95 82.17 Favored 'General case' 0 CA--C 1.492 -1.26 0 C-N-CA 122.5 0.32 . . . . 151.46000000000001 110.638 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.953 HG12 HD11 ' A' ' 57' ' ' ILE . 24.2 m -62.56 -37.98 80.29 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.225 0 C-N-CA 117.445 -1.702 . . . . 117.93000000000001 106.69 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.449 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.1 t30 -60.06 -46.01 90.97 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.833 -1.173 . . . . 56.82 107.833 -177.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.889 HD21 ' CE ' ' A' ' 123' ' ' MET . 8.7 mp -61.43 -43.83 98.18 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 108.93 -0.767 . . . . 145.30000000000001 108.93 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.13 -40.29 95.42 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 108.493 -0.929 . . . . 45.710000000000001 108.493 -175.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -62.48 -41.98 99.16 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 109.356 -0.609 . . . . 105.61 109.356 -178.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.14 -39.46 92.67 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 108.655 -0.869 . . . . 47.890000000000001 108.655 -178.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.59 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.55 -37.36 84.83 Favored 'General case' 0 N--CA 1.438 -1.042 0 O-C-N 122.08 -0.388 . . . . 124.53 109.967 179.677 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.9 -41.16 99.33 Favored 'General case' 0 N--CA 1.436 -1.14 0 O-C-N 121.912 -0.492 . . . . 35.890000000000001 109.873 -178.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.9 t -62.24 -37.37 85.14 Favored 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 106.988 -1.486 . . . . 88.969999999999999 106.988 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.82 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.13 -49.2 76.84 Favored 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 119.813 -0.755 . . . . 239.91 109.041 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.62 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.37 -43.35 91.06 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 121.487 -0.758 . . . . 146.09999999999999 110.636 -177.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.417 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.2 -58.24 3.4 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 117.374 -1.73 . . . . 91.739999999999995 113.843 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -76.49 -61.46 1.95 Allowed 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 115.739 1.755 . . . . 197.44999999999999 115.739 -173.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.936 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.23 -42.28 55.67 Favored 'General case' 0 CA--C 1.489 -1.388 0 C-N-CA 117.928 -1.509 . . . . 242.59999999999999 114.028 -170.012 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.961 HG21 HG22 ' A' ' 43' ' ' VAL . 4.6 t -65.39 -36.51 84.2 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 118.938 -1.105 . . . . 215.61000000000001 109.902 -172.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.423 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.8 t -60.39 -46.91 94.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 C-N-CA 120.31 -0.556 . . . . 87.189999999999998 110.445 -175.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.842 HG21 ' CD2' ' A' ' 108' ' ' HIS . 63.3 t -65.9 -41.83 90.76 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.124 0 N-CA-C 109.765 -0.457 . . . . 231.81999999999999 109.765 -178.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.904 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 87.6 m-20 -62.34 -34.16 76.11 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.329 -0.989 . . . . 364.98000000000002 108.329 -177.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.668 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.2 t80 -68.12 -44.75 75.42 Favored 'General case' 0 N--CA 1.438 -1.074 0 O-C-N 121.496 -0.752 . . . . 181.63 111.298 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.477 HG22 ' ND1' ' A' ' 95' ' ' HIS . 58.0 m -60.83 -45.83 92.92 Favored 'General case' 0 CA--C 1.478 -1.82 0 N-CA-C 107.424 -1.324 . . . . 269.01999999999998 107.424 -175.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 1.058 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.68 -45.04 93.26 Favored 'General case' 0 CA--C 1.468 -2.178 0 C-N-CA 118.626 -1.23 . . . . 562.65999999999997 110.054 -179.061 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.704 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.12 -45.21 95.62 Favored 'General case' 0 CA--C 1.478 -1.791 0 C-N-CA 118.712 -1.195 . . . . 446.75 108.107 -167.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.747 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.386 6.0 m -70.55 -26.27 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.768 0 C-N-CA 115.824 -2.35 . . . . 370.05000000000001 112.206 -178.75 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.496 ' O ' ' HB2' ' A' ' 96' ' ' ASN . 40.7 m80 -74.51 -26.44 60.0 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 121.556 -0.715 . . . . 354.91000000000003 112.518 175.109 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.822 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.4 m-20 82.8 4.47 0.99 Allowed 'General case' 0 CA--C 1.499 -0.988 0 C-N-CA 125.07 1.348 . . . . 462.44 111.93 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.775 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.266 11.9 mm-40 -172.34 178.05 2.92 Favored 'General case' 0 CA--C 1.488 -1.426 0 CA-C-O 122.005 0.907 . . . . 652.37 111.131 171.809 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.791 ' HE3' ' HA ' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.75 86.31 2.18 Favored 'General case' 0 N--CA 1.428 -1.564 0 C-N-CA 128.472 2.709 . . . . 905.99000000000001 107.909 -174.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -67.82 -36.43 80.37 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 108.241 -1.022 . . . . 570.42999999999995 108.241 -176.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.845 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.59 -36.35 82.45 Favored 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 125.299 1.44 . . . . 453.22000000000003 111.147 -174.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.935 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.55 178.64 33.9 Favored Glycine 0 C--N 1.35 1.324 0 C-N-CA 118.751 -1.69 . . . . 445.63 109.906 177.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.805 ' CD1' ' HG ' ' B' ' 374' ' ' LEU . 89.0 mt -56.37 -41.21 75.84 Favored 'General case' 0 CA--C 1.499 -1.005 0 C-N-CA 125.25 1.42 . . . . 457.72000000000003 112.403 -170.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -58.67 -46.92 86.16 Favored 'General case' 0 CA--C 1.485 -1.525 0 C-N-CA 118.64 -1.224 . . . . 340.57999999999998 109.3 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.845 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.2 m-85 -68.67 -32.2 71.86 Favored 'General case' 0 N--CA 1.424 -1.774 0 C-N-CA 118.765 -1.174 . . . . 453.60000000000002 111.544 -176.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.764 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.04 -40.33 73.33 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 105.972 -1.862 . . . . 541.48000000000002 105.972 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.82 -47.15 76.01 Favored 'General case' 0 CA--C 1.486 -1.484 0 O-C-N 123.945 0.778 . . . . 466.68000000000001 110.879 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -61.72 -47.12 86.7 Favored 'General case' 0 N--CA 1.427 -1.605 0 C-N-CA 117.429 -1.709 . . . . 427.33999999999997 107.334 -178.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.842 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.5 m80 -67.07 -36.74 82.69 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 112.441 0.534 . . . . 537.87 112.441 -174.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.575 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.48 -42.6 74.59 Favored 'General case' 0 N--CA 1.433 -1.323 0 C-N-CA 116.821 -1.952 . . . . 422.12 111.611 175.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.856 ' O ' HG22 ' A' ' 113' ' ' ILE . 75.9 t80 -59.1 -50.05 75.55 Favored 'General case' 0 N--CA 1.441 -0.879 0 O-C-N 121.323 -0.861 . . . . 340.17000000000002 111.846 -173.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -65.34 -46.49 70.84 Favored Pre-proline 0 N--CA 1.442 -0.848 0 C-N-CA 119.078 -1.049 . . . . 258.06 111.728 -176.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.936 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.2 Cg_exo -61.54 -31.56 87.44 Favored 'Trans proline' 0 N--CA 1.435 -1.958 0 N-CA-C 115.353 1.251 . . . . 305.70999999999998 115.353 176.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.875 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.89 -40.36 76.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 108.739 -0.838 . . . . 252.69999999999999 108.739 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.422 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.94 -40.63 94.01 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 107.806 -1.183 . . . . 149.27000000000001 107.806 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.95 -44.84 95.92 Favored 'General case' 0 N--CA 1.436 -1.155 0 C-N-CA 120.608 -0.437 . . . . 138.08000000000001 111.519 -176.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.651 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 64.9 t -66.91 -42.4 88.88 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.94 0 O-C-N 121.565 -0.71 . . . . 132.88999999999999 110.942 -177.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.924 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.74 -44.65 92.89 Favored 'General case' 0 N--CA 1.433 -1.287 0 C-N-CA 119.748 -0.781 . . . . 193.61000000000001 108.923 -177.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.556 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.51 -37.63 84.43 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 122.81 0.444 . . . . 63.829999999999998 110.121 -175.295 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.8 m -64.0 -52.37 59.86 Favored 'General case' 0 N--CA 1.435 -1.221 0 C-N-CA 120.712 -0.395 . . . . 76.400000000000006 111.276 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.748 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -63.01 -41.65 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 N-CA-C 108.157 -1.053 . . . . 171.13 108.157 -174.991 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 1.095 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.3 m-85 -63.77 -38.57 91.6 Favored 'General case' 0 N--CA 1.433 -1.294 0 O-C-N 121.846 -0.534 . . . . 78.299999999999997 110.631 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.555 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.2 t -67.04 -35.79 80.65 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 118.939 -1.104 . . . . 92.359999999999999 109.238 -178.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.976 ' HA ' ' HE2' ' A' ' 123' ' ' MET . 5.9 mmt -62.51 -34.27 76.55 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 108.151 -1.055 . . . . 93.730000000000004 108.151 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.903 HG22 HG13 ' A' ' 212' ' ' ILE . 33.2 p -67.45 -41.63 84.39 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.204 -0.998 . . . . 132.74000000000001 109.324 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.26 -42.12 94.68 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 107.203 -1.406 . . . . 43.390000000000001 107.203 -177.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.827 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 94.4 t -58.41 -42.02 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 N-CA-C 108.582 -0.895 . . . . 59.340000000000003 108.582 -178.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.48 -44.07 95.45 Favored 'General case' 0 CA--C 1.497 -1.081 0 O-C-N 121.75 -0.594 . . . . 69.680000000000007 110.525 -177.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.468 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.4 t80 -65.5 -42.73 91.81 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.36 -0.978 . . . . 106.98 108.36 -177.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.827 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.39 -35.59 81.39 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 119.622 -0.831 . . . . 147.63 108.937 -177.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.704 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.09 -41.58 99.43 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.533 -0.914 . . . . 190.06 108.533 178.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.6 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.3 t80 -61.37 -44.06 97.81 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 108.256 -1.016 . . . . 118.84999999999999 108.256 -177.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.806 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.4 mmt -63.37 -42.65 98.88 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 109.981 -0.377 . . . . 102.5 109.981 -177.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.95 -41.64 95.3 Favored 'General case' 0 CA--C 1.489 -1.383 0 O-C-N 121.813 -0.554 . . . . 89.980000000000004 109.839 -176.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.92 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.3 mt -66.55 -50.7 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.666 0 C-N-CA 118.106 -1.438 . . . . 106.09 110.975 -177.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.748 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.09 -48.34 38.25 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.091 0 C-N-CA 117.114 -1.834 . . . . 227.74000000000001 111.797 -174.787 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.754 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.1 p80 -118.79 100.07 51.06 Favored Pre-proline 0 CA--C 1.486 -1.51 0 C-N-CA 116.249 -2.18 . . . . 262.55000000000001 110.07 -175.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.2 Cg_endo -69.63 -10.33 28.39 Favored 'Trans proline' 0 C--N 1.29 -2.548 0 C-N-CA 121.622 1.548 . . . . 210.25 111.366 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.705 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.32 112.07 1.01 Allowed 'General case' 0 CA--C 1.49 -1.34 0 N-CA-C 106.505 -1.665 . . . . 270.57999999999998 106.505 -178.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.891 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.87 -39.5 23.44 Favored Pre-proline 0 N--CA 1.431 -1.418 0 CA-C-N 115.355 -0.839 . . . . 129.84 112.295 -175.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.86 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 82.1 Cg_exo -61.43 -26.56 81.39 Favored 'Trans proline' 0 N--CA 1.431 -2.185 0 N-CA-C 116.287 1.611 . . . . 330.70999999999998 116.287 -174.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.754 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.02 77.23 7.94 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 114.513 -2.875 . . . . 204.50999999999999 107.29 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.876 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.7 147.41 0.09 Allowed 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.485 -1.302 . . . . 387.41000000000003 107.485 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.876 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.5 t -143.71 147.07 33.7 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 118.763 -1.175 . . . . 166.22 109.431 178.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.9 -40.76 87.81 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 107.806 -1.183 . . . . 44.229999999999997 107.806 176.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.485 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.3 m -60.25 -39.18 85.87 Favored 'General case' 0 CA--C 1.492 -1.285 0 N-CA-C 108.157 -1.053 . . . . 28.800000000000001 108.157 -175.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.667 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.81 -38.76 91.98 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 109.084 -0.71 . . . . 30.289999999999999 109.084 -179.141 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.847 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 89.9 m -59.66 -43.01 94.12 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 108.964 -0.754 . . . . 46.109999999999999 108.964 -176.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.4 -42.18 99.23 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 107.713 -1.217 . . . . 87.329999999999998 107.713 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.77 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.5 t -61.69 -42.05 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 N-CA-C 107.952 -1.129 . . . . 23.690000000000001 107.952 -178.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.8 t -63.18 -44.32 99.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 N-CA-C 109.672 -0.492 . . . . 43.859999999999999 109.672 -178.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.919 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.1 mm -61.23 -42.57 93.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 N-CA-C 108.334 -0.987 . . . . 91.129999999999995 108.334 -176.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' CYS . . . . . 0.482 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.1 t -62.56 -37.99 88.3 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 108.712 -0.848 . . . . 65.879999999999995 108.712 -178.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.1 t -62.09 -41.87 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 N-CA-C 109.529 -0.545 . . . . 33.859999999999999 109.529 -177.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 1.095 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.35 -40.32 85.79 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.171 0 N-CA-C 107.576 -1.268 . . . . 146.52000000000001 107.576 -176.786 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 155' ' ' TRP . . . . . 0.699 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.1 m95 -62.9 -38.35 90.57 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 119.483 -0.887 . . . . 75.439999999999998 108.849 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.9 t -60.54 -48.47 88.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 O-C-N 121.073 -1.017 . . . . 43.640000000000001 109.699 -177.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.793 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.64 -37.99 89.41 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 109.068 -0.716 . . . . 102.56999999999999 109.068 -178.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.01 -41.05 86.79 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.433 -1.321 . . . . 58.159999999999997 107.433 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.798 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.12 -32.44 73.83 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 109.045 -0.724 . . . . 121.11 109.045 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.793 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.04 -42.33 85.16 Favored 'General case' 0 CA--C 1.489 -1.404 0 C-N-CA 118.567 -1.253 . . . . 153.15000000000001 109.938 -178.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 1.056 HD13 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.05 -43.72 19.11 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 113.154 -3.419 . . . . 133.66999999999999 113.545 173.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.479 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -63.01 -39.88 96.09 Favored 'General case' 0 CA--C 1.49 -1.352 0 O-C-N 120.951 -1.093 . . . . 157.41999999999999 112.189 -171.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.523 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.3 t80 -74.45 -36.07 2.43 Favored Pre-proline 0 N--CA 1.436 -1.129 0 N-CA-C 115.056 1.502 . . . . 250.91 115.056 -173.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.523 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.291 52.1 Cg_exo -59.59 -25.43 78.82 Favored 'Trans proline' 0 CA--C 1.489 -1.736 0 N-CA-C 117.968 2.257 . . . . 207.34 117.968 -174.331 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.917 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 32.4 mt-30 -61.2 -34.16 74.63 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 106.967 -1.494 . . . . 192.46000000000001 106.967 178.057 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.5 -41.07 98.11 Favored Glycine 0 C--N 1.353 1.513 0 N-CA-C 107.949 -2.06 . . . . 261.0 107.949 177.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.8 159.1 26.03 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 101.466 -3.531 . . . . 491.39999999999998 101.466 172.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -59.89 106.76 0.53 Allowed 'General case' 0 CA--C 1.488 -1.422 0 C-N-CA 116.239 -2.184 . . . . 386.10000000000002 109.849 -176.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.917 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 74.0 m -153.99 -166.6 2.42 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 103.583 -2.747 . . . . 289.80000000000001 103.583 -178.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' THR . . . . . 1.14 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.97 175.47 0.86 Allowed 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 117.748 -1.12 . . . . 402.06 109.555 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.789 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 73.6 p -165.27 177.53 7.54 Favored 'General case' 0 CA--C 1.586 2.363 0 C-N-CA 127.308 2.243 . . . . 690.52999999999997 114.912 177.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.488 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 40.0 mm-40 132.33 160.53 0.0 OUTLIER 'General case' 1 C--N 1.43 4.066 1 N-CA-C 123.195 4.517 . . . . 633.62 123.195 162.673 . . . . . . . . 4 3 . 1 . 003 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.761 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.1 p -85.59 153.85 22.12 Favored 'General case' 0 C--N 1.389 2.283 0 C-N-CA 127.413 2.285 . . . . 617.99000000000001 110.886 178.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' MET . . . . . 1.04 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.7 174.37 6.04 Favored Pre-proline 0 C--N 1.363 1.18 0 C-N-CA 130.304 3.442 . . . . 434.98000000000002 113.433 -175.433 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 1.092 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 51.8 Cg_endo -44.26 -65.63 0.19 Allowed 'Trans proline' 0 N--CA 1.441 -1.569 0 N-CA-C 122.414 3.967 . . . . 365.88 122.414 -168.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' SER . . . . . 0.778 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.304 70.8 m -84.87 20.92 1.69 Allowed 'General case' 0 CA--C 1.467 -2.249 0 N-CA-C 104.812 -2.292 . . . . 635.80999999999995 104.812 178.102 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.749 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.458 5.0 mmp_? -94.35 152.16 18.85 Favored 'General case' 1 CA--C 1.419 -4.066 3 N-CA-C 131.952 7.76 . . . . 999.99000000000001 131.952 -135.714 . . . . . . . . 5 3 . 1 . 003 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 1.058 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.91 37.0 t -131.84 73.2 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.763 1 CA-C-N 103.288 -6.324 . . . . 594.32000000000005 113.611 149.169 . . . . . . . . 4 3 . 1 . 003 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.729 HG13 ' HB2' ' A' ' 174' ' ' MET . 7.4 p -144.2 144.1 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.599 1 N-CA-C 98.285 -4.709 . . . . 811.90999999999997 98.285 162.382 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.761 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.8 m -118.49 144.52 45.96 Favored 'General case' 0 CA--C 1.488 -1.409 0 C-N-CA 117.014 -1.874 . . . . 999.99000000000001 109.42 -178.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.973 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.7 mmm -147.19 -175.6 4.89 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-O 122.0 0.905 . . . . 431.86000000000001 110.055 -177.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 1.037 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.3 tt -69.15 148.73 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 C-N-CA 124.31 1.044 . . . . 457.18000000000001 108.782 -177.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' GLU . . . . . 0.789 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.32 85.44 3.74 Favored 'General case' 0 CA--C 1.5 -0.955 0 C-N-CA 124.155 0.982 . . . . 458.76999999999998 113.527 -174.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.956 ' CZ3' HG22 ' A' ' 182' ' ' ILE . 1.9 p90 -76.4 -31.57 0.97 Allowed Pre-proline 0 N--CA 1.438 -1.058 0 C-N-CA 124.992 1.317 . . . . 999.99000000000001 112.384 168.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.955 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.2 Cg_exo -65.96 -45.77 5.64 Favored 'Trans proline' 0 N--CA 1.438 -1.79 0 N-CA-C 120.883 3.378 . . . . 999.99000000000001 120.883 -174.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.508 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 54.9 mt-10 -119.56 171.78 8.12 Favored 'General case' 0 CA--C 1.471 -2.066 0 C-N-CA 117.129 -1.829 . . . . 81.180000000000007 107.239 -172.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.834 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 6.3 p80 -109.16 45.16 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.865 0 CA-C-O 114.875 -2.488 . . . . 999.99000000000001 108.703 177.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 1.076 ' HB2' HD12 ' A' ' 191' ' ' ILE . 88.3 Cg_endo -41.57 101.86 0.04 OUTLIER 'Trans proline' 0 CA--C 1.502 -1.121 1 C-N-CA 126.071 4.514 . . . . 999.99000000000001 105.634 -170.745 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -62.28 -44.01 97.5 Favored 'General case' 0 CA--C 1.483 -1.597 0 C-N-CA 126.726 2.01 . . . . 967.72000000000003 112.059 -165.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.402 ' HD3' ' HA ' ' A' ' 190' ' ' LYS . 30.3 mmtp -60.28 -36.55 78.08 Favored 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 106.724 -1.584 . . . . 934.29999999999995 106.724 -175.197 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 1.076 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.65 -30.16 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 C-N-CA 129.167 2.987 . . . . 565.14999999999998 113.925 -178.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 61.54 55.31 2.82 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-N 118.425 0.557 . . . . 755.61000000000001 109.903 -175.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 1.14 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.44 -49.29 67.19 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 124.57 1.148 . . . . 325.88999999999999 113.26 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.633 ' HE3' ' OH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.8 -44.97 78.31 Favored 'General case' 0 CA--C 1.495 -1.17 0 C-N-CA 123.558 0.743 . . . . 250.21000000000001 111.631 -169.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 98.0 t -64.75 -43.28 96.52 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 CA-C-O 121.595 0.712 . . . . 142.46000000000001 110.383 -175.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 1.037 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.8 t80 -61.19 -41.46 96.85 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 123.985 0.914 . . . . 247.69 108.821 -173.151 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.824 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 23.1 t60 -60.55 -51.33 69.89 Favored 'General case' 0 CA--C 1.491 -1.292 0 C-N-CA 125.411 1.484 . . . . 199.61000000000001 113.081 -175.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 82.7 mt -65.34 -44.46 94.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 N-CA-C 107.759 -1.201 . . . . 106.73 107.759 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' CYS . . . . . 0.722 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.7 t -59.17 -48.53 81.27 Favored 'General case' 0 CA--C 1.487 -1.473 0 CA-C-N 115.801 -0.636 . . . . 115.01000000000001 110.214 -173.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 1.056 HG13 HD13 ' A' ' 161' ' ' LEU . 85.6 t -65.25 -49.18 80.31 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.655 0 C-N-CA 119.418 -0.913 . . . . 129.41999999999999 111.818 -174.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.793 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.4 m -61.85 -53.12 60.16 Favored 'General case' 0 CA--C 1.483 -1.612 0 C-N-CA 118.228 -1.389 . . . . 172.47999999999999 109.968 -172.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.631 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.5 t -63.89 -54.29 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 C-N-CA 120.539 -0.465 . . . . 55.859999999999999 110.933 -174.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.722 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.57 -51.53 59.07 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.56 -1.256 . . . . 184.68000000000001 111.489 -174.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 1.05 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.62 -52.37 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 C-N-CA 116.637 -2.025 . . . . 291.81 114.757 -174.706 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.548 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.8 t80 -82.05 -55.0 4.84 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 115.16 1.541 . . . . 130.66 115.16 -178.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' PHE . . . . . 0.793 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.8 m-85 -66.88 -48.49 68.61 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 114.515 1.302 . . . . 80.159999999999997 114.515 -170.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.894 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.54 -45.5 83.29 Favored Pre-proline 0 N--CA 1.435 -1.196 0 C-N-CA 119.981 -0.688 . . . . 136.02000000000001 109.494 -174.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.894 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.8 Cg_exo -64.8 -27.16 59.72 Favored 'Trans proline' 0 N--CA 1.432 -2.105 0 CA-C-N 118.703 0.572 . . . . 92.170000000000002 110.622 -179.035 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.688 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.3 -41.39 76.82 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 107.501 -1.296 . . . . 135.59999999999999 107.501 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.17 -44.7 91.26 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 109.563 -0.532 . . . . 52.100000000000001 109.563 -176.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.618 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.67 -43.54 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 N-CA-C 109.063 -0.718 . . . . 95.890000000000001 109.063 -176.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.903 HG13 HG22 ' A' ' 124' ' ' THR . 94.5 mt -61.28 -42.36 93.23 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.398 0 N-CA-C 106.684 -1.599 . . . . 43.409999999999997 106.684 -178.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.44 -42.25 99.09 Favored Glycine 0 N--CA 1.432 -1.606 0 N-CA-C 109.376 -1.49 . . . . 27.690000000000001 109.376 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' TYR . . . . . 0.886 ' O ' HG22 ' A' ' 217' ' ' THR . 77.9 t80 -65.66 -47.42 75.59 Favored 'General case' 0 CA--C 1.497 -1.094 0 O-C-N 122.213 -0.581 . . . . 54.409999999999997 110.483 -177.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ALA . . . . . 0.828 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.42 -34.11 74.83 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 106.955 -1.498 . . . . 53.880000000000003 106.955 -177.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -60.74 -40.89 94.06 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 108.49 -0.929 . . . . 68.290000000000006 108.49 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' THR . . . . . 0.886 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.67 -39.12 93.12 Favored 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 119.721 -0.792 . . . . 107.59 110.631 -175.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.828 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.02 -38.39 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 C-N-CA 119.605 -0.838 . . . . 111.61 109.481 -177.019 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.92 HG13 ' CD1' ' A' ' 134' ' ' ILE . 79.3 t -63.28 -22.48 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.372 -0.973 . . . . 85.260000000000005 108.372 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.87 -41.94 99.43 Favored Glycine 0 C--N 1.349 1.265 0 N-CA-C 111.07 -0.812 . . . . 40.710000000000001 111.07 -176.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.5 mm -64.76 -44.05 96.47 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 N-CA-C 108.378 -0.971 . . . . 95.859999999999999 108.378 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.823 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.6 p -76.93 -137.52 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 108.434 -0.95 . . . . 144.37 108.434 -176.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.902 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.6 mt -55.38 132.11 47.38 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 107.573 -1.269 . . . . 326.72000000000003 107.573 -177.2 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' TRP . . . . . 0.461 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.35 -168.05 1.51 Allowed 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 106.013 -1.847 . . . . 158.38 106.013 -176.184 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.461 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.27 -42.01 99.09 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 109.649 -0.5 . . . . 36.780000000000001 109.649 -178.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.6 m -61.06 125.82 25.12 Favored 'General case' 0 N--CA 1.434 -1.271 0 C-N-CA 119.198 -1.001 . . . . 85.459999999999994 109.793 -174.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' GLU . . . . . 0.693 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.89 126.55 8.83 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 105.58 -2.008 . . . . 127.78 105.58 176.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.927 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.04 139.9 34.78 Favored Pre-proline 0 CA--C 1.493 -1.236 0 N-CA-C 105.982 -1.859 . . . . 164.84 105.982 -179.576 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.927 ' N ' HD13 ' A' ' 228' ' ' ILE . 83.4 Cg_exo -56.8 -39.93 87.87 Favored 'Trans proline' 0 N--CA 1.431 -2.16 0 N-CA-C 113.914 0.698 . . . . 222.34999999999999 113.914 -175.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' GLY . . . . . 0.745 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.11 167.02 45.01 Favored Glycine 0 N--CA 1.428 -1.899 0 N-CA-C 106.446 -2.662 . . . . 45.219999999999999 106.446 178.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.882 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.99 -45.71 93.7 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 106.065 -1.828 . . . . 107.56999999999999 106.065 177.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' SER . . . . . 0.732 ' O ' HG21 ' A' ' 228' ' ' ILE . 68.1 m -65.82 141.83 58.15 Favored 'General case' 0 N--CA 1.429 -1.525 0 C-N-CA 118.89 -1.124 . . . . 167.96000000000001 109.155 -175.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.828 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.6 m 99.52 106.64 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.219 0 C-N-CA 126.695 1.998 . . . . 280.68000000000001 109.761 176.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.712 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.7 m-20 56.05 11.28 0.71 Allowed 'General case' 0 N--CA 1.433 -1.279 0 C-N-CA 124.492 1.117 . . . . 218.25 110.702 174.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.922 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.38 137.64 54.78 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 105.243 -2.132 . . . . 343.56999999999999 105.243 177.412 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.479 ' O ' HG21 ' A' ' 240' ' ' VAL . 85.6 t80 -111.99 81.84 1.53 Allowed 'General case' 0 CA--C 1.491 -1.323 0 N-CA-C 106.871 -1.529 . . . . 263.29000000000002 106.871 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 237' ' ' HIS . . . . . 0.626 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 64.5 m80 104.31 147.09 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 126.607 1.963 . . . . 261.92000000000002 108.511 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.25 -38.13 89.94 Favored 'General case' 0 CA--C 1.488 -1.415 0 N-CA-C 107.822 -1.177 . . . . 106.81 107.822 -177.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.737 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.42 -39.92 94.87 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 118.348 -1.341 . . . . 112.2 107.58 -178.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.736 HG12 ' NH1' ' A' ' 244' ' ' ARG . 75.2 t -64.26 -39.81 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 109.285 -0.635 . . . . 45.409999999999997 109.285 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' SER . . . . . 0.806 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.2 p -70.95 -32.04 68.8 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 110.269 -0.271 . . . . 97.620000000000005 110.269 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.43 -39.56 81.5 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 123.65 0.78 . . . . 59.289999999999999 110.981 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.737 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.31 -36.47 83.81 Favored 'General case' 0 CA--C 1.491 -1.292 0 C-N-CA 124.655 1.182 . . . . 106.48999999999999 110.647 -174.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.922 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -60.0 -30.58 69.23 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 108.331 -0.988 . . . . 106.62 108.331 -176.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.531 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -66.09 -41.0 91.25 Favored 'General case' 0 N--CA 1.436 -1.175 0 O-C-N 121.84 -0.537 . . . . 75.969999999999999 110.052 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.444 ' CG1' ' HE1' ' A' ' 250' ' ' MET . 77.0 t -65.55 -40.84 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 C-N-CA 122.957 0.503 . . . . 65.269999999999996 109.804 -178.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.775 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.7 p -63.99 -41.58 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 C-N-CA 120.385 -0.526 . . . . 107.94 110.186 -177.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.536 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.2 pttt -63.55 -40.78 97.9 Favored 'General case' 0 N--CA 1.434 -1.259 0 O-C-N 121.679 -0.638 . . . . 87.980000000000004 110.31 -176.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' MET . . . . . 0.823 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.64 -40.42 96.81 Favored 'General case' 0 N--CA 1.434 -1.247 0 C-N-CA 118.875 -1.13 . . . . 65.5 108.329 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' MET . . . . . 0.773 ' HE2' ' CG2' ' A' ' 67' ' ' THR . 68.5 mtt -61.73 -36.33 80.66 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 108.169 -1.049 . . . . 85.049999999999997 108.169 -177.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.536 HD12 ' HA ' ' A' ' 248' ' ' LYS . 86.7 mt -63.48 -45.76 96.97 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 N-CA-C 109.082 -0.711 . . . . 42.25 109.082 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.823 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.26 -38.31 82.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 C-N-CA 119.556 -0.858 . . . . 91.010000000000005 109.43 -176.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 1.001 HG22 ' CD1' ' A' ' 304' ' ' ILE . 65.8 t -58.88 -41.48 83.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 N-CA-C 107.998 -1.112 . . . . 66.090000000000003 107.998 -178.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 250' ' ' MET . 94.7 t -66.17 -43.12 92.17 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.363 0 O-C-N 122.089 -0.382 . . . . 52.390000000000001 110.287 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.4 m -61.73 -46.83 87.96 Favored 'General case' 0 CA--C 1.489 -1.393 0 O-C-N 121.851 -0.531 . . . . 46.420000000000002 109.858 -174.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' THR . . . . . 0.745 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.5 t -62.3 -38.1 88.09 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 108.335 -0.987 . . . . 116.51000000000001 108.335 -177.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 257' ' ' PHE . . . . . 0.488 ' N ' HG23 ' A' ' 256' ' ' THR . 86.0 t80 -60.32 -48.2 82.78 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.365 -0.606 . . . . 65.180000000000007 109.365 -178.121 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.99 -42.68 97.12 Favored 'General case' 0 CA--C 1.489 -1.385 0 O-C-N 122.107 -0.371 . . . . 51.329999999999998 110.429 -175.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' ILE . . . . . 0.745 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.6 -43.45 98.21 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 C-N-CA 118.968 -1.093 . . . . 126.3 108.938 -176.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 260' ' ' CYS . . . . . 0.509 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.8 m -65.51 -49.35 69.31 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.524 -0.87 . . . . 133.94 112.513 -176.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.82 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.0 m95 -80.72 -33.34 35.34 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 116.819 2.155 . . . . 134.84 116.819 -176.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.786 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.6 tp -58.43 -41.61 90.17 Favored Pre-proline 0 CA--C 1.493 -1.222 0 CA-C-N 118.641 0.655 . . . . 72.230000000000004 111.671 -167.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 263' ' ' PRO . . . . . 0.786 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 81.3 Cg_exo -60.67 -36.02 86.89 Favored 'Trans proline' 0 C--N 1.294 -2.309 0 CA-C-N 119.822 0.972 . . . . 106.13 111.357 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 264' ' ' PHE . . . . . 0.852 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.6 t80 -66.32 -44.71 82.61 Favored 'General case' 0 N--CA 1.433 -1.3 0 C-N-CA 119.769 -0.772 . . . . 128.34999999999999 110.056 -178.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' HIS . . . . . 0.64 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.4 m-70 -64.41 -37.86 88.99 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 110.244 -0.28 . . . . 100.73 110.244 -177.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.746 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.29 -44.51 94.92 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 C-N-CA 119.257 -0.977 . . . . 172.72 109.126 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 267' ' ' PHE . . . . . 0.734 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.5 m-85 -66.62 -28.12 68.24 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 108.17 -1.048 . . . . 249.22999999999999 108.17 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 268' ' ' PHE . . . . . 0.899 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.52 -55.14 35.37 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 106.698 -1.593 . . . . 259.77999999999997 106.698 178.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 269' ' ' LEU . . . . . 0.492 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.5 mt -69.13 -44.17 72.88 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 113.611 0.967 . . . . 233.11000000000001 113.611 -176.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.837 ' O ' HG13 ' A' ' 273' ' ' ILE . 88.6 mt -61.4 -48.31 91.28 Favored Pre-proline 0 N--CA 1.44 -0.947 0 C-N-CA 119.13 -1.028 . . . . 169.53999999999999 110.567 -171.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 271' ' ' PRO . . . . . 0.734 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 12.0 Cg_exo -61.05 -24.59 79.8 Favored 'Trans proline' 0 N--CA 1.429 -2.302 0 C-N-CA 116.756 -1.696 . . . . 255.47 114.7 174.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 272' ' ' TYR . . . . . 0.824 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.6 t80 -63.58 -44.22 94.69 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 119.232 0.924 . . . . 279.02999999999997 108.874 177.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.837 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.33 -44.76 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 N-CA-C 110.104 -0.332 . . . . 162.21000000000001 110.104 -178.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 274' ' ' ASN . . . . . 0.867 HD22 HD12 ' A' ' 277' ' ' LEU . 49.1 t30 -125.45 84.88 59.4 Favored Pre-proline 0 N--CA 1.43 -1.432 0 C-N-CA 118.73 -1.188 . . . . 128.13 108.064 -178.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 275' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.3 Cg_endo -85.3 164.08 11.19 Favored 'Trans proline' 0 C--N 1.295 -2.268 0 N-CA-C 107.44 -1.792 . . . . 278.35000000000002 107.44 177.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 276' ' ' ASP . . . . . 0.868 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.2 t0 66.06 15.06 9.93 Favored 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 123.83 0.706 . . . . 312.91000000000003 109.335 175.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.868 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.3 mt -132.69 -170.66 2.48 Favored 'General case' 0 CA--C 1.481 -1.675 0 N-CA-C 106.531 -1.655 . . . . 353.54000000000002 106.531 177.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 1.007 ' HA ' ' CB ' ' A' ' 282' ' ' PHE . 42.8 p90 -115.68 142.23 47.03 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 107.398 -1.334 . . . . 251.25999999999999 107.398 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.761 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -76.98 -118.81 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 102.024 -3.324 . . . . 175.25999999999999 102.024 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 280' ' ' LYS . . . . . 0.794 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.46 -44.97 96.17 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 100.883 -3.747 . . . . 99.069999999999993 100.883 172.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 281' ' ' LYS . . . . . 0.794 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.43 124.18 9.18 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 103.46 -2.793 . . . . 243.21000000000001 103.46 171.173 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 1.007 ' CB ' ' HA ' ' A' ' 278' ' ' TYR . 77.3 t80 -92.97 112.99 25.14 Favored 'General case' 0 CA--C 1.473 -1.982 0 C-N-CA 116.007 -2.277 . . . . 201.03999999999999 105.265 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 283' ' ' ILE . . . . . 0.777 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.94 173.72 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.071 0 C-N-CA 116.001 -2.279 . . . . 201.36000000000001 108.768 -175.176 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 284' ' ' GLN . . . . . 1.092 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.284 0.6 OUTLIER -59.54 -41.42 90.03 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-N 113.243 -1.799 . . . . 203.81999999999999 107.864 174.447 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 285' ' ' GLN . . . . . 0.921 ' HG2' HE21 ' A' ' 284' ' ' GLN . 1.2 mm100 -64.26 -45.71 86.89 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 118.226 -1.389 . . . . 215.06 112.576 -171.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.552 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.0 t -65.69 -46.42 89.26 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.473 0 C-N-CA 118.587 -1.245 . . . . 125.28 112.903 -171.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 287' ' ' TYR . . . . . 0.952 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.78 -37.05 86.29 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 107.155 -1.424 . . . . 268.89999999999998 107.155 -171.861 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.798 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.16 -45.05 74.56 Favored 'General case' 0 CA--C 1.483 -1.607 0 C-N-CA 125.63 1.572 . . . . 280.88 108.821 -172.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.6 -47.43 86.24 Favored 'General case' 0 CA--C 1.484 -1.564 0 C-N-CA 118.947 -1.101 . . . . 184.47 109.087 -172.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' ILE . . . . . 0.852 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.8 mp -67.98 -42.11 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 C-N-CA 119.263 -0.975 . . . . 167.91999999999999 112.732 -175.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 291' ' ' MET . . . . . 0.5 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.7 ttt -65.72 -38.76 90.07 Favored 'General case' 0 CA--C 1.495 -1.136 0 C-N-CA 117.784 -1.566 . . . . 367.18000000000001 110.822 -175.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 292' ' ' TRP . . . . . 0.548 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.4 m95 -67.22 -32.67 73.87 Favored 'General case' 0 N--CA 1.435 -1.197 0 O-C-N 121.872 -0.517 . . . . 173.97 110.448 177.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.4 tp -64.49 -36.71 85.09 Favored 'General case' 0 CA--C 1.499 -0.986 0 C-N-CA 123.509 0.724 . . . . 119.66 109.797 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 294' ' ' ALA . . . . . 0.82 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.23 -34.03 74.46 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 107.711 -1.218 . . . . 112.3 107.711 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 295' ' ' MET . . . . . 0.772 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.03 -32.11 73.4 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 116.211 -0.45 . . . . 174.16999999999999 110.222 -177.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.9 m -64.67 -22.8 67.07 Favored 'General case' 0 CA--C 1.486 -1.507 0 C-N-CA 124.648 1.179 . . . . 145.27000000000001 110.606 -175.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' SER . . . . . 0.758 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.7 m -57.67 -35.33 70.41 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 108.043 -1.095 . . . . 170.15000000000001 108.043 -175.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.82 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.8 t -55.33 -34.16 63.97 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 116.324 -0.398 . . . . 214.56999999999999 110.61 -171.111 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 299' ' ' MET . . . . . 0.75 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.1 ttt -77.16 -33.19 56.58 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 126.108 1.763 . . . . 168.28999999999999 115.539 177.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 300' ' ' TYR . . . . . 0.758 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.44 -34.84 79.14 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 114.072 1.138 . . . . 167.15000000000001 114.072 -168.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 301' ' ' ASN . . . . . 0.723 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.283 18.8 p-10 -64.2 -38.31 33.47 Favored Pre-proline 0 N--CA 1.434 -1.253 0 C-N-CA 115.532 -2.467 . . . . 165.13 113.935 -171.619 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 302' ' ' PRO . . . . . 0.723 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 83.9 Cg_exo -62.54 -31.87 79.97 Favored 'Trans proline' 0 N--CA 1.433 -2.048 0 CA-C-N 122.769 2.025 . . . . 123.92 111.28 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 303' ' ' ILE . . . . . 0.716 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.1 pt -68.72 -42.57 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 C-N-CA 118.857 -1.137 . . . . 110.55 109.796 -179.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 304' ' ' ILE . . . . . 1.001 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.1 pt -61.09 -40.08 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 108.852 -0.796 . . . . 145.31 108.852 -177.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 305' ' ' TYR . . . . . 0.921 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.253 63.1 m-85 -58.1 -48.83 78.97 Favored 'General case' 0 CA--C 1.494 -1.191 0 C-N-CA 119.409 -0.916 . . . . 246.68000000000001 109.796 -177.473 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.6 m -62.24 -47.46 84.3 Favored 'General case' 0 CA--C 1.485 -1.539 0 C-N-CA 119.565 -0.854 . . . . 64.430000000000007 109.6 -173.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.8 t -66.8 -45.08 79.48 Favored 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 118.973 -1.091 . . . . 80.719999999999999 110.227 -177.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.708 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.41 -35.71 76.0 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 116.034 1.864 . . . . 140.44 116.034 -173.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 309' ' ' ASN . . . . . 0.655 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.85 132.23 34.32 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 112.692 -3.603 . . . . 178.87 113.048 -177.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 310' ' ' ASP . . . . . 0.613 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.04 -37.09 86.45 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 114.392 -1.277 . . . . 110.22 110.075 -177.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.855 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 38.9 ttm180 -57.7 -50.62 72.59 Favored 'General case' 0 CA--C 1.492 -1.251 0 O-C-N 121.802 -0.561 . . . . 174.78 109.708 -174.176 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.96 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.3 m-85 -64.87 -41.67 95.46 Favored 'General case' 0 CA--C 1.484 -1.571 0 N-CA-C 108.262 -1.014 . . . . 161.84 108.262 178.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 313' ' ' ARG . . . . . 0.516 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.7 ttp180 -57.38 -50.2 73.72 Favored 'General case' 0 CA--C 1.49 -1.353 0 N-CA-C 109.183 -0.673 . . . . 117.2 109.183 -173.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.797 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.55 -44.1 75.22 Favored 'General case' 0 N--CA 1.434 -1.235 0 C-N-CA 120.355 -0.538 . . . . 112.59999999999999 111.03 -177.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 315' ' ' GLY . . . . . 0.872 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -63.95 -37.52 94.74 Favored Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 110.675 -0.97 . . . . 101.45999999999999 110.675 -177.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 316' ' ' PHE . . . . . 1.015 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.7 m-85 -62.16 -45.92 91.29 Favored 'General case' 0 CA--C 1.491 -1.31 0 CA-C-N 118.452 1.126 . . . . 151.49000000000001 109.55 -178.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 317' ' ' LYS . . . . . 0.423 ' HE3' ' HB2' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.19 -36.24 77.17 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 106.922 -1.51 . . . . 142.31999999999999 106.922 -175.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 318' ' ' HIS . . . . . 0.826 ' NE2' HG21 ' A' ' 326' ' ' ILE . 49.9 m80 -59.85 -41.84 92.33 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 106.846 -1.539 . . . . 109.09 106.846 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.84 -42.42 85.81 Favored 'General case' 0 N--CA 1.435 -1.208 0 O-C-N 122.312 -0.242 . . . . 76.109999999999999 111.062 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -61.38 -55.51 30.67 Favored 'General case' 0 CA--C 1.489 -1.374 0 C-N-CA 119.861 -0.736 . . . . 120.23999999999999 109.339 -174.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.579 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.4 mtt180 -74.26 131.53 41.28 Favored 'General case' 0 CA--C 1.482 -1.66 0 N-CA-C 102.946 -2.983 . . . . 192.72999999999999 102.946 177.038 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.4 p -59.14 -44.25 92.05 Favored 'General case' 0 CA--C 1.491 -1.296 0 C-N-CA 119.006 -1.078 . . . . 176.28999999999999 109.204 -172.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 323' ' ' CYS . . . . . 0.752 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.5 m -79.35 -177.11 0.81 Allowed Pre-proline 0 CA--C 1.488 -1.436 0 N-CA-C 106.239 -1.763 . . . . 69.680000000000007 106.239 178.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.567 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.8 Cg_exo -59.0 -75.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.382 0 CA-C-O 118.662 -0.641 . . . . 191.05000000000001 112.566 176.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 325' ' ' PHE . . . . . 0.752 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.3 m-85 47.49 43.89 16.24 Favored 'General case' 0 CA--C 1.493 -1.245 0 O-C-N 123.612 0.57 . . . . 287.02999999999997 109.763 178.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 326' ' ' ILE . . . . . 0.826 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.1 tt -104.55 78.58 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.474 -1.951 0 C-N-CA 112.988 -3.485 . . . . 292.29000000000002 109.854 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 327' ' ' SER . . . . . 0.479 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.1 t -77.43 -152.89 0.05 OUTLIER 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 104.198 -2.519 . . . . 184.56999999999999 104.198 178.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 328' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.76 8.65 4.91 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 113.064 0.764 . . . . 274.56 113.064 176.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.96 0.89 57.28 Favored Glycine 0 C--N 1.348 1.233 0 C-N-CA 117.792 -2.147 . . . . 268.24000000000001 113.496 172.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 330' ' ' ASP . . . . . 0.7 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.8 m-20 51.65 -172.07 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.092 0 CA-C-N 118.673 1.236 . . . . 200.06 110.75 177.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.855 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.91 -33.02 74.76 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 107.854 -1.165 . . . . 114.44 107.854 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 332' ' ' GLU . . . . . 0.543 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.36 46.03 21.72 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 107.589 -1.263 . . . . 263.81 107.589 -177.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 333' ' ' GLY . . . . . 0.634 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.3 -137.36 3.61 Favored Glycine 0 CA--C 1.478 -2.231 1 N-CA-C 102.471 -4.251 . . . . 103.79000000000001 102.471 -179.837 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 1.05 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.2 mt -88.33 95.68 10.29 Favored 'General case' 0 N--CA 1.419 -1.993 0 C-N-CA 114.892 -2.723 . . . . 117.3 105.995 177.038 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 335' ' ' GLU . . . . . 1.025 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.97 -39.76 90.65 Favored 'General case' 0 CA--C 1.468 -2.202 1 N-CA-C 98.023 -4.806 . . . . 231.58000000000001 98.023 167.206 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 336' ' ' MET . . . . . 1.036 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.96 163.48 29.08 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 102.115 -3.291 . . . . 303.24000000000001 102.115 168.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 337' ' ' LYS . . . . . 1.05 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.3 tttt -62.64 -48.6 78.66 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 116.03 -2.268 . . . . 112.72 108.423 179.197 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.9 t -61.05 -63.64 1.23 Allowed 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 109.083 -0.71 . . . . 83.219999999999999 109.083 -176.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 339' ' ' THR . . . . . 0.884 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 35.9 m -156.27 -126.16 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 103.87 -2.641 . . . . 174.36000000000001 103.87 -178.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 340' ' ' ARG . . . . . 1.025 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.93 160.96 8.89 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 105.771 -1.937 . . . . 202.72999999999999 105.771 177.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 341' ' ' TYR . . . . . 1.02 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.97 149.01 52.55 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 107.061 -1.459 . . . . 180.62 107.061 176.422 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.932 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.5 tp -178.45 -171.82 0.27 Allowed 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 105.376 -2.083 . . . . 145.25 105.376 178.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 343' ' ' GLN . . . . . 0.932 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.1 tt0 -66.14 -43.14 87.94 Favored 'General case' 0 CA--C 1.487 -1.446 0 N-CA-C 106.078 -1.823 . . . . 66.049999999999997 106.078 174.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 344' ' ' THR . . . . . 0.765 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.71 -152.18 0.48 Allowed 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 103.486 -2.783 . . . . 266.49000000000001 103.486 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 345' ' ' GLN . . . . . 0.699 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.3 mt-30 66.37 -124.88 0.28 Allowed 'General case' 0 CA--C 1.485 -1.545 0 C-N-CA 117.038 -1.865 . . . . 219.19999999999999 107.742 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 346' ' ' GLY . . . . . 0.902 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.16 -37.38 94.01 Favored Glycine 0 N--CA 1.425 -2.063 0 CA-C-N 114.555 -1.202 . . . . 94.780000000000001 112.84 -175.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 347' ' ' SER . . . . . 0.826 ' HB2' ' H ' ' A' ' 342' ' ' LEU . 48.3 t -81.12 100.38 9.02 Favored 'General case' 0 CA--C 1.483 -1.598 0 C-N-CA 112.346 -3.742 . . . . 121.41 109.477 -171.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 348' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.5 t -73.05 145.47 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 N-CA-C 108.951 -0.759 . . . . 85.340000000000003 108.951 -176.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 349' ' ' TYR . . . . . 0.441 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.5 p90 -57.74 143.44 41.88 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 107.826 -1.176 . . . . 267.56999999999999 107.826 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 350' ' ' LYS . . . . . 0.525 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.03 69.61 0.59 Allowed 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 109.514 -0.55 . . . . 226.09999999999999 109.514 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 351' ' ' VAL . . . . . 0.824 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.5 p -51.0 156.92 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 N-CA-C 106.986 -1.487 . . . . 154.84 106.986 177.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 352' ' ' SER . . . . . 0.581 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.8 m -61.36 161.92 8.54 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.566 0.698 . . . . 180.00999999999999 110.732 -173.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 353' ' ' ARG . . . . . 0.896 ' H ' ' HD3' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.42 156.86 23.73 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 106.971 -1.492 . . . . 333.77999999999997 106.971 -178.595 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 354' ' ' LEU . . . . . 0.974 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.01 142.55 48.71 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 107.371 -1.344 . . . . 335.19999999999999 107.371 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.974 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.5 mm-40 82.77 158.9 0.13 Allowed 'General case' 0 CA--C 1.492 -1.281 0 N-CA-C 108.735 -0.839 . . . . 266.47000000000003 108.735 179.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.5 m -60.62 -46.85 88.73 Favored 'General case' 0 CA--C 1.488 -1.441 0 N-CA-C 105.653 -1.98 . . . . 59.340000000000003 105.653 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.4 t -81.64 173.9 11.91 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 104.376 -2.453 . . . . 201.25999999999999 104.376 176.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.747 HG22 ' O ' ' A' ' 360' ' ' THR . 68.9 mt -95.91 106.73 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 C-N-CA 116.308 -2.157 . . . . 56.229999999999997 105.548 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 359' ' ' SER . . . . . 0.465 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.9 m -61.23 -59.43 5.33 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 109.326 -0.62 . . . . 87.579999999999998 109.326 -175.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 360' ' ' THR . . . . . 0.891 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.1 t -85.47 153.72 22.28 Favored 'General case' 0 CA--C 1.485 -1.533 0 N-CA-C 107.855 -1.165 . . . . 219.94999999999999 107.855 -177.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 361' ' ' VAL . . . . . 0.588 ' O ' HG23 ' A' ' 361' ' ' VAL . 16.0 m -82.01 83.82 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.641 0 C-N-CA 116.324 -2.15 . . . . 121.79000000000001 105.448 177.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.599 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.6 t -154.12 159.72 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.575 0 N-CA-C 105.851 -1.907 . . . . 53.850000000000001 105.851 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 363' ' ' GLY . . . . . 0.599 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.27 16.57 77.13 Favored Glycine 0 N--CA 1.428 -1.87 0 N-CA-C 106.023 -2.831 . . . . 196.55000000000001 106.023 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.674 0 N-CA-C 107.909 -1.145 . . . . 35.880000000000003 107.909 -178.949 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 365' ' ' ARG . . . . . 0.494 ' HD3' ' HA ' ' B' ' 365' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 108.884 -0.784 . . . . 1.0 108.884 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 366' ' ' PRO . . . . . 0.698 ' HB3' ' C ' ' A' ' 4' ' ' VAL . 52.8 Cg_endo -66.85 142.01 61.24 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.056 1.837 . . . . 1.0 110.223 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 367' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -64.42 143.24 98.5 Favored Pre-proline 0 C--N 1.325 -0.496 0 C-N-CA 119.841 -0.744 . . . . 1.0 109.595 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 368' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.27 150.38 76.43 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.331 2.021 . . . . 1.0 111.746 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 369' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.71 131.8 44.42 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.688 -0.405 . . . . 1.0 110.181 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -102.05 115.88 31.49 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.716 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 371' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -63.69 -42.38 98.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.365 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 372' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -64.96 -36.26 83.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.86 -0.609 . . . . 1.0 110.728 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -59.7 -33.08 76.03 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.819 -0.912 . . . . 1.0 110.819 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 374' ' ' LEU . . . . . 0.805 ' HG ' ' CD1' ' A' ' 102' ' ' LEU . 0.5 OUTLIER -67.82 131.31 45.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.93 0.395 . . . . 1.0 110.213 179.89 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 375' ' ' MET . . . . . . . . . . . . . 36.8 mmm . . . . . 0 C--O 1.219 -0.534 0 CA-C-O 117.993 -1.003 . . . . 1.0 110.545 -179.778 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.466 0 N-CA-C 108.386 -0.968 . . . . 97.079999999999998 108.386 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -110.61 155.44 22.37 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-O 122.147 0.975 . . . . 123.41 110.711 -172.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.883 HG11 HD13 ' A' ' 15' ' ' ILE . 28.6 m -134.59 -162.41 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.476 1 N-CA-C 100.12 -4.029 . . . . 151.30000000000001 100.12 173.697 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.912 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.6 -38.65 59.16 Favored Pre-proline 0 N--CA 1.439 -0.984 0 C-N-CA 115.948 -2.301 . . . . 169.25 106.102 178.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.912 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 59.2 Cg_exo -81.29 168.54 16.63 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 N-CA-C 110.513 -0.61 . . . . 185.75999999999999 110.513 171.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.909 HG13 ' CE2' ' A' ' 282' ' ' PHE . 92.2 t -64.45 -25.95 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 C-N-CA 127.012 2.125 . . . . 145.47 110.369 -177.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.776 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.1 t0 -84.26 157.38 21.59 Favored 'General case' 0 N--CA 1.439 -1.005 0 O-C-N 121.08 -1.013 . . . . 102.76000000000001 109.53 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.3 p -82.57 154.14 25.15 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 107.985 -1.117 . . . . 106.25 107.985 178.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.919 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.7 p-10 -105.88 51.88 0.74 Allowed 'General case' 0 N--CA 1.428 -1.547 0 C-N-CA 117.766 -1.574 . . . . 157.81 107.623 178.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.11 -45.91 91.39 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 103.617 -2.734 . . . . 150.19999999999999 103.617 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.8 m -87.09 164.69 35.16 Favored Pre-proline 0 N--CA 1.422 -1.84 0 N-CA-C 103.624 -2.732 . . . . 183.52000000000001 103.624 172.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -76.76 6.89 3.83 Favored 'Trans proline' 0 C--N 1.282 -2.97 0 N-CA-C 109.957 -0.824 . . . . 235.61000000000001 109.957 176.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.424 ' C ' HD21 ' A' ' 14' ' ' ASN . 0.4 OUTLIER -57.92 -41.27 82.35 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 124.813 1.245 . . . . 113.77 113.395 -170.104 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.919 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.4 pt -52.14 136.21 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-N 119.522 1.055 . . . . 150.84999999999999 110.954 -176.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.49 156.26 46.4 Favored 'General case' 0 C--N 1.36 1.061 0 N-CA-C 107.622 -1.251 . . . . 100.42 107.622 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . 1.081 HG23 ' H ' ' A' ' 20' ' ' SER . 14.2 t -64.96 142.62 58.37 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 121.99 0.9 . . . . 129.36000000000001 110.43 -174.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.773 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 74.7 m-20 -63.13 -25.51 68.39 Favored 'General case' 0 CA--C 1.493 -1.221 0 C-N-CA 126.328 1.851 . . . . 112.34 106.63 -177.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.941 HG23 ' HA2' ' A' ' 101' ' ' GLY . 85.9 m -74.18 -40.08 62.76 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 115.575 -0.739 . . . . 131.72999999999999 111.724 177.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . 1.081 ' H ' HG23 ' A' ' 17' ' ' THR . 70.9 m -84.52 -42.79 15.17 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 116.985 2.217 . . . . 80.489999999999995 116.985 -174.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.549 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.5 mt-10 -145.99 174.56 3.33 Favored Pre-proline 0 N--CA 1.442 -0.848 0 C-N-CA 118.176 -1.409 . . . . 98.980000000000004 111.216 -169.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.822 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.332 85.4 Cg_exo -61.84 -10.74 18.23 Favored 'Trans proline' 0 C--N 1.322 -0.868 1 N-CA-C 128.922 6.47 . . . . 246.94999999999999 128.922 -170.091 . . . . . . . . 4 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.0 m120 61.7 17.46 8.72 Favored 'General case' 0 C--N 1.324 -0.512 1 CA-C-N 126.175 4.079 . . . . 269.62 114.213 175.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.495 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 80.8 mt-30 -67.09 -27.34 67.27 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 107.782 -1.192 . . . . 86.799999999999997 107.782 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.551 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.4 p90 -66.76 -29.33 69.27 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 121.153 -0.967 . . . . 85.909999999999997 110.549 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.877 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.3 t -68.51 -40.25 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 C-N-CA 123.706 0.803 . . . . 82.0 111.333 -177.061 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.897 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 27.6 pt20 -151.4 167.71 12.52 Favored Pre-proline 0 CA--C 1.488 -1.407 0 N-CA-C 108.55 -0.907 . . . . 120.73 108.55 -178.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.903 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.6 Cg_endo -64.04 149.77 89.77 Favored 'Trans proline' 0 N--CA 1.432 -2.106 0 C-N-CA 120.638 0.892 . . . . 87.859999999999999 109.89 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.744 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.07 -37.94 89.2 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 108.808 -0.812 . . . . 36.460000000000001 108.808 -176.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.814 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 28.0 p-90 -63.84 -33.86 76.62 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 107.757 -1.201 . . . . 150.59999999999999 107.757 -176.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.903 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.5 mt-30 -62.23 -32.66 73.37 Favored 'General case' 0 CA--C 1.49 -1.351 0 O-C-N 121.272 -0.893 . . . . 123.26000000000001 108.686 -178.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.744 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.49 -47.13 94.84 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 N-CA-C 109.188 -0.671 . . . . 120.14 109.188 176.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.786 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.3 m -67.47 -30.96 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 N-CA-C 107.868 -1.16 . . . . 112.19 107.868 -178.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.814 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.5 tp -63.02 -47.11 84.5 Favored 'General case' 0 N--CA 1.433 -1.323 0 C-N-CA 119.895 -0.722 . . . . 60.869999999999997 109.623 -178.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.67 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.01 -35.68 81.2 Favored 'General case' 0 CA--C 1.489 -1.402 0 C-N-CA 119.952 -0.699 . . . . 157.56999999999999 110.349 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.745 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.63 -40.86 98.34 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 108.638 -0.875 . . . . 47.060000000000002 108.638 178.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.806 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.81 -41.28 97.92 Favored 'General case' 0 CA--C 1.496 -1.115 0 O-C-N 121.724 -0.61 . . . . 43.939999999999998 109.522 -177.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.728 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.84 -43.25 99.22 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 108.752 -0.833 . . . . 42.609999999999999 108.752 -176.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.905 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.4 -41.22 93.9 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 116.649 -0.25 . . . . 140.66 111.059 -178.42 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.806 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.86 -43.93 97.86 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 118.588 -1.245 . . . . 116.04000000000001 110.214 -175.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.675 HG22 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.45 -38.72 83.16 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.28 0 N-CA-C 108.73 -0.841 . . . . 97.159999999999997 108.73 -177.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.854 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.3 mt -61.31 -40.03 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 N-CA-C 108.956 -0.757 . . . . 54.850000000000001 108.956 -176.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.951 HG22 HG21 ' A' ' 86' ' ' THR . 92.7 t -57.72 -42.31 81.42 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.302 0 N-CA-C 108.848 -0.797 . . . . 45.390000000000001 108.848 -175.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.431 ' O ' HG23 ' A' ' 48' ' ' VAL . 97.2 t -63.55 -50.98 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 C-N-CA 118.839 -1.144 . . . . 48.640000000000001 110.162 -177.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.752 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.6 t -65.23 -47.08 78.06 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 120.197 -0.601 . . . . 116.65000000000001 111.694 -174.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.589 ' N ' HG23 ' A' ' 45' ' ' THR . 50.8 m -61.98 -43.88 97.9 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 109.73 -0.471 . . . . 51.159999999999997 109.73 -174.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.1 t -65.63 -48.86 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 C-N-CA 119.846 -0.741 . . . . 44.299999999999997 110.818 -176.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.868 ' O ' HG23 ' A' ' 52' ' ' VAL . 94.0 t -64.75 -46.97 90.54 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 C-N-CA 120.291 -0.564 . . . . 48.82 111.068 -174.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.73 -44.2 95.2 Favored Glycine 0 N--CA 1.437 -1.299 0 C-N-CA 120.515 -0.85 . . . . 58.700000000000003 112.021 -174.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -72.55 -34.28 67.41 Favored 'General case' 0 CA--C 1.488 -1.436 0 O-C-N 122.061 -0.67 . . . . 101.40000000000001 111.072 -175.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.739 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.4 p -66.83 -38.77 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 107.73 -1.211 . . . . 103.56999999999999 107.73 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 48' ' ' VAL . 72.0 t -61.44 -43.01 96.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 N-CA-C 108.974 -0.75 . . . . 61.890000000000001 108.974 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.537 ' O ' HG22 ' A' ' 56' ' ' ILE . 81.6 t -63.5 -50.93 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 109.437 -0.579 . . . . 70.010000000000005 109.437 -178.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.8 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.98 -43.35 99.02 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 109.122 -0.696 . . . . 132.09999999999999 109.122 -176.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.644 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.1 t-105 -64.23 -46.63 82.96 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 116.666 -0.243 . . . . 104.5 110.434 -176.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 1.011 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.69 -49.88 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 C-N-CA 120.194 -0.602 . . . . 142.96000000000001 111.235 -173.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.954 HD11 HG12 ' A' ' 72' ' ' VAL 0.278 24.8 pt -64.78 -41.68 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.707 0 C-N-CA 116.904 -1.919 . . . . 158.31999999999999 110.905 -175.973 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.8 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.69 -41.32 98.16 Favored 'General case' 0 N--CA 1.433 -1.308 0 C-N-CA 117.701 -1.599 . . . . 137.11000000000001 109.527 178.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.39 -44.53 91.03 Favored 'General case' 0 N--CA 1.436 -1.141 0 O-C-N 122.147 -0.346 . . . . 54.659999999999997 111.024 -176.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.923 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.42 117.1 29.39 Favored 'General case' 0 CA--C 1.491 -1.294 0 CA-C-O 121.576 0.703 . . . . 127.18000000000001 109.586 -174.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.621 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.3 tttt -60.81 -36.87 80.13 Favored 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 124.072 0.949 . . . . 87.930000000000007 110.819 -176.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 1.031 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.34 -34.66 78.66 Favored 'General case' 0 CA--C 1.49 -1.355 0 O-C-N 121.636 -0.665 . . . . 131.12 111.541 -175.63 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' MET . . . . . 1.012 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.67 69.49 7.2 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 115.311 -2.556 . . . . 246.56 109.555 -175.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.411 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.27 91.44 3.48 Favored 'General case' 0 CA--C 1.473 -1.987 0 N-CA-C 105.495 -2.039 . . . . 339.35000000000002 105.495 177.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.444 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.6 p -124.18 165.29 17.84 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 102.986 -2.968 . . . . 114.66 102.986 176.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.881 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.14 -39.44 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 N-CA-C 106.773 -1.566 . . . . 143.28 106.773 178.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.833 HG22 HD13 ' A' ' 71' ' ' LEU . 95.4 m -59.75 -37.99 80.52 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 108.652 -0.87 . . . . 160.22 108.652 -176.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.527 ' ND2' ' HB3' ' A' ' 63' ' ' MET . 86.3 m-20 -62.36 -31.77 72.47 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 108.86 -0.793 . . . . 120.54000000000001 108.86 -177.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.903 ' O ' HG22 ' A' ' 72' ' ' VAL . 89.9 m-85 -63.6 -43.77 95.96 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.523 -0.547 . . . . 67.219999999999999 109.523 178.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.881 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.4 m-85 -66.6 -39.72 88.52 Favored 'General case' 0 CA--C 1.498 -1.041 0 O-C-N 121.487 -0.758 . . . . 138.59999999999999 109.639 -177.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.927 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.62 -35.87 81.96 Favored 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 122.435 0.294 . . . . 151.46000000000001 110.639 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.954 HG12 HD11 ' A' ' 57' ' ' ILE . 24.0 m -62.54 -37.96 80.2 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.228 0 C-N-CA 117.41 -1.716 . . . . 117.93000000000001 106.732 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.45 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.0 t30 -60.11 -46.04 90.96 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 107.839 -1.171 . . . . 56.82 107.839 -177.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.999 HD21 ' HE1' ' A' ' 123' ' ' MET . 8.6 mp -61.33 -43.87 98.14 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 109.005 -0.739 . . . . 145.30000000000001 109.005 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.09 -40.33 95.49 Favored 'General case' 0 CA--C 1.492 -1.256 0 N-CA-C 108.5 -0.926 . . . . 45.710000000000001 108.5 -175.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -62.43 -42.01 99.13 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 109.346 -0.613 . . . . 105.61 109.346 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.14 -39.44 92.62 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 108.667 -0.864 . . . . 47.890000000000001 108.667 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.587 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.56 -37.38 84.84 Favored 'General case' 0 N--CA 1.439 -1.014 0 O-C-N 122.059 -0.401 . . . . 124.53 109.969 179.662 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.81 -41.29 99.24 Favored 'General case' 0 CA--C 1.496 -1.116 0 O-C-N 121.991 -0.443 . . . . 35.890000000000001 109.858 -178.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.7 t -62.14 -37.34 84.79 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 107.052 -1.462 . . . . 88.969999999999999 107.052 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.82 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.7 ttm -62.2 -49.19 76.76 Favored 'General case' 0 N--CA 1.428 -1.571 0 C-N-CA 119.816 -0.754 . . . . 239.91 109.03 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.619 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.37 -43.43 90.8 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 121.532 -0.73 . . . . 146.09999999999999 110.56 -177.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.418 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.13 -58.22 3.41 Favored 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 117.416 -1.714 . . . . 91.739999999999995 113.888 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -76.54 -61.41 1.97 Allowed 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 115.75 1.759 . . . . 197.44999999999999 115.75 -173.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.939 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.24 -42.23 55.72 Favored 'General case' 0 CA--C 1.49 -1.357 0 C-N-CA 117.876 -1.53 . . . . 242.59999999999999 114.061 -170.02 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.951 HG21 HG22 ' A' ' 43' ' ' VAL . 4.6 t -65.39 -36.59 84.42 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 118.941 -1.103 . . . . 215.61000000000001 109.812 -172.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.421 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.4 t -60.31 -46.95 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 O-C-N 121.824 -0.548 . . . . 87.189999999999998 110.426 -175.306 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.839 HG21 ' CD2' ' A' ' 108' ' ' HIS . 63.7 t -65.94 -41.84 90.67 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.098 0 N-CA-C 109.727 -0.471 . . . . 231.81999999999999 109.727 -178.016 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.905 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 87.7 m-20 -62.33 -34.11 76.0 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 108.365 -0.976 . . . . 364.98000000000002 108.365 -177.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.669 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.0 t80 -68.16 -44.76 75.27 Favored 'General case' 0 N--CA 1.438 -1.07 0 O-C-N 121.56 -0.713 . . . . 181.63 111.271 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.476 HG22 ' ND1' ' A' ' 95' ' ' HIS . 57.6 m -60.85 -45.8 93.1 Favored 'General case' 0 CA--C 1.477 -1.831 0 N-CA-C 107.438 -1.319 . . . . 269.01999999999998 107.438 -175.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 1.05 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.74 -45.01 93.53 Favored 'General case' 0 N--CA 1.416 -2.165 0 C-N-CA 118.683 -1.207 . . . . 562.65999999999997 110.037 -179.056 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.706 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.08 -45.31 95.24 Favored 'General case' 0 CA--C 1.479 -1.768 0 C-N-CA 118.697 -1.201 . . . . 446.75 108.042 -167.136 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.745 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.387 6.1 m -70.5 -26.28 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.752 0 C-N-CA 115.819 -2.352 . . . . 370.05000000000001 112.244 -178.72 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.496 ' O ' ' HB2' ' A' ' 96' ' ' ASN . 40.7 m80 -74.46 -26.54 60.1 Favored 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 121.592 -0.692 . . . . 354.91000000000003 112.469 175.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.822 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.4 m-20 82.85 4.51 0.98 Allowed 'General case' 0 CA--C 1.5 -0.951 0 C-N-CA 125.044 1.338 . . . . 462.44 111.881 -178.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.773 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.267 11.9 mm-40 -172.36 178.06 2.91 Favored 'General case' 0 CA--C 1.488 -1.409 0 CA-C-O 122.025 0.916 . . . . 652.37 111.122 171.813 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.791 ' HE3' ' HA ' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.72 86.31 2.17 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 128.516 2.726 . . . . 905.99000000000001 107.924 -174.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -67.9 -36.43 80.19 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 108.217 -1.031 . . . . 570.42999999999995 108.217 -176.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.849 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.58 -36.34 82.38 Favored 'General case' 0 N--CA 1.427 -1.586 0 C-N-CA 125.361 1.464 . . . . 453.22000000000003 111.152 -174.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.941 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.55 178.69 33.89 Favored Glycine 0 C--N 1.349 1.266 0 C-N-CA 118.777 -1.678 . . . . 445.63 109.854 177.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.1 mt -56.38 -41.23 75.89 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 125.257 1.423 . . . . 457.72000000000003 112.377 -170.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -58.71 -46.86 86.39 Favored 'General case' 0 CA--C 1.484 -1.56 0 C-N-CA 118.622 -1.231 . . . . 340.57999999999998 109.281 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.849 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.2 m-85 -68.72 -32.14 71.72 Favored 'General case' 0 N--CA 1.423 -1.778 0 C-N-CA 118.784 -1.166 . . . . 453.60000000000002 111.576 -176.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.764 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.2 t -56.08 -40.32 73.44 Favored 'General case' 0 CA--C 1.488 -1.441 0 N-CA-C 105.948 -1.871 . . . . 541.48000000000002 105.948 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.87 -47.17 75.79 Favored 'General case' 0 CA--C 1.485 -1.532 0 O-C-N 123.959 0.787 . . . . 466.68000000000001 110.869 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -61.63 -47.14 86.74 Favored 'General case' 0 N--CA 1.427 -1.621 0 C-N-CA 117.501 -1.68 . . . . 427.33999999999997 107.361 -178.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.839 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.5 m80 -67.05 -36.77 82.78 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 112.456 0.539 . . . . 537.87 112.456 -174.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.574 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.38 -42.68 74.83 Favored 'General case' 0 N--CA 1.432 -1.344 0 C-N-CA 116.884 -1.926 . . . . 422.12 111.608 175.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.856 ' O ' HG22 ' A' ' 113' ' ' ILE . 75.9 t80 -59.1 -50.08 75.41 Favored 'General case' 0 CA--C 1.501 -0.909 0 O-C-N 121.342 -0.849 . . . . 340.17000000000002 111.815 -173.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -65.32 -46.48 71.03 Favored Pre-proline 0 N--CA 1.443 -0.816 0 C-N-CA 119.1 -1.04 . . . . 258.06 111.696 -176.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.939 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.1 Cg_exo -61.57 -31.54 87.24 Favored 'Trans proline' 0 N--CA 1.435 -1.925 0 N-CA-C 115.341 1.246 . . . . 305.70999999999998 115.341 176.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.878 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.87 -40.45 76.54 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.363 0 N-CA-C 108.686 -0.857 . . . . 252.69999999999999 108.686 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.422 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.93 -40.57 93.76 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 107.825 -1.176 . . . . 149.27000000000001 107.825 -179.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.99 -44.84 95.88 Favored 'General case' 0 N--CA 1.436 -1.165 0 C-N-CA 120.614 -0.434 . . . . 138.08000000000001 111.497 -176.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.651 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 65.2 t -66.94 -42.34 88.7 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.944 0 O-C-N 121.604 -0.685 . . . . 132.88999999999999 110.969 -177.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.922 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.6 m-85 -63.76 -44.7 92.69 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 108.871 -0.788 . . . . 193.61000000000001 108.871 -177.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.555 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.43 -37.71 84.5 Favored 'General case' 0 N--CA 1.435 -1.177 0 C-N-CA 122.811 0.445 . . . . 63.829999999999998 110.094 -175.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 72.0 m -63.95 -52.46 59.64 Favored 'General case' 0 N--CA 1.435 -1.194 0 O-C-N 122.031 -0.418 . . . . 76.400000000000006 111.221 -177.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.752 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.96 -41.7 93.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 108.179 -1.045 . . . . 171.13 108.179 -174.963 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 1.103 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.2 m-85 -63.79 -38.53 91.46 Favored 'General case' 0 N--CA 1.433 -1.3 0 O-C-N 121.839 -0.538 . . . . 78.299999999999997 110.631 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.556 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.5 t -67.11 -35.73 80.4 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 118.854 -1.138 . . . . 92.359999999999999 109.229 -178.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.999 ' HE1' HD21 ' A' ' 74' ' ' LEU . 5.9 mmt -62.47 -34.27 76.49 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 108.218 -1.03 . . . . 93.730000000000004 108.218 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.9 HG22 HG13 ' A' ' 212' ' ' ILE . 32.9 p -67.38 -41.72 84.58 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.209 -0.996 . . . . 132.74000000000001 109.302 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.28 -42.04 94.59 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 107.2 -1.408 . . . . 43.390000000000001 107.2 -177.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.827 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.0 t -58.48 -41.95 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 N-CA-C 108.606 -0.887 . . . . 59.340000000000003 108.606 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.55 -44.07 95.23 Favored 'General case' 0 CA--C 1.498 -1.039 0 O-C-N 121.844 -0.535 . . . . 69.680000000000007 110.474 -177.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.468 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.3 t80 -65.44 -42.8 92.01 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 108.313 -0.995 . . . . 106.98 108.313 -177.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.827 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.34 -35.58 81.35 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 119.632 -0.827 . . . . 147.63 108.982 -177.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.703 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.16 -41.52 99.26 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 108.562 -0.903 . . . . 190.06 108.562 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.599 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.4 t80 -61.34 -44.12 97.72 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.253 -1.017 . . . . 118.84999999999999 108.253 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.803 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.4 mmt -63.36 -42.66 98.9 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 109.979 -0.378 . . . . 102.5 109.979 -177.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.91 -41.7 95.35 Favored 'General case' 0 CA--C 1.489 -1.399 0 O-C-N 121.817 -0.552 . . . . 89.980000000000004 109.836 -176.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.92 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.4 mt -66.52 -50.7 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.719 0 C-N-CA 118.103 -1.439 . . . . 106.09 110.997 -177.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.75 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.03 -48.37 38.49 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.13 0 C-N-CA 117.092 -1.843 . . . . 227.74000000000001 111.824 -174.824 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.756 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 23.9 p80 -118.85 100.11 50.98 Favored Pre-proline 0 CA--C 1.486 -1.503 0 C-N-CA 116.26 -2.176 . . . . 262.55000000000001 110.061 -175.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.2 Cg_endo -69.63 -10.35 28.45 Favored 'Trans proline' 0 C--N 1.289 -2.574 0 C-N-CA 121.607 1.538 . . . . 210.25 111.327 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.706 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.35 112.04 1.01 Allowed 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 106.483 -1.673 . . . . 270.57999999999998 106.483 -178.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.887 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.2 tt0 -66.77 -39.53 24.48 Favored Pre-proline 0 N--CA 1.431 -1.425 0 CA-C-N 115.329 -0.851 . . . . 129.84 112.362 -176.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.857 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 82.3 Cg_exo -61.36 -26.57 81.72 Favored 'Trans proline' 0 N--CA 1.431 -2.176 0 N-CA-C 116.322 1.624 . . . . 330.70999999999998 116.322 -174.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.756 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.07 77.24 7.99 Favored 'General case' 0 N--CA 1.429 -1.514 0 C-N-CA 114.47 -2.892 . . . . 204.50999999999999 107.3 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.877 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.68 147.38 0.09 Allowed 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.482 -1.303 . . . . 387.41000000000003 107.482 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.877 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.3 t -143.68 147.0 33.64 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 118.824 -1.151 . . . . 166.22 109.515 178.054 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.8 -40.77 88.21 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 107.869 -1.159 . . . . 44.229999999999997 107.869 176.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.481 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.7 m -60.33 -39.08 85.8 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 108.181 -1.044 . . . . 28.800000000000001 108.181 -175.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.668 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.86 -38.75 92.06 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 109.087 -0.708 . . . . 30.289999999999999 109.087 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.847 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 90.3 m -59.62 -43.03 93.94 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 109.011 -0.737 . . . . 46.109999999999999 109.011 -176.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.46 -42.12 99.25 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 107.7 -1.222 . . . . 87.329999999999998 107.7 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.766 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.4 t -61.71 -42.06 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.359 0 N-CA-C 107.874 -1.158 . . . . 23.690000000000001 107.874 -178.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.8 t -63.2 -44.26 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 N-CA-C 109.73 -0.47 . . . . 43.859999999999999 109.73 -178.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.92 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.1 mm -61.24 -42.54 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 108.359 -0.978 . . . . 91.129999999999995 108.359 -176.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' CYS . . . . . 0.484 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.3 t -62.62 -37.95 88.31 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 108.735 -0.839 . . . . 65.879999999999995 108.735 -178.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.766 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.5 t -62.1 -41.88 92.89 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 109.552 -0.536 . . . . 33.859999999999999 109.552 -177.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 1.103 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.37 -40.37 85.97 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.159 0 N-CA-C 107.583 -1.266 . . . . 146.52000000000001 107.583 -176.791 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 155' ' ' TRP . . . . . 0.699 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.1 m95 -62.84 -38.35 90.43 Favored 'General case' 0 N--CA 1.428 -1.538 0 C-N-CA 119.502 -0.879 . . . . 75.439999999999998 108.942 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.9 t -60.5 -48.42 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 O-C-N 121.058 -1.026 . . . . 43.640000000000001 109.749 -177.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.791 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.65 -38.05 89.67 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 109.041 -0.726 . . . . 102.56999999999999 109.041 -178.09 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.99 -41.06 86.7 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.433 -1.321 . . . . 58.159999999999997 107.433 -178.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.802 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.08 -32.55 73.95 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.014 -0.736 . . . . 121.11 109.014 178.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.791 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.0 -42.3 84.92 Favored 'General case' 0 CA--C 1.489 -1.381 0 C-N-CA 118.554 -1.258 . . . . 153.15000000000001 109.966 -178.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 1.059 HD13 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.09 -43.71 19.07 Favored 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 113.06 -3.456 . . . . 133.66999999999999 113.532 173.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.479 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -63.0 -39.83 95.96 Favored 'General case' 0 CA--C 1.49 -1.344 0 O-C-N 120.888 -1.132 . . . . 157.41999999999999 112.196 -171.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.524 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.3 t80 -74.51 -36.08 2.4 Favored Pre-proline 0 N--CA 1.437 -1.112 0 N-CA-C 114.974 1.472 . . . . 250.91 114.974 -173.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.293 53.0 Cg_exo -59.53 -25.46 78.83 Favored 'Trans proline' 0 CA--C 1.488 -1.817 0 N-CA-C 118.043 2.286 . . . . 207.34 118.043 -174.37 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.916 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 32.4 mt-30 -61.18 -34.23 74.71 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 106.953 -1.499 . . . . 192.46000000000001 106.953 178.07 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.46 -41.07 98.16 Favored Glycine 0 C--N 1.353 1.513 0 N-CA-C 107.974 -2.05 . . . . 261.0 107.974 177.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.78 159.07 26.02 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 101.548 -3.501 . . . . 491.39999999999998 101.548 172.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -59.92 106.79 0.53 Allowed 'General case' 0 CA--C 1.488 -1.42 0 C-N-CA 116.282 -2.167 . . . . 386.10000000000002 109.831 -176.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.916 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 74.0 m -154.05 -166.61 2.42 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 103.553 -2.758 . . . . 289.80000000000001 103.553 -178.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' THR . . . . . 1.142 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.1 p -62.91 175.44 0.86 Allowed 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 117.723 -1.132 . . . . 402.06 109.554 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.788 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 72.5 p -165.3 177.5 7.54 Favored 'General case' 0 CA--C 1.587 2.383 0 C-N-CA 127.309 2.243 . . . . 690.52999999999997 114.927 177.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.486 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.8 mm-40 132.32 160.57 0.0 OUTLIER 'General case' 1 C--N 1.428 4.007 1 N-CA-C 123.183 4.512 . . . . 633.62 123.183 162.691 . . . . . . . . 4 3 . 1 . 004 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.76 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.4 p -85.68 153.82 22.08 Favored 'General case' 0 C--N 1.389 2.313 0 C-N-CA 127.373 2.269 . . . . 617.99000000000001 110.874 178.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' MET . . . . . 1.047 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.66 174.45 5.93 Favored Pre-proline 0 C--N 1.364 1.233 0 C-N-CA 130.284 3.433 . . . . 434.98000000000002 113.387 -175.365 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 1.091 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 52.9 Cg_endo -44.31 -65.63 0.19 Allowed 'Trans proline' 0 N--CA 1.441 -1.576 0 N-CA-C 122.386 3.956 . . . . 365.88 122.386 -168.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' SER . . . . . 0.777 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.306 70.4 m -84.91 20.94 1.7 Allowed 'General case' 0 CA--C 1.466 -2.257 0 N-CA-C 104.807 -2.294 . . . . 635.80999999999995 104.807 178.147 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.75 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.457 5.0 mmp_? -94.33 152.24 18.8 Favored 'General case' 1 CA--C 1.419 -4.081 3 N-CA-C 132.031 7.789 . . . . 999.99000000000001 132.031 -135.787 . . . . . . . . 5 3 . 1 . 004 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 1.05 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.912 37.3 t -131.83 73.12 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.383 -3.8 1 CA-C-N 103.343 -6.299 . . . . 594.32000000000005 113.606 149.235 . . . . . . . . 4 3 . 1 . 004 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.729 HG13 ' HB2' ' A' ' 174' ' ' MET . 7.3 p -144.16 144.14 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.603 1 N-CA-C 98.244 -4.724 . . . . 811.90999999999997 98.244 162.404 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.76 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.9 m -118.48 144.49 45.97 Favored 'General case' 0 CA--C 1.489 -1.391 0 C-N-CA 117.099 -1.84 . . . . 999.99000000000001 109.429 -178.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.971 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.9 mmm -147.17 -175.6 4.89 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 122.019 0.914 . . . . 431.86000000000001 110.069 -177.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 1.037 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.11 148.65 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 C-N-CA 124.397 1.079 . . . . 457.18000000000001 108.796 -177.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' GLU . . . . . 0.788 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.31 85.41 3.74 Favored 'General case' 0 CA--C 1.5 -0.944 0 C-N-CA 124.147 0.979 . . . . 458.76999999999998 113.515 -174.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.96 ' CZ3' HG22 ' A' ' 182' ' ' ILE . 1.9 p90 -76.35 -31.55 0.98 Allowed Pre-proline 0 N--CA 1.438 -1.065 0 C-N-CA 124.941 1.296 . . . . 999.99000000000001 112.452 168.298 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.957 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 50.9 Cg_exo -66.0 -45.71 5.64 Favored 'Trans proline' 0 N--CA 1.438 -1.766 0 N-CA-C 120.895 3.383 . . . . 999.99000000000001 120.895 -174.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.507 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 54.9 mt-10 -119.54 171.73 8.15 Favored 'General case' 0 CA--C 1.472 -2.054 0 C-N-CA 117.204 -1.798 . . . . 81.180000000000007 107.285 -172.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.834 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 6.4 p80 -109.13 45.14 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.828 0 C-N-CA 115.466 -2.493 . . . . 999.99000000000001 108.777 177.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 1.076 ' HB2' HD12 ' A' ' 191' ' ' ILE . 87.3 Cg_endo -41.56 101.84 0.04 OUTLIER 'Trans proline' 0 CA--C 1.5 -1.184 1 C-N-CA 126.039 4.492 . . . . 999.99000000000001 105.683 -170.749 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -62.34 -44.01 97.49 Favored 'General case' 0 CA--C 1.484 -1.586 0 C-N-CA 126.777 2.031 . . . . 967.72000000000003 112.024 -165.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -60.31 -36.49 78.01 Favored 'General case' 0 CA--C 1.487 -1.475 0 N-CA-C 106.741 -1.578 . . . . 934.29999999999995 106.741 -175.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 1.076 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.62 -30.22 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 C-N-CA 129.185 2.994 . . . . 565.14999999999998 113.918 -178.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 61.56 55.38 2.79 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-N 118.469 0.577 . . . . 755.61000000000001 109.853 -175.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 1.142 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.5 -49.33 66.94 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 124.563 1.145 . . . . 325.88999999999999 113.265 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.632 ' HE3' ' OH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.76 -45.0 78.18 Favored 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 123.573 0.749 . . . . 250.21000000000001 111.637 -169.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 96.8 t -64.73 -43.29 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 C-N-CA 119.959 -0.696 . . . . 142.46000000000001 110.389 -175.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 1.037 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.9 t80 -61.15 -41.5 96.86 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 123.982 0.913 . . . . 247.69 108.814 -173.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.824 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 23.0 t60 -60.52 -51.36 69.75 Favored 'General case' 0 CA--C 1.492 -1.279 0 C-N-CA 125.454 1.502 . . . . 199.61000000000001 113.049 -175.091 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 82.8 mt -65.31 -44.52 94.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 107.727 -1.212 . . . . 106.73 107.727 -177.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' CYS . . . . . 0.72 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.5 t -59.11 -48.55 81.21 Favored 'General case' 0 CA--C 1.486 -1.519 0 CA-C-N 115.858 -0.61 . . . . 115.01000000000001 110.245 -173.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 1.059 HG13 HD13 ' A' ' 161' ' ' LEU . 86.1 t -65.27 -49.15 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.647 0 C-N-CA 119.458 -0.897 . . . . 129.41999999999999 111.823 -174.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.791 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.1 m -61.89 -53.14 59.82 Favored 'General case' 0 CA--C 1.483 -1.614 0 C-N-CA 118.245 -1.382 . . . . 172.47999999999999 109.953 -172.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.631 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 85.6 t -63.83 -54.24 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 C-N-CA 120.523 -0.471 . . . . 55.859999999999999 110.989 -174.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.72 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.58 -51.54 58.96 Favored 'General case' 0 N--CA 1.432 -1.355 0 C-N-CA 118.526 -1.27 . . . . 184.68000000000001 111.496 -174.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 1.051 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.6 -52.44 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 C-N-CA 116.696 -2.002 . . . . 291.81 114.737 -174.683 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.55 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.8 t80 -82.04 -55.0 4.84 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 115.142 1.534 . . . . 130.66 115.142 -178.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' PHE . . . . . 0.791 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.9 m-85 -66.87 -48.49 68.62 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 114.532 1.308 . . . . 80.159999999999997 114.532 -170.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.898 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.57 -45.48 83.07 Favored Pre-proline 0 N--CA 1.436 -1.165 0 C-N-CA 119.91 -0.716 . . . . 136.02000000000001 109.495 -174.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.898 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.7 Cg_exo -64.76 -27.16 60.0 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 110.629 -0.566 . . . . 92.170000000000002 110.629 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.686 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.29 -41.41 76.83 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 107.495 -1.298 . . . . 135.59999999999999 107.495 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.8 mt -64.17 -44.73 91.17 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 109.57 -0.529 . . . . 52.100000000000001 109.57 -176.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.617 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.7 p -61.61 -43.53 97.18 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 109.12 -0.696 . . . . 95.890000000000001 109.12 -176.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.9 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.23 -42.35 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 106.728 -1.582 . . . . 43.409999999999997 106.728 -178.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.47 -42.26 99.04 Favored Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 109.361 -1.496 . . . . 27.690000000000001 109.361 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' TYR . . . . . 0.883 ' O ' HG22 ' A' ' 217' ' ' THR . 77.9 t80 -65.65 -47.4 75.69 Favored 'General case' 0 CA--C 1.496 -1.113 0 CA-C-N 117.38 0.59 . . . . 54.409999999999997 110.497 -177.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ALA . . . . . 0.826 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.41 -34.13 74.85 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 106.968 -1.493 . . . . 53.880000000000003 106.968 -177.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -60.74 -40.86 93.98 Favored 'General case' 0 N--CA 1.426 -1.628 0 N-CA-C 108.492 -0.929 . . . . 68.290000000000006 108.492 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' THR . . . . . 0.883 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.74 -39.06 92.99 Favored 'General case' 0 CA--C 1.497 -1.088 0 C-N-CA 119.69 -0.804 . . . . 107.59 110.619 -175.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.826 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.03 -38.36 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 C-N-CA 119.607 -0.837 . . . . 111.61 109.488 -177.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.92 HG13 ' CD1' ' A' ' 134' ' ' ILE . 79.6 t -63.29 -22.52 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 N-CA-C 108.389 -0.967 . . . . 85.260000000000005 108.389 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.84 -41.95 99.39 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 111.051 -0.82 . . . . 40.710000000000001 111.051 -176.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.7 mm -64.66 -44.09 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 108.42 -0.955 . . . . 95.859999999999999 108.42 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.822 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.1 p -76.94 -137.57 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.417 -0.956 . . . . 144.37 108.417 -176.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.901 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.7 mt -55.31 132.1 47.16 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 107.633 -1.247 . . . . 326.72000000000003 107.633 -177.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' TRP . . . . . 0.463 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.31 -168.02 1.5 Allowed 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 106.059 -1.83 . . . . 158.38 106.059 -176.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.463 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.39 -41.93 98.79 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 109.619 -0.512 . . . . 36.780000000000001 109.619 -178.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.8 m -61.13 125.81 25.07 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 119.144 -1.022 . . . . 85.459999999999994 109.813 -174.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' GLU . . . . . 0.692 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.82 126.56 8.89 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 105.547 -2.02 . . . . 127.78 105.547 176.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.928 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.04 139.92 34.8 Favored Pre-proline 0 CA--C 1.493 -1.214 0 N-CA-C 105.946 -1.872 . . . . 164.84 105.946 -179.548 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.928 ' N ' HD13 ' A' ' 228' ' ' ILE . 82.3 Cg_exo -56.87 -39.85 88.44 Favored 'Trans proline' 0 N--CA 1.431 -2.184 0 N-CA-C 113.945 0.71 . . . . 222.34999999999999 113.945 -175.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' GLY . . . . . 0.745 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.18 167.0 44.85 Favored Glycine 0 N--CA 1.428 -1.838 0 N-CA-C 106.39 -2.684 . . . . 45.219999999999999 106.39 178.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.883 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.6 t0 -60.97 -45.79 93.34 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 105.997 -1.853 . . . . 107.56999999999999 105.997 177.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' SER . . . . . 0.73 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.5 m -65.72 141.78 58.23 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 118.899 -1.12 . . . . 167.96000000000001 109.192 -175.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.829 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.3 m 99.5 106.7 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.248 0 C-N-CA 126.73 2.012 . . . . 280.68000000000001 109.768 176.135 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.709 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.5 m-20 55.99 11.31 0.71 Allowed 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 124.42 1.088 . . . . 218.25 110.717 174.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.921 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.41 137.68 54.76 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 105.217 -2.142 . . . . 343.56999999999999 105.217 177.368 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.48 ' O ' HG21 ' A' ' 240' ' ' VAL . 85.6 t80 -112.0 81.92 1.54 Allowed 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 106.826 -1.546 . . . . 263.29000000000002 106.826 179.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 237' ' ' HIS . . . . . 0.627 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 64.5 m80 104.29 147.03 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.285 0 C-N-CA 126.576 1.951 . . . . 261.92000000000002 108.486 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.21 -38.07 89.73 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 107.911 -1.144 . . . . 106.81 107.911 -177.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.739 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.42 -39.95 94.96 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 118.362 -1.335 . . . . 112.2 107.552 -178.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.738 HG12 ' NH1' ' A' ' 244' ' ' ARG . 75.5 t -64.25 -39.85 86.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 N-CA-C 109.254 -0.647 . . . . 45.409999999999997 109.254 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' SER . . . . . 0.803 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.0 p -70.94 -32.01 68.78 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 110.278 -0.267 . . . . 97.620000000000005 110.278 -178.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.38 -39.61 81.7 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 123.698 0.799 . . . . 59.289999999999999 111.012 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.739 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.25 -36.55 84.03 Favored 'General case' 0 CA--C 1.491 -1.3 0 C-N-CA 124.664 1.186 . . . . 106.48999999999999 110.683 -174.127 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.921 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.95 -30.67 69.24 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 108.293 -1.002 . . . . 106.62 108.293 -176.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.534 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -65.97 -41.06 91.68 Favored 'General case' 0 N--CA 1.436 -1.141 0 O-C-N 121.841 -0.537 . . . . 75.969999999999999 110.062 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.44 ' CG1' ' CE ' ' A' ' 250' ' ' MET . 76.8 t -65.53 -40.84 89.36 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 C-N-CA 122.92 0.488 . . . . 65.269999999999996 109.779 -178.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.775 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -64.03 -41.62 93.07 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.317 0 C-N-CA 120.398 -0.521 . . . . 107.94 110.12 -177.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.536 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.2 pttt -63.47 -40.81 98.11 Favored 'General case' 0 N--CA 1.434 -1.239 0 O-C-N 121.663 -0.648 . . . . 87.980000000000004 110.328 -176.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 249' ' ' MET . . . . . 0.821 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.68 -40.41 96.76 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 118.824 -1.15 . . . . 65.5 108.35 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 250' ' ' MET . . . . . 0.76 ' CE ' HG21 ' A' ' 67' ' ' THR . 68.5 mtt -61.64 -36.41 80.71 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.141 -1.059 . . . . 85.049999999999997 108.141 -177.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.536 HD12 ' HA ' ' A' ' 248' ' ' LYS . 86.9 mt -63.48 -45.71 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 N-CA-C 109.061 -0.718 . . . . 42.25 109.061 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.821 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.4 -38.19 81.93 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.13 0 C-N-CA 119.551 -0.86 . . . . 91.010000000000005 109.376 -176.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 1.0 HG22 ' CD1' ' A' ' 304' ' ' ILE . 66.5 t -58.93 -41.53 83.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 N-CA-C 107.931 -1.137 . . . . 66.090000000000003 107.931 -178.114 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 250' ' ' MET . 94.3 t -66.14 -43.15 92.24 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 C-N-CA 120.729 -0.388 . . . . 52.390000000000001 110.282 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.5 m -61.73 -46.75 88.3 Favored 'General case' 0 CA--C 1.489 -1.384 0 O-C-N 121.913 -0.492 . . . . 46.420000000000002 109.903 -174.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' THR . . . . . 0.744 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.5 t -62.33 -38.18 88.45 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 108.333 -0.988 . . . . 116.51000000000001 108.333 -177.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 257' ' ' PHE . . . . . 0.489 ' N ' HG23 ' A' ' 256' ' ' THR . 86.1 t80 -60.23 -48.23 82.6 Favored 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 109.405 -0.591 . . . . 65.180000000000007 109.405 -178.136 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.94 -42.65 97.26 Favored 'General case' 0 CA--C 1.49 -1.364 0 CA-C-O 120.872 0.368 . . . . 51.329999999999998 110.468 -175.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' ILE . . . . . 0.744 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.62 -43.41 98.16 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 C-N-CA 118.941 -1.103 . . . . 126.3 108.974 -176.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 260' ' ' CYS . . . . . 0.508 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.7 m -65.58 -49.3 69.31 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 119.518 -0.873 . . . . 133.94 112.495 -176.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.817 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.0 m95 -80.69 -33.4 35.47 Favored 'General case' 0 CA--C 1.497 -1.071 0 N-CA-C 116.823 2.157 . . . . 134.84 116.823 -176.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.781 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.9 tp -58.47 -41.56 89.88 Favored Pre-proline 0 CA--C 1.493 -1.225 0 O-C-N 121.628 -0.67 . . . . 72.230000000000004 111.648 -167.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 263' ' ' PRO . . . . . 0.781 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 81.9 Cg_exo -60.75 -35.94 86.76 Favored 'Trans proline' 0 C--N 1.294 -2.298 0 CA-C-N 119.837 0.978 . . . . 106.13 111.302 -178.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 264' ' ' PHE . . . . . 0.849 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.5 t80 -66.4 -44.67 82.37 Favored 'General case' 0 N--CA 1.433 -1.321 0 C-N-CA 119.793 -0.763 . . . . 128.34999999999999 110.061 -178.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 265' ' ' HIS . . . . . 0.643 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.47 -37.84 88.95 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 110.236 -0.283 . . . . 100.73 110.236 -177.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.743 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.28 -44.52 94.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 C-N-CA 119.329 -0.949 . . . . 172.72 109.139 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 267' ' ' PHE . . . . . 0.735 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.6 m-85 -66.61 -28.06 68.2 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 108.235 -1.024 . . . . 249.22999999999999 108.235 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 268' ' ' PHE . . . . . 0.902 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.3 t80 -55.56 -55.13 35.52 Favored 'General case' 0 N--CA 1.433 -1.325 0 N-CA-C 106.653 -1.61 . . . . 259.77999999999997 106.653 178.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 269' ' ' LEU . . . . . 0.492 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.5 mt -69.14 -44.2 72.82 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 113.606 0.965 . . . . 233.11000000000001 113.606 -176.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.836 ' O ' HG13 ' A' ' 273' ' ' ILE . 88.7 mt -61.4 -48.34 91.21 Favored Pre-proline 0 CA--C 1.5 -0.946 0 C-N-CA 119.199 -1.0 . . . . 169.53999999999999 110.553 -171.026 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 271' ' ' PRO . . . . . 0.735 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.8 Cg_exo -61.05 -24.64 79.89 Favored 'Trans proline' 0 N--CA 1.429 -2.287 0 C-N-CA 116.797 -1.668 . . . . 255.47 114.64 174.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 272' ' ' TYR . . . . . 0.824 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.6 t80 -63.57 -44.17 94.88 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 119.233 0.924 . . . . 279.02999999999997 108.91 177.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.836 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.34 -44.82 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 N-CA-C 110.076 -0.342 . . . . 162.21000000000001 110.076 -178.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 274' ' ' ASN . . . . . 0.867 HD22 HD12 ' A' ' 277' ' ' LEU . 49.1 t30 -125.38 84.89 59.25 Favored Pre-proline 0 N--CA 1.431 -1.423 0 C-N-CA 118.761 -1.176 . . . . 128.13 108.067 -178.078 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 275' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.26 164.06 11.25 Favored 'Trans proline' 0 C--N 1.295 -2.281 0 N-CA-C 107.487 -1.774 . . . . 278.35000000000002 107.487 177.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 276' ' ' ASP . . . . . 0.866 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.09 15.07 9.94 Favored 'General case' 0 N--CA 1.429 -1.518 0 O-C-N 123.752 0.658 . . . . 312.91000000000003 109.319 175.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.867 HD12 HD22 ' A' ' 274' ' ' ASN . 28.2 mt -132.72 -170.69 2.49 Favored 'General case' 0 CA--C 1.481 -1.686 0 N-CA-C 106.533 -1.654 . . . . 353.54000000000002 106.533 177.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 1.008 ' HA ' ' CB ' ' A' ' 282' ' ' PHE . 42.8 p90 -115.63 142.26 46.98 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 107.419 -1.326 . . . . 251.25999999999999 107.419 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.764 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -76.92 -118.74 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 102.1 -3.296 . . . . 175.25999999999999 102.1 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 280' ' ' LYS . . . . . 0.793 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.51 -44.96 96.13 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 100.892 -3.744 . . . . 99.069999999999993 100.892 172.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 281' ' ' LYS . . . . . 0.793 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.42 124.15 9.18 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 103.508 -2.775 . . . . 243.21000000000001 103.508 171.157 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 1.008 ' CB ' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.97 113.01 25.16 Favored 'General case' 0 CA--C 1.474 -1.967 0 C-N-CA 116.004 -2.278 . . . . 201.03999999999999 105.287 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 283' ' ' ILE . . . . . 0.777 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.95 173.71 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.098 0 C-N-CA 116.006 -2.277 . . . . 201.36000000000001 108.789 -175.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 284' ' ' GLN . . . . . 1.091 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.283 0.6 OUTLIER -59.48 -41.46 89.84 Favored 'General case' 0 N--CA 1.415 -2.189 0 CA-C-N 113.28 -1.782 . . . . 203.81999999999999 107.881 174.44 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 285' ' ' GLN . . . . . 0.925 ' HG2' HE21 ' A' ' 284' ' ' GLN . 1.2 mm100 -64.29 -45.75 86.62 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 118.221 -1.392 . . . . 215.06 112.532 -171.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.553 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.2 t -65.64 -46.41 89.46 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.461 0 C-N-CA 118.562 -1.255 . . . . 125.28 112.948 -171.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 287' ' ' TYR . . . . . 0.951 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.76 -37.01 86.17 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 107.211 -1.404 . . . . 268.89999999999998 107.211 -171.929 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.794 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.26 -44.98 74.4 Favored 'General case' 0 CA--C 1.483 -1.603 0 C-N-CA 125.614 1.566 . . . . 280.88 108.769 -172.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.66 -47.53 85.85 Favored 'General case' 0 CA--C 1.485 -1.534 0 C-N-CA 118.985 -1.086 . . . . 184.47 108.959 -172.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' ILE . . . . . 0.849 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.8 mp -67.93 -42.09 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 C-N-CA 119.273 -0.971 . . . . 167.91999999999999 112.724 -175.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 291' ' ' MET . . . . . 0.502 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.7 ttt -65.7 -38.88 90.45 Favored 'General case' 0 CA--C 1.495 -1.139 0 C-N-CA 117.764 -1.574 . . . . 367.18000000000001 110.767 -175.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 292' ' ' TRP . . . . . 0.548 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.5 m95 -67.12 -32.69 73.99 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 121.804 -0.56 . . . . 173.97 110.477 177.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.4 tp -64.48 -36.73 85.13 Favored 'General case' 0 CA--C 1.499 -1.0 0 C-N-CA 123.517 0.727 . . . . 119.66 109.824 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 294' ' ' ALA . . . . . 0.817 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.26 -33.99 74.44 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 107.659 -1.237 . . . . 112.3 107.659 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 295' ' ' MET . . . . . 0.773 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.12 -31.99 73.26 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 116.252 -0.431 . . . . 174.16999999999999 110.246 -177.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.7 m -64.75 -22.77 67.06 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 124.661 1.184 . . . . 145.27000000000001 110.6 -175.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 297' ' ' SER . . . . . 0.757 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.5 m -57.61 -35.39 70.39 Favored 'General case' 0 N--CA 1.426 -1.675 0 N-CA-C 108.055 -1.091 . . . . 170.15000000000001 108.055 -175.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.82 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.8 t -55.33 -34.08 63.9 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 116.285 -0.416 . . . . 214.56999999999999 110.653 -171.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 299' ' ' MET . . . . . 0.752 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.1 ttt -77.25 -33.24 56.02 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 126.093 1.757 . . . . 168.28999999999999 115.499 177.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 300' ' ' TYR . . . . . 0.757 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.41 -34.83 79.08 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 114.098 1.148 . . . . 167.15000000000001 114.098 -168.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 301' ' ' ASN . . . . . 0.725 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.282 18.8 p-10 -64.2 -38.36 33.84 Favored Pre-proline 0 N--CA 1.434 -1.274 0 C-N-CA 115.536 -2.465 . . . . 165.13 113.89 -171.625 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 302' ' ' PRO . . . . . 0.725 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.4 Cg_exo -62.51 -31.81 80.22 Favored 'Trans proline' 0 N--CA 1.434 -2.004 0 CA-C-N 122.762 2.022 . . . . 123.92 111.272 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 303' ' ' ILE . . . . . 0.714 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.81 -42.57 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 C-N-CA 118.878 -1.129 . . . . 110.55 109.743 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 304' ' ' ILE . . . . . 1.0 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.0 pt -61.17 -39.97 84.29 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.146 0 N-CA-C 108.843 -0.799 . . . . 145.31 108.843 -177.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 305' ' ' TYR . . . . . 0.927 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.254 63.4 m-85 -58.17 -48.75 79.3 Favored 'General case' 0 CA--C 1.494 -1.174 0 C-N-CA 119.373 -0.931 . . . . 246.68000000000001 109.846 -177.509 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.5 m -62.25 -47.47 84.25 Favored 'General case' 0 CA--C 1.485 -1.536 0 C-N-CA 119.536 -0.866 . . . . 64.430000000000007 109.559 -173.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.8 t -66.85 -45.03 79.48 Favored 'General case' 0 N--CA 1.428 -1.532 0 C-N-CA 118.963 -1.095 . . . . 80.719999999999999 110.259 -177.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.708 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.46 -35.71 75.88 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 116.007 1.855 . . . . 140.44 116.007 -173.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 309' ' ' ASN . . . . . 0.658 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.82 132.22 34.36 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 112.704 -3.598 . . . . 178.87 113.08 -177.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 310' ' ' ASP . . . . . 0.609 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.02 -37.09 86.47 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 114.406 -1.27 . . . . 110.22 110.093 -177.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.859 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.73 -50.61 72.63 Favored 'General case' 0 CA--C 1.492 -1.258 0 O-C-N 121.714 -0.617 . . . . 174.78 109.737 -174.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.96 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.1 m-85 -64.87 -41.74 95.41 Favored 'General case' 0 CA--C 1.484 -1.573 0 N-CA-C 108.212 -1.033 . . . . 161.84 108.212 178.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 313' ' ' ARG . . . . . 0.518 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.7 ttp180 -57.24 -50.3 73.3 Favored 'General case' 0 CA--C 1.49 -1.327 0 N-CA-C 109.206 -0.664 . . . . 117.2 109.206 -173.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.798 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.52 -44.06 75.42 Favored 'General case' 0 N--CA 1.433 -1.277 0 C-N-CA 120.385 -0.526 . . . . 112.59999999999999 111.038 -177.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 315' ' ' GLY . . . . . 0.87 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -64.09 -37.42 94.55 Favored Glycine 0 N--CA 1.43 -1.759 0 N-CA-C 110.644 -0.982 . . . . 101.45999999999999 110.644 -177.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 316' ' ' PHE . . . . . 1.011 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.6 m-85 -62.15 -45.99 90.96 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-N 118.491 1.145 . . . . 151.49000000000001 109.519 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 317' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 317' ' ' LYS . 25.6 ttmt -60.1 -36.33 77.18 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 106.942 -1.503 . . . . 142.31999999999999 106.942 -175.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 318' ' ' HIS . . . . . 0.825 ' NE2' HG21 ' A' ' 326' ' ' ILE . 49.9 m80 -59.75 -41.84 91.9 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.883 -1.525 . . . . 109.09 106.883 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.84 -42.45 85.76 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.353 -0.217 . . . . 76.109999999999999 110.999 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -61.41 -55.55 30.2 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 119.914 -0.714 . . . . 120.23999999999999 109.299 -174.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.58 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.4 mtt180 -74.3 131.52 41.25 Favored 'General case' 0 CA--C 1.482 -1.651 0 N-CA-C 102.973 -2.973 . . . . 192.72999999999999 102.973 177.092 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.16 -44.17 92.11 Favored 'General case' 0 CA--C 1.491 -1.312 0 C-N-CA 119.0 -1.08 . . . . 176.28999999999999 109.238 -172.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 323' ' ' CYS . . . . . 0.752 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.2 m -79.34 -177.06 0.8 Allowed Pre-proline 0 N--CA 1.43 -1.47 0 N-CA-C 106.35 -1.722 . . . . 69.680000000000007 106.35 178.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.7 Cg_exo -59.04 -75.58 0.02 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.373 0 C-N-CA 118.337 -0.642 . . . . 191.05000000000001 112.589 176.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 325' ' ' PHE . . . . . 0.752 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.4 m-85 47.5 43.9 16.28 Favored 'General case' 0 CA--C 1.493 -1.212 0 O-C-N 123.613 0.571 . . . . 287.02999999999997 109.73 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 326' ' ' ILE . . . . . 0.825 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.53 78.62 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.474 -1.955 0 C-N-CA 112.918 -3.513 . . . . 292.29000000000002 109.844 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 327' ' ' SER . . . . . 0.48 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.2 t -77.5 -152.87 0.05 Allowed 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 104.237 -2.505 . . . . 184.56999999999999 104.237 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 328' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.69 8.75 4.95 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 113.039 0.755 . . . . 274.56 113.039 176.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.96 0.84 57.3 Favored Glycine 0 C--N 1.349 1.26 0 C-N-CA 117.717 -2.182 . . . . 268.24000000000001 113.48 172.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 330' ' ' ASP . . . . . 0.699 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.8 m-20 51.62 -172.07 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.085 0 CA-C-N 118.694 1.247 . . . . 200.06 110.737 177.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.859 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.3 t80 -63.84 -33.04 74.78 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 107.915 -1.143 . . . . 114.44 107.915 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 332' ' ' GLU . . . . . 0.547 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.27 46.09 21.83 Favored 'General case' 0 CA--C 1.484 -1.571 0 N-CA-C 107.59 -1.263 . . . . 263.81 107.59 -177.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 333' ' ' GLY . . . . . 0.633 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.3 -137.35 3.6 Favored Glycine 0 CA--C 1.479 -2.204 1 N-CA-C 102.529 -4.228 . . . . 103.79000000000001 102.529 -179.871 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 1.04 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.5 mt -88.25 95.67 10.26 Favored 'General case' 0 N--CA 1.419 -2.017 0 C-N-CA 114.91 -2.716 . . . . 117.3 105.997 177.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 335' ' ' GLU . . . . . 1.021 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -66.0 -39.8 90.59 Favored 'General case' 0 CA--C 1.469 -2.173 1 N-CA-C 97.961 -4.829 . . . . 231.58000000000001 97.961 167.235 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 336' ' ' MET . . . . . 1.031 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.93 163.5 29.03 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 102.112 -3.292 . . . . 303.24000000000001 102.112 169.008 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 337' ' ' LYS . . . . . 1.04 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.3 tttt -62.69 -48.56 78.72 Favored 'General case' 0 N--CA 1.432 -1.365 0 C-N-CA 115.997 -2.281 . . . . 112.72 108.381 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.9 t -61.02 -63.67 1.22 Allowed 'General case' 0 CA--C 1.49 -1.334 0 N-CA-C 109.121 -0.696 . . . . 83.219999999999999 109.121 -176.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 339' ' ' THR . . . . . 0.883 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.0 m -156.25 -126.25 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 103.806 -2.664 . . . . 174.36000000000001 103.806 -178.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 340' ' ' ARG . . . . . 1.021 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.84 160.93 8.77 Favored 'General case' 0 CA--C 1.485 -1.552 0 N-CA-C 105.796 -1.927 . . . . 202.72999999999999 105.796 177.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 341' ' ' TYR . . . . . 1.012 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.94 149.01 52.56 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 107.071 -1.455 . . . . 180.62 107.071 176.413 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.929 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.5 tp -178.48 -171.88 0.27 Allowed 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 105.393 -2.077 . . . . 145.25 105.393 178.07 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 343' ' ' GLN . . . . . 0.929 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.06 -43.15 88.27 Favored 'General case' 0 CA--C 1.487 -1.455 0 N-CA-C 106.165 -1.791 . . . . 66.049999999999997 106.165 174.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 344' ' ' THR . . . . . 0.764 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.67 -152.2 0.49 Allowed 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 103.498 -2.778 . . . . 266.49000000000001 103.498 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 345' ' ' GLN . . . . . 0.701 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.3 mt-30 66.35 -124.96 0.28 Allowed 'General case' 0 CA--C 1.485 -1.549 0 C-N-CA 116.99 -1.884 . . . . 219.19999999999999 107.742 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 346' ' ' GLY . . . . . 0.9 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.07 -37.38 94.11 Favored Glycine 0 N--CA 1.425 -2.067 0 CA-C-N 114.572 -1.195 . . . . 94.780000000000001 112.865 -175.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 347' ' ' SER . . . . . 0.825 ' HA ' ' SD ' ' A' ' 336' ' ' MET . 48.4 t -81.23 100.41 9.11 Favored 'General case' 0 CA--C 1.484 -1.566 0 C-N-CA 112.359 -3.736 . . . . 121.41 109.467 -171.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 348' ' ' VAL . . . . . 0.439 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.6 t -73.03 145.49 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 N-CA-C 108.974 -0.75 . . . . 85.340000000000003 108.974 -176.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 349' ' ' TYR . . . . . 0.439 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.6 p90 -57.73 143.37 42.12 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 107.825 -1.176 . . . . 267.56999999999999 107.825 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 350' ' ' LYS . . . . . 0.525 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.07 69.61 0.59 Allowed 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 109.529 -0.545 . . . . 226.09999999999999 109.529 -179.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 351' ' ' VAL . . . . . 0.825 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.5 p -51.08 156.95 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 N-CA-C 106.928 -1.508 . . . . 154.84 106.928 177.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 352' ' ' SER . . . . . 0.582 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.5 m -61.31 161.91 8.46 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-O 121.595 0.712 . . . . 180.00999999999999 110.728 -173.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 353' ' ' ARG . . . . . 0.895 ' H ' ' HD3' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.43 156.94 23.59 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 106.923 -1.51 . . . . 333.77999999999997 106.923 -178.597 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 354' ' ' LEU . . . . . 0.976 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.04 142.51 48.77 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 107.37 -1.345 . . . . 335.19999999999999 107.37 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.976 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.6 mm-40 82.84 158.91 0.13 Allowed 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 108.729 -0.841 . . . . 266.47000000000003 108.729 179.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.9 m -60.66 -46.83 88.84 Favored 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 105.678 -1.971 . . . . 59.340000000000003 105.678 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.58 173.85 11.97 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 104.408 -2.441 . . . . 201.25999999999999 104.408 176.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.75 HG22 ' O ' ' A' ' 360' ' ' THR . 69.1 mt -95.88 106.77 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.529 0 C-N-CA 116.343 -2.143 . . . . 56.229999999999997 105.521 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 359' ' ' SER . . . . . 0.468 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.5 m -61.24 -59.43 5.32 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 109.272 -0.64 . . . . 87.579999999999998 109.272 -175.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 360' ' ' THR . . . . . 0.887 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.2 t -85.59 153.74 22.19 Favored 'General case' 0 CA--C 1.486 -1.496 0 N-CA-C 107.811 -1.181 . . . . 219.94999999999999 107.811 -177.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 361' ' ' VAL . . . . . 0.589 ' O ' HG23 ' A' ' 361' ' ' VAL . 15.9 m -82.04 83.86 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 C-N-CA 116.29 -2.164 . . . . 121.79000000000001 105.436 177.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.596 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.7 t -154.09 159.72 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.548 0 N-CA-C 105.843 -1.91 . . . . 53.850000000000001 105.843 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 363' ' ' GLY . . . . . 0.596 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.22 16.64 77.07 Favored Glycine 0 N--CA 1.428 -1.87 0 N-CA-C 106.057 -2.817 . . . . 196.55000000000001 106.057 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.662 0 N-CA-C 107.911 -1.144 . . . . 35.880000000000003 107.911 -178.942 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 365' ' ' ARG . . . . . 0.62 HH21 ' CG ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 108.865 -0.791 . . . . 1.0 108.865 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 366' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' B' ' 365' ' ' ARG . 52.6 Cg_endo -66.89 142.02 61.05 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.08 1.854 . . . . 1.0 110.245 178.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 367' ' ' LYS . . . . . 0.767 ' HB3' HD11 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -64.43 143.3 98.51 Favored Pre-proline 0 C--N 1.325 -0.498 0 C-N-CA 119.825 -0.75 . . . . 1.0 109.587 -179.894 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 368' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.29 150.44 76.38 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.349 2.033 . . . . 1.0 111.712 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 369' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.74 131.78 44.37 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.749 -0.38 . . . . 1.0 110.243 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.01 115.82 31.36 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.646 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 371' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -63.69 -42.3 98.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.481 . . . . 1.0 110.422 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 372' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.03 -36.26 83.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.678 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -59.68 -33.09 75.92 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.811 -0.916 . . . . 1.0 110.811 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 374' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.79 131.3 45.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.873 0.368 . . . . 1.0 110.192 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 375' ' ' MET . . . . . . . . . . . . . 2.5 mtt . . . . . 0 C--O 1.221 -0.434 0 CA-C-O 118.026 -0.988 . . . . 1.0 110.495 -179.802 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.442 0 N-CA-C 108.377 -0.971 . . . . 97.079999999999998 108.377 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -110.62 155.44 22.37 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-O 122.123 0.963 . . . . 123.41 110.711 -172.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.885 HG11 HD13 ' A' ' 15' ' ' ILE . 28.7 m -134.6 -162.38 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.479 1 N-CA-C 100.081 -4.044 . . . . 151.30000000000001 100.081 173.754 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.915 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.67 -38.57 57.91 Favored Pre-proline 0 N--CA 1.439 -0.996 0 C-N-CA 115.968 -2.293 . . . . 169.25 106.115 178.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.915 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 58.3 Cg_exo -81.32 168.51 16.61 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 122.281 0.621 . . . . 185.75999999999999 110.505 171.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.908 HG13 ' CE2' ' A' ' 282' ' ' PHE . 91.7 t -64.47 -25.92 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 C-N-CA 127.028 2.131 . . . . 145.47 110.347 -177.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.778 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.1 t0 -84.3 157.42 21.53 Favored 'General case' 0 N--CA 1.439 -0.981 0 O-C-N 121.078 -1.014 . . . . 102.76000000000001 109.464 -178.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.6 p -82.58 154.19 25.11 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 107.976 -1.12 . . . . 106.25 107.976 178.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.919 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.7 p-10 -105.89 51.85 0.74 Allowed 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 117.769 -1.573 . . . . 157.81 107.599 178.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.1 tp -60.1 -45.94 91.29 Favored 'General case' 0 CA--C 1.481 -1.696 0 N-CA-C 103.607 -2.738 . . . . 150.19999999999999 103.607 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.9 m -87.07 164.69 35.22 Favored Pre-proline 0 N--CA 1.422 -1.867 0 N-CA-C 103.653 -2.721 . . . . 183.52000000000001 103.653 172.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -76.78 6.86 3.85 Favored 'Trans proline' 0 C--N 1.281 -2.988 0 N-CA-C 109.986 -0.813 . . . . 235.61000000000001 109.986 176.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.421 ' C ' HD21 ' A' ' 14' ' ' ASN . 0.4 OUTLIER -57.88 -41.27 82.15 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 124.813 1.245 . . . . 113.77 113.398 -170.125 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.919 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.4 pt -52.19 136.24 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-N 119.541 1.064 . . . . 150.84999999999999 110.963 -176.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.8 t -140.49 156.24 46.4 Favored 'General case' 0 C--N 1.36 1.036 0 N-CA-C 107.634 -1.247 . . . . 100.42 107.634 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . 1.083 HG23 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.0 142.64 58.36 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 121.895 0.855 . . . . 129.36000000000001 110.455 -174.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.772 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 74.5 m-20 -63.12 -25.5 68.39 Favored 'General case' 0 CA--C 1.493 -1.213 0 C-N-CA 126.309 1.843 . . . . 112.34 106.668 -177.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.938 HG23 ' HA2' ' A' ' 101' ' ' GLY . 85.8 m -74.11 -40.2 62.84 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 115.538 -0.756 . . . . 131.72999999999999 111.741 177.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . 1.083 ' H ' HG23 ' A' ' 17' ' ' THR . 71.4 m -84.42 -42.89 15.19 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 116.989 2.218 . . . . 80.489999999999995 116.989 -174.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.551 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.5 mt-10 -145.96 174.54 3.35 Favored Pre-proline 0 N--CA 1.442 -0.847 0 C-N-CA 118.179 -1.408 . . . . 98.980000000000004 111.234 -169.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.822 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.334 85.7 Cg_exo -61.72 -10.86 18.23 Favored 'Trans proline' 0 C--N 1.321 -0.907 1 N-CA-C 128.931 6.473 . . . . 246.94999999999999 128.931 -170.104 . . . . . . . . 4 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.0 m120 61.68 17.54 8.76 Favored 'General case' 0 C--N 1.324 -0.518 1 CA-C-N 126.154 4.07 . . . . 269.62 114.22 175.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.496 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 80.8 mt-30 -67.14 -27.26 67.17 Favored 'General case' 0 CA--C 1.495 -1.154 0 N-CA-C 107.814 -1.18 . . . . 86.799999999999997 107.814 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.551 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.3 p90 -66.87 -29.3 69.17 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 121.116 -0.99 . . . . 85.909999999999997 110.467 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.877 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.4 t -68.59 -40.18 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 C-N-CA 123.734 0.814 . . . . 82.0 111.346 -177.006 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.898 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 27.6 pt20 -151.39 167.74 12.47 Favored Pre-proline 0 CA--C 1.489 -1.391 0 N-CA-C 108.559 -0.904 . . . . 120.73 108.559 -178.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.903 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -63.99 149.75 89.86 Favored 'Trans proline' 0 N--CA 1.433 -2.07 0 C-N-CA 120.644 0.896 . . . . 87.859999999999999 109.847 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.743 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.0 -37.98 89.37 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 108.87 -0.789 . . . . 36.460000000000001 108.87 -176.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.814 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.9 p-90 -63.82 -33.83 76.56 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 107.81 -1.181 . . . . 150.59999999999999 107.81 -176.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.903 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.5 mt-30 -62.24 -32.72 73.44 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 108.624 -0.88 . . . . 123.26000000000001 108.624 -178.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.743 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.43 -47.27 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 N-CA-C 109.125 -0.694 . . . . 120.14 109.125 176.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.786 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.3 m -67.4 -31.03 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 N-CA-C 107.866 -1.161 . . . . 112.19 107.866 -178.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.814 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.5 tp -62.96 -47.13 84.53 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 119.973 -0.691 . . . . 60.869999999999997 109.61 -178.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.669 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.08 -35.66 81.11 Favored 'General case' 0 CA--C 1.489 -1.386 0 C-N-CA 119.974 -0.69 . . . . 157.56999999999999 110.325 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.744 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.6 -40.87 98.29 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 108.65 -0.871 . . . . 47.060000000000002 108.65 178.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.807 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.76 -41.29 98.01 Favored 'General case' 0 CA--C 1.496 -1.111 0 O-C-N 121.76 -0.587 . . . . 43.939999999999998 109.546 -177.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.727 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.83 -43.38 98.96 Favored 'General case' 0 CA--C 1.49 -1.364 0 N-CA-C 108.657 -0.868 . . . . 42.609999999999999 108.657 -176.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.906 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.29 -41.25 94.3 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 116.631 -0.259 . . . . 140.66 111.079 -178.367 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.807 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.77 -43.98 97.79 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 118.576 -1.249 . . . . 116.04000000000001 110.239 -175.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.673 HG22 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.47 -38.69 83.06 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.302 0 N-CA-C 108.726 -0.842 . . . . 97.159999999999997 108.726 -177.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.854 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.2 mt -61.29 -40.05 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 N-CA-C 108.944 -0.761 . . . . 54.850000000000001 108.944 -176.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.949 HG22 HG21 ' A' ' 86' ' ' THR . 93.0 t -57.69 -42.35 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.32 0 N-CA-C 108.878 -0.786 . . . . 45.390000000000001 108.878 -175.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 48' ' ' VAL . 97.5 t -63.5 -50.98 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 C-N-CA 118.844 -1.142 . . . . 48.640000000000001 110.218 -177.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.75 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.6 t -65.3 -46.95 78.35 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 120.117 -0.633 . . . . 116.65000000000001 111.744 -174.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.588 ' N ' HG23 ' A' ' 45' ' ' THR . 50.7 m -62.0 -43.94 97.79 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 109.718 -0.475 . . . . 51.159999999999997 109.718 -174.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.4 t -65.56 -48.93 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 C-N-CA 119.885 -0.726 . . . . 44.299999999999997 110.818 -176.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.868 ' O ' HG23 ' A' ' 52' ' ' VAL . 93.7 t -64.78 -46.93 90.59 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.048 0 C-N-CA 120.34 -0.544 . . . . 48.82 111.005 -174.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.78 -44.14 95.21 Favored Glycine 0 N--CA 1.438 -1.213 0 C-N-CA 120.529 -0.843 . . . . 58.700000000000003 112.02 -174.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -72.67 -34.19 67.06 Favored 'General case' 0 CA--C 1.488 -1.433 0 O-C-N 122.107 -0.643 . . . . 101.40000000000001 110.993 -175.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.74 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.94 -38.69 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 107.761 -1.199 . . . . 103.56999999999999 107.761 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 48' ' ' VAL . 71.8 t -61.43 -43.05 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 108.989 -0.745 . . . . 61.890000000000001 108.989 -178.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.54 ' O ' HG22 ' A' ' 56' ' ' ILE . 81.8 t -63.42 -50.99 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 109.458 -0.571 . . . . 70.010000000000005 109.458 -178.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.8 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.95 -43.41 98.85 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.13 -0.693 . . . . 132.09999999999999 109.13 -176.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.645 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.12 -46.69 83.02 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 116.705 -0.225 . . . . 104.5 110.469 -176.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 1.006 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.63 -49.93 80.24 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 C-N-CA 120.254 -0.578 . . . . 142.96000000000001 111.253 -173.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.957 HD11 HG12 ' A' ' 72' ' ' VAL 0.277 24.7 pt -64.79 -41.66 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.639 0 C-N-CA 116.956 -1.898 . . . . 158.31999999999999 110.868 -175.965 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.8 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.76 -41.3 98.02 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 117.699 -1.6 . . . . 137.11000000000001 109.514 178.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.46 -44.49 90.94 Favored 'General case' 0 N--CA 1.436 -1.156 0 O-C-N 122.117 -0.364 . . . . 54.659999999999997 110.972 -176.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.921 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.9 m-70 -91.42 117.13 29.41 Favored 'General case' 0 CA--C 1.49 -1.348 0 CA-C-O 121.662 0.744 . . . . 127.18000000000001 109.555 -174.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.621 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.83 -36.81 80.06 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 124.089 0.956 . . . . 87.930000000000007 110.877 -176.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 1.028 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.37 -34.7 78.77 Favored 'General case' 0 CA--C 1.49 -1.341 0 O-C-N 121.622 -0.674 . . . . 131.12 111.512 -175.669 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' MET . . . . . 1.01 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.61 69.46 7.12 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 115.307 -2.557 . . . . 246.56 109.647 -175.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.413 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.23 91.44 3.48 Favored 'General case' 0 CA--C 1.474 -1.946 0 N-CA-C 105.465 -2.05 . . . . 339.35000000000002 105.465 177.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.444 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.5 p -124.15 165.27 17.85 Favored 'General case' 0 N--CA 1.414 -2.251 0 N-CA-C 103.01 -2.959 . . . . 114.66 103.01 176.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.881 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.14 -39.49 85.44 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.615 0 N-CA-C 106.748 -1.575 . . . . 143.28 106.748 178.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.833 HG22 HD13 ' A' ' 71' ' ' LEU . 95.8 m -59.66 -38.05 80.4 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 108.676 -0.861 . . . . 160.22 108.676 -176.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.528 ' ND2' ' HB3' ' A' ' 63' ' ' MET . 86.3 m-20 -62.39 -31.73 72.44 Favored 'General case' 0 CA--C 1.489 -1.37 0 N-CA-C 108.858 -0.793 . . . . 120.54000000000001 108.858 -177.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.903 ' O ' HG22 ' A' ' 72' ' ' VAL . 89.7 m-85 -63.64 -43.76 95.85 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.465 -0.569 . . . . 67.219999999999999 109.465 178.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.881 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.6 m-85 -66.53 -39.8 88.78 Favored 'General case' 0 CA--C 1.498 -1.057 0 O-C-N 121.533 -0.729 . . . . 138.59999999999999 109.675 -177.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.925 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.56 -35.9 82.02 Favored 'General case' 0 CA--C 1.492 -1.26 0 C-N-CA 122.487 0.315 . . . . 151.46000000000001 110.663 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.957 HG12 HD11 ' A' ' 57' ' ' ILE . 23.9 m -62.55 -37.92 80.13 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 C-N-CA 117.406 -1.717 . . . . 117.93000000000001 106.753 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.449 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.0 t30 -60.17 -45.95 91.34 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 107.837 -1.171 . . . . 56.82 107.837 -177.068 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.987 HD21 ' HE1' ' A' ' 123' ' ' MET . 8.7 mp -61.38 -43.89 98.09 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 108.941 -0.763 . . . . 145.30000000000001 108.941 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.07 -40.36 95.53 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 108.535 -0.913 . . . . 45.710000000000001 108.535 -175.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -62.44 -41.95 99.11 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 109.399 -0.593 . . . . 105.61 109.399 -178.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.16 -39.48 92.79 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 108.605 -0.887 . . . . 47.890000000000001 108.605 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.588 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.56 -37.31 84.69 Favored 'General case' 0 N--CA 1.438 -1.062 0 O-C-N 122.084 -0.385 . . . . 124.53 109.988 179.692 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.88 -41.25 99.33 Favored 'General case' 0 N--CA 1.437 -1.089 0 O-C-N 121.942 -0.474 . . . . 35.890000000000001 109.819 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.7 t -62.16 -37.35 84.9 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 107.048 -1.464 . . . . 88.969999999999999 107.048 -178.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.82 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.7 ttm -62.16 -49.18 76.88 Favored 'General case' 0 N--CA 1.427 -1.579 0 C-N-CA 119.792 -0.763 . . . . 239.91 109.055 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.618 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.36 -43.37 91.02 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 121.579 -0.7 . . . . 146.09999999999999 110.62 -177.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.418 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.18 -58.22 3.41 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 117.403 -1.719 . . . . 91.739999999999995 113.826 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -76.57 -61.37 1.98 Allowed 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 115.746 1.758 . . . . 197.44999999999999 115.746 -173.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.945 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.25 -42.26 55.6 Favored 'General case' 0 CA--C 1.49 -1.36 0 C-N-CA 117.884 -1.527 . . . . 242.59999999999999 114.056 -170.045 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.949 HG21 HG22 ' A' ' 43' ' ' VAL . 4.7 t -65.45 -36.55 84.23 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 118.926 -1.109 . . . . 215.61000000000001 109.821 -172.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.422 ' N ' ' CG2' ' A' ' 86' ' ' THR . 71.9 t -60.25 -46.96 94.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 O-C-N 121.811 -0.556 . . . . 87.189999999999998 110.505 -175.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.836 HG21 ' CD2' ' A' ' 108' ' ' HIS . 63.7 t -65.94 -41.88 90.74 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.122 0 N-CA-C 109.704 -0.48 . . . . 231.81999999999999 109.704 -178.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.906 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 87.8 m-20 -62.33 -34.1 75.98 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 108.335 -0.987 . . . . 364.98000000000002 108.335 -177.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.67 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.4 t80 -68.24 -44.66 75.2 Favored 'General case' 0 N--CA 1.438 -1.064 0 O-C-N 121.507 -0.746 . . . . 181.63 111.257 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.474 HG22 ' ND1' ' A' ' 95' ' ' HIS . 57.4 m -60.89 -45.81 93.14 Favored 'General case' 0 CA--C 1.477 -1.829 0 N-CA-C 107.422 -1.325 . . . . 269.01999999999998 107.422 -175.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 1.048 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.66 -45.07 93.16 Favored 'General case' 0 CA--C 1.469 -2.164 0 C-N-CA 118.684 -1.206 . . . . 562.65999999999997 110.052 -179.063 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.705 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.09 -45.3 95.26 Favored 'General case' 0 CA--C 1.479 -1.788 0 C-N-CA 118.744 -1.183 . . . . 446.75 108.067 -167.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.744 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.388 6.1 m -70.48 -26.23 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 C-N-CA 115.791 -2.364 . . . . 370.05000000000001 112.283 -178.746 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.497 ' O ' ' HB2' ' A' ' 96' ' ' ASN . 40.6 m80 -74.58 -26.42 59.92 Favored 'General case' 0 CA--C 1.506 -0.747 0 O-C-N 121.626 -0.672 . . . . 354.91000000000003 112.483 175.085 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.822 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.4 m-20 82.75 4.53 1.01 Allowed 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 125.078 1.351 . . . . 462.44 111.926 -178.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.772 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.267 11.9 mm-40 -172.37 178.03 2.91 Favored 'General case' 0 CA--C 1.488 -1.429 0 CA-C-O 122.044 0.926 . . . . 652.37 111.087 171.797 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.789 ' HE3' ' HA ' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.68 86.27 2.15 Favored 'General case' 0 N--CA 1.428 -1.558 0 C-N-CA 128.494 2.718 . . . . 905.99000000000001 107.95 -174.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -67.85 -36.42 80.28 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 108.266 -1.013 . . . . 570.42999999999995 108.266 -176.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.847 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.56 -36.35 82.36 Favored 'General case' 0 N--CA 1.428 -1.569 0 C-N-CA 125.343 1.457 . . . . 453.22000000000003 111.166 -174.176 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.938 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.56 178.66 33.88 Favored Glycine 0 C--N 1.349 1.288 0 C-N-CA 118.753 -1.689 . . . . 445.63 109.882 177.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.0 mt -56.41 -41.25 76.04 Favored 'General case' 0 CA--C 1.498 -1.022 0 C-N-CA 125.276 1.43 . . . . 457.72000000000003 112.351 -170.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -58.64 -46.87 86.2 Favored 'General case' 0 CA--C 1.484 -1.562 0 C-N-CA 118.63 -1.228 . . . . 340.57999999999998 109.326 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.847 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.0 m-85 -68.76 -32.16 71.71 Favored 'General case' 0 N--CA 1.423 -1.786 0 C-N-CA 118.741 -1.184 . . . . 453.60000000000002 111.559 -176.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.762 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.02 -40.29 73.19 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 105.971 -1.863 . . . . 541.48000000000002 105.971 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.89 -47.1 75.95 Favored 'General case' 0 CA--C 1.485 -1.536 0 O-C-N 124.017 0.823 . . . . 466.68000000000001 110.852 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -61.78 -47.11 86.63 Favored 'General case' 0 N--CA 1.427 -1.6 0 C-N-CA 117.506 -1.678 . . . . 427.33999999999997 107.256 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.836 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.6 m80 -67.08 -36.78 82.75 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 112.425 0.528 . . . . 537.87 112.425 -174.182 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.574 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.4 -42.67 74.8 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 116.861 -1.936 . . . . 422.12 111.607 175.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.855 ' O ' HG22 ' A' ' 113' ' ' ILE . 75.9 t80 -59.12 -50.05 75.54 Favored 'General case' 0 CA--C 1.502 -0.882 0 O-C-N 121.335 -0.853 . . . . 340.17000000000002 111.827 -173.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -65.26 -46.57 71.71 Favored Pre-proline 0 N--CA 1.443 -0.801 0 C-N-CA 119.095 -1.042 . . . . 258.06 111.715 -176.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.945 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.2 Cg_exo -61.49 -31.58 87.84 Favored 'Trans proline' 0 N--CA 1.435 -1.927 0 N-CA-C 115.363 1.255 . . . . 305.70999999999998 115.363 176.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.877 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.84 -40.46 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 108.689 -0.856 . . . . 252.69999999999999 108.689 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.421 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.9 -40.6 93.7 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 107.807 -1.183 . . . . 149.27000000000001 107.807 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.0 -44.83 95.89 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 120.639 -0.424 . . . . 138.08000000000001 111.468 -176.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.651 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 65.1 t -66.98 -42.33 88.57 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.937 0 O-C-N 121.581 -0.699 . . . . 132.88999999999999 110.96 -177.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.92 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.77 -44.64 92.81 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 108.898 -0.779 . . . . 193.61000000000001 108.898 -177.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.554 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.5 -37.68 84.57 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 122.811 0.444 . . . . 63.829999999999998 110.069 -175.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 72.0 m -64.03 -52.37 59.79 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 120.721 -0.392 . . . . 76.400000000000006 111.242 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.757 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.96 -41.65 93.59 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 N-CA-C 108.17 -1.048 . . . . 171.13 108.17 -175.005 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 1.105 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.1 m-85 -63.84 -38.57 91.58 Favored 'General case' 0 N--CA 1.432 -1.331 0 O-C-N 121.838 -0.539 . . . . 78.299999999999997 110.614 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.554 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.5 t -67.1 -35.69 80.32 Favored 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 118.893 -1.123 . . . . 92.359999999999999 109.247 -178.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.987 ' HE1' HD21 ' A' ' 74' ' ' LEU . 5.9 mmt -62.55 -34.24 76.54 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 108.154 -1.054 . . . . 93.730000000000004 108.154 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.896 HG22 HG13 ' A' ' 212' ' ' ILE . 33.3 p -67.44 -41.65 84.4 Favored 'General case' 0 CA--C 1.495 -1.159 0 C-N-CA 119.224 -0.99 . . . . 132.74000000000001 109.318 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.28 -42.09 94.7 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 107.158 -1.423 . . . . 43.390000000000001 107.158 -177.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.827 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.4 t -58.47 -41.98 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.369 0 N-CA-C 108.568 -0.901 . . . . 59.340000000000003 108.568 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.53 -44.02 95.42 Favored 'General case' 0 CA--C 1.497 -1.067 0 O-C-N 121.808 -0.558 . . . . 69.680000000000007 110.529 -177.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.468 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.3 t80 -65.41 -42.82 92.13 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.348 -0.982 . . . . 106.98 108.348 -177.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.827 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.37 -35.51 81.14 Favored 'General case' 0 N--CA 1.433 -1.306 0 C-N-CA 119.598 -0.841 . . . . 147.63 108.972 -177.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.702 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.19 -41.54 99.19 Favored 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 108.524 -0.917 . . . . 190.06 108.524 178.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.6 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.4 t80 -61.35 -44.08 97.78 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 108.29 -1.004 . . . . 118.84999999999999 108.29 -177.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.803 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.5 mmt -63.34 -42.64 98.96 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 109.994 -0.373 . . . . 102.5 109.994 -177.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.98 -41.69 95.21 Favored 'General case' 0 CA--C 1.488 -1.418 0 O-C-N 121.799 -0.563 . . . . 89.980000000000004 109.82 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.92 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.2 mt -66.54 -50.66 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.711 0 C-N-CA 118.119 -1.432 . . . . 106.09 111.024 -177.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.75 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.1 -48.29 38.41 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.09 0 C-N-CA 117.078 -1.849 . . . . 227.74000000000001 111.832 -174.84 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.756 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.84 100.07 50.99 Favored Pre-proline 0 CA--C 1.486 -1.496 0 C-N-CA 116.268 -2.173 . . . . 262.55000000000001 110.069 -175.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.3 Cg_endo -69.61 -10.36 28.49 Favored 'Trans proline' 0 C--N 1.289 -2.558 0 C-N-CA 121.564 1.509 . . . . 210.25 111.386 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.707 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.3 111.99 1.0 Allowed 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 106.54 -1.652 . . . . 270.57999999999998 106.54 -178.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.885 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.77 -39.51 24.23 Favored Pre-proline 0 N--CA 1.43 -1.453 0 CA-C-N 115.358 -0.837 . . . . 129.84 112.325 -175.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.857 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 81.5 Cg_exo -61.44 -26.51 81.28 Favored 'Trans proline' 0 N--CA 1.431 -2.166 0 N-CA-C 116.311 1.62 . . . . 330.70999999999998 116.311 -174.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.756 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.09 77.28 8.0 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 114.445 -2.902 . . . . 204.50999999999999 107.257 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.878 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.7 147.38 0.09 Allowed 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 107.488 -1.301 . . . . 387.41000000000003 107.488 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.878 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.3 t -143.68 147.0 33.64 Favored 'General case' 0 CA--C 1.496 -1.116 0 C-N-CA 118.841 -1.144 . . . . 166.22 109.484 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.85 -40.72 88.0 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 107.872 -1.159 . . . . 44.229999999999997 107.872 176.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.48 ' O ' HG23 ' A' ' 149' ' ' VAL . 88.0 m -60.32 -39.12 85.88 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 108.15 -1.055 . . . . 28.800000000000001 108.15 -175.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.667 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.88 -38.78 92.21 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 109.055 -0.721 . . . . 30.289999999999999 109.055 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.847 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 90.1 m -59.59 -43.01 93.83 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 109.035 -0.728 . . . . 46.109999999999999 109.035 -176.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.46 -42.2 99.3 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 107.665 -1.235 . . . . 87.329999999999998 107.665 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.765 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.7 t -61.58 -42.13 92.89 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.366 0 N-CA-C 107.973 -1.121 . . . . 23.690000000000001 107.973 -178.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.6 t -63.2 -44.28 99.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 N-CA-C 109.678 -0.489 . . . . 43.859999999999999 109.678 -178.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.919 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.0 mm -61.29 -42.49 93.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 N-CA-C 108.327 -0.99 . . . . 91.129999999999995 108.327 -176.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' CYS . . . . . 0.482 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.2 t -62.57 -38.0 88.4 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 108.786 -0.82 . . . . 65.879999999999995 108.786 -178.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.765 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.7 t -62.08 -41.86 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 N-CA-C 109.559 -0.534 . . . . 33.859999999999999 109.559 -177.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 1.105 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.35 -40.32 85.76 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.217 0 N-CA-C 107.642 -1.244 . . . . 146.52000000000001 107.642 -176.815 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 155' ' ' TRP . . . . . 0.696 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.3 m95 -62.86 -38.36 90.54 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 119.477 -0.889 . . . . 75.439999999999998 108.942 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.8 t -60.53 -48.44 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 O-C-N 120.976 -1.078 . . . . 43.640000000000001 109.71 -177.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.792 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.7 -37.98 89.39 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 109.034 -0.728 . . . . 102.56999999999999 109.034 -178.073 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.93 -41.13 86.6 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 107.437 -1.32 . . . . 58.159999999999997 107.437 -178.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.801 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.06 -32.51 73.9 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 109.015 -0.735 . . . . 121.11 109.015 178.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.792 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.01 -42.34 85.02 Favored 'General case' 0 CA--C 1.488 -1.416 0 C-N-CA 118.586 -1.246 . . . . 153.15000000000001 109.951 -178.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 1.061 HD13 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.05 -43.75 19.05 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 113.079 -3.448 . . . . 133.66999999999999 113.522 173.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.478 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -62.95 -39.92 96.1 Favored 'General case' 0 CA--C 1.49 -1.335 0 O-C-N 120.938 -1.101 . . . . 157.41999999999999 112.184 -171.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.524 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.2 t80 -74.4 -36.1 2.47 Favored Pre-proline 0 N--CA 1.437 -1.105 0 N-CA-C 115.058 1.503 . . . . 250.91 115.058 -173.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.291 52.6 Cg_exo -59.58 -25.4 78.75 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 N-CA-C 117.976 2.26 . . . . 207.34 117.976 -174.309 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.919 ' HA ' ' HB2' ' A' ' 169' ' ' SER . 32.4 mt-30 -61.22 -34.18 74.69 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 106.954 -1.498 . . . . 192.46000000000001 106.954 178.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.52 -41.09 98.07 Favored Glycine 0 C--N 1.353 1.523 0 N-CA-C 107.963 -2.055 . . . . 261.0 107.963 177.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -65.71 159.13 25.71 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 101.537 -3.505 . . . . 491.39999999999998 101.537 172.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -59.98 106.82 0.54 Allowed 'General case' 0 CA--C 1.489 -1.403 0 C-N-CA 116.256 -2.178 . . . . 386.10000000000002 109.809 -176.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.919 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 73.8 m -154.07 -166.62 2.42 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 103.533 -2.765 . . . . 289.80000000000001 103.533 -178.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' THR . . . . . 1.144 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.3 p -62.93 175.42 0.86 Allowed 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 117.766 -1.112 . . . . 402.06 109.538 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.789 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 72.9 p -165.24 177.5 7.58 Favored 'General case' 0 CA--C 1.586 2.355 0 C-N-CA 127.336 2.254 . . . . 690.52999999999997 114.935 177.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.485 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.9 mm-40 132.33 160.53 0.0 OUTLIER 'General case' 1 C--N 1.429 4.048 1 N-CA-C 123.195 4.517 . . . . 633.62 123.195 162.689 . . . . . . . . 4 3 . 1 . 005 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.76 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.3 p -85.62 153.81 22.13 Favored 'General case' 0 C--N 1.389 2.284 0 C-N-CA 127.414 2.286 . . . . 617.99000000000001 110.887 177.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' MET . . . . . 1.049 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.7 174.44 5.94 Favored Pre-proline 0 C--N 1.364 1.213 0 C-N-CA 130.213 3.405 . . . . 434.98000000000002 113.382 -175.385 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 1.092 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 51.5 Cg_endo -44.25 -65.59 0.19 Allowed 'Trans proline' 0 N--CA 1.442 -1.503 0 N-CA-C 122.42 3.969 . . . . 365.88 122.42 -168.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' SER . . . . . 0.777 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.305 70.8 m -84.93 20.91 1.72 Allowed 'General case' 0 CA--C 1.467 -2.224 0 N-CA-C 104.79 -2.3 . . . . 635.80999999999995 104.79 178.148 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.747 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.458 5.0 mmp_? -94.28 152.22 18.84 Favored 'General case' 1 CA--C 1.419 -4.059 3 N-CA-C 131.984 7.772 . . . . 999.99000000000001 131.984 -135.756 . . . . . . . . 5 3 . 1 . 005 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 1.048 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.911 37.2 t -131.88 73.16 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.765 1 CA-C-N 103.298 -6.319 . . . . 594.32000000000005 113.603 149.185 . . . . . . . . 4 3 . 1 . 005 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.731 HG13 ' HB2' ' A' ' 174' ' ' MET . 7.3 p -144.17 144.12 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.653 1 N-CA-C 98.31 -4.7 . . . . 811.90999999999997 98.31 162.331 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 180' ' ' CYS . . . . . 0.76 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.8 m -118.44 144.53 45.9 Favored 'General case' 0 CA--C 1.488 -1.41 0 C-N-CA 117.056 -1.858 . . . . 999.99000000000001 109.414 -178.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.945 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.7 mmm -147.18 -175.6 4.89 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-O 121.979 0.895 . . . . 431.86000000000001 110.09 -177.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 1.037 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.3 tt -69.2 148.68 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 C-N-CA 124.357 1.063 . . . . 457.18000000000001 108.796 -177.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' GLU . . . . . 0.789 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.34 85.5 3.76 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 124.164 0.985 . . . . 458.76999999999998 113.472 -174.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.962 ' CZ3' HG22 ' A' ' 182' ' ' ILE . 1.9 p90 -76.42 -31.46 0.96 Allowed Pre-proline 0 N--CA 1.438 -1.062 0 C-N-CA 124.937 1.295 . . . . 999.99000000000001 112.447 168.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.957 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 50.9 Cg_exo -66.03 -45.79 5.48 Favored 'Trans proline' 0 N--CA 1.438 -1.772 0 N-CA-C 120.812 3.351 . . . . 999.99000000000001 120.812 -174.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.506 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 54.9 mt-10 -119.58 171.75 8.14 Favored 'General case' 0 CA--C 1.472 -2.051 0 C-N-CA 117.174 -1.81 . . . . 81.180000000000007 107.273 -172.12 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.834 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 6.4 p80 -109.11 45.1 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.857 0 C-N-CA 115.505 -2.478 . . . . 999.99000000000001 108.759 177.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 1.076 ' HB2' HD12 ' A' ' 191' ' ' ILE . 86.4 Cg_endo -41.51 101.81 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.164 1 C-N-CA 126.037 4.491 . . . . 999.99000000000001 105.709 -170.75 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -62.32 -44.0 97.51 Favored 'General case' 0 CA--C 1.482 -1.642 0 C-N-CA 126.775 2.03 . . . . 967.72000000000003 112.043 -165.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -60.29 -36.55 78.1 Favored 'General case' 0 CA--C 1.487 -1.48 0 N-CA-C 106.745 -1.576 . . . . 934.29999999999995 106.745 -175.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 1.076 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.54 -30.25 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 C-N-CA 129.154 2.981 . . . . 565.14999999999998 113.954 -178.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 61.58 55.4 2.78 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-N 118.403 0.547 . . . . 755.61000000000001 109.828 -175.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 1.144 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.49 -49.26 67.18 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 124.551 1.14 . . . . 325.88999999999999 113.286 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.632 ' HE3' ' OH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.82 -44.98 78.42 Favored 'General case' 0 CA--C 1.495 -1.157 0 C-N-CA 123.576 0.75 . . . . 250.21000000000001 111.629 -169.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.4 t -64.7 -43.36 96.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 CA-C-O 121.581 0.705 . . . . 142.46000000000001 110.374 -175.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 1.037 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.7 t80 -61.15 -41.48 96.82 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 123.935 0.894 . . . . 247.69 108.813 -173.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.822 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 23.1 t60 -60.53 -51.4 69.6 Favored 'General case' 0 CA--C 1.492 -1.28 0 C-N-CA 125.465 1.506 . . . . 199.61000000000001 113.058 -175.116 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 82.8 mt -65.29 -44.47 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 107.748 -1.205 . . . . 106.73 107.748 -177.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' CYS . . . . . 0.719 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.8 t -59.2 -48.51 81.34 Favored 'General case' 0 CA--C 1.487 -1.459 0 CA-C-N 115.867 -0.606 . . . . 115.01000000000001 110.201 -173.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 1.061 HG13 HD13 ' A' ' 161' ' ' LEU . 86.2 t -65.24 -49.17 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.626 0 C-N-CA 119.398 -0.921 . . . . 129.41999999999999 111.847 -174.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.79 HG22 ' CD1' ' A' ' 206' ' ' PHE . 69.1 m -61.85 -53.13 60.07 Favored 'General case' 0 CA--C 1.482 -1.639 0 C-N-CA 118.186 -1.406 . . . . 172.47999999999999 109.977 -172.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.631 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 85.6 t -63.85 -54.25 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 C-N-CA 120.546 -0.462 . . . . 55.859999999999999 110.979 -174.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.719 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.58 -51.54 59.01 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 118.57 -1.252 . . . . 184.68000000000001 111.502 -174.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 1.056 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.65 -52.38 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 C-N-CA 116.607 -2.037 . . . . 291.81 114.731 -174.696 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.552 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.8 t80 -82.04 -55.03 4.83 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 115.143 1.534 . . . . 130.66 115.143 -178.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' PHE . . . . . 0.79 ' CD1' HG22 ' A' ' 201' ' ' THR . 40.0 m-85 -66.86 -48.51 68.58 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 114.492 1.293 . . . . 80.159999999999997 114.492 -170.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.905 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.52 -45.52 83.37 Favored Pre-proline 0 N--CA 1.435 -1.185 0 C-N-CA 119.989 -0.685 . . . . 136.02000000000001 109.504 -174.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.905 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 88.2 Cg_exo -64.76 -27.16 60.01 Favored 'Trans proline' 0 N--CA 1.433 -2.063 0 N-CA-C 110.616 -0.571 . . . . 92.170000000000002 110.616 -179.045 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.685 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.39 -41.33 76.62 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 107.492 -1.299 . . . . 135.59999999999999 107.492 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.2 -44.66 91.28 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 109.577 -0.527 . . . . 52.100000000000001 109.577 -176.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.617 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.71 -43.46 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 N-CA-C 109.088 -0.708 . . . . 95.890000000000001 109.088 -176.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.896 HG13 HG22 ' A' ' 124' ' ' THR . 94.7 mt -61.33 -42.31 93.15 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.386 0 N-CA-C 106.663 -1.606 . . . . 43.409999999999997 106.663 -178.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.46 -42.3 99.05 Favored Glycine 0 N--CA 1.432 -1.63 0 N-CA-C 109.343 -1.503 . . . . 27.690000000000001 109.343 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' TYR . . . . . 0.882 ' O ' HG22 ' A' ' 217' ' ' THR . 77.8 t80 -65.72 -47.29 75.83 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 117.409 0.604 . . . . 54.409999999999997 110.467 -177.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ALA . . . . . 0.825 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.47 -34.11 74.89 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 106.916 -1.513 . . . . 53.880000000000003 106.916 -177.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -60.78 -40.81 93.96 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 108.492 -0.929 . . . . 68.290000000000006 108.492 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' THR . . . . . 0.882 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.81 -38.98 92.79 Favored 'General case' 0 CA--C 1.497 -1.086 0 C-N-CA 119.704 -0.799 . . . . 107.59 110.619 -175.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.825 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.06 -38.37 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 119.584 -0.846 . . . . 111.61 109.49 -177.105 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.92 HG13 ' CD1' ' A' ' 134' ' ' ILE . 79.5 t -63.3 -22.45 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 N-CA-C 108.428 -0.952 . . . . 85.260000000000005 108.428 -178.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.89 -41.95 99.45 Favored Glycine 0 C--N 1.35 1.324 0 N-CA-C 111.014 -0.834 . . . . 40.710000000000001 111.014 -176.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.73 -43.99 96.52 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 N-CA-C 108.414 -0.958 . . . . 95.859999999999999 108.414 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.819 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.4 p -76.98 -137.47 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.452 -0.944 . . . . 144.37 108.452 -176.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.898 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.6 mt -55.39 132.16 47.51 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 107.574 -1.269 . . . . 326.72000000000003 107.574 -177.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' TRP . . . . . 0.466 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 9.0 t90 -119.37 -168.05 1.51 Allowed 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 106.006 -1.85 . . . . 158.38 106.006 -176.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.466 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.34 -41.96 98.9 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 109.632 -0.507 . . . . 36.780000000000001 109.632 -178.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.8 m -61.09 125.86 25.25 Favored 'General case' 0 N--CA 1.433 -1.32 0 C-N-CA 119.167 -1.013 . . . . 85.459999999999994 109.81 -174.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' GLU . . . . . 0.693 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.88 126.52 8.82 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 105.54 -2.022 . . . . 127.78 105.54 176.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.928 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.01 139.93 34.85 Favored Pre-proline 0 CA--C 1.493 -1.241 0 N-CA-C 105.977 -1.86 . . . . 164.84 105.977 -179.614 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.928 ' N ' HD13 ' A' ' 228' ' ' ILE . 83.1 Cg_exo -56.86 -39.9 88.08 Favored 'Trans proline' 0 N--CA 1.431 -2.183 0 N-CA-C 113.916 0.698 . . . . 222.34999999999999 113.916 -175.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' GLY . . . . . 0.747 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.16 167.02 44.92 Favored Glycine 0 N--CA 1.427 -1.915 0 N-CA-C 106.423 -2.671 . . . . 45.219999999999999 106.423 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.882 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.9 t0 -60.93 -45.76 93.4 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 106.045 -1.835 . . . . 107.56999999999999 106.045 177.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' SER . . . . . 0.731 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.9 m -65.77 141.83 58.18 Favored 'General case' 0 N--CA 1.429 -1.509 0 C-N-CA 118.894 -1.122 . . . . 167.96000000000001 109.145 -175.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.83 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.3 m 99.52 106.74 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 126.746 2.019 . . . . 280.68000000000001 109.707 176.087 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.709 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.7 m-20 56.03 11.21 0.7 Allowed 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 124.452 1.101 . . . . 218.25 110.675 174.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.922 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.35 137.62 54.79 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 105.213 -2.143 . . . . 343.56999999999999 105.213 177.407 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.481 ' O ' HG21 ' A' ' 240' ' ' VAL . 85.5 t80 -111.93 81.87 1.53 Allowed 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 106.873 -1.529 . . . . 263.29000000000002 106.873 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' HIS . . . . . 0.627 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 64.6 m80 104.27 147.07 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.268 0 C-N-CA 126.58 1.952 . . . . 261.92000000000002 108.522 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.18 -38.13 89.96 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 107.853 -1.166 . . . . 106.81 107.853 -177.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.738 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.48 -39.9 94.93 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 118.366 -1.334 . . . . 112.2 107.536 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.738 HG12 ' NH1' ' A' ' 244' ' ' ARG . 75.8 t -64.27 -39.78 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 N-CA-C 109.263 -0.643 . . . . 45.409999999999997 109.263 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' SER . . . . . 0.802 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.2 p -70.93 -32.13 68.95 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 110.233 -0.284 . . . . 97.620000000000005 110.233 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.34 -39.66 81.83 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 123.73 0.812 . . . . 59.289999999999999 110.972 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.738 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.2 -36.56 84.04 Favored 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 124.601 1.16 . . . . 106.48999999999999 110.67 -174.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.922 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.97 -30.63 69.23 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 108.294 -1.002 . . . . 106.62 108.294 -176.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.533 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.5 mttm -65.97 -41.04 91.69 Favored 'General case' 0 N--CA 1.435 -1.201 0 O-C-N 121.771 -0.581 . . . . 75.969999999999999 110.094 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.438 ' CG1' ' CE ' ' A' ' 250' ' ' MET . 76.0 t -65.6 -40.81 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 C-N-CA 122.908 0.483 . . . . 65.269999999999996 109.763 -178.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.775 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -64.01 -41.55 92.84 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.343 0 C-N-CA 120.39 -0.524 . . . . 107.94 110.185 -177.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.536 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.2 pttt -63.54 -40.85 98.07 Favored 'General case' 0 N--CA 1.433 -1.279 0 O-C-N 121.68 -0.638 . . . . 87.980000000000004 110.281 -176.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 249' ' ' MET . . . . . 0.822 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.58 -40.44 96.98 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 118.863 -1.135 . . . . 65.5 108.405 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' MET . . . . . 0.758 ' CE ' HG21 ' A' ' 67' ' ' THR . 68.5 mtt -61.7 -36.38 80.74 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 108.141 -1.059 . . . . 85.049999999999997 108.141 -177.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.536 HD12 ' HA ' ' A' ' 248' ' ' LYS . 86.9 mt -63.47 -45.76 97.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 109.061 -0.718 . . . . 42.25 109.061 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.822 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.32 -38.24 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 C-N-CA 119.568 -0.853 . . . . 91.010000000000005 109.396 -176.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 1.0 HG22 ' CD1' ' A' ' 304' ' ' ILE . 65.9 t -58.89 -41.53 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 N-CA-C 108.009 -1.108 . . . . 66.090000000000003 108.009 -178.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 250' ' ' MET . 94.8 t -66.07 -43.22 92.45 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.298 0 O-C-N 122.093 -0.379 . . . . 52.390000000000001 110.285 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 83.9 m -61.76 -46.71 88.44 Favored 'General case' 0 CA--C 1.489 -1.389 0 O-C-N 121.892 -0.505 . . . . 46.420000000000002 109.873 -174.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' THR . . . . . 0.744 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.5 t -62.34 -38.2 88.6 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 108.314 -0.995 . . . . 116.51000000000001 108.314 -177.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 257' ' ' PHE . . . . . 0.491 ' N ' HG23 ' A' ' 256' ' ' THR . 86.0 t80 -60.21 -48.24 82.59 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 109.38 -0.6 . . . . 65.180000000000007 109.38 -178.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.99 -42.63 97.13 Favored 'General case' 0 CA--C 1.489 -1.373 0 O-C-N 122.093 -0.379 . . . . 51.329999999999998 110.448 -175.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' ILE . . . . . 0.744 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.65 -43.37 98.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 C-N-CA 118.883 -1.127 . . . . 126.3 109.015 -176.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 260' ' ' CYS . . . . . 0.506 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.7 m -65.54 -49.34 69.28 Favored 'General case' 0 N--CA 1.432 -1.325 0 C-N-CA 119.512 -0.875 . . . . 133.94 112.508 -176.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.817 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.1 m95 -80.63 -33.38 35.79 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 116.869 2.174 . . . . 134.84 116.869 -176.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.782 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.9 tp -58.49 -41.58 89.94 Favored Pre-proline 0 CA--C 1.493 -1.242 0 O-C-N 121.663 -0.648 . . . . 72.230000000000004 111.643 -167.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 263' ' ' PRO . . . . . 0.782 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 80.9 Cg_exo -60.63 -36.02 87.14 Favored 'Trans proline' 0 N--CA 1.429 -2.287 0 CA-C-N 119.884 0.994 . . . . 106.13 111.349 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 264' ' ' PHE . . . . . 0.847 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.8 t80 -66.45 -44.6 82.36 Favored 'General case' 0 N--CA 1.434 -1.273 0 C-N-CA 119.7 -0.8 . . . . 128.34999999999999 110.019 -178.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 265' ' ' HIS . . . . . 0.643 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.48 -37.87 89.05 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 110.195 -0.298 . . . . 100.73 110.195 -177.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.743 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.23 -44.52 95.14 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 C-N-CA 119.294 -0.962 . . . . 172.72 109.191 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 267' ' ' PHE . . . . . 0.732 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.5 m-85 -66.63 -28.07 68.19 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 108.199 -1.037 . . . . 249.22999999999999 108.199 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 268' ' ' PHE . . . . . 0.904 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.58 -55.1 35.99 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 106.673 -1.603 . . . . 259.77999999999997 106.673 178.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 269' ' ' LEU . . . . . 0.492 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.4 mt -69.16 -44.22 72.7 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 113.58 0.955 . . . . 233.11000000000001 113.58 -176.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.835 ' O ' HG13 ' A' ' 273' ' ' ILE . 88.6 mt -61.36 -48.27 91.57 Favored Pre-proline 0 N--CA 1.44 -0.967 0 C-N-CA 119.193 -1.003 . . . . 169.53999999999999 110.615 -171.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 271' ' ' PRO . . . . . 0.732 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.6 Cg_exo -61.21 -24.5 79.13 Favored 'Trans proline' 0 N--CA 1.43 -2.25 0 C-N-CA 116.689 -1.741 . . . . 255.47 114.639 174.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 272' ' ' TYR . . . . . 0.822 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.6 t80 -63.61 -44.2 94.66 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 119.271 0.941 . . . . 279.02999999999997 108.905 177.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.835 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.27 -44.8 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 N-CA-C 110.102 -0.333 . . . . 162.21000000000001 110.102 -178.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 274' ' ' ASN . . . . . 0.865 HD22 HD12 ' A' ' 277' ' ' LEU . 49.0 t30 -125.45 84.86 59.42 Favored Pre-proline 0 N--CA 1.431 -1.387 0 C-N-CA 118.76 -1.176 . . . . 128.13 108.029 -178.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 275' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.5 Cg_endo -85.22 163.99 11.3 Favored 'Trans proline' 0 C--N 1.295 -2.284 0 N-CA-C 107.482 -1.776 . . . . 278.35000000000002 107.482 177.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 276' ' ' ASP . . . . . 0.864 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.14 15.02 9.93 Favored 'General case' 0 N--CA 1.429 -1.524 0 O-C-N 123.794 0.684 . . . . 312.91000000000003 109.328 175.213 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.865 HD12 HD22 ' A' ' 274' ' ' ASN . 28.5 mt -132.73 -170.72 2.5 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 106.557 -1.646 . . . . 353.54000000000002 106.557 177.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 1.006 ' HA ' ' CB ' ' A' ' 282' ' ' PHE . 42.7 p90 -115.61 142.22 47.03 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 107.441 -1.318 . . . . 251.25999999999999 107.441 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.762 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -76.94 -118.76 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 102.097 -3.297 . . . . 175.25999999999999 102.097 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 280' ' ' LYS . . . . . 0.792 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.1 ttmt -61.45 -45.02 96.01 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 100.889 -3.745 . . . . 99.069999999999993 100.889 172.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 281' ' ' LYS . . . . . 0.792 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.36 124.15 9.21 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 103.488 -2.782 . . . . 243.21000000000001 103.488 171.171 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 1.006 ' CB ' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.95 112.98 25.13 Favored 'General case' 0 CA--C 1.474 -1.979 0 C-N-CA 116.037 -2.265 . . . . 201.03999999999999 105.294 178.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 283' ' ' ILE . . . . . 0.778 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.93 173.69 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.064 0 C-N-CA 116.036 -2.266 . . . . 201.36000000000001 108.754 -175.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 284' ' ' GLN . . . . . 1.092 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.282 0.6 OUTLIER -59.5 -41.43 89.87 Favored 'General case' 0 N--CA 1.416 -2.164 0 CA-C-N 113.184 -1.825 . . . . 203.81999999999999 107.829 174.47 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 285' ' ' GLN . . . . . 0.924 ' HG2' HE21 ' A' ' 284' ' ' GLN . 1.2 mm100 -64.31 -45.75 86.59 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 118.249 -1.38 . . . . 215.06 112.55 -171.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.556 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.7 t -65.66 -46.44 89.31 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.467 0 C-N-CA 118.606 -1.237 . . . . 125.28 112.886 -171.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 287' ' ' TYR . . . . . 0.949 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.83 -36.95 86.0 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 107.169 -1.419 . . . . 268.89999999999998 107.169 -171.836 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.795 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.24 -45.02 74.36 Favored 'General case' 0 N--CA 1.427 -1.602 0 C-N-CA 125.644 1.577 . . . . 280.88 108.808 -172.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.61 -47.53 85.8 Favored 'General case' 0 N--CA 1.428 -1.567 0 C-N-CA 119.01 -1.076 . . . . 184.47 108.988 -172.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' ILE . . . . . 0.847 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.8 mp -67.91 -42.1 85.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 C-N-CA 119.298 -0.961 . . . . 167.91999999999999 112.732 -175.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 291' ' ' MET . . . . . 0.502 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.8 ttt -65.79 -38.75 89.84 Favored 'General case' 0 CA--C 1.495 -1.146 0 C-N-CA 117.779 -1.569 . . . . 367.18000000000001 110.785 -175.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 292' ' ' TRP . . . . . 0.55 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.4 m95 -67.19 -32.71 73.97 Favored 'General case' 0 N--CA 1.435 -1.205 0 O-C-N 121.892 -0.505 . . . . 173.97 110.46 177.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.3 tp -64.48 -36.69 85.01 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 123.523 0.729 . . . . 119.66 109.815 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' ALA . . . . . 0.817 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.29 -33.91 74.34 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.752 -1.203 . . . . 112.3 107.752 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 295' ' ' MET . . . . . 0.773 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.11 -32.09 73.39 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 116.193 -0.458 . . . . 174.16999999999999 110.185 -177.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.5 m -64.74 -22.7 67.04 Favored 'General case' 0 CA--C 1.485 -1.525 0 C-N-CA 124.669 1.188 . . . . 145.27000000000001 110.638 -175.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 297' ' ' SER . . . . . 0.756 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.6 m -57.66 -35.36 70.45 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 108.056 -1.091 . . . . 170.15000000000001 108.056 -175.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.82 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.7 t -55.34 -34.14 63.96 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 116.32 -0.4 . . . . 214.56999999999999 110.654 -171.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 299' ' ' MET . . . . . 0.75 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.1 ttt -77.18 -33.2 56.45 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 126.065 1.746 . . . . 168.28999999999999 115.545 177.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 300' ' ' TYR . . . . . 0.756 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.4 p90 -64.45 -34.86 79.19 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 114.02 1.119 . . . . 167.15000000000001 114.02 -168.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 301' ' ' ASN . . . . . 0.726 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.281 18.8 p-10 -64.22 -38.25 32.78 Favored Pre-proline 0 N--CA 1.433 -1.295 0 C-N-CA 115.536 -2.466 . . . . 165.13 113.961 -171.595 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 302' ' ' PRO . . . . . 0.726 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 83.8 Cg_exo -62.56 -31.8 79.83 Favored 'Trans proline' 0 N--CA 1.433 -2.061 0 CA-C-N 122.791 2.033 . . . . 123.92 111.254 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 303' ' ' ILE . . . . . 0.712 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.76 -42.58 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 C-N-CA 118.859 -1.136 . . . . 110.55 109.739 -179.045 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 304' ' ' ILE . . . . . 1.0 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.1 pt -61.16 -40.02 84.43 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.179 0 N-CA-C 108.825 -0.806 . . . . 145.31 108.825 -177.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 305' ' ' TYR . . . . . 0.925 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.253 63.1 m-85 -58.12 -48.84 78.98 Favored 'General case' 0 CA--C 1.495 -1.171 0 C-N-CA 119.416 -0.914 . . . . 246.68000000000001 109.824 -177.48 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.7 m -62.14 -47.53 84.17 Favored 'General case' 0 CA--C 1.484 -1.564 0 C-N-CA 119.526 -0.87 . . . . 64.430000000000007 109.587 -173.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.6 t -66.83 -45.01 79.62 Favored 'General case' 0 N--CA 1.428 -1.553 0 C-N-CA 118.992 -1.083 . . . . 80.719999999999999 110.226 -177.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.707 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.56 -35.66 75.61 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 115.937 1.828 . . . . 140.44 115.937 -173.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 309' ' ' ASN . . . . . 0.659 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.8 p30 -136.83 132.2 34.3 Favored 'General case' 0 N--CA 1.434 -1.245 0 C-N-CA 112.723 -3.591 . . . . 178.87 113.039 -177.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 310' ' ' ASP . . . . . 0.609 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.06 -37.0 86.13 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 114.409 -1.269 . . . . 110.22 110.151 -177.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.86 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.77 -50.58 72.77 Favored 'General case' 0 CA--C 1.492 -1.27 0 O-C-N 121.753 -0.592 . . . . 174.78 109.737 -174.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.958 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.1 m-85 -64.92 -41.65 95.38 Favored 'General case' 0 CA--C 1.484 -1.575 0 N-CA-C 108.24 -1.022 . . . . 161.84 108.24 178.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 313' ' ' ARG . . . . . 0.518 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.32 -50.24 73.58 Favored 'General case' 0 CA--C 1.49 -1.331 0 N-CA-C 109.182 -0.673 . . . . 117.2 109.182 -173.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.802 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.48 -44.16 75.37 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 120.364 -0.534 . . . . 112.59999999999999 111.037 -177.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 315' ' ' GLY . . . . . 0.869 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -63.99 -37.48 94.68 Favored Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 110.648 -0.981 . . . . 101.45999999999999 110.648 -177.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 316' ' ' PHE . . . . . 1.006 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.6 m-85 -62.15 -46.01 90.9 Favored 'General case' 0 CA--C 1.492 -1.265 0 CA-C-N 118.493 1.147 . . . . 151.49000000000001 109.5 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 317' ' ' LYS . . . . . 0.417 ' HE3' ' HB2' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.06 -36.34 77.12 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 106.959 -1.497 . . . . 142.31999999999999 106.959 -175.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 318' ' ' HIS . . . . . 0.824 ' NE2' HG21 ' A' ' 326' ' ' ILE . 50.0 m80 -59.82 -41.76 92.02 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 106.892 -1.521 . . . . 109.09 106.892 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.9 -42.46 85.45 Favored 'General case' 0 N--CA 1.435 -1.183 0 O-C-N 122.368 -0.208 . . . . 76.109999999999999 110.979 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -61.37 -55.49 30.98 Favored 'General case' 0 CA--C 1.49 -1.36 0 C-N-CA 119.866 -0.734 . . . . 120.23999999999999 109.361 -174.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.578 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.4 mtt180 -74.36 131.54 41.22 Favored 'General case' 0 CA--C 1.482 -1.649 0 N-CA-C 102.943 -2.984 . . . . 192.72999999999999 102.943 177.05 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.11 -44.27 91.96 Favored 'General case' 0 CA--C 1.492 -1.27 0 C-N-CA 119.008 -1.077 . . . . 176.28999999999999 109.212 -172.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 323' ' ' CYS . . . . . 0.754 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 77.9 m -79.34 -177.14 0.82 Allowed Pre-proline 0 N--CA 1.43 -1.439 0 N-CA-C 106.364 -1.717 . . . . 69.680000000000007 106.364 178.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.571 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 84.2 Cg_exo -58.93 -75.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.389 0 C-N-CA 118.343 -0.638 . . . . 191.05000000000001 112.637 176.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 325' ' ' PHE . . . . . 0.754 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.6 m-85 47.45 43.88 16.09 Favored 'General case' 0 CA--C 1.493 -1.234 0 O-C-N 123.571 0.544 . . . . 287.02999999999997 109.803 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 326' ' ' ILE . . . . . 0.824 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.52 78.65 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.474 -1.944 0 C-N-CA 112.885 -3.526 . . . . 292.29000000000002 109.847 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 327' ' ' SER . . . . . 0.48 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.4 t -77.48 -152.84 0.05 Allowed 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 104.199 -2.519 . . . . 184.56999999999999 104.199 178.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 328' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.65 8.67 4.99 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 113.091 0.775 . . . . 274.56 113.091 176.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 99.0 0.89 57.23 Favored Glycine 0 C--N 1.348 1.248 0 C-N-CA 117.725 -2.178 . . . . 268.24000000000001 113.473 172.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 330' ' ' ASP . . . . . 0.699 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.9 m-20 51.6 -172.05 0.03 OUTLIER 'General case' 0 CA--C 1.496 -1.099 0 CA-C-N 118.676 1.238 . . . . 200.06 110.782 177.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.86 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.3 t80 -63.86 -33.02 74.75 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 107.892 -1.151 . . . . 114.44 107.892 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 332' ' ' GLU . . . . . 0.549 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.27 46.05 21.91 Favored 'General case' 0 CA--C 1.484 -1.581 0 N-CA-C 107.627 -1.249 . . . . 263.81 107.627 -177.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 333' ' ' GLY . . . . . 0.633 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.31 -137.37 3.61 Favored Glycine 0 CA--C 1.478 -2.229 1 N-CA-C 102.548 -4.221 . . . . 103.79000000000001 102.548 -179.804 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 1.035 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.4 mt -88.27 95.61 10.25 Favored 'General case' 0 N--CA 1.419 -1.983 0 C-N-CA 114.95 -2.7 . . . . 117.3 106.013 176.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 335' ' ' GLU . . . . . 1.014 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.97 -39.8 90.68 Favored 'General case' 0 CA--C 1.468 -2.177 1 N-CA-C 97.977 -4.823 . . . . 231.58000000000001 97.977 167.232 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 336' ' ' MET . . . . . 1.028 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.91 163.53 28.95 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 102.092 -3.299 . . . . 303.24000000000001 102.092 168.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 337' ' ' LYS . . . . . 1.035 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.4 tttt -62.6 -48.64 78.54 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 116.066 -2.253 . . . . 112.72 108.442 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.9 t -61.03 -63.68 1.22 Allowed 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 109.091 -0.707 . . . . 83.219999999999999 109.091 -176.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 339' ' ' THR . . . . . 0.883 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.4 m -156.28 -126.18 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 103.858 -2.645 . . . . 174.36000000000001 103.858 -178.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 340' ' ' ARG . . . . . 1.014 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.88 160.94 8.81 Favored 'General case' 0 CA--C 1.486 -1.515 0 N-CA-C 105.789 -1.93 . . . . 202.72999999999999 105.789 177.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 341' ' ' TYR . . . . . 1.01 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.94 149.0 52.56 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 107.065 -1.457 . . . . 180.62 107.065 176.432 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.927 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.6 tp -178.49 -171.85 0.27 Allowed 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 105.407 -2.072 . . . . 145.25 105.407 178.05 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 343' ' ' GLN . . . . . 0.927 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.06 -43.2 88.13 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 106.113 -1.81 . . . . 66.049999999999997 106.113 174.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 344' ' ' THR . . . . . 0.765 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.66 -152.14 0.48 Allowed 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 103.521 -2.77 . . . . 266.49000000000001 103.521 179.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 345' ' ' GLN . . . . . 0.702 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.5 mt-30 66.28 -124.97 0.28 Allowed 'General case' 0 N--CA 1.428 -1.572 0 C-N-CA 117.076 -1.85 . . . . 219.19999999999999 107.739 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 346' ' ' GLY . . . . . 0.897 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -64.96 -37.43 94.26 Favored Glycine 0 N--CA 1.426 -2.013 0 CA-C-N 114.536 -1.211 . . . . 94.780000000000001 112.895 -176.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 347' ' ' SER . . . . . 0.825 ' HB2' ' H ' ' A' ' 342' ' ' LEU . 48.4 t -81.21 100.45 9.12 Favored 'General case' 0 CA--C 1.483 -1.599 0 C-N-CA 112.327 -3.749 . . . . 121.41 109.441 -171.047 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 348' ' ' VAL . . . . . 0.439 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.2 t -73.09 145.55 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 108.961 -0.755 . . . . 85.340000000000003 108.961 -176.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 349' ' ' TYR . . . . . 0.439 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.5 p90 -57.78 143.44 42.09 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.848 -1.167 . . . . 267.56999999999999 107.848 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 350' ' ' LYS . . . . . 0.526 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.08 69.53 0.6 Allowed 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 109.532 -0.544 . . . . 226.09999999999999 109.532 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 351' ' ' VAL . . . . . 0.827 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.5 p -50.96 156.97 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.315 0 N-CA-C 107.017 -1.475 . . . . 154.84 107.017 177.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 352' ' ' SER . . . . . 0.581 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.5 m -61.4 161.92 8.64 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-O 121.602 0.715 . . . . 180.00999999999999 110.721 -173.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 353' ' ' ARG . . . . . 0.897 ' H ' ' HD3' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.45 156.91 23.66 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 106.913 -1.514 . . . . 333.77999999999997 106.913 -178.615 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 354' ' ' LEU . . . . . 0.978 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.03 142.54 48.73 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 107.325 -1.361 . . . . 335.19999999999999 107.325 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.978 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.5 mm-40 82.79 158.88 0.13 Allowed 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 108.753 -0.832 . . . . 266.47000000000003 108.753 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.5 m -60.6 -46.84 88.74 Favored 'General case' 0 CA--C 1.487 -1.467 0 N-CA-C 105.708 -1.96 . . . . 59.340000000000003 105.708 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.6 173.83 11.98 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 104.444 -2.428 . . . . 201.25999999999999 104.444 176.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.747 HG22 ' O ' ' A' ' 360' ' ' THR . 69.2 mt -95.92 106.7 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 C-N-CA 116.323 -2.151 . . . . 56.229999999999997 105.53 -179.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 359' ' ' SER . . . . . 0.468 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.7 m -61.15 -59.48 5.26 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 109.308 -0.627 . . . . 87.579999999999998 109.308 -175.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 360' ' ' THR . . . . . 0.885 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.1 t -85.49 153.71 22.27 Favored 'General case' 0 CA--C 1.486 -1.513 0 N-CA-C 107.871 -1.159 . . . . 219.94999999999999 107.871 -177.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 361' ' ' VAL . . . . . 0.59 ' O ' HG23 ' A' ' 361' ' ' VAL . 16.0 m -81.98 83.86 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.656 0 C-N-CA 116.326 -2.15 . . . . 121.79000000000001 105.434 177.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.597 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.5 t -154.16 159.68 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 N-CA-C 105.824 -1.917 . . . . 53.850000000000001 105.824 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 363' ' ' GLY . . . . . 0.597 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.28 16.59 77.15 Favored Glycine 0 N--CA 1.428 -1.875 0 N-CA-C 106.046 -2.822 . . . . 196.55000000000001 106.046 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.681 0 N-CA-C 107.849 -1.167 . . . . 35.880000000000003 107.849 -178.9 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 365' ' ' ARG . . . . . 0.46 HH11 ' HD2' ' B' ' 365' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 108.808 -0.812 . . . . 1.0 108.808 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 366' ' ' PRO . . . . . 0.416 ' CD ' ' N ' ' B' ' 365' ' ' ARG . 52.8 Cg_endo -66.91 141.99 60.78 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.086 1.858 . . . . 1.0 110.228 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 367' ' ' LYS . . . . . 0.888 ' HG3' HD11 ' A' ' 5' ' ' LEU . 0.8 OUTLIER -64.35 143.26 98.45 Favored Pre-proline 0 C--N 1.326 -0.445 0 C-N-CA 119.888 -0.725 . . . . 1.0 109.576 -179.875 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 368' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.31 150.44 76.26 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.272 1.981 . . . . 1.0 111.728 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 369' ' ' GLN . . . . . 0.401 ' OE1' HG21 ' A' ' 19' ' ' THR . 0.0 OUTLIER -70.77 131.75 44.3 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.724 -0.39 . . . . 1.0 110.165 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 370' ' ' GLN . . . . . 0.455 ' OE1' ' HA ' ' B' ' 370' ' ' GLN . 0.0 OUTLIER -102.01 115.93 31.61 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.672 -179.831 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 371' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -63.71 -42.36 97.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.347 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 372' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -65.03 -36.21 83.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.871 -0.604 . . . . 1.0 110.652 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -59.78 -33.0 76.05 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.839 -0.905 . . . . 1.0 110.839 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 374' ' ' LEU . . . . . 0.918 HD13 ' HA ' ' A' ' 20' ' ' SER . 10.0 tp -67.83 131.36 45.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.885 0.374 . . . . 1.0 110.173 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 375' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 117.947 -1.025 . . . . 1.0 110.588 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.457 0 N-CA-C 108.377 -0.971 . . . . 97.08 108.377 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -110.61 155.42 22.39 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-O 122.103 0.954 . . . . 123.41 110.737 -172.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.877 HG11 HD13 ' A' ' 15' ' ' ILE . 28.7 m -134.58 -162.38 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.487 1 N-CA-C 100.093 -4.04 . . . . 151.3 100.093 173.732 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.908 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.63 -38.61 58.55 Favored Pre-proline 0 N--CA 1.439 -0.981 0 C-N-CA 115.961 -2.295 . . . . 169.25 106.123 178.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.908 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 58.0 Cg_exo -81.28 168.53 16.65 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 122.255 0.608 . . . . 185.76 110.536 171.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.906 HG13 ' CE2' ' A' ' 282' ' ' PHE . 92.0 t -64.47 -25.93 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 C-N-CA 127.022 2.129 . . . . 145.47 110.343 -177.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.774 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.2 t0 -84.33 157.41 21.5 Favored 'General case' 0 CA--C 1.499 -0.988 0 O-C-N 121.073 -1.017 . . . . 102.76 109.459 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.5 p -82.59 154.17 25.1 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 107.988 -1.115 . . . . 106.25 107.988 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.918 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.7 p-10 -105.89 51.89 0.74 Allowed 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 117.772 -1.571 . . . . 157.81 107.628 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.16 -45.9 91.51 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 103.586 -2.746 . . . . 150.2 103.586 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.8 m -87.05 164.68 35.29 Favored Pre-proline 0 N--CA 1.422 -1.872 0 N-CA-C 103.672 -2.714 . . . . 183.52 103.672 172.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -76.77 6.87 3.84 Favored 'Trans proline' 0 C--N 1.281 -2.998 0 N-CA-C 109.988 -0.812 . . . . 235.61 109.988 176.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -57.93 -41.25 82.33 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 124.809 1.244 . . . . 113.77 113.379 -170.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.918 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.4 pt -52.16 136.22 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-N 119.558 1.072 . . . . 150.85 110.984 -176.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.49 156.26 46.39 Favored 'General case' 0 C--N 1.36 1.064 0 N-CA-C 107.625 -1.25 . . . . 100.42 107.625 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 1.08 HG23 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.05 142.61 58.35 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 121.953 0.882 . . . . 129.36 110.444 -174.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.775 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.06 -25.5 68.4 Favored 'General case' 0 CA--C 1.494 -1.208 0 C-N-CA 126.303 1.841 . . . . 112.34 106.689 -177.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.941 HG23 ' HA2' ' A' ' 101' ' ' GLY . 85.8 m -74.14 -40.14 62.81 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.542 -0.754 . . . . 131.73 111.744 177.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 1.08 ' H ' HG23 ' A' ' 17' ' ' THR . 71.2 m -84.45 -42.86 15.18 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 116.994 2.22 . . . . 80.49 116.994 -174.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.549 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.4 mt-10 -145.99 174.54 3.34 Favored Pre-proline 0 N--CA 1.443 -0.817 0 C-N-CA 118.152 -1.419 . . . . 98.98 111.198 -169.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.823 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.333 85.7 Cg_exo -61.79 -10.73 18.04 Favored 'Trans proline' 0 C--N 1.321 -0.887 1 N-CA-C 128.934 6.475 . . . . 246.95 128.934 -170.085 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.626 HD21 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.61 17.55 8.7 Favored 'General case' 0 C--N 1.324 -0.515 1 CA-C-N 126.15 4.068 . . . . 269.62 114.216 175.655 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.495 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.6 mt-30 -67.14 -27.26 67.16 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 107.802 -1.184 . . . . 86.8 107.802 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.551 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.3 p90 -66.81 -29.34 69.25 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 121.115 -0.991 . . . . 85.91 110.501 -178.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.873 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.4 t -68.54 -40.21 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 C-N-CA 123.695 0.798 . . . . 82.0 111.346 -177.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.896 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.4 167.73 12.48 Favored Pre-proline 0 CA--C 1.489 -1.4 0 N-CA-C 108.552 -0.907 . . . . 120.73 108.552 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.902 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -64.0 149.76 89.82 Favored 'Trans proline' 0 N--CA 1.432 -2.123 0 C-N-CA 120.616 0.877 . . . . 87.86 109.91 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.744 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.03 -37.96 89.28 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 108.846 -0.798 . . . . 36.46 108.846 -176.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.814 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.8 p-90 -63.8 -33.86 76.61 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 107.807 -1.183 . . . . 150.6 107.807 -176.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.902 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.5 mt-30 -62.21 -32.71 73.41 Favored 'General case' 0 CA--C 1.49 -1.334 0 O-C-N 121.291 -0.88 . . . . 123.26 108.666 -178.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.744 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.47 -47.17 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.57 0 N-CA-C 109.157 -0.682 . . . . 120.14 109.157 176.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.785 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.2 m -67.41 -31.03 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 107.873 -1.158 . . . . 112.19 107.873 -178.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.814 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.5 tp -62.98 -47.12 84.51 Favored 'General case' 0 N--CA 1.432 -1.337 0 C-N-CA 119.921 -0.712 . . . . 60.87 109.601 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.672 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.03 -35.67 81.18 Favored 'General case' 0 CA--C 1.489 -1.382 0 C-N-CA 119.965 -0.694 . . . . 157.57 110.364 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.747 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.61 -40.89 98.39 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 108.629 -0.878 . . . . 47.06 108.629 178.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.805 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.77 -41.28 98.01 Favored 'General case' 0 CA--C 1.496 -1.121 0 O-C-N 121.756 -0.59 . . . . 43.94 109.557 -177.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.731 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.81 -43.3 99.12 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.726 -0.842 . . . . 42.61 108.726 -176.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.902 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.38 -41.26 93.94 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 116.623 -0.262 . . . . 140.66 111.029 -178.364 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.805 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.78 -43.96 97.81 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 118.58 -1.248 . . . . 116.04 110.234 -175.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.673 HG22 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.44 -38.75 83.24 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.292 0 N-CA-C 108.731 -0.84 . . . . 97.16 108.731 -177.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.852 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.2 mt -61.28 -40.0 84.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 N-CA-C 108.975 -0.75 . . . . 54.85 108.975 -176.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.956 HG22 HG21 ' A' ' 86' ' ' THR . 92.9 t -57.71 -42.34 81.48 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.301 0 N-CA-C 108.873 -0.788 . . . . 45.39 108.873 -175.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 48' ' ' VAL . 97.2 t -63.52 -50.97 76.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 C-N-CA 118.848 -1.141 . . . . 48.64 110.171 -177.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.751 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.6 t -65.27 -47.04 78.08 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 120.163 -0.615 . . . . 116.65 111.711 -174.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.59 ' N ' HG23 ' A' ' 45' ' ' THR . 50.8 m -61.96 -43.94 97.79 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 109.715 -0.476 . . . . 51.16 109.715 -174.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.4 t -65.54 -48.93 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 C-N-CA 119.852 -0.739 . . . . 44.3 110.85 -176.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.866 ' O ' HG23 ' A' ' 52' ' ' VAL . 93.8 t -64.75 -46.94 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 C-N-CA 120.299 -0.56 . . . . 48.82 111.032 -174.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.77 -44.15 95.21 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 120.513 -0.851 . . . . 58.7 112.006 -174.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -72.63 -34.21 67.17 Favored 'General case' 0 CA--C 1.488 -1.432 0 O-C-N 122.086 -0.655 . . . . 101.4 111.027 -175.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.742 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.9 -38.73 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 107.745 -1.206 . . . . 103.57 107.745 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 48' ' ' VAL . 72.0 t -61.43 -43.05 96.06 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.225 0 N-CA-C 108.975 -0.75 . . . . 61.89 108.975 -178.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.535 ' O ' HG22 ' A' ' 56' ' ' ILE . 81.8 t -63.44 -50.96 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 N-CA-C 109.47 -0.567 . . . . 70.01 109.47 -178.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.803 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.94 -43.39 98.92 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 109.13 -0.693 . . . . 132.1 109.13 -176.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.643 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.23 -46.62 83.02 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 116.677 -0.238 . . . . 104.5 110.441 -176.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 1.018 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.67 -49.88 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 C-N-CA 120.212 -0.595 . . . . 142.96 111.271 -173.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.949 HD11 HG12 ' A' ' 72' ' ' VAL 0.279 24.8 pt -64.79 -41.68 92.87 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.661 0 C-N-CA 116.947 -1.901 . . . . 158.32 110.877 -175.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.803 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.72 -41.39 98.09 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 117.725 -1.59 . . . . 137.11 109.48 178.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.36 -44.54 91.11 Favored 'General case' 0 N--CA 1.436 -1.165 0 O-C-N 122.164 -0.335 . . . . 54.66 111.019 -176.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.925 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.41 117.12 29.4 Favored 'General case' 0 CA--C 1.491 -1.322 0 CA-C-O 121.623 0.725 . . . . 127.18 109.586 -174.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.62 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.83 -36.84 80.12 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 124.099 0.96 . . . . 87.93 110.832 -176.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 1.036 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.38 -34.67 78.7 Favored 'General case' 0 CA--C 1.49 -1.33 0 O-C-N 121.657 -0.652 . . . . 131.12 111.509 -175.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 1.019 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.61 69.43 7.12 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 115.313 -2.555 . . . . 246.56 109.606 -175.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.412 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.21 91.45 3.48 Favored 'General case' 0 CA--C 1.474 -1.966 0 N-CA-C 105.484 -2.043 . . . . 339.35 105.484 177.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.444 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.5 p -124.15 165.27 17.85 Favored 'General case' 0 N--CA 1.414 -2.248 0 N-CA-C 102.992 -2.966 . . . . 114.66 102.992 176.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.88 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.15 -39.44 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 N-CA-C 106.78 -1.563 . . . . 143.28 106.78 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.836 HG22 HD13 ' A' ' 71' ' ' LEU . 95.4 m -59.69 -38.05 80.5 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 108.687 -0.856 . . . . 160.22 108.687 -176.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.525 ' ND2' ' HB3' ' A' ' 63' ' ' MET . 86.3 m-20 -62.34 -31.78 72.46 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 108.872 -0.788 . . . . 120.54 108.872 -177.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.901 ' O ' HG22 ' A' ' 72' ' ' VAL . 89.8 m-85 -63.59 -43.81 95.86 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 109.481 -0.563 . . . . 67.22 109.481 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.88 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.5 m-85 -66.53 -39.76 88.78 Favored 'General case' 0 CA--C 1.498 -1.055 0 O-C-N 121.488 -0.758 . . . . 138.6 109.668 -177.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.925 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.58 -35.91 82.05 Favored 'General case' 0 CA--C 1.493 -1.237 0 C-N-CA 122.479 0.312 . . . . 151.46 110.641 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.949 HG12 HD11 ' A' ' 57' ' ' ILE . 24.2 m -62.56 -37.95 80.2 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.227 0 C-N-CA 117.39 -1.724 . . . . 117.93 106.715 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.45 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.1 t30 -60.07 -46.03 90.92 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 107.859 -1.163 . . . . 56.82 107.859 -177.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.999 HD21 ' HE1' ' A' ' 123' ' ' MET . 8.7 mp -61.36 -43.91 98.07 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 108.931 -0.766 . . . . 145.3 108.931 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.05 -40.35 95.47 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 108.521 -0.918 . . . . 45.71 108.521 -175.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -62.4 -42.02 99.11 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.377 -0.601 . . . . 105.61 109.377 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.12 -39.45 92.59 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 108.646 -0.872 . . . . 47.89 108.646 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.588 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.56 -37.37 84.83 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 109.966 -0.383 . . . . 124.53 109.966 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.86 -41.22 99.28 Favored 'General case' 0 CA--C 1.496 -1.099 0 O-C-N 121.952 -0.467 . . . . 35.89 109.843 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.8 t -62.23 -37.3 84.86 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 107.025 -1.472 . . . . 88.97 107.025 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.82 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.17 -49.17 76.88 Favored 'General case' 0 N--CA 1.428 -1.55 0 C-N-CA 119.831 -0.748 . . . . 239.91 109.047 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.62 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.38 -43.4 90.81 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 121.536 -0.728 . . . . 146.1 110.596 -177.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.418 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.16 -58.23 3.4 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 117.397 -1.721 . . . . 91.74 113.852 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -76.55 -61.38 1.98 Allowed 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 115.748 1.759 . . . . 197.45 115.748 -173.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.933 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.25 -42.26 55.52 Favored 'General case' 0 CA--C 1.49 -1.365 0 C-N-CA 117.897 -1.521 . . . . 242.6 114.046 -170.036 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.956 HG21 HG22 ' A' ' 43' ' ' VAL . 4.6 t -65.4 -36.55 84.3 Favored 'General case' 0 N--CA 1.434 -1.254 0 C-N-CA 118.912 -1.115 . . . . 215.61 109.838 -172.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.423 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.3 t -60.3 -46.94 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 O-C-N 121.828 -0.545 . . . . 87.19 110.459 -175.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.842 HG21 ' CD2' ' A' ' 108' ' ' HIS . 63.6 t -65.93 -41.86 90.75 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.112 0 N-CA-C 109.731 -0.47 . . . . 231.82 109.731 -178.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.902 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 11.0 m120 -62.32 -34.14 76.06 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 108.317 -0.994 . . . . 364.98 108.317 -177.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.667 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.3 t80 -68.19 -44.72 75.25 Favored 'General case' 0 N--CA 1.438 -1.054 0 O-C-N 121.543 -0.723 . . . . 181.63 111.275 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.81 HG22 ' HD2' ' A' ' 95' ' ' HIS . 57.7 m -60.87 -45.78 93.19 Favored 'General case' 0 CA--C 1.478 -1.809 0 N-CA-C 107.432 -1.321 . . . . 269.02 107.432 -175.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 1.055 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.72 -45.03 93.4 Favored 'General case' 0 N--CA 1.416 -2.149 0 C-N-CA 118.657 -1.217 . . . . 562.66 110.023 -179.058 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.707 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.11 -45.24 95.51 Favored 'General case' 0 CA--C 1.479 -1.787 0 C-N-CA 118.696 -1.202 . . . . 446.75 108.097 -167.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.747 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.388 6.1 m -70.51 -26.31 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 C-N-CA 115.837 -2.345 . . . . 370.05 112.216 -178.755 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.81 ' HD2' HG22 ' A' ' 91' ' ' THR . 90.0 m-70 -74.48 -26.5 60.06 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 121.593 -0.692 . . . . 354.91 112.513 175.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.823 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.4 m-20 82.8 4.53 0.99 Allowed 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 125.067 1.347 . . . . 462.44 111.905 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.775 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.266 11.9 mm-40 -172.35 178.06 2.91 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-O 122.015 0.912 . . . . 652.37 111.122 171.786 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.791 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.73 86.3 2.17 Favored 'General case' 0 N--CA 1.428 -1.565 0 C-N-CA 128.489 2.715 . . . . 905.99 107.929 -174.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -67.87 -36.4 80.21 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 108.244 -1.021 . . . . 570.43 108.244 -176.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.848 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.57 -36.35 82.4 Favored 'General case' 0 N--CA 1.428 -1.54 0 C-N-CA 125.318 1.447 . . . . 453.22 111.157 -174.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.941 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.55 178.66 33.9 Favored Glycine 0 C--N 1.349 1.292 0 C-N-CA 118.768 -1.682 . . . . 445.63 109.891 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.0 mt -56.41 -41.23 75.99 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 125.275 1.43 . . . . 457.72 112.357 -170.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -58.63 -46.93 86.03 Favored 'General case' 0 CA--C 1.484 -1.56 0 C-N-CA 118.662 -1.215 . . . . 340.58 109.296 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.848 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.1 m-85 -68.71 -32.14 71.72 Favored 'General case' 0 N--CA 1.423 -1.775 0 C-N-CA 118.774 -1.171 . . . . 453.6 111.577 -176.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.764 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.05 -40.35 73.37 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 105.976 -1.861 . . . . 541.48 105.976 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.83 -47.14 75.99 Favored 'General case' 0 CA--C 1.486 -1.514 0 O-C-N 123.991 0.807 . . . . 466.68 110.866 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -61.74 -47.08 86.86 Favored 'General case' 0 N--CA 1.427 -1.607 0 C-N-CA 117.48 -1.688 . . . . 427.34 107.315 -178.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.842 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.6 m80 -67.1 -36.79 82.72 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 112.415 0.524 . . . . 537.87 112.415 -174.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.574 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.4 -42.69 74.77 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 116.847 -1.941 . . . . 422.12 111.593 175.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.858 ' O ' HG22 ' A' ' 113' ' ' ILE . 75.9 t80 -59.05 -50.1 75.37 Favored 'General case' 0 CA--C 1.502 -0.883 0 O-C-N 121.324 -0.86 . . . . 340.17 111.834 -173.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -65.29 -46.54 71.37 Favored Pre-proline 0 N--CA 1.443 -0.811 0 C-N-CA 119.082 -1.047 . . . . 258.06 111.723 -176.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.933 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.0 Cg_exo -61.52 -31.54 87.64 Favored 'Trans proline' 0 N--CA 1.435 -1.943 0 N-CA-C 115.368 1.257 . . . . 305.71 115.368 176.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.876 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.91 -40.41 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 N-CA-C 108.687 -0.857 . . . . 252.7 108.687 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.423 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.92 -40.6 93.8 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 107.801 -1.185 . . . . 149.27 107.801 -179.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.0 -44.81 95.93 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 120.625 -0.43 . . . . 138.08 111.506 -176.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.653 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 65.1 t -66.94 -42.39 88.77 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 O-C-N 121.575 -0.703 . . . . 132.89 110.96 -177.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.923 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.76 -44.67 92.79 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 108.884 -0.784 . . . . 193.61 108.884 -177.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.555 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.48 -37.66 84.46 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 122.804 0.442 . . . . 63.83 110.085 -175.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.9 m -64.02 -52.39 59.69 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 120.747 -0.381 . . . . 76.4 111.228 -177.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.749 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.99 -41.63 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 108.185 -1.042 . . . . 171.13 108.185 -174.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 1.098 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.3 m-85 -63.8 -38.56 91.56 Favored 'General case' 0 N--CA 1.433 -1.311 0 O-C-N 121.834 -0.541 . . . . 78.3 110.635 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.557 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.6 t -67.11 -35.74 80.42 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 118.901 -1.12 . . . . 92.36 109.216 -178.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.999 ' HE1' HD21 ' A' ' 74' ' ' LEU . 5.9 mmt -62.5 -34.28 76.55 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 108.173 -1.047 . . . . 93.73 108.173 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.902 HG22 HG13 ' A' ' 212' ' ' ILE . 33.2 p -67.42 -41.65 84.49 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 119.215 -0.994 . . . . 132.74 109.33 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.28 -42.08 94.68 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.18 -1.415 . . . . 43.39 107.18 -177.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.827 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.0 t -58.46 -41.99 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 N-CA-C 108.607 -0.886 . . . . 59.34 108.607 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.48 -44.07 95.45 Favored 'General case' 0 CA--C 1.497 -1.064 0 O-C-N 121.804 -0.56 . . . . 69.68 110.519 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.469 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.3 t80 -65.47 -42.77 91.9 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.326 -0.99 . . . . 106.98 108.326 -177.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.827 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.35 -35.61 81.42 Favored 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 119.662 -0.815 . . . . 147.63 108.951 -177.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.705 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.16 -41.54 99.27 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 108.541 -0.911 . . . . 190.06 108.541 178.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.6 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.5 t80 -61.34 -44.06 97.82 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.31 -0.996 . . . . 118.85 108.31 -177.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.805 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.5 mmt -63.36 -42.66 98.89 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 109.986 -0.375 . . . . 102.5 109.986 -177.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.99 -41.62 95.25 Favored 'General case' 0 CA--C 1.489 -1.39 0 O-C-N 121.82 -0.55 . . . . 89.98 109.841 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.92 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.3 mt -66.52 -50.72 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 C-N-CA 118.13 -1.428 . . . . 106.09 110.991 -177.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.749 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.07 -48.32 38.42 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.099 0 C-N-CA 117.098 -1.841 . . . . 227.74 111.815 -174.792 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.756 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.85 100.08 50.98 Favored Pre-proline 0 CA--C 1.486 -1.505 0 C-N-CA 116.242 -2.183 . . . . 262.55 110.059 -175.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.2 Cg_endo -69.6 -10.39 28.56 Favored 'Trans proline' 0 C--N 1.29 -2.544 0 C-N-CA 121.618 1.545 . . . . 210.25 111.358 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.705 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.28 112.02 1.0 Allowed 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 106.523 -1.658 . . . . 270.58 106.523 -178.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.886 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.82 -39.5 23.87 Favored Pre-proline 0 N--CA 1.43 -1.451 0 CA-C-N 115.358 -0.837 . . . . 129.84 112.347 -175.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.859 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 82.1 Cg_exo -61.36 -26.6 81.77 Favored 'Trans proline' 0 N--CA 1.431 -2.163 0 N-CA-C 116.297 1.614 . . . . 330.71 116.297 -174.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.756 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.03 77.2 7.95 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 114.479 -2.888 . . . . 204.51 107.277 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.877 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.72 147.43 0.09 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 107.435 -1.32 . . . . 387.41 107.435 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.877 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.4 t -143.71 147.02 33.63 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 118.794 -1.162 . . . . 166.22 109.475 178.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.84 -40.76 88.03 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 107.847 -1.168 . . . . 44.23 107.847 176.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.483 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.6 m -60.3 -39.14 85.89 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 108.176 -1.046 . . . . 28.8 108.176 -175.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.668 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.81 -38.79 92.1 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 109.101 -0.703 . . . . 30.29 109.101 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.847 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 89.9 m -59.61 -43.03 93.88 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 108.982 -0.748 . . . . 46.11 108.982 -176.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.46 -42.14 99.26 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 107.693 -1.225 . . . . 87.33 107.693 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.77 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.6 t -61.67 -42.08 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 107.93 -1.137 . . . . 23.69 107.93 -178.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.8 t -63.19 -44.29 99.25 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 109.704 -0.48 . . . . 43.86 109.704 -178.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.918 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.0 mm -61.28 -42.54 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 108.326 -0.991 . . . . 91.13 108.326 -176.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . 0.483 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.2 t -62.6 -37.96 88.29 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.754 -0.832 . . . . 65.88 108.754 -178.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.4 t -62.11 -41.85 92.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.225 0 N-CA-C 109.551 -0.537 . . . . 33.86 109.551 -177.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 1.098 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.4 -40.33 85.87 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.183 0 N-CA-C 107.585 -1.265 . . . . 146.52 107.585 -176.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . 0.7 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.1 m95 -62.86 -38.36 90.51 Favored 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 119.497 -0.881 . . . . 75.44 108.896 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.7 t -60.54 -48.4 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 O-C-N 121.028 -1.045 . . . . 43.64 109.71 -177.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.791 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.7 -38.0 89.47 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 109.029 -0.73 . . . . 102.57 109.029 -178.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.0 -41.09 86.83 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.417 -1.327 . . . . 58.16 107.417 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.801 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.07 -32.48 73.87 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.032 -0.729 . . . . 121.11 109.032 178.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.791 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.02 -42.34 85.09 Favored 'General case' 0 CA--C 1.489 -1.395 0 C-N-CA 118.576 -1.249 . . . . 153.15 109.923 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 1.057 HD13 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.05 -43.75 19.07 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 113.106 -3.437 . . . . 133.67 113.527 173.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.478 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -62.97 -39.9 96.08 Favored 'General case' 0 CA--C 1.489 -1.371 0 O-C-N 120.916 -1.115 . . . . 157.42 112.192 -171.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.522 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.3 t80 -74.45 -36.11 2.45 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 115.012 1.486 . . . . 250.91 115.012 -173.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.292 52.9 Cg_exo -59.5 -25.48 78.84 Favored 'Trans proline' 0 CA--C 1.488 -1.791 0 N-CA-C 118.007 2.272 . . . . 207.34 118.007 -174.351 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 1.013 HE21 HG13 ' A' ' 182' ' ' ILE . 87.6 mt-30 -61.17 -34.19 74.65 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 106.951 -1.5 . . . . 192.46 106.951 178.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.52 -41.03 98.09 Favored Glycine 0 C--N 1.353 1.501 0 N-CA-C 107.969 -2.053 . . . . 261.0 107.969 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.79 159.11 25.96 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 101.513 -3.514 . . . . 491.4 101.513 172.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -59.96 106.82 0.54 Allowed 'General case' 0 CA--C 1.488 -1.434 0 C-N-CA 116.247 -2.181 . . . . 386.1 109.83 -176.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.915 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 73.9 m -154.03 -166.61 2.42 Favored 'General case' 0 N--CA 1.415 -2.224 0 N-CA-C 103.541 -2.763 . . . . 289.8 103.541 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 1.14 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.92 175.4 0.86 Allowed 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 117.736 -1.126 . . . . 402.06 109.565 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.788 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 73.0 p -165.27 177.5 7.56 Favored 'General case' 0 CA--C 1.586 2.353 0 C-N-CA 127.343 2.257 . . . . 690.53 114.94 177.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.487 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.9 mm-40 132.34 160.56 0.0 OUTLIER 'General case' 1 C--N 1.429 4.057 1 N-CA-C 123.19 4.515 . . . . 633.62 123.19 162.704 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.762 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.2 p -85.63 153.83 22.1 Favored 'General case' 0 C--N 1.389 2.3 0 C-N-CA 127.376 2.27 . . . . 617.99 110.903 178.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . 1.047 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.69 174.4 6.0 Favored Pre-proline 0 C--N 1.364 1.206 0 C-N-CA 130.271 3.428 . . . . 434.98 113.405 -175.417 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 1.092 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 51.8 Cg_endo -44.24 -65.65 0.19 Allowed 'Trans proline' 0 N--CA 1.441 -1.56 0 N-CA-C 122.418 3.969 . . . . 365.88 122.418 -168.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . 0.778 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.306 70.5 m -84.89 20.95 1.69 Allowed 'General case' 0 CA--C 1.467 -2.239 0 N-CA-C 104.797 -2.298 . . . . 635.81 104.797 178.144 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.75 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.456 5.0 mmp_? -94.39 152.24 18.78 Favored 'General case' 1 CA--C 1.419 -4.064 3 N-CA-C 131.98 7.771 . . . . 999.99 131.98 -135.76 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 1.055 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.911 37.1 t -131.84 73.18 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.772 1 CA-C-N 103.3 -6.318 . . . . 594.32 113.599 149.217 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.726 HG13 ' HB2' ' A' ' 174' ' ' MET . 7.3 p -144.2 144.1 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.639 1 N-CA-C 98.291 -4.707 . . . . 811.91 98.291 162.374 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.762 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.8 m -118.46 144.53 45.92 Favored 'General case' 0 CA--C 1.489 -1.401 0 C-N-CA 117.058 -1.857 . . . . 999.99 109.427 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.97 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.8 mmm -147.19 -175.61 4.9 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-O 122.004 0.907 . . . . 431.86 110.054 -177.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 1.038 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.13 148.67 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 C-N-CA 124.351 1.06 . . . . 457.18 108.801 -177.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . 0.788 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.32 85.47 3.75 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 124.14 0.976 . . . . 458.77 113.503 -174.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.958 ' CZ3' HG22 ' A' ' 182' ' ' ILE . 1.9 p90 -76.37 -31.57 0.98 Allowed Pre-proline 0 N--CA 1.438 -1.048 0 C-N-CA 124.961 1.304 . . . . 999.99 112.426 168.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.956 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -65.95 -45.77 5.65 Favored 'Trans proline' 0 N--CA 1.438 -1.789 0 N-CA-C 120.875 3.375 . . . . 999.99 120.875 -174.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.508 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.56 171.74 8.15 Favored 'General case' 0 CA--C 1.472 -2.047 0 C-N-CA 117.166 -1.814 . . . . 81.18 107.26 -172.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.834 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.8 p-80 -109.14 45.14 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.848 0 C-N-CA 115.503 -2.479 . . . . 999.99 108.754 177.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 1.072 ' HB2' HD12 ' A' ' 191' ' ' ILE . 87.5 Cg_endo -41.57 101.81 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.14 1 C-N-CA 126.042 4.494 . . . . 999.99 105.683 -170.737 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -62.27 -44.02 97.48 Favored 'General case' 0 CA--C 1.483 -1.599 0 C-N-CA 126.747 2.019 . . . . 967.72 112.048 -165.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 190' ' ' LYS . 30.3 mmtp -60.26 -36.55 78.05 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.748 -1.575 . . . . 934.3 106.748 -175.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 1.072 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.56 -30.25 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 C-N-CA 129.2 3.0 . . . . 565.15 113.923 -178.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 61.53 55.4 2.81 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 118.444 0.565 . . . . 755.61 109.869 -175.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 1.14 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.5 -49.28 67.1 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.551 1.141 . . . . 325.89 113.242 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.633 ' HE3' ' OH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.82 -44.95 78.4 Favored 'General case' 0 CA--C 1.495 -1.16 0 C-N-CA 123.56 0.744 . . . . 250.21 111.627 -169.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.3 t -64.72 -43.35 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 CA-C-O 121.585 0.707 . . . . 142.46 110.382 -175.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 1.038 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.8 t80 -61.12 -41.52 96.85 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 123.981 0.912 . . . . 247.69 108.815 -173.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' HIS . . . . . 0.825 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 23.0 t60 -60.53 -51.31 69.97 Favored 'General case' 0 CA--C 1.491 -1.289 0 C-N-CA 125.424 1.49 . . . . 199.61 113.107 -175.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.2 mt -65.35 -44.48 94.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 107.715 -1.217 . . . . 106.73 107.715 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . 0.722 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.6 t -59.15 -48.53 81.27 Favored 'General case' 0 CA--C 1.487 -1.479 0 CA-C-N 115.867 -0.606 . . . . 115.01 110.231 -173.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 1.057 HG13 HD13 ' A' ' 161' ' ' LEU . 86.1 t -65.24 -49.15 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.657 0 C-N-CA 119.418 -0.913 . . . . 129.42 111.854 -174.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . 0.794 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.2 m -61.88 -53.15 59.72 Favored 'General case' 0 CA--C 1.483 -1.63 0 C-N-CA 118.224 -1.39 . . . . 172.48 109.952 -172.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.632 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.1 t -63.85 -54.26 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 C-N-CA 120.512 -0.475 . . . . 55.86 110.972 -174.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.722 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.54 -51.56 58.95 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 118.542 -1.263 . . . . 184.68 111.513 -174.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 1.044 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.61 -52.4 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 C-N-CA 116.643 -2.023 . . . . 291.81 114.743 -174.699 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.549 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.8 t80 -82.05 -55.01 4.83 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 115.148 1.536 . . . . 130.66 115.148 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . 0.794 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.8 m-85 -66.88 -48.5 68.56 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 114.488 1.292 . . . . 80.16 114.488 -170.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.894 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.55 -45.47 83.16 Favored Pre-proline 0 N--CA 1.435 -1.195 0 C-N-CA 119.965 -0.694 . . . . 136.02 109.506 -174.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.894 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.8 Cg_exo -64.81 -27.12 59.62 Favored 'Trans proline' 0 N--CA 1.433 -2.08 0 N-CA-C 110.621 -0.569 . . . . 92.17 110.621 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.686 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.34 -41.37 76.72 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 107.494 -1.298 . . . . 135.6 107.494 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.16 -44.69 91.33 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 109.591 -0.522 . . . . 52.1 109.591 -176.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.618 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.71 -43.49 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 109.09 -0.707 . . . . 95.89 109.09 -176.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.902 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.27 -42.34 93.16 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 N-CA-C 106.695 -1.595 . . . . 43.41 106.695 -178.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.44 -42.28 99.08 Favored Glycine 0 N--CA 1.432 -1.624 0 N-CA-C 109.367 -1.493 . . . . 27.69 109.367 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . 0.884 ' O ' HG22 ' A' ' 217' ' ' THR . 77.9 t80 -65.68 -47.38 75.65 Favored 'General case' 0 CA--C 1.497 -1.086 0 O-C-N 122.195 -0.591 . . . . 54.41 110.456 -177.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . 0.827 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.43 -34.1 74.83 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 106.96 -1.496 . . . . 53.88 106.96 -177.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -60.76 -40.83 93.97 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 108.48 -0.933 . . . . 68.29 108.48 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . 0.884 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.78 -39.04 92.95 Favored 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 119.701 -0.799 . . . . 107.59 110.615 -175.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.827 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.02 -38.36 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 C-N-CA 119.606 -0.838 . . . . 111.61 109.509 -177.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.92 HG13 ' CD1' ' A' ' 134' ' ' ILE . 79.8 t -63.28 -22.51 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 N-CA-C 108.401 -0.963 . . . . 85.26 108.401 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.85 -41.94 99.39 Favored Glycine 0 C--N 1.349 1.283 0 N-CA-C 111.062 -0.815 . . . . 40.71 111.062 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.72 -44.06 96.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 108.412 -0.959 . . . . 95.86 108.412 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.824 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.3 p -76.93 -137.52 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 108.441 -0.948 . . . . 144.37 108.441 -176.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.904 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.6 mt -55.36 132.12 47.35 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 107.599 -1.26 . . . . 326.72 107.599 -177.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' TRP . . . . . 0.461 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.33 -168.04 1.51 Allowed 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 106.033 -1.84 . . . . 158.38 106.033 -176.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . 0.461 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.32 -41.94 98.95 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 109.661 -0.496 . . . . 36.78 109.661 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.6 m -61.13 125.85 25.22 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 119.151 -1.019 . . . . 85.46 109.82 -174.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . 0.692 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.87 126.53 8.84 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 105.542 -2.021 . . . . 127.78 105.542 176.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.927 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.03 139.9 34.82 Favored Pre-proline 0 CA--C 1.493 -1.239 0 N-CA-C 105.952 -1.87 . . . . 164.84 105.952 -179.592 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.927 ' N ' HD13 ' A' ' 228' ' ' ILE . 82.0 Cg_exo -56.8 -39.92 87.93 Favored 'Trans proline' 0 N--CA 1.431 -2.17 0 N-CA-C 113.937 0.707 . . . . 222.35 113.937 -176.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . 0.744 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.13 166.99 44.94 Favored Glycine 0 N--CA 1.428 -1.894 0 N-CA-C 106.424 -2.67 . . . . 45.22 106.424 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.882 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.94 -45.79 93.29 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 106.029 -1.841 . . . . 107.57 106.029 177.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . 0.73 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.6 m -65.76 141.81 58.2 Favored 'General case' 0 N--CA 1.429 -1.517 0 C-N-CA 118.906 -1.118 . . . . 167.96 109.153 -175.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.83 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.2 m 99.51 106.7 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 126.706 2.002 . . . . 280.68 109.734 176.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.71 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.7 m-20 56.01 11.27 0.71 Allowed 'General case' 0 N--CA 1.434 -1.274 0 C-N-CA 124.459 1.103 . . . . 218.25 110.701 174.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.921 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.38 137.62 54.78 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 105.236 -2.135 . . . . 343.57 105.236 177.395 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.56 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.6 t80 -111.97 81.9 1.54 Allowed 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 106.867 -1.531 . . . . 263.29 106.867 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' HIS . . . . . 0.626 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.4 m-70 104.29 147.05 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.283 0 C-N-CA 126.563 1.945 . . . . 261.92 108.497 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.21 -38.1 89.85 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 107.879 -1.156 . . . . 106.81 107.879 -177.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.737 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.43 -39.94 94.97 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 118.371 -1.331 . . . . 112.2 107.552 -178.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.738 HG12 ' NH1' ' A' ' 244' ' ' ARG . 75.5 t -64.26 -39.82 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.275 0 N-CA-C 109.263 -0.643 . . . . 45.41 109.263 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . 0.807 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.1 p -70.92 -32.07 68.87 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 110.264 -0.273 . . . . 97.62 110.264 -178.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.39 -39.61 81.66 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 123.696 0.799 . . . . 59.29 110.978 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.737 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.24 -36.54 83.99 Favored 'General case' 0 CA--C 1.492 -1.275 0 C-N-CA 124.658 1.183 . . . . 106.49 110.666 -174.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.921 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.96 -30.65 69.23 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 108.299 -1.0 . . . . 106.62 108.299 -176.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.533 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -66.02 -41.02 91.49 Favored 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 121.832 -0.542 . . . . 75.97 110.045 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.441 ' CG1' ' CE ' ' A' ' 250' ' ' MET . 76.6 t -65.54 -40.86 89.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 C-N-CA 122.917 0.487 . . . . 65.27 109.774 -178.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.775 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -64.0 -41.58 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 C-N-CA 120.401 -0.519 . . . . 107.94 110.162 -177.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.537 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.1 pttt -63.54 -40.81 97.98 Favored 'General case' 0 N--CA 1.434 -1.247 0 O-C-N 121.687 -0.633 . . . . 87.98 110.284 -176.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' MET . . . . . 0.822 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.65 -40.4 96.78 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 118.832 -1.147 . . . . 65.5 108.363 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' MET . . . . . 0.761 ' CE ' HG21 ' A' ' 67' ' ' THR . 68.5 mtt -61.7 -36.37 80.71 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 108.146 -1.057 . . . . 85.05 108.146 -177.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.537 HD12 ' HA ' ' A' ' 248' ' ' LYS . 86.9 mt -63.49 -45.74 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 N-CA-C 109.07 -0.715 . . . . 42.25 109.07 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . 0.822 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.34 -38.26 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 C-N-CA 119.548 -0.861 . . . . 91.01 109.402 -176.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 1.001 HG22 ' CD1' ' A' ' 304' ' ' ILE . 65.9 t -58.86 -41.54 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 N-CA-C 107.988 -1.116 . . . . 66.09 107.988 -178.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 250' ' ' MET . 94.8 t -66.09 -43.18 92.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 C-N-CA 120.754 -0.379 . . . . 52.39 110.31 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.1 m -61.74 -46.78 88.15 Favored 'General case' 0 CA--C 1.489 -1.391 0 O-C-N 121.889 -0.507 . . . . 46.42 109.866 -174.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . 0.743 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.5 t -62.33 -38.13 88.26 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 108.324 -0.991 . . . . 116.51 108.324 -177.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' PHE . . . . . 0.487 ' N ' HG23 ' A' ' 256' ' ' THR . 86.1 t80 -60.26 -48.23 82.64 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.394 -0.595 . . . . 65.18 109.394 -178.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.96 -42.68 97.2 Favored 'General case' 0 CA--C 1.49 -1.365 0 O-C-N 122.133 -0.354 . . . . 51.33 110.443 -175.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . 0.743 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.62 -43.37 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 C-N-CA 118.919 -1.112 . . . . 126.3 109.0 -176.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' CYS . . . . . 0.51 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.7 m -65.58 -49.33 69.22 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 119.529 -0.868 . . . . 133.94 112.485 -176.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.82 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.0 m95 -80.68 -33.38 35.52 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 116.856 2.169 . . . . 134.84 116.856 -176.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.784 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.9 tp -58.43 -41.62 90.27 Favored Pre-proline 0 CA--C 1.493 -1.235 0 O-C-N 121.659 -0.65 . . . . 72.23 111.643 -167.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' PRO . . . . . 0.784 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 80.7 Cg_exo -60.66 -35.98 87.1 Favored 'Trans proline' 0 C--N 1.295 -2.278 0 CA-C-N 119.848 0.981 . . . . 106.13 111.349 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' PHE . . . . . 0.851 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.7 t80 -66.41 -44.68 82.32 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 119.749 -0.78 . . . . 128.35 110.03 -178.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' HIS . . . . . 0.643 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.42 -37.88 89.06 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 110.202 -0.296 . . . . 100.73 110.202 -177.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.745 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.25 -44.56 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 C-N-CA 119.31 -0.956 . . . . 172.72 109.142 -179.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . 0.736 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.6 m-85 -66.6 -28.07 68.21 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 108.206 -1.035 . . . . 249.23 108.206 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' PHE . . . . . 0.898 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.56 -55.1 35.85 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 106.679 -1.6 . . . . 259.78 106.679 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' LEU . . . . . 0.491 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.3 mt -69.17 -44.18 72.72 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 113.588 0.959 . . . . 233.11 113.588 -176.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . 0.837 ' O ' HG13 ' A' ' 273' ' ' ILE . 88.8 mt -61.37 -48.3 91.47 Favored Pre-proline 0 N--CA 1.44 -0.968 0 C-N-CA 119.183 -1.007 . . . . 169.54 110.596 -171.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . 0.736 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.6 Cg_exo -61.13 -24.56 79.49 Favored 'Trans proline' 0 N--CA 1.43 -2.259 0 C-N-CA 116.729 -1.714 . . . . 255.47 114.66 174.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' TYR . . . . . 0.825 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.5 t80 -63.56 -44.22 94.75 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 119.225 0.921 . . . . 279.03 108.904 177.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.837 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.33 -44.79 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 110.081 -0.34 . . . . 162.21 110.081 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' ASN . . . . . 0.783 ' N ' HD12 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.41 84.87 59.33 Favored Pre-proline 0 N--CA 1.431 -1.406 0 C-N-CA 118.747 -1.181 . . . . 128.13 108.069 -178.081 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.25 164.04 11.26 Favored 'Trans proline' 0 C--N 1.295 -2.281 0 N-CA-C 107.46 -1.785 . . . . 278.35 107.46 177.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . 0.87 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.11 15.04 9.93 Favored 'General case' 0 N--CA 1.428 -1.533 0 O-C-N 123.8 0.687 . . . . 312.91 109.334 175.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.87 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.3 mt -132.71 -170.68 2.49 Favored 'General case' 0 CA--C 1.481 -1.679 0 N-CA-C 106.537 -1.653 . . . . 353.54 106.537 177.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 1.011 ' HA ' ' HB2' ' A' ' 282' ' ' PHE . 42.8 p90 -115.66 142.25 46.99 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 107.427 -1.323 . . . . 251.26 107.427 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.764 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -76.96 -118.74 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 102.081 -3.303 . . . . 175.26 102.081 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . 0.794 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.5 -44.97 96.12 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 100.878 -3.749 . . . . 99.07 100.878 172.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . 0.794 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.42 124.18 9.19 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 103.494 -2.78 . . . . 243.21 103.494 171.161 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 1.011 ' HB2' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.98 112.96 25.1 Favored 'General case' 0 CA--C 1.474 -1.979 0 C-N-CA 116.049 -2.261 . . . . 201.04 105.278 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' ILE . . . . . 0.776 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.93 173.72 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.09 0 C-N-CA 116.0 -2.28 . . . . 201.36 108.787 -175.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' GLN . . . . . 1.092 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.282 0.6 OUTLIER -59.5 -41.44 89.89 Favored 'General case' 0 N--CA 1.415 -2.179 0 CA-C-N 113.247 -1.797 . . . . 203.82 107.864 174.463 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . 0.925 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.31 -45.71 86.76 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 118.22 -1.392 . . . . 215.06 112.543 -171.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.551 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.3 t -65.68 -46.42 89.3 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.466 0 C-N-CA 118.578 -1.249 . . . . 125.28 112.912 -171.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' TYR . . . . . 0.952 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.79 -37.0 86.14 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 107.193 -1.41 . . . . 268.9 107.193 -171.883 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.798 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.22 -45.01 74.47 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 125.65 1.58 . . . . 280.88 108.795 -172.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.64 -47.48 86.05 Favored 'General case' 0 N--CA 1.428 -1.547 0 C-N-CA 118.97 -1.092 . . . . 184.47 109.002 -172.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . 0.851 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.8 mp -67.94 -42.11 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 C-N-CA 119.279 -0.968 . . . . 167.92 112.73 -175.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' MET . . . . . 0.5 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.8 ttt -65.75 -38.8 90.11 Favored 'General case' 0 CA--C 1.495 -1.144 0 C-N-CA 117.758 -1.577 . . . . 367.18 110.771 -175.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' TRP . . . . . 0.548 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.4 m95 -67.16 -32.71 73.99 Favored 'General case' 0 N--CA 1.435 -1.215 0 O-C-N 121.851 -0.531 . . . . 173.97 110.449 177.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.2 tp -64.46 -36.76 85.23 Favored 'General case' 0 CA--C 1.499 -1.011 0 C-N-CA 123.542 0.737 . . . . 119.66 109.806 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . 0.82 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.25 -33.98 74.39 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.697 -1.224 . . . . 112.3 107.697 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' MET . . . . . 0.772 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.09 -32.05 73.33 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 116.235 -0.439 . . . . 174.17 110.237 -177.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.7 m -64.73 -22.78 67.06 Favored 'General case' 0 CA--C 1.485 -1.525 0 C-N-CA 124.676 1.191 . . . . 145.27 110.608 -175.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' SER . . . . . 0.76 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.5 m -57.61 -35.38 70.37 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 108.078 -1.082 . . . . 170.15 108.078 -175.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.82 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.7 t -55.3 -34.15 63.89 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 116.315 -0.402 . . . . 214.57 110.632 -171.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . 0.751 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.1 ttt -77.2 -33.19 56.33 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 126.072 1.749 . . . . 168.29 115.544 177.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' TYR . . . . . 0.76 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.42 -34.87 79.2 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 114.056 1.132 . . . . 167.15 114.056 -168.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . 0.722 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.282 18.8 p-10 -64.21 -38.29 33.22 Favored Pre-proline 0 N--CA 1.434 -1.264 0 C-N-CA 115.515 -2.474 . . . . 165.13 113.93 -171.599 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' PRO . . . . . 0.722 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.1 Cg_exo -62.54 -31.83 80.02 Favored 'Trans proline' 0 N--CA 1.433 -2.042 0 CA-C-N 122.791 2.033 . . . . 123.92 111.251 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' ILE . . . . . 0.715 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.78 -42.53 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 C-N-CA 118.875 -1.13 . . . . 110.55 109.779 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' ILE . . . . . 1.001 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.1 pt -61.16 -40.02 84.43 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.158 0 N-CA-C 108.828 -0.804 . . . . 145.31 108.828 -177.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . 0.925 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.253 63.2 m-85 -58.11 -48.84 78.97 Favored 'General case' 0 CA--C 1.494 -1.182 0 C-N-CA 119.413 -0.915 . . . . 246.68 109.823 -177.477 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.6 m -62.19 -47.51 84.16 Favored 'General case' 0 CA--C 1.485 -1.538 0 C-N-CA 119.55 -0.86 . . . . 64.43 109.571 -173.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.8 t -66.78 -45.07 79.61 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 118.989 -1.084 . . . . 80.72 110.244 -177.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.708 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.49 -35.69 75.81 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 115.998 1.851 . . . . 140.44 115.998 -173.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . 0.658 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.83 132.23 34.34 Favored 'General case' 0 N--CA 1.434 -1.26 0 C-N-CA 112.711 -3.596 . . . . 178.87 113.056 -177.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . 0.612 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.03 -37.07 86.41 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 114.405 -1.271 . . . . 110.22 110.111 -177.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.855 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.74 -50.59 72.7 Favored 'General case' 0 CA--C 1.492 -1.256 0 O-C-N 121.752 -0.592 . . . . 174.78 109.739 -174.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.96 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.2 m-85 -64.89 -41.69 95.41 Favored 'General case' 0 CA--C 1.484 -1.579 0 N-CA-C 108.245 -1.02 . . . . 161.84 108.245 178.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . 0.518 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.33 -50.22 73.64 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 109.198 -0.667 . . . . 117.2 109.198 -173.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.799 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.51 -44.1 75.37 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 120.373 -0.531 . . . . 112.6 111.061 -177.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . 0.871 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -64.04 -37.43 94.59 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 110.646 -0.982 . . . . 101.46 110.646 -177.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' PHE . . . . . 1.018 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.7 m-85 -62.16 -45.99 90.94 Favored 'General case' 0 CA--C 1.491 -1.296 0 CA-C-N 118.492 1.146 . . . . 151.49 109.522 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . 0.422 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.1 -36.3 77.13 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 106.949 -1.501 . . . . 142.32 106.949 -175.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' HIS . . . . . 0.827 ' NE2' HG21 ' A' ' 326' ' ' ILE . 50.0 m80 -59.79 -41.82 92.01 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 106.891 -1.522 . . . . 109.09 106.891 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.85 -42.43 85.72 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.336 -0.228 . . . . 76.11 111.03 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -61.43 -55.48 30.84 Favored 'General case' 0 CA--C 1.49 -1.361 0 C-N-CA 119.87 -0.732 . . . . 120.24 109.32 -174.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . 0.578 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.4 mtt180 -74.33 131.54 41.24 Favored 'General case' 0 CA--C 1.482 -1.657 0 N-CA-C 102.935 -2.987 . . . . 192.73 102.935 177.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.16 -44.22 92.1 Favored 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 119.021 -1.072 . . . . 176.29 109.194 -172.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' CYS . . . . . 0.754 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.2 m -79.38 -177.11 0.81 Allowed Pre-proline 0 CA--C 1.487 -1.443 0 N-CA-C 106.294 -1.743 . . . . 69.68 106.294 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.569 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.6 Cg_exo -58.99 -75.58 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.389 0 C-N-CA 118.347 -0.635 . . . . 191.05 112.591 176.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' PHE . . . . . 0.754 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.5 m-85 47.49 43.88 16.25 Favored 'General case' 0 CA--C 1.493 -1.228 0 O-C-N 123.574 0.546 . . . . 287.03 109.764 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . 0.827 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.51 78.57 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.933 0 C-N-CA 112.956 -3.497 . . . . 292.29 109.839 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . 0.481 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.3 t -77.47 -152.84 0.05 Allowed 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 104.208 -2.515 . . . . 184.57 104.208 178.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.7 8.68 4.95 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 113.063 0.764 . . . . 274.56 113.063 176.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.97 0.91 57.27 Favored Glycine 0 C--N 1.348 1.228 0 C-N-CA 117.729 -2.177 . . . . 268.24 113.457 172.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' ASP . . . . . 0.699 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.7 m-20 51.6 -172.04 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.071 0 CA-C-N 118.667 1.233 . . . . 200.06 110.747 177.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.855 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.89 -33.0 74.73 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 107.879 -1.156 . . . . 114.44 107.879 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.26 46.06 21.92 Favored 'General case' 0 CA--C 1.484 -1.592 0 N-CA-C 107.625 -1.25 . . . . 263.81 107.625 -177.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' GLY . . . . . 0.634 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.32 -137.35 3.6 Favored Glycine 0 CA--C 1.479 -2.217 1 N-CA-C 102.531 -4.228 . . . . 103.79 102.531 -179.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 1.049 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.2 mt -88.28 95.62 10.25 Favored 'General case' 0 N--CA 1.419 -2.007 0 C-N-CA 114.937 -2.705 . . . . 117.3 106.016 176.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . 1.027 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.96 -39.79 90.72 Favored 'General case' 0 CA--C 1.468 -2.188 1 N-CA-C 98.004 -4.813 . . . . 231.58 98.004 167.23 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . 1.036 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.95 163.48 29.08 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 102.072 -3.307 . . . . 303.24 102.072 168.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' LYS . . . . . 1.049 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.3 tttt -62.63 -48.61 78.61 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 116.051 -2.259 . . . . 112.72 108.409 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.9 t -61.02 -63.66 1.22 Allowed 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 109.103 -0.703 . . . . 83.22 109.103 -176.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' THR . . . . . 0.883 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.1 m -156.28 -126.2 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 103.831 -2.655 . . . . 174.36 103.831 -178.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . 1.027 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.87 160.96 8.78 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 105.763 -1.94 . . . . 202.73 105.763 177.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . 1.019 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.95 149.04 52.55 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 107.064 -1.458 . . . . 180.62 107.064 176.392 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . 0.933 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.5 tp -178.51 -171.86 0.27 Allowed 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 105.394 -2.076 . . . . 145.25 105.394 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' GLN . . . . . 0.933 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.09 -43.14 88.13 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 106.127 -1.805 . . . . 66.05 106.127 174.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' THR . . . . . 0.767 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.7 -152.14 0.48 Allowed 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 103.505 -2.776 . . . . 266.49 103.505 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' GLN . . . . . 0.7 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.4 mt-30 66.31 -124.93 0.28 Allowed 'General case' 0 N--CA 1.428 -1.574 0 C-N-CA 117.033 -1.867 . . . . 219.2 107.772 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 346' ' ' GLY . . . . . 0.902 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.07 -37.4 94.13 Favored Glycine 0 N--CA 1.426 -2.032 0 CA-C-N 114.544 -1.207 . . . . 94.78 112.855 -176.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 347' ' ' SER . . . . . 0.825 ' HB2' ' H ' ' A' ' 342' ' ' LEU . 48.3 t -81.17 100.41 9.07 Favored 'General case' 0 CA--C 1.484 -1.589 0 C-N-CA 112.327 -3.749 . . . . 121.41 109.479 -171.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 348' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.5 t -73.06 145.5 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 108.953 -0.758 . . . . 85.34 108.953 -176.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 349' ' ' TYR . . . . . 0.442 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.5 p90 -57.73 143.43 41.89 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.842 -1.17 . . . . 267.57 107.842 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 350' ' ' LYS . . . . . 0.523 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.03 69.59 0.59 Allowed 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 109.539 -0.541 . . . . 226.1 109.539 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 351' ' ' VAL . . . . . 0.826 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.5 p -51.0 156.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 N-CA-C 106.993 -1.484 . . . . 154.84 106.993 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . 0.582 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.5 m -61.35 161.96 8.47 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.603 0.716 . . . . 180.01 110.711 -173.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 353' ' ' ARG . . . . . 0.893 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.46 156.92 23.66 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 106.946 -1.501 . . . . 333.78 106.946 -178.616 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 354' ' ' LEU . . . . . 0.975 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.04 142.52 48.76 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.356 -1.35 . . . . 335.2 107.356 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.975 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.5 mm-40 82.82 158.9 0.13 Allowed 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 108.74 -0.837 . . . . 266.47 108.74 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.5 m -60.61 -46.88 88.6 Favored 'General case' 0 CA--C 1.487 -1.462 0 N-CA-C 105.677 -1.972 . . . . 59.34 105.677 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.58 173.86 11.97 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 104.431 -2.433 . . . . 201.26 104.431 176.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.75 HG22 ' O ' ' A' ' 360' ' ' THR . 69.1 mt -95.91 106.71 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.555 0 C-N-CA 116.34 -2.144 . . . . 56.23 105.524 -179.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . 0.466 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.7 m -61.19 -59.47 5.28 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 109.287 -0.634 . . . . 87.58 109.287 -175.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . 0.886 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.2 t -85.5 153.76 22.24 Favored 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 107.835 -1.172 . . . . 219.95 107.835 -177.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 361' ' ' VAL . . . . . 0.587 ' O ' HG23 ' A' ' 361' ' ' VAL . 16.0 m -82.02 83.81 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 C-N-CA 116.339 -2.144 . . . . 121.79 105.452 177.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.598 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.6 t -154.11 159.74 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 N-CA-C 105.826 -1.916 . . . . 53.85 105.826 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . 0.598 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.22 16.61 77.06 Favored Glycine 0 N--CA 1.428 -1.88 0 N-CA-C 106.044 -2.822 . . . . 196.55 106.044 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.674 0 N-CA-C 107.87 -1.159 . . . . 35.88 107.87 -178.914 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 365' ' ' ARG . . . . . 0.418 ' N ' ' CD ' ' B' ' 366' ' ' PRO . 4.5 ttp180 . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 108.895 -0.78 . . . . 1.0 108.895 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 366' ' ' PRO . . . . . 0.418 ' CD ' ' N ' ' B' ' 365' ' ' ARG . 52.4 Cg_endo -66.94 141.99 60.58 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.086 1.857 . . . . 1.0 110.172 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 367' ' ' LYS . . . . . 0.738 ' HE2' ' HA ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -64.38 143.26 98.47 Favored Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 119.85 -0.74 . . . . 1.0 109.603 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 368' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -68.25 150.42 76.57 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.31 2.007 . . . . 1.0 111.759 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 369' ' ' GLN . . . . . 0.476 ' O ' ' HG3' ' B' ' 369' ' ' GLN . 0.0 OUTLIER -70.72 131.72 44.3 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.739 -0.384 . . . . 1.0 110.265 179.42 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -101.97 115.85 31.42 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.696 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 371' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -63.65 -42.39 98.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.365 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 372' ' ' PHE . . . . . 0.424 ' HD1' ' HA ' ' B' ' 372' ' ' PHE . 0.1 OUTLIER -65.01 -36.25 83.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.945 -0.57 . . . . 1.0 110.663 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -59.72 -32.98 75.69 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.869 -0.892 . . . . 1.0 110.869 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 374' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.267 0 CA-C-O 120.834 0.349 . . . . 1.0 110.154 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.429 -1.478 0 N-CA-C 108.388 -0.967 . . . . 97.08 108.388 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.731 ' ND2' ' HG3' ' B' ' 366' ' ' PRO . 46.6 t30 -110.62 155.44 22.37 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 122.07 0.938 . . . . 123.41 110.724 -172.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.881 HG11 HD13 ' A' ' 15' ' ' ILE . 28.8 m -134.6 -162.38 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.498 1 N-CA-C 100.117 -4.031 . . . . 151.3 100.117 173.741 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.909 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.1 mp -60.68 -38.58 57.96 Favored Pre-proline 0 N--CA 1.439 -0.995 0 C-N-CA 115.953 -2.299 . . . . 169.25 106.13 178.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.909 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 57.6 Cg_exo -81.26 168.49 16.73 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 122.267 0.614 . . . . 185.76 110.53 171.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.904 HG13 ' CE2' ' A' ' 282' ' ' PHE . 92.3 t -64.44 -25.87 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 C-N-CA 127.037 2.135 . . . . 145.47 110.381 -177.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.774 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.2 t0 -84.34 157.39 21.5 Favored 'General case' 0 CA--C 1.499 -1.014 0 O-C-N 121.043 -1.036 . . . . 102.76 109.473 -178.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.6 p -82.64 154.21 25.02 Favored 'General case' 0 CA--C 1.492 -1.269 0 N-CA-C 107.973 -1.121 . . . . 106.25 107.973 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.921 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.8 p-10 -105.89 51.88 0.74 Allowed 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 117.778 -1.569 . . . . 157.81 107.656 178.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.15 -45.86 91.64 Favored 'General case' 0 CA--C 1.481 -1.681 0 N-CA-C 103.593 -2.743 . . . . 150.2 103.593 178.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.4 m -87.1 164.73 34.96 Favored Pre-proline 0 N--CA 1.421 -1.899 0 N-CA-C 103.663 -2.717 . . . . 183.52 103.663 172.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -76.82 6.91 3.83 Favored 'Trans proline' 0 C--N 1.281 -2.977 0 N-CA-C 109.992 -0.811 . . . . 235.61 109.992 176.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -57.9 -41.29 82.31 Favored 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 124.813 1.245 . . . . 113.77 113.401 -170.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.921 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.3 pt -52.13 136.19 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 CA-C-N 119.517 1.053 . . . . 150.85 110.986 -176.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.46 156.28 46.41 Favored 'General case' 0 C--N 1.36 1.065 0 N-CA-C 107.631 -1.248 . . . . 100.42 107.631 178.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 1.081 HG23 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.09 142.64 58.32 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 122.009 0.909 . . . . 129.36 110.412 -174.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.774 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.06 -25.51 68.4 Favored 'General case' 0 CA--C 1.494 -1.189 0 C-N-CA 126.285 1.834 . . . . 112.34 106.677 -177.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.936 HG23 ' HA2' ' A' ' 101' ' ' GLY . 86.1 m -74.17 -40.15 62.74 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 115.567 -0.742 . . . . 131.73 111.705 177.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 1.081 ' H ' HG23 ' A' ' 17' ' ' THR . 71.3 m -84.35 -42.93 15.24 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 117.034 2.235 . . . . 80.49 117.034 -174.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.55 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.5 mt-10 -145.98 174.54 3.34 Favored Pre-proline 0 N--CA 1.443 -0.798 0 C-N-CA 118.127 -1.429 . . . . 98.98 111.191 -169.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.823 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.334 85.7 Cg_exo -61.74 -10.81 18.16 Favored 'Trans proline' 0 C--N 1.322 -0.853 1 N-CA-C 128.939 6.476 . . . . 246.95 128.939 -170.069 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.626 HD21 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.68 17.5 8.74 Favored 'General case' 0 C--N 1.325 -0.494 1 CA-C-N 126.153 4.07 . . . . 269.62 114.231 175.677 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.495 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.5 mt-30 -67.1 -27.31 67.24 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 107.838 -1.171 . . . . 86.8 107.838 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.551 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.3 p90 -66.76 -29.42 69.37 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 121.09 -1.006 . . . . 85.91 110.508 -178.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.874 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.3 t -68.48 -40.23 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 C-N-CA 123.717 0.807 . . . . 82.0 111.362 -177.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.896 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.39 167.79 12.37 Favored Pre-proline 0 CA--C 1.489 -1.398 0 N-CA-C 108.558 -0.905 . . . . 120.73 108.558 -178.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.902 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -64.04 149.76 89.79 Favored 'Trans proline' 0 N--CA 1.432 -2.116 0 C-N-CA 120.599 0.866 . . . . 87.86 109.9 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.744 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -62.99 -37.96 89.23 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 108.864 -0.791 . . . . 36.46 108.864 -176.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.813 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.9 p-90 -63.81 -33.9 76.7 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 107.797 -1.186 . . . . 150.6 107.797 -176.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.902 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.5 mt-30 -62.22 -32.67 73.37 Favored 'General case' 0 CA--C 1.491 -1.312 0 O-C-N 121.311 -0.868 . . . . 123.26 108.666 -178.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.744 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.46 -47.18 94.58 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.582 0 N-CA-C 109.166 -0.679 . . . . 120.14 109.166 176.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.786 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.3 m -67.42 -31.05 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 N-CA-C 107.855 -1.165 . . . . 112.19 107.855 -178.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.813 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.5 tp -62.96 -47.14 84.49 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 119.917 -0.713 . . . . 60.87 109.648 -178.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.672 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.0 -35.67 81.21 Favored 'General case' 0 CA--C 1.489 -1.391 0 C-N-CA 119.974 -0.69 . . . . 157.57 110.375 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.747 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.65 -40.88 98.42 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 108.591 -0.892 . . . . 47.06 108.591 178.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.806 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.79 -41.23 97.97 Favored 'General case' 0 CA--C 1.496 -1.114 0 O-C-N 121.714 -0.616 . . . . 43.94 109.558 -177.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.731 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.89 -43.26 99.2 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 108.697 -0.853 . . . . 42.61 108.697 -176.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.904 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.41 -41.23 93.85 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 116.66 -0.246 . . . . 140.66 111.029 -178.333 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.806 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.82 -43.92 97.88 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 118.579 -1.248 . . . . 116.04 110.215 -175.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.47 -38.7 83.1 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.325 0 N-CA-C 108.761 -0.829 . . . . 97.16 108.761 -177.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.854 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.1 mt -61.32 -39.97 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 N-CA-C 108.969 -0.752 . . . . 54.85 108.969 -176.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.958 HG22 HG21 ' A' ' 86' ' ' THR . 92.9 t -57.76 -42.28 81.49 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.314 0 N-CA-C 108.888 -0.782 . . . . 45.39 108.888 -175.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.431 ' O ' HG23 ' A' ' 48' ' ' VAL . 97.0 t -63.52 -51.01 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 C-N-CA 118.876 -1.13 . . . . 48.64 110.179 -177.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.751 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.6 t -65.27 -47.04 78.09 Favored 'General case' 0 N--CA 1.436 -1.175 0 C-N-CA 120.181 -0.608 . . . . 116.65 111.701 -174.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.589 ' N ' HG23 ' A' ' 45' ' ' THR . 50.7 m -62.01 -43.89 97.89 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.706 -0.479 . . . . 51.16 109.706 -174.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.3 t -65.55 -48.97 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 C-N-CA 119.88 -0.728 . . . . 44.3 110.803 -176.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.866 ' O ' HG23 ' A' ' 52' ' ' VAL . 93.9 t -64.75 -46.94 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 C-N-CA 120.266 -0.574 . . . . 48.82 111.052 -174.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.71 -44.15 95.29 Favored Glycine 0 N--CA 1.437 -1.272 0 C-N-CA 120.479 -0.867 . . . . 58.7 112.064 -174.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -72.62 -34.23 67.19 Favored 'General case' 0 CA--C 1.488 -1.439 0 O-C-N 122.071 -0.664 . . . . 101.4 110.999 -175.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.741 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.4 p -66.91 -38.71 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 107.71 -1.218 . . . . 103.57 107.71 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 48' ' ' VAL . 71.3 t -61.46 -43.03 96.08 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 108.948 -0.76 . . . . 61.89 108.948 -178.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.537 ' O ' HG22 ' A' ' 56' ' ' ILE . 82.1 t -63.47 -50.96 76.31 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 C-N-CA 120.277 -0.569 . . . . 70.01 109.47 -178.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.805 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.9 -43.38 98.96 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 109.184 -0.672 . . . . 132.1 109.184 -176.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.643 ' N ' ' HG3' ' A' ' 54' ' ' MET . 61.9 t-105 -64.21 -46.67 82.88 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 116.685 -0.234 . . . . 104.5 110.458 -176.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 1.017 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.69 -49.83 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 C-N-CA 120.192 -0.603 . . . . 142.96 111.306 -173.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.953 HD11 HG12 ' A' ' 72' ' ' VAL 0.279 24.9 pt -64.76 -41.71 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 C-N-CA 116.968 -1.893 . . . . 158.32 110.879 -176.035 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.805 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.7 -41.43 98.11 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 117.755 -1.578 . . . . 137.11 109.46 178.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.36 -44.53 91.13 Favored 'General case' 0 N--CA 1.435 -1.216 0 O-C-N 122.189 -0.319 . . . . 54.66 111.012 -176.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.922 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.44 117.13 29.42 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-O 121.633 0.73 . . . . 127.18 109.568 -174.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.619 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.83 -36.89 80.25 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 124.122 0.969 . . . . 87.93 110.78 -175.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 1.036 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.32 -34.69 78.73 Favored 'General case' 0 CA--C 1.49 -1.334 0 O-C-N 121.649 -0.657 . . . . 131.12 111.506 -175.592 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 1.018 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.63 69.45 7.14 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 115.337 -2.545 . . . . 246.56 109.612 -175.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.413 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.27 91.45 3.48 Favored 'General case' 0 CA--C 1.474 -1.958 0 N-CA-C 105.488 -2.041 . . . . 339.35 105.488 177.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.443 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.5 p -124.13 165.24 17.88 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 103.025 -2.954 . . . . 114.66 103.025 176.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.88 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.08 -39.47 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.624 0 N-CA-C 106.825 -1.546 . . . . 143.28 106.825 178.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.835 HG22 HD13 ' A' ' 71' ' ' LEU . 95.6 m -59.67 -38.03 80.36 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 108.731 -0.84 . . . . 160.22 108.731 -176.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.524 ' ND2' ' HB3' ' A' ' 63' ' ' MET . 86.3 m-20 -62.36 -31.81 72.51 Favored 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 108.866 -0.791 . . . . 120.54 108.866 -177.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.901 ' O ' HG22 ' A' ' 72' ' ' VAL . 89.8 m-85 -63.5 -43.87 95.98 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 109.484 -0.562 . . . . 67.22 109.484 178.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.88 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.5 m-85 -66.49 -39.81 88.94 Favored 'General case' 0 CA--C 1.498 -1.051 0 O-C-N 121.533 -0.729 . . . . 138.6 109.662 -177.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.923 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.54 -35.93 82.1 Favored 'General case' 0 CA--C 1.492 -1.253 0 C-N-CA 122.509 0.323 . . . . 151.46 110.648 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.953 HG12 HD11 ' A' ' 57' ' ' ILE . 24.0 m -62.54 -37.94 80.16 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.237 0 C-N-CA 117.383 -1.727 . . . . 117.93 106.739 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.449 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.1 t30 -60.11 -46.04 90.94 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.824 -1.176 . . . . 56.82 107.824 -177.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.991 HD21 ' HE1' ' A' ' 123' ' ' MET . 8.7 mp -61.3 -43.94 98.04 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 108.93 -0.767 . . . . 145.3 108.93 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.04 -40.38 95.52 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 108.527 -0.916 . . . . 45.71 108.527 -175.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -62.42 -41.99 99.11 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 109.34 -0.615 . . . . 105.61 109.34 -178.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.12 -39.48 92.69 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 108.652 -0.87 . . . . 47.89 108.652 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.588 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.57 -37.39 84.85 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 109.922 -0.399 . . . . 124.53 109.922 179.706 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.86 -41.18 99.28 Favored 'General case' 0 CA--C 1.496 -1.101 0 O-C-N 121.931 -0.481 . . . . 35.89 109.85 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.9 t -62.28 -37.28 84.92 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 107.01 -1.478 . . . . 88.97 107.01 -178.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.82 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.2 -49.19 76.77 Favored 'General case' 0 N--CA 1.428 -1.531 0 C-N-CA 119.847 -0.741 . . . . 239.91 109.026 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.62 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.35 -43.42 90.94 Favored 'General case' 0 N--CA 1.431 -1.396 0 O-C-N 121.503 -0.748 . . . . 146.1 110.593 -177.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.417 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.15 -58.24 3.4 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 117.417 -1.713 . . . . 91.74 113.877 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -76.51 -61.39 1.97 Allowed 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 115.761 1.763 . . . . 197.45 115.761 -173.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.935 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.25 -42.29 55.53 Favored 'General case' 0 CA--C 1.49 -1.348 0 C-N-CA 117.902 -1.519 . . . . 242.6 114.014 -170.009 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.958 HG21 HG22 ' A' ' 43' ' ' VAL . 4.6 t -65.35 -36.57 84.41 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 118.949 -1.1 . . . . 215.61 109.859 -172.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.423 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.3 t -60.33 -46.93 94.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 O-C-N 121.818 -0.551 . . . . 87.19 110.442 -175.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.841 HG21 ' CD2' ' A' ' 108' ' ' HIS . 63.3 t -65.91 -41.94 90.95 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.132 0 N-CA-C 109.716 -0.476 . . . . 231.82 109.716 -178.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.904 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 11.0 m120 -62.28 -34.15 76.01 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 108.296 -1.002 . . . . 364.98 108.296 -177.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.668 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.2 t80 -68.24 -44.67 75.17 Favored 'General case' 0 N--CA 1.438 -1.043 0 O-C-N 121.563 -0.71 . . . . 181.63 111.299 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.813 HG22 ' HD2' ' A' ' 95' ' ' HIS . 58.2 m -60.92 -45.75 93.42 Favored 'General case' 0 CA--C 1.478 -1.797 0 N-CA-C 107.405 -1.331 . . . . 269.02 107.405 -175.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 1.057 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.71 -45.06 93.29 Favored 'General case' 0 CA--C 1.469 -2.143 0 C-N-CA 118.694 -1.202 . . . . 562.66 109.994 -179.081 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.705 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.1 -45.25 95.46 Favored 'General case' 0 CA--C 1.479 -1.761 0 C-N-CA 118.719 -1.193 . . . . 446.75 108.098 -167.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.747 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.389 6.1 m -70.47 -26.37 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 C-N-CA 115.816 -2.354 . . . . 370.05 112.196 -178.769 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.813 ' HD2' HG22 ' A' ' 91' ' ' THR . 90.0 m-70 -74.51 -26.45 60.0 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 121.597 -0.689 . . . . 354.91 112.501 175.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.823 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.6 m-20 82.81 4.53 0.99 Allowed 'General case' 0 CA--C 1.499 -0.984 0 C-N-CA 125.075 1.35 . . . . 462.44 111.902 -178.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.774 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.267 11.9 mm-40 -172.32 178.06 2.92 Favored 'General case' 0 CA--C 1.488 -1.436 0 CA-C-O 122.02 0.914 . . . . 652.37 111.092 171.808 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.791 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.72 86.29 2.17 Favored 'General case' 0 N--CA 1.427 -1.576 0 C-N-CA 128.493 2.717 . . . . 905.99 107.931 -174.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -67.84 -36.47 80.41 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 108.254 -1.017 . . . . 570.43 108.254 -176.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.846 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.0 m-85 -62.46 -36.36 82.22 Favored 'General case' 0 N--CA 1.428 -1.531 0 C-N-CA 125.324 1.449 . . . . 453.22 111.203 -174.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.936 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.52 178.61 33.93 Favored Glycine 0 C--N 1.35 1.32 0 C-N-CA 118.744 -1.693 . . . . 445.63 109.892 177.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.656 HD11 ' CD1' ' B' ' 374' ' ' LEU . 89.1 mt -56.41 -41.19 75.93 Favored 'General case' 0 CA--C 1.498 -1.041 0 C-N-CA 125.243 1.417 . . . . 457.72 112.396 -170.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -58.62 -46.9 86.05 Favored 'General case' 0 CA--C 1.485 -1.546 0 C-N-CA 118.671 -1.212 . . . . 340.58 109.291 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.846 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.3 m-85 -68.73 -32.16 71.74 Favored 'General case' 0 N--CA 1.424 -1.751 0 C-N-CA 118.799 -1.16 . . . . 453.6 111.552 -176.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.764 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.2 t -56.08 -40.35 73.47 Favored 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 105.964 -1.865 . . . . 541.48 105.964 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.82 -47.18 75.92 Favored 'General case' 0 CA--C 1.486 -1.504 0 O-C-N 124.02 0.825 . . . . 466.68 110.826 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -61.73 -47.08 86.84 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 117.487 -1.685 . . . . 427.34 107.277 -178.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.841 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.5 m80 -67.09 -36.76 82.66 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 112.405 0.521 . . . . 537.87 112.405 -174.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.574 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.46 -42.67 74.59 Favored 'General case' 0 N--CA 1.433 -1.325 0 C-N-CA 116.869 -1.932 . . . . 422.12 111.543 175.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.856 ' O ' HG22 ' A' ' 113' ' ' ILE . 76.0 t80 -59.06 -50.14 75.2 Favored 'General case' 0 CA--C 1.502 -0.894 0 O-C-N 121.324 -0.86 . . . . 340.17 111.813 -173.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -65.25 -46.56 71.84 Favored Pre-proline 0 N--CA 1.443 -0.808 0 C-N-CA 119.109 -1.036 . . . . 258.06 111.713 -176.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.935 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.2 Cg_exo -61.47 -31.59 87.98 Favored 'Trans proline' 0 N--CA 1.434 -1.993 0 N-CA-C 115.391 1.266 . . . . 305.71 115.391 176.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.875 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.89 -40.43 76.49 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 108.701 -0.851 . . . . 252.7 108.701 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.422 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.92 -40.61 93.84 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 107.821 -1.178 . . . . 149.27 107.821 -179.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.93 -44.87 95.87 Favored 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 120.668 -0.413 . . . . 138.08 111.502 -176.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.652 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 65.0 t -66.92 -42.36 88.79 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 O-C-N 121.6 -0.688 . . . . 132.89 110.98 -177.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.924 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.6 m-85 -63.75 -44.67 92.78 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 119.752 -0.779 . . . . 193.61 108.904 -177.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.555 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.45 -37.73 84.63 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 122.85 0.46 . . . . 63.83 110.055 -175.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.7 m -64.03 -52.38 59.71 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 120.701 -0.4 . . . . 76.4 111.237 -177.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.749 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.94 -41.67 93.64 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 N-CA-C 108.175 -1.046 . . . . 171.13 108.175 -175.01 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 1.098 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.5 m-85 -63.75 -38.59 91.66 Favored 'General case' 0 N--CA 1.433 -1.315 0 O-C-N 121.814 -0.554 . . . . 78.3 110.686 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.556 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.6 t -67.09 -35.75 80.48 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 118.926 -1.11 . . . . 92.36 109.197 -178.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.991 ' HE1' HD21 ' A' ' 74' ' ' LEU . 5.9 mmt -62.55 -34.2 76.46 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 108.176 -1.046 . . . . 93.73 108.176 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.904 HG22 HG13 ' A' ' 212' ' ' ILE . 33.4 p -67.52 -41.56 84.21 Favored 'General case' 0 CA--C 1.494 -1.202 0 C-N-CA 119.171 -1.012 . . . . 132.74 109.332 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.28 -42.14 94.8 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 107.158 -1.423 . . . . 43.39 107.158 -177.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.827 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 94.8 t -58.45 -41.97 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 N-CA-C 108.633 -0.877 . . . . 59.34 108.633 -178.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.47 -44.09 95.44 Favored 'General case' 0 CA--C 1.498 -1.043 0 O-C-N 121.815 -0.553 . . . . 69.68 110.556 -177.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.468 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.2 t80 -65.44 -42.72 92.09 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.375 -0.972 . . . . 106.98 108.375 -177.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.827 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.38 -35.58 81.35 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 119.663 -0.815 . . . . 147.63 108.981 -177.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.704 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.21 -41.51 99.16 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 108.503 -0.925 . . . . 190.06 108.503 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.598 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.6 t80 -61.34 -44.05 97.84 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 108.328 -0.99 . . . . 118.85 108.328 -177.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.804 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.5 mmt -63.42 -42.63 98.73 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 110.009 -0.367 . . . . 102.5 110.009 -177.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.99 -41.63 95.23 Favored 'General case' 0 CA--C 1.488 -1.405 0 O-C-N 121.837 -0.539 . . . . 89.98 109.828 -176.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.92 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.4 mt -66.51 -50.72 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 C-N-CA 118.113 -1.435 . . . . 106.09 110.999 -177.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.75 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.05 -48.3 38.62 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.109 0 C-N-CA 117.133 -1.827 . . . . 227.74 111.86 -174.831 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.754 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 23.8 p80 -118.88 100.06 50.96 Favored Pre-proline 0 CA--C 1.486 -1.498 0 C-N-CA 116.27 -2.172 . . . . 262.55 110.032 -175.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.2 Cg_endo -69.61 -10.37 28.5 Favored 'Trans proline' 0 C--N 1.29 -2.534 0 C-N-CA 121.58 1.52 . . . . 210.25 111.335 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.706 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.26 112.03 1.0 Allowed 'General case' 0 CA--C 1.491 -1.313 0 N-CA-C 106.547 -1.649 . . . . 270.58 106.547 -178.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.891 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.76 -39.55 24.66 Favored Pre-proline 0 N--CA 1.43 -1.46 0 CA-C-N 115.361 -0.836 . . . . 129.84 112.377 -176.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.86 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 82.3 Cg_exo -61.35 -26.58 81.76 Favored 'Trans proline' 0 N--CA 1.432 -2.133 0 N-CA-C 116.291 1.612 . . . . 330.71 116.291 -174.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.754 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.03 77.19 7.95 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 114.497 -2.881 . . . . 204.51 107.263 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.876 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.73 147.4 0.09 Allowed 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 107.497 -1.297 . . . . 387.41 107.497 178.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.876 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.4 t -143.66 146.99 33.66 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 118.807 -1.157 . . . . 166.22 109.496 178.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.81 -40.8 88.19 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.873 -1.158 . . . . 44.23 107.873 176.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.484 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.5 m -60.27 -39.15 85.82 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 108.184 -1.043 . . . . 28.8 108.184 -175.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.668 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.84 -38.74 92.01 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 109.08 -0.711 . . . . 30.29 109.08 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.847 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 90.1 m -59.59 -43.06 93.8 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 108.975 -0.75 . . . . 46.11 108.975 -176.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.49 -42.09 99.26 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 107.656 -1.238 . . . . 87.33 107.656 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.77 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.4 t -61.71 -42.1 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 N-CA-C 107.894 -1.15 . . . . 23.69 107.894 -178.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.7 t -63.18 -44.31 99.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 109.686 -0.487 . . . . 43.86 109.686 -178.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.919 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.0 mm -61.28 -42.47 93.66 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 108.321 -0.992 . . . . 91.13 108.321 -176.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . 0.482 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.2 t -62.69 -37.94 88.43 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 108.715 -0.846 . . . . 65.88 108.715 -178.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.3 t -62.12 -41.84 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 N-CA-C 109.523 -0.547 . . . . 33.86 109.523 -177.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 1.098 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.42 -40.33 85.93 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.147 0 N-CA-C 107.527 -1.286 . . . . 146.52 107.527 -176.749 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . 0.699 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.1 m95 -62.85 -38.34 90.43 Favored 'General case' 0 N--CA 1.428 -1.529 0 C-N-CA 119.501 -0.88 . . . . 75.44 108.934 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.8 t -60.53 -48.42 88.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 O-C-N 121.023 -1.048 . . . . 43.64 109.711 -177.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.792 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.71 -38.01 89.5 Favored 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 109.013 -0.736 . . . . 102.57 109.013 -178.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.97 -41.05 86.62 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.437 -1.32 . . . . 58.16 107.437 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.799 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.08 -32.54 73.94 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.995 -0.743 . . . . 121.11 108.995 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.792 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.0 -42.3 84.88 Favored 'General case' 0 CA--C 1.489 -1.383 0 C-N-CA 118.594 -1.242 . . . . 153.15 109.916 -178.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 1.057 HD13 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.13 -43.68 19.04 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 113.107 -3.437 . . . . 133.67 113.515 173.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.478 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -63.01 -39.87 96.07 Favored 'General case' 0 CA--C 1.489 -1.401 0 O-C-N 120.941 -1.1 . . . . 157.42 112.242 -171.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.522 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.2 t80 -74.44 -36.1 2.44 Favored Pre-proline 0 N--CA 1.437 -1.106 0 N-CA-C 115.06 1.504 . . . . 250.91 115.06 -173.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.293 53.5 Cg_exo -59.47 -25.49 78.83 Favored 'Trans proline' 0 CA--C 1.488 -1.809 0 N-CA-C 118.015 2.275 . . . . 207.34 118.015 -174.385 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 1.011 HE21 HG13 ' A' ' 182' ' ' ILE . 87.6 mt-30 -61.16 -34.24 74.71 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.951 -1.5 . . . . 192.46 106.951 178.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.48 -41.02 98.14 Favored Glycine 0 C--N 1.353 1.499 0 N-CA-C 107.991 -2.044 . . . . 261.0 107.991 177.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.8 159.1 26.04 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 101.519 -3.511 . . . . 491.4 101.519 172.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -59.93 106.79 0.54 Allowed 'General case' 0 CA--C 1.487 -1.443 0 C-N-CA 116.281 -2.168 . . . . 386.1 109.836 -176.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.916 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 73.8 m -154.06 -166.6 2.41 Favored 'General case' 0 N--CA 1.414 -2.249 0 N-CA-C 103.531 -2.766 . . . . 289.8 103.531 -178.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 1.139 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.94 175.37 0.87 Allowed 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 117.767 -1.111 . . . . 402.06 109.566 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.788 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 73.4 p -165.22 177.5 7.59 Favored 'General case' 0 CA--C 1.586 2.361 0 C-N-CA 127.329 2.252 . . . . 690.53 114.909 177.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.488 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.8 mm-40 132.38 160.58 0.0 OUTLIER 'General case' 1 C--N 1.429 4.057 1 N-CA-C 123.149 4.5 . . . . 633.62 123.149 162.669 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.761 HG22 ' SG ' ' A' ' 180' ' ' CYS . 68.9 p -85.61 153.78 22.15 Favored 'General case' 0 C--N 1.389 2.29 0 C-N-CA 127.424 2.289 . . . . 617.99 110.892 178.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . 1.043 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.65 174.35 6.08 Favored Pre-proline 0 C--N 1.363 1.182 0 C-N-CA 130.268 3.427 . . . . 434.98 113.429 -175.499 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 1.091 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 52.7 Cg_endo -44.23 -65.67 0.18 Allowed 'Trans proline' 0 N--CA 1.442 -1.557 0 N-CA-C 122.357 3.945 . . . . 365.88 122.357 -168.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . 0.778 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.305 70.4 m -84.91 20.93 1.7 Allowed 'General case' 0 CA--C 1.467 -2.228 0 N-CA-C 104.772 -2.307 . . . . 635.81 104.772 178.197 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.75 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.456 5.0 mmp_? -94.35 152.28 18.76 Favored 'General case' 1 CA--C 1.419 -4.092 3 N-CA-C 131.969 7.766 . . . . 999.99 131.969 -135.771 . . . . . . . . 5 3 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 1.057 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.911 37.1 t -131.86 73.18 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.383 -3.797 1 CA-C-N 103.288 -6.323 . . . . 594.32 113.628 149.186 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.729 HG13 ' HB2' ' A' ' 174' ' ' MET . 7.3 p -144.21 144.11 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.642 1 N-CA-C 98.296 -4.705 . . . . 811.91 98.296 162.403 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.761 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.9 m -118.46 144.54 45.92 Favored 'General case' 0 CA--C 1.488 -1.413 0 C-N-CA 117.081 -1.848 . . . . 999.99 109.408 -178.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.971 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.8 mmm -147.21 -175.59 4.89 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-O 121.988 0.899 . . . . 431.86 110.058 -177.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 1.037 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.19 148.66 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 C-N-CA 124.345 1.058 . . . . 457.18 108.811 -177.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . 0.788 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.32 85.46 3.74 Favored 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 124.132 0.973 . . . . 458.77 113.495 -174.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.957 ' CZ3' HG22 ' A' ' 182' ' ' ILE . 1.9 p90 -76.37 -31.56 0.98 Allowed Pre-proline 0 N--CA 1.438 -1.055 0 C-N-CA 124.98 1.312 . . . . 999.99 112.425 168.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.956 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -65.94 -45.81 5.62 Favored 'Trans proline' 0 N--CA 1.437 -1.817 0 N-CA-C 120.847 3.364 . . . . 999.99 120.847 -174.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.507 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.59 171.75 8.14 Favored 'General case' 0 CA--C 1.472 -2.033 0 C-N-CA 117.156 -1.817 . . . . 81.18 107.213 -172.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.834 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.7 p-80 -109.15 45.16 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.84 0 C-N-CA 115.498 -2.481 . . . . 999.99 108.72 177.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 1.074 ' HB2' HD12 ' A' ' 191' ' ' ILE . 87.2 Cg_endo -41.58 101.8 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.146 1 C-N-CA 126.021 4.481 . . . . 999.99 105.696 -170.75 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -62.21 -44.07 97.41 Favored 'General case' 0 CA--C 1.484 -1.586 0 C-N-CA 126.755 2.022 . . . . 967.72 112.062 -165.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 190' ' ' LYS . 30.3 mmtp -60.24 -36.57 78.03 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 106.732 -1.581 . . . . 934.3 106.732 -175.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 1.074 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.57 -30.29 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 C-N-CA 129.2 3.0 . . . . 565.15 113.888 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 61.54 55.42 2.8 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-N 118.464 0.575 . . . . 755.61 109.855 -175.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 1.139 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.49 -49.27 67.16 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 124.532 1.133 . . . . 325.89 113.278 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.632 ' HE3' ' OH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.8 -44.96 78.29 Favored 'General case' 0 CA--C 1.495 -1.163 0 C-N-CA 123.537 0.735 . . . . 250.21 111.679 -169.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.5 t -64.72 -43.35 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-O 121.589 0.709 . . . . 142.46 110.389 -175.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 1.037 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.7 t80 -61.07 -41.54 96.83 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 123.986 0.914 . . . . 247.69 108.836 -173.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' HIS . . . . . 0.824 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 23.1 t60 -60.49 -51.37 69.75 Favored 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 125.45 1.5 . . . . 199.61 113.059 -175.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.1 mt -65.37 -44.42 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 107.732 -1.21 . . . . 106.73 107.732 -177.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . 0.722 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.6 t -59.21 -48.49 81.42 Favored 'General case' 0 CA--C 1.486 -1.495 0 CA-C-N 115.881 -0.599 . . . . 115.01 110.245 -173.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 1.057 HG13 HD13 ' A' ' 161' ' ' LEU . 86.2 t -65.21 -49.21 80.24 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.671 0 C-N-CA 119.428 -0.909 . . . . 129.42 111.846 -174.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . 0.793 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.9 m -61.84 -53.13 60.02 Favored 'General case' 0 CA--C 1.482 -1.651 0 C-N-CA 118.213 -1.395 . . . . 172.48 109.971 -172.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.632 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.5 t -63.9 -54.26 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 C-N-CA 120.519 -0.472 . . . . 55.86 110.946 -174.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.722 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.53 -51.54 59.13 Favored 'General case' 0 N--CA 1.432 -1.362 0 C-N-CA 118.533 -1.267 . . . . 184.68 111.541 -174.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 1.05 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.6 -52.45 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 C-N-CA 116.663 -2.015 . . . . 291.81 114.704 -174.713 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.549 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.8 t80 -82.1 -54.97 4.86 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 115.136 1.532 . . . . 130.66 115.136 -178.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . 0.793 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.7 m-85 -66.84 -48.57 68.47 Favored 'General case' 0 CA--C 1.496 -1.096 0 N-CA-C 114.473 1.286 . . . . 80.16 114.473 -170.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.894 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.48 -45.5 83.63 Favored Pre-proline 0 N--CA 1.435 -1.201 0 C-N-CA 119.97 -0.692 . . . . 136.02 109.504 -174.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.894 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.3 Cg_exo -64.82 -27.13 59.55 Favored 'Trans proline' 0 N--CA 1.433 -2.065 0 N-CA-C 110.595 -0.579 . . . . 92.17 110.595 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.686 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.29 -41.48 76.76 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 107.456 -1.312 . . . . 135.6 107.456 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.17 -44.68 91.3 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 109.555 -0.535 . . . . 52.1 109.555 -176.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.616 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.72 -43.5 97.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 109.055 -0.72 . . . . 95.89 109.055 -176.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.904 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.25 -42.39 93.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 106.699 -1.593 . . . . 43.41 106.699 -178.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.39 -42.32 99.14 Favored Glycine 0 N--CA 1.432 -1.626 0 N-CA-C 109.384 -1.487 . . . . 27.69 109.384 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . 0.887 ' O ' HG22 ' A' ' 217' ' ' THR . 78.0 t80 -65.63 -47.41 75.71 Favored 'General case' 0 CA--C 1.497 -1.086 0 O-C-N 122.209 -0.583 . . . . 54.41 110.466 -177.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . 0.827 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.43 -34.07 74.78 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 106.989 -1.485 . . . . 53.88 106.989 -177.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -60.82 -40.76 93.97 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 108.447 -0.946 . . . . 68.29 108.447 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . 0.887 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.85 -38.99 92.83 Favored 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 119.677 -0.809 . . . . 107.59 110.618 -175.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.827 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.06 -38.35 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 C-N-CA 119.615 -0.834 . . . . 111.61 109.488 -177.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.92 HG13 ' CD1' ' A' ' 134' ' ' ILE . 79.8 t -63.27 -22.51 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.392 -0.966 . . . . 85.26 108.392 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.85 -41.95 99.4 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.07 -0.812 . . . . 40.71 111.07 -176.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.5 mm -64.72 -44.0 96.53 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 N-CA-C 108.414 -0.958 . . . . 95.86 108.414 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.822 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.9 p -76.99 -137.5 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.408 -0.96 . . . . 144.37 108.408 -176.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.902 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.6 mt -55.36 132.14 47.4 Favored 'General case' 0 CA--C 1.487 -1.452 0 N-CA-C 107.63 -1.248 . . . . 326.72 107.63 -177.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' TRP . . . . . 0.462 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 9.0 t90 -119.32 -168.07 1.51 Allowed 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 106.011 -1.848 . . . . 158.38 106.011 -176.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . 0.462 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.37 -41.93 98.85 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 109.627 -0.509 . . . . 36.78 109.627 -178.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 73.0 m -61.19 125.88 25.35 Favored 'General case' 0 N--CA 1.434 -1.274 0 C-N-CA 119.115 -1.034 . . . . 85.46 109.802 -174.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . 0.693 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.86 126.54 8.85 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 105.538 -2.023 . . . . 127.78 105.538 176.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.927 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -85.99 139.89 34.89 Favored Pre-proline 0 CA--C 1.492 -1.253 0 N-CA-C 105.964 -1.865 . . . . 164.84 105.964 -179.624 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.927 ' N ' HD13 ' A' ' 228' ' ' ILE . 81.3 Cg_exo -56.8 -39.89 88.15 Favored 'Trans proline' 0 N--CA 1.431 -2.185 0 N-CA-C 113.977 0.722 . . . . 222.35 113.977 -176.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . 0.744 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.12 166.96 44.93 Favored Glycine 0 N--CA 1.427 -1.912 0 N-CA-C 106.432 -2.667 . . . . 45.22 106.432 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.882 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.8 t0 -60.93 -45.77 93.37 Favored 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 106.045 -1.835 . . . . 107.57 106.045 177.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . 0.73 ' O ' HG21 ' A' ' 228' ' ' ILE . 68.0 m -65.82 141.82 58.16 Favored 'General case' 0 N--CA 1.428 -1.539 0 C-N-CA 118.907 -1.117 . . . . 167.96 109.128 -175.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.828 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.1 m 99.53 106.73 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 126.729 2.012 . . . . 280.68 109.754 176.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.711 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.6 m-20 56.06 11.18 0.7 Allowed 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 124.417 1.087 . . . . 218.25 110.679 174.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.921 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.32 137.61 54.8 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 105.222 -2.14 . . . . 343.57 105.222 177.448 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.562 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.5 t80 -111.98 81.94 1.54 Allowed 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 106.852 -1.536 . . . . 263.29 106.852 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' HIS . . . . . 0.625 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.4 m-70 104.27 147.08 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.283 0 C-N-CA 126.602 1.961 . . . . 261.92 108.497 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.23 -38.08 89.75 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 107.882 -1.155 . . . . 106.81 107.882 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.738 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.49 -39.87 94.86 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 118.325 -1.35 . . . . 112.2 107.549 -178.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.736 HG12 ' NH1' ' A' ' 244' ' ' ARG . 75.7 t -64.32 -39.8 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 N-CA-C 109.254 -0.647 . . . . 45.41 109.254 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . 0.805 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.4 p -70.93 -32.02 68.8 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 110.296 -0.261 . . . . 97.62 110.296 -178.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.42 -39.62 81.51 Favored 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 123.713 0.805 . . . . 59.29 110.959 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.738 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.23 -36.58 84.11 Favored 'General case' 0 CA--C 1.492 -1.265 0 C-N-CA 124.722 1.209 . . . . 106.49 110.682 -174.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.921 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.95 -30.64 69.22 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 108.313 -0.995 . . . . 106.62 108.313 -176.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.531 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -66.03 -40.99 91.48 Favored 'General case' 0 N--CA 1.435 -1.175 0 O-C-N 121.821 -0.55 . . . . 75.97 110.065 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.444 ' CG1' ' HE1' ' A' ' 250' ' ' MET . 76.8 t -65.55 -40.82 89.26 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 C-N-CA 122.926 0.49 . . . . 65.27 109.815 -178.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.775 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.9 p -63.99 -41.65 93.16 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 C-N-CA 120.42 -0.512 . . . . 107.94 110.125 -177.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.536 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.1 pttt -63.55 -40.77 97.86 Favored 'General case' 0 N--CA 1.434 -1.239 0 O-C-N 121.71 -0.619 . . . . 87.98 110.286 -176.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' MET . . . . . 0.823 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.65 -40.4 96.76 Favored 'General case' 0 CA--C 1.492 -1.268 0 C-N-CA 118.849 -1.141 . . . . 65.5 108.355 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' MET . . . . . 0.772 ' HE2' ' CG2' ' A' ' 67' ' ' THR . 68.5 mtt -61.75 -36.36 80.8 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 108.095 -1.076 . . . . 85.05 108.095 -177.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.536 HD12 ' HA ' ' A' ' 248' ' ' LYS . 86.8 mt -63.5 -45.76 96.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 N-CA-C 109.032 -0.729 . . . . 42.25 109.032 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . 0.823 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.3 -38.27 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 C-N-CA 119.594 -0.842 . . . . 91.01 109.443 -176.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 1.002 HG22 ' CD1' ' A' ' 304' ' ' ILE . 65.9 t -58.9 -41.55 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 N-CA-C 107.965 -1.124 . . . . 66.09 107.965 -178.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 250' ' ' MET . 94.7 t -66.08 -43.18 92.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 C-N-CA 120.719 -0.393 . . . . 52.39 110.323 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.1 m -61.7 -46.79 88.18 Favored 'General case' 0 CA--C 1.489 -1.4 0 O-C-N 121.847 -0.533 . . . . 46.42 109.877 -174.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . 0.744 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.5 t -62.31 -38.12 88.19 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 108.322 -0.992 . . . . 116.51 108.322 -177.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' PHE . . . . . 0.488 ' N ' HG23 ' A' ' 256' ' ' THR . 86.1 t80 -60.28 -48.25 82.53 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 109.358 -0.608 . . . . 65.18 109.358 -178.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.91 -42.72 97.33 Favored 'General case' 0 CA--C 1.49 -1.358 0 CA-C-O 120.869 0.366 . . . . 51.33 110.458 -175.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . 0.744 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.57 -43.38 98.22 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.573 0 C-N-CA 118.89 -1.124 . . . . 126.3 109.038 -176.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' CYS . . . . . 0.509 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.5 m -65.6 -49.32 69.23 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 119.521 -0.872 . . . . 133.94 112.462 -176.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.82 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.0 m95 -80.68 -33.29 35.57 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 116.888 2.181 . . . . 134.84 116.888 -176.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.785 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.9 tp -58.48 -41.6 90.06 Favored Pre-proline 0 CA--C 1.493 -1.219 0 O-C-N 121.689 -0.632 . . . . 72.23 111.658 -167.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' PRO . . . . . 0.785 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 79.8 Cg_exo -60.7 -35.94 87.09 Favored 'Trans proline' 0 C--N 1.295 -2.281 0 CA-C-N 119.813 0.969 . . . . 106.13 111.368 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' PHE . . . . . 0.851 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.6 t80 -66.42 -44.69 82.27 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 119.775 -0.77 . . . . 128.35 110.045 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' HIS . . . . . 0.643 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.43 -37.83 88.9 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 110.249 -0.278 . . . . 100.73 110.249 -177.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.745 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.22 -44.6 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 C-N-CA 119.346 -0.942 . . . . 172.72 109.149 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . 0.734 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.7 m-85 -66.59 -28.03 68.19 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 108.264 -1.013 . . . . 249.23 108.264 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' PHE . . . . . 0.9 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.57 -55.14 35.4 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.687 -1.597 . . . . 259.78 106.687 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' LEU . . . . . 0.492 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.2 mt -69.17 -44.12 72.88 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 113.612 0.967 . . . . 233.11 113.612 -176.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . 0.838 ' O ' HG13 ' A' ' 273' ' ' ILE . 89.1 mt -61.37 -48.31 91.41 Favored Pre-proline 0 N--CA 1.439 -0.976 0 C-N-CA 119.155 -1.018 . . . . 169.54 110.642 -171.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . 0.734 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.9 Cg_exo -61.13 -24.49 79.34 Favored 'Trans proline' 0 N--CA 1.429 -2.276 0 C-N-CA 116.715 -1.723 . . . . 255.47 114.698 174.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' TYR . . . . . 0.824 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.6 t80 -63.58 -44.26 94.6 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 119.228 0.922 . . . . 279.03 108.854 177.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.838 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.36 -44.77 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 N-CA-C 110.056 -0.35 . . . . 162.21 110.056 -178.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' ASN . . . . . 0.781 ' N ' HD12 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.38 84.87 59.27 Favored Pre-proline 0 N--CA 1.43 -1.428 0 C-N-CA 118.775 -1.17 . . . . 128.13 108.12 -178.119 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.5 Cg_endo -85.22 164.01 11.3 Favored 'Trans proline' 0 C--N 1.294 -2.304 0 N-CA-C 107.455 -1.787 . . . . 278.35 107.455 177.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . 0.869 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.4 t0 66.12 15.01 9.92 Favored 'General case' 0 N--CA 1.428 -1.569 0 O-C-N 123.777 0.673 . . . . 312.91 109.326 175.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.869 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.3 mt -132.71 -170.67 2.49 Favored 'General case' 0 CA--C 1.481 -1.679 0 N-CA-C 106.556 -1.646 . . . . 353.54 106.556 177.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 1.009 ' HA ' ' CB ' ' A' ' 282' ' ' PHE . 42.8 p90 -115.67 142.25 46.99 Favored 'General case' 0 N--CA 1.427 -1.619 0 N-CA-C 107.439 -1.319 . . . . 251.26 107.439 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.762 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -76.97 -118.71 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 102.103 -3.295 . . . . 175.26 102.103 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . 0.796 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.5 -44.96 96.14 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 100.884 -3.747 . . . . 99.07 100.884 172.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . 0.796 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.45 124.18 9.17 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 103.45 -2.796 . . . . 243.21 103.45 171.186 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 1.009 ' CB ' ' HA ' ' A' ' 278' ' ' TYR . 77.1 t80 -93.0 112.98 25.13 Favored 'General case' 0 CA--C 1.473 -2.003 0 C-N-CA 116.065 -2.254 . . . . 201.04 105.286 178.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' ILE . . . . . 0.776 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.96 173.71 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.085 0 C-N-CA 116.004 -2.278 . . . . 201.36 108.802 -175.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' GLN . . . . . 1.091 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.283 0.6 OUTLIER -59.48 -41.44 89.8 Favored 'General case' 0 N--CA 1.415 -2.176 0 CA-C-N 113.233 -1.803 . . . . 203.82 107.896 174.462 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . 0.923 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.29 -45.72 86.77 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 118.215 -1.394 . . . . 215.06 112.553 -171.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.552 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.2 t -65.63 -46.45 89.36 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.476 0 C-N-CA 118.565 -1.254 . . . . 125.28 112.951 -171.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' TYR . . . . . 0.952 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.73 -37.04 86.23 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 107.205 -1.405 . . . . 268.9 107.205 -171.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.796 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.26 -44.97 74.41 Favored 'General case' 0 N--CA 1.427 -1.583 0 C-N-CA 125.657 1.583 . . . . 280.88 108.762 -172.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.67 -47.47 86.11 Favored 'General case' 0 N--CA 1.428 -1.564 0 C-N-CA 118.987 -1.085 . . . . 184.47 108.979 -172.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . 0.851 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.8 mp -67.94 -42.1 85.28 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 C-N-CA 119.247 -0.981 . . . . 167.92 112.739 -175.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' MET . . . . . 0.501 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.8 ttt -65.72 -38.83 90.26 Favored 'General case' 0 CA--C 1.495 -1.136 0 C-N-CA 117.751 -1.58 . . . . 367.18 110.802 -175.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' TRP . . . . . 0.548 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.5 m95 -67.14 -32.7 74.0 Favored 'General case' 0 N--CA 1.435 -1.208 0 O-C-N 121.856 -0.527 . . . . 173.97 110.466 177.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.1 tp -64.44 -36.85 85.51 Favored 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 123.6 0.76 . . . . 119.66 109.777 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . 0.82 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.16 -33.99 74.3 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 107.734 -1.21 . . . . 112.3 107.734 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' MET . . . . . 0.773 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.13 -32.04 73.33 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 116.202 -0.454 . . . . 174.17 110.237 -177.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.7 m -64.69 -22.76 67.06 Favored 'General case' 0 CA--C 1.485 -1.536 0 C-N-CA 124.629 1.171 . . . . 145.27 110.645 -175.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' SER . . . . . 0.758 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.6 m -57.65 -35.35 70.41 Favored 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 108.084 -1.08 . . . . 170.15 108.084 -175.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.82 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.7 t -55.28 -34.21 63.9 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 116.282 -0.417 . . . . 214.57 110.64 -171.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . 0.751 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.1 ttt -77.17 -33.22 56.52 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 126.065 1.746 . . . . 168.29 115.534 177.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' TYR . . . . . 0.758 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.4 p90 -64.38 -34.86 79.13 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 114.066 1.135 . . . . 167.15 114.066 -168.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . 0.723 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.282 18.8 p-10 -64.23 -38.32 33.25 Favored Pre-proline 0 N--CA 1.434 -1.266 0 C-N-CA 115.52 -2.472 . . . . 165.13 113.921 -171.59 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' PRO . . . . . 0.723 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.2 Cg_exo -62.52 -31.84 80.17 Favored 'Trans proline' 0 N--CA 1.433 -2.035 0 CA-C-N 122.755 2.019 . . . . 123.92 111.271 -178.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' ILE . . . . . 0.717 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.0 pt -68.75 -42.55 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 C-N-CA 118.869 -1.132 . . . . 110.55 109.755 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' ILE . . . . . 1.002 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.1 pt -61.2 -39.99 84.37 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.168 0 N-CA-C 108.806 -0.813 . . . . 145.31 108.806 -177.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . 0.923 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.253 63.2 m-85 -58.13 -48.78 79.17 Favored 'General case' 0 CA--C 1.493 -1.212 0 C-N-CA 119.375 -0.93 . . . . 246.68 109.837 -177.499 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 87.3 m -62.23 -47.52 84.03 Favored 'General case' 0 CA--C 1.485 -1.532 0 C-N-CA 119.549 -0.86 . . . . 64.43 109.52 -173.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.7 t -66.83 -45.01 79.61 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 118.993 -1.083 . . . . 80.72 110.226 -177.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.709 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.53 -35.69 75.7 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 115.972 1.841 . . . . 140.44 115.972 -173.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . 0.657 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.85 132.23 34.3 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 112.685 -3.606 . . . . 178.87 113.064 -177.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . 0.614 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.6 p-10 -65.03 -37.03 86.29 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 114.382 -1.281 . . . . 110.22 110.113 -177.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.856 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.75 -50.59 72.72 Favored 'General case' 0 CA--C 1.492 -1.263 0 O-C-N 121.697 -0.627 . . . . 174.78 109.765 -174.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.958 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.1 m-85 -64.87 -41.7 95.44 Favored 'General case' 0 CA--C 1.485 -1.536 0 N-CA-C 108.228 -1.027 . . . . 161.84 108.228 178.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . 0.517 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.31 -50.22 73.62 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.196 -0.668 . . . . 117.2 109.196 -173.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.797 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.54 -44.06 75.36 Favored 'General case' 0 N--CA 1.433 -1.275 0 C-N-CA 120.352 -0.539 . . . . 112.6 111.092 -177.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . 0.872 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -64.08 -37.43 94.57 Favored Glycine 0 N--CA 1.431 -1.678 0 N-CA-C 110.59 -1.004 . . . . 101.46 110.59 -177.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' PHE . . . . . 1.017 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.6 m-85 -62.17 -46.01 90.86 Favored 'General case' 0 CA--C 1.491 -1.307 0 CA-C-N 118.521 1.16 . . . . 151.49 109.523 -178.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . 0.422 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.07 -36.3 77.06 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 106.957 -1.498 . . . . 142.32 106.957 -175.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' HIS . . . . . 0.826 ' NE2' HG21 ' A' ' 326' ' ' ILE . 49.9 m80 -59.79 -41.82 92.01 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 106.903 -1.517 . . . . 109.09 106.903 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.86 -42.41 85.71 Favored 'General case' 0 N--CA 1.435 -1.177 0 O-C-N 122.334 -0.228 . . . . 76.11 111.037 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -61.46 -55.43 31.37 Favored 'General case' 0 CA--C 1.49 -1.36 0 C-N-CA 119.849 -0.74 . . . . 120.24 109.331 -174.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . 0.578 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.5 mtt180 -74.34 131.52 41.21 Favored 'General case' 0 CA--C 1.482 -1.66 0 N-CA-C 102.957 -2.979 . . . . 192.73 102.957 177.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.14 -44.24 92.05 Favored 'General case' 0 CA--C 1.492 -1.266 0 C-N-CA 119.042 -1.063 . . . . 176.29 109.153 -172.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' CYS . . . . . 0.753 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.6 m -79.37 -177.07 0.8 Allowed Pre-proline 0 CA--C 1.487 -1.453 0 N-CA-C 106.241 -1.762 . . . . 69.68 106.241 178.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.567 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.5 Cg_exo -59.08 -75.51 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.403 0 C-N-CA 118.31 -0.66 . . . . 191.05 112.614 176.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' PHE . . . . . 0.753 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.5 m-85 47.48 43.92 16.24 Favored 'General case' 0 CA--C 1.493 -1.229 0 O-C-N 123.575 0.547 . . . . 287.03 109.737 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . 0.826 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.51 78.59 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.474 -1.946 0 C-N-CA 112.992 -3.483 . . . . 292.29 109.8 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . 0.48 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.3 t -77.53 -152.81 0.05 Allowed 'General case' 0 N--CA 1.424 -1.775 0 N-CA-C 104.209 -2.515 . . . . 184.57 104.209 178.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.74 8.6 4.92 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 113.045 0.757 . . . . 274.56 113.045 176.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.97 0.91 57.26 Favored Glycine 0 C--N 1.348 1.198 0 C-N-CA 117.746 -2.168 . . . . 268.24 113.465 172.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' ASP . . . . . 0.698 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.5 m-20 51.59 -172.04 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.063 0 CA-C-N 118.677 1.239 . . . . 200.06 110.734 177.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.856 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.88 -32.98 74.68 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 107.878 -1.156 . . . . 114.44 107.878 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.28 46.04 21.92 Favored 'General case' 0 CA--C 1.484 -1.591 0 N-CA-C 107.638 -1.245 . . . . 263.81 107.638 -177.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' GLY . . . . . 0.634 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.3 -137.36 3.61 Favored Glycine 0 CA--C 1.479 -2.204 1 N-CA-C 102.556 -4.218 . . . . 103.79 102.556 -179.815 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 1.048 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.2 mt -88.26 95.54 10.22 Favored 'General case' 0 N--CA 1.419 -1.996 0 C-N-CA 114.936 -2.706 . . . . 117.3 106.018 177.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . 1.028 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.91 -39.83 90.91 Favored 'General case' 0 CA--C 1.469 -2.16 1 N-CA-C 97.994 -4.817 . . . . 231.58 97.994 167.264 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . 1.036 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.92 163.49 29.05 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 102.11 -3.293 . . . . 303.24 102.11 168.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' LYS . . . . . 1.048 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.3 tttt -62.62 -48.6 78.68 Favored 'General case' 0 N--CA 1.432 -1.365 0 C-N-CA 116.038 -2.265 . . . . 112.72 108.411 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.9 t -61.04 -63.63 1.23 Allowed 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 109.117 -0.697 . . . . 83.22 109.117 -176.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' THR . . . . . 0.884 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.1 m -156.28 -126.21 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 103.833 -2.654 . . . . 174.36 103.833 -178.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . 1.028 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.86 160.95 8.77 Favored 'General case' 0 CA--C 1.486 -1.504 0 N-CA-C 105.761 -1.94 . . . . 202.73 105.761 177.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . 1.018 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.98 149.08 52.53 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 107.046 -1.465 . . . . 180.62 107.046 176.358 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . 0.931 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.4 tp -178.52 -171.86 0.27 Allowed 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 105.409 -2.071 . . . . 145.25 105.409 178.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' GLN . . . . . 0.931 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.08 -43.17 88.11 Favored 'General case' 0 CA--C 1.487 -1.477 0 N-CA-C 106.129 -1.804 . . . . 66.05 106.129 174.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' THR . . . . . 0.766 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.1 t -132.68 -152.12 0.48 Allowed 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 103.505 -2.776 . . . . 266.49 103.505 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' GLN . . . . . 0.699 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.4 mt-30 66.27 -124.96 0.28 Allowed 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 117.043 -1.863 . . . . 219.2 107.801 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 346' ' ' GLY . . . . . 0.902 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.02 -37.43 94.23 Favored Glycine 0 N--CA 1.425 -2.044 0 CA-C-N 114.558 -1.201 . . . . 94.78 112.852 -176.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 347' ' ' SER . . . . . 0.826 ' HB2' ' H ' ' A' ' 342' ' ' LEU . 48.4 t -81.11 100.38 9.01 Favored 'General case' 0 CA--C 1.484 -1.575 0 C-N-CA 112.316 -3.753 . . . . 121.41 109.468 -171.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 348' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.8 t -72.99 145.47 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 108.997 -0.742 . . . . 85.34 108.997 -176.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 349' ' ' TYR . . . . . 0.441 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.5 p90 -57.76 143.47 41.86 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 107.839 -1.171 . . . . 267.57 107.839 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 350' ' ' LYS . . . . . 0.525 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.01 69.58 0.6 Allowed 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 109.553 -0.536 . . . . 226.1 109.553 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 351' ' ' VAL . . . . . 0.825 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.5 p -50.94 156.94 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.315 0 N-CA-C 106.994 -1.484 . . . . 154.84 106.994 177.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . 0.582 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.4 m -61.35 161.87 8.59 Favored 'General case' 0 CA--C 1.494 -1.21 0 CA-C-O 121.588 0.709 . . . . 180.01 110.722 -173.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 353' ' ' ARG . . . . . 0.895 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.41 156.92 23.6 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 106.976 -1.49 . . . . 333.78 106.976 -178.653 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 354' ' ' LEU . . . . . 0.974 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.06 142.51 48.79 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 107.364 -1.347 . . . . 335.2 107.364 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.974 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.6 mm-40 82.88 158.91 0.13 Allowed 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 108.703 -0.851 . . . . 266.47 108.703 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.8 m -60.66 -46.92 88.5 Favored 'General case' 0 CA--C 1.487 -1.465 0 N-CA-C 105.632 -1.988 . . . . 59.34 105.632 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.53 173.87 11.97 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 104.462 -2.421 . . . . 201.26 104.462 176.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.748 HG22 ' O ' ' A' ' 360' ' ' THR . 69.3 mt -95.94 106.78 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 C-N-CA 116.29 -2.164 . . . . 56.23 105.503 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . 0.464 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.9 m -61.19 -59.45 5.29 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 109.319 -0.623 . . . . 87.58 109.319 -175.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . 0.891 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.2 t -85.55 153.74 22.22 Favored 'General case' 0 CA--C 1.485 -1.535 0 N-CA-C 107.821 -1.178 . . . . 219.95 107.821 -177.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 361' ' ' VAL . . . . . 0.588 ' O ' HG23 ' A' ' 361' ' ' VAL . 16.0 m -81.98 83.85 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 C-N-CA 116.35 -2.14 . . . . 121.79 105.432 177.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.597 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.3 t -154.14 159.72 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.559 0 N-CA-C 105.78 -1.933 . . . . 53.85 105.78 -179.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . 0.597 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.2 16.62 77.02 Favored Glycine 0 N--CA 1.428 -1.889 0 N-CA-C 106.029 -2.828 . . . . 196.55 106.029 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.653 0 N-CA-C 107.883 -1.154 . . . . 35.88 107.883 -178.971 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 365' ' ' ARG . . . . . 0.512 ' HE ' ' HB3' ' B' ' 365' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 108.867 -0.79 . . . . 1.0 108.867 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 366' ' ' PRO . . . . . 0.731 ' HG3' ' ND2' ' A' ' 3' ' ' ASN . 52.3 Cg_endo -66.89 142.0 60.98 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.059 1.839 . . . . 1.0 110.195 179.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 367' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -64.46 143.29 98.53 Favored Pre-proline 0 C--N 1.324 -0.503 0 C-N-CA 119.854 -0.738 . . . . 1.0 109.545 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 368' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.25 150.39 76.56 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.312 2.008 . . . . 1.0 111.738 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 369' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.71 131.71 44.29 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.709 -0.396 . . . . 1.0 110.248 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -101.95 115.9 31.54 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.372 -0.377 . . . . 1.0 110.727 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 371' ' ' PHE . . . . . 0.405 ' HA ' HD12 ' B' ' 374' ' ' LEU . 86.1 m-85 -63.6 -42.51 98.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.318 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 372' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -65.07 -36.14 83.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.839 -0.619 . . . . 1.0 110.672 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -59.73 -33.08 76.12 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.776 -0.93 . . . . 1.0 110.776 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 374' ' ' LEU . . . . . 0.656 ' CD1' HD11 ' A' ' 102' ' ' LEU . 3.2 mt . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 120.929 0.395 . . . . 1.0 110.16 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.471 0 N-CA-C 108.398 -0.964 . . . . 97.08 108.398 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.682 ' ND2' ' HG3' ' B' ' 366' ' ' PRO . 46.5 t30 -110.62 155.43 22.38 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-O 122.172 0.987 . . . . 123.41 110.671 -172.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.881 HG11 HD13 ' A' ' 15' ' ' ILE . 28.8 m -134.56 -162.33 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.477 1 N-CA-C 100.121 -4.029 . . . . 151.3 100.121 173.72 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.908 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.69 -38.6 58.17 Favored Pre-proline 0 N--CA 1.439 -0.985 0 C-N-CA 115.961 -2.296 . . . . 169.25 106.104 178.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.908 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 57.6 Cg_exo -81.28 168.53 16.66 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 122.283 0.623 . . . . 185.76 110.568 171.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.904 HG13 ' CE2' ' A' ' 282' ' ' PHE . 91.7 t -64.5 -25.92 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 C-N-CA 127.041 2.137 . . . . 145.47 110.332 -177.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.774 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.2 t0 -84.32 157.44 21.5 Favored 'General case' 0 CA--C 1.499 -0.993 0 O-C-N 121.087 -1.008 . . . . 102.76 109.45 -178.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.6 p -82.6 154.23 25.06 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 107.943 -1.132 . . . . 106.25 107.943 178.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.921 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.7 p-10 -105.97 51.93 0.74 Allowed 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 117.763 -1.575 . . . . 157.81 107.597 178.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.22 -45.87 91.71 Favored 'General case' 0 CA--C 1.481 -1.698 0 N-CA-C 103.58 -2.748 . . . . 150.2 103.58 178.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 71.0 m -87.01 164.69 35.36 Favored Pre-proline 0 N--CA 1.421 -1.9 0 N-CA-C 103.689 -2.708 . . . . 183.52 103.689 172.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -76.75 6.86 3.84 Favored 'Trans proline' 0 C--N 1.281 -2.987 0 N-CA-C 110.011 -0.803 . . . . 235.61 110.011 176.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -57.92 -41.24 82.26 Favored 'General case' 0 N--CA 1.435 -1.198 0 C-N-CA 124.82 1.248 . . . . 113.77 113.386 -170.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.921 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.3 pt -52.22 136.26 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.912 0 CA-C-N 119.553 1.069 . . . . 150.85 110.942 -176.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.51 156.24 46.39 Favored 'General case' 0 C--N 1.36 1.06 0 N-CA-C 107.61 -1.256 . . . . 100.42 107.61 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 1.081 HG23 ' H ' ' A' ' 20' ' ' SER . 14.2 t -64.99 142.6 58.38 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 121.971 0.891 . . . . 129.36 110.449 -174.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.775 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.1 -25.5 68.39 Favored 'General case' 0 CA--C 1.494 -1.174 0 C-N-CA 126.28 1.832 . . . . 112.34 106.645 -177.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.935 HG23 ' HA2' ' A' ' 101' ' ' GLY . 85.3 m -74.11 -40.13 62.88 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 115.562 -0.744 . . . . 131.73 111.769 177.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 1.081 ' H ' HG23 ' A' ' 17' ' ' THR . 70.8 m -84.47 -42.84 15.18 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 117.006 2.225 . . . . 80.49 117.006 -174.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.549 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.4 mt-10 -145.99 174.52 3.36 Favored Pre-proline 0 N--CA 1.442 -0.827 0 C-N-CA 118.124 -1.43 . . . . 98.98 111.172 -169.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.822 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.332 85.6 Cg_exo -61.84 -10.67 18.0 Favored 'Trans proline' 0 C--N 1.321 -0.87 1 N-CA-C 128.882 6.455 . . . . 246.95 128.882 -170.053 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.626 HD21 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.58 17.52 8.65 Favored 'General case' 0 C--N 1.324 -0.519 1 CA-C-N 126.181 4.082 . . . . 269.62 114.237 175.65 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.495 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.5 mt-30 -67.1 -27.24 67.17 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 107.806 -1.183 . . . . 86.8 107.806 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.552 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.4 p90 -66.85 -29.29 69.16 Favored 'General case' 0 N--CA 1.431 -1.391 0 O-C-N 121.166 -0.959 . . . . 85.91 110.514 -178.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.872 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.4 t -68.59 -40.2 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 C-N-CA 123.734 0.814 . . . . 82.0 111.312 -177.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.897 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.41 167.73 12.48 Favored Pre-proline 0 CA--C 1.489 -1.401 0 N-CA-C 108.551 -0.907 . . . . 120.73 108.551 -178.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.904 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -64.0 149.76 89.82 Favored 'Trans proline' 0 N--CA 1.432 -2.136 0 C-N-CA 120.645 0.896 . . . . 87.86 109.912 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.743 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.03 -37.94 89.2 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.829 -0.804 . . . . 36.46 108.829 -176.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.813 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 28.0 p-90 -63.83 -33.84 76.58 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 107.837 -1.171 . . . . 150.6 107.837 -176.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.904 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.4 mt-30 -62.22 -32.66 73.35 Favored 'General case' 0 CA--C 1.49 -1.328 0 O-C-N 121.303 -0.873 . . . . 123.26 108.705 -178.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.743 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.5 -47.19 94.54 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.59 0 N-CA-C 109.162 -0.681 . . . . 120.14 109.162 176.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.785 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.3 m -67.38 -31.04 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 N-CA-C 107.865 -1.161 . . . . 112.19 107.865 -178.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.813 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.6 tp -62.99 -47.1 84.58 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 119.887 -0.725 . . . . 60.87 109.588 -178.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.672 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.04 -35.67 81.16 Favored 'General case' 0 CA--C 1.489 -1.389 0 C-N-CA 119.999 -0.681 . . . . 157.57 110.309 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.747 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.68 -40.83 98.33 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 108.617 -0.883 . . . . 47.06 108.617 178.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.805 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.8 -41.27 97.95 Favored 'General case' 0 CA--C 1.496 -1.112 0 O-C-N 121.728 -0.607 . . . . 43.94 109.535 -177.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.728 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.84 -43.31 99.1 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 108.714 -0.847 . . . . 42.61 108.714 -176.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.904 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.33 -41.29 94.11 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 116.615 -0.266 . . . . 140.66 111.018 -178.351 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.805 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.82 -43.91 97.91 Favored 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 118.547 -1.261 . . . . 116.04 110.252 -175.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.5 -38.71 83.1 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.29 0 N-CA-C 108.71 -0.848 . . . . 97.16 108.71 -177.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.855 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.2 mt -61.27 -39.99 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 108.995 -0.743 . . . . 54.85 108.995 -176.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.961 HG22 HG21 ' A' ' 86' ' ' THR . 92.6 t -57.73 -42.33 81.52 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.312 0 N-CA-C 108.864 -0.791 . . . . 45.39 108.864 -175.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 48' ' ' VAL . 97.2 t -63.56 -50.95 76.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 C-N-CA 118.875 -1.13 . . . . 48.64 110.163 -177.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.75 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.5 t -65.29 -46.99 78.21 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 120.119 -0.633 . . . . 116.65 111.731 -174.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.587 ' N ' HG23 ' A' ' 45' ' ' THR . 50.7 m -61.98 -43.96 97.74 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 109.729 -0.471 . . . . 51.16 109.729 -174.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.9 t -65.48 -48.95 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 C-N-CA 119.872 -0.731 . . . . 44.3 110.88 -177.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.866 ' O ' HG23 ' A' ' 52' ' ' VAL . 93.8 t -64.75 -46.94 90.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 C-N-CA 120.296 -0.561 . . . . 48.82 111.043 -174.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.79 -44.11 95.24 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 120.479 -0.867 . . . . 58.7 112.015 -174.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -72.67 -34.21 67.07 Favored 'General case' 0 CA--C 1.488 -1.418 0 O-C-N 122.102 -0.646 . . . . 101.4 111.014 -175.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.742 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.85 -38.77 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 107.755 -1.202 . . . . 103.57 107.755 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 48' ' ' VAL . 72.1 t -61.4 -43.04 96.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 N-CA-C 109.016 -0.735 . . . . 61.89 109.016 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.536 ' O ' HG22 ' A' ' 56' ' ' ILE . 82.1 t -63.43 -50.95 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 C-N-CA 120.284 -0.566 . . . . 70.01 109.506 -178.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.806 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.9 -43.45 98.77 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 109.142 -0.688 . . . . 132.1 109.142 -176.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.644 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.1 t-105 -64.18 -46.65 83.03 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 116.671 -0.24 . . . . 104.5 110.442 -176.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 1.015 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.68 -49.87 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 C-N-CA 120.216 -0.594 . . . . 142.96 111.244 -173.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.953 HD11 HG12 ' A' ' 72' ' ' VAL 0.278 24.8 pt -64.78 -41.67 92.82 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 C-N-CA 116.933 -1.907 . . . . 158.32 110.878 -175.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.806 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.76 -41.34 98.0 Favored 'General case' 0 N--CA 1.434 -1.273 0 C-N-CA 117.713 -1.595 . . . . 137.11 109.451 178.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.35 -44.6 90.94 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 122.128 -0.358 . . . . 54.66 110.994 -176.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.923 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.38 117.15 29.43 Favored 'General case' 0 CA--C 1.491 -1.323 0 CA-C-O 121.63 0.728 . . . . 127.18 109.572 -174.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.619 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.87 -36.79 80.09 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 124.022 0.929 . . . . 87.93 110.857 -176.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 1.036 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.38 -34.7 78.77 Favored 'General case' 0 CA--C 1.49 -1.356 0 O-C-N 121.623 -0.673 . . . . 131.12 111.467 -175.622 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 1.02 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.62 69.44 7.13 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 115.34 -2.544 . . . . 246.56 109.583 -175.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.411 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.2 91.42 3.48 Favored 'General case' 0 CA--C 1.474 -1.974 0 N-CA-C 105.514 -2.032 . . . . 339.35 105.514 177.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.445 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.5 p -124.15 165.2 17.96 Favored 'General case' 0 N--CA 1.413 -2.275 0 N-CA-C 102.987 -2.968 . . . . 114.66 102.987 176.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.879 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.07 -39.51 85.51 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.604 0 N-CA-C 106.798 -1.556 . . . . 143.28 106.798 178.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.835 HG22 HD13 ' A' ' 71' ' ' LEU . 95.1 m -59.63 -38.08 80.4 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 108.704 -0.851 . . . . 160.22 108.704 -176.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.524 ' ND2' ' HB3' ' A' ' 63' ' ' MET . 86.3 m-20 -62.3 -31.79 72.44 Favored 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 108.918 -0.771 . . . . 120.54 108.918 -177.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.9 ' O ' HG22 ' A' ' 72' ' ' VAL . 89.8 m-85 -63.61 -43.74 96.01 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 109.511 -0.552 . . . . 67.22 109.511 178.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.879 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.4 m-85 -66.56 -39.77 88.67 Favored 'General case' 0 CA--C 1.498 -1.033 0 O-C-N 121.455 -0.778 . . . . 138.6 109.659 -177.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.921 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.52 -35.95 82.17 Favored 'General case' 0 CA--C 1.492 -1.26 0 C-N-CA 122.5 0.32 . . . . 151.46 110.638 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.953 HG12 HD11 ' A' ' 57' ' ' ILE . 24.2 m -62.56 -37.98 80.29 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.225 0 C-N-CA 117.445 -1.702 . . . . 117.93 106.69 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.449 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.1 t30 -60.06 -46.01 90.97 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.833 -1.173 . . . . 56.82 107.833 -177.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.889 HD21 ' CE ' ' A' ' 123' ' ' MET . 8.7 mp -61.43 -43.83 98.18 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 108.93 -0.767 . . . . 145.3 108.93 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.13 -40.29 95.42 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 108.493 -0.929 . . . . 45.71 108.493 -175.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -62.48 -41.98 99.16 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 109.356 -0.609 . . . . 105.61 109.356 -178.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.14 -39.46 92.67 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 108.655 -0.869 . . . . 47.89 108.655 -178.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.59 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.55 -37.36 84.83 Favored 'General case' 0 N--CA 1.438 -1.042 0 O-C-N 122.08 -0.388 . . . . 124.53 109.967 179.677 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.9 -41.16 99.33 Favored 'General case' 0 N--CA 1.436 -1.14 0 O-C-N 121.912 -0.492 . . . . 35.89 109.873 -178.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.9 t -62.24 -37.37 85.14 Favored 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 106.988 -1.486 . . . . 88.97 106.988 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.82 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.13 -49.2 76.84 Favored 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 119.813 -0.755 . . . . 239.91 109.041 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.62 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.37 -43.35 91.06 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 121.487 -0.758 . . . . 146.1 110.636 -177.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.417 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.2 -58.24 3.4 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 117.374 -1.73 . . . . 91.74 113.843 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -76.49 -61.46 1.95 Allowed 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 115.739 1.755 . . . . 197.45 115.739 -173.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.936 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.23 -42.28 55.67 Favored 'General case' 0 CA--C 1.489 -1.388 0 C-N-CA 117.928 -1.509 . . . . 242.6 114.028 -170.012 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.961 HG21 HG22 ' A' ' 43' ' ' VAL . 4.6 t -65.39 -36.51 84.2 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 118.938 -1.105 . . . . 215.61 109.902 -172.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.423 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.8 t -60.39 -46.91 94.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 C-N-CA 120.31 -0.556 . . . . 87.19 110.445 -175.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.842 HG21 ' CD2' ' A' ' 108' ' ' HIS . 63.3 t -65.9 -41.83 90.76 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.124 0 N-CA-C 109.765 -0.457 . . . . 231.82 109.765 -178.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.904 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 11.0 m120 -62.34 -34.16 76.11 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.329 -0.989 . . . . 364.98 108.329 -177.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.668 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.2 t80 -68.12 -44.75 75.42 Favored 'General case' 0 N--CA 1.438 -1.074 0 O-C-N 121.496 -0.752 . . . . 181.63 111.298 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.815 HG22 ' HD2' ' A' ' 95' ' ' HIS . 58.0 m -60.83 -45.83 92.92 Favored 'General case' 0 CA--C 1.478 -1.82 0 N-CA-C 107.424 -1.324 . . . . 269.02 107.424 -175.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 1.058 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.68 -45.04 93.26 Favored 'General case' 0 CA--C 1.468 -2.178 0 C-N-CA 118.626 -1.23 . . . . 562.66 110.054 -179.061 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.704 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.12 -45.21 95.62 Favored 'General case' 0 CA--C 1.478 -1.791 0 C-N-CA 118.712 -1.195 . . . . 446.75 108.107 -167.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.747 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.386 6.0 m -70.55 -26.27 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.768 0 C-N-CA 115.824 -2.35 . . . . 370.05 112.206 -178.75 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.815 ' HD2' HG22 ' A' ' 91' ' ' THR . 89.9 m-70 -74.51 -26.44 60.0 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 121.556 -0.715 . . . . 354.91 112.518 175.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.822 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.4 m-20 82.8 4.47 0.99 Allowed 'General case' 0 CA--C 1.499 -0.988 0 C-N-CA 125.07 1.348 . . . . 462.44 111.93 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.775 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.266 11.9 mm-40 -172.34 178.05 2.92 Favored 'General case' 0 CA--C 1.488 -1.426 0 CA-C-O 122.005 0.907 . . . . 652.37 111.131 171.809 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.791 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.75 86.31 2.18 Favored 'General case' 0 N--CA 1.428 -1.564 0 C-N-CA 128.472 2.709 . . . . 905.99 107.909 -174.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -67.82 -36.43 80.37 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 108.241 -1.022 . . . . 570.43 108.241 -176.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.845 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.59 -36.35 82.45 Favored 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 125.299 1.44 . . . . 453.22 111.147 -174.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.935 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.55 178.64 33.9 Favored Glycine 0 C--N 1.35 1.324 0 C-N-CA 118.751 -1.69 . . . . 445.63 109.906 177.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.805 ' CD1' ' HG ' ' B' ' 374' ' ' LEU . 89.0 mt -56.37 -41.21 75.84 Favored 'General case' 0 CA--C 1.499 -1.005 0 C-N-CA 125.25 1.42 . . . . 457.72 112.403 -170.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -58.67 -46.92 86.16 Favored 'General case' 0 CA--C 1.485 -1.525 0 C-N-CA 118.64 -1.224 . . . . 340.58 109.3 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.845 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.2 m-85 -68.67 -32.2 71.86 Favored 'General case' 0 N--CA 1.424 -1.774 0 C-N-CA 118.765 -1.174 . . . . 453.6 111.544 -176.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.764 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.04 -40.33 73.33 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 105.972 -1.862 . . . . 541.48 105.972 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.82 -47.15 76.01 Favored 'General case' 0 CA--C 1.486 -1.484 0 O-C-N 123.945 0.778 . . . . 466.68 110.879 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -61.72 -47.12 86.7 Favored 'General case' 0 N--CA 1.427 -1.605 0 C-N-CA 117.429 -1.709 . . . . 427.34 107.334 -178.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.842 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.5 m80 -67.07 -36.74 82.69 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 112.441 0.534 . . . . 537.87 112.441 -174.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.575 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.48 -42.6 74.59 Favored 'General case' 0 N--CA 1.433 -1.323 0 C-N-CA 116.821 -1.952 . . . . 422.12 111.611 175.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.856 ' O ' HG22 ' A' ' 113' ' ' ILE . 75.9 t80 -59.1 -50.05 75.55 Favored 'General case' 0 N--CA 1.441 -0.879 0 O-C-N 121.323 -0.861 . . . . 340.17 111.846 -173.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -65.34 -46.49 70.84 Favored Pre-proline 0 N--CA 1.442 -0.848 0 C-N-CA 119.078 -1.049 . . . . 258.06 111.728 -176.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.936 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.2 Cg_exo -61.54 -31.56 87.44 Favored 'Trans proline' 0 N--CA 1.435 -1.958 0 N-CA-C 115.353 1.251 . . . . 305.71 115.353 176.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.875 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.89 -40.36 76.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 108.739 -0.838 . . . . 252.7 108.739 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.422 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.94 -40.63 94.01 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 107.806 -1.183 . . . . 149.27 107.806 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.95 -44.84 95.92 Favored 'General case' 0 N--CA 1.436 -1.155 0 C-N-CA 120.608 -0.437 . . . . 138.08 111.519 -176.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.651 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 64.9 t -66.91 -42.4 88.88 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.94 0 O-C-N 121.565 -0.71 . . . . 132.89 110.942 -177.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.924 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.74 -44.65 92.89 Favored 'General case' 0 N--CA 1.433 -1.287 0 C-N-CA 119.748 -0.781 . . . . 193.61 108.923 -177.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.556 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.51 -37.63 84.43 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 122.81 0.444 . . . . 63.83 110.121 -175.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.8 m -64.0 -52.37 59.86 Favored 'General case' 0 N--CA 1.435 -1.221 0 C-N-CA 120.712 -0.395 . . . . 76.4 111.276 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.748 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -63.01 -41.65 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 N-CA-C 108.157 -1.053 . . . . 171.13 108.157 -174.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 1.095 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.3 m-85 -63.77 -38.57 91.6 Favored 'General case' 0 N--CA 1.433 -1.294 0 O-C-N 121.846 -0.534 . . . . 78.3 110.631 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.555 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.2 t -67.04 -35.79 80.65 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 118.939 -1.104 . . . . 92.36 109.238 -178.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.976 ' HA ' ' HE2' ' A' ' 123' ' ' MET . 5.9 mmt -62.51 -34.27 76.55 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 108.151 -1.055 . . . . 93.73 108.151 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.903 HG22 HG13 ' A' ' 212' ' ' ILE . 33.2 p -67.45 -41.63 84.39 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.204 -0.998 . . . . 132.74 109.324 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.26 -42.12 94.68 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 107.203 -1.406 . . . . 43.39 107.203 -177.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.827 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 94.4 t -58.41 -42.02 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 N-CA-C 108.582 -0.895 . . . . 59.34 108.582 -178.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.48 -44.07 95.45 Favored 'General case' 0 CA--C 1.497 -1.081 0 O-C-N 121.75 -0.594 . . . . 69.68 110.525 -177.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.468 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.4 t80 -65.5 -42.73 91.81 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.36 -0.978 . . . . 106.98 108.36 -177.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.827 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.39 -35.59 81.39 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 119.622 -0.831 . . . . 147.63 108.937 -177.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.704 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.09 -41.58 99.43 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.533 -0.914 . . . . 190.06 108.533 178.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.6 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.3 t80 -61.37 -44.06 97.81 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 108.256 -1.016 . . . . 118.85 108.256 -177.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.806 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.4 mmt -63.37 -42.65 98.88 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 109.981 -0.377 . . . . 102.5 109.981 -177.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.95 -41.64 95.3 Favored 'General case' 0 CA--C 1.489 -1.383 0 O-C-N 121.813 -0.554 . . . . 89.98 109.839 -176.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.92 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.3 mt -66.55 -50.7 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.666 0 C-N-CA 118.106 -1.438 . . . . 106.09 110.975 -177.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.748 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.09 -48.34 38.25 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.091 0 C-N-CA 117.114 -1.834 . . . . 227.74 111.797 -174.787 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.754 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.1 p80 -118.79 100.07 51.06 Favored Pre-proline 0 CA--C 1.486 -1.51 0 C-N-CA 116.249 -2.18 . . . . 262.55 110.07 -175.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.2 Cg_endo -69.63 -10.33 28.39 Favored 'Trans proline' 0 C--N 1.29 -2.548 0 C-N-CA 121.622 1.548 . . . . 210.25 111.366 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.705 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.32 112.07 1.01 Allowed 'General case' 0 CA--C 1.49 -1.34 0 N-CA-C 106.505 -1.665 . . . . 270.58 106.505 -178.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.891 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.87 -39.5 23.44 Favored Pre-proline 0 N--CA 1.431 -1.418 0 CA-C-N 115.355 -0.839 . . . . 129.84 112.295 -175.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.86 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 82.1 Cg_exo -61.43 -26.56 81.39 Favored 'Trans proline' 0 N--CA 1.431 -2.185 0 N-CA-C 116.287 1.611 . . . . 330.71 116.287 -174.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.754 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.02 77.23 7.94 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 114.513 -2.875 . . . . 204.51 107.29 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.876 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.7 147.41 0.09 Allowed 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.485 -1.302 . . . . 387.41 107.485 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.876 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.5 t -143.71 147.07 33.7 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 118.763 -1.175 . . . . 166.22 109.431 178.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.9 -40.76 87.81 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 107.806 -1.183 . . . . 44.23 107.806 176.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.485 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.3 m -60.25 -39.18 85.87 Favored 'General case' 0 CA--C 1.492 -1.285 0 N-CA-C 108.157 -1.053 . . . . 28.8 108.157 -175.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.667 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.81 -38.76 91.98 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 109.084 -0.71 . . . . 30.29 109.084 -179.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.847 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 89.9 m -59.66 -43.01 94.12 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 108.964 -0.754 . . . . 46.11 108.964 -176.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.4 -42.18 99.23 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 107.713 -1.217 . . . . 87.33 107.713 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.77 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.5 t -61.69 -42.05 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 N-CA-C 107.952 -1.129 . . . . 23.69 107.952 -178.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.8 t -63.18 -44.32 99.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 N-CA-C 109.672 -0.492 . . . . 43.86 109.672 -178.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.919 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.1 mm -61.23 -42.57 93.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 N-CA-C 108.334 -0.987 . . . . 91.13 108.334 -176.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . 0.482 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.1 t -62.56 -37.99 88.3 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 108.712 -0.848 . . . . 65.88 108.712 -178.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.1 t -62.09 -41.87 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 N-CA-C 109.529 -0.545 . . . . 33.86 109.529 -177.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 1.095 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.35 -40.32 85.79 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.171 0 N-CA-C 107.576 -1.268 . . . . 146.52 107.576 -176.786 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . 0.699 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.1 m95 -62.9 -38.35 90.57 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 119.483 -0.887 . . . . 75.44 108.849 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.9 t -60.54 -48.47 88.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 O-C-N 121.073 -1.017 . . . . 43.64 109.699 -177.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.793 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.64 -37.99 89.41 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 109.068 -0.716 . . . . 102.57 109.068 -178.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.01 -41.05 86.79 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.433 -1.321 . . . . 58.16 107.433 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.798 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.12 -32.44 73.83 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 109.045 -0.724 . . . . 121.11 109.045 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.793 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.04 -42.33 85.16 Favored 'General case' 0 CA--C 1.489 -1.404 0 C-N-CA 118.567 -1.253 . . . . 153.15 109.938 -178.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 1.056 HD13 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.05 -43.72 19.11 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 113.154 -3.419 . . . . 133.67 113.545 173.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.479 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -63.01 -39.88 96.09 Favored 'General case' 0 CA--C 1.49 -1.352 0 O-C-N 120.951 -1.093 . . . . 157.42 112.189 -171.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.523 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.3 t80 -74.45 -36.07 2.43 Favored Pre-proline 0 N--CA 1.436 -1.129 0 N-CA-C 115.056 1.502 . . . . 250.91 115.056 -173.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.523 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.291 52.1 Cg_exo -59.59 -25.43 78.82 Favored 'Trans proline' 0 CA--C 1.489 -1.736 0 N-CA-C 117.968 2.257 . . . . 207.34 117.968 -174.331 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 1.009 HE21 HG13 ' A' ' 182' ' ' ILE . 87.6 mt-30 -61.2 -34.16 74.63 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 106.967 -1.494 . . . . 192.46 106.967 178.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.5 -41.07 98.11 Favored Glycine 0 C--N 1.353 1.513 0 N-CA-C 107.949 -2.06 . . . . 261.0 107.949 177.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.8 159.1 26.03 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 101.466 -3.531 . . . . 491.4 101.466 172.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -59.89 106.76 0.53 Allowed 'General case' 0 CA--C 1.488 -1.422 0 C-N-CA 116.239 -2.184 . . . . 386.1 109.849 -176.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.917 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 74.0 m -153.99 -166.6 2.42 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 103.583 -2.747 . . . . 289.8 103.583 -178.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 1.14 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.97 175.47 0.86 Allowed 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 117.748 -1.12 . . . . 402.06 109.555 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.789 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 73.6 p -165.27 177.53 7.54 Favored 'General case' 0 CA--C 1.586 2.363 0 C-N-CA 127.308 2.243 . . . . 690.53 114.912 177.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.488 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 40.0 mm-40 132.33 160.53 0.0 OUTLIER 'General case' 1 C--N 1.43 4.066 1 N-CA-C 123.195 4.517 . . . . 633.62 123.195 162.673 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.761 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.1 p -85.59 153.85 22.12 Favored 'General case' 0 C--N 1.389 2.283 0 C-N-CA 127.413 2.285 . . . . 617.99 110.886 178.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . 1.04 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.7 174.37 6.04 Favored Pre-proline 0 C--N 1.363 1.18 0 C-N-CA 130.304 3.442 . . . . 434.98 113.433 -175.433 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 1.092 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 51.8 Cg_endo -44.26 -65.63 0.19 Allowed 'Trans proline' 0 N--CA 1.441 -1.569 0 N-CA-C 122.414 3.967 . . . . 365.88 122.414 -168.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . 0.778 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.304 70.8 m -84.87 20.92 1.69 Allowed 'General case' 0 CA--C 1.467 -2.249 0 N-CA-C 104.812 -2.292 . . . . 635.81 104.812 178.102 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.749 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.458 5.0 mmp_? -94.35 152.16 18.85 Favored 'General case' 1 CA--C 1.419 -4.066 3 N-CA-C 131.952 7.76 . . . . 999.99 131.952 -135.714 . . . . . . . . 5 3 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 1.058 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.91 37.0 t -131.84 73.2 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.763 1 CA-C-N 103.288 -6.324 . . . . 594.32 113.611 149.169 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.729 HG13 ' HB2' ' A' ' 174' ' ' MET . 7.4 p -144.2 144.1 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.599 1 N-CA-C 98.285 -4.709 . . . . 811.91 98.285 162.382 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.761 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.8 m -118.49 144.52 45.96 Favored 'General case' 0 CA--C 1.488 -1.409 0 C-N-CA 117.014 -1.874 . . . . 999.99 109.42 -178.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.973 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.7 mmm -147.19 -175.6 4.89 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-O 122.0 0.905 . . . . 431.86 110.055 -177.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 1.037 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.3 tt -69.15 148.73 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 C-N-CA 124.31 1.044 . . . . 457.18 108.782 -177.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . 0.789 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.32 85.44 3.74 Favored 'General case' 0 CA--C 1.5 -0.955 0 C-N-CA 124.155 0.982 . . . . 458.77 113.527 -174.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.956 ' CZ3' HG22 ' A' ' 182' ' ' ILE . 1.9 p90 -76.4 -31.57 0.97 Allowed Pre-proline 0 N--CA 1.438 -1.058 0 C-N-CA 124.992 1.317 . . . . 999.99 112.384 168.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.955 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.2 Cg_exo -65.96 -45.77 5.64 Favored 'Trans proline' 0 N--CA 1.438 -1.79 0 N-CA-C 120.883 3.378 . . . . 999.99 120.883 -174.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.508 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 54.9 mt-10 -119.56 171.78 8.12 Favored 'General case' 0 CA--C 1.471 -2.066 0 C-N-CA 117.129 -1.829 . . . . 81.18 107.239 -172.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.834 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.7 p-80 -109.16 45.16 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.865 0 CA-C-O 114.875 -2.488 . . . . 999.99 108.703 177.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 1.076 ' HB2' HD12 ' A' ' 191' ' ' ILE . 88.3 Cg_endo -41.57 101.86 0.04 OUTLIER 'Trans proline' 0 CA--C 1.502 -1.121 1 C-N-CA 126.071 4.514 . . . . 999.99 105.634 -170.745 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -62.28 -44.01 97.5 Favored 'General case' 0 CA--C 1.483 -1.597 0 C-N-CA 126.726 2.01 . . . . 967.72 112.059 -165.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . 0.402 ' HD3' ' HA ' ' A' ' 190' ' ' LYS . 30.3 mmtp -60.28 -36.55 78.08 Favored 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 106.724 -1.584 . . . . 934.3 106.724 -175.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 1.076 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.65 -30.16 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 C-N-CA 129.167 2.987 . . . . 565.15 113.925 -178.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 61.54 55.31 2.82 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-N 118.425 0.557 . . . . 755.61 109.903 -175.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 1.14 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.44 -49.29 67.19 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 124.57 1.148 . . . . 325.89 113.26 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.633 ' HE3' ' OH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.8 -44.97 78.31 Favored 'General case' 0 CA--C 1.495 -1.17 0 C-N-CA 123.558 0.743 . . . . 250.21 111.631 -169.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 98.0 t -64.75 -43.28 96.52 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 CA-C-O 121.595 0.712 . . . . 142.46 110.383 -175.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 1.037 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.8 t80 -61.19 -41.46 96.85 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 123.985 0.914 . . . . 247.69 108.821 -173.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' HIS . . . . . 0.824 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 23.1 t60 -60.55 -51.33 69.89 Favored 'General case' 0 CA--C 1.491 -1.292 0 C-N-CA 125.411 1.484 . . . . 199.61 113.081 -175.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 82.7 mt -65.34 -44.46 94.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 N-CA-C 107.759 -1.201 . . . . 106.73 107.759 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . 0.722 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.7 t -59.17 -48.53 81.27 Favored 'General case' 0 CA--C 1.487 -1.473 0 CA-C-N 115.801 -0.636 . . . . 115.01 110.214 -173.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 1.056 HG13 HD13 ' A' ' 161' ' ' LEU . 85.6 t -65.25 -49.18 80.31 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.655 0 C-N-CA 119.418 -0.913 . . . . 129.42 111.818 -174.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . 0.793 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.4 m -61.85 -53.12 60.16 Favored 'General case' 0 CA--C 1.483 -1.612 0 C-N-CA 118.228 -1.389 . . . . 172.48 109.968 -172.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.631 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.5 t -63.89 -54.29 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 C-N-CA 120.539 -0.465 . . . . 55.86 110.933 -174.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.722 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.57 -51.53 59.07 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.56 -1.256 . . . . 184.68 111.489 -174.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 1.05 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.62 -52.37 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 C-N-CA 116.637 -2.025 . . . . 291.81 114.757 -174.706 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.548 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.8 t80 -82.05 -55.0 4.84 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 115.16 1.541 . . . . 130.66 115.16 -178.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . 0.793 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.8 m-85 -66.88 -48.49 68.61 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 114.515 1.302 . . . . 80.16 114.515 -170.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.894 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.54 -45.5 83.29 Favored Pre-proline 0 N--CA 1.435 -1.196 0 C-N-CA 119.981 -0.688 . . . . 136.02 109.494 -174.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.894 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.8 Cg_exo -64.8 -27.16 59.72 Favored 'Trans proline' 0 N--CA 1.432 -2.105 0 CA-C-N 118.703 0.572 . . . . 92.17 110.622 -179.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.688 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.3 -41.39 76.82 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 107.501 -1.296 . . . . 135.6 107.501 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.17 -44.7 91.26 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 109.563 -0.532 . . . . 52.1 109.563 -176.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.618 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.67 -43.54 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 N-CA-C 109.063 -0.718 . . . . 95.89 109.063 -176.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.903 HG13 HG22 ' A' ' 124' ' ' THR . 94.5 mt -61.28 -42.36 93.23 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.398 0 N-CA-C 106.684 -1.599 . . . . 43.41 106.684 -178.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.44 -42.25 99.09 Favored Glycine 0 N--CA 1.432 -1.606 0 N-CA-C 109.376 -1.49 . . . . 27.69 109.376 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . 0.886 ' O ' HG22 ' A' ' 217' ' ' THR . 77.9 t80 -65.66 -47.42 75.59 Favored 'General case' 0 CA--C 1.497 -1.094 0 O-C-N 122.213 -0.581 . . . . 54.41 110.483 -177.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . 0.828 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.42 -34.11 74.83 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 106.955 -1.498 . . . . 53.88 106.955 -177.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -60.74 -40.89 94.06 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 108.49 -0.929 . . . . 68.29 108.49 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . 0.886 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.67 -39.12 93.12 Favored 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 119.721 -0.792 . . . . 107.59 110.631 -175.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.828 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.02 -38.39 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 C-N-CA 119.605 -0.838 . . . . 111.61 109.481 -177.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.92 HG13 ' CD1' ' A' ' 134' ' ' ILE . 79.3 t -63.28 -22.48 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.372 -0.973 . . . . 85.26 108.372 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.87 -41.94 99.43 Favored Glycine 0 C--N 1.349 1.265 0 N-CA-C 111.07 -0.812 . . . . 40.71 111.07 -176.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.5 mm -64.76 -44.05 96.47 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 N-CA-C 108.378 -0.971 . . . . 95.86 108.378 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.823 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.6 p -76.93 -137.52 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 108.434 -0.95 . . . . 144.37 108.434 -176.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.902 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.6 mt -55.38 132.11 47.38 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 107.573 -1.269 . . . . 326.72 107.573 -177.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' TRP . . . . . 0.461 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.35 -168.05 1.51 Allowed 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 106.013 -1.847 . . . . 158.38 106.013 -176.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . 0.461 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.27 -42.01 99.09 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 109.649 -0.5 . . . . 36.78 109.649 -178.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.6 m -61.06 125.82 25.12 Favored 'General case' 0 N--CA 1.434 -1.271 0 C-N-CA 119.198 -1.001 . . . . 85.46 109.793 -174.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . 0.693 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.89 126.55 8.83 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 105.58 -2.008 . . . . 127.78 105.58 176.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.927 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.04 139.9 34.78 Favored Pre-proline 0 CA--C 1.493 -1.236 0 N-CA-C 105.982 -1.859 . . . . 164.84 105.982 -179.576 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.927 ' N ' HD13 ' A' ' 228' ' ' ILE . 83.4 Cg_exo -56.8 -39.93 87.87 Favored 'Trans proline' 0 N--CA 1.431 -2.16 0 N-CA-C 113.914 0.698 . . . . 222.35 113.914 -175.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . 0.745 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.11 167.02 45.01 Favored Glycine 0 N--CA 1.428 -1.899 0 N-CA-C 106.446 -2.662 . . . . 45.22 106.446 178.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.882 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.99 -45.71 93.7 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 106.065 -1.828 . . . . 107.57 106.065 177.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . 0.732 ' O ' HG21 ' A' ' 228' ' ' ILE . 68.1 m -65.82 141.83 58.15 Favored 'General case' 0 N--CA 1.429 -1.525 0 C-N-CA 118.89 -1.124 . . . . 167.96 109.155 -175.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.828 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.6 m 99.52 106.64 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.219 0 C-N-CA 126.695 1.998 . . . . 280.68 109.761 176.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.712 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.7 m-20 56.05 11.28 0.71 Allowed 'General case' 0 N--CA 1.433 -1.279 0 C-N-CA 124.492 1.117 . . . . 218.25 110.702 174.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.922 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.38 137.64 54.78 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 105.243 -2.132 . . . . 343.57 105.243 177.412 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.563 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.6 t80 -111.99 81.84 1.53 Allowed 'General case' 0 CA--C 1.491 -1.323 0 N-CA-C 106.871 -1.529 . . . . 263.29 106.871 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' HIS . . . . . 0.626 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.4 m-70 104.31 147.09 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 126.607 1.963 . . . . 261.92 108.511 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.25 -38.13 89.94 Favored 'General case' 0 CA--C 1.488 -1.415 0 N-CA-C 107.822 -1.177 . . . . 106.81 107.822 -177.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.737 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.42 -39.92 94.87 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 118.348 -1.341 . . . . 112.2 107.58 -178.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.736 HG12 ' NH1' ' A' ' 244' ' ' ARG . 75.2 t -64.26 -39.81 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 109.285 -0.635 . . . . 45.41 109.285 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . 0.806 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.2 p -70.95 -32.04 68.8 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 110.269 -0.271 . . . . 97.62 110.269 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.43 -39.56 81.5 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 123.65 0.78 . . . . 59.29 110.981 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.737 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.31 -36.47 83.81 Favored 'General case' 0 CA--C 1.491 -1.292 0 C-N-CA 124.655 1.182 . . . . 106.49 110.647 -174.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.922 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -60.0 -30.58 69.23 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 108.331 -0.988 . . . . 106.62 108.331 -176.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.531 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -66.09 -41.0 91.25 Favored 'General case' 0 N--CA 1.436 -1.175 0 O-C-N 121.84 -0.537 . . . . 75.97 110.052 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.444 ' CG1' ' HE1' ' A' ' 250' ' ' MET . 77.0 t -65.55 -40.84 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 C-N-CA 122.957 0.503 . . . . 65.27 109.804 -178.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.775 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.7 p -63.99 -41.58 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 C-N-CA 120.385 -0.526 . . . . 107.94 110.186 -177.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.536 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.2 pttt -63.55 -40.78 97.9 Favored 'General case' 0 N--CA 1.434 -1.259 0 O-C-N 121.679 -0.638 . . . . 87.98 110.31 -176.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' MET . . . . . 0.823 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.64 -40.42 96.81 Favored 'General case' 0 N--CA 1.434 -1.247 0 C-N-CA 118.875 -1.13 . . . . 65.5 108.329 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' MET . . . . . 0.773 ' HE2' ' CG2' ' A' ' 67' ' ' THR . 68.5 mtt -61.73 -36.33 80.66 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 108.169 -1.049 . . . . 85.05 108.169 -177.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.536 HD12 ' HA ' ' A' ' 248' ' ' LYS . 86.7 mt -63.48 -45.76 96.97 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 N-CA-C 109.082 -0.711 . . . . 42.25 109.082 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . 0.823 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.26 -38.31 82.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 C-N-CA 119.556 -0.858 . . . . 91.01 109.43 -176.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 1.001 HG22 ' CD1' ' A' ' 304' ' ' ILE . 65.8 t -58.88 -41.48 83.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 N-CA-C 107.998 -1.112 . . . . 66.09 107.998 -178.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 250' ' ' MET . 94.7 t -66.17 -43.12 92.17 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.363 0 O-C-N 122.089 -0.382 . . . . 52.39 110.287 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.4 m -61.73 -46.83 87.96 Favored 'General case' 0 CA--C 1.489 -1.393 0 O-C-N 121.851 -0.531 . . . . 46.42 109.858 -174.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . 0.745 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.5 t -62.3 -38.1 88.09 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 108.335 -0.987 . . . . 116.51 108.335 -177.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' PHE . . . . . 0.488 ' N ' HG23 ' A' ' 256' ' ' THR . 86.0 t80 -60.32 -48.2 82.78 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.365 -0.606 . . . . 65.18 109.365 -178.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.99 -42.68 97.12 Favored 'General case' 0 CA--C 1.489 -1.385 0 O-C-N 122.107 -0.371 . . . . 51.33 110.429 -175.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . 0.745 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.6 -43.45 98.21 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 C-N-CA 118.968 -1.093 . . . . 126.3 108.938 -176.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' CYS . . . . . 0.509 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.8 m -65.51 -49.35 69.31 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.524 -0.87 . . . . 133.94 112.513 -176.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.82 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.0 m95 -80.72 -33.34 35.34 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 116.819 2.155 . . . . 134.84 116.819 -176.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.786 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.6 tp -58.43 -41.61 90.17 Favored Pre-proline 0 CA--C 1.493 -1.222 0 CA-C-N 118.641 0.655 . . . . 72.23 111.671 -167.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' PRO . . . . . 0.786 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 81.3 Cg_exo -60.67 -36.02 86.89 Favored 'Trans proline' 0 C--N 1.294 -2.309 0 CA-C-N 119.822 0.972 . . . . 106.13 111.357 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' PHE . . . . . 0.852 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.6 t80 -66.32 -44.71 82.61 Favored 'General case' 0 N--CA 1.433 -1.3 0 C-N-CA 119.769 -0.772 . . . . 128.35 110.056 -178.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' HIS . . . . . 0.64 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.4 m-70 -64.41 -37.86 88.99 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 110.244 -0.28 . . . . 100.73 110.244 -177.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.746 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.29 -44.51 94.92 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 C-N-CA 119.257 -0.977 . . . . 172.72 109.126 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . 0.734 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.5 m-85 -66.62 -28.12 68.24 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 108.17 -1.048 . . . . 249.23 108.17 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' PHE . . . . . 0.899 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.52 -55.14 35.37 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 106.698 -1.593 . . . . 259.78 106.698 178.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' LEU . . . . . 0.492 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.5 mt -69.13 -44.17 72.88 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 113.611 0.967 . . . . 233.11 113.611 -176.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . 0.837 ' O ' HG13 ' A' ' 273' ' ' ILE . 88.6 mt -61.4 -48.31 91.28 Favored Pre-proline 0 N--CA 1.44 -0.947 0 C-N-CA 119.13 -1.028 . . . . 169.54 110.567 -171.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . 0.734 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 12.0 Cg_exo -61.05 -24.59 79.8 Favored 'Trans proline' 0 N--CA 1.429 -2.302 0 C-N-CA 116.756 -1.696 . . . . 255.47 114.7 174.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' TYR . . . . . 0.824 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.6 t80 -63.58 -44.22 94.69 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 119.232 0.924 . . . . 279.03 108.874 177.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.837 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.33 -44.76 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 N-CA-C 110.104 -0.332 . . . . 162.21 110.104 -178.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' ASN . . . . . 0.779 ' N ' HD12 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.45 84.88 59.4 Favored Pre-proline 0 N--CA 1.43 -1.432 0 C-N-CA 118.73 -1.188 . . . . 128.13 108.064 -178.078 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.3 Cg_endo -85.3 164.08 11.19 Favored 'Trans proline' 0 C--N 1.295 -2.268 0 N-CA-C 107.44 -1.792 . . . . 278.35 107.44 177.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . 0.868 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.2 t0 66.06 15.06 9.93 Favored 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 123.83 0.706 . . . . 312.91 109.335 175.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.868 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.3 mt -132.69 -170.66 2.48 Favored 'General case' 0 CA--C 1.481 -1.675 0 N-CA-C 106.531 -1.655 . . . . 353.54 106.531 177.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 1.007 ' HA ' ' CB ' ' A' ' 282' ' ' PHE . 42.8 p90 -115.68 142.23 47.03 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 107.398 -1.334 . . . . 251.26 107.398 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.761 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -76.98 -118.81 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 102.024 -3.324 . . . . 175.26 102.024 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . 0.794 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.46 -44.97 96.17 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 100.883 -3.747 . . . . 99.07 100.883 172.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . 0.794 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.43 124.18 9.18 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 103.46 -2.793 . . . . 243.21 103.46 171.173 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 1.007 ' CB ' ' HA ' ' A' ' 278' ' ' TYR . 77.3 t80 -92.97 112.99 25.14 Favored 'General case' 0 CA--C 1.473 -1.982 0 C-N-CA 116.007 -2.277 . . . . 201.04 105.265 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' ILE . . . . . 0.777 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.94 173.72 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.071 0 C-N-CA 116.001 -2.279 . . . . 201.36 108.768 -175.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' GLN . . . . . 1.092 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.284 0.6 OUTLIER -59.54 -41.42 90.03 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-N 113.243 -1.799 . . . . 203.82 107.864 174.447 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . 0.921 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.26 -45.71 86.89 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 118.226 -1.389 . . . . 215.06 112.576 -171.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.552 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.0 t -65.69 -46.42 89.26 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.473 0 C-N-CA 118.587 -1.245 . . . . 125.28 112.903 -171.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' TYR . . . . . 0.952 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.78 -37.05 86.29 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 107.155 -1.424 . . . . 268.9 107.155 -171.861 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.798 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.16 -45.05 74.56 Favored 'General case' 0 CA--C 1.483 -1.607 0 C-N-CA 125.63 1.572 . . . . 280.88 108.821 -172.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.6 -47.43 86.24 Favored 'General case' 0 CA--C 1.484 -1.564 0 C-N-CA 118.947 -1.101 . . . . 184.47 109.087 -172.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . 0.852 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.8 mp -67.98 -42.11 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 C-N-CA 119.263 -0.975 . . . . 167.92 112.732 -175.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' MET . . . . . 0.5 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.7 ttt -65.72 -38.76 90.07 Favored 'General case' 0 CA--C 1.495 -1.136 0 C-N-CA 117.784 -1.566 . . . . 367.18 110.822 -175.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' TRP . . . . . 0.548 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.4 m95 -67.22 -32.67 73.87 Favored 'General case' 0 N--CA 1.435 -1.197 0 O-C-N 121.872 -0.517 . . . . 173.97 110.448 177.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.4 tp -64.49 -36.71 85.09 Favored 'General case' 0 CA--C 1.499 -0.986 0 C-N-CA 123.509 0.724 . . . . 119.66 109.797 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . 0.82 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.23 -34.03 74.46 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 107.711 -1.218 . . . . 112.3 107.711 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' MET . . . . . 0.772 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.03 -32.11 73.4 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 116.211 -0.45 . . . . 174.17 110.222 -177.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.9 m -64.67 -22.8 67.07 Favored 'General case' 0 CA--C 1.486 -1.507 0 C-N-CA 124.648 1.179 . . . . 145.27 110.606 -175.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' SER . . . . . 0.758 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.7 m -57.67 -35.33 70.41 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 108.043 -1.095 . . . . 170.15 108.043 -175.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.82 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.8 t -55.33 -34.16 63.97 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 116.324 -0.398 . . . . 214.57 110.61 -171.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . 0.75 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.1 ttt -77.16 -33.19 56.58 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 126.108 1.763 . . . . 168.29 115.539 177.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' TYR . . . . . 0.758 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.44 -34.84 79.14 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 114.072 1.138 . . . . 167.15 114.072 -168.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . 0.723 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.283 18.8 p-10 -64.2 -38.31 33.47 Favored Pre-proline 0 N--CA 1.434 -1.253 0 C-N-CA 115.532 -2.467 . . . . 165.13 113.935 -171.619 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' PRO . . . . . 0.723 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 83.9 Cg_exo -62.54 -31.87 79.97 Favored 'Trans proline' 0 N--CA 1.433 -2.048 0 CA-C-N 122.769 2.025 . . . . 123.92 111.28 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' ILE . . . . . 0.716 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.1 pt -68.72 -42.57 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 C-N-CA 118.857 -1.137 . . . . 110.55 109.796 -179.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' ILE . . . . . 1.001 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.1 pt -61.09 -40.08 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 108.852 -0.796 . . . . 145.31 108.852 -177.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . 0.921 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.253 63.1 m-85 -58.1 -48.83 78.97 Favored 'General case' 0 CA--C 1.494 -1.191 0 C-N-CA 119.409 -0.916 . . . . 246.68 109.796 -177.473 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.6 m -62.24 -47.46 84.3 Favored 'General case' 0 CA--C 1.485 -1.539 0 C-N-CA 119.565 -0.854 . . . . 64.43 109.6 -173.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.8 t -66.8 -45.08 79.48 Favored 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 118.973 -1.091 . . . . 80.72 110.227 -177.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.708 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.41 -35.71 76.0 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 116.034 1.864 . . . . 140.44 116.034 -173.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . 0.655 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.85 132.23 34.32 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 112.692 -3.603 . . . . 178.87 113.048 -177.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . 0.613 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.04 -37.09 86.45 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 114.392 -1.277 . . . . 110.22 110.075 -177.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.855 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 38.9 ttm180 -57.7 -50.62 72.59 Favored 'General case' 0 CA--C 1.492 -1.251 0 O-C-N 121.802 -0.561 . . . . 174.78 109.708 -174.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.96 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.3 m-85 -64.87 -41.67 95.46 Favored 'General case' 0 CA--C 1.484 -1.571 0 N-CA-C 108.262 -1.014 . . . . 161.84 108.262 178.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . 0.516 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.7 ttp180 -57.38 -50.2 73.72 Favored 'General case' 0 CA--C 1.49 -1.353 0 N-CA-C 109.183 -0.673 . . . . 117.2 109.183 -173.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.797 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.55 -44.1 75.22 Favored 'General case' 0 N--CA 1.434 -1.235 0 C-N-CA 120.355 -0.538 . . . . 112.6 111.03 -177.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . 0.872 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -63.95 -37.52 94.74 Favored Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 110.675 -0.97 . . . . 101.46 110.675 -177.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' PHE . . . . . 1.015 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.7 m-85 -62.16 -45.92 91.29 Favored 'General case' 0 CA--C 1.491 -1.31 0 CA-C-N 118.452 1.126 . . . . 151.49 109.55 -178.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . 0.423 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.19 -36.24 77.17 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 106.922 -1.51 . . . . 142.32 106.922 -175.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' HIS . . . . . 0.826 ' NE2' HG21 ' A' ' 326' ' ' ILE . 49.9 m80 -59.85 -41.84 92.33 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 106.846 -1.539 . . . . 109.09 106.846 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.84 -42.42 85.81 Favored 'General case' 0 N--CA 1.435 -1.208 0 O-C-N 122.312 -0.242 . . . . 76.11 111.062 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -61.38 -55.51 30.67 Favored 'General case' 0 CA--C 1.489 -1.374 0 C-N-CA 119.861 -0.736 . . . . 120.24 109.339 -174.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . 0.579 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.4 mtt180 -74.26 131.53 41.28 Favored 'General case' 0 CA--C 1.482 -1.66 0 N-CA-C 102.946 -2.983 . . . . 192.73 102.946 177.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.4 p -59.14 -44.25 92.05 Favored 'General case' 0 CA--C 1.491 -1.296 0 C-N-CA 119.006 -1.078 . . . . 176.29 109.204 -172.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' CYS . . . . . 0.752 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.5 m -79.35 -177.11 0.81 Allowed Pre-proline 0 CA--C 1.488 -1.436 0 N-CA-C 106.239 -1.763 . . . . 69.68 106.239 178.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.567 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.8 Cg_exo -59.0 -75.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.382 0 CA-C-O 118.662 -0.641 . . . . 191.05 112.566 176.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' PHE . . . . . 0.752 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.3 m-85 47.49 43.89 16.24 Favored 'General case' 0 CA--C 1.493 -1.245 0 O-C-N 123.612 0.57 . . . . 287.03 109.763 178.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . 0.826 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.1 tt -104.55 78.58 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.474 -1.951 0 C-N-CA 112.988 -3.485 . . . . 292.29 109.854 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . 0.479 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.1 t -77.43 -152.89 0.05 OUTLIER 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 104.198 -2.519 . . . . 184.57 104.198 178.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.76 8.65 4.91 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 113.064 0.764 . . . . 274.56 113.064 176.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.96 0.89 57.28 Favored Glycine 0 C--N 1.348 1.233 0 C-N-CA 117.792 -2.147 . . . . 268.24 113.496 172.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' ASP . . . . . 0.7 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.8 m-20 51.65 -172.07 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.092 0 CA-C-N 118.673 1.236 . . . . 200.06 110.75 177.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.855 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.91 -33.02 74.76 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 107.854 -1.165 . . . . 114.44 107.854 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' GLU . . . . . 0.543 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.36 46.03 21.72 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 107.589 -1.263 . . . . 263.81 107.589 -177.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' GLY . . . . . 0.634 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.3 -137.36 3.61 Favored Glycine 0 CA--C 1.478 -2.231 1 N-CA-C 102.471 -4.251 . . . . 103.79 102.471 -179.837 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 1.05 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.2 mt -88.33 95.68 10.29 Favored 'General case' 0 N--CA 1.419 -1.993 0 C-N-CA 114.892 -2.723 . . . . 117.3 105.995 177.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . 1.025 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.97 -39.76 90.65 Favored 'General case' 0 CA--C 1.468 -2.202 1 N-CA-C 98.023 -4.806 . . . . 231.58 98.023 167.206 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . 1.036 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.96 163.48 29.08 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 102.115 -3.291 . . . . 303.24 102.115 168.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' LYS . . . . . 1.05 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.3 tttt -62.64 -48.6 78.66 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 116.03 -2.268 . . . . 112.72 108.423 179.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.9 t -61.05 -63.64 1.23 Allowed 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 109.083 -0.71 . . . . 83.22 109.083 -176.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' THR . . . . . 0.884 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 35.9 m -156.27 -126.16 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 103.87 -2.641 . . . . 174.36 103.87 -178.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . 1.025 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.93 160.96 8.89 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 105.771 -1.937 . . . . 202.73 105.771 177.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . 1.02 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.97 149.01 52.55 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 107.061 -1.459 . . . . 180.62 107.061 176.422 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . 0.932 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.5 tp -178.45 -171.82 0.27 Allowed 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 105.376 -2.083 . . . . 145.25 105.376 178.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' GLN . . . . . 0.932 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.1 tt0 -66.14 -43.14 87.94 Favored 'General case' 0 CA--C 1.487 -1.446 0 N-CA-C 106.078 -1.823 . . . . 66.05 106.078 174.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' THR . . . . . 0.765 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.71 -152.18 0.48 Allowed 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 103.486 -2.783 . . . . 266.49 103.486 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 345' ' ' GLN . . . . . 0.699 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.3 mt-30 66.37 -124.88 0.28 Allowed 'General case' 0 CA--C 1.485 -1.545 0 C-N-CA 117.038 -1.865 . . . . 219.2 107.742 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 346' ' ' GLY . . . . . 0.902 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.16 -37.38 94.01 Favored Glycine 0 N--CA 1.425 -2.063 0 CA-C-N 114.555 -1.202 . . . . 94.78 112.84 -175.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 347' ' ' SER . . . . . 0.826 ' HB2' ' H ' ' A' ' 342' ' ' LEU . 48.3 t -81.12 100.38 9.02 Favored 'General case' 0 CA--C 1.483 -1.598 0 C-N-CA 112.346 -3.742 . . . . 121.41 109.477 -171.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 348' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.5 t -73.05 145.47 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 N-CA-C 108.951 -0.759 . . . . 85.34 108.951 -176.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 349' ' ' TYR . . . . . 0.441 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.5 p90 -57.74 143.44 41.88 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 107.826 -1.176 . . . . 267.57 107.826 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 350' ' ' LYS . . . . . 0.525 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.03 69.61 0.59 Allowed 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 109.514 -0.55 . . . . 226.1 109.514 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 351' ' ' VAL . . . . . 0.824 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.5 p -51.0 156.92 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 N-CA-C 106.986 -1.487 . . . . 154.84 106.986 177.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . 0.581 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.8 m -61.36 161.92 8.54 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.566 0.698 . . . . 180.01 110.732 -173.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 353' ' ' ARG . . . . . 0.896 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.42 156.86 23.73 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 106.971 -1.492 . . . . 333.78 106.971 -178.595 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 354' ' ' LEU . . . . . 0.974 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.01 142.55 48.71 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 107.371 -1.344 . . . . 335.2 107.371 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.974 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.5 mm-40 82.77 158.9 0.13 Allowed 'General case' 0 CA--C 1.492 -1.281 0 N-CA-C 108.735 -0.839 . . . . 266.47 108.735 179.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.5 m -60.62 -46.85 88.73 Favored 'General case' 0 CA--C 1.488 -1.441 0 N-CA-C 105.653 -1.98 . . . . 59.34 105.653 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.4 t -81.64 173.9 11.91 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 104.376 -2.453 . . . . 201.26 104.376 176.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.747 HG22 ' O ' ' A' ' 360' ' ' THR . 68.9 mt -95.91 106.73 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 C-N-CA 116.308 -2.157 . . . . 56.23 105.548 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . 0.465 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.9 m -61.23 -59.43 5.33 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 109.326 -0.62 . . . . 87.58 109.326 -175.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . 0.891 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.1 t -85.47 153.72 22.28 Favored 'General case' 0 CA--C 1.485 -1.533 0 N-CA-C 107.855 -1.165 . . . . 219.95 107.855 -177.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 361' ' ' VAL . . . . . 0.588 ' O ' HG23 ' A' ' 361' ' ' VAL . 16.0 m -82.01 83.82 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.641 0 C-N-CA 116.324 -2.15 . . . . 121.79 105.448 177.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.599 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.6 t -154.12 159.72 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.575 0 N-CA-C 105.851 -1.907 . . . . 53.85 105.851 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . 0.599 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.27 16.57 77.13 Favored Glycine 0 N--CA 1.428 -1.87 0 N-CA-C 106.023 -2.831 . . . . 196.55 106.023 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.674 0 N-CA-C 107.909 -1.145 . . . . 35.88 107.909 -178.949 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 365' ' ' ARG . . . . . 0.494 ' HA ' ' HD3' ' B' ' 365' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 108.884 -0.784 . . . . 1.0 108.884 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 366' ' ' PRO . . . . . 0.698 ' HB3' ' C ' ' A' ' 4' ' ' VAL . 52.8 Cg_endo -66.85 142.01 61.24 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.056 1.837 . . . . 1.0 110.223 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 367' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -64.42 143.24 98.5 Favored Pre-proline 0 C--N 1.325 -0.496 0 C-N-CA 119.841 -0.744 . . . . 1.0 109.595 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 368' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.27 150.38 76.43 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.331 2.021 . . . . 1.0 111.746 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 369' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -70.71 131.8 44.42 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.688 -0.405 . . . . 1.0 110.181 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -102.05 115.88 31.49 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.716 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 371' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -63.69 -42.38 98.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.365 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 372' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -64.96 -36.26 83.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.86 -0.609 . . . . 1.0 110.728 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -59.7 -33.08 76.03 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.819 -0.912 . . . . 1.0 110.819 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 374' ' ' LEU . . . . . 0.805 ' HG ' ' CD1' ' A' ' 102' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 120.93 0.395 . . . . 1.0 110.213 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.466 0 N-CA-C 108.386 -0.968 . . . . 97.08 108.386 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -110.61 155.44 22.37 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-O 122.147 0.975 . . . . 123.41 110.711 -172.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.883 HG11 HD13 ' A' ' 15' ' ' ILE . 28.6 m -134.59 -162.41 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.476 1 N-CA-C 100.12 -4.029 . . . . 151.3 100.12 173.697 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.912 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.6 -38.65 59.16 Favored Pre-proline 0 N--CA 1.439 -0.984 0 C-N-CA 115.948 -2.301 . . . . 169.25 106.102 178.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.912 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 59.2 Cg_exo -81.29 168.54 16.63 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 N-CA-C 110.513 -0.61 . . . . 185.76 110.513 171.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.909 HG13 ' CE2' ' A' ' 282' ' ' PHE . 92.2 t -64.45 -25.95 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 C-N-CA 127.012 2.125 . . . . 145.47 110.369 -177.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.776 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.1 t0 -84.26 157.38 21.59 Favored 'General case' 0 N--CA 1.439 -1.005 0 O-C-N 121.08 -1.013 . . . . 102.76 109.53 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.3 p -82.57 154.14 25.15 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 107.985 -1.117 . . . . 106.25 107.985 178.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.919 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.7 p-10 -105.88 51.88 0.74 Allowed 'General case' 0 N--CA 1.428 -1.547 0 C-N-CA 117.766 -1.574 . . . . 157.81 107.623 178.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.11 -45.91 91.39 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 103.617 -2.734 . . . . 150.2 103.617 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.8 m -87.09 164.69 35.16 Favored Pre-proline 0 N--CA 1.422 -1.84 0 N-CA-C 103.624 -2.732 . . . . 183.52 103.624 172.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -76.76 6.89 3.83 Favored 'Trans proline' 0 C--N 1.282 -2.97 0 N-CA-C 109.957 -0.824 . . . . 235.61 109.957 176.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -57.92 -41.27 82.35 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 124.813 1.245 . . . . 113.77 113.395 -170.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.919 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.4 pt -52.14 136.21 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-N 119.522 1.055 . . . . 150.85 110.954 -176.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.49 156.26 46.4 Favored 'General case' 0 C--N 1.36 1.061 0 N-CA-C 107.622 -1.251 . . . . 100.42 107.622 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 1.081 HG23 ' H ' ' A' ' 20' ' ' SER . 14.2 t -64.96 142.62 58.37 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 121.99 0.9 . . . . 129.36 110.43 -174.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.773 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.13 -25.51 68.39 Favored 'General case' 0 CA--C 1.493 -1.221 0 C-N-CA 126.328 1.851 . . . . 112.34 106.63 -177.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.941 HG23 ' HA2' ' A' ' 101' ' ' GLY . 85.9 m -74.18 -40.08 62.76 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 115.575 -0.739 . . . . 131.73 111.724 177.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 1.081 ' H ' HG23 ' A' ' 17' ' ' THR . 70.9 m -84.52 -42.79 15.17 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 116.985 2.217 . . . . 80.49 116.985 -174.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.549 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.5 mt-10 -145.99 174.56 3.33 Favored Pre-proline 0 N--CA 1.442 -0.848 0 C-N-CA 118.176 -1.409 . . . . 98.98 111.216 -169.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.822 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.332 85.4 Cg_exo -61.84 -10.74 18.23 Favored 'Trans proline' 0 C--N 1.322 -0.868 1 N-CA-C 128.922 6.47 . . . . 246.95 128.922 -170.091 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.627 HD21 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.7 17.46 8.72 Favored 'General case' 0 C--N 1.324 -0.512 1 CA-C-N 126.175 4.079 . . . . 269.62 114.213 175.628 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.495 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.6 mt-30 -67.09 -27.34 67.27 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 107.782 -1.192 . . . . 86.8 107.782 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.551 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.4 p90 -66.76 -29.33 69.27 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 121.153 -0.967 . . . . 85.91 110.549 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.877 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.3 t -68.51 -40.25 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 C-N-CA 123.706 0.803 . . . . 82.0 111.333 -177.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.897 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.4 167.71 12.52 Favored Pre-proline 0 CA--C 1.488 -1.407 0 N-CA-C 108.55 -0.907 . . . . 120.73 108.55 -178.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.903 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.6 Cg_endo -64.04 149.77 89.77 Favored 'Trans proline' 0 N--CA 1.432 -2.106 0 C-N-CA 120.638 0.892 . . . . 87.86 109.89 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.744 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.07 -37.94 89.2 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 108.808 -0.812 . . . . 36.46 108.808 -176.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.814 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 28.0 p-90 -63.84 -33.86 76.62 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 107.757 -1.201 . . . . 150.6 107.757 -176.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.903 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.5 mt-30 -62.23 -32.66 73.37 Favored 'General case' 0 CA--C 1.49 -1.351 0 O-C-N 121.272 -0.893 . . . . 123.26 108.686 -178.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.744 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.49 -47.13 94.84 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 N-CA-C 109.188 -0.671 . . . . 120.14 109.188 176.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.786 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.3 m -67.47 -30.96 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 N-CA-C 107.868 -1.16 . . . . 112.19 107.868 -178.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.814 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.5 tp -63.02 -47.11 84.5 Favored 'General case' 0 N--CA 1.433 -1.323 0 C-N-CA 119.895 -0.722 . . . . 60.87 109.623 -178.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.67 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.01 -35.68 81.2 Favored 'General case' 0 CA--C 1.489 -1.402 0 C-N-CA 119.952 -0.699 . . . . 157.57 110.349 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.745 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.63 -40.86 98.34 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 108.638 -0.875 . . . . 47.06 108.638 178.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.806 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.81 -41.28 97.92 Favored 'General case' 0 CA--C 1.496 -1.115 0 O-C-N 121.724 -0.61 . . . . 43.94 109.522 -177.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.728 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.84 -43.25 99.22 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 108.752 -0.833 . . . . 42.61 108.752 -176.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.905 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.4 -41.22 93.9 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 116.649 -0.25 . . . . 140.66 111.059 -178.42 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.806 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.86 -43.93 97.86 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 118.588 -1.245 . . . . 116.04 110.214 -175.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.675 HG22 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.45 -38.72 83.16 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.28 0 N-CA-C 108.73 -0.841 . . . . 97.16 108.73 -177.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.854 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.3 mt -61.31 -40.03 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 N-CA-C 108.956 -0.757 . . . . 54.85 108.956 -176.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.951 HG22 HG21 ' A' ' 86' ' ' THR . 92.7 t -57.72 -42.31 81.42 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.302 0 N-CA-C 108.848 -0.797 . . . . 45.39 108.848 -175.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.431 ' O ' HG23 ' A' ' 48' ' ' VAL . 97.2 t -63.55 -50.98 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 C-N-CA 118.839 -1.144 . . . . 48.64 110.162 -177.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.752 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.6 t -65.23 -47.08 78.06 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 120.197 -0.601 . . . . 116.65 111.694 -174.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.589 ' N ' HG23 ' A' ' 45' ' ' THR . 50.8 m -61.98 -43.88 97.9 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 109.73 -0.471 . . . . 51.16 109.73 -174.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.1 t -65.63 -48.86 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 C-N-CA 119.846 -0.741 . . . . 44.3 110.818 -176.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.868 ' O ' HG23 ' A' ' 52' ' ' VAL . 94.0 t -64.75 -46.97 90.54 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 C-N-CA 120.291 -0.564 . . . . 48.82 111.068 -174.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.73 -44.2 95.2 Favored Glycine 0 N--CA 1.437 -1.299 0 C-N-CA 120.515 -0.85 . . . . 58.7 112.021 -174.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -72.55 -34.28 67.41 Favored 'General case' 0 CA--C 1.488 -1.436 0 O-C-N 122.061 -0.67 . . . . 101.4 111.072 -175.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.739 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.4 p -66.83 -38.77 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 107.73 -1.211 . . . . 103.57 107.73 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 48' ' ' VAL . 72.0 t -61.44 -43.01 96.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 N-CA-C 108.974 -0.75 . . . . 61.89 108.974 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.537 ' O ' HG22 ' A' ' 56' ' ' ILE . 81.6 t -63.5 -50.93 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 109.437 -0.579 . . . . 70.01 109.437 -178.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.8 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.98 -43.35 99.02 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 109.122 -0.696 . . . . 132.1 109.122 -176.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.644 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.1 t-105 -64.23 -46.63 82.96 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 116.666 -0.243 . . . . 104.5 110.434 -176.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 1.011 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.69 -49.88 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 C-N-CA 120.194 -0.602 . . . . 142.96 111.235 -173.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.954 HD11 HG12 ' A' ' 72' ' ' VAL 0.278 24.8 pt -64.78 -41.68 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.707 0 C-N-CA 116.904 -1.919 . . . . 158.32 110.905 -175.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.8 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.69 -41.32 98.16 Favored 'General case' 0 N--CA 1.433 -1.308 0 C-N-CA 117.701 -1.599 . . . . 137.11 109.527 178.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.39 -44.53 91.03 Favored 'General case' 0 N--CA 1.436 -1.141 0 O-C-N 122.147 -0.346 . . . . 54.66 111.024 -176.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.923 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.42 117.1 29.39 Favored 'General case' 0 CA--C 1.491 -1.294 0 CA-C-O 121.576 0.703 . . . . 127.18 109.586 -174.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.621 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.3 tttt -60.81 -36.87 80.13 Favored 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 124.072 0.949 . . . . 87.93 110.819 -176.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 1.031 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.34 -34.66 78.66 Favored 'General case' 0 CA--C 1.49 -1.355 0 O-C-N 121.636 -0.665 . . . . 131.12 111.541 -175.63 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 1.012 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.67 69.49 7.2 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 115.311 -2.556 . . . . 246.56 109.555 -175.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.411 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.27 91.44 3.48 Favored 'General case' 0 CA--C 1.473 -1.987 0 N-CA-C 105.495 -2.039 . . . . 339.35 105.495 177.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.444 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.6 p -124.18 165.29 17.84 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 102.986 -2.968 . . . . 114.66 102.986 176.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.881 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.14 -39.44 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 N-CA-C 106.773 -1.566 . . . . 143.28 106.773 178.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.833 HG22 HD13 ' A' ' 71' ' ' LEU . 95.4 m -59.75 -37.99 80.52 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 108.652 -0.87 . . . . 160.22 108.652 -176.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.527 ' ND2' ' HB3' ' A' ' 63' ' ' MET . 86.3 m-20 -62.36 -31.77 72.47 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 108.86 -0.793 . . . . 120.54 108.86 -177.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.903 ' O ' HG22 ' A' ' 72' ' ' VAL . 89.9 m-85 -63.6 -43.77 95.96 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.523 -0.547 . . . . 67.22 109.523 178.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.881 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.4 m-85 -66.6 -39.72 88.52 Favored 'General case' 0 CA--C 1.498 -1.041 0 O-C-N 121.487 -0.758 . . . . 138.6 109.639 -177.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.927 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.62 -35.87 81.96 Favored 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 122.435 0.294 . . . . 151.46 110.639 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.954 HG12 HD11 ' A' ' 57' ' ' ILE . 24.0 m -62.54 -37.96 80.2 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.228 0 C-N-CA 117.41 -1.716 . . . . 117.93 106.732 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.45 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.0 t30 -60.11 -46.04 90.96 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 107.839 -1.171 . . . . 56.82 107.839 -177.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.999 HD21 ' HE1' ' A' ' 123' ' ' MET . 8.6 mp -61.33 -43.87 98.14 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 109.005 -0.739 . . . . 145.3 109.005 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.09 -40.33 95.49 Favored 'General case' 0 CA--C 1.492 -1.256 0 N-CA-C 108.5 -0.926 . . . . 45.71 108.5 -175.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -62.43 -42.01 99.13 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 109.346 -0.613 . . . . 105.61 109.346 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.14 -39.44 92.62 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 108.667 -0.864 . . . . 47.89 108.667 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.587 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.56 -37.38 84.84 Favored 'General case' 0 N--CA 1.439 -1.014 0 O-C-N 122.059 -0.401 . . . . 124.53 109.969 179.662 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.81 -41.29 99.24 Favored 'General case' 0 CA--C 1.496 -1.116 0 O-C-N 121.991 -0.443 . . . . 35.89 109.858 -178.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.7 t -62.14 -37.34 84.79 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 107.052 -1.462 . . . . 88.97 107.052 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.82 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.7 ttm -62.2 -49.19 76.76 Favored 'General case' 0 N--CA 1.428 -1.571 0 C-N-CA 119.816 -0.754 . . . . 239.91 109.03 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.619 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.37 -43.43 90.8 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 121.532 -0.73 . . . . 146.1 110.56 -177.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.418 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.13 -58.22 3.41 Favored 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 117.416 -1.714 . . . . 91.74 113.888 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -76.54 -61.41 1.97 Allowed 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 115.75 1.759 . . . . 197.45 115.75 -173.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.939 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.24 -42.23 55.72 Favored 'General case' 0 CA--C 1.49 -1.357 0 C-N-CA 117.876 -1.53 . . . . 242.6 114.061 -170.02 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.951 HG21 HG22 ' A' ' 43' ' ' VAL . 4.6 t -65.39 -36.59 84.42 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 118.941 -1.103 . . . . 215.61 109.812 -172.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.421 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.4 t -60.31 -46.95 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 O-C-N 121.824 -0.548 . . . . 87.19 110.426 -175.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.839 HG21 ' CD2' ' A' ' 108' ' ' HIS . 63.7 t -65.94 -41.84 90.67 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.098 0 N-CA-C 109.727 -0.471 . . . . 231.82 109.727 -178.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.905 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 11.0 m120 -62.33 -34.11 76.0 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 108.365 -0.976 . . . . 364.98 108.365 -177.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.669 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.0 t80 -68.16 -44.76 75.27 Favored 'General case' 0 N--CA 1.438 -1.07 0 O-C-N 121.56 -0.713 . . . . 181.63 111.271 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.813 HG22 ' HD2' ' A' ' 95' ' ' HIS . 57.6 m -60.85 -45.8 93.1 Favored 'General case' 0 CA--C 1.477 -1.831 0 N-CA-C 107.438 -1.319 . . . . 269.02 107.438 -175.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 1.05 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.74 -45.01 93.53 Favored 'General case' 0 N--CA 1.416 -2.165 0 C-N-CA 118.683 -1.207 . . . . 562.66 110.037 -179.056 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.706 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.08 -45.31 95.24 Favored 'General case' 0 CA--C 1.479 -1.768 0 C-N-CA 118.697 -1.201 . . . . 446.75 108.042 -167.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.745 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.387 6.1 m -70.5 -26.28 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.752 0 C-N-CA 115.819 -2.352 . . . . 370.05 112.244 -178.72 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.813 ' HD2' HG22 ' A' ' 91' ' ' THR . 90.0 m-70 -74.46 -26.54 60.1 Favored 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 121.592 -0.692 . . . . 354.91 112.469 175.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.822 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.4 m-20 82.85 4.51 0.98 Allowed 'General case' 0 CA--C 1.5 -0.951 0 C-N-CA 125.044 1.338 . . . . 462.44 111.881 -178.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.773 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.267 11.9 mm-40 -172.36 178.06 2.91 Favored 'General case' 0 CA--C 1.488 -1.409 0 CA-C-O 122.025 0.916 . . . . 652.37 111.122 171.813 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.791 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.72 86.31 2.17 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 128.516 2.726 . . . . 905.99 107.924 -174.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -67.9 -36.43 80.19 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 108.217 -1.031 . . . . 570.43 108.217 -176.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.849 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.58 -36.34 82.38 Favored 'General case' 0 N--CA 1.427 -1.586 0 C-N-CA 125.361 1.464 . . . . 453.22 111.152 -174.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.941 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.55 178.69 33.89 Favored Glycine 0 C--N 1.349 1.266 0 C-N-CA 118.777 -1.678 . . . . 445.63 109.854 177.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.1 mt -56.38 -41.23 75.89 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 125.257 1.423 . . . . 457.72 112.377 -170.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -58.71 -46.86 86.39 Favored 'General case' 0 CA--C 1.484 -1.56 0 C-N-CA 118.622 -1.231 . . . . 340.58 109.281 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.849 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.2 m-85 -68.72 -32.14 71.72 Favored 'General case' 0 N--CA 1.423 -1.778 0 C-N-CA 118.784 -1.166 . . . . 453.6 111.576 -176.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.764 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.2 t -56.08 -40.32 73.44 Favored 'General case' 0 CA--C 1.488 -1.441 0 N-CA-C 105.948 -1.871 . . . . 541.48 105.948 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.87 -47.17 75.79 Favored 'General case' 0 CA--C 1.485 -1.532 0 O-C-N 123.959 0.787 . . . . 466.68 110.869 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -61.63 -47.14 86.74 Favored 'General case' 0 N--CA 1.427 -1.621 0 C-N-CA 117.501 -1.68 . . . . 427.34 107.361 -178.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.839 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.5 m80 -67.05 -36.77 82.78 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 112.456 0.539 . . . . 537.87 112.456 -174.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.574 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.38 -42.68 74.83 Favored 'General case' 0 N--CA 1.432 -1.344 0 C-N-CA 116.884 -1.926 . . . . 422.12 111.608 175.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.856 ' O ' HG22 ' A' ' 113' ' ' ILE . 75.9 t80 -59.1 -50.08 75.41 Favored 'General case' 0 CA--C 1.501 -0.909 0 O-C-N 121.342 -0.849 . . . . 340.17 111.815 -173.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -65.32 -46.48 71.03 Favored Pre-proline 0 N--CA 1.443 -0.816 0 C-N-CA 119.1 -1.04 . . . . 258.06 111.696 -176.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.939 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.1 Cg_exo -61.57 -31.54 87.24 Favored 'Trans proline' 0 N--CA 1.435 -1.925 0 N-CA-C 115.341 1.246 . . . . 305.71 115.341 176.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.878 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.87 -40.45 76.54 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.363 0 N-CA-C 108.686 -0.857 . . . . 252.7 108.686 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.422 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.93 -40.57 93.76 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 107.825 -1.176 . . . . 149.27 107.825 -179.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.99 -44.84 95.88 Favored 'General case' 0 N--CA 1.436 -1.165 0 C-N-CA 120.614 -0.434 . . . . 138.08 111.497 -176.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.651 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 65.2 t -66.94 -42.34 88.7 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.944 0 O-C-N 121.604 -0.685 . . . . 132.89 110.969 -177.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.922 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.6 m-85 -63.76 -44.7 92.69 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 108.871 -0.788 . . . . 193.61 108.871 -177.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.555 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.43 -37.71 84.5 Favored 'General case' 0 N--CA 1.435 -1.177 0 C-N-CA 122.811 0.445 . . . . 63.83 110.094 -175.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 72.0 m -63.95 -52.46 59.64 Favored 'General case' 0 N--CA 1.435 -1.194 0 O-C-N 122.031 -0.418 . . . . 76.4 111.221 -177.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.752 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.96 -41.7 93.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 108.179 -1.045 . . . . 171.13 108.179 -174.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 1.103 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.2 m-85 -63.79 -38.53 91.46 Favored 'General case' 0 N--CA 1.433 -1.3 0 O-C-N 121.839 -0.538 . . . . 78.3 110.631 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.556 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.5 t -67.11 -35.73 80.4 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 118.854 -1.138 . . . . 92.36 109.229 -178.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.999 ' HE1' HD21 ' A' ' 74' ' ' LEU . 5.9 mmt -62.47 -34.27 76.49 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 108.218 -1.03 . . . . 93.73 108.218 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.9 HG22 HG13 ' A' ' 212' ' ' ILE . 32.9 p -67.38 -41.72 84.58 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.209 -0.996 . . . . 132.74 109.302 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.28 -42.04 94.59 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 107.2 -1.408 . . . . 43.39 107.2 -177.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.827 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.0 t -58.48 -41.95 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 N-CA-C 108.606 -0.887 . . . . 59.34 108.606 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.55 -44.07 95.23 Favored 'General case' 0 CA--C 1.498 -1.039 0 O-C-N 121.844 -0.535 . . . . 69.68 110.474 -177.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.468 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.3 t80 -65.44 -42.8 92.01 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 108.313 -0.995 . . . . 106.98 108.313 -177.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.827 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.34 -35.58 81.35 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 119.632 -0.827 . . . . 147.63 108.982 -177.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.703 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.16 -41.52 99.26 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 108.562 -0.903 . . . . 190.06 108.562 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.599 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.4 t80 -61.34 -44.12 97.72 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.253 -1.017 . . . . 118.85 108.253 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.803 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.4 mmt -63.36 -42.66 98.9 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 109.979 -0.378 . . . . 102.5 109.979 -177.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.91 -41.7 95.35 Favored 'General case' 0 CA--C 1.489 -1.399 0 O-C-N 121.817 -0.552 . . . . 89.98 109.836 -176.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.92 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.4 mt -66.52 -50.7 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.719 0 C-N-CA 118.103 -1.439 . . . . 106.09 110.997 -177.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.75 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.03 -48.37 38.49 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.13 0 C-N-CA 117.092 -1.843 . . . . 227.74 111.824 -174.824 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.756 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 23.9 p80 -118.85 100.11 50.98 Favored Pre-proline 0 CA--C 1.486 -1.503 0 C-N-CA 116.26 -2.176 . . . . 262.55 110.061 -175.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.2 Cg_endo -69.63 -10.35 28.45 Favored 'Trans proline' 0 C--N 1.289 -2.574 0 C-N-CA 121.607 1.538 . . . . 210.25 111.327 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.706 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.35 112.04 1.01 Allowed 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 106.483 -1.673 . . . . 270.58 106.483 -178.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.887 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.2 tt0 -66.77 -39.53 24.48 Favored Pre-proline 0 N--CA 1.431 -1.425 0 CA-C-N 115.329 -0.851 . . . . 129.84 112.362 -176.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.857 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 82.3 Cg_exo -61.36 -26.57 81.72 Favored 'Trans proline' 0 N--CA 1.431 -2.176 0 N-CA-C 116.322 1.624 . . . . 330.71 116.322 -174.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.756 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.07 77.24 7.99 Favored 'General case' 0 N--CA 1.429 -1.514 0 C-N-CA 114.47 -2.892 . . . . 204.51 107.3 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.877 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.68 147.38 0.09 Allowed 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.482 -1.303 . . . . 387.41 107.482 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.877 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.3 t -143.68 147.0 33.64 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 118.824 -1.151 . . . . 166.22 109.515 178.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.8 -40.77 88.21 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 107.869 -1.159 . . . . 44.23 107.869 176.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.481 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.7 m -60.33 -39.08 85.8 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 108.181 -1.044 . . . . 28.8 108.181 -175.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.668 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.86 -38.75 92.06 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 109.087 -0.708 . . . . 30.29 109.087 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.847 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 90.3 m -59.62 -43.03 93.94 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 109.011 -0.737 . . . . 46.11 109.011 -176.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.46 -42.12 99.25 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 107.7 -1.222 . . . . 87.33 107.7 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.766 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.4 t -61.71 -42.06 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.359 0 N-CA-C 107.874 -1.158 . . . . 23.69 107.874 -178.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.8 t -63.2 -44.26 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 N-CA-C 109.73 -0.47 . . . . 43.86 109.73 -178.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.92 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.1 mm -61.24 -42.54 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 108.359 -0.978 . . . . 91.13 108.359 -176.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . 0.484 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.3 t -62.62 -37.95 88.31 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 108.735 -0.839 . . . . 65.88 108.735 -178.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.766 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.5 t -62.1 -41.88 92.89 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 109.552 -0.536 . . . . 33.86 109.552 -177.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 1.103 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.37 -40.37 85.97 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.159 0 N-CA-C 107.583 -1.266 . . . . 146.52 107.583 -176.791 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . 0.699 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.1 m95 -62.84 -38.35 90.43 Favored 'General case' 0 N--CA 1.428 -1.538 0 C-N-CA 119.502 -0.879 . . . . 75.44 108.942 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.9 t -60.5 -48.42 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 O-C-N 121.058 -1.026 . . . . 43.64 109.749 -177.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.791 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.65 -38.05 89.67 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 109.041 -0.726 . . . . 102.57 109.041 -178.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.99 -41.06 86.7 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.433 -1.321 . . . . 58.16 107.433 -178.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.802 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.08 -32.55 73.95 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.014 -0.736 . . . . 121.11 109.014 178.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.791 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.0 -42.3 84.92 Favored 'General case' 0 CA--C 1.489 -1.381 0 C-N-CA 118.554 -1.258 . . . . 153.15 109.966 -178.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 1.059 HD13 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.09 -43.71 19.07 Favored 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 113.06 -3.456 . . . . 133.67 113.532 173.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.479 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -63.0 -39.83 95.96 Favored 'General case' 0 CA--C 1.49 -1.344 0 O-C-N 120.888 -1.132 . . . . 157.42 112.196 -171.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.524 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.3 t80 -74.51 -36.08 2.4 Favored Pre-proline 0 N--CA 1.437 -1.112 0 N-CA-C 114.974 1.472 . . . . 250.91 114.974 -173.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.293 53.0 Cg_exo -59.53 -25.46 78.83 Favored 'Trans proline' 0 CA--C 1.488 -1.817 0 N-CA-C 118.043 2.286 . . . . 207.34 118.043 -174.37 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 1.011 HE21 HG13 ' A' ' 182' ' ' ILE . 87.7 mt-30 -61.18 -34.23 74.71 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 106.953 -1.499 . . . . 192.46 106.953 178.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.46 -41.07 98.16 Favored Glycine 0 C--N 1.353 1.513 0 N-CA-C 107.974 -2.05 . . . . 261.0 107.974 177.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.78 159.07 26.02 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 101.548 -3.501 . . . . 491.4 101.548 172.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -59.92 106.79 0.53 Allowed 'General case' 0 CA--C 1.488 -1.42 0 C-N-CA 116.282 -2.167 . . . . 386.1 109.831 -176.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.916 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 74.0 m -154.05 -166.61 2.42 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 103.553 -2.758 . . . . 289.8 103.553 -178.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 1.142 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.1 p -62.91 175.44 0.86 Allowed 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 117.723 -1.132 . . . . 402.06 109.554 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.788 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 72.5 p -165.3 177.5 7.54 Favored 'General case' 0 CA--C 1.587 2.383 0 C-N-CA 127.309 2.243 . . . . 690.53 114.927 177.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.486 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.8 mm-40 132.32 160.57 0.0 OUTLIER 'General case' 1 C--N 1.428 4.007 1 N-CA-C 123.183 4.512 . . . . 633.62 123.183 162.691 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.76 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.4 p -85.68 153.82 22.08 Favored 'General case' 0 C--N 1.389 2.313 0 C-N-CA 127.373 2.269 . . . . 617.99 110.874 178.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . 1.047 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.66 174.45 5.93 Favored Pre-proline 0 C--N 1.364 1.233 0 C-N-CA 130.284 3.433 . . . . 434.98 113.387 -175.365 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 1.091 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 52.9 Cg_endo -44.31 -65.63 0.19 Allowed 'Trans proline' 0 N--CA 1.441 -1.576 0 N-CA-C 122.386 3.956 . . . . 365.88 122.386 -168.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . 0.777 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.306 70.4 m -84.91 20.94 1.7 Allowed 'General case' 0 CA--C 1.466 -2.257 0 N-CA-C 104.807 -2.294 . . . . 635.81 104.807 178.147 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.75 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.457 5.0 mmp_? -94.33 152.24 18.8 Favored 'General case' 1 CA--C 1.419 -4.081 3 N-CA-C 132.031 7.789 . . . . 999.99 132.031 -135.787 . . . . . . . . 5 3 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 1.05 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.912 37.3 t -131.83 73.12 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.383 -3.8 1 CA-C-N 103.343 -6.299 . . . . 594.32 113.606 149.235 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.729 HG13 ' HB2' ' A' ' 174' ' ' MET . 7.3 p -144.16 144.14 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.603 1 N-CA-C 98.244 -4.724 . . . . 811.91 98.244 162.404 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.76 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.9 m -118.48 144.49 45.97 Favored 'General case' 0 CA--C 1.489 -1.391 0 C-N-CA 117.099 -1.84 . . . . 999.99 109.429 -178.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.971 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.9 mmm -147.17 -175.6 4.89 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 122.019 0.914 . . . . 431.86 110.069 -177.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 1.037 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.11 148.65 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 C-N-CA 124.397 1.079 . . . . 457.18 108.796 -177.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . 0.788 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.31 85.41 3.74 Favored 'General case' 0 CA--C 1.5 -0.944 0 C-N-CA 124.147 0.979 . . . . 458.77 113.515 -174.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.96 ' CZ3' HG22 ' A' ' 182' ' ' ILE . 1.9 p90 -76.35 -31.55 0.98 Allowed Pre-proline 0 N--CA 1.438 -1.065 0 C-N-CA 124.941 1.296 . . . . 999.99 112.452 168.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.957 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 50.9 Cg_exo -66.0 -45.71 5.64 Favored 'Trans proline' 0 N--CA 1.438 -1.766 0 N-CA-C 120.895 3.383 . . . . 999.99 120.895 -174.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.507 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 54.9 mt-10 -119.54 171.73 8.15 Favored 'General case' 0 CA--C 1.472 -2.054 0 C-N-CA 117.204 -1.798 . . . . 81.18 107.285 -172.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.834 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.9 p-80 -109.13 45.14 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.828 0 C-N-CA 115.466 -2.493 . . . . 999.99 108.777 177.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 1.076 ' HB2' HD12 ' A' ' 191' ' ' ILE . 87.3 Cg_endo -41.56 101.84 0.04 OUTLIER 'Trans proline' 0 CA--C 1.5 -1.184 1 C-N-CA 126.039 4.492 . . . . 999.99 105.683 -170.749 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -62.34 -44.01 97.49 Favored 'General case' 0 CA--C 1.484 -1.586 0 C-N-CA 126.777 2.031 . . . . 967.72 112.024 -165.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -60.31 -36.49 78.01 Favored 'General case' 0 CA--C 1.487 -1.475 0 N-CA-C 106.741 -1.578 . . . . 934.3 106.741 -175.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 1.076 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.62 -30.22 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 C-N-CA 129.185 2.994 . . . . 565.15 113.918 -178.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 61.56 55.38 2.79 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-N 118.469 0.577 . . . . 755.61 109.853 -175.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 1.142 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.5 -49.33 66.94 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 124.563 1.145 . . . . 325.89 113.265 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.632 ' HE3' ' OH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.76 -45.0 78.18 Favored 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 123.573 0.749 . . . . 250.21 111.637 -169.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 96.8 t -64.73 -43.29 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 C-N-CA 119.959 -0.696 . . . . 142.46 110.389 -175.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 1.037 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.9 t80 -61.15 -41.5 96.86 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 123.982 0.913 . . . . 247.69 108.814 -173.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' HIS . . . . . 0.824 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 23.0 t60 -60.52 -51.36 69.75 Favored 'General case' 0 CA--C 1.492 -1.279 0 C-N-CA 125.454 1.502 . . . . 199.61 113.049 -175.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 82.8 mt -65.31 -44.52 94.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 107.727 -1.212 . . . . 106.73 107.727 -177.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . 0.72 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.5 t -59.11 -48.55 81.21 Favored 'General case' 0 CA--C 1.486 -1.519 0 CA-C-N 115.858 -0.61 . . . . 115.01 110.245 -173.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 1.059 HG13 HD13 ' A' ' 161' ' ' LEU . 86.1 t -65.27 -49.15 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.647 0 C-N-CA 119.458 -0.897 . . . . 129.42 111.823 -174.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . 0.791 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.1 m -61.89 -53.14 59.82 Favored 'General case' 0 CA--C 1.483 -1.614 0 C-N-CA 118.245 -1.382 . . . . 172.48 109.953 -172.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.631 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 85.6 t -63.83 -54.24 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 C-N-CA 120.523 -0.471 . . . . 55.86 110.989 -174.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.72 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.58 -51.54 58.96 Favored 'General case' 0 N--CA 1.432 -1.355 0 C-N-CA 118.526 -1.27 . . . . 184.68 111.496 -174.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 1.051 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.6 -52.44 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 C-N-CA 116.696 -2.002 . . . . 291.81 114.737 -174.683 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.55 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.8 t80 -82.04 -55.0 4.84 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 115.142 1.534 . . . . 130.66 115.142 -178.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . 0.791 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.9 m-85 -66.87 -48.49 68.62 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 114.532 1.308 . . . . 80.16 114.532 -170.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.898 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.57 -45.48 83.07 Favored Pre-proline 0 N--CA 1.436 -1.165 0 C-N-CA 119.91 -0.716 . . . . 136.02 109.495 -174.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.898 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.7 Cg_exo -64.76 -27.16 60.0 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 110.629 -0.566 . . . . 92.17 110.629 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.686 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.29 -41.41 76.83 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 107.495 -1.298 . . . . 135.6 107.495 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.8 mt -64.17 -44.73 91.17 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 109.57 -0.529 . . . . 52.1 109.57 -176.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.617 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.7 p -61.61 -43.53 97.18 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 109.12 -0.696 . . . . 95.89 109.12 -176.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.9 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.23 -42.35 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 106.728 -1.582 . . . . 43.41 106.728 -178.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.47 -42.26 99.04 Favored Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 109.361 -1.496 . . . . 27.69 109.361 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . 0.883 ' O ' HG22 ' A' ' 217' ' ' THR . 77.9 t80 -65.65 -47.4 75.69 Favored 'General case' 0 CA--C 1.496 -1.113 0 CA-C-N 117.38 0.59 . . . . 54.41 110.497 -177.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . 0.826 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.41 -34.13 74.85 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 106.968 -1.493 . . . . 53.88 106.968 -177.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -60.74 -40.86 93.98 Favored 'General case' 0 N--CA 1.426 -1.628 0 N-CA-C 108.492 -0.929 . . . . 68.29 108.492 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . 0.883 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.74 -39.06 92.99 Favored 'General case' 0 CA--C 1.497 -1.088 0 C-N-CA 119.69 -0.804 . . . . 107.59 110.619 -175.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.826 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.03 -38.36 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 C-N-CA 119.607 -0.837 . . . . 111.61 109.488 -177.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.92 HG13 ' CD1' ' A' ' 134' ' ' ILE . 79.6 t -63.29 -22.52 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 N-CA-C 108.389 -0.967 . . . . 85.26 108.389 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.84 -41.95 99.39 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 111.051 -0.82 . . . . 40.71 111.051 -176.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.7 mm -64.66 -44.09 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 108.42 -0.955 . . . . 95.86 108.42 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.822 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.1 p -76.94 -137.57 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.417 -0.956 . . . . 144.37 108.417 -176.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.901 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.7 mt -55.31 132.1 47.16 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 107.633 -1.247 . . . . 326.72 107.633 -177.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' TRP . . . . . 0.463 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.31 -168.02 1.5 Allowed 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 106.059 -1.83 . . . . 158.38 106.059 -176.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . 0.463 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.39 -41.93 98.79 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 109.619 -0.512 . . . . 36.78 109.619 -178.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.8 m -61.13 125.81 25.07 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 119.144 -1.022 . . . . 85.46 109.813 -174.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . 0.692 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.82 126.56 8.89 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 105.547 -2.02 . . . . 127.78 105.547 176.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.928 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.04 139.92 34.8 Favored Pre-proline 0 CA--C 1.493 -1.214 0 N-CA-C 105.946 -1.872 . . . . 164.84 105.946 -179.548 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.928 ' N ' HD13 ' A' ' 228' ' ' ILE . 82.3 Cg_exo -56.87 -39.85 88.44 Favored 'Trans proline' 0 N--CA 1.431 -2.184 0 N-CA-C 113.945 0.71 . . . . 222.35 113.945 -175.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . 0.745 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.18 167.0 44.85 Favored Glycine 0 N--CA 1.428 -1.838 0 N-CA-C 106.39 -2.684 . . . . 45.22 106.39 178.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.883 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.6 t0 -60.97 -45.79 93.34 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 105.997 -1.853 . . . . 107.57 105.997 177.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . 0.73 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.5 m -65.72 141.78 58.23 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 118.899 -1.12 . . . . 167.96 109.192 -175.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.829 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.3 m 99.5 106.7 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.248 0 C-N-CA 126.73 2.012 . . . . 280.68 109.768 176.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.709 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.5 m-20 55.99 11.31 0.71 Allowed 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 124.42 1.088 . . . . 218.25 110.717 174.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.921 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.41 137.68 54.76 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 105.217 -2.142 . . . . 343.57 105.217 177.368 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.564 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.6 t80 -112.0 81.92 1.54 Allowed 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 106.826 -1.546 . . . . 263.29 106.826 179.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' HIS . . . . . 0.627 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.3 m-70 104.29 147.03 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.285 0 C-N-CA 126.576 1.951 . . . . 261.92 108.486 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.21 -38.07 89.73 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 107.911 -1.144 . . . . 106.81 107.911 -177.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.739 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.42 -39.95 94.96 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 118.362 -1.335 . . . . 112.2 107.552 -178.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.738 HG12 ' NH1' ' A' ' 244' ' ' ARG . 75.5 t -64.25 -39.85 86.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 N-CA-C 109.254 -0.647 . . . . 45.41 109.254 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . 0.803 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.0 p -70.94 -32.01 68.78 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 110.278 -0.267 . . . . 97.62 110.278 -178.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.38 -39.61 81.7 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 123.698 0.799 . . . . 59.29 111.012 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.739 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.25 -36.55 84.03 Favored 'General case' 0 CA--C 1.491 -1.3 0 C-N-CA 124.664 1.186 . . . . 106.49 110.683 -174.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.921 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.95 -30.67 69.24 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 108.293 -1.002 . . . . 106.62 108.293 -176.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.534 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -65.97 -41.06 91.68 Favored 'General case' 0 N--CA 1.436 -1.141 0 O-C-N 121.841 -0.537 . . . . 75.97 110.062 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.44 ' CG1' ' CE ' ' A' ' 250' ' ' MET . 76.8 t -65.53 -40.84 89.36 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 C-N-CA 122.92 0.488 . . . . 65.27 109.779 -178.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.775 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -64.03 -41.62 93.07 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.317 0 C-N-CA 120.398 -0.521 . . . . 107.94 110.12 -177.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.536 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.2 pttt -63.47 -40.81 98.11 Favored 'General case' 0 N--CA 1.434 -1.239 0 O-C-N 121.663 -0.648 . . . . 87.98 110.328 -176.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' MET . . . . . 0.821 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.68 -40.41 96.76 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 118.824 -1.15 . . . . 65.5 108.35 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' MET . . . . . 0.76 ' CE ' HG21 ' A' ' 67' ' ' THR . 68.5 mtt -61.64 -36.41 80.71 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.141 -1.059 . . . . 85.05 108.141 -177.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.536 HD12 ' HA ' ' A' ' 248' ' ' LYS . 86.9 mt -63.48 -45.71 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 N-CA-C 109.061 -0.718 . . . . 42.25 109.061 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . 0.821 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.4 -38.19 81.93 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.13 0 C-N-CA 119.551 -0.86 . . . . 91.01 109.376 -176.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 1.0 HG22 ' CD1' ' A' ' 304' ' ' ILE . 66.5 t -58.93 -41.53 83.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 N-CA-C 107.931 -1.137 . . . . 66.09 107.931 -178.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 250' ' ' MET . 94.3 t -66.14 -43.15 92.24 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 C-N-CA 120.729 -0.388 . . . . 52.39 110.282 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.5 m -61.73 -46.75 88.3 Favored 'General case' 0 CA--C 1.489 -1.384 0 O-C-N 121.913 -0.492 . . . . 46.42 109.903 -174.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . 0.744 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.5 t -62.33 -38.18 88.45 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 108.333 -0.988 . . . . 116.51 108.333 -177.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' PHE . . . . . 0.489 ' N ' HG23 ' A' ' 256' ' ' THR . 86.1 t80 -60.23 -48.23 82.6 Favored 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 109.405 -0.591 . . . . 65.18 109.405 -178.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.94 -42.65 97.26 Favored 'General case' 0 CA--C 1.49 -1.364 0 CA-C-O 120.872 0.368 . . . . 51.33 110.468 -175.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . 0.744 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.62 -43.41 98.16 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 C-N-CA 118.941 -1.103 . . . . 126.3 108.974 -176.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' CYS . . . . . 0.508 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.7 m -65.58 -49.3 69.31 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 119.518 -0.873 . . . . 133.94 112.495 -176.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.817 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.0 m95 -80.69 -33.4 35.47 Favored 'General case' 0 CA--C 1.497 -1.071 0 N-CA-C 116.823 2.157 . . . . 134.84 116.823 -176.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.781 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.9 tp -58.47 -41.56 89.88 Favored Pre-proline 0 CA--C 1.493 -1.225 0 O-C-N 121.628 -0.67 . . . . 72.23 111.648 -167.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' PRO . . . . . 0.781 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 81.9 Cg_exo -60.75 -35.94 86.76 Favored 'Trans proline' 0 C--N 1.294 -2.298 0 CA-C-N 119.837 0.978 . . . . 106.13 111.302 -178.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' PHE . . . . . 0.849 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.5 t80 -66.4 -44.67 82.37 Favored 'General case' 0 N--CA 1.433 -1.321 0 C-N-CA 119.793 -0.763 . . . . 128.35 110.061 -178.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' HIS . . . . . 0.643 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.47 -37.84 88.95 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 110.236 -0.283 . . . . 100.73 110.236 -177.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.743 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.28 -44.52 94.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 C-N-CA 119.329 -0.949 . . . . 172.72 109.139 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . 0.735 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.6 m-85 -66.61 -28.06 68.2 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 108.235 -1.024 . . . . 249.23 108.235 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' PHE . . . . . 0.902 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.3 t80 -55.56 -55.13 35.52 Favored 'General case' 0 N--CA 1.433 -1.325 0 N-CA-C 106.653 -1.61 . . . . 259.78 106.653 178.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' LEU . . . . . 0.492 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.5 mt -69.14 -44.2 72.82 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 113.606 0.965 . . . . 233.11 113.606 -176.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . 0.836 ' O ' HG13 ' A' ' 273' ' ' ILE . 88.7 mt -61.4 -48.34 91.21 Favored Pre-proline 0 CA--C 1.5 -0.946 0 C-N-CA 119.199 -1.0 . . . . 169.54 110.553 -171.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . 0.735 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.8 Cg_exo -61.05 -24.64 79.89 Favored 'Trans proline' 0 N--CA 1.429 -2.287 0 C-N-CA 116.797 -1.668 . . . . 255.47 114.64 174.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' TYR . . . . . 0.824 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.6 t80 -63.57 -44.17 94.88 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 119.233 0.924 . . . . 279.03 108.91 177.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.836 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.34 -44.82 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 N-CA-C 110.076 -0.342 . . . . 162.21 110.076 -178.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' ASN . . . . . 0.784 ' N ' HD12 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.38 84.89 59.25 Favored Pre-proline 0 N--CA 1.431 -1.423 0 C-N-CA 118.761 -1.176 . . . . 128.13 108.067 -178.078 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.26 164.06 11.25 Favored 'Trans proline' 0 C--N 1.295 -2.281 0 N-CA-C 107.487 -1.774 . . . . 278.35 107.487 177.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . 0.866 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.09 15.07 9.94 Favored 'General case' 0 N--CA 1.429 -1.518 0 O-C-N 123.752 0.658 . . . . 312.91 109.319 175.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.866 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.2 mt -132.72 -170.69 2.49 Favored 'General case' 0 CA--C 1.481 -1.686 0 N-CA-C 106.533 -1.654 . . . . 353.54 106.533 177.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 1.008 ' HA ' ' CB ' ' A' ' 282' ' ' PHE . 42.8 p90 -115.63 142.26 46.98 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 107.419 -1.326 . . . . 251.26 107.419 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.764 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -76.92 -118.74 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 102.1 -3.296 . . . . 175.26 102.1 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . 0.793 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.51 -44.96 96.13 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 100.892 -3.744 . . . . 99.07 100.892 172.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . 0.793 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.42 124.15 9.18 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 103.508 -2.775 . . . . 243.21 103.508 171.157 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 1.008 ' CB ' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.97 113.01 25.16 Favored 'General case' 0 CA--C 1.474 -1.967 0 C-N-CA 116.004 -2.278 . . . . 201.04 105.287 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' ILE . . . . . 0.777 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.95 173.71 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.098 0 C-N-CA 116.006 -2.277 . . . . 201.36 108.789 -175.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' GLN . . . . . 1.091 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.283 0.6 OUTLIER -59.48 -41.46 89.84 Favored 'General case' 0 N--CA 1.415 -2.189 0 CA-C-N 113.28 -1.782 . . . . 203.82 107.881 174.44 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . 0.925 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.29 -45.75 86.62 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 118.221 -1.392 . . . . 215.06 112.532 -171.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.553 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.2 t -65.64 -46.41 89.46 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.461 0 C-N-CA 118.562 -1.255 . . . . 125.28 112.948 -171.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' TYR . . . . . 0.951 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.76 -37.01 86.17 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 107.211 -1.404 . . . . 268.9 107.211 -171.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.794 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.26 -44.98 74.4 Favored 'General case' 0 CA--C 1.483 -1.603 0 C-N-CA 125.614 1.566 . . . . 280.88 108.769 -172.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.66 -47.53 85.85 Favored 'General case' 0 CA--C 1.485 -1.534 0 C-N-CA 118.985 -1.086 . . . . 184.47 108.959 -172.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . 0.849 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.8 mp -67.93 -42.09 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 C-N-CA 119.273 -0.971 . . . . 167.92 112.724 -175.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' MET . . . . . 0.502 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.7 ttt -65.7 -38.88 90.45 Favored 'General case' 0 CA--C 1.495 -1.139 0 C-N-CA 117.764 -1.574 . . . . 367.18 110.767 -175.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' TRP . . . . . 0.548 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.5 m95 -67.12 -32.69 73.99 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 121.804 -0.56 . . . . 173.97 110.477 177.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.4 tp -64.48 -36.73 85.13 Favored 'General case' 0 CA--C 1.499 -1.0 0 C-N-CA 123.517 0.727 . . . . 119.66 109.824 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . 0.817 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.26 -33.99 74.44 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 107.659 -1.237 . . . . 112.3 107.659 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' MET . . . . . 0.773 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.12 -31.99 73.26 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 116.252 -0.431 . . . . 174.17 110.246 -177.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.7 m -64.75 -22.77 67.06 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 124.661 1.184 . . . . 145.27 110.6 -175.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' SER . . . . . 0.757 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.5 m -57.61 -35.39 70.39 Favored 'General case' 0 N--CA 1.426 -1.675 0 N-CA-C 108.055 -1.091 . . . . 170.15 108.055 -175.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.82 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.8 t -55.33 -34.08 63.9 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 116.285 -0.416 . . . . 214.57 110.653 -171.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . 0.752 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.1 ttt -77.25 -33.24 56.02 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 126.093 1.757 . . . . 168.29 115.499 177.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' TYR . . . . . 0.757 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.41 -34.83 79.08 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 114.098 1.148 . . . . 167.15 114.098 -168.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . 0.725 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.282 18.8 p-10 -64.2 -38.36 33.84 Favored Pre-proline 0 N--CA 1.434 -1.274 0 C-N-CA 115.536 -2.465 . . . . 165.13 113.89 -171.625 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' PRO . . . . . 0.725 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.4 Cg_exo -62.51 -31.81 80.22 Favored 'Trans proline' 0 N--CA 1.434 -2.004 0 CA-C-N 122.762 2.022 . . . . 123.92 111.272 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' ILE . . . . . 0.714 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.81 -42.57 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 C-N-CA 118.878 -1.129 . . . . 110.55 109.743 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' ILE . . . . . 1.0 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.0 pt -61.17 -39.97 84.29 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.146 0 N-CA-C 108.843 -0.799 . . . . 145.31 108.843 -177.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . 0.927 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.254 63.4 m-85 -58.17 -48.75 79.3 Favored 'General case' 0 CA--C 1.494 -1.174 0 C-N-CA 119.373 -0.931 . . . . 246.68 109.846 -177.509 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.5 m -62.25 -47.47 84.25 Favored 'General case' 0 CA--C 1.485 -1.536 0 C-N-CA 119.536 -0.866 . . . . 64.43 109.559 -173.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.8 t -66.85 -45.03 79.48 Favored 'General case' 0 N--CA 1.428 -1.532 0 C-N-CA 118.963 -1.095 . . . . 80.72 110.259 -177.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.708 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.46 -35.71 75.88 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 116.007 1.855 . . . . 140.44 116.007 -173.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . 0.658 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.82 132.22 34.36 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 112.704 -3.598 . . . . 178.87 113.08 -177.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . 0.609 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.02 -37.09 86.47 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 114.406 -1.27 . . . . 110.22 110.093 -177.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.859 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.73 -50.61 72.63 Favored 'General case' 0 CA--C 1.492 -1.258 0 O-C-N 121.714 -0.617 . . . . 174.78 109.737 -174.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.96 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.1 m-85 -64.87 -41.74 95.41 Favored 'General case' 0 CA--C 1.484 -1.573 0 N-CA-C 108.212 -1.033 . . . . 161.84 108.212 178.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . 0.518 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.7 ttp180 -57.24 -50.3 73.3 Favored 'General case' 0 CA--C 1.49 -1.327 0 N-CA-C 109.206 -0.664 . . . . 117.2 109.206 -173.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.798 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.52 -44.06 75.42 Favored 'General case' 0 N--CA 1.433 -1.277 0 C-N-CA 120.385 -0.526 . . . . 112.6 111.038 -177.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . 0.87 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -64.09 -37.42 94.55 Favored Glycine 0 N--CA 1.43 -1.759 0 N-CA-C 110.644 -0.982 . . . . 101.46 110.644 -177.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' PHE . . . . . 1.011 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.6 m-85 -62.15 -45.99 90.96 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-N 118.491 1.145 . . . . 151.49 109.519 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . 0.415 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.6 ttmt -60.1 -36.33 77.18 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 106.942 -1.503 . . . . 142.32 106.942 -175.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' HIS . . . . . 0.825 ' NE2' HG21 ' A' ' 326' ' ' ILE . 49.9 m80 -59.75 -41.84 91.9 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.883 -1.525 . . . . 109.09 106.883 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.84 -42.45 85.76 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.353 -0.217 . . . . 76.11 110.999 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -61.41 -55.55 30.2 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 119.914 -0.714 . . . . 120.24 109.299 -174.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . 0.58 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.4 mtt180 -74.3 131.52 41.25 Favored 'General case' 0 CA--C 1.482 -1.651 0 N-CA-C 102.973 -2.973 . . . . 192.73 102.973 177.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.16 -44.17 92.11 Favored 'General case' 0 CA--C 1.491 -1.312 0 C-N-CA 119.0 -1.08 . . . . 176.29 109.238 -172.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' CYS . . . . . 0.752 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.2 m -79.34 -177.06 0.8 Allowed Pre-proline 0 N--CA 1.43 -1.47 0 N-CA-C 106.35 -1.722 . . . . 69.68 106.35 178.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.7 Cg_exo -59.04 -75.58 0.02 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.373 0 C-N-CA 118.337 -0.642 . . . . 191.05 112.589 176.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' PHE . . . . . 0.752 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.4 m-85 47.5 43.9 16.28 Favored 'General case' 0 CA--C 1.493 -1.212 0 O-C-N 123.613 0.571 . . . . 287.03 109.73 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . 0.825 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.53 78.62 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.474 -1.955 0 C-N-CA 112.918 -3.513 . . . . 292.29 109.844 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . 0.48 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.2 t -77.5 -152.87 0.05 Allowed 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 104.237 -2.505 . . . . 184.57 104.237 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.69 8.75 4.95 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 113.039 0.755 . . . . 274.56 113.039 176.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.96 0.84 57.3 Favored Glycine 0 C--N 1.349 1.26 0 C-N-CA 117.717 -2.182 . . . . 268.24 113.48 172.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' ASP . . . . . 0.699 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.8 m-20 51.62 -172.07 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.085 0 CA-C-N 118.694 1.247 . . . . 200.06 110.737 177.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.859 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.3 t80 -63.84 -33.04 74.78 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 107.915 -1.143 . . . . 114.44 107.915 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' GLU . . . . . 0.547 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.27 46.09 21.83 Favored 'General case' 0 CA--C 1.484 -1.571 0 N-CA-C 107.59 -1.263 . . . . 263.81 107.59 -177.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' GLY . . . . . 0.633 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.3 -137.35 3.6 Favored Glycine 0 CA--C 1.479 -2.204 1 N-CA-C 102.529 -4.228 . . . . 103.79 102.529 -179.871 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 1.04 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.5 mt -88.25 95.67 10.26 Favored 'General case' 0 N--CA 1.419 -2.017 0 C-N-CA 114.91 -2.716 . . . . 117.3 105.997 177.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . 1.021 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -66.0 -39.8 90.59 Favored 'General case' 0 CA--C 1.469 -2.173 1 N-CA-C 97.961 -4.829 . . . . 231.58 97.961 167.235 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . 1.031 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.93 163.5 29.03 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 102.112 -3.292 . . . . 303.24 102.112 169.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' LYS . . . . . 1.04 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.3 tttt -62.69 -48.56 78.72 Favored 'General case' 0 N--CA 1.432 -1.365 0 C-N-CA 115.997 -2.281 . . . . 112.72 108.381 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.9 t -61.02 -63.67 1.22 Allowed 'General case' 0 CA--C 1.49 -1.334 0 N-CA-C 109.121 -0.696 . . . . 83.22 109.121 -176.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' THR . . . . . 0.883 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.0 m -156.25 -126.25 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 103.806 -2.664 . . . . 174.36 103.806 -178.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . 1.021 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.84 160.93 8.77 Favored 'General case' 0 CA--C 1.485 -1.552 0 N-CA-C 105.796 -1.927 . . . . 202.73 105.796 177.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . 1.012 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.94 149.01 52.56 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 107.071 -1.455 . . . . 180.62 107.071 176.413 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . 0.929 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.5 tp -178.48 -171.88 0.27 Allowed 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 105.393 -2.077 . . . . 145.25 105.393 178.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' GLN . . . . . 0.929 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.06 -43.15 88.27 Favored 'General case' 0 CA--C 1.487 -1.455 0 N-CA-C 106.165 -1.791 . . . . 66.05 106.165 174.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' THR . . . . . 0.764 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.67 -152.2 0.49 Allowed 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 103.498 -2.778 . . . . 266.49 103.498 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 345' ' ' GLN . . . . . 0.701 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.3 mt-30 66.35 -124.96 0.28 Allowed 'General case' 0 CA--C 1.485 -1.549 0 C-N-CA 116.99 -1.884 . . . . 219.2 107.742 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 346' ' ' GLY . . . . . 0.9 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.07 -37.38 94.11 Favored Glycine 0 N--CA 1.425 -2.067 0 CA-C-N 114.572 -1.195 . . . . 94.78 112.865 -175.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 347' ' ' SER . . . . . 0.825 ' HA ' ' SD ' ' A' ' 336' ' ' MET . 48.4 t -81.23 100.41 9.11 Favored 'General case' 0 CA--C 1.484 -1.566 0 C-N-CA 112.359 -3.736 . . . . 121.41 109.467 -171.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 348' ' ' VAL . . . . . 0.439 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.6 t -73.03 145.49 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 N-CA-C 108.974 -0.75 . . . . 85.34 108.974 -176.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 349' ' ' TYR . . . . . 0.439 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.6 p90 -57.73 143.37 42.12 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 107.825 -1.176 . . . . 267.57 107.825 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 350' ' ' LYS . . . . . 0.525 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.07 69.61 0.59 Allowed 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 109.529 -0.545 . . . . 226.1 109.529 -179.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 351' ' ' VAL . . . . . 0.825 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.5 p -51.08 156.95 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 N-CA-C 106.928 -1.508 . . . . 154.84 106.928 177.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . 0.582 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.5 m -61.31 161.91 8.46 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-O 121.595 0.712 . . . . 180.01 110.728 -173.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 353' ' ' ARG . . . . . 0.895 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.43 156.94 23.59 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 106.923 -1.51 . . . . 333.78 106.923 -178.597 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 354' ' ' LEU . . . . . 0.976 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.04 142.51 48.77 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 107.37 -1.345 . . . . 335.2 107.37 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.976 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.6 mm-40 82.84 158.91 0.13 Allowed 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 108.729 -0.841 . . . . 266.47 108.729 179.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.9 m -60.66 -46.83 88.84 Favored 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 105.678 -1.971 . . . . 59.34 105.678 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.58 173.85 11.97 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 104.408 -2.441 . . . . 201.26 104.408 176.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.75 HG22 ' O ' ' A' ' 360' ' ' THR . 69.1 mt -95.88 106.77 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.529 0 C-N-CA 116.343 -2.143 . . . . 56.23 105.521 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . 0.468 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.5 m -61.24 -59.43 5.32 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 109.272 -0.64 . . . . 87.58 109.272 -175.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . 0.887 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.2 t -85.59 153.74 22.19 Favored 'General case' 0 CA--C 1.486 -1.496 0 N-CA-C 107.811 -1.181 . . . . 219.95 107.811 -177.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 361' ' ' VAL . . . . . 0.589 ' O ' HG23 ' A' ' 361' ' ' VAL . 15.9 m -82.04 83.86 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 C-N-CA 116.29 -2.164 . . . . 121.79 105.436 177.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.596 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.7 t -154.09 159.72 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.548 0 N-CA-C 105.843 -1.91 . . . . 53.85 105.843 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . 0.596 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.22 16.64 77.07 Favored Glycine 0 N--CA 1.428 -1.87 0 N-CA-C 106.057 -2.817 . . . . 196.55 106.057 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.662 0 N-CA-C 107.911 -1.144 . . . . 35.88 107.911 -178.942 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 365' ' ' ARG . . . . . 0.62 HH21 ' CG ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 108.865 -0.791 . . . . 1.0 108.865 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 366' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' B' ' 365' ' ' ARG . 52.6 Cg_endo -66.89 142.02 61.05 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.08 1.854 . . . . 1.0 110.245 178.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 367' ' ' LYS . . . . . 0.767 ' HB3' HD11 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -64.43 143.3 98.51 Favored Pre-proline 0 C--N 1.325 -0.498 0 C-N-CA 119.825 -0.75 . . . . 1.0 109.587 -179.894 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 368' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.29 150.44 76.38 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.349 2.033 . . . . 1.0 111.712 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 369' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.74 131.78 44.37 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.749 -0.38 . . . . 1.0 110.243 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.01 115.82 31.36 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.646 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 371' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -63.69 -42.3 98.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.481 . . . . 1.0 110.422 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 372' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.03 -36.26 83.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.678 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -59.68 -33.09 75.92 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.811 -0.916 . . . . 1.0 110.811 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 374' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 120.873 0.368 . . . . 1.0 110.192 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.442 0 N-CA-C 108.377 -0.971 . . . . 97.08 108.377 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -110.62 155.44 22.37 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-O 122.123 0.963 . . . . 123.41 110.711 -172.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.885 HG11 HD13 ' A' ' 15' ' ' ILE . 28.7 m -134.6 -162.38 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.479 1 N-CA-C 100.081 -4.044 . . . . 151.3 100.081 173.754 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.915 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.67 -38.57 57.91 Favored Pre-proline 0 N--CA 1.439 -0.996 0 C-N-CA 115.968 -2.293 . . . . 169.25 106.115 178.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.915 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 58.3 Cg_exo -81.32 168.51 16.61 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 122.281 0.621 . . . . 185.76 110.505 171.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.908 HG13 ' CE2' ' A' ' 282' ' ' PHE . 91.7 t -64.47 -25.92 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 C-N-CA 127.028 2.131 . . . . 145.47 110.347 -177.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.778 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.1 t0 -84.3 157.42 21.53 Favored 'General case' 0 N--CA 1.439 -0.981 0 O-C-N 121.078 -1.014 . . . . 102.76 109.464 -178.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.6 p -82.58 154.19 25.11 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 107.976 -1.12 . . . . 106.25 107.976 178.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.919 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.7 p-10 -105.89 51.85 0.74 Allowed 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 117.769 -1.573 . . . . 157.81 107.599 178.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.1 tp -60.1 -45.94 91.29 Favored 'General case' 0 CA--C 1.481 -1.696 0 N-CA-C 103.607 -2.738 . . . . 150.2 103.607 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.9 m -87.07 164.69 35.22 Favored Pre-proline 0 N--CA 1.422 -1.867 0 N-CA-C 103.653 -2.721 . . . . 183.52 103.653 172.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -76.78 6.86 3.85 Favored 'Trans proline' 0 C--N 1.281 -2.988 0 N-CA-C 109.986 -0.813 . . . . 235.61 109.986 176.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -57.88 -41.27 82.15 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 124.813 1.245 . . . . 113.77 113.398 -170.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.919 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.4 pt -52.19 136.24 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-N 119.541 1.064 . . . . 150.85 110.963 -176.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.8 t -140.49 156.24 46.4 Favored 'General case' 0 C--N 1.36 1.036 0 N-CA-C 107.634 -1.247 . . . . 100.42 107.634 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 1.083 HG23 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.0 142.64 58.36 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 121.895 0.855 . . . . 129.36 110.455 -174.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.772 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.12 -25.5 68.39 Favored 'General case' 0 CA--C 1.493 -1.213 0 C-N-CA 126.309 1.843 . . . . 112.34 106.668 -177.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.938 HG23 ' HA2' ' A' ' 101' ' ' GLY . 85.8 m -74.11 -40.2 62.84 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 115.538 -0.756 . . . . 131.73 111.741 177.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 1.083 ' H ' HG23 ' A' ' 17' ' ' THR . 71.4 m -84.42 -42.89 15.19 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 116.989 2.218 . . . . 80.49 116.989 -174.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.551 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.5 mt-10 -145.96 174.54 3.35 Favored Pre-proline 0 N--CA 1.442 -0.847 0 C-N-CA 118.179 -1.408 . . . . 98.98 111.234 -169.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.822 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.334 85.7 Cg_exo -61.72 -10.86 18.23 Favored 'Trans proline' 0 C--N 1.321 -0.907 1 N-CA-C 128.931 6.473 . . . . 246.95 128.931 -170.104 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.629 HD21 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.68 17.54 8.76 Favored 'General case' 0 C--N 1.324 -0.518 1 CA-C-N 126.154 4.07 . . . . 269.62 114.22 175.68 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.496 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.5 mt-30 -67.14 -27.26 67.17 Favored 'General case' 0 CA--C 1.495 -1.154 0 N-CA-C 107.814 -1.18 . . . . 86.8 107.814 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.551 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.3 p90 -66.87 -29.3 69.17 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 121.116 -0.99 . . . . 85.91 110.467 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.877 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.4 t -68.59 -40.18 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 C-N-CA 123.734 0.814 . . . . 82.0 111.346 -177.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.898 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.39 167.74 12.47 Favored Pre-proline 0 CA--C 1.489 -1.391 0 N-CA-C 108.559 -0.904 . . . . 120.73 108.559 -178.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.903 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -63.99 149.75 89.86 Favored 'Trans proline' 0 N--CA 1.433 -2.07 0 C-N-CA 120.644 0.896 . . . . 87.86 109.847 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.743 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.0 -37.98 89.37 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 108.87 -0.789 . . . . 36.46 108.87 -176.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.814 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.9 p-90 -63.82 -33.83 76.56 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 107.81 -1.181 . . . . 150.6 107.81 -176.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.903 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.5 mt-30 -62.24 -32.72 73.44 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 108.624 -0.88 . . . . 123.26 108.624 -178.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.743 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.43 -47.27 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 N-CA-C 109.125 -0.694 . . . . 120.14 109.125 176.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.786 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.3 m -67.4 -31.03 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 N-CA-C 107.866 -1.161 . . . . 112.19 107.866 -178.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.814 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.5 tp -62.96 -47.13 84.53 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 119.973 -0.691 . . . . 60.87 109.61 -178.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.669 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.08 -35.66 81.11 Favored 'General case' 0 CA--C 1.489 -1.386 0 C-N-CA 119.974 -0.69 . . . . 157.57 110.325 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.744 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.6 -40.87 98.29 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 108.65 -0.871 . . . . 47.06 108.65 178.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.807 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.76 -41.29 98.01 Favored 'General case' 0 CA--C 1.496 -1.111 0 O-C-N 121.76 -0.587 . . . . 43.94 109.546 -177.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.727 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.83 -43.38 98.96 Favored 'General case' 0 CA--C 1.49 -1.364 0 N-CA-C 108.657 -0.868 . . . . 42.61 108.657 -176.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.906 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.29 -41.25 94.3 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 116.631 -0.259 . . . . 140.66 111.079 -178.367 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.807 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.77 -43.98 97.79 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 118.576 -1.249 . . . . 116.04 110.239 -175.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.673 HG22 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.47 -38.69 83.06 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.302 0 N-CA-C 108.726 -0.842 . . . . 97.16 108.726 -177.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.854 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.2 mt -61.29 -40.05 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 N-CA-C 108.944 -0.761 . . . . 54.85 108.944 -176.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.949 HG22 HG21 ' A' ' 86' ' ' THR . 93.0 t -57.69 -42.35 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.32 0 N-CA-C 108.878 -0.786 . . . . 45.39 108.878 -175.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 48' ' ' VAL . 97.5 t -63.5 -50.98 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 C-N-CA 118.844 -1.142 . . . . 48.64 110.218 -177.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.75 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.6 t -65.3 -46.95 78.35 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 120.117 -0.633 . . . . 116.65 111.744 -174.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.588 ' N ' HG23 ' A' ' 45' ' ' THR . 50.7 m -62.0 -43.94 97.79 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 109.718 -0.475 . . . . 51.16 109.718 -174.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.4 t -65.56 -48.93 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 C-N-CA 119.885 -0.726 . . . . 44.3 110.818 -176.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.868 ' O ' HG23 ' A' ' 52' ' ' VAL . 93.7 t -64.78 -46.93 90.59 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.048 0 C-N-CA 120.34 -0.544 . . . . 48.82 111.005 -174.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.78 -44.14 95.21 Favored Glycine 0 N--CA 1.438 -1.213 0 C-N-CA 120.529 -0.843 . . . . 58.7 112.02 -174.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -72.67 -34.19 67.06 Favored 'General case' 0 CA--C 1.488 -1.433 0 O-C-N 122.107 -0.643 . . . . 101.4 110.993 -175.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.74 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.94 -38.69 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 107.761 -1.199 . . . . 103.57 107.761 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 48' ' ' VAL . 71.8 t -61.43 -43.05 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 108.989 -0.745 . . . . 61.89 108.989 -178.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.54 ' O ' HG22 ' A' ' 56' ' ' ILE . 81.8 t -63.42 -50.99 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 109.458 -0.571 . . . . 70.01 109.458 -178.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.8 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.95 -43.41 98.85 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.13 -0.693 . . . . 132.1 109.13 -176.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.645 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.12 -46.69 83.02 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 116.705 -0.225 . . . . 104.5 110.469 -176.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 1.006 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.63 -49.93 80.24 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 C-N-CA 120.254 -0.578 . . . . 142.96 111.253 -173.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.957 HD11 HG12 ' A' ' 72' ' ' VAL 0.277 24.7 pt -64.79 -41.66 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.639 0 C-N-CA 116.956 -1.898 . . . . 158.32 110.868 -175.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.8 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.76 -41.3 98.02 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 117.699 -1.6 . . . . 137.11 109.514 178.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.46 -44.49 90.94 Favored 'General case' 0 N--CA 1.436 -1.156 0 O-C-N 122.117 -0.364 . . . . 54.66 110.972 -176.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.921 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.9 m-70 -91.42 117.13 29.41 Favored 'General case' 0 CA--C 1.49 -1.348 0 CA-C-O 121.662 0.744 . . . . 127.18 109.555 -174.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.621 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.83 -36.81 80.06 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 124.089 0.956 . . . . 87.93 110.877 -176.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 1.028 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.37 -34.7 78.77 Favored 'General case' 0 CA--C 1.49 -1.341 0 O-C-N 121.622 -0.674 . . . . 131.12 111.512 -175.669 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 1.01 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.61 69.46 7.12 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 115.307 -2.557 . . . . 246.56 109.647 -175.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.413 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.23 91.44 3.48 Favored 'General case' 0 CA--C 1.474 -1.946 0 N-CA-C 105.465 -2.05 . . . . 339.35 105.465 177.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.444 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.5 p -124.15 165.27 17.85 Favored 'General case' 0 N--CA 1.414 -2.251 0 N-CA-C 103.01 -2.959 . . . . 114.66 103.01 176.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.881 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.14 -39.49 85.44 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.615 0 N-CA-C 106.748 -1.575 . . . . 143.28 106.748 178.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.833 HG22 HD13 ' A' ' 71' ' ' LEU . 95.8 m -59.66 -38.05 80.4 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 108.676 -0.861 . . . . 160.22 108.676 -176.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.528 ' ND2' ' HB3' ' A' ' 63' ' ' MET . 86.3 m-20 -62.39 -31.73 72.44 Favored 'General case' 0 CA--C 1.489 -1.37 0 N-CA-C 108.858 -0.793 . . . . 120.54 108.858 -177.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.903 ' O ' HG22 ' A' ' 72' ' ' VAL . 89.7 m-85 -63.64 -43.76 95.85 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.465 -0.569 . . . . 67.22 109.465 178.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.881 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.6 m-85 -66.53 -39.8 88.78 Favored 'General case' 0 CA--C 1.498 -1.057 0 O-C-N 121.533 -0.729 . . . . 138.6 109.675 -177.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.925 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.56 -35.9 82.02 Favored 'General case' 0 CA--C 1.492 -1.26 0 C-N-CA 122.487 0.315 . . . . 151.46 110.663 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.957 HG12 HD11 ' A' ' 57' ' ' ILE . 23.9 m -62.55 -37.92 80.13 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 C-N-CA 117.406 -1.717 . . . . 117.93 106.753 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.449 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.0 t30 -60.17 -45.95 91.34 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 107.837 -1.171 . . . . 56.82 107.837 -177.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.987 HD21 ' HE1' ' A' ' 123' ' ' MET . 8.7 mp -61.38 -43.89 98.09 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 108.941 -0.763 . . . . 145.3 108.941 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.07 -40.36 95.53 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 108.535 -0.913 . . . . 45.71 108.535 -175.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -62.44 -41.95 99.11 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 109.399 -0.593 . . . . 105.61 109.399 -178.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.16 -39.48 92.79 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 108.605 -0.887 . . . . 47.89 108.605 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.588 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.56 -37.31 84.69 Favored 'General case' 0 N--CA 1.438 -1.062 0 O-C-N 122.084 -0.385 . . . . 124.53 109.988 179.692 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.88 -41.25 99.33 Favored 'General case' 0 N--CA 1.437 -1.089 0 O-C-N 121.942 -0.474 . . . . 35.89 109.819 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.7 t -62.16 -37.35 84.9 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 107.048 -1.464 . . . . 88.97 107.048 -178.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.82 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.7 ttm -62.16 -49.18 76.88 Favored 'General case' 0 N--CA 1.427 -1.579 0 C-N-CA 119.792 -0.763 . . . . 239.91 109.055 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.618 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.36 -43.37 91.02 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 121.579 -0.7 . . . . 146.1 110.62 -177.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.418 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.18 -58.22 3.41 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 117.403 -1.719 . . . . 91.74 113.826 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -76.57 -61.37 1.98 Allowed 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 115.746 1.758 . . . . 197.45 115.746 -173.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.945 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.25 -42.26 55.6 Favored 'General case' 0 CA--C 1.49 -1.36 0 C-N-CA 117.884 -1.527 . . . . 242.6 114.056 -170.045 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.949 HG21 HG22 ' A' ' 43' ' ' VAL . 4.7 t -65.45 -36.55 84.23 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 118.926 -1.109 . . . . 215.61 109.821 -172.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.422 ' N ' ' CG2' ' A' ' 86' ' ' THR . 71.9 t -60.25 -46.96 94.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 O-C-N 121.811 -0.556 . . . . 87.19 110.505 -175.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.836 HG21 ' CD2' ' A' ' 108' ' ' HIS . 63.7 t -65.94 -41.88 90.74 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.122 0 N-CA-C 109.704 -0.48 . . . . 231.82 109.704 -178.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.906 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 11.0 m120 -62.33 -34.1 75.98 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 108.335 -0.987 . . . . 364.98 108.335 -177.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.67 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.4 t80 -68.24 -44.66 75.2 Favored 'General case' 0 N--CA 1.438 -1.064 0 O-C-N 121.507 -0.746 . . . . 181.63 111.257 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.812 HG22 ' HD2' ' A' ' 95' ' ' HIS . 57.4 m -60.89 -45.81 93.14 Favored 'General case' 0 CA--C 1.477 -1.829 0 N-CA-C 107.422 -1.325 . . . . 269.02 107.422 -175.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 1.048 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.66 -45.07 93.16 Favored 'General case' 0 CA--C 1.469 -2.164 0 C-N-CA 118.684 -1.206 . . . . 562.66 110.052 -179.063 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.705 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.09 -45.3 95.26 Favored 'General case' 0 CA--C 1.479 -1.788 0 C-N-CA 118.744 -1.183 . . . . 446.75 108.067 -167.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.744 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.388 6.1 m -70.48 -26.23 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 C-N-CA 115.791 -2.364 . . . . 370.05 112.283 -178.746 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.812 ' HD2' HG22 ' A' ' 91' ' ' THR . 89.8 m-70 -74.58 -26.42 59.92 Favored 'General case' 0 CA--C 1.506 -0.747 0 O-C-N 121.626 -0.672 . . . . 354.91 112.483 175.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.822 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.4 m-20 82.75 4.53 1.01 Allowed 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 125.078 1.351 . . . . 462.44 111.926 -178.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.772 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.267 11.9 mm-40 -172.37 178.03 2.91 Favored 'General case' 0 CA--C 1.488 -1.429 0 CA-C-O 122.044 0.926 . . . . 652.37 111.087 171.797 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.789 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.68 86.27 2.15 Favored 'General case' 0 N--CA 1.428 -1.558 0 C-N-CA 128.494 2.718 . . . . 905.99 107.95 -174.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -67.85 -36.42 80.28 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 108.266 -1.013 . . . . 570.43 108.266 -176.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.847 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.56 -36.35 82.36 Favored 'General case' 0 N--CA 1.428 -1.569 0 C-N-CA 125.343 1.457 . . . . 453.22 111.166 -174.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.938 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.56 178.66 33.88 Favored Glycine 0 C--N 1.349 1.288 0 C-N-CA 118.753 -1.689 . . . . 445.63 109.882 177.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.0 mt -56.41 -41.25 76.04 Favored 'General case' 0 CA--C 1.498 -1.022 0 C-N-CA 125.276 1.43 . . . . 457.72 112.351 -170.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -58.64 -46.87 86.2 Favored 'General case' 0 CA--C 1.484 -1.562 0 C-N-CA 118.63 -1.228 . . . . 340.58 109.326 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.847 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.0 m-85 -68.76 -32.16 71.71 Favored 'General case' 0 N--CA 1.423 -1.786 0 C-N-CA 118.741 -1.184 . . . . 453.6 111.559 -176.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.762 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.02 -40.29 73.19 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 105.971 -1.863 . . . . 541.48 105.971 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.89 -47.1 75.95 Favored 'General case' 0 CA--C 1.485 -1.536 0 O-C-N 124.017 0.823 . . . . 466.68 110.852 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -61.78 -47.11 86.63 Favored 'General case' 0 N--CA 1.427 -1.6 0 C-N-CA 117.506 -1.678 . . . . 427.34 107.256 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.836 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.6 m80 -67.08 -36.78 82.75 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 112.425 0.528 . . . . 537.87 112.425 -174.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.574 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.4 -42.67 74.8 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 116.861 -1.936 . . . . 422.12 111.607 175.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.855 ' O ' HG22 ' A' ' 113' ' ' ILE . 75.9 t80 -59.12 -50.05 75.54 Favored 'General case' 0 CA--C 1.502 -0.882 0 O-C-N 121.335 -0.853 . . . . 340.17 111.827 -173.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -65.26 -46.57 71.71 Favored Pre-proline 0 N--CA 1.443 -0.801 0 C-N-CA 119.095 -1.042 . . . . 258.06 111.715 -176.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.945 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.2 Cg_exo -61.49 -31.58 87.84 Favored 'Trans proline' 0 N--CA 1.435 -1.927 0 N-CA-C 115.363 1.255 . . . . 305.71 115.363 176.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.877 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.84 -40.46 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 108.689 -0.856 . . . . 252.7 108.689 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.421 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.9 -40.6 93.7 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 107.807 -1.183 . . . . 149.27 107.807 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.0 -44.83 95.89 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 120.639 -0.424 . . . . 138.08 111.468 -176.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.651 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 65.1 t -66.98 -42.33 88.57 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.937 0 O-C-N 121.581 -0.699 . . . . 132.89 110.96 -177.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.92 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.77 -44.64 92.81 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 108.898 -0.779 . . . . 193.61 108.898 -177.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.554 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.5 -37.68 84.57 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 122.811 0.444 . . . . 63.83 110.069 -175.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 72.0 m -64.03 -52.37 59.79 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 120.721 -0.392 . . . . 76.4 111.242 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.757 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.96 -41.65 93.59 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 N-CA-C 108.17 -1.048 . . . . 171.13 108.17 -175.005 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 1.105 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.1 m-85 -63.84 -38.57 91.58 Favored 'General case' 0 N--CA 1.432 -1.331 0 O-C-N 121.838 -0.539 . . . . 78.3 110.614 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.554 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.5 t -67.1 -35.69 80.32 Favored 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 118.893 -1.123 . . . . 92.36 109.247 -178.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.987 ' HE1' HD21 ' A' ' 74' ' ' LEU . 5.9 mmt -62.55 -34.24 76.54 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 108.154 -1.054 . . . . 93.73 108.154 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.896 HG22 HG13 ' A' ' 212' ' ' ILE . 33.3 p -67.44 -41.65 84.4 Favored 'General case' 0 CA--C 1.495 -1.159 0 C-N-CA 119.224 -0.99 . . . . 132.74 109.318 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.28 -42.09 94.7 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 107.158 -1.423 . . . . 43.39 107.158 -177.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.827 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.4 t -58.47 -41.98 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.369 0 N-CA-C 108.568 -0.901 . . . . 59.34 108.568 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.53 -44.02 95.42 Favored 'General case' 0 CA--C 1.497 -1.067 0 O-C-N 121.808 -0.558 . . . . 69.68 110.529 -177.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.468 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.3 t80 -65.41 -42.82 92.13 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.348 -0.982 . . . . 106.98 108.348 -177.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.827 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.37 -35.51 81.14 Favored 'General case' 0 N--CA 1.433 -1.306 0 C-N-CA 119.598 -0.841 . . . . 147.63 108.972 -177.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.702 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.19 -41.54 99.19 Favored 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 108.524 -0.917 . . . . 190.06 108.524 178.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.6 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.4 t80 -61.35 -44.08 97.78 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 108.29 -1.004 . . . . 118.85 108.29 -177.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.803 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.5 mmt -63.34 -42.64 98.96 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 109.994 -0.373 . . . . 102.5 109.994 -177.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.98 -41.69 95.21 Favored 'General case' 0 CA--C 1.488 -1.418 0 O-C-N 121.799 -0.563 . . . . 89.98 109.82 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.92 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.2 mt -66.54 -50.66 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.711 0 C-N-CA 118.119 -1.432 . . . . 106.09 111.024 -177.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.75 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.1 -48.29 38.41 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.09 0 C-N-CA 117.078 -1.849 . . . . 227.74 111.832 -174.84 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.756 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.84 100.07 50.99 Favored Pre-proline 0 CA--C 1.486 -1.496 0 C-N-CA 116.268 -2.173 . . . . 262.55 110.069 -175.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.3 Cg_endo -69.61 -10.36 28.49 Favored 'Trans proline' 0 C--N 1.289 -2.558 0 C-N-CA 121.564 1.509 . . . . 210.25 111.386 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.707 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.3 111.99 1.0 Allowed 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 106.54 -1.652 . . . . 270.58 106.54 -178.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.885 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.77 -39.51 24.23 Favored Pre-proline 0 N--CA 1.43 -1.453 0 CA-C-N 115.358 -0.837 . . . . 129.84 112.325 -175.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.857 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 81.5 Cg_exo -61.44 -26.51 81.28 Favored 'Trans proline' 0 N--CA 1.431 -2.166 0 N-CA-C 116.311 1.62 . . . . 330.71 116.311 -174.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.756 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.09 77.28 8.0 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 114.445 -2.902 . . . . 204.51 107.257 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.878 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.7 147.38 0.09 Allowed 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 107.488 -1.301 . . . . 387.41 107.488 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.878 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.3 t -143.68 147.0 33.64 Favored 'General case' 0 CA--C 1.496 -1.116 0 C-N-CA 118.841 -1.144 . . . . 166.22 109.484 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.85 -40.72 88.0 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 107.872 -1.159 . . . . 44.23 107.872 176.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.48 ' O ' HG23 ' A' ' 149' ' ' VAL . 88.0 m -60.32 -39.12 85.88 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 108.15 -1.055 . . . . 28.8 108.15 -175.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.667 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.88 -38.78 92.21 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 109.055 -0.721 . . . . 30.29 109.055 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.847 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 90.1 m -59.59 -43.01 93.83 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 109.035 -0.728 . . . . 46.11 109.035 -176.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.46 -42.2 99.3 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 107.665 -1.235 . . . . 87.33 107.665 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.765 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.7 t -61.58 -42.13 92.89 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.366 0 N-CA-C 107.973 -1.121 . . . . 23.69 107.973 -178.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.6 t -63.2 -44.28 99.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 N-CA-C 109.678 -0.489 . . . . 43.86 109.678 -178.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.919 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.0 mm -61.29 -42.49 93.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 N-CA-C 108.327 -0.99 . . . . 91.13 108.327 -176.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . 0.482 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.2 t -62.57 -38.0 88.4 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 108.786 -0.82 . . . . 65.88 108.786 -178.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.765 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.7 t -62.08 -41.86 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 N-CA-C 109.559 -0.534 . . . . 33.86 109.559 -177.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 1.105 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.35 -40.32 85.76 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.217 0 N-CA-C 107.642 -1.244 . . . . 146.52 107.642 -176.815 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . 0.696 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.3 m95 -62.86 -38.36 90.54 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 119.477 -0.889 . . . . 75.44 108.942 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.8 t -60.53 -48.44 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 O-C-N 120.976 -1.078 . . . . 43.64 109.71 -177.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.792 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.7 -37.98 89.39 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 109.034 -0.728 . . . . 102.57 109.034 -178.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.93 -41.13 86.6 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 107.437 -1.32 . . . . 58.16 107.437 -178.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.801 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.06 -32.51 73.9 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 109.015 -0.735 . . . . 121.11 109.015 178.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.792 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.01 -42.34 85.02 Favored 'General case' 0 CA--C 1.488 -1.416 0 C-N-CA 118.586 -1.246 . . . . 153.15 109.951 -178.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 1.061 HD13 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.05 -43.75 19.05 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 113.079 -3.448 . . . . 133.67 113.522 173.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.478 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -62.95 -39.92 96.1 Favored 'General case' 0 CA--C 1.49 -1.335 0 O-C-N 120.938 -1.101 . . . . 157.42 112.184 -171.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.524 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.2 t80 -74.4 -36.1 2.47 Favored Pre-proline 0 N--CA 1.437 -1.105 0 N-CA-C 115.058 1.503 . . . . 250.91 115.058 -173.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.291 52.6 Cg_exo -59.58 -25.4 78.75 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 N-CA-C 117.976 2.26 . . . . 207.34 117.976 -174.309 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 1.011 HE21 HG13 ' A' ' 182' ' ' ILE . 87.6 mt-30 -61.22 -34.18 74.69 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 106.954 -1.498 . . . . 192.46 106.954 178.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.52 -41.09 98.07 Favored Glycine 0 C--N 1.353 1.523 0 N-CA-C 107.963 -2.055 . . . . 261.0 107.963 177.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -65.71 159.13 25.71 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 101.537 -3.505 . . . . 491.4 101.537 172.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -59.98 106.82 0.54 Allowed 'General case' 0 CA--C 1.489 -1.403 0 C-N-CA 116.256 -2.178 . . . . 386.1 109.809 -176.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.919 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 73.8 m -154.07 -166.62 2.42 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 103.533 -2.765 . . . . 289.8 103.533 -178.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 1.144 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.3 p -62.93 175.42 0.86 Allowed 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 117.766 -1.112 . . . . 402.06 109.538 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.789 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 72.9 p -165.24 177.5 7.58 Favored 'General case' 0 CA--C 1.586 2.355 0 C-N-CA 127.336 2.254 . . . . 690.53 114.935 177.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.485 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.9 mm-40 132.33 160.53 0.0 OUTLIER 'General case' 1 C--N 1.429 4.048 1 N-CA-C 123.195 4.517 . . . . 633.62 123.195 162.689 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.76 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.3 p -85.62 153.81 22.13 Favored 'General case' 0 C--N 1.389 2.284 0 C-N-CA 127.414 2.286 . . . . 617.99 110.887 177.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . 1.049 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.7 174.44 5.94 Favored Pre-proline 0 C--N 1.364 1.213 0 C-N-CA 130.213 3.405 . . . . 434.98 113.382 -175.385 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 1.092 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 51.5 Cg_endo -44.25 -65.59 0.19 Allowed 'Trans proline' 0 N--CA 1.442 -1.503 0 N-CA-C 122.42 3.969 . . . . 365.88 122.42 -168.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . 0.777 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.305 70.8 m -84.93 20.91 1.72 Allowed 'General case' 0 CA--C 1.467 -2.224 0 N-CA-C 104.79 -2.3 . . . . 635.81 104.79 178.148 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.747 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.458 5.0 mmp_? -94.28 152.22 18.84 Favored 'General case' 1 CA--C 1.419 -4.059 3 N-CA-C 131.984 7.772 . . . . 999.99 131.984 -135.756 . . . . . . . . 5 3 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 1.048 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.911 37.2 t -131.88 73.16 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.765 1 CA-C-N 103.298 -6.319 . . . . 594.32 113.603 149.185 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.731 HG13 ' HB2' ' A' ' 174' ' ' MET . 7.3 p -144.17 144.12 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.653 1 N-CA-C 98.31 -4.7 . . . . 811.91 98.31 162.331 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . 0.76 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.8 m -118.44 144.53 45.9 Favored 'General case' 0 CA--C 1.488 -1.41 0 C-N-CA 117.056 -1.858 . . . . 999.99 109.414 -178.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.945 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.7 mmm -147.18 -175.6 4.89 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-O 121.979 0.895 . . . . 431.86 110.09 -177.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 1.037 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.3 tt -69.2 148.68 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 C-N-CA 124.357 1.063 . . . . 457.18 108.796 -177.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . 0.789 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.34 85.5 3.76 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 124.164 0.985 . . . . 458.77 113.472 -174.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.962 ' CZ3' HG22 ' A' ' 182' ' ' ILE . 1.9 p90 -76.42 -31.46 0.96 Allowed Pre-proline 0 N--CA 1.438 -1.062 0 C-N-CA 124.937 1.295 . . . . 999.99 112.447 168.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.957 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 50.9 Cg_exo -66.03 -45.79 5.48 Favored 'Trans proline' 0 N--CA 1.438 -1.772 0 N-CA-C 120.812 3.351 . . . . 999.99 120.812 -174.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.506 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 54.9 mt-10 -119.58 171.75 8.14 Favored 'General case' 0 CA--C 1.472 -2.051 0 C-N-CA 117.174 -1.81 . . . . 81.18 107.273 -172.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.834 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.9 p-80 -109.11 45.1 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.857 0 C-N-CA 115.505 -2.478 . . . . 999.99 108.759 177.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 1.076 ' HB2' HD12 ' A' ' 191' ' ' ILE . 86.4 Cg_endo -41.51 101.81 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.164 1 C-N-CA 126.037 4.491 . . . . 999.99 105.709 -170.75 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -62.32 -44.0 97.51 Favored 'General case' 0 CA--C 1.482 -1.642 0 C-N-CA 126.775 2.03 . . . . 967.72 112.043 -165.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -60.29 -36.55 78.1 Favored 'General case' 0 CA--C 1.487 -1.48 0 N-CA-C 106.745 -1.576 . . . . 934.3 106.745 -175.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 1.076 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.54 -30.25 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 C-N-CA 129.154 2.981 . . . . 565.15 113.954 -178.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 61.58 55.4 2.78 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-N 118.403 0.547 . . . . 755.61 109.828 -175.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 1.144 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.49 -49.26 67.18 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 124.551 1.14 . . . . 325.89 113.286 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.632 ' HE3' ' OH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.82 -44.98 78.42 Favored 'General case' 0 CA--C 1.495 -1.157 0 C-N-CA 123.576 0.75 . . . . 250.21 111.629 -169.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.4 t -64.7 -43.36 96.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 CA-C-O 121.581 0.705 . . . . 142.46 110.374 -175.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 1.037 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.7 t80 -61.15 -41.48 96.82 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 123.935 0.894 . . . . 247.69 108.813 -173.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' HIS . . . . . 0.822 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 23.1 t60 -60.53 -51.4 69.6 Favored 'General case' 0 CA--C 1.492 -1.28 0 C-N-CA 125.465 1.506 . . . . 199.61 113.058 -175.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 82.8 mt -65.29 -44.47 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 107.748 -1.205 . . . . 106.73 107.748 -177.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . 0.719 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.8 t -59.2 -48.51 81.34 Favored 'General case' 0 CA--C 1.487 -1.459 0 CA-C-N 115.867 -0.606 . . . . 115.01 110.201 -173.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 1.061 HG13 HD13 ' A' ' 161' ' ' LEU . 86.2 t -65.24 -49.17 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.626 0 C-N-CA 119.398 -0.921 . . . . 129.42 111.847 -174.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . 0.79 HG22 ' CD1' ' A' ' 206' ' ' PHE . 69.1 m -61.85 -53.13 60.07 Favored 'General case' 0 CA--C 1.482 -1.639 0 C-N-CA 118.186 -1.406 . . . . 172.48 109.977 -172.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.631 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 85.6 t -63.85 -54.25 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 C-N-CA 120.546 -0.462 . . . . 55.86 110.979 -174.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.719 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.58 -51.54 59.01 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 118.57 -1.252 . . . . 184.68 111.502 -174.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 1.056 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.65 -52.38 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 C-N-CA 116.607 -2.037 . . . . 291.81 114.731 -174.696 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.552 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.8 t80 -82.04 -55.03 4.83 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 115.143 1.534 . . . . 130.66 115.143 -178.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . 0.79 ' CD1' HG22 ' A' ' 201' ' ' THR . 40.0 m-85 -66.86 -48.51 68.58 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 114.492 1.293 . . . . 80.16 114.492 -170.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.905 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.52 -45.52 83.37 Favored Pre-proline 0 N--CA 1.435 -1.185 0 C-N-CA 119.989 -0.685 . . . . 136.02 109.504 -174.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.905 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 88.2 Cg_exo -64.76 -27.16 60.01 Favored 'Trans proline' 0 N--CA 1.433 -2.063 0 N-CA-C 110.616 -0.571 . . . . 92.17 110.616 -179.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.685 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.39 -41.33 76.62 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 107.492 -1.299 . . . . 135.6 107.492 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.2 -44.66 91.28 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 109.577 -0.527 . . . . 52.1 109.577 -176.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.617 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.71 -43.46 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 N-CA-C 109.088 -0.708 . . . . 95.89 109.088 -176.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.896 HG13 HG22 ' A' ' 124' ' ' THR . 94.7 mt -61.33 -42.31 93.15 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.386 0 N-CA-C 106.663 -1.606 . . . . 43.41 106.663 -178.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.46 -42.3 99.05 Favored Glycine 0 N--CA 1.432 -1.63 0 N-CA-C 109.343 -1.503 . . . . 27.69 109.343 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . 0.882 ' O ' HG22 ' A' ' 217' ' ' THR . 77.8 t80 -65.72 -47.29 75.83 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 117.409 0.604 . . . . 54.41 110.467 -177.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . 0.825 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.47 -34.11 74.89 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 106.916 -1.513 . . . . 53.88 106.916 -177.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -60.78 -40.81 93.96 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 108.492 -0.929 . . . . 68.29 108.492 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . 0.882 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.81 -38.98 92.79 Favored 'General case' 0 CA--C 1.497 -1.086 0 C-N-CA 119.704 -0.799 . . . . 107.59 110.619 -175.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.825 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.06 -38.37 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 119.584 -0.846 . . . . 111.61 109.49 -177.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.92 HG13 ' CD1' ' A' ' 134' ' ' ILE . 79.5 t -63.3 -22.45 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 N-CA-C 108.428 -0.952 . . . . 85.26 108.428 -178.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.89 -41.95 99.45 Favored Glycine 0 C--N 1.35 1.324 0 N-CA-C 111.014 -0.834 . . . . 40.71 111.014 -176.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.73 -43.99 96.52 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 N-CA-C 108.414 -0.958 . . . . 95.86 108.414 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.819 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.4 p -76.98 -137.47 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.452 -0.944 . . . . 144.37 108.452 -176.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.898 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.6 mt -55.39 132.16 47.51 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 107.574 -1.269 . . . . 326.72 107.574 -177.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' TRP . . . . . 0.466 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 9.0 t90 -119.37 -168.05 1.51 Allowed 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 106.006 -1.85 . . . . 158.38 106.006 -176.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . 0.466 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.34 -41.96 98.9 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 109.632 -0.507 . . . . 36.78 109.632 -178.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.8 m -61.09 125.86 25.25 Favored 'General case' 0 N--CA 1.433 -1.32 0 C-N-CA 119.167 -1.013 . . . . 85.46 109.81 -174.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . 0.693 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.88 126.52 8.82 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 105.54 -2.022 . . . . 127.78 105.54 176.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.928 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.01 139.93 34.85 Favored Pre-proline 0 CA--C 1.493 -1.241 0 N-CA-C 105.977 -1.86 . . . . 164.84 105.977 -179.614 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.928 ' N ' HD13 ' A' ' 228' ' ' ILE . 83.1 Cg_exo -56.86 -39.9 88.08 Favored 'Trans proline' 0 N--CA 1.431 -2.183 0 N-CA-C 113.916 0.698 . . . . 222.35 113.916 -175.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . 0.747 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.16 167.02 44.92 Favored Glycine 0 N--CA 1.427 -1.915 0 N-CA-C 106.423 -2.671 . . . . 45.22 106.423 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.882 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.9 t0 -60.93 -45.76 93.4 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 106.045 -1.835 . . . . 107.57 106.045 177.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . 0.731 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.9 m -65.77 141.83 58.18 Favored 'General case' 0 N--CA 1.429 -1.509 0 C-N-CA 118.894 -1.122 . . . . 167.96 109.145 -175.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.83 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.3 m 99.52 106.74 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 126.746 2.019 . . . . 280.68 109.707 176.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.709 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.7 m-20 56.03 11.21 0.7 Allowed 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 124.452 1.101 . . . . 218.25 110.675 174.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.922 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.35 137.62 54.79 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 105.213 -2.143 . . . . 343.57 105.213 177.407 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.566 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.5 t80 -111.93 81.87 1.53 Allowed 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 106.873 -1.529 . . . . 263.29 106.873 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' HIS . . . . . 0.627 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.4 m-70 104.27 147.07 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.268 0 C-N-CA 126.58 1.952 . . . . 261.92 108.522 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.18 -38.13 89.96 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 107.853 -1.166 . . . . 106.81 107.853 -177.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.738 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.48 -39.9 94.93 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 118.366 -1.334 . . . . 112.2 107.536 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.738 HG12 ' NH1' ' A' ' 244' ' ' ARG . 75.8 t -64.27 -39.78 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 N-CA-C 109.263 -0.643 . . . . 45.41 109.263 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . 0.802 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.2 p -70.93 -32.13 68.95 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 110.233 -0.284 . . . . 97.62 110.233 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.34 -39.66 81.83 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 123.73 0.812 . . . . 59.29 110.972 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.738 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.2 -36.56 84.04 Favored 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 124.601 1.16 . . . . 106.49 110.67 -174.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.922 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.97 -30.63 69.23 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 108.294 -1.002 . . . . 106.62 108.294 -176.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.533 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.5 mttm -65.97 -41.04 91.69 Favored 'General case' 0 N--CA 1.435 -1.201 0 O-C-N 121.771 -0.581 . . . . 75.97 110.094 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.438 ' CG1' ' CE ' ' A' ' 250' ' ' MET . 76.0 t -65.6 -40.81 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 C-N-CA 122.908 0.483 . . . . 65.27 109.763 -178.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.775 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -64.01 -41.55 92.84 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.343 0 C-N-CA 120.39 -0.524 . . . . 107.94 110.185 -177.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.536 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.2 pttt -63.54 -40.85 98.07 Favored 'General case' 0 N--CA 1.433 -1.279 0 O-C-N 121.68 -0.638 . . . . 87.98 110.281 -176.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' MET . . . . . 0.822 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.58 -40.44 96.98 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 118.863 -1.135 . . . . 65.5 108.405 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' MET . . . . . 0.758 ' CE ' HG21 ' A' ' 67' ' ' THR . 68.5 mtt -61.7 -36.38 80.74 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 108.141 -1.059 . . . . 85.05 108.141 -177.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.536 HD12 ' HA ' ' A' ' 248' ' ' LYS . 86.9 mt -63.47 -45.76 97.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 109.061 -0.718 . . . . 42.25 109.061 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . 0.822 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.32 -38.24 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 C-N-CA 119.568 -0.853 . . . . 91.01 109.396 -176.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 1.0 HG22 ' CD1' ' A' ' 304' ' ' ILE . 65.9 t -58.89 -41.53 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 N-CA-C 108.009 -1.108 . . . . 66.09 108.009 -178.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 250' ' ' MET . 94.8 t -66.07 -43.22 92.45 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.298 0 O-C-N 122.093 -0.379 . . . . 52.39 110.285 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 83.9 m -61.76 -46.71 88.44 Favored 'General case' 0 CA--C 1.489 -1.389 0 O-C-N 121.892 -0.505 . . . . 46.42 109.873 -174.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . 0.744 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.5 t -62.34 -38.2 88.6 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 108.314 -0.995 . . . . 116.51 108.314 -177.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' PHE . . . . . 0.491 ' N ' HG23 ' A' ' 256' ' ' THR . 86.0 t80 -60.21 -48.24 82.59 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 109.38 -0.6 . . . . 65.18 109.38 -178.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.99 -42.63 97.13 Favored 'General case' 0 CA--C 1.489 -1.373 0 O-C-N 122.093 -0.379 . . . . 51.33 110.448 -175.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . 0.744 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.65 -43.37 98.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 C-N-CA 118.883 -1.127 . . . . 126.3 109.015 -176.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' CYS . . . . . 0.506 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.7 m -65.54 -49.34 69.28 Favored 'General case' 0 N--CA 1.432 -1.325 0 C-N-CA 119.512 -0.875 . . . . 133.94 112.508 -176.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.817 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.1 m95 -80.63 -33.38 35.79 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 116.869 2.174 . . . . 134.84 116.869 -176.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.782 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.9 tp -58.49 -41.58 89.94 Favored Pre-proline 0 CA--C 1.493 -1.242 0 O-C-N 121.663 -0.648 . . . . 72.23 111.643 -167.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' PRO . . . . . 0.782 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 80.9 Cg_exo -60.63 -36.02 87.14 Favored 'Trans proline' 0 N--CA 1.429 -2.287 0 CA-C-N 119.884 0.994 . . . . 106.13 111.349 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' PHE . . . . . 0.847 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.8 t80 -66.45 -44.6 82.36 Favored 'General case' 0 N--CA 1.434 -1.273 0 C-N-CA 119.7 -0.8 . . . . 128.35 110.019 -178.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' HIS . . . . . 0.643 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.48 -37.87 89.05 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 110.195 -0.298 . . . . 100.73 110.195 -177.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.743 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.23 -44.52 95.14 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 C-N-CA 119.294 -0.962 . . . . 172.72 109.191 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . 0.732 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.5 m-85 -66.63 -28.07 68.19 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 108.199 -1.037 . . . . 249.23 108.199 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' PHE . . . . . 0.904 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.58 -55.1 35.99 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 106.673 -1.603 . . . . 259.78 106.673 178.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' LEU . . . . . 0.492 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.4 mt -69.16 -44.22 72.7 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 113.58 0.955 . . . . 233.11 113.58 -176.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . 0.835 ' O ' HG13 ' A' ' 273' ' ' ILE . 88.6 mt -61.36 -48.27 91.57 Favored Pre-proline 0 N--CA 1.44 -0.967 0 C-N-CA 119.193 -1.003 . . . . 169.54 110.615 -171.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . 0.732 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.6 Cg_exo -61.21 -24.5 79.13 Favored 'Trans proline' 0 N--CA 1.43 -2.25 0 C-N-CA 116.689 -1.741 . . . . 255.47 114.639 174.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' TYR . . . . . 0.822 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.6 t80 -63.61 -44.2 94.66 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 119.271 0.941 . . . . 279.03 108.905 177.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.835 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.27 -44.8 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 N-CA-C 110.102 -0.333 . . . . 162.21 110.102 -178.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' ASN . . . . . 0.784 ' N ' HD12 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.45 84.86 59.42 Favored Pre-proline 0 N--CA 1.431 -1.387 0 C-N-CA 118.76 -1.176 . . . . 128.13 108.029 -178.039 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.5 Cg_endo -85.22 163.99 11.3 Favored 'Trans proline' 0 C--N 1.295 -2.284 0 N-CA-C 107.482 -1.776 . . . . 278.35 107.482 177.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . 0.864 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.14 15.02 9.93 Favored 'General case' 0 N--CA 1.429 -1.524 0 O-C-N 123.794 0.684 . . . . 312.91 109.328 175.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.864 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.5 mt -132.73 -170.72 2.5 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 106.557 -1.646 . . . . 353.54 106.557 177.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 1.006 ' HA ' ' CB ' ' A' ' 282' ' ' PHE . 42.7 p90 -115.61 142.22 47.03 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 107.441 -1.318 . . . . 251.26 107.441 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.762 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -76.94 -118.76 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 102.097 -3.297 . . . . 175.26 102.097 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . 0.792 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.1 ttmt -61.45 -45.02 96.01 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 100.889 -3.745 . . . . 99.07 100.889 172.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . 0.792 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.36 124.15 9.21 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 103.488 -2.782 . . . . 243.21 103.488 171.171 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 1.006 ' CB ' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.95 112.98 25.13 Favored 'General case' 0 CA--C 1.474 -1.979 0 C-N-CA 116.037 -2.265 . . . . 201.04 105.294 178.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' ILE . . . . . 0.778 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.93 173.69 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.064 0 C-N-CA 116.036 -2.266 . . . . 201.36 108.754 -175.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' GLN . . . . . 1.092 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.282 0.6 OUTLIER -59.5 -41.43 89.87 Favored 'General case' 0 N--CA 1.416 -2.164 0 CA-C-N 113.184 -1.825 . . . . 203.82 107.829 174.47 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . 0.924 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.31 -45.75 86.59 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 118.249 -1.38 . . . . 215.06 112.55 -171.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.556 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.7 t -65.66 -46.44 89.31 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.467 0 C-N-CA 118.606 -1.237 . . . . 125.28 112.886 -171.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' TYR . . . . . 0.949 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.83 -36.95 86.0 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 107.169 -1.419 . . . . 268.9 107.169 -171.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.795 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.24 -45.02 74.36 Favored 'General case' 0 N--CA 1.427 -1.602 0 C-N-CA 125.644 1.577 . . . . 280.88 108.808 -172.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.61 -47.53 85.8 Favored 'General case' 0 N--CA 1.428 -1.567 0 C-N-CA 119.01 -1.076 . . . . 184.47 108.988 -172.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . 0.847 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.8 mp -67.91 -42.1 85.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 C-N-CA 119.298 -0.961 . . . . 167.92 112.732 -175.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' MET . . . . . 0.502 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.8 ttt -65.79 -38.75 89.84 Favored 'General case' 0 CA--C 1.495 -1.146 0 C-N-CA 117.779 -1.569 . . . . 367.18 110.785 -175.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' TRP . . . . . 0.55 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.4 m95 -67.19 -32.71 73.97 Favored 'General case' 0 N--CA 1.435 -1.205 0 O-C-N 121.892 -0.505 . . . . 173.97 110.46 177.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.3 tp -64.48 -36.69 85.01 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 123.523 0.729 . . . . 119.66 109.815 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . 0.817 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.29 -33.91 74.34 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.752 -1.203 . . . . 112.3 107.752 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' MET . . . . . 0.773 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.11 -32.09 73.39 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 116.193 -0.458 . . . . 174.17 110.185 -177.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.5 m -64.74 -22.7 67.04 Favored 'General case' 0 CA--C 1.485 -1.525 0 C-N-CA 124.669 1.188 . . . . 145.27 110.638 -175.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' SER . . . . . 0.756 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.6 m -57.66 -35.36 70.45 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 108.056 -1.091 . . . . 170.15 108.056 -175.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.82 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.7 t -55.34 -34.14 63.96 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 116.32 -0.4 . . . . 214.57 110.654 -171.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . 0.75 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.1 ttt -77.18 -33.2 56.45 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 126.065 1.746 . . . . 168.29 115.545 177.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' TYR . . . . . 0.756 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.4 p90 -64.45 -34.86 79.19 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 114.02 1.119 . . . . 167.15 114.02 -168.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . 0.726 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.281 18.8 p-10 -64.22 -38.25 32.78 Favored Pre-proline 0 N--CA 1.433 -1.295 0 C-N-CA 115.536 -2.466 . . . . 165.13 113.961 -171.595 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' PRO . . . . . 0.726 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 83.8 Cg_exo -62.56 -31.8 79.83 Favored 'Trans proline' 0 N--CA 1.433 -2.061 0 CA-C-N 122.791 2.033 . . . . 123.92 111.254 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' ILE . . . . . 0.712 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.76 -42.58 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 C-N-CA 118.859 -1.136 . . . . 110.55 109.739 -179.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' ILE . . . . . 1.0 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.1 pt -61.16 -40.02 84.43 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.179 0 N-CA-C 108.825 -0.806 . . . . 145.31 108.825 -177.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . 0.925 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.253 63.1 m-85 -58.12 -48.84 78.98 Favored 'General case' 0 CA--C 1.495 -1.171 0 C-N-CA 119.416 -0.914 . . . . 246.68 109.824 -177.48 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.7 m -62.14 -47.53 84.17 Favored 'General case' 0 CA--C 1.484 -1.564 0 C-N-CA 119.526 -0.87 . . . . 64.43 109.587 -173.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.6 t -66.83 -45.01 79.62 Favored 'General case' 0 N--CA 1.428 -1.553 0 C-N-CA 118.992 -1.083 . . . . 80.72 110.226 -177.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.707 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.56 -35.66 75.61 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 115.937 1.828 . . . . 140.44 115.937 -173.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . 0.659 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.8 p30 -136.83 132.2 34.3 Favored 'General case' 0 N--CA 1.434 -1.245 0 C-N-CA 112.723 -3.591 . . . . 178.87 113.039 -177.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . 0.609 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.06 -37.0 86.13 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 114.409 -1.269 . . . . 110.22 110.151 -177.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.86 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.77 -50.58 72.77 Favored 'General case' 0 CA--C 1.492 -1.27 0 O-C-N 121.753 -0.592 . . . . 174.78 109.737 -174.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.958 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.1 m-85 -64.92 -41.65 95.38 Favored 'General case' 0 CA--C 1.484 -1.575 0 N-CA-C 108.24 -1.022 . . . . 161.84 108.24 178.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . 0.518 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.32 -50.24 73.58 Favored 'General case' 0 CA--C 1.49 -1.331 0 N-CA-C 109.182 -0.673 . . . . 117.2 109.182 -173.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.802 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.48 -44.16 75.37 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 120.364 -0.534 . . . . 112.6 111.037 -177.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . 0.869 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -63.99 -37.48 94.68 Favored Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 110.648 -0.981 . . . . 101.46 110.648 -177.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' PHE . . . . . 1.006 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.6 m-85 -62.15 -46.01 90.9 Favored 'General case' 0 CA--C 1.492 -1.265 0 CA-C-N 118.493 1.147 . . . . 151.49 109.5 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . 0.417 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.06 -36.34 77.12 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 106.959 -1.497 . . . . 142.32 106.959 -175.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' HIS . . . . . 0.824 ' NE2' HG21 ' A' ' 326' ' ' ILE . 50.0 m80 -59.82 -41.76 92.02 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 106.892 -1.521 . . . . 109.09 106.892 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.9 -42.46 85.45 Favored 'General case' 0 N--CA 1.435 -1.183 0 O-C-N 122.368 -0.208 . . . . 76.11 110.979 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -61.37 -55.49 30.98 Favored 'General case' 0 CA--C 1.49 -1.36 0 C-N-CA 119.866 -0.734 . . . . 120.24 109.361 -174.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . 0.578 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.4 mtt180 -74.36 131.54 41.22 Favored 'General case' 0 CA--C 1.482 -1.649 0 N-CA-C 102.943 -2.984 . . . . 192.73 102.943 177.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.11 -44.27 91.96 Favored 'General case' 0 CA--C 1.492 -1.27 0 C-N-CA 119.008 -1.077 . . . . 176.29 109.212 -172.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' CYS . . . . . 0.754 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 77.9 m -79.34 -177.14 0.82 Allowed Pre-proline 0 N--CA 1.43 -1.439 0 N-CA-C 106.364 -1.717 . . . . 69.68 106.364 178.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.571 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 84.2 Cg_exo -58.93 -75.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.389 0 C-N-CA 118.343 -0.638 . . . . 191.05 112.637 176.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' PHE . . . . . 0.754 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.6 m-85 47.45 43.88 16.09 Favored 'General case' 0 CA--C 1.493 -1.234 0 O-C-N 123.571 0.544 . . . . 287.03 109.803 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . 0.824 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.52 78.65 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.474 -1.944 0 C-N-CA 112.885 -3.526 . . . . 292.29 109.847 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . 0.48 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.4 t -77.48 -152.84 0.05 Allowed 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 104.199 -2.519 . . . . 184.57 104.199 178.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.65 8.67 4.99 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 113.091 0.775 . . . . 274.56 113.091 176.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 99.0 0.89 57.23 Favored Glycine 0 C--N 1.348 1.248 0 C-N-CA 117.725 -2.178 . . . . 268.24 113.473 172.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' ASP . . . . . 0.699 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.9 m-20 51.6 -172.05 0.03 OUTLIER 'General case' 0 CA--C 1.496 -1.099 0 CA-C-N 118.676 1.238 . . . . 200.06 110.782 177.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.86 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.3 t80 -63.86 -33.02 74.75 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 107.892 -1.151 . . . . 114.44 107.892 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' GLU . . . . . 0.549 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.27 46.05 21.91 Favored 'General case' 0 CA--C 1.484 -1.581 0 N-CA-C 107.627 -1.249 . . . . 263.81 107.627 -177.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' GLY . . . . . 0.633 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.31 -137.37 3.61 Favored Glycine 0 CA--C 1.478 -2.229 1 N-CA-C 102.548 -4.221 . . . . 103.79 102.548 -179.804 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 1.035 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.4 mt -88.27 95.61 10.25 Favored 'General case' 0 N--CA 1.419 -1.983 0 C-N-CA 114.95 -2.7 . . . . 117.3 106.013 176.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . 1.014 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.97 -39.8 90.68 Favored 'General case' 0 CA--C 1.468 -2.177 1 N-CA-C 97.977 -4.823 . . . . 231.58 97.977 167.232 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . 1.028 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.91 163.53 28.95 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 102.092 -3.299 . . . . 303.24 102.092 168.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' LYS . . . . . 1.035 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.4 tttt -62.6 -48.64 78.54 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 116.066 -2.253 . . . . 112.72 108.442 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.9 t -61.03 -63.68 1.22 Allowed 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 109.091 -0.707 . . . . 83.22 109.091 -176.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 339' ' ' THR . . . . . 0.883 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.4 m -156.28 -126.18 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 103.858 -2.645 . . . . 174.36 103.858 -178.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . 1.014 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.88 160.94 8.81 Favored 'General case' 0 CA--C 1.486 -1.515 0 N-CA-C 105.789 -1.93 . . . . 202.73 105.789 177.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . 1.01 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.94 149.0 52.56 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 107.065 -1.457 . . . . 180.62 107.065 176.432 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . 0.927 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.6 tp -178.49 -171.85 0.27 Allowed 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 105.407 -2.072 . . . . 145.25 105.407 178.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' GLN . . . . . 0.927 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.06 -43.2 88.13 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 106.113 -1.81 . . . . 66.05 106.113 174.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' THR . . . . . 0.765 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.66 -152.14 0.48 Allowed 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 103.521 -2.77 . . . . 266.49 103.521 179.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 345' ' ' GLN . . . . . 0.702 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.5 mt-30 66.28 -124.97 0.28 Allowed 'General case' 0 N--CA 1.428 -1.572 0 C-N-CA 117.076 -1.85 . . . . 219.2 107.739 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 346' ' ' GLY . . . . . 0.897 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -64.96 -37.43 94.26 Favored Glycine 0 N--CA 1.426 -2.013 0 CA-C-N 114.536 -1.211 . . . . 94.78 112.895 -176.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 347' ' ' SER . . . . . 0.825 ' HB2' ' H ' ' A' ' 342' ' ' LEU . 48.4 t -81.21 100.45 9.12 Favored 'General case' 0 CA--C 1.483 -1.599 0 C-N-CA 112.327 -3.749 . . . . 121.41 109.441 -171.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 348' ' ' VAL . . . . . 0.439 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.2 t -73.09 145.55 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 108.961 -0.755 . . . . 85.34 108.961 -176.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 349' ' ' TYR . . . . . 0.439 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.5 p90 -57.78 143.44 42.09 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.848 -1.167 . . . . 267.57 107.848 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 350' ' ' LYS . . . . . 0.526 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.08 69.53 0.6 Allowed 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 109.532 -0.544 . . . . 226.1 109.532 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 351' ' ' VAL . . . . . 0.827 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.5 p -50.96 156.97 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.315 0 N-CA-C 107.017 -1.475 . . . . 154.84 107.017 177.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . 0.581 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.5 m -61.4 161.92 8.64 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-O 121.602 0.715 . . . . 180.01 110.721 -173.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 353' ' ' ARG . . . . . 0.897 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.45 156.91 23.66 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 106.913 -1.514 . . . . 333.78 106.913 -178.615 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 354' ' ' LEU . . . . . 0.978 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.03 142.54 48.73 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 107.325 -1.361 . . . . 335.2 107.325 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.978 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.5 mm-40 82.79 158.88 0.13 Allowed 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 108.753 -0.832 . . . . 266.47 108.753 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.5 m -60.6 -46.84 88.74 Favored 'General case' 0 CA--C 1.487 -1.467 0 N-CA-C 105.708 -1.96 . . . . 59.34 105.708 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.6 173.83 11.98 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 104.444 -2.428 . . . . 201.26 104.444 176.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.747 HG22 ' O ' ' A' ' 360' ' ' THR . 69.2 mt -95.92 106.7 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 C-N-CA 116.323 -2.151 . . . . 56.23 105.53 -179.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . 0.468 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.7 m -61.15 -59.48 5.26 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 109.308 -0.627 . . . . 87.58 109.308 -175.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . 0.885 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.1 t -85.49 153.71 22.27 Favored 'General case' 0 CA--C 1.486 -1.513 0 N-CA-C 107.871 -1.159 . . . . 219.95 107.871 -177.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 361' ' ' VAL . . . . . 0.59 ' O ' HG23 ' A' ' 361' ' ' VAL . 16.0 m -81.98 83.86 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.656 0 C-N-CA 116.326 -2.15 . . . . 121.79 105.434 177.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.597 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.5 t -154.16 159.68 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 N-CA-C 105.824 -1.917 . . . . 53.85 105.824 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . 0.597 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.28 16.59 77.15 Favored Glycine 0 N--CA 1.428 -1.875 0 N-CA-C 106.046 -2.822 . . . . 196.55 106.046 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.681 0 N-CA-C 107.849 -1.167 . . . . 35.88 107.849 -178.9 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 365' ' ' ARG . . . . . 0.46 HH11 ' HD2' ' B' ' 365' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 108.808 -0.812 . . . . 1.0 108.808 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 366' ' ' PRO . . . . . 0.416 ' CD ' ' N ' ' B' ' 365' ' ' ARG . 52.8 Cg_endo -66.91 141.99 60.78 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.086 1.858 . . . . 1.0 110.228 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 367' ' ' LYS . . . . . 0.888 ' HG3' HD11 ' A' ' 5' ' ' LEU . 0.8 OUTLIER -64.35 143.26 98.45 Favored Pre-proline 0 C--N 1.326 -0.445 0 C-N-CA 119.888 -0.725 . . . . 1.0 109.576 -179.875 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 368' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.31 150.44 76.26 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.272 1.981 . . . . 1.0 111.728 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 369' ' ' GLN . . . . . 0.401 ' OE1' HG21 ' A' ' 19' ' ' THR . 0.0 OUTLIER -70.77 131.75 44.3 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.724 -0.39 . . . . 1.0 110.165 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 370' ' ' GLN . . . . . 0.685 ' NE2' ' HA ' ' B' ' 370' ' ' GLN . 0.0 OUTLIER -102.01 115.93 31.61 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.672 -179.831 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 371' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -63.71 -42.36 97.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.347 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 372' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -65.03 -36.21 83.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.871 -0.604 . . . . 1.0 110.652 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -59.78 -33.0 76.05 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.839 -0.905 . . . . 1.0 110.839 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 374' ' ' LEU . . . . . 0.918 HD13 ' HA ' ' A' ' 20' ' ' SER . 10.0 tp . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 120.885 0.374 . . . . 1.0 110.173 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.457 0 N-CA-C 108.377 -0.971 . . . . 97.08 108.377 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -110.61 155.42 22.39 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-O 122.103 0.954 . . . . 123.41 110.737 -172.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.877 HG11 HD13 ' A' ' 15' ' ' ILE . 28.7 m -134.58 -162.38 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.487 1 N-CA-C 100.093 -4.04 . . . . 151.3 100.093 173.732 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.908 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.63 -38.61 58.55 Favored Pre-proline 0 N--CA 1.439 -0.981 0 C-N-CA 115.961 -2.295 . . . . 169.25 106.123 178.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.908 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 58.0 Cg_exo -81.28 168.53 16.65 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 122.255 0.608 . . . . 185.76 110.536 171.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.906 HG13 ' CE2' ' A' ' 282' ' ' PHE . 92.0 t -64.47 -25.93 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 C-N-CA 127.022 2.129 . . . . 145.47 110.343 -177.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.774 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.2 t0 -84.33 157.41 21.5 Favored 'General case' 0 CA--C 1.499 -0.988 0 O-C-N 121.073 -1.017 . . . . 102.76 109.459 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.5 p -82.59 154.17 25.1 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 107.988 -1.115 . . . . 106.25 107.988 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.918 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.7 p-10 -105.89 51.89 0.74 Allowed 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 117.772 -1.571 . . . . 157.81 107.628 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.16 -45.9 91.51 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 103.586 -2.746 . . . . 150.2 103.586 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.8 m -87.05 164.68 35.29 Favored Pre-proline 0 N--CA 1.422 -1.872 0 N-CA-C 103.672 -2.714 . . . . 183.52 103.672 172.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -76.77 6.87 3.84 Favored 'Trans proline' 0 C--N 1.281 -2.998 0 N-CA-C 109.988 -0.812 . . . . 235.61 109.988 176.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -57.93 -41.25 82.33 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 124.809 1.244 . . . . 113.77 113.379 -170.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.918 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.4 pt -52.16 136.22 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-N 119.558 1.072 . . . . 150.85 110.984 -176.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.49 156.26 46.39 Favored 'General case' 0 C--N 1.36 1.064 0 N-CA-C 107.625 -1.25 . . . . 100.42 107.625 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 1.08 HG23 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.05 142.61 58.35 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 121.953 0.882 . . . . 129.36 110.444 -174.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.775 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.06 -25.5 68.4 Favored 'General case' 0 CA--C 1.494 -1.208 0 C-N-CA 126.303 1.841 . . . . 112.34 106.689 -177.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.941 HG23 ' HA2' ' A' ' 101' ' ' GLY . 85.8 m -74.14 -40.14 62.81 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.542 -0.754 . . . . 131.73 111.744 177.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 1.08 ' H ' HG23 ' A' ' 17' ' ' THR . 71.2 m -84.45 -42.86 15.18 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 116.994 2.22 . . . . 80.49 116.994 -174.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.549 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.4 mt-10 -145.99 174.54 3.34 Favored Pre-proline 0 N--CA 1.443 -0.817 0 C-N-CA 118.152 -1.419 . . . . 98.98 111.198 -169.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.823 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.333 85.7 Cg_exo -61.79 -10.73 18.04 Favored 'Trans proline' 0 C--N 1.321 -0.887 1 N-CA-C 128.934 6.475 . . . . 246.95 128.934 -170.085 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.626 HD21 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.61 17.55 8.7 Favored 'General case' 0 C--N 1.324 -0.515 1 CA-C-N 126.15 4.068 . . . . 269.62 114.216 175.655 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.495 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.6 mt-30 -67.14 -27.26 67.16 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 107.802 -1.184 . . . . 86.8 107.802 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.551 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.3 p90 -66.81 -29.34 69.25 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 121.115 -0.991 . . . . 85.91 110.501 -178.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.873 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.4 t -68.54 -40.21 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 C-N-CA 123.695 0.798 . . . . 82.0 111.346 -177.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.896 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.4 167.73 12.48 Favored Pre-proline 0 CA--C 1.489 -1.4 0 N-CA-C 108.552 -0.907 . . . . 120.73 108.552 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.902 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -64.0 149.76 89.82 Favored 'Trans proline' 0 N--CA 1.432 -2.123 0 C-N-CA 120.616 0.877 . . . . 87.86 109.91 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.744 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.03 -37.96 89.28 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 108.846 -0.798 . . . . 36.46 108.846 -176.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.814 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.8 p-90 -63.8 -33.86 76.61 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 107.807 -1.183 . . . . 150.6 107.807 -176.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.902 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.5 mt-30 -62.21 -32.71 73.41 Favored 'General case' 0 CA--C 1.49 -1.334 0 O-C-N 121.291 -0.88 . . . . 123.26 108.666 -178.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.744 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.47 -47.17 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.57 0 N-CA-C 109.157 -0.682 . . . . 120.14 109.157 176.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.785 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.2 m -67.41 -31.03 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 107.873 -1.158 . . . . 112.19 107.873 -178.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.814 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.5 tp -62.98 -47.12 84.51 Favored 'General case' 0 N--CA 1.432 -1.337 0 C-N-CA 119.921 -0.712 . . . . 60.87 109.601 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.672 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.03 -35.67 81.18 Favored 'General case' 0 CA--C 1.489 -1.382 0 C-N-CA 119.965 -0.694 . . . . 157.57 110.364 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.747 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.61 -40.89 98.39 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 108.629 -0.878 . . . . 47.06 108.629 178.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.805 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.77 -41.28 98.01 Favored 'General case' 0 CA--C 1.496 -1.121 0 O-C-N 121.756 -0.59 . . . . 43.94 109.557 -177.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.731 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.81 -43.3 99.12 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.726 -0.842 . . . . 42.61 108.726 -176.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.902 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.38 -41.26 93.94 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 116.623 -0.262 . . . . 140.66 111.029 -178.364 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.805 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.78 -43.96 97.81 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 118.58 -1.248 . . . . 116.04 110.234 -175.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.673 HG22 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.44 -38.75 83.24 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.292 0 N-CA-C 108.731 -0.84 . . . . 97.16 108.731 -177.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.852 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.2 mt -61.28 -40.0 84.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 N-CA-C 108.975 -0.75 . . . . 54.85 108.975 -176.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.956 HG22 HG21 ' A' ' 86' ' ' THR . 92.9 t -57.71 -42.34 81.48 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.301 0 N-CA-C 108.873 -0.788 . . . . 45.39 108.873 -175.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 48' ' ' VAL . 97.2 t -63.52 -50.97 76.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 C-N-CA 118.848 -1.141 . . . . 48.64 110.171 -177.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.751 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.6 t -65.27 -47.04 78.08 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 120.163 -0.615 . . . . 116.65 111.711 -174.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.59 ' N ' HG23 ' A' ' 45' ' ' THR . 50.8 m -61.96 -43.94 97.79 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 109.715 -0.476 . . . . 51.16 109.715 -174.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.4 t -65.54 -48.93 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 C-N-CA 119.852 -0.739 . . . . 44.3 110.85 -176.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.866 ' O ' HG23 ' A' ' 52' ' ' VAL . 93.8 t -64.75 -46.94 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 C-N-CA 120.299 -0.56 . . . . 48.82 111.032 -174.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.77 -44.15 95.21 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 120.513 -0.851 . . . . 58.7 112.006 -174.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -72.63 -34.21 67.17 Favored 'General case' 0 CA--C 1.488 -1.432 0 O-C-N 122.086 -0.655 . . . . 101.4 111.027 -175.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.742 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.9 -38.73 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 107.745 -1.206 . . . . 103.57 107.745 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 48' ' ' VAL . 72.0 t -61.43 -43.05 96.06 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.225 0 N-CA-C 108.975 -0.75 . . . . 61.89 108.975 -178.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.535 ' O ' HG22 ' A' ' 56' ' ' ILE . 81.8 t -63.44 -50.96 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 N-CA-C 109.47 -0.567 . . . . 70.01 109.47 -178.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.803 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.94 -43.39 98.92 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 109.13 -0.693 . . . . 132.1 109.13 -176.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.643 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.23 -46.62 83.02 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 116.677 -0.238 . . . . 104.5 110.441 -176.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 1.018 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.67 -49.88 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 C-N-CA 120.212 -0.595 . . . . 142.96 111.271 -173.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.949 HD11 HG12 ' A' ' 72' ' ' VAL 0.279 24.8 pt -64.79 -41.68 92.87 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.661 0 C-N-CA 116.947 -1.901 . . . . 158.32 110.877 -175.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.803 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.72 -41.39 98.09 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 117.725 -1.59 . . . . 137.11 109.48 178.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.36 -44.54 91.11 Favored 'General case' 0 N--CA 1.436 -1.165 0 O-C-N 122.164 -0.335 . . . . 54.66 111.019 -176.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.925 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.41 117.12 29.4 Favored 'General case' 0 CA--C 1.491 -1.322 0 CA-C-O 121.623 0.725 . . . . 127.18 109.586 -174.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.62 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.83 -36.84 80.12 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 124.099 0.96 . . . . 87.93 110.832 -176.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 1.036 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.38 -34.67 78.7 Favored 'General case' 0 CA--C 1.49 -1.33 0 O-C-N 121.657 -0.652 . . . . 131.12 111.509 -175.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 1.019 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.61 69.43 7.12 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 115.313 -2.555 . . . . 246.56 109.606 -175.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.412 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.21 91.45 3.48 Favored 'General case' 0 CA--C 1.474 -1.966 0 N-CA-C 105.484 -2.043 . . . . 339.35 105.484 177.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.444 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.5 p -124.15 165.27 17.85 Favored 'General case' 0 N--CA 1.414 -2.248 0 N-CA-C 102.992 -2.966 . . . . 114.66 102.992 176.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.88 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.15 -39.44 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 N-CA-C 106.78 -1.563 . . . . 143.28 106.78 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.836 HG22 HD13 ' A' ' 71' ' ' LEU . 95.4 m -59.69 -38.05 80.5 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 108.687 -0.856 . . . . 160.22 108.687 -176.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.525 ' ND2' ' HB3' ' A' ' 63' ' ' MET . 86.3 m-20 -62.34 -31.78 72.46 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 108.872 -0.788 . . . . 120.54 108.872 -177.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.901 ' O ' HG22 ' A' ' 72' ' ' VAL . 89.8 m-85 -63.59 -43.81 95.86 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 109.481 -0.563 . . . . 67.22 109.481 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.88 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.5 m-85 -66.53 -39.76 88.78 Favored 'General case' 0 CA--C 1.498 -1.055 0 O-C-N 121.488 -0.758 . . . . 138.6 109.668 -177.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.925 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.58 -35.91 82.05 Favored 'General case' 0 CA--C 1.493 -1.237 0 C-N-CA 122.479 0.312 . . . . 151.46 110.641 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.949 HG12 HD11 ' A' ' 57' ' ' ILE . 24.2 m -62.56 -37.95 80.2 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.227 0 C-N-CA 117.39 -1.724 . . . . 117.93 106.715 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.45 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.1 t30 -60.07 -46.03 90.92 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 107.859 -1.163 . . . . 56.82 107.859 -177.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.999 HD21 ' HE1' ' A' ' 123' ' ' MET . 8.7 mp -61.36 -43.91 98.07 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 108.931 -0.766 . . . . 145.3 108.931 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.05 -40.35 95.47 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 108.521 -0.918 . . . . 45.71 108.521 -175.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -62.4 -42.02 99.11 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.377 -0.601 . . . . 105.61 109.377 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.12 -39.45 92.59 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 108.646 -0.872 . . . . 47.89 108.646 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.588 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.56 -37.37 84.83 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 109.966 -0.383 . . . . 124.53 109.966 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.86 -41.22 99.28 Favored 'General case' 0 CA--C 1.496 -1.099 0 O-C-N 121.952 -0.467 . . . . 35.89 109.843 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.8 t -62.23 -37.3 84.86 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 107.025 -1.472 . . . . 88.97 107.025 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.82 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.17 -49.17 76.88 Favored 'General case' 0 N--CA 1.428 -1.55 0 C-N-CA 119.831 -0.748 . . . . 239.91 109.047 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.62 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.38 -43.4 90.81 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 121.536 -0.728 . . . . 146.1 110.596 -177.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.418 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.16 -58.23 3.4 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 117.397 -1.721 . . . . 91.74 113.852 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -76.55 -61.38 1.98 Allowed 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 115.748 1.759 . . . . 197.45 115.748 -173.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.933 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.25 -42.26 55.52 Favored 'General case' 0 CA--C 1.49 -1.365 0 C-N-CA 117.897 -1.521 . . . . 242.6 114.046 -170.036 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.956 HG21 HG22 ' A' ' 43' ' ' VAL . 4.6 t -65.4 -36.55 84.3 Favored 'General case' 0 N--CA 1.434 -1.254 0 C-N-CA 118.912 -1.115 . . . . 215.61 109.838 -172.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.423 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.3 t -60.3 -46.94 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 O-C-N 121.828 -0.545 . . . . 87.19 110.459 -175.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.842 HG21 ' CD2' ' A' ' 108' ' ' HIS . 63.6 t -65.93 -41.86 90.75 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.112 0 N-CA-C 109.731 -0.47 . . . . 231.82 109.731 -178.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.902 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 11.0 m120 -62.32 -34.14 76.06 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 108.317 -0.994 . . . . 364.98 108.317 -177.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.667 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.3 t80 -68.19 -44.72 75.25 Favored 'General case' 0 N--CA 1.438 -1.054 0 O-C-N 121.543 -0.723 . . . . 181.63 111.275 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.81 HG22 ' HD2' ' A' ' 95' ' ' HIS . 57.7 m -60.87 -45.78 93.19 Favored 'General case' 0 CA--C 1.478 -1.809 0 N-CA-C 107.432 -1.321 . . . . 269.02 107.432 -175.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 1.055 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.72 -45.03 93.4 Favored 'General case' 0 N--CA 1.416 -2.149 0 C-N-CA 118.657 -1.217 . . . . 562.66 110.023 -179.058 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.707 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.11 -45.24 95.51 Favored 'General case' 0 CA--C 1.479 -1.787 0 C-N-CA 118.696 -1.202 . . . . 446.75 108.097 -167.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.747 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.388 6.1 m -70.51 -26.31 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 C-N-CA 115.837 -2.345 . . . . 370.05 112.216 -178.755 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.81 ' HD2' HG22 ' A' ' 91' ' ' THR . 90.0 m-70 -74.48 -26.5 60.06 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 121.593 -0.692 . . . . 354.91 112.513 175.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.823 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.4 m-20 82.8 4.53 0.99 Allowed 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 125.067 1.347 . . . . 462.44 111.905 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.775 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.266 11.9 mm-40 -172.35 178.06 2.91 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-O 122.015 0.912 . . . . 652.37 111.122 171.786 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.791 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.73 86.3 2.17 Favored 'General case' 0 N--CA 1.428 -1.565 0 C-N-CA 128.489 2.715 . . . . 905.99 107.929 -174.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -67.87 -36.4 80.21 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 108.244 -1.021 . . . . 570.43 108.244 -176.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.848 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.57 -36.35 82.4 Favored 'General case' 0 N--CA 1.428 -1.54 0 C-N-CA 125.318 1.447 . . . . 453.22 111.157 -174.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.941 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.55 178.66 33.9 Favored Glycine 0 C--N 1.349 1.292 0 C-N-CA 118.768 -1.682 . . . . 445.63 109.891 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.0 mt -56.41 -41.23 75.99 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 125.275 1.43 . . . . 457.72 112.357 -170.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -58.63 -46.93 86.03 Favored 'General case' 0 CA--C 1.484 -1.56 0 C-N-CA 118.662 -1.215 . . . . 340.58 109.296 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.848 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.1 m-85 -68.71 -32.14 71.72 Favored 'General case' 0 N--CA 1.423 -1.775 0 C-N-CA 118.774 -1.171 . . . . 453.6 111.577 -176.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.764 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.05 -40.35 73.37 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 105.976 -1.861 . . . . 541.48 105.976 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.83 -47.14 75.99 Favored 'General case' 0 CA--C 1.486 -1.514 0 O-C-N 123.991 0.807 . . . . 466.68 110.866 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -61.74 -47.08 86.86 Favored 'General case' 0 N--CA 1.427 -1.607 0 C-N-CA 117.48 -1.688 . . . . 427.34 107.315 -178.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.842 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.6 m80 -67.1 -36.79 82.72 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 112.415 0.524 . . . . 537.87 112.415 -174.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.574 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.4 -42.69 74.77 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 116.847 -1.941 . . . . 422.12 111.593 175.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.858 ' O ' HG22 ' A' ' 113' ' ' ILE . 75.9 t80 -59.05 -50.1 75.37 Favored 'General case' 0 CA--C 1.502 -0.883 0 O-C-N 121.324 -0.86 . . . . 340.17 111.834 -173.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -65.29 -46.54 71.37 Favored Pre-proline 0 N--CA 1.443 -0.811 0 C-N-CA 119.082 -1.047 . . . . 258.06 111.723 -176.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.933 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.0 Cg_exo -61.52 -31.54 87.64 Favored 'Trans proline' 0 N--CA 1.435 -1.943 0 N-CA-C 115.368 1.257 . . . . 305.71 115.368 176.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.876 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.91 -40.41 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 N-CA-C 108.687 -0.857 . . . . 252.7 108.687 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.423 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.92 -40.6 93.8 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 107.801 -1.185 . . . . 149.27 107.801 -179.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.0 -44.81 95.93 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 120.625 -0.43 . . . . 138.08 111.506 -176.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.653 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 65.1 t -66.94 -42.39 88.77 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 O-C-N 121.575 -0.703 . . . . 132.89 110.96 -177.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.923 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.76 -44.67 92.79 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 108.884 -0.784 . . . . 193.61 108.884 -177.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.555 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.48 -37.66 84.46 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 122.804 0.442 . . . . 63.83 110.085 -175.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.9 m -64.02 -52.39 59.69 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 120.747 -0.381 . . . . 76.4 111.228 -177.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.749 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.99 -41.63 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 108.185 -1.042 . . . . 171.13 108.185 -174.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 1.098 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.3 m-85 -63.8 -38.56 91.56 Favored 'General case' 0 N--CA 1.433 -1.311 0 O-C-N 121.834 -0.541 . . . . 78.3 110.635 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.557 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.6 t -67.11 -35.74 80.42 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 118.901 -1.12 . . . . 92.36 109.216 -178.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.999 ' HE1' HD21 ' A' ' 74' ' ' LEU . 5.9 mmt -62.5 -34.28 76.55 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 108.173 -1.047 . . . . 93.73 108.173 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.902 HG22 HG13 ' A' ' 212' ' ' ILE . 33.2 p -67.42 -41.65 84.49 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 119.215 -0.994 . . . . 132.74 109.33 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.28 -42.08 94.68 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.18 -1.415 . . . . 43.39 107.18 -177.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.827 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.0 t -58.46 -41.99 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 N-CA-C 108.607 -0.886 . . . . 59.34 108.607 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.48 -44.07 95.45 Favored 'General case' 0 CA--C 1.497 -1.064 0 O-C-N 121.804 -0.56 . . . . 69.68 110.519 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.469 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.3 t80 -65.47 -42.77 91.9 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.326 -0.99 . . . . 106.98 108.326 -177.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.827 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.35 -35.61 81.42 Favored 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 119.662 -0.815 . . . . 147.63 108.951 -177.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.705 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.16 -41.54 99.27 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 108.541 -0.911 . . . . 190.06 108.541 178.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.6 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.5 t80 -61.34 -44.06 97.82 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.31 -0.996 . . . . 118.85 108.31 -177.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.805 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.5 mmt -63.36 -42.66 98.89 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 109.986 -0.375 . . . . 102.5 109.986 -177.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.99 -41.62 95.25 Favored 'General case' 0 CA--C 1.489 -1.39 0 O-C-N 121.82 -0.55 . . . . 89.98 109.841 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.92 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.3 mt -66.52 -50.72 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 C-N-CA 118.13 -1.428 . . . . 106.09 110.991 -177.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.749 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.07 -48.32 38.42 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.099 0 C-N-CA 117.098 -1.841 . . . . 227.74 111.815 -174.792 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.756 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.85 100.08 50.98 Favored Pre-proline 0 CA--C 1.486 -1.505 0 C-N-CA 116.242 -2.183 . . . . 262.55 110.059 -175.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.2 Cg_endo -69.6 -10.39 28.56 Favored 'Trans proline' 0 C--N 1.29 -2.544 0 C-N-CA 121.618 1.545 . . . . 210.25 111.358 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.705 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.28 112.02 1.0 Allowed 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 106.523 -1.658 . . . . 270.58 106.523 -178.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.886 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.82 -39.5 23.87 Favored Pre-proline 0 N--CA 1.43 -1.451 0 CA-C-N 115.358 -0.837 . . . . 129.84 112.347 -175.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.859 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 82.1 Cg_exo -61.36 -26.6 81.77 Favored 'Trans proline' 0 N--CA 1.431 -2.163 0 N-CA-C 116.297 1.614 . . . . 330.71 116.297 -174.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.756 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.03 77.2 7.95 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 114.479 -2.888 . . . . 204.51 107.277 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.877 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.72 147.43 0.09 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 107.435 -1.32 . . . . 387.41 107.435 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.877 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.4 t -143.71 147.02 33.63 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 118.794 -1.162 . . . . 166.22 109.475 178.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.84 -40.76 88.03 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 107.847 -1.168 . . . . 44.23 107.847 176.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.483 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.6 m -60.3 -39.14 85.89 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 108.176 -1.046 . . . . 28.8 108.176 -175.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.668 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.81 -38.79 92.1 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 109.101 -0.703 . . . . 30.29 109.101 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.847 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 89.9 m -59.61 -43.03 93.88 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 108.982 -0.748 . . . . 46.11 108.982 -176.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.46 -42.14 99.26 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 107.693 -1.225 . . . . 87.33 107.693 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.77 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.6 t -61.67 -42.08 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 107.93 -1.137 . . . . 23.69 107.93 -178.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.8 t -63.19 -44.29 99.25 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 109.704 -0.48 . . . . 43.86 109.704 -178.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.918 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.0 mm -61.28 -42.54 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 108.326 -0.991 . . . . 91.13 108.326 -176.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . 0.483 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.2 t -62.6 -37.96 88.29 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.754 -0.832 . . . . 65.88 108.754 -178.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.4 t -62.11 -41.85 92.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.225 0 N-CA-C 109.551 -0.537 . . . . 33.86 109.551 -177.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 1.098 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.4 -40.33 85.87 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.183 0 N-CA-C 107.585 -1.265 . . . . 146.52 107.585 -176.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . 0.7 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.1 m95 -62.86 -38.36 90.51 Favored 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 119.497 -0.881 . . . . 75.44 108.896 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.7 t -60.54 -48.4 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 O-C-N 121.028 -1.045 . . . . 43.64 109.71 -177.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.791 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.7 -38.0 89.47 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 109.029 -0.73 . . . . 102.57 109.029 -178.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.0 -41.09 86.83 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.417 -1.327 . . . . 58.16 107.417 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.801 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.07 -32.48 73.87 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.032 -0.729 . . . . 121.11 109.032 178.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.791 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.02 -42.34 85.09 Favored 'General case' 0 CA--C 1.489 -1.395 0 C-N-CA 118.576 -1.249 . . . . 153.15 109.923 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 1.057 HD13 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.05 -43.75 19.07 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 113.106 -3.437 . . . . 133.67 113.527 173.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.478 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -62.97 -39.9 96.08 Favored 'General case' 0 CA--C 1.489 -1.371 0 O-C-N 120.916 -1.115 . . . . 157.42 112.192 -171.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.522 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.3 t80 -74.45 -36.11 2.45 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 115.012 1.486 . . . . 250.91 115.012 -173.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.292 52.9 Cg_exo -59.5 -25.48 78.84 Favored 'Trans proline' 0 CA--C 1.488 -1.791 0 N-CA-C 118.007 2.272 . . . . 207.34 118.007 -174.351 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 1.013 HE21 HG13 ' A' ' 182' ' ' ILE . 87.6 mt-30 -61.17 -34.19 74.65 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 106.951 -1.5 . . . . 192.46 106.951 178.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.52 -41.03 98.09 Favored Glycine 0 C--N 1.353 1.501 0 N-CA-C 107.969 -2.053 . . . . 261.0 107.969 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.79 159.11 25.96 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 101.513 -3.514 . . . . 491.4 101.513 172.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -59.96 106.82 0.54 Allowed 'General case' 0 CA--C 1.488 -1.434 0 C-N-CA 116.247 -2.181 . . . . 386.1 109.83 -176.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.915 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 73.9 m -154.03 -166.61 2.42 Favored 'General case' 0 N--CA 1.415 -2.224 0 N-CA-C 103.541 -2.763 . . . . 289.8 103.541 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 1.14 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.92 175.4 0.86 Allowed 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 117.736 -1.126 . . . . 402.06 109.565 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.788 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 73.0 p -165.27 177.5 7.56 Favored 'General case' 0 CA--C 1.586 2.353 0 C-N-CA 127.343 2.257 . . . . 690.53 114.94 177.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.487 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.9 mm-40 132.34 160.56 0.0 OUTLIER 'General case' 1 C--N 1.429 4.057 1 N-CA-C 123.19 4.515 . . . . 633.62 123.19 162.704 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.762 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.2 p -85.63 153.83 22.1 Favored 'General case' 0 C--N 1.389 2.3 0 C-N-CA 127.376 2.27 . . . . 617.99 110.903 178.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 1.047 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.69 174.4 6.0 Favored Pre-proline 0 C--N 1.364 1.206 0 C-N-CA 130.271 3.428 . . . . 434.98 113.405 -175.417 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 1.092 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 51.8 Cg_endo -44.24 -65.65 0.19 Allowed 'Trans proline' 0 N--CA 1.441 -1.56 0 N-CA-C 122.418 3.969 . . . . 365.88 122.418 -168.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . 0.778 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.306 70.5 m -84.89 20.95 1.69 Allowed 'General case' 0 CA--C 1.467 -2.239 0 N-CA-C 104.797 -2.298 . . . . 635.81 104.797 178.144 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.75 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.456 5.0 mmp_? -94.39 152.24 18.78 Favored 'General case' 1 CA--C 1.419 -4.064 3 N-CA-C 131.98 7.771 . . . . 999.99 131.98 -135.76 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 1.055 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.911 37.1 t -131.84 73.18 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.772 1 CA-C-N 103.3 -6.318 . . . . 594.32 113.599 149.217 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.726 HG13 ' HB2' ' A' ' 174' ' ' MET . 7.3 p -144.2 144.1 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.639 1 N-CA-C 98.291 -4.707 . . . . 811.91 98.291 162.374 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.762 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.8 m -118.46 144.53 45.92 Favored 'General case' 0 CA--C 1.489 -1.401 0 C-N-CA 117.058 -1.857 . . . . 999.99 109.427 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.97 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.8 mmm -147.19 -175.61 4.9 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-O 122.004 0.907 . . . . 431.86 110.054 -177.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 1.038 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.13 148.67 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 C-N-CA 124.351 1.06 . . . . 457.18 108.801 -177.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . 0.788 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.32 85.47 3.75 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 124.14 0.976 . . . . 458.77 113.503 -174.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.958 ' CZ3' HG22 ' A' ' 182' ' ' ILE . 1.9 p90 -76.37 -31.57 0.98 Allowed Pre-proline 0 N--CA 1.438 -1.048 0 C-N-CA 124.961 1.304 . . . . 999.99 112.426 168.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.956 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -65.95 -45.77 5.65 Favored 'Trans proline' 0 N--CA 1.438 -1.789 0 N-CA-C 120.875 3.375 . . . . 999.99 120.875 -174.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.508 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.56 171.74 8.15 Favored 'General case' 0 CA--C 1.472 -2.047 0 C-N-CA 117.166 -1.814 . . . . 81.18 107.26 -172.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.834 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.8 p-80 -109.14 45.14 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.848 0 C-N-CA 115.503 -2.479 . . . . 999.99 108.754 177.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 1.072 ' HB2' HD12 ' A' ' 191' ' ' ILE . 87.5 Cg_endo -41.57 101.81 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.14 1 C-N-CA 126.042 4.494 . . . . 999.99 105.683 -170.737 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -62.27 -44.02 97.48 Favored 'General case' 0 CA--C 1.483 -1.599 0 C-N-CA 126.747 2.019 . . . . 967.72 112.048 -165.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 190' ' ' LYS . 30.3 mmtp -60.26 -36.55 78.05 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.748 -1.575 . . . . 934.3 106.748 -175.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 1.072 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.56 -30.25 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 C-N-CA 129.2 3.0 . . . . 565.15 113.923 -178.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 61.53 55.4 2.81 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 118.444 0.565 . . . . 755.61 109.869 -175.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 1.14 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.5 -49.28 67.1 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.551 1.141 . . . . 325.89 113.242 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.633 ' HE3' ' OH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.82 -44.95 78.4 Favored 'General case' 0 CA--C 1.495 -1.16 0 C-N-CA 123.56 0.744 . . . . 250.21 111.627 -169.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.3 t -64.72 -43.35 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 CA-C-O 121.585 0.707 . . . . 142.46 110.382 -175.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 1.038 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.8 t80 -61.12 -41.52 96.85 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 123.981 0.912 . . . . 247.69 108.815 -173.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.825 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 23.0 t60 -60.53 -51.31 69.97 Favored 'General case' 0 CA--C 1.491 -1.289 0 C-N-CA 125.424 1.49 . . . . 199.61 113.107 -175.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.2 mt -65.35 -44.48 94.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 107.715 -1.217 . . . . 106.73 107.715 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . 0.722 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.6 t -59.15 -48.53 81.27 Favored 'General case' 0 CA--C 1.487 -1.479 0 CA-C-N 115.867 -0.606 . . . . 115.01 110.231 -173.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 1.057 HG13 HD13 ' A' ' 161' ' ' LEU . 86.1 t -65.24 -49.15 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.657 0 C-N-CA 119.418 -0.913 . . . . 129.42 111.854 -174.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.794 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.2 m -61.88 -53.15 59.72 Favored 'General case' 0 CA--C 1.483 -1.63 0 C-N-CA 118.224 -1.39 . . . . 172.48 109.952 -172.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.632 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.1 t -63.85 -54.26 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 C-N-CA 120.512 -0.475 . . . . 55.86 110.972 -174.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.722 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.54 -51.56 58.95 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 118.542 -1.263 . . . . 184.68 111.513 -174.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 1.044 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.61 -52.4 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 C-N-CA 116.643 -2.023 . . . . 291.81 114.743 -174.699 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.549 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.8 t80 -82.05 -55.01 4.83 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 115.148 1.536 . . . . 130.66 115.148 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . 0.794 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.8 m-85 -66.88 -48.5 68.56 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 114.488 1.292 . . . . 80.16 114.488 -170.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.894 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.55 -45.47 83.16 Favored Pre-proline 0 N--CA 1.435 -1.195 0 C-N-CA 119.965 -0.694 . . . . 136.02 109.506 -174.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.894 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.8 Cg_exo -64.81 -27.12 59.62 Favored 'Trans proline' 0 N--CA 1.433 -2.08 0 N-CA-C 110.621 -0.569 . . . . 92.17 110.621 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.686 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.34 -41.37 76.72 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 107.494 -1.298 . . . . 135.6 107.494 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.16 -44.69 91.33 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 109.591 -0.522 . . . . 52.1 109.591 -176.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.618 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.71 -43.49 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 109.09 -0.707 . . . . 95.89 109.09 -176.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.902 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.27 -42.34 93.16 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 N-CA-C 106.695 -1.595 . . . . 43.41 106.695 -178.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.44 -42.28 99.08 Favored Glycine 0 N--CA 1.432 -1.624 0 N-CA-C 109.367 -1.493 . . . . 27.69 109.367 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . 0.884 ' O ' HG22 ' A' ' 217' ' ' THR . 77.9 t80 -65.68 -47.38 75.65 Favored 'General case' 0 CA--C 1.497 -1.086 0 O-C-N 122.195 -0.591 . . . . 54.41 110.456 -177.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . 0.827 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.43 -34.1 74.83 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 106.96 -1.496 . . . . 53.88 106.96 -177.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -60.76 -40.83 93.97 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 108.48 -0.933 . . . . 68.29 108.48 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . 0.884 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.78 -39.04 92.95 Favored 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 119.701 -0.799 . . . . 107.59 110.615 -175.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.827 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.02 -38.36 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 C-N-CA 119.606 -0.838 . . . . 111.61 109.509 -177.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.92 HG13 ' CD1' ' A' ' 134' ' ' ILE . 79.8 t -63.28 -22.51 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 N-CA-C 108.401 -0.963 . . . . 85.26 108.401 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.85 -41.94 99.39 Favored Glycine 0 C--N 1.349 1.283 0 N-CA-C 111.062 -0.815 . . . . 40.71 111.062 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.72 -44.06 96.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 108.412 -0.959 . . . . 95.86 108.412 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.824 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.3 p -76.93 -137.52 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 108.441 -0.948 . . . . 144.37 108.441 -176.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.904 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.6 mt -55.36 132.12 47.35 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 107.599 -1.26 . . . . 326.72 107.599 -177.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' TRP . . . . . 0.461 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.33 -168.04 1.51 Allowed 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 106.033 -1.84 . . . . 158.38 106.033 -176.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.461 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.32 -41.94 98.95 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 109.661 -0.496 . . . . 36.78 109.661 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.6 m -61.13 125.85 25.22 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 119.151 -1.019 . . . . 85.46 109.82 -174.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . 0.692 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.87 126.53 8.84 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 105.542 -2.021 . . . . 127.78 105.542 176.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.927 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.03 139.9 34.82 Favored Pre-proline 0 CA--C 1.493 -1.239 0 N-CA-C 105.952 -1.87 . . . . 164.84 105.952 -179.592 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.927 ' N ' HD13 ' A' ' 228' ' ' ILE . 82.0 Cg_exo -56.8 -39.92 87.93 Favored 'Trans proline' 0 N--CA 1.431 -2.17 0 N-CA-C 113.937 0.707 . . . . 222.35 113.937 -176.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . 0.744 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.13 166.99 44.94 Favored Glycine 0 N--CA 1.428 -1.894 0 N-CA-C 106.424 -2.67 . . . . 45.22 106.424 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.882 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.94 -45.79 93.29 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 106.029 -1.841 . . . . 107.57 106.029 177.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . 0.73 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.6 m -65.76 141.81 58.2 Favored 'General case' 0 N--CA 1.429 -1.517 0 C-N-CA 118.906 -1.118 . . . . 167.96 109.153 -175.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.83 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.2 m 99.51 106.7 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 126.706 2.002 . . . . 280.68 109.734 176.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.71 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.7 m-20 56.01 11.27 0.71 Allowed 'General case' 0 N--CA 1.434 -1.274 0 C-N-CA 124.459 1.103 . . . . 218.25 110.701 174.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.921 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.38 137.62 54.78 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 105.236 -2.135 . . . . 343.57 105.236 177.395 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.56 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.6 t80 -111.97 81.9 1.54 Allowed 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 106.867 -1.531 . . . . 263.29 106.867 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' HIS . . . . . 0.626 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.4 m-70 104.29 147.05 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.283 0 C-N-CA 126.563 1.945 . . . . 261.92 108.497 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.21 -38.1 89.85 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 107.879 -1.156 . . . . 106.81 107.879 -177.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.737 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.43 -39.94 94.97 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 118.371 -1.331 . . . . 112.2 107.552 -178.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.738 HG12 ' NH1' ' A' ' 244' ' ' ARG . 75.5 t -64.26 -39.82 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.275 0 N-CA-C 109.263 -0.643 . . . . 45.41 109.263 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . 0.807 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.1 p -70.92 -32.07 68.87 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 110.264 -0.273 . . . . 97.62 110.264 -178.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.39 -39.61 81.66 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 123.696 0.799 . . . . 59.29 110.978 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.737 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.24 -36.54 83.99 Favored 'General case' 0 CA--C 1.492 -1.275 0 C-N-CA 124.658 1.183 . . . . 106.49 110.666 -174.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.921 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.96 -30.65 69.23 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 108.299 -1.0 . . . . 106.62 108.299 -176.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.533 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -66.02 -41.02 91.49 Favored 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 121.832 -0.542 . . . . 75.97 110.045 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.441 ' CG1' ' CE ' ' A' ' 250' ' ' MET . 76.6 t -65.54 -40.86 89.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 C-N-CA 122.917 0.487 . . . . 65.27 109.774 -178.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.775 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -64.0 -41.58 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 C-N-CA 120.401 -0.519 . . . . 107.94 110.162 -177.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.537 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.1 pttt -63.54 -40.81 97.98 Favored 'General case' 0 N--CA 1.434 -1.247 0 O-C-N 121.687 -0.633 . . . . 87.98 110.284 -176.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' MET . . . . . 0.822 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.65 -40.4 96.78 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 118.832 -1.147 . . . . 65.5 108.363 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' MET . . . . . 0.761 ' CE ' HG21 ' A' ' 67' ' ' THR . 68.5 mtt -61.7 -36.37 80.71 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 108.146 -1.057 . . . . 85.05 108.146 -177.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.537 HD12 ' HA ' ' A' ' 248' ' ' LYS . 86.9 mt -63.49 -45.74 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 N-CA-C 109.07 -0.715 . . . . 42.25 109.07 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.822 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.34 -38.26 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 C-N-CA 119.548 -0.861 . . . . 91.01 109.402 -176.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 1.001 HG22 ' CD1' ' A' ' 304' ' ' ILE . 65.9 t -58.86 -41.54 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 N-CA-C 107.988 -1.116 . . . . 66.09 107.988 -178.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 250' ' ' MET . 94.8 t -66.09 -43.18 92.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 C-N-CA 120.754 -0.379 . . . . 52.39 110.31 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.1 m -61.74 -46.78 88.15 Favored 'General case' 0 CA--C 1.489 -1.391 0 O-C-N 121.889 -0.507 . . . . 46.42 109.866 -174.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . 0.743 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.5 t -62.33 -38.13 88.26 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 108.324 -0.991 . . . . 116.51 108.324 -177.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' PHE . . . . . 0.487 ' N ' HG23 ' A' ' 256' ' ' THR . 86.1 t80 -60.26 -48.23 82.64 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.394 -0.595 . . . . 65.18 109.394 -178.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.96 -42.68 97.2 Favored 'General case' 0 CA--C 1.49 -1.365 0 O-C-N 122.133 -0.354 . . . . 51.33 110.443 -175.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . 0.743 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.62 -43.37 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 C-N-CA 118.919 -1.112 . . . . 126.3 109.0 -176.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' CYS . . . . . 0.51 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.7 m -65.58 -49.33 69.22 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 119.529 -0.868 . . . . 133.94 112.485 -176.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.82 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.0 m95 -80.68 -33.38 35.52 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 116.856 2.169 . . . . 134.84 116.856 -176.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.784 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.9 tp -58.43 -41.62 90.27 Favored Pre-proline 0 CA--C 1.493 -1.235 0 O-C-N 121.659 -0.65 . . . . 72.23 111.643 -167.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' PRO . . . . . 0.784 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 80.7 Cg_exo -60.66 -35.98 87.1 Favored 'Trans proline' 0 C--N 1.295 -2.278 0 CA-C-N 119.848 0.981 . . . . 106.13 111.349 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' PHE . . . . . 0.851 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.7 t80 -66.41 -44.68 82.32 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 119.749 -0.78 . . . . 128.35 110.03 -178.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' HIS . . . . . 0.643 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.42 -37.88 89.06 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 110.202 -0.296 . . . . 100.73 110.202 -177.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.745 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.25 -44.56 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 C-N-CA 119.31 -0.956 . . . . 172.72 109.142 -179.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . 0.736 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.6 m-85 -66.6 -28.07 68.21 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 108.206 -1.035 . . . . 249.23 108.206 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' PHE . . . . . 0.898 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.56 -55.1 35.85 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 106.679 -1.6 . . . . 259.78 106.679 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . 0.491 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.3 mt -69.17 -44.18 72.72 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 113.588 0.959 . . . . 233.11 113.588 -176.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.837 ' O ' HG13 ' A' ' 273' ' ' ILE . 88.8 mt -61.37 -48.3 91.47 Favored Pre-proline 0 N--CA 1.44 -0.968 0 C-N-CA 119.183 -1.007 . . . . 169.54 110.596 -171.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . 0.736 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.6 Cg_exo -61.13 -24.56 79.49 Favored 'Trans proline' 0 N--CA 1.43 -2.259 0 C-N-CA 116.729 -1.714 . . . . 255.47 114.66 174.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' TYR . . . . . 0.825 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.5 t80 -63.56 -44.22 94.75 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 119.225 0.921 . . . . 279.03 108.904 177.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.837 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.33 -44.79 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 110.081 -0.34 . . . . 162.21 110.081 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' ASN . . . . . 0.783 ' N ' HD12 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.41 84.87 59.33 Favored Pre-proline 0 N--CA 1.431 -1.406 0 C-N-CA 118.747 -1.181 . . . . 128.13 108.069 -178.081 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.25 164.04 11.26 Favored 'Trans proline' 0 C--N 1.295 -2.281 0 N-CA-C 107.46 -1.785 . . . . 278.35 107.46 177.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . 0.87 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.11 15.04 9.93 Favored 'General case' 0 N--CA 1.428 -1.533 0 O-C-N 123.8 0.687 . . . . 312.91 109.334 175.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.87 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.3 mt -132.71 -170.68 2.49 Favored 'General case' 0 CA--C 1.481 -1.679 0 N-CA-C 106.537 -1.653 . . . . 353.54 106.537 177.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 1.011 ' HA ' ' HB2' ' A' ' 282' ' ' PHE . 42.8 p90 -115.66 142.25 46.99 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 107.427 -1.323 . . . . 251.26 107.427 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.764 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -76.96 -118.74 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 102.081 -3.303 . . . . 175.26 102.081 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . 0.794 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.5 -44.97 96.12 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 100.878 -3.749 . . . . 99.07 100.878 172.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . 0.794 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.42 124.18 9.19 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 103.494 -2.78 . . . . 243.21 103.494 171.161 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 1.011 ' HB2' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.98 112.96 25.1 Favored 'General case' 0 CA--C 1.474 -1.979 0 C-N-CA 116.049 -2.261 . . . . 201.04 105.278 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' ILE . . . . . 0.776 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.93 173.72 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.09 0 C-N-CA 116.0 -2.28 . . . . 201.36 108.787 -175.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . 1.092 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.282 0.6 OUTLIER -59.5 -41.44 89.89 Favored 'General case' 0 N--CA 1.415 -2.179 0 CA-C-N 113.247 -1.797 . . . . 203.82 107.864 174.463 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . 0.925 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.31 -45.71 86.76 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 118.22 -1.392 . . . . 215.06 112.543 -171.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.551 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.3 t -65.68 -46.42 89.3 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.466 0 C-N-CA 118.578 -1.249 . . . . 125.28 112.912 -171.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' TYR . . . . . 0.952 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.79 -37.0 86.14 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 107.193 -1.41 . . . . 268.9 107.193 -171.883 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.798 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.22 -45.01 74.47 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 125.65 1.58 . . . . 280.88 108.795 -172.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.64 -47.48 86.05 Favored 'General case' 0 N--CA 1.428 -1.547 0 C-N-CA 118.97 -1.092 . . . . 184.47 109.002 -172.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . 0.851 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.8 mp -67.94 -42.11 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 C-N-CA 119.279 -0.968 . . . . 167.92 112.73 -175.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' MET . . . . . 0.5 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.8 ttt -65.75 -38.8 90.11 Favored 'General case' 0 CA--C 1.495 -1.144 0 C-N-CA 117.758 -1.577 . . . . 367.18 110.771 -175.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' TRP . . . . . 0.548 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.4 m95 -67.16 -32.71 73.99 Favored 'General case' 0 N--CA 1.435 -1.215 0 O-C-N 121.851 -0.531 . . . . 173.97 110.449 177.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.2 tp -64.46 -36.76 85.23 Favored 'General case' 0 CA--C 1.499 -1.011 0 C-N-CA 123.542 0.737 . . . . 119.66 109.806 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . 0.82 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.25 -33.98 74.39 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.697 -1.224 . . . . 112.3 107.697 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' MET . . . . . 0.772 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.09 -32.05 73.33 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 116.235 -0.439 . . . . 174.17 110.237 -177.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.7 m -64.73 -22.78 67.06 Favored 'General case' 0 CA--C 1.485 -1.525 0 C-N-CA 124.676 1.191 . . . . 145.27 110.608 -175.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' SER . . . . . 0.76 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.5 m -57.61 -35.38 70.37 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 108.078 -1.082 . . . . 170.15 108.078 -175.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.82 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.7 t -55.3 -34.15 63.89 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 116.315 -0.402 . . . . 214.57 110.632 -171.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . 0.751 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.1 ttt -77.2 -33.19 56.33 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 126.072 1.749 . . . . 168.29 115.544 177.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' TYR . . . . . 0.76 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.42 -34.87 79.2 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 114.056 1.132 . . . . 167.15 114.056 -168.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . 0.722 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.282 18.8 p-10 -64.21 -38.29 33.22 Favored Pre-proline 0 N--CA 1.434 -1.264 0 C-N-CA 115.515 -2.474 . . . . 165.13 113.93 -171.599 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' PRO . . . . . 0.722 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.1 Cg_exo -62.54 -31.83 80.02 Favored 'Trans proline' 0 N--CA 1.433 -2.042 0 CA-C-N 122.791 2.033 . . . . 123.92 111.251 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' ILE . . . . . 0.715 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.78 -42.53 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 C-N-CA 118.875 -1.13 . . . . 110.55 109.779 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' ILE . . . . . 1.001 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.1 pt -61.16 -40.02 84.43 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.158 0 N-CA-C 108.828 -0.804 . . . . 145.31 108.828 -177.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . 0.925 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.253 63.2 m-85 -58.11 -48.84 78.97 Favored 'General case' 0 CA--C 1.494 -1.182 0 C-N-CA 119.413 -0.915 . . . . 246.68 109.823 -177.477 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.6 m -62.19 -47.51 84.16 Favored 'General case' 0 CA--C 1.485 -1.538 0 C-N-CA 119.55 -0.86 . . . . 64.43 109.571 -173.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.8 t -66.78 -45.07 79.61 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 118.989 -1.084 . . . . 80.72 110.244 -177.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.708 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.49 -35.69 75.81 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 115.998 1.851 . . . . 140.44 115.998 -173.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . 0.658 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.83 132.23 34.34 Favored 'General case' 0 N--CA 1.434 -1.26 0 C-N-CA 112.711 -3.596 . . . . 178.87 113.056 -177.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . 0.612 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.03 -37.07 86.41 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 114.405 -1.271 . . . . 110.22 110.111 -177.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.855 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.74 -50.59 72.7 Favored 'General case' 0 CA--C 1.492 -1.256 0 O-C-N 121.752 -0.592 . . . . 174.78 109.739 -174.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.96 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.2 m-85 -64.89 -41.69 95.41 Favored 'General case' 0 CA--C 1.484 -1.579 0 N-CA-C 108.245 -1.02 . . . . 161.84 108.245 178.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . 0.518 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.33 -50.22 73.64 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 109.198 -0.667 . . . . 117.2 109.198 -173.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.799 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.51 -44.1 75.37 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 120.373 -0.531 . . . . 112.6 111.061 -177.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . 0.871 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -64.04 -37.43 94.59 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 110.646 -0.982 . . . . 101.46 110.646 -177.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' PHE . . . . . 1.018 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.7 m-85 -62.16 -45.99 90.94 Favored 'General case' 0 CA--C 1.491 -1.296 0 CA-C-N 118.492 1.146 . . . . 151.49 109.522 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . 0.422 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.1 -36.3 77.13 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 106.949 -1.501 . . . . 142.32 106.949 -175.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' HIS . . . . . 0.827 ' NE2' HG21 ' A' ' 326' ' ' ILE . 50.0 m80 -59.79 -41.82 92.01 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 106.891 -1.522 . . . . 109.09 106.891 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.85 -42.43 85.72 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.336 -0.228 . . . . 76.11 111.03 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -61.43 -55.48 30.84 Favored 'General case' 0 CA--C 1.49 -1.361 0 C-N-CA 119.87 -0.732 . . . . 120.24 109.32 -174.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.578 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.4 mtt180 -74.33 131.54 41.24 Favored 'General case' 0 CA--C 1.482 -1.657 0 N-CA-C 102.935 -2.987 . . . . 192.73 102.935 177.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.16 -44.22 92.1 Favored 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 119.021 -1.072 . . . . 176.29 109.194 -172.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' CYS . . . . . 0.754 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.2 m -79.38 -177.11 0.81 Allowed Pre-proline 0 CA--C 1.487 -1.443 0 N-CA-C 106.294 -1.743 . . . . 69.68 106.294 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.569 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.6 Cg_exo -58.99 -75.58 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.389 0 C-N-CA 118.347 -0.635 . . . . 191.05 112.591 176.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' PHE . . . . . 0.754 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.5 m-85 47.49 43.88 16.25 Favored 'General case' 0 CA--C 1.493 -1.228 0 O-C-N 123.574 0.546 . . . . 287.03 109.764 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . 0.827 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.51 78.57 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.933 0 C-N-CA 112.956 -3.497 . . . . 292.29 109.839 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . 0.481 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.3 t -77.47 -152.84 0.05 Allowed 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 104.208 -2.515 . . . . 184.57 104.208 178.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.7 8.68 4.95 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 113.063 0.764 . . . . 274.56 113.063 176.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.97 0.91 57.27 Favored Glycine 0 C--N 1.348 1.228 0 C-N-CA 117.729 -2.177 . . . . 268.24 113.457 172.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' ASP . . . . . 0.699 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.7 m-20 51.6 -172.04 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.071 0 CA-C-N 118.667 1.233 . . . . 200.06 110.747 177.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.855 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.89 -33.0 74.73 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 107.879 -1.156 . . . . 114.44 107.879 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.26 46.06 21.92 Favored 'General case' 0 CA--C 1.484 -1.592 0 N-CA-C 107.625 -1.25 . . . . 263.81 107.625 -177.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' GLY . . . . . 0.634 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.32 -137.35 3.6 Favored Glycine 0 CA--C 1.479 -2.217 1 N-CA-C 102.531 -4.228 . . . . 103.79 102.531 -179.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 1.049 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.2 mt -88.28 95.62 10.25 Favored 'General case' 0 N--CA 1.419 -2.007 0 C-N-CA 114.937 -2.705 . . . . 117.3 106.016 176.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . 1.027 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.96 -39.79 90.72 Favored 'General case' 0 CA--C 1.468 -2.188 1 N-CA-C 98.004 -4.813 . . . . 231.58 98.004 167.23 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . 1.036 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.95 163.48 29.08 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 102.072 -3.307 . . . . 303.24 102.072 168.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' LYS . . . . . 1.049 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.3 tttt -62.63 -48.61 78.61 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 116.051 -2.259 . . . . 112.72 108.409 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.9 t -61.02 -63.66 1.22 Allowed 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 109.103 -0.703 . . . . 83.22 109.103 -176.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . 0.883 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.1 m -156.28 -126.2 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 103.831 -2.655 . . . . 174.36 103.831 -178.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . 1.027 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.87 160.96 8.78 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 105.763 -1.94 . . . . 202.73 105.763 177.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . 1.019 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.95 149.04 52.55 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 107.064 -1.458 . . . . 180.62 107.064 176.392 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.933 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.5 tp -178.51 -171.86 0.27 Allowed 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 105.394 -2.076 . . . . 145.25 105.394 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' GLN . . . . . 0.933 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.09 -43.14 88.13 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 106.127 -1.805 . . . . 66.05 106.127 174.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . 0.767 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.7 -152.14 0.48 Allowed 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 103.505 -2.776 . . . . 266.49 103.505 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' GLN . . . . . 0.7 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.4 mt-30 66.31 -124.93 0.28 Allowed 'General case' 0 N--CA 1.428 -1.574 0 C-N-CA 117.033 -1.867 . . . . 219.2 107.772 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . 0.902 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.07 -37.4 94.13 Favored Glycine 0 N--CA 1.426 -2.032 0 CA-C-N 114.544 -1.207 . . . . 94.78 112.855 -176.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . 0.825 ' HB2' ' H ' ' A' ' 342' ' ' LEU . 48.3 t -81.17 100.41 9.07 Favored 'General case' 0 CA--C 1.484 -1.589 0 C-N-CA 112.327 -3.749 . . . . 121.41 109.479 -171.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.5 t -73.06 145.5 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 108.953 -0.758 . . . . 85.34 108.953 -176.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' TYR . . . . . 0.442 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.5 p90 -57.73 143.43 41.89 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.842 -1.17 . . . . 267.57 107.842 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . 0.523 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.03 69.59 0.59 Allowed 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 109.539 -0.541 . . . . 226.1 109.539 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' VAL . . . . . 0.826 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.5 p -51.0 156.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 N-CA-C 106.993 -1.484 . . . . 154.84 106.993 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . 0.582 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.5 m -61.35 161.96 8.47 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.603 0.716 . . . . 180.01 110.711 -173.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' ARG . . . . . 0.893 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.46 156.92 23.66 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 106.946 -1.501 . . . . 333.78 106.946 -178.616 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . 0.975 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.04 142.52 48.76 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.356 -1.35 . . . . 335.2 107.356 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.975 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.5 mm-40 82.82 158.9 0.13 Allowed 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 108.74 -0.837 . . . . 266.47 108.74 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.5 m -60.61 -46.88 88.6 Favored 'General case' 0 CA--C 1.487 -1.462 0 N-CA-C 105.677 -1.972 . . . . 59.34 105.677 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.58 173.86 11.97 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 104.431 -2.433 . . . . 201.26 104.431 176.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.75 HG22 ' O ' ' A' ' 360' ' ' THR . 69.1 mt -95.91 106.71 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.555 0 C-N-CA 116.34 -2.144 . . . . 56.23 105.524 -179.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . 0.466 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.7 m -61.19 -59.47 5.28 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 109.287 -0.634 . . . . 87.58 109.287 -175.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . 0.886 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.2 t -85.5 153.76 22.24 Favored 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 107.835 -1.172 . . . . 219.95 107.835 -177.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' VAL . . . . . 0.587 ' O ' HG23 ' A' ' 361' ' ' VAL . 16.0 m -82.02 83.81 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 C-N-CA 116.339 -2.144 . . . . 121.79 105.452 177.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.598 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.6 t -154.11 159.74 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 N-CA-C 105.826 -1.916 . . . . 53.85 105.826 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . 0.598 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.22 16.61 77.06 Favored Glycine 0 N--CA 1.428 -1.88 0 N-CA-C 106.044 -2.822 . . . . 196.55 106.044 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.674 0 N-CA-C 107.87 -1.159 . . . . 35.88 107.87 -178.914 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 365' ' ' ARG . . . . . 0.418 ' N ' ' CD ' ' B' ' 366' ' ' PRO . 4.5 ttp180 . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 108.895 -0.78 . . . . 1.0 108.895 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 366' ' ' PRO . . . . . 0.418 ' CD ' ' N ' ' B' ' 365' ' ' ARG . 52.4 Cg_endo -66.94 141.99 60.58 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.086 1.857 . . . . 1.0 110.172 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 367' ' ' LYS . . . . . 0.738 ' HE2' ' HA ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -64.38 143.26 98.47 Favored Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 119.85 -0.74 . . . . 1.0 109.603 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 368' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -68.25 150.42 76.57 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.31 2.007 . . . . 1.0 111.759 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 369' ' ' GLN . . . . . 0.476 ' O ' ' HG3' ' B' ' 369' ' ' GLN . 0.0 OUTLIER -70.72 131.72 44.3 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.739 -0.384 . . . . 1.0 110.265 179.42 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -101.97 115.85 31.42 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.696 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 371' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -63.65 -42.39 98.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.365 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 372' ' ' PHE . . . . . 0.424 ' HD1' ' HA ' ' B' ' 372' ' ' PHE . 0.1 OUTLIER -65.01 -36.25 83.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.945 -0.57 . . . . 1.0 110.663 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -59.72 -32.98 75.69 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.869 -0.892 . . . . 1.0 110.869 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 374' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.83 131.35 45.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.834 0.349 . . . . 1.0 110.154 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 375' ' ' MET . . . . . 0.439 ' HB2' ' OG ' ' A' ' 20' ' ' SER . 0.7 OUTLIER . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 117.946 -1.026 . . . . 1.0 110.558 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.429 -1.478 0 N-CA-C 108.388 -0.967 . . . . 97.08 108.388 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.731 ' ND2' ' HG3' ' B' ' 366' ' ' PRO . 46.6 t30 -110.62 155.44 22.37 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 122.07 0.938 . . . . 123.41 110.724 -172.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.881 HG11 HD13 ' A' ' 15' ' ' ILE . 28.8 m -134.6 -162.38 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.486 -1.498 1 N-CA-C 100.117 -4.031 . . . . 151.3 100.117 173.741 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.909 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.1 mp -60.68 -38.58 57.96 Favored Pre-proline 0 N--CA 1.439 -0.995 0 C-N-CA 115.953 -2.299 . . . . 169.25 106.13 178.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.909 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 57.6 Cg_exo -81.26 168.49 16.73 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 122.267 0.614 . . . . 185.76 110.53 171.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.904 HG13 ' CE2' ' A' ' 282' ' ' PHE . 92.3 t -64.44 -25.87 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 C-N-CA 127.037 2.135 . . . . 145.47 110.381 -177.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.774 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.2 t0 -84.34 157.39 21.5 Favored 'General case' 0 CA--C 1.499 -1.014 0 O-C-N 121.043 -1.036 . . . . 102.76 109.473 -178.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.6 p -82.64 154.21 25.02 Favored 'General case' 0 CA--C 1.492 -1.269 0 N-CA-C 107.973 -1.121 . . . . 106.25 107.973 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.921 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.8 p-10 -105.89 51.88 0.74 Allowed 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 117.778 -1.569 . . . . 157.81 107.656 178.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.15 -45.86 91.64 Favored 'General case' 0 CA--C 1.481 -1.681 0 N-CA-C 103.593 -2.743 . . . . 150.2 103.593 178.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.4 m -87.1 164.73 34.96 Favored Pre-proline 0 N--CA 1.421 -1.899 0 N-CA-C 103.663 -2.717 . . . . 183.52 103.663 172.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -76.82 6.91 3.83 Favored 'Trans proline' 0 C--N 1.281 -2.977 0 N-CA-C 109.992 -0.811 . . . . 235.61 109.992 176.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -57.9 -41.29 82.31 Favored 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 124.813 1.245 . . . . 113.77 113.401 -170.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.921 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.3 pt -52.13 136.19 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 CA-C-N 119.517 1.053 . . . . 150.85 110.986 -176.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.46 156.28 46.41 Favored 'General case' 0 C--N 1.36 1.065 0 N-CA-C 107.631 -1.248 . . . . 100.42 107.631 178.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 1.081 HG23 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.09 142.64 58.32 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 122.009 0.909 . . . . 129.36 110.412 -174.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.774 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.06 -25.51 68.4 Favored 'General case' 0 CA--C 1.494 -1.189 0 C-N-CA 126.285 1.834 . . . . 112.34 106.677 -177.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.936 HG23 ' HA2' ' A' ' 101' ' ' GLY . 86.1 m -74.17 -40.15 62.74 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 115.567 -0.742 . . . . 131.73 111.705 177.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 1.081 ' H ' HG23 ' A' ' 17' ' ' THR . 71.3 m -84.35 -42.93 15.24 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 117.034 2.235 . . . . 80.49 117.034 -174.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.55 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.5 mt-10 -145.98 174.54 3.34 Favored Pre-proline 0 N--CA 1.443 -0.798 0 C-N-CA 118.127 -1.429 . . . . 98.98 111.191 -169.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.823 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.334 85.7 Cg_exo -61.74 -10.81 18.16 Favored 'Trans proline' 0 C--N 1.322 -0.853 1 N-CA-C 128.939 6.476 . . . . 246.95 128.939 -170.069 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.626 HD21 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.68 17.5 8.74 Favored 'General case' 0 C--N 1.325 -0.494 1 CA-C-N 126.153 4.07 . . . . 269.62 114.231 175.677 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.495 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.5 mt-30 -67.1 -27.31 67.24 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 107.838 -1.171 . . . . 86.8 107.838 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.551 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.3 p90 -66.76 -29.42 69.37 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 121.09 -1.006 . . . . 85.91 110.508 -178.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.874 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.3 t -68.48 -40.23 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 C-N-CA 123.717 0.807 . . . . 82.0 111.362 -177.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.896 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.39 167.79 12.37 Favored Pre-proline 0 CA--C 1.489 -1.398 0 N-CA-C 108.558 -0.905 . . . . 120.73 108.558 -178.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.902 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -64.04 149.76 89.79 Favored 'Trans proline' 0 N--CA 1.432 -2.116 0 C-N-CA 120.599 0.866 . . . . 87.86 109.9 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.744 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -62.99 -37.96 89.23 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 108.864 -0.791 . . . . 36.46 108.864 -176.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.813 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.9 p-90 -63.81 -33.9 76.7 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 107.797 -1.186 . . . . 150.6 107.797 -176.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.902 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.5 mt-30 -62.22 -32.67 73.37 Favored 'General case' 0 CA--C 1.491 -1.312 0 O-C-N 121.311 -0.868 . . . . 123.26 108.666 -178.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.744 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.46 -47.18 94.58 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.582 0 N-CA-C 109.166 -0.679 . . . . 120.14 109.166 176.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.786 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.3 m -67.42 -31.05 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 N-CA-C 107.855 -1.165 . . . . 112.19 107.855 -178.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.813 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.5 tp -62.96 -47.14 84.49 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 119.917 -0.713 . . . . 60.87 109.648 -178.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.672 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.0 -35.67 81.21 Favored 'General case' 0 CA--C 1.489 -1.391 0 C-N-CA 119.974 -0.69 . . . . 157.57 110.375 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.747 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.65 -40.88 98.42 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 108.591 -0.892 . . . . 47.06 108.591 178.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.806 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.79 -41.23 97.97 Favored 'General case' 0 CA--C 1.496 -1.114 0 O-C-N 121.714 -0.616 . . . . 43.94 109.558 -177.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.731 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.89 -43.26 99.2 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 108.697 -0.853 . . . . 42.61 108.697 -176.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.904 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.41 -41.23 93.85 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 116.66 -0.246 . . . . 140.66 111.029 -178.333 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.806 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.82 -43.92 97.88 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 118.579 -1.248 . . . . 116.04 110.215 -175.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.47 -38.7 83.1 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.325 0 N-CA-C 108.761 -0.829 . . . . 97.16 108.761 -177.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.854 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.1 mt -61.32 -39.97 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 N-CA-C 108.969 -0.752 . . . . 54.85 108.969 -176.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.958 HG22 HG21 ' A' ' 86' ' ' THR . 92.9 t -57.76 -42.28 81.49 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.314 0 N-CA-C 108.888 -0.782 . . . . 45.39 108.888 -175.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.431 ' O ' HG23 ' A' ' 48' ' ' VAL . 97.0 t -63.52 -51.01 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 C-N-CA 118.876 -1.13 . . . . 48.64 110.179 -177.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.751 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.6 t -65.27 -47.04 78.09 Favored 'General case' 0 N--CA 1.436 -1.175 0 C-N-CA 120.181 -0.608 . . . . 116.65 111.701 -174.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.589 ' N ' HG23 ' A' ' 45' ' ' THR . 50.7 m -62.01 -43.89 97.89 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.706 -0.479 . . . . 51.16 109.706 -174.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.3 t -65.55 -48.97 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 C-N-CA 119.88 -0.728 . . . . 44.3 110.803 -176.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.866 ' O ' HG23 ' A' ' 52' ' ' VAL . 93.9 t -64.75 -46.94 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 C-N-CA 120.266 -0.574 . . . . 48.82 111.052 -174.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.71 -44.15 95.29 Favored Glycine 0 N--CA 1.437 -1.272 0 C-N-CA 120.479 -0.867 . . . . 58.7 112.064 -174.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -72.62 -34.23 67.19 Favored 'General case' 0 CA--C 1.488 -1.439 0 O-C-N 122.071 -0.664 . . . . 101.4 110.999 -175.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.741 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.4 p -66.91 -38.71 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 107.71 -1.218 . . . . 103.57 107.71 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 48' ' ' VAL . 71.3 t -61.46 -43.03 96.08 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 108.948 -0.76 . . . . 61.89 108.948 -178.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.537 ' O ' HG22 ' A' ' 56' ' ' ILE . 82.1 t -63.47 -50.96 76.31 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 C-N-CA 120.277 -0.569 . . . . 70.01 109.47 -178.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.805 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.9 -43.38 98.96 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 109.184 -0.672 . . . . 132.1 109.184 -176.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.643 ' N ' ' HG3' ' A' ' 54' ' ' MET . 61.9 t-105 -64.21 -46.67 82.88 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 116.685 -0.234 . . . . 104.5 110.458 -176.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 1.017 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.69 -49.83 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 C-N-CA 120.192 -0.603 . . . . 142.96 111.306 -173.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.953 HD11 HG12 ' A' ' 72' ' ' VAL 0.279 24.9 pt -64.76 -41.71 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 C-N-CA 116.968 -1.893 . . . . 158.32 110.879 -176.035 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.805 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.7 -41.43 98.11 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 117.755 -1.578 . . . . 137.11 109.46 178.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.36 -44.53 91.13 Favored 'General case' 0 N--CA 1.435 -1.216 0 O-C-N 122.189 -0.319 . . . . 54.66 111.012 -176.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.922 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.44 117.13 29.42 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-O 121.633 0.73 . . . . 127.18 109.568 -174.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.619 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.83 -36.89 80.25 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 124.122 0.969 . . . . 87.93 110.78 -175.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 1.036 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.32 -34.69 78.73 Favored 'General case' 0 CA--C 1.49 -1.334 0 O-C-N 121.649 -0.657 . . . . 131.12 111.506 -175.592 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 1.018 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.63 69.45 7.14 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 115.337 -2.545 . . . . 246.56 109.612 -175.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.413 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.27 91.45 3.48 Favored 'General case' 0 CA--C 1.474 -1.958 0 N-CA-C 105.488 -2.041 . . . . 339.35 105.488 177.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.443 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.5 p -124.13 165.24 17.88 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 103.025 -2.954 . . . . 114.66 103.025 176.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.88 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.08 -39.47 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.624 0 N-CA-C 106.825 -1.546 . . . . 143.28 106.825 178.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.835 HG22 HD13 ' A' ' 71' ' ' LEU . 95.6 m -59.67 -38.03 80.36 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 108.731 -0.84 . . . . 160.22 108.731 -176.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.524 ' ND2' ' HB3' ' A' ' 63' ' ' MET . 86.3 m-20 -62.36 -31.81 72.51 Favored 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 108.866 -0.791 . . . . 120.54 108.866 -177.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.901 ' O ' HG22 ' A' ' 72' ' ' VAL . 89.8 m-85 -63.5 -43.87 95.98 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 109.484 -0.562 . . . . 67.22 109.484 178.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.88 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.5 m-85 -66.49 -39.81 88.94 Favored 'General case' 0 CA--C 1.498 -1.051 0 O-C-N 121.533 -0.729 . . . . 138.6 109.662 -177.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.923 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.54 -35.93 82.1 Favored 'General case' 0 CA--C 1.492 -1.253 0 C-N-CA 122.509 0.323 . . . . 151.46 110.648 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.953 HG12 HD11 ' A' ' 57' ' ' ILE . 24.0 m -62.54 -37.94 80.16 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.237 0 C-N-CA 117.383 -1.727 . . . . 117.93 106.739 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.449 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.1 t30 -60.11 -46.04 90.94 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.824 -1.176 . . . . 56.82 107.824 -177.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.991 HD21 ' HE1' ' A' ' 123' ' ' MET . 8.7 mp -61.3 -43.94 98.04 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 108.93 -0.767 . . . . 145.3 108.93 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.04 -40.38 95.52 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 108.527 -0.916 . . . . 45.71 108.527 -175.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -62.42 -41.99 99.11 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 109.34 -0.615 . . . . 105.61 109.34 -178.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.12 -39.48 92.69 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 108.652 -0.87 . . . . 47.89 108.652 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.588 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.57 -37.39 84.85 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 109.922 -0.399 . . . . 124.53 109.922 179.706 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.86 -41.18 99.28 Favored 'General case' 0 CA--C 1.496 -1.101 0 O-C-N 121.931 -0.481 . . . . 35.89 109.85 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.9 t -62.28 -37.28 84.92 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 107.01 -1.478 . . . . 88.97 107.01 -178.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.82 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.2 -49.19 76.77 Favored 'General case' 0 N--CA 1.428 -1.531 0 C-N-CA 119.847 -0.741 . . . . 239.91 109.026 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.62 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.35 -43.42 90.94 Favored 'General case' 0 N--CA 1.431 -1.396 0 O-C-N 121.503 -0.748 . . . . 146.1 110.593 -177.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.417 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.15 -58.24 3.4 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 117.417 -1.713 . . . . 91.74 113.877 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -76.51 -61.39 1.97 Allowed 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 115.761 1.763 . . . . 197.45 115.761 -173.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.935 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.25 -42.29 55.53 Favored 'General case' 0 CA--C 1.49 -1.348 0 C-N-CA 117.902 -1.519 . . . . 242.6 114.014 -170.009 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.958 HG21 HG22 ' A' ' 43' ' ' VAL . 4.6 t -65.35 -36.57 84.41 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 118.949 -1.1 . . . . 215.61 109.859 -172.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.423 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.3 t -60.33 -46.93 94.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 O-C-N 121.818 -0.551 . . . . 87.19 110.442 -175.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.841 HG21 ' CD2' ' A' ' 108' ' ' HIS . 63.3 t -65.91 -41.94 90.95 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.132 0 N-CA-C 109.716 -0.476 . . . . 231.82 109.716 -178.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.904 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 11.0 m120 -62.28 -34.15 76.01 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 108.296 -1.002 . . . . 364.98 108.296 -177.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.668 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.2 t80 -68.24 -44.67 75.17 Favored 'General case' 0 N--CA 1.438 -1.043 0 O-C-N 121.563 -0.71 . . . . 181.63 111.299 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.813 HG22 ' HD2' ' A' ' 95' ' ' HIS . 58.2 m -60.92 -45.75 93.42 Favored 'General case' 0 CA--C 1.478 -1.797 0 N-CA-C 107.405 -1.331 . . . . 269.02 107.405 -175.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 1.057 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.71 -45.06 93.29 Favored 'General case' 0 CA--C 1.469 -2.143 0 C-N-CA 118.694 -1.202 . . . . 562.66 109.994 -179.081 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.705 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.1 -45.25 95.46 Favored 'General case' 0 CA--C 1.479 -1.761 0 C-N-CA 118.719 -1.193 . . . . 446.75 108.098 -167.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.747 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.389 6.1 m -70.47 -26.37 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 C-N-CA 115.816 -2.354 . . . . 370.05 112.196 -178.769 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.813 ' HD2' HG22 ' A' ' 91' ' ' THR . 90.0 m-70 -74.51 -26.45 60.0 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 121.597 -0.689 . . . . 354.91 112.501 175.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.823 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.6 m-20 82.81 4.53 0.99 Allowed 'General case' 0 CA--C 1.499 -0.984 0 C-N-CA 125.075 1.35 . . . . 462.44 111.902 -178.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.774 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.267 11.9 mm-40 -172.32 178.06 2.92 Favored 'General case' 0 CA--C 1.488 -1.436 0 CA-C-O 122.02 0.914 . . . . 652.37 111.092 171.808 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.791 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.72 86.29 2.17 Favored 'General case' 0 N--CA 1.427 -1.576 0 C-N-CA 128.493 2.717 . . . . 905.99 107.931 -174.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -67.84 -36.47 80.41 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 108.254 -1.017 . . . . 570.43 108.254 -176.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.846 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.0 m-85 -62.46 -36.36 82.22 Favored 'General case' 0 N--CA 1.428 -1.531 0 C-N-CA 125.324 1.449 . . . . 453.22 111.203 -174.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.936 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.52 178.61 33.93 Favored Glycine 0 C--N 1.35 1.32 0 C-N-CA 118.744 -1.693 . . . . 445.63 109.892 177.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.656 HD11 ' CD1' ' B' ' 374' ' ' LEU . 89.1 mt -56.41 -41.19 75.93 Favored 'General case' 0 CA--C 1.498 -1.041 0 C-N-CA 125.243 1.417 . . . . 457.72 112.396 -170.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -58.62 -46.9 86.05 Favored 'General case' 0 CA--C 1.485 -1.546 0 C-N-CA 118.671 -1.212 . . . . 340.58 109.291 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.846 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.3 m-85 -68.73 -32.16 71.74 Favored 'General case' 0 N--CA 1.424 -1.751 0 C-N-CA 118.799 -1.16 . . . . 453.6 111.552 -176.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.764 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.2 t -56.08 -40.35 73.47 Favored 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 105.964 -1.865 . . . . 541.48 105.964 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.82 -47.18 75.92 Favored 'General case' 0 CA--C 1.486 -1.504 0 O-C-N 124.02 0.825 . . . . 466.68 110.826 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -61.73 -47.08 86.84 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 117.487 -1.685 . . . . 427.34 107.277 -178.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.841 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.5 m80 -67.09 -36.76 82.66 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 112.405 0.521 . . . . 537.87 112.405 -174.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.574 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.46 -42.67 74.59 Favored 'General case' 0 N--CA 1.433 -1.325 0 C-N-CA 116.869 -1.932 . . . . 422.12 111.543 175.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.856 ' O ' HG22 ' A' ' 113' ' ' ILE . 76.0 t80 -59.06 -50.14 75.2 Favored 'General case' 0 CA--C 1.502 -0.894 0 O-C-N 121.324 -0.86 . . . . 340.17 111.813 -173.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -65.25 -46.56 71.84 Favored Pre-proline 0 N--CA 1.443 -0.808 0 C-N-CA 119.109 -1.036 . . . . 258.06 111.713 -176.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.935 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.2 Cg_exo -61.47 -31.59 87.98 Favored 'Trans proline' 0 N--CA 1.434 -1.993 0 N-CA-C 115.391 1.266 . . . . 305.71 115.391 176.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.875 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.89 -40.43 76.49 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 108.701 -0.851 . . . . 252.7 108.701 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.422 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.92 -40.61 93.84 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 107.821 -1.178 . . . . 149.27 107.821 -179.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.93 -44.87 95.87 Favored 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 120.668 -0.413 . . . . 138.08 111.502 -176.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.652 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 65.0 t -66.92 -42.36 88.79 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 O-C-N 121.6 -0.688 . . . . 132.89 110.98 -177.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.924 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.6 m-85 -63.75 -44.67 92.78 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 119.752 -0.779 . . . . 193.61 108.904 -177.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.555 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.45 -37.73 84.63 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 122.85 0.46 . . . . 63.83 110.055 -175.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.7 m -64.03 -52.38 59.71 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 120.701 -0.4 . . . . 76.4 111.237 -177.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.749 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.94 -41.67 93.64 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 N-CA-C 108.175 -1.046 . . . . 171.13 108.175 -175.01 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 1.098 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.5 m-85 -63.75 -38.59 91.66 Favored 'General case' 0 N--CA 1.433 -1.315 0 O-C-N 121.814 -0.554 . . . . 78.3 110.686 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.556 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.6 t -67.09 -35.75 80.48 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 118.926 -1.11 . . . . 92.36 109.197 -178.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.991 ' HE1' HD21 ' A' ' 74' ' ' LEU . 5.9 mmt -62.55 -34.2 76.46 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 108.176 -1.046 . . . . 93.73 108.176 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.904 HG22 HG13 ' A' ' 212' ' ' ILE . 33.4 p -67.52 -41.56 84.21 Favored 'General case' 0 CA--C 1.494 -1.202 0 C-N-CA 119.171 -1.012 . . . . 132.74 109.332 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.28 -42.14 94.8 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 107.158 -1.423 . . . . 43.39 107.158 -177.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.827 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 94.8 t -58.45 -41.97 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 N-CA-C 108.633 -0.877 . . . . 59.34 108.633 -178.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.47 -44.09 95.44 Favored 'General case' 0 CA--C 1.498 -1.043 0 O-C-N 121.815 -0.553 . . . . 69.68 110.556 -177.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.468 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.2 t80 -65.44 -42.72 92.09 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.375 -0.972 . . . . 106.98 108.375 -177.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.827 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.38 -35.58 81.35 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 119.663 -0.815 . . . . 147.63 108.981 -177.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.704 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.21 -41.51 99.16 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 108.503 -0.925 . . . . 190.06 108.503 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.598 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.6 t80 -61.34 -44.05 97.84 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 108.328 -0.99 . . . . 118.85 108.328 -177.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.804 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.5 mmt -63.42 -42.63 98.73 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 110.009 -0.367 . . . . 102.5 110.009 -177.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.99 -41.63 95.23 Favored 'General case' 0 CA--C 1.488 -1.405 0 O-C-N 121.837 -0.539 . . . . 89.98 109.828 -176.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.92 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.4 mt -66.51 -50.72 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 C-N-CA 118.113 -1.435 . . . . 106.09 110.999 -177.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.75 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.05 -48.3 38.62 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.109 0 C-N-CA 117.133 -1.827 . . . . 227.74 111.86 -174.831 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.754 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 23.8 p80 -118.88 100.06 50.96 Favored Pre-proline 0 CA--C 1.486 -1.498 0 C-N-CA 116.27 -2.172 . . . . 262.55 110.032 -175.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.2 Cg_endo -69.61 -10.37 28.5 Favored 'Trans proline' 0 C--N 1.29 -2.534 0 C-N-CA 121.58 1.52 . . . . 210.25 111.335 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.706 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.26 112.03 1.0 Allowed 'General case' 0 CA--C 1.491 -1.313 0 N-CA-C 106.547 -1.649 . . . . 270.58 106.547 -178.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.891 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.76 -39.55 24.66 Favored Pre-proline 0 N--CA 1.43 -1.46 0 CA-C-N 115.361 -0.836 . . . . 129.84 112.377 -176.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.86 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 82.3 Cg_exo -61.35 -26.58 81.76 Favored 'Trans proline' 0 N--CA 1.432 -2.133 0 N-CA-C 116.291 1.612 . . . . 330.71 116.291 -174.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.754 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.03 77.19 7.95 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 114.497 -2.881 . . . . 204.51 107.263 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.876 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.73 147.4 0.09 Allowed 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 107.497 -1.297 . . . . 387.41 107.497 178.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.876 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.4 t -143.66 146.99 33.66 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 118.807 -1.157 . . . . 166.22 109.496 178.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.81 -40.8 88.19 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.873 -1.158 . . . . 44.23 107.873 176.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.484 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.5 m -60.27 -39.15 85.82 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 108.184 -1.043 . . . . 28.8 108.184 -175.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.668 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.84 -38.74 92.01 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 109.08 -0.711 . . . . 30.29 109.08 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.847 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 90.1 m -59.59 -43.06 93.8 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 108.975 -0.75 . . . . 46.11 108.975 -176.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.49 -42.09 99.26 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 107.656 -1.238 . . . . 87.33 107.656 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.77 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.4 t -61.71 -42.1 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 N-CA-C 107.894 -1.15 . . . . 23.69 107.894 -178.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.7 t -63.18 -44.31 99.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 109.686 -0.487 . . . . 43.86 109.686 -178.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.919 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.0 mm -61.28 -42.47 93.66 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 108.321 -0.992 . . . . 91.13 108.321 -176.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . 0.482 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.2 t -62.69 -37.94 88.43 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 108.715 -0.846 . . . . 65.88 108.715 -178.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.3 t -62.12 -41.84 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 N-CA-C 109.523 -0.547 . . . . 33.86 109.523 -177.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 1.098 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.42 -40.33 85.93 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.147 0 N-CA-C 107.527 -1.286 . . . . 146.52 107.527 -176.749 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . 0.699 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.1 m95 -62.85 -38.34 90.43 Favored 'General case' 0 N--CA 1.428 -1.529 0 C-N-CA 119.501 -0.88 . . . . 75.44 108.934 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.8 t -60.53 -48.42 88.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 O-C-N 121.023 -1.048 . . . . 43.64 109.711 -177.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.792 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.71 -38.01 89.5 Favored 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 109.013 -0.736 . . . . 102.57 109.013 -178.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.97 -41.05 86.62 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.437 -1.32 . . . . 58.16 107.437 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.799 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.08 -32.54 73.94 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.995 -0.743 . . . . 121.11 108.995 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.792 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.0 -42.3 84.88 Favored 'General case' 0 CA--C 1.489 -1.383 0 C-N-CA 118.594 -1.242 . . . . 153.15 109.916 -178.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 1.057 HD13 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.13 -43.68 19.04 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 113.107 -3.437 . . . . 133.67 113.515 173.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.478 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -63.01 -39.87 96.07 Favored 'General case' 0 CA--C 1.489 -1.401 0 O-C-N 120.941 -1.1 . . . . 157.42 112.242 -171.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.522 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.2 t80 -74.44 -36.1 2.44 Favored Pre-proline 0 N--CA 1.437 -1.106 0 N-CA-C 115.06 1.504 . . . . 250.91 115.06 -173.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.293 53.5 Cg_exo -59.47 -25.49 78.83 Favored 'Trans proline' 0 CA--C 1.488 -1.809 0 N-CA-C 118.015 2.275 . . . . 207.34 118.015 -174.385 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 1.011 HE21 HG13 ' A' ' 182' ' ' ILE . 87.6 mt-30 -61.16 -34.24 74.71 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.951 -1.5 . . . . 192.46 106.951 178.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.48 -41.02 98.14 Favored Glycine 0 C--N 1.353 1.499 0 N-CA-C 107.991 -2.044 . . . . 261.0 107.991 177.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.8 159.1 26.04 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 101.519 -3.511 . . . . 491.4 101.519 172.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -59.93 106.79 0.54 Allowed 'General case' 0 CA--C 1.487 -1.443 0 C-N-CA 116.281 -2.168 . . . . 386.1 109.836 -176.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.916 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 73.8 m -154.06 -166.6 2.41 Favored 'General case' 0 N--CA 1.414 -2.249 0 N-CA-C 103.531 -2.766 . . . . 289.8 103.531 -178.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 1.139 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.94 175.37 0.87 Allowed 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 117.767 -1.111 . . . . 402.06 109.566 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.788 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 73.4 p -165.22 177.5 7.59 Favored 'General case' 0 CA--C 1.586 2.361 0 C-N-CA 127.329 2.252 . . . . 690.53 114.909 177.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.488 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.8 mm-40 132.38 160.58 0.0 OUTLIER 'General case' 1 C--N 1.429 4.057 1 N-CA-C 123.149 4.5 . . . . 633.62 123.149 162.669 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.761 HG22 ' SG ' ' A' ' 180' ' ' CYS . 68.9 p -85.61 153.78 22.15 Favored 'General case' 0 C--N 1.389 2.29 0 C-N-CA 127.424 2.289 . . . . 617.99 110.892 178.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 1.043 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.65 174.35 6.08 Favored Pre-proline 0 C--N 1.363 1.182 0 C-N-CA 130.268 3.427 . . . . 434.98 113.429 -175.499 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 1.091 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 52.7 Cg_endo -44.23 -65.67 0.18 Allowed 'Trans proline' 0 N--CA 1.442 -1.557 0 N-CA-C 122.357 3.945 . . . . 365.88 122.357 -168.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . 0.778 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.305 70.4 m -84.91 20.93 1.7 Allowed 'General case' 0 CA--C 1.467 -2.228 0 N-CA-C 104.772 -2.307 . . . . 635.81 104.772 178.197 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.75 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.456 5.0 mmp_? -94.35 152.28 18.76 Favored 'General case' 1 CA--C 1.419 -4.092 3 N-CA-C 131.969 7.766 . . . . 999.99 131.969 -135.771 . . . . . . . . 5 3 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 1.057 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.911 37.1 t -131.86 73.18 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.383 -3.797 1 CA-C-N 103.288 -6.323 . . . . 594.32 113.628 149.186 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.729 HG13 ' HB2' ' A' ' 174' ' ' MET . 7.3 p -144.21 144.11 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.642 1 N-CA-C 98.296 -4.705 . . . . 811.91 98.296 162.403 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.761 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.9 m -118.46 144.54 45.92 Favored 'General case' 0 CA--C 1.488 -1.413 0 C-N-CA 117.081 -1.848 . . . . 999.99 109.408 -178.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.971 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.8 mmm -147.21 -175.59 4.89 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-O 121.988 0.899 . . . . 431.86 110.058 -177.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 1.037 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.19 148.66 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 C-N-CA 124.345 1.058 . . . . 457.18 108.811 -177.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . 0.788 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.32 85.46 3.74 Favored 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 124.132 0.973 . . . . 458.77 113.495 -174.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.957 ' CZ3' HG22 ' A' ' 182' ' ' ILE . 1.9 p90 -76.37 -31.56 0.98 Allowed Pre-proline 0 N--CA 1.438 -1.055 0 C-N-CA 124.98 1.312 . . . . 999.99 112.425 168.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.956 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.0 Cg_exo -65.94 -45.81 5.62 Favored 'Trans proline' 0 N--CA 1.437 -1.817 0 N-CA-C 120.847 3.364 . . . . 999.99 120.847 -174.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.507 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 55.0 mt-10 -119.59 171.75 8.14 Favored 'General case' 0 CA--C 1.472 -2.033 0 C-N-CA 117.156 -1.817 . . . . 81.18 107.213 -172.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.834 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.7 p-80 -109.15 45.16 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.84 0 C-N-CA 115.498 -2.481 . . . . 999.99 108.72 177.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 1.074 ' HB2' HD12 ' A' ' 191' ' ' ILE . 87.2 Cg_endo -41.58 101.8 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.146 1 C-N-CA 126.021 4.481 . . . . 999.99 105.696 -170.75 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -62.21 -44.07 97.41 Favored 'General case' 0 CA--C 1.484 -1.586 0 C-N-CA 126.755 2.022 . . . . 967.72 112.062 -165.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 190' ' ' LYS . 30.3 mmtp -60.24 -36.57 78.03 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 106.732 -1.581 . . . . 934.3 106.732 -175.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 1.074 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.57 -30.29 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 C-N-CA 129.2 3.0 . . . . 565.15 113.888 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 61.54 55.42 2.8 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-N 118.464 0.575 . . . . 755.61 109.855 -175.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 1.139 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.49 -49.27 67.16 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 124.532 1.133 . . . . 325.89 113.278 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.632 ' HE3' ' OH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.8 -44.96 78.29 Favored 'General case' 0 CA--C 1.495 -1.163 0 C-N-CA 123.537 0.735 . . . . 250.21 111.679 -169.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.5 t -64.72 -43.35 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-O 121.589 0.709 . . . . 142.46 110.389 -175.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 1.037 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.7 t80 -61.07 -41.54 96.83 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 123.986 0.914 . . . . 247.69 108.836 -173.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.824 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 23.1 t60 -60.49 -51.37 69.75 Favored 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 125.45 1.5 . . . . 199.61 113.059 -175.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.1 mt -65.37 -44.42 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 107.732 -1.21 . . . . 106.73 107.732 -177.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . 0.722 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.6 t -59.21 -48.49 81.42 Favored 'General case' 0 CA--C 1.486 -1.495 0 CA-C-N 115.881 -0.599 . . . . 115.01 110.245 -173.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 1.057 HG13 HD13 ' A' ' 161' ' ' LEU . 86.2 t -65.21 -49.21 80.24 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.671 0 C-N-CA 119.428 -0.909 . . . . 129.42 111.846 -174.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.793 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.9 m -61.84 -53.13 60.02 Favored 'General case' 0 CA--C 1.482 -1.651 0 C-N-CA 118.213 -1.395 . . . . 172.48 109.971 -172.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.632 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.5 t -63.9 -54.26 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 C-N-CA 120.519 -0.472 . . . . 55.86 110.946 -174.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.722 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.53 -51.54 59.13 Favored 'General case' 0 N--CA 1.432 -1.362 0 C-N-CA 118.533 -1.267 . . . . 184.68 111.541 -174.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 1.05 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.6 -52.45 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 C-N-CA 116.663 -2.015 . . . . 291.81 114.704 -174.713 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.549 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.8 t80 -82.1 -54.97 4.86 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 115.136 1.532 . . . . 130.66 115.136 -178.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . 0.793 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.7 m-85 -66.84 -48.57 68.47 Favored 'General case' 0 CA--C 1.496 -1.096 0 N-CA-C 114.473 1.286 . . . . 80.16 114.473 -170.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.894 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.48 -45.5 83.63 Favored Pre-proline 0 N--CA 1.435 -1.201 0 C-N-CA 119.97 -0.692 . . . . 136.02 109.504 -174.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.894 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.3 Cg_exo -64.82 -27.13 59.55 Favored 'Trans proline' 0 N--CA 1.433 -2.065 0 N-CA-C 110.595 -0.579 . . . . 92.17 110.595 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.686 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.29 -41.48 76.76 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 107.456 -1.312 . . . . 135.6 107.456 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.17 -44.68 91.3 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 109.555 -0.535 . . . . 52.1 109.555 -176.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.616 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.72 -43.5 97.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 109.055 -0.72 . . . . 95.89 109.055 -176.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.904 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.25 -42.39 93.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 106.699 -1.593 . . . . 43.41 106.699 -178.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.39 -42.32 99.14 Favored Glycine 0 N--CA 1.432 -1.626 0 N-CA-C 109.384 -1.487 . . . . 27.69 109.384 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . 0.887 ' O ' HG22 ' A' ' 217' ' ' THR . 78.0 t80 -65.63 -47.41 75.71 Favored 'General case' 0 CA--C 1.497 -1.086 0 O-C-N 122.209 -0.583 . . . . 54.41 110.466 -177.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . 0.827 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.43 -34.07 74.78 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 106.989 -1.485 . . . . 53.88 106.989 -177.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -60.82 -40.76 93.97 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 108.447 -0.946 . . . . 68.29 108.447 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . 0.887 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.85 -38.99 92.83 Favored 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 119.677 -0.809 . . . . 107.59 110.618 -175.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.827 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.06 -38.35 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 C-N-CA 119.615 -0.834 . . . . 111.61 109.488 -177.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.92 HG13 ' CD1' ' A' ' 134' ' ' ILE . 79.8 t -63.27 -22.51 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.392 -0.966 . . . . 85.26 108.392 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.85 -41.95 99.4 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.07 -0.812 . . . . 40.71 111.07 -176.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.5 mm -64.72 -44.0 96.53 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 N-CA-C 108.414 -0.958 . . . . 95.86 108.414 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.822 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.9 p -76.99 -137.5 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.408 -0.96 . . . . 144.37 108.408 -176.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.902 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.6 mt -55.36 132.14 47.4 Favored 'General case' 0 CA--C 1.487 -1.452 0 N-CA-C 107.63 -1.248 . . . . 326.72 107.63 -177.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' TRP . . . . . 0.462 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 9.0 t90 -119.32 -168.07 1.51 Allowed 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 106.011 -1.848 . . . . 158.38 106.011 -176.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.462 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.37 -41.93 98.85 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 109.627 -0.509 . . . . 36.78 109.627 -178.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 73.0 m -61.19 125.88 25.35 Favored 'General case' 0 N--CA 1.434 -1.274 0 C-N-CA 119.115 -1.034 . . . . 85.46 109.802 -174.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . 0.693 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.86 126.54 8.85 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 105.538 -2.023 . . . . 127.78 105.538 176.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.927 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -85.99 139.89 34.89 Favored Pre-proline 0 CA--C 1.492 -1.253 0 N-CA-C 105.964 -1.865 . . . . 164.84 105.964 -179.624 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.927 ' N ' HD13 ' A' ' 228' ' ' ILE . 81.3 Cg_exo -56.8 -39.89 88.15 Favored 'Trans proline' 0 N--CA 1.431 -2.185 0 N-CA-C 113.977 0.722 . . . . 222.35 113.977 -176.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . 0.744 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.12 166.96 44.93 Favored Glycine 0 N--CA 1.427 -1.912 0 N-CA-C 106.432 -2.667 . . . . 45.22 106.432 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.882 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.8 t0 -60.93 -45.77 93.37 Favored 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 106.045 -1.835 . . . . 107.57 106.045 177.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . 0.73 ' O ' HG21 ' A' ' 228' ' ' ILE . 68.0 m -65.82 141.82 58.16 Favored 'General case' 0 N--CA 1.428 -1.539 0 C-N-CA 118.907 -1.117 . . . . 167.96 109.128 -175.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.828 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.1 m 99.53 106.73 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 126.729 2.012 . . . . 280.68 109.754 176.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.711 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.6 m-20 56.06 11.18 0.7 Allowed 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 124.417 1.087 . . . . 218.25 110.679 174.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.921 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.32 137.61 54.8 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 105.222 -2.14 . . . . 343.57 105.222 177.448 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.562 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.5 t80 -111.98 81.94 1.54 Allowed 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 106.852 -1.536 . . . . 263.29 106.852 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' HIS . . . . . 0.625 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.4 m-70 104.27 147.08 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.283 0 C-N-CA 126.602 1.961 . . . . 261.92 108.497 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.23 -38.08 89.75 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 107.882 -1.155 . . . . 106.81 107.882 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.738 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.49 -39.87 94.86 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 118.325 -1.35 . . . . 112.2 107.549 -178.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.736 HG12 ' NH1' ' A' ' 244' ' ' ARG . 75.7 t -64.32 -39.8 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 N-CA-C 109.254 -0.647 . . . . 45.41 109.254 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . 0.805 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.4 p -70.93 -32.02 68.8 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 110.296 -0.261 . . . . 97.62 110.296 -178.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.42 -39.62 81.51 Favored 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 123.713 0.805 . . . . 59.29 110.959 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.738 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.23 -36.58 84.11 Favored 'General case' 0 CA--C 1.492 -1.265 0 C-N-CA 124.722 1.209 . . . . 106.49 110.682 -174.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.921 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.95 -30.64 69.22 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 108.313 -0.995 . . . . 106.62 108.313 -176.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.531 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -66.03 -40.99 91.48 Favored 'General case' 0 N--CA 1.435 -1.175 0 O-C-N 121.821 -0.55 . . . . 75.97 110.065 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.444 ' CG1' ' HE1' ' A' ' 250' ' ' MET . 76.8 t -65.55 -40.82 89.26 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 C-N-CA 122.926 0.49 . . . . 65.27 109.815 -178.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.775 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.9 p -63.99 -41.65 93.16 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 C-N-CA 120.42 -0.512 . . . . 107.94 110.125 -177.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.536 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.1 pttt -63.55 -40.77 97.86 Favored 'General case' 0 N--CA 1.434 -1.239 0 O-C-N 121.71 -0.619 . . . . 87.98 110.286 -176.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' MET . . . . . 0.823 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.65 -40.4 96.76 Favored 'General case' 0 CA--C 1.492 -1.268 0 C-N-CA 118.849 -1.141 . . . . 65.5 108.355 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' MET . . . . . 0.772 ' HE2' ' CG2' ' A' ' 67' ' ' THR . 68.5 mtt -61.75 -36.36 80.8 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 108.095 -1.076 . . . . 85.05 108.095 -177.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.536 HD12 ' HA ' ' A' ' 248' ' ' LYS . 86.8 mt -63.5 -45.76 96.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 N-CA-C 109.032 -0.729 . . . . 42.25 109.032 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.823 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.3 -38.27 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 C-N-CA 119.594 -0.842 . . . . 91.01 109.443 -176.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 1.002 HG22 ' CD1' ' A' ' 304' ' ' ILE . 65.9 t -58.9 -41.55 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 N-CA-C 107.965 -1.124 . . . . 66.09 107.965 -178.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 250' ' ' MET . 94.7 t -66.08 -43.18 92.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 C-N-CA 120.719 -0.393 . . . . 52.39 110.323 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.1 m -61.7 -46.79 88.18 Favored 'General case' 0 CA--C 1.489 -1.4 0 O-C-N 121.847 -0.533 . . . . 46.42 109.877 -174.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . 0.744 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.5 t -62.31 -38.12 88.19 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 108.322 -0.992 . . . . 116.51 108.322 -177.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' PHE . . . . . 0.488 ' N ' HG23 ' A' ' 256' ' ' THR . 86.1 t80 -60.28 -48.25 82.53 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 109.358 -0.608 . . . . 65.18 109.358 -178.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.91 -42.72 97.33 Favored 'General case' 0 CA--C 1.49 -1.358 0 CA-C-O 120.869 0.366 . . . . 51.33 110.458 -175.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . 0.744 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.57 -43.38 98.22 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.573 0 C-N-CA 118.89 -1.124 . . . . 126.3 109.038 -176.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' CYS . . . . . 0.509 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.5 m -65.6 -49.32 69.23 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 119.521 -0.872 . . . . 133.94 112.462 -176.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.82 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.0 m95 -80.68 -33.29 35.57 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 116.888 2.181 . . . . 134.84 116.888 -176.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.785 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.9 tp -58.48 -41.6 90.06 Favored Pre-proline 0 CA--C 1.493 -1.219 0 O-C-N 121.689 -0.632 . . . . 72.23 111.658 -167.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' PRO . . . . . 0.785 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 79.8 Cg_exo -60.7 -35.94 87.09 Favored 'Trans proline' 0 C--N 1.295 -2.281 0 CA-C-N 119.813 0.969 . . . . 106.13 111.368 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' PHE . . . . . 0.851 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.6 t80 -66.42 -44.69 82.27 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 119.775 -0.77 . . . . 128.35 110.045 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' HIS . . . . . 0.643 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.43 -37.83 88.9 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 110.249 -0.278 . . . . 100.73 110.249 -177.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.745 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.22 -44.6 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 C-N-CA 119.346 -0.942 . . . . 172.72 109.149 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . 0.734 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.7 m-85 -66.59 -28.03 68.19 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 108.264 -1.013 . . . . 249.23 108.264 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' PHE . . . . . 0.9 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.57 -55.14 35.4 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.687 -1.597 . . . . 259.78 106.687 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . 0.492 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.2 mt -69.17 -44.12 72.88 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 113.612 0.967 . . . . 233.11 113.612 -176.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.838 ' O ' HG13 ' A' ' 273' ' ' ILE . 89.1 mt -61.37 -48.31 91.41 Favored Pre-proline 0 N--CA 1.439 -0.976 0 C-N-CA 119.155 -1.018 . . . . 169.54 110.642 -171.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . 0.734 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.9 Cg_exo -61.13 -24.49 79.34 Favored 'Trans proline' 0 N--CA 1.429 -2.276 0 C-N-CA 116.715 -1.723 . . . . 255.47 114.698 174.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' TYR . . . . . 0.824 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.6 t80 -63.58 -44.26 94.6 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 119.228 0.922 . . . . 279.03 108.854 177.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.838 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.36 -44.77 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 N-CA-C 110.056 -0.35 . . . . 162.21 110.056 -178.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' ASN . . . . . 0.781 ' N ' HD12 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.38 84.87 59.27 Favored Pre-proline 0 N--CA 1.43 -1.428 0 C-N-CA 118.775 -1.17 . . . . 128.13 108.12 -178.119 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.5 Cg_endo -85.22 164.01 11.3 Favored 'Trans proline' 0 C--N 1.294 -2.304 0 N-CA-C 107.455 -1.787 . . . . 278.35 107.455 177.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . 0.869 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.4 t0 66.12 15.01 9.92 Favored 'General case' 0 N--CA 1.428 -1.569 0 O-C-N 123.777 0.673 . . . . 312.91 109.326 175.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.869 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.3 mt -132.71 -170.67 2.49 Favored 'General case' 0 CA--C 1.481 -1.679 0 N-CA-C 106.556 -1.646 . . . . 353.54 106.556 177.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 1.009 ' HA ' ' CB ' ' A' ' 282' ' ' PHE . 42.8 p90 -115.67 142.25 46.99 Favored 'General case' 0 N--CA 1.427 -1.619 0 N-CA-C 107.439 -1.319 . . . . 251.26 107.439 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.762 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -76.97 -118.71 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 102.103 -3.295 . . . . 175.26 102.103 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . 0.796 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.5 -44.96 96.14 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 100.884 -3.747 . . . . 99.07 100.884 172.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . 0.796 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.45 124.18 9.17 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 103.45 -2.796 . . . . 243.21 103.45 171.186 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 1.009 ' CB ' ' HA ' ' A' ' 278' ' ' TYR . 77.1 t80 -93.0 112.98 25.13 Favored 'General case' 0 CA--C 1.473 -2.003 0 C-N-CA 116.065 -2.254 . . . . 201.04 105.286 178.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' ILE . . . . . 0.776 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.96 173.71 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.085 0 C-N-CA 116.004 -2.278 . . . . 201.36 108.802 -175.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . 1.091 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.283 0.6 OUTLIER -59.48 -41.44 89.8 Favored 'General case' 0 N--CA 1.415 -2.176 0 CA-C-N 113.233 -1.803 . . . . 203.82 107.896 174.462 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . 0.923 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.29 -45.72 86.77 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 118.215 -1.394 . . . . 215.06 112.553 -171.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.552 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.2 t -65.63 -46.45 89.36 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.476 0 C-N-CA 118.565 -1.254 . . . . 125.28 112.951 -171.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' TYR . . . . . 0.952 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.73 -37.04 86.23 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 107.205 -1.405 . . . . 268.9 107.205 -171.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.796 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.26 -44.97 74.41 Favored 'General case' 0 N--CA 1.427 -1.583 0 C-N-CA 125.657 1.583 . . . . 280.88 108.762 -172.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.67 -47.47 86.11 Favored 'General case' 0 N--CA 1.428 -1.564 0 C-N-CA 118.987 -1.085 . . . . 184.47 108.979 -172.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . 0.851 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.8 mp -67.94 -42.1 85.28 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 C-N-CA 119.247 -0.981 . . . . 167.92 112.739 -175.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' MET . . . . . 0.501 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.8 ttt -65.72 -38.83 90.26 Favored 'General case' 0 CA--C 1.495 -1.136 0 C-N-CA 117.751 -1.58 . . . . 367.18 110.802 -175.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' TRP . . . . . 0.548 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.5 m95 -67.14 -32.7 74.0 Favored 'General case' 0 N--CA 1.435 -1.208 0 O-C-N 121.856 -0.527 . . . . 173.97 110.466 177.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.1 tp -64.44 -36.85 85.51 Favored 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 123.6 0.76 . . . . 119.66 109.777 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . 0.82 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.16 -33.99 74.3 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 107.734 -1.21 . . . . 112.3 107.734 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' MET . . . . . 0.773 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.13 -32.04 73.33 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 116.202 -0.454 . . . . 174.17 110.237 -177.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.7 m -64.69 -22.76 67.06 Favored 'General case' 0 CA--C 1.485 -1.536 0 C-N-CA 124.629 1.171 . . . . 145.27 110.645 -175.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' SER . . . . . 0.758 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.6 m -57.65 -35.35 70.41 Favored 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 108.084 -1.08 . . . . 170.15 108.084 -175.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.82 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.7 t -55.28 -34.21 63.9 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 116.282 -0.417 . . . . 214.57 110.64 -171.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . 0.751 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.1 ttt -77.17 -33.22 56.52 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 126.065 1.746 . . . . 168.29 115.534 177.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' TYR . . . . . 0.758 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.4 p90 -64.38 -34.86 79.13 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 114.066 1.135 . . . . 167.15 114.066 -168.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . 0.723 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.282 18.8 p-10 -64.23 -38.32 33.25 Favored Pre-proline 0 N--CA 1.434 -1.266 0 C-N-CA 115.52 -2.472 . . . . 165.13 113.921 -171.59 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' PRO . . . . . 0.723 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.2 Cg_exo -62.52 -31.84 80.17 Favored 'Trans proline' 0 N--CA 1.433 -2.035 0 CA-C-N 122.755 2.019 . . . . 123.92 111.271 -178.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' ILE . . . . . 0.717 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.0 pt -68.75 -42.55 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 C-N-CA 118.869 -1.132 . . . . 110.55 109.755 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' ILE . . . . . 1.002 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.1 pt -61.2 -39.99 84.37 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.168 0 N-CA-C 108.806 -0.813 . . . . 145.31 108.806 -177.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . 0.923 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.253 63.2 m-85 -58.13 -48.78 79.17 Favored 'General case' 0 CA--C 1.493 -1.212 0 C-N-CA 119.375 -0.93 . . . . 246.68 109.837 -177.499 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 87.3 m -62.23 -47.52 84.03 Favored 'General case' 0 CA--C 1.485 -1.532 0 C-N-CA 119.549 -0.86 . . . . 64.43 109.52 -173.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.7 t -66.83 -45.01 79.61 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 118.993 -1.083 . . . . 80.72 110.226 -177.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.709 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.53 -35.69 75.7 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 115.972 1.841 . . . . 140.44 115.972 -173.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . 0.657 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.85 132.23 34.3 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 112.685 -3.606 . . . . 178.87 113.064 -177.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . 0.614 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.6 p-10 -65.03 -37.03 86.29 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 114.382 -1.281 . . . . 110.22 110.113 -177.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.856 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.75 -50.59 72.72 Favored 'General case' 0 CA--C 1.492 -1.263 0 O-C-N 121.697 -0.627 . . . . 174.78 109.765 -174.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.958 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.1 m-85 -64.87 -41.7 95.44 Favored 'General case' 0 CA--C 1.485 -1.536 0 N-CA-C 108.228 -1.027 . . . . 161.84 108.228 178.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . 0.517 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.31 -50.22 73.62 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.196 -0.668 . . . . 117.2 109.196 -173.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.797 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.54 -44.06 75.36 Favored 'General case' 0 N--CA 1.433 -1.275 0 C-N-CA 120.352 -0.539 . . . . 112.6 111.092 -177.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . 0.872 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -64.08 -37.43 94.57 Favored Glycine 0 N--CA 1.431 -1.678 0 N-CA-C 110.59 -1.004 . . . . 101.46 110.59 -177.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' PHE . . . . . 1.017 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.6 m-85 -62.17 -46.01 90.86 Favored 'General case' 0 CA--C 1.491 -1.307 0 CA-C-N 118.521 1.16 . . . . 151.49 109.523 -178.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . 0.422 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.07 -36.3 77.06 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 106.957 -1.498 . . . . 142.32 106.957 -175.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' HIS . . . . . 0.826 ' NE2' HG21 ' A' ' 326' ' ' ILE . 49.9 m80 -59.79 -41.82 92.01 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 106.903 -1.517 . . . . 109.09 106.903 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.86 -42.41 85.71 Favored 'General case' 0 N--CA 1.435 -1.177 0 O-C-N 122.334 -0.228 . . . . 76.11 111.037 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -61.46 -55.43 31.37 Favored 'General case' 0 CA--C 1.49 -1.36 0 C-N-CA 119.849 -0.74 . . . . 120.24 109.331 -174.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.578 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.5 mtt180 -74.34 131.52 41.21 Favored 'General case' 0 CA--C 1.482 -1.66 0 N-CA-C 102.957 -2.979 . . . . 192.73 102.957 177.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.14 -44.24 92.05 Favored 'General case' 0 CA--C 1.492 -1.266 0 C-N-CA 119.042 -1.063 . . . . 176.29 109.153 -172.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' CYS . . . . . 0.753 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.6 m -79.37 -177.07 0.8 Allowed Pre-proline 0 CA--C 1.487 -1.453 0 N-CA-C 106.241 -1.762 . . . . 69.68 106.241 178.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.567 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.5 Cg_exo -59.08 -75.51 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.403 0 C-N-CA 118.31 -0.66 . . . . 191.05 112.614 176.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' PHE . . . . . 0.753 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.5 m-85 47.48 43.92 16.24 Favored 'General case' 0 CA--C 1.493 -1.229 0 O-C-N 123.575 0.547 . . . . 287.03 109.737 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . 0.826 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.51 78.59 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.474 -1.946 0 C-N-CA 112.992 -3.483 . . . . 292.29 109.8 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . 0.48 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.3 t -77.53 -152.81 0.05 Allowed 'General case' 0 N--CA 1.424 -1.775 0 N-CA-C 104.209 -2.515 . . . . 184.57 104.209 178.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.74 8.6 4.92 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 113.045 0.757 . . . . 274.56 113.045 176.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.97 0.91 57.26 Favored Glycine 0 C--N 1.348 1.198 0 C-N-CA 117.746 -2.168 . . . . 268.24 113.465 172.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' ASP . . . . . 0.698 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.5 m-20 51.59 -172.04 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.063 0 CA-C-N 118.677 1.239 . . . . 200.06 110.734 177.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.856 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.88 -32.98 74.68 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 107.878 -1.156 . . . . 114.44 107.878 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.28 46.04 21.92 Favored 'General case' 0 CA--C 1.484 -1.591 0 N-CA-C 107.638 -1.245 . . . . 263.81 107.638 -177.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' GLY . . . . . 0.634 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.3 -137.36 3.61 Favored Glycine 0 CA--C 1.479 -2.204 1 N-CA-C 102.556 -4.218 . . . . 103.79 102.556 -179.815 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 1.048 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.2 mt -88.26 95.54 10.22 Favored 'General case' 0 N--CA 1.419 -1.996 0 C-N-CA 114.936 -2.706 . . . . 117.3 106.018 177.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . 1.028 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.91 -39.83 90.91 Favored 'General case' 0 CA--C 1.469 -2.16 1 N-CA-C 97.994 -4.817 . . . . 231.58 97.994 167.264 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . 1.036 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.92 163.49 29.05 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 102.11 -3.293 . . . . 303.24 102.11 168.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' LYS . . . . . 1.048 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.3 tttt -62.62 -48.6 78.68 Favored 'General case' 0 N--CA 1.432 -1.365 0 C-N-CA 116.038 -2.265 . . . . 112.72 108.411 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.9 t -61.04 -63.63 1.23 Allowed 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 109.117 -0.697 . . . . 83.22 109.117 -176.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . 0.884 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.1 m -156.28 -126.21 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 103.833 -2.654 . . . . 174.36 103.833 -178.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . 1.028 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.86 160.95 8.77 Favored 'General case' 0 CA--C 1.486 -1.504 0 N-CA-C 105.761 -1.94 . . . . 202.73 105.761 177.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . 1.018 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.98 149.08 52.53 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 107.046 -1.465 . . . . 180.62 107.046 176.358 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.931 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.4 tp -178.52 -171.86 0.27 Allowed 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 105.409 -2.071 . . . . 145.25 105.409 178.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' GLN . . . . . 0.931 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.08 -43.17 88.11 Favored 'General case' 0 CA--C 1.487 -1.477 0 N-CA-C 106.129 -1.804 . . . . 66.05 106.129 174.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . 0.766 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.1 t -132.68 -152.12 0.48 Allowed 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 103.505 -2.776 . . . . 266.49 103.505 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' GLN . . . . . 0.699 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.4 mt-30 66.27 -124.96 0.28 Allowed 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 117.043 -1.863 . . . . 219.2 107.801 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . 0.902 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.02 -37.43 94.23 Favored Glycine 0 N--CA 1.425 -2.044 0 CA-C-N 114.558 -1.201 . . . . 94.78 112.852 -176.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . 0.826 ' HB2' ' H ' ' A' ' 342' ' ' LEU . 48.4 t -81.11 100.38 9.01 Favored 'General case' 0 CA--C 1.484 -1.575 0 C-N-CA 112.316 -3.753 . . . . 121.41 109.468 -171.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.8 t -72.99 145.47 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 108.997 -0.742 . . . . 85.34 108.997 -176.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' TYR . . . . . 0.441 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.5 p90 -57.76 143.47 41.86 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 107.839 -1.171 . . . . 267.57 107.839 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . 0.525 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.01 69.58 0.6 Allowed 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 109.553 -0.536 . . . . 226.1 109.553 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' VAL . . . . . 0.825 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.5 p -50.94 156.94 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.315 0 N-CA-C 106.994 -1.484 . . . . 154.84 106.994 177.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . 0.582 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.4 m -61.35 161.87 8.59 Favored 'General case' 0 CA--C 1.494 -1.21 0 CA-C-O 121.588 0.709 . . . . 180.01 110.722 -173.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' ARG . . . . . 0.895 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.41 156.92 23.6 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 106.976 -1.49 . . . . 333.78 106.976 -178.653 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . 0.974 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.06 142.51 48.79 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 107.364 -1.347 . . . . 335.2 107.364 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.974 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.6 mm-40 82.88 158.91 0.13 Allowed 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 108.703 -0.851 . . . . 266.47 108.703 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.8 m -60.66 -46.92 88.5 Favored 'General case' 0 CA--C 1.487 -1.465 0 N-CA-C 105.632 -1.988 . . . . 59.34 105.632 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.53 173.87 11.97 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 104.462 -2.421 . . . . 201.26 104.462 176.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.748 HG22 ' O ' ' A' ' 360' ' ' THR . 69.3 mt -95.94 106.78 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 C-N-CA 116.29 -2.164 . . . . 56.23 105.503 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . 0.464 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.9 m -61.19 -59.45 5.29 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 109.319 -0.623 . . . . 87.58 109.319 -175.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . 0.891 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.2 t -85.55 153.74 22.22 Favored 'General case' 0 CA--C 1.485 -1.535 0 N-CA-C 107.821 -1.178 . . . . 219.95 107.821 -177.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' VAL . . . . . 0.588 ' O ' HG23 ' A' ' 361' ' ' VAL . 16.0 m -81.98 83.85 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 C-N-CA 116.35 -2.14 . . . . 121.79 105.432 177.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.597 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.3 t -154.14 159.72 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.559 0 N-CA-C 105.78 -1.933 . . . . 53.85 105.78 -179.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . 0.597 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.2 16.62 77.02 Favored Glycine 0 N--CA 1.428 -1.889 0 N-CA-C 106.029 -2.828 . . . . 196.55 106.029 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.653 0 N-CA-C 107.883 -1.154 . . . . 35.88 107.883 -178.971 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 365' ' ' ARG . . . . . 0.512 ' HE ' ' HB3' ' B' ' 365' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 108.867 -0.79 . . . . 1.0 108.867 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 366' ' ' PRO . . . . . 0.731 ' HG3' ' ND2' ' A' ' 3' ' ' ASN . 52.3 Cg_endo -66.89 142.0 60.98 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.059 1.839 . . . . 1.0 110.195 179.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 367' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -64.46 143.29 98.53 Favored Pre-proline 0 C--N 1.324 -0.503 0 C-N-CA 119.854 -0.738 . . . . 1.0 109.545 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 368' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.25 150.39 76.56 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.312 2.008 . . . . 1.0 111.738 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 369' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.71 131.71 44.29 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.709 -0.396 . . . . 1.0 110.248 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -101.95 115.9 31.54 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.372 -0.377 . . . . 1.0 110.727 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 371' ' ' PHE . . . . . 0.405 ' HA ' HD12 ' B' ' 374' ' ' LEU . 86.1 m-85 -63.6 -42.51 98.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.318 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 372' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -65.07 -36.14 83.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.839 -0.619 . . . . 1.0 110.672 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -59.73 -33.08 76.12 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.776 -0.93 . . . . 1.0 110.776 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 374' ' ' LEU . . . . . 0.656 ' CD1' HD11 ' A' ' 102' ' ' LEU . 3.2 mt -67.85 131.38 45.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.929 0.395 . . . . 1.0 110.16 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 375' ' ' MET . . . . . 0.416 ' HE2' ' HB2' ' B' ' 375' ' ' MET . 0.4 OUTLIER . . . . . 0 C--O 1.221 -0.424 0 CA-C-O 118.014 -0.993 . . . . 1.0 110.534 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.471 0 N-CA-C 108.398 -0.964 . . . . 97.08 108.398 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.682 ' ND2' ' HG3' ' B' ' 366' ' ' PRO . 46.5 t30 -110.62 155.43 22.38 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-O 122.172 0.987 . . . . 123.41 110.671 -172.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.881 HG11 HD13 ' A' ' 15' ' ' ILE . 28.8 m -134.56 -162.33 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.477 1 N-CA-C 100.121 -4.029 . . . . 151.3 100.121 173.72 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.908 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.69 -38.6 58.17 Favored Pre-proline 0 N--CA 1.439 -0.985 0 C-N-CA 115.961 -2.296 . . . . 169.25 106.104 178.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.908 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 57.6 Cg_exo -81.28 168.53 16.66 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 122.283 0.623 . . . . 185.76 110.568 171.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.904 HG13 ' CE2' ' A' ' 282' ' ' PHE . 91.7 t -64.5 -25.92 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 C-N-CA 127.041 2.137 . . . . 145.47 110.332 -177.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.774 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.2 t0 -84.32 157.44 21.5 Favored 'General case' 0 CA--C 1.499 -0.993 0 O-C-N 121.087 -1.008 . . . . 102.76 109.45 -178.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.6 p -82.6 154.23 25.06 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 107.943 -1.132 . . . . 106.25 107.943 178.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.921 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.7 p-10 -105.97 51.93 0.74 Allowed 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 117.763 -1.575 . . . . 157.81 107.597 178.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.22 -45.87 91.71 Favored 'General case' 0 CA--C 1.481 -1.698 0 N-CA-C 103.58 -2.748 . . . . 150.2 103.58 178.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 71.0 m -87.01 164.69 35.36 Favored Pre-proline 0 N--CA 1.421 -1.9 0 N-CA-C 103.689 -2.708 . . . . 183.52 103.689 172.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -76.75 6.86 3.84 Favored 'Trans proline' 0 C--N 1.281 -2.987 0 N-CA-C 110.011 -0.803 . . . . 235.61 110.011 176.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -57.92 -41.24 82.26 Favored 'General case' 0 N--CA 1.435 -1.198 0 C-N-CA 124.82 1.248 . . . . 113.77 113.386 -170.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.921 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.3 pt -52.22 136.26 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.912 0 CA-C-N 119.553 1.069 . . . . 150.85 110.942 -176.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.51 156.24 46.39 Favored 'General case' 0 C--N 1.36 1.06 0 N-CA-C 107.61 -1.256 . . . . 100.42 107.61 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 1.081 HG23 ' H ' ' A' ' 20' ' ' SER . 14.2 t -64.99 142.6 58.38 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 121.971 0.891 . . . . 129.36 110.449 -174.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.775 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.1 -25.5 68.39 Favored 'General case' 0 CA--C 1.494 -1.174 0 C-N-CA 126.28 1.832 . . . . 112.34 106.645 -177.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.935 HG23 ' HA2' ' A' ' 101' ' ' GLY . 85.3 m -74.11 -40.13 62.88 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 115.562 -0.744 . . . . 131.73 111.769 177.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 1.081 ' H ' HG23 ' A' ' 17' ' ' THR . 70.8 m -84.47 -42.84 15.18 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 117.006 2.225 . . . . 80.49 117.006 -174.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.549 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.4 mt-10 -145.99 174.52 3.36 Favored Pre-proline 0 N--CA 1.442 -0.827 0 C-N-CA 118.124 -1.43 . . . . 98.98 111.172 -169.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.822 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.332 85.6 Cg_exo -61.84 -10.67 18.0 Favored 'Trans proline' 0 C--N 1.321 -0.87 1 N-CA-C 128.882 6.455 . . . . 246.95 128.882 -170.053 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.626 HD21 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.58 17.52 8.65 Favored 'General case' 0 C--N 1.324 -0.519 1 CA-C-N 126.181 4.082 . . . . 269.62 114.237 175.65 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.495 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.5 mt-30 -67.1 -27.24 67.17 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 107.806 -1.183 . . . . 86.8 107.806 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.552 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.4 p90 -66.85 -29.29 69.16 Favored 'General case' 0 N--CA 1.431 -1.391 0 O-C-N 121.166 -0.959 . . . . 85.91 110.514 -178.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.872 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.4 t -68.59 -40.2 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 C-N-CA 123.734 0.814 . . . . 82.0 111.312 -177.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.897 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.41 167.73 12.48 Favored Pre-proline 0 CA--C 1.489 -1.401 0 N-CA-C 108.551 -0.907 . . . . 120.73 108.551 -178.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.904 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -64.0 149.76 89.82 Favored 'Trans proline' 0 N--CA 1.432 -2.136 0 C-N-CA 120.645 0.896 . . . . 87.86 109.912 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.743 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.03 -37.94 89.2 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.829 -0.804 . . . . 36.46 108.829 -176.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.813 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 28.0 p-90 -63.83 -33.84 76.58 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 107.837 -1.171 . . . . 150.6 107.837 -176.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.904 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.4 mt-30 -62.22 -32.66 73.35 Favored 'General case' 0 CA--C 1.49 -1.328 0 O-C-N 121.303 -0.873 . . . . 123.26 108.705 -178.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.743 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.5 -47.19 94.54 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.59 0 N-CA-C 109.162 -0.681 . . . . 120.14 109.162 176.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.785 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.3 m -67.38 -31.04 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 N-CA-C 107.865 -1.161 . . . . 112.19 107.865 -178.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.813 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.6 tp -62.99 -47.1 84.58 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 119.887 -0.725 . . . . 60.87 109.588 -178.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.672 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.04 -35.67 81.16 Favored 'General case' 0 CA--C 1.489 -1.389 0 C-N-CA 119.999 -0.681 . . . . 157.57 110.309 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.747 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.68 -40.83 98.33 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 108.617 -0.883 . . . . 47.06 108.617 178.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.805 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.8 -41.27 97.95 Favored 'General case' 0 CA--C 1.496 -1.112 0 O-C-N 121.728 -0.607 . . . . 43.94 109.535 -177.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.728 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.84 -43.31 99.1 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 108.714 -0.847 . . . . 42.61 108.714 -176.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.904 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.33 -41.29 94.11 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 116.615 -0.266 . . . . 140.66 111.018 -178.351 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.805 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.82 -43.91 97.91 Favored 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 118.547 -1.261 . . . . 116.04 110.252 -175.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.5 -38.71 83.1 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.29 0 N-CA-C 108.71 -0.848 . . . . 97.16 108.71 -177.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.855 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.2 mt -61.27 -39.99 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 108.995 -0.743 . . . . 54.85 108.995 -176.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.961 HG22 HG21 ' A' ' 86' ' ' THR . 92.6 t -57.73 -42.33 81.52 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.312 0 N-CA-C 108.864 -0.791 . . . . 45.39 108.864 -175.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 48' ' ' VAL . 97.2 t -63.56 -50.95 76.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 C-N-CA 118.875 -1.13 . . . . 48.64 110.163 -177.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.75 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.5 t -65.29 -46.99 78.21 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 120.119 -0.633 . . . . 116.65 111.731 -174.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.587 ' N ' HG23 ' A' ' 45' ' ' THR . 50.7 m -61.98 -43.96 97.74 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 109.729 -0.471 . . . . 51.16 109.729 -174.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.9 t -65.48 -48.95 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 C-N-CA 119.872 -0.731 . . . . 44.3 110.88 -177.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.866 ' O ' HG23 ' A' ' 52' ' ' VAL . 93.8 t -64.75 -46.94 90.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 C-N-CA 120.296 -0.561 . . . . 48.82 111.043 -174.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.79 -44.11 95.24 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 120.479 -0.867 . . . . 58.7 112.015 -174.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -72.67 -34.21 67.07 Favored 'General case' 0 CA--C 1.488 -1.418 0 O-C-N 122.102 -0.646 . . . . 101.4 111.014 -175.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.742 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.85 -38.77 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 107.755 -1.202 . . . . 103.57 107.755 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 48' ' ' VAL . 72.1 t -61.4 -43.04 96.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 N-CA-C 109.016 -0.735 . . . . 61.89 109.016 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.536 ' O ' HG22 ' A' ' 56' ' ' ILE . 82.1 t -63.43 -50.95 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 C-N-CA 120.284 -0.566 . . . . 70.01 109.506 -178.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.806 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.9 -43.45 98.77 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 109.142 -0.688 . . . . 132.1 109.142 -176.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.644 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.1 t-105 -64.18 -46.65 83.03 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 116.671 -0.24 . . . . 104.5 110.442 -176.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 1.015 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.68 -49.87 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 C-N-CA 120.216 -0.594 . . . . 142.96 111.244 -173.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.953 HD11 HG12 ' A' ' 72' ' ' VAL 0.278 24.8 pt -64.78 -41.67 92.82 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 C-N-CA 116.933 -1.907 . . . . 158.32 110.878 -175.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.806 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.76 -41.34 98.0 Favored 'General case' 0 N--CA 1.434 -1.273 0 C-N-CA 117.713 -1.595 . . . . 137.11 109.451 178.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.35 -44.6 90.94 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 122.128 -0.358 . . . . 54.66 110.994 -176.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.923 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.38 117.15 29.43 Favored 'General case' 0 CA--C 1.491 -1.323 0 CA-C-O 121.63 0.728 . . . . 127.18 109.572 -174.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.619 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.87 -36.79 80.09 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 124.022 0.929 . . . . 87.93 110.857 -176.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 1.036 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.38 -34.7 78.77 Favored 'General case' 0 CA--C 1.49 -1.356 0 O-C-N 121.623 -0.673 . . . . 131.12 111.467 -175.622 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 1.02 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.62 69.44 7.13 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 115.34 -2.544 . . . . 246.56 109.583 -175.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.411 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.2 91.42 3.48 Favored 'General case' 0 CA--C 1.474 -1.974 0 N-CA-C 105.514 -2.032 . . . . 339.35 105.514 177.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.445 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.5 p -124.15 165.2 17.96 Favored 'General case' 0 N--CA 1.413 -2.275 0 N-CA-C 102.987 -2.968 . . . . 114.66 102.987 176.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.879 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.07 -39.51 85.51 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.604 0 N-CA-C 106.798 -1.556 . . . . 143.28 106.798 178.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.835 HG22 HD13 ' A' ' 71' ' ' LEU . 95.1 m -59.63 -38.08 80.4 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 108.704 -0.851 . . . . 160.22 108.704 -176.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.524 ' ND2' ' HB3' ' A' ' 63' ' ' MET . 86.3 m-20 -62.3 -31.79 72.44 Favored 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 108.918 -0.771 . . . . 120.54 108.918 -177.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.9 ' O ' HG22 ' A' ' 72' ' ' VAL . 89.8 m-85 -63.61 -43.74 96.01 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 109.511 -0.552 . . . . 67.22 109.511 178.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.879 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.4 m-85 -66.56 -39.77 88.67 Favored 'General case' 0 CA--C 1.498 -1.033 0 O-C-N 121.455 -0.778 . . . . 138.6 109.659 -177.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.921 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.52 -35.95 82.17 Favored 'General case' 0 CA--C 1.492 -1.26 0 C-N-CA 122.5 0.32 . . . . 151.46 110.638 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.953 HG12 HD11 ' A' ' 57' ' ' ILE . 24.2 m -62.56 -37.98 80.29 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.225 0 C-N-CA 117.445 -1.702 . . . . 117.93 106.69 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.449 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.1 t30 -60.06 -46.01 90.97 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.833 -1.173 . . . . 56.82 107.833 -177.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.889 HD21 ' CE ' ' A' ' 123' ' ' MET . 8.7 mp -61.43 -43.83 98.18 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 108.93 -0.767 . . . . 145.3 108.93 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.13 -40.29 95.42 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 108.493 -0.929 . . . . 45.71 108.493 -175.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -62.48 -41.98 99.16 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 109.356 -0.609 . . . . 105.61 109.356 -178.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.14 -39.46 92.67 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 108.655 -0.869 . . . . 47.89 108.655 -178.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.59 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.55 -37.36 84.83 Favored 'General case' 0 N--CA 1.438 -1.042 0 O-C-N 122.08 -0.388 . . . . 124.53 109.967 179.677 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.9 -41.16 99.33 Favored 'General case' 0 N--CA 1.436 -1.14 0 O-C-N 121.912 -0.492 . . . . 35.89 109.873 -178.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.9 t -62.24 -37.37 85.14 Favored 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 106.988 -1.486 . . . . 88.97 106.988 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.82 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.6 ttm -62.13 -49.2 76.84 Favored 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 119.813 -0.755 . . . . 239.91 109.041 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.62 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.37 -43.35 91.06 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 121.487 -0.758 . . . . 146.1 110.636 -177.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.417 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.2 -58.24 3.4 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 117.374 -1.73 . . . . 91.74 113.843 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -76.49 -61.46 1.95 Allowed 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 115.739 1.755 . . . . 197.45 115.739 -173.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.936 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.23 -42.28 55.67 Favored 'General case' 0 CA--C 1.489 -1.388 0 C-N-CA 117.928 -1.509 . . . . 242.6 114.028 -170.012 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.961 HG21 HG22 ' A' ' 43' ' ' VAL . 4.6 t -65.39 -36.51 84.2 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 118.938 -1.105 . . . . 215.61 109.902 -172.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.423 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.8 t -60.39 -46.91 94.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 C-N-CA 120.31 -0.556 . . . . 87.19 110.445 -175.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.842 HG21 ' CD2' ' A' ' 108' ' ' HIS . 63.3 t -65.9 -41.83 90.76 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.124 0 N-CA-C 109.765 -0.457 . . . . 231.82 109.765 -178.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.904 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 11.0 m120 -62.34 -34.16 76.11 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.329 -0.989 . . . . 364.98 108.329 -177.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.668 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.2 t80 -68.12 -44.75 75.42 Favored 'General case' 0 N--CA 1.438 -1.074 0 O-C-N 121.496 -0.752 . . . . 181.63 111.298 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.815 HG22 ' HD2' ' A' ' 95' ' ' HIS . 58.0 m -60.83 -45.83 92.92 Favored 'General case' 0 CA--C 1.478 -1.82 0 N-CA-C 107.424 -1.324 . . . . 269.02 107.424 -175.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 1.058 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.68 -45.04 93.26 Favored 'General case' 0 CA--C 1.468 -2.178 0 C-N-CA 118.626 -1.23 . . . . 562.66 110.054 -179.061 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.704 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.12 -45.21 95.62 Favored 'General case' 0 CA--C 1.478 -1.791 0 C-N-CA 118.712 -1.195 . . . . 446.75 108.107 -167.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.747 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.386 6.0 m -70.55 -26.27 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.768 0 C-N-CA 115.824 -2.35 . . . . 370.05 112.206 -178.75 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.815 ' HD2' HG22 ' A' ' 91' ' ' THR . 89.9 m-70 -74.51 -26.44 60.0 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 121.556 -0.715 . . . . 354.91 112.518 175.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.822 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.4 m-20 82.8 4.47 0.99 Allowed 'General case' 0 CA--C 1.499 -0.988 0 C-N-CA 125.07 1.348 . . . . 462.44 111.93 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.775 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.266 11.9 mm-40 -172.34 178.05 2.92 Favored 'General case' 0 CA--C 1.488 -1.426 0 CA-C-O 122.005 0.907 . . . . 652.37 111.131 171.809 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.791 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.75 86.31 2.18 Favored 'General case' 0 N--CA 1.428 -1.564 0 C-N-CA 128.472 2.709 . . . . 905.99 107.909 -174.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -67.82 -36.43 80.37 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 108.241 -1.022 . . . . 570.43 108.241 -176.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.845 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.59 -36.35 82.45 Favored 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 125.299 1.44 . . . . 453.22 111.147 -174.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.935 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.55 178.64 33.9 Favored Glycine 0 C--N 1.35 1.324 0 C-N-CA 118.751 -1.69 . . . . 445.63 109.906 177.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.805 ' CD1' ' HG ' ' B' ' 374' ' ' LEU . 89.0 mt -56.37 -41.21 75.84 Favored 'General case' 0 CA--C 1.499 -1.005 0 C-N-CA 125.25 1.42 . . . . 457.72 112.403 -170.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -58.67 -46.92 86.16 Favored 'General case' 0 CA--C 1.485 -1.525 0 C-N-CA 118.64 -1.224 . . . . 340.58 109.3 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.845 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.2 m-85 -68.67 -32.2 71.86 Favored 'General case' 0 N--CA 1.424 -1.774 0 C-N-CA 118.765 -1.174 . . . . 453.6 111.544 -176.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.764 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.04 -40.33 73.33 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 105.972 -1.862 . . . . 541.48 105.972 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.82 -47.15 76.01 Favored 'General case' 0 CA--C 1.486 -1.484 0 O-C-N 123.945 0.778 . . . . 466.68 110.879 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -61.72 -47.12 86.7 Favored 'General case' 0 N--CA 1.427 -1.605 0 C-N-CA 117.429 -1.709 . . . . 427.34 107.334 -178.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.842 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.5 m80 -67.07 -36.74 82.69 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 112.441 0.534 . . . . 537.87 112.441 -174.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.575 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.48 -42.6 74.59 Favored 'General case' 0 N--CA 1.433 -1.323 0 C-N-CA 116.821 -1.952 . . . . 422.12 111.611 175.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.856 ' O ' HG22 ' A' ' 113' ' ' ILE . 75.9 t80 -59.1 -50.05 75.55 Favored 'General case' 0 N--CA 1.441 -0.879 0 O-C-N 121.323 -0.861 . . . . 340.17 111.846 -173.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -65.34 -46.49 70.84 Favored Pre-proline 0 N--CA 1.442 -0.848 0 C-N-CA 119.078 -1.049 . . . . 258.06 111.728 -176.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.936 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.2 Cg_exo -61.54 -31.56 87.44 Favored 'Trans proline' 0 N--CA 1.435 -1.958 0 N-CA-C 115.353 1.251 . . . . 305.71 115.353 176.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.875 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.89 -40.36 76.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 108.739 -0.838 . . . . 252.7 108.739 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.422 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.94 -40.63 94.01 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 107.806 -1.183 . . . . 149.27 107.806 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.95 -44.84 95.92 Favored 'General case' 0 N--CA 1.436 -1.155 0 C-N-CA 120.608 -0.437 . . . . 138.08 111.519 -176.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.651 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 64.9 t -66.91 -42.4 88.88 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.94 0 O-C-N 121.565 -0.71 . . . . 132.89 110.942 -177.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.924 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.74 -44.65 92.89 Favored 'General case' 0 N--CA 1.433 -1.287 0 C-N-CA 119.748 -0.781 . . . . 193.61 108.923 -177.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.556 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.51 -37.63 84.43 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 122.81 0.444 . . . . 63.83 110.121 -175.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.8 m -64.0 -52.37 59.86 Favored 'General case' 0 N--CA 1.435 -1.221 0 C-N-CA 120.712 -0.395 . . . . 76.4 111.276 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.748 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -63.01 -41.65 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 N-CA-C 108.157 -1.053 . . . . 171.13 108.157 -174.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 1.095 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.3 m-85 -63.77 -38.57 91.6 Favored 'General case' 0 N--CA 1.433 -1.294 0 O-C-N 121.846 -0.534 . . . . 78.3 110.631 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.555 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.2 t -67.04 -35.79 80.65 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 118.939 -1.104 . . . . 92.36 109.238 -178.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.976 ' HA ' ' HE2' ' A' ' 123' ' ' MET . 5.9 mmt -62.51 -34.27 76.55 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 108.151 -1.055 . . . . 93.73 108.151 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.903 HG22 HG13 ' A' ' 212' ' ' ILE . 33.2 p -67.45 -41.63 84.39 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.204 -0.998 . . . . 132.74 109.324 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.26 -42.12 94.68 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 107.203 -1.406 . . . . 43.39 107.203 -177.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.827 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 94.4 t -58.41 -42.02 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 N-CA-C 108.582 -0.895 . . . . 59.34 108.582 -178.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.48 -44.07 95.45 Favored 'General case' 0 CA--C 1.497 -1.081 0 O-C-N 121.75 -0.594 . . . . 69.68 110.525 -177.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.468 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.4 t80 -65.5 -42.73 91.81 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.36 -0.978 . . . . 106.98 108.36 -177.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.827 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.39 -35.59 81.39 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 119.622 -0.831 . . . . 147.63 108.937 -177.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.704 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.09 -41.58 99.43 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.533 -0.914 . . . . 190.06 108.533 178.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.6 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.3 t80 -61.37 -44.06 97.81 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 108.256 -1.016 . . . . 118.85 108.256 -177.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.806 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.4 mmt -63.37 -42.65 98.88 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 109.981 -0.377 . . . . 102.5 109.981 -177.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.95 -41.64 95.3 Favored 'General case' 0 CA--C 1.489 -1.383 0 O-C-N 121.813 -0.554 . . . . 89.98 109.839 -176.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.92 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.3 mt -66.55 -50.7 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.666 0 C-N-CA 118.106 -1.438 . . . . 106.09 110.975 -177.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.748 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.09 -48.34 38.25 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.091 0 C-N-CA 117.114 -1.834 . . . . 227.74 111.797 -174.787 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.754 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.1 p80 -118.79 100.07 51.06 Favored Pre-proline 0 CA--C 1.486 -1.51 0 C-N-CA 116.249 -2.18 . . . . 262.55 110.07 -175.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.2 Cg_endo -69.63 -10.33 28.39 Favored 'Trans proline' 0 C--N 1.29 -2.548 0 C-N-CA 121.622 1.548 . . . . 210.25 111.366 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.705 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.32 112.07 1.01 Allowed 'General case' 0 CA--C 1.49 -1.34 0 N-CA-C 106.505 -1.665 . . . . 270.58 106.505 -178.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.891 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.87 -39.5 23.44 Favored Pre-proline 0 N--CA 1.431 -1.418 0 CA-C-N 115.355 -0.839 . . . . 129.84 112.295 -175.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.86 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 82.1 Cg_exo -61.43 -26.56 81.39 Favored 'Trans proline' 0 N--CA 1.431 -2.185 0 N-CA-C 116.287 1.611 . . . . 330.71 116.287 -174.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.754 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.02 77.23 7.94 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 114.513 -2.875 . . . . 204.51 107.29 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.876 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.7 147.41 0.09 Allowed 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.485 -1.302 . . . . 387.41 107.485 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.876 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.5 t -143.71 147.07 33.7 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 118.763 -1.175 . . . . 166.22 109.431 178.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.9 -40.76 87.81 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 107.806 -1.183 . . . . 44.23 107.806 176.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.485 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.3 m -60.25 -39.18 85.87 Favored 'General case' 0 CA--C 1.492 -1.285 0 N-CA-C 108.157 -1.053 . . . . 28.8 108.157 -175.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.667 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.81 -38.76 91.98 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 109.084 -0.71 . . . . 30.29 109.084 -179.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.847 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 89.9 m -59.66 -43.01 94.12 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 108.964 -0.754 . . . . 46.11 108.964 -176.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.4 -42.18 99.23 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 107.713 -1.217 . . . . 87.33 107.713 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.77 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.5 t -61.69 -42.05 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 N-CA-C 107.952 -1.129 . . . . 23.69 107.952 -178.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.8 t -63.18 -44.32 99.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 N-CA-C 109.672 -0.492 . . . . 43.86 109.672 -178.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.919 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.1 mm -61.23 -42.57 93.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 N-CA-C 108.334 -0.987 . . . . 91.13 108.334 -176.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . 0.482 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.1 t -62.56 -37.99 88.3 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 108.712 -0.848 . . . . 65.88 108.712 -178.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.1 t -62.09 -41.87 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 N-CA-C 109.529 -0.545 . . . . 33.86 109.529 -177.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 1.095 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.35 -40.32 85.79 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.171 0 N-CA-C 107.576 -1.268 . . . . 146.52 107.576 -176.786 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . 0.699 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.1 m95 -62.9 -38.35 90.57 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 119.483 -0.887 . . . . 75.44 108.849 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.9 t -60.54 -48.47 88.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 O-C-N 121.073 -1.017 . . . . 43.64 109.699 -177.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.793 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.64 -37.99 89.41 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 109.068 -0.716 . . . . 102.57 109.068 -178.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.01 -41.05 86.79 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.433 -1.321 . . . . 58.16 107.433 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.798 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.12 -32.44 73.83 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 109.045 -0.724 . . . . 121.11 109.045 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.793 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.04 -42.33 85.16 Favored 'General case' 0 CA--C 1.489 -1.404 0 C-N-CA 118.567 -1.253 . . . . 153.15 109.938 -178.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 1.056 HD13 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.05 -43.72 19.11 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 113.154 -3.419 . . . . 133.67 113.545 173.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.479 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -63.01 -39.88 96.09 Favored 'General case' 0 CA--C 1.49 -1.352 0 O-C-N 120.951 -1.093 . . . . 157.42 112.189 -171.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.523 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.3 t80 -74.45 -36.07 2.43 Favored Pre-proline 0 N--CA 1.436 -1.129 0 N-CA-C 115.056 1.502 . . . . 250.91 115.056 -173.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.523 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.291 52.1 Cg_exo -59.59 -25.43 78.82 Favored 'Trans proline' 0 CA--C 1.489 -1.736 0 N-CA-C 117.968 2.257 . . . . 207.34 117.968 -174.331 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 1.009 HE21 HG13 ' A' ' 182' ' ' ILE . 87.6 mt-30 -61.2 -34.16 74.63 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 106.967 -1.494 . . . . 192.46 106.967 178.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.5 -41.07 98.11 Favored Glycine 0 C--N 1.353 1.513 0 N-CA-C 107.949 -2.06 . . . . 261.0 107.949 177.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.8 159.1 26.03 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 101.466 -3.531 . . . . 491.4 101.466 172.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -59.89 106.76 0.53 Allowed 'General case' 0 CA--C 1.488 -1.422 0 C-N-CA 116.239 -2.184 . . . . 386.1 109.849 -176.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.917 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 74.0 m -153.99 -166.6 2.42 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 103.583 -2.747 . . . . 289.8 103.583 -178.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 1.14 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.2 p -62.97 175.47 0.86 Allowed 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 117.748 -1.12 . . . . 402.06 109.555 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.789 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 73.6 p -165.27 177.53 7.54 Favored 'General case' 0 CA--C 1.586 2.363 0 C-N-CA 127.308 2.243 . . . . 690.53 114.912 177.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.488 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 40.0 mm-40 132.33 160.53 0.0 OUTLIER 'General case' 1 C--N 1.43 4.066 1 N-CA-C 123.195 4.517 . . . . 633.62 123.195 162.673 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.761 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.1 p -85.59 153.85 22.12 Favored 'General case' 0 C--N 1.389 2.283 0 C-N-CA 127.413 2.285 . . . . 617.99 110.886 178.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 1.04 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.7 174.37 6.04 Favored Pre-proline 0 C--N 1.363 1.18 0 C-N-CA 130.304 3.442 . . . . 434.98 113.433 -175.433 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 1.092 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 51.8 Cg_endo -44.26 -65.63 0.19 Allowed 'Trans proline' 0 N--CA 1.441 -1.569 0 N-CA-C 122.414 3.967 . . . . 365.88 122.414 -168.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . 0.778 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.304 70.8 m -84.87 20.92 1.69 Allowed 'General case' 0 CA--C 1.467 -2.249 0 N-CA-C 104.812 -2.292 . . . . 635.81 104.812 178.102 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.749 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.458 5.0 mmp_? -94.35 152.16 18.85 Favored 'General case' 1 CA--C 1.419 -4.066 3 N-CA-C 131.952 7.76 . . . . 999.99 131.952 -135.714 . . . . . . . . 5 3 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 1.058 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.91 37.0 t -131.84 73.2 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.763 1 CA-C-N 103.288 -6.324 . . . . 594.32 113.611 149.169 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.729 HG13 ' HB2' ' A' ' 174' ' ' MET . 7.4 p -144.2 144.1 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.599 1 N-CA-C 98.285 -4.709 . . . . 811.91 98.285 162.382 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.761 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.8 m -118.49 144.52 45.96 Favored 'General case' 0 CA--C 1.488 -1.409 0 C-N-CA 117.014 -1.874 . . . . 999.99 109.42 -178.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.973 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.7 mmm -147.19 -175.6 4.89 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-O 122.0 0.905 . . . . 431.86 110.055 -177.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 1.037 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.3 tt -69.15 148.73 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 C-N-CA 124.31 1.044 . . . . 457.18 108.782 -177.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . 0.789 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.32 85.44 3.74 Favored 'General case' 0 CA--C 1.5 -0.955 0 C-N-CA 124.155 0.982 . . . . 458.77 113.527 -174.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.956 ' CZ3' HG22 ' A' ' 182' ' ' ILE . 1.9 p90 -76.4 -31.57 0.97 Allowed Pre-proline 0 N--CA 1.438 -1.058 0 C-N-CA 124.992 1.317 . . . . 999.99 112.384 168.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.955 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 51.2 Cg_exo -65.96 -45.77 5.64 Favored 'Trans proline' 0 N--CA 1.438 -1.79 0 N-CA-C 120.883 3.378 . . . . 999.99 120.883 -174.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.508 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 54.9 mt-10 -119.56 171.78 8.12 Favored 'General case' 0 CA--C 1.471 -2.066 0 C-N-CA 117.129 -1.829 . . . . 81.18 107.239 -172.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.834 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.7 p-80 -109.16 45.16 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.865 0 CA-C-O 114.875 -2.488 . . . . 999.99 108.703 177.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 1.076 ' HB2' HD12 ' A' ' 191' ' ' ILE . 88.3 Cg_endo -41.57 101.86 0.04 OUTLIER 'Trans proline' 0 CA--C 1.502 -1.121 1 C-N-CA 126.071 4.514 . . . . 999.99 105.634 -170.745 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -62.28 -44.01 97.5 Favored 'General case' 0 CA--C 1.483 -1.597 0 C-N-CA 126.726 2.01 . . . . 967.72 112.059 -165.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.402 ' HD3' ' HA ' ' A' ' 190' ' ' LYS . 30.3 mmtp -60.28 -36.55 78.08 Favored 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 106.724 -1.584 . . . . 934.3 106.724 -175.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 1.076 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.65 -30.16 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 C-N-CA 129.167 2.987 . . . . 565.15 113.925 -178.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 61.54 55.31 2.82 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-N 118.425 0.557 . . . . 755.61 109.903 -175.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 1.14 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.44 -49.29 67.19 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 124.57 1.148 . . . . 325.89 113.26 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.633 ' HE3' ' OH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.8 -44.97 78.31 Favored 'General case' 0 CA--C 1.495 -1.17 0 C-N-CA 123.558 0.743 . . . . 250.21 111.631 -169.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 98.0 t -64.75 -43.28 96.52 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 CA-C-O 121.595 0.712 . . . . 142.46 110.383 -175.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 1.037 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.8 t80 -61.19 -41.46 96.85 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 123.985 0.914 . . . . 247.69 108.821 -173.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.824 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 23.1 t60 -60.55 -51.33 69.89 Favored 'General case' 0 CA--C 1.491 -1.292 0 C-N-CA 125.411 1.484 . . . . 199.61 113.081 -175.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 82.7 mt -65.34 -44.46 94.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 N-CA-C 107.759 -1.201 . . . . 106.73 107.759 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . 0.722 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.7 t -59.17 -48.53 81.27 Favored 'General case' 0 CA--C 1.487 -1.473 0 CA-C-N 115.801 -0.636 . . . . 115.01 110.214 -173.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 1.056 HG13 HD13 ' A' ' 161' ' ' LEU . 85.6 t -65.25 -49.18 80.31 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.655 0 C-N-CA 119.418 -0.913 . . . . 129.42 111.818 -174.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.793 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.4 m -61.85 -53.12 60.16 Favored 'General case' 0 CA--C 1.483 -1.612 0 C-N-CA 118.228 -1.389 . . . . 172.48 109.968 -172.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.631 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 86.5 t -63.89 -54.29 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 C-N-CA 120.539 -0.465 . . . . 55.86 110.933 -174.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.722 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.57 -51.53 59.07 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.56 -1.256 . . . . 184.68 111.489 -174.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 1.05 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.62 -52.37 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 C-N-CA 116.637 -2.025 . . . . 291.81 114.757 -174.706 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.548 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.8 t80 -82.05 -55.0 4.84 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 115.16 1.541 . . . . 130.66 115.16 -178.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . 0.793 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.8 m-85 -66.88 -48.49 68.61 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 114.515 1.302 . . . . 80.16 114.515 -170.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.894 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.54 -45.5 83.29 Favored Pre-proline 0 N--CA 1.435 -1.196 0 C-N-CA 119.981 -0.688 . . . . 136.02 109.494 -174.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.894 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.8 Cg_exo -64.8 -27.16 59.72 Favored 'Trans proline' 0 N--CA 1.432 -2.105 0 CA-C-N 118.703 0.572 . . . . 92.17 110.622 -179.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.688 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.3 -41.39 76.82 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 107.501 -1.296 . . . . 135.6 107.501 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.17 -44.7 91.26 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 109.563 -0.532 . . . . 52.1 109.563 -176.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.618 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.67 -43.54 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 N-CA-C 109.063 -0.718 . . . . 95.89 109.063 -176.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.903 HG13 HG22 ' A' ' 124' ' ' THR . 94.5 mt -61.28 -42.36 93.23 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.398 0 N-CA-C 106.684 -1.599 . . . . 43.41 106.684 -178.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.44 -42.25 99.09 Favored Glycine 0 N--CA 1.432 -1.606 0 N-CA-C 109.376 -1.49 . . . . 27.69 109.376 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . 0.886 ' O ' HG22 ' A' ' 217' ' ' THR . 77.9 t80 -65.66 -47.42 75.59 Favored 'General case' 0 CA--C 1.497 -1.094 0 O-C-N 122.213 -0.581 . . . . 54.41 110.483 -177.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . 0.828 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.42 -34.11 74.83 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 106.955 -1.498 . . . . 53.88 106.955 -177.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -60.74 -40.89 94.06 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 108.49 -0.929 . . . . 68.29 108.49 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . 0.886 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.67 -39.12 93.12 Favored 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 119.721 -0.792 . . . . 107.59 110.631 -175.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.828 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.02 -38.39 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 C-N-CA 119.605 -0.838 . . . . 111.61 109.481 -177.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.92 HG13 ' CD1' ' A' ' 134' ' ' ILE . 79.3 t -63.28 -22.48 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.372 -0.973 . . . . 85.26 108.372 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.87 -41.94 99.43 Favored Glycine 0 C--N 1.349 1.265 0 N-CA-C 111.07 -0.812 . . . . 40.71 111.07 -176.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.5 mm -64.76 -44.05 96.47 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 N-CA-C 108.378 -0.971 . . . . 95.86 108.378 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.823 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.6 p -76.93 -137.52 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 108.434 -0.95 . . . . 144.37 108.434 -176.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.902 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.6 mt -55.38 132.11 47.38 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 107.573 -1.269 . . . . 326.72 107.573 -177.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' TRP . . . . . 0.461 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.35 -168.05 1.51 Allowed 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 106.013 -1.847 . . . . 158.38 106.013 -176.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.461 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.27 -42.01 99.09 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 109.649 -0.5 . . . . 36.78 109.649 -178.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.6 m -61.06 125.82 25.12 Favored 'General case' 0 N--CA 1.434 -1.271 0 C-N-CA 119.198 -1.001 . . . . 85.46 109.793 -174.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . 0.693 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.89 126.55 8.83 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 105.58 -2.008 . . . . 127.78 105.58 176.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.927 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.04 139.9 34.78 Favored Pre-proline 0 CA--C 1.493 -1.236 0 N-CA-C 105.982 -1.859 . . . . 164.84 105.982 -179.576 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.927 ' N ' HD13 ' A' ' 228' ' ' ILE . 83.4 Cg_exo -56.8 -39.93 87.87 Favored 'Trans proline' 0 N--CA 1.431 -2.16 0 N-CA-C 113.914 0.698 . . . . 222.35 113.914 -175.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . 0.745 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.11 167.02 45.01 Favored Glycine 0 N--CA 1.428 -1.899 0 N-CA-C 106.446 -2.662 . . . . 45.22 106.446 178.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.882 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.7 t0 -60.99 -45.71 93.7 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 106.065 -1.828 . . . . 107.57 106.065 177.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . 0.732 ' O ' HG21 ' A' ' 228' ' ' ILE . 68.1 m -65.82 141.83 58.15 Favored 'General case' 0 N--CA 1.429 -1.525 0 C-N-CA 118.89 -1.124 . . . . 167.96 109.155 -175.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.828 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.6 m 99.52 106.64 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.219 0 C-N-CA 126.695 1.998 . . . . 280.68 109.761 176.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.712 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.7 m-20 56.05 11.28 0.71 Allowed 'General case' 0 N--CA 1.433 -1.279 0 C-N-CA 124.492 1.117 . . . . 218.25 110.702 174.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.922 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.38 137.64 54.78 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 105.243 -2.132 . . . . 343.57 105.243 177.412 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.563 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.6 t80 -111.99 81.84 1.53 Allowed 'General case' 0 CA--C 1.491 -1.323 0 N-CA-C 106.871 -1.529 . . . . 263.29 106.871 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' HIS . . . . . 0.626 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.4 m-70 104.31 147.09 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 126.607 1.963 . . . . 261.92 108.511 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.25 -38.13 89.94 Favored 'General case' 0 CA--C 1.488 -1.415 0 N-CA-C 107.822 -1.177 . . . . 106.81 107.822 -177.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.737 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.42 -39.92 94.87 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 118.348 -1.341 . . . . 112.2 107.58 -178.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.736 HG12 ' NH1' ' A' ' 244' ' ' ARG . 75.2 t -64.26 -39.81 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 109.285 -0.635 . . . . 45.41 109.285 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . 0.806 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.2 p -70.95 -32.04 68.8 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 110.269 -0.271 . . . . 97.62 110.269 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.43 -39.56 81.5 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 123.65 0.78 . . . . 59.29 110.981 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.737 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.31 -36.47 83.81 Favored 'General case' 0 CA--C 1.491 -1.292 0 C-N-CA 124.655 1.182 . . . . 106.49 110.647 -174.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.922 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -60.0 -30.58 69.23 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 108.331 -0.988 . . . . 106.62 108.331 -176.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.531 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -66.09 -41.0 91.25 Favored 'General case' 0 N--CA 1.436 -1.175 0 O-C-N 121.84 -0.537 . . . . 75.97 110.052 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.444 ' CG1' ' HE1' ' A' ' 250' ' ' MET . 77.0 t -65.55 -40.84 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 C-N-CA 122.957 0.503 . . . . 65.27 109.804 -178.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.775 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.7 p -63.99 -41.58 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 C-N-CA 120.385 -0.526 . . . . 107.94 110.186 -177.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.536 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.2 pttt -63.55 -40.78 97.9 Favored 'General case' 0 N--CA 1.434 -1.259 0 O-C-N 121.679 -0.638 . . . . 87.98 110.31 -176.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' MET . . . . . 0.823 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.64 -40.42 96.81 Favored 'General case' 0 N--CA 1.434 -1.247 0 C-N-CA 118.875 -1.13 . . . . 65.5 108.329 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' MET . . . . . 0.773 ' HE2' ' CG2' ' A' ' 67' ' ' THR . 68.5 mtt -61.73 -36.33 80.66 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 108.169 -1.049 . . . . 85.05 108.169 -177.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.536 HD12 ' HA ' ' A' ' 248' ' ' LYS . 86.7 mt -63.48 -45.76 96.97 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 N-CA-C 109.082 -0.711 . . . . 42.25 109.082 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.823 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.26 -38.31 82.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 C-N-CA 119.556 -0.858 . . . . 91.01 109.43 -176.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 1.001 HG22 ' CD1' ' A' ' 304' ' ' ILE . 65.8 t -58.88 -41.48 83.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 N-CA-C 107.998 -1.112 . . . . 66.09 107.998 -178.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 250' ' ' MET . 94.7 t -66.17 -43.12 92.17 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.363 0 O-C-N 122.089 -0.382 . . . . 52.39 110.287 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.4 m -61.73 -46.83 87.96 Favored 'General case' 0 CA--C 1.489 -1.393 0 O-C-N 121.851 -0.531 . . . . 46.42 109.858 -174.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . 0.745 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.5 t -62.3 -38.1 88.09 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 108.335 -0.987 . . . . 116.51 108.335 -177.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' PHE . . . . . 0.488 ' N ' HG23 ' A' ' 256' ' ' THR . 86.0 t80 -60.32 -48.2 82.78 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.365 -0.606 . . . . 65.18 109.365 -178.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.99 -42.68 97.12 Favored 'General case' 0 CA--C 1.489 -1.385 0 O-C-N 122.107 -0.371 . . . . 51.33 110.429 -175.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . 0.745 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.6 -43.45 98.21 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 C-N-CA 118.968 -1.093 . . . . 126.3 108.938 -176.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' CYS . . . . . 0.509 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.8 m -65.51 -49.35 69.31 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.524 -0.87 . . . . 133.94 112.513 -176.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.82 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.0 m95 -80.72 -33.34 35.34 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 116.819 2.155 . . . . 134.84 116.819 -176.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.786 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.6 tp -58.43 -41.61 90.17 Favored Pre-proline 0 CA--C 1.493 -1.222 0 CA-C-N 118.641 0.655 . . . . 72.23 111.671 -167.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' PRO . . . . . 0.786 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 81.3 Cg_exo -60.67 -36.02 86.89 Favored 'Trans proline' 0 C--N 1.294 -2.309 0 CA-C-N 119.822 0.972 . . . . 106.13 111.357 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' PHE . . . . . 0.852 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.6 t80 -66.32 -44.71 82.61 Favored 'General case' 0 N--CA 1.433 -1.3 0 C-N-CA 119.769 -0.772 . . . . 128.35 110.056 -178.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' HIS . . . . . 0.64 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.4 m-70 -64.41 -37.86 88.99 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 110.244 -0.28 . . . . 100.73 110.244 -177.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.746 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.29 -44.51 94.92 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 C-N-CA 119.257 -0.977 . . . . 172.72 109.126 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . 0.734 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.5 m-85 -66.62 -28.12 68.24 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 108.17 -1.048 . . . . 249.23 108.17 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' PHE . . . . . 0.899 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.52 -55.14 35.37 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 106.698 -1.593 . . . . 259.78 106.698 178.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . 0.492 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.5 mt -69.13 -44.17 72.88 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 113.611 0.967 . . . . 233.11 113.611 -176.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.837 ' O ' HG13 ' A' ' 273' ' ' ILE . 88.6 mt -61.4 -48.31 91.28 Favored Pre-proline 0 N--CA 1.44 -0.947 0 C-N-CA 119.13 -1.028 . . . . 169.54 110.567 -171.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . 0.734 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 12.0 Cg_exo -61.05 -24.59 79.8 Favored 'Trans proline' 0 N--CA 1.429 -2.302 0 C-N-CA 116.756 -1.696 . . . . 255.47 114.7 174.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' TYR . . . . . 0.824 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.6 t80 -63.58 -44.22 94.69 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 119.232 0.924 . . . . 279.03 108.874 177.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.837 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.33 -44.76 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 N-CA-C 110.104 -0.332 . . . . 162.21 110.104 -178.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' ASN . . . . . 0.779 ' N ' HD12 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.45 84.88 59.4 Favored Pre-proline 0 N--CA 1.43 -1.432 0 C-N-CA 118.73 -1.188 . . . . 128.13 108.064 -178.078 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.3 Cg_endo -85.3 164.08 11.19 Favored 'Trans proline' 0 C--N 1.295 -2.268 0 N-CA-C 107.44 -1.792 . . . . 278.35 107.44 177.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . 0.868 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.2 t0 66.06 15.06 9.93 Favored 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 123.83 0.706 . . . . 312.91 109.335 175.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.868 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.3 mt -132.69 -170.66 2.48 Favored 'General case' 0 CA--C 1.481 -1.675 0 N-CA-C 106.531 -1.655 . . . . 353.54 106.531 177.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 1.007 ' HA ' ' CB ' ' A' ' 282' ' ' PHE . 42.8 p90 -115.68 142.23 47.03 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 107.398 -1.334 . . . . 251.26 107.398 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.761 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -76.98 -118.81 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 102.024 -3.324 . . . . 175.26 102.024 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . 0.794 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.46 -44.97 96.17 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 100.883 -3.747 . . . . 99.07 100.883 172.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . 0.794 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.43 124.18 9.18 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 103.46 -2.793 . . . . 243.21 103.46 171.173 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 1.007 ' CB ' ' HA ' ' A' ' 278' ' ' TYR . 77.3 t80 -92.97 112.99 25.14 Favored 'General case' 0 CA--C 1.473 -1.982 0 C-N-CA 116.007 -2.277 . . . . 201.04 105.265 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' ILE . . . . . 0.777 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.94 173.72 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.071 0 C-N-CA 116.001 -2.279 . . . . 201.36 108.768 -175.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . 1.092 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.284 0.6 OUTLIER -59.54 -41.42 90.03 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-N 113.243 -1.799 . . . . 203.82 107.864 174.447 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . 0.921 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.26 -45.71 86.89 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 118.226 -1.389 . . . . 215.06 112.576 -171.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.552 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.0 t -65.69 -46.42 89.26 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.473 0 C-N-CA 118.587 -1.245 . . . . 125.28 112.903 -171.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' TYR . . . . . 0.952 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.78 -37.05 86.29 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 107.155 -1.424 . . . . 268.9 107.155 -171.861 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.798 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.16 -45.05 74.56 Favored 'General case' 0 CA--C 1.483 -1.607 0 C-N-CA 125.63 1.572 . . . . 280.88 108.821 -172.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.6 -47.43 86.24 Favored 'General case' 0 CA--C 1.484 -1.564 0 C-N-CA 118.947 -1.101 . . . . 184.47 109.087 -172.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . 0.852 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.8 mp -67.98 -42.11 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 C-N-CA 119.263 -0.975 . . . . 167.92 112.732 -175.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' MET . . . . . 0.5 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.7 ttt -65.72 -38.76 90.07 Favored 'General case' 0 CA--C 1.495 -1.136 0 C-N-CA 117.784 -1.566 . . . . 367.18 110.822 -175.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' TRP . . . . . 0.548 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.4 m95 -67.22 -32.67 73.87 Favored 'General case' 0 N--CA 1.435 -1.197 0 O-C-N 121.872 -0.517 . . . . 173.97 110.448 177.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.4 tp -64.49 -36.71 85.09 Favored 'General case' 0 CA--C 1.499 -0.986 0 C-N-CA 123.509 0.724 . . . . 119.66 109.797 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . 0.82 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.23 -34.03 74.46 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 107.711 -1.218 . . . . 112.3 107.711 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' MET . . . . . 0.772 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.03 -32.11 73.4 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 116.211 -0.45 . . . . 174.17 110.222 -177.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.9 m -64.67 -22.8 67.07 Favored 'General case' 0 CA--C 1.486 -1.507 0 C-N-CA 124.648 1.179 . . . . 145.27 110.606 -175.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' SER . . . . . 0.758 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.7 m -57.67 -35.33 70.41 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 108.043 -1.095 . . . . 170.15 108.043 -175.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.82 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.8 t -55.33 -34.16 63.97 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 116.324 -0.398 . . . . 214.57 110.61 -171.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . 0.75 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.1 ttt -77.16 -33.19 56.58 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 126.108 1.763 . . . . 168.29 115.539 177.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' TYR . . . . . 0.758 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.44 -34.84 79.14 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 114.072 1.138 . . . . 167.15 114.072 -168.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . 0.723 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.283 18.8 p-10 -64.2 -38.31 33.47 Favored Pre-proline 0 N--CA 1.434 -1.253 0 C-N-CA 115.532 -2.467 . . . . 165.13 113.935 -171.619 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' PRO . . . . . 0.723 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 83.9 Cg_exo -62.54 -31.87 79.97 Favored 'Trans proline' 0 N--CA 1.433 -2.048 0 CA-C-N 122.769 2.025 . . . . 123.92 111.28 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' ILE . . . . . 0.716 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.1 pt -68.72 -42.57 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 C-N-CA 118.857 -1.137 . . . . 110.55 109.796 -179.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' ILE . . . . . 1.001 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.1 pt -61.09 -40.08 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 108.852 -0.796 . . . . 145.31 108.852 -177.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . 0.921 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.253 63.1 m-85 -58.1 -48.83 78.97 Favored 'General case' 0 CA--C 1.494 -1.191 0 C-N-CA 119.409 -0.916 . . . . 246.68 109.796 -177.473 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.6 m -62.24 -47.46 84.3 Favored 'General case' 0 CA--C 1.485 -1.539 0 C-N-CA 119.565 -0.854 . . . . 64.43 109.6 -173.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.8 t -66.8 -45.08 79.48 Favored 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 118.973 -1.091 . . . . 80.72 110.227 -177.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.708 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.41 -35.71 76.0 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 116.034 1.864 . . . . 140.44 116.034 -173.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . 0.655 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.85 132.23 34.32 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 112.692 -3.603 . . . . 178.87 113.048 -177.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . 0.613 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.04 -37.09 86.45 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 114.392 -1.277 . . . . 110.22 110.075 -177.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.855 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 38.9 ttm180 -57.7 -50.62 72.59 Favored 'General case' 0 CA--C 1.492 -1.251 0 O-C-N 121.802 -0.561 . . . . 174.78 109.708 -174.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.96 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.3 m-85 -64.87 -41.67 95.46 Favored 'General case' 0 CA--C 1.484 -1.571 0 N-CA-C 108.262 -1.014 . . . . 161.84 108.262 178.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . 0.516 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.7 ttp180 -57.38 -50.2 73.72 Favored 'General case' 0 CA--C 1.49 -1.353 0 N-CA-C 109.183 -0.673 . . . . 117.2 109.183 -173.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.797 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.55 -44.1 75.22 Favored 'General case' 0 N--CA 1.434 -1.235 0 C-N-CA 120.355 -0.538 . . . . 112.6 111.03 -177.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . 0.872 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -63.95 -37.52 94.74 Favored Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 110.675 -0.97 . . . . 101.46 110.675 -177.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' PHE . . . . . 1.015 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.7 m-85 -62.16 -45.92 91.29 Favored 'General case' 0 CA--C 1.491 -1.31 0 CA-C-N 118.452 1.126 . . . . 151.49 109.55 -178.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . 0.423 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.19 -36.24 77.17 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 106.922 -1.51 . . . . 142.32 106.922 -175.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' HIS . . . . . 0.826 ' NE2' HG21 ' A' ' 326' ' ' ILE . 49.9 m80 -59.85 -41.84 92.33 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 106.846 -1.539 . . . . 109.09 106.846 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.84 -42.42 85.81 Favored 'General case' 0 N--CA 1.435 -1.208 0 O-C-N 122.312 -0.242 . . . . 76.11 111.062 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -61.38 -55.51 30.67 Favored 'General case' 0 CA--C 1.489 -1.374 0 C-N-CA 119.861 -0.736 . . . . 120.24 109.339 -174.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.579 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.4 mtt180 -74.26 131.53 41.28 Favored 'General case' 0 CA--C 1.482 -1.66 0 N-CA-C 102.946 -2.983 . . . . 192.73 102.946 177.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.4 p -59.14 -44.25 92.05 Favored 'General case' 0 CA--C 1.491 -1.296 0 C-N-CA 119.006 -1.078 . . . . 176.29 109.204 -172.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' CYS . . . . . 0.752 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.5 m -79.35 -177.11 0.81 Allowed Pre-proline 0 CA--C 1.488 -1.436 0 N-CA-C 106.239 -1.763 . . . . 69.68 106.239 178.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.567 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.8 Cg_exo -59.0 -75.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.382 0 CA-C-O 118.662 -0.641 . . . . 191.05 112.566 176.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' PHE . . . . . 0.752 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.3 m-85 47.49 43.89 16.24 Favored 'General case' 0 CA--C 1.493 -1.245 0 O-C-N 123.612 0.57 . . . . 287.03 109.763 178.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . 0.826 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.1 tt -104.55 78.58 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.474 -1.951 0 C-N-CA 112.988 -3.485 . . . . 292.29 109.854 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . 0.479 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.1 t -77.43 -152.89 0.05 OUTLIER 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 104.198 -2.519 . . . . 184.57 104.198 178.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.76 8.65 4.91 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 113.064 0.764 . . . . 274.56 113.064 176.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.96 0.89 57.28 Favored Glycine 0 C--N 1.348 1.233 0 C-N-CA 117.792 -2.147 . . . . 268.24 113.496 172.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' ASP . . . . . 0.7 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.8 m-20 51.65 -172.07 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.092 0 CA-C-N 118.673 1.236 . . . . 200.06 110.75 177.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.855 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.4 t80 -63.91 -33.02 74.76 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 107.854 -1.165 . . . . 114.44 107.854 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' GLU . . . . . 0.543 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.36 46.03 21.72 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 107.589 -1.263 . . . . 263.81 107.589 -177.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' GLY . . . . . 0.634 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.3 -137.36 3.61 Favored Glycine 0 CA--C 1.478 -2.231 1 N-CA-C 102.471 -4.251 . . . . 103.79 102.471 -179.837 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 1.05 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.2 mt -88.33 95.68 10.29 Favored 'General case' 0 N--CA 1.419 -1.993 0 C-N-CA 114.892 -2.723 . . . . 117.3 105.995 177.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . 1.025 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.97 -39.76 90.65 Favored 'General case' 0 CA--C 1.468 -2.202 1 N-CA-C 98.023 -4.806 . . . . 231.58 98.023 167.206 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . 1.036 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.96 163.48 29.08 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 102.115 -3.291 . . . . 303.24 102.115 168.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' LYS . . . . . 1.05 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.3 tttt -62.64 -48.6 78.66 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 116.03 -2.268 . . . . 112.72 108.423 179.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.9 t -61.05 -63.64 1.23 Allowed 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 109.083 -0.71 . . . . 83.22 109.083 -176.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . 0.884 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 35.9 m -156.27 -126.16 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 103.87 -2.641 . . . . 174.36 103.87 -178.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . 1.025 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.93 160.96 8.89 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 105.771 -1.937 . . . . 202.73 105.771 177.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . 1.02 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.97 149.01 52.55 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 107.061 -1.459 . . . . 180.62 107.061 176.422 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.932 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.5 tp -178.45 -171.82 0.27 Allowed 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 105.376 -2.083 . . . . 145.25 105.376 178.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' GLN . . . . . 0.932 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.1 tt0 -66.14 -43.14 87.94 Favored 'General case' 0 CA--C 1.487 -1.446 0 N-CA-C 106.078 -1.823 . . . . 66.05 106.078 174.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . 0.765 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.71 -152.18 0.48 Allowed 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 103.486 -2.783 . . . . 266.49 103.486 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' GLN . . . . . 0.699 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.3 mt-30 66.37 -124.88 0.28 Allowed 'General case' 0 CA--C 1.485 -1.545 0 C-N-CA 117.038 -1.865 . . . . 219.2 107.742 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . 0.902 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.16 -37.38 94.01 Favored Glycine 0 N--CA 1.425 -2.063 0 CA-C-N 114.555 -1.202 . . . . 94.78 112.84 -175.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . 0.826 ' HB2' ' H ' ' A' ' 342' ' ' LEU . 48.3 t -81.12 100.38 9.02 Favored 'General case' 0 CA--C 1.483 -1.598 0 C-N-CA 112.346 -3.742 . . . . 121.41 109.477 -171.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.5 t -73.05 145.47 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 N-CA-C 108.951 -0.759 . . . . 85.34 108.951 -176.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' TYR . . . . . 0.441 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.5 p90 -57.74 143.44 41.88 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 107.826 -1.176 . . . . 267.57 107.826 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . 0.525 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.03 69.61 0.59 Allowed 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 109.514 -0.55 . . . . 226.1 109.514 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' VAL . . . . . 0.824 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.5 p -51.0 156.92 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 N-CA-C 106.986 -1.487 . . . . 154.84 106.986 177.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . 0.581 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.8 m -61.36 161.92 8.54 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.566 0.698 . . . . 180.01 110.732 -173.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' ARG . . . . . 0.896 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.42 156.86 23.73 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 106.971 -1.492 . . . . 333.78 106.971 -178.595 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . 0.974 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.01 142.55 48.71 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 107.371 -1.344 . . . . 335.2 107.371 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.974 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.5 mm-40 82.77 158.9 0.13 Allowed 'General case' 0 CA--C 1.492 -1.281 0 N-CA-C 108.735 -0.839 . . . . 266.47 108.735 179.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.5 m -60.62 -46.85 88.73 Favored 'General case' 0 CA--C 1.488 -1.441 0 N-CA-C 105.653 -1.98 . . . . 59.34 105.653 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.4 t -81.64 173.9 11.91 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 104.376 -2.453 . . . . 201.26 104.376 176.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.747 HG22 ' O ' ' A' ' 360' ' ' THR . 68.9 mt -95.91 106.73 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 C-N-CA 116.308 -2.157 . . . . 56.23 105.548 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . 0.465 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.9 m -61.23 -59.43 5.33 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 109.326 -0.62 . . . . 87.58 109.326 -175.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . 0.891 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.1 t -85.47 153.72 22.28 Favored 'General case' 0 CA--C 1.485 -1.533 0 N-CA-C 107.855 -1.165 . . . . 219.95 107.855 -177.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' VAL . . . . . 0.588 ' O ' HG23 ' A' ' 361' ' ' VAL . 16.0 m -82.01 83.82 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.641 0 C-N-CA 116.324 -2.15 . . . . 121.79 105.448 177.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.599 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.6 t -154.12 159.72 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.575 0 N-CA-C 105.851 -1.907 . . . . 53.85 105.851 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . 0.599 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.27 16.57 77.13 Favored Glycine 0 N--CA 1.428 -1.87 0 N-CA-C 106.023 -2.831 . . . . 196.55 106.023 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.674 0 N-CA-C 107.909 -1.145 . . . . 35.88 107.909 -178.949 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 365' ' ' ARG . . . . . 0.494 ' HA ' ' HD3' ' B' ' 365' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 108.884 -0.784 . . . . 1.0 108.884 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 366' ' ' PRO . . . . . 0.698 ' HB3' ' C ' ' A' ' 4' ' ' VAL . 52.8 Cg_endo -66.85 142.01 61.24 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.056 1.837 . . . . 1.0 110.223 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 367' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -64.42 143.24 98.5 Favored Pre-proline 0 C--N 1.325 -0.496 0 C-N-CA 119.841 -0.744 . . . . 1.0 109.595 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 368' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.27 150.38 76.43 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.331 2.021 . . . . 1.0 111.746 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 369' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -70.71 131.8 44.42 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.688 -0.405 . . . . 1.0 110.181 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -102.05 115.88 31.49 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.716 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 371' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -63.69 -42.38 98.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.365 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 372' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -64.96 -36.26 83.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.86 -0.609 . . . . 1.0 110.728 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -59.7 -33.08 76.03 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.819 -0.912 . . . . 1.0 110.819 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 374' ' ' LEU . . . . . 0.805 ' HG ' ' CD1' ' A' ' 102' ' ' LEU . 0.5 OUTLIER -67.82 131.31 45.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.93 0.395 . . . . 1.0 110.213 179.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 375' ' ' MET . . . . . . . . . . . . . 36.8 mmm . . . . . 0 C--O 1.219 -0.534 0 CA-C-O 117.993 -1.003 . . . . 1.0 110.545 -179.778 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.466 0 N-CA-C 108.386 -0.968 . . . . 97.08 108.386 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -110.61 155.44 22.37 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-O 122.147 0.975 . . . . 123.41 110.711 -172.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.883 HG11 HD13 ' A' ' 15' ' ' ILE . 28.6 m -134.59 -162.41 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.476 1 N-CA-C 100.12 -4.029 . . . . 151.3 100.12 173.697 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.912 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.6 -38.65 59.16 Favored Pre-proline 0 N--CA 1.439 -0.984 0 C-N-CA 115.948 -2.301 . . . . 169.25 106.102 178.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.912 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 59.2 Cg_exo -81.29 168.54 16.63 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 N-CA-C 110.513 -0.61 . . . . 185.76 110.513 171.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.909 HG13 ' CE2' ' A' ' 282' ' ' PHE . 92.2 t -64.45 -25.95 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 C-N-CA 127.012 2.125 . . . . 145.47 110.369 -177.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.776 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.1 t0 -84.26 157.38 21.59 Favored 'General case' 0 N--CA 1.439 -1.005 0 O-C-N 121.08 -1.013 . . . . 102.76 109.53 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.3 p -82.57 154.14 25.15 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 107.985 -1.117 . . . . 106.25 107.985 178.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.919 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.7 p-10 -105.88 51.88 0.74 Allowed 'General case' 0 N--CA 1.428 -1.547 0 C-N-CA 117.766 -1.574 . . . . 157.81 107.623 178.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.11 -45.91 91.39 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 103.617 -2.734 . . . . 150.2 103.617 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.8 m -87.09 164.69 35.16 Favored Pre-proline 0 N--CA 1.422 -1.84 0 N-CA-C 103.624 -2.732 . . . . 183.52 103.624 172.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -76.76 6.89 3.83 Favored 'Trans proline' 0 C--N 1.282 -2.97 0 N-CA-C 109.957 -0.824 . . . . 235.61 109.957 176.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -57.92 -41.27 82.35 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 124.813 1.245 . . . . 113.77 113.395 -170.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.919 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.4 pt -52.14 136.21 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-N 119.522 1.055 . . . . 150.85 110.954 -176.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.7 t -140.49 156.26 46.4 Favored 'General case' 0 C--N 1.36 1.061 0 N-CA-C 107.622 -1.251 . . . . 100.42 107.622 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 1.081 HG23 ' H ' ' A' ' 20' ' ' SER . 14.2 t -64.96 142.62 58.37 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 121.99 0.9 . . . . 129.36 110.43 -174.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.773 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.13 -25.51 68.39 Favored 'General case' 0 CA--C 1.493 -1.221 0 C-N-CA 126.328 1.851 . . . . 112.34 106.63 -177.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.941 HG23 ' HA2' ' A' ' 101' ' ' GLY . 85.9 m -74.18 -40.08 62.76 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 115.575 -0.739 . . . . 131.73 111.724 177.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 1.081 ' H ' HG23 ' A' ' 17' ' ' THR . 70.9 m -84.52 -42.79 15.17 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 116.985 2.217 . . . . 80.49 116.985 -174.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.549 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.5 mt-10 -145.99 174.56 3.33 Favored Pre-proline 0 N--CA 1.442 -0.848 0 C-N-CA 118.176 -1.409 . . . . 98.98 111.216 -169.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.822 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.332 85.4 Cg_exo -61.84 -10.74 18.23 Favored 'Trans proline' 0 C--N 1.322 -0.868 1 N-CA-C 128.922 6.47 . . . . 246.95 128.922 -170.091 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.627 HD21 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.7 17.46 8.72 Favored 'General case' 0 C--N 1.324 -0.512 1 CA-C-N 126.175 4.079 . . . . 269.62 114.213 175.628 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.495 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.6 mt-30 -67.09 -27.34 67.27 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 107.782 -1.192 . . . . 86.8 107.782 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.551 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.4 p90 -66.76 -29.33 69.27 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 121.153 -0.967 . . . . 85.91 110.549 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.877 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.3 t -68.51 -40.25 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 C-N-CA 123.706 0.803 . . . . 82.0 111.333 -177.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.897 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.4 167.71 12.52 Favored Pre-proline 0 CA--C 1.488 -1.407 0 N-CA-C 108.55 -0.907 . . . . 120.73 108.55 -178.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.903 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.6 Cg_endo -64.04 149.77 89.77 Favored 'Trans proline' 0 N--CA 1.432 -2.106 0 C-N-CA 120.638 0.892 . . . . 87.86 109.89 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.744 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.07 -37.94 89.2 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 108.808 -0.812 . . . . 36.46 108.808 -176.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.814 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 28.0 p-90 -63.84 -33.86 76.62 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 107.757 -1.201 . . . . 150.6 107.757 -176.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.903 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.5 mt-30 -62.23 -32.66 73.37 Favored 'General case' 0 CA--C 1.49 -1.351 0 O-C-N 121.272 -0.893 . . . . 123.26 108.686 -178.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.744 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.49 -47.13 94.84 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 N-CA-C 109.188 -0.671 . . . . 120.14 109.188 176.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.786 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.3 m -67.47 -30.96 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 N-CA-C 107.868 -1.16 . . . . 112.19 107.868 -178.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.814 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.5 tp -63.02 -47.11 84.5 Favored 'General case' 0 N--CA 1.433 -1.323 0 C-N-CA 119.895 -0.722 . . . . 60.87 109.623 -178.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.67 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.01 -35.68 81.2 Favored 'General case' 0 CA--C 1.489 -1.402 0 C-N-CA 119.952 -0.699 . . . . 157.57 110.349 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.745 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.63 -40.86 98.34 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 108.638 -0.875 . . . . 47.06 108.638 178.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.806 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.81 -41.28 97.92 Favored 'General case' 0 CA--C 1.496 -1.115 0 O-C-N 121.724 -0.61 . . . . 43.94 109.522 -177.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.728 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.84 -43.25 99.22 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 108.752 -0.833 . . . . 42.61 108.752 -176.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.905 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.4 -41.22 93.9 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 116.649 -0.25 . . . . 140.66 111.059 -178.42 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.806 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.86 -43.93 97.86 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 118.588 -1.245 . . . . 116.04 110.214 -175.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.675 HG22 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.45 -38.72 83.16 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.28 0 N-CA-C 108.73 -0.841 . . . . 97.16 108.73 -177.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.854 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.3 mt -61.31 -40.03 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 N-CA-C 108.956 -0.757 . . . . 54.85 108.956 -176.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.951 HG22 HG21 ' A' ' 86' ' ' THR . 92.7 t -57.72 -42.31 81.42 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.302 0 N-CA-C 108.848 -0.797 . . . . 45.39 108.848 -175.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.431 ' O ' HG23 ' A' ' 48' ' ' VAL . 97.2 t -63.55 -50.98 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 C-N-CA 118.839 -1.144 . . . . 48.64 110.162 -177.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.752 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.6 t -65.23 -47.08 78.06 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 120.197 -0.601 . . . . 116.65 111.694 -174.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.589 ' N ' HG23 ' A' ' 45' ' ' THR . 50.8 m -61.98 -43.88 97.9 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 109.73 -0.471 . . . . 51.16 109.73 -174.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.1 t -65.63 -48.86 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 C-N-CA 119.846 -0.741 . . . . 44.3 110.818 -176.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.868 ' O ' HG23 ' A' ' 52' ' ' VAL . 94.0 t -64.75 -46.97 90.54 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 C-N-CA 120.291 -0.564 . . . . 48.82 111.068 -174.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.73 -44.2 95.2 Favored Glycine 0 N--CA 1.437 -1.299 0 C-N-CA 120.515 -0.85 . . . . 58.7 112.021 -174.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -72.55 -34.28 67.41 Favored 'General case' 0 CA--C 1.488 -1.436 0 O-C-N 122.061 -0.67 . . . . 101.4 111.072 -175.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.739 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.4 p -66.83 -38.77 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 107.73 -1.211 . . . . 103.57 107.73 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 48' ' ' VAL . 72.0 t -61.44 -43.01 96.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 N-CA-C 108.974 -0.75 . . . . 61.89 108.974 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.537 ' O ' HG22 ' A' ' 56' ' ' ILE . 81.6 t -63.5 -50.93 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 109.437 -0.579 . . . . 70.01 109.437 -178.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.8 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.98 -43.35 99.02 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 109.122 -0.696 . . . . 132.1 109.122 -176.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.644 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.1 t-105 -64.23 -46.63 82.96 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 116.666 -0.243 . . . . 104.5 110.434 -176.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 1.011 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.69 -49.88 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 C-N-CA 120.194 -0.602 . . . . 142.96 111.235 -173.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.954 HD11 HG12 ' A' ' 72' ' ' VAL 0.278 24.8 pt -64.78 -41.68 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.707 0 C-N-CA 116.904 -1.919 . . . . 158.32 110.905 -175.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.8 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.69 -41.32 98.16 Favored 'General case' 0 N--CA 1.433 -1.308 0 C-N-CA 117.701 -1.599 . . . . 137.11 109.527 178.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.39 -44.53 91.03 Favored 'General case' 0 N--CA 1.436 -1.141 0 O-C-N 122.147 -0.346 . . . . 54.66 111.024 -176.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.923 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.8 m-70 -91.42 117.1 29.39 Favored 'General case' 0 CA--C 1.491 -1.294 0 CA-C-O 121.576 0.703 . . . . 127.18 109.586 -174.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.621 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.3 tttt -60.81 -36.87 80.13 Favored 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 124.072 0.949 . . . . 87.93 110.819 -176.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 1.031 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.34 -34.66 78.66 Favored 'General case' 0 CA--C 1.49 -1.355 0 O-C-N 121.636 -0.665 . . . . 131.12 111.541 -175.63 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 1.012 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.67 69.49 7.2 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 115.311 -2.556 . . . . 246.56 109.555 -175.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.411 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.27 91.44 3.48 Favored 'General case' 0 CA--C 1.473 -1.987 0 N-CA-C 105.495 -2.039 . . . . 339.35 105.495 177.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.444 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.6 p -124.18 165.29 17.84 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 102.986 -2.968 . . . . 114.66 102.986 176.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.881 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.14 -39.44 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 N-CA-C 106.773 -1.566 . . . . 143.28 106.773 178.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.833 HG22 HD13 ' A' ' 71' ' ' LEU . 95.4 m -59.75 -37.99 80.52 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 108.652 -0.87 . . . . 160.22 108.652 -176.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.527 ' ND2' ' HB3' ' A' ' 63' ' ' MET . 86.3 m-20 -62.36 -31.77 72.47 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 108.86 -0.793 . . . . 120.54 108.86 -177.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.903 ' O ' HG22 ' A' ' 72' ' ' VAL . 89.9 m-85 -63.6 -43.77 95.96 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.523 -0.547 . . . . 67.22 109.523 178.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.881 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.4 m-85 -66.6 -39.72 88.52 Favored 'General case' 0 CA--C 1.498 -1.041 0 O-C-N 121.487 -0.758 . . . . 138.6 109.639 -177.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.927 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.62 -35.87 81.96 Favored 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 122.435 0.294 . . . . 151.46 110.639 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.954 HG12 HD11 ' A' ' 57' ' ' ILE . 24.0 m -62.54 -37.96 80.2 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.228 0 C-N-CA 117.41 -1.716 . . . . 117.93 106.732 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.45 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.0 t30 -60.11 -46.04 90.96 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 107.839 -1.171 . . . . 56.82 107.839 -177.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.999 HD21 ' HE1' ' A' ' 123' ' ' MET . 8.6 mp -61.33 -43.87 98.14 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 109.005 -0.739 . . . . 145.3 109.005 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.09 -40.33 95.49 Favored 'General case' 0 CA--C 1.492 -1.256 0 N-CA-C 108.5 -0.926 . . . . 45.71 108.5 -175.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -62.43 -42.01 99.13 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 109.346 -0.613 . . . . 105.61 109.346 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.14 -39.44 92.62 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 108.667 -0.864 . . . . 47.89 108.667 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.587 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.56 -37.38 84.84 Favored 'General case' 0 N--CA 1.439 -1.014 0 O-C-N 122.059 -0.401 . . . . 124.53 109.969 179.662 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.81 -41.29 99.24 Favored 'General case' 0 CA--C 1.496 -1.116 0 O-C-N 121.991 -0.443 . . . . 35.89 109.858 -178.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.7 t -62.14 -37.34 84.79 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 107.052 -1.462 . . . . 88.97 107.052 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.82 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.7 ttm -62.2 -49.19 76.76 Favored 'General case' 0 N--CA 1.428 -1.571 0 C-N-CA 119.816 -0.754 . . . . 239.91 109.03 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.619 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.37 -43.43 90.8 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 121.532 -0.73 . . . . 146.1 110.56 -177.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.418 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.13 -58.22 3.41 Favored 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 117.416 -1.714 . . . . 91.74 113.888 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -76.54 -61.41 1.97 Allowed 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 115.75 1.759 . . . . 197.45 115.75 -173.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.939 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.24 -42.23 55.72 Favored 'General case' 0 CA--C 1.49 -1.357 0 C-N-CA 117.876 -1.53 . . . . 242.6 114.061 -170.02 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.951 HG21 HG22 ' A' ' 43' ' ' VAL . 4.6 t -65.39 -36.59 84.42 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 118.941 -1.103 . . . . 215.61 109.812 -172.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.421 ' N ' ' CG2' ' A' ' 86' ' ' THR . 72.4 t -60.31 -46.95 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 O-C-N 121.824 -0.548 . . . . 87.19 110.426 -175.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.839 HG21 ' CD2' ' A' ' 108' ' ' HIS . 63.7 t -65.94 -41.84 90.67 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.098 0 N-CA-C 109.727 -0.471 . . . . 231.82 109.727 -178.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.905 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 11.0 m120 -62.33 -34.11 76.0 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 108.365 -0.976 . . . . 364.98 108.365 -177.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.669 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.0 t80 -68.16 -44.76 75.27 Favored 'General case' 0 N--CA 1.438 -1.07 0 O-C-N 121.56 -0.713 . . . . 181.63 111.271 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.813 HG22 ' HD2' ' A' ' 95' ' ' HIS . 57.6 m -60.85 -45.8 93.1 Favored 'General case' 0 CA--C 1.477 -1.831 0 N-CA-C 107.438 -1.319 . . . . 269.02 107.438 -175.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 1.05 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.74 -45.01 93.53 Favored 'General case' 0 N--CA 1.416 -2.165 0 C-N-CA 118.683 -1.207 . . . . 562.66 110.037 -179.056 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.706 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.08 -45.31 95.24 Favored 'General case' 0 CA--C 1.479 -1.768 0 C-N-CA 118.697 -1.201 . . . . 446.75 108.042 -167.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.745 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.387 6.1 m -70.5 -26.28 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.752 0 C-N-CA 115.819 -2.352 . . . . 370.05 112.244 -178.72 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.813 ' HD2' HG22 ' A' ' 91' ' ' THR . 90.0 m-70 -74.46 -26.54 60.1 Favored 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 121.592 -0.692 . . . . 354.91 112.469 175.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.822 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.4 m-20 82.85 4.51 0.98 Allowed 'General case' 0 CA--C 1.5 -0.951 0 C-N-CA 125.044 1.338 . . . . 462.44 111.881 -178.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.773 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.267 11.9 mm-40 -172.36 178.06 2.91 Favored 'General case' 0 CA--C 1.488 -1.409 0 CA-C-O 122.025 0.916 . . . . 652.37 111.122 171.813 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.791 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.72 86.31 2.17 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 128.516 2.726 . . . . 905.99 107.924 -174.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -67.9 -36.43 80.19 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 108.217 -1.031 . . . . 570.43 108.217 -176.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.849 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.58 -36.34 82.38 Favored 'General case' 0 N--CA 1.427 -1.586 0 C-N-CA 125.361 1.464 . . . . 453.22 111.152 -174.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.941 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.55 178.69 33.89 Favored Glycine 0 C--N 1.349 1.266 0 C-N-CA 118.777 -1.678 . . . . 445.63 109.854 177.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.1 mt -56.38 -41.23 75.89 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 125.257 1.423 . . . . 457.72 112.377 -170.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -58.71 -46.86 86.39 Favored 'General case' 0 CA--C 1.484 -1.56 0 C-N-CA 118.622 -1.231 . . . . 340.58 109.281 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.849 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.2 m-85 -68.72 -32.14 71.72 Favored 'General case' 0 N--CA 1.423 -1.778 0 C-N-CA 118.784 -1.166 . . . . 453.6 111.576 -176.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.764 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.2 t -56.08 -40.32 73.44 Favored 'General case' 0 CA--C 1.488 -1.441 0 N-CA-C 105.948 -1.871 . . . . 541.48 105.948 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.87 -47.17 75.79 Favored 'General case' 0 CA--C 1.485 -1.532 0 O-C-N 123.959 0.787 . . . . 466.68 110.869 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -61.63 -47.14 86.74 Favored 'General case' 0 N--CA 1.427 -1.621 0 C-N-CA 117.501 -1.68 . . . . 427.34 107.361 -178.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.839 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.5 m80 -67.05 -36.77 82.78 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 112.456 0.539 . . . . 537.87 112.456 -174.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.574 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.38 -42.68 74.83 Favored 'General case' 0 N--CA 1.432 -1.344 0 C-N-CA 116.884 -1.926 . . . . 422.12 111.608 175.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.856 ' O ' HG22 ' A' ' 113' ' ' ILE . 75.9 t80 -59.1 -50.08 75.41 Favored 'General case' 0 CA--C 1.501 -0.909 0 O-C-N 121.342 -0.849 . . . . 340.17 111.815 -173.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -65.32 -46.48 71.03 Favored Pre-proline 0 N--CA 1.443 -0.816 0 C-N-CA 119.1 -1.04 . . . . 258.06 111.696 -176.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.939 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.1 Cg_exo -61.57 -31.54 87.24 Favored 'Trans proline' 0 N--CA 1.435 -1.925 0 N-CA-C 115.341 1.246 . . . . 305.71 115.341 176.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.878 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.87 -40.45 76.54 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.363 0 N-CA-C 108.686 -0.857 . . . . 252.7 108.686 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.422 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.93 -40.57 93.76 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 107.825 -1.176 . . . . 149.27 107.825 -179.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.99 -44.84 95.88 Favored 'General case' 0 N--CA 1.436 -1.165 0 C-N-CA 120.614 -0.434 . . . . 138.08 111.497 -176.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.651 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 65.2 t -66.94 -42.34 88.7 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.944 0 O-C-N 121.604 -0.685 . . . . 132.89 110.969 -177.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.922 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.6 m-85 -63.76 -44.7 92.69 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 108.871 -0.788 . . . . 193.61 108.871 -177.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.555 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.43 -37.71 84.5 Favored 'General case' 0 N--CA 1.435 -1.177 0 C-N-CA 122.811 0.445 . . . . 63.83 110.094 -175.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 72.0 m -63.95 -52.46 59.64 Favored 'General case' 0 N--CA 1.435 -1.194 0 O-C-N 122.031 -0.418 . . . . 76.4 111.221 -177.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.752 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.96 -41.7 93.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 108.179 -1.045 . . . . 171.13 108.179 -174.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 1.103 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.2 m-85 -63.79 -38.53 91.46 Favored 'General case' 0 N--CA 1.433 -1.3 0 O-C-N 121.839 -0.538 . . . . 78.3 110.631 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.556 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.5 t -67.11 -35.73 80.4 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 118.854 -1.138 . . . . 92.36 109.229 -178.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.999 ' HE1' HD21 ' A' ' 74' ' ' LEU . 5.9 mmt -62.47 -34.27 76.49 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 108.218 -1.03 . . . . 93.73 108.218 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.9 HG22 HG13 ' A' ' 212' ' ' ILE . 32.9 p -67.38 -41.72 84.58 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.209 -0.996 . . . . 132.74 109.302 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.28 -42.04 94.59 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 107.2 -1.408 . . . . 43.39 107.2 -177.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.827 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.0 t -58.48 -41.95 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 N-CA-C 108.606 -0.887 . . . . 59.34 108.606 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.55 -44.07 95.23 Favored 'General case' 0 CA--C 1.498 -1.039 0 O-C-N 121.844 -0.535 . . . . 69.68 110.474 -177.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.468 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.3 t80 -65.44 -42.8 92.01 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 108.313 -0.995 . . . . 106.98 108.313 -177.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.827 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.34 -35.58 81.35 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 119.632 -0.827 . . . . 147.63 108.982 -177.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.703 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.16 -41.52 99.26 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 108.562 -0.903 . . . . 190.06 108.562 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.599 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.4 t80 -61.34 -44.12 97.72 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.253 -1.017 . . . . 118.85 108.253 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.803 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.4 mmt -63.36 -42.66 98.9 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 109.979 -0.378 . . . . 102.5 109.979 -177.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.91 -41.7 95.35 Favored 'General case' 0 CA--C 1.489 -1.399 0 O-C-N 121.817 -0.552 . . . . 89.98 109.836 -176.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.92 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.4 mt -66.52 -50.7 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.719 0 C-N-CA 118.103 -1.439 . . . . 106.09 110.997 -177.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.75 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.03 -48.37 38.49 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.13 0 C-N-CA 117.092 -1.843 . . . . 227.74 111.824 -174.824 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.756 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 23.9 p80 -118.85 100.11 50.98 Favored Pre-proline 0 CA--C 1.486 -1.503 0 C-N-CA 116.26 -2.176 . . . . 262.55 110.061 -175.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.2 Cg_endo -69.63 -10.35 28.45 Favored 'Trans proline' 0 C--N 1.289 -2.574 0 C-N-CA 121.607 1.538 . . . . 210.25 111.327 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.706 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.35 112.04 1.01 Allowed 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 106.483 -1.673 . . . . 270.58 106.483 -178.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.887 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.2 tt0 -66.77 -39.53 24.48 Favored Pre-proline 0 N--CA 1.431 -1.425 0 CA-C-N 115.329 -0.851 . . . . 129.84 112.362 -176.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.857 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 82.3 Cg_exo -61.36 -26.57 81.72 Favored 'Trans proline' 0 N--CA 1.431 -2.176 0 N-CA-C 116.322 1.624 . . . . 330.71 116.322 -174.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.756 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.07 77.24 7.99 Favored 'General case' 0 N--CA 1.429 -1.514 0 C-N-CA 114.47 -2.892 . . . . 204.51 107.3 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.877 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.68 147.38 0.09 Allowed 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.482 -1.303 . . . . 387.41 107.482 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.877 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.3 t -143.68 147.0 33.64 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 118.824 -1.151 . . . . 166.22 109.515 178.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.8 -40.77 88.21 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 107.869 -1.159 . . . . 44.23 107.869 176.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.481 ' O ' HG23 ' A' ' 149' ' ' VAL . 87.7 m -60.33 -39.08 85.8 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 108.181 -1.044 . . . . 28.8 108.181 -175.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.668 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.86 -38.75 92.06 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 109.087 -0.708 . . . . 30.29 109.087 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.847 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 90.3 m -59.62 -43.03 93.94 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 109.011 -0.737 . . . . 46.11 109.011 -176.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.46 -42.12 99.25 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 107.7 -1.222 . . . . 87.33 107.7 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.766 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.4 t -61.71 -42.06 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.359 0 N-CA-C 107.874 -1.158 . . . . 23.69 107.874 -178.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.8 t -63.2 -44.26 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 N-CA-C 109.73 -0.47 . . . . 43.86 109.73 -178.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.92 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.1 mm -61.24 -42.54 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 108.359 -0.978 . . . . 91.13 108.359 -176.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . 0.484 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.3 t -62.62 -37.95 88.31 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 108.735 -0.839 . . . . 65.88 108.735 -178.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.766 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.5 t -62.1 -41.88 92.89 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 109.552 -0.536 . . . . 33.86 109.552 -177.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 1.103 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.37 -40.37 85.97 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.159 0 N-CA-C 107.583 -1.266 . . . . 146.52 107.583 -176.791 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . 0.699 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.1 m95 -62.84 -38.35 90.43 Favored 'General case' 0 N--CA 1.428 -1.538 0 C-N-CA 119.502 -0.879 . . . . 75.44 108.942 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.9 t -60.5 -48.42 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 O-C-N 121.058 -1.026 . . . . 43.64 109.749 -177.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.791 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.65 -38.05 89.67 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 109.041 -0.726 . . . . 102.57 109.041 -178.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.99 -41.06 86.7 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.433 -1.321 . . . . 58.16 107.433 -178.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.802 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.08 -32.55 73.95 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.014 -0.736 . . . . 121.11 109.014 178.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.791 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.0 -42.3 84.92 Favored 'General case' 0 CA--C 1.489 -1.381 0 C-N-CA 118.554 -1.258 . . . . 153.15 109.966 -178.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 1.059 HD13 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.09 -43.71 19.07 Favored 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 113.06 -3.456 . . . . 133.67 113.532 173.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.479 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -63.0 -39.83 95.96 Favored 'General case' 0 CA--C 1.49 -1.344 0 O-C-N 120.888 -1.132 . . . . 157.42 112.196 -171.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.524 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.3 t80 -74.51 -36.08 2.4 Favored Pre-proline 0 N--CA 1.437 -1.112 0 N-CA-C 114.974 1.472 . . . . 250.91 114.974 -173.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.293 53.0 Cg_exo -59.53 -25.46 78.83 Favored 'Trans proline' 0 CA--C 1.488 -1.817 0 N-CA-C 118.043 2.286 . . . . 207.34 118.043 -174.37 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 1.011 HE21 HG13 ' A' ' 182' ' ' ILE . 87.7 mt-30 -61.18 -34.23 74.71 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 106.953 -1.499 . . . . 192.46 106.953 178.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.46 -41.07 98.16 Favored Glycine 0 C--N 1.353 1.513 0 N-CA-C 107.974 -2.05 . . . . 261.0 107.974 177.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -65.78 159.07 26.02 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 101.548 -3.501 . . . . 491.4 101.548 172.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -59.92 106.79 0.53 Allowed 'General case' 0 CA--C 1.488 -1.42 0 C-N-CA 116.282 -2.167 . . . . 386.1 109.831 -176.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.916 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 74.0 m -154.05 -166.61 2.42 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 103.553 -2.758 . . . . 289.8 103.553 -178.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 1.142 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.1 p -62.91 175.44 0.86 Allowed 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 117.723 -1.132 . . . . 402.06 109.554 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.788 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 72.5 p -165.3 177.5 7.54 Favored 'General case' 0 CA--C 1.587 2.383 0 C-N-CA 127.309 2.243 . . . . 690.53 114.927 177.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.486 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.8 mm-40 132.32 160.57 0.0 OUTLIER 'General case' 1 C--N 1.428 4.007 1 N-CA-C 123.183 4.512 . . . . 633.62 123.183 162.691 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.76 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.4 p -85.68 153.82 22.08 Favored 'General case' 0 C--N 1.389 2.313 0 C-N-CA 127.373 2.269 . . . . 617.99 110.874 178.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 1.047 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.66 174.45 5.93 Favored Pre-proline 0 C--N 1.364 1.233 0 C-N-CA 130.284 3.433 . . . . 434.98 113.387 -175.365 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 1.091 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 52.9 Cg_endo -44.31 -65.63 0.19 Allowed 'Trans proline' 0 N--CA 1.441 -1.576 0 N-CA-C 122.386 3.956 . . . . 365.88 122.386 -168.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . 0.777 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.306 70.4 m -84.91 20.94 1.7 Allowed 'General case' 0 CA--C 1.466 -2.257 0 N-CA-C 104.807 -2.294 . . . . 635.81 104.807 178.147 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.75 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.457 5.0 mmp_? -94.33 152.24 18.8 Favored 'General case' 1 CA--C 1.419 -4.081 3 N-CA-C 132.031 7.789 . . . . 999.99 132.031 -135.787 . . . . . . . . 5 3 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 1.05 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.912 37.3 t -131.83 73.12 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.383 -3.8 1 CA-C-N 103.343 -6.299 . . . . 594.32 113.606 149.235 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.729 HG13 ' HB2' ' A' ' 174' ' ' MET . 7.3 p -144.16 144.14 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.603 1 N-CA-C 98.244 -4.724 . . . . 811.91 98.244 162.404 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.76 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.9 m -118.48 144.49 45.97 Favored 'General case' 0 CA--C 1.489 -1.391 0 C-N-CA 117.099 -1.84 . . . . 999.99 109.429 -178.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.971 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.9 mmm -147.17 -175.6 4.89 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 122.019 0.914 . . . . 431.86 110.069 -177.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 1.037 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.2 tt -69.11 148.65 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 C-N-CA 124.397 1.079 . . . . 457.18 108.796 -177.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . 0.788 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.31 85.41 3.74 Favored 'General case' 0 CA--C 1.5 -0.944 0 C-N-CA 124.147 0.979 . . . . 458.77 113.515 -174.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.96 ' CZ3' HG22 ' A' ' 182' ' ' ILE . 1.9 p90 -76.35 -31.55 0.98 Allowed Pre-proline 0 N--CA 1.438 -1.065 0 C-N-CA 124.941 1.296 . . . . 999.99 112.452 168.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.957 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 50.9 Cg_exo -66.0 -45.71 5.64 Favored 'Trans proline' 0 N--CA 1.438 -1.766 0 N-CA-C 120.895 3.383 . . . . 999.99 120.895 -174.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.507 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 54.9 mt-10 -119.54 171.73 8.15 Favored 'General case' 0 CA--C 1.472 -2.054 0 C-N-CA 117.204 -1.798 . . . . 81.18 107.285 -172.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.834 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.9 p-80 -109.13 45.14 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.828 0 C-N-CA 115.466 -2.493 . . . . 999.99 108.777 177.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 1.076 ' HB2' HD12 ' A' ' 191' ' ' ILE . 87.3 Cg_endo -41.56 101.84 0.04 OUTLIER 'Trans proline' 0 CA--C 1.5 -1.184 1 C-N-CA 126.039 4.492 . . . . 999.99 105.683 -170.749 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -62.34 -44.01 97.49 Favored 'General case' 0 CA--C 1.484 -1.586 0 C-N-CA 126.777 2.031 . . . . 967.72 112.024 -165.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -60.31 -36.49 78.01 Favored 'General case' 0 CA--C 1.487 -1.475 0 N-CA-C 106.741 -1.578 . . . . 934.3 106.741 -175.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 1.076 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.62 -30.22 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 C-N-CA 129.185 2.994 . . . . 565.15 113.918 -178.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 61.56 55.38 2.79 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-N 118.469 0.577 . . . . 755.61 109.853 -175.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 1.142 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.5 -49.33 66.94 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 124.563 1.145 . . . . 325.89 113.265 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.632 ' HE3' ' OH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.76 -45.0 78.18 Favored 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 123.573 0.749 . . . . 250.21 111.637 -169.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 96.8 t -64.73 -43.29 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 C-N-CA 119.959 -0.696 . . . . 142.46 110.389 -175.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 1.037 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.9 t80 -61.15 -41.5 96.86 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 123.982 0.913 . . . . 247.69 108.814 -173.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.824 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 23.0 t60 -60.52 -51.36 69.75 Favored 'General case' 0 CA--C 1.492 -1.279 0 C-N-CA 125.454 1.502 . . . . 199.61 113.049 -175.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 82.8 mt -65.31 -44.52 94.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 107.727 -1.212 . . . . 106.73 107.727 -177.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . 0.72 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.5 t -59.11 -48.55 81.21 Favored 'General case' 0 CA--C 1.486 -1.519 0 CA-C-N 115.858 -0.61 . . . . 115.01 110.245 -173.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 1.059 HG13 HD13 ' A' ' 161' ' ' LEU . 86.1 t -65.27 -49.15 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.647 0 C-N-CA 119.458 -0.897 . . . . 129.42 111.823 -174.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.791 HG22 ' CD1' ' A' ' 206' ' ' PHE . 68.1 m -61.89 -53.14 59.82 Favored 'General case' 0 CA--C 1.483 -1.614 0 C-N-CA 118.245 -1.382 . . . . 172.48 109.953 -172.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.631 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 85.6 t -63.83 -54.24 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 C-N-CA 120.523 -0.471 . . . . 55.86 110.989 -174.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.72 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.58 -51.54 58.96 Favored 'General case' 0 N--CA 1.432 -1.355 0 C-N-CA 118.526 -1.27 . . . . 184.68 111.496 -174.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 1.051 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.6 -52.44 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 C-N-CA 116.696 -2.002 . . . . 291.81 114.737 -174.683 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.55 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.8 t80 -82.04 -55.0 4.84 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 115.142 1.534 . . . . 130.66 115.142 -178.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . 0.791 ' CD1' HG22 ' A' ' 201' ' ' THR . 39.9 m-85 -66.87 -48.49 68.62 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 114.532 1.308 . . . . 80.16 114.532 -170.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.898 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.57 -45.48 83.07 Favored Pre-proline 0 N--CA 1.436 -1.165 0 C-N-CA 119.91 -0.716 . . . . 136.02 109.495 -174.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.898 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 87.7 Cg_exo -64.76 -27.16 60.0 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 110.629 -0.566 . . . . 92.17 110.629 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.686 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.29 -41.41 76.83 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 107.495 -1.298 . . . . 135.6 107.495 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.8 mt -64.17 -44.73 91.17 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 109.57 -0.529 . . . . 52.1 109.57 -176.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.617 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.7 p -61.61 -43.53 97.18 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 109.12 -0.696 . . . . 95.89 109.12 -176.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.9 HG13 HG22 ' A' ' 124' ' ' THR . 94.6 mt -61.23 -42.35 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 106.728 -1.582 . . . . 43.41 106.728 -178.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.47 -42.26 99.04 Favored Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 109.361 -1.496 . . . . 27.69 109.361 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . 0.883 ' O ' HG22 ' A' ' 217' ' ' THR . 77.9 t80 -65.65 -47.4 75.69 Favored 'General case' 0 CA--C 1.496 -1.113 0 CA-C-N 117.38 0.59 . . . . 54.41 110.497 -177.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . 0.826 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.41 -34.13 74.85 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 106.968 -1.493 . . . . 53.88 106.968 -177.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -60.74 -40.86 93.98 Favored 'General case' 0 N--CA 1.426 -1.628 0 N-CA-C 108.492 -0.929 . . . . 68.29 108.492 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . 0.883 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.74 -39.06 92.99 Favored 'General case' 0 CA--C 1.497 -1.088 0 C-N-CA 119.69 -0.804 . . . . 107.59 110.619 -175.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.826 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.03 -38.36 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 C-N-CA 119.607 -0.837 . . . . 111.61 109.488 -177.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.92 HG13 ' CD1' ' A' ' 134' ' ' ILE . 79.6 t -63.29 -22.52 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 N-CA-C 108.389 -0.967 . . . . 85.26 108.389 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.84 -41.95 99.39 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 111.051 -0.82 . . . . 40.71 111.051 -176.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.7 mm -64.66 -44.09 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 108.42 -0.955 . . . . 95.86 108.42 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.822 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.1 p -76.94 -137.57 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.417 -0.956 . . . . 144.37 108.417 -176.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.901 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.7 mt -55.31 132.1 47.16 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 107.633 -1.247 . . . . 326.72 107.633 -177.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' TRP . . . . . 0.463 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 8.9 t90 -119.31 -168.02 1.5 Allowed 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 106.059 -1.83 . . . . 158.38 106.059 -176.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.463 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.39 -41.93 98.79 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 109.619 -0.512 . . . . 36.78 109.619 -178.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.8 m -61.13 125.81 25.07 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 119.144 -1.022 . . . . 85.46 109.813 -174.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . 0.692 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.82 126.56 8.89 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 105.547 -2.02 . . . . 127.78 105.547 176.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.928 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.04 139.92 34.8 Favored Pre-proline 0 CA--C 1.493 -1.214 0 N-CA-C 105.946 -1.872 . . . . 164.84 105.946 -179.548 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.928 ' N ' HD13 ' A' ' 228' ' ' ILE . 82.3 Cg_exo -56.87 -39.85 88.44 Favored 'Trans proline' 0 N--CA 1.431 -2.184 0 N-CA-C 113.945 0.71 . . . . 222.35 113.945 -175.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . 0.745 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.18 167.0 44.85 Favored Glycine 0 N--CA 1.428 -1.838 0 N-CA-C 106.39 -2.684 . . . . 45.22 106.39 178.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.883 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.6 t0 -60.97 -45.79 93.34 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 105.997 -1.853 . . . . 107.57 105.997 177.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . 0.73 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.5 m -65.72 141.78 58.23 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 118.899 -1.12 . . . . 167.96 109.192 -175.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.829 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.3 m 99.5 106.7 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.248 0 C-N-CA 126.73 2.012 . . . . 280.68 109.768 176.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.709 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.5 m-20 55.99 11.31 0.71 Allowed 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 124.42 1.088 . . . . 218.25 110.717 174.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.921 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.41 137.68 54.76 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 105.217 -2.142 . . . . 343.57 105.217 177.368 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.564 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.6 t80 -112.0 81.92 1.54 Allowed 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 106.826 -1.546 . . . . 263.29 106.826 179.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' HIS . . . . . 0.627 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.3 m-70 104.29 147.03 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.285 0 C-N-CA 126.576 1.951 . . . . 261.92 108.486 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.21 -38.07 89.73 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 107.911 -1.144 . . . . 106.81 107.911 -177.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.739 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.42 -39.95 94.96 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 118.362 -1.335 . . . . 112.2 107.552 -178.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.738 HG12 ' NH1' ' A' ' 244' ' ' ARG . 75.5 t -64.25 -39.85 86.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 N-CA-C 109.254 -0.647 . . . . 45.41 109.254 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . 0.803 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.0 p -70.94 -32.01 68.78 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 110.278 -0.267 . . . . 97.62 110.278 -178.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.38 -39.61 81.7 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 123.698 0.799 . . . . 59.29 111.012 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.739 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.25 -36.55 84.03 Favored 'General case' 0 CA--C 1.491 -1.3 0 C-N-CA 124.664 1.186 . . . . 106.49 110.683 -174.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.921 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.95 -30.67 69.24 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 108.293 -1.002 . . . . 106.62 108.293 -176.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.534 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.6 mttm -65.97 -41.06 91.68 Favored 'General case' 0 N--CA 1.436 -1.141 0 O-C-N 121.841 -0.537 . . . . 75.97 110.062 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.44 ' CG1' ' CE ' ' A' ' 250' ' ' MET . 76.8 t -65.53 -40.84 89.36 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 C-N-CA 122.92 0.488 . . . . 65.27 109.779 -178.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.775 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -64.03 -41.62 93.07 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.317 0 C-N-CA 120.398 -0.521 . . . . 107.94 110.12 -177.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.536 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.2 pttt -63.47 -40.81 98.11 Favored 'General case' 0 N--CA 1.434 -1.239 0 O-C-N 121.663 -0.648 . . . . 87.98 110.328 -176.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' MET . . . . . 0.821 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.68 -40.41 96.76 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 118.824 -1.15 . . . . 65.5 108.35 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' MET . . . . . 0.76 ' CE ' HG21 ' A' ' 67' ' ' THR . 68.5 mtt -61.64 -36.41 80.71 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.141 -1.059 . . . . 85.05 108.141 -177.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.536 HD12 ' HA ' ' A' ' 248' ' ' LYS . 86.9 mt -63.48 -45.71 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 N-CA-C 109.061 -0.718 . . . . 42.25 109.061 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.821 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.4 -38.19 81.93 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.13 0 C-N-CA 119.551 -0.86 . . . . 91.01 109.376 -176.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 1.0 HG22 ' CD1' ' A' ' 304' ' ' ILE . 66.5 t -58.93 -41.53 83.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 N-CA-C 107.931 -1.137 . . . . 66.09 107.931 -178.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 250' ' ' MET . 94.3 t -66.14 -43.15 92.24 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 C-N-CA 120.729 -0.388 . . . . 52.39 110.282 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 84.5 m -61.73 -46.75 88.3 Favored 'General case' 0 CA--C 1.489 -1.384 0 O-C-N 121.913 -0.492 . . . . 46.42 109.903 -174.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . 0.744 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.5 t -62.33 -38.18 88.45 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 108.333 -0.988 . . . . 116.51 108.333 -177.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' PHE . . . . . 0.489 ' N ' HG23 ' A' ' 256' ' ' THR . 86.1 t80 -60.23 -48.23 82.6 Favored 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 109.405 -0.591 . . . . 65.18 109.405 -178.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.94 -42.65 97.26 Favored 'General case' 0 CA--C 1.49 -1.364 0 CA-C-O 120.872 0.368 . . . . 51.33 110.468 -175.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . 0.744 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.62 -43.41 98.16 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 C-N-CA 118.941 -1.103 . . . . 126.3 108.974 -176.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' CYS . . . . . 0.508 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.7 m -65.58 -49.3 69.31 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 119.518 -0.873 . . . . 133.94 112.495 -176.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.817 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.0 m95 -80.69 -33.4 35.47 Favored 'General case' 0 CA--C 1.497 -1.071 0 N-CA-C 116.823 2.157 . . . . 134.84 116.823 -176.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.781 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.9 tp -58.47 -41.56 89.88 Favored Pre-proline 0 CA--C 1.493 -1.225 0 O-C-N 121.628 -0.67 . . . . 72.23 111.648 -167.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' PRO . . . . . 0.781 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 81.9 Cg_exo -60.75 -35.94 86.76 Favored 'Trans proline' 0 C--N 1.294 -2.298 0 CA-C-N 119.837 0.978 . . . . 106.13 111.302 -178.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' PHE . . . . . 0.849 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.5 t80 -66.4 -44.67 82.37 Favored 'General case' 0 N--CA 1.433 -1.321 0 C-N-CA 119.793 -0.763 . . . . 128.35 110.061 -178.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' HIS . . . . . 0.643 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.47 -37.84 88.95 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 110.236 -0.283 . . . . 100.73 110.236 -177.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.743 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.28 -44.52 94.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 C-N-CA 119.329 -0.949 . . . . 172.72 109.139 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . 0.735 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.6 m-85 -66.61 -28.06 68.2 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 108.235 -1.024 . . . . 249.23 108.235 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' PHE . . . . . 0.902 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.3 t80 -55.56 -55.13 35.52 Favored 'General case' 0 N--CA 1.433 -1.325 0 N-CA-C 106.653 -1.61 . . . . 259.78 106.653 178.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . 0.492 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.5 mt -69.14 -44.2 72.82 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 113.606 0.965 . . . . 233.11 113.606 -176.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.836 ' O ' HG13 ' A' ' 273' ' ' ILE . 88.7 mt -61.4 -48.34 91.21 Favored Pre-proline 0 CA--C 1.5 -0.946 0 C-N-CA 119.199 -1.0 . . . . 169.54 110.553 -171.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . 0.735 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.8 Cg_exo -61.05 -24.64 79.89 Favored 'Trans proline' 0 N--CA 1.429 -2.287 0 C-N-CA 116.797 -1.668 . . . . 255.47 114.64 174.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' TYR . . . . . 0.824 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.6 t80 -63.57 -44.17 94.88 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 119.233 0.924 . . . . 279.03 108.91 177.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.836 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.34 -44.82 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 N-CA-C 110.076 -0.342 . . . . 162.21 110.076 -178.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' ASN . . . . . 0.784 ' N ' HD12 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.38 84.89 59.25 Favored Pre-proline 0 N--CA 1.431 -1.423 0 C-N-CA 118.761 -1.176 . . . . 128.13 108.067 -178.078 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.4 Cg_endo -85.26 164.06 11.25 Favored 'Trans proline' 0 C--N 1.295 -2.281 0 N-CA-C 107.487 -1.774 . . . . 278.35 107.487 177.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . 0.866 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.09 15.07 9.94 Favored 'General case' 0 N--CA 1.429 -1.518 0 O-C-N 123.752 0.658 . . . . 312.91 109.319 175.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.866 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.2 mt -132.72 -170.69 2.49 Favored 'General case' 0 CA--C 1.481 -1.686 0 N-CA-C 106.533 -1.654 . . . . 353.54 106.533 177.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 1.008 ' HA ' ' CB ' ' A' ' 282' ' ' PHE . 42.8 p90 -115.63 142.26 46.98 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 107.419 -1.326 . . . . 251.26 107.419 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.764 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -76.92 -118.74 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 102.1 -3.296 . . . . 175.26 102.1 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . 0.793 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.0 ttmt -61.51 -44.96 96.13 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 100.892 -3.744 . . . . 99.07 100.892 172.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . 0.793 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.42 124.15 9.18 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 103.508 -2.775 . . . . 243.21 103.508 171.157 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 1.008 ' CB ' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.97 113.01 25.16 Favored 'General case' 0 CA--C 1.474 -1.967 0 C-N-CA 116.004 -2.278 . . . . 201.04 105.287 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' ILE . . . . . 0.777 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.95 173.71 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.098 0 C-N-CA 116.006 -2.277 . . . . 201.36 108.789 -175.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . 1.091 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.283 0.6 OUTLIER -59.48 -41.46 89.84 Favored 'General case' 0 N--CA 1.415 -2.189 0 CA-C-N 113.28 -1.782 . . . . 203.82 107.881 174.44 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . 0.925 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.29 -45.75 86.62 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 118.221 -1.392 . . . . 215.06 112.532 -171.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.553 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.2 t -65.64 -46.41 89.46 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.461 0 C-N-CA 118.562 -1.255 . . . . 125.28 112.948 -171.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' TYR . . . . . 0.951 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.76 -37.01 86.17 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 107.211 -1.404 . . . . 268.9 107.211 -171.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.794 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.26 -44.98 74.4 Favored 'General case' 0 CA--C 1.483 -1.603 0 C-N-CA 125.614 1.566 . . . . 280.88 108.769 -172.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.66 -47.53 85.85 Favored 'General case' 0 CA--C 1.485 -1.534 0 C-N-CA 118.985 -1.086 . . . . 184.47 108.959 -172.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . 0.849 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.8 mp -67.93 -42.09 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 C-N-CA 119.273 -0.971 . . . . 167.92 112.724 -175.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' MET . . . . . 0.502 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.7 ttt -65.7 -38.88 90.45 Favored 'General case' 0 CA--C 1.495 -1.139 0 C-N-CA 117.764 -1.574 . . . . 367.18 110.767 -175.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' TRP . . . . . 0.548 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.5 m95 -67.12 -32.69 73.99 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 121.804 -0.56 . . . . 173.97 110.477 177.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.4 tp -64.48 -36.73 85.13 Favored 'General case' 0 CA--C 1.499 -1.0 0 C-N-CA 123.517 0.727 . . . . 119.66 109.824 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . 0.817 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.26 -33.99 74.44 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 107.659 -1.237 . . . . 112.3 107.659 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' MET . . . . . 0.773 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.12 -31.99 73.26 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 116.252 -0.431 . . . . 174.17 110.246 -177.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.7 m -64.75 -22.77 67.06 Favored 'General case' 0 CA--C 1.485 -1.548 0 C-N-CA 124.661 1.184 . . . . 145.27 110.6 -175.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' SER . . . . . 0.757 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.5 m -57.61 -35.39 70.39 Favored 'General case' 0 N--CA 1.426 -1.675 0 N-CA-C 108.055 -1.091 . . . . 170.15 108.055 -175.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.82 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.8 t -55.33 -34.08 63.9 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 116.285 -0.416 . . . . 214.57 110.653 -171.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . 0.752 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.1 ttt -77.25 -33.24 56.02 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 126.093 1.757 . . . . 168.29 115.499 177.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' TYR . . . . . 0.757 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.5 p90 -64.41 -34.83 79.08 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 114.098 1.148 . . . . 167.15 114.098 -168.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . 0.725 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.282 18.8 p-10 -64.2 -38.36 33.84 Favored Pre-proline 0 N--CA 1.434 -1.274 0 C-N-CA 115.536 -2.465 . . . . 165.13 113.89 -171.625 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' PRO . . . . . 0.725 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 84.4 Cg_exo -62.51 -31.81 80.22 Favored 'Trans proline' 0 N--CA 1.434 -2.004 0 CA-C-N 122.762 2.022 . . . . 123.92 111.272 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' ILE . . . . . 0.714 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.81 -42.57 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 C-N-CA 118.878 -1.129 . . . . 110.55 109.743 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' ILE . . . . . 1.0 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.0 pt -61.17 -39.97 84.29 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.146 0 N-CA-C 108.843 -0.799 . . . . 145.31 108.843 -177.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . 0.927 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.254 63.4 m-85 -58.17 -48.75 79.3 Favored 'General case' 0 CA--C 1.494 -1.174 0 C-N-CA 119.373 -0.931 . . . . 246.68 109.846 -177.509 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.5 m -62.25 -47.47 84.25 Favored 'General case' 0 CA--C 1.485 -1.536 0 C-N-CA 119.536 -0.866 . . . . 64.43 109.559 -173.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.8 t -66.85 -45.03 79.48 Favored 'General case' 0 N--CA 1.428 -1.532 0 C-N-CA 118.963 -1.095 . . . . 80.72 110.259 -177.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.708 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.46 -35.71 75.88 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 116.007 1.855 . . . . 140.44 116.007 -173.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . 0.658 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.9 p30 -136.82 132.22 34.36 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 112.704 -3.598 . . . . 178.87 113.08 -177.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . 0.609 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.02 -37.09 86.47 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 114.406 -1.27 . . . . 110.22 110.093 -177.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.859 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.73 -50.61 72.63 Favored 'General case' 0 CA--C 1.492 -1.258 0 O-C-N 121.714 -0.617 . . . . 174.78 109.737 -174.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.96 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.1 m-85 -64.87 -41.74 95.41 Favored 'General case' 0 CA--C 1.484 -1.573 0 N-CA-C 108.212 -1.033 . . . . 161.84 108.212 178.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . 0.518 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.7 ttp180 -57.24 -50.3 73.3 Favored 'General case' 0 CA--C 1.49 -1.327 0 N-CA-C 109.206 -0.664 . . . . 117.2 109.206 -173.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.798 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.52 -44.06 75.42 Favored 'General case' 0 N--CA 1.433 -1.277 0 C-N-CA 120.385 -0.526 . . . . 112.6 111.038 -177.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . 0.87 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -64.09 -37.42 94.55 Favored Glycine 0 N--CA 1.43 -1.759 0 N-CA-C 110.644 -0.982 . . . . 101.46 110.644 -177.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' PHE . . . . . 1.011 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.6 m-85 -62.15 -45.99 90.96 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-N 118.491 1.145 . . . . 151.49 109.519 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . 0.415 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.6 ttmt -60.1 -36.33 77.18 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 106.942 -1.503 . . . . 142.32 106.942 -175.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' HIS . . . . . 0.825 ' NE2' HG21 ' A' ' 326' ' ' ILE . 49.9 m80 -59.75 -41.84 91.9 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.883 -1.525 . . . . 109.09 106.883 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.84 -42.45 85.76 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.353 -0.217 . . . . 76.11 110.999 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -61.41 -55.55 30.2 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 119.914 -0.714 . . . . 120.24 109.299 -174.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.58 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.4 mtt180 -74.3 131.52 41.25 Favored 'General case' 0 CA--C 1.482 -1.651 0 N-CA-C 102.973 -2.973 . . . . 192.73 102.973 177.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.16 -44.17 92.11 Favored 'General case' 0 CA--C 1.491 -1.312 0 C-N-CA 119.0 -1.08 . . . . 176.29 109.238 -172.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' CYS . . . . . 0.752 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 78.2 m -79.34 -177.06 0.8 Allowed Pre-proline 0 N--CA 1.43 -1.47 0 N-CA-C 106.35 -1.722 . . . . 69.68 106.35 178.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 83.7 Cg_exo -59.04 -75.58 0.02 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.373 0 C-N-CA 118.337 -0.642 . . . . 191.05 112.589 176.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' PHE . . . . . 0.752 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.4 m-85 47.5 43.9 16.28 Favored 'General case' 0 CA--C 1.493 -1.212 0 O-C-N 123.613 0.571 . . . . 287.03 109.73 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . 0.825 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.53 78.62 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.474 -1.955 0 C-N-CA 112.918 -3.513 . . . . 292.29 109.844 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . 0.48 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.2 t -77.5 -152.87 0.05 Allowed 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 104.237 -2.505 . . . . 184.57 104.237 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.69 8.75 4.95 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 113.039 0.755 . . . . 274.56 113.039 176.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.96 0.84 57.3 Favored Glycine 0 C--N 1.349 1.26 0 C-N-CA 117.717 -2.182 . . . . 268.24 113.48 172.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' ASP . . . . . 0.699 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.8 m-20 51.62 -172.07 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.085 0 CA-C-N 118.694 1.247 . . . . 200.06 110.737 177.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.859 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.3 t80 -63.84 -33.04 74.78 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 107.915 -1.143 . . . . 114.44 107.915 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' GLU . . . . . 0.547 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.27 46.09 21.83 Favored 'General case' 0 CA--C 1.484 -1.571 0 N-CA-C 107.59 -1.263 . . . . 263.81 107.59 -177.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' GLY . . . . . 0.633 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.3 -137.35 3.6 Favored Glycine 0 CA--C 1.479 -2.204 1 N-CA-C 102.529 -4.228 . . . . 103.79 102.529 -179.871 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 1.04 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.5 mt -88.25 95.67 10.26 Favored 'General case' 0 N--CA 1.419 -2.017 0 C-N-CA 114.91 -2.716 . . . . 117.3 105.997 177.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . 1.021 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -66.0 -39.8 90.59 Favored 'General case' 0 CA--C 1.469 -2.173 1 N-CA-C 97.961 -4.829 . . . . 231.58 97.961 167.235 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . 1.031 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.93 163.5 29.03 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 102.112 -3.292 . . . . 303.24 102.112 169.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' LYS . . . . . 1.04 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.3 tttt -62.69 -48.56 78.72 Favored 'General case' 0 N--CA 1.432 -1.365 0 C-N-CA 115.997 -2.281 . . . . 112.72 108.381 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.9 t -61.02 -63.67 1.22 Allowed 'General case' 0 CA--C 1.49 -1.334 0 N-CA-C 109.121 -0.696 . . . . 83.22 109.121 -176.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . 0.883 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.0 m -156.25 -126.25 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 103.806 -2.664 . . . . 174.36 103.806 -178.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . 1.021 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.84 160.93 8.77 Favored 'General case' 0 CA--C 1.485 -1.552 0 N-CA-C 105.796 -1.927 . . . . 202.73 105.796 177.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . 1.012 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.94 149.01 52.56 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 107.071 -1.455 . . . . 180.62 107.071 176.413 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.929 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.5 tp -178.48 -171.88 0.27 Allowed 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 105.393 -2.077 . . . . 145.25 105.393 178.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' GLN . . . . . 0.929 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.06 -43.15 88.27 Favored 'General case' 0 CA--C 1.487 -1.455 0 N-CA-C 106.165 -1.791 . . . . 66.05 106.165 174.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . 0.764 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.67 -152.2 0.49 Allowed 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 103.498 -2.778 . . . . 266.49 103.498 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' GLN . . . . . 0.701 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.3 mt-30 66.35 -124.96 0.28 Allowed 'General case' 0 CA--C 1.485 -1.549 0 C-N-CA 116.99 -1.884 . . . . 219.2 107.742 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . 0.9 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -65.07 -37.38 94.11 Favored Glycine 0 N--CA 1.425 -2.067 0 CA-C-N 114.572 -1.195 . . . . 94.78 112.865 -175.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . 0.825 ' HA ' ' SD ' ' A' ' 336' ' ' MET . 48.4 t -81.23 100.41 9.11 Favored 'General case' 0 CA--C 1.484 -1.566 0 C-N-CA 112.359 -3.736 . . . . 121.41 109.467 -171.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . 0.439 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.6 t -73.03 145.49 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 N-CA-C 108.974 -0.75 . . . . 85.34 108.974 -176.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' TYR . . . . . 0.439 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.6 p90 -57.73 143.37 42.12 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 107.825 -1.176 . . . . 267.57 107.825 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . 0.525 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.07 69.61 0.59 Allowed 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 109.529 -0.545 . . . . 226.1 109.529 -179.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' VAL . . . . . 0.825 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.5 p -51.08 156.95 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 N-CA-C 106.928 -1.508 . . . . 154.84 106.928 177.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . 0.582 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.5 m -61.31 161.91 8.46 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-O 121.595 0.712 . . . . 180.01 110.728 -173.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' ARG . . . . . 0.895 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.43 156.94 23.59 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 106.923 -1.51 . . . . 333.78 106.923 -178.597 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . 0.976 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.04 142.51 48.77 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 107.37 -1.345 . . . . 335.2 107.37 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.976 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.6 mm-40 82.84 158.91 0.13 Allowed 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 108.729 -0.841 . . . . 266.47 108.729 179.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.9 m -60.66 -46.83 88.84 Favored 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 105.678 -1.971 . . . . 59.34 105.678 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.58 173.85 11.97 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 104.408 -2.441 . . . . 201.26 104.408 176.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.75 HG22 ' O ' ' A' ' 360' ' ' THR . 69.1 mt -95.88 106.77 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.529 0 C-N-CA 116.343 -2.143 . . . . 56.23 105.521 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . 0.468 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.5 m -61.24 -59.43 5.32 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 109.272 -0.64 . . . . 87.58 109.272 -175.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . 0.887 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.2 t -85.59 153.74 22.19 Favored 'General case' 0 CA--C 1.486 -1.496 0 N-CA-C 107.811 -1.181 . . . . 219.95 107.811 -177.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' VAL . . . . . 0.589 ' O ' HG23 ' A' ' 361' ' ' VAL . 15.9 m -82.04 83.86 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 C-N-CA 116.29 -2.164 . . . . 121.79 105.436 177.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.596 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.7 t -154.09 159.72 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.548 0 N-CA-C 105.843 -1.91 . . . . 53.85 105.843 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . 0.596 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.22 16.64 77.07 Favored Glycine 0 N--CA 1.428 -1.87 0 N-CA-C 106.057 -2.817 . . . . 196.55 106.057 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.662 0 N-CA-C 107.911 -1.144 . . . . 35.88 107.911 -178.942 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 365' ' ' ARG . . . . . 0.62 HH21 ' CG ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 108.865 -0.791 . . . . 1.0 108.865 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 366' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' B' ' 365' ' ' ARG . 52.6 Cg_endo -66.89 142.02 61.05 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.08 1.854 . . . . 1.0 110.245 178.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 367' ' ' LYS . . . . . 0.767 ' HB3' HD11 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -64.43 143.3 98.51 Favored Pre-proline 0 C--N 1.325 -0.498 0 C-N-CA 119.825 -0.75 . . . . 1.0 109.587 -179.894 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 368' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.29 150.44 76.38 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.349 2.033 . . . . 1.0 111.712 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 369' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.74 131.78 44.37 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.749 -0.38 . . . . 1.0 110.243 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.01 115.82 31.36 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.646 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 371' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -63.69 -42.3 98.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.481 . . . . 1.0 110.422 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 372' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.03 -36.26 83.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.678 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -59.68 -33.09 75.92 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.811 -0.916 . . . . 1.0 110.811 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 374' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.79 131.3 45.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.873 0.368 . . . . 1.0 110.192 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 375' ' ' MET . . . . . . . . . . . . . 2.5 mtt . . . . . 0 C--O 1.221 -0.434 0 CA-C-O 118.026 -0.988 . . . . 1.0 110.495 -179.802 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.43 -1.442 0 N-CA-C 108.377 -0.971 . . . . 97.08 108.377 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -110.62 155.44 22.37 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-O 122.123 0.963 . . . . 123.41 110.711 -172.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.885 HG11 HD13 ' A' ' 15' ' ' ILE . 28.7 m -134.6 -162.38 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.479 1 N-CA-C 100.081 -4.044 . . . . 151.3 100.081 173.754 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.915 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.2 mp -60.67 -38.57 57.91 Favored Pre-proline 0 N--CA 1.439 -0.996 0 C-N-CA 115.968 -2.293 . . . . 169.25 106.115 178.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.915 ' HD3' ' HB2' ' A' ' 5' ' ' LEU . 58.3 Cg_exo -81.32 168.51 16.61 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 122.281 0.621 . . . . 185.76 110.505 171.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.908 HG13 ' CE2' ' A' ' 282' ' ' PHE . 91.7 t -64.47 -25.92 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 C-N-CA 127.028 2.131 . . . . 145.47 110.347 -177.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.778 ' O ' HG22 ' A' ' 4' ' ' VAL . 39.1 t0 -84.3 157.42 21.53 Favored 'General case' 0 N--CA 1.439 -0.981 0 O-C-N 121.078 -1.014 . . . . 102.76 109.464 -178.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.6 p -82.58 154.19 25.11 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 107.976 -1.12 . . . . 106.25 107.976 178.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.919 ' HB3' HD13 ' A' ' 15' ' ' ILE . 46.7 p-10 -105.89 51.85 0.74 Allowed 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 117.769 -1.573 . . . . 157.81 107.599 178.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.1 tp -60.1 -45.94 91.29 Favored 'General case' 0 CA--C 1.481 -1.696 0 N-CA-C 103.607 -2.738 . . . . 150.2 103.607 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.9 m -87.07 164.69 35.22 Favored Pre-proline 0 N--CA 1.422 -1.867 0 N-CA-C 103.653 -2.721 . . . . 183.52 103.653 172.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -76.78 6.86 3.85 Favored 'Trans proline' 0 C--N 1.281 -2.988 0 N-CA-C 109.986 -0.813 . . . . 235.61 109.986 176.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -57.88 -41.27 82.15 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 124.813 1.245 . . . . 113.77 113.398 -170.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.919 HD13 ' HB3' ' A' ' 10' ' ' ASP . 33.4 pt -52.19 136.24 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-N 119.541 1.064 . . . . 150.85 110.963 -176.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.8 t -140.49 156.24 46.4 Favored 'General case' 0 C--N 1.36 1.036 0 N-CA-C 107.634 -1.247 . . . . 100.42 107.634 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 1.083 HG23 ' H ' ' A' ' 20' ' ' SER . 14.3 t -65.0 142.64 58.36 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 121.895 0.855 . . . . 129.36 110.455 -174.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.772 ' O ' ' HB3' ' A' ' 97' ' ' GLU . 12.5 m120 -63.12 -25.5 68.39 Favored 'General case' 0 CA--C 1.493 -1.213 0 C-N-CA 126.309 1.843 . . . . 112.34 106.668 -177.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.938 HG23 ' HA2' ' A' ' 101' ' ' GLY . 85.8 m -74.11 -40.2 62.84 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 115.538 -0.756 . . . . 131.73 111.741 177.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 1.083 ' H ' HG23 ' A' ' 17' ' ' THR . 71.4 m -84.42 -42.89 15.19 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 116.989 2.218 . . . . 80.49 116.989 -174.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.551 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 42.5 mt-10 -145.96 174.54 3.35 Favored Pre-proline 0 N--CA 1.442 -0.847 0 C-N-CA 118.179 -1.408 . . . . 98.98 111.234 -169.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.822 ' O ' ' HB3' ' A' ' 96' ' ' ASN 0.334 85.7 Cg_exo -61.72 -10.86 18.23 Favored 'Trans proline' 0 C--N 1.321 -0.907 1 N-CA-C 128.931 6.473 . . . . 246.95 128.931 -170.104 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.629 HD21 ' ND2' ' A' ' 18' ' ' ASN . 3.0 m120 61.68 17.54 8.76 Favored 'General case' 0 C--N 1.324 -0.518 1 CA-C-N 126.154 4.07 . . . . 269.62 114.22 175.68 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.496 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 25.5 mt-30 -67.14 -27.26 67.17 Favored 'General case' 0 CA--C 1.495 -1.154 0 N-CA-C 107.814 -1.18 . . . . 86.8 107.814 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.551 ' CE1' HG22 ' A' ' 26' ' ' VAL . 50.3 p90 -66.87 -29.3 69.17 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 121.116 -0.99 . . . . 85.91 110.467 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.877 HG12 ' OE1' ' A' ' 284' ' ' GLN . 40.4 t -68.59 -40.18 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 C-N-CA 123.734 0.814 . . . . 82.0 111.346 -177.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.898 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 2.3 pt20 -151.39 167.74 12.47 Favored Pre-proline 0 CA--C 1.489 -1.391 0 N-CA-C 108.559 -0.904 . . . . 120.73 108.559 -178.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.903 ' HG2' ' HG3' ' A' ' 31' ' ' GLN . 3.7 Cg_endo -63.99 149.75 89.86 Favored 'Trans proline' 0 N--CA 1.433 -2.07 0 C-N-CA 120.644 0.896 . . . . 87.86 109.847 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.743 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -63.0 -37.98 89.37 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 108.87 -0.789 . . . . 36.46 108.87 -176.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.814 ' CZ3' ' HB2' ' A' ' 34' ' ' LEU . 27.9 p-90 -63.82 -33.83 76.56 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 107.81 -1.181 . . . . 150.6 107.81 -176.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.903 ' HG3' ' HG2' ' A' ' 28' ' ' PRO . 80.5 mt-30 -62.24 -32.72 73.44 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 108.624 -0.88 . . . . 123.26 108.624 -178.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.743 ' HB ' ' O ' ' A' ' 29' ' ' ALA . 1.7 mp -61.43 -47.27 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 N-CA-C 109.125 -0.694 . . . . 120.14 109.125 176.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.786 HG22 ' O ' ' A' ' 30' ' ' TRP . 20.3 m -67.4 -31.03 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 N-CA-C 107.866 -1.161 . . . . 112.19 107.866 -178.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.814 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 58.5 tp -62.96 -47.13 84.53 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 119.973 -0.691 . . . . 60.87 109.61 -178.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.669 ' HE3' ' O ' ' A' ' 31' ' ' GLN . 3.5 m-90 -66.08 -35.66 81.11 Favored 'General case' 0 CA--C 1.489 -1.386 0 C-N-CA 119.974 -0.69 . . . . 157.57 110.325 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.744 ' CB ' HG13 ' A' ' 94' ' ' VAL . . . -62.6 -40.87 98.29 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 108.65 -0.871 . . . . 47.06 108.65 178.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.807 ' O ' HG22 ' A' ' 40' ' ' THR . . . -63.76 -41.29 98.01 Favored 'General case' 0 CA--C 1.496 -1.111 0 O-C-N 121.76 -0.587 . . . . 43.94 109.546 -177.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.727 ' O ' HG13 ' A' ' 42' ' ' ILE . . . -61.83 -43.38 98.96 Favored 'General case' 0 CA--C 1.49 -1.364 0 N-CA-C 108.657 -0.868 . . . . 42.61 108.657 -176.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.906 ' CE2' ' HB2' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -65.29 -41.25 94.3 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 116.631 -0.259 . . . . 140.66 111.079 -178.367 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.807 HG22 ' O ' ' A' ' 37' ' ' ALA . 14.7 t -61.77 -43.98 97.79 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 118.576 -1.249 . . . . 116.04 110.239 -175.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.673 HG22 ' O ' ' A' ' 38' ' ' ALA . 35.0 m -65.47 -38.69 83.06 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.302 0 N-CA-C 108.726 -0.842 . . . . 97.16 108.726 -177.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.854 HD12 ' HD1' ' A' ' 39' ' ' TYR . 93.2 mt -61.29 -40.05 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 N-CA-C 108.944 -0.761 . . . . 54.85 108.944 -176.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.949 HG22 HG21 ' A' ' 86' ' ' THR . 93.0 t -57.69 -42.35 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.32 0 N-CA-C 108.878 -0.786 . . . . 45.39 108.878 -175.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 48' ' ' VAL . 97.5 t -63.5 -50.98 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 C-N-CA 118.844 -1.142 . . . . 48.64 110.218 -177.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.75 HG21 ' SD ' ' A' ' 299' ' ' MET . 10.6 t -65.3 -46.95 78.35 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 120.117 -0.633 . . . . 116.65 111.744 -174.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.588 ' N ' HG23 ' A' ' 45' ' ' THR . 50.7 m -62.0 -43.94 97.79 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 109.718 -0.475 . . . . 51.16 109.718 -174.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 43' ' ' VAL . 97.4 t -65.56 -48.93 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 C-N-CA 119.885 -0.726 . . . . 44.3 110.818 -176.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.868 ' O ' HG23 ' A' ' 52' ' ' VAL . 93.7 t -64.78 -46.93 90.59 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.048 0 C-N-CA 120.34 -0.544 . . . . 48.82 111.005 -174.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.78 -44.14 95.21 Favored Glycine 0 N--CA 1.438 -1.213 0 C-N-CA 120.529 -0.843 . . . . 58.7 112.02 -174.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -72.67 -34.19 67.06 Favored 'General case' 0 CA--C 1.488 -1.433 0 O-C-N 122.107 -0.643 . . . . 101.4 110.993 -175.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.74 HG12 ' O ' ' A' ' 48' ' ' VAL . 8.3 p -66.94 -38.69 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 107.761 -1.199 . . . . 103.57 107.761 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 48' ' ' VAL . 71.8 t -61.43 -43.05 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 108.989 -0.745 . . . . 61.89 108.989 -178.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.54 ' O ' HG22 ' A' ' 56' ' ' ILE . 81.8 t -63.42 -50.99 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 109.458 -0.571 . . . . 70.01 109.458 -178.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.8 ' O ' HD13 ' A' ' 58' ' ' LEU . 26.0 ptm -62.95 -43.41 98.85 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.13 -0.693 . . . . 132.1 109.13 -176.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.645 ' N ' ' HG3' ' A' ' 54' ' ' MET . 62.0 t-105 -64.12 -46.69 83.02 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 116.705 -0.225 . . . . 104.5 110.469 -176.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 1.006 HD12 ' HA ' ' A' ' 316' ' ' PHE . 18.9 tt -63.63 -49.93 80.24 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 C-N-CA 120.254 -0.578 . . . . 142.96 111.253 -173.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.957 HD11 HG12 ' A' ' 72' ' ' VAL 0.277 24.7 pt -64.79 -41.66 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.639 0 C-N-CA 116.956 -1.898 . . . . 158.32 110.868 -175.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.8 HD13 ' O ' ' A' ' 54' ' ' MET . 8.6 mp -63.76 -41.3 98.02 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 117.699 -1.6 . . . . 137.11 109.514 178.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.46 -44.49 90.94 Favored 'General case' 0 N--CA 1.436 -1.156 0 O-C-N 122.117 -0.364 . . . . 54.66 110.972 -176.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.921 ' HB3' ' CD2' ' A' ' 341' ' ' TYR . 33.9 m-70 -91.42 117.13 29.41 Favored 'General case' 0 CA--C 1.49 -1.348 0 CA-C-O 121.662 0.744 . . . . 127.18 109.555 -174.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.621 ' HB3' ' OG ' ' A' ' 347' ' ' SER . 84.4 tttt -60.83 -36.81 80.06 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 124.089 0.956 . . . . 87.93 110.877 -176.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 1.028 ' HG3' ' HA ' ' A' ' 336' ' ' MET . 0.0 OUTLIER -64.37 -34.7 78.77 Favored 'General case' 0 CA--C 1.49 -1.341 0 O-C-N 121.622 -0.674 . . . . 131.12 111.512 -175.669 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 1.01 ' HG3' ' HE2' ' A' ' 341' ' ' TYR . 81.7 mtp -80.61 69.46 7.12 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 115.307 -2.557 . . . . 246.56 109.647 -175.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.413 HH22 ' C ' ' A' ' 57' ' ' ILE . 9.6 mmp_? -123.23 91.44 3.48 Favored 'General case' 0 CA--C 1.474 -1.946 0 N-CA-C 105.465 -2.05 . . . . 339.35 105.465 177.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.444 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 82.5 p -124.15 165.27 17.85 Favored 'General case' 0 N--CA 1.414 -2.251 0 N-CA-C 103.01 -2.959 . . . . 114.66 103.01 176.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.881 HG22 ' CE2' ' A' ' 70' ' ' PHE . 7.7 p -63.14 -39.49 85.44 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.615 0 N-CA-C 106.748 -1.575 . . . . 143.28 106.748 178.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.833 HG22 HD13 ' A' ' 71' ' ' LEU . 95.8 m -59.66 -38.05 80.4 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 108.676 -0.861 . . . . 160.22 108.676 -176.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.528 ' ND2' ' HB3' ' A' ' 63' ' ' MET . 86.3 m-20 -62.39 -31.73 72.44 Favored 'General case' 0 CA--C 1.489 -1.37 0 N-CA-C 108.858 -0.793 . . . . 120.54 108.858 -177.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.903 ' O ' HG22 ' A' ' 72' ' ' VAL . 89.7 m-85 -63.64 -43.76 95.85 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.465 -0.569 . . . . 67.22 109.465 178.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.881 ' CE2' HG22 ' A' ' 66' ' ' VAL . 82.6 m-85 -66.53 -39.8 88.78 Favored 'General case' 0 CA--C 1.498 -1.057 0 O-C-N 121.533 -0.729 . . . . 138.6 109.675 -177.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.925 HD23 ' HE1' ' A' ' 305' ' ' TYR . 10.1 mp -63.56 -35.9 82.02 Favored 'General case' 0 CA--C 1.492 -1.26 0 C-N-CA 122.487 0.315 . . . . 151.46 110.663 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.957 HG12 HD11 ' A' ' 57' ' ' ILE . 23.9 m -62.55 -37.92 80.13 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 C-N-CA 117.406 -1.717 . . . . 117.93 106.753 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.449 ' N ' HG23 ' A' ' 72' ' ' VAL . 66.0 t30 -60.17 -45.95 91.34 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 107.837 -1.171 . . . . 56.82 107.837 -177.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.987 HD21 ' HE1' ' A' ' 123' ' ' MET . 8.7 mp -61.38 -43.89 98.09 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 108.941 -0.763 . . . . 145.3 108.941 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.07 -40.36 95.53 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 108.535 -0.913 . . . . 45.71 108.535 -175.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -62.44 -41.95 99.11 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 109.399 -0.593 . . . . 105.61 109.399 -178.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.16 -39.48 92.79 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 108.605 -0.887 . . . . 47.89 108.605 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.588 ' HG3' ' HA ' ' A' ' 298' ' ' THR . 0.4 OUTLIER -66.56 -37.31 84.69 Favored 'General case' 0 N--CA 1.438 -1.062 0 O-C-N 122.084 -0.385 . . . . 124.53 109.988 179.692 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.88 -41.25 99.33 Favored 'General case' 0 N--CA 1.437 -1.089 0 O-C-N 121.942 -0.474 . . . . 35.89 109.819 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.7 t -62.16 -37.35 84.9 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 107.048 -1.464 . . . . 88.97 107.048 -178.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.82 ' SD ' ' HB ' ' A' ' 298' ' ' THR . 60.7 ttm -62.16 -49.18 76.88 Favored 'General case' 0 N--CA 1.427 -1.579 0 C-N-CA 119.792 -0.763 . . . . 239.91 109.055 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.618 ' O ' HG22 ' A' ' 86' ' ' THR . . . -65.36 -43.37 91.02 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 121.579 -0.7 . . . . 146.1 110.62 -177.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.418 ' O ' HG23 ' A' ' 87' ' ' VAL . . . -76.18 -58.22 3.41 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 117.403 -1.719 . . . . 91.74 113.826 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -76.57 -61.37 1.98 Allowed 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 115.746 1.758 . . . . 197.45 115.746 -173.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.945 ' HB3' ' HG3' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -75.25 -42.26 55.6 Favored 'General case' 0 CA--C 1.49 -1.36 0 C-N-CA 117.884 -1.527 . . . . 242.6 114.056 -170.045 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.949 HG21 HG22 ' A' ' 43' ' ' VAL . 4.7 t -65.45 -36.55 84.23 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 118.926 -1.109 . . . . 215.61 109.821 -172.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.422 ' N ' ' CG2' ' A' ' 86' ' ' THR . 71.9 t -60.25 -46.96 94.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 O-C-N 121.811 -0.556 . . . . 87.19 110.505 -175.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.836 HG21 ' CD2' ' A' ' 108' ' ' HIS . 63.7 t -65.94 -41.88 90.74 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.122 0 N-CA-C 109.704 -0.48 . . . . 231.82 109.704 -178.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.906 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 11.0 m120 -62.33 -34.1 75.98 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 108.335 -0.987 . . . . 364.98 108.335 -177.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.67 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 85.4 t80 -68.24 -44.66 75.2 Favored 'General case' 0 N--CA 1.438 -1.064 0 O-C-N 121.507 -0.746 . . . . 181.63 111.257 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.812 HG22 ' HD2' ' A' ' 95' ' ' HIS . 57.4 m -60.89 -45.81 93.14 Favored 'General case' 0 CA--C 1.477 -1.829 0 N-CA-C 107.422 -1.325 . . . . 269.02 107.422 -175.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 1.048 ' CD1' ' HB ' ' A' ' 178' ' ' VAL . 0.1 OUTLIER -59.66 -45.07 93.16 Favored 'General case' 0 CA--C 1.469 -2.164 0 C-N-CA 118.684 -1.206 . . . . 562.66 110.052 -179.063 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.705 ' O ' HG23 ' A' ' 32' ' ' ILE . . . -61.09 -45.3 95.26 Favored 'General case' 0 CA--C 1.479 -1.788 0 C-N-CA 118.744 -1.183 . . . . 446.75 108.067 -167.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.744 HG13 ' CB ' ' A' ' 36' ' ' ALA 0.388 6.1 m -70.48 -26.23 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 C-N-CA 115.791 -2.364 . . . . 370.05 112.283 -178.746 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.812 ' HD2' HG22 ' A' ' 91' ' ' THR . 89.8 m-70 -74.58 -26.42 59.92 Favored 'General case' 0 CA--C 1.506 -0.747 0 O-C-N 121.626 -0.672 . . . . 354.91 112.483 175.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.822 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 78.4 m-20 82.75 4.53 1.01 Allowed 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 125.078 1.351 . . . . 462.44 111.926 -178.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.772 ' HB3' ' O ' ' A' ' 18' ' ' ASN 0.267 11.9 mm-40 -172.37 178.03 2.91 Favored 'General case' 0 CA--C 1.488 -1.429 0 CA-C-O 122.044 0.926 . . . . 652.37 111.087 171.797 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.789 ' HA ' ' HE3' ' A' ' 98' ' ' TRP . 4.8 t-105 -74.68 86.27 2.15 Favored 'General case' 0 N--CA 1.428 -1.558 0 C-N-CA 128.494 2.718 . . . . 905.99 107.95 -174.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -67.85 -36.42 80.28 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 108.266 -1.013 . . . . 570.43 108.266 -176.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.847 ' HB3' ' CD2' ' A' ' 104' ' ' TYR . 94.1 m-85 -62.56 -36.35 82.36 Favored 'General case' 0 N--CA 1.428 -1.569 0 C-N-CA 125.343 1.457 . . . . 453.22 111.166 -174.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.938 ' HA2' HG23 ' A' ' 19' ' ' THR . . . 97.56 178.66 33.88 Favored Glycine 0 C--N 1.349 1.288 0 C-N-CA 118.753 -1.689 . . . . 445.63 109.882 177.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.0 mt -56.41 -41.25 76.04 Favored 'General case' 0 CA--C 1.498 -1.022 0 C-N-CA 125.276 1.43 . . . . 457.72 112.351 -170.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -58.64 -46.87 86.2 Favored 'General case' 0 CA--C 1.484 -1.562 0 C-N-CA 118.63 -1.228 . . . . 340.58 109.326 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.847 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 88.0 m-85 -68.76 -32.16 71.71 Favored 'General case' 0 N--CA 1.423 -1.786 0 C-N-CA 118.741 -1.184 . . . . 453.6 111.559 -176.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.762 ' HA ' ' CZ2' ' A' ' 98' ' ' TRP . 13.3 t -56.02 -40.29 73.19 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 105.971 -1.863 . . . . 541.48 105.971 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -65.89 -47.1 75.95 Favored 'General case' 0 CA--C 1.485 -1.536 0 O-C-N 124.017 0.823 . . . . 466.68 110.852 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -61.78 -47.11 86.63 Favored 'General case' 0 N--CA 1.427 -1.6 0 C-N-CA 117.506 -1.678 . . . . 427.34 107.256 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.836 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.6 m80 -67.08 -36.78 82.75 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 112.425 0.528 . . . . 537.87 112.425 -174.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.574 ' ND2' ' HA ' ' A' ' 181' ' ' MET . 2.9 t-20 -69.4 -42.67 74.8 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 116.861 -1.936 . . . . 422.12 111.607 175.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.855 ' O ' HG22 ' A' ' 113' ' ' ILE . 75.9 t80 -59.12 -50.05 75.54 Favored 'General case' 0 CA--C 1.502 -0.882 0 O-C-N 121.335 -0.853 . . . . 340.17 111.827 -173.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -65.26 -46.57 71.71 Favored Pre-proline 0 N--CA 1.443 -0.801 0 C-N-CA 119.095 -1.042 . . . . 258.06 111.715 -176.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.945 ' HG3' ' HB3' ' A' ' 85' ' ' ASN . 23.2 Cg_exo -61.49 -31.58 87.84 Favored 'Trans proline' 0 N--CA 1.435 -1.927 0 N-CA-C 115.363 1.255 . . . . 305.71 115.363 176.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.877 HG13 ' CE2' ' A' ' 117' ' ' PHE . 8.3 tp -70.84 -40.46 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 108.689 -0.856 . . . . 252.7 108.689 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.421 ' N ' ' CG2' ' A' ' 113' ' ' ILE . . . -60.9 -40.6 93.7 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 107.807 -1.183 . . . . 149.27 107.807 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.0 -44.83 95.89 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 120.639 -0.424 . . . . 138.08 111.468 -176.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.651 HG22 ' CZ2' ' A' ' 261' ' ' TRP . 65.1 t -66.98 -42.33 88.57 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.937 0 O-C-N 121.581 -0.699 . . . . 132.89 110.96 -177.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.92 ' CE1' HG21 ' A' ' 204' ' ' ILE . 26.5 m-85 -63.77 -44.64 92.81 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 108.898 -0.779 . . . . 193.61 108.898 -177.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.554 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . . . -61.5 -37.68 84.57 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 122.811 0.444 . . . . 63.83 110.069 -175.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 72.0 m -64.03 -52.37 59.79 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 120.721 -0.392 . . . . 76.4 111.242 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.757 HD12 ' HB2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -62.96 -41.65 93.59 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 N-CA-C 108.17 -1.048 . . . . 171.13 108.17 -175.005 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 1.105 ' HB2' HD11 ' A' ' 154' ' ' ILE . 29.1 m-85 -63.84 -38.57 91.58 Favored 'General case' 0 N--CA 1.432 -1.331 0 O-C-N 121.838 -0.539 . . . . 78.3 110.614 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.554 ' O ' HG23 ' A' ' 126' ' ' VAL . 41.5 t -67.1 -35.69 80.32 Favored 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 118.893 -1.123 . . . . 92.36 109.247 -178.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.987 ' HE1' HD21 ' A' ' 74' ' ' LEU . 5.9 mmt -62.55 -34.24 76.54 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 108.154 -1.054 . . . . 93.73 108.154 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.896 HG22 HG13 ' A' ' 212' ' ' ILE . 33.3 p -67.44 -41.65 84.4 Favored 'General case' 0 CA--C 1.495 -1.159 0 C-N-CA 119.224 -0.99 . . . . 132.74 109.318 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.28 -42.09 94.7 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 107.158 -1.423 . . . . 43.39 107.158 -177.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.827 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 95.4 t -58.47 -41.98 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.369 0 N-CA-C 108.568 -0.901 . . . . 59.34 108.568 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.53 -44.02 95.42 Favored 'General case' 0 CA--C 1.497 -1.067 0 O-C-N 121.808 -0.558 . . . . 69.68 110.529 -177.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.468 ' CE2' ' SD ' ' A' ' 132' ' ' MET . 60.3 t80 -65.41 -42.82 92.13 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.348 -0.982 . . . . 106.98 108.348 -177.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.827 ' OD2' ' HA ' ' A' ' 126' ' ' VAL . 2.9 p30 -64.37 -35.51 81.14 Favored 'General case' 0 N--CA 1.433 -1.306 0 C-N-CA 119.598 -0.841 . . . . 147.63 108.972 -177.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.702 ' HD2' ' SD ' ' A' ' 250' ' ' MET . 7.1 mmp_? -63.19 -41.54 99.19 Favored 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 108.524 -0.917 . . . . 190.06 108.524 178.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.6 ' CD1' HG11 ' A' ' 218' ' ' VAL . 66.4 t80 -61.35 -44.08 97.78 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 108.29 -1.004 . . . . 118.85 108.29 -177.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.803 ' HE2' ' HA ' ' A' ' 132' ' ' MET . 4.5 mmt -63.34 -42.64 98.96 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 109.994 -0.373 . . . . 102.5 109.994 -177.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.98 -41.69 95.21 Favored 'General case' 0 CA--C 1.488 -1.418 0 O-C-N 121.799 -0.563 . . . . 89.98 109.82 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.92 ' CD1' HG13 ' A' ' 219' ' ' VAL . 95.2 mt -66.54 -50.66 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.711 0 C-N-CA 118.119 -1.432 . . . . 106.09 111.024 -177.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.75 ' CD1' ' HA ' ' A' ' 132' ' ' MET . 0.1 OUTLIER -74.1 -48.29 38.41 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.09 0 C-N-CA 117.078 -1.849 . . . . 227.74 111.832 -174.84 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.756 ' ND1' ' HD2' ' A' ' 141' ' ' ARG . 24.0 p80 -118.84 100.07 50.99 Favored Pre-proline 0 CA--C 1.486 -1.496 0 C-N-CA 116.268 -2.173 . . . . 262.55 110.069 -175.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 136' ' ' HIS . 9.3 Cg_endo -69.61 -10.36 28.49 Favored 'Trans proline' 0 C--N 1.289 -2.558 0 C-N-CA 121.564 1.509 . . . . 210.25 111.386 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.707 HD13 ' N ' ' A' ' 140' ' ' PRO . 2.9 tm? -55.3 111.99 1.0 Allowed 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 106.54 -1.652 . . . . 270.58 106.54 -178.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.885 HE22 ' HA ' ' A' ' 360' ' ' THR . 16.3 tt0 -66.77 -39.51 24.23 Favored Pre-proline 0 N--CA 1.43 -1.453 0 CA-C-N 115.358 -0.837 . . . . 129.84 112.325 -175.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.857 ' HD3' ' HB3' ' A' ' 139' ' ' GLN . 81.5 Cg_exo -61.44 -26.51 81.28 Favored 'Trans proline' 0 N--CA 1.431 -2.166 0 N-CA-C 116.311 1.62 . . . . 330.71 116.311 -174.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.756 ' HD2' ' ND1' ' A' ' 136' ' ' HIS . 14.2 ptp180 -81.09 77.28 8.0 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 114.445 -2.902 . . . . 204.51 107.257 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.878 HD13 ' N ' ' A' ' 143' ' ' SER . 3.1 tm? 175.7 147.38 0.09 Allowed 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 107.488 -1.301 . . . . 387.41 107.488 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.878 ' N ' HD13 ' A' ' 142' ' ' LEU . 47.3 t -143.68 147.0 33.64 Favored 'General case' 0 CA--C 1.496 -1.116 0 C-N-CA 118.841 -1.144 . . . . 166.22 109.484 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.85 -40.72 88.0 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 107.872 -1.159 . . . . 44.23 107.872 176.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.48 ' O ' HG23 ' A' ' 149' ' ' VAL . 88.0 m -60.32 -39.12 85.88 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 108.15 -1.055 . . . . 28.8 108.15 -175.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.667 ' O ' HG23 ' A' ' 150' ' ' VAL . . . -62.88 -38.78 92.21 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 109.055 -0.721 . . . . 30.29 109.055 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.847 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 90.1 m -59.59 -43.01 93.83 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 109.035 -0.728 . . . . 46.11 109.035 -176.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.46 -42.2 99.3 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 107.665 -1.235 . . . . 87.33 107.665 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.765 ' O ' HG23 ' A' ' 153' ' ' VAL . 96.7 t -61.58 -42.13 92.89 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.366 0 N-CA-C 107.973 -1.121 . . . . 23.69 107.973 -178.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 146' ' ' ALA . 92.6 t -63.2 -44.28 99.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 N-CA-C 109.678 -0.489 . . . . 43.86 109.678 -178.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.919 ' O ' HG22 ' A' ' 154' ' ' ILE . 46.0 mm -61.29 -42.49 93.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 N-CA-C 108.327 -0.99 . . . . 91.13 108.327 -176.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . 0.482 ' O ' HG23 ' A' ' 156' ' ' VAL . 52.2 t -62.57 -38.0 88.4 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 108.786 -0.82 . . . . 65.88 108.786 -178.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.765 HG23 ' O ' ' A' ' 149' ' ' VAL . 95.7 t -62.08 -41.86 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 N-CA-C 109.559 -0.534 . . . . 33.86 109.559 -177.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 1.105 HD11 ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -61.35 -40.32 85.76 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.217 0 N-CA-C 107.642 -1.244 . . . . 146.52 107.642 -176.815 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . 0.696 ' O ' HD23 ' A' ' 159' ' ' LEU . 88.3 m95 -62.86 -38.36 90.54 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 119.477 -0.889 . . . . 75.44 108.942 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 152' ' ' CYS . 98.8 t -60.53 -48.44 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 O-C-N 120.976 -1.078 . . . . 43.64 109.71 -177.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.792 ' HA ' HD23 ' A' ' 160' ' ' LEU . 7.1 mp -63.7 -37.98 89.39 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 109.034 -0.728 . . . . 102.57 109.034 -178.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.93 -41.13 86.6 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 107.437 -1.32 . . . . 58.16 107.437 -178.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.801 ' CD1' ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mm? -63.06 -32.51 73.9 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 109.015 -0.735 . . . . 121.11 109.015 178.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.792 HD23 ' HA ' ' A' ' 157' ' ' LEU . 4.4 mm? -58.01 -42.34 85.02 Favored 'General case' 0 CA--C 1.488 -1.416 0 C-N-CA 118.586 -1.246 . . . . 153.15 109.951 -178.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 1.061 HD13 HG13 ' A' ' 200' ' ' VAL . 11.5 mt -81.05 -43.75 19.05 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 113.079 -3.448 . . . . 133.67 113.522 173.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.478 ' CB ' HG23 ' A' ' 113' ' ' ILE . . . -62.95 -39.92 96.1 Favored 'General case' 0 CA--C 1.49 -1.335 0 O-C-N 120.938 -1.101 . . . . 157.42 112.184 -171.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.524 ' HB3' ' HD3' ' A' ' 164' ' ' PRO . 6.2 t80 -74.4 -36.1 2.47 Favored Pre-proline 0 N--CA 1.437 -1.105 0 N-CA-C 115.058 1.503 . . . . 250.91 115.058 -173.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 163' ' ' PHE 0.291 52.6 Cg_exo -59.58 -25.4 78.75 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 N-CA-C 117.976 2.26 . . . . 207.34 117.976 -174.309 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 1.011 HE21 HG13 ' A' ' 182' ' ' ILE . 87.6 mt-30 -61.22 -34.18 74.69 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 106.954 -1.498 . . . . 192.46 106.954 178.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.52 -41.09 98.07 Favored Glycine 0 C--N 1.353 1.523 0 N-CA-C 107.963 -2.055 . . . . 261.0 107.963 177.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -65.71 159.13 25.71 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 101.537 -3.505 . . . . 491.4 101.537 172.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -59.98 106.82 0.54 Allowed 'General case' 0 CA--C 1.489 -1.403 0 C-N-CA 116.256 -2.178 . . . . 386.1 109.809 -176.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.919 ' HB2' ' HA ' ' A' ' 165' ' ' GLN . 73.8 m -154.07 -166.62 2.42 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 103.533 -2.765 . . . . 289.8 103.533 -178.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 1.144 HG22 ' HA ' ' A' ' 193' ' ' GLU . 43.3 p -62.93 175.42 0.86 Allowed 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 117.766 -1.112 . . . . 402.06 109.538 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.789 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 72.9 p -165.24 177.5 7.58 Favored 'General case' 0 CA--C 1.586 2.355 0 C-N-CA 127.336 2.254 . . . . 690.53 114.935 177.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.485 ' HG3' ' OE1' ' A' ' 183' ' ' GLU . 39.9 mm-40 132.33 160.53 0.0 OUTLIER 'General case' 1 C--N 1.429 4.048 1 N-CA-C 123.195 4.517 . . . . 633.62 123.195 162.689 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.76 HG22 ' SG ' ' A' ' 180' ' ' CYS . 69.3 p -85.62 153.81 22.13 Favored 'General case' 0 C--N 1.389 2.284 0 C-N-CA 127.414 2.286 . . . . 617.99 110.887 177.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 1.049 ' HB3' ' HD2' ' A' ' 175' ' ' PRO . 0.0 OUTLIER -83.7 174.44 5.94 Favored Pre-proline 0 C--N 1.364 1.213 0 C-N-CA 130.213 3.405 . . . . 434.98 113.382 -175.385 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 1.092 ' HB2' ' HA ' ' A' ' 284' ' ' GLN . 51.5 Cg_endo -44.25 -65.59 0.19 Allowed 'Trans proline' 0 N--CA 1.442 -1.503 0 N-CA-C 122.42 3.969 . . . . 365.88 122.42 -168.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . 0.777 ' OG ' ' HG3' ' A' ' 284' ' ' GLN 0.305 70.8 m -84.93 20.91 1.72 Allowed 'General case' 0 CA--C 1.467 -2.224 0 N-CA-C 104.79 -2.3 . . . . 635.81 104.79 178.148 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.747 ' HB2' ' O ' ' A' ' 174' ' ' MET 0.458 5.0 mmp_? -94.28 152.22 18.84 Favored 'General case' 1 CA--C 1.419 -4.059 3 N-CA-C 131.984 7.772 . . . . 999.99 131.984 -135.756 . . . . . . . . 5 3 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 1.048 ' HB ' ' CD1' ' A' ' 92' ' ' TYR 0.911 37.2 t -131.88 73.16 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.384 -3.765 1 CA-C-N 103.298 -6.319 . . . . 594.32 113.603 149.185 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.731 HG13 ' HB2' ' A' ' 174' ' ' MET . 7.3 p -144.17 144.12 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.653 1 N-CA-C 98.31 -4.7 . . . . 811.91 98.31 162.331 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . 0.76 ' SG ' HG22 ' A' ' 173' ' ' THR . 3.8 m -118.44 144.53 45.9 Favored 'General case' 0 CA--C 1.488 -1.41 0 C-N-CA 117.056 -1.858 . . . . 999.99 109.414 -178.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.945 ' HB2' ' HE1' ' A' ' 174' ' ' MET . 70.7 mmm -147.18 -175.6 4.89 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-O 121.979 0.895 . . . . 431.86 110.09 -177.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 1.037 HD11 ' CD2' ' A' ' 196' ' ' TYR . 11.3 tt -69.2 148.68 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 C-N-CA 124.357 1.063 . . . . 457.18 108.796 -177.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . 0.789 ' HB2' ' O ' ' A' ' 171' ' ' THR . 3.6 tp10 -77.34 85.5 3.76 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 124.164 0.985 . . . . 458.77 113.472 -174.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.962 ' CZ3' HG22 ' A' ' 182' ' ' ILE . 1.9 p90 -76.42 -31.46 0.96 Allowed Pre-proline 0 N--CA 1.438 -1.062 0 C-N-CA 124.937 1.295 . . . . 999.99 112.447 168.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.957 ' HD3' ' CD1' ' A' ' 184' ' ' TRP . 50.9 Cg_exo -66.03 -45.79 5.48 Favored 'Trans proline' 0 N--CA 1.438 -1.772 0 N-CA-C 120.812 3.351 . . . . 999.99 120.812 -174.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.506 ' C ' ' HD3' ' A' ' 188' ' ' PRO . 54.9 mt-10 -119.58 171.75 8.14 Favored 'General case' 0 CA--C 1.472 -2.051 0 C-N-CA 117.174 -1.81 . . . . 81.18 107.273 -172.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.834 ' HA ' ' OE1' ' A' ' 193' ' ' GLU . 17.9 p-80 -109.11 45.1 0.19 Allowed Pre-proline 0 N--CA 1.422 -1.857 0 C-N-CA 115.505 -2.478 . . . . 999.99 108.759 177.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 1.076 ' HB2' HD12 ' A' ' 191' ' ' ILE . 86.4 Cg_endo -41.51 101.81 0.04 OUTLIER 'Trans proline' 0 CA--C 1.501 -1.164 1 C-N-CA 126.037 4.491 . . . . 999.99 105.709 -170.75 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -62.32 -44.0 97.51 Favored 'General case' 0 CA--C 1.482 -1.642 0 C-N-CA 126.775 2.03 . . . . 967.72 112.043 -165.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -60.29 -36.55 78.1 Favored 'General case' 0 CA--C 1.487 -1.48 0 N-CA-C 106.745 -1.576 . . . . 934.3 106.745 -175.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 1.076 HD12 ' HB2' ' A' ' 188' ' ' PRO . 96.6 mt -69.54 -30.25 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 C-N-CA 129.154 2.981 . . . . 565.15 113.954 -178.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 61.58 55.4 2.78 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-N 118.403 0.547 . . . . 755.61 109.828 -175.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 1.144 ' HA ' HG22 ' A' ' 170' ' ' THR . 5.6 tm-20 -66.49 -49.26 67.18 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 124.551 1.14 . . . . 325.89 113.286 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.632 ' HE3' ' OH ' ' A' ' 272' ' ' TYR . 79.0 tttt -55.82 -44.98 78.42 Favored 'General case' 0 CA--C 1.495 -1.157 0 C-N-CA 123.576 0.75 . . . . 250.21 111.629 -169.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 97.4 t -64.7 -43.36 96.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 CA-C-O 121.581 0.705 . . . . 142.46 110.374 -175.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 1.037 ' CD2' HD11 ' A' ' 182' ' ' ILE . 34.7 t80 -61.15 -41.48 96.82 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 123.935 0.894 . . . . 247.69 108.813 -173.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.822 ' CE1' ' HB2' ' A' ' 272' ' ' TYR . 23.1 t60 -60.53 -51.4 69.6 Favored 'General case' 0 CA--C 1.492 -1.28 0 C-N-CA 125.465 1.506 . . . . 199.61 113.058 -175.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 82.8 mt -65.29 -44.47 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 107.748 -1.205 . . . . 106.73 107.748 -177.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . 0.719 ' O ' HD13 ' A' ' 203' ' ' LEU . 41.8 t -59.2 -48.51 81.34 Favored 'General case' 0 CA--C 1.487 -1.459 0 CA-C-N 115.867 -0.606 . . . . 115.01 110.201 -173.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 1.061 HG13 HD13 ' A' ' 161' ' ' LEU . 86.2 t -65.24 -49.17 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.626 0 C-N-CA 119.398 -0.921 . . . . 129.42 111.847 -174.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.79 HG22 ' CD1' ' A' ' 206' ' ' PHE . 69.1 m -61.85 -53.13 60.07 Favored 'General case' 0 CA--C 1.482 -1.639 0 C-N-CA 118.186 -1.406 . . . . 172.48 109.977 -172.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.631 ' HA ' ' HB2' ' A' ' 206' ' ' PHE . 85.6 t -63.85 -54.25 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 C-N-CA 120.546 -0.462 . . . . 55.86 110.979 -174.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.719 HD13 ' O ' ' A' ' 199' ' ' CYS . 6.6 mp -65.58 -51.54 59.01 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 118.57 -1.252 . . . . 184.68 111.502 -174.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 1.056 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -76.65 -52.38 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 C-N-CA 116.607 -2.037 . . . . 291.81 114.731 -174.696 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.552 ' N ' HG23 ' A' ' 204' ' ' ILE . 87.8 t80 -82.04 -55.03 4.83 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 115.143 1.534 . . . . 130.66 115.143 -178.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . 0.79 ' CD1' HG22 ' A' ' 201' ' ' THR . 40.0 m-85 -66.86 -48.51 68.58 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 114.492 1.293 . . . . 80.16 114.492 -170.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.905 ' HB3' ' HD3' ' A' ' 208' ' ' PRO . 3.1 tm? -63.52 -45.52 83.37 Favored Pre-proline 0 N--CA 1.435 -1.185 0 C-N-CA 119.989 -0.685 . . . . 136.02 109.504 -174.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.905 ' HD3' ' HB3' ' A' ' 207' ' ' LEU . 88.2 Cg_exo -64.76 -27.16 60.01 Favored 'Trans proline' 0 N--CA 1.433 -2.063 0 N-CA-C 110.616 -0.571 . . . . 92.17 110.616 -179.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.685 HD23 ' O ' ' A' ' 209' ' ' LEU . 3.4 tt -69.39 -41.33 76.62 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 107.492 -1.299 . . . . 135.6 107.492 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.2 -44.66 91.28 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 109.577 -0.527 . . . . 52.1 109.577 -176.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.617 HG12 ' O ' ' A' ' 208' ' ' PRO . 13.6 p -61.71 -43.46 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 N-CA-C 109.088 -0.708 . . . . 95.89 109.088 -176.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.896 HG13 HG22 ' A' ' 124' ' ' THR . 94.7 mt -61.33 -42.31 93.15 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.386 0 N-CA-C 106.663 -1.606 . . . . 43.41 106.663 -178.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.46 -42.3 99.05 Favored Glycine 0 N--CA 1.432 -1.63 0 N-CA-C 109.343 -1.503 . . . . 27.69 109.343 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . 0.882 ' O ' HG22 ' A' ' 217' ' ' THR . 77.8 t80 -65.72 -47.29 75.83 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 117.409 0.604 . . . . 54.41 110.467 -177.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . 0.825 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -61.47 -34.11 74.89 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 106.916 -1.513 . . . . 53.88 106.916 -177.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -60.78 -40.81 93.96 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 108.492 -0.929 . . . . 68.29 108.492 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . 0.882 HG22 ' O ' ' A' ' 214' ' ' TYR . 4.8 t -64.81 -38.98 92.79 Favored 'General case' 0 CA--C 1.497 -1.086 0 C-N-CA 119.704 -0.799 . . . . 107.59 110.619 -175.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.825 HG12 ' O ' ' A' ' 215' ' ' ALA . 10.9 p -63.06 -38.37 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 119.584 -0.846 . . . . 111.61 109.49 -177.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.92 HG13 ' CD1' ' A' ' 134' ' ' ILE . 79.5 t -63.3 -22.45 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 N-CA-C 108.428 -0.952 . . . . 85.26 108.428 -178.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.89 -41.95 99.45 Favored Glycine 0 C--N 1.35 1.324 0 N-CA-C 111.014 -0.834 . . . . 40.71 111.014 -176.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.73 -43.99 96.52 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 N-CA-C 108.414 -0.958 . . . . 95.86 108.414 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.819 ' CB ' HG21 ' A' ' 134' ' ' ILE . 67.4 p -76.98 -137.47 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.452 -0.944 . . . . 144.37 108.452 -176.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.898 HD22 ' NE ' ' A' ' 244' ' ' ARG . 87.6 mt -55.39 132.16 47.51 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 107.574 -1.269 . . . . 326.72 107.574 -177.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' TRP . . . . . 0.466 ' CG ' ' N ' ' A' ' 225' ' ' ALA . 9.0 t90 -119.37 -168.05 1.51 Allowed 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 106.006 -1.85 . . . . 158.38 106.006 -176.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.466 ' N ' ' CG ' ' A' ' 224' ' ' TRP . . . -63.34 -41.96 98.9 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 109.632 -0.507 . . . . 36.78 109.632 -178.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.8 m -61.09 125.86 25.25 Favored 'General case' 0 N--CA 1.433 -1.32 0 C-N-CA 119.167 -1.013 . . . . 85.46 109.81 -174.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . 0.693 ' HG3' ' HB2' ' A' ' 244' ' ' ARG . 8.8 tm-20 -152.88 126.52 8.82 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 105.54 -2.022 . . . . 127.78 105.54 176.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.928 HD13 ' N ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -86.01 139.93 34.85 Favored Pre-proline 0 CA--C 1.493 -1.241 0 N-CA-C 105.977 -1.86 . . . . 164.84 105.977 -179.614 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.928 ' N ' HD13 ' A' ' 228' ' ' ILE . 83.1 Cg_exo -56.86 -39.9 88.08 Favored 'Trans proline' 0 N--CA 1.431 -2.183 0 N-CA-C 113.916 0.698 . . . . 222.35 113.916 -175.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . 0.747 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -83.16 167.02 44.92 Favored Glycine 0 N--CA 1.427 -1.915 0 N-CA-C 106.423 -2.671 . . . . 45.22 106.423 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.882 ' O ' ' HB2' ' A' ' 235' ' ' ARG . 57.9 t0 -60.93 -45.76 93.4 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 106.045 -1.835 . . . . 107.57 106.045 177.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . 0.731 ' O ' HG21 ' A' ' 228' ' ' ILE . 67.9 m -65.77 141.83 58.18 Favored 'General case' 0 N--CA 1.429 -1.509 0 C-N-CA 118.894 -1.122 . . . . 167.96 109.145 -175.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.83 ' HB2' HG21 ' A' ' 228' ' ' ILE . 68.3 m 99.52 106.74 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 126.746 2.019 . . . . 280.68 109.707 176.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.709 ' HB2' ' NH1' ' A' ' 235' ' ' ARG . 81.7 m-20 56.03 11.21 0.7 Allowed 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 124.452 1.101 . . . . 218.25 110.675 174.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.922 ' HG3' ' NH1' ' A' ' 244' ' ' ARG . 0.0 OUTLIER -123.35 137.62 54.79 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 105.213 -2.143 . . . . 343.57 105.213 177.407 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.566 ' CD2' ' HD2' ' A' ' 237' ' ' HIS . 85.5 t80 -111.93 81.87 1.53 Allowed 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 106.873 -1.529 . . . . 263.29 106.873 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' HIS . . . . . 0.627 ' HB3' ' OE1' ' A' ' 239' ' ' GLN . 90.4 m-70 104.27 147.07 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.268 0 C-N-CA 126.58 1.952 . . . . 261.92 108.522 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -63.18 -38.13 89.96 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 107.853 -1.166 . . . . 106.81 107.853 -177.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.738 ' O ' ' HG2' ' A' ' 243' ' ' LYS . 17.8 pm0 -62.48 -39.9 94.93 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 118.366 -1.334 . . . . 112.2 107.536 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.738 HG12 ' NH1' ' A' ' 244' ' ' ARG . 75.8 t -64.27 -39.78 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 N-CA-C 109.263 -0.643 . . . . 45.41 109.263 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . 0.802 ' CB ' ' HG2' ' A' ' 235' ' ' ARG . 95.2 p -70.93 -32.13 68.95 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 110.233 -0.284 . . . . 97.62 110.233 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -68.34 -39.66 81.83 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 123.73 0.812 . . . . 59.29 110.972 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.738 ' HG2' ' O ' ' A' ' 239' ' ' GLN . 74.8 mmtt -63.2 -36.56 84.04 Favored 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 124.601 1.16 . . . . 106.49 110.67 -174.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.922 ' NH1' ' HG3' ' A' ' 235' ' ' ARG . 85.2 mtt85 -59.97 -30.63 69.23 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 108.294 -1.002 . . . . 106.62 108.294 -176.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.533 ' HA ' ' HE2' ' A' ' 248' ' ' LYS . 60.5 mttm -65.97 -41.04 91.69 Favored 'General case' 0 N--CA 1.435 -1.201 0 O-C-N 121.771 -0.581 . . . . 75.97 110.094 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.438 ' CG1' ' CE ' ' A' ' 250' ' ' MET . 76.0 t -65.6 -40.81 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 C-N-CA 122.908 0.483 . . . . 65.27 109.763 -178.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.775 HG12 ' O ' ' A' ' 244' ' ' ARG . 7.8 p -64.01 -41.55 92.84 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.343 0 C-N-CA 120.39 -0.524 . . . . 107.94 110.185 -177.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.536 ' HA ' HD12 ' A' ' 251' ' ' ILE . 59.2 pttt -63.54 -40.85 98.07 Favored 'General case' 0 N--CA 1.433 -1.279 0 O-C-N 121.68 -0.638 . . . . 87.98 110.281 -176.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' MET . . . . . 0.822 ' O ' HG12 ' A' ' 252' ' ' VAL . 21.3 ttt -63.58 -40.44 96.98 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 118.863 -1.135 . . . . 65.5 108.405 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' MET . . . . . 0.758 ' CE ' HG21 ' A' ' 67' ' ' THR . 68.5 mtt -61.7 -36.38 80.74 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 108.141 -1.059 . . . . 85.05 108.141 -177.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.536 HD12 ' HA ' ' A' ' 248' ' ' LYS . 86.9 mt -63.47 -45.76 97.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 109.061 -0.718 . . . . 42.25 109.061 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.822 HG12 ' O ' ' A' ' 249' ' ' MET . 9.9 p -64.32 -38.24 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 C-N-CA 119.568 -0.853 . . . . 91.01 109.396 -176.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 1.0 HG22 ' CD1' ' A' ' 304' ' ' ILE . 65.9 t -58.89 -41.53 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 N-CA-C 108.009 -1.108 . . . . 66.09 108.009 -178.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 250' ' ' MET . 94.8 t -66.07 -43.22 92.45 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.298 0 O-C-N 122.093 -0.379 . . . . 52.39 110.285 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' CYS . . . . . . . . . . . . . 83.9 m -61.76 -46.71 88.44 Favored 'General case' 0 CA--C 1.489 -1.389 0 O-C-N 121.892 -0.505 . . . . 46.42 109.873 -174.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . 0.744 ' O ' HG22 ' A' ' 259' ' ' ILE . 9.5 t -62.34 -38.2 88.6 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 108.314 -0.995 . . . . 116.51 108.314 -177.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' PHE . . . . . 0.491 ' N ' HG23 ' A' ' 256' ' ' THR . 86.0 t80 -60.21 -48.24 82.59 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 109.38 -0.6 . . . . 65.18 109.38 -178.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -63.99 -42.63 97.13 Favored 'General case' 0 CA--C 1.489 -1.373 0 O-C-N 122.093 -0.379 . . . . 51.33 110.448 -175.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . 0.744 HG22 ' O ' ' A' ' 256' ' ' THR . 10.7 tp -63.65 -43.37 98.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 C-N-CA 118.883 -1.127 . . . . 126.3 109.015 -176.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' CYS . . . . . 0.506 ' N ' HG23 ' A' ' 259' ' ' ILE . 69.7 m -65.54 -49.34 69.28 Favored 'General case' 0 N--CA 1.432 -1.325 0 C-N-CA 119.512 -0.875 . . . . 133.94 112.508 -176.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.817 ' CH2' ' HB1' ' A' ' 294' ' ' ALA . 97.1 m95 -80.63 -33.38 35.79 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 116.869 2.174 . . . . 134.84 116.869 -176.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.782 ' HB3' ' HD3' ' A' ' 263' ' ' PRO . 47.9 tp -58.49 -41.58 89.94 Favored Pre-proline 0 CA--C 1.493 -1.242 0 O-C-N 121.663 -0.648 . . . . 72.23 111.643 -167.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' PRO . . . . . 0.782 ' HD3' ' HB3' ' A' ' 262' ' ' LEU . 80.9 Cg_exo -60.63 -36.02 87.14 Favored 'Trans proline' 0 N--CA 1.429 -2.287 0 CA-C-N 119.884 0.994 . . . . 106.13 111.349 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' PHE . . . . . 0.847 ' N ' HG21 ' A' ' 290' ' ' ILE . 71.8 t80 -66.45 -44.6 82.36 Favored 'General case' 0 N--CA 1.434 -1.273 0 C-N-CA 119.7 -0.8 . . . . 128.35 110.019 -178.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' HIS . . . . . 0.643 ' O ' ' HB3' ' A' ' 268' ' ' PHE . 93.3 m-70 -64.48 -37.87 89.05 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 110.195 -0.298 . . . . 100.73 110.195 -177.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.743 HG22 ' O ' ' A' ' 263' ' ' PRO . 11.2 tp -65.23 -44.52 95.14 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 C-N-CA 119.294 -0.962 . . . . 172.72 109.191 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . 0.732 ' O ' ' HD2' ' A' ' 271' ' ' PRO . 61.5 m-85 -66.63 -28.07 68.19 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 108.199 -1.037 . . . . 249.23 108.199 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' PHE . . . . . 0.904 ' CZ ' HG21 ' A' ' 182' ' ' ILE . 20.4 t80 -55.58 -55.1 35.99 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 106.673 -1.603 . . . . 259.78 106.673 178.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . 0.492 ' HA ' ' NE2' ' A' ' 197' ' ' HIS . 89.4 mt -69.16 -44.22 72.7 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 113.58 0.955 . . . . 233.11 113.58 -176.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.835 ' O ' HG13 ' A' ' 273' ' ' ILE . 88.6 mt -61.36 -48.27 91.57 Favored Pre-proline 0 N--CA 1.44 -0.967 0 C-N-CA 119.193 -1.003 . . . . 169.54 110.615 -171.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . 0.732 ' HD2' ' O ' ' A' ' 267' ' ' PHE . 11.6 Cg_exo -61.21 -24.5 79.13 Favored 'Trans proline' 0 N--CA 1.43 -2.25 0 C-N-CA 116.689 -1.741 . . . . 255.47 114.639 174.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' TYR . . . . . 0.822 ' HB2' ' CE1' ' A' ' 197' ' ' HIS . 19.6 t80 -63.61 -44.2 94.66 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 119.271 0.941 . . . . 279.03 108.905 177.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.835 HG13 ' O ' ' A' ' 270' ' ' LEU . 2.4 pp -68.27 -44.8 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 N-CA-C 110.102 -0.333 . . . . 162.21 110.102 -178.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' ASN . . . . . 0.784 ' N ' HD12 ' A' ' 273' ' ' ILE . 1.0 OUTLIER -125.45 84.86 59.42 Favored Pre-proline 0 N--CA 1.431 -1.387 0 C-N-CA 118.76 -1.176 . . . . 128.13 108.029 -178.039 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 272' ' ' TYR . 11.5 Cg_endo -85.22 163.99 11.3 Favored 'Trans proline' 0 C--N 1.295 -2.284 0 N-CA-C 107.482 -1.776 . . . . 278.35 107.482 177.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . 0.864 ' O ' HD23 ' A' ' 277' ' ' LEU . 39.3 t0 66.14 15.02 9.93 Favored 'General case' 0 N--CA 1.429 -1.524 0 O-C-N 123.794 0.684 . . . . 312.91 109.328 175.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.864 HD23 ' O ' ' A' ' 276' ' ' ASP . 28.5 mt -132.73 -170.72 2.5 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 106.557 -1.646 . . . . 353.54 106.557 177.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 1.006 ' HA ' ' CB ' ' A' ' 282' ' ' PHE . 42.7 p90 -115.61 142.22 47.03 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 107.441 -1.318 . . . . 251.26 107.441 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.762 HD21 HD13 ' A' ' 270' ' ' LEU . 1.7 tm? -76.94 -118.76 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 102.097 -3.297 . . . . 175.26 102.097 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . 0.792 ' HG2' ' HE2' ' A' ' 281' ' ' LYS . 34.1 ttmt -61.45 -45.02 96.01 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 100.889 -3.745 . . . . 99.07 100.889 172.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . 0.792 ' HE2' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -150.36 124.15 9.21 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 103.488 -2.782 . . . . 243.21 103.488 171.171 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 1.006 ' CB ' ' HA ' ' A' ' 278' ' ' TYR . 77.2 t80 -92.95 112.98 25.13 Favored 'General case' 0 CA--C 1.474 -1.979 0 C-N-CA 116.037 -2.265 . . . . 201.04 105.294 178.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' ILE . . . . . 0.778 HG13 ' H ' ' A' ' 284' ' ' GLN . 10.7 tp -147.93 173.69 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.064 0 C-N-CA 116.036 -2.266 . . . . 201.36 108.754 -175.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . 1.092 ' HA ' ' HB2' ' A' ' 175' ' ' PRO 0.282 0.6 OUTLIER -59.5 -41.43 89.87 Favored 'General case' 0 N--CA 1.416 -2.164 0 CA-C-N 113.184 -1.825 . . . . 203.82 107.829 174.47 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . 0.924 ' HG2' HE21 ' A' ' 284' ' ' GLN . 34.3 mm-40 -64.31 -45.75 86.59 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 118.249 -1.38 . . . . 215.06 112.55 -171.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.556 ' O ' HD13 ' A' ' 290' ' ' ILE . 78.7 t -65.66 -46.44 89.31 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.467 0 C-N-CA 118.606 -1.237 . . . . 125.28 112.886 -171.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' TYR . . . . . 0.949 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 0.5 OUTLIER -64.83 -36.95 86.0 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 107.169 -1.419 . . . . 268.9 107.169 -171.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.795 ' N ' ' HG3' ' A' ' 175' ' ' PRO . 2.6 tt -68.24 -45.02 74.36 Favored 'General case' 0 N--CA 1.427 -1.602 0 C-N-CA 125.644 1.577 . . . . 280.88 108.808 -172.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.61 -47.53 85.8 Favored 'General case' 0 N--CA 1.428 -1.567 0 C-N-CA 119.01 -1.076 . . . . 184.47 108.988 -172.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . 0.847 HG21 ' N ' ' A' ' 264' ' ' PHE . 1.8 mp -67.91 -42.1 85.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 C-N-CA 119.298 -0.961 . . . . 167.92 112.732 -175.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' MET . . . . . 0.502 ' SD ' ' HG2' ' A' ' 174' ' ' MET . 21.8 ttt -65.79 -38.75 89.84 Favored 'General case' 0 CA--C 1.495 -1.146 0 C-N-CA 117.779 -1.569 . . . . 367.18 110.785 -175.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' TRP . . . . . 0.55 ' CD2' ' HD1' ' A' ' 35' ' ' TRP . 20.4 m95 -67.19 -32.71 73.97 Favored 'General case' 0 N--CA 1.435 -1.205 0 O-C-N 121.892 -0.505 . . . . 173.97 110.46 177.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.3 tp -64.48 -36.69 85.01 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 123.523 0.729 . . . . 119.66 109.815 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . 0.817 ' HB1' ' CH2' ' A' ' 261' ' ' TRP . . . -61.29 -33.91 74.34 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.752 -1.203 . . . . 112.3 107.752 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' MET . . . . . 0.773 ' O ' HG22 ' A' ' 298' ' ' THR . 21.9 mmt -63.11 -32.09 73.39 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 116.193 -0.458 . . . . 174.17 110.185 -177.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.5 m -64.74 -22.7 67.04 Favored 'General case' 0 CA--C 1.485 -1.525 0 C-N-CA 124.669 1.188 . . . . 145.27 110.638 -175.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' SER . . . . . 0.756 ' HA ' ' CD2' ' A' ' 300' ' ' TYR . 11.6 m -57.66 -35.36 70.45 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 108.056 -1.091 . . . . 170.15 108.056 -175.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.82 ' HB ' ' SD ' ' A' ' 81' ' ' MET . 8.7 t -55.34 -34.14 63.96 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 116.32 -0.4 . . . . 214.57 110.654 -171.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . 0.75 ' SD ' HG21 ' A' ' 45' ' ' THR . 28.1 ttt -77.18 -33.2 56.45 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 126.065 1.746 . . . . 168.29 115.545 177.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' TYR . . . . . 0.756 ' CD2' ' HA ' ' A' ' 297' ' ' SER . 7.4 p90 -64.45 -34.86 79.19 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 114.02 1.119 . . . . 167.15 114.02 -168.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . 0.726 ' CG ' ' HD3' ' A' ' 302' ' ' PRO 0.281 18.8 p-10 -64.22 -38.25 32.78 Favored Pre-proline 0 N--CA 1.433 -1.295 0 C-N-CA 115.536 -2.466 . . . . 165.13 113.961 -171.595 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' PRO . . . . . 0.726 ' HD3' ' CG ' ' A' ' 301' ' ' ASN . 83.8 Cg_exo -62.56 -31.8 79.83 Favored 'Trans proline' 0 N--CA 1.433 -2.061 0 CA-C-N 122.791 2.033 . . . . 123.92 111.254 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' ILE . . . . . 0.712 HG12 ' O ' ' A' ' 300' ' ' TYR . 34.2 pt -68.76 -42.58 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 C-N-CA 118.859 -1.136 . . . . 110.55 109.739 -179.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' ILE . . . . . 1.0 ' CD1' HG22 ' A' ' 253' ' ' VAL . 31.1 pt -61.16 -40.02 84.43 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.179 0 N-CA-C 108.825 -0.806 . . . . 145.31 108.825 -177.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . 0.925 ' HE1' HD23 ' A' ' 71' ' ' LEU 0.253 63.1 m-85 -58.12 -48.84 78.98 Favored 'General case' 0 CA--C 1.495 -1.171 0 C-N-CA 119.416 -0.914 . . . . 246.68 109.824 -177.48 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' CYS . . . . . . . . . . . . . 86.7 m -62.14 -47.53 84.17 Favored 'General case' 0 CA--C 1.484 -1.564 0 C-N-CA 119.526 -0.87 . . . . 64.43 109.587 -173.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 52.6 t -66.83 -45.01 79.62 Favored 'General case' 0 N--CA 1.428 -1.553 0 C-N-CA 118.992 -1.083 . . . . 80.72 110.226 -177.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.707 HD23 ' O ' ' A' ' 304' ' ' ILE . 3.5 mm? -69.56 -35.66 75.61 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 115.937 1.828 . . . . 140.44 115.937 -173.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . 0.659 ' OD1' ' HB2' ' A' ' 312' ' ' PHE . 22.8 p30 -136.83 132.2 34.3 Favored 'General case' 0 N--CA 1.434 -1.245 0 C-N-CA 112.723 -3.591 . . . . 178.87 113.039 -177.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . 0.609 ' O ' HD23 ' A' ' 314' ' ' LEU . 25.7 p-10 -65.06 -37.0 86.13 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 114.409 -1.269 . . . . 110.22 110.151 -177.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.86 ' HA ' ' HD1' ' A' ' 331' ' ' TYR . 39.0 ttm180 -57.77 -50.58 72.77 Favored 'General case' 0 CA--C 1.492 -1.27 0 O-C-N 121.753 -0.592 . . . . 174.78 109.737 -174.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.958 ' HB3' ' CE2' ' A' ' 316' ' ' PHE . 30.1 m-85 -64.92 -41.65 95.38 Favored 'General case' 0 CA--C 1.484 -1.575 0 N-CA-C 108.24 -1.022 . . . . 161.84 108.24 178.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . 0.518 ' HE ' HD22 ' A' ' 314' ' ' LEU . 57.8 ttp180 -57.32 -50.24 73.58 Favored 'General case' 0 CA--C 1.49 -1.331 0 N-CA-C 109.182 -0.673 . . . . 117.2 109.182 -173.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.802 ' HB3' HD11 ' A' ' 326' ' ' ILE . 3.0 mm? -68.48 -44.16 75.37 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 120.364 -0.534 . . . . 112.6 111.037 -177.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . 0.869 ' HA3' ' OH ' ' A' ' 341' ' ' TYR . . . -63.99 -37.48 94.68 Favored Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 110.648 -0.981 . . . . 101.46 110.648 -177.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' PHE . . . . . 1.006 ' HA ' HD12 ' A' ' 56' ' ' ILE . 36.6 m-85 -62.15 -46.01 90.9 Favored 'General case' 0 CA--C 1.492 -1.265 0 CA-C-N 118.493 1.147 . . . . 151.49 109.5 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . 0.417 ' HB2' ' HE3' ' A' ' 317' ' ' LYS . 25.5 ttmt -60.06 -36.34 77.12 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 106.959 -1.497 . . . . 142.32 106.959 -175.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' HIS . . . . . 0.824 ' NE2' HG21 ' A' ' 326' ' ' ILE . 50.0 m80 -59.82 -41.76 92.02 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 106.892 -1.521 . . . . 109.09 106.892 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.9 -42.46 85.45 Favored 'General case' 0 N--CA 1.435 -1.183 0 O-C-N 122.368 -0.208 . . . . 76.11 110.979 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -61.37 -55.49 30.98 Favored 'General case' 0 CA--C 1.49 -1.36 0 C-N-CA 119.866 -0.734 . . . . 120.24 109.361 -174.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.578 ' HD2' ' HB3' ' A' ' 325' ' ' PHE . 83.4 mtt180 -74.36 131.54 41.22 Favored 'General case' 0 CA--C 1.482 -1.649 0 N-CA-C 102.943 -2.984 . . . . 192.73 102.943 177.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' CYS . . . . . . . . . . . . . 28.3 p -59.11 -44.27 91.96 Favored 'General case' 0 CA--C 1.492 -1.27 0 C-N-CA 119.008 -1.077 . . . . 176.29 109.212 -172.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' CYS . . . . . 0.754 ' HB2' ' CD1' ' A' ' 325' ' ' PHE . 77.9 m -79.34 -177.14 0.82 Allowed Pre-proline 0 N--CA 1.43 -1.439 0 N-CA-C 106.364 -1.717 . . . . 69.68 106.364 178.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.571 ' HD2' ' HB3' ' A' ' 323' ' ' CYS . 84.2 Cg_exo -58.93 -75.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.427 -2.389 0 C-N-CA 118.343 -0.638 . . . . 191.05 112.637 176.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' PHE . . . . . 0.754 ' CD1' ' HB2' ' A' ' 323' ' ' CYS . 70.6 m-85 47.45 43.88 16.09 Favored 'General case' 0 CA--C 1.493 -1.234 0 O-C-N 123.571 0.544 . . . . 287.03 109.803 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . 0.824 HG21 ' NE2' ' A' ' 318' ' ' HIS . 16.0 tt -104.52 78.65 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.474 -1.944 0 C-N-CA 112.885 -3.526 . . . . 292.29 109.847 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . 0.48 ' O ' ' HB3' ' A' ' 328' ' ' ALA . 30.4 t -77.48 -152.84 0.05 Allowed 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 104.199 -2.519 . . . . 184.57 104.199 178.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 327' ' ' SER . . . 73.65 8.67 4.99 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 113.091 0.775 . . . . 274.56 113.091 176.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 99.0 0.89 57.23 Favored Glycine 0 C--N 1.348 1.248 0 C-N-CA 117.725 -2.178 . . . . 268.24 113.473 172.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' ASP . . . . . 0.699 ' C ' ' HG ' ' A' ' 314' ' ' LEU . 57.9 m-20 51.6 -172.05 0.03 OUTLIER 'General case' 0 CA--C 1.496 -1.099 0 CA-C-N 118.676 1.238 . . . . 200.06 110.782 177.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.86 ' HD1' ' HA ' ' A' ' 311' ' ' ARG . 92.3 t80 -63.86 -33.02 74.75 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 107.892 -1.151 . . . . 114.44 107.892 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' GLU . . . . . 0.549 ' HG2' ' O ' ' A' ' 331' ' ' TYR . 22.7 pt-20 56.27 46.05 21.91 Favored 'General case' 0 CA--C 1.484 -1.581 0 N-CA-C 107.627 -1.249 . . . . 263.81 107.627 -177.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' GLY . . . . . 0.633 ' CA ' ' HD2' ' A' ' 331' ' ' TYR . . . 176.31 -137.37 3.61 Favored Glycine 0 CA--C 1.478 -2.229 1 N-CA-C 102.548 -4.221 . . . . 103.79 102.548 -179.804 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 1.035 HD22 ' HA ' ' A' ' 337' ' ' LYS . 61.4 mt -88.27 95.61 10.25 Favored 'General case' 0 N--CA 1.419 -1.983 0 C-N-CA 114.95 -2.7 . . . . 117.3 106.013 176.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . 1.014 ' HG3' ' HA ' ' A' ' 340' ' ' ARG . 1.5 pm0 -65.97 -39.8 90.68 Favored 'General case' 0 CA--C 1.468 -2.177 1 N-CA-C 97.977 -4.823 . . . . 231.58 97.977 167.232 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . 1.028 ' HA ' ' HG3' ' A' ' 62' ' ' ARG . 12.4 ttt -132.91 163.53 28.95 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 102.092 -3.299 . . . . 303.24 102.092 168.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' LYS . . . . . 1.035 ' HA ' HD22 ' A' ' 334' ' ' LEU . 84.4 tttt -62.6 -48.64 78.54 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 116.066 -2.253 . . . . 112.72 108.442 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' SER . . . . . . . . . . . . . 47.9 t -61.03 -63.68 1.22 Allowed 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 109.091 -0.707 . . . . 83.22 109.091 -176.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . 0.883 ' O ' ' HG2' ' A' ' 335' ' ' GLU . 36.4 m -156.28 -126.18 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 103.858 -2.645 . . . . 174.36 103.858 -178.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . 1.014 ' HA ' ' HG3' ' A' ' 335' ' ' GLU . 80.3 mtt180 -60.88 160.94 8.81 Favored 'General case' 0 CA--C 1.486 -1.515 0 N-CA-C 105.789 -1.93 . . . . 202.73 105.789 177.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . 1.01 ' HE2' ' HG3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -131.94 149.0 52.56 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 107.065 -1.457 . . . . 180.62 107.065 176.432 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.927 ' HG ' ' H ' ' A' ' 343' ' ' GLN . 53.6 tp -178.49 -171.85 0.27 Allowed 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 105.407 -2.072 . . . . 145.25 105.407 178.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' GLN . . . . . 0.927 ' H ' ' HG ' ' A' ' 342' ' ' LEU . 67.0 tt0 -66.06 -43.2 88.13 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 106.113 -1.81 . . . . 66.05 106.113 174.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . 0.765 ' O ' ' HB3' ' A' ' 342' ' ' LEU . 13.2 t -132.66 -152.14 0.48 Allowed 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 103.521 -2.77 . . . . 266.49 103.521 179.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' GLN . . . . . 0.702 ' CD ' HD22 ' A' ' 342' ' ' LEU . 79.5 mt-30 66.28 -124.97 0.28 Allowed 'General case' 0 N--CA 1.428 -1.572 0 C-N-CA 117.076 -1.85 . . . . 219.2 107.739 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . 0.897 ' HA3' ' HB2' ' A' ' 340' ' ' ARG . . . -64.96 -37.43 94.26 Favored Glycine 0 N--CA 1.426 -2.013 0 CA-C-N 114.536 -1.211 . . . . 94.78 112.895 -176.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . 0.825 ' HB2' ' H ' ' A' ' 342' ' ' LEU . 48.4 t -81.21 100.45 9.12 Favored 'General case' 0 CA--C 1.483 -1.599 0 C-N-CA 112.327 -3.749 . . . . 121.41 109.441 -171.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . 0.439 HG12 ' N ' ' A' ' 349' ' ' TYR . 94.2 t -73.09 145.55 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 108.961 -0.755 . . . . 85.34 108.961 -176.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' TYR . . . . . 0.439 ' N ' HG12 ' A' ' 348' ' ' VAL . 48.5 p90 -57.78 143.44 42.09 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.848 -1.167 . . . . 267.57 107.848 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . 0.526 ' H ' ' NZ ' ' A' ' 61' ' ' LYS . 50.0 mtmt 50.08 69.53 0.6 Allowed 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 109.532 -0.544 . . . . 226.1 109.532 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' VAL . . . . . 0.827 ' HB ' ' CE ' ' A' ' 336' ' ' MET . 7.5 p -50.96 156.97 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.315 0 N-CA-C 107.017 -1.475 . . . . 154.84 107.017 177.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . 0.581 ' N ' HG22 ' A' ' 351' ' ' VAL . 71.5 m -61.4 161.92 8.64 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-O 121.602 0.715 . . . . 180.01 110.721 -173.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' ARG . . . . . 0.897 ' HD3' ' H ' ' A' ' 353' ' ' ARG . 0.0 OUTLIER -114.45 156.91 23.66 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 106.913 -1.514 . . . . 333.78 106.913 -178.615 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . 0.978 ' CD1' ' HG2' ' A' ' 355' ' ' GLU . 3.1 tm? -120.03 142.54 48.73 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 107.325 -1.361 . . . . 335.2 107.325 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.978 ' HG2' ' CD1' ' A' ' 354' ' ' LEU . 39.5 mm-40 82.79 158.88 0.13 Allowed 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 108.753 -0.832 . . . . 266.47 108.753 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 91.5 m -60.6 -46.84 88.74 Favored 'General case' 0 CA--C 1.487 -1.467 0 N-CA-C 105.708 -1.96 . . . . 59.34 105.708 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 13.5 t -81.6 173.83 11.98 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 104.444 -2.428 . . . . 201.26 104.444 176.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.747 HG22 ' O ' ' A' ' 360' ' ' THR . 69.2 mt -95.92 106.7 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 C-N-CA 116.323 -2.151 . . . . 56.23 105.53 -179.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . 0.468 ' OG ' ' HG3' ' A' ' 355' ' ' GLU . 70.7 m -61.15 -59.48 5.26 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 109.308 -0.627 . . . . 87.58 109.308 -175.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . 0.885 ' HA ' HE22 ' A' ' 139' ' ' GLN . 15.1 t -85.49 153.71 22.27 Favored 'General case' 0 CA--C 1.486 -1.513 0 N-CA-C 107.871 -1.159 . . . . 219.95 107.871 -177.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' VAL . . . . . 0.59 ' O ' HG23 ' A' ' 361' ' ' VAL . 16.0 m -81.98 83.86 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.656 0 C-N-CA 116.326 -2.15 . . . . 121.79 105.434 177.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.597 HG12 ' N ' ' A' ' 363' ' ' GLY . 64.5 t -154.16 159.68 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 N-CA-C 105.824 -1.917 . . . . 53.85 105.824 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . 0.597 ' N ' HG12 ' A' ' 362' ' ' VAL . . . 72.28 16.59 77.15 Favored Glycine 0 N--CA 1.428 -1.875 0 N-CA-C 106.046 -2.822 . . . . 196.55 106.046 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.681 0 N-CA-C 107.849 -1.167 . . . . 35.88 107.849 -178.9 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 365' ' ' ARG . . . . . 0.46 HH11 ' HD2' ' B' ' 365' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 108.808 -0.812 . . . . 1.0 108.808 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 366' ' ' PRO . . . . . 0.416 ' CD ' ' N ' ' B' ' 365' ' ' ARG . 52.8 Cg_endo -66.91 141.99 60.78 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.086 1.858 . . . . 1.0 110.228 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 367' ' ' LYS . . . . . 0.888 ' HG3' HD11 ' A' ' 5' ' ' LEU . 0.8 OUTLIER -64.35 143.26 98.45 Favored Pre-proline 0 C--N 1.326 -0.445 0 C-N-CA 119.888 -0.725 . . . . 1.0 109.576 -179.875 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 368' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.31 150.44 76.26 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.272 1.981 . . . . 1.0 111.728 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 369' ' ' GLN . . . . . 0.401 ' OE1' HG21 ' A' ' 19' ' ' THR . 0.0 OUTLIER -70.77 131.75 44.3 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.724 -0.39 . . . . 1.0 110.165 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 370' ' ' GLN . . . . . 0.685 ' NE2' ' HA ' ' B' ' 370' ' ' GLN . 0.0 OUTLIER -102.01 115.93 31.61 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.672 -179.831 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 371' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -63.71 -42.36 97.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.347 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 372' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -65.03 -36.21 83.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.871 -0.604 . . . . 1.0 110.652 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -59.78 -33.0 76.05 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.839 -0.905 . . . . 1.0 110.839 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 374' ' ' LEU . . . . . 0.918 HD13 ' HA ' ' A' ' 20' ' ' SER . 10.0 tp -67.83 131.36 45.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.885 0.374 . . . . 1.0 110.173 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 375' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 117.947 -1.025 . . . . 1.0 110.588 -179.883 . . . . . . . . 1 1 . 1 stop_ save_